PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kaya, B; Goceri, E; Becker, A; Elder, B; Puduvalli, V; Winter, J; Gurcan, M; Otero, JJ				Kaya, Behiye; Goceri, Evgin; Becker, Aline; Elder, Brad; Puduvalli, Vinay; Winter, Jessica; Gurcan, Metin; Otero, Jose Javier			Automated fluorescent miscroscopic image analysis of PTBP1 expression in glioma	PLOS ONE			English	Article							TRACT-BINDING-PROTEIN; GLIOBLASTOMA; BRAIN; AUTOFLUORESCENCE; PATHOLOGY	Multiplexed immunofluorescent testing has not entered into diagnostic neuropathology due to the presence of several technical barriers, amongst which includes autofluorescence. This study presents the implementation of a methodology capable of overcoming the visual challenges of fluorescent microscopy for diagnostic neuropathology by using automated digital image analysis, with long term goal of providing unbiased quantitative analyses of multiplexed biomarkers for solid tissue neuropathology. In this study, we validated PTBP1, a putative biomarker for glioma, and tested the extent to which immunofluorescent microscopy combined with automated and unbiased image analysis would permit the utility of PTBP1 as a biomarker to distinguish diagnostically challenging surgical biopsies. As a paradigm, we utilized second resections from patients diagnosed either with reactive brain changes (pseudoprogression) and recurrent glioblastoma (true progression). Our image analysis workflow was capable of removing background autofluorescence and permitted quantification of DAPI-PTBP1 positive cells. PTBP1-positive nuclei, and the mean intensity value of PTBP1 signal in cells. Traditional pathological interpretation was unable to distinguish between groups due to unacceptably high discordance rates amongst expert neuropathologists. Our data demonstrated that recurrent glioblastoma showed more DAPI-PTBP1 positive cells and a higher mean intensity value of PTBP1 signal compared to resections from second surgeries that showed only reactive gliosis. Our work demonstrates the potential of utilizing automated image analysis to overcome the challenges of implementing fluorescent microscopy in diagnostic neuropathology.	[Kaya, Behiye; Otero, Jose Javier] Ohio State Univ, Coll Med, Dept Pathol, Div Neuropathol, Columbus, OH 43210 USA; [Goceri, Evgin] Akdeniz Univ, Fac Engn, Dept Comp Engn, Antalya, Turkey; [Becker, Aline] Ohio State Univ, Dept Radiat Oncol, Columbus, OH 43210 USA; [Elder, Brad] Ohio State Univ, Dept Neurol Surg, Columbus, OH 43210 USA; [Puduvalli, Vinay] Ohio State Univ, Wexner Med Ctr, Div Neurooncol, Columbus, OH 43210 USA; [Winter, Jessica] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Winter, Jessica] Ohio State Univ, William G Lowie Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Gurcan, Metin] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Akdeniz University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Otero, JJ (corresponding author), Ohio State Univ, Coll Med, Dept Pathol, Div Neuropathol, Columbus, OH 43210 USA.; Gurcan, M (corresponding author), Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA.	Metin.Gurcan@osumc.edu; jose.otero@osumc.edu	Becker, Aline/AAD-2209-2021; Winter, Jessica O./AAO-5773-2020; Otero, Jose/AAI-4891-2020	Winter, Jessica O./0000-0002-5370-0137; Otero, Jose/0000-0003-0680-4520; Gurcan, Metin/0000-0002-2421-8229	Pelotonia Foundation Idea Grant; NIH/NHLBI [1R01HL132355-01A1]; NIH/NIBIB [R21EB017539]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB017539] Funding Source: NIH RePORTER	Pelotonia Foundation Idea Grant; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	JO, JW, BE, VP, and MG acknowledge Pelotonia Foundation Idea Grant. JO acknowledges support from NIH/NHLBI for 1R01HL132355-01A1 and NIH/NIBIB R21EB017539.	Baschong W, 2001, J HISTOCHEM CYTOCHEM, V49, P1565, DOI 10.1177/002215540104901210; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Cheung HC, 2006, MODERN PATHOL, V19, P1034, DOI 10.1038/modpathol.3800635; Fauzi MFA, 2015, J NEURO-ONCOL, V124, P393, DOI 10.1007/s11060-015-1872-4; Ferrarese R, 2014, J CLIN INVEST, V124, P2861, DOI 10.1172/JCI68836; Fitzgibbons PL, 2014, ARCH PATHOL LAB MED, V138, P1432, DOI 10.5858/arpa.2013-0610-CP; Ghaznavi F, 2013, ANNU REV PATHOL-MECH, V8, P331, DOI 10.1146/annurev-pathol-011811-120902; Huang S, 1997, J CELL BIOL, V137, P965, DOI 10.1083/jcb.137.5.965; Khandelwal S, 2007, J BIOSCIENCES, V32, P1139, DOI 10.1007/s12038-007-0115-z; Kim JH, 2012, AM J SURG PATHOL, V36, P620, DOI 10.1097/PAS.0b013e318246040c; Lillevali K, 2001, MECH DEVELOP, V101, P217, DOI 10.1016/S0925-4773(00)00566-9; McCutcheon IE, 2004, NEURO-ONCOLOGY, V6, P9, DOI 10.1215/S1152851703000279; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1897, DOI 10.1093/jnci/djt306; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1677, DOI 10.1093/jnci/djt282; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Schulte A, 2013, NEURO-ONCOLOGY, V15, P1289, DOI 10.1093/neuonc/not093; Spitzer N, 2011, J NEUROSCI METH, V197, P48, DOI 10.1016/j.jneumeth.2011.01.029; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taylor CR, 2006, HISTOPATHOLOGY, V49, P411, DOI 10.1111/j.1365-2559.2006.02513.x; Webster JD, 2014, VET PATHOL, V51, P211, DOI 10.1177/0300985813503570; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984	21	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0170991	10.1371/journal.pone.0170991	http://dx.doi.org/10.1371/journal.pone.0170991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282372	Green Published, gold			2022-12-27	WOS:000396091800002
J	Sun, DX; Ahn, H; Lievens, T; Zeng, W				Sun, Daxin; Ahn, Haksoon; Lievens, Tomas; Zeng, Wu			Evaluation of the performance of national health systems in 2004-2011: An analysis of 173 countries	PLOS ONE			English	Article							CARE-SYSTEMS; EFFICIENCY; DETERMINANTS	In an effort to improve health service delivery and achieve better health outcomes, the World Health Organization (WHO) has called for improved efficiency of health care systems to better use the available funding. This study aims to examine the efficiency of national health systems using longitudinal country-level data. Data on health spending per capita, infant mortality rate (IMR), under 5 mortality rate (U5MR), and life expectancy (LE) were collected from or imputed for 173 countries from 2004 through 2011. Data envelopment analyses were used to evaluate the efficiency and regression models were constructed to examine the determinants of efficiency. The average efficiency of the national health system, when examined yearly, was 78.9%, indicating a potential saving of 21.1% of health spending per capita to achieve the same level of health status for children and the entire population, if all countries performed as well as their peers. Additionally, the efficiency of the national health system varied widely among countries. On average, Africa had the lowest efficiency of 67%, while West Pacific countries had the highest efficiency of 86%. National economic status, HIV/AIDS prevalence, health financing mechanisms and governance were found to be statistically associated with the efficiency of national health systems. Taking health financing as an example, a 1% point increase of social security expenses as a percentage of total health expenditure correlated to a 1.9% increase in national health system efficiency. The study underscores the need to enhance efficiency of national health systems to meet population health needs, and highlights the importance of health financing and governance in improving the efficiency of health systems, to ultimately improve health outcomes.	[Sun, Daxin] Fujian Agr & Forestry Univ, Sch Transportat & Civil Engn, Fuzhou, Fujian, Peoples R China; [Ahn, Haksoon] Univ Maryland, Sch Social Work, 525 W Redwood St, Baltimore, MD 21201 USA; [Lievens, Tomas] Oxford Policy Management, Oxford, England; [Zeng, Wu] Brandeis Univ, Heller Sch, Schneider Inst Hlth Policy, Waltham, MA 02254 USA	Fujian Agriculture & Forestry University; University System of Maryland; University of Maryland Baltimore; Brandeis University	Zeng, W (corresponding author), Brandeis Univ, Heller Sch, Schneider Inst Hlth Policy, Waltham, MA 02254 USA.	wuzengcn@brandeis.edu			Africa Development Bank; OPM	Africa Development Bank; OPM	This study was part of the project that Oxford Policy Management (OPM) undertook through the financial support from Africa Development Bank. TL is an employee of OPM. OPM provided support in the form of salary for author TL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 2015, GLOB OBS HLTH RES DE; Boerma T, 2009, B WORLD HEALTH ORGAN, V87, P2, DOI 10.2471/BLT.08.061945; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Chisholm D, 2010, IMPROVING HLTH SYST; Evans D, 2000, COMP EFFICIENCY NATL; Gotteret P, 2006, HLTH FINANCING REVIS; Greene W, 2004, HEALTH ECON, V13, P959, DOI 10.1002/hec.938; Grigoli F, 2013, WASTE NOT WANT NOT E; Gupta S, 2001, J POLICY MODEL, V23, P433, DOI 10.1016/S0161-8938(00)00036-3; Gupta S, 2000, CORRUPTION PROVISION; Hadad S, 2013, EUR J HEALTH ECON, V14, P253, DOI 10.1007/s10198-011-0366-3; Health Finance & Governance Project, 2017, HLTH FIN GOV EXP ACC; Heller P., 2005, UNDERSTANDING FISCAL; Herrera S, 2005, EFFICIENCY PUBLIC SP; Hsiao WC, 2007, HEALTH AFFAIR, V26, P950, DOI 10.1377/hlthaff.26.4.950; Johnson AL, 2012, EUR J OPER RES, V220, P559, DOI 10.1016/j.ejor.2012.01.023; Kaufmann D., 2008, GOVERNANCE MATTERS; Lu C, 2006, LANCET, V368, P483, DOI 10.1016/S0140-6736(06)69156-3; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; Ogloblin C., 2011, APPL ECONOMETRICS IN, V11, P5; Rajkumar AS, 2008, J DEV ECON, V86, P96, DOI 10.1016/j.jdeveco.2007.08.003; Reidpath Daniel D, 2006, BMC Int Health Hum Rights, V6, P12, DOI 10.1186/1472-698X-6-12; Savedoff W., 2003, HLTH SYSTEMS PERFORM; Tavares G., 2002, BIBLIO DATA ENVELOPM; The Henry J. Kaiser Family Foundation, 2012, USAID OFF HLTH SYST; Vian T, 2008, HEALTH POLICY PLANN, V23, P83, DOI 10.1093/heapol/czm048; WHO, 2010, WOR HEALT REP, P1; World Bank, 2014, THE WORLD BANK DAT; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 2013, RES UN HLTH COV WORL; World Health Organization, 2014, WHO GLOB HLTH EXP AT; Zeng W, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-74	34	27	27	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e3346	10.1371/journal.pone.0173346	http://dx.doi.org/10.1371/journal.pone.0173346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6CJ	28282397	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800031
J	Bayles, BR; Thomas, SM; Simmons, GS; Grafton-Cardwell, EE; Daugherty, MP				Bayles, Brett R.; Thomas, Shyam M.; Simmons, Gregory S.; Grafton-Cardwell, Elizabeth E.; Daugherty, Mathew P.			Spatiotemporal dynamics of the Southern California Asian citrus psyllid (Diaphorina citri) invasion	PLOS ONE			English	Article							SPATIAL ASSOCIATION; HEMIPTERA PSYLLIDAE; DISEASE; SPREAD; TEMPERATURE; HOMOPTERA; MANAGEMENT; DISPERSAL; DISTANCE; ECOLOGY	Biological invasions are governed by spatial processes that tend to be distributed in non-ran-dom ways across landscapes. Characterizing the spatial and temporal heterogeneities of the introduction, establishment, and spread of non-native insect species is a key aspect of effectively managing their geographic expansion. The Asian citrus psyllid (Diaphorina citri), a vector of the bacterium associated with huanglongbing (HLB), poses a serious threat to commercial and residential citrus trees. In 2008, D. citri first began expanding northward from Mexico into parts of Southern California. Using georeferenced D. citri occurrence data from 2008-2014, we sought to better understand the extent of the geographic expansion of this invasive vector species. Our objectives were to: 1) describe the spatial and temporal distribution of D. citri in Southern California, 2) identify the locations of statistically significant D. citri hotspots, and 3) quantify the dynamics of anisotropic spread. We found clear evi-dence that the spatial and temporal distribution of D. citri in Southern California is non-ran-dom. Further, we identified the existence of statistically significant hotspots of D. citri occurrence and described the anisotropic dispersion across the Southern California land-scape. For example, the dominant hotspot surrounding Los Angeles showed rapid and strongly asymmetric spread to the south and east. Our study demonstrates the feasibility of quantitative invasive insect risk assessment with the application of a spatial epidemiology framework.	[Bayles, Brett R.; Thomas, Shyam M.; Grafton-Cardwell, Elizabeth E.; Daugherty, Mathew P.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Bayles, Brett R.] Dominican Univ Calif, Sch Hlth & Nat Sci, San Rafael, CA 94901 USA; [Simmons, Gregory S.] US Anim & Plant Hlth Inspect Serv, USDA, Salinas, CA USA	University of California System; University of California Riverside; United States Department of Agriculture (USDA)	Bayles, BR (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.; Bayles, BR (corresponding author), Dominican Univ Calif, Sch Hlth & Nat Sci, San Rafael, CA 94901 USA.	brett.bayles@dominican.edu	Bayles, Brett/AAA-2751-2020; Thomas, Shyam/AAN-4043-2020	Bayles, Brett/0000-0002-3474-4353; 	USDA-APHIS-PPQ; NIFA-AFRI grant [2012-01803]	USDA-APHIS-PPQ(United States Department of Agriculture (USDA)); NIFA-AFRI grant	This work was supported by funding from USDA-APHIS-PPQ and NIFA-AFRI grant #2012-01803 to M.P.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to R. Johnson and R. Dunn for providing the D. citri geodatabase, T. Galindo, M. Luque-Williams, D. Tanoue, and R. Broadway for ACP trapping summary statistics, and J. Morse and R. Stouthamer for helpful discussion. This work was supported by funding from USDA-APHIS-PPQ and NIFA-AFRI grant #2012-01803 to Mathew P Daugherty.	Alston KP, 2006, BIOL CONSERV, V132, P183, DOI 10.1016/j.biocon.2006.03.023; Anderson K, 2010, PHILOS T R SOC B, V365, P3007, DOI 10.1098/rstb.2010.0131; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Arakawa Kenryo, 2007, Research Bulletin of the Plant Protection Service Japan, V43, P23; Beloti VH, 2013, FLA ENTOMOL, V96, P173, DOI 10.1653/024.096.0123; Boina DR, 2009, ENVIRON ENTOMOL, V38, P1250, DOI 10.1603/022.038.0436; Bove JM, 2006, J PLANT PATHOL, V88, P7; Boyd IL, 2013, SCIENCE, V342, P823, DOI 10.1126/science.1235773; Chiyaka C, 2012, P NATL ACAD SCI USA, V109, P12213, DOI 10.1073/pnas.1208326109; Coletta HD, 2014, PHYTOPATHOLOGY, V104, P416, DOI 10.1094/PHYTO-06-13-0157-R; Dagulo L, 2010, J FOOD SCI, V75, pC199, DOI 10.1111/j.1750-3841.2009.01495.x; Daugherty M, 2013, CAPCA ADVISER MAGAZI, V16, P14; ESRI, 2011, ARCG1S DESKT REL 10; Gavier-Pizarro GI, 2010, ECOL APPL, V20, P1913, DOI 10.1890/09-2168.1; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gottwald T., 2014, J CITRUS PATHOL, V1, P121; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Halbert S.E., 2012, FLORIDA ENTOMOLOGIST, V95, P620; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Halbert SE, 2010, FLA ENTOMOL, V93, P33, DOI 10.1653/024.093.0104; Hall DG, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.8301; Hoddle M.S., 2012, CAPCA ADVISER, V15, P18; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kaplan H, 2014, BIOL INVASIONS, V16, P691, DOI 10.1007/s10530-013-0611-z; Kistner EJ, 2016, ANN ENTOMOL SOC AM; Kistner EJ, 2016, J ECON ENTOMOL, V109, P1047, DOI 10.1093/jee/tow021; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lee JA, 2015, P NATL ACAD SCI USA, V112, P7605, DOI 10.1073/pnas.1508253112; Lefever DW, 1926, AM J SOCIOL, V32, P88, DOI 10.1086/214027; Lewis-Rosenblum H, 2015, J ECON ENTOMOL, V108, P3, DOI 10.1093/jee/tou008; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Liu YH, 2000, ANN APPL BIOL, V137, P201, DOI 10.1111/j.1744-7348.2000.tb00060.x; MA, 2005, ECOSYSTEMS HUMAN WEL; Martini X, 2014, ANN ENTOMOL SOC AM, V107, P842, DOI 10.1603/AN14028; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Morin RS, 2009, BIOL INVASIONS, V11, P2341, DOI 10.1007/s10530-008-9420-1; Nakata T, 2006, APPL ENTOMOL ZOOL, V41, P383, DOI 10.1303/aez.2006.383; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Pereira-Peixoto MH, 2014, J INSECT CONSERV, V18, P815, DOI 10.1007/s10841-014-9688-7; Poland TM, 2006, J FOREST, V104, P118; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Qureshi JA, 2009, J ECON ENTOMOL, V102, P247, DOI 10.1603/029.102.0134; Richards TJ, 2014, AM J AGR ECON, V96, P615, DOI 10.1093/ajae/aat099; Rigot T, 2014, ECOGRAPHY, V37, P648, DOI 10.1111/j.1600-0587.2013.00447.x; Saumel I, 2010, LANDSCAPE URBAN PLAN, V94, P244, DOI 10.1016/j.landurbplan.2009.10.009; Sakamaki Y., 2005, KURCPI OCCASIONAL PA, V42, P121; Setamou M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131917; Shaver GR, 2005, Ecosystem Function in Heterogeneous Landscapes, P443, DOI 10.1007/0-387-24091-8_22; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Spreen TH, 2014, HORTSCIENCE, V49, P1052, DOI 10.21273/HORTSCI.49.8.1052; Thomas SM, USING REGUL IN PRESS; Tsai JH, 2002, FLA ENTOMOL, V85, P446, DOI 10.1653/0015-4040(2002)085[0446:SAOTAC]2.0.CO;2; Vinatier F, 2011, METHODS ECOL EVOL, V2, P11, DOI 10.1111/j.2041-210X.2010.00059.x; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494	58	37	39	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173226	10.1371/journal.pone.0173226	http://dx.doi.org/10.1371/journal.pone.0173226			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278188	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900055
J	Dale, AG; Frank, SD				Dale, Adam G.; Frank, Steven D.			Warming and drought combine to increase pest insect fitness on urban trees	PLOS ONE			English	Article							CLIMATE-CHANGE; GLOBAL CHANGE; TEMPERATURE; ECOLOGY; SCALE; CONSEQUENCES; HOMOPTERA; HERBIVORY; NITROGEN; PLANTS	Urban habitats are characterized by impervious surfaces, which increase temperatures and reduce water availability to plants. The effects of these conditions on herbivorous insects are not well understood, but may provide insight into future conditions. Three primary hypotheses have been proposed to explain why multiple herbivorous arthropods are more abundant and damaging in cities, and support has been found for each. First, less complex vegetation may reduce biological control of pests. Second, plant stress can increase plant quality for pests. And third, urban warming can directly increase pest fitness and abundance. These hypotheses are not mutually exclusive, and the effects of temperature and plant stress are particularly related. Thus, we test the hypothesis that urban warming and drought stress combine to increase the fitness and abundance of the scale insect, Melanaspis tenebricosa, an urban tree pest that is more abundant in urban than rural areas of the southeastern U.S. We did this by manipulating drought stress across an existing mosaic of urban warming. We found support for the additive effect of temperature and drought stress such that female embryo production and body size increased with temperature and was greater on drought stressed than watered trees. This study provides further evidence that drivers of pest insect outbreaks act in concert, rather than independently, and calls for more research that manipulates multiple abiotic factors related to urbanization and climate change to predict their effects on ecological interactions. As cities expand and the climate changes, warmer temperatures and drought conditions may become more widespread in the native range of this pest. These changes have direct physiological benefits for M. tenebricosa, and potentially other pests, that may increase their fitness and abundance in urban and natural forests.	[Dale, Adam G.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Frank, Steven D.] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC USA	State University System of Florida; University of Florida; University of North Carolina; North Carolina State University	Dale, AG (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.	agdale@ufl.edu			United States Geological Survey [G11AC20471, G13AC00405, G15AP00153]; Southeast Climate Science Center; National Institute of Food and Agriculture, U.S. Department of Agriculture [2013-02476]	United States Geological Survey(United States Geological Survey); Southeast Climate Science Center; National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	Raleigh Parks, Recreation, and Cultural Resources provided tree maps and approved this study. The project described in this publication was supported by Cooperative Agreement no. G11AC20471, G13AC00405, and G15AP00153 from the United States Geological Survey. Its contents are solely the responsibility of the authors and do not necessarily represent the views of the Southeast Climate Science Center or the USGS. This manuscript is submitted for publication with the understanding that the United States Government is authorized to reproduce and distribute reprints for governmental purposes. Funding for this work was also provided by a Southeast Climate Science Center graduate fellowship awarded to Adam Dale. This research was also supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 2013-02476 to SDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, ROCK MOUNT RES STAT; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; BEARDSLEY JW, 1975, ANNU REV ENTOMOL, V20, P47, DOI 10.1146/annurev.en.20.010175.000403; Berger D, 2008, FUNCT ECOL, V22, P523, DOI 10.1111/j.1365-2435.2008.01392.x; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; CHRISTENSEN NL, 1977, AM MIDL NAT, V97, P176, DOI 10.2307/2424693; Climate Office NC, 2016, N CAR 1971 2000 CLIM; Cregg B. M., 2001, Journal of Arboriculture, V27, P8; Dale Adam G., 2016, Arboriculture & Urban Forestry, V42, P181; Dale AG, 2014, ECOL APPL, V24, P1596, DOI 10.1890/13-1961.1; Dale AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102996; Dale AG, 2015, EFFECTS URBAN WARMIN; Donovan GH, 2013, AM J PREV MED, V44, P139, DOI 10.1016/j.amepre.2012.09.066; Frank SD, 2013, J INTEGR PEST MANAG, V4, DOI 10.1603/IPM12007; George K, 2007, ATMOS ENVIRON, V41, P7654, DOI 10.1016/j.atmosenv.2007.08.018; Graves William R., 1994, Journal of Arboriculture, V20, P24; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hahs AK, 2015, FUNCT ECOL, V29, P863, DOI 10.1111/1365-2435.12488; Herms DA, 2002, ENVIRON ENTOMOL, V31, P923, DOI 10.1603/0046-225X-31.6.923; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Jamieson MA, 2012, PLANT PHYSIOL, V160, P1719, DOI 10.1104/pp.112.206524; Jochner S, 2013, TREE PHYSIOL, V33, P1256, DOI 10.1093/treephys/tpt079; Johnson DM, 2011, TREE PHYSIOL, V31, P659, DOI 10.1093/treephys/tpr050; KIM HH, 1992, INT J REMOTE SENS, V13, P2319, DOI 10.1080/01431169208904271; Koricheva J, 1998, ANNU REV ENTOMOL, V43, P195, DOI 10.1146/annurev.ento.43.1.195; Koricheva J, 1998, ANN REV ENTOMOLOGY, V1998; Kozlov MV, 2015, GLOBAL CHANGE BIOL, V21, P106, DOI 10.1111/gcb.12682; KOZLOWSKI J, 1992, TRENDS ECOL EVOL, V7, P15, DOI 10.1016/0169-5347(92)90192-E; Leuzinger S, 2011, TRENDS ECOL EVOL, V26, P236, DOI 10.1016/j.tree.2011.02.011; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; MCCLURE MS, 1980, ECOLOGY, V61, P72, DOI 10.2307/1937157; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Meineke E, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1574; Meineke EK, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0586; Meineke EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059687; Metcalf ZP, 1922, NC AGR EXPT STATION, V21, P1; METCALF ZP, 1912, J E MITCHELL SCI SOC, V28, P88; Mullaney J, 2015, LANDSCAPE URBAN PLAN, V134, P157, DOI 10.1016/j.landurbplan.2014.10.013; Nowak DJ, 2013, ENVIRON POLLUT, V178, P229, DOI 10.1016/j.envpol.2013.03.019; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; OKE TR, 1989, PHILOS T ROY SOC B, V324, P335, DOI 10.1098/rstb.1989.0051; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Raupp MJ, 2010, ANNU REV ENTOMOL, V55, P19, DOI 10.1146/annurev-ento-112408-085351; Raupp Michael J., 2006, Arboriculture & Urban Forestry, V32, P297; Robinet C, 2012, BIOL INVASIONS, V14, P1557, DOI 10.1007/s10530-011-9979-9; Robinson EA, 2012, NEW PHYTOL, V194, P321, DOI 10.1111/j.1469-8137.2012.04074.x; SCHAFFER B, 1990, OECOLOGIA, V84, P468, DOI 10.1007/BF00328162; Scherber C, 2013, ECOL EVOL, V3, P1449, DOI 10.1002/ece3.564; Shrewsbury PM, 2000, ENVIRON ENTOMOL, V29, P919, DOI 10.1603/0046-225X-29.5.919; Speight MR, 1998, ECOLOGY, V79, P1503, DOI 10.1890/0012-9658(1998)079[1503:HCSPRH]2.0.CO;2; Sperry Chad E., 2001, Journal of Arboriculture, V27, P263; Tooker JF, 2000, ENVIRON ENTOMOL, V29, P1305, DOI 10.1603/0046-225X-29.6.1305; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790; Yasuda S., 1983, J SERICULTURAL SCI J, V52, P106; Youngsteadt E, 2015, GLOBAL CHANGE BIOL, V21, P97, DOI 10.1111/gcb.12692; Zvereva EL, 2006, GLOBAL CHANGE BIOL, V12, P27, DOI 10.1111/j.1365-2486.2005.01086.x	59	74	78	6	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173844	10.1371/journal.pone.0173844	http://dx.doi.org/10.1371/journal.pone.0173844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278206	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900039
J	Sawadogo, SP; Niang, A; Bilgo, E; Millogo, A; Maiga, H; Dabire, RK; Tripet, F; Diabate, A				Sawadogo, Simon Peguedwinde; Niang, Abdoulaye; Bilgo, Etienne; Millogo, Azize; Maiga, Hamidou; Dabire, Roch K.; Tripet, Frederic; Diabate, Abdoulaye			Targeting male mosquito swarms to control malaria vector density	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; MATING-BEHAVIOR; INSECTICIDE RESISTANCE; BURKINA-FASO; AREA; SYMPATRY; COLUZZII; SUCCESS	Malaria control programs are being jeopardized by the spread of insecticide resistance in mosquito vector populations. It has been estimated that the spread of resistance could lead to an additional 120000 deaths per year, and interfere with the prospects for sustained control or the feasibility of achieving malaria elimination. Another complication for the development of resistance management strategies is that, in addition to insecticide resistance, mosquito behavior evolves in a manner that diminishes the impact of LLINs and IRS. Mosquitoes may circumvent LLIN and IRS control through preferential feeding and resting outside human houses and/or being active earlier in the evening before people go to sleep. Recent developments in our understanding of mosquito swarming suggest that new tools targeting mosquito swarms can be designed to cut down the high reproductive rate of malaria vectors. Targeting swarms of major malaria vectors may provide an effective control method to counteract behavioral resistance developed by mosquitoes. Here, we evaluated the impact of systematic spraying of swarms of Anopheles gambiae s.l. using a mixed carbamate and pyrethroid aerosol. The impact of this intervention on vector density, female insemination rates and the age structure of males was measured. We showed that the resulting mass killing of swarming males and some mate-seeking females resulted in a dramatic 80% decrease in population size compared to a control population. A significant decrease in female insemination rate and a significant shift in the age structure of the male population towards younger males incapable of mating were observed. This paradigm-shift study therefore demonstrates that targeting primarily males rather than females, can have a drastic impact on mosquito population.	[Sawadogo, Simon Peguedwinde; Niang, Abdoulaye; Bilgo, Etienne; Maiga, Hamidou; Dabire, Roch K.; Diabate, Abdoulaye] IRSS, Dept Med Biol & Publ Hlth, Bobo Dioulasso, Burkina Faso; [Millogo, Azize] Inst Sci Soc INSS, Deparment Populat Sci, Ouagadougou, Burkina Faso; [Tripet, Frederic] Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele, Staffs, England	Keele University	Sawadogo, SP (corresponding author), IRSS, Dept Med Biol & Publ Hlth, Bobo Dioulasso, Burkina Faso.	sawsimp2005@yahoo.fr	MILLOGO, Abdoul Azize/CAI-1274-2022; MAIGA, Hamidou/AAR-3023-2020; Dabire, Roch Kounbobr/ABF-3525-2020; Tripet, Frederic/M-6693-2015	MILLOGO, Abdoul Azize/0000-0003-3301-9149; MAIGA, Hamidou/0000-0001-8662-4700; Sawadogo, Simon Peguedwinde/0000-0002-9414-4659; Niang, Abdoulaye/0000-0003-3196-3064; Tripet, Frederic/0000-0002-7939-0712; DIABATE, Abdoulaye/0000-0002-9666-9395	Medical Research Concil/DFID; UK Medical Research Council (MRC); Department for International Development (DFID) under the MRC/DFID Concordat agreement [G1001336/1, 97014]; Medical Research Council [G1001336] Funding Source: researchfish; MRC [G1001336] Funding Source: UKRI	Medical Research Concil/DFID; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development (DFID) under the MRC/DFID Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This Study was suppoorted by the Medical Research Concil/DFID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the populations of the study sites for their sincere cooperation during mosquito sampling. This work was funded by the UK Medical Research Council (MRC) and Department for International Development (DFID) under the MRC/DFID Concordat agreement (Grant Reference No: G1001336/1, Grant ID: 97014 to Abdoulaye Diabate and Frederic Trip et).	[Anonymous], GLOBAL STRATEGIC PLA; Assogba BS, 2014, ACTA TROP, V132, pS53, DOI 10.1016/j.actatropica.2013.09.006; Wilke ABB, 2012, REV INST MED TROP SP, V54, P287, DOI 10.1590/S0036-46652012000500009; Charlwood JD, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-2; CHARLWOOD JD, 1979, PHYSIOL ENTOMOL, V4, P111, DOI 10.1111/j.1365-3032.1979.tb00185.x; Charlwood JD, 2002, MED VET ENTOMOL, V16, P109, DOI 10.1046/j.0269-283x.2002.00342.x; CHARLWOOD JD, 1980, PHYSIOL ENTOMOL, V5, P315, DOI 10.1111/j.1365-3032.1980.tb00241.x; Dabire KR, 2014, ACTA TROP, V132, pS35, DOI 10.1016/j.actatropica.2013.12.012; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; Diabate A, 2006, J MED ENTOMOL, V43, P480, DOI 10.1603/0022-2585(2006)43[480:MSOTMM]2.0.CO;2; Diabate A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0961-8; Diabate A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-184; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; DOWNES JA, 1969, ANNU REV ENTOMOL, V14, P271, DOI 10.1146/annurev.en.14.010169.001415; Howell PI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S8; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Koella JC, 2009, EVOL APPL, V2, P469, DOI 10.1111/j.1752-4571.2009.00072.x; MARCHAND RP, 1984, NETH J ZOOL, V34, P367, DOI 10.1163/002829684X00209; Mnzava AP, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0693-4; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Oliva CF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-135; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Sawadogo PS, 2014, ACTA TROP, V132, pS42, DOI 10.1016/j.actatropica.2013.12.011; Shutt B, 2010, MED VET ENTOMOL, V24, P91, DOI 10.1111/j.1365-2915.2009.00849.x; West PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001630; WHO, 2012, WORLD MALARIA REPORT 2012, P1; World Health Organization, 2015, WORLD MAL REP 2015	29	27	27	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173273	10.1371/journal.pone.0173273	http://dx.doi.org/10.1371/journal.pone.0173273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278212	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000396087900064
J	Tran, HT; Liong, S; Lim, R; Barker, G; Lappas, M				Tran, Ha T.; Liong, Stella; Lim, Ratana; Barker, Gillian; Lappas, Martha			Resveratrol ameliorates the chemical and microbial induction of inflammation and insulin resistance in human placenta, adipose tissue and skeletal muscle	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; NECROSIS-FACTOR-ALPHA; PREEXISTING MATERNAL OBESITY; PROINFLAMMATORY CYTOKINES; METABOLIC ENDOTOXEMIA; RECEPTOR SUBSTRATE-1; FETAL MEMBRANES; DOWN-REGULATION; PREGNANT-WOMEN; KAPPA-B	Gestational diabetes mellitus (GDM), which complicates up to 20% of all pregnancies, is associated with low-grade maternal inflammation and peripheral insulin resistance. Sterile inflammation and infection are key mediators of this inflammation and peripheral insulin resistance. Resveratrol, a stilbene-type phytophenol, has been implicated to exert beneficial properties including potent anti-inflammatory and antidiabetic effects in non-pregnant humans and experimental animal models of GDM. However, studies showing the effects of resveratrol on inflammation and insulin resistance associated with GDM in human tissues have been limited. In this study, human placenta, adipose (omental and subcutaneous) tissue and skeletal muscle were stimulated with pro-inflammatory cytokines TNF-alpha and IL-1 beta, the bacterial product lipopolysaccharide (LPS) and the synthetic viral dsRNA analogue polyinosinic:polycytidylic acid (poly(I:C)) to induce a GDM-like model. Treatment with resveratrol significantly reduced the expression and secretion of pro-inflammatory cytokines IL-6, IL 1 alpha, IL-1 beta and pro-inflammatory chemokines IL-8 and MCP-1 in human placenta and omental and subcutaneous adipose tissue. Resveratrol also significantly restored the defects in the insulin signalling pathway and glucose uptake induced by TNF-alpha, LPS and poly(I:C). Collectively, these findings suggest that resveratrol reduces inflammation and insulin resistance induced by chemical and microbial products. Resveratrol may be a useful preventative therapeutic for pregnancies complicated by inflammation and insulin resistance, like GDM.	[Tran, Ha T.; Liong, Stella; Lim, Ratana; Barker, Gillian; Lappas, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Obstet Nutr & Endocrinol Grp, Heidelberg, Vic, Australia; [Tran, Ha T.; Liong, Stella; Lim, Ratana; Barker, Gillian; Lappas, Martha] Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia	University of Melbourne	Lappas, M (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Obstet Nutr & Endocrinol Grp, Heidelberg, Vic, Australia.; Lappas, M (corresponding author), Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia.	mlappas@unimelb.edu.au	Liong, Stella/AAQ-5308-2021	Liong, Stella/0000-0001-6131-858X	Career Development Fellowship from the National Health and Medical Research Council (NHMRC) [1047025]; Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Research Foundation; University of Melbourne; Endocrine Society of Australia (ESA); Norman Beischer Medical Research Foundation; Diabetes Australia; Austin Medical Research Foundation; Rebecca L Cooper Medical Research Foundation	Career Development Fellowship from the National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Research Foundation; University of Melbourne(University of Melbourne); Endocrine Society of Australia (ESA); Norman Beischer Medical Research Foundation; Diabetes Australia; Austin Medical Research Foundation; Rebecca L Cooper Medical Research Foundation	Associate Professor Martha Lappas is supported by a Career Development Fellowship from the National Health and Medical Research Council (NHMRC; grant no. 1047025). Dr. Stella Liong is a recipient of the Glyn White Research Fellowship by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Research Foundation, the Early Career Researcher Fellowship by The University of Melbourne, and the Postdoctoral Award by the Endocrine Society of Australia (ESA). Funding for this study was provided by grants from the Norman Beischer Medical Research Foundation, Diabetes Australia, Rebecca L Cooper Medical Research Foundation and Austin Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ategbo JM, 2006, J CLIN ENDOCR METAB, V91, P4137, DOI 10.1210/jc.2006-0980; Barbour LA, 2006, REDUCED IRS 1 INCREA; Bari MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101327; Basu S, 2011, OBESITY, V19, P476, DOI 10.1038/oby.2010.215; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003; Boyadzhieva M, 2013, J ENDOCRINOL INVEST, V36, P944, DOI 10.3275/8968; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Catalano P, 2015, INT J OBESITY, V39, P642, DOI 10.1038/ijo.2015.15; CATALANO PM, 1991, AM J OBSTET GYNECOL, V165, P1667, DOI 10.1016/0002-9378(91)90012-G; Catalano PM, 2003, AM J OBSTET GYNECOL, V189, P1698, DOI 10.1016/S0002-9378(03)00828-7; Colomiere M, 2009, EUR J ENDOCRINOL, V160, P567, DOI 10.1530/EJE-09-0031; Coustan DR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.04.006; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Dhurandhar NV, 1997, OBES RES, V5, P464, DOI 10.1002/j.1550-8528.1997.tb00672.x; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Friedman JE, 2008, DIABETES, V57, P606, DOI 10.2337/db07-1356; Friedman JE, 1999, DIABETES, V48, P1807, DOI 10.2337/diabetes.48.9.1807; Gao XL, 2008, CHINESE MED J-PEKING, V121, P701, DOI 10.1097/00029330-200804020-00008; Ghanim H, 2010, J CLIN ENDOCR METAB, V95, pE1, DOI 10.1210/jc.2010-0482; Hauguel-de Mouzon S, 2006, PLACENTA, V27, P794, DOI 10.1016/j.placenta.2005.08.009; Hawkesworth S, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.24; Hornstra G, EUROPEAN JOURNAL OF, V61, P57; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jones HN, 2009, AM J PHYSIOL-CELL PH, V297, pC1228, DOI 10.1152/ajpcell.00195.2009; Kaaja Risto, 2008, Rev Diabet Stud, V5, P194, DOI 10.1900/RDS.2008.5.194; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Kim S, 2011, BIOCHEM PHARMACOL, V81, P1343, DOI 10.1016/j.bcp.2011.03.012; Kinalski M, 2005, HORM METAB RES, V37, P450, DOI 10.1055/s-2005-870238; Klein K, 2008, PRENATAL DIAG, V28, P845, DOI 10.1002/pd.2064; Koga K, 2009, AM J REPROD IMMUNOL, V61, P196, DOI 10.1111/j.1600-0897.2008.00682.x; Kuzmicki M, 2013, EUR J ENDOCRINOL, V168, P419, DOI 10.1530/EJE-12-0654; Lager S, 2011, PLACENTA, V32, P121, DOI 10.1016/j.placenta.2010.10.012; Langer O, 2005, AM J OBSTET GYNECOL, V192, P989, DOI 10.1016/j.ajog.2004.11.039; Lappas M, 2005, J ENDOCRINOL, V186, P457, DOI 10.1677/joe.1.06227; Lappas M, 2004, J CLIN ENDOCR METAB, V89, P5627, DOI 10.1210/jc.2003-032097; Lappas M, 2014, PLACENTA, V35, P866, DOI 10.1016/j.placenta.2014.08.089; Lappas M, 2005, ENDOCRINOLOGY, V146, P3334, DOI 10.1210/en.2005-0406; Lappas M, 2014, J ENDOCRINOL, V222, P99, DOI 10.1530/JOE-14-0179; Lappas M, 2014, METABOLISM, V63, P860, DOI 10.1016/j.metabol.2014.03.007; Lappas M, 2014, METABOLISM, V63, P250, DOI 10.1016/j.metabol.2013.10.001; Lappas M, 2014, MOL CELL ENDOCRINOL, V382, P74, DOI 10.1016/j.mce.2013.09.011; Lappas M, 2011, BIOL REPROD, V84, P167, DOI 10.1095/biolreprod.110.086983; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Lim R, 2015, AM J REPROD IMMUNOL, V73, P66, DOI 10.1111/aji.12334; Lim R, 2013, MOL HUM REPROD, V19, P451, DOI 10.1093/molehr/gat015; Liong S., 2015, J PHYSL BIOCH, P1; Liong S, 2016, MOL CELL ENDOCRINOL, V425, P11, DOI 10.1016/j.mce.2016.02.016; Liong S, 2015, AM J REPROD IMMUNOL, V74, P62, DOI 10.1111/aji.12366; Liong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122633; Lou YQ, 2014, DIABETES RES CLIN PR, V104, P136, DOI 10.1016/j.diabres.2014.01.014; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Movahed A, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/851267; Mrizak I, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-93; O'Tierney-Ginn P, 2015, PLACENTA, V36, P903, DOI 10.1016/j.placenta.2015.06.002; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; Radaelli T, 2003, DIABETES, V52, P2951, DOI 10.2337/diabetes.52.12.2951; Roberts VHJ, 2014, FASEB J, V28, P2466, DOI 10.1096/fj.13-245472; Shao JH, 2002, DIABETES, V51, P19, DOI 10.2337/diabetes.51.1.19; Shintani Y, 2004, GASTROENTEROLOGY, V126, P840, DOI 10.1053/j.gastro.2003.11.056; SOBEL DO, 1992, DIABETES, V41, P515, DOI 10.2337/diabetes.41.4.515; Szkudelska K, 2010, EUR J PHARMACOL, V635, P1, DOI 10.1016/j.ejphar.2010.02.054; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Wolf M, 2004, DIABETES CARE, V27, P21, DOI 10.2337/diacare.27.1.21; Xiong X, 2001, INT J GYNECOL OBSTET, V75, P221, DOI 10.1016/S0020-7292(01)00496-9; Xiong X, 2009, J PERIODONTOL, V80, P1742, DOI 10.1902/jop.2009.090250; Yao LQ, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0114-0; Yoshino J, 2012, CELL METAB, V16, P658, DOI 10.1016/j.cmet.2012.09.015	71	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173373	10.1371/journal.pone.0173373	http://dx.doi.org/10.1371/journal.pone.0173373			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278187	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900080
J	Yang, H; Guo, WZ; Li, J; Cao, SL; Zhang, JK; Pan, J; Wang, ZH; Wen, PH; Shi, XY; Zhang, SJ				Yang, Han; Guo, Wenzhi; Li, Jie; Cao, Shengli; Zhang, Jiakai; Pan, Jie; Wang, Zhihui; Wen, Peihao; Shi, Xiaoyi; Zhang, Shuijun			Leptin concentration and risk of coronary heart disease and stroke: A systematic review and meta-analysis	PLOS ONE			English	Review							C-REACTIVE PROTEIN; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; PLASMA LEPTIN; ISCHEMIC-STROKE; ADIPOCYTOKINES; ADIPONECTIN; OBESITY; ATHEROSCLEROSIS; ASSOCIATION	Background and purpose Although high leptin concentration has been shown to be correlated with established vascular risk factors, epidemiologic studies have reported inconclusive results on the association between leptin and cardiovascular diseases (CVD). Therefore, a meta-analysis was performed to evaluate this issue. Methods We searched Pubmed, Embase, and the Cochrane Library from their inception to Jan 2016 for both case-control and cohort studies that assessed leptin concentration and CVD risk. Reports with odds ratio (OR), risk ratio (RR) and corresponding 95% confidence intervals (CI) were considered. The data were extracted by two investigators independently. Results A total of 13 epidemiologic studies totaling 4257 CVD patients and 26710 controls were included. A significant inverse association was shown between leptin and coronary heart disease (CHD), with an overall OR of 1.16 (95% CI: 1.02-1.32), but not for stroke (OR = 1.21, 95% CI 0.98-1.48) under sociodemographic adjustment. Further adjustment for additional cardiovascular risk factors resulted in ORs of 1.16 (95% CI 0.97-1.40) for CHD and 1.10 (95% CI 0.89-1.35) for stroke. The findings remained when analyses were restricted to high-quality studies and indicated OR estimates of 1.07 (95% CI 0.96-1.19) for CHD and 0.98 (95% CI 0.76-1.25) for stroke. In a subgroup meta-analysis, a high leptin level was not independently associated with CHD in both females (OR = 1.03, 95% CI 0.86-1.23) and males (OR = 1.09, 95% CI 0.95-1.26) or with stroke in both females (OR = 1.13, 95% CI 0.87-1.47) and males (OR = 0.80, 95% CI 0.59-1.09). There was no significant publication bias as suggested by Egger test outcomes. Conclusions Our findings indicate that high leptin levels may not be associated with risks of CHD and stroke. Further large, well-designed prospective cohort studies are needed to fully evaluate the role of leptin on the risk of CVD.	[Yang, Han; Guo, Wenzhi; Li, Jie; Cao, Shengli; Zhang, Jiakai; Pan, Jie; Wang, Zhihui; Wen, Peihao; Shi, Xiaoyi; Zhang, Shuijun] Zhengzhou Univ, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Zhengzhou, Henan Province, Peoples R China; [Yang, Han; Guo, Wenzhi; Li, Jie; Cao, Shengli; Zhang, Jiakai; Pan, Jie; Wang, Zhihui; Wen, Peihao; Shi, Xiaoyi; Zhang, Shuijun] Key Lab Hepatobiliary & Pancreat Surg & Digest Or, Zhengzhou, Henan Province, Peoples R China	Zhengzhou University	Zhang, SJ (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Zhengzhou, Henan Province, Peoples R China.; Zhang, SJ (corresponding author), Key Lab Hepatobiliary & Pancreat Surg & Digest Or, Zhengzhou, Henan Province, Peoples R China.	zhangshuijun@zzu.edu.cn			National Natural Science Foundation of China [81571947]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant 81571947 from the National Natural Science Foundation of China (to Dr. Shui-jun Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostoulis S, 2008, CYTOKINE, V42, P353, DOI 10.1016/j.cyto.2008.03.009; Bhatnagar P, 2015, HEART, V101, P1182, DOI 10.1136/heartjnl-2015-307516; Bigalke B, 2010, PLATELETS, V21, P11, DOI 10.3109/09537100903377584; Blum WF, 1997, J CLIN ENDOCR METAB, V82, P2904, DOI 10.1210/jc.82.9.2904; Cao HM, 2014, J ENDOCRINOL, V220, pT47, DOI 10.1530/JOE-13-0339; Chai SB, 2014, ATHEROSCLEROSIS, V233, P3, DOI 10.1016/j.atherosclerosis.2013.11.069; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Golia E, 2014, WORLD J CARDIOL, V6, P539, DOI 10.4330/wjc.v6.i7.539; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang F, 2010, ACTA BIOCH BIOPH SIN, V42, P325, DOI 10.1093/abbs/gmq025; Jose V Jacob, 2005, Indian Heart J, V57, P39; Jun JY, 2012, ATHEROSCLEROSIS, V225, P341, DOI 10.1016/j.atherosclerosis.2012.10.031; Lawlor DA, 2007, OBESITY, V15, P1694, DOI 10.1038/oby.2007.202; Liu JK, 2010, CLIN ENDOCRINOL, V72, P32, DOI 10.1111/j.1365-2265.2009.03627.x; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Martin SS, 2015, ATHEROSCLEROSIS, V239, P67, DOI 10.1016/j.atherosclerosis.2014.12.033; Mattu HS, 2013, J ENDOCRINOL, V216, pT17, DOI 10.1530/JOE-12-0232; Nakata M, 1999, DIABETES, V48, P426, DOI 10.2337/diabetes.48.2.426; O'Rourke L, 2002, J BIOL CHEM, V277, P42557, DOI 10.1074/jbc.M202151200; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Prugger C, 2012, ANN NEUROL, V71, P478, DOI 10.1002/ana.22669; Rajpathak SN, 2011, STROKE, V42, P1813, DOI 10.1161/STROKEAHA.110.607853; Rondinone CM, 2006, ENDOCRINE, V29, P81, DOI 10.1385/ENDO:29:1:81; Saber H, 2015, STROKE, V46, P2881, DOI 10.1161/STROKEAHA.115.009463; Sattar N, 2009, J AM COLL CARDIOL, V53, P167, DOI 10.1016/j.jacc.2008.09.035; Seven E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128987; Shamsuzzaman ASM, 2004, CIRCULATION, V109, P2181, DOI 10.1161/01.CIR.0000127960.28627.75; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Sierra-Johnson J, 2007, AM J CARDIOL, V100, P234, DOI 10.1016/j.amjcard.2007.02.088; Singh P, 2007, ARTERIOSCL THROM VAS, V27, pE302, DOI 10.1161/ATVBAHA.107.148353; Soderberg S, 2004, J INTERN MED, V256, P128, DOI 10.1111/j.1365-2796.2004.01351.x; Soderberg S, 1999, J INTERN MED, V246, P409, DOI 10.1046/j.1365-2796.1999.00571.x; de Voorde J, 2013, METABOLISM, V62, P1513, DOI 10.1016/j.metabol.2013.06.004; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wallace AM, 2001, CIRCULATION, V104, P3052, DOI 10.1161/hc5001.101061; Waters AM, 2013, CLIN EXP PHARMACOL P, V40, P347, DOI 10.1111/1440-1681.12079; Yang F, 2016, CLIN TRIALS REGUL SC, V15, P1, DOI DOI 10.1016/j.ctrsc.2016.01.007; Zeng R, 2014, ARQ BRAS ENDOCRINOL, V58, P817, DOI 10.1590/0004-2730000003390	41	33	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0166360	10.1371/journal.pone.0166360	http://dx.doi.org/10.1371/journal.pone.0166360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278178	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900103
J	Yuan, L; Li, RM; Meng, AF; Feng, YL; Wu, XC; Yang, YQ; Chen, P; Qiu, ZZ; Qi, J; Chen, CY; Wei, J; Qin, MY; Kong, WW; Chen, XY; Xu, W				Yuan, Ling; Li, Rongmei; Meng, Aifeng; Feng, Yuling; Wu, Xiancui; Yang, Yiqun; Chen, Ping; Qiu, Zhenzhu; Qi, Jing; Chen, Chuanying; Wei, Jia; Qin, Minyi; Kong, Weiwei; Chen, Xiangyu; Xu, Wei			Superior success rate of intracavitary electrocardiogram guidance for peripherally inserted central catheter placement in patients with cancer: A randomized open-label controlled multicenter study	PLOS ONE			English	Article							CENTRAL VENOUS CATHETERS; ECG METHOD; TIP; COMPLICATIONS; MALPOSITION; POSITION	Background Intracavitary electrocardiogram (IC ECG) guidance emerges as a new technique for peripherally inserted central catheters (PICCs) placement and demonstrates many potential advantages in recent observational studies. Aims To determine whether IC ECG-guided PICCs provide more accurate positioning of catheter tips compared to conventional anatomical landmarks in patients with cancer undergoing chemotherapy. Methods In this multicenter, open-label, randomized controlled study (ClinicalTrials.gov number, NCT02409589), a total of 1,007 adult patients were assigned to receive either IC ECG guidance (n = 500) or anatomical landmark guidance (n = 507) for PICC positioning. The confirmative catheter tip positioning x-ray data were centrally interpreted by independent radiologists. All reported analyses in the overall population were performed on an intention-to-treat basis. Analyses of pre-specified subgroups and a selected large subpopulation were conducted to explore consistency and accuracy. Results In the IC ECG-guided group, the first-attempt success rate was 89.2% (95% confidence interval [CI], 86.5% to 91.9%), which was significantly higher than 77.4% (95% CI, 73.7% to 81.0%) in the anatomical landmark group (P < 0.0001). This trend of superiority of IC ECG guidance was consistently noted in almost all prespecified patient subgroups and two selected large subpopulations, even when using optimal target rates for measurement. In contrast, the superiority nearly disappeared when PICCs were used via the left instead of right arms (interaction P-value = 0.021). No catheter-related adverse events were reported during the PICC intra-procedures in either group. Conclusions Our findings indicated that the IC ECG-guided method had a more favorable positioning accuracy versus traditional anatomical landmarks for PICC placement in adult patients with cancer undergoing chemotherapy. Furthermore, there were no significant safety concerns reported for catheterization using the two techniques.	[Yuan, Ling; Li, Rongmei; Wei, Jia; Kong, Weiwei] Nanjing Univ, Ctr Comprehens Canc, Drum Tower Hosp, Clin Canc Inst,Sch Med, Nanjing, Jiangsu, Peoples R China; [Meng, Aifeng; Chen, Chuanying] Jiangsu Canc Hosp, Dept Nursing, Nanjing, Jiangsu, Peoples R China; [Feng, Yuling] Jiangsu Univ, Comprehens Canc Ctr Peoples Hosp, Zhenjiang, Jiangsu, Peoples R China; [Wu, Xiancui] Nanjing Med Univ, Nanjing Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China; [Yang, Yiqun] Soochow Univ, Affiliated Hosp 1, Dept Nursing, Suzhou, Jiangsu, Peoples R China; [Chen, Ping] Nanjing Med Univ, Affiliated Hosp 2, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China; [Qiu, Zhenzhu] Soochow Univ, Affiliated Hosp 2, Dept Med Oncol, Suzhou, Jiangsu, Peoples R China; [Qi, Jing] Nanjing Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China; [Qin, Minyi] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Med Imaging, Nanjing, Jiangsu, Peoples R China; [Chen, Xiangyu] Nanjing Univ, Dept Nursing, Sch Med, Clin Canc Inst, Nanjing, Jiangsu, Peoples R China; [Xu, Wei] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University; Jiangsu University; Nanjing Medical University; Soochow University - China; Nanjing Medical University; Soochow University - China; Nanjing University; Nanjing University; Nanjing University	Yuan, L (corresponding author), Nanjing Univ, Ctr Comprehens Canc, Drum Tower Hosp, Clin Canc Inst,Sch Med, Nanjing, Jiangsu, Peoples R China.; Xu, W (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	yuanling73@hotmail.com; xuwei2003@medmail.com.cn	Wei, Jia/AAE-9973-2020		Drum Tower Hospital-based Science and Research Fund [2015-001]; Key Project of Medical Science and Technology Development, Nanjing Health Bureau [ZKX15017]	Drum Tower Hospital-based Science and Research Fund; Key Project of Medical Science and Technology Development, Nanjing Health Bureau	This work was supported by Drum Tower Hospital-based Science and Research Fund (No: 2015-001). This study was funded by Key Project of Medical Science and Technology Development, Nanjing Health Bureau (No: ZKX15017). The funding sources had no role in the study design, data collection, analysis, preparation of the manuscript, or decision to publish. The corresponding author had full access to all the data in the study and had the final responsibility for the decision to submit for publication.	Amerasekera SSH, 2009, CLIN RADIOL, V64, P832, DOI 10.1016/j.crad.2009.02.021; [Anonymous], 2014, R LANG ENV STAT COMP; Baldinelli F, 2015, J VASC ACCESS, V16, P394, DOI 10.5301/jva.5000431; Brass P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006962.pub2; Capozzoli G, 2012, J VASC ACCESS, V13, P393, DOI 10.5301/jva.5000065; Fricke BL, 2005, RADIOLOGY, V234, P887, DOI 10.1148/radiol.2343031823; Gao YF, 2015, THER CLIN RISK MANAG, V11, P863, DOI 10.2147/TCRM.S83776; HELLERSTEIN H. K., 1949, PROC SOC EXPTL BIOL AND MED, V71, P58; Infusion Nurses Society, 2011, J INFUS NURS, V34, P72; Johnston AJ, 2014, ANAESTHESIA, V69, P1322, DOI 10.1111/anae.12785; Johnston AJ, 2013, ANAESTHESIA, V68, P484, DOI 10.1111/anae.12188; Li J, 2014, EUR J ONCOL NURS, V18, P94, DOI 10.1016/j.ejon.2013.08.003; Liu YX, 2015, THER CLIN RISK MANAG, V11, DOI 10.2147/TCRM.S73379; Mehta N, 2013, EMERG MED J, V30, P355, DOI 10.1136/emermed-2012-201230; Minkovich L, 2011, CAN J ANESTH, V58, P709, DOI 10.1007/s12630-011-9512-8; NAVAN- National Association of Vascular Access Networks, 1998, J VASCULAR ACCESS DE, V3, P8; Oliver Gemma, 2014, Br J Nurs, V23 Suppl 19, pS10, DOI 10.12968/bjon.2014.23.Sup19.S10; Oliver Gemma, 2013, Br J Nurs, V22, pS24; Pittiruti M, 2012, J VASC ACCESS, V13, P357, DOI 10.5301/JVA.2012.9020; Pittiruti M, 2011, J VASC ACCESS, V12, P280, DOI 10.5301/JVA.2011.8381; Pittiruti M, 2009, CLIN NUTR, V28, P365, DOI 10.1016/j.clnu.2009.03.015; Rossetti F, 2015, J VASC ACCESS, V16, P137, DOI 10.5301/jva.5000281; ROUNTREE D, 1991, AM J NURS, V91, P26; Scott W L, 1995, Surg Oncol Clin N Am, V4, P377; SCOTT WL, 1988, CHEST, V94, P1221, DOI 10.1378/chest.94.6.1221; Smith B, 2010, J ELECTROCARDIOL, V43, P274, DOI 10.1016/j.jelectrocard.2010.02.003; Trerotola SO, 2007, J VASC INTERV RADIOL, V18, P513, DOI 10.1016/j.jvir.2007.01.020; Yuan L, 2013, J ASS VASCULAR ACCES, V18, P225; Yuan L, 2015, CHIN J NURS, V50, P1056	29	31	37	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0171630	10.1371/journal.pone.0171630	http://dx.doi.org/10.1371/journal.pone.0171630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278167	gold, Green Published, Green Submitted			2022-12-27	WOS:000396087900108
J	Abramovitch, JB; Lopata, AL; O'Hehir, RE; Rolland, JM				Abramovitch, Jodie B.; Lopata, Andreas L.; O'Hehir, Robyn E.; Rolland, Jennifer M.			Effect of thermal processing on T cell reactivity of shellfish allergens - Discordance with IgE reactivity	PLOS ONE			English	Article							BLACK TIGER PRAWN; MASS-SPECTROMETRY; PENAEUS-MONODON; FOOD ALLERGY; TROPOMYOSIN; CHILDREN; EXPRESSION; PROTEINS; IMMUNOTHERAPY; KINASE	Crustacean allergy is a major cause of food-induced anaphylaxis. We showed previously that heating increases IgE reactivity of crustacean allergens. Here we investigate the effects of thermal processing of crustacean extracts on cellular immune reactivity. Raw and cooked black tiger prawn, banana prawn, mud crab and blue swimmer crab extracts were prepared and IgE reactivity assessed by ELISA. Mass spectrometry revealed a mix of several allergens in the raw mud crab extract but predominant heat-stable tropomyosin in the cooked extract. PBMC from crustacean-allergic and non-atopic control subjects were cultured with the crab and prawn extracts and proliferation of lymphocyte subsets was analysed by CFSE labelling and flow cytometry. Effector responses were assessed by intracellular IL-4 and IFN-gamma, and regulatory T (CD4(+)CD25(+)CD127(lo)Foxp3(+)) cell proportions in cultures were also compared by flow cytometry. For each crustacean species, the cooked extract had greater IgE reactivity than the raw (mud crab p<0.05, other species p<0.01). In contrast, there was a trend for lower PBMC proliferative responses to cooked compared with raw extracts. In crustacean-stimulated PBMC cultures, dividing CD4(+) and CD56(+) lymphocytes showed higher IL-4(+)/IFN-gamma(+) ratios for crustacean-allergic subjects than for non-atopics (p<0.01), but there was no significant difference between raw and cooked extracts. The percentage IL-4(+) of dividing CD4(+) cells correlated with total and allergen-specific IgE levels (prawns p<0.01, crabs p<0.05). Regulatory T cell proportions were lower in cultures stimulated with cooked compared with raw extracts (mud crab p<0.001, banana prawn p<0.05). In conclusion, cooking did not substantially alter overall T cell proliferative or cytokine reactivity of crustacean extracts, but decreased induction of Tregs. In contrast, IgE reactivity of cooked extracts was increased markedly. These novel findings have important implications for improved diagnostics, managing crustacean allergy and development of future therapeutics. Assessment of individual allergen T cell reactivity is required.	[Abramovitch, Jodie B.; O'Hehir, Robyn E.; Rolland, Jennifer M.] Monash Univ, Dept Pathol & Immunol, Melbourne, Vic, Australia; [Abramovitch, Jodie B.; O'Hehir, Robyn E.; Rolland, Jennifer M.] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia; [Abramovitch, Jodie B.; O'Hehir, Robyn E.; Rolland, Jennifer M.] Monash Univ, Melbourne, Vic, Australia; [Lopata, Andreas L.] James Cook Univ, Dept Mol & Cell Biol, Townsville, Qld, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; Monash University; James Cook University	Rolland, JM (corresponding author), Monash Univ, Dept Pathol & Immunol, Melbourne, Vic, Australia.	jennifer.rolland@monash.edu	Lopata, Andreas L/O-2143-2017; O'Hehir, Robyn E/H-3627-2011	Lopata, Andreas L/0000-0002-2940-9235; O'Hehir, Robyn E/0000-0002-3489-7595	Alfred Research Trusts; Australian Research Council	Alfred Research Trusts; Australian Research Council(Australian Research Council)	ROH received funding for this project from the Alfred Research Trusts and the Australian Research Council. AL is supported by an Australian Research Council Future Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067487; Aktas E, 2005, CLIN EXP IMMUNOL, V140, P301, DOI 10.1111/j.1365-2249.2005.02777.x; Barnes PJ, 2011, IMMUNOL REV, V242, P31, DOI 10.1111/j.1600-065X.2011.01020.x; Bullens DMA, 2005, CLIN EXP ALLERGY, V35, P1535, DOI 10.1111/j.1365-2222.2005.02352.x; Crack LR, 2011, CLIN EXP ALLERGY, V41, P1555, DOI 10.1111/j.1365-2222.2011.03819.x; Deniz G, 2011, EXPERT OPIN BIOL TH, V11, P833, DOI 10.1517/14712598.2011.572549; Eusebius NP, 2002, INT ARCH ALLERGY IMM, V127, P234, DOI 10.1159/000053868; Flinterman AE, 2010, CLIN EXP ALLERGY, V40, P590, DOI 10.1111/j.1365-2222.2009.03431.x; Gabrielsson S, 2001, CLIN EXP IMMUNOL, V126, P390, DOI 10.1046/j.1365-2249.2001.01703.x; Gamez C, 2015, FOOD CHEM, V173, P475, DOI 10.1016/j.foodchem.2014.10.063; Hilmenyuk T, 2010, IMMUNOLOGY, V129, P437, DOI 10.1111/j.1365-2567.2009.03199.x; Ilchmann A, 2010, J ALLERGY CLIN IMMUN, V125, P175, DOI 10.1016/j.jaci.2009.08.013; Kamath SD, 2014, MOL NUTR FOOD RES, V58, P1144, DOI 10.1002/mnfr.201300584; Kamath SD, 2013, FOOD CHEM, V141, P4031, DOI 10.1016/j.foodchem.2013.06.105; Karlsson MR, 2004, J EXP MED, V199, P1679, DOI 10.1084/jem.20032121; Koeberl M, 2014, J IMMUNOL METHODS, V415, P6, DOI 10.1016/j.jim.2014.10.008; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Liu GM, 2010, J FOOD SCI, V75, pT1, DOI 10.1111/j.1750-3841.2009.01391.x; Lopata AL, 2010, CLIN EXP ALLERGY, V40, P850, DOI 10.1111/j.1365-2222.2010.03513.x; Maleki SJ, 2000, J ALLERGY CLIN IMMUN, V106, P763, DOI 10.1067/mai.2000.109620; Mills ENC, 2009, MOL NUTR FOOD RES, V53, P963, DOI 10.1002/mnfr.200800236; Moldaver D, 2011, ALLERGY, V66, P784, DOI 10.1111/j.1398-9995.2011.02610.x; Nowak-Wegrzyn A, 2009, CURR OPIN ALLERGY CL, V9, P234, DOI 10.1097/ACI.0b013e32832b88e7; O'Hehir RE, 2009, AM J RESP CRIT CARE, V180, P936, DOI 10.1164/rccm.200905-0686OC; Palomares O, 2014, GENES IMMUN, V15, P511, DOI 10.1038/gene.2014.45; Pedrosa M, 2015, CLIN REV ALLERG IMMU, V49, P203, DOI 10.1007/s12016-014-8429-8; Prickett SR, 2015, CLIN EXP ALLERGY, V45, P1015, DOI 10.1111/cea.12554; Rahman AMA, 2011, J PROTEOMICS, V74, P231, DOI 10.1016/j.jprot.2010.10.010; Rahman AMA, 2010, RAPID COMMUN MASS SP, V24, P2462, DOI 10.1002/rcm.4664; Ravkov EV, 2013, HUM IMMUNOL, V74, P1542, DOI 10.1016/j.humimm.2013.08.276; Renand A, 2014, J ALLERGY CLIN IMMUN, V134, P1456, DOI 10.1016/j.jaci.2014.07.048; Rolland JM, 2010, CURR OPIN ALLERGY CL, V10, P559, DOI 10.1097/ACI.0b013e32833ff2b2; Rolland JM, 2009, PHARMACOL THERAPEUT, V121, P273, DOI 10.1016/j.pharmthera.2008.11.007; Sampath V, 2017, ANN ALLERG ASTHMA IM, V118, P21, DOI 10.1016/j.anai.2016.10.017; Schouten B, 2012, INT ARCH ALLERGY IMM, V159, P51, DOI 10.1159/000335242; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Smith M, 2008, J ALLERGY CLIN IMMUN, V121, P1460, DOI 10.1016/j.jaci.2008.03.025; Stelmaszczyk-Emmel A, 2013, INT ARCH ALLERGY IMM, V162, P16, DOI 10.1159/000350769; Stock P, 2008, CURR ALLERGY ASTHM R, V8, P165, DOI 10.1007/s11882-008-0027-5; Untersmayr E, 2006, PHARMACOL THERAPEUT, V112, P787, DOI 10.1016/j.pharmthera.2006.06.004; Verhoeckx KCM, 2015, FOOD CHEM TOXICOL, V80, P223, DOI 10.1016/j.fct.2015.03.005; Wang SP, 2012, HUM IMMUNOL, V73, P426, DOI 10.1016/j.humimm.2011.12.019; Yu HL, 2013, J SCI FOOD AGR, V93, P245, DOI 10.1002/jsfa.5748	44	15	17	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173549	10.1371/journal.pone.0173549	http://dx.doi.org/10.1371/journal.pone.0173549			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273149	Green Accepted, gold, Green Published			2022-12-27	WOS:000396073700016
J	Besemer, S; Farrington, DP; Bijleveld, CCJH				Besemer, Sytske; Farrington, David P.; Bijleveld, Catrien C. J. H.			Labeling and intergenerational transmission of crime: The interaction between criminal justice intervention and a convicted parent	PLOS ONE			English	Article							LIFE CHANCES; YOUTH CRIME; DELINQUENCY; RACE; PREVENTION; INCARCERATION; IMPRISONMENT; CHILDHOOD; BENEFITS; BEHAVIOR	Labeling theory suggests that criminal justice interventions amplify offending behavior. Theories of intergenerational transmission suggest why children of convicted parents have a higher risk of offending. This paper combines these two perspectives and investigates whether labeling effects might be stronger for children of convicted parents. We first investigated labeling effects within the individual: we examined the impact of a conviction between ages 19-26 on self- reported offending behavior between 27-32 while controlling for self-reported behavior between 15-18. Our results show that a conviction predicted someone's later self- reported offending behavior, even when previous offending behavior was taken into account. Second, we investigated whether having a convicted parent influenced this association. When we added this interaction to the analysis, a labeling effect was only visible among people with convicted parents. This supports the idea of cumulative disadvantage: Labeling seems stronger for people who are already in a disadvantaged situation having a convicted parent.	[Besemer, Sytske] Univ Calif Berkeley, Inst Human Dev, Berkeley, CA 94720 USA; [Farrington, David P.] Univ Cambridge, Inst Criminol, Cambridge CB2 1TN, England; [Bijleveld, Catrien C. J. H.] Vrije Univ Amsterdam, Netherlands Inst Study Crime & Law Enforcement, Amsterdam, Netherlands	University of California System; University of California Berkeley; University of Cambridge; Vrije Universiteit Amsterdam	Besemer, S (corresponding author), Univ Calif Berkeley, Inst Human Dev, Berkeley, CA 94720 USA.	besemer@berkeley.edu		Besemer, Sytske/0000-0002-8473-2991	Home Office UK; Bill and Melinda Gates Cambridge Scholarship	Home Office UK; Bill and Melinda Gates Cambridge Scholarship	Data collections for the CSDD at ages 18 and 32 were funded by the Home Office UK. SB was funded by a Bill and Melinda Gates Cambridge Scholarship: https://www.gatescambridge.org/.	AGETON SS, 1974, SOC PROBL, V22, P87, DOI 10.1525/sp.1974.22.1.03a00070; Aiken L. S., 1991, MULTIPLE REGRESSION; [Anonymous], ONE 100 BARS AM 2008; Becker HS., 1963, OUTSIDERS STUDIES SO; Bernburg JG, 2006, J RES CRIME DELINQ, V43, P67, DOI 10.1177/0022427805280068; Bernburg JG, 2003, CRIMINOLOGY, V41, P1287, DOI 10.1111/j.1745-9125.2003.tb01020.x; Bernburg JG, 2009, HANDB SOCIOL SOC RES, P187, DOI 10.1007/978-1-4419-0245-0_10; Besemer S, 2012, THESIS; Besemer S, 2013, BRIT J CRIMINOL, V53, P438, DOI 10.1093/bjc/azt006; BISHOP DM, 2005, OUR CHILDREN THEIR C; Bishop DM, 1996, J CRIM LAW CRIM, V86, P392, DOI 10.2307/1144031; BISHOP DM, 1992, J CRIM LAW CRIM, V82, P1162, DOI 10.2307/1143718; Blumstein A, 1986, CRIMINAL CAREERS CAR; Braithwaite J, 1989, SHAME REINTEGRATION; Brennan P.K., 2008, J CONTEMP CRIM JUST, V24, P371, DOI [10.1177/1043986208322712, DOI 10.1177/1043986208322712]; BRIDGES GS, 1988, SOC FORCES, V66, P699, DOI 10.2307/2579572; Cullen F. T., 2014, LABELING THEORY EMPI, V18, P63; De Li S, 1999, SOCIOL PERSPECT, V42, P305, DOI 10.2307/1389631; Dossetor K, 2011, COST BENEFIT ANAL IT; Farrington D., 2007, SAVING CHILDREN LIFE; Farrington D.P., 1990, STRAIGHT DEVIOUS PAT, P62; Farrington D.P., 2003, TAKING STOCK DELINQU, P137, DOI DOI 10.1007/0-306-47945-1_5; Farrington D.P., 2011, CRIME PUBLIC POLICY, P130; Farrington D. P., 1990, CRIMINALITY PERSONAL, P115, DOI DOI 10.1007/978-3-642-75418-0_9; Farrington D.P., 2013, OFFENDING CHILDHOOD; Farrington DP, 2013, CRIMINOL PUBLIC POL, V12, P295, DOI 10.1111/1745-9133.12043; FARRINGTON DP, 1995, J CHILD PSYCHOL PSYC, V36, P929, DOI 10.1111/j.1469-7610.1995.tb01342.x; FARRINGTON DP, 1978, BRIT J CRIMINOL, V18, P277, DOI 10.1093/oxfordjournals.bjc.a046913; FARRINGTON DP, 1989, NATO ADV SCI I D-BEH, V50, P399; FARRINGTON DP, 1977, BRIT J CRIMINOL, V17, P112, DOI 10.1093/oxfordjournals.bjc.a046802; FARRINGTON DP, 1996, LEGAL CRIMINOLOGICAL, V0001; Farrington DP, 2006, HOME OFFICE RES STUD, V299; Farrington DP, 2004, 0904 HOM OFF; Farrington DP, 2009, MONATS KRIMINOL, P160; Foster H, 2007, SOC PROBL, V54, P399, DOI 10.1525/sp.2007.54.4.399; Garland D., 2001, MASS IMPRISONMENT; Gottschalk M, 2006, CAMB STUD CRIMINOL, P1, DOI 10.2277/ 0521682916; HAGAN J, 1990, AM J SOCIOL, V96, P265, DOI 10.1086/229530; Hagan J, 2012, SOCIOL EDUC, V85, P259, DOI 10.1177/0038040711431587; HARRIS AR, 1976, AM SOCIOL REV, V41, P432, DOI 10.2307/2094252; Hedderman C., 1997, HOME OFFICE RES STUD, V170; JENSEN GF, 1980, CRIMINOLOGY, V18, P121, DOI 10.1111/j.1745-9125.1980.tb01352.x; Johnson LM, 2004, YOUTH SOC, V36, P3, DOI 10.1177/0044118X03260323; Jolliffe D, 2014, ENCY CRIMINOLOGY CRI, P4716, DOI [DOI 10.1007/978-1-4614-5690-2, 10.1007/978-1-4614-5690-2_648, DOI 10.1007/978-1-4614-5690-2_648]; Jolliffe Darrick, 2003, Crim Behav Ment Health, V13, P179, DOI 10.1002/cbm.541; Jolliffe D, 2015, CRIME DELINQUENCY, V61, P1051, DOI 10.1177/0011128712466007; Junger-Tas J, 1999, CRIME JUSTICE, V25, P291, DOI 10.1086/449291; Kaplan H. B., 2006, CYCLE DEVIANT BEHAV; Kaplan HB, 1991, SOCIAL SCI Q, V72; Krohn M. D., 2014, ADV CRIMINOLOGICAL T, V18; Lanctot N, 2007, CRIMINOLOGY, V45, P131, DOI 10.1111/j.1745-9125.2007.00074.x; Leiber MJ, 2008, CRIME DELINQUENCY, V54, P560, DOI 10.1177/0011128707308857; Lemert E. M., 1967, HUMAN DEVIANCE SOCIA; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Lopes G, 2012, CRIME DELINQUENCY, V58, P456, DOI 10.1177/0011128712436414; Losel F, 2012, FUTURE CRIMINOLOGY, P196; MATSUEDA RL, 1992, AM J SOCIOL, V97, P1577, DOI 10.1086/229940; McAra L., 2005, CRIMINAL JUSTICE, V5, P5, DOI DOI 10.1177/1466802505050977; McAra L., 2007, EUR J CRIMINOL, V4, P315, DOI DOI 10.1177/1477370807077186; McAra L, 2007, 14 CTR LAW SOC ED ST; McAra L, 2010, CRIMINOL CRIM JUSTIC, V10, P179, DOI 10.1177/1748895809360971; McIntosh Cameron, 2012, INTRO EC ANAL CRIME; Mitchell O, 2005, J QUANT CRIMINOL, V21, P439, DOI 10.1007/s10940-005-7362-7; Murray J., 2014, ADV CRIMINOLOGICAL T, P209; Nagin DS, 2001, CRIME JUSTICE, V28, P347, DOI 10.1086/652213; NELSON JF, 1994, J RES CRIME DELINQ, V31, P183, DOI 10.1177/0022427894031002006; Paternoster R., 1989, JUSTICE Q, V6, P359, DOI [DOI 10.1080/07418828900090261, 10.1080/07418828900090261]; Petersilia J., 1983, RACIAL DISPARITIES C; Piquero AR, 2007, CAMB STUD CRIMINOL, P1, DOI 10.2277/ 0521613094; Raphael Steven, 2014, ADV CRIMINOLOGICAL T, p237 259; Roman J., 2010, COST BENEFIT ANAL CR; Sampson R.J., 1997, DEV THEORIES CRIME D, V7, P133, DOI DOI 10.4324/9780203793350-4; Scheff T. J., 1984, BEING MENTALLY ILL S, V2nd; SCHEFF TJ, 1974, AM SOCIOL REV, V39, P444, DOI 10.2307/2094300; SEALOCK MD, 1998, JUSTICE Q, V0015; Sherman L.W., 2014, ADV CRIMINOL THEORY, P149; Sherman L. W., 2010, SAGE HDB CRIMINOLOGI, P360, DOI DOI 10.4135/9781446200926; SHERMAN LW, 1993, J RES CRIME DELINQ, V30, P445, DOI 10.1177/0022427893030004006; Spohn C., 2000, CRIMINAL JUSTICE POL, V11, P149, DOI [10.1177/0887403400011002004, DOI 10.1177/0887403400011002004]; Stewart EA, 2002, J RES CRIME DELINQ, V39, P36, DOI 10.1177/002242780203900102; Thornberry T. P., 2009, CRIMINOLOGY INTERDIS, V47, P297, DOI [10.1111/j.1745-9125.2009.00153.x, DOI 10.1111/J.1745-9125.2009.0015.X]; Tillyer R, 2015, CRIM JUSTICE BEHAV, V42, P703, DOI 10.1177/0093854814560624; Tonry M., 2001, PENAL REFORM OVERCRO; van de Rakt M., 2009, CRIM BEHAV MENT HEAL, V19, P19, DOI DOI 10.1002/CBM.715; Van De Weijer S., 2014, INTERGENERATIONAL TR; Wakefield S, 2010, ANNU REV SOCIOL, V36, P387, DOI 10.1146/annurev.soc.012809.102551; Wakefield Sara., 2014, CHILDREN PRISON BOOM; Walmsley R, 2011, WORLD PRISON POPULAT; Welsh B. C., 2001, COSTS BENEFITS PREVE, DOI [10.4324/9780429501265, DOI 10.4324/9780429501265]; Welsh BC, 2000, CRIME JUSTICE, V27, P305, DOI 10.1086/652202; Welsh BC., 2007, CRIMINOL PUBLIC POL, V4, P871, DOI [DOI 10.1111/J.1745-9133.2007.00465.X, 10.1111/j.1745-9133.2007.00465.x]; Welsh BC, 2015, CRIMINOL PUBLIC POL, V14, P673, DOI 10.1111/1745-9133.12167; West D. J., 1969, PRESENT CONDUCT FUTU; West D. J., 1973, WHO BECOMES DELINQUE; West DJ., 1977, DELINQUENT WAY LIFE; Wildeman C, 2009, DEMOGRAPHY, V46, P265, DOI 10.1353/dem.0.0052; Wu BS, 1998, JUVENILE FAM COURT J, V49, P41, DOI 10.1111/j.1755-6988.1998.tb00780.x	97	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172419	10.1371/journal.pone.0172419	http://dx.doi.org/10.1371/journal.pone.0172419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273104	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700073
J	He, YT; Zhang, L; Zhu, ZL; Xiao, AQ; Yu, HY; Gan, XQ				He, Yuting; Zhang, Ling; Zhu, Zhuoli; Xiao, Anqi; Yu, Haiyang; Gan, Xueqi			Blockade of cyclophilin D rescues dexamethasone-induced oxidative stress in gingival tissue	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; INDUCED APOPTOSIS; MITOCHONDRIA; ROS; OSTEOBLASTS; PROTECTS; ALVEOLAR; NECROSIS; RELEASE; DAMAGE	Glucocorticoids (GCs) are frequently used for the suppression of inflammation in chronic inflammatory diseases. Excessive GCs usage is greatly associated with several side effects, including gingival ulceration, the downward migration of the epithelium, attachment loss and disruption of transeptal fibers. The mechanisms underlying GCs-induced impairments in gingival tissue remains poorly understood. Mitochondrial dysfunction is associated with various oral diseases, such as chronic periodontitis, age-related alveolar bone loss and hydrogen peroxide-induced cell injury in gingival. Here, we reported an unexplored role of cyclophilin D (CypD), the major component of mitochondrial permeability transition pore (mPTP), in dexamethasone (Dex)-induced oxidative stress accumulation and cell dysfunctions in gingival tissue. We demonstrated that the expression level of CypD significantly increased under Dex treatment. Blockade of CypD by pharmaceutical inhibitor cyclosporine A (CsA) significantly protected against Dex-induced oxidative stress accumulation in gingival tissue. And the protective effects of blocking CypD in Dex-induced gingival fibroblasts dysfunction were evidenced by rescued mitochondrial function and suppressed production of reactive oxygen species (ROS). In addition, blockade of CypD by pharmaceutical inhibitor CsA or gene knockdown also restored Dex-induced cell toxicity in HGF-1 cells, as shown by suppressed mitochondrial ROS production, increased CcO activity and decreased apoptosis. We also suggested a role of oxidative stress-mediated p38 signal transduction in this event, and antioxidant N-acety-l-cysteine (NAC) could obviously blunted Dex-induced oxidative stress. These findings provide new insights into the role of CypD-dependent mitochondrial pathway in the Dex-induced gingival injury, indicating that CypD may be potential therapeutic strategy for preventing Dex-induced oxidative stress and cell injury in gingival tissue.	[He, Yuting; Zhang, Ling; Zhu, Zhuoli; Yu, Haiyang; Gan, Xueqi] Sichuan Univ, West China Hosp Stomatol, Dept Prosthodont, Chengdu, Peoples R China; [Xiao, Anqi] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Peoples R China	Sichuan University; Sichuan University	Gan, XQ (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dept Prosthodont, Chengdu, Peoples R China.	xueqigan@scu.edu.cn			National Natural Science Foundation of China [81400483]; National Key Research and Development Program of China [2016YFC1102704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This study was sponsored by National Natural Science Foundation of China (no. 81400483) and National Key Research and Development Program of China (no.2016YFC1102704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines CP, 2009, J MOL CELL CARDIOL, V46, P850, DOI 10.1016/j.yjmcc.2009.02.007; Bouvard B, 2013, JOINT BONE SPINE, V80, P77, DOI 10.1016/j.jbspin.2012.01.009; Cavagni Juliano, 2005, Braz. oral res., V19, P290, DOI 10.1590/S1806-83242005000400010; Chang MC, 2016, ONCOTARGET, V7, P16879, DOI 10.18632/oncotarget.7621; Du H, 2014, BBA-MOL BASIS DIS, V1842, P2517, DOI 10.1016/j.bbadis.2013.03.004; Du H, 2010, BBA-MOL BASIS DIS, V1802, P198, DOI 10.1016/j.bbadis.2009.07.005; Elrod JW, 2013, CIRC J, V77, P1111, DOI 10.1253/circj.CJ-13-0321; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Ezzat BA, 2014, J ORAL PATHOL MED, V43, P148, DOI 10.1111/jop.12104; Feng YL, 2014, CHEM-BIOL INTERACT, V207, P26, DOI 10.1016/j.cbi.2013.11.004; Filipovic D, 2011, J NEUROSCI RES, V89, P1461, DOI 10.1002/jnr.22687; Fonai F, 2015, BBA-MOL BASIS DIS, V1852, P2563, DOI 10.1016/j.bbadis.2015.09.004; Garcia VG, 2010, LASER MED SCI, V25, P197, DOI 10.1007/s10103-009-0678-z; Ghezzi P, 2016, BRIT J PHARM; Guo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054914; Jandova J, 2013, EXP CELL RES, V319, P750, DOI 10.1016/j.yexcr.2012.11.016; Jung WW, 2014, INT J MOL MED, V33, P1327, DOI 10.3892/ijmm.2014.1666; Li J, 2015, INT J CLIN EXP PATHO, V8, P13695; Li X, 2016, EXP CELL RES, V347, P212, DOI 10.1016/j.yexcr.2016.08.007; LIPARI WA, 1974, J PERIODONTOL, V45, P879, DOI 10.1902/jop.1974.45.12.879; Liu J, 2016, MOL PHARMACEUT, V13, P73, DOI 10.1021/acs.molpharmaceut.5b00516; Miura T, 2012, CARDIOVASC RES, V94, P181, DOI 10.1093/cvr/cvr302; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Psarra AMG, 2008, IUBMB LIFE, V60, P210, DOI 10.1002/iub.37; Qin LS, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0174-1; Shen C, 2015, OSTEOARTHR CARTILAGE, V23, P2279, DOI 10.1016/j.joca.2015.06.020; Sionov RV, 2006, J EXP MED, V203, P189, DOI 10.1084/jem.20050433; Suwanjang W, 2016, NEUROCHEM INT, V97, P34, DOI 10.1016/j.neuint.2016.05.003; Zhen YF, 2014, J CELL PHYSIOL, V229, P1475, DOI 10.1002/jcp.24589; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	30	7	7	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173270	10.1371/journal.pone.0173270	http://dx.doi.org/10.1371/journal.pone.0173270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273124	Green Published, gold			2022-12-27	WOS:000396073700051
J	Puhakka, N; Bot, AM; Vuokila, N; Debski, KJ; Lukasiuk, K; Pitkanen, A				Puhakka, Noora; Bot, Anna Maria; Vuokila, Niina; Debski, Konrad Jozef; Lukasiuk, Katarzyna; Pitkanen, Asla			Chronically dysregulated NOTCH1 interactome in the dentate gyrus after traumatic brain injury	PLOS ONE			English	Article							MICRORNA EXPRESSION; HIPPOCAMPUS; EPILEPSY; MODELS; CELLS; EPILEPTOGENESIS; EPIDEMIOLOGY; ACTIVATION; BIOMARKERS; PROFILES	Traumatic brain injury (TBI) can result in several dentate gyrus-regulated disabilities. Almost nothing is known about the chronic molecular changes after TBI, and their potential as treatment targets. We hypothesized that chronic transcriptional alterations after TBI are under microRNA (miRNA) control. Expression of miRNAs and their targets in the dentate gyrus was analyzed using microarrays at 3 months after experimental TBI. Of 305 miRNAs present on the miRNA-array, 12 were downregulated (p<0.05). In parallel, 75 of their target genes were upregulated (p<0.05). A bioinformatics analysis of miRNA targets highlighted the dysregulation of the transcription factor NOTCH1 and 39 of its target genes (NOTCH1 interactome). Validation assays confirmed downregulation of miR-139-5p, upregulation of Notch1 and its activated protein, and positive enrichment of NOTCH1 target gene expression. These findings demonstrate that miRNA-based transcriptional regulation can be present at chronic time points after TBI, and highlight the NOTCH1 interactome as one of the mechanisms behind the dentate gyrus pathology-related morbidities.	[Puhakka, Noora; Vuokila, Niina; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, Kuopio, Finland; [Bot, Anna Maria; Debski, Konrad Jozef; Lukasiuk, Katarzyna] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland	University of Eastern Finland; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, Kuopio, Finland.	asla.pitkanen@uef.fi		Lukasiuk, Katarzyna/0000-0002-1582-0920; Debski, Konrad/0000-0001-5949-9211	Academy of Finland; FP7-HEALTH project [602102]; National Research Centre [2011/01/M/NZ3/02139]; Ministry of Science and Education [DNP/N119/ESF-EuroEPINOMICS/2012]	Academy of Finland(Academy of Finland); FP7-HEALTH project; National Research Centre(National Research Centre (NRC)); Ministry of Science and Education	This study was supported by the Academy of Finland http://www.aka.fi/en (AP) and FP7-HEALTH project 602102 https://ec.europa.eu/research/fp7/index_en.cfm (EPITARGET), National Research Centre grant 2011/01/M/NZ3/02139 (KL), and Ministry of Science and Education grant DNP/N119/ESF-EuroEPINOMICS/2012.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Balaraman S, 2012, ALCOHOL CLIN EXP RES, V36, P1669, DOI 10.1111/j.1530-0277.2012.01793.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barth JMI, 2014, MIOMED RES; Bekris LM, 2015, NEURODEGENER DIS MAN, V5, P61, DOI [10.2217/nmt.14.52, 10.2217/NMT.14.52]; Boese AS, 2016, MOL CELL NEUROSCI, V71, P13, DOI 10.1016/j.mcn.2015.12.001; Bot AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076051; Brai E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00447; Brennan GP, 2016, CELL REP, V14, P2402, DOI 10.1016/j.celrep.2016.02.042; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Debski KJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep25668; Deprez F, 2011, NEUROBIOL DIS, V44, P174, DOI 10.1016/j.nbd.2011.06.011; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Fernandez-Espejo D, 2013, NAT REV NEUROSCI, V14, P801, DOI 10.1038/nrn3608; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorter JA, 2014, NEUROBIOL DIS, V62, P508, DOI 10.1016/j.nbd.2013.10.026; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Grasso M, 2014, MOLECULES, V19, P6891, DOI 10.3390/molecules19056891; Guo YJ, 2009, PROG NEURO-PSYCHOPH, V33, P688, DOI 10.1016/j.pnpbp.2009.03.022; He M, 2012, NEURON, V73, P35, DOI 10.1016/j.neuron.2011.11.010; Hook G, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00178; Hu K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-115; Huang Yen-Hua, 2014, Biomed Res Int, V2014, P195162, DOI 10.1155/2014/195162; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Jovicic A, 2013, J NEUROSCI, V33, P5127, DOI 10.1523/JNEUROSCI.0600-12.2013; Kan AA, 2012, CELL MOL LIFE SCI, V69, P3127, DOI 10.1007/s00018-012-0992-7; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; LEWIS DA, 1986, J COMP NEUROL, V248, P1, DOI 10.1002/cne.902480102; Li MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04734; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Liu L, 2014, ADV DIFFER EQU, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0103948; Liu X, 2015, PLOS ONE; Liu XZ, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201300053; Liu Zhong, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P1, DOI 10.3724/SP.J.1011.2012.00001; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKiernan RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035921; Mi L, 2015, J CELL BIOCHEM, V116, P1195, DOI 10.1002/jcb.25065; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Naghavian R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124555; Nagy Gergely, 2002, Pathology and Oncology Research, V8, P115; Niessen K, 2011, BLOOD, V118, P1989, DOI 10.1182/blood-2010-11-319129; Patino GA, 2011, J NEUROSCI, V31, P14577, DOI 10.1523/JNEUROSCI.0361-11.2011; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Qu Y, 2014, NEUROBIOL DIS, V63, P184, DOI 10.1016/j.nbd.2013.11.023; R Core Team, 2012, LANG ENV STAT COMP; Rao P, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00039; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Risbud RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053464; Roncon P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14143; Roopra A, 2012, EPILEPSIA, V53, P2, DOI 10.1111/epi.12030; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sha LZ, 2014, MOL NEUROBIOL, V49, P633, DOI 10.1007/s12035-013-8545-0; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimada IS, 2011, STROKE, V42, P3231, DOI 10.1161/STROKEAHA.111.623280; Sibbe M, 2012, EUR J NEUROSCI, V36, P3643, DOI 10.1111/j.1460-9568.2012.08279.x; Song MX, 2014, PROTEIN CELL, V5, P851, DOI 10.1007/s13238-014-0093-5; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanase C, 2015, FUTURE ONCOL, V11, P511, DOI 10.2217/fon.14.238; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Tu J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/368082; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wang J, 2014, EXP THER MED, V8, P1671, DOI 10.3892/etm.2014.2014; Wang S., 2010, SIGN SYST EL ISSSE 2, V1, P1, DOI DOI 10.1097/FBP.0B013E328334B677; Wang Y, 2012, EXP BIOL MED, V237, P1424, DOI 10.1258/ebm.2012.012123; Zattoni M, 2011, J NEUROSCI, V31, P4037, DOI 10.1523/JNEUROSCI.6210-10.2011; Zhang LJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-124; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang Z, 2015, BRAIN RES BULL, V113, P8, DOI 10.1016/j.brainresbull.2015.02.003	85	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172521	10.1371/journal.pone.0172521	http://dx.doi.org/10.1371/journal.pone.0172521			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273100	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700077
J	Riad, FS; Razak, E; Saba, S; Shalaby, A; Nemec, J				Riad, Fady S.; Razak, Eathar; Saba, Samir; Shalaby, Alaa; Nemec, Jan			Recent heart rate history affects QT interval duration in atrial fibrillation	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; RATE DEPENDENCE; MORTALITY; TORSADE; DYNAMICS; FORMULAS; POINTES	QT interval prolongation is associated with a risk of polymorphic ventricular tachycardia. QT interval shortens with increasing heart rate and correction for this effect is necessary for meaningful QT interval assessment. We aim to improve current methods of correcting the QT interval during atrial fibrillation (AF). Digitized Holter recordings were analyzed from patients with AF. Models of QT interval dependence on RR intervals were tested by sorting the beats into 20 bins based on corrected RR interval and assessing ST-T variability within the bins. Signal-averaging within bins was performed to determine QT/RR dependence. Data from 30 patients (29 men, 69.3 7.3 years) were evaluated. QT behavior in AF is well described by a linear function (slope-0.19) of steady-state corrected RR interval. Corrected RR is calculated as a combination of an exponential weight function with time-constant of 2 minutes and a smaller "immediate response" component (weight- 0.18). This model performs significantly (p<0.0001) better than models based on instantaneous RR interval only including Bazett and Fridericia. It also outperforms models based on shorter time-constants and other previously proposed models. This model may improve detection of repolarization delay in AF. QT response to heart rate changes in AF is similar to previously published QT dynamics during atrial pacing and in sinus rhythm.	[Riad, Fady S.] Univ Pittsburgh, Med Ctr, Dept Internal Med, Pittsburgh, PA USA; [Razak, Eathar; Shalaby, Alaa] VA Pittsburgh Healthcare Syst, Dept Cardiol, Pittsburgh, PA USA; [Saba, Samir; Nemec, Jan] Univ Pittsburgh, Med Ctr, Inst Heart & Vasc, Pittsburgh, PA 15260 USA; [Razak, Eathar] CHI Franciscan Hlth, Franciscan Heart & Vasc Associates St Joseph, Tacoma, WA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Nemec, J (corresponding author), Univ Pittsburgh, Med Ctr, Inst Heart & Vasc, Pittsburgh, PA 15260 USA.	limidus@hotmail.com		Riad, Fady/0000-0001-7874-2328				Aytemir K, 1999, PACE, V22, P1397, DOI 10.1111/j.1540-8159.1999.tb00635.x; Batchvarov VN, 2002, AM J PHYSIOL-HEART C, V282, pH2356, DOI 10.1152/ajpheart.00860.2001; Choy AMJ, 1999, J AM COLL CARDIOL, V34, P396, DOI 10.1016/S0735-1097(99)00226-0; Darbar D, 2007, J CARDIOVASC ELECTR, V18, P636, DOI 10.1111/j.1540-8167.2007.00817.x; EHLERT FA, 1992, AM J CARDIOL, V70, P332, DOI 10.1016/0002-9149(92)90614-5; Eisner DA, 2009, EXP PHYSIOL, V94, P520, DOI 10.1113/expphysiol.2008.044008; Fujiki A, 2011, J CARDIOL, V57, P269, DOI 10.1016/j.jjcc.2011.01.013; Fujiki A, 2011, CIRC J, V75, P274, DOI 10.1253/circj.CJ-10-0654; Gilmour RF, 1997, J AM COLL CARDIOL, V30, P209, DOI 10.1016/S0735-1097(97)00105-8; KAY GN, 1983, J AM COLL CARDIOL, V2, P806; Larroude CE, 2006, HEART RHYTHM, V3, P660, DOI 10.1016/j.hrthm.2006.02.021; LAU CP, 1988, CARDIOVASC RES, V22, P67, DOI 10.1093/cvr/22.1.67; Lin JF, 2015, INT J MED SCI, V12, P968, DOI 10.7150/ijms.13121; Luo S, 2004, J ELECTROCARDIOL, V37, P81, DOI 10.1016/j.jelectrocard.2004.08.030; Malik M, 1996, PACE, V19, P490, DOI 10.1111/j.1540-8159.1996.tb06521.x; Medenwald D, 2016, EUR J PREV CARDIOL, V23, P428, DOI 10.1177/2047487315587271; Musat DL, 2013, AM J CARDIOL, V112, P1379, DOI 10.1016/j.amjcard.2013.06.027; Nemec J, 2004, J CARDIOVASC ELECTR, V15, P550, DOI 10.1046/j.1540-8167.2004.03096.x; Noseworthy PA, 2012, ANN NONINVAS ELECTRO, V17, P340, DOI 10.1111/j.1542-474X.2012.00535.x; Pickham D, 2012, J ELECTROCARDIOL, V45, P556, DOI 10.1016/j.jelectrocard.2012.08.052; Razak E, 2011, ANN NONINVAS ELECTRO, V16, P148, DOI 10.1111/j.1542-474X.2011.00420.x; Roden DM, 2007, EUROPACE, V9, P1, DOI 10.1093/europace/eum165; Seethala S, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002395; Seethala S, 2011, HEART RHYTHM, V8, P263, DOI 10.1016/j.hrthm.2010.10.012; Tolkacheva EG, 2006, BIOPHYS J, V91, P2735, DOI 10.1529/biophysj.106.083865; Viswanathan PC, 1999, CIRCULATION, V99, P2466, DOI 10.1161/01.CIR.99.18.2466; Williams ES, 2012, AM HEART J, V164, P434, DOI 10.1016/j.ahj.2012.05.024; Yamaguchi Y, 2015, PACE, V38, P1418, DOI 10.1111/pace.12746; Zhang YY, 2011, ARCH INTERN MED, V171, P1727, DOI 10.1001/archinternmed.2011.433	29	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172962	10.1371/journal.pone.0172962	http://dx.doi.org/10.1371/journal.pone.0172962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273109	Green Submitted, Green Published, gold			2022-12-27	WOS:000396073700033
J	Rosenberger, A; Sohns, M; Friedrichs, S; Hung, RJ; Fehringer, G; McLaughlin, J; Amos, CI; Brennan, P; Risch, A; Bruske, I; Caporaso, NE; Landi, MT; Christiani, DC; Wei, YY; Bickeboller, H				Rosenberger, Albert; Sohns, Melanie; Friedrichs, Stefanie; Hung, Rayjean J.; Fehringer, Gord; McLaughlin, John; Amos, Christopher I.; Brennan, Paul; Risch, Angela; Brueske, Irene; Caporaso, Neil E.; Landi, Maria Teresa; Christiani, David C.; Wei, Yongyue; Bickeboeller, Heike			Gene-set meta-analysis of lung cancer identifies pathway related to systemic lupus erythematosus	PLOS ONE			English	Article							POOLED ANALYSIS; DNA-REPAIR; SUSCEPTIBILITY LOCUS; NEVER-SMOKERS; RISK-FACTORS; ASSOCIATION; VARIANTS; POLYMORPHISMS; INFLAMMATION; 15Q25	Introduction Gene-set analysis (GSA) is an approach using the results of single-marker genome-wide association studies when investigating pathways as a whole with respect to the genetic basis of a disease. Methods We performed a meta-analysis of seven GSAs for lung cancer, applying the method METAGSA. Overall, the information taken from 11,365 cases and 22,505 controls from within the TRICL/ILCCO consortia was used to investigate a total of 234 pathways from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. Results META-GSA reveals the systemic lupus erythematosus KEGG pathway hsa05322, driven by the gene region 6p21-22, as also implicated in lung cancer (p = 0.0306). This gene region is known to be associated with squamous cell lung carcinoma. The most important genes driving the significance of this pathway belong to the genomic areas HIST1-H4L,- 1BN, -2BN, -H2AK, -H4K and C2/C4A/C4B. Within these areas, the markers most significantly associated with LC are rs13194781 (located within HIST12BN) and rs1270942 (located between C2 and C4A). Conclusions We have discovered a pathway currently marked as specific to systemic lupus erythematosus as being significantly implicated in lung cancer. The gene region 6p21-22 in this pathway appears to be more extensively associated with lung cancer than previously assumed. Given wide-stretched linkage disequilibrium to the area APOM/BAG6/MSH5, there is currently simply not enough information or evidence to conclude whether the potential pleiotropy of lung cancer and systemic lupus erythematosus is spurious, biological, or mediated. Further research into this pathway and gene region will be necessary.	[Rosenberger, Albert; Sohns, Melanie; Friedrichs, Stefanie; Bickeboeller, Heike] Georg August Univ Gottingen, Univ Med Ctr, Dept Genet Epidemiol, Gottingen, Germany; [Hung, Rayjean J.; Fehringer, Gord] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Hung, Rayjean J.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [McLaughlin, John] Publ Hlth Ontario, Toronto, ON, Canada; [Amos, Christopher I.] Geisel Sch Med Dartmouth, Dept Biomed Data Sci, Hanover, NH USA; [Brennan, Paul] Int Agcy Res Canc, Lyon, France; [Risch, Angela] Salzburg Univ, Div Mol Biol, Salzburg, Austria; [Brueske, Irene] Helmholtz Ctr Munich, Inst Epidemiol 1, Munich, Germany; [Caporaso, Neil E.; Landi, Maria Teresa] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Christiani, David C.; Wei, Yongyue] Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA	University of Gottingen; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Dartmouth College; World Health Organization; International Agency for Research on Cancer (IARC); Salzburg University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health	Rosenberger, A (corresponding author), Georg August Univ Gottingen, Univ Med Ctr, Dept Genet Epidemiol, Gottingen, Germany.	arosenb@gwdg.de	Bickeböller, Heike/V-2318-2018; Hung, Rayjean J/A-7439-2013; Risch, Angela/H-2669-2013; Wei, Yongyue/GYV-5660-2022	Bickeböller, Heike/0000-0002-3361-5488; Risch, Angela/0000-0002-8026-5505; Wei, Yongyue/0000-0002-1132-1796; Rosenberger, Albert/0000-0001-7848-1332	National Institute of Health (NIH) [U19CA148127]; Canadian Cancer Society Research Institute [020214]; Cancer Care Ontario Chair Award; Deutsche Krebshilfe [70-2919]; Helmholtz-Gemeinschaft (HGF) Munich; National Genome Research Network (NGFN); Deutsche Forschungsgemeinschaft DFG [BI 576/2-1, BI 576/2-2]; Federal Office for Radiation Protection [BfS: STSch4454]; European Community [LSHG-CT-2005-512113]; Norwegian Cancer Association; Functional Genomics Programme of Research Council of Norway; European Regional Development Fund; State Budget of the Czech Republic (RECAMO) [CZ.1.05/2.1.00/03.0101]; FP7 [REGPOT 245536]; Estonian Government [SF0180142s08]; EU RDF in the frame of Centre of Excellence in Genomics and Estoinian Research Infrastructure's Roadmap; University of Tartu (SP1GVARENG); Intramural Research Program of National Institute of Health (NIH), National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics; U.S. Public Health Service from the NCI [N01-CN-45165, N01-RC-45035, N01-RC 37004]; NCI [N01-CN-25514]; Georgetown University [N01-CN-25522]; Pacific Health Research Institute [N01-CN-25515]; Henry Ford Health System [N01-CN-25512]; University of Minnesota [N01-CN-25513]; Washington University [N01-CN-25516]; University of Pittsburgh [N01-CN-25511]; University of Utah [N01-CN-25524]; Marshfield Clinic Research Foundation [N01-CN-25518]; University of Alabama at Birmingham (Westat, Inc.) [N01-CN-75022, NO1-CN-25476]; University of California, Los Angeles [N01-CN-25404]; American Cancer Society; NIH Genes, Environment and Health Initiative [HG-06-033-NCI-01, RO1HL091172-01]; NIH grants [P50 CA70907, RO1CA121197, RO1 CA127219, U19 CA148127, RO1 CA55769]; CPRIT [RP100443]; NIH [HHSN2682007820 96C]; NHI [CA074386, CA092824, CA090578]; HGF; Institut National du Cancer, France; NATIONAL CANCER INSTITUTE [R35CA197449, P30CA023108] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Cancer Care Ontario Chair Award; Deutsche Krebshilfe(Deutsche Krebshilfe); Helmholtz-Gemeinschaft (HGF) Munich; National Genome Research Network (NGFN); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Federal Office for Radiation Protection; European Community(European Commission); Norwegian Cancer Association; Functional Genomics Programme of Research Council of Norway; European Regional Development Fund(European Commission); State Budget of the Czech Republic (RECAMO); FP7; Estonian Government; EU RDF in the frame of Centre of Excellence in Genomics and Estoinian Research Infrastructure's Roadmap; University of Tartu (SP1GVARENG); Intramural Research Program of National Institute of Health (NIH), National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics; U.S. Public Health Service from the NCI; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgetown University; Pacific Health Research Institute; Henry Ford Health System; University of Minnesota(University of Minnesota System); Washington University; University of Pittsburgh(University of Pittsburgh); University of Utah; Marshfield Clinic Research Foundation; University of Alabama at Birmingham (Westat, Inc.); University of California, Los Angeles(University of California System); American Cancer Society(American Cancer Society); NIH Genes, Environment and Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHI; HGF; Institut National du Cancer, France(Institut National du Cancer (INCA) France); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a grant from the National Institute of Health (NIH) (U19CA148127). The Toronto study was supported by Canadian Cancer Society Research Institute (020214), Ontario Institute of Cancer and ILCCO data management was supported by the Cancer Care Ontario Chair Award to R.H. The German Lung Cancer Study (GLC) consists of three data sets. The Heidelberg Lung Cancer Study was in part supported by a grant (70-2919) from the Deutsche Krebshilfe. The KORA Surveys were financed by the Helmholtz-Gemeinschaft (HGF) Munich. The LUng Cancer in the Young (LUCY) study was funded in part by the National Genome Research Network (NGFN), the Deutsche Forschungsgemeinschaft DFG (BI 576/2-1; BI 576/2-2), the HGF and the Federal Office for Radiation Protection (BfS: STSch4454). Genotyping was performed in the Genome-Analysis-Center (GAC) of the Helmholtz Zentrum MOnchen (HMGU). Support for the Central Europe, HUNT2/Tromso and CARET genome-wide studies was provided by Institut National du Cancer, France. Support for the HUNT2/Tromso genome-wide study was also provided by the European Community (Integrated Project DNA repair, LSHG-CT-2005-512113), the Norwegian Cancer Association and the Functional Genomics Programme of Research Council of Norway. Support for the Central Europe study, Czech Republic, was also provided by the European Regional Development Fund and the State Budget of the Czech Republic (RECAMO, CZ.1.05/2.1.00/03.0101). The lung cancer GWAS from Estonia was partly supported by a FP7 grant (REGPOT 245536), by the Estonian Government (SF0180142s08), by EU RDF in the frame of Centre of Excellence in Genomics and Estoinian Research Infrastructure's Roadmap and by University of Tartu (SP1GVARENG). The Environment and Genetics in Lung Cancer Etiology (EAGLE), the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC) and the Prostate, Lung, Colon, Ovary Screening Trial (PLCO) studies and the genotyping of ATBC, the Cancer Prevention Study II Nutrition Cohort (CPS-II) and part of PLCO were supported by the Intramural Research Program of National Institute of Health (NIH), National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics. ATBC was also supported by U.S. Public Health Service contracts (N01-CN-45165, N01-RC-45035 and N01-RC 37004) from the NCI. PLCO was also supported by individual contracts from the NCI to the University of Colorado Denver (N01-CN-25514), Georgetown University (N01-CN-25522), Pacific Health Research Institute (N01-CN-25515), Henry Ford Health System (N01-CN-25512), University of Minnesota (N01-CN-25513), Washington University (N01-CN-25516), University of Pittsburgh (N01-CN-25511), University of Utah (N01-CN-25524), Marshfield Clinic Research Foundation (N01-CN-25518), University of Alabama at Birmingham (N01-CN-75022, Westat, Inc. NO1-CN-25476), University of California, Los Angeles (N01-CN-25404). The Cancer Prevention Study II Nutrition Cohort was supported by the American Cancer Society. The NIH Genes, Environment and Health Initiative (GED partly funded DNA extraction and statistical analyses (HG-06-033-NCI-01 and RO1HL091172-01), genotyping at the Johns Hopkins University Center for Inherited Disease Research (U01HG004438 and NIH HHSN268200782096C) and study coordination at the GENEVA Coordination Center (U01 HG004446) for EAGLE and part of PLCO studies. Funding for the MD Anderson Cancer Study was provided by NIH grants (P50 CA70907, RO1CA121197, RO1 CA127219, U19 CA148127, RO1 CA55769) and CPRIT grant (RP100443).; Genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is funded through a federal contract from the NIH to The Johns Hopkins University (HHSN2682007820 96C). The Harvard Lung Cancer Study was funded by Funded by NHI (CA074386, CA092824, CA090578).	1000 Genomes Project Consortium, 2012, Nature, V491, P56, DOI 10.1038/nature11632; Ahmad T, 2003, HUM MOL GENET, V12, P647, DOI 10.1093/hmg/ddg066; Alonso MD, 2014, RHEUMATOL INT, V34, P11, DOI 10.1007/s00296-013-2798-9; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; [Anonymous], 1995, KEEG PATHW DAT; Brennan P, 2011, LANCET ONCOL, V12, P399, DOI 10.1016/S1470-2045(10)70126-1; Brenner DR, 2013, HUM GENET, V132, P579, DOI 10.1007/s00439-013-1270-y; Brenner DR, 2012, AM J EPIDEMIOL, V176, P573, DOI 10.1093/aje/kws151; Brenner DR, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-285; Brinks R, 2014, LUPUS, V23, P1407, DOI 10.1177/0961203314540352; Burkart KM, 2014, EUR RESPIR J, V43, P1003, DOI 10.1183/09031936.00147612; Cassidy A, 2006, BRIT J CANCER, V95, P1288, DOI 10.1038/sj.bjc.6603386; Chang M., 2008, ADAPTIVE DESIGN THEO; Chang M, 2007, STAT MED, V26, P2772, DOI 10.1002/sim.2755; Chervona Y, 2012, AM J CANCER RES, V2, P589; Costa-Reis P, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0369-4; Cunningham F, 2014, NUCL ACIDS RES; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Fehringer G, 2012, CANCER EPIDEM BIOMAR, V21, P1097, DOI 10.1158/1055-9965.EPI-11-1123-T; Fehringer G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031816; Fernando Michelle M A, 2012, Ann Rheum Dis, V71, P777, DOI 10.1136/annrheumdis-2011-200808; Gomes M, 2014, ADV EXP MED BIOL, V816, P1, DOI 10.1007/978-3-0348-0837-8_1; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; House NCM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00296; Hsueh Huey-miin, 2003, J Biopharm Stat, V13, P675, DOI 10.1081/BIP-120024202; Hung RJ, 2008, CANCER EPIDEM BIOMAR, V17, P3081, DOI 10.1158/1055-9965.EPI-08-0411; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kazma R, 2012, CARCINOGENESIS, V33, P1059, DOI 10.1093/carcin/bgs116; Kiyohara C, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/701760; Kreuzer M, 1998, AM J EPIDEMIOL, V147, P1028; Lee PN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-385; Leffler J, 2014, ANN RHEUM DIS, V73, P1601, DOI 10.1136/annrheumdis-2014-205287; Leng SG, 2013, CARCINOGENESIS, V34, P1044, DOI 10.1093/carcin/bgt024; Luo L, 2010, EUR J HUM GENET, V18, P1045, DOI 10.1038/ejhg.2010.62; Malzahn D, 2015, BMC P 2015 IN PRESS; Manuguerra M, 2006, AM J EPIDEMIOL, V164, P297, DOI 10.1093/aje/kwj189; Nguyen JDU, 2014, CARCINOGENESIS, V35, P2653, DOI 10.1093/carcin/bgu184; Ni J, 2014, LUPUS, V23, P284, DOI 10.1177/0961203313520060; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Rosenberger A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140179; Sohns Melanie, 2009, BMC Proc, V3 Suppl 7, pS95, DOI 10.1186/1753-6561-3-S7-S95; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Timofeeva M, 2010, INT J CANCER, V127, P1547, DOI 10.1002/ijc.25175; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Tintle N, 2009, GENET EPIDEMIOL, V33, pS74, DOI 10.1002/gepi.20476; Truong T, 2010, JNCI-J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178; Wang YF, 2014, NAT GENET, V46, P736, DOI 10.1038/ng.3002; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273	51	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173339	10.1371/journal.pone.0173339	http://dx.doi.org/10.1371/journal.pone.0173339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273134	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700053
J	Rubio, CA				Rubio, Carlos A.			Corrupted colonic crypt fission in carcinogen-treated rats	PLOS ONE			English	Article							LYMPHOID-TISSUE; TUMORS; CANCER; FOCI	Background The colonic crypts in rats reproduce themselves by symmetric fission at the base of the crypts, and proceeding upwards, generate two separate identical crypts. Recently we reported corrupted colonic crypt fission (CCCF) in rats with colonic carcinoma. Here we investigated whether CCCF also occurred in the colonic mucosa without carcinoma in carcinogen-treated rats. Methods Filed Swiss-roll sections from 35 male rats (25 treated with 1,2-dimethyhydrazine (DMH) suspended in EDTA solution, and 10 EDTA-treated) were reviewed. CCCF were regarded those with either asymmetric basal fission, asymmetric lateral sprouting/lateral fission, basal dilatations, or spatial aberrations of the normal (vertical) axis. Results 202 CCCF (38%) were recorded amongst 533 crypts with fission in DMH-treated rats, and only one CCCF (0.1%) was found amongst 571 crypts with fission in EDTA-treated rats (p<0.05). The basal aspect of four adenomas included in Swiss roll sections exhibited CCCF lined either with indigenous (non-dysplastic) epithelium or with dysplastic epithelium. Conclusion It was demonstrated that CCCF without dysplasia develop in carcinogen-treated SD rats. As judged by the figures presented, the possibility that the epithelium in those corrupted crypts was successively replaced by top-down growing dysplastic cells, could not be totally rejected. This is the first report showing that non-dysplastic CCCF may antedate the very early stages of colonic carcinogenesis in SD rats.	[Rubio, Carlos A.] Karolinska Inst, Dept Pathol, Stockholm, Sweden; [Rubio, Carlos A.] Univ Hosp, Stockholm, Sweden	Karolinska Institutet	Rubio, CA (corresponding author), Karolinska Inst, Dept Pathol, Stockholm, Sweden.; Rubio, CA (corresponding author), Univ Hosp, Stockholm, Sweden.	Carlos.Rubio@ki.se			Karolinska University Hospital Research and Development Fund [77147]	Karolinska University Hospital Research and Development Fund	This study was supported by The Karolinska University Hospital Research and Development Fund No. 77147. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRD RP, 1989, CANCER SURV, V8, P189; Boman BM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00244; DEASY JM, 1983, J SURG ONCOL, V24, P36, DOI 10.1002/jso.2930240109; DRUCKREY H, 1967, NATURWISSENSCHAFTEN, V54, P285, DOI 10.1007/BF00620890; Femia AP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-194; Ghirardi M, 1999, EUR SURG RES, V31, P272, DOI 10.1159/000008703; Jang HR, 2005, J NUTR, V135, p2967S, DOI 10.1093/jn/135.12.2967S; LAQUEUR GL, 1965, VIRCHOWS ARCH A, V340, P151, DOI 10.1007/BF00958669; LAQUEUR GL, 1963, J NATL CANCER I, V31, P919; MARTIN MS, 1986, INT J CANCER, V38, P75, DOI 10.1002/ijc.2910380113; Nascimbeni R, 1999, AM J SURG PATHOL, V23, P1256, DOI 10.1097/00000478-199910000-00011; Ochiai M, 2014, CANCER SCI, V105, P943, DOI 10.1111/cas.12446; Rubio CA, 1998, APOPTOSIS, V3, P35, DOI 10.1023/A:1009607102797; RUBIO CA, 1989, DIS COLON RECTUM, V32, P488, DOI 10.1007/BF02554503; RUBIO CA, 1980, J NATL CANCER I, V64, P569; RUBIO CA, 1986, AM J PATHOL, V123, P161; RUBIO CA, 1991, APMIS, V99, P993, DOI 10.1111/j.1699-0463.1991.tb01290.x; Rubio CA, 2011, STEM CELL REGENERATI, P279; Rubio CA, 2016, J CLIN PATHOL; Rubio CA, 2017, ANTICANCER RES, V37, P15, DOI 10.21873/anticanres.11284; Rubio CA, 2016, ANTICANCER RES, V36, P5385, DOI 10.21873/anticanres.11113; SHETYE JD, 1990, CANCER RES, V50, P6358; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; STCLAIR WH, 1985, CELL TISSUE KINET, V18, P255; Tan CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078519	25	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172824	10.1371/journal.pone.0172824	http://dx.doi.org/10.1371/journal.pone.0172824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273142	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700031
J	Akpaka, PE; Kissoon, S; Wilson, C; Jayaratne, P; Smith, A; Golding, GR				Akpaka, Patrick Eberechi; Kissoon, Shivnarine; Wilson, Clyde; Jayaratne, Padman; Smith, Ashley; Golding, George R.			Molecular characterization of vancomycin-resistant Enterococcus faecium isolates from Bermuda	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; EPIDEMIOLOGY; DETERMINANTS; ESP; PCR	Molecular characteristics of vancomycin resistant enterococci isolates from Bermuda Island is currently unknown. This study was conducted to investigate phenotypic and genotypic characteristics of VRE isolates from Bermuda Island using the chromogenic agar, E-tests, polymerase chain reaction (PCR), pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Eighteen E. faecium isolates were completely analyzed and were all resistant to vancomycin, susceptible to linezolid and quinupristin/dalfopristin, positive for vanA and esp genes. The MLST analysis confirmed most isolates were of the sequence types linked to clonal complex 17 (CC17) that is widely associated with outbreaks in hospitals. Infection control measures, antibiotic stewardship, and surveillance activities will continue to be a priority in hospital on the Island.	[Akpaka, Patrick Eberechi; Kissoon, Shivnarine] Univ West Indies, Dept Paraclin Sci, St Augustine, Trinidad Tobago; [Wilson, Clyde] King Edward VII Mem Hosp, Dept Pathol & Microbiol, Hamilton, Bermuda; [Jayaratne, Padman] McMaster Univ, Dept Pathol Sci, Hamilton, ON, Canada; [Smith, Ashley] King Edward VII Mem Hosp, Dept Pharm, Hamilton, Bermuda; [Golding, George R.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	University West Indies Mona Jamaica; University West Indies Saint Augustine; McMaster University; Public Health Agency of Canada	Wilson, C (corresponding author), King Edward VII Mem Hosp, Dept Pathol & Microbiol, Hamilton, Bermuda.	clyde.wilson@bermudahospitals.bm	Smith, Ashley/GZB-0298-2022		University of the West Indies, St. Augustine Campus, Trinidad and Tobago	University of the West Indies, St. Augustine Campus, Trinidad and Tobago	The funds were provided by the University of the West Indies, St. Augustine Campus, Trinidad and Tobago. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpaka PE, 2016, ADV MED; BANNERMAN TL, 1995, J CLIN MICROBIOL, V33, P551, DOI 10.1128/JCM.33.3.551-555.1995; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P322; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; Chuang YC, 2010, J CLIN MICROBIOL, V48, P2897, DOI 10.1128/JCM.00136-10; Clinical and Laboratory Standards Institute, 2015, M100S25 CLSI; Corso AC, 2007, INT J INFECT DIS, V11, P69, DOI 10.1016/j.ijid.2006.02.003; Deshpande LM, 2007, DIAGN MICR INFEC DIS, V58, P163, DOI 10.1016/j.diagmicrobio.2006.12.022; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Healy M, 2005, J CLIN MICROBIOL, V43, P199, DOI 10.1128/JCM.43.1.199-207.2005; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Jayaratne P, 1999, J CLIN MICROBIOL, V37, P2090, DOI 10.1128/JCM.37.6.2090-2092.1999; Kissoon S, 2015, BRIT MICROBIOLOGY RE, V9, P1; Ko KS, 2005, J CLIN MICROBIOL, V43, P2303, DOI 10.1128/JCM.43.5.2303-2306.2005; Leavis H, 2004, J BACTERIOL, V186, P672, DOI 10.1128/JB.186.3.672-682.2004; McCracken M, 2013, J ANTIMICROB CHEMOTH; MURRAY BE, 1990, J CLIN MICROBIOL, V28, P2059, DOI 10.1128/JCM.28.9.2059-2063.1990; MURRAY BE, 1991, J CLIN MICROBIOL, V29, P418; NNIS System, 2001, AM J INFECT CONTROL, V29, P404, DOI 10.1067/mic.2001.119952; Panesso D, 2010, J CLIN MICROBIOL, V48, P1562, DOI 10.1128/JCM.02526-09; Smith S, 1999, J CLIN MICROBIOL, V37, P1231, DOI 10.1128/JCM.37.4.1231-1232.1999; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Turabelidze D, 2000, J CLIN MICROBIOL, V38, P4242, DOI 10.1128/JCM.38.11.4242-4245.2000; UTTLEY AHC, 1988, LANCET, V1, P57; Vankerckhoven V, 2004, J CLIN MICROBIOL, V42, P4473, DOI 10.1128/JCM.42.10.4473-4479.2004; Vergis EN, 2001, ANN INTERN MED, V135, P484, DOI 10.7326/0003-4819-135-7-200110020-00007; Willems RJL, 2005, EMERG INFECT DIS, V11, P821, DOI 10.3201/1106.041204	28	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0171317	10.1371/journal.pone.0171317	http://dx.doi.org/10.1371/journal.pone.0171317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267763	gold, Green Published, Green Submitted			2022-12-27	WOS:000396060600058
J	Koenen, A; Babendreyer, A; Schumacher, J; Pasqualon, T; Schwarz, N; Seifert, A; Deupi, X; Ludwig, A; Dreymueller, D				Koenen, Andrea; Babendreyer, Aaron; Schumacher, Julian; Pasqualon, Tobias; Schwarz, Nicole; Seifert, Anke; Deupi, Xavier; Ludwig, Andreas; Dreymueller, Daniela			The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion	PLOS ONE			English	Article							LIGAND CXCL16; TNF-ALPHA; T-CELLS; INFLAMMATION; INTERNALIZATION; MIGRATION; SYSTEM; ATHEROSCLEROSIS; PROLIFERATION; ACCUMULATION	The CXC-chemokine receptor 6 (CXCR6) is a class A GTP-binding protein-coupled receptor (GPCRs) that mediates adhesion of leukocytes by interacting with the transmembrane cell surface-expressed chemokine ligand 16 (CXCL16), and also regulates leukocyte migration by interacting with the soluble shed variant of CXCL16. In contrast to virtually all other chemokine receptors with chemotactic activity, CXCR6 carries a DRF motif instead of the typical DRY motif as a key element in receptor activation and G protein coupling. In this work, modeling analyses revealed that the phenylalanine F-3.51 in CXCR6 might have impact on intramolecular interactions including hydrogen bonds by this possibly changing receptor function. Initial investigations with embryonic kidney HEK293 cells and further studies with monocytic THP-1 cells showed that mutation of DRF into DRY does not influence ligand binding, receptor internalization, receptor recycling, and protein kinase B (AKT) signaling. Adhesion was slightly decreased in a time-dependent manner. However, CXCL16-induced calcium signaling and migration were increased. Vice versa, when the DRY motif of the related receptor CX(3)CR1 was mutated into DRF the migratory response towards CX(3)CL1 was diminished, indicating that the presence of a DRF motif generally impairs chemotaxis in chemokine receptors. Transmembrane and soluble CXCL16 play divergent roles in homeostasis, inflammation, and cancer, which can be beneficial or detrimental. Therefore, the DRF motif of CXCR6 may display a receptor adaptation allowing adhesion and cell retention by transmembrane CXCL16 but reducing the chemotactic response to soluble CXCL16. This adaptation may avoid permanent or uncontrolled recruitment of inflammatory cells as well as cancer metastasis.	[Koenen, Andrea; Babendreyer, Aaron; Schumacher, Julian; Pasqualon, Tobias; Seifert, Anke; Ludwig, Andreas; Dreymueller, Daniela] Rhein Westfal TH Aachen, Fac Med, Inst Pharmacol & Toxicol, Aachen, Germany; [Schwarz, Nicole] Rhein Westfal TH Aachen, Fac Med, Inst Mol & Cellular Anat, Aachen, Germany; [Deupi, Xavier] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Deupi, Xavier] Paul Scherrer Inst, Condensed Matter Theory Grp, Villigen, Switzerland	RWTH Aachen University; RWTH Aachen University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Dreymueller, D (corresponding author), Rhein Westfal TH Aachen, Fac Med, Inst Pharmacol & Toxicol, Aachen, Germany.	daniela.dreymueller@rwth-aachen.de	Dreymueller, Daniela/B-9590-2016; Schwarz, Nicole/ABC-8096-2020; Deupi, Xavier/B-2424-2009; Yildiz, Daniela/AAP-9473-2020; Ludwig, Andreas/I-5685-2012	Dreymueller, Daniela/0000-0002-9702-8581; Deupi, Xavier/0000-0003-4572-9316; Yildiz, Daniela/0000-0002-9702-8581; Ludwig, Andreas/0000-0001-8536-4986; Babendreyer, Aaron/0000-0001-7207-8139; Schwarz, Nicole/0000-0001-7888-6970	START (RWTH Aachen, Germany); DFG grant [Lu869/4-1-2]; Swiss National Science Foundation [146520]; COST Action [CM1207]	START (RWTH Aachen, Germany); DFG grant(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); COST Action(European Cooperation in Science and Technology (COST))	This work was supported in part by START (RWTH Aachen, Germany (D.D.)), by the DFG grant Lu869/4-1-2 (AL), and by the Swiss National Science Foundation grant 146520 (X.D.). This work was also supported by COST Action CM1207 (GLISTEN) (X.D.). Molecular dynamics simulations were run at the Swiss National Supercomputing Centre (CSCS).	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; Andrzejewski MG, 2010, BIOCHEM BIOPH RES CO, V395, P178, DOI 10.1016/j.bbrc.2010.03.139; Berchiche YA, 2007, J BIOL CHEM, V282, P5111, DOI 10.1074/jbc.C600270200; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Borst O, 2012, AM J PHYSIOL-CELL PH, V302, pC644, DOI 10.1152/ajpcell.00340.2011; Burger M, 1999, J IMMUNOL, V163, P2017; Chandrasekar B, 2004, J BIOL CHEM, V279, P3188, DOI 10.1074/jbc.M311660200; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Dawaliby R, 2016, NAT CHEM BIOL, V12, P35, DOI [10.1038/NCHEMBIO.1960, 10.1038/nchembio.1960]; Day C, 2009, EXP LUNG RES, V35, P272, DOI 10.1080/01902140802635517; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dreymueller D, 2016, J CELL MOL MED, V20, P104, DOI 10.1111/jcmm.12708; Fang YY, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/478641; Galkina E, 2007, CIRCULATION, V116, P1801, DOI 10.1161/CIRCULATIONAHA.106.678474; Germanov E, 2008, J IMMUNOL, V181, P81, DOI 10.4049/jimmunol.181.1.81; Han XB, 2015, FEBS OPEN BIO, V5, P182, DOI 10.1016/j.fob.2015.03.001; Hase K, 2006, J IMMUNOL, V176, P43, DOI 10.4049/jimmunol.176.1.43; Hattermann K, 2008, MOL CELL NEUROSCI, V39, P133, DOI 10.1016/j.mcn.2008.03.009; Hattermann K, 2016, ELIFE, V5, DOI 10.7554/eLife.10820; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Heydtmann M, 2005, J IMMUNOL, V174, P1055, DOI 10.4049/jimmunol.174.2.1055; Hofnagel O, 2011, ATHEROSCLEROSIS, V217, P371, DOI 10.1016/j.atherosclerosis.2011.04.021; Hu WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099056; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Isberg V, 2016, NUCLEIC ACIDS RES, V44, pD356, DOI 10.1093/nar/gkv1178; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Jensen ASM, 2012, ADV VIROL, V2012, DOI 10.1155/2012/231813; Kee JY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-949; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Latta M, 2007, IMMUNOLOGY, V121, P555, DOI 10.1111/j.1365-2567.2007.02603.x; Lehrke M, 2007, J AM COLL CARDIOL, V49, P442, DOI 10.1016/j.jacc.2006.09.034; Leschner J, 2013, J PHARMACOL EXP THER, V344, P85, DOI 10.1124/jpet.112.199190; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Matsumura S, 2008, J IMMUNOL, V181, P3099, DOI 10.4049/jimmunol.181.5.3099; Meijer J, 2008, CANCER RES, V68, P4701, DOI 10.1158/0008-5472.CAN-08-0482; Morgan AJ, 2005, CLIN EXP ALLERGY, V35, P1572, DOI 10.1111/j.1365-2222.2005.02383.x; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; Nomiyama H, 2015, J LEUKOCYTE BIOL, V97, P39, DOI 10.1189/jlb.2RU0614-290R; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Petit SJ, 2011, ARTERIOSCL THROM VAS, V31, P914, DOI 10.1161/ATVBAHA.110.220558; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reig G, 2014, DEVELOPMENT, V141, P1999, DOI 10.1242/dev.101451; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Schramme A, 2008, BIOCHEM BIOPH RES CO, V370, P311, DOI 10.1016/j.bbrc.2008.03.088; Schwarz N, 2010, CELL MOL LIFE SCI, V67, P4233, DOI 10.1007/s00018-010-0433-4; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh SP, 2015, MOL PHARMACOL, V88, P894, DOI 10.1124/mol.115.099960; Speyer CL, 2011, J INVEST SURG, V24, P18, DOI 10.3109/08941939.2010.521232; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Tsai FC, 2014, NAT CELL BIOL, V16, P133, DOI 10.1038/ncb2906; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang J, 2014, DEVELOPMENT, V141, P4199, DOI 10.1242/dev.101071; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Wehr A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112327; Wehr A, 2013, J IMMUNOL, V190, P5226, DOI 10.4049/jimmunol.1202909; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Xia YF, 2014, KIDNEY INT, V86, P327, DOI 10.1038/ki.2014.64; Yamauchi R, 2004, ARTERIOSCL THROM VAS, V24, P282, DOI 10.1161/01.ATV.0000114565.42679.c6; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhao LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087786	67	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173486	10.1371/journal.pone.0173486	http://dx.doi.org/10.1371/journal.pone.0173486			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267793	Green Published, Green Submitted, gold			2022-12-27	WOS:000396060600036
J	Knipe, DW; Chang, SS; Dawson, A; Eddleston, M; Konradsen, F; Metcalfe, C; Gunnell, D				Knipe, Duleeka W.; Chang, Shu-Sen; Dawson, Andrew; Eddleston, Michael; Konradsen, Flemming; Metcalfe, Chris; Gunnell, David			Suicide prevention through means restriction: Impact of the 2008-2011 pesticide restrictions on suicide in Sri Lanka	PLOS ONE			English	Article							REGULATORY ACTION; SELF-HARM; MORTALITY; CHINA	Objective To investigate the effect of 3-year phased bans of the pesticides dimethoate and fenthion in 2008-2010, and paraquat in 2009-2011, on suicide mortality in Sri Lanka. Methods Age-standardised overall, sex-specific, and method-specific suicide rates were calculated using Sri Lankan police data (1989-2015). Using negative binomial regression models, we estimated the change in the rate and number of suicide deaths in post-ban years (2011-15) compared to those expected based on pre-ban trends (2001-10). Findings Overall suicide mortality dropped by 21% between 2011 and 2015, from 18.3 to 14.3 per 100,000. The decline in pesticide suicides during this same period was larger than for overall suicides: from 8.5 to 4.2 per 100,000, a 50% reduction. This was accompanied by a smaller concurrent rise in non-pesticide suicide mortality with a 2% increase (9.9 to 10.1 per 100,000). In 2015, the ratio between the observed and expected pesticide suicide rates was 0.49 (95% confidence interval [CI] 0.40, 0.62), corresponding to an estimated 937 (95% CI 574, 1389) fewer pesticide suicides than expected from pre-ban suicide rates. Findings were similar in sensitivity analyses using 2008 or 2012 as commencement of the post intervention period. Conclusion Bans of paraquat, dimethoate and fenthion in Sri Lanka were associated with a reduction in pesticide suicide mortality and in overall suicide mortality despite a small rise in other methods. This study provides further evidence for the effectiveness of pesticide regulation in limiting the availability of highly hazardous pesticides and thereby reducing the number of global suicides.	[Knipe, Duleeka W.; Dawson, Andrew; Eddleston, Michael; Konradsen, Flemming] Univ Peradeniya, Fac Med, SACTRC, Peradeniya, Sri Lanka; [Knipe, Duleeka W.; Metcalfe, Chris; Gunnell, David] Univ Bristol, Sch Social & Community Med, Canynge Hall, Bristol, Avon, England; [Chang, Shu-Sen] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Behaviors & Community Sci, Taipei, Taiwan; [Chang, Shu-Sen] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei, Taiwan; [Dawson, Andrew] Univ Sydney, Cent Clin Sch, Sydney, NSW, Australia; [Eddleston, Michael] Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Pharmacol Toxicol & Therapeut, Edinburgh, Midlothian, Scotland; [Konradsen, Flemming] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark	University of Peradeniya; University of Bristol; National Taiwan University; National Taiwan University; University of Sydney; University of Edinburgh; University of Copenhagen	Gunnell, D (corresponding author), Univ Bristol, Sch Social & Community Med, Canynge Hall, Bristol, Avon, England.	D.J.Gunnell@Bristol.ac.uk	Chang, Shu-Sen/B-3518-2012; Chang, Shu-Sen/AAH-6733-2021; Dawson, Andrew H/U-8041-2019; Gunnell, David/ABE-6653-2020	Chang, Shu-Sen/0000-0001-5012-1132; Chang, Shu-Sen/0000-0001-5012-1132; Dawson, Andrew H/0000-0002-8047-397X; Gunnell, David/0000-0002-0829-6470; Knipe, Duleeka/0000-0002-1040-7635; Konradsen, Flemming/0000-0003-1036-6949; Metcalfe, Chris/0000-0001-8318-8907	Wellcome Trust [WT099874MA]; ESRC [ES/P009735/1] Funding Source: UKRI; Economic and Social Research Council [ES/P009735/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10068] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	DK is funded by the Wellcome Trust (WT099874MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad OB, AGE STANDARDIZATION; Bourke T, 2001, Pac Health Dialog, V8, P213; Cha ES, 2015, INT J EPIDEMIOL; Chang SS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5239; Dawson A, 2016, CLIN TOXICOL, V54, P664; Dawson AH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000357; de Silva VA, 2012, B WORLD HEALTH ORGAN, V90, P40, DOI 10.2471/BLT.11.091785; Eddleston M, 2002, LANCET, V360, P1163, DOI 10.1016/S0140-6736(02)11204-9; Eddleston M, 2011, SOC SCI MED, V72, P1, DOI 10.1016/j.socscimed.2010.10.013; Food and Agriculture Organization of the United Nations WHO, 2016, INT COD COND PEST MA; Gunnell D, 2007, INT J EPIDEMIOL, V36, P1235, DOI 10.1093/ije/dym164; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; Ito T., 2008, J RURAL MED, V3, P5; Knipe DW, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-839; Liu S, 2015, PSYCHOL MED, V45, P3259, DOI 10.1017/S0033291715001269; National Cancer Institute, 2017, NUMB JOINP; Page A, 2017, J AFFECT DISORDERS, V208, P418, DOI 10.1016/j.jad.2016.10.047; Patel V, 2012, LANCET, V379, P2343, DOI 10.1016/S0140-6736(12)60606-0; Pearson M, 2013, HLTH POLICY PLAN; Rajapakse T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2435-5; Wang CW, 2014, SOC PSYCH PSYCH EPID, V49, P929, DOI 10.1007/s00127-013-0789-5; Wheeler BW, 2008, BMJ-BRIT MED J, V336, P542, DOI 10.1136/bmj.39462.375613.BE; Wheeler BW, 2009, PHARMACOEPIDEM DR S, V18, P579, DOI 10.1002/pds.1753; World Health Organization, 2014, PREV SUIC PREV SUIC; Wu KCC, 2012, INT J ENV RES PUB HE, V9, P1135, DOI 10.3390/ijerph9041135; Yip PSF, 2012, LANCET, V379, P2393, DOI 10.1016/S0140-6736(12)60521-2	26	56	57	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172893	10.1371/journal.pone.0172893	http://dx.doi.org/10.1371/journal.pone.0172893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5OE	28264041	Green Published, gold			2022-12-27	WOS:000396054300028
J	Mousavi, M; Yap, HJ; Musa, SN; Tahriri, F; Dawal, SZM				Mousavi, Maryam; Yap, Hwa Jen; Musa, Siti Nurmaya; Tahriri, Farzad; Dawal, Siti Zawiah Md			Multi-objective AGV scheduling in an FMS using a hybrid of genetic algorithm and particle swarm optimization	PLOS ONE			English	Article							AUTOMATED GUIDED VEHICLES; MANUFACTURING SYSTEM; SEARCH; PATH	Flexible manufacturing system (FMS) enhances the firm's flexibility and responsiveness to the ever-changing customer demand by providing a fast product diversification capability. Performance of an FMS is highly dependent upon the accuracy of scheduling policy for the components of the system, such as automated guided vehicles (AGVs). An AGV as a mobile robot provides remarkable industrial capabilities for material and goods transportation within a manufacturing facility or a warehouse. Allocating AGVs to tasks, while considering the cost and time of operations, defines the AGV scheduling process. Multi-objective scheduling of AGVs, unlike single objective practices, is a complex and combinatorial process. In the main draw of the research, a mathematical model was developed and integrated with evolutionary algorithms (genetic algorithm (GA), particle swarm optimization (PSO), and hybrid GA-PSO) to optimize the task scheduling of AGVs with the objectives of minimizing makespan and number of AGVs while considering the AGVs' battery charge. Assessment of the numerical examples' scheduling before and after the optimization proved the applicability of all the three algorithms in decreasing the makespan and AGV numbers. The hybrid GA-PSO produced the optimum result and outperformed the other two algorithms, in which the mean of AGVs operation efficiency was found to be 69.4, 74, and 79.8 percent in PSO, GA, and hybrid GA-PSO, respectively. Evaluation and validation of the model was performed by simulation via Flexsim software.	[Mousavi, Maryam; Yap, Hwa Jen; Musa, Siti Nurmaya; Tahriri, Farzad; Dawal, Siti Zawiah Md] Univ Malaya, Dept Mech Engn, Fac Engn, Ctr Product Design & Mfg, Kuala Lumpur, Malaysia	Universiti Malaya	Yap, HJ (corresponding author), Univ Malaya, Dept Mech Engn, Fac Engn, Ctr Product Design & Mfg, Kuala Lumpur, Malaysia.	hjyap737@um.edu.my	Musa, S. Nurmaya/AAZ-8487-2020; MUSA, S. NURMAYA/B-9803-2010; DAWAL, SITI ZAWIAH MD/B-9816-2010; YAP, HWA JEN/C-1065-2010; Mousavi, maryam/AAE-8757-2020; tahriri, farzad/K-3692-2013	Musa, S. Nurmaya/0000-0002-5165-4106; MUSA, S. NURMAYA/0000-0002-5165-4106; DAWAL, SITI ZAWIAH MD/0000-0003-0496-5128; YAP, HWA JEN/0000-0001-7637-9297; Mousavi, maryam/0000-0003-2317-3409; tahriri, farzad/0000-0002-8929-0707	University of Malaya's under UMRG Top Down Programme [RP027-14AET]; Ministry of Higher Education of Malaysia under High Impact Research [UM.C/HIR/MOHE/ENG/35, D000035-16001]	University of Malaya's under UMRG Top Down Programme; Ministry of Higher Education of Malaysia under High Impact Research	The authors would like to acknowledge University of Malaya's financial support of this project under UMRG Top Down Programme (Grant No. RP027-14AET). The authors would also like to acknowledge the Ministry of Higher Education of Malaysia for the facility support under High Impact Research Grant UM.C/HIR/MOHE/ENG/35 (D000035-16001).	Aized T, 2009, COMPUT IND ENG, V57, P822, DOI 10.1016/j.cie.2009.02.009; Anwar MF, 1998, INT J PROD RES, V36, P653, DOI 10.1080/002075498193624; Azimi P, 2011, MODELLING SIMULATION, V2011, P2; Beheshti Z., 2013, INT J ADV SOFT COMPU, V5, P1; Blazewicz J., 1991, International Journal of Flexible Manufacturing Systems, V4, P5, DOI 10.1007/BF01325094; Cai QX, 2014, INT J SMART SENS INT, V7, P1613; Chelouah R, 2003, EUR J OPER RES, V148, P335, DOI 10.1016/S0377-2217(02)00401-0; Chudasama C, 2011, INT C COMP COMM NETW; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; Eichfelder G, 2008, VECTOR OPTIM, P1, DOI 10.1007/978-3-540-79159-1; Elsayed SM, 2014, ENG APPL ARTIF INTEL, V27, P57, DOI 10.1016/j.engappai.2013.09.013; Fan SKS, 2007, EUR J OPER RES, V181, P527, DOI 10.1016/j.ejor.2006.06.034; Fauadi MHFBM, 2010, P INT MULTICONFERENC; Fazlollahtabar H, 2014, J MANUF SCI PROD, V14, P87, DOI 10.1515/jmsp-2013-0026; Gao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09295; Ghane-Kanafi A, 2015, APPL MATH MODEL, V39, P7483, DOI 10.1016/j.apm.2015.03.022; Giagkiozis I, 2015, INFORM SCIENCES, V293, P338, DOI 10.1016/j.ins.2014.08.071; Holland J.H., 1975, ADAPTATION NATURAL A; Hsiao-Fan Wang, 2014, International Journal of Modelling in Operations Management, V4, P35, DOI 10.1504/IJMOM.2014.063585; Huang D, 2013, 6 INT C ADV INF TECH; Inc. EA, 2006, BATT CHARG SYST AUT; INSTITUUT AK, 2015, GEN TECHN DESCR AGV; Jamrus T, 2013, 14TH ASIA PACIFIC IN; Joshi Gopesh, 2014, INT J ADV RES COMPUT, V4, P802; Kao YT, 2008, APPL SOFT COMPUT, V8, P849, DOI 10.1016/j.asoc.2007.07.002; Kapianogiu v, 2014, 4 IAJC ISAM JOINT IN; Kato F, 2010, P SICE ANN C 2010; Kaveh A, 2010, IRAN J SCI TECHNOL B, V34, P15; Kawakami T., 2012, DESIGN INNOVATIVE VA, P403; Kennedy J., 1995, P ICNN 95 INT C NEUR, P1942; Kennedy J, 2002, EV COMP 2002 CEC 02; Kumar MVS, 2011, INT J ADV MANUF TECH, V53, P339, DOI 10.1007/s00170-010-2820-2; Kuo IH, 2009, EXPERT SYST APPL, V36, P7027, DOI 10.1016/j.eswa.2008.08.054; Li XD, 2012, IEEE T EVOLUT COMPUT, V16, P210, DOI 10.1109/TEVC.2011.2112662; Liou CD, 2013, INT J SYST SCI, V44, P77, DOI 10.1080/00207721.2011.581396; Mehta M. H., 2012, INT J ADV COMPUTER R, V2, P300; Nageswararao M, 2014, INROADS AN INT J JAI, V3, P62; Natarajan A.M., 2009, INT J OPEN PROBLEMS, V2, P597; Nearchou AC, 2004, INT J PROD ECON, V88, P191, DOI 10.1016/S0925-5273(03)00184-1; Novas JM, 2014, EXPERT SYST APPL, V41, P2286, DOI 10.1016/j.eswa.2013.09.026; Oliveira MM, 2011, IEEE INT CONF ROBOT; Pan XY, 2013, APPL MECH MATER, V411-414, P2351, DOI 10.4028/www.scientific.net/AMM.411-414.2351; Pareto V, 1961, CORSO EC POLITICA; Rashmi M, 2014, INT J LATEST TRENDS, V4, P177; Reddy BSP, 2011, INT J SIMUL MODEL, V10, P78, DOI 10.2507/IJSIMM10(2)3.176; Ren NF, 2013, APPL MECH MATER, V300-301, P55, DOI 10.4028/www.scientific.net/AMM.300-301.55; SABUNCUOGLU I, 1992, INT J PROD RES, V30, P1059, DOI 10.1080/00207549208942943; Saidi-Mehrabad M, 2015, COMPUT IND ENG, V86, P2, DOI 10.1016/j.cie.2015.01.003; Song ML, 2014, APPL MECH MAT; Spears W.M., 1991, STUDY CROSSOVER OPER; Suzuki T, 2014, ASME 2014 INT DES EN; Tang JC, 2010, LECT NOTES COMPUT SC, V6145, P566, DOI 10.1007/978-3-642-13495-1_69; Tasgetiren MF, 2004, EVOLUTIONARY COMPUTA; Thakur M, 2014, APPL MATH COMPUT, V235, P292, DOI 10.1016/j.amc.2014.02.093; Udhayakumar P, 2010, INT J SIMUL MODEL, V9, P28, DOI 10.2507/IJSIMM09(1)3.139; Vasava AS, 2014, INT J INNOVATIVE RES, V1, P262; Ventura JA, 2015, INT J PROD ECON, V170, P850, DOI 10.1016/j.ijpe.2015.03.007; Wang JB, 2014, ADV MAT RES, V926-930, P1562, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/AMR.926-930.1562; Wang L, 2010, EL CIRC SYST ICECS 2; Wu CH, 2010, LECT NOTES COMPUT SC, V6024, P302; Xia WJ, 2006, INT J ADV MANUF TECH, V29, P360, DOI 10.1007/s00170-005-2513-4; Xia WJ, 2005, COMPUT IND ENG, V48, P409, DOI 10.1016/j.cie.2005.01.018; Zeng CK, 2014, APPL SOFT COMPUT, V24, P1033, DOI 10.1016/j.asoc.2014.08.028; Zheng K, 2013, PROD ENG-RES DEV, V7, P433, DOI 10.1007/s11740-013-0456-4	64	48	59	13	192	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0169817	10.1371/journal.pone.0169817	http://dx.doi.org/10.1371/journal.pone.0169817			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28263994	Green Submitted, Green Published, gold			2022-12-27	WOS:000396054300002
J	Zhou, J; Fang, L; Liao, JX; Li, L; Yao, WX; Xiong, ZJ; Zhou, X				Zhou, Jin; Fang, Li; Liao, Jiaxu; Li, Lin; Yao, Wenxiu; Xiong, Zhujuan; Zhou, Xiang			Investigation of the anti-cancer effect of quercetin on HepG2 cells in vivo	PLOS ONE			English	Article							OVEREXPRESSION; RECEPTOR; PROLIFERATION	Quercetin, a natural polyphenolic flavonoid compound, can inhibit the growth of several malignant cancers. However, the mechanism still remains unclear. Our previous findings have suggested that quercetin can significantly inhibit HepG2 cell proliferation and induce cell apoptosis in vitro. It can also affect cell cycle distribution and significantly decrease cyclin D1 expression. In this study, we investigated the anti-cancer effect of quercetin on HepG2 tumor-bearing nude mice and its effect on cyclin D1 expression in the tumor tissue. First, the nude murine tumor model was established by subcutaneous inoculation of HepG2 cells, then quercetin was administered intraperitoneally, and the mice injected with saline solution were used as controls. The daily behavior of the tumor-bearing mice was observed and differences in tumor growth and survival rate were monitored. The expression of cyclin D1 in isolated tumor sections was evaluated by immunohistochemistry. We found that HepG2 tumor became palpable in the mice one-week post-inoculation. Tumors in the control group grew rapidly and the daily behavior of the mice changed significantly, including listlessness, poor feeding and ataxia. The mice in quercetin-treated group showed delayed tumor growth, no significant changes in daily behavior, and the survival rate was significantly improved. Finally, we observed increased tumor necrosis and a lighter cyclin D1 staining with reduced staining areas. Our findings thus suggest that quercetin can significantly inhibit HepG2 cell proliferation, and this effect may be achieved through the regulation of cyclin D1 expression.	[Zhou, Jin; Yao, Wenxiu; Xiong, Zhujuan; Zhou, Xiang] Univ Elect Sci & Technol China, Sch Med, Dept Chemotherapy, Sichuan Canc Ctr, Chengdu, Sichuan, Peoples R China; [Fang, Li] Chengdu Med Coll, Affiliated Hosp 1, Dept Gastroenterol, Chengdu, Sichuan, Peoples R China; [Liao, Jiaxu] Sixth Hosp, Dept Radiol, Chengdu, Sichuan, Peoples R China; [Li, Lin] Second Hosp, Dept Nucl Med, Chengdu, Sichuan, Peoples R China	University of Electronic Science & Technology of China; Chengdu Medical College	Zhou, J (corresponding author), Univ Elect Sci & Technol China, Sch Med, Dept Chemotherapy, Sichuan Canc Ctr, Chengdu, Sichuan, Peoples R China.	zhoujt521@163.com			Basic Research Programs of Sichuan Province [2016JY0115, 2011JYZ034, 120035]	Basic Research Programs of Sichuan Province	This work was supported by Basic Research Programs of Sichuan Province (nos. 2016JY0115, 2011JYZ034 and 120035).	Adnane J, 1999, ONCOGENE, V18, P239, DOI 10.1038/sj.onc.1202297; Borska S, 2012, FOOD CHEM TOXICOL, V50, P3375, DOI 10.1016/j.fct.2012.06.035; Cantor JP, 2007, INT J CANCER, V120, P24, DOI 10.1002/ijc.22073; Chan ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054255; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; de Boer VCJ, 2005, J NUTR, V135, P1718, DOI 10.1093/jn/135.7.1718; Hwang SJ, 2015, ONCOTARGET, V6, P20434, DOI 10.18632/oncotarget.3886; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jing S, 2008, INT J HYPERTHER, V24, P151, DOI 10.1080/02656730701843109; Kahraman A, 2012, MOL BIOL REP, V39, P2789, DOI 10.1007/s11033-011-1037-2; Kenny FS, 1999, CLIN CANCER RES, V5, P2069; Kim MK, 2015, FITOTERAPIA, V101, P162, DOI 10.1016/j.fitote.2015.01.010; Luk'ianova L D, 2007, Vestn Ross Akad Med Nauk, P55; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Lutz JA, 2014, FITOTERAPIA, V98, P11, DOI 10.1016/j.fitote.2014.06.012; Mahmoud MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063784; Miranda-Carboni GA, 2008, GENE DEV, V22, P3121, DOI 10.1101/gad.1692808; Noel EE, 2010, AM J PATHOL, V176, P2607, DOI 10.2353/ajpath.2010.090780; Pereira RA, 2014, BRAZ J MED BIOL RES, V47, P515, DOI 10.1590/1414-431X20143240; Pratheeshkumar P, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047516, 10.1371/journal.pone.0052279]; Ravishankar D, 2015, EUR J MED CHEM, V97, P259, DOI 10.1016/j.ejmech.2015.04.056; Refolo MG, 2015, J CELL PHYSIOL, V230, P2973, DOI 10.1002/jcp.25026; Shimura T, 2010, ONCOGENE, V29, P4826, DOI 10.1038/onc.2010.238; Tao SF, 2015, MOL CELL BIOCHEM, V402, P93, DOI 10.1007/s11010-014-2317-7; Yuan Huiqing, 2010, Mol Cell Biochem, V339, P253, DOI 10.1007/s11010-010-0388-7; Zhang Y, 2012, MOL BIOL REP, V39, P7785, DOI 10.1007/s11033-012-1621-0; Zhou J, 2016, ONCOL LETT, V12, P516, DOI 10.3892/ol.2016.4639; Zhou J, 2009, OMICS, V13, P93, DOI 10.1089/omi.2008.0075	28	44	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172838	10.1371/journal.pone.0172838	http://dx.doi.org/10.1371/journal.pone.0172838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264020	gold, Green Published, Green Submitted			2022-12-27	WOS:000396054300020
J	Pollegioni, P; Woeste, K; Chiocchini, F; Del Lungo, S; Ciolfi, M; Olimpieri, I; Tortolano, V; Clark, J; Hemery, GE; Mapelli, S; Malvolti, ME				Pollegioni, Paola; Woeste, Keith; Chiocchini, Francesca; Del Lungo, Stefano; Ciolfi, Marco; Olimpieri, Irene; Tortolano, Virginia; Clark, Jo; Hemery, Gabriel E.; Mapelli, Sergio; Malvolti, Maria Emilia			Rethinking the history of common walnut (Juglans regia L.) in Europe: Its origins and human interactions	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; MEDITERRANEAN BASIN; POPULATION-STRUCTURE; LANDSCAPE GENETICS; GLACIAL REFUGIA; NORTHERN GREECE; QUERCUS-SUBER; BRONZE-AGE; VEGETATION; CLIMATE	Common walnut (Juglans regia L) is an economically important species cultivated worldwide for its high-quality wood and nuts. It is generally accepted that after the last glaciation J. regia survived and grew in almost completely isolated stands in Asia, and that ancient humans dispersed walnuts across Asia and into new habitats via trade and cultural expansion. The history of walnut in Europe is a matter of debate, however. In this study, we estimated the genetic diversity and structure of 91 Eurasian walnut populations using 14 neutral microsatellites. By integrating fossil pollen, cultural, and historical data with population genetics, and approximate Bayesian analysis, we reconstructed the demographic history of walnut and its routes of dispersal across Europe. The genetic data confirmed the presence of walnut in glacial refugia in the Balkans and western Europe. We conclude that human-mediated admixture between Anatolian and Balkan walnut germplasm started in the Early Bronze Age, and between western Europe and the Balkans in eastern Europe during the Roman Empire. A population size expansion and subsequent decline in northeastern and western Europe was detected in the last five centuries. The actual distribution of walnut in Europe resulted from the combined effects of expansion/contraction from multiple refugia after the Last Glacial Maximum and its human exploitation over the last 5,000 years.	[Pollegioni, Paola; Chiocchini, Francesca; Ciolfi, Marco; Olimpieri, Irene; Tortolano, Virginia; Malvolti, Maria Emilia] CNR, Inst Agroenvironm & Forest Biol, Porano, Terni, Italy; [Woeste, Keith] Purdue Univ, Dept Forestry & Nat Resources, Hardwood Tree Improvement & Regenerat Ctr, USDA Forest Serv, W Lafayette, IN 47907 USA; [Del Lungo, Stefano] CNR, Inst Archaeol & Monumental Heritage, Potenza, Italy; [Clark, Jo] Earth Trust, Abingdon, Oxon, England; [Hemery, Gabriel E.] Sylva Fdn, Little Wittenham, Oxon, England; [Mapelli, Sergio] CNR, Inst Agr Biol & Biotechnol, Milan, Italy; [Pollegioni, Paola] Genom Genet & Biol Innovat Pole, Perugia, Italy	Consiglio Nazionale delle Ricerche (CNR); Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA); United States Forest Service; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR)	Pollegioni, P (corresponding author), CNR, Inst Agroenvironm & Forest Biol, Porano, Terni, Italy.; Pollegioni, P (corresponding author), Genom Genet & Biol Innovat Pole, Perugia, Italy.	paola.pollegioni@ibaf.cnr.it	Hemery, Gabriel/AAX-9424-2020; Ciolfi, Marco/AAZ-5495-2020; Del+Lungo, Stefano/AAK-9915-2021; CIOLFI, MARCO/Q-4101-2018	Hemery, Gabriel/0000-0002-0839-9293; Chiocchini, Francesca/0000-0002-5122-8756; CIOLFI, MARCO/0000-0003-4831-8053; DEL LUNGO, Stefano/0000-0001-7326-462X	European Community under the Marie Curie Actions COFUND project "I-MOVE" [267232, 206405]	European Community under the Marie Curie Actions COFUND project "I-MOVE"	This study was supported by the European Community in the framework of the Seventh Framework Programme under the Marie Curie Actions COFUND project "I-MOVE" (N. 267232) Grant number 206405.	Allen JRM, 1996, J QUATERNARY SCI, V11, P125, DOI 10.1002/(SICI)1099-1417(199603/04)11:2<125::AID-JQS232>3.0.CO;2-U; Allevato E, WOODLAND EXPLOITATIO; [Anonymous], 2014, PREHISTORIC EC ANATO; Ariztegui D, 2000, PALAEOGEOGR PALAEOCL, V158, P215, DOI 10.1016/S0031-0182(00)00051-1; Bagnoli F, 2016, J BIOGEOGR, V43, P679, DOI 10.1111/jbi.12673; Bai WN, 2016, NEW PHYTOL, V209, P1757, DOI 10.1111/nph.13711; Bakels C, 2003, WORLD ARCHAEOL, V34, P542, DOI 10.1080/0043824021000026503; Barnes T., 1974, JRS, V64, P21; Beaumont MA, 2002, GENETICS, V162, P2025; Beer R, 2008, QUATERNARY SCI REV, V27, P621, DOI 10.1016/j.quascirev.2007.11.012; Besnard G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2833; Bottema S., 2000, PALLAS, V52, P35; Breton C, 2006, J BIOGEOGR, V33, P1916, DOI 10.1111/j.1365-2699.2006.01544.x; Brewer S, 2016, J MAPS; BRUGIAPAGLIA E., 1996, THESIS; CARRION JS, 1992, J BIOGEOGR, V19, P623, DOI 10.2307/2845705; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Conord C, 2012, ECOL EVOL, V2, P2595, DOI 10.1002/ece3.350; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Djamali M., PALEORIENT, V36, P175, DOI [DOI 10.3406/PALEO.2010.5394, 10.3406/paleo.2010.5394]; Emeis KC, 2000, PALAEOGEOGR PALAEOCL, V158, P259, DOI 10.1016/S0031-0182(00)00053-5; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fady B, 2010, DIVERS DISTRIB, V16, P53, DOI 10.1111/j.1472-4642.2009.00621.x; Filipova M., 1986, STUDIA PRAEHISTORICA, V8, P160; Fornari B, 2001, ACTA HORTIC, V544, P167; Fyfe RM, 2009, VEG HIST ARCHAEOBOT, V18, P417, DOI 10.1007/s00334-009-0215-9; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gavin DG, 2014, NEW PHYTOL, V204, P37, DOI 10.1111/nph.12929; Geraga M, 2000, PALAEOGEOGR PALAEOCL, V156, P1, DOI 10.1016/S0031-0182(99)00123-6; Grivet D, 2009, NEW PHYTOL, V184, P1016, DOI 10.1111/j.1469-8137.2009.03015.x; Guillemaud T, 2010, HEREDITY, V104, P88, DOI 10.1038/hdy.2009.92; Gyulai F, 2011, PLANT ARCHAEOGENETIC, P31; Hemery G. E., 2000, THESIS; Henry P, 2009, MOL ECOL, V18, P3173, DOI 10.1111/j.1365-294X.2009.04266.x; Holderegger R, 2010, TRENDS PLANT SCI, V15, P675, DOI 10.1016/j.tplants.2010.09.002; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jeraj M, 2014, VEG HIST ARCHAEBOT, V18, P75; Joly C, 2009, REV PALAEOBOT PALYNO, V154, P124, DOI 10.1016/j.revpalbo.2008.12.011; Jones G, 2005, VEG HIST ARCHAEOBOT, V14, P571, DOI 10.1007/s00334-005-0004-z; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kaltenrieder P, 2010, HOLOCENE, V20, P679, DOI 10.1177/0959683609358911; Kaplan JO, 2009, QUATERNARY SCI REV, V28, P3016, DOI 10.1016/j.quascirev.2009.09.028; KELLY MG, 1991, J QUATERNARY SCI, V6, P209, DOI 10.1002/jqs.3390060304; Korfmann M, 2001, J PHASIS, V4, P1; Kouli K, 2015, PLANT BIOSYST, V149, P195, DOI 10.1080/11263504.2014.992998; Kouli K, 2010, GRANA, V49, P154, DOI 10.1080/00173131003780016; Krebs P, 2004, VEG HIST ARCHAEOBOT, V13, P145, DOI 10.1007/s00334-004-0041-z; Lazarova M, 2011, GRANA, V50, P162, DOI 10.1080/00173134.2011.573863; Leslie C.A., 1998, WALNUT PRODUCTION MA, P3; Litt T, 2009, QUATERNARY SCI REV, V28, P1555, DOI 10.1016/j.quascirev.2009.03.002; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Lumaret R, 2005, ANN BOT-LONDON, V96, P853, DOI 10.1093/aob/mci237; Magri D, 2007, MOL ECOL, V16, P5259, DOI 10.1111/j.1365-294X.2007.03587.x; Magri D, 2010, QUATERN INT, V219, P145, DOI 10.1016/j.quaint.2009.10.032; Malvolti M. E., 1993, Acta Horticulturae, P86; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; Postigo-Mijarra JM, 2010, REV PALAEOBOT PALYNO, V162, P416, DOI 10.1016/j.revpalbo.2010.02.015; Marinova E, 2012, VEG HIST ARCHAEOBOT, V21, P245, DOI 10.1007/s00334-012-0361-3; Marinova E, 2009, VEG HIST ARCHAEOBOT, V18, P341, DOI 10.1007/s00334-009-0212-z; Mattioni C, 2013, AM J BOT, V100, P951, DOI 10.3732/ajb.1200194; McGranahan G., 1991, ACTA HORTIC, V290, P907, DOI [10.17660/ActaHortic.1991.290.20, DOI 10.17660/ACTAHORTIC.1991.290.20]; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Mercuri AM, 2013, QUATERN INT, V303, P24, DOI 10.1016/j.quaint.2013.01.005; Nakagawa T, 1998, THESIS; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Feliner GN, 2014, PERSPECT PLANT ECOL, V16, P265, DOI 10.1016/j.ppees.2014.07.002; Ohlemuller R, 2012, GLOBAL ECOL BIOGEOGR, V21, P152, DOI 10.1111/j.1466-8238.2011.00674.x; Panagiotopoulos K, 2013, QUATERN INT, V293, P157, DOI 10.1016/j.quaint.2012.05.048; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pollegioni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135980; Pollegioni P, 2014, TREE GENET GENOMES, V10, P1027, DOI 10.1007/s11295-014-0740-2; Pollegioni P, 2011, TREE GENET GENOMES, V7, P707, DOI 10.1007/s11295-011-0368-4; Pritchard JK, 2000, GENETICS, V155, P945; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Roberts N, 2011, HOLOCENE, V21, P3, DOI 10.1177/0959683610388058; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rottoli M, 2009, VEG HIST ARCHAEOBOT, V18, P91, DOI 10.1007/s00334-007-0139-1; Sadori L, 2013, CLIM PAST, V9, P1969, DOI 10.5194/cp-9-1969-2013; Sadori L, 2013, ENCY QUATERNARY SCI, P179, DOI 10.1016/B978-0-444-53643-3.00199-0; Sadori L, 2015, HOLOCENE, V25, P435, DOI 10.1177/0959683614561891; Stika H.-P., 2013, OXFORD HDB EUROPEAN, P348, DOI DOI 10.1093/OXFORDHB/9780199572861.013.0019; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tzedakis PC, 2013, TRENDS ECOL EVOL, V28, P696, DOI 10.1016/j.tree.2013.09.001; Tzedakis PC, 2002, SCIENCE, V297, P2044, DOI 10.1126/science.1073083; Vahdati K, 2014, ACTA HORTIC, V1032, P19; Vendramin GG, 2008, EVOLUTION, V62, P680, DOI 10.1111/j.1558-5646.2007.00294.x; Ward C, 2003, WORLD ARCHAEOL, V34, P529, DOI 10.1080/0043824021000026495; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Woeste K, 2011, WILD CROP RELATIVES, P77; Woldring Henk, 2001, Turkish Journal of Botany, V25, P1; Wu HB, 2007, CLIM DYNAM, V29, P211, DOI 10.1007/s00382-007-0231-3; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	95	61	63	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172541	10.1371/journal.pone.0172541	http://dx.doi.org/10.1371/journal.pone.0172541			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257470	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100020
J	Tian, DD; Jiang, R; Chen, XJ; Ye, Q				Tian, Dan-dan; Jiang, Rong; Chen, Xue-jun; Ye, Qing			Meteorological factors on the incidence of MP and RSV pneumonia in children	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY-INFECTIONS; HOSPITALIZED CHILDREN; VIRUSES	Background Pneumonia is common in children and mostly caused by many pathogens. The aim of this study was to investigate whether the incidence of pediatric mycoplasma pneumoniae (MP) pneumonia and respiratory syncytial virus (RSV) pneumonia was associated with meteorological factors in Hangzhou, China. Methods A total of 36500 pneumonia patients were recruited to participate in the study. Nasopharyngeal swabs were collected for the detection of MP and RSV using real-time polymerase chain reaction (RT-PCR) and direct immunofluorescence (DIF) assays, respectively. We used a distributed lag non-linear model (DLNM) to evaluate the correlations between the MP/RSV incidence and meteorological factors. Results The detection rates of MP and RSV were 18.4% and 10.4%, respectively. There was a positive correlation between temperature and the MP infection rate, but RSV infection rate was negatively associated with temperature. Moreover, the impact of temperature on infection with RSV presented evident lag and cumulative effects. There was also an evident lag effect of temperature on the infection rate of MP; however, there was no evident cumulative effect. Conclusions In this study, the results showed meteorological factors play an important role in the incidence of these two pathogens. All these results can provide the laboratory basis for the early diagnosis and treatment of pneumonia in children.	[Tian, Dan-dan; Jiang, Rong; Chen, Xue-jun; Ye, Qing] Zhejiang Univ, Sch Med, Childrens Hosp, Clin Lab, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Ye, Q (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Clin Lab, Hangzhou, Zhejiang, Peoples R China.	qingye@zju.edu.cn			National Natural Science Foundation of China [81501760]; Zhejiang Provincial Healthy Science Foundation of China [2015KYB191]; Zhejiang Provincial Natural Science Foundation of China [LQ16H050002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Healthy Science Foundation of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This project was funded by grants from the National Natural Science Foundation of China (Grant No. 81501760), Zhejiang Provincial Healthy Science Foundation of China (Grant No. 2015KYB191), and Zhejiang Provincial Natural Science Foundation of China (Grant No. LQ16H050002). Qing Ye received all the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Cui BL, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0863-6; du Prel JB, 2009, CLIN INFECT DIS, V49, P861, DOI 10.1086/605435; Gasparrini A, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-55; Ji Wei, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P205; Khor CS, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-32; Kochanek KD, 2009, NATL VITAL STAT REP, V59, P1; Lin YK, 2013, ENVIRON RES, V120, P109, DOI 10.1016/j.envres.2012.09.002; Mathisen M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-35; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Nascimento-Carvalho CM, 2010, SCAND J INFECT DIS, V42, P839, DOI 10.3109/00365548.2010.498020; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Tang JW, 2010, J MED VIROL, V82, P1958, DOI 10.1002/jmv.21892; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Xu YC, 2011, WORLD J PEDIATR, V7, P240, DOI 10.1007/s12519-011-0318-0; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X; Zhang HY, 2009, JPN J INFECT DIS, V62, P458; Zou LR, 2012, APMIS, V120, P683, DOI 10.1111/j.1600-0463.2012.02890.x	18	24	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e173409	10.1371/journal.pone.0173409	http://dx.doi.org/10.1371/journal.pone.0173409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282391	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800039
J	Clair, MP; Rambaud, J; Flahault, A; Guedj, R; Guilbert, J; Guellec, I; Durandy, A; Demoulin, M; Jean, S; Mitanchez, D; Chalard, F; Sileo, C; Carbajal, R; Renolleau, S; Leger, PL				Clair, Marie-Philippine; Rambaud, Jerome; Flahault, Adrien; Guedj, Romain; Guilbert, Julia; Guellec, Isabelle; Durandy, Amelie; Demoulin, Maryne; Jean, Sandrine; Mitanchez, Delphine; Chalard, Francois; Sileo, Chiara; Carbajal, Ricardo; Renolleau, Sylvain; Leger, Pierre-Louis			Prognostic value of cerebral tissue oxygen saturation during neonatal extracorporeal membrane oxygenation	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; CARDIAC-SURGERY; CARDIOPULMONARY BYPASS; RESPIRATORY-FAILURE; CARBON-DIOXIDE; CHILDREN; INJURY; BRAIN; CANNULATION; ECMO	Objectives Extracorporeal membrane oxygenation support is indicated in severe and refractory respiratory or circulatory failures. Neurological complications are typically represented by acute ischemic or hemorrhagic lesions, which induce higher morbidity and mortality. The primary goal of this study was to assess the prognostic value of cerebral tissue oxygen saturation (StcO(2)) on mortality in neonates and young infants treated with ECMO. A secondary objective was to evaluate the association between StcO(2) and the occurrence of cerebral lesions. Study design This was a prospective study in infants < 3 months of age admitted to a pediatric intensive care unit and requiring ECMO support. Measurements The assessment of cerebral perfusion was made by continuous StcO(2) monitoring using near-infrared spectroscopy (NIRS) sensors placed on the two temporo-parietal regions. Neurological lesions were identified by MRI or transfontanellar echography. Results Thirty-four infants < 3 months of age were included in the study over a period of 18 months. The ECMO duration was 10 +/- 7 days. The survival rate was 50% (17/34 patients), and the proportion of brain injuries was 20% (7/34 patients). The mean StcO(2) during ECMO in the non-survivors was reduced in both hemispheres (p = 0.0008 right, p = 0.03 left) compared to the survivors. StcO(2) was also reduced in deceased or brain-injured patients compared to the survivors without brain injury (p = 0.002). Conclusion StcO(2) appears to be a strong prognostic factor of survival and of the presence of cerebral lesions in young infants during ECMO.	[Clair, Marie-Philippine; Rambaud, Jerome; Guilbert, Julia; Guellec, Isabelle; Durandy, Amelie; Demoulin, Maryne; Jean, Sandrine; Carbajal, Ricardo; Leger, Pierre-Louis] Trousseau Hosp, AP HP, Dept Neonatal, Paris, France; [Clair, Marie-Philippine; Rambaud, Jerome; Guilbert, Julia; Guellec, Isabelle; Durandy, Amelie; Demoulin, Maryne; Jean, Sandrine; Carbajal, Ricardo; Leger, Pierre-Louis] Trousseau Hosp, AP HP, Pediat Intens Care Unit, Paris, France; [Flahault, Adrien] CIRB, INSERM, Lab Cent Neuropeptides Regulat Body Fluid Homeost, U1050, Paris, France; [Flahault, Adrien] CNRS, UMR 7241, Paris, France; [Guedj, Romain; Carbajal, Ricardo] Trousseau Hosp, AP HP, Dept Emergency Med, Paris, France; [Mitanchez, Delphine] Trousseau Hosp, AP HP, Dept Neonatol, Paris, France; [Chalard, Francois; Sileo, Chiara] Trousseau Hosp, AP HP, Dept Pediat Radiol, Paris, France; [Carbajal, Ricardo] UPMC Pierre & Marie Curie Univ, Paris VI, France; [Renolleau, Sylvain] Hop Necker Enfants Malad, AP HP, Dept Pediat Intens Care Unit, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Leger, PL (corresponding author), Trousseau Hosp, AP HP, Dept Neonatal, Paris, France.; Leger, PL (corresponding author), Trousseau Hosp, AP HP, Pediat Intens Care Unit, Paris, France.	pierre-louis.leger@aphp.fr	ISABELLE, GUELLEC/EXE-5877-2022; Flahault, Adrien/Q-4576-2017; Guedj, Romain/AAE-1419-2021; Chalard, François/GNH-5041-2022	Flahault, Adrien/0000-0003-4632-6332; Guedj, Romain/0000-0002-9497-4396; Rambaud, Jerome/0000-0001-5906-9107; Sileo, Chiara/0000-0001-6406-1951				Amigoni A, 2005, PEDIATR NEUROL, V32, P173, DOI 10.1016/j.pediatrneurol.2004.10.002; Ariturk C, 2014, HEART SURG FORUM, V17, pE169, DOI 10.1532/HSF98.2014319; Austin EH, 1997, J THORAC CARDIOV SUR, V114, P707, DOI 10.1016/S0022-5223(97)70074-6; AUSTIN EH, 1997, J THORAC CARDIOVASC, V114, P715, DOI DOI 10.1016/S0022-5223(97)70074-6; Brambrink A, 2010, ANESTHESIOLOGY, V112, P274, DOI 10.1097/ALN.0b013e3181ca8273; BRAZY JE, 1986, J PEDIATR-US, V108, P983, DOI 10.1016/S0022-3476(86)80944-1; CAMPBELL LR, 1988, J PEDIATR-US, V113, P110, DOI 10.1016/S0022-3476(88)80543-2; Chakravarti S, 2008, SEMIN CARDIOTHORAC V, V12, P70, DOI 10.1177/1089253208316444; Fenik JC, 2009, J PERINATOL, V29, P376, DOI 10.1038/jp.2008.231; Hayashida M, 2004, BRIT J ANAESTH, V92, P662, DOI 10.1093/bja/aeh120; Hirsch JC, 2009, J THORAC CARDIOV SUR, V137, P154, DOI 10.1016/j.jtcvs.2008.08.005; Leger PL, 2013, ARTIF ORGANS, V37, P57, DOI 10.1111/aor.12024; Liem K D, 1995, Acta Anaesthesiol Scand Suppl, V107, P157; Maldonado Y, 2014, CURR OPIN ANESTHESIO, V27, P81, DOI 10.1097/ACO.0000000000000035; Mehta Amit, 2013, World J Crit Care Med, V2, P40, DOI 10.5492/wjccm.v2.i4.40; Nasr DM, 2015, J CLIN NEUROL, V11, P383, DOI 10.3988/jcn.2015.11.4.383; Phelps HM, 2009, ANN THORAC SURG, V87, P1490, DOI 10.1016/j.athoracsur.2009.01.071; Quarti A, 2013, PERFUSION-UK, V28, P152, DOI 10.1177/0267659112464382; Raets MMA, 2013, PEDIATR CRIT CARE ME, V14, P884, DOI 10.1097/PCC.0b013e3182a555ac; Rollins MD, 2012, J PEDIATR SURG, V47, P68, DOI 10.1016/j.jpedsurg.2011.10.017; SEVERINGHAUS JW, 1979, J APPL PHYSIOL, V46, P599, DOI 10.1152/jappl.1979.46.3.599; SHORT BL, 1993, PEDIATR RES, V33, P289, DOI 10.1203/00006450-199303000-00018; Short BL, 2005, SEMIN PERINATOL, V29, P45, DOI 10.1053/j.semperi.2005.02.007; Skarsgard ED, 2004, J PEDIATR SURG, V39, P672, DOI 10.1016/j.jpedsurg.2004.01.033; Soll RF, 1996, LANCET, V348, P70; Sood ED, 2013, J THORAC CARDIOV SUR, V145, P438, DOI 10.1016/j.jtcvs.2012.10.033; Wong JK, 2012, ARTIF ORGANS, V36, P659, DOI 10.1111/j.1525-1594.2012.01496.x; Zulueta JL, 2013, J CARDIAC SURG, V28, P446, DOI 10.1111/jocs.12122	28	19	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172991	10.1371/journal.pone.0172991	http://dx.doi.org/10.1371/journal.pone.0172991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE2BH	28278259	Green Published, gold, Green Submitted			2022-12-27	WOS:000431020000001
J	Islam, MA; Grosse-Brinkhaus, C; Proll, MJ; Uddin, MJ; Rony, SA; Tesfaye, D; Tholen, E; Hoelker, M; Schellander, K; Neuhoff, C				Islam, Md. Aminul; Grosse-Brinkhaus, Christine; Proell, Maren Julia; Uddin, Muhammad Jasim; Rony, Sharmin Aqter; Tesfaye, Dawit; Tholen, Ernst; Hoelker, Michael; Schellander, Karl; Neuhoff, Christiane			PBMC transcriptome profiles identifies potential candidate genes and functional networks controlling the innate and the adaptive immune response to PRRSV vaccine in Pietrain pig	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; BLOOD MONONUCLEAR-CELLS; INFECTION; EXPRESSION; RECOGNITION; PROTECTION; RECEPTORS; CYTOKINES; EFFICACY; SWINE	The porcine reproductive and respiratory syndrome (PRRS) is a devastating viral disease affecting swine production, health and welfare throughout the world. A synergistic action of the innate and the adaptive immune system of the host is essential for mounting a durable protective immunity through vaccination. Therefore, the current study aimed to investigate the transcriptome profiles of peripheral blood mononuclear cells (PBMCs) to characterize the innate and the adaptive immune response to PRRS Virus (PRRSV) vaccination in Pie-train pigs. The Affymetrix gene chip porcine gene 1.0 ST array was used for the transcriptome profiling of PBMCs collected at immediately before (D0), at one (D1) and 28 days (D28) post PRRSV vaccination with three biological replications. With FDR < 0.05 and log2 fold change +/- 1.5 as cutoff criteria, 295 and 115 transcripts were found to be differentially expressed in PBMCs during the stage of innate and adaptive response, respectively. The microarray expression results were technically validated by qRT-PCR. The gene ontology terms such as viral life cycle, regulation of lymphocyte activation, cytokine activity and inflammatory response were enriched during the innate immunity; cytolysis, T cell mediated cytotoxicity, immunoglobulin production were enriched during adaptive immunity to PRRSV vaccination. Significant enrichment of cytokine-cytokine receptor interaction, signaling by interleukins, signaling by the B cell receptor (BCR), viral mRNA translation, IFN-gamma pathway and AP-1 transcription factor network pathways were indicating the involvement of altered genes in the antiviral defense. Network analysis revealed that four network modules were functionally involved with the transcriptional network of innate immunity, and five modules were linked to adaptive immunity in PBMCs. The innate immune transcriptional network was found to be regulated by LCK, STAT3, ATP5B, UBB and RSP17. While TGF beta 1, IL7R, RAD21, SP1 and GZMB are likely to be predictive for the adaptive immune transcriptional response to PRRSV vaccine in PBMCs. Results of the current immunogenomics study advances our understanding of PRRS in term of host-vaccine interaction, and thereby contribute to design a rationale for disease control strategy.	[Islam, Md. Aminul; Grosse-Brinkhaus, Christine; Proell, Maren Julia; Rony, Sharmin Aqter; Tesfaye, Dawit; Tholen, Ernst; Hoelker, Michael; Schellander, Karl; Neuhoff, Christiane] Univ Bonn, Inst Anim Sci, Dept Anim Breeding & Husb, Endenicher Allee 15, D-53115 Bonn, Germany; [Islam, Md. Aminul; Uddin, Muhammad Jasim] Bangladesh Agr Univ, Fac Vet Sci, Dept Med, Mymensingh 2202, Bangladesh; [Uddin, Muhammad Jasim] Univ Queensland, Sch Vet Sci, Gatton, Qld 4343, Australia; [Hoelker, Michael; Schellander, Karl] Univ Bonn, Fac Agr, Teaching & Res Stn Frankenfrost, Konigswinter, Germany	University of Bonn; Bangladesh Agricultural University (BAU); University of Queensland; University of Bonn	Neuhoff, C (corresponding author), Univ Bonn, Inst Anim Sci, Dept Anim Breeding & Husb, Endenicher Allee 15, D-53115 Bonn, Germany.	cneu@itw.uni-bonn.de	Große-Brinkhaus, Christine/AAF-6712-2020; Islam, Aminul/AAE-9484-2019; Uddin, Muhammad Jasim/P-8497-2019; Uddin, Muhammad Jasim/N-3866-2013	Große-Brinkhaus, Christine/0000-0002-6190-4463; Islam, Aminul/0000-0003-1979-9652; Uddin, Muhammad Jasim/0000-0002-6732-5534; Uddin, Dr. Md. Jashim/0000-0002-3243-3455	State of North Rhine Westphalia of Germany [17-02.04.01-4/15]	State of North Rhine Westphalia of Germany	This work was financially supported by the State of North Rhine Westphalia of Germany with the program "Umweltvertragliche and Standortgerechte Landwirtschaft (USL)" with the grant nr. 17-02.04.01-4/15. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Aasted B, 2002, CLIN DIAGN LAB IMMUN, V9, P1229, DOI 10.1128/CDLI.9.6.1229-1234.2002; Adler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058306; Ait-Ali T, 2011, IMMUNOGENETICS, V63, P437, DOI 10.1007/s00251-011-0518-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; [Anonymous], 2001, NUCLEIC ACIDS RES, V29, DOI [10.1093/nar/29.9.e45, DOI 10.1093/NAR/29.9.E45]; Badaoui B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091918; Badaoui B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-220; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Breuer K, 2013, NUCLEIC ACIDS RES, V41, P24, DOI DOI 10.1093/NARL0KS1147; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; COLLINS JE, 1992, J VET DIAGN INVEST, V4, P117, DOI 10.1177/104063879200400201; Corzo CA, 2010, VIRUS RES, V154, P185, DOI 10.1016/j.virusres.2010.08.016; Garcia-Nicolas O, 2014, VET IMMUNOL IMMUNOP, V160, P26, DOI 10.1016/j.vetimm.2014.03.008; Gardy JL, 2009, TRENDS IMMUNOL, V30, P249, DOI 10.1016/j.it.2009.03.009; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glass Elizabeth J., 2012, Frontiers in Genetics, V3, P263, DOI 10.3389/fgene.2012.00263; Goldman FD, 1998, J CLIN INVEST, V102, P421, DOI 10.1172/JCI3205; Islam MS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3249-2; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Kohane IS, 2012, BIOINFORMATICS, V28, P538, DOI 10.1093/bioinformatics/btr713; Li J, 2010, VIRUS RES, V148, P60, DOI 10.1016/j.virusres.2009.12.004; [李杏春 Li Xingchun], 2014, [生物技术通报, Biotechnology Bulletin], P26; Li Y, 2014, BIOMASS BIOENERG, V71, P162, DOI 10.1016/j.biombioe.2014.10.010; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Lockhart Stephen, 2003, Expert Rev Vaccines, V2, P633, DOI 10.1586/14760584.2.5.633; Loemba HD, 1996, ARCH VIROL, V141, P751, DOI 10.1007/BF01718333; Lopez OJ, 2004, VET IMMUNOL IMMUNOP, V102, P155, DOI 10.1016/j.vetimm.2004.09.005; Loving CL, 2015, VET IMMUNOL IMMUNOP, V167, P1, DOI 10.1016/j.vetimm.2015.07.003; Martelli P, 2007, VACCINE, V25, P3400, DOI 10.1016/j.vaccine.2006.12.050; Martelli P, 2009, VACCINE, V27, P3788, DOI 10.1016/j.vaccine.2009.03.028; Meier WA, 2003, VIROLOGY, V309, P18, DOI 10.1016/S0042-6822(03)00009-6; Miller LC, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-208; Motulsky HJ, 2007, PRISM 5 STAT GUIDE, V31, P39; Nielsen J, 1997, VET MICROBIOL, V55, P289, DOI 10.1016/S0378-1135(96)01334-X; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Renukaradhya GJ, 2010, VIRAL IMMUNOL, V23, P457, DOI 10.1089/vim.2010.0051; Rowland Raymond R. R., 2012, Frontiers in Genetics, V3, P260, DOI 10.3389/fgene.2012.00260; Rozen S, 2000, Methods Mol Biol, V132, P365; Schroyen M, 2015, MAMM GENOME, V26, P1, DOI 10.1007/s00335-014-9549-4; Shimizu M, 1996, VET IMMUNOL IMMUNOP, V50, P19, DOI 10.1016/0165-2427(95)05494-4; Shoemaker JE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-460; Silva-Campa E, 2012, VIROLOGY, V430, P73, DOI 10.1016/j.virol.2012.04.009; Silva-Campa E, 2010, VIROLOGY, V396, P264, DOI 10.1016/j.virol.2009.10.024; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Trus I, 2014, VACCINE, V32, P2995, DOI 10.1016/j.vaccine.2014.03.077; Uddin MJ, 2012, VET IMMUNOL IMMUNOP, V147, P211, DOI 10.1016/j.vetimm.2012.04.020; Van Breedam W, 2010, J GEN VIROL, V91, P1659, DOI 10.1099/vir.0.020503-0; Van Gucht S, 2005, VIRAL IMMUNOL, V18, P116; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Wang IM, 2012, MICROB BIOTECHNOL, V5, P177, DOI 10.1111/j.1751-7915.2011.00317.x; Weesendorp E, 2013, VET MICROBIOL, V163, P1, DOI 10.1016/j.vetmic.2012.09.013; Wilkie B, 1999, VET IMMUNOL IMMUNOP, V72, P231, DOI 10.1016/S0165-2427(99)00136-1; Wysocki M, 2012, ANIM GENET, V43, P328, DOI 10.1111/j.1365-2052.2011.02251.x; Xia J, 2014, NUCLEIC ACIDS RES, V42, P26, DOI DOI 10.1093/NALL0KU443; Xiao SQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-544; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Xu DQ, 2012, VIRUS RES, V169, P264, DOI 10.1016/j.virusres.2012.07.002; Yoon KJ, 1996, VIRAL IMMUNOL, V9, P51, DOI 10.1089/vim.1996.9.51; Zhang HM, 2012, VET MICROBIOL, V159, P494, DOI 10.1016/j.vetmic.2012.04.025; Zhou P, 2011, INT J BIOL SCI, V7, P947, DOI 10.7150/ijbs.7.947; Zhuge ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029320	67	10	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0171828	10.1371/journal.pone.0171828	http://dx.doi.org/10.1371/journal.pone.0171828			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278192	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900111
J	Mattie, J; Borisoff, J; Miller, WC; Noureddin, B				Mattie, Johanne; Borisoff, Jaimie; Miller, William C.; Noureddin, Borna			Characterizing the community use of an ultralight wheelchair with "on the fly" adjustable seating functions: A pilot study	PLOS ONE			English	Article							TILT-IN-SPACE; MANUAL WHEELCHAIR; RESNA POSITION; MOBILITY; PARTICIPATION; VALIDATION; BEHAVIORS; RECLINE	An ultralight manual wheelchair that allows users to independently adjust rear seat height and backrest angle during normal everyday usage was recently commercialized. Prior research has been performed on wheelchair tilt, recline, and seat elevation use in the community, however no such research has been done on this new class of manual ultralight wheelchair with "on the fly" adjustments. The objective of this pilot study was to investigate and characterize the use of the two adjustable seating functions available on the Elevation T ultralight dynamic wheelchair during its use in the community. Eight participants had data loggers installed onto their own wheelchair for seven days to measure rear seat height, backrest angle position, occupied sitting time, and distance traveled. Analysis of rear seat height and backrest adjustment data revealed considerable variability in the frequency of use and positions used by participants. There was a wide spread of mean daily rear seat heights among participants, from 34.1 cm to 46.7 cm. Two sub-groups of users were further identified: those who sat habitually at a single typical rear seat height, and those who varied their rear seat height more continuously. Findings also showed that participants used the rear seat height adjustment feature significantly more often than the backrest adjustment feature. This obvious contrast in feature use may indicate that new users of this class of wheelchair may benefit from specific training. While the small sample size and exploratory nature of this study limit the generalizability of our results, our findings offer a first look at how active wheelchairs users are using a new class of ultralight wheelchair with "on the fly" seating adjustments in their communities. Further studies are recommended to better understand the impact of dynamic seating and positioning on activity, participation and quality of life.	[Mattie, Johanne; Noureddin, Borna] British Columbia Inst Technol, MAKE, Burnaby, BC, Canada; [Borisoff, Jaimie; Miller, William C.] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Fac Med, Vancouver, BC, Canada; [Borisoff, Jaimie; Miller, William C.] Int Collaborat Repair Discoveries, Vancouver, BC, Canada; [Borisoff, Jaimie] British Columbia Inst Technol, Canada Res Chair Rehabil Engn Design, Burnaby, BC, Canada; [Borisoff, Jaimie] Univ British Columbia, Biomed Engn Program, Vancouver, BC, Canada; [Miller, William C.] GF Strong Rehabil Res Lab, Vancouver, BC, Canada	British Columbia Institute of Technology; University of British Columbia; British Columbia Institute of Technology; University of British Columbia	Borisoff, J (corresponding author), Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Fac Med, Vancouver, BC, Canada.	Jaimie_Borisoff@bcit.ca	Miller, William/S-7407-2019		Canada Research Chair in Rehabilitation Engineering Design; National Science and Engineering Research Council of Canada -NSERC [RGPIN 418586-2013]; BCIT Discovery Parks Fund	Canada Research Chair in Rehabilitation Engineering Design; National Science and Engineering Research Council of Canada -NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); BCIT Discovery Parks Fund	This project has been supported by the Canada Research Chair in Rehabilitation Engineering Design (JB) (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx); National Science and Engineering Research Council of Canada -NSERC grant # RGPIN 418586-2013 (JB) (http://www.nserc-crsng.gc.ca/index _eng.asp) and the BCIT Discovery Parks Fund (JB), (http://www. bcit.ca/appliecresearch/funding/institute.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arva J, 2009, ASSIST TECHNOL, V21, P69, DOI 10.1080/10400430902945587; Best KL, 2005, ARCH PHYS MED REHAB, V86, P2316, DOI 10.1016/j.apmr.2005.07.300; Borisoff JF, 2011, P RESNA 2011 ANN C 2; Carlson Dawn, 2002, TOP SPINAL CORD INJ, V7, P28, DOI DOI 10.1310/4VAG-D0BF-QLU5-Y1LT; Chaves ES, 2004, ARCH PHYS MED REHAB, V85, P1854, DOI 10.1016/j.apmr.2004.03.033; Collin C, 1988, Int Disabil Stud, V10, P61; Cooper RA, 2011, ASSIST TECHNOL, V23, P177, DOI 10.1080/10400435.2011.588991; Dicianno BE, 2009, ASSIST TECHNOL, V21, P13, DOI 10.1080/10400430902945769; Ding D, 2005, P 27 ANN INT C IEEE; Ding D, 2008, J REHABIL RES DEV, V45, P973, DOI 10.1682/JRRD.2007.11.0178; Fitzgerald SG, 2005, J REHABIL RES DEV, V42, P853, DOI 10.1682/JRRD.2004.10.0130; Frank AO, 2012, DISABIL REHABIL, V34, P770, DOI 10.3109/09638288.2011.619620; Hong EK, 2011, ASSIST TECHNOL, V23, P24, DOI 10.1080/10400435.2010.541405; Janssen-Potten YJM, 2000, ARCH PHYS MED REHAB, V81, P401, DOI 10.1053/mr.2000.3859; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kroemer KHE, 1994, HARD FACTS SOFT MACH, P181; Lueder R, 2005, ERGONOMICS OF SITTIN; MacPhee AH, 2004, ARCH PHYS MED REHAB, V85, P41, DOI 10.1016/S0003-9993(03)00364-2; Marshall S, 2010, AM J PREV MED, V39, P389, DOI 10.1016/j.amepre.2010.07.001; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; Mills T, 2002, DISABIL REHABIL, V24, P38, DOI 10.1080/09638280110066334; Mills TL, 2007, ASSIST TECHNOL, V19, P61, DOI 10.1080/10400435.2007.10131866; Oyster ML, 2011, ARCH PHYS MED REHAB, V92, P484, DOI 10.1016/j.apmr.2010.09.025; Paralyzed Veterans of America Consortium for Spinal Cord Medicine, 2005, J Spinal Cord Med, V28, P434; PDG Mobility, 2012, PDG MOB WHEELCH FUNC; Sakakibara BM, 2013, ARCH PHYS MED REHAB, V94, P1031, DOI 10.1016/j.apmr.2013.01.016; Smith EM, 2014, DISABIL REHABIL ASSI, V11, P1; Sonenblum SE, 2008, ARCH PHYS MED REHAB, V89, P486, DOI 10.1016/j.apmr.2007.09.029; Sonenblum SE, 2011, DISABIL REHABIL-ASSI, V6, P526, DOI 10.3109/17483107.2011.580900; Sprigle S, 2013, DISABIL REHABIL-ASSI, V8, P225, DOI 10.3109/17483107.2012.713436; Tolerico ML, 2007, J REHABIL RES DEV, V44, P561, DOI 10.1682/JRRD.2006.02.0017; Wee J, 2009, DISABIL REHABIL, V31, P1633, DOI 10.1080/09638280902736346; Yang YS, 2009, SPINAL CORD, V47, P67, DOI 10.1038/sc.2008.72	33	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173662	10.1371/journal.pone.0173662	http://dx.doi.org/10.1371/journal.pone.0173662			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278254	Green Submitted, gold, Green Published			2022-12-27	WOS:000396087900025
J	Nickerson, KM; Wang, YJ; Bastacky, S; Shlomchik, MJ				Nickerson, Kevin M.; Wang, Yujuan; Bastacky, Sheldon; Shlomchik, Mark J.			Toll-like receptor 9 suppresses lupus disease in Fas-sufficient MRL Mice	PLOS ONE			English	Article							ANTI-RNA AUTOANTIBODY; AUTOREACTIVE B-CELLS; INDUCED MURINE LUPUS; GERMINAL-CENTERS; DENDRITIC CELLS; MOUSE MODEL; T-CELLS; SYSTEMIC AUTOIMMUNITY; SOMATIC HYPERMUTATION; INTRINSIC TLR7	Genetic deficiency in TLR9 accelerates pathogenesis in the spontaneous polygenic MRL. Fas(lpr) murine model of systemic lupus erythematosus, despite the absence of anti-nucleosome autoantibodies. However, it could be argued that this result was dependent on Fas-deficiency rather than lupus-promoting genes in the MRL genetic background. Here we report the effects of TLR9 deficiency on autoimmune disease independent of the lpr mutation in Fas by characterizing Tlr9(-/-) and Tlr9(+/+) mice on the Fas-intact MRL/+ genetic background. By 30 weeks of age, Tlr9-deficient MRL/+ had more severe renal disease, increased T cell activation, and higher titers of anti-Sm and anti-RNA autoantibodies than Tlr9-intact animals, as had been the case in the MRL. Fas(lpr) model. In addition, Tlr9-deficient MRL/+ mice had increased numbers of germinal center phenotype B cells and an increase in splenic neutrophils and conventional dendritic cell populations. Thus, the disease accelerating effects of Tlr9 deficiency are separable from those mediated by the Fas mutation in the lupus-prone MRL genetic background. Nonetheless, disease acceleration in Tlr9-deficient MRL/+ mice was phenotypically distinct from that in Fas-deficient counterparts, which has important implications.	[Nickerson, Kevin M.; Wang, Yujuan; Shlomchik, Mark J.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA; [Bastacky, Sheldon] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Nickerson, KM (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA.	kevin.nickerson@pitt.edu	Shlomchik, Mark J./AAN-6189-2020; Nickerson, Kevin M/B-1351-2009	Shlomchik, Mark J./0000-0002-2152-0959; Nickerson, Kevin M/0000-0002-0114-2671	National Institutes of Health [7R01A1084958, 1R37A1118841]; Kidney Imaging Core of the Pittsburgh Center for Kidney Research (NIH) [P30DK079307]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI118841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kidney Imaging Core of the Pittsburgh Center for Kidney Research (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work supported by National Institutes of Health (www://nih.gov) grants 7R01A1084958 and 1R37A1118841 (MJS) and in part by the Kidney Imaging Core of the Pittsburgh Center for Kidney Research (NIH grant P30DK079307) (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Blander JM, 2014, NAT REV IMMUNOL, V14, P601, DOI 10.1038/nri3720; Bossaller L, 2016, J IMMUNOL, V197, P1044, DOI 10.4049/jimmunol.1501943; Brint E, 2013, CELL MOL LIFE SCI, V70, P4085, DOI 10.1007/s00018-013-1327-z; Buechler MB, 2013, J IMMUNOL, V190, P886, DOI 10.4049/jimmunol.1202739; Celhar T, 2012, IMMUNOL RES, V53, P58, DOI 10.1007/s12026-012-8270-1; Chan OTM, 1999, J IMMUNOL, V163, P3592; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; D'Acquisto F, 2011, BIOCHEM PHARMACOL, V82, P333, DOI 10.1016/j.bcp.2011.05.019; Desnues B, 2014, P NATL ACAD SCI USA, V111, P1497, DOI 10.1073/pnas.1314121111; EISENBERG RA, 1978, J EXP MED, V147, P582, DOI 10.1084/jem.147.2.582; Freeley SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074112; Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010; Han JH, 2014, EUR J IMMUNOL, V44, P215, DOI 10.1002/eji.201343714; Herlands RA, 2007, EUR J IMMUNOL, V37, P3339, DOI 10.1002/eji.200737752; Hwang SH, 2012, J IMMUNOL, V189, P5786, DOI 10.4049/jimmunol.1202195; IZUI S, 1984, J IMMUNOL, V133, P227; Jackson SW, 2014, J IMMUNOL, V192, P4525, DOI 10.4049/jimmunol.1400098; Joosten LAB, 2016, NAT REV RHEUMATOL, V12, P344, DOI 10.1038/nrrheum.2016.61; Khan WN, 2013, IMMUNOL RES, V57, P335, DOI 10.1007/s12026-013-8466-z; Kono DH, 2009, P NATL ACAD SCI USA, V106, P12061, DOI 10.1073/pnas.0905441106; Lartigue A, 2006, J IMMUNOL, V177, P1349, DOI 10.4049/jimmunol.177.2.1349; Lartigue A, 2009, J IMMUNOL, V183, P6207, DOI 10.4049/jimmunol.0803219; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Lucas JA, 2008, J IMMUNOL, V181, P2513, DOI 10.4049/jimmunol.181.4.2513; Martina MN, 2015, IMMUNOL CELL BIOL, V93, P305, DOI 10.1038/icb.2014.99; Nickerson KM, 2013, J IMMUNOL, V190, P3889, DOI 10.4049/jimmunol.1203525; Nickerson KM, 2013, J IMMUNOL, V190, P1447, DOI 10.4049/jimmunol.1202115; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Nickerson KM, 2016, ENCY IMMUNOBIOLOGY, V5, P227; Nundel K, 2015, J IMMUNOL, V194, P2504, DOI 10.4049/jimmunol.1402425; Ols ML, 2016, IMMUNITY, V45, P1052, DOI 10.1016/j.immuni.2016.10.005; Peng SL, 1998, CLIN EXP IMMUNOL, V111, P107; Pillai S, 2011, CURR OPIN IMMUNOL, V23, P721, DOI 10.1016/j.coi.2011.10.007; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Relle M, 2015, AUTOIMMUN REV, V14, P1005, DOI 10.1016/j.autrev.2015.07.003; Sang A, 2014, MOL IMMUNOL, V62, P329, DOI 10.1016/j.molimm.2013.11.013; Sang A, 2014, J IMMUNOL, V193, P1609, DOI 10.4049/jimmunol.1303000; Santiago-Raber ML, 2010, J AUTOIMMUN, V34, P339, DOI 10.1016/j.jaut.2009.11.001; Shah S, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0462-4; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Soni C, 2014, J IMMUNOL, V193, P4400, DOI 10.4049/jimmunol.1401720; Stoehr AD, 2011, J IMMUNOL, V187, P2953, DOI 10.4049/jimmunol.1003340; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Summers SA, 2010, J AUTOIMMUN, V35, P291, DOI 10.1016/j.jaut.2010.05.004; Sweet RA, 2011, P NATL ACAD SCI USA, V108, P7932, DOI 10.1073/pnas.1018571108; Sweet RA, 2010, AUTOIMMUNITY, V43, P607, DOI 10.3109/08916930903567500; Teichmann LL, 2013, IMMUNITY, V38, P528, DOI 10.1016/j.immuni.2012.11.017; Walsh ER, 2012, P NATL ACAD SCI USA, V109, P16276, DOI 10.1073/pnas.1209372109; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; WOFSY D, 1984, J EXP MED, V159, P629, DOI 10.1084/jem.159.2.629; Yu P, 2006, INT IMMUNOL, V18, P1211, DOI 10.1093/intimm/dxl067	57	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173471	10.1371/journal.pone.0173471	http://dx.doi.org/10.1371/journal.pone.0173471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278279	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900098
J	Cienfuegos, PJ; Shoemaker, A; Grange, RW; Abaid, N; Leonessa, A				Cienfuegos, Paola Jaramillo; Shoemaker, Adam; Grange, Robert W.; Abaid, Nicole; Leonessa, Alexander			Classical and adaptive control of ex vivo skeletal muscle contractions using Functional Electrical Stimulation (FES)	PLOS ONE			English	Article							NEURAL-NETWORK; MODEL; FREQUENCY; PATTERNS; FATIGUE	Functional Electrical Stimulation is a promising approach to treat patients by stimulating the peripheral nerves and their corresponding motor neurons using electrical current. This technique helps maintain muscle mass and promote blood flow in the absence of a functioning nervous system. The goal of this work is to control muscle contractions from FES via three different algorithms and assess the most appropriate controller providing effective stimulation of the muscle. An open-loop system and a closed-loop system with three types of model-free feedback controllers were assessed for tracking control of skeletal muscle contractions: a Proportional-Integral (PI) controller, a Model Reference Adaptive Control algorithm, and an Adaptive Augmented PI system. Furthermore, a mathematical model of a muscle-mass-spring system was implemented in simulation to test the open-loop case and closed-loop controllers. These simulations were carried out and then validated through experiments ex vivo. The experiments included muscle contractions following four distinct trajectories: a step, sine, ramp, and square wave. Overall, the closed-loop controllers followed the stimulation trajectories set for all the simulated and tested muscles. When comparing the experimental outcomes of each controller, we concluded that the Adaptive Augmented PI algorithm provided the best closed-loop performance for speed of convergence and disturbance rejection.	[Cienfuegos, Paola Jaramillo] US Naval Acad, Dept Weap & Syst Engn, Annapolis, MD 21402 USA; [Shoemaker, Adam; Leonessa, Alexander] Virginia Polytech Inst & State Univ, Dept Mech Engn, Blacksburg, VA 24061 USA; [Grange, Robert W.] Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA; [Abaid, Nicole] Virginia Polytech Inst & State Univ, Dept Biomed Engn & Mech, Foods, Blacksburg, VA 24061 USA	United States Department of Defense; United States Navy; United States Naval Academy; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Cienfuegos, PJ (corresponding author), US Naval Acad, Dept Weap & Syst Engn, Annapolis, MD 21402 USA.	paola.jaramillo.co@usna.edu			National Science Foundation Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET); Collaborative Research: Adaptive Control and Functional Electrical Stimulation for the Control and Understanding of Muscle Dynamics [0828114]; CAREER: Functional Electrical Stimulation to Aid Phonation in the Presence of Unilateral Vocal Fold Paralysis [1055315]; National Science Foundation [0828114, 1055315]; Directorate For Engineering [1055315] Funding Source: National Science Foundation	National Science Foundation Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)(National Science Foundation (NSF)); Collaborative Research: Adaptive Control and Functional Electrical Stimulation for the Control and Understanding of Muscle Dynamics; CAREER: Functional Electrical Stimulation to Aid Phonation in the Presence of Unilateral Vocal Fold Paralysis; National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research work was funded by the National Science Foundation Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET). Funds were awarded for the proposal No. 0828114 titled "Collaborative Research: Adaptive Control and Functional Electrical Stimulation for the Control and Understanding of Muscle Dynamics" and the proposal No. 1055315 titled "CAREER: Functional Electrical Stimulation to Aid Phonation in the Presence of Unilateral Vocal Fold Paralysis". The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Many thanks to the National Science Foundation for funding this study (Grant Funding No. 0828114 and No. 1055315). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Alexander Leonessa is the senior author and PI of the Center for Dynamic Systems Modeling and Control. This material is based upon work supported by (while serving at) the National Science Foundation.	ALAMOOD WS, 1987, J PHYSIOL-LONDON, V392, P377, DOI 10.1113/jphysiol.1987.sp016786; Asadi AR, 2012, IEEE T NEUR SYS REH, V20, P499, DOI 10.1109/TNSRE.2012.2197828; Brend O, 2015, IEEE T CONTR SYST T, V23, P1901, DOI 10.1109/TCST.2015.2394508; Chang G C, 1997, IEEE Trans Rehabil Eng, V5, P2, DOI 10.1109/86.559344; CHIZECK HJ, 1991, IEEE T BIO-MED ENG, V38, P1224, DOI 10.1109/10.137288; Coste C. Azevedo, 2015, IFAC - Papers Online, V48, P333, DOI 10.1016/j.ifacol.2015.10.161; D'Souza A., 1988, DESIGN OF CONTROL SY; Dennis RG, 2003, MED ENG PHYS, V25, P239, DOI 10.1016/S1350-4533(02)00193-5; Dow DE, 2004, MUSCLE NERVE, V30, P77, DOI 10.1002/mus.20054; EKEN T, 1988, J PHYSIOL-LONDON, V402, P651, DOI 10.1113/jphysiol.1988.sp017227; Grange RW, 2002, AM J PHYSIOL-CELL PH, V283, pC1090, DOI 10.1152/ajpcell.00450.2001; Gregory CM, 2005, PHYS THER, V85, P358, DOI 10.1093/ptj/85.4.358; GUNDERSEN K, 1992, ACTA PHYSIOL SCAND, V145, P49, DOI 10.1111/j.1748-1716.1992.tb09335.x; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hunt KJ, 2001, CONTROL ENG PRACT, V9, P313, DOI 10.1016/S0967-0661(00)00126-X; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Ianno M., 2002, ANN C INT FUNCT EL S; IOANNOU PA, 1996, ROBUST ADAPTIVE CONT; Jaramillo P., 2012, INT C NEUROREHABILIT; John CT, 2013, COMPUT METHOD BIOMEC, V16, P451, DOI 10.1080/10255842.2011.627560; Khalil H. K., 2002, NONLINEAR SYSTEM; Kralj A.R., 1989, FUNCTIONAL ELECT STI, DOI DOI 10.1201/9780203755402; Krsti M., 1995, NONLINEAR ADAPTIVE C; Li Z, 2014, IEEE COMPUT INTELL M, V9, P38, DOI 10.1109/MCI.2014.2307224; Lynch C. L., 2005, 10 ANN C INT FES SOC; Lynch CL, 2008, IEEE CONTR SYST MAG, V28, P40, DOI 10.1109/MCS.2007.914689; Lynch CL, 2012, IEEE T NEUR SYS REH, V20, P539, DOI 10.1109/TNSRE.2012.2185065; Maffiuletti NA, 2010, EUR J APPL PHYSIOL, V110, P223, DOI 10.1007/s00421-010-1502-y; Narendra K. S., 2012, STABLEADAPTIVESYSTEM; Narendra KS, 1989, STABLE ADAPTIVE SYST; Popovic DB, 2014, J ELECTROMYOGR KINES, V24, P795, DOI 10.1016/j.jelekin.2014.09.008; Riener R, 1996, J BIOMECH, V29, P1157, DOI 10.1016/0021-9290(96)00012-7; Riess J, 2000, IEEE T REHABIL ENG, V8, P42, DOI 10.1109/86.830948; Rouhani E., 2014, 2014 IEEE 19 INT FUN, P1; Sayenko DG, 2014, EUR J APPL PHYSIOL, V114, P793, DOI 10.1007/s00421-013-2807-4; Sheffler LR, 2007, MUSCLE NERVE, V35, P562, DOI 10.1002/mus.20758; Tamura Y, 2002, J BIOMECH, V35, P1273, DOI 10.1016/S0021-9290(02)00082-9; Thelen DG, 2003, J BIOMECH ENG-T ASME, V125, P70, DOI 10.1115/1.1531112; Watanabe T., 2002, P 7 IFESS, P265; WESTGAARD RH, 1988, J NEUROSCI, V8, P4415; Williams H. Bruce, 1996, Microsurgery, V17, P589, DOI 10.1002/(SICI)1098-2752(1996)17:11<589::AID-MICR5>3.0.CO;2-K; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Zhang DG, 2004, P ANN INT IEEE EMBS, V26, P4877; Zhang DG, 2004, IEEE IJCNN, P1245	46	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172761	10.1371/journal.pone.0172761	http://dx.doi.org/10.1371/journal.pone.0172761			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273101	gold, Green Published, Green Submitted			2022-12-27	WOS:000396073700029
J	Clemensson, EKH; Clemensson, LE; Fabry, B; Riess, O; Nguyen, HP				Clemensson, Erik Karl Hakan; Clemensson, Laura Emily; Fabry, Benedikt; Riess, Olaf; Huu Phuc Nguyen			Further investigation of phenotypes and confounding factors of progressive ratio performance and feeding behavior in the BACHD rat model of Huntington disease	PLOS ONE			English	Article							MONOSODIUM GLUTAMATE; COGNITIVE IMPAIRMENT; ENERGY-BALANCE; LEPTIN; NUCLEUS; MOTOR; FOOD; MOTIVATION; OBESITY; LESIONS	Huntington disease is an inherited neurodegenerative disorder characterized by motor, cognitive, psychiatric and metabolic symptoms. We recently published a study describing that the BACHD rat model of HD shows an obesity phenotype, which might affect their motivation to perform food-based behavioral tests. Further, we argued that using a food restriction protocol based on matching BACHD and wild type rats' food consumption rates might resolve these motivational differences. In the current study, we followed up on these ideas in a longitudinal study of the rats' performance in a progressive ratio test. We also investigated the phenotype of reduced food consumption rate, which is typically seen in food-restricted BACHD rats, in greater detail. In line with our previous study, the BACHD rats were less motivated to perform the progressive ratio test compared to their wild type littermates, although the phenotype was no longer present when the rats' food consumption rates had been matched. However, video analysis of food consumption tests suggested that the reduced consumption rate found in the BACHD rats was not entirely based on differences in hunger, but likely involved motoric impairments. Thus, restriction protocols based on food consumption rates are not appropriate when working with BACHD rats. As an alternative, we suggest that studies where BACHD rats are used should investigate how the readouts of interest are affected by motivational differences, and use appropriate control tests to avoid misleading results. In addition, we show that BACHD rats display distinct behavioral changes in their progressive ratio performance, which might be indicative of striatal dysfunction.	[Clemensson, Erik Karl Hakan; Clemensson, Laura Emily; Riess, Olaf; Huu Phuc Nguyen] Inst Med Genet & Appl Genom, Tubingen, Tuebingen, Germany; [Clemensson, Erik Karl Hakan; Clemensson, Laura Emily; Riess, Olaf; Huu Phuc Nguyen] Ctr Rare Dis, Tubingen, Tuebingen, Germany; [Clemensson, Laura Emily; Fabry, Benedikt] QPS Austria, Grambach, Austria		Nguyen, HP (corresponding author), Inst Med Genet & Appl Genom, Tubingen, Tuebingen, Germany.; Nguyen, HP (corresponding author), Ctr Rare Dis, Tubingen, Tuebingen, Germany.	Hoa.nguyen@med.uni-tuebingen.de	Nguyen, Huu Phuc/HDO-3462-2022	Nguyen, Huu Phuc/0000-0001-6139-788X; Clemensson, Erik/0000-0002-5158-6924	EU 7th Framework program [324495]	EU 7th Framework program(European Commission)	HPN, LEC, and BF were supported by EU 7th Framework program (FP7/2012), project "SWITCH-HD," under grant agreement no. 324495. LEC and BF are employees of QPS Austria, but their salaries for this study were provided by the above-mentioned grant. QPS Austria had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada YK, 2013, PLOS ONE; Adam OR, 2008, NEUROTHERAPEUTICS, V5, P181, DOI 10.1016/j.nurt.2008.01.008; Alhadeff AL, 2014, AM J PHYSIOL-REG I, V307, pR1338, DOI 10.1152/ajpregu.00329.2014; Balthasar N, 2003, ENDOCRINOLOGY, V144, P2728, DOI 10.1210/en.2003-0006; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Baudic S, 2006, DEMENT GERIATR COGN, V21, P316, DOI 10.1159/000091523; Berryman DE, 2010, J GERONTOL A-BIOL, V65, P31, DOI 10.1093/gerona/glp175; Berryman DE, 2004, GROWTH HORM IGF RES, V14, P309, DOI 10.1016/j.ghir.2004.02.005; BERTHERAT J, 1992, NEUROENDOCRINOLOGY, V56, P25, DOI 10.1159/000126204; BESSER GM, 1974, J CLIN PATHOL, V27, P173, DOI 10.1136/jcp.27.3.173; BLOCH B, 1984, NATURE, V307, P272, DOI 10.1038/307272a0; Bradbury MJ, 2005, J PHARMACOL EXP THER, V313, P395, DOI 10.1124/jpet.104.076406; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Brooks SP, 2015, CURR TOP BEHAV NEURO, V22, P101, DOI 10.1007/7854_2013_256; Carreira JC, 2015, CURR TOP BEHAV NEURO, V22, P135, DOI 10.1007/7854_2013_245; Chang RB, 2015, DRUG DES DEV THER, V9, P2179, DOI 10.2147/DDDT.S58470; Chen W, 2013, N-S ARCH PHARMACOL, V386, P721, DOI 10.1007/s00210-013-0875-y; Clemens LE, 2015, BRAIN, V138, P3632, DOI 10.1093/brain/awv290; Davis JF, 2011, BIOL PSYCHIAT, V69, P668, DOI 10.1016/j.biopsych.2010.08.028; de Tommaso M, 2015, EUR NEUROL, V74, P49, DOI 10.1159/000435833; DONAHUE LR, 1993, J ENDOCRINOL, V136, P91, DOI 10.1677/joe.0.1360091; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Eagle DM, 1999, BEHAV NEUROSCI, V113, P718, DOI 10.1037/0735-7044.113.4.718; Enkel T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00010; Fielding SA, 2012, BRAIN RES BULL, V88, P223, DOI 10.1016/j.brainresbull.2011.09.011; Figlewicz DP, 2006, PHYSIOL BEHAV, V89, P611, DOI 10.1016/j.physbeh.2006.07.023; Hayward MD, 2002, J NEUROSCI, V22, P8251; Hult S, 2011, CELL METAB, V13, P428, DOI 10.1016/j.cmet.2011.02.013; Hunt V P, 1989, J Neurosci Nurs, V21, P92; Jansson EKH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105662; KAGEL M C, 1992, Dysphagia, V7, P106, DOI 10.1007/BF02493441; Kanoski SE, 2014, NEUROPSYCHOPHARMACOL, V39, P605, DOI 10.1038/npp.2013.235; Kudwa AE, 2013, PLOS ONE; LEOPOLD NA, 1985, ARCH NEUROL-CHICAGO, V42, P57, DOI 10.1001/archneur.1985.04060010063017; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; McFadyen MP, 2003, GENES BRAIN BEHAV, V2, P214, DOI 10.1034/j.1601-183X.2003.00028.x; Morris MJ, 1998, REGUL PEPTIDES, V75-6, P441, DOI 10.1016/S0167-0115(98)00100-1; Morton AJ, 2013, J HUNTINGTONS DIS, V2, P3, DOI 10.3233/JHD-130050; Murray PG, 2013, AM J MED GENET C, V163C, P76, DOI 10.1002/ajmg.c.31357; Naarding P, 2009, J NEUROPSYCH CLIN N, V21, P266, DOI 10.1176/appi.neuropsych.21.3.266; Nader K, 1997, ANNU REV PSYCHOL, V48, P85, DOI 10.1146/annurev.psych.48.1.85; Oakeshott S, 2012, PLOS CURR; Oakeshott S, 2013, PLOS CURR; Paulsen JS, 2001, J NEUROL NEUROSUR PS, V71, P310, DOI 10.1136/jnnp.71.3.310; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; Pouladi MA, 2009, BRAIN, V132, P919, DOI 10.1093/brain/awp006; Reiner A, 2011, INT REV NEUROBIOL, V98, P325, DOI [10.1016/B978-0-12-387003-2.00014-8, 10.1016/B978-0-12-381328-2.00014-6]; Roth JD, 2012, DIABETES OBES METAB, V14, P608, DOI 10.1111/j.1463-1326.2012.01570.x; SCALLET AC, 1986, BRAIN RES, V374, P380, DOI 10.1016/0006-8993(86)90434-8; TANAKA K, 1978, EXP NEUROL, V62, P191, DOI 10.1016/0014-4886(78)90050-X; Tennant K. A., 2010, J VIS EXP; Thompson JC, 2002, J NEUROPSYCH CLIN N, V14, P37, DOI 10.1176/appi.neuropsych.14.1.37; Thompson JC, 2012, J NEUROPSYCH CLIN N, V24, P53, DOI 10.1176/appi.neuropsych.11030057; Trueman RC, 2012, BRAIN RES BULL, V88, P261, DOI 10.1016/j.brainresbull.2011.03.015; Urbach YK, 2014, J NEUROSCI METH, V234, P38, DOI 10.1016/j.jneumeth.2014.06.017; Vonsattel Jean Paul G, 2008, Handb Clin Neurol, V89, P599, DOI 10.1016/S0072-9752(07)01256-0; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Youn J, 2012, BEHAV BRAIN RES, V226, P397, DOI 10.1016/j.bbr.2011.09.034; Yu-Taeger L, 2012, J NEUROSCI, V32, P15426, DOI 10.1523/JNEUROSCI.1148-12.2012; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	61	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173232	10.1371/journal.pone.0173232	http://dx.doi.org/10.1371/journal.pone.0173232			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273120	Green Submitted, Green Published, gold			2022-12-27	WOS:000396073700046
J	Chen, PC; Shih, CH; Chu, TJ; Lee, YC; Tzeng, TD				Chen, Po-Cheng; Shih, Chun-Han; Chu, Ta-Jen; Lee, Ying-Chou; Tzeng, Tzong-Der			Phylogeography and genetic structure of the oriental river prawn Macrobrachium nipponense (Crustacea: Decapoda: Palaemonidae) in East Asia	PLOS ONE			English	Article							ERIOCHEIR-SENSU-STRICTO; LAST GLACIAL MAXIMUM; MOLECULAR SYSTEMATICS; POPULATION-GROWTH; TAIWAN; HISTORY; MTDNA; SEA; DIFFERENTIATION; CYPRINIDAE	The oriental river prawn (Macrobrachium nipponense) is mainly distributed in East Asia. The phylogeography, population genetic structure and historical demography of this species in the East Asia were examined by using partial sequences of the cytochrome oxidase subunit I (COI) and 16S rRNA in mitochondrial DNA. Ten populations that included 239 individuals were collected from Taiwan (Shihmen Reservoir, SMR, Mingte Reservoir, MTR and Chengching Lake Reservoir, CLR), mainland China (Taihu Lake, TLC, Min River, MRC, Jiulong River, JRC and Shenzhen Reservoir, SRC), Japan (Biwa Lake, BLJ and Kasumigaura Lake, KLJ) and Korea (Han River, HRK). The nucleotide diversity (p) of all individuals was 0.01134, with values ranging from 0.0089 (BLJ, Japan) to 0.01425 (MTR, Taiwan). A total of 83 haplotypes were obtained, and the haplotypes were divided into 2 main lineages: lineage A included the specimens from BLJ, KLJ, CLR, MTR, TLC, MRC and JRC, and lineage B comprised the ones from HRK, SRC, SMR, MTR, TLC, MRC and JRC. Lineage A could be further divided two sub-lineages (A1 and A2). Individuals of lineage A2 were only from TLC. Demographic expansion was observed in each lineage, starting within the second-to-latest interglacial period for lineage A and within the last glacial period for lineage B. All FST values among the ten populations were significantly different, except for the values between MRC and JRC, and SMR and SRC. The phylogeography and genetic structure ofM. nipponense in East Asia might be influenced by Pleistocene glacial cycles, lake isolation and human introduction. The possible dispersal routes of M. nipponense in the East Asia were also discussed.	[Chen, Po-Cheng; Lee, Ying-Chou] Natl Taiwan Univ, Coll Life Sci, Inst Fisheries Sci, Taipei, Taiwan; [Shih, Chun-Han] Tungnan Univ, Dept Leisure Management, New Taipei, Taiwan; [Chu, Ta-Jen] Chung Hua Univ, Dept Leisure & Recreat Management, Hsinchu, Taiwan; [Tzeng, Tzong-Der] Shu Te Univ, Dept Leisure Recreat & Tourism Management, Kaohsiung, Taiwan	National Taiwan University; Chung Hua University; Shu-Te University	Lee, YC (corresponding author), Natl Taiwan Univ, Coll Life Sci, Inst Fisheries Sci, Taipei, Taiwan.; Tzeng, TD (corresponding author), Shu Te Univ, Dept Leisure Recreat & Tourism Management, Kaohsiung, Taiwan.	i812@ntu.edu.tw; tdtzeng@stu.edu.tw	, 朱達仁/AGA-5114-2022		Ministry of Science and Technology [MOST 104-2611-M-366-001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by the Ministry of Science and Technology grant number MOST 104-2611-M-366-001.	Avise JC, 2000, PHYLOGEOGRAPHY HIST, P301; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; Chen P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134694; Chen RT, 2009, J CRUSTACEAN BIOL, V29, P232, DOI 10.1651/08-3072.1; Chiang TY, 2010, J FISH BIOL, V76, P1173, DOI 10.1111/j.1095-8649.2010.02589.x; Chiang TY, 1999, MOL ECOL, V8, P1037, DOI 10.1046/j.1365-294x.1999.00668.x; Chiang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050844; Crandall KA, 1996, SYST BIOL, V45, P1; CRANDALL KA, 1993, GENETICS, V134, P959; Craw D, 2007, GEOMORPHOLOGY, V84, P98, DOI 10.1016/j.geomorph.2006.07.008; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Feng JB, 2010, J FISH SCI CHN, V17, P1; Feng JianBin, 2008, Journal of Fisheries of China, V32, P517; Fu YX, 1997, GENETICS, V147, P915; GASCOYNE M, 1979, SCIENCE, V205, P806, DOI 10.1126/science.205.4408.806; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; HUANG CY, 1995, TECTONICS, V14, P19, DOI 10.1029/94TC02452; Hudson RR, 1990, OXFORD SURVEYS EVOLU, V1, P1; Jiang S F, 2008, CHINESE AGR SCI BULL, V24, P554; Jiang SF., 2006, J YANGTZE U NATURAL, V3, P179; Liao TY, 2008, ZOOL STUD, V47, P383; Liu J, 2003, J LAKE SCI, V15, P177; Liu MY, 2007, ZOOL STUD, V46, P272; Liu MY, 2011, HYDROBIOLOGIA, V671, P1, DOI 10.1007/s10750-011-0699-z; LUNDBERG JG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P156; MANTEL N, 1967, CANCER RES, V27, P209; MASHIKO K, 1990, J CRUSTACEAN BIOL, V10, P306, DOI 10.2307/1548489; MASHIKO K, 1993, ZOOL SCI, V10, P161; Mashiko K, 2000, J CRUSTACEAN BIOL, V20, P118, DOI 10.1651/0278-0372(2000)020[0118:DOPWDS]2.0.CO;2; NEI M, 1981, GENETICS, V97, P145; NEI M, 1987, MOL EVOLUTIONARY GEN, P1, DOI DOI 10.7312/NEI-92038; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J, 2001, MOL CLONING LAB MANU, P66; Shih HT, 2006, J BIOGEOGR, V33, P980, DOI 10.1111/j.1365-2699.2006.01472.x; Stanley HF, 1996, MOL BIOL EVOL, V13, P368, DOI 10.1093/oxfordjournals.molbev.a025596; Su Xiang, 2011, Shengtaixue Zazhi, V30, P2007; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vilaca ST, 2010, MOL PHYLOGENET EVOL, V57, P585, DOI 10.1016/j.ympev.2010.07.010; Wang HY, 1999, MOL ECOL, V8, P1879, DOI 10.1046/j.1365-294x.1999.00787.x; Wang JP, 2004, MOL PHYLOGENET EVOL, V31, P1143, DOI 10.1016/j.ympev.2003.10.001; Wang JP, 2000, MOL ECOL, V9, P1483, DOI 10.1046/j.1365-294x.2000.01023.x; WANG PX, 1994, CATENA, V23, P341; WONG JTY, 1990, AQUACULTURE, V88, P151, DOI 10.1016/0044-8486(90)90290-4; Wu JT, 2008, WIRELESS COMMUNICATI, P1; Wu Yan, 2008, Shanghai Shuichan Daxue Xuebao, V17, P620; Xiao SB, 2004, J COASTAL RES, V20, P599, DOI 10.2112/1551-5036(2004)020[0599:THOTYR]2.0.CO;2; Xu JW, 2012, MOL PHYLOGENET EVOL, V64, P118, DOI 10.1016/j.ympev.2012.03.009; Xu JW, 2009, MOL PHYLOGENET EVOL, V52, P45, DOI 10.1016/j.ympev.2009.02.007; Yang Pin, 2007, Zoological Research, V28, P113; Yu HP, 1984, ACTA MARIMA AQUAC, V19, P117	57	11	12	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173490	10.1371/journal.pone.0173490	http://dx.doi.org/10.1371/journal.pone.0173490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267807	Green Published, Green Submitted, gold			2022-12-27	WOS:000396060600037
J	Sun, LL; Wu, RH; Su, WC; Gao, ZG; Lu, CT				Sun, Lanlan; Wu, Renhai; Su, Wangcang; Gao, Zenggui; Lu, Chuantao			Physiological basis for isoxadifen-ethyl induction of nicosulfuron detoxification in maize hybrids	PLOS ONE			English	Article							CORN ZEA-MAYS; HERBICIDE SAFENERS; XENOBIOTIC DETOXIFICATION; PRIMISULFURON; METABOLISM; TOLERANCE; WHEAT; GLUTATHIONE; SELECTIVITY; ENZYME	Isoxadifen-ethyl can effectively alleviate nicosulfuron injury in the maize. However, the effects of safener isoxadifen-ethyl on detoxifying enzymes in maize is unknown. The individual and combined effects of the sulfonylurea herbicide nicosulfuron and the safener isoxadifen-ethyl on the growth and selected physiological processes of maize were evaluated. Bioassays showed that the EC50 values of nicosulfuron and nicosulfuron plus isoxadifen-ethyl for maize cultivar Zhengdan958 were 18.87 and 249.28 mg kg(-1), respectively, and were 24.8 and 275.51 mg kg(-1), respectively, for Zhenghuangnuo No. 2 cultivar. Evaluations of the target enzyme of acetolactate synthase showed that the I-50 values of nicosulfuron and nicosulfuron plus isoxadifen-ethyl for the ALS of Zhengdan958 were 15.46 and 28.56 mu mol L-1, respectively, and were 0.57 and 2.17 mu mol L-1, respectively, for the acetolactate synthase of Zhenghuangnuo No. 2. The safener isoxadifen-ethyl significantly enhanced tolerance of maize to nicosulfuron. The enhanced tolerance of maize to nicosulfuron in the presence of the safener, coupled with the enhanced injury observed in the presence of piperonyl butoxide, 1-aminobenzotriazole, and malathion, suggested cytochrome P450 monooxygenases may be involved in metabolism of nicosulfuron. We proposed that isoxadifen-ethyl increases plant metabolism of nicosulfuron through non-P450-catalyzed routes or through P450 monooxygenases not inhibited by piperonyl butoxide, 1-aminobenzotriazole, and malathion. Isoxadifen-ethyl, at a rate of 33 mg kg(-1), completely reversed the effects of all doses (37.5-300 mg kg(-1)) of nicosulfuron on both of the maize cultivars. When the two compounds were given simultaneously, isoxadifen-ethyl enhanced activity of glutathione S-transferases (GSTs) and acetolactate synthase activity in maize. The free acid 4,5-dihydro5,5-diphenyl-1,2-oxazole-3-carboxylic was equally effective at inducing GSTs as the parent ester and appeared to be the active safener. GST induction in the maize Zhenghuangnuo No. 2 was faster than in Zhengdan 958.	[Sun, Lanlan; Gao, Zenggui] Shenyang Agr Univ, Dept Plant Protect, Shenyang, Peoples R China; [Wu, Renhai; Su, Wangcang; Lu, Chuantao] Henan Acad Agr Sci, Inst Plant Protect, Zhengzhou, Peoples R China	Shenyang Agricultural University; Henan Academy of Agricultural Sciences	Gao, ZG (corresponding author), Shenyang Agr Univ, Dept Plant Protect, Shenyang, Peoples R China.; Lu, CT (corresponding author), Henan Acad Agr Sci, Inst Plant Protect, Zhengzhou, Peoples R China.	gaozenggui@sina.com; luchuantao@yeah.net			Special Fund for Agro-scientific Research in the Public Interest [201203098]	Special Fund for Agro-scientific Research in the Public Interest	The present study has been supported by the Special Fund for Agro-scientific Research in the Public Interest (201203098).	Baerg RJ, 1996, PESTIC BIOCHEM PHYS, V55, P10, DOI 10.1006/pest.1996.0030; Barroso A. L. de L., 2012, Comunicata Scientiae, V3, P255; Behringer C, 2011, PLANT CELL ENVIRON, V34, P1970, DOI 10.1111/j.1365-3040.2011.02392.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazier M, 2002, PHYTOCHEMISTRY, V59, P149, DOI 10.1016/S0031-9422(01)00458-7; Bunting JA, 2004, WEED SCI, V52, P711, DOI 10.1614/WS-04-008R; Cataneo AC, 2013, PLANTA DANINHA, V31, P387, DOI 10.1590/S0100-83582013000200016; Cavalieri SD, 2012, PLANTA DANINHA, V30, P377, DOI 10.1590/S0100-83582012000200017; Cieslik LF, 2014, ACTA SCI-AGRON, V36, P329, DOI 10.4025/actasciagron.v36i3.17630; Cummins I, 2011, DRUG METAB REV, V43, P266, DOI 10.3109/03602532.2011.552910; Davies J, 1999, PESTIC SCI, V55, P1043, DOI 10.1002/(SICI)1096-9063(199911)55:11&lt;1043::AID-PS60&gt;3.0.CO;2-L; DIEHL KE, 1995, PESTIC BIOCHEM PHYS, V51, P137, DOI 10.1006/pest.1995.1014; Dong XiaoWen, 2007, Acta Phytophylacica Sinica, V34, P182; Fan ZhiJin, 2003, Agricultural Sciences in China, V2, P176; FRAZIER TL, 1994, WEED SCI, V42, P168, DOI 10.1017/S004317450008022X; GAILLARD C, 1994, FEBS LETT, V352, P219, DOI 10.1016/0014-5793(94)00961-9; Grey TL, 2012, WEED TECHNOL, V26, P207, DOI 10.1614/WT-D-11-00143.1; Grey TL, 2000, HORTSCIENCE, V35, P1070, DOI 10.21273/HORTSCI.35.6.1070; [郭玉莲 Guo Yulian], 2011, [农业环境科学学报, Journal of Agro-Environment Science], V30, P645; Hatzios KK, 2004, WEED SCI, V52, P454, DOI 10.1614/P2002-168C; Hinz JRR, 1996, WEED SCI, V44, P219, DOI 10.1017/S0043174500093814; Jursik M, 2010, LISTY CUKROV REPAR, V126, P14; Kang ZH, 2012, J INTEGR AGR, V11, P1485, DOI 10.1016/S2095-3119(12)60148-8; KREUZ K, 1992, PESTIC BIOCHEM PHYS, V43, P232, DOI 10.1016/0048-3575(92)90036-Y; Kreuz K, 1996, PLANT PHYSIOL, V111, P349, DOI 10.1104/pp.111.2.349; LAMOUREUX GL, 1992, PESTIC BIOCHEM PHYS, V42, P128, DOI 10.1016/0048-3575(92)90060-D; Lei XT, 2008, AGROCHEM, V47, P540; Li W, 2014, CROPS, V2, P64; Matola T, 2007, CROP PROT, V26, P278, DOI 10.1016/j.cropro.2005.07.015; Meyer MD, 2010, AGRON J, V102, P1138, DOI 10.2134/agronj2010.0093; Mimmo T, 2015, CHEMOSPHERE, V119, P31, DOI 10.1016/j.chemosphere.2014.04.114; O'Sullivan J, 2000, CAN J PLANT SCI, V80, P419, DOI 10.4141/P99-066; Pataky JK, 2009, J AM SOC HORTIC SCI, V134, P252, DOI 10.21273/JASHS.134.2.252; Riechers DE, 2010, PLANT PHYSIOL, V153, P3, DOI 10.1104/pp.110.153601; ROBINSON DK, 1994, WEED SCI, V42, P614, DOI 10.1017/S0043174500077031; Rosinger C., 2014, Julius-Kuhn-Archiv, P516; Rosinger C, 2012, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 2ND EDITION, P371; Schulte W., 2009, BAYER CROPSCI J, V62, P35; Taylor VL, 2013, ENVIRON EXP BOT, V88, P93, DOI 10.1016/j.envexpbot.2011.12.030; Yang CH, 2007, WEED SCI, V55, P537, DOI 10.1614/WS-07-016.1; Ye F, 2016, ZEMDIRBYSTE, V103, P29, DOI 10.13080/z-a.2016.103.004; Yun MS, 2001, PEST MANAG SCI, V57, P283, DOI 10.1002/ps.298; Zhang Q, 2007, PROTEOMICS, V7, P1261, DOI 10.1002/pmic.200600423	43	17	17	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173502	10.1371/journal.pone.0173502	http://dx.doi.org/10.1371/journal.pone.0173502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267798	gold, Green Published, Green Submitted			2022-12-27	WOS:000396060600038
J	Tekko, T; Lakspere, T; Allikalt, A; End, J; Kolvart, KR; Jagomae, T; Terasmaa, A; Philips, MA; Visnapuu, T; Vaartnou, F; Gilbert, SF; Rinken, A; Vasar, E; Lillevali, K				Tekko, Triin; Lakspere, Triin; Allikalt, Anni; End, Jaanus; Kolvart, Karl Rene; Jagomae, Toomas; Terasmaa, Anton; Philips, Mari-Anne; Visnapuu, Tanel; Vaartnou, Fred; Gilbert, Scott F.; Rinken, Ago; Vasar, Eero; Lillevali, Kersti			Wfs1 is expressed in dopaminoceptive regions of the amniote brain and modulates levels of D1-like receptors	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; WOLFRAM-SYNDROME 1; ENDOPLASMIC-RETICULUM STRESS; NIGRA DOPAMINERGIC-NEURONS; TURTLE TRACHEMYS-SCRIPTA; FRESH-WATER TURTLE; MOLECULAR PARTNER; UP-REGULATION; ER STRESS; WFS1-DEFICIENT MICE	During amniote evolution, the construction of the forebrain has diverged across different lineages, and accompanying the structural changes, functional diversification of the homologous brain regions has occurred. This can be assessed by studying the expression patterns of marker genes that are relevant in particular functional circuits. In all vertebrates, the dopaminergic system is responsible for the behavioral responses to environmental stimuli. Here we show that the brain regions that receive dopaminergic input through dopamine receptor D-1 are relatively conserved, but with some important variations between three evolutionarily distant vertebrate lines-house mouse (Mus musculus), domestic chick (Gallus gallus domesticus) / common quail (Coturnix coturnix) and red-eared slider turtle (Trachemys scripta). Moreover, we find that in almost all instances, those brain regions expressing D-1 like dopamine receptor genes also express Wfsl. Wfsl has been studied primarily in the pancreas, where it regulates the endoplasmic reticulum (ER) stress response, cellular Ca2+ homeostasis, and insulin production and secretion. Using radioligand binding assays in wild type and Wfsli-mouse brains, we show that the number of binding sites of Dl-like dopamine receptors is increased in the hippocampus of the mutant mice. We propose that the functional link between Wfsl and Dl-like dopamine receptors is evolutionarily conserved and plays an important role in adjusting behavioral reactions to environmental stimuli.	[Tekko, Triin; Jagomae, Toomas; Terasmaa, Anton; Philips, Mari-Anne; Visnapuu, Tanel; Vasar, Eero; Lillevali, Kersti] Univ Tartu, Inst Biomed & Translat Med, Dept Physiol, Tartu, Estonia; [Tekko, Triin; Jagomae, Toomas; Terasmaa, Anton; Philips, Mari-Anne; Visnapuu, Tanel; Vasar, Eero; Lillevali, Kersti] Univ Tartu, Ctr Excellence Genom & Translat Med, Tartu, Estonia; [Lakspere, Triin; End, Jaanus; Vaartnou, Fred] Univ Tartu, Inst Mol & Cell Biol, Dept Dev Biol, Tartu, Estonia; [Allikalt, Anni; Kolvart, Karl Rene; Rinken, Ago] Univ Tartu, Inst Chem, Tartu, Estonia; [Gilbert, Scott F.] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA	University of Tartu; University of Tartu; University of Tartu; University of Tartu; Swarthmore College	Lillevali, K (corresponding author), Univ Tartu, Inst Biomed & Translat Med, Dept Physiol, Tartu, Estonia.; Lillevali, K (corresponding author), Univ Tartu, Ctr Excellence Genom & Translat Med, Tartu, Estonia.	kersti.lillevali@ut.ee	Lilleväli, Kersti/AGD-6838-2022; Rinken, Ago/AAG-7025-2020; Philips, Mari-Anne/AAZ-7624-2021; Visnapuu, Tanel/AAJ-5503-2020; Allikalt, Anni/AAD-1538-2022; Terasmaa, Anton/I-3312-2015	Lilleväli, Kersti/0000-0001-5470-3818; Rinken, Ago/0000-0002-7238-749X; Philips, Mari-Anne/0000-0001-7103-4038; Allikalt, Anni/0000-0002-3056-3088; Vasar, Eero/0000-0001-5226-345X; Terasmaa, Anton/0000-0002-5139-1764; Tekko, Triin/0000-0003-2669-5835	Estonian Science Foundation [8408]; Institutional investigation grant from the Estonian Research Council [IUT20-41, IUT20-17]; Estonian Research Council [PUT784]; Ministry of Education and Research [SF0180019s11]; European Union through the European Regional Development Fund (Competence Centre on Health Technology) [EU48695]; National Science Foundation [IOS 145177]; Centre of Excellence in Genomics and Translational Medicine, University of Tartu - European Union through the European Regional Development Fund [2014-2020.4.01.15-0012]; Direct For Biological Sciences [1457177] Funding Source: National Science Foundation	Estonian Science Foundation; Institutional investigation grant from the Estonian Research Council(Estonian Research Council); Estonian Research Council(Estonian Research Council); Ministry of Education and Research; European Union through the European Regional Development Fund (Competence Centre on Health Technology); National Science Foundation(National Science Foundation (NSF)); Centre of Excellence in Genomics and Translational Medicine, University of Tartu - European Union through the European Regional Development Fund; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Estonian Science Foundation, grant 8408 (www.etag.ee) to KL; Institutional investigation grant IUT20-41 from the Estonian Research Council (www.etag.ee) to EV; Institutional investigation grant IUT20-17 from the Estonian Research Council (www.etag.ee) to AR; Personal investigation grant PUT784 from the Estonian Research Council (www.etag.ee to AT; the Ministry of Education and Research (SF0180019s11) (www.hm.ee); European Union through the European Regional Development Fund (Competence Centre on Health Technology, EU48695)(1ww.eas.ee); National Science Foundation (www.nsf.gov) Grant IOS 145177 to SFG; and Centre of Excellence in Genomics and Translational Medicine, University of Tartu, funded by the European Union through the European Regional Development Fund (Project No. 2014-2020.4.01.15-0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan A, 2009, J COMP NEUROL, V515, P465, DOI 10.1002/cne.22083; BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; BRUCE LL, 1995, BRAIN BEHAV EVOLUT, V46, P224, DOI 10.1159/000113276; Bruce LL, 2009, EVOLUTIONARY NEUROSC, P233; Celada P, 1999, NEUROSCIENCE, V89, P813, DOI 10.1016/S0306-4522(98)00356-X; Chiu K, 2005, BRAIN RES, V1046, P207, DOI 10.1016/j.brainres.2005.04.016; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Fonseca SG, 2005, J BIOL CHEM, V280, P39609, DOI 10.1074/jbc.M507426200; Fonseca SG, 2012, NAT CELL BIOL, V14, P1105, DOI 10.1038/ncb2578; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; Franco R, 2006, MOL PHARMACOL, V69, P1905, DOI 10.1124/mol.105.020685; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gabreels BATF, 1998, J CLIN ENDOCR METAB, V83, P4026, DOI 10.1210/jc.83.11.4026; Gharanei S, 2013, HUM MOL GENET, V22, P203, DOI 10.1093/hmg/dds400; Hatanaka M, 2011, HUM MOL GENET, V20, P1274, DOI 10.1093/hmg/ddq568; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; Kaplinsky NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066357; Kawano J, 2009, NEUROSCI RES, V64, P213, DOI 10.1016/j.neures.2009.03.005; Kesaraju S, 2014, BRAIN RES, V1582, P247, DOI 10.1016/j.brainres.2014.07.044; Kesaraju S, 2009, J NEUROCHEM, V109, P1413, DOI 10.1111/j.1471-4159.2009.06068.x; Koido K, 2005, INT J NEUROPSYCHOPH, V8, P235, DOI 10.1017/S1461145704004791; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lu SM, 2014, P NATL ACAD SCI USA, V111, pE5292, DOI 10.1073/pnas.1421055111; LUTZ PL, 1995, AM J PHYSIOL-REG I, V268, pR1332, DOI 10.1152/ajpregu.1995.268.5.R1332; Luuk H, 2008, J COMP NEUROL, V509, P642, DOI 10.1002/cne.21777; Luuk H, 2009, BEHAV BRAIN RES, V198, P334, DOI 10.1016/j.bbr.2008.11.007; Martinez-Garcia F., 2009, EVOLUTIONARY NEUROSC, P313; Matto V, 2011, J PHYSIOL BIOCHEM, V67, P53, DOI 10.1007/s13105-010-0048-0; Milton SL, 2006, J BIOMED SCI, V13, P509, DOI 10.1007/s11373-006-9084-8; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nayak G, 2009, J NEUROCHEM, V110, P603, DOI 10.1111/j.1471-4159.2009.06157.x; Nilsson GE, 2004, J CEREBR BLOOD F MET, V24, P475, DOI 10.1097/00004647-200405000-00001; Osman AA, 2003, J BIOL CHEM, V278, P52755, DOI 10.1074/jbc.M310331200; POWERS AS, 1980, J HIRNFORSCH, V21, P125; Prentice HM, 2004, J CEREBR BLOOD F MET, V24, P826, DOI 10.1097/01.WCB.0000126565.27130.79; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; Rami A, 2003, NEUROBIOL DIS, V13, P75, DOI 10.1016/S0969-9961(03)00018-4; Reinart-Okugbeni R, 2013, BIOORGAN MED CHEM, V21, P4143, DOI 10.1016/j.bmc.2013.05.014; Rigoli L, 2011, CLIN GENET, V79, P103, DOI 10.1111/j.1399-0004.2010.01522.x; Sarinana J, 2014, P NATL ACAD SCI USA, V111, P8245, DOI 10.1073/pnas.1407395111; Shang LS, 2014, DIABETES, V63, P923, DOI 10.2337/db13-0717; Shen XX, 2011, MOL BIOL EVOL, V28, P3237, DOI 10.1093/molbev/msr148; Swift M, 2005, MOL PSYCHIATR, V10, P799, DOI 10.1038/sj.mp.4001681; SWIFT RG, 1990, LANCET, V336, P667, DOI 10.1016/0140-6736(90)92157-D; Takeda K, 2001, HUM MOL GENET, V10, P477, DOI 10.1093/hmg/10.5.477; Takei D, 2006, FEBS LETT, V580, P5635, DOI 10.1016/j.febslet.2006.09.007; Tekko T, 2014, INT J DEV NEUROSCI, V35, P80, DOI 10.1016/j.ijdevneu.2014.03.009; Tepper JM, 2007, PROG BRAIN RES, V160, P189, DOI 10.1016/S0079-6123(06)60011-3; Tonissaar M, 2008, NEUROSCIENCE, V152, P867, DOI 10.1016/j.neuroscience.2008.01.028; Ueda K, 2005, EUR J ENDOCRINOL, V153, P167, DOI 10.1530/eje.1.01945; Vicario A, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00090; Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27; Visnapuu T, 2013, BEHAV BRAIN RES, V244, P90, DOI 10.1016/j.bbr.2013.01.046; WILSON AM, 1991, BRAIN RES, V540, P297, DOI 10.1016/0006-8993(91)90523-X; Windels F, 2006, EUR J NEUROSCI, V24, P1385, DOI 10.1111/j.1460-9568.2006.05015.x; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Xia Y, 2001, J COMP NEUROL, V436, P202; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E; Zatyka M, 2008, HUM MOL GENET, V17, P190, DOI 10.1093/hmg/ddm296; Zatyka M, 2015, HUM MOL GENET, V24, P814, DOI 10.1093/hmg/ddu499	63	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0172825	10.1371/journal.pone.0172825	http://dx.doi.org/10.1371/journal.pone.0172825			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267787	Green Submitted, gold, Green Published			2022-12-27	WOS:000396060600004
J	Liu, ZJ; Rong, QL; Zhou, W; Liang, GQ				Liu, Zhanjun; Rong, Qinlei; Zhou, Wei; Liang, Guoqing			Effects of inorganic and organic amendment on soil chemical properties, enzyme activities, microbial community and soil quality in yellow clayey soil	PLOS ONE			English	Article							LONG-TERM FERTILIZATION; RICE STRAW INCORPORATION; CROPPING SYSTEM; CARBON SEQUESTRATION; GREEN MANURE; PADDY SOILS; NITROGEN; RESPONSES; BIOMASS; LITTER	Understanding the effects of external organic and inorganic components on soil fertility and quality is essential for improving low-yielding soils. We conducted a field study over two consecutive rice growing seasons to investigate the effect of applying chemical fertilizer (NPK), NPK plus green manure (NPKG), NPK plus pig manure (NPKM), and NPK plus straw (NPKS) on the soil nutrient status, enzyme activities involved in C, N, P, and S cycling, microbial community and rice yields of yellow clayey soil. Results showed that the fertilized treatments significantly improved rice yields over the first three experimental seasons. Compared with the NPK treatment, organic amendments produced more favorable effects on soil productivity. Notably, the NPKM treatment exhibited the highest levels of nutrient availability, microbial biomass carbon (MBC), activities of most enzymes and the microbial community. This resulted in the highest soil quality index (SQI) and rice yield, indicating better soil fertility and quality. Significant differences in enzyme activities and the microbial community were observed among the treatments, and redundancy analysis showed that MBC and available N were the key determinants affecting the soil enzyme activities and microbial community. The SQI score of the non -fertilized control (0.72) was comparable to that of the NPK (0.77), NPKG (0.81) and NPKS (0.79) treatments but significantly lower compared with NPKM (0.85). The significant correlation between rice yield and SQI suggests that SQI can be a useful to quantify soil quality changes caused by different agricultural management practices. The results indicate that application of NPK plus pig manure is the preferred option to enhance SOC accumulation, improve soil fertility and quality, and increase rice yield in yellow clayey soil.	[Liu, Zhanjun] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Peoples R China; [Rong, Qinlei; Zhou, Wei; Liang, Guoqing] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Crop Nutr & Fertilizat, Beijing, Peoples R China	Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs	Zhou, W (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Crop Nutr & Fertilizat, Beijing, Peoples R China.	wzhou@caas.ac.cn	Rong, Qinlei/ABF-7363-2020; Zhang, Kevin/F-5215-2010; rong, qinlei/AAC-9833-2022		Special Fund for Agro-scientific Research in the Public Interest [201003016]; Ministry of Agriculture of the People's Republic of China; China Agriculture Research System; National Basic Research Program of China, Ministry of Science and Technology of the People's Republic of China [2013CB127405]	Special Fund for Agro-scientific Research in the Public Interest; Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs); China Agriculture Research System; National Basic Research Program of China, Ministry of Science and Technology of the People's Republic of China	Support was provided by The Special Fund for Agro-scientific Research in the Public Interest (201003016), Ministry of Agriculture of the People's Republic of China (WZ received the funding); and the earmarked fund for China Agriculture Research System and the National Basic Research Program of China (2013CB127405), Ministry of Science and Technology of the People's Republic of China (WZ received the funding).	Ai C, 2015, BIOL FERT SOILS, V51, P465, DOI 10.1007/s00374-015-0994-3; Alagoz Z, 2009, SOIL TILL RES, V103, P419, DOI 10.1016/j.still.2008.12.006; Almagro M, 2014, AGR ECOSYST ENVIRON, V196, P167, DOI 10.1016/j.agee.2014.06.027; ASMAR F, 1994, BIOL FERT SOILS, V17, P32, DOI 10.1007/BF00418669; Bhardwaj AK, 2011, AGR ECOSYST ENVIRON, V140, P419, DOI 10.1016/j.agee.2011.01.005; Bhattacharyya R, 2009, AGR ECOSYST ENVIRON, V132, P126, DOI 10.1016/j.agee.2009.03.007; Bhattacharyya R, 2015, EUR J AGRON, V70, P11, DOI 10.1016/j.eja.2015.06.006; Billings SA, 2008, GLOBAL CHANGE BIOL, V14, P1025, DOI 10.1111/j.1365-2486.2008.01562.x; Bray SR, 2012, SOIL BIOL BIOCHEM, V49, P30, DOI 10.1016/j.soilbio.2012.02.009; Bruun TB, 2006, AGR ECOSYST ENVIRON, V113, P139, DOI 10.1016/j.agee.2005.09.012; Cederlund H, 2014, APPL SOIL ECOL, V84, P62, DOI 10.1016/j.apsoil.2014.06.003; [陈海飞 Chen Haifei], 2014, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V20, P517; Chen X, 2011, BIOL FERT SOILS, V47, P323, DOI 10.1007/s00374-011-0542-8; Chen Y, 2010, J SOIL SEDIMENT, V10, P1018, DOI 10.1007/s11368-009-0123-8; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P2971, DOI 10.1016/j.soilbio.2007.05.031; Dong WY, 2014, APPL SOIL ECOL, V84, P140, DOI 10.1016/j.apsoil.2014.06.007; DORAN JW, 1994, SSSA SPEC PUBL, P3; Elzobair KA, 2016, CHEMOSPHERE, V142, P145, DOI 10.1016/j.chemosphere.2015.06.044; Fanin N, 2016, SOIL BIOL BIOCHEM, V94, P48, DOI 10.1016/j.soilbio.2015.11.007; Geisseler D, 2012, EUR J SOIL BIOL, V53, P107, DOI 10.1016/j.ejsobi.2012.09.006; Giacometti C, 2013, APPL SOIL ECOL, V64, P32, DOI 10.1016/j.apsoil.2012.10.002; Hai L, 2010, SOIL BIOL BIOCHEM, V42, P253, DOI 10.1016/j.soilbio.2009.10.023; Hall DJM, 2015, PEDOSPHERE, V25, P720, DOI 10.1016/S1002-0160(15)30053-9; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Huang M, 2015, FIELD CROP RES, V183, P126, DOI 10.1016/j.fcr.2015.07.022; Jiang YJ, 2014, ENVIRON MICROBIOL, V16, P3083, DOI 10.1111/1462-2920.12339; Li P, 2013, SOIL TILL RES, V126, P112, DOI 10.1016/j.still.2012.07.011; Li SY, 2016, SOIL TILL RES, V155, P199, DOI 10.1016/j.still.2015.08.009; Liebig MA, 2001, AGRON J, V93, P313, DOI 10.2134/agronj2001.932313x; Lima ACR, 2013, APPL SOIL ECOL, V64, P194, DOI 10.1016/j.apsoil.2012.12.009; Liu ZJ, 2014, BIOL FERT SOILS, V50, P537, DOI 10.1007/s00374-013-0864-9; Lu RK, 2000, SOIL ANALYTICALMETHO; Moeskops B, 2010, APPL SOIL ECOL, V45, P112, DOI 10.1016/j.apsoil.2010.03.005; Mohanty M, 2007, SOIL TILL RES, V92, P243, DOI 10.1016/j.still.2006.03.005; Navas M, 2011, APPL SOIL ECOL, V49, P242, DOI 10.1016/j.apsoil.2011.04.017; Papadopoulos A, 2014, GEODERMA, V213, P435, DOI 10.1016/j.geoderma.2013.08.033; Paz-Ferreiro J, 2007, NEW ZEAL J AGR RES, V50, P537, DOI 10.1080/00288230709510321; Paz-Ferreiro J, 2011, BIOL FERT SOILS, V47, P633, DOI 10.1007/s00374-011-0570-4; Qi YB, 2009, GEODERMA, V149, P325, DOI 10.1016/j.geoderma.2008.12.015; [荣勤雷 Rong Qinlei], 2014, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V20, P1168; Saetre P, 2000, SOIL BIOL BIOCHEM, V32, P909, DOI 10.1016/S0038-0717(99)00215-1; SHEN SM, 1984, SOIL BIOL BIOCHEM, V16, P437, DOI 10.1016/0038-0717(84)90049-X; Shukla MK, 2006, SOIL TILL RES, V87, P194, DOI 10.1016/j.still.2005.03.011; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Sun RB, 2015, APPL SOIL ECOL, V95, P171, DOI 10.1016/j.apsoil.2015.06.010; Tesfahunegn GB, 2011, GEODERMA, V163, P209, DOI 10.1016/j.geoderma.2011.04.016; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang W, 2015, SOIL TILL RES, V152, P8, DOI 10.1016/j.still.2015.03.011; Wu YP, 2009, GEODERMA, V150, P171, DOI 10.1016/j.geoderma.2009.02.003; Xie ZJ, 2016, FIELD CROP RES, V188, P142, DOI 10.1016/j.fcr.2016.01.006; Yan X, 2013, SOIL TILL RES, V130, P42, DOI 10.1016/j.still.2013.01.013; Yuan L, 2014, FIELD CROP RES, V155, P164, DOI 10.1016/j.fcr.2013.09.009; Zhang Q, 2015, APPL SOIL ECOL, V94, P59, DOI 10.1016/j.apsoil.2015.05.005; Zhang XY, 2015, SCI TOTAL ENVIRON, V536, P59, DOI 10.1016/j.scitotenv.2015.07.043; Zhu HH, 2010, PLANT SOIL, V331, P427, DOI 10.1007/s11104-009-0263-z; Zhu LQ, 2015, ECOL INDIC, V53, P144, DOI 10.1016/j.ecolind.2015.01.038	56	58	65	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172767	10.1371/journal.pone.0172767	http://dx.doi.org/10.1371/journal.pone.0172767			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28263999	Green Submitted, Green Published, gold			2022-12-27	WOS:000396054300017
J	Na, ML; Wang, WZ; Fei, Y; Josefsson, E; Ali, A; Jin, T				Na, Manli; Wang, Wanzhong; Fei, Ying; Josefsson, Elisabet; Ali, Abukar; Jin, Tao			Both anti-TNF and CTLA4 Ig treatments attenuate the disease severity of staphylococcal dermatitis in mice	PLOS ONE			English	Article							NECROSIS FACTOR THERAPY; RHEUMATOLOGY BIOLOGICS REGISTER; INTENSIVE-CARE-UNIT; AUREUS COLONIZATION; SKIN INFECTION; FACTOR-ALPHA; HUMAN NEUTROPHILS; SEPTIC ARTHRITIS; BRITISH SOCIETY; RISK	Background RA patients being treated with biologics are known to have an increased risk of infections. We recently demonstrated that both CTLA4 Ig and anti-TNF treatment aggravate systemic Staphylococcus aureus (S. aureus) infection in mice, but with distinct clinical manifestations. However, the effects of CTLA4 Ig and anti-TNF treatments on a local S. aureus infection (e.g., skin infection) might differ from their effects on a systemic infection. Aims The aim of this study was to examine the differential effects of anti-TNF versus CTLA4 Ig treatment on S. aureus skin infections in mice. Method Abatacept (CTLA4 Ig), etanercept (anti-TNF treatment) or PBS was given to NMRI mice subcutaneously inoculated with S. aureus strain SH1000. The clinical signs of dermatitis, along with histopathological changes due to skin infection, were compared between the groups. Results Both CTLA4 Ig and anti-TNF treatment resulted in less severe skin infections and smaller post-infectious hyperpigmentation compared with controls. Consistent with the clinical signs of dermatitis, smaller lesion size, more epithelial hyperplasia and more granulation were found in skin biopsies from mice receiving anti-TNF compared with PBS controls. However, both CTLA4 Ig and anti-TNF therapy tended to prolong the healing time, although this finding was not statistically significant. Serum MCP-1 levels were elevated in the anti-TNF group relative to the CTLA4 Ig and PBS groups, whereas IL-6 levels were higher in PBS controls than in the other two groups. Both anti-TNF and CTLA4 Ig treatments tended to down-regulate the necrosis/apoptosis ratio in the locally infected skin tissue. Importantly, no tangible difference was found in the bacterial burden among groups. Conclusion Both CTLA4 Ig and anti-TNF therapies attenuate disease severity but may prolong the healing time required for S. aureus skin infections. Neither treatment has an impact on bacterial clearance in skin tissues.	[Na, Manli; Josefsson, Elisabet; Ali, Abukar; Jin, Tao] Gothenburg Univ, Dept Rheumatol & Inflammat Res, Inst Med, Sahlgrenska Acad, S-41346 Gothenburg, Sweden; [Wang, Wanzhong] Umea Univ, Dept Med Biosci, Umea, Sweden; [Fei, Ying] GuiZhou Med Univ, Dept Microbiol & Immunol, Affiliated Hosp, Guiyang, Peoples R China; [Jin, Tao] Sahlgrens Univ Hosp, Dept Rheumatol, Gothenburg, Sweden	University of Gothenburg; Umea University; Guizhou Medical University; Sahlgrenska University Hospital	Jin, T (corresponding author), Gothenburg Univ, Dept Rheumatol & Inflammat Res, Inst Med, Sahlgrenska Acad, S-41346 Gothenburg, Sweden.; Jin, T (corresponding author), Sahlgrens Univ Hosp, Dept Rheumatol, Gothenburg, Sweden.	tao.jin@rheuma.gu.se	Na, Manli/AAM-9864-2020; Jin, Tao/K-3323-2015	Jin, Tao/0000-0001-9039-0628; Ali, Abukar/0000-0002-1963-3356; Na, Manli/0000-0002-7306-8941	Swedish Medical Research Council [523-2013-2750]; Swedish Medical Society [SLS-496741, SLS-402871]; Stiftelsen Clas Groschinskys Minnesfond [M1566, M14099, M1626]; Royal Society of Arts and Sciences in Gothenburg; Wilhelm and Martina Lundgren Foundation; Scandinavian Society for Antimicrobial Chemotherapy Foundation [SLS-501701]; Rune och Ulla Amlovs Stiftelse for Neurologisk och Reumatologisk Forskning [2015-00056, 2016-075]; Professor Nanna Svartz Fond [2015-00074]; Adlerbertska Forskningsstiftelsen	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Medical Society; Stiftelsen Clas Groschinskys Minnesfond; Royal Society of Arts and Sciences in Gothenburg; Wilhelm and Martina Lundgren Foundation; Scandinavian Society for Antimicrobial Chemotherapy Foundation; Rune och Ulla Amlovs Stiftelse for Neurologisk och Reumatologisk Forskning; Professor Nanna Svartz Fond; Adlerbertska Forskningsstiftelsen	This work was supported by the Swedish Medical Research Council (grant 523-2013-2750 to T. Jin), the Swedish Medical Society (SLS-496741 and SLS-402871 to T. Jin), the Stiftelsen Clas Groschinskys Minnesfond (grant M1566, M14099, and M1626 to T. Jin), the Royal Society of Arts and Sciences in Gothenburg (grant to T. Jin and ML. Na), the Wilhelm and Martina Lundgren Foundation (grant to T. Jin, ML. Na, and A. Ali), the Scandinavian Society for Antimicrobial Chemotherapy Foundation (grant SLS-501701 to T. Jin), Rune och Ulla Amlovs Stiftelse for Neurologisk och Reumatologisk Forskning (grant 2015-00056 and 2016-075 to T. Jin), Professor Nanna Svartz Fond (grant 2015-00074 to T. Jin), and Adlerbertska Forskningsstiftelsen (grant to T. Jin and ML. Na). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Alayan J, 2007, ORAL MICROBIOL IMMUN, V22, P304, DOI 10.1111/j.1399-302X.2007.00360.x; Ali A, 2015, J INFECT DIS, V212, P1308, DOI 10.1093/infdis/jiv212; Ali A, 2015, ARTHRITIS RHEUMATOL, V67, P107, DOI 10.1002/art.38902; Amar S, 1996, J INFLAMM, V47, P180; Askling J, 2008, CURR OPIN RHEUMATOL, V20, P138, DOI 10.1097/BOR.0b013e3282f4b392; Assuma R, 1998, J IMMUNOL, V160, P403; Bassetti S, 2005, J RHEUMATOL, V32, P2125; Bergkvist PI, 1997, SCAND J INFECT DIS, V29, P377, DOI 10.3109/00365549709011834; Bigbee CL, 2007, ARTHRITIS RHEUM-US, V56, P2557, DOI 10.1002/art.22750; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Davis Erica C, 2010, J Clin Aesthet Dermatol, V3, P20; Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2287, DOI 10.1002/art.10524; Fei Y, 2011, J INFECT DIS, V204, P348, DOI 10.1093/infdis/jir266; FEIKEN E, 1995, J INVEST DERMATOL, V105, P120, DOI 10.1111/1523-1747.ep12313429; Feuerstein R, 2015, J IMMUNOL, V194, P2735, DOI 10.4049/jimmunol.1402566; Fraser TG, 2010, INFECT CONT HOSP EP, V31, P779, DOI 10.1086/654001; Galloway JB, 2013, ANN RHEUM DIS, V72, P229, DOI 10.1136/annrheumdis-2011-201108; Galloway JB, 2011, RHEUMATOLOGY, V50, P124, DOI 10.1093/rheumatology/keq242; Garcia-Doval I, 2010, ANN RHEUM DIS, V69, P1751, DOI 10.1136/ard.2009.125658; Honda H, 2010, INFECT CONT HOSP EP, V31, P584, DOI 10.1086/652530; Kaandorp CJE, 1995, ARTHRITIS RHEUM, V38, P1819, DOI 10.1002/art.1780381215; Keene A, 2005, INFECT CONT HOSP EP, V26, P622, DOI 10.1086/502591; Kengatharan KM, 1998, J EXP MED, V188, P305, DOI 10.1084/jem.188.2.305; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kwiecinski J, 2014, APMIS, V122, P1240, DOI 10.1111/apm.12295; Kwiecinski J, 2013, J INFECT DIS, V208, P990, DOI 10.1093/infdis/jit288; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Molne L, 2000, INFECT IMMUN, V68, P6162, DOI 10.1128/IAI.68.11.6162-6167.2000; Na M, 2016, INFECT IMMUN; Nam JL, 2014, ANN RHEUM DIS, V73, P516, DOI 10.1136/annrheumdis-2013-204577; Parker D, 2015, J INFECT DIS, V211, P835, DOI 10.1093/infdis/jiu525; Perez-Alvarez R, 2011, MEDICINE, V90, P359, DOI 10.1097/MD.0b013e3182380a76; Saha B, 1996, J IMMUNOL, V157, P3869; Sakiniene E, 1996, ARTHRITIS RHEUM, V39, P1596, DOI 10.1002/art.1780390921; Salliot C, 2009, ANN RHEUM DIS, V68, P25, DOI 10.1136/ard.2007.083188; Schiff M, 2014, ANN RHEUM DIS, V73, P86, DOI 10.1136/annrheumdis-2013-203843; Tseng CW, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005292; Tsiodras S, 2008, MAYO CLIN PROC, V83, P181; Tzianabos AO, 2000, INFECT IMMUN, V68, P6650, DOI 10.1128/IAI.68.12.6650-6655.2000; Varley CD, 2014, RHEUMATOLOGY, V53, P332, DOI 10.1093/rheumatology/ket351; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Wasson NJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-533; Yun HF, 2016, ARTHRITIS RHEUMATOL, V68, P56, DOI 10.1002/art.39399; Zacharioudakis IM, 2014, J AM SOC NEPHROL, V25, P2131, DOI 10.1681/ASN.2013091028	47	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173492	10.1371/journal.pone.0173492	http://dx.doi.org/10.1371/journal.pone.0173492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264025	Green Submitted, Green Published, gold			2022-12-27	WOS:000396054300066
J	Brabers, AEM; Rademakers, JJDJM; Groenewegen, PP; van Dijk, L; de Jong, JD				Brabers, Anne E. M.; Rademakers, Jany J. D. J. M.; Groenewegen, Peter P.; van Dijk, Liset; de Jong, Judith D.			What role does health literacy play in patients' involvement in medical decision-making?	PLOS ONE			English	Article							PATIENTS PREFERENCES; PUBLIC-HEALTH; CARE; PARTICIPATION; INTEGRATION; STRATEGIES; ENCOUNTER; PHYSICIAN; EDUCATION	Patients vary in their preferences towards involvement in medical decision-making. Previous research, however, gives no clear explanation for this observed variation in their involvement. One possible explanation might be health literacy. Health literacy refers to personal characteristics and social resources needed for people to access, understand and use information to make decisions about their health. This study aimed to examine the relationship between health literacy and self-reported patient involvement. With respect to health literacy, we focused on those competences relevant for medical decision-making. We hypothesized that people with higher health literacy report that they are more involved in medical decision-making. A structured questionnaire was sent to members of the Dutch Health Care Consumer Panel in May 2015 (response 46%, N = 974). Health literacy was measured using five scales of the Health Literacy Questionnaire. A regression model was used to estimate the relationship between health literacy and self-reported involvement. In general, our results did not show a relationship between health literacy and self-reported involvement. We did find a positive significant association between the health literacy scale appraisal of health information and self-reported involvement. Our hypothesis was partly confirmed. The results from this study suggest that higher order competences, that is to say critical health literacy, in particular, are important in reporting involvement in medical decision-making. Future research is recommended to unravel further the relationship between health literacy and patient involvement in order to gain insight into whether health literacy might be an asset to enhance patient participation in medical decision making.	[Brabers, Anne E. M.; Rademakers, Jany J. D. J. M.; Groenewegen, Peter P.; van Dijk, Liset; de Jong, Judith D.] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; [Rademakers, Jany J. D. J. M.] Maastricht Univ, Dept Gen Practice, CAPHRI, Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [Groenewegen, Peter P.] Univ Utrecht, Dept Sociol, Dept Human Geog, Utrecht, Netherlands	Netherlands Institute for Health Services Research; Maastricht University; Maastricht University Medical Centre (MUMC); Utrecht University	Brabers, AEM (corresponding author), Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands.	a.brabers@nivel.nl			Dutch Ministry of Health, Welfare and Sport	Dutch Ministry of Health, Welfare and Sport	The Dutch Ministry of Health, Welfare and Sport funds the Dutch Health Care Consumer Panel. The funder had no role in the design, execution and writing of the study.	Ambigapathy R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010063; Arora NK, 2000, MED CARE, V38, P335, DOI 10.1097/00005650-200003000-00010; Barton JL, 2014, J RHEUMATOL, V41, P1290, DOI 10.3899/jrheum.131350; Beauchamp A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2056-z; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Brabers A.E.M., 2015, CONSUMENTENPANEL GEZ; Brabers AE, 2016, EUR J PUBLIC HLTH; Brom L, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-25; Burke NJ, 2009, HEALTH EDUC BEHAV, V36, p55S, DOI 10.1177/1090198109335338; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Charles C, 1999, SOC SCI MED, V49, P651, DOI 10.1016/S0277-9536(99)00145-8; Chewning B, 2012, PATIENT EDUC COUNS, V86, P9, DOI 10.1016/j.pec.2011.02.004; Chinn D, 2011, SOC SCI MED, V73, P60, DOI 10.1016/j.socscimed.2011.04.004; Coleman J., 1990, FDN SOCIAL THEORY; Coulter A, 2007, BMJ-BRIT MED J, V335, P24, DOI 10.1136/bmj.39246.581169.80; Coulter A, 2012, J AMBUL CARE MANAG, V35, P80, DOI 10.1097/JAC.0b013e318249e0fd; DEGNER LF, 1992, J CLIN EPIDEMIOL, V45, P941, DOI 10.1016/0895-4356(92)90110-9; Dodson S, OPHELIA TOOLKIT STEP; Duell P, 2015, PATIENT EDUC COUNS, V98, P1295, DOI 10.1016/j.pec.2015.04.003; Elwyn G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5146; Flynn KE, 2006, SOC SCI MED, V63, P1158, DOI 10.1016/j.socscimed.2006.03.030; Goggins KM, 2014, J HEALTH COMMUN, V19, P29, DOI 10.1080/10810730.2014.938841; Guadagnoli E, 1998, SOC SCI MED, V47, P329, DOI 10.1016/S0277-9536(98)00059-8; Heijmans M, 2015, PATIENT EDUC COUNS, V98, P41, DOI 10.1016/j.pec.2014.10.006; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Lin GA, 2014, CIRC-CARDIOVASC QUAL, V7, P328, DOI 10.1161/CIRCOUTCOMES.113.000322; Makoul G, 2006, PATIENT EDUC COUNS, V60, P301, DOI 10.1016/j.pec.2005.06.010; McCaffery KJ, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S10; Murray E, 2007, PATIENT EDUC COUNS, V65, P189, DOI 10.1016/j.pec.2006.07.007; Naik AD, 2011, PATIENT EDUC COUNS, V85, P499, DOI 10.1016/j.pec.2010.12.015; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Osborne RH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-658; Parker RM, 1999, JAMA-J AM MED ASSOC, V281, P552; Peerson A, 2009, HEALTH PROMOT INT, V24, P285, DOI 10.1093/heapro/dap014; Rademakers J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-261; RVZ, 2013, PART PAT; Say R, 2006, PATIENT EDUC COUNS, V60, P102, DOI 10.1016/j.pec.2005.02.003; Seo J, 2016, MED DECIS MAKING; Smith SK, 2014, MED DECIS MAKING, V34, P756, DOI 10.1177/0272989X13518976; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Sykes S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-150; Vahdat S, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.12454; van de Bovenkamp HM, 2010, HEALTH EXPECT, V13, P73, DOI 10.1111/j.1369-7625.2009.00567.x; van den Brink-Muinen A, 2011, PATIENT EDUC COUNS, V84, P111, DOI 10.1016/j.pec.2010.07.032; van der Heide I, 2015, PATIENT EDUC COUNS, V98, P998, DOI 10.1016/j.pec.2015.04.006; WHO Commission on the Social Determinants of Health, 2007, ACH HLTH EQ ROOT CAU; Yin HS, 2012, ACAD PEDIATR, V12, P117, DOI 10.1016/j.acap.2012.01.001	51	49	51	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173316	10.1371/journal.pone.0173316	http://dx.doi.org/10.1371/journal.pone.0173316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257472	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100086
J	Puller, C; Arbogast, P; Keeley, PW; Reese, BE; Haverkamp, S				Puller, Christian; Arbogast, Patrick; Keeley, Patrick W.; Reese, Benjamin E.; Haverkamp, Silke			Dendritic stratification differs among retinal OFF bipolar cell types in the absence of rod photoreceptors	PLOS ONE			English	Article							MOUSE RETINA; PRIMATE RETINA; GLUTAMATE RECEPTORS; ELECTRON-MICROSCOPY; KAINATE RECEPTORS; M-CONE; NRL; PATHWAY; INPUT; IDENTIFICATION	Retinal OFF bipolar cells show distinct connectivity patterns with photoreceptors in the wild type mouse retina. Some types are cone-specific while others penetrate further through the outer plexiform layer (OPL) to contact rods in addition to cones. To explore dendritic stratification of OFF bipolar cells in the absence of rods, we made use of the 'cone-full' WI mouse retina in which all photoreceptor precursor cells commit to a cone fate including those which would have become rods in wild -type retinas. The dendritic distribution of OFF bipolar cell types was investigated by confocal and electron microscopic imaging of immunolabeled tissue sections. The cells' dendrites formed basal contacts with cone terminals and expressed the corresponding glutamate receptor subunits at those sites, indicating putative synapses. All of the four analyzed cell populations showed distinctive patterns of vertical dendritic invasion through the OPL. This disparate behavior of dendritic extension in an environment containing only cone terminals demonstrates type -dependent specificity for dendritic outgrowth in OFF bipolar cells: rod terminals are not required for inducing dendritic extension into distal areas of the OPL.	[Puller, Christian] Carl von Ossietzky Univ Oldenburg, Dept Neurosci, Oldenburg, Germany; [Puller, Christian; Arbogast, Patrick; Haverkamp, Silke] Max Planck Inst Brain Res, Frankfurt, Germany; [Keeley, Patrick W.; Reese, Benjamin E.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Reese, Benjamin E.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Haverkamp, Silke] Goethe Univ, Inst Cellular & Mol Anat, Frankfurt, Germany	Carl von Ossietzky Universitat Oldenburg; Max Planck Society; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Goethe University Frankfurt	Puller, C (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Neurosci, Oldenburg, Germany.; Puller, C (corresponding author), Max Planck Inst Brain Res, Frankfurt, Germany.	christian.puller@uni-oldenburg.de		Puller, Christian/0000-0003-1730-8733	Deutsche Forschungsgemeinschft [HA 5277/2-2]; National Institutes of Health [EY-019968]; NATIONAL EYE INSTITUTE [R01EY019968] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by Deutsche Forschungsgemeinschft www.dfg.de (grant HA 5277/2-2 to SH) and National Institutes of Health nttps://neLnih.govi (grant EY-019968 to BER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens C, 2016, BIORXIV; Borghuis BG, 2014, J NEUROSCI, V34, P6128, DOI 10.1523/JNEUROSCI.4941-13.2014; Cheng CW, 2005, DEV BIOL, V287, P48, DOI 10.1016/j.ydbio.2005.08.029; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; Dunn FA, 2012, J NEUROSCI, V32, P10306, DOI 10.1523/JNEUROSCI.1581-12.2012; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Fyk-Kolodziej B, 2003, J COMP NEUROL, V464, P104, DOI 10.1002/cne.10784; Hack I, 1999, P NATL ACAD SCI USA, V96, P14130, DOI 10.1073/pnas.96.24.14130; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2001, J COMP NEUROL, V436, P471, DOI 10.1002/cne.1081; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Haverkamp S, 2008, J COMP NEUROL, V507, P1087, DOI 10.1002/cne.21612; Haverkamp S, 2006, J NEUROSCI, V26, P5248, DOI 10.1523/JNEUROSCI.4483-05.2006; Ichinose T, 2016, J PHYSIOL-LONDON, V594, P883, DOI 10.1113/JP271458; Keeley PW, 2010, J NEUROSCI, V30, P1677, DOI 10.1523/JNEUROSCI.5153-09.2010; KOLB H, 1970, PHILOS T R SOC B, V258, P261, DOI 10.1098/rstb.1970.0036; Li W, 2004, J COMP NEUROL, V474, P1, DOI 10.1002/cne.20075; Mataruga A, 2007, J COMP NEUROL, V502, P1123, DOI 10.1002/cne.21367; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Missotten L, 1965, ULTRASTRUCTURE HUMAN; Morrow EM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-2; Nikonov SS, 2005, J GEN PHYSIOL, V125, P287, DOI 10.1085/jgp.200409208; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Pang JJ, 2012, J PHYSIOL-LONDON, V590, P845, DOI 10.1113/jphysiol.2011.224113; Puller C, 2013, NEUROSCIENCE, V243, P136, DOI 10.1016/j.neuroscience.2013.03.054; Raven MA, 2007, J NEUROSCI, V27, P3540, DOI 10.1523/JNEUROSCI.0372-07.2007; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; Strettoi E, 2004, J NEUROSCI, V24, P7576, DOI 10.1523/JNEUROSCI.2245-04.2004; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Tsukamoto Y, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00105; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160	36	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173455	10.1371/journal.pone.0173455	http://dx.doi.org/10.1371/journal.pone.0173455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257490	Green Published, Green Accepted, gold			2022-12-27	WOS:000396021100092
J	Parikh, JD; Kakarla, J; Keavney, B; O'Sullivan, JJ; Ford, GA; Blamire, AM; Hollingsworth, KG; Coats, L				Parikh, Jehill D.; Kakarla, Jayant; Keavney, Bernard; O'Sullivan, John J.; Ford, Gary A.; Blamire, Andrew M.; Hollingsworth, Kieren G.; Coats, Louise			4D flow MRI assessment of right atrial flow patterns in the normal heart - influence of caval vein arrangement and implications for the patent foramen ovale	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; CRYPTOGENIC STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; DESCENDING AORTA; EMBOLISM; VISUALIZATION; HEMODYNAMICS; FIBRILLATION; RISK; AGE	Aim To investigate atrial flow patterns in the normal adult heart, to explore whether caval vein arrangement and patency of the foramen ovale (PFO) may be associated with flow pattern. Materials and Methods Time-resolved, three-dimensional velocity encoded magnetic resonance imaging (4D flow) was employed to assess atrial flow patterns in thirteen healthy subjects (6 male, 40 years, range 25-50) and thirteen subjects (6 male, 40 years, range 21-50) with cryptogenic stroke and patent foramen ovale (CS-PFO). Right atrial flow was defined as vortical, helico-vortical, helical and multiple vortices. Time-averaged and peak systolic and diastolic flows in the caval and pulmonary veins and their anatomical arrangement were compared. Results A spectrum of right atrial flow was observed across the four defined categories. The right atrial flow patterns were strongly associated with the relative position of the caval veins. Right atrial flow patterns other than vortical were more common (p = 0.015) and the separation between the superior and inferior vena cava greater (10 +/- 5mm versus 3 +/- 3mm, p = 0.002) in the CS-PFO group. In the left atrium all subjects except one had counter-clockwise vortical flow. Vortex size varied and was associated with left lower pulmonary vein flow (systolic r = 0.61, p = 0.001, diastolic r = 0.63 p = 0.002). A diastolic vortex was less common and time-averaged left atrial velocity was greater in the CS-PFO group (17 +/- 2cm/sec versus 15 +/- 1, p = 0.048). One CS-PFO subject demonstrated vortical retrograde flow in the descending aortic arch; all other subjects had laminar descending aortic flow. Conclusion Right atrial flow patterns in the normal heart are heterogeneous and are associated with the relative position of the caval veins. Patterns, other than 'typical' vortical flow, are more prevalent in the right atrium of those with cryptogenic stroke in the context of PFO. Left atrial flow patterns are more homogenous in normal hearts and show a relationship with flow arising from the left pulmonary veins.	[Parikh, Jehill D.; Blamire, Andrew M.; Hollingsworth, Kieren G.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Kakarla, Jayant; O'Sullivan, John J.; Coats, Louise] Freeman Rd Hosp, Dept Congenital Cardiol, Newcastle Upon Tyne, Tyne & Wear, England; [Keavney, Bernard] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England; [O'Sullivan, John J.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Ford, Gary A.; Coats, Louise] Univ Oxford, Div Med Sci, Oxford, England	Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK; University of Manchester; Newcastle University - UK; University of Oxford	Coats, L (corresponding author), Freeman Rd Hosp, Dept Congenital Cardiol, Newcastle Upon Tyne, Tyne & Wear, England.; Coats, L (corresponding author), Univ Oxford, Div Med Sci, Oxford, England.	louise.coats@newcastle.ac.uk	Blamire, Andrew/AAU-6100-2021; Ford, Gary/AAY-6405-2020	Ford, Gary/0000-0001-8719-4968; Coats, Louise/0000-0003-3422-5497; Keavney, Bernard/0000-0001-9573-0812; Blamire, Andrew/0000-0002-8749-1257	Academy of Medical Sciences start up grant; British Heart Foundation (SGCL7), London, United Kingdom; Newcastle Health Care Charity; Newcastle upon Tyne Hospitals NHS Charity, Newcastle upon Tyne, United Kingdom [BH120740]; Academy of Medical Sciences (AMS) [AMS-SGCL7-Coats] Funding Source: researchfish; National Institute for Health Research [CL-2010-01-003] Funding Source: researchfish	Academy of Medical Sciences start up grant; British Heart Foundation (SGCL7), London, United Kingdom; Newcastle Health Care Charity; Newcastle upon Tyne Hospitals NHS Charity, Newcastle upon Tyne, United Kingdom; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by an Academy of Medical Sciences start up grant with funding provided from the British Heart Foundation (SGCL7), London, United Kingdom and the Newcastle Health Care Charity and the Newcastle upon Tyne Hospitals NHS Charity (BH120740), Newcastle upon Tyne, United Kingdom [http://www.acmeasci.ac.uk/grants-and-schemes/grant-schemes/starter-grants]; [http://www.newcastle-hospitals.org.uk/patient-guides/charity-matters_applications-for-research-grants.aspx]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzola GP, 1999, NEUROLOGY, V52, P1622, DOI 10.1212/WNL.52.8.1622; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Calkoen EE, 2015, J THORAC CARDIOV SUR, V150, P1233, DOI 10.1016/j.jtcvs.2015.07.048; Carlsson M, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-55; Cramer SC, 2004, STROKE, V35, P46, DOI 10.1161/01.STR.0000106137.42649.AB; Dyverfeldt P, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0174-5; Fluckiger JU, 2013, J MAGN RESON IMAGING, V38, P580, DOI 10.1002/jmri.23994; Foll D, 2013, EUR HEART J-CARD IMG, V14, P366, DOI 10.1093/ehjci/jes196; Fyrenius A, 2001, HEART, V86, P448, DOI 10.1136/heart.86.4.448; Groves AM, 2012, PEDIATR RES, V71, P380, DOI 10.1038/pr.2011.77; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; Harloff A, 2010, STROKE, V41, P1145, DOI 10.1161/STROKEAHA.109.577775; Harloff A, 2009, STROKE, V40, P1505, DOI 10.1161/STROKEAHA.108.530030; Hollingsworth KG, 2012, AM J PHYSIOL-HEART C, V302, pH885, DOI 10.1152/ajpheart.00985.2011; Jung JM, 2013, J STROKE CEREBROVASC, V22, P1399, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.034; Kakarla J, 2014, HEART, V100, pA69, DOI 10.1136/heartjnl-2014-306118.120; Kanski M, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0211-4; Kilner PJ, 2000, NATURE, V404, P759, DOI 10.1038/35008075; Komar M, 2012, KARDIOL POL, V70, P1258; Maceira AM, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-65; Malik SB, 2015, RADIOGRAPHICS, V35, P14, DOI 10.1148/rg.351130010; Markl M, 2016, INT J CARDIOVAS IMAG, V32, P807, DOI 10.1007/s10554-015-0830-8; Markl M, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-7; Meissner I, 1999, MAYO CLIN PROC, V74, P862, DOI 10.4065/74.9.862; Rajabzadeh-Oghaz H, 2016, MED BIOL ENG COMPUT; Rigatelli G, 2009, JACC-CARDIOVASC INTE, V2, P655, DOI 10.1016/j.jcin.2009.05.010; Suwa K, 2015, CIRC J, V79, P144, DOI 10.1253/circj.CJ-14-0562; Wessler BS, 2014, CIRC-CARDIOVASC IMAG, V7, P125, DOI 10.1161/CIRCIMAGING.113.000807; WILMSHURST PT, 1989, LANCET, V2, P1302	29	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173046	10.1371/journal.pone.0173046	http://dx.doi.org/10.1371/journal.pone.0173046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282389	Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800016
J	Garcia-Gutierrez, V; Gomez-Casares, MT; Puerta, JM; Alonso-Dominguez, JM; Osorio, S; Hernandez-Boiuda, JC; Collado, R; Ramirez, MJ; Ibanez, F; Martin, ML; Rodriguez-Gambarte, JD; Martinez-Laperche, C; Gomez, M; Fiallo, DV; Redondo, S; Rodriguez, A; Ruiz-Nuno, C; Steegmann, JL; Jimenez-Velasco, A				Garcia-Gutierrez, Valentin; Gomez-Casares, Maria T.; Puerta, Jose M.; Alonso-Dominguez, Juan M.; Osorio, Santiago; Hernandez-Boiuda, Juan C.; Collado, Rosa; Ramirez, Maria J.; Ibanez, Fatima; Martin, Maria L.; Rodriguez-Gambarte, Juan D.; Martinez-Laperche, Carolina; Gomez, Montse; Fiallo, Dolly V.; Redondo, Sara; Rodriguez, Alicia; Ruiz-Nuno, Concepcion; Steegmann, Juan L.; Jimenez-Velasco, Antonio		Spanish Grp Chronic Myeloid	A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia	PLOS ONE			English	Article							MOLECULAR RESPONSE; FOLLOW-UP; IMATINIB; GUIDELINES; NILOTINIB; ASSAY; STANDARDIZATION; PERFORMANCE; SURVIVAL; OUTCOMES	In chronic myeloid leukemia (CML) patients, 3-month BCR-ABL1 levels have consistently been correlated with further outcomes. Monitoring molecular responses in CML using the GeneXpert (Cepheid) platform has shown an optimal correlation with standardized RQ-PCR (IS) when measuring BCR-ABL1 levels lower than 10%, as it is not accurate for values over 10%. The aim of the present study was to determine the predictive molecular value at three months on different outcome variables using the Xpert BCR-ABL1 Monitor (TM) assay (Xpert BCR-ABL1). We monitored 125 newly diagnosed consecutive CML patients in the chronic phase (CML-CP) using an automated method: Xpert BCR-ABL1. Only 5% of patients did not achieve an optimal response at 3 months, and the 10% BCR-ABL1 cutoff defined by RQ-PCR (IS) methods was unable to identify significant differences in the probabilities of achieving a complete cytogenetic response (CCyR) (50% vs. 87%, p = 0.1) or a major molecular response (MMR) (60% vs. 80%, p = 0.29) by 12 months. In contrast, a cutoff of 1.5% more accurately identified differences in the probabilities of achieving CCyR (98% vs. 54%, p< 0.001) and MMR (88% vs. 56%, p< 0.001) by 12 months, as well as probabilities of treatment changes (p = 0.005). Therefore, when using the Xpert BCR-ABL1 assay, a cutoff of 1.5% at 3 months could with high probability identify patients able to achieve an optimal response at 12 months.	[Garcia-Gutierrez, Valentin; Rodriguez-Gambarte, Juan D.] Hosp Univ Ramon y Cajal, Dept Hematol, Madrid, Spain; [Gomez-Casares, Maria T.; Fiallo, Dolly V.] Hosp Univ Doctor Negrin, Dept Hematol, Las Palmas Gran Canaria, Spain; [Puerta, Jose M.] Hosp Univ Virgen de las Nieves, Unidad Gest Clin Hematol & Hemoterapia, Granada, Spain; [Alonso-Dominguez, Juan M.] Univ Hosp, Fdn Jimenez Diaz, Madrid, Spain; [Osorio, Santiago; Martinez-Laperche, Carolina; Redondo, Sara] Hosp Univ Gregorio Maranon, Dept Hematol, Madrid, Spain; [Hernandez-Boiuda, Juan C.; Gomez, Montse] Hosp Clin, Dept Hematol, Valencia, Spain; [Collado, Rosa] Consorcio Hosp Gen Univ, Dept Hematol, Genet Lab, Valencia, Spain; [Ramirez, Maria J.] Hosp Jerez de la Frontera, Dept Hematol, Cadiz, Spain; [Ibanez, Fatima] Hosp San Pedro de Alcantara, Dept Hematol, Caceres, Spain; [Martin, Maria L.; Rodriguez, Alicia] Hosp Univ Virgen Macarena, Dept Hematol, Seville, Spain; [Ruiz-Nuno, Concepcion; Jimenez-Velasco, Antonio] Hosp Reg Univ Malaga, IBIMA, Dept Hematol, Malaga, Spain; [Steegmann, Juan L.] Hosp Univ Princesa, Dept Hematol, Madrid, Spain; [Steegmann, Juan L.] Hosp Univ Princesa, IIS IP, Madrid, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario Virgen de las Nieves; Fundacion Jimenez Diaz; General University Gregorio Maranon Hospital; Hospital Universitario Virgen Macarena; Universidad de Malaga; Hospital de La Princesa	Jimenez-Velasco, A (corresponding author), Hosp Reg Univ Malaga, IBIMA, Dept Hematol, Malaga, Spain.	a.jimenez.velasco@gmail.com	osorio, santiago/AAY-4337-2020; Collado Nieto, Rosa María/GZK-9557-2022; CASARES, MARIA TERESA GOMEZ/R-6060-2018; Martinez-Laperche, Carolina/G-8664-2013	CASARES, MARIA TERESA GOMEZ/0000-0003-0505-5126; Collado, Rosa/0000-0002-8205-6192; Fiallo Suarez, Dolly Viviana/0000-0002-2901-9405; Hernandez-Boluda, Juan Carlos/0000-0002-4289-3113; Rodriguez-Fernandez, Alicia/0000-0001-5999-7288; Martinez-Laperche, Carolina/0000-0001-6802-3485; Garcia, Valentin/0000-0003-4752-0815; Alonso-Dominguez, Juan Manuel/0000-0001-6233-5912	Asociacion Malaguena para la Investigacion en Leucemia (AMPILE)	Asociacion Malaguena para la Investigacion en Leucemia (AMPILE)	This work was partially supported by grants from the Asociacion Malaguena para la Investigacion en Leucemia (AMPILE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by grants from the Asociacion Malaguena para la Investigacion en Leucemia (AMPILE).	Baccarani M, 2012, ANN ONCOL, V23, P72, DOI 10.1093/annonc/mds228; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Branford S, 2008, BLOOD, V112, P3330, DOI 10.1182/blood-2008-04-150680; Branford S, 2012, J CLIN ONCOL, V30, P4323, DOI 10.1200/JCO.2011.40.5217; Brummendorf TH, 2015, BRIT J HAEMATOL, V168, P69, DOI 10.1111/bjh.13108; Cayuela JM, 2011, HAEMATOL-HEMATOL J, V96, P664, DOI 10.3324/haematol.2010.034389; Cross NCP, 2012, LEUKEMIA, V26, P2172, DOI 10.1038/leu.2012.104; Dufresne SD, 2007, ARCH PATHOL LAB MED, V131, P947; Enjeti A, 2015, PATHOLOGY, V47, P570, DOI 10.1097/PAT.0000000000000293; Foroni L, 2011, BRIT J HAEMATOL, V153, P179, DOI 10.1111/j.1365-2141.2011.08603.x; Hanfstein B, 2012, LEUKEMIA, V26, P2096, DOI 10.1038/leu.2012.85; Hughes TP, 2014, BLOOD, V123, P1353, DOI 10.1182/blood-2013-06-510396; Jabbour E, 2014, BLOOD, V123, P494, DOI 10.1182/blood-2013-06-511592; Jain P, 2013, BLOOD, V121, P4867, DOI 10.1182/blood-2013-03-490128; Lopez-Jorge CE, 2012, ANN HEMATOL, V91, P1245, DOI 10.1007/s00277-012-1468-4; McNiven M, 2012, PATHOLOGY, V44, P55, DOI 10.1097/PAT.0b013e32834e4203; O'Brien S, 2013, J NATL COMPR CANC NE, V11, P1327, DOI 10.6004/jnccn.2013.0157; O'Dwyer ME, 2014, LEUKEMIA RES, V38, P310, DOI 10.1016/j.leukres.2013.11.016; Pearson E, 2016, LEUKEMIA RES, V43, P1, DOI 10.1016/j.leukres.2016.02.001; Pfirrmann M, 2016, LEUKEMIA, V30, P48, DOI 10.1038/leu.2015.261	20	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173532	10.1371/journal.pone.0173532	http://dx.doi.org/10.1371/journal.pone.0173532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278193	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900008
J	Jiang, TT; Shi, LY; Wei, LL; Li, X; Yang, S; Wang, C; Liu, CM; Chen, ZL; Tu, HH; Li, ZJ; Li, JC				Jiang, Ting-Ting; Shi, Li-Ying; Wei, Li-Liang; Li, Xiang; Yang, Su; Wang, Chong; Liu, Chang-Ming; Chen, Zhong-Liang; Tu, Hui-Hui; Li, Zhong-Jie; Li, Ji-Cheng			Serum amyloid A, protein Z, and C4b-binding protein beta chain as new potential biomarkers for pulmonary tuberculosis	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; ACUTE-PHASE RESPONSE; C-REACTIVE PROTEIN; ANTICOAGULANT PROTEIN; DIAGNOSTIC BIOMARKERS; PROTEOMIC SIGNATURE; VENOUS THROMBOSIS; ISCHEMIC-STROKE; TISSUE FACTOR; IDENTIFICATION	The aim of this study was to discover novel biomarkers for pulmonary tuberculosis (TB). Differentially expressed proteins in the serum of patients with TB were screened and identified by iTRAQ-two dimensional liquid chromatography tandem mass spectrometry analysis. A total of 79 abnormal proteins were discovered in patients with TB compared with healthy controls. Of these, significant differences were observed in 47 abnormally expressed proteins between patients with TB or pneumonia and chronic obstructive pulmonary disease (COPD). Patients with TB (n = 136) exhibited significantly higher levels of serum amyloid A (SAA), vitamin K-dependent protein Z (PROZ), and C4b-binding protein beta chain (C4BPB) than those in healthy controls (n = 66) (P<0.0001 for each) albeit significantly lower levels compared with those in patients with pneumonia (n = 72) (P<0.0001 for each) or COPD (n = 72) (P<0.0001, P<0.0001, P = 0.0016, respectively). After 6 months of treatment, the levels of SAA and PROZ were significantly increased (P = 0.022, P<0.0001, respectively), whereas the level of C4BPB was significantly decreased (P = 0.0038) in treated TB cases (n = 72). Clinical analysis showed that there were significant differences in blood clotting and lipid indices in patients with TB compared with healthy controls, patients with pneumonia or COPD, and treated TB cases (P<0.05). Correlation analysis revealed significant correlations between PROZ and INR (rs = 0.414, P = 0.044), and between C4BPB and FIB (rs = 0.617, P = 0.0002) in patients with TB. Receiver operating characteristic curve analysis revealed that the area under the curve value of the diagnostic model combining SAA, PROZ, and C4BPB to discriminate the TB group from the healthy control, pneumonia, COPD, and cured TB groups was 0.972, 0.928, 0.957, and 0.969, respectively. Together, these results suggested that SAA, PROZ, and C4BPB may serve as new potential biomarkers for TB. Our study may thus provide experimental data for the differential diagnosis of TB.	[Jiang, Ting-Ting; Li, Ji-Cheng] South China Univ Technol, Sch Med, Guangzhou, Guangdong, Peoples R China; [Shi, Li-Ying] Zhejiang Hosp, Dept Clin Lab, Hangzhou, Zhejiang, Peoples R China; [Wei, Li-Liang] Shaoxing Municipal Hosp, Dept Pneumol, Shaoxing, Peoples R China; [Li, Xiang] Zhejiang Prov Peoples Hosp, Key Lab Gastroenteropathy, Hangzhou, Zhejiang, Peoples R China; [Yang, Su; Wang, Chong; Liu, Chang-Ming; Chen, Zhong-Liang; Tu, Hui-Hui; Li, Zhong-Jie; Li, Ji-Cheng] Zhejiang Univ, Inst Cell Biol, Hangzhou, Zhejiang, Peoples R China	South China University of Technology; Zhejiang Provincial People's Hospital; Zhejiang University	Li, JC (corresponding author), South China Univ Technol, Sch Med, Guangzhou, Guangdong, Peoples R China.; Li, JC (corresponding author), Zhejiang Univ, Inst Cell Biol, Hangzhou, Zhejiang, Peoples R China.	lijichen@zju.edu.cn	Yang, Su/GWQ-4862-2022		National Basic Research Program of China [2014CB543002]; National Natural Science Foundation of China [81573709, 81273882]; scientific research fund project of South China University of Technology School of Medicine [yxy2016006]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific research fund project of South China University of Technology School of Medicine	This work was supported by grants from National Basic Research Program of China (No.2014CB543002, Zhejiang University, received by JCL), National Natural Science Foundation of China (No.81573709, No.81273882, Zhejiang University, received by JCL), and scientific research fund project of South China University of Technology School of Medicine (NO. yxy2016006, South China University of Technology School of Medicine, received by TTJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Almawi WY, 2013, REPRODUCTION, V146, pR73, DOI 10.1530/REP-13-0072; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Broze GJ, 2001, THROMB HAEMOSTASIS, V86, P8; Buil A, 2010, BLOOD, V115, P4644, DOI 10.1182/blood-2010-01-263038; Carlsson S, 2010, J BIOL CHEM, V285, P32038, DOI 10.1074/jbc.M110.148452; Cordovilla R, 2016, ARCH BRONCONEUMOL, V52, P368, DOI 10.1016/j.arbres.2015.12.002; DE FRUTOS PG, 1994, BLOOD, V84, P815; Deguchi H, 2013, THROMB HAEMOSTASIS, V109, P358, DOI 10.1160/TH12-10-0722; Emuakhagbon V, 2016, AM J SURG, V211, P768, DOI 10.1016/j.amjsurg.2015.11.028; Fujita M, 1997, INTERNAL MED, V36, P218, DOI 10.2169/internalmedicine.36.218; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; GRIFFIN JH, 1992, BLOOD, V79, P3203; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; Havey TC, 2012, AM J TROP MED HYG, V86, P264, DOI 10.4269/ajtmh.2012.11-0598; Huang X, 2012, BLOOD, V120, P1726, DOI 10.1182/blood-2012-03-419598; Jin GZ, 2011, J PROTEOME RES, V10, P3418, DOI 10.1021/pr200482t; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Kager LM, 2015, J INFECTION, V70, P324, DOI 10.1016/j.jinf.2014.10.006; Kishiwada M, 2008, J THROMB HAEMOST, V6, P1858, DOI 10.1111/j.1538-7836.2008.03129.x; Kobelt K, 2001, BRIT J HAEMATOL, V114, P169, DOI 10.1046/j.1365-2141.2001.02913.x; KOEDAM JA, 1988, J CLIN INVEST, V82, P1236, DOI 10.1172/JCI113721; Kothari H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114141; Kothari H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045700; Lange C, 2009, EUR RESPIR J, V33, P1250, DOI 10.1183/09031936.00019709; Lange C, 2010, RESPIROLOGY, V15, P220, DOI 10.1111/j.1440-1843.2009.01692.x; Lannergard A, 2009, SCAND J INFECT DIS, V41, P663, DOI 10.1080/00365540903127417; Liu JY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-506; Lwaleed BA, 2006, J PATHOL, V208, P327, DOI 10.1002/path.1871; Maurissen LFA, 2008, BLOOD, V111, P3034, DOI 10.1182/blood-2007-06-089987; McQuillan AM, 2003, STROKE, V34, P2415, DOI 10.1161/01.STR.0000092124.52084.4B; Nilsen MM, 2011, J PROTEOMICS, V74, P2995, DOI 10.1016/j.jprot.2011.06.027; Olivar R, 2013, J IMMUNOL, V190, P2857, DOI 10.4049/jimmunol.1200503; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Robson SC, 1996, BRIT J HAEMATOL, V93, P943, DOI 10.1046/j.1365-2141.1996.d01-1722.x; Rodriguez-Flores E, 2012, TUBERCULOSIS, V92, P497, DOI 10.1016/j.tube.2012.07.002; Sakamoto K, 2010, INFECT IMMUN, V78, P1004, DOI 10.1128/IAI.00451-09; Sanchez-Pernaute O, 2006, ANN RHEUM DIS, V65, P1279, DOI 10.1136/ard.2006.052118; Shah M, 2014, CURR OPIN INFECT DIS, V27, P403, DOI 10.1097/QCO.0000000000000090; Sharma R, 2015, J PROTEOME RES, V14, P2466, DOI 10.1021/pr501324n; Sierko E, 2012, THROMB RES, V129, pE112, DOI 10.1016/j.thromres.2011.10.027; Silva DR, 2012, COPD, V9, P426, DOI 10.3109/15412555.2012.683840; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Technical Guidance Group of the Fifth National TB Epidemiological Survey, 2012, CHINESE J ANTITUBERC, V34, P485; Turken O, 2002, INT J TUBERC LUNG D, V6, P927; Violi F, 2014, J THROMB HAEMOST, V12, P1391, DOI 10.1111/jth.12646; Wang C, 2016, INT J BIOL SCI, V12, P246, DOI 10.7150/ijbs.13805; Wang C, 2015, SCI REP-UK, V5, DOI 10.1038/srep15615; Wang C, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-52; Wei DH, 2016, J PROTEOME RES, V15, P487, DOI 10.1021/acs.jproteome.5b00838; Xu DD, 2015, PROTEOMICS, V15, P58, DOI 10.1002/pmic.201400366; Xu Y, 2014, INT J CLIN EXP PATHO, V7, P5569; Yang Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158611; Zha C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122322; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081076; Zhao Y, 2007, ARTERIOSCL THROM VAS, V27, P1645, DOI 10.1161/ATVBAHA.106.137455	57	26	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173304	10.1371/journal.pone.0173304	http://dx.doi.org/10.1371/journal.pone.0173304			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278182	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900070
J	Lim, H; Powell, S; Mcnamara, HC; Howie, AF; Doust, A; Bowman, ME; Smith, R; Norman, JE; Stock, SJ				Lim, Hui; Powell, Sioned; Mcnamara, Helen C.; Howie, A. Forbes; Doust, Ann; Bowman, Maria E.; Smith, Roger; Norman, Jane E.; Stock, Sarah J.			Placental hormone profiles as predictors of preterm birth in twin pregnancy: A prospective cohort study	PLOS ONE			English	Article							INCREASED RISK; SALIVA; PROGESTERONE; WOMEN; METAANALYSIS; ESTRIOL; LABOR	Objective The objective of the study was to analyse placental hormone profiles in twin pregnancies to determine if they could be used to predict preterm birth. Study design Progesterone, estradiol, estriol and corticotropin-releasing hormone were measured using competitive immunoassay and radioimmunoassay in serum and saliva samples of 98 women with twin pregnancies,at 3 or more gestational timepoints. Hormone profiles throughout gestation were compared between very preterm (<34 weeks; n = 8), preterm (<37 weeks; n = 40) and term (37+ weeks; n = 50) deliveries. Results No significant differences were found between preterm and term deliveries in either absolute hormone concentrations or ratios. Estimated hormone concentrations and ratios at 26 weeks did not appear to predict preterm delivery. Salivary and serum hormone concentrations were generally poorly correlated. Conclusion Our results suggest that serial progesterone, estradiol, estriol and corticotropin-releasing hormone measurements in saliva and serum are not robust biomarkers for preterm birth in twin pregnancies.	[Lim, Hui; Powell, Sioned; Mcnamara, Helen C.; Howie, A. Forbes; Doust, Ann; Norman, Jane E.; Stock, Sarah J.] Univ Edinburgh, Queens Med Res Inst, Tommys Ctr Maternal & Fetal Hlth, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Bowman, Maria E.; Smith, Roger] Univ Newcastle, Hunter Med Res Inst, John Hunter Hosp, Mothers & Babies Res Ctr, Newcastle, NSW, Australia; [Stock, Sarah J.] Univ Western Australia, King Edward Mem Hosp, Sch Womens & Infants Hlth, Crawley, WA, Australia	University of Edinburgh; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; King Edward Memorial Hospital; University of Western Australia	Stock, SJ (corresponding author), Univ Edinburgh, Queens Med Res Inst, Tommys Ctr Maternal & Fetal Hlth, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.; Stock, SJ (corresponding author), Univ Western Australia, King Edward Mem Hosp, Sch Womens & Infants Hlth, Crawley, WA, Australia.	sarah.stock@ed.ac.uk		Bowman, Maria/0000-0002-2333-7883; Norman, Jane/0000-0001-6031-6953; Smith, Roger/0000-0003-4720-0280	Albert McKern Bequest	Albert McKern Bequest	The research was funded by the Albert McKern Bequest, administered by the University of Edinburgh, and Tommy's Baby Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiappin S, 2007, CLIN CHIM ACTA, V383, P30, DOI 10.1016/j.cca.2007.04.011; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Groschl M, 2009, BIOESSAYS, V31, P843, DOI 10.1002/bies.200900013; Hampson E, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-7; Heine RP, 2000, OBSTET GYNECOL, V96, P490, DOI 10.1016/S0029-7844(00)01004-8; Kaufman E, 2002, CRIT REV ORAL BIOL M, V13, P197, DOI 10.1177/154411130201300209; Lachelin GCL, 2009, BJOG-INT J OBSTET GY, V116, P1515, DOI 10.1111/j.1471-0528.2009.02293.x; Martin J. A., 2013, NATL VITAL STA REP, V64, P1; Office for National Statistics, 2014, CHILDH INF PER MORT; Office for National Statistics, 2012, GEST SPEC INF MORT 2; Priya B, 2013, BJOG-INT J OBSTET GY, V120, P1003, DOI 10.1111/1471-0528.12217; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Schuit E, 2015, BJOG-INT J OBSTET GY, V122, P27, DOI 10.1111/1471-0528.13032; Smith R, 2009, J CLIN ENDOCR METAB, V94, P2066, DOI 10.1210/jc.2008-2257; Suhag A, 2015, AM J OBSTET GYNECOL, V213, P479, DOI 10.1016/j.ajog.2015.03.031; Wood P, 2009, ANN CLIN BIOCHEM, V46, P183, DOI 10.1258/acb.2008.008208	16	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173732	10.1371/journal.pone.0173732	http://dx.doi.org/10.1371/journal.pone.0173732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278220	gold, Green Published, Green Submitted			2022-12-27	WOS:000396087900034
J	Marshall, L; Vivien, C; Girardot, F; Pericard, L; Demeneix, BA; Coen, L; Chai, N				Marshall, Lindsey; Vivien, Celine; Girardot, Fabrice; Pericard, Louise; Demeneix, Barbara A.; Coen, Laurent; Chai, Norin			Persistent fibrosis, hypertrophy and sarcomere disorganisation after endoscopy-guided heart resection in adult Xenopus	PLOS ONE			English	Article							NEONATAL MOUSE HEART; CARDIAC-TROPONIN-T; ANIMAL-MODELS; REGENERATION; ZEBRAFISH; INJURY; MECHANISMS; AMPHIBIANS; DISEASE; ALPHA-ACTININ-3	Models of cardiac repair are needed to understand mechanisms underlying failure to regenerate in human cardiac tissue. Such studies are currently dominated by the use of zebrafish and mice. Remarkably, it is between these two evolutionary separated species that the adult cardiac regenerative capacity is thought to be lost, but causes of this difference remain largely unknown. Amphibians, evolutionary positioned between these two models, are of particular interest to help fill this lack of knowledge. We thus developed an endoscopy-based resection method to explore the consequences of cardiac injury in adult Xenopus laevis. This method allowed in situ live heart observation, standardised tissue amputation size and reproducibility. During the first week following amputation, gene expression of cell proliferation markers remained unchanged, whereas those relating to sarcomere organisation decreased and markers of inflammation, fibrosis and hypertrophy increased. One-month post-amputation, fibrosis and hypertrophy were evident at the injury site, persisting through 11 months. Moreover, cardiomyocyte sarcomere organisation deteriorated early following amputation, and was not completely recovered as far as 11 months later. We conclude that the adult Xenopus heart is unable to regenerate, displaying cellular and molecular marks of scarring. Our work suggests that, contrary to urodeles and teleosts, with the exception of medaka, adult anurans share a cardiac injury outcome similar to adult mammals. This observation is at odds with current hypotheses that link loss of cardiac regenerative capacity with acquisition of homeothermy.	[Marshall, Lindsey; Vivien, Celine; Girardot, Fabrice; Pericard, Louise; Demeneix, Barbara A.; Coen, Laurent] Sorbonne Univ, Museum Natl Hist Nat, Evolut Regulat Endocriniennes, Dept Regulat,Dev & Diversite Mol,UNR CNRS 7221, Paris, France; [Chai, Norin] Museum Natl Hist Nat, Menagerie Jardin Plantes, Paris, France; [Vivien, Celine] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Vivien, Celine] Univ Queensland, Ctr Cardiac & Vasc Biol, Brisbane, Qld, Australia	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Museum National d'Histoire Naturelle (MNHN); University of Queensland; University of Queensland	Coen, L (corresponding author), Sorbonne Univ, Museum Natl Hist Nat, Evolut Regulat Endocriniennes, Dept Regulat,Dev & Diversite Mol,UNR CNRS 7221, Paris, France.; Chai, N (corresponding author), Museum Natl Hist Nat, Menagerie Jardin Plantes, Paris, France.	coen@mnhn.fr; chai@mnhn.fr	Girardot, Fabrice/B-7587-2012; Vivien, Celine/AAJ-8066-2020	Girardot, Fabrice/0000-0002-0916-877X; 	EU Grant Crescendo; French PNR-PE Program; Watchfrog S.A. under CIFRE Convention [216/2011]; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant [607142]	EU Grant Crescendo; French PNR-PE Program; Watchfrog S.A. under CIFRE Convention; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant	The research leading to these results has received funding from EU Grant Crescendo and the French PNR-PE Program, by Watchfrog S.A. under CIFRE Convention 216/2011 Ph.D. fellowship (to C. V.) and the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7-2013 under REA grant agreement no607142, DevCom Ph.D fellowship (to L. M.).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andersen DC, 2016, J MOL CELL CARDIOL, V90, P47, DOI 10.1016/j.yjmcc.2015.11.031; Andersen DC, 2014, STEM CELL REP, V2, P406, DOI 10.1016/j.stemcr.2014.02.008; Bao XM, 2013, CELL STEM CELL, V12, P193, DOI 10.1016/j.stem.2012.12.014; Becker JR, 2011, DIS MODEL MECH, V4, P400, DOI 10.1242/dmm.006148; BECKER RO, 1974, NATURE, V248, P145, DOI 10.1038/248145a0; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Boppart SA, 1997, P NATL ACAD SCI USA, V94, P4256, DOI 10.1073/pnas.94.9.4256; Borchardt T, 2007, THROMB HAEMOSTASIS, V98, P311, DOI 10.1160/TH07-02-0153; Bryant DM, 2015, J MOL CELL CARDIOL, V79, P315, DOI 10.1016/j.yjmcc.2014.12.011; Burchfield JS, 2013, CIRCULATION, V128, P388, DOI 10.1161/CIRCULATIONAHA.113.001878; Burggren WW, 2007, ILAR J, V48, P260, DOI 10.1093/ilar.48.3.260; Cano-Martínez Agustina, 2010, Arch. Cardiol. Méx., V80, P79; Chai Norin, 2016, Vet Clin North Am Exot Anim Pract, V19, P77, DOI 10.1016/j.cvex.2015.08.004; Chai Norin, 2015, Veterinary Clinics of North America Exotic Animal Practice, V18, P479, DOI 10.1016/j.cvex.2015.04.006; Chen J, 2013, ZEBRAFISH, V10, P389, DOI 10.1089/zeb.2013.0875; Coen L, 2007, P NATL ACAD SCI USA, V104, P8502, DOI 10.1073/pnas.0608877104; Dickover MS, 2013, METHODS MOL BIOL, V1037, P463, DOI 10.1007/978-1-62703-505-7_27; Gamba Laurent, 2014, Curr Treat Options Cardiovasc Med, V16, P288, DOI 10.1007/s11936-013-0288-8; Gardner S, 2012, AM J PHYSIOL-CELL PH, V303, pC1292, DOI 10.1152/ajpcell.00259.2012; Gilchrist J, 1919, DISSECTION PLATANA F; Goss RJ., 1969, PRINCIPLES REGENERAT; Hein SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122665; Heinz-Taheny Kathleen M., 2009, Veterinary Clinics of North America Exotic Animal Practice, V12, P39, DOI 10.1016/j.cvex.2008.08.005; Hempel A, 2016, J CARDIOVASC DEV DIS, V3, DOI 10.3390/jcdd3020021; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Holterhoff CK, 2009, DEV DYNAM, V238, P2936, DOI 10.1002/dvdy.22123; Huang W, 2009, DEV BIOL, V331, P237, DOI 10.1016/j.ydbio.2009.04.039; Ito K, 2014, DEV DYNAM, V243, P1106, DOI [10.1002/DVDY.24154, 10.1002/dvdy.24154]; Jaworska-Wilczynska M, 2016, FOLIA HISTOCHEM CYTO, V54, P121, DOI 10.5603/FHC.a2016.0014; Jazwinska A, 2016, J PATHOL, V238, P233, DOI 10.1002/path.4644; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Karmon A, 2016, ELIFE, V5, DOI 10.7554/eLife.14424; Klocke R, 2007, CARDIOVASC RES, V74, P29, DOI 10.1016/j.cardiores.2006.11.026; Konfino T, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001320; Krasteva V, 2012, BLOOD, V120, P4720, DOI 10.1182/blood-2012-04-427047; Liu LS, 2016, ZOOL RES, V37, P237, DOI 10.13918/j.issn.2095-8137.2016.4.237; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacArthur DG, 2004, BIOESSAYS, V26, P786, DOI 10.1002/bies.20061; Mercer SE, 2013, DEV BIOL, V382, P457, DOI 10.1016/j.ydbio.2013.08.002; Nakamura R, 2016, DEV GROWTH DIFFER, V58, P367, DOI 10.1111/dgd.12281; Nishii K, 2008, DEV BIOL, V322, P65, DOI 10.1016/j.ydbio.2008.07.007; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Polizzotti BD, 2016, NAT PROTOC, V11, P542, DOI 10.1038/nprot.2016.031; Porrello ER, 2014, STEM CELL RES, V13, P556, DOI 10.1016/j.scr.2014.06.003; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Rasband W.S., 1997, IMAGE J; REICHMAN OJ, 1984, AM NAT, V123, P752, DOI 10.1086/284237; Rumyantsev P., 1961, ARKH ANAT GISTOL EMB, V376, P65; RUMYANTSEV PP, 1973, Z ZELLFORSCH MIK ANA, V139, P431, DOI 10.1007/BF00306596; RUMYANTSEV PP, 1977, INT REV CYTOL, V51, P187; Sallin P, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160012; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Seto JT, 2011, HUM MOL GENET, V20, P2914, DOI 10.1093/hmg/ddr196; Simon HG, 2015, METHODS MOL BIOL, V1290, P227, DOI 10.1007/978-1-4939-2495-0_18; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Szibor M, 2014, CELL MOL LIFE SCI, V71, P1907, DOI 10.1007/s00018-013-1535-6; Teramoto N, 2011, J NUCL MED, V52, P761, DOI 10.2967/jnumed.110.084848; Uygur A, 2016, DEV CELL, V36, P362, DOI 10.1016/j.devcel.2016.01.018; Vargas-Gonzalez A., 2005, ARCH CARDIOL MEX S3, V75; Vivien CJ, 2016, NPJ REGEN MED, V1, DOI 10.1038/npjregenmed.2016.12; Warkman AS, 2007, SEMIN CELL DEV BIOL, V18, P46, DOI 10.1016/j.semcdb.2006.11.010; Witman N, 2011, DEV BIOL, V354, P67, DOI 10.1016/j.ydbio.2011.03.021; World Health Organization, 2014, TOP 10 CAUS DEATH; Xiang MSW, 2016, INT REV CEL MOL BIO, V326, P67, DOI 10.1016/bs.ircmb.2016.04.002; Yang N, 2009, MED SPORT SCI, V54, P88, DOI 10.1159/000235698; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhou HY, 2015, P NATL ACAD SCI USA, V112, P11864, DOI 10.1073/pnas.1516237112; Zielonko J., 1874, ARCH PATHOL ANAT PHY, V62, P29	71	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173418	10.1371/journal.pone.0173418	http://dx.doi.org/10.1371/journal.pone.0173418			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278282	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900090
J	Vientos-Plotts, AI; Ericsson, AC; Rindt, H; Grobman, ME; Graham, A; Bishop, K; Cohn, LA; Reinero, CR				Vientos-Plotts, Aida I.; Ericsson, Aaron C.; Rindt, Hansjorg; Grobman, Megan E.; Graham, Amber; Bishop, Kaitlin; Cohn, Leah A.; Reinero, Carol R.			Dynamic changes of the respiratory microbiota and its relationship to fecal and blood microbiota in healthy young cats	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY MICROBIOME; LUNG; BACTERIAL; ASTHMA; COMMUNITIES; FIBROSIS; DIVERSITY; COMMENSAL; DNA	Advances in the field of metagenomics using culture-independent methods of microbial identification have allowed characterization of rich and diverse communities of bacteria in the lungs of healthy humans, mice, dogs, sheep and pigs. These data challenge the long held belief that the lungs are sterile and microbial colonization is synonymous with pathology. Studies in humans and animals demonstrate differences in the composition of airway microbiota in health versus disease suggesting respiratory dysbiosis occurs. Using 16S rRNA amplicon sequencing of DNA extracted from rectal and oropharyngeal (OP) swabs, bronchoalveolar lavage fluid (BALF), and blood, our objective was to characterize the fecal, OP, blood, and lower airway microbiota over time in healthy cats. This work in healthy cats, a species in which a respiratory microbiota has not yet been characterized, sets the stage for future studies in feline asthma in which cats serve as a comparative and translational model for humans. Fecal, OP and BALF samples were collected from six healthy research cats at day 0, week 2, and week 10; blood was collected at week 10. DNA was extracted, amplified via PCR, and sequenced using the Illumina MiSeq platform. Representative operational taxonomic units (OTUs) were identified and microbial richness and diversity were assessed. Principal component analysis (PCA) was used to visualize relatedness of samples and PERMANOVA was used to test for significant differences in microbial community composition. Fecal and OP swabs provided abundant DNA yielding a mean +/- SEM of 65,653 6,145 and 20,6323 +/- 4,360 sequences per sample, respectively while BALF and blood samples had lower coverage (1,489 +/- 430 and 269 +/- 18 sequences per sample, respectively). Oropharyngeal and fecal swabs were significantly richer than BALF (mean number OTUs 93, 88 and 36, respectively; p < 0.001) with no significant difference (p = 0.180) in richness between time points. PCA revealed site-specific microbial communities in the feces, and upper and lower airways. In comparison, blood had an apparent compositional similarity with BALF with regard to a few dominant taxa, but shared more OTUs with feces. Samples clustered more by time than by individual, with OP swabs having subjectively greater variation than other samples. In summary, healthy cats have a rich and distinct lower airway microbiome with dynamic bacterial populations. The microbiome is likely to be altered by factors such as age, environmental influences, and disease states. Further data are necessary to determine how the distinct feline microbiomes from the upper and lower airways, feces and blood are established and evolve. These data are relevant for comparisons between healthy cats and cats with respiratory disease.	[Vientos-Plotts, Aida I.; Ericsson, Aaron C.; Rindt, Hansjorg; Grobman, Megan E.; Graham, Amber; Bishop, Kaitlin; Cohn, Leah A.; Reinero, Carol R.] Univ Missouri, Coll Vet Med, Columbia, MO 65211 USA; [Vientos-Plotts, Aida I.; Grobman, Megan E.; Cohn, Leah A.; Reinero, Carol R.] Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Vientos-Plotts, Aida I.; Rindt, Hansjorg; Grobman, Megan E.; Cohn, Leah A.; Reinero, Carol R.] Univ Missouri, Comparat Internal Med Lab, Columbia, MO 65211 USA; [Ericsson, Aaron C.] Univ Missouri, Metagen Ctr, Columbia, MO 65211 USA; [Ericsson, Aaron C.] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Ericsson, AC; Reinero, CR (corresponding author), Univ Missouri, Coll Vet Med, Columbia, MO 65211 USA.; Reinero, CR (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA.; Reinero, CR (corresponding author), Univ Missouri, Comparat Internal Med Lab, Columbia, MO 65211 USA.; Ericsson, AC (corresponding author), Univ Missouri, Metagen Ctr, Columbia, MO 65211 USA.; Ericsson, AC (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA.	ericssona@missouri.edu; reineroc@missouri.edu	Ericsson, Aaron C./AAJ-1406-2021; Graham, Amber/GVS-1651-2022	Ericsson, Aaron C./0000-0002-3053-7269; Vientos-Plotts, Aida/0000-0002-8146-0580	NIH HHS [K01 OD019924] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019924] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Amar J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054461; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Charlson ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042786; Dickson R. R, 2016, GUT; Dickson RP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004923; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; Dye JA, 1996, J VET INTERN MED, V10, P385, DOI 10.1111/j.1939-1676.1996.tb02086.x; Einarsson GG, 2016, THORAX, V71, P795, DOI 10.1136/thoraxjnl-2015-207235; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Ericsson AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154646; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hogan DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149998; Huang YJ, 2017, TRANSL RES, V179, P71, DOI 10.1016/j.trsl.2016.06.007; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V136, P874, DOI 10.1016/j.jaci.2015.05.044; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Kennedy PJ, 2014, WORLD J GASTROENTERO, V20, P14105, DOI 10.3748/wjg.v20.i39.14105; Lelouvier B, 2016, HEPATOLOGY, V64, P2015, DOI 10.1002/hep.28829; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; Lohmann P, 2014, PEDIATR RES, V76, P294, DOI 10.1038/pr.2014.85; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Marsland BJ, 2014, NAT REV IMMUNOL, V14, P827, DOI 10.1038/nri3769; Martin R, 2014, VIRULENCE, V5, P413, DOI 10.4161/viru.27864; Martin R, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-71; MCCARTHY GM, 1991, AM J VET RES, V52, P254; Mentula S, 2005, APPL ENVIRON MICROB, V71, P4169, DOI 10.1128/AEM.71.8.4169-4175.2005; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Nikkari S, 2001, J CLIN MICROBIOL, V39, P1956, DOI 10.1128/JCM.39.5.1956-1959.2001; PADRID PA, 1991, AM J VET RES, V52, P1300; Paisse S, 2016, TRANSFUSION, V56, P1138, DOI 10.1111/trf.13477; Park H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109710; Petersen C, 2014, CELL MICROBIOL, V16, P1024, DOI 10.1111/cmi.12308; Potgieter M, 2015, FEMS MICROBIOL REV, V39, P567, DOI 10.1093/femsre/fuv013; Reinero CR, 2009, ENVIRON RES, V109, P634, DOI 10.1016/j.envres.2009.02.001; Reinero CRN, 2004, INT ARCH ALLERGY IMM, V135, P117, DOI 10.1159/000080654; Ritchie LE, 2008, FEMS MICROBIOL ECOL, V66, P590, DOI 10.1111/j.1574-6941.2008.00609.x; Ritchie LE, 2010, VET MICROBIOL, V144, P140, DOI 10.1016/j.vetmic.2009.12.045; Smits HH, 2016, J ALLERGY CLIN IMMUN, V137, P690, DOI 10.1016/j.jaci.2016.01.004; Wang H, 2013, WORLD J GASTROENTERO, V19, P6794, DOI 10.3748/wjg.v19.i40.6794; Wang Y, 2014, BRAIN BEHAV IMMUN, V38, P1, DOI 10.1016/j.bbi.2013.12.015; Warner BB, 2015, NEONATOLOGY, V107, P337, DOI 10.1159/000381124; Williams K, 2016, J PATHOL, V238, P220, DOI 10.1002/path.4658; Willner D, 2012, ISME J, V6, P471, DOI 10.1038/ismej.2011.104; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Yun YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113466	51	35	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173818	10.1371/journal.pone.0173818	http://dx.doi.org/10.1371/journal.pone.0173818			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278278	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900037
J	Herrington, WG; Smith, M; Bankhead, C; Matsushita, K; Stevens, S; Holt, T; Hobbs, FDR; Coresh, J; Woodward, M				Herrington, William G.; Smith, Margaret; Bankhead, Clare; Matsushita, Kunihiro; Stevens, Sarah; Holt, Tim; Hobbs, F. D. Richard; Coresh, Josef; Woodward, Mark			Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England	PLOS ONE			English	Article							OBESITY-RELATED GLOMERULOPATHY; STAGE RENAL-DISEASE; LIFE-STYLE; BLOOD-PRESSURE; HYPERFILTRATION; ASSOCIATIONS; POPULATION; MORTALITY; EVENTS; COST	Background It is uncertain whether being overweight, but not obese, is associated with advanced chronic kidney disease (CKD) and how the size and shape of associations between body-mass index (BMI) and advanced CKD differs among different types of people. Methods We used Clinical Practice Research Datalink records (2000-2014) with linkage to English secondary care and mortality data to identify a prospective cohort with at least one BMI measure. Cox models adjusted for age, sex, smoking and social deprivation and subgroup analyses by diabetes, hypertension and prior cardiovascular disease assessed relationships between BMI and CKD stages 4-5 and end-stage renal disease (ESRD). Findings 1,405,016 adults aged 20-79 with mean BMI 27.4kg/m(2) (SD 5.6) were followed for 7.5 years. Compared to a BMI of 20 to <25kg/m(2), higher BMI was associated with a progressively increased risk of CKD stages 4-5 (hazard ratio 1.34, 95% CI 1.30-1.38 for BMI 25 to <30kg/m(2); 1.94, 1.87-2.01 for BMI 30 to <35kg/m(2); and 3.10, 2.95-3.25 for BMI >= 35kg/m(2)). The association between BMI and ESRD was shallower and reversed at low BMI. Current smoking, prior diabetes, hypertension or cardiovascular disease all increased risk of CKD, but the relative strength and shape of BMI-CKD associations, which were generally log-linear above a BMI of 25kg/m(2), were similar among those with and without these risk factors. There was direct evidence that being overweight was associated with increased risk of CKD stages 4-5 in these subgroups. Assuming causality, since 2000 an estimated 39% (36-42%) of advanced CKD in women and 26% (22-30%) in men aged 40-79 resulted from being overweight or obese. Conclusions This study provides direct evidence that being overweight increases risk of advanced CKD, that being obese substantially increases such risk, and that this remains true for those with and without diabetes, hypertension or cardiovascular disease. Strategies to reduce weight among those who are overweight, as well as those who are obese may reduce CKD risk, with each unit reduction in BMI yielding similar relative reductions in risk.	[Herrington, William G.] Univ Oxford, Nuffield Dept Populat Hlth NDPH, Oxford, England; [Herrington, William G.] Oxford Univ Hosp NHS Fdn Trust, Churchill Hosp, Oxford Kidney Unit, Oxford, England; [Smith, Margaret; Bankhead, Clare; Stevens, Sarah; Holt, Tim; Hobbs, F. D. Richard] Univ Oxford, Nuffield Dept Primary Care Hlth Sci NDPCHS, Oxford, England; [Matsushita, Kunihiro; Coresh, Josef; Woodward, Mark] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Woodward, Mark] Univ Oxford, George Inst Global Hlth, Oxford, England; [Woodward, Mark] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; Johns Hopkins University; University of Oxford; George Institute for Global Health; University of Sydney	Bankhead, C (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth NDPH, Oxford, England.	will.herrington@ndph.ox.ac.uk; clare.bankhead@phc.ox.ac.uk	Matsushita, Kunihiro/AAJ-5817-2020; Woodward, Mark/L-6817-2017; Matsushita, Kunihiro/B-1021-2018	Matsushita, Kunihiro/0000-0002-7179-718X; Matsushita, Kunihiro/0000-0002-7179-718X; Smith, Margaret/0000-0002-0946-742X; Woodward, Mark/0000-0001-9800-5296; Lay-Flurrie, Sarah/0000-0003-1094-8455	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme; NIHR; School for Primary Care Research; NIHR Collaboration for Leadership and Applied Health Research Care Oxford; Oxford Biomedical Research Centre; UK Medical Research Council (MRC) [A310]; British Heart Foundation; Cancer Research UK; Australian National Health and Medical Research Council [APP1080206, APP1052555]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100446] Funding Source: NIH RePORTER	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); School for Primary Care Research; NIHR Collaboration for Leadership and Applied Health Research Care Oxford; Oxford Biomedical Research Centre; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in decision to submit the manuscript for publication. This paper summarises independent research funded by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. FDRH at NDPCHS is supported by the NIHR, School for Primary Care Research, the NIHR Collaboration for Leadership and Applied Health Research & Care Oxford, and Oxford Biomedical Research Centre. WH at NDPH is supported by core funding from the UK Medical Research Council (MRC: reference A310), British Heart Foundation and Cancer Research UK. MW is supported by an Australian National Health and Medical Research Council Primary Fellowship (APP1080206) and program grant (APP1052555). NDPCHS met the CPRD access and data management costs.	Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704; Belhatem N, 2015, DIABETES RES CLIN PR, V108, P143, DOI 10.1016/j.diabres.2015.01.028; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Bhaskaran K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003389; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chagnac A, 2000, AM J PHYSIOL-RENAL, V278, pF817, DOI 10.1152/ajprenal.2000.278.5.F817; Chen HM, 2008, AM J KIDNEY DIS, V52, P58, DOI 10.1053/j.ajkd.2008.02.303; Chen HM, 2006, AM J KIDNEY DIS, V48, P772, DOI 10.1053/j.ajkd.2006.07.025; D'Agati VD, 2016, NAT REV NEPHROL, V12, P453, DOI 10.1038/nrneph.2016.75; Department for Communities and Local Government, 2015, ENGL IND DEPR 2015; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Fall T, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001474; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Foster MC, 2011, HYPERTENSION, V58, P784, DOI 10.1161/HYPERTENSIONAHA.111.175315; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goumenos DS, 2009, NEPHROL DIAL TRANSPL, V24, P3732, DOI 10.1093/ndt/gfp329; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880; HM Treasury, 2016, BUDGET 2016 SOME OF; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holmes MV, 2014, AM J HUM GENET, V94, P198, DOI 10.1016/j.ajhg.2013.12.014; Honeycutt AA, 2013, J AM SOC NEPHROL, V24, P1478, DOI 10.1681/ASN.2012040392; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kerr M, 2012, NEPHROL DIAL TRANSPL, V27, P73, DOI 10.1093/ndt/gfs269; Knowler WC, 2014, LANCET DIABETES ENDO, V2, P801, DOI 10.1016/S2213-8587(14)70156-1; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lemoine S, 2014, CLIN J AM SOC NEPHRO, V9, P720, DOI 10.2215/CJN.03610413; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lewko B, 2009, J CELL PHYSIOL, V221, P288, DOI 10.1002/jcp.21856; Lu JL, 2015, LANCET DIABETES ENDO, V3, P704, DOI 10.1016/S2213-8587(15)00128-X; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mascali A, 2016, INT J IMMUNOPATH PH, V29, P354, DOI 10.1177/0394632016643550; Melsom T, 2016, AM J KIDNEY DIS, V67, P841, DOI 10.1053/j.ajkd.2015.10.025; Montani JP, 2004, INT J OBESITY, V28, pS58, DOI 10.1038/sj.ijo.0802858; Moody A., HLTH SURVEY ENGLAND, V1; National Institute of Clinical Excellence, 2014, CHRON KIDN DIS EARL; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Office of National Statistics, 2011, 2011 CENS POP EST UK; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Quinn MP, 2008, NEPHROL DIAL TRANSPL, V23, P542, DOI 10.1093/ndt/gfm599; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Ruggenenti P, 2012, DIABETES CARE, V35, P2061, DOI 10.2337/dc11-2189; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Smith DH, 2004, J AM SOC NEPHROL, V15, P1300, DOI 10.1097/01.ASN.0000125670.64996.BB; Stengel B, 2003, EPIDEMIOLOGY, V14, P479, DOI 10.1097/01.EDE.0000071413.55296.c4; Stevens PE, 2007, KIDNEY INT, V72, P92, DOI 10.1038/sj.ki.5002273; Tsuboi N, 2013, NEPHROL DIAL TRANSPL, V28, P108, DOI 10.1093/ndt/gft258; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vivante A, 2012, ARCH INTERN MED, V172, P1644, DOI 10.1001/2013.jamainternmed.85; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	59	49	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173515	10.1371/journal.pone.0173515	http://dx.doi.org/10.1371/journal.pone.0173515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273171	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700011
J	Rodriguez-Arboli, E; Mwamelo, K; Kalinjuma, AV; Furrer, H; Hatz, C; Tanner, M; Battegay, M; Letang, E				Rodriguez-Arboli, Eduardo; Mwamelo, Kim; Kalinjuma, Aneth Vedastus; Furrer, Hansjakob; Hatz, Christoph; Tanner, Marcel; Battegay, Manuel; Letang, Emilio		KIULARCO Study Grp	Incidence and risk factors for hypertension among HIV patients in rural Tanzania - A prospective cohort study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SUB-SAHARAN AFRICA; BLOOD-PRESSURE; INFECTED PATIENTS; CARDIOVASCULAR-DISEASE; LIFE EXPECTANCY; PREVALENCE; ASSOCIATION; POPULATION; PREDICTORS	Introduction Scarce data are available on the epidemiology of hypertension among HIV patients in rural sub-Saharan Africa. We explored the prevalence, incidence and risk factors for incident hypertension among patients who were enrolled in a rural HIV cohort in Tanzania. Methods Prospective longitudinal study including HIV patients enrolled in the Kilombero and Ulanga Antiretroviral Cohort between 2013 and 2015. Non-ART na ve subjects at baseline and pregnant women during follow-up were excluded from the analysis. Incident hypertension was defined as systolic blood pressure >= 140 mmHg and/or diastolic blood pressure >= 90 mmHg on two consecutive visits. Cox proportional hazards models were used to assess the association of baseline characteristics and incident hypertension. Results Among 955 ART-na ve, eligible subjects, 111 (11.6%) were hypertensive at recruitment. Ten women were excluded due to pregnancy. The remaining 834 individuals contributed 7967 person-months to follow-up (median 231 days, IQR 119-421) and 80 (9.6%) of them developed hypertension during a median follow-up of 144 days from time of enrolment into the cohort [incidence rate 120.0 cases/1000 person-years, 95% confidence interval (CI) 97.2-150.0]. ART was started in 630 (75.5%) patients, with a median follow-up on ART of 7 months (IQR 4-14). Cox regression models identified age [adjusted hazard ratio (aHR) 1.34 per 10 years increase, 95% CI 1.07-1.68, p = 0.010], body mass index (aHR per 5 kg/m(2) 1.45, 95% CI 1.07-1.99, p = 0.018) and estimated glomerular filtration rate (aHR < 60 versus >= 60 ml/min/1.73 m(2) 3.79, 95% CI 1.60-8.99, p = 0.003) as independent risk factors for hypertension development. Conclusions The prevalence and incidence of hypertension were high in our cohort. Traditional cardiovascular risk factors predicted incident hypertension, but no association was observed with immunological or ART status. These data support the implementation of routine hypertension screening and integrated management into HIV programmes in rural sub-Saharan Africa.	[Rodriguez-Arboli, Eduardo] Virgen del Rocio Univ Hosp, Seville, Spain; [Mwamelo, Kim; Kalinjuma, Aneth Vedastus; Letang, Emilio] Ifakara Hlth Inst, Ifakara, Tanzania; [Furrer, Hansjakob] Univ Hosp Bern, Dept Infect Dis, Bern, Switzerland; [Furrer, Hansjakob] Univ Bern, Bern, Switzerland; [Hatz, Christoph; Tanner, Marcel; Letang, Emilio] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Hatz, Christoph; Tanner, Marcel; Battegay, Manuel; Letang, Emilio] Univ Basel, Basel, Switzerland; [Battegay, Manuel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland; [Letang, Emilio] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain	Virgen del Rocio University Hospital; Ifakara Health Institute; University of Bern; University Hospital of Bern; University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Basel; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona	Letang, E (corresponding author), Ifakara Hlth Inst, Ifakara, Tanzania.; Letang, E (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Letang, E (corresponding author), Univ Basel, Basel, Switzerland.; Letang, E (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.	emili.letang@unibas.ch	Furrer, Hansjakob/G-6768-2013	Furrer, Hansjakob/0000-0002-1375-3146; Rodriguez-Arboli, Eduardo/0000-0002-2237-6733	Government of the Canton of Basel, Switzerland; Ministry of Health and Socia Welfare of Tanzania; USAID through its local implementer TUNAJALI-Deloitte; Ifakara Health Institute; Swiss Tropical and Public Health Institute	Government of the Canton of Basel, Switzerland; Ministry of Health and Socia Welfare of Tanzania; USAID through its local implementer TUNAJALI-Deloitte(United States Agency for International Development (USAID)); Ifakara Health Institute; Swiss Tropical and Public Health Institute	The KIULARCO cohort receives funding from the Government of the Canton of Basel, Switzerland, the Ministry of Health and Socia Welfare of Tanzania, USAID through its local implementer TUNAJALI-Deloitte, The Ifakara Health Institute, and the Swiss Tropical and Public Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for this work.	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394; Barnighausen T, 2008, J HUM HYPERTENS, V22, P236, DOI 10.1038/sj.jhh.1002308; Bergersen BM, 2003, EUR J CLIN MICROBIOL, V22, P731, DOI 10.1007/s10096-003-1034-z; Bloomfield GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022288; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Crane HM, 2006, AIDS, V20, P1019, DOI 10.1097/01.aids.0000222074.45372.00; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Dillon DG, 2013, INT J EPIDEMIOL, V42, P1754, DOI 10.1093/ije/dyt198; Haraka F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129185; Hatleberg CI, 2015, C RETR OPP INF CROI; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Jerico C, 2005, AM J HYPERTENS, V18, P1396, DOI 10.1016/j.amjhyper.2005.05.016; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Joint United Nations Programme on HIV/AIDS, 2015, AIDS NUMB 2015; Letang E, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv046; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Mattana J, 1999, AM J MED SCI, V317, P232, DOI 10.1097/00000441-199904000-00004; McDonald CL, 2009, J AM COLL CARDIOL, V54, P1185, DOI 10.1016/j.jacc.2009.05.055; Medina-Torne Sheila, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P20, DOI 10.1177/1545109711418361; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Mulenga L, 2014, CLIN INFECT DIS, V58, P1473, DOI 10.1093/cid/ciu117; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Okello S, 2015, J HYPERTENS, V33, P2039, DOI 10.1097/HJH.0000000000000657; Palacios R, 2006, HIV MED, V7, P10, DOI 10.1111/j.1468-1293.2005.00333.x; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Peck RN, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0125-2; Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Sander LD, 2015, TROP MED INT HEALTH, V20, P391, DOI 10.1111/tmi.12443; Seaberg EC, 2005, AIDS, V19, P953, DOI 10.1097/01.aids.0000171410.76607.f8; Thiebaut R, 2005, ANTIVIR THER, V10, P811; World Health Organization, 2000, WHO TECHN REP SER, V894; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082	40	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172089	10.1371/journal.pone.0172089	http://dx.doi.org/10.1371/journal.pone.0172089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273105	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700067
J	Farmer, NA; Heyman, WD; Karnauskas, M; Kobara, S; Smart, TI; Ballenger, JC; Reichert, MJM; Wyanski, DM; Tishler, MS; Lindeman, KC; Lowerre-Barbieri, SK; Switzer, TS; Solomon, JJ; McCain, K; Marhefka, M; Sedberry, GR				Farmer, Nicholas A.; Heyman, William D.; Karnauskas, Mandy; Kobara, Shinichi; Smart, Tracey I.; Ballenger, Joseph C.; Reichert, Marcel J. M.; Wyanski, David M.; Tishler, Michelle S.; Lindeman, Kenyon C.; Lowerre-Barbieri, Susan K.; Switzer, Theodore S.; Solomon, Justin J.; McCain, Kyle; Marhefka, Mark; Sedberry, George R.			Timing and locations of reef fish spawning off the southeastern United States	PLOS ONE			English	Article							NASSAU GROUPER; SHELF-EDGE; EPINEPHELUS-STRIATUS; PISCES SERRANIDAE; AGGREGATION SITES; CAYMAN ISLANDS; CLIMATE-CHANGE; REGIME SHIFTS; SNOWY GROUPER; FLORIDA-KEYS	Managed reef fish in the Atlantic Ocean of the southeastern United States (SEUS) support a multi-billion dollar industry. There is a broad interest in locating and protecting spawning fish from harvest, to enhance productivity and reduce the potential for overfishing. We assessed spatiotemporal cues for spawning for six species from four reef fish families, using data on individual spawning condition collected by over three decades of regional fishery-independent reef fish surveys, combined with a series of predictors derived from bathymetric features. We quantified the size of spawning areas used by reef fish across many years and identified several multispecies spawning locations. We quantitatively identified cues for peak spawning and generated predictive maps for Gray Triggerfish (Balistes capriscus), White Grunt (Haemulon plumierii), Red Snapper (Lutjanus campechanus), Vermilion Snapper (Rhomboplites aurorubens), Black Sea Bass (Centropristis striata), and Scamp (Mycteroperca phenax). For example, Red Snapper peak spawning was predicted in 24.7-29.0 degrees C water prior to the new moon at locations with high curvature in the 24-30 m depth range off northeast Florida during June and July. External validation using scientific and fisherydependent data collections strongly supported the predictive utility of our models. We identified locations where reconfiguration or expansion of existing marine protected areas would protect spawning reef fish. We recommend increased sampling off southern Florida (south of 27 degrees N), during winter months, and in high-relief, high current habitats to improve our understanding of timing and location of reef fish spawning off the southeastern United States.	[Farmer, Nicholas A.] NOAA, Natl Marine Fisheries Serv, Southeast Reg Off, St Petersburg, FL 33701 USA; [Heyman, William D.; McCain, Kyle] LGL Ecol Res Associates Inc, Bryan, TX USA; [Karnauskas, Mandy] NOAA, Natl Marine Fisheries Serv, Southeast Fishery Sci Ctr, Miami, FL USA; [Kobara, Shinichi] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Smart, Tracey I.; Ballenger, Joseph C.; Reichert, Marcel J. M.; Wyanski, David M.] Marine Resources Res Inst, South Carolina Dept Nat Resources, Charleston, SC 29412 USA; [Tishler, Michelle S.] Meadows Ecol Inc, Indialantic, FL USA; [Lindeman, Kenyon C.] Florida Inst Technol, Melbourne, FL 32901 USA; [Lowerre-Barbieri, Susan K.; Switzer, Theodore S.] Florida Fish & Wildlife Conservat Commiss, Florida Fish & Wildlife Res Inst, St Petersburg, FL USA; [Solomon, Justin J.] Florida Fish & Wildlife Conservat Commiss, Florida Fish & Wildlife Res Inst, Jacksonville Field Lab, Jacksonville, FL USA; [Marhefka, Mark] Abundant Seafood, Charleston, SC USA; [Sedberry, George R.] NOAA, Off Natl Marine Sanctuaries, Savannah, GA USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Texas A&M University System; Texas A&M University College Station; Florida Institute of Technology; Florida Fish & Wildlife Conservation Commission; Florida Fish & Wildlife Conservation Commission; National Oceanic Atmospheric Admin (NOAA) - USA	Farmer, NA (corresponding author), NOAA, Natl Marine Fisheries Serv, Southeast Reg Off, St Petersburg, FL 33701 USA.	nick.farmer@noaa.gov	Ballenger, Joseph/O-7078-2018; Kobara, Shinichi/J-1988-2012	Kobara, Shinichi/0000-0003-2125-3982; Wyanski, David/0000-0003-3495-7479; Tishler, Michelle/0000-0002-9234-7495; Karnauskas, Mandy/0000-0002-6631-0592; Ballenger, Joseph/0000-0003-4785-4698				AguilarPerera A, 1996, ENVIRON BIOL FISH, V45, P351, DOI 10.1007/BF00002527; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ault JS, 2006, B MAR SCI, V78, P633; Beyer HL, 2011, GEOSPATIAL MODELLING; Brooke S, 2005, OCULINA BANKS RESTOR, P607; Brown-Peterson NJ, 2011, MAR COAST FISH, V3, P52, DOI 10.1080/19425120.2011.555724; Burton ML, 2005, FISH B-NOAA, V103, P404; Carter J., 1999, Proceedings of the Gulf and Caribbean Fisheries Institute, V45, P631; CARTER J, 1994, B MAR SCI, V55, P228; Carter Jacque, 1994, Proceedings of the Gulf and Caribbean Fisheries Institute, V43, P65; Choat JH, 2012, FISH FISH SER, V35, P85, DOI 10.1007/978-94-007-1980-4_4; Claro Rodolfo, 2003, Gulf and Caribbean Research, V14, P91; Claydon JAB, 2014, J FISH BIOL, V2014, P1; Coleman FC, 1996, ENVIRON BIOL FISH, V47, P129, DOI 10.1007/BF00005035; Coleman FC, 2011, PROF GEOGR, V63, P456, DOI 10.1080/00330124.2011.585076; COLIN PL, 1991, ENVIRON BIOL FISH, V31, P229, DOI 10.1007/BF00000690; COLIN PL, 1988, B MAR SCI, V43, P249; Colin PL, 2003, MANUAL STUDY CONSERV; Cowie-Haskell BD, 2003, MAR TECHNOL SOC J, V37, P68, DOI 10.4031/002533203787537447; Craig A.K., 1966, GEOGRAPHY FISHING BR; Cuellar N, 1996, REPROD SEASONALITY M; De Mitcheson YS, 2008, CONSERV BIOL, V22, P1233, DOI 10.1111/j.1523-1739.2008.01020.x; de Mitcheson YS, 2016, BIOSCIENCE, V66, P295, DOI 10.1093/biosci/biw013; de Roos AM, 2006, P ROY SOC B-BIOL SCI, V273, P1873, DOI 10.1098/rspb.2006.3518; Domeier ML, 2012, FISH FISH SER, V35, P1, DOI 10.1007/978-94-007-1980-4_1; Domeier ML, 1997, B MAR SCI, V60, P698; Domeier ML, 1996, REPROD BIOL GRAY SNA, P189; Donaldson TJ, 2011, P GULF CARIB FISH I, V64, P227; Eklund AM, 2000, B MAR SCI, V66, P721; Erisman B, 2017, FISH FISH, V18, P128, DOI 10.1111/faf.12132; Fine JC, 1990, SEA FRONTIERS, V36, P42; Fine John C., 1992, Wildlife Conservation, V95, P68; FITZHUGH GR, 1993, FISH B-NOAA, V91, P244; FWC: Florida Fish and Wildlife Conservation Commission, 2001, SEAMAP BOTT MAPP PRO, P166; Garcia-Cagide Alida, 2001, P73; Gibson J, 2004, BELIZES EVOLVING SYS, P287; GILMORE RG, 1992, B MAR SCI, V51, P83; Gleason ACR, 2011, PROF GEOGR, V63, P443, DOI 10.1080/00330124.2011.585075; Gomez Gaspar Alfredo, 1993, Boletin del Instituto Oceanografico de Venezuela Universidad de Oriente, V32, P27; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harris PJ, 2002, B MAR SCI, V70, P113; Heyman W., 2004, SPAWNING AGGREGATION; Heyman W. D., 2014, ENHANCING STEWARDSHI, P73; HEYMAN WD, 2014, P GULF CARIBBEAN FIS, V66, P104; Heyman WD, 2016, COOPERATIVE RES MONI; Heyman WD, 2008, B MAR SCI, V83, P531; Heyman WD, 2012, ELSEV INSIGHT, P387, DOI 10.1016/B978-0-12-385140-6.00026-8; Heyman WD, 2011, PROF GEOGR, V63, P475, DOI 10.1080/00330124.2011.585078; Hilborn R, 2005, ARE SUSTAINABLE FISH, P247; Hood P.B., 1997, STUDY AGE STRUCTURE; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; HUNTER JR, 1986, FISH B-NOAA, V84, P895; Hunter JR, 1985, MEASUREMENT SPAWING, P79; Jeffrey CFG, 2012, INTEGRATED BIOGEOGRA; JOHANNES R E, 1978, Environmental Biology of Fishes, V3, P65, DOI 10.1007/BF00006309; Karnauskas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022067; Kobara S, 2013, OCEANOGR MAR BIOL, V51, P281; Kobara S, 2010, MAR ECOL PROG SER, V405, P243, DOI 10.3354/meps08512; Kobara S, 2008, MAR GEOD, V31, P231, DOI 10.1080/01490410802466397; Koenig CC, 2000, B MAR SCI, V66, P593; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Lecours V, 2015, MAR ECOL PROG SER, V535, P259, DOI 10.3354/meps11378; Lee T, 1985, SHELF CIRCULATION CA, P33; LGL Ecological Research Associates Inc, 2015, COOP PRED VER MULT S; Lindeman KC, 2000, B MAR SCI, V66, P929; LOBEL PS, 1980, ENVIRON BIOL FISH, V5, P251, DOI 10.1007/BF00005359; Lobel PS., 1978, ECOL MONOGR, V17, P349; Locascio JV, 2016, FISH B-NOAA, V114, P103, DOI 10.7755/FB.114.1.9; Lowerre-Barbieri S, 2016, FISH FISHERIES; Lowerre-Barbieri S, 2015, MAR ECOL PROG SER, V526, P125, DOI 10.3354/meps11212; Lowerre-Barbieri SK, 2011, MAR COAST FISH, V3, P71, DOI 10.1080/19425120.2011.556932; Lowerre-Barbieri SK, 2009, MAR ECOL PROG SER, V394, P231, DOI 10.3354/meps08262; MacKichan CA, 2007, REPROD BEHAV GRAY TR, P231; MATHESON RH, 1984, T AM FISH SOC, V113, P607, DOI 10.1577/1548-8659(1984)113<607:GMAYMF>2.0.CO;2; McGovern JC, 2005, B MAR SCI, V76, P47; McGovern JC, 2002, N AM J FISH MANAGE, V22, P1151, DOI 10.1577/1548-8675(2002)022<1151:TASDIL>2.0.CO;2; Meynard CN, 2007, J BIOGEOGR, V34, P1455, DOI 10.1111/j.1365-2699.2007.01720.x; MUNRO JL, 1973, J FISH BIOL, V5, P69, DOI 10.1111/j.1095-8649.1973.tb04431.x; [National Oceanic and Atmospheric Administration NOAA Fisheries Service], 2013, NMFSFSPO137 NOAA US; Padgett SM, 1997, AGE GROWTH REPROD BI; Palazon-Fernandez JL, 2007, SCI MAR, V71, P429, DOI 10.3989/scimar.2007.71n3429; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; SADOVY Y, 1994, P GULF CARIB FISH I, V43, P43; Sadovy Y., 1999, SYNOPSIS BIOL DATA N, P68; SAFMC: South Atlantic Fishery Management Council MPA Expert Workgroup, 2013, REP 2 MPA EXP WORKGR; Sala E, 2001, FISHERIES, V26, P23, DOI 10.1577/1548-8446(2001)026<0023:RDONGS>2.0.CO;2; Schobernd CM, 2009, B MAR SCI, V84, P67; SEDAR, 2013, SE DAT ASS REV SEDAR, P139; SEDAR (Southeast Data Assessment and Review), 2010, SEDAR 8 UPDATE ASSES; SEDBERRY GR, 2004, CHARACTERIZATION DEE; Sedberry GR, 2006, SPAWNING LOCATIONS A, P463; Silvano RAM, 2006, ENVIRON BIOL FISH, V76, P371, DOI 10.1007/s10641-006-9043-2; Simmons CM, 2012, B MAR SCI, V88, P197, DOI 10.5343/bms.2011.1012; Stallings CD, 2016, B MAR SCI, V92, P545, DOI 10.5343/bms.2016.1971; Tishler-Meadows MS, 2012, SPAWNING INDICATORS; Van Sant SB, 1994, PRELIMINARY EVIDENCE, P7; Vert-pre KA, 2013, P NATL ACAD SCI USA, V110, P1779, DOI 10.1073/pnas.1214879110; Wenner CA, 1986, CONTRIBUTIONS LIFE H; Whaylen L, 2004, ENVIRON BIOL FISH, V70, P305, DOI 10.1023/B:EBFI.0000033341.57920.a8; White DB, 2004, B MAR SCI, V75, P335; Wright D.J., 2012, ARCGIS BENTHIC TERRA; Wyanski DM, 2000, FISH B-NOAA, V98, P199; Zhao BX, 1997, T AM FISH SOC, V126, P181, DOI 10.1577/1548-8659(1997)126<0181:AGATCI>2.3.CO;2	106	25	28	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172968	10.1371/journal.pone.0172968	http://dx.doi.org/10.1371/journal.pone.0172968			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264006	Green Submitted, Green Published, gold			2022-12-27	WOS:000396054300029
J	Jing, Z; Kang, L				Jing, Zheng; Kang, Ling			High-order scheme for the source-sink term in a one-dimensional water temperature model	PLOS ONE			English	Article							METEOROLOGICAL CONDITIONS; THERMAL STRATIFICATION; SIMULATION; LAKE; TRANSPORT; CLIMATE	The source-sink term in water temperature models represents the net heat absorbed or released by a water system. This term is very important because it accounts for solar radiation that can significantly affect water temperature, especially in lakes. However, existing numerical methods for discretizing the source-sink term are very simplistic, causing significant deviations between simulation results and measured data. To address this problem, we present a numerical method specific to the source-sink term. A vertical one-dimensional heat conduction equation was chosen to describe water temperature changes. A two-step operator-splitting method was adopted as the numerical solution. In the first step, using the undetermined coefficient method, a high-order scheme was adopted for discretizing the source-sink term. In the second step, the diffusion term was discretized using the Crank-Nicolson scheme. The effectiveness and capability of the numerical method was assessed by performing numerical tests. Then, the proposed numerical method was applied to a simulation of Guozheng Lake (located in central China). The modeling results were in an excellent agreement with measured data.	[Jing, Zheng; Kang, Ling] Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan, Peoples R China	Huazhong University of Science & Technology	Kang, L (corresponding author), Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan, Peoples R China.	kling@hust.edu.cn			Hubei Support Plan of Science and Technology of China [2015BCA291]; National Key Research and Development Program of China [2016YFC0402204]	Hubei Support Plan of Science and Technology of China; National Key Research and Development Program of China	This study was partly supported by the Hubei Support Plan of Science and Technology of China (No. 2015BCA291) and the National Key Research and Development Program of China (Item Nos. 2016YFC0402204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan AKMQ, 1999, J HYDRAUL ENG-ASCE, V125, P912, DOI 10.1061/(ASCE)0733-9429(1999)125:9(912); Antonopoulos VZ, 2003, ECOL MODEL, V160, P39, DOI 10.1016/S0304-3800(02)00286-7; Blom JG, 2000, J COMPUT APPL MATH, V126, P381, DOI 10.1016/S0377-0427(99)00366-0; BOLTON D, 1980, MON WEATHER REV, V108, P1046, DOI 10.1175/1520-0493(1980)108<1046:TCOEPT>2.0.CO;2; Boxin J, 1980, J CENTRAL CHINA NORM, V3; Branco BF, 2007, THESIS; Carey CC, 2012, WATER RES, V46, P1394, DOI 10.1016/j.watres.2011.12.016; Cole T. M., 2006, EL061 US ARM ENG RES; Condie SA, 2001, J HYDRAUL ENG, V127, P286, DOI 10.1061/(ASCE)0733-9429(2001)127:4(286); DAKE JMK, 1969, WATER RESOUR RES, V5, P484, DOI 10.1029/WR005i002p00484; Danis PA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020833; EDINGER JE, 1968, WATER RESOUR RES, V4, P1137, DOI 10.1029/WR004i005p01137; Garcia-Navarro P, 2000, COMPUT FLUIDS, V29, P951, DOI 10.1016/S0045-7930(99)00038-9; GU R, 1990, COLD REG SCI TECHNOL, V18, P147, DOI 10.1016/0165-232X(90)90004-G; Hamrick JM, 1994, JMHSFWMD9401 CONS EN; Henderson-Sellers B, 1984, ENG LIMNOLOGY; HOLLY FM, 1977, J HYDR ENG DIV-ASCE, V103, P1259; HONDZO M, 1993, J HYDRAUL ENG, V119, P1251, DOI 10.1061/(ASCE)0733-9429(1993)119:11(1251); HONDZO M, 1991, J HYDRAUL ENG-ASCE, V117, P1352, DOI 10.1061/(ASCE)0733-9429(1991)117:10(1352); Ji Z.-G., 2008, HYDRODYNAMICS WATER; Kim KS, 1997, J HYDRAUL ENG-ASCE, V123, P30, DOI 10.1061/(ASCE)0733-9429(1997)123:1(30); KOMATSU T., 1985, J HYDROSCI HYDRAUL E, V3, P15; ROSATI A, 1988, J PHYS OCEANOGR, V18, P1601, DOI 10.1175/1520-0485(1988)018<1601:AGCMFU>2.0.CO;2; SINOKROT BA, 1993, WATER RESOUR RES, V29, P2299, DOI 10.1029/93WR00540; Siviglia A, 2009, J HYDRAUL ENG, V135, P651, DOI 10.1061/(ASCE)HY.1943-7900.0000054; STRANG G, 1968, SIAM J NUMER ANAL, V5, P506, DOI 10.1137/0705041; Thomann R.V., 1987, PRINCIPLES SURFACE W; Thomas LH, 1949, ELLIPTIC PROBLEMS LI, P1; Toro EF, 2007, J HYDRAUL RES, V45, P736, DOI 10.1080/00221686.2007.9521812; TSAY TK, 1992, J HYDRAUL ENG-ASCE, V118, P407, DOI 10.1061/(ASCE)0733-9429(1992)118:3(407); VALOCCHI AJ, 1992, WATER RESOUR RES, V28, P1471, DOI 10.1029/92WR00423; Xiaofeng Z, 2002, J HYDRODYNAMICS B, V14, P81	32	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173236	10.1371/journal.pone.0173236	http://dx.doi.org/10.1371/journal.pone.0173236			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264005	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300048
J	Morettini, M; Faelli, E; Perasso, L; Fioretti, S; Burattini, L; Ruggeri, P; Di Nardo, F				Morettini, Micaela; Faelli, Emanuela; Perasso, Luisa; Fioretti, Sandro; Burattini, Laura; Ruggeri, Piero; Di Nardo, Francesco			IVGTT-based simple assessment of glucose tolerance in the Zucker fatty rat: Validation against minimal models	PLOS ONE			English	Article							BETA-CELL FUNCTION; AGE-RELATED ANALYSIS; INSULIN SENSITIVITY; SURROGATE INDEXES; C-PEPTIDE; SECRETION; RESISTANCE; MICE; HUMANS; CLAMP	For the assessment of glucose tolerance from IVGTT data in Zucker rat, minimal model methodology is reliable but time-and money-consuming. This study aimed to validate for the first time in Zucker rat, simple surrogate indexes of insulin sensitivity and secretion against the glucose-minimal-model insulin sensitivity index (S-I) and against first-(Phi(1)) and second-phase (Phi(2)) beta-cell responsiveness indexes provided by C-peptide minimal model. Validation of the surrogate insulin sensitivity index (ISI) and of two sets of coupled insulin-based indexes for insulin secretion, differing from the cut-off point between phases (FPIR3-SPIR3, t = 3 min and FPIR5-SPIR5, t = 5 min), was carried out in a population of ten Zucker fatty rats (ZFR) and ten Zucker lean rats (ZLR). Considering the whole rat population (ZLR+ZFR), ISI showed a significant strong correlation with SI (Spearman's correlation coefficient, r = 0.88; P<0.001). Both FPIR3 and FPIR5 showed a significant (P<0.001) strong correlation with Phi(1) (r = 0.76 and r = 0.75, respectively). Both SPIR3 and SPIR5 showed a significant (P<0.001) strong correlation with Phi(2) (r = 0.85 and r = 0.83, respectively). ISI is able to detect (P<0.001) the well-recognized reduction in insulin sensitivity in ZFRs, compared to ZLRs. The insulin-based indexes of insulin secretion are able to detect in ZFRs (P<0.001) the compensatory increase of first-and second-phase secretion, associated to the insulin-resistant state. The ability of the surrogate indexes in describing glucose tolerance in the ZFRs was confirmed by the Disposition Index analysis. The model-based validation performed in the present study supports the utilization of low-cost, insulin-based indexes for the assessment of glucose tolerance in Zucker rat, reliable animal model of human metabolic syndrome.	[Morettini, Micaela; Fioretti, Sandro; Burattini, Laura; Di Nardo, Francesco] Univ Politecn Marche, Dept Informat Engn, Ancona, Italy; [Faelli, Emanuela; Perasso, Luisa; Ruggeri, Piero] Univ Genoa, Dept Expt Med, Genoa, Italy	Marche Polytechnic University; University of Genoa	Di Nardo, F (corresponding author), Univ Politecn Marche, Dept Informat Engn, Ancona, Italy.	f.dinardo@univpm.it	Morettini, Micaela/K-3097-2018; Burattini, Laura/I-7962-2012; Di Nardo, Francesco/AAD-1680-2019; faelli, emanuela/AAF-3607-2021	Morettini, Micaela/0000-0002-8327-8379; Burattini, Laura/0000-0002-9474-7046; Di Nardo, Francesco/0000-0002-5362-3776; ruggeri, piero/0000-0001-5939-1489				Alonso LC, 2012, OBESITY, V20, P1403, DOI 10.1038/oby.2012.36; Barrett PHR, 1998, METABOLISM, V47, P484, DOI 10.1016/S0026-0495(98)90064-6; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; BERGMAN RN, 1989, DIABETES, V38, P1512, DOI 10.2337/diabetes.38.12.1512; BERGMAN RN, 1987, J CLIN INVEST, V79, P790, DOI 10.1172/JCI112886; BRAY GA, 1977, FED PROC, V36, P148; Burattini R, 2011, MED BIOL ENG COMPUT, V49, P831, DOI 10.1007/s11517-011-0760-0; Carson ER, 1983, THE MATHEMATICAL MOD; COBELLI C, 1988, DIABETES, V37, P223, DOI 10.2337/diabetes.37.2.223; Di Nardo F, 2016, IFMBE PROC, V57, P545, DOI 10.1007/978-3-319-32703-7_106; Di Nardo F, 2009, EXP PHYSIOL, V94, P162, DOI 10.1113/expphysiol.2008.044529; Di Nardo F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125252; Di Nardo F, 2013, COMPUT METH PROG BIO, V110, P215, DOI 10.1016/j.cmpb.2012.10.007; Di Nardo F, 2010, COMPUT METH PROG BIO, V97, P189, DOI 10.1016/j.cmpb.2009.08.007; Ferrannini E, 2004, DIABETOLOGIA, V47, P943, DOI 10.1007/s00125-004-1381-z; Filipsson K, 1998, AM J PHYSIOL-ENDOC M, V274, pE834, DOI 10.1152/ajpendo.1998.274.5.E834; Flecknell PA., 1987, LAB ANIMAL ANAESTHES, P156; GALVIN P, 1992, DIABETIC MED, V9, P921, DOI 10.1111/j.1464-5491.1992.tb01732.x; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Lee S, 2008, AM J PHYSIOL-ENDOC M, V294, pE261, DOI 10.1152/ajpendo.00676.2007; Morettini M, 2016, IFMBE PROC, V57, P549, DOI 10.1007/978-3-319-32703-7_107; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Muniyappa R, 2009, AM J PHYSIOL-ENDOC M, V297, pE1023, DOI 10.1152/ajpendo.00397.2009; Natalucci S, 2003, EXP PHYSIOL, V88, P399, DOI 10.1113/eph8802565; Natalucci S, 2000, EXP PHYSIOL, V85, P775; Pacini G, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/986906; Pacini G, 2009, AM J PHYSIOL-REG I, V296, pR1316, DOI 10.1152/ajpregu.90575.2008; Quddusi S, 2003, DIABETES CARE, V26, P791, DOI 10.2337/diacare.26.3.791; Ruggeri P, 1999, PFLUGERS ARCHIV, V438, pR15; Ruggeri P, 2006, AM J PHYSIOL-REG I, V291, pR376, DOI 10.1152/ajpregu.00644.2005; Tura A, 2010, DIABETOLOGIA, V53, P144, DOI 10.1007/s00125-009-1547-9; Tura A, 2006, DIABETES RES CLIN PR, V72, P298, DOI 10.1016/j.diabres.2005.10.005	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173200	10.1371/journal.pone.0173200	http://dx.doi.org/10.1371/journal.pone.0173200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264067	Green Published, gold, Green Submitted			2022-12-27	WOS:000396054300044
J	Ducrotoy, MJ; Revie, CW; Shaw, APM; Musa, UB; Bertu, WJ; Gusi, AM; Ocholi, RA; Majekodunmi, AO; Welburn, SC				Ducrotoy, Marie J.; Revie, Crawford W.; Shaw, Alexandra P. M.; Musa, Usman B.; Bertu, Wilson J.; Gusi, Amahyel M.; Ocholi, Reuben A.; Majekodunmi, Ayodele O.; Welburn, Susan C.			Wealth, household heterogeneity and livelihood diversification of Fulani pastoralists in the Kachia Grazing Reserve, northern Nigeria, during a period of social transition	PLOS ONE			English	Article							CATTLE; CULTIVATION; MIGRATION; MAASAI	Background A mixed methods study was undertaken in the Kachia Grazing Reserve of northern Nigeria. Surveys in March, June and October 2011 included focus group discussions, key informant and in-depth household interviews, concerning livelihood practices, animal health, ownership, and productivity. In May 2011, 249 Fulani families fleeing post-election violence entered the reserve with their livestock, increasing the number of households by one third. Results Despite being settled within a grazing reserve, over half of households sent all their cattle away on seasonal transhumance and another third sent some away. Cattle accounted for 96% of total tropical livestock units (TLU), of which 26% were cattle kept permanently outside the reserve. While all households cited livestock as their main source of income, 90% grew crops and 55% derived income from off-farm activities. A multiple correspondence analysis showed that for each extra member of a household its TLU value increased by 2.0 [95% CI, 1.4 - 2.7], while for each additional marriage its TLU increased by 15.7 [95% CI, 7.1 - 24.3]. A strong association was also observed between small herds, small households with only one wife, alongside marked geographical wealth differences within the reserve. New immigrant families had larger household sizes (33) and livestock holdings (122 TLU) than old settlers (22 people and 67 TLU). Prior to the mass immigration, the distribution of TLU per person was unimodal: 41% of households were classified as 'poor' and 27% as 'medium', whereas post-immigration it was bi-modal, with 26% classified as 'very poor' and 28% as 'medium'. Conclusions While cattle remain the principal source of Fulani income and wealth, the inhabitants of Kachia Grazing Reserve have diversified their livelihood strategies to respond to changing circumstances and stress, especially the limited availability of grazing within the reserve and political insecurity outside, resulting in continued transhumance, the maintenance of smaller livestock holdings and pushing households into poverty.	[Ducrotoy, Marie J.; Shaw, Alexandra P. M.; Majekodunmi, Ayodele O.; Welburn, Susan C.] Univ Edinburgh, Div Infect & Pathway Med, Edinburgh Med Sch Biomed Sci, Coll Med & Vet Med, Chancellors Bldg,49 Little France Crescent, Edinburgh, Midlothian, Scotland; [Revie, Crawford W.] Univ Prince Edward Isl, Dept Hlth Management, Atlantic Vet Coll, Ctr Vet & Epidemiol Res, 550 Univ Ave, Charlottetown, PE, Canada; [Shaw, Alexandra P. M.] Avia GIS, Risschotlei 33, Zoersel, Belgium; [Musa, Usman B.] Ungwan Rimi GRA, Nigerian Inst Trypanosomiasis Res, PMB, Kaduna, Nigeria; [Bertu, Wilson J.; Gusi, Amahyel M.; Ocholi, Reuben A.] Natl Inst Vet Res, Brucellosis Res Unit, PMB 01, Vom, Plateau State, Nigeria	University of Edinburgh; University of Prince Edward Island	Welburn, SC (corresponding author), Univ Edinburgh, Div Infect & Pathway Med, Edinburgh Med Sch Biomed Sci, Coll Med & Vet Med, Chancellors Bldg,49 Little France Crescent, Edinburgh, Midlothian, Scotland.	sue.welburn@ed.ac.uk	Majekodunmi, Ayodele/ABR-1323-2022; Revie, Crawford/B-5002-2011	Majekodunmi, Ayodele/0000-0003-4986-8284; Revie, Crawford/0000-0002-5018-0340; Gusi, Amahyel/0000-0002-0600-5270	UK's Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H009213/1]; European Union [221948]; BBSRC [BB/H009213/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H009213/1] Funding Source: researchfish	UK's Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the UK's Biotechnology and Biological Sciences Research Council (BBSRC) under the 'Combating Infectious Diseases in Livestock for International Development' (CIDLID) scheme, grant number BB/H009213/1 [SCW and AOM]. The work was also supported by the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement no 221948, ICONZ (Integrated control of Neglected Zoonoses) [MJD, SCW, RAO]. Neither funder had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriansen HK, 2006, AGR HUM VALUES, V23, P215, DOI 10.1007/s10460-005-6108-3; Adunga E, 2013, INT J SOC ECON, V40, P207, DOI 10.1108/03068291311291509; [Anonymous], 2014, R LANG ENV STAT COMP; Asad T, 1979, NOTES DISSOLUTION AN; Awogbade MO., 1983, FULANI PASTORALISM J; Azuwike O.D., 2010, P BERL C HUM DIM GLO; Bassett T., 1986, ANN AM ASSOC GEOGR, V78, P453; Bonfiglioli AM., 1993, AGROPASTORALISM CHAD; CHAMBERS R, 1994, WORLD DEV, V22, P953, DOI 10.1016/0305-750X(94)90141-4; Dahl G., 1976, HAVING HERDS PASTORA; Ducrotoy MJ, 2016, PASTORALISM, V6, DOI 10.1186/s13570-016-0072-y; Ducrotoy MJ., 2015, THESIS; Enwezor FNC, 2009, VET PARASITOL, V159, P121, DOI 10.1016/j.vetpar.2008.10.032; [FAOSTAT-Food and Agriculture Organisation of the United Nations Statistics Division FAO], 2016, PROD LIV AN NIG 2014; Fratkin E., 2005, PASTORALISTS SETTLE; Hampshire K, 2002, J DEV STUD, V38, P15, DOI 10.1080/00220380412331322491; Hampshire K, 2006, AFRICA, V76, P402, DOI 10.1353/afr.2006.0044; Hopen C. E., 1958, PASTORAL FULBE FAMIL; Iro IS., 1995, THESIS; JABBAR MA, 1995, TROP ANIM HEALTH PRO, V27, P55, DOI 10.1007/BF02236341; Konczacki Z., 1978, EC PASTORALISM CASE; Little P.D., 2003, SOMALIA EC STATE; Little PD., 1982, P 3 INT C GOAT PROD, P428; Little PD, 2008, DEV CHANGE, V39, P587, DOI 10.1111/j.1467-7660.2008.00497.x; MACE R, 1993, CURR ANTHROPOL, V34, P363, DOI 10.1086/204183; Majekodunmi AO, 2014, PASTORALISM, V4, DOI 10.1186/s13570-014-0020-7; Manger Leif, 2000, PASTORALISTS ENV EXP, P1; McCabe JT, 2010, HUM ECOL, V38, P322, DOI 10.1007/s10745-010-9312-8; McCabe JT, 2003, HUM ORGAN, V62, P100, DOI 10.17730/humo.62.2.4rwrt1n3xptg29b8; Otte M.J., 2002, CATTLE SMALL RUMINAN; Potkanski T., 1997, PASTORAL LAND TENURE, V6; RIM, 1992, URB REP COMM MAN LIV; RIM, 1988, CATTL CULT HUM SETTL, P36; Santirso C., 2015, THESIS; Sieff DF, 1999, AGR SYST, V59, P1, DOI 10.1016/S0308-521X(98)00078-X; Spencer P., 1965, ANTHR AFRICAN STUDIE, V26; Spencer P, 2005, FOCAAL, P46, DOI 10.3167/092012905780909261; Stenning Derrick J., 1959, SAVANNAH NOMADS STUD; Suleiman H., 1986, SEM 2 NAT LIV DEV PR; Suleiman H., 1988, POLICY ISSUES AGROPA; SUTTER JW, 1987, AFRICA, V57, P196, DOI 10.2307/1159821; Swift J.J., 1988, MAJOR ISSUES PASTORA; Tache B, 2010, WORLD DEV, V38, P1168, DOI 10.1016/j.worlddev.2010.01.001; Tewolde W, 2010, AFR GEOGR REV, V29, P21, DOI 10.1080/19376812.2010.9756224; van Raay HGI., 1975, RURAL PLANNING SAVAN; Waters-Bayer A, 1984, P 2 ILCA NAPRI S KAD	46	11	12	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172866	10.1371/journal.pone.0172866	http://dx.doi.org/10.1371/journal.pone.0172866			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257477	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000396021100033
J	Gao, YS; Jia, XX; Tang, XJ; Fan, YF; Lu, JX; Huang, SH; Tang, MJ				Gao, Yu-shi; Jia, Xiao-xu; Tang, Xiu-jun; Fan, Yan-feng; Lu, Jun-xian; Huang, Sheng-hai; Tang, Meng-jun			The genetic diversity of chicken breeds from Jiangxi, assessed with BCDO2 and the complete mitochondrial DNA D-loop region	PLOS ONE			English	Article							MATERNAL ORIGINS; DOMESTICATION; GENOMES	The Jiangxi Province of China has numerous native domestic chicken breeds, including some black skin breeds. The genetic diversity of Jiangxi native chickens is largely unknown, and specifically, the genetic contribution of the grey junglefowl to black skin chickens is not well understood. To address these questions, the complete D-loop region of the mitochondrial DNA (mtDNA) and beta-carotene dioxygenase 2(BCDO2) gene was sequenced in a total of 209 chickens representing seven Jiangxi native breeds. Thirty-one polymorphic sites were identified across the complete mtDNA D-loop region sequence. Twenty-three haplotypes were observed in the seven breeds, which belonged to four distinct mitochondrial clades (A, B, C and E). Clade A and B were dominant in the chickens with a frequency of approximately 67.9%. There were five SNPs that defined two haplotypes, Wand Y in BCDO2. Four breeds had one haplotype and three breeds had two. We conclude that Jiangxi native chicken breeds have relatively low genetic diversity and likely share four common maternal lineages from two different maternal ancestors of junglefowl. Furthermore, some Jiangxi chicken populations may have been mixed with chickens with exotic lineage. Further research should be established to protect these domestic chicken resources.	[Gao, Yu-shi; Jia, Xiao-xu; Tang, Xiu-jun; Fan, Yan-feng; Lu, Jun-xian; Huang, Sheng-hai; Tang, Meng-jun] Jiangsu Inst Poultry Sci, Yangzhou, Jiangsu, Peoples R China		Gao, YS; Jia, XX (corresponding author), Jiangsu Inst Poultry Sci, Yangzhou, Jiangsu, Peoples R China.	gaoys100@sina.com; 596374801@qq.com			National Natural Science Foundation of China [31372277, 31501917, 31672382]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The National Natural Science Foundation of China (31372277, 31501917 and 31672382). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by The National Natural Science Foundation of China (31372277, 31501917 and 31672382).	Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Berry SD, 2009, GENETICS, V182, P923, DOI 10.1534/genetics.109.101741; Chang CS, 2012, ANIM GENET, V43, P172, DOI 10.1111/j.1365-2052.2011.02226.x; Chen GH, 2008, ASIAN AUSTRAL J ANIM, V21, P331, DOI 10.5713/ajas.2008.70125; China National Commission of Anima Genetic Resources, 2012, AN GEN RES CHIN CHIC; Di Lorenzo P, 2015, WORLD POULTRY SCI J, V71, P311, DOI 10.1017/S0043933915000318; Eriksson J, 2008, PLOS GENET, V4, P78; FAO, 2015, COPING CLIMATE CHANG; Hogue MR, 2013, ASIAN AUSTRAL J ANIM, V26, P157, DOI 10.5713/ajas.2012.12459; Jia XX, 2016, MITOCHONDRIAL DNA A, V27, P3001, DOI 10.3109/19401736.2015.1060478; Kawabe K, 2014, ASIAN AUSTRAL J ANIM, V27, P19, DOI 10.5713/ajas.2013.13443; Lancioni H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073712; Li HF, 2011, POULTRY SCI, V90, P2705, DOI 10.3382/ps.2011-01425; Li HF, 2010, MOL PHYLOGENET EVOL, V57, P634, DOI 10.1016/j.ympev.2010.07.011; Liao YY, 2016, MOL BIOL REP, V43, P415, DOI 10.1007/s11033-016-3976-0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; Miao YW, 2013, HEREDITY, V110, P277, DOI 10.1038/hdy.2012.83; Miao YongWang, 2015, Journal of Yunnan Agricultural University, V30, P395; Muchadeyi FC, 2008, ANIM GENET, V39, P615, DOI 10.1111/j.1365-2052.2008.01785.x; Muira WM, 2008, P NATL ACAD SCI USA, V105, P17312, DOI 10.1073/pnas.0806569105; Oka T, 2007, ANIM GENET, V38, P287, DOI 10.1111/j.1365-2052.2007.01604.x; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sambrook J, 2001, MOL CLONING LAB 316; Shi NN, 2014, MOL ECOL, V23, P5393, DOI 10.1111/mec.12955; Smith DR, 2016, BRIEF FUNCT GENOMICS, V15, P47, DOI 10.1093/bfgp/elv027; Tadano R, 2007, POULTRY SCI, V86, P460, DOI 10.1093/ps/86.3.460; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ulfah M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2652-z; Vaarst M, 2015, WORLD POULTRY SCI J, V71, P609, DOI 10.1017/S0043933915002433; Vage DI, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-10; Wu GS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r245	34	20	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173192	10.1371/journal.pone.0173192	http://dx.doi.org/10.1371/journal.pone.0173192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257510	gold, Green Submitted, Green Published			2022-12-27	WOS:000396021100072
J	Haglund, S; Vikingsson, S; Almer, S; Soderman, J				Haglund, Sofie; Vikingsson, Svante; Almer, Sven; Soderman, Jan			Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells - Effects on gene expression levels and thiopurine metabolism	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LOW-DOSE AZATHIOPRINE; ACUTE LYMPHOBLASTIC-LEUKEMIA; HEPATOMA HEPARG CELLS; IN-VITRO; 6-THIOGUANINE NUCLEOTIDE; MITOCHONDRIAL INJURY; XANTHINE-OXIDASE; T-LYMPHOCYTES; BLOOD	Combination treatment with low-dose thiopurine and allopurinol (AP) has successfully been used in patients with inflammatory bowel disease with a so called skewed thiopurine metabolite profile. In red blood cells in vivo, it reduces the concentration of methylated metabolites and increases the concentration of the phosphorylated ones, which is associated with improved therapeutic efficacy. This study aimed to investigate the largely unknown mechanism of AP on thiopurine metabolism in cells with an active thiopurine metabolic pathway using HepG2 and HEK293 cells. Cells were treated with 6-mercaptopurine (6MP) and AP or its metabolite oxypurinol. The expression of genes known to be associated with thiopurine metabolism, and the concentration of thiopurine metabolites were analyzed. Gene expression levels were only affected by AP in the presence of 6MP. The addition of AP to 6MP affected the expression of in total 19 genes in the two cell lines. In both cell lines the expression of the transporter SLC29A2 was reduced by the combined treatment. Six regulated genes in HepG2 cells and 8 regulated genes in HEK293 cells were connected to networks with 18 and 35 genes, respectively, present at known susceptibility loci for inflammatory bowel disease, when analyzed using a protein-protein interaction database. The genes identified as regulated as well as the disease associated interacting genes represent new candidates for further investigation in the context of combination therapy with thiopurines and AP. However, no differences in absolute metabolite concentrations were observed between 6MP+AP or 6MP +oxypurinol vs. 6MP alone in either of the two cell lines. In conclusion; the effect of AP on=gene expression levels requires the presence of 6MP, at least in vitro. Previously described AP-effects on metabolite concentrations observed in red blood cells in vivo could not be reproduced in our cell lines in vitro. AP's effects in relation to thiopurine metabolism are complex. The network-identified susceptibility genes represented biological processes mainly associated with purine nucleotide biosynthetic processes, lymphocyte proliferation, NF-KB activation, JAK-STAT signaling, and apoptotic signaling at oxidative stress.	[Haglund, Sofie; Soderman, Jan] Reg Jonkoping Cty, Lab Med, Jonkoping, Sweden; [Haglund, Sofie; Almer, Sven] Karolinska Inst, Dept Med, Stockholm, Sweden; [Vikingsson, Svante] Linkoping Univ, Dept Med & Hlth Sci, Div Drug Res, Linkoping, Sweden; [Almer, Sven] Karolinska Univ Hosp, Ctr Digest Dis, Stockholm, Sweden; [Soderman, Jan] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Karolinska Institutet; Linkoping University; Karolinska Institutet; Karolinska University Hospital; Linkoping University	Haglund, S (corresponding author), Reg Jonkoping Cty, Lab Med, Jonkoping, Sweden.	sofie.haglund@rjl.se		Almer, Sven/0000-0001-9334-1821; Soderman, Jan/0000-0001-7505-7210	Futurum - the academy for health and care; Region Jonkoping County; Magtarm-fonden; Bengt-Ihre fonden; Karolinska Institutets forskningsfonder, Sweden	Futurum - the academy for health and care; Region Jonkoping County; Magtarm-fonden; Bengt-Ihre fonden; Karolinska Institutets forskningsfonder, Sweden	This study was performed with financial support from Futurum - the academy for health and care, Region Jonkoping County, Magtarm-fonden, Bengt-Ihre fonden, and Karolinska Institutets forskningsfonder, Sweden.	Aldinucci A, 2010, J NEUROIMMUNOL, V218, P28, DOI 10.1016/j.jneuroim.2009.11.001; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andersson TB, 2012, EXPERT OPIN DRUG MET, V8, P909, DOI 10.1517/17425255.2012.685159; Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759; Ansari A, 2008, ALIMENT PHARM THER, V28, P734, DOI 10.1111/j.1365-2036.2008.03782.x; Ansari A, 2010, ALIMENT PHARM THER, V31, P640, DOI 10.1111/j.1365-2036.2009.04221.x; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Appell ML, 2013, J CROHNS COLITIS, V7, P510, DOI 10.1016/j.crohns.2012.10.016; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergan S, 1997, THER DRUG MONIT, V19, P502, DOI 10.1097/00007691-199710000-00003; BOKKERINK JPM, 1993, BIOCHEM PHARMACOL, V45, P1455, DOI 10.1016/0006-2952(93)90045-X; Broekman MMTJ, 2015, CELL BIOL TOXICOL, V31, P161, DOI 10.1007/s10565-015-9301-1; Broekman MM, 2017, PHARMACOGENOMICS J; Burnstock G, 2014, PURINERG SIGNAL, V10, P51, DOI 10.1007/s11302-013-9398-8; Coulthard SA, 2002, MOL PHARMACOL, V62, P102, DOI 10.1124/mol.62.1.102; Day RO, 2007, CLIN PHARMACOKINET, V46, P623, DOI 10.2165/00003088-200746080-00001; De MIRANDA P, 1973, J Pharmacol Exp Ther, V187, P588; Duley JA, 2005, ALIMENT PHARM THERAP, V22, P1161, DOI 10.1111/j.1365-2036.2005.02703.x; Egmond Rv, 2011, GUT, V60, pA187; Eklund BI, 2006, MOL PHARMACOL, V70, P747, DOI 10.1124/mol.106.025288; ELION GB, 1972, P ROY SOC MED, V65, P257, DOI 10.1177/003591577206500315; ELION GB, 1967, FED PROC, V26, P898; Fotoohi AK, 2006, BIOCHEM BIOPH RES CO, V343, P208, DOI 10.1016/j.bbrc.2006.02.134; Glander P, 2001, CLIN BIOCHEM, V34, P543, DOI 10.1016/S0009-9120(01)00267-3; Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003; Guo L, 2011, DRUG METAB DISPOS, V39, P528, DOI 10.1124/dmd.110.035873; Haglund S, 2008, BRIT J CLIN PHARMACO, V65, P69, DOI 10.1111/j.1365-2125.2007.02985.x; Haglund S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056989; Haglund S, 2011, THER DRUG MONIT, V33, P200, DOI 10.1097/FTD.0b013e31820b42bb; Hart SN, 2010, DRUG METAB DISPOS, V38, P988, DOI 10.1124/dmd.109.031831; Hatano R, 2013, IMMUNOLOGY, V138, P165, DOI 10.1111/imm.12028; Hindorf U, 2006, GUT, V55, P1423, DOI 10.1136/gut.2005.074930; Hogarth LA, 2008, BIOCH PHARM; Jharap B, 2010, INFLAMM BOWEL DIS, V16, P1541, DOI 10.1002/ibd.21221; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Lancaster DL, 2002, CANCER CHEMOTH PHARM, V50, P33, DOI 10.1007/s00280-002-0442-6; Lee AU, 2001, J HEPATOL, V35, P756, DOI 10.1016/S0168-8278(01)00196-9; LENNARD L, 1992, J CHROMATOGR-BIOMED, V583, P83, DOI 10.1016/0378-4347(92)80347-S; LENNARD L, 1993, BRIT J CLIN PHARMACO, V36, P277, DOI 10.1111/j.1365-2125.1993.tb00365.x; LENNARD L, 1983, J PHARM PHARMACOL, V35, P15, DOI 10.1111/j.2042-7158.1983.tb04255.x; Leung Y, 2009, J CROHNS COLITIS, V3, P162, DOI 10.1016/j.crohns.2009.02.003; LILIEMARK J, 1990, CANCER RES, V50, P108; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Nelson D J, 1977, Adv Exp Med Biol, V76A, P121; PARKS DA, 1986, ACTA PHYSIOL SCAND, V126, P87; PARKS RE, 1975, ANN NY ACAD SCI, V255, P412, DOI 10.1111/j.1749-6632.1975.tb29249.x; PATERSON ARP, 1975, ANTINEOPLASTIC IMM 2, P384; Pelin M, 2016, CURR DRUG METAB, V17, P542, DOI 10.2174/1389200217666160303104153; Petit E, 2008, TOXICOL IN VITRO, V22, P632, DOI 10.1016/j.tiv.2007.12.004; Rowland K, 1999, XENOBIOTICA, V29, P615, DOI 10.1080/004982599238434; Saleh EM, 2013, ONCOL LETT, V5, P321, DOI 10.3892/ol.2012.965; Sparrow MP, 2007, CLIN GASTROENTEROL H, V5, P209, DOI 10.1016/j.cgh.2006.11.020; STET EH, 1993, BIOCHIM BIOPHYS ACTA, V1180, P277, DOI 10.1016/0925-4439(93)90050-B; Tapner MJ, 2004, J HEPATOL, V40, P454, DOI 10.1016/j.jhep.2003.11.024; Thomas CW, 2005, J PHARMACOL EXP THER, V312, P537, DOI 10.1124/jpet.104.074815; TIDD DM, 1974, CANCER RES, V34, P738; Tiede I, 2003, J CLIN INVEST, V111, P1133, DOI 10.1172/JCI200316432; Timmer A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000478.pub2; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; van Asseldonk DP, 2011, DIGEST LIVER DIS, V43, P270, DOI 10.1016/j.dld.2010.09.001; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wei FY, 2011, ENDOCR J, V58, P819, DOI 10.1507/endocrj.EJ11-0099; WEINSHILBOUM RM, 1978, CLIN CHIM ACTA, V85, P323, DOI 10.1016/0009-8981(78)90311-X; Wielinga PR, 2002, MOL PHARMACOL, V62, P1321, DOI 10.1124/mol.62.6.1321; Wong DR, 2007, THER DRUG MONIT, V29, P845, DOI 10.1097/FTD.0b013e31815bf4dc	66	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173825	10.1371/journal.pone.0173825	http://dx.doi.org/10.1371/journal.pone.0173825			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278299	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900038
J	Harrison, C; Henderson, J; Miller, G; Britt, H				Harrison, Christopher; Henderson, Joan; Miller, Graeme; Britt, Helena			The prevalence of diagnosed chronic conditions and multimorbidity in Australia: A method for estimating population prevalence from general practice patient encounter data	PLOS ONE			English	Article							ELECTRONIC HEALTH RECORD; PRIMARY-CARE	Objectives To estimate the prevalence of common chronic conditions and multimorbidity among patients at GP encounters and among people in the Australian population. To assess the extent to which use of each individual patient's GP attendance over the previous year, instead of the average for their age-sex group, affects the precision of national population prevalence estimates of diagnosed chronic conditions. Design, setting and participants A sub-study (between November 2012 and March 2016) of the Bettering the Evaluation and Care of Health program, a continuous national study of GP activity. Each of 1,449 GPs provided data for about 30 consecutive patients (total 43,501) indicating for each, number of GP attendances in previous year and all diagnosed chronic conditions, using their knowledge of the patient, patient self-report, and patient's health record. Results Hypertension (26.5%) was the most prevalent diagnosed chronic condition among patients surveyed, followed by osteoarthritis (22.7%), hyperlipidaemia (16.6%), depression (16.3%), anxiety (11.9%), gastroesophageal reflux disease (GORD) (11.3%), chronic back pain (9.7%) and Type 2 diabetes (9.6%). After adjustment, we estimated population prevalence of hypertension as 12.4%, 9.5% osteoarthritis, 8.2% hyperlipidaemia, 8.0% depression, 5.8% anxiety and 5.2% asthma. Estimates were significantly lower than those derived using the previous method. About half (51.6%) the patients at GP encounters had two or more diagnosed chronic conditions and over one third (37.4%) had three or more. Population estimates were: 25.7% had two or more diagnosed chronic conditions and 15.8% had three or more. Conclusions Of the three approaches we have tested to date, this study provides the most accurate method for estimation of population prevalence of chronic conditions using the GP as an expert interviewer, by adjusting for each patient's reported attendance.	[Harrison, Christopher] Univ Sydney, Sydney Sch Publ Hlth, Menzies Ctr Hlth Policy, Sydney, NSW, Australia; [Harrison, Christopher; Henderson, Joan; Miller, Graeme; Britt, Helena] Univ Sydney, Sydney Sch Publ Hlth, Family Med Res Ctr, Sydney, NSW, Australia	University of Sydney; University of Sydney	Harrison, C (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Menzies Ctr Hlth Policy, Sydney, NSW, Australia.; Harrison, C (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Family Med Res Ctr, Sydney, NSW, Australia.	christopher.harrison@sydney.edu.au		Henderson, Joan/0000-0002-8456-7455; Harrison, Christopher/0000-0002-8769-6877				[Anonymous], 2015, NAT HLTH SURV; Aus Tender, 2016, PROV RISK STRAT INCL; Austin PC, 2002, J VASC SURG, V36, P194, DOI 10.1067/mva.2002.125015; Australian Bureau of Statistics, 2013, POP PROJ AUSTR 2012; Australian Bureau of Statistics, 2014, AUSTR HIST POP STAT; Australian Government Department of Health, 2016, HEALTH MED REF PRIM; Brett T, 2013, ANN FAM MED, V11, P535, DOI 10.1370/afm.1570; BRITT H, 1992, FAM PRACT, V9, P191, DOI 10.1093/fampra/9.2.191; Britt H, 2016, GEN PRACTICE SERIES; Britt H., 2016, GEN PRACTICE ACTIVIT; Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; Classification Committee of the World Organization of Family Doctors, 1998, ICPC 2 INTERNATIONAL; Harrison C, 2014, PHCRIS ANN M; Harrison C, 2016, AUST NZ J PUBL HEAL, V40, P239, DOI 10.1111/1753-6405.12509; Harrison C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004694; Harrison C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067494; Harrison C, 2011, AUST FAM PHYSICIAN, V40, P12; Hersh WR, 2013, MED CARE, V51, pS30, DOI 10.1097/MLR.0b013e31829b1dbd; Knox SA, 2008, MED J AUSTRALIA, V189, P66, DOI 10.5694/j.1326-5377.2008.tb01918.x; Liaw Siaw-Teng, 2013, Aust Fam Physician, V42, P820; LINET MS, 1989, J CLIN EPIDEMIOL, V42, P1207, DOI 10.1016/0895-4356(89)90119-4; Mackenbach JP, 1996, AM J PUBLIC HEALTH, V86, P706, DOI 10.2105/AJPH.86.5.706; Merkin SS, 2007, J CLIN EPIDEMIOL, V60, P634, DOI 10.1016/j.jclinepi.2006.09.003; Mohangoo AD, 2006, EUR J PUBLIC HEALTH, V16, P101, DOI 10.1093/eurpub/cki043; National Center for Health Statistics. National Health Interview Survey, 2016, NAT HLTH INT SURV; NHS Information Centre for Health and Social Care, 2015, HLTH SURV ENGL 2014; O'Halloran J, 2004, FAM PRACT, V21, P381, DOI 10.1093/fampra/cmh407; Statistics Canada, 2016, CAN COMM HLTH SURV; Tse J, 2011, STUD HEALTH TECHNOL, V168, P158, DOI 10.3233/978-1-60750-791-8-158; Willis E., 2016, UNDERSTANDING AUSTR; Win KT, 2007, J MED SYST, V31, P91, DOI 10.1007/s10916-006-9030-3	31	51	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172935	10.1371/journal.pone.0172935	http://dx.doi.org/10.1371/journal.pone.0172935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278241	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900133
J	Lee, HJ; Lee, DG; Choi, SM; Park, SH; Cho, SY; Choi, JK; Kim, SH; Choi, JH; Yoo, JH; Cho, BS; Eom, KS; Lee, S; Kim, YJ; Kim, HJ; Min, CK; Kim, DW; Lee, JW; Min, WS; Jung, JI				Lee, Hyo-Jin; Lee, Dong-Gun; Choi, Su-Mi; Park, Sun Hee; Cho, Sung-Yeon; Choi, Jae-Ki; Kim, Si-Hyun; Choi, Jung-Hyun; Yoo, Jin-Hong; Cho, Byung-Sik; Eom, Ki-Seong; Lee, Seok; Kim, Yoo-Jin; Kim, Hee-Je; Min, Chang-Ki; Kim, Dong-Wook; Lee, Jong-Wook; Min, Woo-Sung; Jung, Im Jung			The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general population	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; IN-TUBE TEST; SINGLE-CENTER; MYCOBACTERIUM-TUBERCULOSIS; INFECTIOUS COMPLICATIONS; PULMONARY TUBERCULOSIS; CLINICAL CHARACTERISTICS; RISK; SURVEILLANCE; EXPERIENCE	Background The risk of developing tuberculosis (TB) in allogeneic hematopoietic stem cell transplantation (HSCT) recipients is expected to be relatively high in an intermediate TB burden country. This single-center retrospective study was conducted to investigate risk factors and the incidence of TB after allogeneic HSCT. Methods From January 2004 to March 2011, 845 adult patients were enrolled. Starting April 2009, patients were given isoniazid (INH) prophylaxis based on interferon-gamma release assay results. The incidence of TB was analyzed before and after April 2009, and compared it with that of the general population in Korea. Results TB was diagnosed in 21 (2.49%) of the 845 allogeneic HSCT patients. The median time to the development of TB was 386 days after transplantation (range, 49-886). Compared with the general population, the standardized incidence ratio of TB was 9.10 (95% CI; 5.59- 14.79). Extensive chronic graft-versus-host disease (GVHD) was associated with the development of TB (P = 0.003). Acute GVHD, conditioning regimen with total body irradiation and conditioning intensity were not significantly related. INH prophylaxis did not reduce the incidence of TB (P = 0.548). Among 21 TB patients, one patient had INH prophylaxis. Conclusion Allogeneic HSCT recipients especially those who suffer from extensive chronic GVHD are at a high risk of developing TB. INH prophylaxis did not statistically change the incidence of TB, however, further well-designed prospective studies are needed.	[Lee, Hyo-Jin; Lee, Dong-Gun; Choi, Su-Mi; Park, Sun Hee; Cho, Sung-Yeon; Choi, Jae-Ki; Kim, Si-Hyun; Choi, Jung-Hyun; Yoo, Jin-Hong] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Lee, Hyo-Jin; Lee, Dong-Gun; Choi, Su-Mi; Park, Sun Hee; Cho, Sung-Yeon; Choi, Jae-Ki; Kim, Si-Hyun; Choi, Jung-Hyun; Yoo, Jin-Hong] Catholic Univ Korea, Coll Med, Vaccine Bio Res Inst, Seoul, South Korea; [Lee, Dong-Gun; Cho, Byung-Sik; Eom, Ki-Seong; Lee, Seok; Kim, Yoo-Jin; Kim, Hee-Je; Min, Chang-Ki; Kim, Dong-Wook; Lee, Jong-Wook; Min, Woo-Sung] Catholic Univ Korea, Coll Med, Catholic Blood & Marrow Transplantat Ctr, Seoul, South Korea; [Jung, Im Jung] Catholic Univ Korea, Coll Med, Dept Radiol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Lee, DG (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea.; Lee, DG (corresponding author), Catholic Univ Korea, Coll Med, Vaccine Bio Res Inst, Seoul, South Korea.; Lee, DG (corresponding author), Catholic Univ Korea, Coll Med, Catholic Blood & Marrow Transplantat Ctr, Seoul, South Korea.	symonlee@catholic.ac.kr	Park, Sun/GSD-9620-2022; Lee, Dong-Gun/AGF-9891-2022	Lee, Dong-Gun/0000-0003-4655-0641; Jung, Jung Im/0000-0001-8264-9388; Kim, Si-Hyun/0000-0002-6392-0221; Choi, Su-Mi/0000-0002-8187-5110	Catholic Research Coordinating Center of the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea [A070001]	Catholic Research Coordinating Center of the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea	The statistical consultation was supported by Catholic Research Coordinating Center of the Korea Health 21 R&D Project (A070001), Ministry of Health & Welfare, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The statistical consultation was supported by Catholic Research Coordinating Center of the Korea Health 21 R&D Project (A070001), Ministry of Health & Welfare, Republic of Korea.	Ahmed Parvez, 2005, JPMA Journal of the Pakistan Medical Association, V55, P378; Akan H, 2006, J HOSP INFECT, V62, P421, DOI 10.1016/j.jhin.2005.09.020; Al-Anazi KA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00231; Al-Anazi Khalid Ahmed, 2007, Ann Clin Microbiol Antimicrob, V6, P16, DOI 10.1186/1476-0711-6-16; Aljurf M, 1999, BONE MARROW TRANSPL, V24, P551, DOI 10.1038/sj.bmt.1701930; Ambrossi GG, 2005, BONE MARROW TRANSPL, V36, P741, DOI 10.1038/sj.bmt.1705129; Arslan O, 1998, HAEMATOLOGIA, V29, P59; Budak-Alpdogan T, 2000, BIOL BLOOD MARROW TR, V6, P370, DOI 10.1016/S1083-8791(00)70013-9; Bumbacea D, 2012, EUR RESPIR J, V40, P990, DOI 10.1183/09031936.00000712; Cobelens FGJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006094; de la Camara R, 2000, BONE MARROW TRANSPL, V26, P291, DOI 10.1038/sj.bmt.1702506; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Eom KS, 2015, TRANSPL INFECT DIS, V17, P73, DOI 10.1111/tid.12341; Erdstein A A, 2004, Transpl Infect Dis, V6, P142, DOI 10.1111/j.1399-3062.2004.00068.x; Falzon D, 2013, LANCET INFECT DIS, V13, P690, DOI 10.1016/S1473-3099(13)70130-0; Fan WC, 2015, INT J TUBERC LUNG D, V19, P58, DOI 10.5588/ijtld.14.0301; George B, 2004, BONE MARROW TRANSPL, V33, P311, DOI 10.1038/sj.bmt.1704347; Ip MSM, 1998, AM J RESP CRIT CARE, V158, P1173, DOI 10.1164/ajrccm.158.4.9712072; Jung JI, 2009, J THORAC IMAG, V24, P10, DOI 10.1097/RTI.0b013e31818c6b97; Kim SH, 2013, TRANSPL INFECT DIS, V15, P49, DOI 10.1111/tid.12003; Kim SH, 2007, ARCH INTERN MED, V167, P2255, DOI 10.1001/archinte.167.20.2255; Korea Centers for Disease Control and Prevention, 2013, ANN REP NOT TUB KOR; Korea Centers for Disease Control and Prevention, 2012, REV NAT TUB CONTR PR; Ku SC, 2001, BONE MARROW TRANSPL, V27, P1293, DOI 10.1038/sj.bmt.1703092; Kumar R, 2009, BONE MARROW TRANSPL, V43, P115, DOI 10.1038/bmt.2008.307; Kwon JC, 2013, KOREAN J INTERN MED, V28, P187, DOI 10.3904/kjim.2013.28.2.187; Lee Dong-Gun, 2013, [The Korean Journal of Medicine, 대한내과학회지], V84, P158, DOI 10.3904/kjm.2013.84.2.158; Lee Dong-Gun, 2011, Korean Journal of Internal Medicine, V26, P220, DOI 10.3904/kjim.2011.26.2.220; Lee J, 2004, INT J HEMATOL, V79, P185, DOI 10.1532/IJH97.A10219; Lee YM, 2014, INFECT CHEMOTHER, V46, P248, DOI 10.3947/ic.2014.46.4.248; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Moon SM, 2013, TRANSPL INFECT DIS, V15, P104, DOI 10.1111/j.1399-3062.2012.00765.x; Park SH, 2006, J KOREAN MED SCI, V21, P199, DOI 10.3346/jkms.2006.21.2.199; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Roy V, 1997, BONE MARROW TRANSPL, V19, P467, DOI 10.1038/sj.bmt.1700686; Sester M, 2014, AM J RESP CRIT CARE, V190, P1168, DOI 10.1164/rccm.201405-0967OC; Shim TS, 2008, TUBERC RESPIR DIS, V65, P79, DOI 10.4046/trd.2008.65.2.79; Sun HY, 2013, TRANSPLANTATION, V95, P1173, DOI 10.1097/TP.0b013e31828719c8; Tuon FF, 2006, ACTA TROP, V99, P67, DOI 10.1016/j.actatropica.2006.07.004; Ullah K, 2007, TRANSPL P, V39, P3347, DOI 10.1016/j.transproceed.2007.08.099; Won YW, 2011, INT J HEMATOL, V93, P383, DOI 10.1007/s12185-011-0797-8; World Health Oraganization, 2016, EST TB MDR BURD PROD; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Yoo JH, 2004, BONE MARROW TRANSPL, V34, P497, DOI 10.1038/sj.bmt.1704636; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585	45	14	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173250	10.1371/journal.pone.0173250	http://dx.doi.org/10.1371/journal.pone.0173250			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278166	gold, Green Published			2022-12-27	WOS:000396087900060
J	Levin, I; Zaretsky, M; Aharoni, A				Levin, Itay; Zaretsky, Marianna; Aharoni, Amir			Directed evolution of a soluble human DR3 receptor for the inhibition of TL1A induced cytokine secretion	PLOS ONE			English	Article							NECROSIS-FACTOR RECEPTOR; YEAST SURFACE DISPLAY; ENZYME EVOLUTION; T-CELL; INFLAMMATION; PROTEINS; DISEASE; SUPERFAMILY; EXPRESSION; GENERATION	TNF-like 1A (TL1A) is a cytokine belonging to the TNF superfamily that promotes inflammation in autoimmune diseases. Inhibiting the interaction of TL1A with the endogenous death-domain receptor 3 (DR3) offers a therapeutic approach for treating TL1A-induced autoimmune diseases. Here, we generated improved DR3 variants showing increased TL1A binding affinity and stability using a directed evolution approach. Given the high cysteine content and post-translational modification of DR3, we employed yeast surface display and expression in mammalian cell lines for screening, expression and characterization of improved DR3 variants. A cell-based assay performed with the human TF-1 cell line and CD4(+) T cells showed that two improved DR3 mutants efficiently inhibited TL1A-induced cell death and secretion of IFN-gamma, respectively. These DR3 mutants can be used as drug candidates for the treatment of inflammatory bowel diseases and for other autoimmune diseases, including rheumatic arthritis and asthma.	[Levin, Itay; Zaretsky, Marianna; Aharoni, Amir] Ben Gurion Univ Negev, NIBN, Beer Sheva, Israel; [Zaretsky, Marianna; Aharoni, Amir] Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Aharoni, A (corresponding author), Ben Gurion Univ Negev, NIBN, Beer Sheva, Israel.; Aharoni, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel.	aaharoni@bgu.ac.il		Aharoni, Amir/0000-0003-2701-6996	National Institute for Biotechnology in the Negev (NIBN); Israeli Science Foundation (ISF)	National Institute for Biotechnology in the Negev (NIBN); Israeli Science Foundation (ISF)(Israel Science Foundation)	This work was supported by a grant from the National Institute for Biotechnology in the Negev (NIBN) and the Israeli Science Foundation (ISF) to AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Chen Varol, Nahum Shpigel and Irit Sagi for stimulating discussions on the role of TL1A in IBD. We thank the National Institute for Biotechnology in the Negev (NIBN) and the Israeli Science Foundation (ISF) for grant support.	Aharoni A, 2005, CHEM BIOL, V12, P1281, DOI 10.1016/j.chembiol.2005.09.012; Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Amar D, 2012, J MOL BIOL, V416, P21, DOI 10.1016/j.jmb.2011.12.013; Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Bamias G, 2006, P NATL ACAD SCI USA, V103, P8441, DOI 10.1073/pnas.0510903103; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bull MJ, 2008, J EXP MED, V205, P2457, DOI 10.1084/jem.20072378; Cassatella MA, 2007, J IMMUNOL, V178, P7325, DOI 10.4049/jimmunol.178.11.7325; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chew LJ, 2002, FASEB J, V16, P742, DOI 10.1096/fj.01-0757fje; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Gershoni JM, 2008, CURR OPIN BIOTECH, V19, P644, DOI 10.1016/j.copbio.2008.10.001; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; Kariolis MS, 2013, CURR OPIN BIOTECH, V24, P1072, DOI 10.1016/j.copbio.2013.03.017; Lehmann M, 2001, CURR OPIN BIOTECH, V12, P371, DOI 10.1016/S0958-1669(00)00229-9; Lutz S, 2010, CURR OPIN BIOTECH, V21, P734, DOI 10.1016/j.copbio.2010.08.011; Meylan F, 2011, MUCOSAL IMMUNOL, V4, P172, DOI 10.1038/mi.2010.67; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Naismith JH, 1996, STRUCTURE, V4, P1251, DOI 10.1016/S0969-2126(96)00134-7; Papadakis KA, 2004, J IMMUNOL, V172, P7002, DOI 10.4049/jimmunol.172.11.7002; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Tao HY, 2002, CURR OPIN CHEM BIOL, V6, P858, DOI 10.1016/S1367-5931(02)00396-4; Tootle TL, 2005, BIOESSAYS, V27, P285, DOI 10.1002/bies.20198; Umetsu M, 2010, FEBS J, V277, P2006, DOI 10.1111/j.1742-4658.2010.07627.x; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Young HA, 2006, P NATL ACAD SCI USA, V103, P8303, DOI 10.1073/pnas.0602655103; Yu KY, 1999, J BIOL CHEM, V274, P13733, DOI 10.1074/jbc.274.20.13733; Zaretsky M, 2013, CHEM BIOL, V20, P202, DOI 10.1016/j.chembiol.2012.11.012; Zhan CY, 2011, STRUCTURE, V19, P162, DOI 10.1016/j.str.2010.12.004	36	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173460	10.1371/journal.pone.0173460	http://dx.doi.org/10.1371/journal.pone.0173460			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278297	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900096
J	Parkkonen, O; Nieminen, MT; Vesterinen, P; Tervahartiala, T; Perola, M; Salomaa, V; Jousilahti, P; Sorsa, T; Pussinen, PJ; Sinisalo, J				Parkkonen, Olavi; Nieminen, Mikko T.; Vesterinen, Paula; Tervahartiala, Taina; Perola, Markus; Salomaa, Veikko; Jousilahti, Pekka; Sorsa, Timo; Pussinen, Pirkko J.; Sinisalo, Juha			Low MMP-8/TIMP-1 reflects left ventricle impairment in takotsubo cardiomyopathy and high TIM P-1 may help to differentiate it from acute coronary syndrome	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE EXPRESSION; TAKO-TSUBO CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; NEUTROPHIL COLLAGENASE; STRESS CARDIOMYOPATHY; TISSUE INHIBITORS; ST-ELEVATION; RISK; ATHEROSCLEROSIS; FINLAND	Background Matrix metalloproteinase 8 (MMP-8) is the most potent type-I collagen protease. Such collagen mainly constitutes the transient fibrosis in takotsubo cardiomyopathy (TTC) endomyocardial biopsies. High MMP-8 and tissue-inhibitor of matrix metalloproteinase-1 (TIMP-1) levels are implicated in acute coronary syndrome (ACS). We compared MMP-8 and TIM P-1 levels in consecutive TTC and ACS patients, and their association to TTC severity. Methods and results In 45 acute serum samples of TTC, 2072 ACS and 1000 controls, TI MP-1 differed between ACS 146.7ng/mL (115.0-186.3) (median (interquartile range)), TTC 115.7 (94.3-137.7) and controls 80.9 (73.2-90.4), (p<0.0001). MMP-8 levels were similar between ACS and TTC. In receiver-operating characteristics analysis, TIM P-1 differentiated TTC from ACS with an area under the curve (AUC) of 0.679 (p<0.0001) surpassing troponin T (TnT) at 0.522 (p = 0.66). Compared to other differing factors (age, sex, smoking), TIMP-1 improved diagnostic specificity and sensitivity from AUC of 0.821 to 0.844 (p = 0.007). The MMP8/TIMP-1 molar ratio differentiated normal ejection fraction (EF) at 0.27 (0.13-0.51) from decreased EF<50 at 0.08 (0.05-0.20), (p = 0.04) in TTC, but not in ACS. Conclusions Even with other differing factors considered, TIMP-1 differentiated TTC from ACS better than TnT. In TTC, the low MMP-8/TIM P-1 molar ratio may reflect decreased proteolysis and increased transient fibrosis, perhaps in part explaining the left-ventricle impairment.	[Parkkonen, Olavi; Vesterinen, Paula; Sinisalo, Juha] Helsinki Univ Hosp, Heart & Lung Ctr, Helsinki, Finland; [Parkkonen, Olavi; Vesterinen, Paula; Sinisalo, Juha] Univ Helsinki, Helsinki, Finland; [Nieminen, Mikko T.; Tervahartiala, Taina; Sorsa, Timo; Pussinen, Pirkko J.] Univ Helsinki, Dept Oral & Maxillofacial Dis, Helsinki, Finland; [Nieminen, Mikko T.; Tervahartiala, Taina; Sorsa, Timo; Pussinen, Pirkko J.] Helsinki Univ Hosp, Helsinki, Finland; [Perola, Markus; Salomaa, Veikko; Jousilahti, Pekka] Natl Inst Hlth & Welf, Helsinki, Finland; [Sorsa, Timo] Karolinska Inst, Dept Dent Med, Div Periodontol, Huddinge, Sweden	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; Karolinska Institutet	Parkkonen, O (corresponding author), Helsinki Univ Hosp, Heart & Lung Ctr, Helsinki, Finland.; Parkkonen, O (corresponding author), Univ Helsinki, Helsinki, Finland.	olavi.parkkonen@hus.fi; juha.sinisalo@hus.fi		Sinisalo, Juha/0000-0002-0169-5137; Nieminen, Mikko/0000-0001-6427-3196; Pussinen, Pirkko/0000-0003-3563-1876	Finnish Foundation for Cardiovascular Research; Academy of Finland [1266053]; Sigrid Juselius Foundation; Yrjo Jahnsson Foundation; Aarno Koskelo Foundation; Helsinki University Central Hospital [TYH7215, TKK2012005, TYH2012209, TYH2014312, TYH2014244, TYH2016251]	Finnish Foundation for Cardiovascular Research; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Yrjo Jahnsson Foundation; Aarno Koskelo Foundation; Helsinki University Central Hospital	This study was funded by grants from the Finnish Foundation for Cardiovascular Research (to OP, VS and JS) (http.//www.sydantutkimussaabo. Wen/foundation); the Academy of Finland (#1266053 to PJP) (http://www.aka.fi/en/); the Sigrid Juselius Foundation (to PJP) (http://www. sigridjuselius.fi/foundafien); the Yrjo Jahnsson Foundation (to PJP) (http://www.yjs/en/); the Aarno Koskelo Foundation (to JS) (rittp://www. aarnekoskelonsaatio.fi/); and Helsinki University Central Hospital special government funds (to JS EVO #TYH7215, #TKK2012005, #TYH2012209, #TYH2014312, TS EVO #TYH2014244, #TYH2016251).	Akashi YJ, 2015, NAT REV CARDIOL, V12, P387, DOI 10.1038/nrcardio.2015.39; Borodulin K, 2015, EUR J PUBLIC HEALTH, V25, P539, DOI 10.1093/eurpub/cku174; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Cerqueira MD, 2002, INT J CARDIOVAS IMAG, V18, P539; Coker ML, 2001, AM J PHYSIOL-HEART C, V281, pH543, DOI 10.1152/ajpheart.2001.281.2.H543; Djuric T, 2010, J CLIN LAB ANAL, V24, P246, DOI 10.1002/jcla.20393; Essa EM, 2012, J CARD FAIL, V18, P487, DOI 10.1016/j.cardfail.2012.04.002; Fertin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071280; Galiuto L, 2010, EUR HEART J, V31, P1319, DOI 10.1093/eurheartj/ehq039; Guzel S, 2013, KOREAN J INTERN MED, V28, P165, DOI 10.3904/kjim.2013.28.2.165; HASTY KA, 1987, J BIOL CHEM, V262, P10048; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Jones CB, 2003, CARDIOVASC RES, V59, P812, DOI 10.1016/S0008-6363(03)00516-9; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035; Nef HM, 2007, EUR HEART J, V28, P2456, DOI 10.1093/eurheartj/ehl570; Parkkonen O, 2014, J ELECTROCARDIOL, V47, P692, DOI 10.1016/j.jelectrocard.2014.06.006; Paur H, 2012, CIRCULATION, V126, P697, DOI 10.1161/CIRCULATIONAHA.112.111591; Peltonen M, 2008, KANSALLINEN FINRISK1; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Pussinen PJ, 2013, INT J CARDIOL, V167, P362, DOI 10.1016/j.ijcard.2011.12.095; Pussinen PJ, 2011, DIABETES CARE, V34, P392, DOI 10.2337/dc10-1676; Sharkey SW, 2008, AM J CARDIOL, V101, P1723, DOI 10.1016/j.amjcard.2008.02.062; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882; Szardien S, 2013, INT J CARDIOL, V168, P1685, DOI 10.1016/j.ijcard.2013.03.075; Tanindi A, 2011, OPEN CARDIOVASC MED, V5, P110, DOI 10.2174/1874192401105010110; Tuomainen AM, 2007, ARTERIOSCL THROM VAS, V27, P2722, DOI 10.1161/ATVBAHA.107.154831; Vaara S, 2012, INT J EPIDEMIOL, V41, P1265, DOI 10.1093/ije/dyr090; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; Yang EV, 2002, J NEUROIMMUNOL, V133, P144, DOI 10.1016/S0165-5728(02)00270-9; Yoshiji H, 1998, INT J CANCER, V75, P81, DOI 10.1002/(SICI)1097-0215(19980105)75:1<81::AID-IJC13>3.3.CO;2-J	32	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173371	10.1371/journal.pone.0173371	http://dx.doi.org/10.1371/journal.pone.0173371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278213	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900079
J	Yoneoka, D; Ota, E				Yoneoka, Daisuke; Ota, Erika			Evaluating association between linguistic characteristics of abstracts and risk of bias: Case of Japanese randomized controlled trials	PLOS ONE			English	Article							SYSTEMATIC REVIEWS; QUALITY	Despite the ongoing growth in the number of published randomized controlled trials (RCTs) and increased quality assessment of RCTs, the association between the quality and characteristics in the text has not been sufficiently studied. We are interested in a specific question: what kind of sentences is a good indicator of high quality RCTs? To help researchers to efficiently screen articles worth reading, this study aims 1) to quantify the linguistic features of articles and 2) to build a document assessment model to evaluate quality of RCTs using only the abstract. All RCTs that were conducted in Japan in 2010 as original articles were included in the analysis. Data were independently assessed by two reviewers using a risk-of-bias tool. Three aspects of linguistic style were quantitatively measured, and a document model was constructed to evaluate the RCTs. A total of 302 RCTs were selected for quality assessment. Of these, 255 articles were assessed as high quality and 47 as low quality. High-quality articles tended to use longer words than low-quality articles (p = 0.048), however sentences were generally shorter (p = 0.004). Further, high-quality articles included a larger proportion of noun phrases (p = 0.026) but a smaller proportion of verb phrases (p = 0.041). The optimal number of topics to assess the quality of articles was four, while two topics had a significant association with quality. Despite a number of articles published about RCTs in Japan, significant differences exist in several textual features between high- and low-quality RCTs. Instead of the risk-of-bias tool, these results can be used as the new criteria to rapidly screen valuable articles and it also revealed quality control of RCT articles is urgently needed in Japan.	[Yoneoka, Daisuke] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Yoneoka, Daisuke] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 332 N Lauderdale St, Memphis, TN 38105 USA; [Ota, Erika] St Jukes Int Univ, Grad Sch Nursing Sci, Tokyo, Japan	University of Tokyo; St Jude Children's Research Hospital	Yoneoka, D (corresponding author), Univ Tokyo, Grad Sch Med, Tokyo, Japan.; Yoneoka, D (corresponding author), St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 332 N Lauderdale St, Memphis, TN 38105 USA.	blue.sky.sea.dy@gmail.com	Yoneoka, Daisuke/A-9336-2016	Yoneoka, Daisuke/0000-0002-3525-5092; Ota, Erika/0000-0002-3945-7441	Grant of National Center for Child Health and Development, Japan [26A-5]	Grant of National Center for Child Health and Development, Japan	The authors are supported by the Grant of National Center for Child Health and Development 26A-5, Japan.	Ashok V. G., 2013, POETRY, V580, P70; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Druck G., 2008, WIKIAI, V8, P7; DuBay W. H., 2004, PRINCIPLES READABILI; Eysenbach G, 1998, BRIT MED J, V317, P1496, DOI 10.1136/bmj.317.7171.1496; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Gluud C, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-7; HERDAN G, 1960, LANG SPEECH, V3, P78, DOI 10.1177/002383096000300203; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Louis A., 2013, DIALOGUE DISCOURSE, V4, P87, DOI DOI 10.5087/DAD.2013.205; Mcauliffe J. D., 2008, ADV NEURAL INFORM PR, P121; Moher D., 1999, HEALTH TECHNOL ASSES, V3, pi, DOI [DOI 10.3310/HTA3120, 10.3310/hta3120]; Nenkova A., 2013, T ACL, V1, P341, DOI DOI 10.1162/TACL_A_00232; Pepe MS, 2004, STAT EVALUATION MED; Pitler E., 2008, P C EMP METH NAT LAN, P186, DOI DOI 10.3115/1613715.1613742; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Pon RK, 2011, INFORM PROCESS MANAG, V47, P97, DOI 10.1016/j.ipm.2010.03.001; Schulz KF, 2011, INT J SURG, V9, P672, DOI 10.1016/j.ijsu.2011.09.004; Strippoli GFM, 2004, J AM SOC NEPHROL, V15, P411, DOI 10.1097/01.ASN.0000100125.21491.46; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Yoneoka D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090127	23	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173526	10.1371/journal.pone.0173526	http://dx.doi.org/10.1371/journal.pone.0173526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278271	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900006
J	Zhang, D; Cui, YC; Li, B; Luo, XK; Li, B; Tang, Y				Zhang, Dong; Cui, Yongchun; Li, Bin; Luo, Xiaokang; Li, Bo; Tang, Yue			A comparative study of the characterization of miR-155 in knockout mice	PLOS ONE			English	Article							INDUCED APOPTOSIS; IN-VIVO; EXPRESSION; MICRORNA-155; INFLAMMATION; TOXICITY; PROTECTS; CANCER	miR-155 is one of the most important miRNAs and plays a very important role in numerous biological processes. However, few studies have characterized this miRNA in mice under normal physiological conditions. We aimed to characterize miR-155 in vivo by using a comparative analysis. In our study, we compared miR-155 knockout (KO) mice with C57BL/6 wild type (WT) mice in order to characterize miR-155 in mice under normal physiological conditions using many evaluation methods, including a reproductive performance analysis, growth curve, ultrasonic estimation, haematological examination, and histopathological analysis. These analyses showed no significant differences between groups in the main evaluation indices. The growth and development were nearly normal for all mice and did not differ between the control and model groups. Using a comparative analysis and a summary of related studies published in recent years, we found that miR-155 was not essential for normal physiological processes in 8-week-old mice. miR-155 deficiency did not affect the development and growth of naturally ageing mice during the 42 days after birth. Thus, studying the complex biological functions of miR-155 requires the further use of KO mouse models.	[Zhang, Dong; Cui, Yongchun; Li, Bin; Luo, Xiaokang; Li, Bo; Tang, Yue] Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis,Anim Expt Ctr, Fuwai Hosp,State Key Lab Cardiovasc Dis,Beijing K, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College	Tang, Y (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis,Anim Expt Ctr, Fuwai Hosp,State Key Lab Cardiovasc Dis,Beijing K, Beijing, Peoples R China.	tangyue@fuwaihospital.org	Cui, Yong/AAF-9300-2020	Luo, Xiaokang/0000-0002-1343-4372	National High Technology Research and Development Program of China (863 Program, China) [SS2012AA023503]	National High Technology Research and Development Program of China (863 Program, China)(National High Technology Research and Development Program of China)	This work was supported by National High Technology Research and Development Program of China (863 Program, Project No: SS2012AA023503, China), YT (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm).	Arruda LCM, 2015, BONE MARROW TRANSPL, V50, P380, DOI 10.1038/bmt.2014.277; Balijepalli MK, 2015, PHARMACOGN RES, V7, P38, DOI 10.4103/0974-8490.147197; Christmann RB, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1054-6; Churov AV, 2015, AUTOIMMUN REV, V14, P1029, DOI 10.1016/j.autrev.2015.07.005; Elton TS, 2013, GENE, V532, P1, DOI 10.1016/j.gene.2012.12.009; Fan Y, 2016, J AM HEART ASS; Fayssoil A, 2013, NEUROL INT, V5, P75, DOI 10.4081/ni.2013.e22; Fu XM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/831641; Gaudet AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep22862; Huang P, 2016, BIOMED PHARMACOTHER, V83, P850, DOI 10.1016/j.biopha.2016.07.050; Husakova M, 2016, BIOMED PAP, V160, P327, DOI 10.5507/bp.2016.004; Lawrie CH, 2013, BRIT J HAEMATOL, V160, P571, DOI 10.1111/bjh.12157; Leah Emma, 2011, Nat Rev Rheumatol, V7, P437, DOI 10.1038/nrrheum.2011.101; Lee HJ, 2016, YONSEI MED J, V57, P247, DOI 10.3349/ymj.2016.57.1.247; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu YA, 2016, IRAN J IMMUNOL, V13, P89, DOI IJIv13i2A2; Luo XB, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4194; Moore CS, 2013, ANN NEUROL, V74, P709, DOI 10.1002/ana.23967; Morton LT, 2016, CURR OPIN RHEUMATOL, V28, P39, DOI 10.1097/BOR.0000000000000234; O'Connell RM, 2011, BLOOD, V118, P2960, DOI 10.1182/blood-2011-03-291971; Omrane I, 2015, BBA-REV CANCER, V1856, P28, DOI 10.1016/j.bbcan.2015.04.001; Park HK, 2016, J VET SCI, V17, P45, DOI 10.4142/jvs.2016.17.1.45; Ranganath P, 2015, BIOMARK INSIGHTS, V10, P95, DOI [10.4137/BMI.S27676, 10.4137/BMIMI.S27676]; Seok HY, 2014, CIRC RES, V114, P1585, DOI 10.1161/CIRCRESAHA.114.303784; Springer DA, 2014, PATHOBIOL AGING AGE, V4, DOI 10.3402/pba.v4.24932; Tili E, 2015, ONCOTARGET, V6, P24599, DOI 10.18632/oncotarget.5248; Tombak A, 2015, INDIAN J HEMATOL BLO, V31, P416, DOI 10.1007/s12288-014-0492-z; Wang CZ, 2015, MOLECULES, V20, P22257, DOI 10.3390/molecules201219839; Yan QR, 2016, SCI REP-UK, V6, DOI 10.1038/srep20314; Yin QY, 2016, VIROLOGY, V494, P158, DOI 10.1016/j.virol.2016.04.005; Zadeh MM, 2016, J BREAST CANCER, V19, P45, DOI 10.4048/jbc.2016.19.1.45; Zhou SY, 2016, ARTHRITIS RHEUMATOL, V68, P953, DOI 10.1002/art.39485	32	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173487	10.1371/journal.pone.0173487	http://dx.doi.org/10.1371/journal.pone.0173487			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278287	gold, Green Submitted, Green Published			2022-12-27	WOS:000396087900102
J	Zhang, Z; Joyce, BT; Kresovich, JK; Zheng, YA; Zhong, J; Patel, R; Zhang, W; Liu, L; Dou, C; McCracken, JP; Diaz, A; Motta, V; Sanchez-Guerra, M; Bian, S; Bertazzi, PA; Schwartz, J; Baccarelli, AA; Wang, S; Hou, LF				Zhang, Zhou; Joyce, Brian Thomas; Kresovich, Jacob K.; Zheng, Yinan; Zhong, Jia; Patel, Ruchi; Zhang, Wei; Liu, Lei; Dou, Chang; McCracken, John P.; Diaz, Anaite; Motta, Valeria; Sanchez-Guerra, Marco; Bian, Shurui; Bertazzi, Pier Alberto; Schwartz, Joel; Baccarelli, Andrea A.; Wang, Sheng; Hou, Lifang			Blood pressure and expression of microRNAs in whole blood	PLOS ONE			English	Article							PARTICULATE MATTER EXPOSURE; GENE-EXPRESSION; AIR-POLLUTION; HYPERTENSION; INDIVIDUALS; METHYLATION; EPIGENETICS; PROGNOSIS; PROFILES; DISEASE	Background Blood pressure (BP) is a complex, multifactorial clinical outcome driven by genetic susceptibility, behavioral choices, and environmental factors. Many molecular mechanisms have been proposed for the pathophysiology of high BP even as its prevalence continues to grow worldwide, increasing morbidity and marking it as a major public health concern. To address this, we evaluated miRNA profiling in blood leukocytes as potential biomarkers of BP and BP-related risk factors. Methods The Beijing Truck Driver Air Pollution Study included 60 truck drivers and 60 office workers examined in 2008. On two days separated by 1-2 weeks, we examined three BP measures: systolic, diastolic, and mean arterial pressure measured at both pre-and post-work exams for blood NanoString nCounter miRNA profiles. We used covariate-adjusted linear mixed-effect models to examine associations between BP and increased miRNA expression in both pooled and risk factor-stratified analyses. Results Overall 43 miRNAs were associated with pre-work BP (FDR<0.05). In stratified analyses different but overlapping groups of miRNAs were associated with pre-work BP in truck drivers, high-BMI participants, and usual alcohol drinkers (FDR<0.05). Only four miRNAs were associated with post-work BP (FDR<0.05), in ever smokers. Conclusion Our results suggest that many miRNAs were significantly associated with BP in subgroups exposed to known hypertension risk factors. These findings shed light on the underlying molecular mechanisms of BP, and may assist with the development of a miRNA panel for early detection of hypertension.	[Zhang, Zhou; Bian, Shurui] Northwestern Univ, Feinberg Sch Med, Driskill Grad Program Life Sci, Chicago, IL 60611 USA; [Zhang, Zhou; Joyce, Brian Thomas; Kresovich, Jacob K.; Zheng, Yinan; Patel, Ruchi; Zhang, Wei; Liu, Lei; Hou, Lifang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Joyce, Brian Thomas; Kresovich, Jacob K.] Univ Illinois, Sch Publ Hlth, Div Epidemiol Biostat, Chicago, IL USA; [Zheng, Yinan] Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth & Med, Chicago, IL 60611 USA; [Zhong, Jia; Sanchez-Guerra, Marco; Schwartz, Joel; Hou, Lifang] Harvard Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Zhang, Wei; McCracken, John P.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Dou, Chang] China Inst Ind Relat, Dept Safety Engn, Beijing, Peoples R China; [Diaz, Anaite] Univ Valle Guatemala, Ctr Hlth Studies, Guatemala City, Guatemala; [Motta, Valeria; Bertazzi, Pier Alberto] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Motta, Valeria; Bertazzi, Pier Alberto] IRCCS Fdn Ca Granda, Osped Maggiore Policlin, Milan, Italy; [Sanchez-Guerra, Marco] CDMX, Natl Inst Perinatol, Dept Dev Neurobiol, Mexico City, DF, Mexico; [Baccarelli, Andrea A.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA; [Wang, Sheng] Peking Univ, Hlth Sci Ctr, Dept Occupat & Environm Hlth, Beijing, Peoples R China	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Feinberg School of Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Universidad del Valle de Guatemala; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Columbia University; Peking University	Hou, LF (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.	shengw@bjmu.edu.cn; l-hou@northwestern.edu	diaz-artiga, anaite/GOJ-7894-2022; Joyce, Brian/AAF-2478-2020; Stefanadis, Christodoulos/ABH-2232-2020; Sanchez-Guerra, Marco/V-7693-2019; Liu, Lei/B-4968-2009	diaz-artiga, anaite/0000-0002-2508-8710; Joyce, Brian/0000-0002-5271-6161; Stefanadis, Christodoulos/0000-0001-5974-6454; Sanchez-Guerra, Marco/0000-0002-8354-1157; Liu, Lei/0000-0003-1844-338X; Kresovich, Jacob/0000-0002-9577-226X; Zhang, Zhou/0000-0002-9639-052X; Zheng, Yinan/0000-0002-2006-7320	National Institute of Environmental Health Sciences [R21ES020984]; American Heart Association [12GRNT12070254]; Robert H. Lurie Comprehensive Cancer Center - Rosenberg Family Cancer Research Fund; Fundacion Mexico en Harvard, A.C.; Consejo Nacional de Ciencia y Tecnologia (CONACYT-Mexico); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES020010, P30ES009089] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Heart Association(American Heart Association); Robert H. Lurie Comprehensive Cancer Center - Rosenberg Family Cancer Research Fund; Fundacion Mexico en Harvard, A.C.; Consejo Nacional de Ciencia y Tecnologia (CONACYT-Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (grant numbers, R21ES020984), American Heart Association (grant number 12GRNT12070254), and the Robert H. Lurie Comprehensive Cancer Center - Rosenberg Family Cancer Research Fund. MSG was financially supported by the Fundacion Mexico en Harvard, A.C. and Consejo Nacional de Ciencia y Tecnologia (CONACYT-Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, RISK FACT HIGH BLOOD; Arora P, 2013, J CLIN INVEST, V123, P3378, DOI 10.1172/JCI67383; Asayama K, 2015, HYPERTENSION, V65, P1170, DOI 10.1161/HYPERTENSIONAHA.115.04808; Baccarelli A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-108; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertero T, 2015, J BIOL CHEM, V290, P2069, DOI 10.1074/jbc.M114.617845; Bye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057496; Calderon-Garciduenas L, 2008, INHAL TOXICOL, V20, P499, DOI 10.1080/08958370701864797 ; Cesari M, 2003, AM J CARDIOL, V92, P522, DOI 10.1016/S0002-9149(03)00718-5; Cui K, 2014, INTEGR BIOL-UK, V6, P1141, DOI 10.1039/c4ib00156g; das Neves VJ, 2014, WORLD J CARDIOL, V6, P713, DOI 10.4330/wjc.v6.i8.713; Dubowsky SD, 2006, ENVIRON HEALTH PERSP, V114, P992, DOI 10.1289/ehp.8469; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Friese RS, 2013, HUM MOL GENET, V22, P3624, DOI 10.1093/hmg/ddt213; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Holgate Stephen T, 2003, Res Rep Health Eff Inst, P1; Hou L, 2015, ENV HLTH PERSPECT; Hou LF, 2016, ENVIRON HEALTH PERSP, V124, P344, DOI 10.1289/ehp.1408519; Hou LF, 2014, ENVIRON MOL MUTAGEN, V55, P256, DOI 10.1002/em.21829; Hou LF, 2013, PART FIBRE TOXICOL, V10, DOI [10.1186/1743-8977-10-17, 10.1186/1743-8977-10-47]; Jiang JY, 2015, J HYPERTENS, V33, P2223, DOI 10.1097/HJH.0000000000000710; Kario K, 2015, HYPERTENSION, V65, P1163, DOI 10.1161/HYPERTENSIONAHA.115.04800; Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149; Li PX, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000972; Liu C, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0052-5; Ma L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140339; MANCIA G, 1983, CIRC RES, V53, P96, DOI 10.1161/01.RES.53.1.96; MILLARCRAIG MW, 1978, LANCET, V1, P795; Millis RM, 2011, CURR HYPERTENS REP, V13, P21, DOI 10.1007/s11906-010-0173-8; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; National Climatic Data Center (U.S.), NNDC CLIM DAT ONL; Nwankwo T, 2013, NCHS DATA BRIEF, V133, P1; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Raftopoulos L, 2015, LIFE SCI, V129, P22, DOI 10.1016/j.lfs.2014.08.003; Sanchez-Guerra M, 2015, EPIGENETICS-US, V10, P633, DOI 10.1080/15592294.2015.1050174; Tabassum R, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0209-4; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wallace E, 2015, AM J RESP CRIT CARE, V191, P1432, DOI 10.1164/rccm.201412-2148OC; Wang W, 2014, BIOMED ENVIRON SCI, V27, P552, DOI 10.3967/bes2014.085; Wang ZX, 2005, ENVIRON HEALTH PERSP, V113, P233, DOI 10.1289/txg.7273; Wei CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064396; Weinhold B, 2006, ENVIRON HEALTH PERSP, V114, pA160, DOI 10.1289/ehp.114-a160; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wong MCS, 2015, EUR HEART J, V36, P2598, DOI 10.1093/eurheartj/ehv329; Xu JH, 2012, J MOL MED, V90, P865, DOI 10.1007/s00109-011-0840-5; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zheng YA, 2017, ENVIRON RES, V153, P112, DOI 10.1016/j.envres.2016.11.015; Zhou GF, 2015, AM J RESP CELL MOL, V52, P139, DOI 10.1165/rcmb.2014-0166TR	51	8	8	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173550	10.1371/journal.pone.0173550	http://dx.doi.org/10.1371/journal.pone.0173550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278198	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900011
J	Lee, JS; Yoo, JE; Kim, H; Rhee, H; Koh, MJ; Nahm, JH; Choi, JS; Lee, KH; Park, YN				Lee, Jee San; Yoo, Jeong Eun; Kim, Haeryoung; Rhee, Hyungjin; Koh, Myoung Ju; Nahm, Ji Hae; Choi, Jin Sub; Lee, Kee-Ho; Park, Young Nyun			Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma	PLOS ONE			English	Article							METABOLIC SYNDROME; MICROENVIRONMENT; TUMORIGENESIS; FIBROBLASTS; INFECTION; CANCER	Senescence secretome was recently reported to promote liver cancer in an obese mouse model. Steatohepatitic hepatocellular carcinoma (SH-HCC), a new variant of HCC, has been found in metabolic syndrome patients, and pericellular fibrosis, a characteristic feature of SH-HCC, suggests that alteration of the tumor stroma might play an important role in SHHCC development. Clinicopathological characteristics and tumor stroma showing senescence and senescence-associated secretory phenotype (SASP) were investigated in 21 SH-HCCs and 34 conventional HCCs (C-HCCs). The expression of a-smooth muscle actin (a-SMA), p21(Waf1/Cifi), y-H2AX, and IL-6 was investigated by immunohistochemistry or immunofluorescence. SH-HCCs were associated with older age, higher body mass index, and a higher incidence of metabolic syndrome, compared to C-HCC (P <0.05, all). The numbers of a-SMA-positive cancer-associated fibroblasts (CAFs) (P= 0.049) and a-SMA-positive CAFs co-expressing p21(Waf1/Cif1) (P = 0.038), y-H2AX (P = 0.065), and IL-6 (P = 0.048) were greater for SH-HCCs than C-HCCs. Additionally, non-tumoral liver from SH-HCCs showed a higher incidence of non-alcoholic fatty liver disease and a higher number of aSMA-positive stellate cells expressing y-H2AX and p21(Waf1/Cif1) than that from C-HCCs (P <0.05, all). In conclusion, SH-HCCs are considered to occur more frequently in metabolic syndrome patients. Therein, senescent and damaged CAFs, as well as non-tumoral stellate cells, expressing SASP including IL-6 may contribute to the development of SH-HCC.	[Lee, Jee San; Yoo, Jeong Eun; Rhee, Hyungjin; Koh, Myoung Ju; Nahm, Ji Hae; Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Lee, Jee San; Rhee, Hyungjin; Park, Young Nyun] Yonsei Univ, Coll Med, PLUS Project Med Sci BK21, Seoul, South Korea; [Lee, Jee San; Yoo, Jeong Eun; Rhee, Hyungjin; Koh, Myoung Ju; Nahm, Ji Hae; Park, Young Nyun] Yonsei Univ, Coll Med, Integrated Genom Res Ctr Metab Regulat, Seoul, South Korea; [Kim, Haeryoung] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Pathol, Seongnam, South Korea; [Choi, Jin Sub] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Lee, Kee-Ho] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Korea Institute of Radiological & Medical Sciences; Yonsei University; Yonsei University Health System	Park, YN (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea.; Park, YN (corresponding author), Yonsei Univ, Coll Med, PLUS Project Med Sci BK21, Seoul, South Korea.; Park, YN (corresponding author), Yonsei Univ, Coll Med, Integrated Genom Res Ctr Metab Regulat, Seoul, South Korea.; Park, YN (corresponding author), Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.	young0608@yuhs.ac	Rhee, Hyungjin/T-7619-2019	Nahm, Ji Hae/0000-0003-0902-866X; Kim, Haeryoung/0000-0002-4205-9081; Rhee, Hyungjin/0000-0001-7759-4458; Park, Young Nyun/0000-0003-0357-7967	National Research Foundation of Korea (NRF) grant - Korea government (MISP) [NRF-2012M3A9B6055350]	National Research Foundation of Korea (NRF) grant - Korea government (MISP)	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MISP) (Grant number: NRF-2012M3A9B6055350, to PYN). We declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2005, J HEPATOL, V42, P188, DOI 10.1016/j.jhep.2004.10.026; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Chen CL, 2008, GASTROENTEROLOGY, V135, P111, DOI 10.1053/j.gastro.2008.03.073; Cho HK, 2014, FEBS J, V281, P2228, DOI 10.1111/febs.12776; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Esposito K, 2014, J CLIN GASTROENTEROL, V48, P742, DOI 10.1097/MCG.0000000000000097; Gupta EK, 2014, CANCER GROWTH METAST, V7, P1, DOI 10.4137/CGM.S14205; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Jing YY, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-29; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; KASL, 2013, CLIN MOL HEPATOL, V19, P325, DOI 10.3350/cmh.2013.19.4.325; Kim GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105094; Kim K. J., 2007, J CREATIVE INFORM CO, V1, P1, DOI DOI 10.1053/J.GASTR0.2007.03.039; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Merican I, 2000, J GASTROEN HEPATOL, V15, P1356, DOI 10.1046/j.1440-1746.2000.0150121356.x; Na TY, 2009, HEPATOLOGY, V49, P1122, DOI 10.1002/hep.22740; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pollicino T, 2004, GASTROENTEROLOGY, V126, P102, DOI 10.1053/j.gastro.2003.10.048; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Salomao M, 2012, HUM PATHOL, V43, P737, DOI 10.1016/j.humpath.2011.07.005; Salomao M, 2010, AM J SURG PATHOL, V34, P1630, DOI 10.1097/PAS.0b013e3181f31caa; Shibahara J, 2014, HISTOPATHOLOGY, V64, P951, DOI 10.1111/his.12343; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347	28	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171922	10.1371/journal.pone.0171922	http://dx.doi.org/10.1371/journal.pone.0171922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273155	Green Submitted, gold, Green Published			2022-12-27	WOS:000396073700063
J	Ro, JS; Lee, JS; Kang, SC; Jung, HM				Ro, Jun-Soo; Lee, Jin-Seok; Kang, Sung-Chan; Jung, Hye-Min			Worry experienced during the 2015 Middle East Respiratory Syndrome (MERS) pandemic in Korea	PLOS ONE			English	Article							RISK; PERCEPTIONS; BREAST; BEHAVIOR; ANXIETY	Background Korea failed in its risk communication during the early stage of the Middle East Respiratory Syndrome (MERS) outbreak; consequently, it faced difficulties in managing MERS, while disease-related worry increased. Disease-related worry can help disease prevention and management, but can also have a detrimental effect. This study measured the overall level of disease-related worry during the MERS outbreak period in Korea and the influencing factors and levels of disease-related worry during key outbreak periods. Methods The cross-sectional survey included 1,000 adults who resided in Korea. An ordinal logistic regression was performed for the overall level of MERS-related worry, and influencing factors of worry were analyzed. A reliability test was performed on the levels of MERS-related worry during key outbreak periods. Results The overall level of MERS-related worry was 2.44. Multivariate analysis revealed that women and respondents w very poor subjective health status had higher levels of worry. Respondents with very high stress in daily life had higher levels of worry than those who reported having little stress. The reliability test results on MERS-related worry scores during key outbreak periods showed consistent scores during each period. Conclusion Level of worry increased in cases having higher perceived susceptibility and greater trust in informal information, while initial stage of outbreak was closely associated with that at later stages. These findings suggest the importance of managing the level of worry by providing timely and accurate disease-related information during the initial stage of disease outbreak.	[Ro, Jun-Soo] Armed Forces Med Res Inst, Res Ctr Infect & Environm Dis, Dept Infect Dis, Daejeon, South Korea; [Lee, Jin-Seok; Jung, Hye-Min] Seoul Natl Univ, Coll Med, Dept Hlth Policy & Management, Seoul, South Korea; [Lee, Jin-Seok; Kang, Sung-Chan] Seoul Natl Univ, Med Res Ctr, Inst Hlth Policy & Management, Seoul, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Seoul National University (SNU); Seoul National University (SNU)	Lee, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Hlth Policy & Management, Seoul, South Korea.; Lee, JS (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Hlth Policy & Management, Seoul, South Korea.	phealth@snu.ac.kr		Ro, Jun-soo/0000-0002-8156-5294; Kang, Sungchan/0000-0002-4876-3205; Jung, Hyemin/0000-0001-7339-7983	Ministry of Health and Welfare (Republic of Korea)	Ministry of Health and Welfare (Republic of Korea)(Ministry of Health & Welfare (MOHW), Republic of Korea)	Ministry of Health and Welfare (Republic of Korea) has supported J-SL, grant numbers: none, URLs: http://www.mohvi.go.kr/eng/index.jsp. The Funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akan H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-413; Balkhy HH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-42; Bults M, 2001, BMC PUBLIC HEALTH, V11; Cameron LD, 2006, PSYCHOL HEALTH, V21, P211, DOI 10.1080/14768320500230318; Cameron LD, 2001, J HEALTH PSYCHOL, V6, P47, DOI 10.1177/135910530100600104; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Choi JW, 2015, J KOREAN MED ASSOC, V58, P624, DOI 10.5124/jkma.2015.58.7.624; Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811; Diefenbach MA, 1999, HEALTH PSYCHOL, V18, P532, DOI 10.1037/0278-6133.18.5.532; Goodwin R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-166; Liao QY, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-169; Liao QY, 2011, INT J BEHAV MED, V18, P93, DOI 10.1007/s12529-010-9123-8; MERS, 2015, OS KOR CTR DIS CONTR; Raude J, 2009, EUR J EPIDEMIOL, V24, P339, DOI 10.1007/s10654-009-9351-x; Rubin G., 2009, BMJ-BRIT MED J, V339, P2651, DOI DOI 10.1136/BMJ.B2651; Sun GQ, 2016, PHYS LIFE REV, V19, P43, DOI 10.1016/j.plrev.2016.08.002; Xia ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144778	17	46	48	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173234	10.1371/journal.pone.0173234	http://dx.doi.org/10.1371/journal.pone.0173234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273131	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700047
J	Russo, J; Mateus, O; Marzola, M; Balbino, A				Russo, Joao; Mateus, Octavio; Marzola, Marco; Balbino, Ausenda			Two new ootaxa from the late Jurassic: The oldest record of crocodylomorph eggs, from the Lourinha Formation, Portugal	PLOS ONE			English	Article							CROCODILIAN EGGS; MIDDLE EOCENE; EGGSHELLS; MESOEUCROCODYLIA; DIVERSITY; CROCODYLIFORM; TRANSITION; ALLOMETRY; REVISION; DINOSAUR	The Late Jurassic Lourinha Formation is known for its abundant remains of dinosaurs, crocodylomorphs and other vertebrates. Among this record are nine localities that have produced either dinosaur embryos, eggs or eggshell fragments. Herein, we describe and identify the first crocodiloid morphotype eggs and eggshells from the Lourinha Formation, from five occurrences. One clutch from Cambelas, composed of 13 eggs, eggshell fragments from Casal da Rola and Peralta, one crushed egg and eggshells from Paimogo North, and four crushed eggs as well as eggshell fragments from Paimogo South. We observed and confirmed diagnostic morphological characters for crocodiloid eggshells and which are consistent with a crocodylomorph affinity, such as the ellipsoidal shape, wedgeshaped shell units, triangular extinction under cross-polarized light, and tabular ultrastructure. This material is distinctive enough to propose two new ootaxa within the oofamily Krokolithidae, Suchoolithus portucalensis, oogen. and oosp. nov., for the material from Cambelas, the most complete clutch known for crocodiloid eggs, and Krokolithes dinophilus, oosp. nov., for the remaining material. These are the oldest crocodylomorph eggs known, extending the fossil record for this group to the Late Jurassic. Furthermore, except for the clutch from Cambelas, the material was found with theropod eggs and nests, in the other four occurrences, which seem to suggest some form of biological relationship, still unclear at this point.	[Russo, Joao; Mateus, Octavio; Marzola, Marco; Balbino, Ausenda] Univ Nova Lisboa, Fac Ciencias & Tecnol, GeoBioTec, Caparica, Portugal; [Russo, Joao; Mateus, Octavio; Marzola, Marco] Museu Lourinha, Lourinha, Portugal; [Marzola, Marco] Univ Copenhagen, Dept Geosci & Nat Resource Management, Copenhagen, Denmark; [Balbino, Ausenda] Univ Evora, Dept Geociencias, Evora, Portugal	Universidade Nova de Lisboa; University of Copenhagen; University of Evora	Russo, J (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, GeoBioTec, Caparica, Portugal.; Russo, J (corresponding author), Museu Lourinha, Lourinha, Portugal.	jpvmrusso@gmail.com	Mateus, Octávio/F-2910-2010; Marzola, Marco/I-5121-2019	Mateus, Octávio/0000-0003-1253-3616; Marzola, Marco/0000-0002-7067-2502; Russo, Joao/0000-0001-7730-1395; Caceres Balbino, Ausenda/0000-0001-9441-1043	Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/BIA-EVF/11322/2009]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This research was partly funded by Fundacao para a Ciencia e Tecnologia (http://www.fct.pt/), Portugal, through the grant PTDC/BIA-EVF/11322/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, REV MUSEO ARGENTINE, V5, P13; Antunes MT, 2003, CR PALEVOL, V2, P77, DOI 10.1016/S1631-0683(03)00003-4; Antunes MT, 1998, MEM ACAD CIEN LISB, V37, P83; Araujo R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01924; Araujo R, 2012, J VERTEBR PALEONTOL, V32, P57; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Bronzati M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140385; Bryan TA, 2005, MORPHOLOGICAL CONSTI; Buscalioni AD, 2008, CRETACEOUS RES, V29, P687, DOI 10.1016/j.cretres.2008.02.004; Canudo JI, 2010, J IBER GEOL, V36, P205, DOI 10.5209/rev_JIGE.2010.v36.n2.8; Carpenter K., 1999, EGGS NESTS BABY DINO; Carrano M, 2013, J VERTEBR PALEONTOL, V101; Castanhinha R, 2009, PORTUGAL J VERTEBR P, V29; de Lapparent AF, 1957, DINOSAURIENS PORTUGA; de Ricqles A, 2001, CR ACAD SCI II A, V332, P647, DOI 10.1016/S1251-8050(01)01580-4; Ensom P.C., 1997, P DORSET NATURAL HIS, V118, P79; Ensom PC, 2002, SPEC PAP PALAEONTOL, P221; Erben HK, 1970, ULTRASTRUKTUREN MINE; Erben HK, 1972, BIOMINERALISATION, V6, P32; Erickson BR, 1978, AMNIOTE EGG UPPER CR; FERGUSON M W J, 1982, Transactions of the Zoological Society of London, V36, P99; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; Garcia G, 2000, GEOBIOS-LYON, V33, P113, DOI 10.1016/S0016-6995(00)80155-2; Garcia JJM, 1993, RESTOS INDIRECTOS DI; Grellet-Tinner G, 2008, DOC LAB GEOLOGIE LYO, V164; Hastings AK, 2015, PALAIOS, V30, P446, DOI 10.2110/palo.2014.062; Heller F, 1931, NOVA ACTA LEOPOLDINA, V1, P55; Hendrickx C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088905; Hill G., 1988, SEDIMENTOLOGY LITHOS; Hirsch K.F., 1992, Journal of Vertebrate Paleontology, V12, P59; Hirsch K.F., 1990, Journal of Vertebrate Paleontology, V10, P491; Hirsch Karl F., 1994, P137; HIRSCH KF, 1985, J PALEONTOL, V59, P531; Jackson FD, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1185432; Jackson FD, 2010, J VERTEBR PALEONTOL, V30, P1142, DOI 10.1080/02724634.2010.483537; Karl H-V, 2006, CLAUSTHALER GEOWISSE, V5, P59; KEROURIO P, 1987, GEOBIOS-LYON, V20, P275, DOI 10.1016/S0016-6995(87)80038-4; Kohring R., 1990, Journal of Vertebrate Paleontology, V10, P128; Kohring R, 1996, J VERTEBR PALEONTOL, V16, P67, DOI 10.1080/02724634.1996.10011285; KOHRING R, 1990, Palaeontologische Zeitschrift, V64, P329; Kohring R., 1992, FOSSILE KROKODIL EIS; Kohring R, 2000, EGGSHELLS GUIMAROTA, V87-90; Kohring Rolf, 1993, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V9, P1; Kohring Rolf, 1992, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V3, P253; Kohring Rolf R., 1995, Historical Biology, V10, P259; Krebs B., 1967, Palaeontologische Zeitschrift, V41, P46; Krebs B., 1968, CROCODILIEN MACHIMOS; KULLBERG JC, 2000, EVOLUCAO TECTONICA M; Kullberg JC, 2006, BACIA LUSITANIANA ES; Lapparent A. F., 1957, Memorias Servicos Geologicos Portugal NS, V2, P1; Larriera A, 2004, J HERPETOL, V38, P301, DOI 10.1670/145-03A; Mannion PD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9438; Mannion PD, 2013, ZOOL J LINN SOC-LOND, V168, P98, DOI 10.1111/zoj.12029; Markwick PJ, 1998, PALEOBIOLOGY, V24, P470, DOI 10.1017/S009483730002011X; Martins RM, 2011, MRS P; Marzola M, 2014, 12 ANN M EUR ASS VER, P109; Marzola M, 2015, HIST BIOL, V27, P115, DOI 10.1080/08912963.2013.871009; Mateus I, 1997, CR ACAD SCI II A, V325, P71, DOI 10.1016/S1251-8050(97)83275-2; Mateus I, 1998, MEM ACAD CIENC LISB, V37; Mateus O., 2006, N MEX MUS NAT HIST S, V36, P223; Mateus O., 2008, RES 10 C LUS ESP HER; Mateus O., 2013, HWAS INT DIN EXP S S, P66; Mateus O., 2006, PALEONTOLOGY GEOLOGY, V36, P123; Mateus O, 2014, CIENC TERRA SPEC; Mikhailov K.E., 1991, ACTA PALAENTOL POL, V36, P1991; Mikhailov K.E., 1997, FOSSIL RECENT EGGSHE; Mikhailov KE, 1996, J VERTEBR PALEONTOL, V16, P763, DOI 10.1080/02724634.1996.10011364; Moreno-Azanza M, 2014, THESIS; Moreno-Azanza M, 2015, 13 ANN M EUR ASS VER, P97; Moreno-Azanza M, 2015, CRETACEOUS RES, V56, P617, DOI 10.1016/j.cretres.2015.06.019; Moreno-Azanza M, 2014, HIST BIOL, V26, P195, DOI 10.1080/08912963.2013.786067; Murray CM, 2013, COPEIA, P268, DOI 10.1643/CH-11-136; Novas FE, 2009, J VERTEBR PALEONTOL, V29, P1316, DOI 10.1671/039.029.0409; Oliveira CEM, 2011, PALAEONTOLOGY, V54, P309, DOI 10.1111/j.1475-4983.2010.01028.x; Packard M.J., 1991, P53, DOI 10.1017/CBO9780511585739.006; PACKARD MJ, 1982, HERPETOLOGICA, V38, P136; Panades I, 2009, PAL ARCHS J VERTEBR, V6; Patnaik Rajeev, 1993, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V33, P91; Prasad GVR, 2015, CR PALEVOL, V14, P513, DOI 10.1016/j.crpv.2015.05.006; Ribeiro CMM, 2006, OVOS CROCODILOMORTOS, P285; Ribeiro CMM, 2011, OVOS CROCODILOMORFOS, P663; Ribeiro V, 2014, HIST BIOL, V26, P206, DOI 10.1080/08912963.2013.807254; Ribeiro V, 2012, J VERTEBR PALEONTOL, V32, P161; Rogers JV, 2000, J VERTEBR PALEONTOL, V20, P780, DOI 10.1671/0272-4634(2000)020[0780:ACCEFT]2.0.CO;2; Russo J, 2014, CROCODYLOMORPH EGGS; Salminen J, 2014, SPR GEOL, P873, DOI 10.1007/978-3-319-04364-7_165; Schmidt W. J., 1943, Z MORPHOL OKOL TIERE, V40, P17; Schneider S, 2009, INT J EARTH SCI, V98, P1949, DOI 10.1007/s00531-008-0359-3; Schwarz D, 2005, GEOBIOS-LYON, V38, P779, DOI 10.1016/j.geobios.2004.04.005; Schwarz D, 2004, CAN J EARTH SCI, V41, P1259, DOI 10.1139/E04-059; Schwarz D, 2002, PALAEONTOLOGY, V45, P185, DOI 10.1111/1475-4983.00233; Schwarz D, 2008, J VERTEBR PALEONTOL, V28, P264, DOI 10.1671/0272-4634(2008)28[264:TFDOLC]2.0.CO;2; Seiffert J, 1973, UPPER JURASSIC LIZAR; Singh SD, 1998, OFFENTLICHUNGEN FUHL, V4, P307; Somaweera R, 2013, HERPETOL MONOGR, V27, P23, DOI 10.1655/HERPMONOGRAPHS-D-11-00001; Srivastava R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144369; Stewart James R., 1997, P291, DOI 10.1016/B978-012676460-4/50010-X; Tanaka K, 2011, HIST BIOL, V23, P41, DOI 10.1080/08912963.2010.499171; Tennant JP, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2840; Tennant JP, 2014, PEERJ, V2, DOI 10.7717/peerj.599; Thorbjarnarson JB, 1996, HERPETOLOGICA, V52, P8; Tschopp E, 2015, PEERJ, V3, DOI 10.7717/peerj.857; Verdade L. M., 2001, Brazilian Journal of Biology, V61, P431, DOI 10.1590/S1519-69842001000300012; vonMeyer H, 1837, NEUES JB MINERAL GEO, V1837, P572; Young MT, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140269; Young MT, 2010, ZOOL J LINN SOC-LOND, V158, P801, DOI 10.1111/j.1096-3642.2009.00571.x; Zhao Zi-kui, 1975, Vertebrata Palasiatica, V13, P105	107	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171919	10.1371/journal.pone.0171919	http://dx.doi.org/10.1371/journal.pone.0171919			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273086	gold, Green Published, Green Submitted			2022-12-27	WOS:000396073700062
J	Uhlig, CH; Gutschalk, A				Uhlig, Christian Harm; Gutschalk, Alexander			Transient human auditory cortex activation during volitional attention shifting	PLOS ONE			English	Article							SPATIAL ATTENTION; SELECTIVE ATTENTION; VISUAL-CORTEX; BRAIN; MAINTENANCE; MODULATION; AUDITION; VISION; SENSITIVITY	While strong activation of auditory cortex is generally found for exogenous orienting of attention, endogenous, intra-modal shifting of auditory attention has not yet been demonstrated to evoke transient activation of the auditory cortex. Here, we used fMRI to test if endogenous shifting of attention is also associated with transient activation of the auditory cortex. In contrast to previous studies, attention shifts were completely self-initiated and not cued by transient auditory or visual stimuli. Stimuli were two dichotic, continuous streams of tones, whose perceptual grouping was not ambiguous. Participants were instructed to continuously focus on one of the streams and switch between the two after a while, indicating the time and direction of each attentional shift by pressing one of two response buttons. The BOLD response around the time of the button presses revealed robust activation of the auditory cortex, along with activation of a distributed task network. To test if the transient auditory cortex activation was specifically related to auditory orienting, a self-paced motor task was added, where participants were instructed to ignore the auditory stimulation while they pressed the response buttons in alternation and at a similar pace. Results showed that attentional orienting produced stronger activity in auditory cortex, but auditory cortex activation was also observed for button presses without focused attention to the auditory stimulus. The response related to attention shifting was stronger contralateral to the side where attention was shifted to. Contralateral-dominant activation was also observed in dorsal parietal cortex areas, confirming previous observations for auditory attention shifting in studies that used auditory cues.	[Uhlig, Christian Harm; Gutschalk, Alexander] Heidelberg Univ, Dept Neurol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Gutschalk, A (corresponding author), Heidelberg Univ, Dept Neurol, Heidelberg, Germany.	Alexander.Gutschalk@med.uni-heidelberg.de			Deutsche Forschungsgemeinschaft (DFG) [GU593/3-2]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	Research was supported by Deutsche Forschungsgemeinschaft (DFG, grant GU593/3-2). Open access publishing was supported by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Alho K, 1999, COGNITIVE BRAIN RES, V7, P335, DOI 10.1016/S0926-6410(98)00036-6; Braga RM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00164; Brosch M, 2005, J NEUROSCI, V25, P6797, DOI 10.1523/JNEUROSCI.1571-05.2005; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coste CP, 2016, NEUROIMAGE, V128, P264, DOI 10.1016/j.neuroimage.2016.01.026; Cusack R, 2005, J COGNITIVE NEUROSCI, V17, P641, DOI 10.1162/0898929053467541; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Degerman A, 2006, BRAIN RES, V1077, P123, DOI 10.1016/j.brainres.2006.01.025; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Edmister WB, 1999, HUM BRAIN MAPP, V7, P89, DOI 10.1002/(SICI)1097-0193(1999)7:2<89::AID-HBM2>3.3.CO;2-E; Elkhetali AS, 2015, NEUROIMAGE, V107, P277, DOI 10.1016/j.neuroimage.2014.11.061; Ewertsen H. W., 1966, ACTA OTO-LARYNGOL, V63, P211, DOI [10.3109/00016486709123581, DOI 10.3109/00016486709123581]; Fedorenko E, 2013, P NATL ACAD SCI USA, V110, P16616, DOI 10.1073/pnas.1315235110; Feng WF, 2014, J NEUROSCI, V34, P9817, DOI 10.1523/JNEUROSCI.4869-13.2014; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gutschalk A, 2005, J NEUROSCI, V25, P5382, DOI 10.1523/JNEUROSCI.0347-05.2005; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Huang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044062; Hugdahl K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00430; Jack AI, 2006, NEURON, V51, P135, DOI 10.1016/j.neuron.2006.06.003; Jancke L, 2003, COGNITIVE BRAIN RES, V16, P257, DOI 10.1016/S0926-6410(02)00281-1; Joshi S, 2016, NEURON, V89, P221, DOI 10.1016/j.neuron.2015.11.028; Kondo HM, 2009, J NEUROSCI, V29, P12695, DOI 10.1523/JNEUROSCI.1549-09.2009; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Krumbholz K, 2009, HUM BRAIN MAPP, V30, P1457, DOI 10.1002/hbm.20615; Lee AKC, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00190; Maddox RK, 2014, CURR BIOL, V24, P748, DOI 10.1016/j.cub.2014.02.021; Martikainen MH, 2005, CEREB CORTEX, V15, P299, DOI 10.1093/cercor/bhh131; McGinley MJ, 2015, NEURON, V87, P179, DOI 10.1016/j.neuron.2015.05.038; Paltoglou AE, 2011, EUR J NEUROSCI, V33, P1733, DOI 10.1111/j.1460-9568.2011.07656.x; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; [R Core Team Team C], 2015, R FOUNDATION FOR STA; Reznik D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127651; Reznik D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5059; Riecke L, 1991, FREQUENCY SELECTIVE; Rif J., 1991, CLIN NEUROPHYSIOL, V79, P464, DOI [10.1016/0013-4694(91)90166-2, DOI 10.1016/0013-4694(91)90166-2]; Salmi J, 2007, BRAIN STRUCT FUNCT, V212, P181, DOI 10.1007/s00429-007-0152-2; Salmi J, 2007, EUR J NEUROSCI, V25, P3725, DOI 10.1111/j.1460-9568.2007.05616.x; Salmi J, 2009, BRAIN RES, V1286, P155, DOI 10.1016/j.brainres.2009.06.083; Schadwinkel S, 2011, J NEUROPHYSIOL, V105, P1977, DOI 10.1152/jn.00461.2010; Schneider DM, 2014, NATURE, V513, P189, DOI 10.1038/nature13724; Seydell-Greenwald A, 2014, HUM BRAIN MAPP, V35, P2233, DOI 10.1002/hbm.22323; Shomstein S, 2006, J NEUROSCI, V26, P435, DOI 10.1523/JNEUROSCI.4408-05.2006; Shomstein S, 2004, J NEUROSCI, V24, P10702, DOI 10.1523/JNEUROSCI.2939-04.2004; Smith DT, 2009, BRAIN STIMUL, V2, P81, DOI 10.1016/j.brs.2008.07.005; Steinschneider M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00240; Voisin J, 2006, J NEUROSCI, V26, P273, DOI 10.1523/JNEUROSCI.2967-05.2006; Werner-Reiss U, 2008, J NEUROSCI, V28, P3747, DOI 10.1523/JNEUROSCI.5044-07.2008; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Yellin D, 2015, NEUROIMAGE, V106, P414, DOI 10.1016/j.neuroimage.2014.11.034	56	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172907	10.1371/journal.pone.0172907	http://dx.doi.org/10.1371/journal.pone.0172907			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273110	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700032
J	Geiss, LS; Kirtland, K; Lin, J; Shrestha, S; Thompson, T; Albright, A; Gregg, EW				Geiss, Linda S.; Kirtland, Karen; Lin, Ji; Shrestha, Sundar; Thompson, Ted; Albright, Ann; Gregg, Edward W.			Changes in diagnosed diabetes, obesity, and physical inactivity prevalence in US counties, 2004-2012	PLOS ONE			English	Article							UNITED-STATES; TRENDS; ADULTS	Recent studies suggest that prevalence of diagnosed diabetes in the United States reached a plateau or slowed around 2008, and that this change coincided with obesity plateaus and increases in physical activity. However, national estimates can obscure important variations in geographic subgroups. We examine whether a slowing or leveling off in diagnosed diabetes, obesity, and leisure time physical inactivity prevalence is also evident across the 3143 counties of the United States. We used publicly available county estimates of the age-adjusted prevalence of diagnosed diabetes, obesity, and leisure-time physical inactivity, which were generated by the Centers for Disease Control and Prevention (CDC). Using a Bayesian multi-level regression that included random effects by county and year and applied cubic splines to smooth these estimates over time, we estimated the average annual percentage point change (APPC) from 2004 to 2008 and from 2008 to 2012 for diabetes, obesity, and physical inactivity prevalence in each county. Compared to 2004-2008, the median APPCs for diabetes, obesity, and physical inactivity were lower in 2008-2012 (diabetes APPC difference = 0.16, 95% CI 0.14, 0.18; obesity APPC difference = 0.65, 95% CI 0.59, 0.70; physical inactivity APPC difference = 0.43, 95% CI 0.37, 0.48). APPCs and APPC differences between time periods varied among counties and U.S. regions. Despite improvements, levels of these risk factors remained high with most counties merely slowing rather than reversing, which suggests that all counties would likely benefit from reductions in these risk factors. The diversity of trajectories in the prevalence of these risk factors across counties underscores the continued need to identify high risk areas and populations for preventive interventions. Awareness of how these factors are changing might assist local policy makers in targeting and tracking the impact of efforts to reduce diabetes, obesity and physical inactivity.	[Geiss, Linda S.; Lin, Ji; Shrestha, Sundar; Thompson, Ted; Albright, Ann; Gregg, Edward W.] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30329 USA; [Kirtland, Karen] Northrop Grumman Corp, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Northrop Grumman Corporation	Geiss, LS (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30329 USA.	lsg2@cdc.gov		Gregg, Edward/0000-0003-2381-6822	Northrop Grumman Corporation	Northrop Grumman Corporation	KK is an employee of Northrop Grumman Corporation which provides scientific analysis services as directed by the Centers for Disease Control and Prevention (CDC) through a contract with CDC. Other than providing the salary of KK, Northrop Grumman Corporation did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of KK are articulated in the "author contributions" section.	Abraham TM, 2015, DIABETES CARE, V38, P482, DOI 10.2337/dc14-1432; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Barker LE, 2011, AM J PREV MED, V40, P434, DOI 10.1016/j.amepre.2010.12.019; Cadwell BL, 2010, J DATA SCI, V11, P249; Centers for Disease Control and Prevention, 2012, NAT DIAB SURV SYST 2; Dall TM, 2009, POPUL HEALTH MANAG, V12, P103, DOI 10.1089/pop.2009.12203; Dwyer-Lindgren L, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-7; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Ford ES, 2013, AM J CLIN NUTR, V97, P848, DOI 10.3945/ajcn.112.052662; Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Gregg E. W., 2009, Morbidity and Mortality Weekly Report, V58, P1259; Gustat J, 2014, AM J HEALTH PROMOT, V28, pS33, DOI 10.4278/ajhp.130430-QUAN-216; [Healthy People 2020 Prevention. CfDCa], 2014, HLTH PEOPL 2020 NO I; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Moore LV, 2012, RES Q EXERCISE SPORT, V83, P587; Ng SW, 2014, AM J CLIN NUTR; Nichols GA, 2015, AM J EPIDEMIOL, V181, P32, DOI 10.1093/aje/kwu255; Ogden CL, 2013, NCHS DATA BRIEF, V131, P1; Ogden CL, 2015, NCHS DATA BRIEF, P1, DOI DOI 10.1017/S1368980017000088; Pearson JF, 2010, DIABETES CARE, V33, P2196, DOI 10.2337/dc10-0698; Salois M, 2007, EC HUMAN BIOL, V10, P35, DOI DOI 10.1016/J.EHB.2011.04.001; Shrestha SS, 2012, OPEN DIABETES J, V5; Shrestha SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159876; Slack T, 2014, OBESITY, V22, P868, DOI 10.1002/oby.20502; Statistics NCfH, 2015, TABL 63 PART LEIS TI; Tabaei BP, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110320; Wang DD, 2015, HEALTH AFFAIR, V34, P1916, DOI 10.1377/hlthaff.2015.0640; Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366	31	29	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173428	10.1371/journal.pone.0173428	http://dx.doi.org/10.1371/journal.pone.0173428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267760	Green Published, gold, Green Submitted			2022-12-27	WOS:000396060600032
J	Rossoni, RD; Fuchs, BB; de Barros, PP; Velloso, MD; Jorge, AOC; Junqueira, JC; Mylonakis, E				Rossoni, Rodnei Dennis; Fuchs, Beth Burgwyn; de Barros, Patricia Pimentel; Velloso, Marisol dos Santos; Cardoso Jorge, Antonio Olavo; Junqueira, Juliana Campos; Mylonakis, Eleftherios			Lactobacillus paracasei modulates the immune system of Galleria mellonella and protects against Candida albicans infection	PLOS ONE			English	Article							MODEL HOST; IN-VITRO; PROBIOTIC LACTOBACILLUS; ANTIMICROBIAL PEPTIDES; VIRULENCE FACTORS; GENE-EXPRESSION; INNATE IMMUNITY; LARVAE; RESPONSES; PATHOGENESIS	Probiotics have been described as a potential strategy to control opportunistic infections due to their ability to stimulate the immune system. Using the non-vertebrate model host Galleria mellonella, we evaluated whether clinical isolates of Lactobacillus spp. are able to provide protection against Candida albicans infection. Among different strains of Lactobacillus paracasei, Lactobacillus rhamnosus and Lactobacillus fermentum, we verified that L. paracasei 28.4 strain had the greatest ability to prolong the survival of larvae infected with a lethal dose of C. albicans. We found that the injection of 10(7) cells/larvae of L. paracasei into G. mellonella larvae infected by C. albicans increased the survival of these insects compared to the control group (P = 0.0001). After that, we investigated the immune mechanisms involved in the protection against C. albicans infection, evaluating the number of hemocytes and the gene expression of antifungal peptides. We found that L. paracasei increased the hemocyte quantity (2.38 x 10(6) cells/mL) in relation to the control group (1.29 x 10(6) cells/mL), indicating that this strain is capable of raising the number of circulating hemocytes into the G. mellonella hemolymph. Further, we found that L. paracasei 28.4 upregulated genes that encode the antifungal peptides galiomicin and gallerymicin. In relation to the control group, L. paracasei 28.4 increased gene expression of galiomicin by 6.67-fold and 17.29-fold for gallerymicin. Finally, we verified that the prophylactic provision of probiotic led to a significant reduction of the number of fungal cells in G. mellonella hemolymph. In conclusion, L. paracasei 28.4 can modulate the immune system of G. mellonella and protect against candidiasis.	[Rossoni, Rodnei Dennis; de Barros, Patricia Pimentel; Velloso, Marisol dos Santos; Cardoso Jorge, Antonio Olavo; Junqueira, Juliana Campos] Univ Estadual Paulista UNESP, Dept Biosci & Oral Diag, Sao Paulo, Brazil; [Rossoni, Rodnei Dennis; Fuchs, Beth Burgwyn; Mylonakis, Eleftherios] Brown Univ, Alpert Med Sch, Rhode Isl Hosp, Div Infect Dis, Providence, RI 02912 USA	Universidade Estadual Paulista; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Junqueira, JC (corresponding author), Univ Estadual Paulista UNESP, Dept Biosci & Oral Diag, Sao Paulo, Brazil.	juliana@ict.unesp.br	Rossoni, Rodnei D/K-2390-2013; de Barros, Patrícia Pimentel/M-8160-2019; De Barros, Patrícia Pimentel/B-3496-2016; Junqueira, Juliana/GQZ-4509-2022; Junqueira, Juliana Campos/Q-3108-2019	Rossoni, Rodnei D/0000-0002-9977-3040; de Barros, Patrícia Pimentel/0000-0003-4885-2811; De Barros, Patrícia Pimentel/0000-0003-4885-2811; Junqueira, Juliana Campos/0000-0001-6646-6856	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/25181-8, 2014/12458-4, 2015/09770-9]; FAPESP [2013/25181-8, 2014/12458-4, 2015/09770-9]; Brown/Brazil Initiative at Brown University	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brown/Brazil Initiative at Brown University	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2013/25181-8, 2014/12458-4 and 2015/09770-9). RDR received a doctoral fellowship from FAPESP (2013/25181-8, 2014/12458-4). JCJ received a grant from FAPESP (2015/09770-9). Funding was also made available through a grant from the Brown/Brazil Initiative at Brown University.	Abedin-Do A, 2015, IMMUNOTHERAPY-UK, V7, P1307, DOI 10.2217/imt.15.92; Aoudia N, 2016, FOOD MICROBIOL, V53, P51, DOI 10.1016/j.fm.2015.04.009; Arvanitis M, 2013, BBA-MOL BASIS DIS, V1832, P1378, DOI 10.1016/j.bbadis.2013.03.008; Barbosa JO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150457; Bergin D, 2003, MICROBES INFECT, V5, P1389, DOI 10.1016/j.micinf.2003.09.019; Bergin D, 2006, MICROBES INFECT, V8, P2105, DOI 10.1016/j.micinf.2006.03.005; Brown SE, 2009, INSECT BIOCHEM MOLEC, V39, P792, DOI 10.1016/j.ibmb.2009.09.004; Chassot F, 2010, CONTRACEPTION, V81, P331, DOI 10.1016/j.contraception.2009.12.011; Chibebe J, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-217; Chon H, 2009, J APPL MICROBIOL, V107, P1588, DOI 10.1111/j.1365-2672.2009.04343.x; Chon H, 2010, COMP IMMUNOL MICROB, V33, pE41, DOI 10.1016/j.cimid.2009.11.002; Coronado-Castellote Laura, 2013, J Clin Exp Dent, V5, pe279, DOI 10.4317/jced.51242; Fallon JP, 2011, VIRULENCE, V2, P413, DOI 10.4161/viru.2.5.17811; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Galdeano CM, 2006, CLIN VACCINE IMMUNOL, V13, P219, DOI 10.1128/CVI.13.2.219-226.2006; GANZ T, 1995, PHARMACOL THERAPEUT, V66, P191, DOI 10.1016/0163-7258(94)00076-F; Grounta A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161263; Guarner F, 2012, J CLIN GASTROENTEROL, V46, P468, DOI 10.1097/MCG.0b013e3182549092; Hasslof P, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-18; Hofs S, 2016, J MICROBIOL, V54, P149, DOI 10.1007/s12275-016-5514-0; Jiang QR, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0759-7; Jorjao Adeline Lacerda, 2015, ScientificWorldJournal, V2015, P716749, DOI 10.1155/2015/716749; Joyce SA, 2010, MICROBIOL-SGM, V156, P3456, DOI 10.1099/mic.0.040782-0; Junqueira JC, 2012, VIRULENCE, V3, P474, DOI 10.4161/viru.22493; Kim YG, 2006, MICROBES INFECT, V8, P994, DOI 10.1016/j.micinf.2005.10.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowenberger C, 2001, INSECT BIOCHEM MOLEC, V31, P219, DOI 10.1016/S0965-1748(00)00141-7; Martinez-Alvarez JA, 2014, REV IBEROAM MICOL, V31, P62, DOI 10.1016/j.riam.2013.09.015; Matsubara VH, 2016, APPL MICROBIOL BIOT, V100, P6415, DOI 10.1007/s00253-016-7527-3; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Morales DK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000886; Mowlds P, 2008, MYCOPATHOLOGIA, V165, P5, DOI 10.1007/s11046-007-9069-9; Mowlds P, 2010, MICROBES INFECT, V12, P146, DOI 10.1016/j.micinf.2009.11.004; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Oliveira VMC, 2016, J APPL MICROBIOL, V121, P1737, DOI 10.1111/jam.13289; RATCLIFFE NA, 1985, IMMUNOL LETT, V10, P253, DOI 10.1016/0165-2478(85)90100-2; Ribeiro FC, 2017, J APPL MICROBIOL, V122, P201, DOI 10.1111/jam.13324; Ryan KA, 2009, J MED MICROBIOL, V58, P996, DOI 10.1099/jmm.0.009407-0; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Soloviev DA, 2011, INFECT IMMUN, V79, P1546, DOI 10.1128/IAI.00650-10; Song YL, 2000, FEMS MICROBIOL LETT, V187, P167, DOI 10.1016/S0378-1097(00)00196-8; Vilela SFG, 2015, VIRULENCE, V6, P29, DOI 10.4161/21505594.2014.981486; Vilmos P, 1998, IMMUNOL LETT, V62, P59, DOI 10.1016/S0165-2478(98)00023-6; Wagner RD, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-58; Wickens K, 2008, J ALLERGY CLIN IMMUN, V122, P788, DOI 10.1016/j.jaci.2008.07.011; Zdybicka-Barabas A, 2014, ARCH INSECT BIOCHEM, V87, P1, DOI 10.1002/arch.21175	47	53	55	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173332	10.1371/journal.pone.0173332	http://dx.doi.org/10.1371/journal.pone.0173332			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267809	gold, Green Published, Green Submitted			2022-12-27	WOS:000396060600022
J	Eliasson, P; Svensson, RB; Giannopoulos, A; Eismark, C; Kjaer, M; Schjerling, P; Heinemeier, KM				Eliasson, Pernilla; Svensson, Rene B.; Giannopoulos, Antonis; Eismark, Christian; Kjaer, Michael; Schjerling, Peter; Heinemeier, Katja M.			Simvastatin and atorvastatin reduce the mechanical properties of tendon constructs in vitro and introduce catabolic changes in the gene expression pattern	PLOS ONE			English	Article							ACHILLES-TENDON; COLLAGEN FIBRILLOGENESIS; STATIN THERAPY; RUPTURE; CELLS; FIBROBLASTS	Treatment with lipid-lowering drugs, statins, is common all over the world. Lately, the occurrence of spontaneous tendon ruptures or tendinosis have suggested a negative influence of statins upon tendon tissue. But how statins might influence tendons is not clear. In the present study, we investigated the effect of statin treatment on mechanical strength, cell proliferation, collagen content and gene expression pattern in a tendon-like tissue made from human tenocytes in vitro. Human tendon fibroblasts were grown in a 3D tissue culture model (tendon constructs), and treated with either simvastatin or atorvastatin, low or high dose, respectively, for up to seven days. After seven days of treatment, mechanical testing of the constructs was performed. Collagen content and cell proliferation were also determined. mRNA levels of several target genes were measured after one or seven days. The maximum force and stiffness were reduced by both statins after 7 days (p<0.05), while the cross sectional area was unaffected. Further, the collagen content was reduced by atorvastatin (p = 0.01) and the cell proliferation rate was decreased by both types of statins (p<0.05). Statin treatment also introduced increased mRNA levels of MMP-1, MMP-3, MMP-13, TIMP-1 and decreased levels of collagen type 1 and 3. In conclusion, statin treatment appears to have a negative effect on tendon matrix quality as seen by a reduced strength of the tendon constructs. Further, activated catabolic changes in the gene expression pattern and a reduced collagen content indicated a disturbed balance in matrix production of tendon due to statin administration.	[Eliasson, Pernilla; Svensson, Rene B.; Giannopoulos, Antonis; Eismark, Christian; Kjaer, Michael; Schjerling, Peter; Heinemeier, Katja M.] Bispebjerg Hosp, Dept Orthoped Surg M, Inst Sports Med Copenhagen, Copenhagen, Denmark; [Eliasson, Pernilla; Svensson, Rene B.; Giannopoulos, Antonis; Eismark, Christian; Kjaer, Michael; Schjerling, Peter; Heinemeier, Katja M.] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Aging, Copenhagen, Denmark; [Eliasson, Pernilla] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Linkoping University	Eliasson, P (corresponding author), Bispebjerg Hosp, Dept Orthoped Surg M, Inst Sports Med Copenhagen, Copenhagen, Denmark.; Eliasson, P (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Aging, Copenhagen, Denmark.; Eliasson, P (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	pernilla.eliasson@gmail.com	Svensson, Rene B./AGZ-3181-2022; Kjaer, Michael/W-6842-2019; Eliasson, Pernilla/AAY-2126-2020; Schjerling, Peter/F-6194-2011	Svensson, Rene B./0000-0002-1607-5379; Kjaer, Michael/0000-0002-4582-8755; Eliasson, Pernilla/0000-0001-6718-034X; Schjerling, Peter/0000-0001-7138-3211	Lundbeck Foundation; Nordea Foundation; IOC Sports medicine Copenhagen; Danish Medical Research Council [0602-02960B]; Swedish Society for Medical Research; Magnus Bergyall Foundation; Lions research foundation; Lundbeck Foundation [R198-2015-207] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0012491, NNF16OC0022846] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Nordea Foundation; IOC Sports medicine Copenhagen; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Society for Medical Research; Magnus Bergyall Foundation; Lions research foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by grants from Lundbeck Foundation), Nordea Foundation (Center of Healthy Aging grant), IOC Sports medicine Copenhagen, Danish Medical Research Council (grant number 0602-02960B), Swedish Society for Medical Research, Magnus Bergyall Foundation, and Lions research foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud JA, 2010, CLIN ORTHOP RELAT R, V468, P1493, DOI 10.1007/s11999-009-1151-9; Bayer ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086078; Bayer ML, 2010, BIOMATERIALS, V31, P4889, DOI 10.1016/j.biomaterials.2010.02.062; Beri A, 2008, ARTHRIT RHEUM-ARTHR, V59, P1202, DOI 10.1002/art.23917; Beri A, 2009, J CARDIOVASC PHARM, V53, P401, DOI 10.1097/FJC.0b013e3181a0ce8b; Carmont MR, 2009, PHYS THER SPORT, V10, P150, DOI 10.1016/j.ptsp.2009.01.003; Contractor T, 2015, AM J THER, V22, P377, DOI 10.1097/MJT.0000000000000039; Davis ME, 2015, J SHOULDER ELB SURG, V24, P280, DOI 10.1016/j.jse.2014.06.048; de Oliveira LP, 2015, FOOD CHEM TOXICOL, V77, P50, DOI 10.1016/j.fct.2014.12.014; de Oliveira LP, 2013, TOXICOLOGY, V311, P162, DOI 10.1016/j.tox.2013.06.010; Dolkart O, 2014, AM J SPORT MED, V42, P2869, DOI 10.1177/0363546514545856; Esenkaya Irfan, 2010, Orthopedics, V33, P398, DOI 10.3928/01477447-20100429-06; Ferri N, 2007, ARTERIOSCL THROM VAS, V27, P1043, DOI 10.1161/ATVBAHA.107.139881; Heinemeier KM, 2013, FASEB J, V27, P2074, DOI 10.1096/fj.12-225599; Herchenhan A, 2015, J BIOL CHEM, V290, P16440, DOI 10.1074/jbc.M115.641670; Herchenhan A, 2013, DEV DYNAM, V242, P2, DOI 10.1002/dvdy.23896; Hoffman KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042866; Jackevicius CA, 2008, NEW ENGL J MED, V358, P1819, DOI 10.1056/NEJMsa0801461; Kaleagasioglu F, 2015, KNEE SURG SPORTS TRA; KLEMP P, 1993, ANN RHEUM DIS, V52, P44, DOI 10.1136/ard.52.1.44; Kuzma-Kuzniarska M, 2015, J CELL PHYSIOL, V230, P2543, DOI 10.1002/jcp.25010; Lin TTL, 2015, AM J SPORT MED, V43, P2126, DOI 10.1177/0363546515588173; Lindner D, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/875742; Marie I, 2008, ARTHRIT RHEUM-ARTHR, V59, P367, DOI 10.1002/art.23309; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; NEUMAN RE, 1950, J BIOL CHEM, V184, P299; Oka S, 2013, TISSUE ENG PT A, V19, P1233, DOI [10.1089/ten.tea.2012.0325, 10.1089/ten.TEA.2012.0325]; Pullatt RC, 2007, AM J CARDIOL, V100, P152, DOI 10.1016/j.amjcard.2007.02.068; Savvidou C, 2012, J HAND SURG-ASIAN-PA, V17, P167, DOI 10.1142/S0218810412500153; Tsai WC, 2016, TOXICOL SCI, V149, P326, DOI 10.1093/toxsci/kfv239	30	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172797	10.1371/journal.pone.0172797	http://dx.doi.org/10.1371/journal.pone.0172797			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264197	Green Published, gold, Green Submitted			2022-12-27	WOS:000396054300018
J	Jumper, N; Hodgkinson, T; Paus, R; Bayat, A				Jumper, N.; Hodgkinson, T.; Paus, R.; Bayat, A.			Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSFORMING-GROWTH-FACTOR; LASER-CAPTURE MICRODISSECTION; IDIOPATHIC PULMONARY-FIBROSIS; OLIGOMERIC MATRIX PROTEIN; CELL-ADHESION MOLECULE-1; TRIPLE-HELIX REPEAT; STEM-CELLS; PROSTATE-CANCER; DRUG-RESISTANCE	Keloid disease (KD) is a fibroproliferative cutaneous tumour characterised by heterogeneity, excess collagen deposition and aggressive local invasion. Lack of a validated animal model and resistance to a multitude of current therapies has resulted in unsatisfactory clinical outcomes of KD management. In order to address KD from a new perspective, we applied for the first time a site-specific in situ microdissection and gene expression profiling approach, through combined laser capture microdissection and transcriptomic array. The aim here was to analyse the utility of this approach compared with established methods of investigation, including whole tissue biopsy and monolayer cell culture techniques. This study was designed to approach KD from a hypothesis-free and compartment-specific angle, using state-of-the-art microdissection and gene expression profiling technology. We sought to characterise expression differences between specific keloid lesional sites and elucidate potential contributions of significantly dysregulated genes to mechanisms underlying keloid pathobiology, thus informing future explorative research into KD. Here, we highlight the advantages of our in situ microdissection strategy in generating expression data with improved sensitivity and accuracy over traditional methods. This methodological approach supports an active role for the epidermis in the pathogenesis of KD through identification of genes and upstream regulators implicated in epithelial-mesenchymal transition, inflammation and immune modulation. We describe dermal expression patterns crucial to collagen deposition that are associated with TGF beta-mediated signalling, which have not previously been examined in KD. Additionally, this study supports the previously proposed presence of a cancer-like stem cell population in KD and explores the possible contribution of gene dysregulation to the resistance of KD to conventional therapy. Through this innovative in situ microdissection gene profiling approach, we provide better-defined gene signatures of distinct KD regions, thereby addressing KD heterogeneity, facilitating differential diagnosis with other cutaneous fibroses via transcriptional fingerprinting, and highlighting key areas for future KD research.	[Jumper, N.; Hodgkinson, T.; Bayat, A.] Univ Manchester, Plast & Reconstruct Surg Res, Oxford Rd, Manchester, Lancs, England; [Hodgkinson, T.] Univ Manchester, Ctr Tissue Injury & Repair, Manchester, Lancs, England; [Hodgkinson, T.; Paus, R.; Bayat, A.] MAHSC, Manchester, Lancs, England; [Paus, R.; Bayat, A.] Univ Manchester, Ctr Dermatol Res, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Bayat, A (corresponding author), Univ Manchester, Plast & Reconstruct Surg Res, Oxford Rd, Manchester, Lancs, England.; Bayat, A (corresponding author), MAHSC, Manchester, Lancs, England.; Bayat, A (corresponding author), Univ Manchester, Ctr Dermatol Res, Manchester, Lancs, England.	Ardeshir.Bayat@manchester.ac.uk	Hodgkinson, Tom/AAJ-1373-2021; Hodgkinson, Tom/E-5767-2016	Hodgkinson, Tom/0000-0002-3242-1593				Agarwal P, 2013, MATRIX BIOL, V32, P325, DOI 10.1016/j.matbio.2013.02.010; Alessio M, 1998, INT J CLIN LAB RES, V28, P47, DOI 10.1007/s005990050017; Andrews JP, 2016, MATRIX BIOL; Arno AI, 2014, BURNS, V40, P1255, DOI 10.1016/j.burns.2014.02.011; Ashcroft KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075600; Ashkenazi S, 2016, ONCOTARGET; Bagabir R, 2012, BRIT J DERMATOL, V167, P1053, DOI 10.1111/j.1365-2133.2012.11190.x; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Baraut J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0708-0; Bauer Y, 2015, AM J RESP CELL MOL, V52, P217, DOI 10.1165/rcmb.2013-0310OC; Bayat A, 2005, BRIT J PLAST SURG, V58, P28, DOI 10.1016/j.bjps.2004.04.024; Bekhouche M, 2016, FASEB J; Bekhouche M, 2015, MATRIX BIOL, V44-46, P46, DOI 10.1016/j.matbio.2015.04.001; Benevides L, 2015, CANCER RES, V75, P3788, DOI 10.1158/0008-5472.CAN-15-0054; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman B, 2002, J AM ACAD DERMATOL, V47, pS209, DOI 10.1067/mjd.2002.126585; Berschneider B, 2014, INT J BIOCHEM CELL B, V53, P432, DOI 10.1016/j.biocel.2014.06.011; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonyadi Rad E, 2016, CANC RES; Borthwick LA, 2015, CURRENT PATHOBIOLOGY, V3, P273, DOI [10.1007/s40139-015-0091-1, DOI 10.1007/S40139-015-0091-1]; Broder C, 2013, P NATL ACAD SCI USA, V110, P14219, DOI 10.1073/pnas.1305464110; Bujko M, 2015, ONCOL LETT, V9, P2463, DOI 10.3892/ol.2015.3107; Busch C, 2002, HUM PATHOL, V33, P290, DOI 10.1053/hupa.2002.32218; Butler PD, 2008, J AM COLL SURGEONS, V206, P731, DOI 10.1016/j.jamcollsurg.2007.12.001; Cal S, 2015, MATRIX BIOL, V44-46, P77, DOI 10.1016/j.matbio.2015.01.013; Charrad R, 2016, IMMUNOBIOLOGY, V221, P182, DOI 10.1016/j.imbio.2015.09.009; Chen Z, 2008, CYTOKINE, V41, P71, DOI 10.1016/j.cyto.2007.09.009; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; Clavel G, 2013, JOINT BONE SPINE, V80, P449, DOI 10.1016/j.jbspin.2013.04.014; Clement-Ziza M, 2008, RNA, V14, P2698, DOI 10.1261/rna.1261708; Colige A, 2004, J INVEST DERMATOL, V123, P656, DOI 10.1111/j.0022-202X.2004.23406.x; Colige A, 2002, J BIOL CHEM, V277, P5756, DOI 10.1074/jbc.M105601200; Conley SJ, 2016, ONCOGENE; Cruz PV, 2005, CANCER-AM CANCER SOC, V104, P354, DOI 10.1002/cncr.21159; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; De Marchi T, 2016, PROTEOMICS, V16, P1474, DOI 10.1002/pmic.201600004; Derynck R, 2014, CURR OPIN CELL BIOL, V31, P56, DOI 10.1016/j.ceb.2014.09.001; Ding Q, 2015, ONCOL REP, V33, P1783, DOI 10.3892/or.2015.3791; Do DV, 2012, BRIT J DERMATOL, V166, P1275, DOI 10.1111/j.1365-2133.2011.10721.x; Dong XL, 2013, BIOMED REP, V1, P833, DOI 10.3892/br.2013.169; Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848; Duran GE, 2015, MOL CANCER THER, V14, P193, DOI 10.1158/1535-7163.MCT-14-0155; El-Serag HB, 2009, SCAND J GASTROENTERO, V44, P787, DOI 10.1080/00365520902898127; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Eo HJ, 2016, MAR DRUGS, V14, DOI 10.3390/md14040069; Eriksson J., 2016, ONCOTARGET, DOI 10.18632/oncotarget.7604; Ferrandina G, 2006, CLIN CANCER RES, V12, P2774, DOI 10.1158/1078-0432.CCR-05-2715; Francois A, 2015, J AUTOIMMUN, V56, P1, DOI 10.1016/j.jaut.2014.08.003; Granel B, 2006, J RHEUMATOL, V33, P2015; Grant C, 2016, J CLIN PATHOL; Gu FM, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-150; Hackl C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-668; Hahn JM, 2013, WOUND REPAIR REGEN, V21, P530, DOI 10.1111/wrr.12060; Hakvoort TE, 1999, VIRCHOWS ARCH, V434, P221, DOI 10.1007/s004280050331; Harries MJ, 2013, J PATHOL, V231, P236, DOI 10.1002/path.4233; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; He S, 2010, BRIT J DERMATOL, V162, P538, DOI 10.1111/j.1365-2133.2009.09511.x; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honoki K, 2010, ONCOL REP, V24, P501, DOI 10.3892/or_00000885; Huang XW, 2008, J BIOL CHEM, V283, P29795, DOI 10.1074/jbc.M802515200; Hurley PJ, 2016, CLIN CANCER RES, V22, P448, DOI 10.1158/1078-0432.CCR-15-0256; Imaeda H, 2013, CLIN EXP IMMUNOL, V172, P410, DOI 10.1111/cei.12061; Inui S, 2011, AM J PATHOL, V179, P1951, DOI 10.1016/j.ajpath.2011.06.034; Isailovic N, 2015, J AUTOIMMUN, V60, P1, DOI 10.1016/j.jaut.2015.04.006; Jadidi-Niaragh F, 2013, TUMOR BIOL, V34, P929, DOI 10.1007/s13277-012-0628-4; Januchowski R, 2013, BIOMED PHARMACOTHER, V67, P669, DOI 10.1016/j.biopha.2013.04.005; Jian YC, 2014, CLIN LAB, V60, P29, DOI 10.7754/Clin.Lab.2013.121035; Jiliang S., 2016, ONCOTARGET; Johnston P, 2007, J HAND SURG-AM, V32A, P343, DOI 10.1016/j.jhsa.2006.12.010; Jones CD, 2015, DERMATOL REP, V7, DOI 10.4081/dr.2015.5880; Jones GC, 2005, ARTHRITIS RES THER, V7, P160, DOI 10.1186/ar1783; Jumper N, 2015, HISTOL HISTOPATHOL, V30, P1033, DOI 10.14670/HH-11-624; Jumper N, 2016, J INVEST DERMATOL, V136, P1500, DOI 10.1016/j.jid.2016.03.022; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamdje AHN, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.17; Kameda T, 2015, GENOM DATA, V4, P102, DOI 10.1016/j.gdata.2015.04.002; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Keane MP, 2007, J IMMUNOL, V178, P511, DOI 10.4049/jimmunol.178.1.511; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; Kerkhoff C, 2012, EXP DERMATOL, V21, P822, DOI 10.1111/j.1600-0625.2012.01571.x; Kesteloot F, 2007, HEPATOLOGY, V46, P1620, DOI 10.1002/hep.21868; Kolijn K, 2016, BMC RES NOTES, V9, P1; Kolodsick JE, 2004, J IMMUNOL, V172, P4068, DOI 10.4049/jimmunol.172.7.4068; Kumar Saran, 2012, Cancers (Basel), V4, P1252, DOI 10.3390/cancers4041252; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lan CCE, 2014, J EUR ACAD DERMATOL, V28, P204, DOI 10.1111/jdv.12086; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; Lebok P, 2016, ONCOL LETT, V11, P1987, DOI 10.3892/ol.2016.4206; LeClair R, 2007, TRENDS CARDIOVAS MED, V17, P202, DOI 10.1016/j.tcm.2007.05.004; Lee JYY, 2004, AM J DERMATOPATH, V26, P379, DOI 10.1097/00000372-200410000-00006; Lee WJ, 2015, WOUND REPAIR REGEN, V23, P435, DOI 10.1111/wrr.12300; Leguen I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139938; LEIGH IM, 1995, BRIT J DERMATOL, V133, P501, DOI 10.1111/j.1365-2133.1995.tb02696.x; Li J, 2011, BRIT J DERMATOL, V164, P1030, DOI 10.1111/j.1365-2133.2011.10215.x; Li SW, 2001, BIOCHEM J, V355, P271, DOI 10.1042/0264-6021:3550271; Lin XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067496; Loubaki L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081983; Lu F, 2007, PLAST RECONSTR SURG, V120, P625, DOI 10.1097/01.prs.0000270293.93612.7b; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Luo S, 2011, INT J LOW EXTR WOUND, V10, P122, DOI 10.1177/1534734611418157; Ma XY, 2015, INT J MOL MED, V35, P1246, DOI 10.3892/ijmm.2015.2135; Mabry KM, 2016, BIOMATERIALS, V74, P31, DOI 10.1016/j.biomaterials.2015.09.035; MacKenzie PI, 2011, MOL PHARMACOL, V79, P472, DOI 10.1124/mol.110.069336; Makhzami S, 2012, PIGM CELL MELANOMA R, V25, P783, DOI 10.1111/pcmr.12013; Mariani M, 2011, CURR MOL MED, V11, P726, DOI 10.2174/156652411798062368; Marmai C, 2011, AM J PHYSIOL-LUNG C, V301, pL71, DOI 10.1152/ajplung.00212.2010; Marttala J, 2016, MATRIX BIOL; Masuda A, 2016, J REPROD DEVELOP, V62, P213, DOI 10.1262/jrd.2015-137; McCarroll JA, 2015, CANCER RES, V75, P415, DOI 10.1158/0008-5472.CAN-14-2740; McCormick SM, 2015, CYTOKINE, V75, P38, DOI 10.1016/j.cyto.2015.05.023; Meech R, 2012, J BIOL CHEM, V287, P24122, DOI 10.1074/jbc.M112.343608; Michl P, 2003, CANCER RES, V63, P6265; Mitsui H, 2012, J INVEST DERMATOL, V132, P1615, DOI 10.1038/jid.2012.33; Miyamoto A, 2010, AM J DERMATOPATH, V32, P578, DOI 10.1097/DAD.0b013e3181cd35e0; Moon JH, 2008, STEM CELLS DEV, V17, P713, DOI 10.1089/scd.2007.0210; Morikawa Y, 2015, CHEM-BIOL INTERACT, V230, P30, DOI 10.1016/j.cbi.2015.02.005; Naitoh M, 2005, GENES CELLS, V10, P1081, DOI 10.1111/j.1365-2443.2005.00902.x; Nittka S, 2004, ONCOGENE, V23, P9306, DOI 10.1038/sj.onc.1208259; Okamoto Y, 2012, ARTHRITIS RHEUM-US, V64, P3726, DOI 10.1002/art.34643; Oliveira-Ferrer L, 2004, CANCER RES, V64, P8932, DOI 10.1158/0008-5472.CAN-04-0505; Oliveros JC., 2007, INTERACTIVE TOOL COM; Ong CT, 2010, BRIT J DERMATOL, V162, P1302, DOI 10.1111/j.1365-2133.2010.09660.x; Oriente A, 2000, J PHARMACOL EXP THER, V292, P988; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Pratap A, 2012, J DRUG TARGET, V20, P770, DOI 10.3109/1061186X.2012.719900; Qian LW, 2016, WOUND REPAIR REGEN, V24, P26, DOI 10.1111/wrr.12381; Qu M, 2013, MED HYPOTHESES, V81, P807, DOI 10.1016/j.mehy.2013.08.033; Raspaglio G, 2014, GENE, V542, P173, DOI 10.1016/j.gene.2014.03.037; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Roda G, 2009, INFLAMM BOWEL DIS, V15, P1775, DOI 10.1002/ibd.21023; Rotty JD, 2012, J CELL BIOL, V197, P381, DOI 10.1083/jcb.201107078; Ruff M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139179; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Santucci M, 2001, VIRCHOWS ARCH, V438, P457, DOI 10.1007/s004280000335; Seifert O, 2008, WOUND REPAIR REGEN, V16, P254, DOI 10.1111/j.1524-475X.2007.00343.x; Shang XY, 2012, NEOPLASIA, V14, P974, DOI 10.1593/neo.12942; Shekouh AR, 2003, PROTEOMICS, V3, P1988, DOI 10.1002/pmic.200300466; Shih Barbara, 2010, Eplasty, V10, pe24; Shih B, 2009, J HAND SURG-AM, V34A, P124, DOI 10.1016/j.jhsa.2008.09.017; Sidgwick GP, 2016, ARCH DERMATOL RES, V308, P297, DOI 10.1007/s00403-016-1645-8; Simoes BM, 2015, CELL REP, V12, P1968, DOI 10.1016/j.celrep.2015.08.050; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Song HM, 2016, BIOMOL THER, V24, P140, DOI 10.4062/biomolther.2015.109; Song N, 2012, HUM PATHOL, V43, P2024, DOI 10.1016/j.humpath.2011.12.026; Steplewski A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S29; Strzyz P., 2016, NATURE REV MOL CELL; Syed F, 2011, BRIT J DERMATOL, V164, P83, DOI 10.1111/j.1365-2133.2010.10048.x; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Touchi R, 2016, J PLAST RECONSTR AES, V69, pE35, DOI 10.1016/j.bjps.2015.11.006; Tsourlakis MC, 2014, AM J PATHOL, V184, P609, DOI 10.1016/j.ajpath.2013.11.007; Valcourt U, 2016, METHODS MOL BIOL, V1344, P147, DOI 10.1007/978-1-4939-2966-5_9; Van Beuge MM, 2015, TRANSL RES, V166, P762, DOI 10.1016/j.trsl.2015.09.006; van Leeuwen MCE, 2015, PRS-GLOB OPEN, V3, DOI 10.1097/GOX.0000000000000357; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Wang C, 2016, IEEE T COMPUT, V1, P1, DOI DOI 10.1109/TC.2015.2417542; Wang LY, 2011, INT J MOL MED, V27, P385, DOI 10.3892/ijmm.2011.594; Wang Q, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-137; Wang WM, 2006, BIOCHEM J, V398, P515, DOI 10.1042/BJ20060630; Wang WM, 2003, J BIOL CHEM, V278, P19549, DOI 10.1074/jbc.M300767200; Whitman M.C., 1993, GENEREVIEWS R; Wood N, 2003, J EXP MED, V197, P703, DOI 10.1084/jem.20020906; Wu CS, 2012, BRIT J DERMATOL, V167, P532, DOI 10.1111/j.1365-2133.2012.11023.x; Xie JJ, 2014, ONCOTARGET, V5, P8569, DOI 10.18632/oncotarget.2322; Xiong WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072772; Yan CH, 2006, CELL CYCLE, V5, P926, DOI 10.4161/cc.5.9.2714; Yan L, 2015, WOUND REPAIR REGEN, V23, P601, DOI 10.1111/wrr.12320; Yang YL, 2011, J CELL BIOCHEM, V112, P2558, DOI 10.1002/jcb.23180; Zalzali H, 2008, ONCOGENE, V27, P7131, DOI 10.1038/onc.2008.331; Zhang MZ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003082; Zhang QZ, 2009, PLOS ONE, V4, pA192, DOI 10.1371/journal.pone.0007798; Zhang Z, 2014, INT J MOL MED, V34, P253, DOI 10.3892/ijmm.2014.1760; Zheng JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053711; Zhong AM, 2016, AM J PATHOL, V186, P109, DOI 10.1016/j.ajpath.2015.09.005; Zhou H, 2016, INT J CARDIOL, V206, P87, DOI 10.1016/j.ijcard.2016.01.143; Zhou P, 2015, INT J CLIN EXP MED, V8, P15262; Zhou SH, 2014, INT J CLIN EXP PATHO, V7, P8532	178	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172955	10.1371/journal.pone.0172955	http://dx.doi.org/10.1371/journal.pone.0172955			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257480	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100046
J	Seidl, SE; Pessolano, LG; Bishop, CA; Best, M; Rich, CB; Stone, PJ; Schreiber, BM				Seidl, Stephanie E.; Pessolano, Lawrence G., Jr.; Bishop, Christopher A.; Best, Michael; Rich, Celeste B.; Stone, Phillip J.; Schreiber, Barbara M.			Toll-like receptor 2 activation and serum amyloid A regulate smooth muscle cell extracellular matrix	PLOS ONE			English	Article							ELASTIN GENE-TRANSCRIPTION; NITRIC-OXIDE SYNTHASE; IN-VITRO; PROTEASOME INHIBITORS; MESSENGER-RNA; C/EBP-BETA; EXPRESSION; MATRIX-METALLOPROTEINASE-9; MIGRATION; METALLOPROTEINASES	Smooth muscle cells contribute to extracellular matrix remodeling during atherogenesis. De-differentiated, synthetic smooth muscle cells are involved in processes of migration, pro-liferation and changes in expression of extracellular matrix components, all of which contribute to loss of homeostasis accompanying atherogenesis. Elevated levels of acute phase proteins, including serum amyloid A (SAA), are associated with an increased risk for athero-sclerosis. Although infection with periodontal and respiratory pathogens via activation of inflammatory cell Toll-like receptor (TLR) 2 has been linked to vascular disease, little is known about smooth muscle cell TLR2 in atherosclerosis. This study addresses the role of SAA and TLR2 activation on smooth muscle cell matrix gene expression and insoluble elas-tin accumulation. Cultured rat aortic smooth muscle cells were treated with SAA or TLR2 agonists and the effect on expression of matrix metallopeptidase 9 (MMP9) and tropoelastin studied. SAA up-regulated MMP9 expression. Tropoelastin is an MMP9 substrate and decreased tropoelastin levels in SAA-treated cells supported the concept of extracellular matrix remodeling. Interestingly, SAA-induced down-regulation of tropoelastin was not only evident at the protein level but at the level of gene transcription as well. Contributions of pro-teasomes, nuclear factor. B and CCAAT/enhancer binding protein a on regulation of MMP9 vs. tropoleastin expression were revealed. Effects on Mmp9 and Eln mRNA expres-sion persisted with long-term SAA treatment, resulting in decreased insoluble elastin accu-mulation. Interestingly, the SAA effects were TLR2-dependent and TLR2 activation by bacterial ligands also induced MMP9 expression and decreased tropoelastin expression. These data reveal a novel mechanism whereby SAA and/or infection induce changes in vas-cular elastin consistent with atherosclerosis.	[Seidl, Stephanie E.; Pessolano, Lawrence G., Jr.; Bishop, Christopher A.; Best, Michael; Rich, Celeste B.; Stone, Phillip J.; Schreiber, Barbara M.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Schreiber, BM (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	schreibe@bu.edu	Gao, Jing/M-8264-2018	Schreiber, Barbara/0000-0001-8560-4249; Stone, Phillip/0000-0001-6220-690X; Bishop, Christopher/0000-0003-2247-3602	National Institutes of Health [HL079201]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (grant #HL079201). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; BERK JL, 1991, J BIOL CHEM, V266, P3192; Beutler B, 2000, CURR OPIN MICROBIOL, V3, P23, DOI 10.1016/S1369-5274(99)00046-6; Black LD, 2005, J APPL PHYSIOL, V98, P1434, DOI 10.1152/japplphysiol.00921.2004; Campbell LA, 2015, ARCH MED RES, V46, P339, DOI 10.1016/j.arcmed.2015.05.006; Chen ES, 2010, AM J RESP CRIT CARE, V181, P360, DOI 10.1164/rccm.200905-0696OC; Chen T, 2006, CANCER RES, V66, P2853, DOI 10.1158/0008-5472.CAN-05-3279; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Cho A, 2002, CIRC RES, V91, P845, DOI 10.1161/01.RES.0000040420.17366.2E; Cole JE, 2013, TRENDS PHARMACOL SCI, V34, P629, DOI 10.1016/j.tips.2013.09.008; Connolly M, 2012, ARTHRITIS RHEUM-US, V64, P1035, DOI 10.1002/art.33455; Connolly M, 2010, J IMMUNOL, V184, P6427, DOI 10.4049/jimmunol.0902941; Curtiss LK, 2009, J LIPID RES, V50, pS340, DOI 10.1194/jlr.R800056-JLR200; de Lara LGV, 2003, AM J PHYSIOL-LUNG C, V285, pL899, DOI 10.1152/ajplung.00082.2003; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Galis ZS, 2002, CIRC RES, V91, P852, DOI 10.1161/01.RES.0000041036.86977.14; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; Gebbia JA, 2004, J INFECT DIS, V189, P113, DOI 10.1086/380414; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; Heinz A, 2010, FEBS J, V277, P1939, DOI 10.1111/j.1742-4658.2010.07616.x; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; HOSPELHORN AC, 1988, J HISTOCHEM CYTOCHEM, V36, P1353, DOI 10.1177/36.10.3418110; HOUGLUM K, 1994, J CLIN INVEST, V94, P808, DOI 10.1172/JCI117400; Hungness ES, 2002, BIOCHEM BIOPH RES CO, V290, P469, DOI 10.1006/bbrc.2001.6168; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; JACOBS DM, 1977, J IMMUNOL, V118, P21; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Kao SJ, 2005, IMMUNOLOGY, V115, P366, DOI 10.1111/j.1365-2567.2005.02160.x; Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223; King VL, 2011, CURR OPIN LIPIDOL, V22, P302, DOI 10.1097/MOL.0b013e3283488c39; Krishack PA, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001858; Kuang PP, 2005, AM J PHYSIOL-CELL PH, V289, pC766, DOI 10.1152/ajpcell.00525.2004; Kuang PP, 2003, AM J PHYSIOL-CELL PH, V285, pC1349, DOI 10.1152/ajpcell.00173.2003; Kuang PP, 2002, AM J PHYSIOL-CELL PH, V283, pC58, DOI 10.1152/ajpcell.00314.2001; Kumon Y, 1997, SCAND J IMMUNOL, V46, P284, DOI 10.1046/j.1365-3083.1997.d01-128.x; LANSING AI, 1952, ANAT RECORD, V114, P555, DOI 10.1002/ar.1091140404; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee GL, 2012, ARTERIOSCL THROM VAS, V32, P2751, DOI 10.1161/ATVBAHA.112.300302; Lee HJ, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-15; Lee HS, 2008, AM J PHYSIOL-LUNG C, V294, pL225, DOI 10.1152/ajplung.00370.2007; Lemaitre V, 2009, ATHEROSCLEROSIS, V205, P107, DOI 10.1016/j.atherosclerosis.2008.11.030; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; LIN GF, 1994, J BIOL CHEM, V269, P77; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Qin ZY, 2015, PEPTIDES, V67, P64, DOI 10.1016/j.peptides.2015.03.006; Rippe RA, 1999, DNA CELL BIOL, V18, P751, DOI 10.1089/104454999314890; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; SATO H, 1993, ONCOGENE, V8, P395; Schreiber BM, 2002, AMYLOID, V9, P276, DOI 10.3109/13506120209114107; SCHREIBER BM, 1988, ATHEROSCLEROSIS, V69, P69, DOI 10.1016/0021-9150(88)90290-0; SCHREIBER BM, 1992, ATHEROSCLEROSIS, V95, P201, DOI 10.1016/0021-9150(92)90023-A; Shin HS, 2011, J IMMUNOL, V186, P1119, DOI 10.4049/jimmunol.1001647; Slocum C, 2016, J INTERN MED; STONE PJ, 1987, IN VITRO CELL DEV B, V23, P663; Sullivan CP, 2010, J BIOL CHEM, V285, P565, DOI 10.1074/jbc.M109.070565; TOSELLI P, 1992, MATRIX, V12, P321, DOI 10.1016/S0934-8832(11)80084-3; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017; Ye RD, 2015, J LEUKOCYTE BIOL, V98, P923, DOI 10.1189/jlb.3VMR0315-080R; ZANDOMENI R, 1982, P NATL ACAD SCI-BIOL, V79, P3167, DOI 10.1073/pnas.79.10.3167	65	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0171711	10.1371/journal.pone.0171711	http://dx.doi.org/10.1371/journal.pone.0171711			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257481	gold, Green Published, Green Submitted			2022-12-27	WOS:000396021100008
J	van de Ven, RM; Buitenweg, JIV; Schmand, B; Veltman, DJ; Aaronson, JA; Nijboer, TCW; Kruiper-Doesborgh, SJC; van Bennekom, CAM; Rasquin, SMC; Ridderinkhof, KR; Murre, JMJ				van de Ven, Renate M.; Buitenweg, Jessika I. V.; Schmand, Ben; Veltman, Dick J.; Aaronson, Justine A.; Nijboer, Tanja C. W.; Kruiper-Doesborgh, Suzanne J. C.; van Bennekom, Coen A. M.; Rasquin, Sascha M. C.; Ridderinkhof, K. Richard; Murre, Jaap M. J.			Brain training improves recovery after stroke but waiting list improves equally: A multicenter randomized controlled trial of a computer-based cognitive flexibility training	PLOS ONE			English	Article							WORKING-MEMORY; IMPAIRMENT; THERAPY; DYSFUNCTION; FREQUENCY; INJURY; ADULTS; TASK; LIFE	Background Brain training is currently widely used in an attempt to improve cognitive functioning. Computer-based training can be performed at home and could therefore be an effective add-on to available rehabilitation programs aimed at improving cognitive functioning. Several studies have reported cognitive improvements after computer training, but most lacked proper active and passive control conditions. Objective Our aim was to investigate whether computer-based cognitive flexibility training improves executive functioning after stroke. We also conducted within-group analyses similar to those used in previous studies, to assess inferences about transfer effects when comparisons to proper control groups are missing. Methods We conducted a randomized controlled, double blind trial. Adults (30 - 80 years old) who had suffered a stroke within the last 5 years were assigned to either an intervention group (n = 38), active control group (i. e., mock training; n = 35), or waiting list control group (n = 24). The intervention and mock training consisted of 58 half-hour sessions within a 12-week period. Cognitive functioning was assessed using several paper-and-pencil and computerized neuropsychological tasks before the training, immediately after training, and 4 weeks after training completion. Results and conclusions Both training groups improved on training tasks, and all groups improved on several transfer tasks (three executive functioning tasks, attention, reasoning, and psychomotor speed). Improvements remained 4 weeks after training completion. However, the amount of improvement in executive and general cognitive functioning in the intervention group was similar to that of both control groups (active control and waiting list). Therefore, this improvement was likely due to training-unspecific effects. Our results stress the importance to include both active and passive control conditions in the study design and analyses. Results from studies without proper control conditions should be interpreted with care.	[van de Ven, Renate M.; Buitenweg, Jessika I. V.; Schmand, Ben; Ridderinkhof, K. Richard; Murre, Jaap M. J.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Schmand, Ben] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, Amsterdam, Netherlands; [Veltman, Dick J.] Vrije Univ Amsterdam, Dept Psychiat, Med Ctr, Amsterdam, Netherlands; [Aaronson, Justine A.; van Bennekom, Coen A. M.] Heliomare Rehabil Ctr, Dept Res & Dev, Wijk Aan Zee, Netherlands; [Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Nijboer, Tanja C. W.] De Hoogstr Rehabil, Utrecht, Netherlands; [Nijboer, Tanja C. W.] Univ Utrecht, Dept Expt Psychol, Utrecht, Netherlands; [Kruiper-Doesborgh, Suzanne J. C.] Reade, Amsterdam Rehabil Res Ctr, Amsterdam, Netherlands; [Rasquin, Sascha M. C.] Maastricht Univ, Adelante Zorggrp, Caphri, Rehabil Med, Maastricht, Netherlands; [Ridderinkhof, K. Richard] Univ Amsterdam, ABC, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Maastricht University; Maastricht University Medical Centre (MUMC); University of Amsterdam	van de Ven, RM (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	r.m.vandeven@uva.nl	Murre, Jaap MJ/A-3813-2010	van Bennekom, coen/0000-0002-9754-261X	Netherlands Initiative Brain and Cognition part of the Organization for Scientific Research (NWO) [056-14-013]	Netherlands Initiative Brain and Cognition part of the Organization for Scientific Research (NWO)	This project is part of the research program "Treatment of cognitive disorders based on functional brain imaging" funded by the Netherlands Initiative Brain and Cognition, a part of the Organization for Scientific Research (NWO) under grant number 056-14-013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund E, 2013, BRAIN INJURY, V27, P1649, DOI 10.3109/02699052.2013.830195; Benton AL., 1983, MULTILINGUAL APHASIA; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; Buitenweg JIV, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00183; Chen SHA, 1997, BRAIN INJURY, V11, P197; Cohen J.E., 1988, STAT POWER ANAL BEHA; Corbett A, 2015, J AM MED DIR ASSOC, V16, P990, DOI 10.1016/j.jamda.2015.06.014; Culbertson WC., 2005, TOWER LONDON DREXEL; De Luca R, 2014, DISABIL HEALTH J, V7, P356, DOI 10.1016/j.dhjo.2014.04.003; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Glass BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070350; Gray JM, 1992, NEUROPSYCHOL REHABIL, V2, P97, DOI [10.1080/09602019208401399, DOI 10.1080/09602019208401399]; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Hardy JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134467; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; Kurland J, 2010, APHASIOLOGY, V24, P737, DOI 10.1080/02687030903524711; Lampit A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001756; Lesniak M, 2008, DEMENT GERIATR COGN, V26, P356, DOI 10.1159/000162262; Lever AG, 2015, J ABNORM PSYCHOL, V124, P1014, DOI 10.1037/abn0000108; Lin ZC, 2014, J INT MED RES, V42, P659, DOI 10.1177/0300060513505809; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Maaijwee NAMM, 2014, J NEUROL, V261, P1300, DOI 10.1007/s00415-014-7346-3; Mayo, 1933, HUMAN PROBLEMS IND C; Middleton LE, 2014, NEUROREHABILITATION, V34, P305, DOI 10.3233/NRE-131030; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nys GMS, 2006, J NEUROL SCI, V247, P149, DOI 10.1016/j.jns.2006.04.005; Raven J, 1998, SECTION 4 ADV PROGRE; Roethlisberger F.J., 1939, MANAGEMENT WORKER AC; Rogers RD, 1995, J EXPT PSYCHOL GEN, V124; RUFF R, 1994, BRAIN INJURY, V8, P3, DOI 10.3109/02699059409150954; Saan R, 1986, 15 WOORDENTEST A B V; Saghaei M., 2011, J BIOMED SCI ENG, V4, P734, DOI [10.4236/jbise.2011.411090, DOI 10.4236/JBISE.2011.411090]; Slagter HA, 2012, TRENDS COGN SCI, V16, P582, DOI 10.1016/j.tics.2012.10.001; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Thrane G, 2014, J REHABIL MED, V46, P833, DOI 10.2340/16501977-1859; Thurnstone LL, 1938, PRIMARY MENTAL ABILI; van de Ven RM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00150; van de Ven RM, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0397-y; Van Vleet TM, 2015, NEUROCASE, V21, P489, DOI 10.1080/13554794.2014.928329; Wechsler D, 1999, WECHSLER ADULT INTEL; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Zachary R., 1991, SHIPLEY I LIVING SCA	44	23	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172993	10.1371/journal.pone.0172993	http://dx.doi.org/10.1371/journal.pone.0172993			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257436	Green Submitted, Green Published, gold			2022-12-27	WOS:000396021100048
J	Zhang, MWB; Hong, YX; Husain, SF; Harris, KM; Ho, RCM				Zhang, Melvyn W. B.; Hong, Ying X.; Husain, Syeda F.; Harris, Keith M.; Ho, Roger C. M.			Analysis of print news media framing of ketamine treatment in the United States and Canada from 2000 to 2015	PLOS ONE			English	Article							RAPID ANTIDEPRESSANT; DEPRESSION; ABUSE; INFUSIONS; EFFICACY; TRIALS; MODEL	Objectives There are multifaceted views on the use of ketamine, a potentially addictive substance, to treat mental health problems. The past 15 years have seen growing media coverage of ketamine for medical and other purposes. This study examined the print news media coverage of medical and other uses of ketamine in North America to determine orientations and trends over time. Methods Print newspaper coverage of ketamine from 2000 to 2015 was reviewed, resulting in 43 print news articles from 28 North American newspapers. A 55-item structured coding instrument was applied to assess news reports of ketamine. Items captured negative and positive aspects, therapeutic use of ketamine, and adverse side effects. Chi-squares tested for changes in trends over time. Results In the 15-year reviewed period, the three most frequent themes related to ketamine were: abuse (68.2%), legal status (34.1%), and clinical use in anesthesia (31.8%). There was significant change in trends during two periods (2000-2007 and 2008-2015). In 2008-2015, print news media articles were significantly more likely to encourage clinical use of ketamine to treat depression (p = 0.002), to treat treatment resistant depression (p = 0.043), and to claim that ketamine is more effective than conventional antidepressants (p = 0.043). Conclusions Our review found consistent positive changes in the portrayals of ketamine by the print news media as a therapeutic antidepressant that mirror the recent scientific publications. These changes in news media reporting might influence the popularity of ketamine use to treat clinical depression. Guidance is required for journalists on objective reporting of medical research findings, including limitations of current research evidence and potential risks of ketamine.	[Zhang, Melvyn W. B.] Natl Univ Singapore, Ctr Healthcare Innovat & Med Engn, Singapore, Singapore; [Hong, Ying X.; Husain, Syeda F.; Ho, Roger C. M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore, Singapore; [Harris, Keith M.] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Harris, Keith M.] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia	National University of Singapore; National University of Singapore; University of Tasmania; University of Queensland	Zhang, MWB (corresponding author), Natl Univ Singapore, Ctr Healthcare Innovat & Med Engn, Singapore, Singapore.	melvynzhangweibin@gmail.com	Ho, Roger C./ABD-9061-2021; Harris, Keith M/K-9957-2013; Ho, Roger/ABD-8859-2021	Ho, Roger C./0000-0001-9629-4493; Harris, Keith M/0000-0002-1199-2856; Husain, Syeda Fabeha/0000-0001-7460-397X				Barr AM, 2002, TRENDS PHARMACOL SCI, V23, P475, DOI 10.1016/S0165-6147(02)02086-2; Bella T, 2015, AL JAZEERA AM   0212; Bonnet U, 2015, J PSYCHOACTIVE DRUGS, V47, P276, DOI 10.1080/02791072.2015.1072653; Borwein A, 2013, J PAIN, V14, P1686, DOI 10.1016/j.jpain.2013.08.012; Caddy C, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011612.pub2; Canadian Agency for Drugs and Technologies in Health, 2014, INTR KET TREATM MENT; Canpolat DG, 2016, PAK J MED SCI, V32, P682, DOI 10.12669/pjms.323.9834; Cartwright N., 2007, BIOSOCIETIES, V2, P11, DOI [10.1017/S1745855207005029, DOI 10.1017/S1745855207005029]; Dasgupta N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007758; Diamond PR, 2014, J PSYCHOPHARMACOL, V28, P536, DOI 10.1177/0269881114527361; Dillon P, 2003, DRUG ALCOHOL DEPEN, V69, P23, DOI 10.1016/S0376-8716(02)00243-0; Fan DP, 1996, SUBST USE MISUSE, V31, P1413, DOI 10.3109/10826089609063984; Hashimoto K, 2016, EXPERT OPIN THER TAR, V20, P1389, DOI 10.1080/14728222.2016.1238899; Hashimoto K, 2016, AM J PSYCHIAT, V173, P1044, DOI 10.1176/appi.ajp.2016.16040411; Hashimoto K, 2014, CLIN PSYCHOPHARM NEU, V12, P72, DOI 10.9758/cpn.2014.12.1.72; Ho R., 2016, BJPSYCH ADV, V22, P222, DOI 10.1192/apt.bp.114.014274; Katalinic N, 2013, AUST NZ J PSYCHIAT, V47, P710, DOI 10.1177/0004867413486842; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; KRYSTAL JH, 2005, NEUROSCI BULL, V32, P557, DOI DOI 10.1001/ARCHPSYC.62.9.985; Li JH, 2011, SUBST ABUSE REHABIL, V2, P11, DOI 10.2147/SAR.S15458; LO JN, 1975, ANESTHESIOLOGY, V43, P307, DOI 10.1097/00000542-197509000-00007; McCloud TL, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011611.pub2; McGinty EE, 2016, PSYCHIAT SERV, V67, P405, DOI 10.1176/appi.ps.201500065; Netherland J, CULT MED PSYCHIAT; Newport DJ, 2015, AM J PSYCHIAT, V172, P950, DOI 10.1176/appi.ajp.2015.15040465; Pal R, 2013, DRUG ALCOHOL DEPEN, V132, P189, DOI 10.1016/j.drugalcdep.2013.02.005; Papakostas GI, 2008, J PSYCHOPHARMACOL, V22, P843, DOI 10.1177/0269881107083808; Rasmussen KG, 2015, PROGR NEUROPSYCHOPHA; Sackeim HA, 2001, J CLIN PSYCHIAT, V62, pS10; Schatzberg AF, 2014, AM J PSYCHIAT, V171, P262, DOI 10.1176/appi.ajp.2014.13101434; Singh I, 2016, LANCET PSYCHIAT; Sisti D, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0527-z; Solovitch S., 2016, WASHINGTON POST; Soroka S, 2013, J HEALTH POLIT POLIC, V38, P893, DOI 10.1215/03616878-2334656; Substance Abuse and Mental Health Services Administration, 2003, DRUG AB WARN NETW D, VD-24; Tam YH, 2014, BJU INT, V114, P754, DOI 10.1111/bju.12675; Taylor MJ, 2006, ARCH GEN PSYCHIAT, V63, P1217, DOI 10.1001/archpsyc.63.11.1217; Trujillo KA, 2011, ILAR J, V52, P366, DOI 10.1093/ilar.52.3.366; Ubogu EE, 2003, EPILEPSY BEHAV, V4, P70, DOI 10.1016/S1525-5050(02)00643-1; Yang C, 2014, PSYCHOPHARMACOLOGY, V231, P2041, DOI 10.1007/s00213-014-3543-0; Zarate CA, 2012, BIOL PSYCHIAT, V71, P939, DOI 10.1016/j.biopsych.2011.12.010; Zhang MW, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0087-3; Zhang MW, 2015, LANCET PSYCHIAT, V2, P1057, DOI 10.1016/S2215-0366(15)00472-1; Zhang MWB, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00047; Zhang MWB, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4467; Zhang MW, 2016, AM J PSYCHIAT, V173, P431, DOI 10.1176/appi.ajp.2016.15111401; Zhang MW, 2016, ETHICS BEHAV; Zhu WL, 2016, NEUROSCI BULL, V32, P557, DOI 10.1007/s12264-016-0081-2	48	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173202	10.1371/journal.pone.0173202	http://dx.doi.org/10.1371/journal.pone.0173202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257514	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000396021100076
J	Park, YG; Mun, BG; Kang, SM; Hussain, A; Shahzad, R; Seo, CW; Kim, AY; Lee, SU; Oh, KY; Lee, DY; Lee, IJ; Yun, BW				Park, Yeon-Gyeong; Mun, Bong-Gyu; Kang, Sang-Mo; Hussain, Adil; Shahzad, Raheem; Seo, Chang-Woo; Kim, Ah-Yeong; Lee, Sang-Uk; Oh, Kyeong Yeol; Lee, Dong Yeol; Lee, In-Jung; Yun, Byung-Wook			Bacillus aryabhattai SRB02 tolerates oxidative and nitrosative stress and promotes the growth of soybean by modulating the production of phytohormones	PLOS ONE			English	Article							PHYTOCHROME-MEDIATED ATTACHMENT; INDUCED SYSTEMIC RESISTANCE; ABSCISIC-ACID ANTAGONISM; PLANT-GROWTH; HEAT-STRESS; CYTOKININ PRODUCTION; PSEUDOMONAS-AERUGINOSA; INDOLEACETIC-ACID; DROUGHT STRESS; SALICYLIC-ACID	Plant growth promoting rhizobacteria (PGPR) are diverse, naturally occurring bacteria that establish a close association with plant roots and promote the growth and immunity of plants. Established mechanisms involved in PGPR-mediated plant growth promotion include regulation of phytohormones, improved nutrient availability, and antagonistic effects on plant pathogens. In this study, we isolated a bacterium from the rhizospheric soil of a soybean field in Chungcheong buk-do, South Korea. Using 16S rRNA sequencing, the bacterium was identified as Bacillus aryabhattai strain SRB02. Here we show that this strain significantly promotes the growth of soybean. Gas chromatography-mass spectrometry analysis showed that SRB02 produced significant amounts of abscisic acid, indole acetic acid, cytokinin and different gibberellic acids in culture. SRB02-treated soybean plants showed significantly better heat stress tolerance than did untreated plants. These plants also produced consistent levels of ABA under heat stress and exhibited ABA-mediated stomatal closure. High levels of IAA, JA, GA12, GA4, and GA7, were recorded in SRB02-treated plants. These plants produced longer roots and shoots than those of control plants. B. aryabhattai SRB02 was found to be highly tolerant to oxidative stress induced by H2O2 and MV potentiated by high catalase (CAT) and superoxide dismutase (SOD) activities. SRB02 also tolerated high nitrosative stress induced by the nitric oxide donors GSNO and CysNO. Because of these attributes, B. aryabhattai SRB02 may prove to be a valuable resource for incorporation in biofertilizers and other soil amendments that seek to improve crop productivity.	[Park, Yeon-Gyeong; Mun, Bong-Gyu; Kang, Sang-Mo; Hussain, Adil; Shahzad, Raheem; Seo, Chang-Woo; Kim, Ah-Yeong; Lee, Sang-Uk; Lee, In-Jung; Yun, Byung-Wook] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea; [Hussain, Adil] Abdul Wali Khan Univ, Dept Agr, Mardan, Khyber Pakhtunk, Pakistan; [Oh, Kyeong Yeol; Lee, Dong Yeol] Gyeongnam Oriental Med Herb Inst, Sancheong, South Korea	Kyungpook National University; Abdul Wali Khan University	Lee, IJ; Yun, BW (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.	ijlee@knu.ac.kr; bwyun@knu.ac.kr	Hussain, Adil/K-6016-2018; Mun, BongGyu/GYD-6010-2022; Lee, In-Jung/GLS-0432-2022; Shahzad, Raheem/AAG-8370-2019	Hussain, Adil/0000-0002-7803-429X; Mun, BongGyu/0000-0002-6670-1315; Lee, In-Jung/0000-0001-7154-4820; Shahzad, Raheem/0000-0002-6594-8287	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2A10058022]; Next Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea [PJ01110201]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Next Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2A10058022) to In-Jung Lee and by a grant from the Next Generation BioGreen 21 Program (SSAC, Grant No. PJ01110201), Rural Development Administration, Republic of Korea to Byung-Wook Yun.	Abd El-Daim IA, 2014, PLANT SOIL, V379, P337, DOI 10.1007/s11104-014-2063-3; Ahemad Munees, 2014, Journal of King Saud University Science, V26, P1, DOI 10.1016/j.jksus.2013.05.001; Ali SZ, 2011, J PLANT INTERACT, V6, P239, DOI 10.1080/17429145.2010.545147; Astacio MG, 2011, HORTSCIENCE, V46, P1640, DOI 10.21273/HORTSCI.46.12.1640; ATZORN R, 1988, PLANTA, V175, P532, DOI 10.1007/BF00393076; Babalola OO, 2010, BIOTECHNOL LETT, V32, P1559, DOI 10.1007/s10529-010-0347-0; Beneduzi A, 2012, GENET MOL BIOL, V35, P1044, DOI 10.1590/S1415-47572012000600020; Bertrand H, 2001, BIOL FERT SOILS, V33, P152, DOI 10.1007/s003740000305; Bhattacharyya PN, 2012, WORLD J MICROB BIOT, V28, P1327, DOI 10.1007/s11274-011-0979-9; Bita CE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00273; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Bohme L, 2006, EUR J SOIL BIOL, V42, P1, DOI 10.1016/j.ejsobi.2005.08.001; Bottini R, 2004, APPL MICROBIOL BIOT, V65, P497, DOI 10.1007/s00253-004-1696-1; BOTTINI R, 1989, PLANT PHYSIOL, V90, P45, DOI 10.1104/pp.90.1.45; Chang WS, 2009, ENVIRON MICROBIOL, V11, P1482, DOI 10.1111/j.1462-2920.2009.01876.x; Chanway CP, 1997, FOREST SCI, V43, P99; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Cohen AC, 2008, PLANT GROWTH REGUL, V54, P97, DOI 10.1007/s10725-007-9232-9; Cohen AC, 2015, PHYSIOL PLANTARUM, V153, P79, DOI 10.1111/ppl.12221; Cohen AC, 2009, BOTANY, V87, P455, DOI 10.1139/B09-023; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; Creus CM, 2005, PLANTA, V221, P297, DOI 10.1007/s00425-005-1523-7; CROZIER A, 1988, APPL ENVIRON MICROB, V54, P2833, DOI 10.1128/AEM.54.11.2833-2837.1988; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; de Salamone IEG, 2001, CAN J MICROBIOL, V47, P404, DOI 10.1139/cjm-47-5-404; Ding W, 2010, BIOL PLANTARUM, V54, P607, DOI 10.1007/s10535-010-0110-3; Djanaguiraman M, 2013, J AGRON CROP SCI, V199, P171, DOI 10.1111/jac.12005; Dobbelaere S, 1999, PLANT SOIL, V212, P155, DOI 10.1023/A:1004658000815; Dodd IC, 2010, ANN APPL BIOL, V157, P361, DOI 10.1111/j.1744-7348.2010.00439.x; Du H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00397; Etesami H, 2014, J PLANT GROWTH REGUL, V33, P654, DOI 10.1007/s00344-014-9415-3; Fan SK, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00721; Fones H, 2012, FEMS MICROBIOL LETT, V327, P1, DOI 10.1111/j.1574-6968.2011.02449.x; Frey AD, 2003, FEMS MICROBIOL REV, V27, P525, DOI 10.1016/S0168-6445(03)00056-1; Garcia JAL, 2004, ENVIRON EXP BOT, V52, P239, DOI 10.1016/j.envexpbot.2004.02.003; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Govind Gupta, 2015, Journal of Microbial and Biochemical Technology, V7, P96; Grosskinsky DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep23310; Grosskinsky DK, 2014, PHYTOPATHOLOGY, V104, P1283, DOI 10.1094/PHYTO-03-14-0076-R; Gu RL, 2010, J PLANT GROWTH REGUL, V29, P428, DOI 10.1007/s00344-010-9155-y; Gutierrez-Manero FJ, 2001, PHYSIOL PLANTARUM, V111, P206, DOI 10.1034/j.1399-3054.2001.1110211.x; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; Huang XD, 2004, ENVIRON POLLUT, V130, P453, DOI 10.1016/j.envpol.2003.12.018; Hussain A, 2009, AFR J MICROBIOL RES, V3, P704; Idris EE, 2004, Z PFLANZENK PFLANZEN, V111, P583; Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619; Islam F, 2014, ECOTOX ENVIRON SAFE, V104, P285, DOI 10.1016/j.ecoenv.2014.03.008; JANZEN RA, 1992, SOIL BIOL BIOCHEM, V24, P1061, DOI 10.1016/0038-0717(92)90036-W; Jiang CJ, 2013, MOL PLANT MICROBE IN, V26, P287, DOI 10.1094/MPMI-06-12-0152-R; Kalita M, 2015, INDIAN J EXP BIOL, V53, P56; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P250, DOI 10.1094/MPMI-19-0250; Kang SM, 2012, J MICROBIOL, V50, P902, DOI 10.1007/s12275-012-2273-4; Karlidag H, 2013, HORTSCIENCE, V48, P563, DOI 10.21273/HORTSCI.48.5.563; Khan N, 2016, INT J PHYTOREMEDIAT; KOBAYASHI M, 1995, P NATL ACAD SCI USA, V92, P714, DOI 10.1073/pnas.92.3.714; Kokalis-Burelle N, 2006, APPL SOIL ECOL, V31, P91, DOI 10.1016/j.apsoil.2005.03.007; Kuiper I, 2004, MOL PLANT MICROBE IN, V17, P6, DOI 10.1094/MPMI.2004.17.1.6; Kumar A, 2011, BACTERIA IN AGROBIOLOGY: CROP ECOSYSTEMS, P37, DOI 10.1007/978-3-642-18357-7_2; KUMAR SP, 2012, INDIAN J DENT ED, V5, P5; Lee IJ, 1998, PLANT PHYSIOL, V116, P1003, DOI 10.1104/pp.116.3.1003; Lee S, 2012, J MICROBIOL, V50, P45, DOI 10.1007/s12275-012-1415-z; Li PS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1009; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Lim JH, 2013, PLANT PATHOLOGY J, V29, P201, DOI 10.5423/PPJ.SI.02.2013.0021; Liu FC, 2013, APPL MICROBIOL BIOT, V97, P4617, DOI 10.1007/s00253-012-4255-1; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Loper J, 1982, PHYTOPATHOLOGY; Lu YD, 2014, PLANT J, V80, P52, DOI 10.1111/tpj.12615; Lucy M, 2004, ANTON LEEUW INT J G, V86, P1, DOI 10.1023/B:ANTO.0000024903.10757.6e; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Majeed A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00198; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Meena H, 2015, BIOSCI BIOTECHNO RES, V8, P171; Miransari M., 2015, ABIOTIC BIOTIC STRES; Naseem M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003026; Ng JLP, QUANTIFYING AUXIN ME; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Ortiz-Castro R, 2008, PLANT SIGNAL BEHAV, V3, P263, DOI 10.4161/psb.3.4.5204; Pailan S, 2015, INT BIODETER BIODEGR, V103, P191, DOI 10.1016/j.ibiod.2015.05.006; Pan XQ, 2010, NAT PROTOC, V5, P986, DOI 10.1038/nprot.2010.37; Park JM, 2015, INDIAN J MICROBIOL, V55, P207, DOI 10.1007/s12088-015-0515-y; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Perez-Montano F, 2014, MICROBIOL RES, V169, P325, DOI 10.1016/j.micres.2013.09.011; Porcel R, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-36; Press CM, 1997, MOL PLANT MICROBE IN, V10, P761, DOI 10.1094/MPMI.1997.10.6.761; Press CM, 2001, PHYTOPATHOLOGY, V91, P593, DOI 10.1094/PHYTO.2001.91.6.593; Qi QG, 1998, PLANT PHYSIOL, V117, P979, DOI 10.1104/pp.117.3.979; Rahman A, 2010, BIOSCI BIOTECH BIOCH, V74, P2202, DOI 10.1271/bbb.100360; Ramasarma T, 2015, MOL CELL BIOCHEM, V400, P277, DOI 10.1007/s11010-014-2284-z; Ramesh A, 2014, APPL SOIL ECOL, V73, P87, DOI 10.1016/j.apsoil.2013.08.009; Richardson AE, 2009, PLANT SOIL, V321, P305, DOI 10.1007/s11104-009-9895-2; Ryu CM, 2005, PLANT SOIL, V268, P285, DOI 10.1007/s11104-004-0301-9; Ryu CM, 2004, PLANT J, V39, P381, DOI 10.1111/j.1365-313X.2004.02142.x; Schmulling T, 2003, J PLANT RES, V116, P241, DOI 10.1007/s10265-003-0096-4; Schwartz SH, 2003, PLANT PHYSIOL, V131, P1591, DOI 10.1104/pp.102.017921; Selim S, 2015, FASEB J, V29; Serrani JC, 2008, PLANT J, V56, P922, DOI 10.1111/j.1365-313X.2008.03654.x; Seskar M, 1998, PLANT PHYSIOL, V116, P387, DOI 10.1104/pp.116.1.387; Sharp RE, 2000, J EXP BOT, V51, P1575, DOI 10.1093/jexbot/51.350.1575; Shen XM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-271; 이현주, 2008, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V37, P1095; Shivaji S, 2009, INT J SYST EVOL MICR, V59, P2977, DOI 10.1099/ijs.0.002527-0; Siewers V, 2006, APPL ENVIRON MICROB, V72, P4619, DOI 10.1128/AEM.02919-05; Singh Y, 2014, J CHEM TECHNOL BIOT, V89, P117, DOI 10.1002/jctb.4121; Singh Y, 2013, INDIAN J EXP BIOL, V51, P322; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Swamy PM, 1999, CURR SCI INDIA, V76, P1220; Szkop M, 2012, FOLIA MICROBIOL, V57, P1, DOI 10.1007/s12223-011-0089-y; Talanova VV, 2003, RUSS J PLANT PHYSL+, V50, P90, DOI 10.1023/A:1021996703940; TANADA T, 1973, PLANT PHYSIOL, V51, P154, DOI 10.1104/pp.51.1.154; TANADA T, 1973, PLANT PHYSIOL, V51, P150, DOI 10.1104/pp.51.1.150; Tanada T., 1972, ANTAGONISM INDOLEACE; Terrile MC, 2012, PLANT J, V70, P492, DOI 10.1111/j.1365-313X.2011.04885.x; Timmusk S, 1999, SOIL BIOL BIOCHEM, V31, P1847, DOI 10.1016/S0038-0717(99)00113-3; Vacheron J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00356; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Vandeputte O, 2005, APPL ENVIRON MICROB, V71, P1169, DOI 10.1128/AEM.71.3.1169-1177.2005; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Vurukonda SSKP, 2016, MICROBIOL RES, V184, P13, DOI 10.1016/j.micres.2015.12.003; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Weaver GM, 2014, HORTSCIENCE, V49, P779, DOI 10.21273/HORTSCI.49.6.779; Whistler CA, 1998, J BACTERIOL, V180, P6635, DOI 10.1128/JB.180.24.6635-6641.1998; Wu C, 2016, SCI REP-UK, V6, DOI 10.1038/srep34978; Yan Y, 2016, GENES GENOM, V38, P293, DOI 10.1007/s13258-015-0366-2; Yan YS, 2011, PLANT J, V65, P820, DOI 10.1111/j.1365-313X.2010.04467.x; Yang SH, 2007, APPL ENVIRON MICROB, V73, P1079, DOI 10.1128/AEM.01770-06; Yuan J, 2015, SCI REP-UK, V5, DOI 10.1038/srep13438; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026	132	120	136	8	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173203	10.1371/journal.pone.0173203	http://dx.doi.org/10.1371/journal.pone.0173203			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282395	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800020
J	Le, M; Fernandez-Palomo, C; McNeill, FE; Seymour, CB; Rainbow, AJ; Mothersill, CE				Le, Michelle; Fernandez-Palomo, Cristian; McNeill, Fiona E.; Seymour, Colin B.; Rainbow, Andrew J.; Mothersill, Carmel E.			Exosomes are released by bystander cells exposed to radiation-induced biophoton signals: Reconciling the mechanisms mediating the bystander effect	PLOS ONE			English	Article							SISTER-CHROMATID EXCHANGES; HUMAN KERATINOCYTE CELLS; CHRONIC-FATIGUE-SYNDROME; IONIZING-RADIATION; PHOTON-EMISSION; ALPHA-PARTICLES; INTERCELLULAR COMMUNICATION; INDUCTION; BIOLOGY; IMMUNE	Objective The objective of our study was to explore a possible molecular mechanism by which ultraviolet (UV) biophotons could elicit bystander responses in reporter cells and resolve the problem of seemingly mutually exclusive mechanisms of a physical UV signal & a soluble factormediated bystander signal. Methods The human colon carcinoma cell line, HCT116 p53+/+, was directly irradiated with 0.5 Gy tritium beta particles to induce ultraviolet biophoton emission. Bystander cells were not directly irradiated but were exposed to the emitted UV biophotons. Medium was subsequently harvested from UV-exposed bystander cells. The exosomes extracted from this medium were incubated with reporter cell populations. These reporter cells were then assayed for clonogenic survival and mitochondrial membrane potential with and without prior treatment of the exosomes with RNase. Results Clonogenic cell survival was significantly reduced in reporter cells incubated with exosomes extracted from cells exposed to secondarily-emitted UV. These exosomes also induced significant mitochondrial membrane depolarization in receiving reporter cells. Conversely, exosomes extracted from non-UV-exposed cells did not produce bystander effects in reporter cells. The treatment of exosomes with RNase prior to their incubation with reporter cells effectively abolished bystander effects in reporter cells and this suggests a role for RNA in mediating the bystander response elicited by UV biophotons and their produced exosomes. Conclusion This study supports a role for exosomes released from UV biophoton-exposed bystander cells in eliciting bystander responses and also indicates a reconciliation between the UVmediated bystander effect and the bystander effect which has been suggested in the literature to be mediated by soluble factors.	[Le, Michelle; McNeill, Fiona E.] McMaster Univ, Radiat Sci Grad Program, Hamilton, ON, Canada; [Fernandez-Palomo, Cristian] Univ Bern, Inst Anat, Bern, Switzerland; [McNeill, Fiona E.] McMaster Univ, Dept Phys & Astron, Hamilton, ON, Canada; [Seymour, Colin B.; Rainbow, Andrew J.; Mothersill, Carmel E.] McMaster Univ, Dept Biol, Hamilton, ON, Canada	McMaster University; University of Bern; McMaster University; McMaster University	Le, M (corresponding author), McMaster Univ, Radiat Sci Grad Program, Hamilton, ON, Canada.	lem8@mcmaster.ca	Fernandez-Palomo, Cristian/J-8943-2019	Fernandez-Palomo, Cristian/0000-0002-5095-262X	National Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS) Foundation; Natural Sciences and Engineering Research Council of Canada [RGPIN293153-12, RGPIN203611-12]; Canada Research Chairs Programme [950-221284]; CANDU Owners Group [CRDPJ484381-15]	National Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS) Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Programme(Canada Research Chairs); CANDU Owners Group	The authors would like to thank the following funding agencies for providing financial support for this research endeavour: The National Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS) Foundation (url: http://www.ncf-net.org/; recipient: CEM), the Natural Sciences and Engineering Research Council of Canada (url: http://www.nserc-crsng.gc.ca/index_eng.asp; recipient: CEM; grant number RGPIN293153-12; recipient: FEM; grant number RGPIN203611-12), Canada Research Chairs Programme (url: http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx; recipient: CEM; grant number 950-221284), CANDU Owners Group (url: http://www.candu.org/; recipient: CBS; grant number CRDPJ484381-15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SB, 2012, NUCL INSTRUM METH B, V288, P81, DOI 10.1016/j.nimb.2012.05.043; Ahmad SB, 2014, NUCL INSTRUM METH B, V319, P48, DOI 10.1016/j.nimb.2013.10.012; Ahmad SB, 2013, DOSE-RESPONSE, V11, P498, DOI 10.2203/dose-response.12-048.Ahmad; Al-Mayah A, 2015, MUTAT RES-FUND MOL M, V772, P38, DOI 10.1016/j.mrfmmm.2014.12.007; Al-Mayah AHJ, 2012, RADIAT RES, V177, P539, DOI 10.1667/RR2868.1; Albanese J, 2003, EXP HEMATOL, V31, P455, DOI 10.1016/S0301-472X(03)00050-X; [Anonymous], 2016, ANTI TSG101 ANTIBODY; [Anonymous], 2016, ANTI CD63 ANTIBODY; Arscott WT, 2013, TRANSL ONCOL, V6, P638, DOI 10.1593/tlo.13640; Azzam EI, 1998, RADIAT RES, V150, P497, DOI 10.2307/3579865; BAJPAI RP, 1991, J BIOLUM CHEMILUM, V6, P227, DOI 10.1002/bio.1170060403; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Gow MD, 2010, RADIAT RES, V173, P769, DOI 10.1667/RR1895.1; GURWITSCH AA, 1988, EXPERIENTIA, V44, P545, DOI 10.1007/BF01953301; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Iyer R, 2000, CANCER RES, V60, P1290; Jella KK, 2014, RADIAT RES, V181, P138, DOI 10.1667/RR13337.1; Jelonek K, 2015, ACTA BIOCHIM POL, V62, P265, DOI 10.18388/abp.2015_970; KAZNACHEEV VP, 1980, B EXP BIOL MED+, V89, P345; Le M, 2015, PHYS MED BIOL, V60, P6371, DOI 10.1088/0031-9155/60/16/6371; Le M., 2016, RADIAT RES MANUSCRIP; Le M, 2015, RADIAT RES, V183, P279, DOI 10.1667/RR13827.1; Lehnert BE, 1997, CANCER RES, V57, P2164; Lo Cicero A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8506; Lotvall J, 2014, COMMUNICATION; Lyng FM, 2006, RADIAT RES, V165, P400, DOI 10.1667/RR3527.1; Lyng FM, 2002, RADIAT RES, V157, P365, DOI 10.1667/0033-7587(2002)157[0365:IOAICE]2.0.CO;2; Mayburov SN, 2012, QUANT COM COM, V11, P1; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421, DOI 10.1080/095530097144030; Myhill S, 2009, INT J CLIN EXP MED, V2, P1; NAGASAWA H, 1992, CANCER RES, V52, P6394; Pall ML, 2008, MED HYPOTHESES, V71, P537, DOI 10.1016/j.mehy.2008.05.023; POPP FA, 1984, CELL BIOPHYS, V6, P33, DOI 10.1007/BF02788579; Prise KM, 1998, STUDIES OF BYSTANDER, V74; Sharetsky A. N., 2012, Radiatsionnaya Biologiya Radioekologiya, V52, P229; Surinov BP, 2007, NATO SCI PEACE SECUR, P127, DOI 10.1007/978-1-4020-6335-0_9; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; VANWIJK R, 1993, J PHOTOCH PHOTOBIO B, V18, P75, DOI 10.1016/1011-1344(93)80042-8; VANWIJK R, 2001, J SCI EXPLOR, V0015, P00183; Whiteside JR, 2011, PHOTOCHEM PHOTOBIOL, V87, P435, DOI 10.1111/j.1751-1097.2010.00881.x; Whiteside JR, 2009, RADIAT RES, V171, P204, DOI 10.1667/RR1508.1; Wu L, 2016, TUMOUR BIOL; Xiao X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089534; Xu S, 2015, RNA BIOL, V12, P1355, DOI 10.1080/15476286.2015.1100795; Zhang HG, 2016, ONCOTARGET, V5	46	60	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173685	10.1371/journal.pone.0173685	http://dx.doi.org/10.1371/journal.pone.0173685			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278290	Green Published, gold			2022-12-27	WOS:000396087900028
J	Sellam, A; Lode, N; Ayachi, A; Jourdain, G; Dauger, S; Jones, P				Sellam, Aurelie; Lode, Noella; Ayachi, Azzedine; Jourdain, Gilles; Dauger, Stephane; Jones, Peter			Passive hypothermia (>= 35-< 36 degrees C) during transport of newborns with hypoxic-ischaemic encephalopathy	PLOS ONE			English	Article							WHOLE-BODY HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; NEONATAL ENCEPHALOPATHY; MODERATE HYPOTHERMIA; ASPHYXIA; INFANTS; TERM	Background Hypothermia initiated in the first six hours of life in term infants with hypoxic ischemic encephalopathy reduces the risk of death and severe neurological sequelae. Our study's principal objective was to evaluate transport predictors potentially influencing arrival in NICU (Neonatal Intensive Care Unit) at a temperature >= 35-<36 degrees C. Methodology/Principal findings A multi-centric, prospective cohort study was conducted during 18 months by the three Neonatal Transport Teams and 13 NICUs. Newborns were selected for inclusion according to biological and clinical criteria before transport using passive hypothermia using a target temperature of >= 35-<36 degrees C. Data on 120 of 126 inclusions were available for analysis. Thirty-three percent of the children arrived in NICU with the target temperature of >= 35-<36 degrees C. The mean temperature for the whole group of infants on arrival in NICU was 35.4 degrees C (34.3-36.5). The median age of all infants on arrival in NICU was 3h03min [2h25min-3h56min]. Three infants arrived in NICU with a temperature of <33 degrees C and eleven with a temperature >= 37 degrees C. Adrenaline during resuscitation was associated with a lower mean temperature on arrival in NICU. Conclusions/Significance Our strategy using >= 35-<36 degrees C passive hypothermia combined with short transport times had little effect on temperature after the arrival of Neonatal Transport Team although did reduce numbers of infants arriving in NICU in deep hypothermia. For those infants where hypothermia was discontinued in NICU our strategy facilitated re-warming. Re-adjustment to a lower target temperature to >= 34.5-<35.5 degrees C may reduce the proportion of infants with high/normothermic temperatures.	[Sellam, Aurelie; Lode, Noella; Jones, Peter] Hop Robert Debre, AP HP, SMUR Pediat, Paris, France; [Ayachi, Azzedine] Hop Andre Gregoire, AP HP, SMUR Pediat, Montreuil, France; [Jourdain, Gilles] Hop Clamart, SMUR Pediat, Clamart, France; [Dauger, Stephane; Jones, Peter] Hop Robert Debre, Reanimat Pediat PICU, Paris, France; [Jones, Peter] UCL, Inst Child Hlth, Portex Unit, Crit Care Grp,Portex Unit, London, England; [Jones, Peter] London Sch Hyg & Trop Med, London, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Jones, P (corresponding author), Hop Robert Debre, AP HP, SMUR Pediat, Paris, France.; Jones, P (corresponding author), Hop Robert Debre, Reanimat Pediat PICU, Paris, France.; Jones, P (corresponding author), UCL, Inst Child Hlth, Portex Unit, Crit Care Grp,Portex Unit, London, England.; Jones, P (corresponding author), London Sch Hyg & Trop Med, London, England.	sejjprj@ucl.ac.uk	Dauger, Stéphane/AAX-9669-2021					Akula VP, 2012, AM J PERINAT, V29, P319, DOI 10.1055/s-0031-1295661; Azzopardi D, NEW ENGL J MED, V371, P140, DOI [10.1056/NEJMeal315788, DOI 10.1056/NEJMEAL315788]; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; BURNARD ED, 1958, BRIT MED J, V2, P1197, DOI 10.1136/bmj.2.5106.1197; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Eicher DJ, 2005, PEDIATR NEUROL, V32, P18, DOI 10.1016/j.pediatrneurol.2004.06.015; Fairchild K, 2010, J PERINATOL, V30, P324, DOI 10.1038/jp.2009.168; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gunn AJ, 1999, PEDIATR RES, V46, P274, DOI 10.1203/00006450-199909000-00005; Hallberg B, 2009, ACTA PAEDIATR, V98, P942, DOI 10.1111/j.1651-2227.2009.01303.x; Hobson Andrea, 2011, Air Med J, V30, P197, DOI 10.1016/j.amj.2011.03.010; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; Johnston ED, 2010, ARCH DIS CHILD-FETAL, V97, pF365; Kendall GS, 2010, ARCH DIS CHILD-FETAL, V95, pF408, DOI 10.1136/adc.2010.187211; Khurshid F, 2011, PAED CHILD HEALT-CAN, V16, P153, DOI 10.1093/pch/16.3.153; Laptook AR, 2013, ANN NEUROL, V73, P520, DOI 10.1002/ana.23843; Laptook AR, 2010, PEDIATRICS, V126, pE965, DOI 10.1542/peds.2010-2075; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Merchant N, 2015, DEV MED CHILD NEUROL, V57, P8, DOI 10.1111/dmcn.12726; MYERS RE, 1975, BIOL NEONATE, V26, P21; O'Reilly D, 2013, J PERINATOL, V33, P435, DOI 10.1038/jp.2012.138; Oncel MY, 2013, PEDIATR HEMAT ONCOL, V30, P246, DOI 10.3109/08880018.2013.771240; Robertson NJ, 2008, LANCET, V372, P801, DOI 10.1016/S0140-6736(08)61329-X; Savarese I, 2015, J MATERN-FETAL NEO M, V14, P1; Schierholz Elizabeth, 2014, Adv Neonatal Care, V14 Suppl 5, pS24, DOI 10.1097/ANC.0000000000000121; Shah NA, 2015, AM J PERINAT, V32, P755, DOI 10.1055/s-0034-1395483; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; SHANKARAN S, 1991, EARLY HUM DEV, V25, P135, DOI 10.1016/0378-3782(91)90191-5; THORESEN M, 1995, PEDIATR RES, V37, P667, DOI 10.1203/00006450-199505000-00019; Thoresen M, 2013, NEONATOLOGY, V104, P228, DOI 10.1159/000353948; Thoresen M, 2010, PEDIATRICS, V126, pE131, DOI 10.1542/peds.2009-2938; Weiss M D, 2014, J Neonatal Perinatal Med, V7, P173, DOI 10.3233/NPM-14814018	32	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0170100	10.1371/journal.pone.0170100	http://dx.doi.org/10.1371/journal.pone.0170100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278217	gold, Green Published, Green Submitted			2022-12-27	WOS:000396087900105
J	Witting, M; Ruttkies, C; Neumann, S; Schmitt-Kopplin, P				Witting, Michael; Ruttkies, Christoph; Neumann, Steffen; Schmitt-Kopplin, Philippe			LipidFrag: Improving reliability of in silico fragmentation of lipids and application to the Caenorhabditis elegans lipidome	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; DATA-DEPENDENT ACQUISITION; SHOTGUN LIPIDOMICS; ELECTROSPRAY-IONIZATION; IDENTIFICATION; DATABASE; METABOLOMICS	Lipid identification is a major bottleneck in high-throughput lipidomics studies. However, tools for the analysis of lipid tandem MS spectra are rather limited. While the comparison against spectra in reference libraries is one of the preferred methods, these libraries are far from being complete. In order to improve identification rates, the in silico fragmentation tool MetFrag was combined with Lipid Maps and lipid-class specific classifiers which calculate probabilities for lipid class assignments. The resulting LipidFrag workflow was trained and evaluated on different commercially available lipid standard materials, measured with data dependent UPLC-Q-ToF-MS/MS acquisition. The automatic analysis was compared against manual MS/MS spectra interpretation. With the lipid class specific models, identification of the true positives was improved especially for cases where candidate lipids from different lipid classes had similar MetFrag scores by removing up to 56% of false positive results. This LipidFrag approach was then applied to MS/MS spectra of lipid extracts of the nematode Caenorhabditis elegans. Fragments explained by LipidFrag match known fragmentation pathways, e.g., neutral losses of lipid headgroups and fatty acid side chain fragments. Based on prediction models trained on standard lipid materials, high probabilities for correct annotations were achieved, which makes LipidFrag a good choice for automated lipid data analysis and reliability testing of lipid identifications.	[Witting, Michael; Schmitt-Kopplin, Philippe] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Analyt BioGeoChem, Ingolstaedter Landstr, Neuherberg, Germany; [Witting, Michael; Schmitt-Kopplin, Philippe] Tech Univ Munich, Chair Analyt Food Chem, Alte Akad 10, D-85354 Freising Weihenstephan, Germany; [Ruttkies, Christoph; Neumann, Steffen] IPB Halle, Leibniz Inst Plant Biochem, Dept Stress & Dev Biol, Halle, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Leibniz Institut fur Pflanzenbiochemie	Witting, M (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Analyt BioGeoChem, Ingolstaedter Landstr, Neuherberg, Germany.; Witting, M (corresponding author), Tech Univ Munich, Chair Analyt Food Chem, Alte Akad 10, D-85354 Freising Weihenstephan, Germany.	michael.witting@helmholtz-muenchen.de	Neumann, Steffen/K-5554-2012; Schmitt-Kopplin, Philippe/H-6271-2011; Witting, Michael/AAI-1338-2019	Neumann, Steffen/0000-0002-7899-7192; Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Witting, Michael/0000-0002-1462-4426	DFG [NE/1396/5-1]	DFG(German Research Foundation (DFG))	Christoph Ruttkies acknowledges funding from DFG grant NE/1396/5-1.r Christoph Ruttkies acknowledges funding from DFG grant NE/1396/5-1. C. elegans samples were kindly provided by Steve Garvis, ENS Lyon. We thank Emma Schymanski (Eawag, Dubendorf, Switzerland) for fruitful and intensive discussions and comments on the manuscript.	Ahmed Z, 2015, BIOINFORMATICS, V31, P1150, DOI 10.1093/bioinformatics/btu796; Aimo L, 2015, BIOINFORMATICS, V31, P2860, DOI 10.1093/bioinformatics/btv285; Almeida R, 2015, J AM SOC MASS SPECTR, V26, P133, DOI 10.1007/s13361-014-1013-x; Bird SS, 2012, ANAL CHEM, V84, P5509, DOI 10.1021/ac300953j; CAFFREY M, 1992, CHEM PHYS LIPIDS, V61, P1, DOI 10.1016/0009-3084(92)90002-7; Castro-Perez JM, 2010, J PROTEOME RES, V9, P2377, DOI 10.1021/pr901094j; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Foster JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061951; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P797, DOI 10.1016/S1044-0305(00)00151-3; Hsu FF, 2002, J AM SOC MASS SPECTR, V13, P558, DOI 10.1016/S1044-0305(02)00358-6; Hu CX, 2008, J PROTEOME RES, V7, P4982, DOI 10.1021/pr800373m; Ishida M, 2004, RAPID COMMUN MASS SP, V18, P2486, DOI 10.1002/rcm.1650; Kall L, 2008, J PROTEOME RES, V7, P40, DOI 10.1021/pr700739d; Kerber A, 1998, MATCH-COMMUN MATH CO, P205; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Kochen MA, 2016, ANAL CHEM, V88, P5733, DOI 10.1021/acs.analchem.6b00021; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Luo P, 2015, ANAL CHEM, V87, P5050, DOI 10.1021/acs.analchem.5b00615; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Michalski A, 2011, J PROTEOME RES, V10, P1785, DOI 10.1021/pr101060v; Murphy RC, 2007, ANAL BIOCHEM, V366, P59, DOI 10.1016/j.ab.2007.03.012; Papan C, 2014, ANAL CHEM, V86, P2703, DOI 10.1021/ac404083u; Pham HT, 2014, ANALYST, V139, P204, DOI 10.1039/c3an01712e; Schwudke D, 2007, METHOD ENZYMOL, V433, P175, DOI 10.1016/S0076-6879(07)33010-3; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Wagele B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039860; Watanabe K, 2000, TRENDS GLYCOSCI GLYC, V12, P175, DOI 10.4052/tigg.12.175; Witting M, 2016, ARCH BIOCHEM BIOPHYS, V589, P27, DOI 10.1016/j.abb.2015.06.003; Witting M, 2014, COMP ANAL C, V63, P421, DOI 10.1016/B978-0-444-62651-6.00018-0; Witting M, 2014, J CHROMATOGR A, V1359, P91, DOI 10.1016/j.chroma.2014.07.021; Wolf S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-148; Yan ZX, 2015, ANAL CHEM, V87, P2861, DOI 10.1021/ac504325x; Yang K, 2011, METABOLITES, V1, P21, DOI 10.3390/metabo1010021; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u	39	17	18	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172311	10.1371/journal.pone.0172311	http://dx.doi.org/10.1371/journal.pone.0172311			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278196	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900117
J	Rodriguez-Caro, RC; Oedekoven, CS; Gracia, E; Anadon, JD; Buckland, ST; Esteve-Selma, MA; Martinez, J; Gimenez, A				Rodriguez-Caro, Roberto C.; Oedekoven, Cornelia S.; Gracia, Eva; Anadon, Jose D.; Buckland, Stephen T.; Esteve-Selma, Miguel A.; Martinez, Julia; Gimenez, Andres			Low tortoise abundances in pine forest plantations in forest-shrubland transition areas	PLOS ONE			English	Article							HABITAT SELECTION; TESTUDO-GRAECA; LANDSCAPE; FRAGMENTATION; CONSERVATION; BIODIVERSITY; COMMUNITIES; ASSEMBLAGES; GRADIENTS; PATTERNS	In the transition between Mediterranean forest and the arid subtropical shrublands of the southeastern Iberian Peninsula, humans have transformed habitat since ancient times. Understanding the role of the original mosaic landscapes in wildlife species and the effects of the current changes as pine forest plantations, performed even outside the forest ecological boundaries, are important conservation issues. We studied variation in the density of the endangered spur-thighed tortoise (Testudo graeca) in three areas that include the four most common land types within the species' range (pine forests, natural shrubs, dryland crop fields, and abandoned crop fields). Tortoise densities were estimated using a two-stage modeling approach with line transect distance sampling. Densities in dryland crop fields, abandoned crop fields and natural shrubs were higher (> 6 individuals/ha) than in pine forests (1.25 individuals/ha). We also found large variation in density in the pine forests. Recent pine plantations showed higher densities than mature pine forests where shrub and herbaceous cover was taller and thicker. We hypothesize that mature pine forest might constrain tortoise activity by acting as partial barriers to movements. This issue is relevant for management purposes given that large areas in the tortoise's range have recently been converted to pine plantations.	[Rodriguez-Caro, Roberto C.; Gracia, Eva; Gimenez, Andres] Univ Miguel Hernandez, Area Ecol, Dept Biol Aplicada, Av Univ, Elche, Spain; [Oedekoven, Cornelia S.; Buckland, Stephen T.] Univ St Andrews, Ctr Res Ecol & Environm Modeling, Buchanan Gardens, St Andrews, Fife, Scotland; [Anadon, Jose D.] CUNY Queens Coll, Dept Biol, New York, NY USA; [Esteve-Selma, Miguel A.] Univ Murcia, Area Ecol, Dept Ecol & Hidrol, Murcia, Spain; [Martinez, Julia] Fdn Nueva Cultura Agua, Zaragoza, Spain	Universidad Miguel Hernandez de Elche; University of St Andrews; City University of New York (CUNY) System; University of Murcia	Rodriguez-Caro, RC (corresponding author), Univ Miguel Hernandez, Area Ecol, Dept Biol Aplicada, Av Univ, Elche, Spain.	r.rodriguez@umh.es	Graciá, Eva/H-2270-2015; Giménez, Andrés/H-4354-2015; Rodríguez-Caro, Roberto/ABE-6957-2020; Buckland, Stephen T/A-1998-2012; Martinez-Fernandez, Julia/J-9681-2012; Esteve-Selma, Miguel Angel/ABG-7689-2020	Graciá, Eva/0000-0003-0790-163X; Giménez, Andrés/0000-0002-5248-9819; Rodríguez-Caro, Roberto/0000-0003-2321-9497; Martinez-Fernandez, Julia/0000-0001-8675-947X; Esteve-Selma, Miguel Angel/0000-0003-1803-3217; Buckland, Stephen/0000-0002-9939-709X; Oedekoven, Cornelia/0000-0002-5610-7814	Spanish Ministry of Science and European Regional Development Fund [CGL2012-33536, CGL2015-64144]; MINECIO/FEDER; Regional Government of the Community of Valencia [ACIF/2010/133, APOSTD/2015/048]	Spanish Ministry of Science and European Regional Development Fund; MINECIO/FEDER; Regional Government of the Community of Valencia	The Spanish Ministry of Science and European Regional Development Fund funded this work through Projects CGL2012-33536 and CGL2015-64144; MINECIO/FEDER. Regional Government of the Community of Valencia supported R.R-C. by a postgraduate grant (ACIF/2010/133) and E.G. by a postdoctoral grant (APOSTD/2015/048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1979, BIOMETRIKA, V66, P237, DOI 10.1093/biomet/66.2.237; Amo L, 2007, BIODIVERS CONSERV, V16, P3409, DOI 10.1007/s10531-006-9003-3; Anadon JD, 2006, BIODIVERS CONSERV, V15, P2287, DOI 10.1007/s10531-004-8226-4; Anadon JD, 2006, ECOGRAPHY, V29, P339, DOI 10.1111/j.2006.0906-7590.04486.x; Anderson DR, 2001, J WILDLIFE MANAGE, V65, P583, DOI 10.2307/3803111; Azor JS, 2015, FOREST ECOL MANAG, V354, P185, DOI 10.1016/j.foreco.2015.06.020; Barton PS, 2013, BIODIVERS CONSERV, V22, P2091, DOI 10.1007/s10531-013-0530-4; Belmonte-Serrano F., 2008, EROSION FORESTACIONE; Bignal EM, 1996, J APPL ECOL, V33, P413, DOI 10.2307/2404973; Billeter R, 2008, J APPL ECOL, V45, P141, DOI 10.1111/j.1365-2664.2007.01393.x; Blouin-Demers G, 2001, ECOLOGY, V82, P3025; Bottema S., 1990, MANS ROLE SHAPING E; Buckland S.T., 2001, pi; Buckland ST, 2009, J AGR BIOL ENVIR ST, V14, P432, DOI 10.1198/jabes.2009.08030; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calix M., 2018, EUROPEAN RED LIST SA; Anadon JD, 2009, CONSERV BIOL, V23, P617, DOI 10.1111/j.1523-1739.2008.01145.x; DARGIE TCD, 1987, J BIOGEOGR, V14, P197, DOI 10.2307/2844891; de Wit AMW, 1998, ADV ECOL SCI, V1, P165; Diaz JA, 2000, ANIM CONSERV, V3, P235, DOI 10.1017/S1367943000000950; Diaz M, 1998, J APPL ECOL, V35, P562, DOI 10.1046/j.1365-2664.1998.3540562.x; ESTEVE MA, 2003, RECURSOS NATURALES R, P248; Esteve-Selma MA, 2012, CLIMATIC CHANGE, V113, P663, DOI 10.1007/s10584-011-0378-0; Evans K. O., 2013, J WILDLIFE MANAGEMEN, DOI 10. 1002/jwmg. 502; Gao JiXi, 2012, Journal of Resources and Ecology, V3, P297, DOI 10.5814/j.issn.1674-764x.2012.04.002; Gimenez A., 2001, TECHNICAL REPORT; Goldstein MI, 2003, ECOL MODEL, V162, P155, DOI 10.1016/S0304-3800(03)00005-X; GREENBERG CH, 1994, CONSERV BIOL, V8, P1047, DOI 10.1046/j.1523-1739.1994.08041047.x; Jaggi C, 1999, AMPHIBIA-REPTILIA, V20, P25, DOI 10.1163/156853899506870; Kazmaier RT, 2001, J WILDLIFE MANAGE, V65, P653, DOI 10.2307/3803016; Lal R, 2010, BIOSCIENCE, V60, P708, DOI 10.1525/bio.2010.60.9.8; Leuteritz TEJ, 2005, BIOL CONSERV, V124, P451, DOI 10.1016/j.biocon.2005.02.003; Litzgus JD, 2000, J HERPETOL, V34, P178, DOI 10.2307/1565413; Lloret F, 2002, LANDSCAPE ECOL, V17, P745, DOI 10.1023/A:1022966930861; Lopez-Jurado L.F, 1979, NATURALIA HISPANICA, V17, P1, DOI [10.5061/dryad.q83bk3jhs, DOI 10.5061/DRYAD.Q83BK3JHS]; Luiselli L, 2008, ACTA HERPETOL, V3, P19; Mac Nally R, 2001, OECOLOGIA, V128, P116, DOI 10.1007/s004420100632; Maestre FT, 2004, FOREST ECOL MANAG, V198, P303, DOI 10.1016/j.foreco.2004.05.040; Martinez-Fernandez J, 2005, LAND DEGRAD DEV, V16, P529, DOI 10.1002/ldr.707; Meyfroidt P, 2011, ANNU REV ENV RESOUR, V36, P343, DOI 10.1146/annurev-environ-090710-143732; Oxbrough A, 2012, FOREST ECOL MANAG, V270, P11, DOI 10.1016/j.foreco.2012.01.006; Perez I., 2002, ANALES BIOL, V24, P55; RISSER PG, 1995, BIOSCIENCE, V45, P318, DOI 10.2307/1312492; Rodriguez-Caro R. C., 2016, J ZOOLOGY; Santos X, 2016, OECOLOGIA, V180, P205, DOI 10.1007/s00442-015-3453-9; Schreuder E, 2016, OECOLOGIA, V182, P1213, DOI 10.1007/s00442-016-3726-y; Stubbs David, 1995, P94; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Lantschner MV, 2011, MAMMALIA, V75, P249, DOI 10.1515/MAMM.2011.031; Walter H., 1979, VEGETATION EARTH ECO; Walter H., 1985, COMMUNITY ECOSYSTEMS, P167; White D, 1997, CONSERV BIOL, V11, P349, DOI 10.1046/j.1523-1739.1997.95458.x; WRIGHT J, 1988, CAN J ZOOL, V66, P1537, DOI 10.1139/z88-225	53	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173485	10.1371/journal.pone.0173485	http://dx.doi.org/10.1371/journal.pone.0173485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273135	gold, Green Published, Green Submitted			2022-12-27	WOS:000396073700009
J	Dale, ML; Horak, FB; Wright, WG; Schoneburg, BM; Nutt, JG; Mancini, M				Dale, Marian L.; Horak, Fay B.; Wright, W. Geoffrey; Schoneburg, Bernadette M.; Nutt, John G.; Mancini, Martina			Impaired perception of surface tilt in progressive supranuclear palsy	PLOS ONE			English	Article							PARKINSONS-DISEASE; VERTICALITY; RESPONSES; STANCE; STIMULATION; STABILITY; POSTURE	Introduction Progressive supranuclear palsy (PSP) is characterized by early postural instability and backward falls. The mechanisms underlying backward postural instability in PSP are not understood. The aim of this study was to test the hypothesis that postural instability in PSP is a result of dysfunction in the perception of postural verticality. Methods We gathered posturography data on 12 subjects with PSP to compare with 12 subjects with idiopathic Parkinson's Disease (PD) and 12 healthy subjects. Objective tests of postural impairment included: dynamic sensory perception tests of gravity and of surface oscillations, postural responses to surface perturbations, the sensory organization test of postural sway under altered sensory conditions and limits of stability in stance. Results Perception of toes up (but not toes down) surface tilt was reduced in subjects with PSP compared to both control subjects (p <= 0.001 standing, p <= 0.007 seated) and subjects with PD (p <= 0.03 standing, p <= 0.04 seated). Subjects with PSP, PD and normal controls accurately perceived the direction of gravity when standing on a tilting surface. Unlike PD and control subjects, subjects with PSP exerted less postural corrective torque in response to toes up surface tilts. Discussion Difficulty perceiving backward tilt of the surface or body may account for backward falls and postural impairments in patients with PSP. These observations suggest that abnormal central integration of sensory inputs for perception of body and surface orientation contributes to the pathophysiology of postural instability in PSP.	[Dale, Marian L.; Horak, Fay B.; Schoneburg, Bernadette M.; Nutt, John G.; Mancini, Martina] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Dale, Marian L.; Horak, Fay B.] Vet Affairs Portland Healthcare Syst VAPORHCS, PADRECC P3, Parkinsons Dis Res Educ & Clin Ctr, Portland, OR 97239 USA; [Wright, W. Geoffrey] Temple Univ, Dept Phys Therapy, Philadelphia, PA 19122 USA; [Wright, W. Geoffrey] Temple Univ, Dept Bioengn, Philadelphia, PA 19122 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Dale, ML (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA.; Dale, ML (corresponding author), Vet Affairs Portland Healthcare Syst VAPORHCS, PADRECC P3, Parkinsons Dis Res Educ & Clin Ctr, Portland, OR 97239 USA.	dalem@ohsu.edu	Dale, Marian/AAO-7163-2020	Dale, Marian/0000-0003-1010-982X; Mancini, Martina/0000-0002-4532-3984	Medical Research Foundation of Oregon; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD078492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006457] Funding Source: NIH RePORTER	Medical Research Foundation of Oregon; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Medical Research Foundation of Oregon: Early Clinical Investigator Grant awarded to BS. OHSU and FH have a significant financial interest in APDM, a company that may have a commercial interest in the results of this research and technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers DS, 2001, TRENDS NEUROSCI, V24, P347, DOI 10.1016/S0166-2236(00)01794-X; Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; BLASZCZYK JW, 1994, GAIT POSTURE, V2, P11, DOI 10.1016/0966-6362(94)90012-4; BLASZCZYK JW, 1993, GAIT POSTURE, V1, P211, DOI 10.1016/0966-6362(93)90048-6; Boeve BF, 2012, PARKINSONISM RELA S1, V18, pS1142; BRANDT T, 1994, ANN NEUROL, V35, P403, DOI 10.1002/ana.410350406; Ganesan M, 2012, GAIT POSTURE, V35, P625, DOI 10.1016/j.gaitpost.2011.12.012; Henderson JM, 2000, BRAIN, V123, P1410, DOI 10.1093/brain/123.7.1410; HORAK FB, 1994, EXP BRAIN RES, V100, P93; Liao K, 2008, NEUROLOGY, V70, P802, DOI 10.1212/01.wnl.0000304134.33380.1e; Litvan I, 1996, NEUROLOGY, V46, P922, DOI 10.1212/WNL.46.4.922; Manckoundia P, 2007, CLIN NEUROPHYSIOL, V118, P786, DOI 10.1016/j.clinph.2006.11.274; MASDEU JC, 1988, ANN NEUROL, V23, P596, DOI 10.1002/ana.410230612; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; Maurer C, 2006, EXP BRAIN RES, V168, P41, DOI 10.1007/s00221-005-0087-x; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Ondo W, 2000, ARCH NEUROL-CHICAGO, V57, P1464, DOI 10.1001/archneur.57.10.1464; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Shinotoh H, 1999, Rinsho Shinkeigaku, V39, P33; Vaugoyeau M, 2011, HUM MOVEMENT SCI, V30, P405, DOI 10.1016/j.humov.2010.10.006; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Wright WG, 2007, EXP BRAIN RES, V182, P321, DOI 10.1007/s00221-007-0990-4; Wright WG, 2009, EXP BRAIN RES, V192, P683, DOI 10.1007/s00221-008-1581-8; Wright WG, 2003, ANN NY ACAD SCI, V1004, P531, DOI 10.1196/annals.1303.069; ZWEIG RM, 1987, ANN NEUROL, V22, P18, DOI 10.1002/ana.410220107; Zwergal A, 2011, NEUROLOGY, V77, P101, DOI 10.1212/WNL.0b013e318223c79d	26	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173351	10.1371/journal.pone.0173351	http://dx.doi.org/10.1371/journal.pone.0173351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267762	Green Submitted, Green Published, gold			2022-12-27	WOS:000396060600024
J	Lin, SY; Lin, CL; Ju, SW; Wang, IK; Lin, CC; Lin, CH; Hsu, WH; Liang, JA				Lin, Shih-Yi; Lin, Cheng-Li; Ju, Shu-Woei; Wang, I-Kuan; Lin, Cheng-Chieh; Lin, Chih-Hsueh; Hsu, Wu-Huei; Liang, Ji-An			Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study	PLOS ONE			English	Article							HEPATITIS-C VIRUS; OXIDATIVE STRESS; DISEASE; INTERFERON-ALPHA-2B; ASSOCIATION; RETINOPATHY; PREVALENCE; INFECTION; INDICATOR; STROKE	Purpose Hepatitis C virus (HCV) infection is associated with increased systemic oxidative stress, which leads to cardiovascular events, diabetes, and chronic kidney disease. Similarly, cataract is also associated with increased oxidative stress. The association between HCV infection and increased risk of cataract remains unclear. Methods A total of 11,652 HCV-infected patients and 46,608 age-and sex-matched non-HCV infected patients were identified during 2003-2011. All patient data were tracked until a diagnosis of cataract, death, or the end of 2011. Cumulative incidences and hazard ratios (HRs) were calculated. Results The mean follow-up durations were 5.29 and 5.86 years for the HCV and non-HCV cohorts, respectively. The overall incidence density rate for cataract was 1.36 times higher in the HCV cohort than in the non-HCV cohort (1.86 and 1.37 per 100 person-y, respectively). After adjusting for age, sex, comorbidities of diabetes, hypertension, hyperlipidemia, asthma, chronic obstructive pulmonary disease, coronary artery disease, and anxiety, patients with HCV infection had an increased risk of cataract compared with those without HCV infection [ adjusted HR = 1.23, 95% confidence interval (CI) = 1.14-1.32]. HCV-infected patients receiving interferon-ribavirin therapy had a 1.83 times higher (95% CI = 1.40-2.38) risk of cataract than non-HCV infected patients did. Conclusion HCV infection, even without the complication of cirrhosis, is associated with an increased risk of cataract, and this risk is higher in HCV-infected patients undergoing interferon-ribavirin therapy.	[Lin, Shih-Yi; Wang, I-Kuan; Lin, Cheng-Chieh; Lin, Chih-Hsueh; Hsu, Wu-Huei; Liang, Ji-An] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Lin, Shih-Yi; Ju, Shu-Woei; Wang, I-Kuan] China Med Univ Hosp, Div Nephrol, Taichung, Taiwan; [Lin, Shih-Yi; Ju, Shu-Woei; Wang, I-Kuan] China Med Univ Hosp, Kidney Inst, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Lin, Cheng-Chieh; Lin, Chih-Hsueh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Hsu, Wu-Huei] China Med Univ Hosp, Div Pulm & Crit Care Med, Taichung, Taiwan; [Hsu, Wu-Huei] China Med Univ, Taichung, Taiwan; [Liang, Ji-An] China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Liang, JA (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan.; Liang, JA (corresponding author), China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan.	d4615@mail.cmuh.org.tw	; Lin, Cheng-Chieh/P-2564-2015	Liang, Ji-An/0000-0002-4170-7155; Lin, Cheng-Chieh/0000-0002-9625-6216	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Babizhayev MA, 2001, PEPTIDES, V22, P979, DOI 10.1016/S0196-9781(01)00407-7; Chen PC, 2011, STROKE, V42, P3034, DOI 10.1161/STROKEAHA.111.615534; Chen YC, 2014, KIDNEY INT, V85, P1200, DOI 10.1038/ki.2013.455; Chi MJ, 2011, ARCH GERONTOL GERIAT, V52, P284, DOI 10.1016/j.archger.2010.04.017; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; El-Zayadi AR, 2012, WORLD J GASTROENTERO, V18, P212, DOI 10.3748/wjg.v18.i3.212; Farel C, 2004, AIDS, V18, P1805, DOI 10.1097/00002030-200409030-00009; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Grimes CE, 2014, WORLD J SURG, V38, P252, DOI 10.1007/s00268-013-2243-y; Jain K, 2001, BRIT J OPHTHALMOL, V85, P1171, DOI 10.1136/bjo.85.10.1171; Ku JY, 2009, CLIN EXP OPHTHALMOL, V37, P743, DOI 10.1111/j.1442-9071.2009.02125.x; Levent G, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-25; Lin SY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002847; Lin SY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001141; Lonardo A, 2004, GASTROENTEROLOGY, V126, P586, DOI 10.1053/j.gastro.2003.11.020; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Negro F, 2009, WORLD J GASTROENTERO, V15, P1537, DOI 10.3748/wjg.15.1537; Okuse C, 2006, WORLD J GASTROENTERO, V12, P3756, DOI 10.3748/wjg.v12.i23.3756; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Pollreisz A, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/608751; Roed T, 2012, CLIN PHYSIOL FUNCT I, V32, P421, DOI 10.1111/j.1475-097X.2012.01152.x; Shiels A, 2013, CLIN GENET, V84, P120, DOI 10.1111/cge.12182; Sumida Y, 2000, J HEPATOL, V33, P616, DOI 10.1034/j.1600-0641.2000.033004616.x; Thorne JE, 2010, OPHTHALMOLOGY, V117, P1436, DOI 10.1016/j.ophtha.2009.12.003; VARMA SD, 1984, CURR EYE RES, V3, P35, DOI 10.3109/02713688408997186; Vashist P, 2011, OPHTHALMOLOGY, V118, P272, DOI 10.1016/j.ophtha.2010.05.020; Williams DL, 2006, VET OPHTHALMOL, V9, P292, DOI 10.1111/j.1463-5224.2006.00498.x; Yoshida K, 2002, J CATARACT REFR SURG, V28, P1789, DOI 10.1016/S0886-3350(02)01335-4	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173125	10.1371/journal.pone.0173125	http://dx.doi.org/10.1371/journal.pone.0173125			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264004	gold, Green Published, Green Submitted			2022-12-27	WOS:000396054300040
J	Mollerup, PM; Gamborg, M; Trier, C; Bojsoe, C; Nielsen, TRH; Baker, JL; Holm, JC				Mollerup, Pernille Maria; Gamborg, Michael; Trier, Caecilie; Bojsoe, Christine; Nielsen, Tenna Ruest Haarmark; Baker, Jennifer Lyn; Holm, Jens-Christian			A hospital-based child and adolescent overweight and obesity treatment protocol transferred into a community healthcare setting	PLOS ONE			English	Article							BODY-MASS INDEX; TASK-FORCE COTF; WAIST CIRCUMFERENCE; EUROPEAN ASSOCIATION; PEDIATRIC OBESITY; PUBERTAL CHANGES; PREVENTION; RECOMMENDATIONS; OUTCOMES; DISEASE	Background Due to the pandemic of child and adolescent overweight and obesity, improvements in overweight and obesity treatment availability and accessibility are needed. Methods In this prospective study, we investigated if reductions in body mass index (BMI) standard deviation scores (SDS) and waist circumference (WC) would occur during 1.5 years of community- based overweight and obesity treatment based upon an effective hospital-based overweight and obesity treatment protocol, The Children's Obesity Clinics' Treatment protocol. Height, weight, and WC were measured at all consultations. Changes in BMI SDS and WC were analyzed using linear mixed models based upon the repeated measures in each child. Results From June 2012 to January 2015, 1,001 children (455 boys) were consecutively enrolled in the community-based treatment program. Upon entry, the median age was 11 years (range: 3-18), and the median BMI SDS was 2.85 (range: 1.26-8.96) in boys and 2.48 (range: 1.08 -4.41) in girls. After 1.5 years of treatment BMI SDS was reduced in 74% of the children. BMI SDS was reduced by a mean of 0.38 (95% confidence interval (CI): 0.30-0.45, p<0.0001) in boys and 0.18 (95% CI: 0.12-0.25, p<0.0001) in girls after 1.5 years of treatment, independently of baseline age, BMI SDS, and Tanner stage (all p>0.08). WC was reduced by a mean of 3.8 cm (95% CI: 2.7-4.9, p>0.0001) in boys and 5.1 cm (95% CI: 4.0 -6.2, p>0.0001) in girls. The dropout rate was 31% after 1.5 years. A median of 4.5 consultation hours was invested per child per year. Conclusion BMI SDS and WC were reduced after 1.5 years of treatment. Hence, this community-based overweight and obesity treatment program may help accommodate the need for improvements in treatment availability and accessibility.	[Mollerup, Pernille Maria; Trier, Caecilie; Bojsoe, Christine; Nielsen, Tenna Ruest Haarmark; Holm, Jens-Christian] Copenhagen Univ Hosp Holbaek, Dept Pediat, Childrens Obes Clin, Holbaek, Denmark; [Gamborg, Michael; Baker, Jennifer Lyn] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Frederiksberg, Denmark; [Trier, Caecilie; Bojsoe, Christine; Nielsen, Tenna Ruest Haarmark; Baker, Jennifer Lyn; Holm, Jens-Christian] Univ Copenhagen, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Holm, Jens-Christian] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Mollerup, PM (corresponding author), Copenhagen Univ Hosp Holbaek, Dept Pediat, Childrens Obes Clin, Holbaek, Denmark.	Pmm@regionsjaelland.dk	Holm, Jens-Christian/T-4594-2017	Holm, Jens-Christian/0000-0003-4653-342X; Frithioff-Bojsoe, Christine/0000-0002-5005-7780	Region of Zealand; Region Zealand Health Scientific Research Foundation; Aase and Ejnar Danielsens Foundation; Danish Childhood Obesity Biobank [NCT00928473]; Innovation Fund Denmark [0603-00484B, 0603-00457B]; Novo Nordisk Foundation [NNF15OC0016544]	Region of Zealand; Region Zealand Health Scientific Research Foundation; Aase and Ejnar Danielsens Foundation; Danish Childhood Obesity Biobank; Innovation Fund Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The study was funded by the Region of Zealand, the Region Zealand Health Scientific Research Foundation, and the Aase and Ejnar Danielsens Foundation. The study was a part of the research project The Danish Childhood Obesity Biobank (ClinicalTrials.gov ID-no.: NCT00928473) conducted in collaboration with the TARGET (The Impact of our Genomes on Individual Treatment Response in Obese Children, www.target.ku.dk) and BIOCHILD (Genetics and Systems Biology of Childhood Obesity in India and Denmark, www.biochild.ku.dk) consortia, which are funded by grants from the Innovation Fund Denmark (0603-00484B and 0603-00457B), The Novo Nordisk Foundation (NNF15OC0016544) and the Region Zealand Health Scientific Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Croker H, 2012, INT J OBESITY, V36, P16, DOI 10.1038/ijo.2011.182; Danielsen YS, 2013, OBES RES CLIN PRACT, V7, pE116, DOI 10.1016/j.orcp.2012.06.003; Davis MM, 2007, PEDIATRICS, V120, pS229, DOI 10.1542/peds.2007-2329E; de Silva-Sanigorski A, 2011, COCHRANE DB SYST REV, V132, P128; Dhaliwal J, 2014, CHILD OBES, V10, P461, DOI 10.1089/chi.2014.0060; Farpour-Lambert NJ, 2015, OBESITY FACTS, V8, P342, DOI 10.1159/000441483; Fonvig CE, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0513-6; Foster BA, 2015, ACAD PEDIATR, V15, P353, DOI 10.1016/j.acap.2015.04.037; Foster GD, 2014, PEDIATR OBES, V9, pE63, DOI 10.1111/j.2047-6310.2013.00197.x; Foster GD, 2012, PEDIATRICS, V130, P652, DOI 10.1542/peds.2012-0344; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Holm JC, 2014, OBESITY FACTS, V7, P274, DOI 10.1159/000365773; Holm JC, 2011, INT J PEDIATR OBES, V6, P188, DOI 10.3109/17477166.2011.575157; Hvidt KN, 2014, J HYPERTENS, V32, P1470, DOI 10.1097/HJH.0000000000000188; Johnson ST, 2010, J PEDIATR-US, V156, P247, DOI 10.1016/j.jpeds.2009.08.010; Katzmarzyk PT, 2014, INT J OBESITY, V38, P887, DOI 10.1038/ijo.2014.49; Kolotourou M, 2015, CHILD OBES, V11, P325, DOI 10.1089/chi.2014.0092; Kolotourou M, 2013, CHILD OBES, V9, P350, DOI 10.1089/chi.2013.0019; Krebs NF, 2003, PEDIATRICS, V112, P424, DOI 10.1542/peds.112.2.424; Larsen LM, 2012, ACTA PAEDIATR, V101, P201, DOI 10.1111/j.1651-2227.2011.02551.x; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Matthiessen J, 2014, ACTA PAEDIATR, V103, P1083, DOI 10.1111/apa.12722; Most SW, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0332-9; Nielsen LA, 2015, OBESITY FACTS, V8, P319, DOI 10.1159/000441375; Nielsen TRH, 2012, CHILD OBES, V8, P533, DOI 10.1089/chi.2011.0098; Nowicka P, 2008, INT J PEDIATR OBES, V3, P141, DOI 10.1080/17477160802102475; Nysom K, 2001, INT J OBESITY, V25, P177, DOI 10.1038/sj.ijo.0801515; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Pearson S, 2010, ACTA PAEDIATR, V99, P1675, DOI 10.1111/j.1651-2227.2010.01897.x; Peirson Leslea, 2015, CMAJ Open, V3, pE23, DOI 10.9778/cmajo.20140053; Rasmussen AR, 2015, PEDIATRICS, V135, P86, DOI 10.1542/peds.2014-0793; Reinehr T, 2009, ATHEROSCLEROSIS, V207, P174, DOI 10.1016/j.atherosclerosis.2009.03.041; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Rosenbaum M, 2014, J ENDOCRINOL, V223, pT83, DOI 10.1530/JOE-14-0358; Sacher PM, 2010, OBESITY, V18, pS62, DOI 10.1038/oby.2009.433; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; Spear BA, 2007, PEDIATRICS, V120, pS254, DOI 10.1542/peds.2007-2329F; Watson PM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006519; Weiss R., 2004, NEW ENGL J MED, V350, P470; Wohlfahrt-Veje C, 2014, EUR J CLIN NUTR, V68, P664, DOI 10.1038/ejcn.2013.282; World Health Organization, 2008, WAIST CIRCUMFERENCE	46	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173033	10.1371/journal.pone.0173033	http://dx.doi.org/10.1371/journal.pone.0173033			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264043	Green Published, gold, Green Submitted			2022-12-27	WOS:000396054300036
J	Liu, L; Li, JY; Ji, HZ; Zhang, NA; Wang, YY; Zheng, GN; Wang, H; Luo, E				Liu, Li; Li, Jiayang; Ji, Huanzhong; Zhang, Nian; Wang, Yiyao; Zheng, Guangning; Wang, Hu; Luo, En			Cone-beam computed tomography evaluation of the maxillofacial features of patients with unilateral temporomandibular joint ankylosis undergoing condylar reconstruction with an autogenous coronoid process graft	PLOS ONE			English	Article							AIRWAY; BONE	Objective To evaluate the changes in the jaws and the upper airways of unilateral temporomandibular joint ankylosis patients who underwent condylar reconstruction via autogenous coronoid process grafts using cone-beam computed tomography (CBCT). Study design The 27 included patients underwent CBCT examinations at three stages: T0 (within two weeks before surgery), T1 (two weeks after surgery), and T2 (an average of 13 months after surgery). Forty items related to the maxillofacial hard tissues and the upper airway collected at the three times and the coronoid process graft volumes after surgery were compared. Results Some integral items related to the mandibular hard tissues exhibited statistical difference shortly after surgery. Some integral items related to maxillofacial hard tissues changing obviously long period after surgery may result from graft remodeling. Asymmetry-related item regarding local neo-condyle and some airway items were significantly different between T0 and T1. Due to variations in graft remodeling, some related local asymmetry items and airway items differed significantly between T0 and T2. Conclusions Anteriorly and inferiorly located neo-condyles and a trend toward the pronation of the mandible were observed and the narrowness of the upper airway was improved shortly after surgery. The grafts remodeled differently and some integral and asymmetry items related to neo-condyle changed. The improvements in the upper airway were slightly reduced.	[Liu, Li; Li, Jiayang; Ji, Huanzhong; Zhang, Nian; Wang, Yiyao; Zheng, Guangning; Wang, Hu; Luo, En] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Peoples R China; [Liu, Li; Zheng, Guangning; Wang, Hu] Sichuan Univ, West China Hosp Stomatol, Dept Oral Radiol, Natl Clin Res Ctr Oral Dis, Chengdu, Peoples R China; [Li, Jiayang; Ji, Huanzhong; Zhang, Nian; Wang, Yiyao; Luo, En] Sichuan Univ, West China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Natl Clin Res Ctr Oral Dis, Chengdu, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Wang, H; Luo, E (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Peoples R China.; Wang, H (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dept Oral Radiol, Natl Clin Res Ctr Oral Dis, Chengdu, Peoples R China.; Luo, E (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Natl Clin Res Ctr Oral Dis, Chengdu, Peoples R China.	1328548883@qq.com; luoen521125@sina.com		Luo, En/0000-0002-7447-1097	National Natural Science Foundation of China [81621062]; Municipal Science and Technology Foundation of Chengdu [2015-HM01-00181-SF]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Municipal Science and Technology Foundation of Chengdu	This study was supported by Grants from the National Natural Science Foundation of China with NO. 81621062 and and the Municipal Science and Technology Foundation of Chengdu with NO. 2015-HM01-00181-SF. The funders had played role in study design, data collection and decision to publish.; This study was supported by grants from the National Natural Science Foundation of China with NO. 81621062 and the Municipal Science and Technology Foundation of Chengdu with NO. 2015-HM01-00181-SF.	Battagel JM, 1999, EUR J ORTHODONT, V21, P363, DOI 10.1093/ejo/21.4.363; Choung PH, 2001, ORAL SURG ORAL MED O, V91, P28, DOI 10.1067/moe.2001.111759; Lorenzoni DC, 2012, INT J DENT, V2012, DOI 10.1155/2012/813768; ElSheikh MM, 1996, J CRANIO MAXILL SURG, V24, P96, DOI 10.1016/S1010-5182(96)80020-5; Hashimoto K, 2003, ORAL SURG ORAL MED O, V95, P371, DOI 10.1067/moe.2003.120; Hong M, 1980, J CHINESE PLA POSTGR, V1, P54; Jafarian M, 2014, J CRANIOFAC SURG, V25, pE38, DOI 10.1097/SCS.0b013e3182a2ee26; Lee JJ, 1999, J ORAL MAXIL SURG, V57, P457, DOI 10.1016/S0278-2391(99)90290-2; Liao YF, 2004, LARYNGOSCOPE, V114, P1052, DOI 10.1097/00005537-200406000-00018; Muto T, 2008, INT J ORAL MAX SURG, V37, P419, DOI 10.1016/j.ijom.2007.12.012; ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017; Park SB, 2012, INT J ORAL MAX SURG, V41, P87, DOI 10.1016/j.ijom.2011.09.008; Sears CR, 2011, J ORAL MAXIL SURG, V69, pE385, DOI 10.1016/j.joms.2011.03.015; Ueno T, 2001, ANAT REC, V264, P348, DOI 10.1002/ar.10024; Zhang WN, 2014, BRIT J ORAL MAX SURG, V52, P928, DOI 10.1016/j.bjoms.2014.08.018; Zhu SS, 2008, ORAL SURG ORAL MED O, V106, P662, DOI 10.1016/j.tripleo.2008.03.028; Zhu SS, 2011, J ORAL MAXIL SURG, V69, pE565, DOI 10.1016/j.joms.2011.07.025; Zhu SS, 2006, ORAL SURG ORAL MED O, V101, P572, DOI 10.1016/j.tripleo.2005.08.023	18	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173142	10.1371/journal.pone.0173142	http://dx.doi.org/10.1371/journal.pone.0173142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257487	Green Published, gold			2022-12-27	WOS:000396021100065
J	Wood, LE; De Grave, S; Daniels, SR				Wood, Louisa E.; De Grave, Sammy; Daniels, Savel R.			Phylogeographic patterning among two codistributed shrimp species (Crustacea: Decapoda: Palaemonidae) reveals high levels of connectivity across biogeographic regions along the South African coast	PLOS ONE			English	Article							GENETIC-STRUCTURE; LARVAL DEVELOPMENT; CARIDEA PALAEMONIDAE; POPULATION-GENETICS; PACIFICUS STIMPSON; FISH EVIDENCE; LIFE-HISTORY; SPECIATION; GROWTH; PLEISTOCENE	We compare the genetic structuring and demographic history of two sympatric caridean shrimp species with distinct life history traits, one amphidromous species Palaemon capensis and one marine/estuarine species Palaemon peringueyi, in the historical biogeographical context of South Africa. A total of 103 specimens of P. capensis collected from 12 localities and 217 specimens of P. peringueyi collected from 24 localities were sequenced for the mitochondrial cytochrome oxidase one (CO1) locus. Results from analyses of molecular variance (AMOVA), pairwise phi(ST) comparisons and haplotype networks demonstrate weak to moderate genetic differentiation in P. capensis and P. peringueyi respectively. P. peringueyi exhibits partial isolation between populations associated with distinct biogeographic regions, likely driven by the region's oceanography. However, there is minimal evidence for the occurrence of discrete regional evolutionary lineages. This demonstrated lack of genetic differentiation is consistent with a marine, highly dispersive planktonic phase in both the amphidromous P. capensis and the marine/estuarine P. peringueyi. Bayesian skyline plots, mismatch expansions and time since expansion indicate that both species maintained stable populations during the Last Glacial Maximum (LGM), unlike other southern African aquatic species.	[Wood, Louisa E.; Daniels, Savel R.] Univ Stellenbosch, Dept Bot & Zool, Private Bag X1, Matieland, South Africa; [De Grave, Sammy] Univ Oxford, Museum Nat Hist, Parks Rd, Oxford, England	Stellenbosch University; University of Oxford	Wood, LE (corresponding author), Univ Stellenbosch, Dept Bot & Zool, Private Bag X1, Matieland, South Africa.	LEWood@sun.ac.za		Daniels, Savel/0000-0003-2956-3256; Wood, Louisa/0000-0002-8649-5010	National Research Foundation [98122]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	National Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by funding provided by the National Research Foundation to SD (98122) http://www.nrf.ac.za/. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Baeza JA, 2013, MAR ECOL-EVOL PERSP, V34, P381, DOI 10.1111/maec.12038; Ashelby CW, 2012, ZOOL SCR, V41, P293, DOI 10.1111/j.1463-6409.2012.00535.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Bauer RT, 2013, LAT AM J AQUAT RES, V41, P633, DOI 10.3856/vol41-issue4-fulltext-2; Bauer Raymond T., 2011, V15, P145; Brown L, 2012, STORY LIFE ENV AFRIC; Buston PM, 2012, P ROY SOC B-BIOL SCI, V279, P1883, DOI 10.1098/rspb.2011.2041; Chaves-Campos J, 2011, CONSERV GENET, V12, P557, DOI 10.1007/s10592-010-0163-z; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COETZEE DJ, 1989, S AFR J WILDL RES, V19, P107; COETZEE DJ, 1988, S AFR J ZOOL, V23, P59; Compton JS, 2011, QUATERNARY SCI REV, V30, P506, DOI 10.1016/j.quascirev.2010.12.012; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Crandall ED, 2010, HEREDITY, V104, P563, DOI 10.1038/hdy.2009.138; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dawson MN, 2005, J BIOGEOGR, V32, P515, DOI 10.1111/j.1365-2699.2004.01193.x; de Carvalho FL, 2013, LAT AM J AQUAT RES, V41, P707, DOI 10.3856/vol41-issue4-fulltext-7; de Villiers Casper, 1999, P167, DOI 10.1017/CBO9780511525490.008; Dennenmoser S, 2010, J CRUSTACEAN BIOL, V30, P762, DOI 10.1651/09-3273.1; Dobkin S, 1963, CRUSTACEANA, V6, P41; Drost E, 2016, MAR BIODIVERS, V46, P465, DOI 10.1007/s12526-015-0389-6; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; EMMERSON WD, 1986, T ROY SOC S AFR, V46, P79, DOI 10.1080/00359198609520108; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Grant WS, 2006, BIOL J LINN SOC, V88, P673, DOI 10.1111/j.1095-8312.2006.00651.x; Grant WS, 2015, J HERED, V106, P333, DOI 10.1093/jhered/esv020; Griffiths CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012008; GUERAO G, 1994, J CRUSTACEAN BIOL, V14, P280, DOI 10.2307/1548908; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Henriques R, 2016, J BIOGEOGR, V43, P1820, DOI 10.1111/jbi.12829; Henriques R, 2015, MAR BIOL RES, V11, P423, DOI 10.1080/17451000.2014.952309; Henriques R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087907; Hoareau TB, 2007, MAR ECOL PROG SER, V333, P303, DOI 10.3354/meps333303; Hughes JM, 2014, MOL ECOL, V23, P1000, DOI 10.1111/mec.12661; HUTSON WH, 1980, SCIENCE, V207, P64, DOI 10.1126/science.207.4426.64; Keating JP, 2014, FISH RES, V157, P1, DOI 10.1016/j.fishres.2014.03.009; Keith P, 2003, J FISH BIOL, V63, P831, DOI 10.1046/j.1095-8649.2003.00197.x; Kikkert DA, 2009, J N AM BENTHOL SOC, V28, P233, DOI 10.1899/08-019.1; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Le Roux JJ, 2011, DIVERS DISTRIB, V17, P861, DOI 10.1111/j.1472-4642.2011.00784.x; MACPHERSON E, 1990, J NAT HIST, V24, P627, DOI 10.1080/00222939000770421; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; Mmonwa KL, 2015, AFR J MAR SCI, V37, P11, DOI 10.2989/1814232X.2015.1009165; Muller CM, 2012, MAR ECOL PROG SER, V468, P203, DOI 10.3354/meps09956; Myers MJ, 2000, FRESHWATER BIOL, V44, P535, DOI 10.1046/j.1365-2427.2000.00599.x; Page TJ, 2007, LIMNOL OCEANOGR, V52, P1055, DOI 10.4319/lo.2007.52.3.1055; Page TJ, 2013, BIOTROPICA, V45, P236, DOI 10.1111/j.1744-7429.2012.00900.x; Papadopoulos I, 2014, AFR J AQUAT SCI, V39, P347, DOI 10.2989/16085914.2014.938600; Pelc RA, 2009, J BIOGEOGR, V36, P1881, DOI 10.1111/j.1365-2699.2009.02138.x; PEREIRA GA, 1995, J CRUSTACEAN BIOL, V15, P117; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pyron M, 2003, CARIBB J SCI, V39, P338; Qhaji Y, 2015, AFR J MAR SCI, V37, P345, DOI 10.2989/1814232X.2015.1077474; Rambaut A., 2007, TRACER V1 5; Reynolds TV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102115; Rodriguez-Almaraz GA, 2010, REV MEX BIODIVERS, V81, pS73; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Romero O, 2003, J QUATERNARY SCI, V18, P733, DOI 10.1002/jqs.789; Rossi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054698; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; TAJIMA F, 1989, GENETICS, V123, P585; Teske PR, 2007, AFR J MAR SCI, V29, P253, DOI 10.2989/AJMS.2007.29.2.9.192; Teske PR, 2007, MAR BIOL, V152, P697, DOI 10.1007/s00227-007-0724-y; Teske PR, 2006, MAR ECOL PROG SER, V314, P283, DOI 10.3354/meps314283; Teske PR, 2011, S AFR J SCI, V107, P43, DOI 10.4102/sajs.v107i5/6.514; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thuesen PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026685; von der Heyden S, 2009, AFR J MAR SCI, V31, P263, DOI 10.2989/AJMS.2009.31.2.14.886; von der Heyden S, 2008, MOL ECOL, V17, P4812, DOI 10.1111/j.1365-294X.2008.03959.x; von der Heyden S, 2007, MOL PHYLOGENET EVOL, V42, P517, DOI 10.1016/j.ympev.2006.08.004; VONDERHEYDEN S, 2013, FRONT BIOGEOG, V5, P1; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Whitfield AK, 2000, 577300 WRC; Zardi GI, 2007, MAR ECOL PROG SER, V337, P135, DOI 10.3354/meps337135	80	13	13	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e3356	10.1371/journal.pone.0173356	http://dx.doi.org/10.1371/journal.pone.0173356			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282399	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800032
J	Yin, XX; Hadjiloucas, S; Chen, JH; Zhang, Y; Wu, JL; Su, MY				Yin, X. -X.; Hadjiloucas, S.; Chen, J. -H.; Zhang, Y.; Wu, J. -L.; Su, M. -Y.			Tensor based multichannel reconstruction for breast tumours identification from DCE-MRIs	PLOS ONE			English	Article							SOFT-TISSUE TUMORS; LESIONS; CANCER; DECOMPOSITIONS; CLASSIFICATION; ENHANCEMENT; FEATURES; BONE	A new methodology based on tensor algebra that uses a higher order singular value decomposition to perform three-dimensional voxel reconstruction from a series of temporal images obtained using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is proposed. Principal component analysis (PCA) is used to robustly extract the spatial and temporal image features and simultaneously de-noise the datasets. Tumour segmentation on enhanced scaled (ES) images performed using a fuzzy C-means (FCM) cluster algorithm is compared with that achieved using the proposed tensorial framework. The proposed algorithm explores the correlations between spatial and temporal features in the tumours. The multi-channel reconstruction enables improved breast tumour identification through enhanced de-noising and improved intensity consistency. The reconstructed tumours have clear and continuous boundaries; furthermore the reconstruction shows better voxel clustering in tumour regions of interest. A more homogenous intensity distribution is also observed, enabling improved image contrast between tumours and background, especially in places where fatty tissue is imaged. The fidelity of reconstruction is further evaluated on the basis of five new qualitative metrics. Results confirm the superiority of the tensorial approach. The proposed reconstruction metrics should also find future applications in the assessment of other reconstruction algorithms.	[Yin, X. -X.; Zhang, Y.] Victoria Univ, Sch Sci & Engn, Ctr Appl Informat, Melbourne, Vic, Australia; [Hadjiloucas, S.] Univ Reading, Sch Syst Engn, Reading RG6 6AY, Berks, England; [Hadjiloucas, S.] Univ Reading, Dept Bioengn, Reading RG6 6AY, Berks, England; [Chen, J. -H.; Su, M. -Y.] Univ Calif Irvine, Dept Radiol Sci, Tu & Yuen Ctr Funct Oncoimaging, Irvine, CA 92717 USA; [Chen, J. -H.] EDa Hosp, Dept Radiol, Kaohsiung, Taiwan; [Chen, J. -H.; Zhang, Y.] I Shou Univ, Kaohsiung, Taiwan; [Zhang, Y.] Fudan Univ, Sch Comp Sci, Shanghai, Peoples R China; [Wu, J. -L.] Dalian Univ, Affiliated Zhongshan Hosp, Dept Radiol, Dalian, Liaoning, Peoples R China	Victoria University; University of Reading; University of Reading; University of California System; University of California Irvine; E-Da Hospital; I Shou University; Fudan University; Dalian University	Yin, XX; Zhang, Y (corresponding author), Victoria Univ, Sch Sci & Engn, Ctr Appl Informat, Melbourne, Vic, Australia.; Zhang, Y (corresponding author), Fudan Univ, Sch Comp Sci, Shanghai, Peoples R China.; Wu, JL (corresponding author), Dalian Univ, Affiliated Zhongshan Hosp, Dept Radiol, Dalian, Liaoning, Peoples R China.	xiaoxia.yin@vu.edu.au; yanchun.zhang@vu.edu.au; cjr.wujianlin@vip.163.com		Su, Min-Ying/0000-0002-3069-0271; Hadjiloucas, Sillas/0000-0003-2380-6114	Australian Research Council [140100841]; National Natural Science Foundation of China [63132013, 81371526]; Nanjing Nandian Technology PTY LTD, China; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Nandian Technology PTY LTD, China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Australian Research Council Discovery Project 140100841, National Natural Science Foundation of China 63132013, National Natural Science Foundation of China 81371526, and Nanjing Nandian Technology PTY LTD, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the Australian Research Council Discovery Project 140100841, National Natural Science Foundation of China (No. 63132013 and No. 81371526) and Nanjing Nandian Technology PTY LTD, China	Agner SC, 2011, J DIGIT IMAGING, V24, P446, DOI 10.1007/s10278-010-9298-1; Andreea GI, 2011, J CURR HLTH SCI, V37, P55; Phan AH, 2010, IEICE NONLINEAR THEO, V1, P37, DOI 10.1587/nolta.1.37; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Bediou B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088432; Bennani-Baiti B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160346; Bradley P. S., 1998, Proceedings Fourth International Conference on Knowledge Discovery and Data Mining, P9; Brawley OW, 2012, ANN INTERN MED, V156, P662, DOI 10.7326/0003-4819-156-9-201205010-00012; Cichocki A, 2009, NONNEGATIVE MATRIX A; Dorrius MD, 2011, EUR RADIOL, V21, P1600, DOI 10.1007/s00330-011-2091-9; Evans KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064366; Eyal E, 2009, NMR BIOMED, V22, P40, DOI 10.1002/nbm.1221; Gibbs P, 2003, MAGN RESON MED, V50, P92, DOI 10.1002/mrm.10496; Gubern-Merida A, 2015, MED IMAGE ANAL, V20, P265, DOI 10.1016/j.media.2014.12.001; Gubern-Merida A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085952; Hauth EAM, 2008, EUR J RADIOL, V66, P300, DOI 10.1016/j.ejrad.2007.05.026; Hawighorst H, 1999, JMRI-J MAGN RESON IM, V10, P286, DOI 10.1002/(SICI)1522-2586(199909)10:3<286::AID-JMRI9>3.3.CO;2-E; Hendrick RE., 2008, FUNDAMENTALS AND TEC; Karathanasis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005843; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Kroonenberg PM., 1983, THREE MODE PRINCIPAL; Lee SH, 2010, MED PHYS, V37, P3940, DOI 10.1118/1.3446799; Levman J, 2008, IEEE T MED IMAGING, V27, P688, DOI 10.1109/TMI.2008.916959; Morris EA, 2014, J CLIN ONCOL, V32, P2281, DOI 10.1200/JCO.2014.56.1514; Newell D, 2010, EUR RADIOL, V20, P771, DOI 10.1007/s00330-009-1616-y; Pages EB, 2012, RADIOLOGY, V264, P40, DOI 10.1148/radiol.12111917; Pan J, 2013, J DIGIT IMAGING, V26, P971, DOI 10.1007/s10278-013-9602-y; Rakoczy M, 2013, J DIGIT IMAGING, V26, P198, DOI 10.1007/s10278-012-9506-2; Stoutjesdijk MJ, 2007, J MAGN RESON IMAGING, V26, P606, DOI 10.1002/jmri.21026; Sun J., 2006, ACM SIGKDD INT C KNO, P374, DOI DOI 10.1145/1150402.1150445; Szabo BK, 2004, ACAD RADIOL, V11, P1344, DOI 10.1016/j.acra.2004.09.006; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464; Twellmann T, 2008, ENG APPL ARTIF INTEL, V21, P129, DOI 10.1016/j.engappai.2007.04.005; van Rijswijk CSP, 2004, RADIOLOGY, V233, P493, DOI 10.1148/radiol.2332031110; Verstraete KL, 2000, EUR J RADIOL, V34, P229, DOI 10.1016/S0720-048X(00)00202-3; Wang JH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062876, 10.1371/journal.pone.0080980]; Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747; Yamaguchi K, 2013, AM J ROENTGENOL, V201, P1155, DOI 10.2214/AJR.12.9707; Yin X, 2012, TERAHERTZ IMAGING FO; Zheng YJ, 2009, MED PHYS, V36, P3192, DOI 10.1118/1.3151811	42	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0172111	10.1371/journal.pone.0172111	http://dx.doi.org/10.1371/journal.pone.0172111			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282379	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800007
J	Cuvelier, ML; Guo, J; Ortiz, AC; van Baren, MJ; Tariq, MA; Partensky, F; Worden, AZ				Cuvelier, Marie L.; Guo, Jian; Ortiz, Alejandra C.; van Baren, Marijke J.; Tariq, Muhammad Akram; Partensky, Frederic; Worden, Alexandra Z.			Responses of the picoprasinophyte Micromonas commoda to light and ultraviolet stress	PLOS ONE			English	Article							ALGA CHLAMYDOMONAS-REINHARDTII; XANTHOPHYLL-DEFICIENT MUTANT; CHLOROPHYLL-A/B PROTEINS; GENE-EXPRESSION; UV-B; PHOTOSYNTHETIC EUKARYOTES; PHOTOOXIDATIVE STRESS; OSTREOCOCCUS-TAURI; NITRITE REDUCTASE; PHOTOSYSTEM-II	Micromonas is a unicellular marine green alga that thrives from tropical to polar ecosystems. We investigated the growth and cellular characteristics of acclimated mid-exponential phase Micromonas commoda RCC299 over multiple light levels and over the diel cycle (14: 10 hour light: dark). We also exposed the light: dark acclimated M. commoda to experimental shifts from moderate to high light (HL), and to HL plus ultraviolet radiation (HL+UV), 4.5 hours into the light period. Cellular responses of this prasinophyte were quantified by flow cytometry and changes in gene expression by qPCR and RNA-seq. While proxies for chlorophyll a content and cell size exhibited similar diel variations in HL and controls, with progressive increases during day and decreases at night, both parameters sharply decreased after the HL+UV shift. Two distinct transcriptional responses were observed among chloroplast genes in the light shift experiments: i) expression of transcription and translation-related genes decreased over the time course, and this transition occurred earlier in treatments than controls; ii) expression of several photosystem I and II genes increased in HL relative to controls, as did the growth rate within the same diel period. However, expression of these genes decreased in HL+UV, likely as a photoprotective mechanism. RNA-seq also revealed two genes in the chloroplast genome, ycf2-like and ycf1-like, that had not previously been reported. The latter encodes the second largest chloroplast protein in Micromonas and has weak homology to plant Ycf1, an essential component of the plant protein translocon. Analysis of several nuclear genes showed that the expression of LHCSR2, which is involved in non-photochemical quenching, and five light-harvesting-like genes, increased 30 to >50-fold in HL+UV, but was largely unchanged in HL and controls. Under HL alone, a gene encoding a novel nitrite reductase fusion protein (NIRFU) increased, possibly reflecting enhanced N-assimilation under the 625 mu mol photons m(-2) s(-1) supplied in the HL treatment. NIRFU's domain structure suggests it may have more efficient electron transfer than plant NIR proteins. Our analyses indicate that Micromonas can readily respond to abrupt environmental changes, such that strong photoinhibition was provoked by combined exposure to HL and UV, but a ca. 6-fold increase in light was stimulatory.	[Cuvelier, Marie L.; Guo, Jian; Ortiz, Alejandra C.; van Baren, Marijke J.; Worden, Alexandra Z.] MBARI, Moss Landing, CA USA; [Tariq, Muhammad Akram] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Partensky, Frederic] UPMC Univ Paris 06, Sorbonne Univ, CNRS, UMR,Stn Biol,CS, Roscoff, France; [Worden, Alexandra Z.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Worden, Alexandra Z.] Canadian Inst Adv Res, Integrated Microbial Biodivers Program, Toronto, ON, Canada; [Cuvelier, Marie L.] Nova Southeastern Univ, Dept Biol Sci, Ft Lauderdale, FL 33314 USA; [Guo, Jian] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Ortiz, Alejandra C.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Tariq, Muhammad Akram] Univ Management & Technol, Sch Hlth Sci, Lahore, Pakistan	Monterey Bay Aquarium Research Institute; University of California System; University of California Santa Cruz; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Santa Cruz; Canadian Institute for Advanced Research (CIFAR); Nova Southeastern University; University of California System; University of California Santa Cruz; Indiana University System; Indiana University Bloomington; University of Management & Technology (UMT)	Worden, AZ (corresponding author), MBARI, Moss Landing, CA USA.; Worden, AZ (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.; Worden, AZ (corresponding author), Canadian Inst Adv Res, Integrated Microbial Biodivers Program, Toronto, ON, Canada.	azworden@mbari.org	Worden, Alexandra Z./AAD-6567-2019; Tariq, Muhammad/ABC-2204-2020; Partensky, Frédéric/B-9194-2018; Partensky, Frédéric/AAH-1170-2021	Tariq, Muhammad/0000-0002-8239-9339; Partensky, Frédéric/0000-0003-1274-4050; Partensky, Frédéric/0000-0003-1274-4050; Worden, Alexandra/0000-0002-9888-9324	Gordon and Betty Moore Foundation [NSF-IOS0843119, DOE-DE-SC0004765, GBMF3788]; National Science Foundation [NSF-IOS0843119]; US Department of Energy [DOE-DE SC0004765]; Hanse-Wissenschaftskolleg; Directorate For Geosciences [1246761] Funding Source: National Science Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); Hanse-Wissenschaftskolleg; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding comes from grants from the Gordon and Betty Moore Foundation (GBMF3788), https://www.moore.org/; the National Science Foundation (NSF-IOS0843119), https://www.nsf.gov/; and the US Department of Energy (DOE-DE SC0004765). A.Z.W. thanks the Hanse-Wissenschaftskolleg for a Marine and Climate Fellowship that facilitated writing of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank C. Bachy, C. Berthiaume, E. Demir-Hilton, A. Engman, J. Lake, S. McDonald, M. P. Simmons, R. M. Welsh and H. M. Wilcox for help with experiments, qPCR design, and/or discussion of analysis approaches. We are grateful to V. Shankey and Beckman-Coulter Corporation for loaning us the Epics XL instrument, Pierre Setif for discussing NIRFU and the reviewers of the manuscript for constructive comments. This research was supported by a Gordon and Betty Moore Foundation Investigator Award (GBMF3788), NSF-IOS0843119 and DOE-DE-SC0004765 grants to A.Z.W.	Adamska I, 2001, J BIOL CHEM, V276, P8582, DOI 10.1074/jbc.M010447200; Andersson B, 2001, ADV PHOTOSYNTH, V11, P377; Andersson U, 2003, PLANT PHYSIOL, V132, P811, DOI 10.1104/pp.102.019281; Anning T, 2000, LIMNOL OCEANOGR, V45, P1807, DOI 10.4319/lo.2000.45.8.1807; [Anonymous], 2012, USDA TECHNICAL B, V8160; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Baroli I, 2004, J BIOL CHEM, V279, P6337, DOI 10.1074/jbc.M312919200; Bonente G, 2012, J BIOL CHEM, V287, P5833, DOI 10.1074/jbc.M111.304279; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Calderon RH, 2013, J BIOL CHEM, V288, P26688, DOI 10.1074/jbc.M113.487629; Castenholz RW, 2002, ECOLOGY CYANOBACTERI, P591; Chaturvedi R, 2000, J BIOSCIENCE, V25, P65; Choquet Y, 1998, P NATL ACAD SCI USA, V95, P4380, DOI 10.1073/pnas.95.8.4380; Cohen I, 2005, PLANT PHYSIOL, V137, P738, DOI 10.1104/pp.104.056341; Davis MC, 2013, PLANT CELL ENVIRON, V36, P1391, DOI 10.1111/pce.12071; Demir-Hilton E, 2011, ISME J, V5, P1095, DOI 10.1038/ismej.2010.209; DOLGANOV NAM, 1995, P NATL ACAD SCI USA, V92, P636, DOI 10.1073/pnas.92.2.636; Duanmu DQ, 2014, P NATL ACAD SCI USA, V111, P15827, DOI 10.1073/pnas.1416751111; DuRand MD, 2002, J PHYCOL, V38, P1132, DOI 10.1046/j.1529-8817.2002.02008.x; Durnford DG, 2003, PHYSIOL PLANTARUM, V118, P193, DOI 10.1034/j.1399-3054.2003.00078.x; Einsle O, 2011, METHOD ENZYMOL, V496, P399, DOI 10.1016/B978-0-12-386489-5.00016-6; Farinas B, 2006, PLANT MOL BIOL, V60, P277, DOI 10.1007/s11103-005-4066-1; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Foulon E, 2008, ENVIRON MICROBIOL, V10, P2433, DOI 10.1111/j.1462-2920.2008.01673.x; Geider RJ, 1998, LIMNOL OCEANOGR, V43, P679, DOI 10.4319/lo.1998.43.4.0679; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Heddad M, 2002, COMP FUNCT GENOM, V3, P504, DOI 10.1002/cfg.221; Heddad M, 2006, PLANT PHYSIOL, V142, P75, DOI 10.1104/pp.106.081489; Hirasawa M, 2009, MOL PLANT, V2, P407, DOI 10.1093/mp/ssn098; Huang LX, 2002, J BACTERIOL, V184, P6845, DOI 10.1128/JB.184.24.6845-6858.2002; Hutin C, 2003, P NATL ACAD SCI USA, V100, P4921, DOI 10.1073/pnas.0736939100; Inoue-Kashino N, 2011, J PHOTOCH PHOTOBIO B, V104, P220, DOI 10.1016/j.jphotobiol.2011.01.024; IRIARTE A, 1993, J EXP MAR BIOL ECOL, V168, P239, DOI 10.1016/0022-0981(93)90263-N; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Jacquet S, 2001, J PHYCOL, V37, P357, DOI 10.1046/j.1529-8817.2001.037003357.x; Jansson S, 2000, PLANT MOL BIOL, V42, P345, DOI 10.1023/A:1006365213954; Kataria S, 2014, J PHOTOCH PHOTOBIO B, V137, P55, DOI 10.1016/j.jphotobiol.2014.02.004; KELLER MD, 1987, J PHYCOL, V23, P633; Kikuchi S, 2013, SCIENCE, V339, P571, DOI 10.1126/science.1229262; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P226, DOI 10.1562/0031-8655(2003)077&lt;0226:IOAGRB&gt;2.0.CO;2; Kirk J. T. O., 1994, ARCH HYDROBIOL BEIH, V43, P1; Kovacs-Bogdan E, 2010, BBA-MOL CELL RES, V1803, P740, DOI 10.1016/j.bbamcr.2010.01.015; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; Kucho K, 2005, PLANT MOL BIOL, V57, P889, DOI 10.1007/s11103-005-3248-1; KURAS R, 1994, EMBO J, V13, P1019, DOI 10.1002/j.1460-2075.1994.tb06350.x; Kurn N, 2005, CLIN CHEM, V51, P1973, DOI 10.1373/clinchem.2005.053694; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ledford HK, 2004, MOL GENET GENOMICS, V272, P470, DOI 10.1007/s00438-004-1078-5; Lee J, 2002, PHOTOSYNTH RES, V72, P295, DOI 10.1023/A:1019881306640; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maclntyre H.L., 2002, J PHYCOL, V38, P17, DOI DOI 10.1046/J.1529; Marin B, 2010, PROTIST, V161, P304, DOI 10.1016/j.protis.2009.10.002; Massana R, 2011, ANNU REV MICROBIOL, V65, P91, DOI 10.1146/annurev-micro-090110-102903; McDonald SM, 2010, MOL BIOL EVOL, V27, P2268, DOI 10.1093/molbev/msq113; Mckim SM, 2006, PLANT PHYSIOL BIOCH, V44, P857, DOI 10.1016/j.plaphy.2006.10.018; MEYER G, 1984, EUR J BIOCHEM, V138, P201, DOI 10.1111/j.1432-1033.1984.tb07900.x; Miura K, 2004, PLANT PHYSIOL, V135, P1595, DOI 10.1104/pp.104.041400; Monnier A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-192; Montane MH, 2000, GENE, V258, P1, DOI 10.1016/S0378-1119(00)00413-3; Moreau H, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r74; Moulager M, 2007, PLANT PHYSIOL, V144, P1360, DOI 10.1104/pp.107.096149; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Neilson JAD, 2010, GENOME, V53, P68, DOI [10.1139/G09-081, 10.1139/g09-081]; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Noren H, 2003, PLANT CELL ENVIRON, V26, P245, DOI 10.1046/j.1365-3040.2003.00954.x; Not F, 2004, APPL ENVIRON MICROB, V70, P4064, DOI 10.1128/AEM.70.7.4064-4072.2004; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Pinnola A, 2015, PLANT CELL, V27, P3213, DOI 10.1105/tpc.15.00443; POST AF, 1984, MAR BIOL, V83, P231, DOI 10.1007/BF00397454; R Core Team, 2013, R LANG ENV STAT COMP; Rodriguez F, 2005, ENVIRON MICROBIOL, V7, P853, DOI 10.1111/j.1462-2920.2005.00758.x; Schmollinger S, 2014, PLANT CELL, V26, P1410, DOI 10.1105/tpc.113.122523; Setif P, 2009, BIOCHEMISTRY-US, V48, P2828, DOI 10.1021/bi802096f; Shapira M, 1997, PLANT MOL BIOL, V33, P1001, DOI 10.1023/A:1005814800641; Simmons MP, 2016, APPL ENVIRON MICROB, V82, P1693, DOI 10.1128/AEM.02730-15; Simmons MP, 2015, MOL BIOL EVOL, V32, P2219, DOI 10.1093/molbev/msv122; Six C, 2005, MOL BIOL EVOL, V22, P2217, DOI 10.1093/molbev/msi220; Six C, 2008, LIMNOL OCEANOGR, V53, P255, DOI 10.4319/lo.2008.53.1.0255; Slapeta J, 2006, MOL BIOL EVOL, V23, P23, DOI 10.1093/molbev/msj001; Smith DR, 2013, BRIEF FUNCT GENOMICS, V12, P454, DOI 10.1093/bfgp/els066; Swingley WD, 2010, BBA-BIOENERGETICS, V1797, P1458, DOI 10.1016/j.bbabio.2010.04.017; TERADA Y, 1995, BIOSCI BIOTECH BIOCH, V59, P2183, DOI 10.1271/bbb.59.2183; Teramoto H, 2006, PLANT CELL PHYSIOL, V47, P419, DOI 10.1093/pcp/pcj009; Teramoto H, 2004, PLANT CELL PHYSIOL, V45, P1221, DOI 10.1093/pcp/pch157; Teramoto H, 2002, PLANT PHYSIOL, V130, P325, DOI 10.1104/pp.004622; Tilbrook K, 2016, PLANT CELL, V28, P966, DOI 10.1105/tpc.15.00287; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Treusch AH, 2012, ISME J, V6, P481, DOI 10.1038/ismej.2011.117; van Baren MJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2585-6; Waltman PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155839; Worden AZ, 2015, SCIENCE, V347, DOI 10.1126/science.1257594; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Wostrikoff K, 2004, EMBO J, V23, P2696, DOI 10.1038/sj.emboj.7600266; Yoshioka-Nishimura M, 2016, PLANT CELL PHYSL; Zhang ZD, 2004, EUKARYOT CELL, V3, P1331, DOI 10.1128/EC.3.5.1331-1348.2004; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135	102	10	10	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172135	10.1371/journal.pone.0172135	http://dx.doi.org/10.1371/journal.pone.0172135			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278262	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000396087900116
J	Liu, JX; Wu, ZB; Wu, J; Dong, J; Zhao, Y; Wen, DX				Liu, Jiaxi; Wu, Zhibo; Wu, Jin; Dong, Jian; Zhao, Yao; Wen, Dongxin			A Weibull distribution accrual failure detector for cloud computing	PLOS ONE			English	Article							SERVICE	Failure detectors are used to build high availability distributed systems as the fundamental component. To meet the requirement of a complicated large-scale distributed system, accrual failure detectors that can adapt to multiple applications have been studied extensively. However, several implementations of accrual failure detectors do not adapt well to the cloud service environment. To solve this problem, a new accrual failure detector based on Weibull Distribution, called the Weibull Distribution Failure Detector, has been proposed specifically for cloud computing. It can adapt to the dynamic and unexpected network conditions in cloud computing. The performance of the Weibull Distribution Failure Detector is evaluated and compared based on public classical experiment data and cloud computing experiment data. The results show that the Weibull Distribution Failure Detector has better performance in terms of speed and accuracy in unstable scenarios, especially in cloud computing.	[Liu, Jiaxi; Wu, Zhibo; Wu, Jin; Dong, Jian; Zhao, Yao; Wen, Dongxin] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin, Heilongjiang Pr, Peoples R China	Harbin Institute of Technology	Dong, J (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Harbin, Heilongjiang Pr, Peoples R China.	hitljx@gmail.com			National Natural Science Foundation of China [61100029, 61370087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China (No. 61100029 and 61370087); the website is http.// www.nsfc.gov.cn/. Jian Dong is responsible for organizing and implementing the project 61100029, while Dongxin Wen is responsible for organizing and implementing the project 61370087.; This work was supported by the National Natural Science Foundation of China (No. 61100029 and 61370087).	Butun I, 2016, IEEE COMMUN MAG, V54, P47, DOI 10.1109/MCOM.2016.7452265; Chandra TD, 1996, J ACM, V43, P225, DOI 10.1145/226643.226647; Chen W, 2002, IEEE T COMPUT, V51, P561, DOI 10.1109/TC.2002.1004595; Defago X, 2005, I C DEPEND SYS NETWO, P206, DOI 10.1109/DSN.2005.37; Felber P., 1999, Proceedings of the International Symposium on Distributed Objects and Applications, P132, DOI 10.1109/DOA.1999.794001; Fetzer C, 2001, 2001 PACIFIC RIM INTERNATIONAL SYMPOSIUM ON DEPENDABLE COMPUTING, PROCEEDINGS, P146, DOI 10.1109/PRDC.2001.992691; Ganga K., 2013, Proceedings of the 2013 International Conference on Pattern Recognition, Informatics and Mobile Engineering (PRIME), P387, DOI 10.1109/ICPRIME.2013.6496507; Guo CX, 2008, ACM SIGCOMM COMP COM, V38, P75, DOI 10.1145/1402946.1402968; Hayashibara N, 2004, SYM REL DIST SYST, P66, DOI 10.1109/RELDIS.2004.1353004; Horita Y, 2005, 2005 6TH INTERNATIONAL WORKSHOP ON GRID COMPUTING (GRID), P202; Lavinia Andrei, 2010, Proceedings of the Fourth International Conference on Complex, Intelligent and Software Intensive Systems (CISIS 2010), P482, DOI 10.1109/CISIS.2010.29; Lin RH, 2014, CHINA COMMUN, V11, P1, DOI 10.1109/CC.2014.6827564; Shojafar M, 2020, IEEE T CLOUD COMPUT, V8, P1162, DOI 10.1109/TCC.2016.2617367; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Takeuchi K, 2008, IEEE J SEL AREA COMM, V26, P486, DOI 10.1109/JSAC.2008.080407; Tomsic AZ, 2015, INT PARALL DISTRIB P, P885, DOI 10.1109/IPDPS.2015.74; Wang F, 2014, P 2014 INT C C COMP, P14; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; Xiong N., 2007, JAIST; Xiong NX, 2012, INT PARALL DISTRIB P, P668, DOI 10.1109/IPDPS.2012.126	20	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173666	10.1371/journal.pone.0173666	http://dx.doi.org/10.1371/journal.pone.0173666			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278229	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900026
J	Maeda, K; Doi, S; Nakashima, A; Nagai, T; Irifuku, T; Ueno, T; Masaki, T				Maeda, Kazuya; Doi, Shigehiro; Nakashima, Ayumu; Nagai, Takuo; Irifuku, Taisuke; Ueno, Toshinori; Masaki, Takao			Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis	PLOS ONE			English	Article							MESOTHELIAL CELLS; MESENCHYMAL TRANSITION; HUMAN-DISEASE; RAT MODEL; DIALYSIS; MEMBRANE; DAMAGE; METHYLATION; PROGRESSION; SUPPRESSES	Activity of H3K9 histone methyltransferase G9a is reportedly induced by transforming growth factor-beta 1 (TGF-beta 1) and plays an important role in the progression of cancer and fibrosis. In this study, we investigated whether inhibition of G9a-mediated H3K9 methylation attenuates peritoneal fibrosis in mice and human peritoneal mesothelial cells (HPMCs). Nonadherent cells of peritoneal dialysis (PD) patients were isolated from PD effluent to examine expression of G9a. Peritoneal fibrosis was induced by peritoneal injection of methylglyoxal (MGO) in male C57/ B6 mice for 3 weeks. BIX01294, a G9a inhibitor, was administered by subcutaneous injection. Effects of BIX01294 on MGO-induced pathological and functional changes in mice were evaluated by immunohistochemistry and a peritoneal equilibration test. HPMCs were isolated from human omentum, and the inhibitory effect of BIX01294 on TGF-beta 1-induced fibrotic changes was investigated in the HPMCs by western blotting. G9a was upregulated in nonadherent cells of human PD effluent, the peritoneum of MGO-injected mice, and TGF-beta 1-stimulated HPMCs. BIX01294 significantly reduced the submesothelial zone thickness and cell density in MGO-injected mice. Immunohistochemical staining revealed that BIX01294 treatment decreased not only mono-methylation of H3K9 (H3K9me1), but also the number of mesenchymal cells, accumulation of collagen, and infiltration of monocytes. In addition to the pathological changes, BIX01294 reduced the level of TGF-beta 1 in peritoneal fluid and improved peritoneal functions. Furthermore, BIX01294 inhibited TGF-beta 1-induced fibrotic changes along with suppression of H3K9me1 in HPMCs. Therefore, inhibition of H3K9 methyltransferase G9a suppresses peritoneal fibrosis through a reduction of H3K9me1.	[Maeda, Kazuya; Doi, Shigehiro; Nakashima, Ayumu; Nagai, Takuo; Irifuku, Taisuke; Ueno, Toshinori; Masaki, Takao] Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan	Hiroshima University	Doi, S (corresponding author), Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan.	sdoi@hiroshima-u.ac.jp	Nakashima, Ayumu/CAF-0274-2022; Doi, Shigehiro/AAQ-2655-2020; Nakashima, Ayumu/N-9158-2017	Nakashima, Ayumu/0000-0002-7838-1494; Nakashima, Ayumu/0000-0002-7838-1494	Hiroshima University Education and Research Support Foundation; Japanese Association of Dialysis Physicians [270805]; Ministry of Education, Culture, Sports, Science and Technology of Japan [16K09618]	Hiroshima University Education and Research Support Foundation; Japanese Association of Dialysis Physicians; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Hiroshima University Education and Research Support Foundation, grants-in-aid for kidney failure and hemodialysis research from the Japanese Association of Dialysis Physicians(Award Number:270805) and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Award Number:16K09618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Hiroshima University Education and Research Support Foundation.	Baxter E, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-45; Callinan PA, 2006, HUM MOL GENET, V15, pR95, DOI 10.1093/hmg/ddl095; Devuyst O, 2010, J AM SOC NEPHROL, V21, P1077, DOI 10.1681/ASN.2009070694; DOBBIE JW, 1992, PERITON DIALYSIS INT, V12, P14; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Heimburger O, 1999, PERITON DIALYSIS INT, V19, pS83; Hirahara I, 2006, PERITON DIALYSIS INT, V26, P380; Io K, 2015, PERITON DIALYSIS INT, V35, P246, DOI 10.3747/pdi.2013.00089; Irifuku T, 2016, KIDNEY INT, V89, P147, DOI 10.1038/ki.2015.291; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kiribayashi I, 2005, KIDNEY INT, V67, P1126, DOI 10.1111/j.1523-1755.2005.00179.x; Kitamura M, 2012, CHEM-BIOL INTERACT, V195, P95, DOI 10.1016/j.cbi.2011.11.002; Lapolla A, 2005, ANN NY ACAD SCI, V1043, P217, DOI 10.1196/annals.1333.027; Loureiro J, 2011, J AM SOC NEPHROL, V22, P1682, DOI 10.1681/ASN.2010111197; Loureiro J, 2010, NEPHROL DIAL TRANSPL, V25, P1098, DOI 10.1093/ndt/gfp618; Margetts PJ, 2005, J AM SOC NEPHROL, V16, P425, DOI 10.1681/ASN.2004060436; Margetts PJ, 2001, J AM SOC NEPHROL, V12, P2029, DOI 10.1681/ASN.V12102029; Mortier S, 2005, KIDNEY INT, V67, P1559, DOI 10.1111/j.1523-1755.2005.00237.x; Nakayama M, 2003, AM J NEPHROL, V23, P390, DOI 10.1159/000074065; Onishi A, 2014, AM J NEPHROL, V40, P381, DOI 10.1159/000368424; Phillips AO, 2010, NEPHROL DIAL TRANSPL, V25, P1036, DOI 10.1093/ndt/gfq032; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Sanders YY, 2014, EUR RESPIR J, V43, P1448, DOI 10.1183/09031936.00095113; Schwenger V, 2006, CONTRIB NEPHROL, V150, P77, DOI 10.1159/000093505; Schwenger V, 2006, J AM SOC NEPHROL, V17, P199, DOI 10.1681/ASN.2005020155; STYLIANOU E, 1990, KIDNEY INT, V37, P1563, DOI 10.1038/ki.1990.150; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Takahashi S, 2009, NEPHRON EXP NEPHROL, V112, pE59, DOI 10.1159/000213896; Thannickal VJ, 2014, J CLIN INVEST, V124, P4673, DOI 10.1172/JCI74368; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Yang YY, 2015, INT J CLIN EXP PATHO, V8, P2746; Yu MA, 2009, J AM SOC NEPHROL, V20, P567, DOI 10.1681/ASN.2008040424	34	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173706	10.1371/journal.pone.0173706	http://dx.doi.org/10.1371/journal.pone.0173706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK4UV	28278257	Green Published, Green Submitted, gold			2022-12-27	WOS:000436162200001
J	Mohanty, RP; Buchheim, MA; Anderson, J; Levetin, E				Mohanty, Rashmi Prava; Buchheim, Mark Alan; Anderson, James; Levetin, Estelle			Molecular analysis confirms the long-distance transport of Juniperus ashei pollen	PLOS ONE			English	Article							MOUNTAIN CEDAR POLLEN; AIRBORNE-POLLEN; ALLERGENIC POLLEN; DNA; IDENTIFICATION; PCR; QUANTIFICATION; TRAJECTORIES; POLLINATION; SEQUENCES	Although considered rare, airborne pollen can be deposited far from its place of origin under a confluence of favorable conditions. Temporally anomalous records of Cupressacean pollen collected from January air samples in London, Ontario, Canada have been cited as a new case of long-distance transport. Data on pollination season implicated Juniperus ashei (mountain cedar), with populations in central Texas and south central Oklahoma, as the nearest source of the Cupressacean pollen in the Canadian air samples. This finding is of special significance given the allergenicity of mountain cedar pollen. While microscopy is used extensively to identify particles in the air spora, pollen from all members of the Cupressaceae, including Juniperus, are morphologically indistinguishable. Consequently, we implemented a molecular approach to characterize Juniperus pollen using PCR in order to test the long-distance transport hypothesis. Our PCR results using species-specific primers confirmed that the anomalous Cupressacean pollen collected in Canada was from J. ashei. Forward trajectory analysis from source areas in Texas and the Arbuckle Mountains in Oklahoma and backward trajectory analysis from the destination area near London, Ontario were completed using models implemented in HYSPLIT4 (Hybrid Single-Particle Lagrangian Integrated Trajectory). Results from these trajectory analyses strongly supported the conclusion that the J. ashei pollen detected in Canada had its origins in Texas or Oklahoma. The results from the molecular findings are significant as they provide a new method to confirm the long-distance transport of pollen that bears allergenic importance.	[Mohanty, Rashmi Prava; Buchheim, Mark Alan; Levetin, Estelle] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA; [Anderson, James] Environm Allergy Assays, London, ON, Canada	University of Tulsa	Levetin, E (corresponding author), Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA.	estelle-levetin@utulsa.edu		Levetin, Estelle/0000-0002-2409-5142	University of Tulsa, Office of Research	University of Tulsa, Office of Research	This study was supported by University of Tulsa, Office of Research. Received by RPM.	Adams R.P., 2014, JUNIPERS WORLD GENUS; Bennett KD, 2006, HOLOCENE, V16, P1031, DOI 10.1177/0959683606069383; Borchert JR, 1950, ANN ASSOC AM GEOGR, V40, P1; BORTENSCHLAGER S, 1990, GRANA, V29, P129, DOI 10.1080/00173139009427743; Bowker GE, 2007, ATMOS ENVIRON, V41, P1587, DOI 10.1016/j.atmosenv.2006.10.047; Bunderson LD, 2015, INT J BIOMETEOROL, V59, P533, DOI 10.1007/s00484-014-0866-9; CAMBON G, 1992, CAN J BOT, V70, P2284, DOI 10.1139/b92-284; Campbell ID, 1999, NATURE, V399, P29, DOI 10.1038/19891; Chen PH, 2008, J INTEGR PLANT BIOL, V50, P375, DOI 10.1111/j.1744-7909.2007.00624.x; CHRISTIE AD, 1969, NAT CAN, V96, P531; Draxier RR, 1998, AUST METEOROL MAG, V47, P295; Draxler R, 2003, HYSPLIT4 MODEL HY BR; Fawley MW, 2004, J PHYCOL, V40, P223, DOI 10.1111/j.0022-3646.2004.03-081.x; Folloni S, 2012, MOL ECOL RESOUR, V12, P810, DOI 10.1111/j.1755-0998.2012.03168.x; Galimberti A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109363; Glaum MC, 2014, J ALLERGY CLIN IMMUN, V133, pAB18, DOI 10.1016/j.jaci.2013.12.090; GREGORY PH, 1978, PURE APPL GEOPHYS, V116, P309, DOI 10.1007/BF01636888; Hasegawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120393; Hirose Y, 2016, AEROBIOLOGIA, V32, P385, DOI 10.1007/s10453-015-9408-0; HJELMROOS M, 1991, GRANA, V30, P215, DOI 10.1080/00173139109427802; Isagi Y, 2010, SINGLE POLLEN GENOTY; Ito M, 2008, MOL ECOL, V17, P5092, DOI 10.1111/j.1365-294X.2008.03966.x; Jackson ST, 1999, BOT REV, V65, P39, DOI 10.1007/BF02856557; Jain SA, 2013, FOOD SCI TECH-BRAZIL, V33, P753, DOI 10.1590/S0101-20612013000400022; Kostia S, 1995, GENOME, V38, P1244, DOI 10.1139/g95-163; Levetin E, 2003, IMMUNOL ALLERGY CLIN, V23, P423, DOI 10.1016/S0889-8561(03)00019-5; LEVETIN E, 1986, ANN ALLERGY, V56, P295; Levetin E, 1998, AEROBIOLOGIA, V14, P21, DOI DOI 10.1007/BF02694591; Little E.L., 1971, MISC PUBL, V1146; Longhi S, 2009, ANN ALLERG ASTHMA IM, V103, P508, DOI 10.1016/S1081-1206(10)60268-2; Matsuki Y, 2007, MOL ECOL NOTES, V7, P194, DOI 10.1111/j.1471-8286.2006.01588.x; Matsuki Y, 2008, AM J BOT, V95, P925, DOI 10.3732/ajb.0800036; Mohanty RP, 2017, ANN ALLERG ASTHMA IM, V118, P204, DOI 10.1016/j.anai.2016.11.015; Mohanty RP, 2016, THESIS; Muller-Germann I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140949; Nakazawa F, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014032; NIKLAS KJ, 1985, BOT REV, V51, P328, DOI 10.1007/BF02861079; Parducci L, 2005, MOL ECOL, V14, P2873, DOI 10.1111/j.1365-294X.2005.02644.x; Petersen G, 1996, PLANT MOL BIOL, V31, P189, DOI 10.1007/BF00020620; Pettyjohn ME, 1997, AEROBIOLOGIA, V13, P259; Reid CE, 2009, ECOHEALTH, V6, P458, DOI 10.1007/s10393-009-0261-x; Ritchie J, 1963, MANITOBA POLLEN SPOR, V5, P95; Rogers CA, 1998, INT J BIOMETEOROL, V42, P65, DOI 10.1007/s004840050086; Rousseau DD, 2006, REV PALAEOBOT PALYNO, V141, P277, DOI 10.1016/j.revpalbo.2006.05.001; Rousseau DD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017539; Teng M, 2016, J ALLERGY CLIN IMMUN, V137, pAB119, DOI 10.1016/j.jaci.2015.12.519; Van de Water PK, 2003, INT J BIOMETEOROL, V48, P74, DOI 10.1007/s00484-003-0184-0; Zhou LJ, 2007, AM J BOT, V94, P477, DOI 10.3732/ajb.94.3.477	48	28	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173465	10.1371/journal.pone.0173465	http://dx.doi.org/10.1371/journal.pone.0173465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273170	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700006
J	Popovych, OV; Lysyansky, B; Rosenblum, M; Pikovsky, A; Tass, PA				Popovych, Oleksandr V.; Lysyansky, Borys; Rosenblum, Michael; Pikovsky, Arkady; Tass, Peter A.			Pulsatile desynchronizing delayed feedback for closed-loop deep brain stimulation	PLOS ONE			English	Article							COORDINATED RESET NEUROMODULATION; SUBTHALAMIC NUCLEUS STIMULATION; HIGH-FREQUENCY STIMULATION; ADVANCED PARKINSON-DISEASE; SUBJECTS MIMICKING TREMOR; STN-DBS; SYNCHRONY; MODEL; GAIT; OSCILLATIONS	High-frequency (HF) deep brain stimulation (DBS) is the gold standard for the treatment of medically refractory movement disorders like Parkinson's disease, essential tremor, and dystonia, with a significant potential for application to other neurological diseases. The standard setup of HF DBS utilizes an open-loop stimulation protocol, where a permanent HF electrical pulse train is administered to the brain target areas irrespectively of the ongoing neuronal dynamics. Recent experimental and clinical studies demonstrate that a closed loop, adaptive DBS might be superior to the open-loop setup. We here combine the notion of the adaptive high-frequency stimulation approach, that aims at delivering stimulation adapted to the extent of appropriately detected biomarkers, with specifically desynchronizing stimulation protocols. To this end, we extend the delayed feedback stimulation methods, which are intrinsically closed-loop techniques and specifically designed to desynchronize abnormal neuronal synchronization, to pulsatile electrical brain stimulation. We show that permanent pulsatile high-frequency stimulation subjected to an amplitude modulation by linear or nonlinear delayed feedback methods can effectively and robustly desynchronize a STN-GPe network of model neurons and suggest this approach for desynchronizing closedloop DBS.	[Popovych, Oleksandr V.; Lysyansky, Borys; Tass, Peter A.] Julich Res Ctr, Inst Neurosci & Med Neuromodulat, Julich, Germany; [Rosenblum, Michael; Pikovsky, Arkady] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany; [Tass, Peter A.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Tass, Peter A.] Univ Cologne, Dept Neuromodulat, Cologne, Germany	Helmholtz Association; Research Center Julich; University of Potsdam; Stanford University; University of Cologne	Popovych, OV (corresponding author), Julich Res Ctr, Inst Neurosci & Med Neuromodulat, Julich, Germany.	o.popovych@fz-juelich.de	Popovych, Oleksandr V/H-8738-2013; Pikovsky, Arkady/A-5225-2015	Popovych, Oleksandr V/0000-0001-9994-1764; Pikovsky, Arkady/0000-0001-9682-7122	Helmholtz Society	Helmholtz Society(Helmholtz Association)	The study was funded by the Helmholtz Society (OVP, BL, PAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamchic I, 2014, MOVEMENT DISORD, V29, P1679, DOI 10.1002/mds.25923; Andres FG, 1999, J CLIN NEUROPHYSIOL, V16, P520, DOI 10.1097/00004691-199911000-00004; BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Beudel M, 2016, PARKINSONISM RELAT D, V22, pS123, DOI 10.1016/j.parkreldis.2015.09.028; BRITTON TC, 1993, ANN NEUROL, V33, P473, DOI 10.1002/ana.410330510; BRITTON TC, 1993, J NEUROL NEUROSUR PS, V56, P1085, DOI 10.1136/jnnp.56.10.1085; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Bronte-Stewart H, 2009, EXP NEUROL, V215, P20, DOI 10.1016/j.expneurol.2008.09.008; Butson CR, 2007, CLIN NEUROPHYSIOL, V118, P1889, DOI 10.1016/j.clinph.2007.05.061; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Cagnan H, 2013, BRAIN, V136, P3062, DOI 10.1093/brain/awt239; Carron R, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00112; Deniau JM, 2010, EUR J NEUROSCI, V32, P1080, DOI 10.1111/j.1460-9568.2010.07413.x; Dovzhenok A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058264; Eggermont JJ, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00029; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Ferraye MU, 2008, NEUROLOGY, V70, P1431, DOI 10.1212/01.wnl.0000310416.90757.85; Foutz TJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066008; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grahn PJ, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00169; Graupe D, 2010, NEUROL RES, V32, P899, DOI 10.1179/016164110X12767786356354; Haken H, 1983, ADV SYNERGETICS; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Harnack D, 2004, J NEUROSCI METH, V138, P207, DOI 10.1016/j.jneumeth.2004.04.019; Hauptmann C, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016004; Holt AB, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005011; Hosain MK, 2014, AUSTRALAS PHYS ENG S, V37, P619, DOI 10.1007/s13246-014-0297-2; Johnson LA, 2016, BRAIN STIMUL, V9, P892, DOI 10.1016/j.brs.2016.06.051; Johnson MD, 2008, NEUROTHERAPEUTICS, V5, P294, DOI 10.1016/j.nurt.2008.01.010; Kiss IZ, 2007, SCIENCE, V316, P1886, DOI 10.1126/science.1140858; Kuhn AA, 2008, J NEUROSCI, V28, P6165, DOI 10.1523/JNEUROSCI.0282-08.2008; Kuhn AA, 2017, MOVEMENT DISORD, V32, P11, DOI 10.1002/mds.26703; Kuncel AM, 2004, CLIN NEUROPHYSIOL, V115, P2431, DOI 10.1016/j.clinph.2004.05.031; LILLY JC, 1955, SCIENCE, V121, P468, DOI 10.1126/science.121.3144.468; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Little S, 2016, J NEUROL NEUROSUR PS, V87, P717, DOI 10.1136/jnnp-2015-310972; Little S, 2013, ANN NEUROL, V74, P449, DOI 10.1002/ana.23951; Little S, 2012, ANN NY ACAD SCI, V1265, P9, DOI 10.1111/j.1749-6632.2012.06650.x; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Luo M, 2009, BIOL CYBERN, V101, P241, DOI 10.1007/s00422-009-0334-5; Majtanik M, 2007, EFFEKTE SENSORISCHER; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020; Montaseri G, 2013, CHAOS, V23, DOI 10.1063/1.4817393; Moreau C, 2008, NEUROLOGY, V71, P80, DOI 10.1212/01.wnl.0000303972.16279.46; Moro E, 2002, NEUROLOGY, V59, P706, DOI 10.1212/WNL.59.5.706; Moro E, 2006, ARCH NEUROL-CHICAGO, V63, pE1, DOI 10.1001/archneur.63.9.noc60069; Nabi A, 2013, J COMPUT NEUROSCI, V34, P259, DOI 10.1007/s10827-012-0419-3; NINI A, 1995, J NEUROPHYSIOL, V74, P1800, DOI 10.1152/jn.1995.74.4.1800; Ozkurt TE, 2011, EXP NEUROL, V229, P324, DOI 10.1016/j.expneurol.2011.02.015; Parasuram H, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00065; Park C, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.042901; Pikovsky A, 1999, PHYS REV E, V59, P1633, DOI 10.1103/PhysRevE.59.1633; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Popovych OV, 2006, BIOL CYBERN, V95, P69, DOI 10.1007/s00422-006-0066-8; Popovych OV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117205; Popovych OV, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00058; Popovych OV, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026204; Popovych OV, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.164102; Priori A, 2013, EXP NEUROL, V245, P77, DOI 10.1016/j.expneurol.2012.09.013; Pyragas K, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/40002; Quinn EJ, 2015, MOVEMENT DISORD, V30, P1750, DOI 10.1002/mds.26376; Ratas I, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032914; Rizzone M, 2001, J NEUROL NEUROSUR PS, V71, P215, DOI 10.1136/jnnp.71.2.215; Rosa M, 2015, MOVEMENT DISORD, V30, P1003, DOI 10.1002/mds.26241; Rosenblum M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041904; Rosenblum MG, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.114102; Rosenblum M, 2006, INT J BIFURCAT CHAOS, V16, P1989, DOI 10.1142/S0218127406015842; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Rubin JE, 2004, J COMPUT NEUROSCI, V16, P211, DOI 10.1023/B:JCNS.0000025686.47117.67; Schnitzler A, 2009, MOVEMENT DISORD, V24, P1629, DOI 10.1002/mds.22633; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Tass PA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011902; Tass P.A., 1999, PHASE RESETTING MED; Tass PA, 2006, BIOL CYBERN, V94, P58, DOI 10.1007/s00422-005-0028-6; Tass PA, 2003, BIOL CYBERN, V89, P81, DOI [10.1007/s00422-003-0425-7, 10.1007/S00422-003-0425-7]; Tass PA, 2001, EUROPHYS LETT, V53, P15, DOI 10.1209/epl/i2001-00117-6; Tass PA, 2000, PROG THEOR PHYS SUPP, P301, DOI 10.1143/PTPS.139.301; Tass PA, 2012, ANN NEUROL, V72, P816, DOI 10.1002/ana.23663; Tass PA, 2012, RESTOR NEUROL NEUROS, V30, P137, DOI 10.3233/RNN-2012-110218; Tass PA, 2012, BIOL CYBERN, V106, P27, DOI 10.1007/s00422-012-0479-5; Temperli P, 2003, NEUROLOGY, V60, P78, DOI 10.1212/WNL.60.1.78; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Tukhlina N, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011918; van Nuenen BFL, 2008, MOVEMENT DISORD, V23, P2404, DOI 10.1002/mds.21986; van Wijk BCM, 2016, CLIN NEUROPHYSIOL, V127, P2010, DOI 10.1016/j.clinph.2016.01.015; Volkmann J, 2002, MOVEMENT DISORD, V17, pS181, DOI 10.1002/mds.10162; Wang DD, 2016, NEUROBIOL DIS, V89, P213, DOI 10.1016/j.nbd.2016.02.015; Wang J, 2016, BRAIN STIMUL, V9, P611, DOI 10.1016/j.brs.2016.03.014; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Wilson CJ, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00050; Wilson D, 2014, SIAM J APPL DYN SYST, V13, P276, DOI 10.1137/120901702; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; Wong R K, 1986, Adv Neurol, V44, P583; Wongsarnpigoon A, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046009; Xie T, 2012, J NEUROL NEUROSUR PS, V83, P1015, DOI 10.1136/jnnp-2011-302091; Yamamoto T, 2013, NEUROMODULATION, V16, P230, DOI 10.1111/j.1525-1403.2012.00521.x; Yanagisawa T, 2012, J NEUROSCI, V32, P15467, DOI 10.1523/JNEUROSCI.2929-12.2012; Yang AI, 2014, J NEUROSCI, V34, P12816, DOI 10.1523/JNEUROSCI.1895-14.2014; Yeung MKS, 1999, PHYS REV LETT, V82, P648, DOI 10.1103/PhysRevLett.82.648; Zhai Y, 2008, IND ENG CHEM RES, V47, P3502, DOI 10.1021/ie0708632	104	47	47	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173363	10.1371/journal.pone.0173363	http://dx.doi.org/10.1371/journal.pone.0173363			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273176	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700055
J	Gill, J; Connolly, P; Roth, M; Chung, SH; Zhang, WD; Piperdi, S; Hoang, B; Yang, R; Guzik, H; Morris, J; Gorlick, R; Geller, DS				Gill, Jonathan; Connolly, Patrick; Roth, Michael; Chung, So Hak; Zhang, Wendong; Piperdi, Sajida; Hoang, Bang; Yang, Rui; Guzik, Hillary; Morris, Jonathan; Gorlick, Richard; Geller, David S.			The effect of bone morphogenetic protein-2 on osteosarcoma metastasis	PLOS ONE			English	Article							STEM-CELLS; GROWTH; DIFFERENTIATION; EXPRESSION; RECEPTORS; ALLOGRAFT; SURGERY; SALVAGE; BMPS	Purpose Bone Morphogenetic Protein-2 (BMP-2) may offer the potential to enhance allograft-host osseous union in limb-salvage surgery following osteosarcoma resection. However, there is concern regarding the effect of locally applied BMP-2 on tumor recurrence and metastasis. The purpose of this project was to evaluate the effect of exogenous BMP-2 on osteosarcoma migration and invasion across a panel of tumor cell lines in vitro and to characterize the effect of BMP-2 on pulmonary osteosarcoma metastasis within a xenograft model. Experimental design The effect of BMP-2 on in vitro tumor growth and development was assessed across multiple standard and patient-derived xenograft osteosarcoma cell lines. Tumor migration capacity, invasion, and cell proliferation were characterized. In addition, the effect on metastasis was measured using a xenograft model following tail-vein injection. The effect of exogenous BMP-2 on the development of metastases was measured following both single and multiple BMP-2 administrations. Results There was no significant difference in migration capacity, invasion, or cell proliferation between the BMP-2 treated and the untreated osteosarcoma cell lines. There was no significant difference in pulmonary metastases between either the single-dose or multi-dose BMP-2 treated animals and the untreated control animals. Conclusions In the model systems tested, the addition of BMP-2 does not increase osteosarcoma proliferation, migration, invasion, or metastasis to the lungs.	[Gill, Jonathan; Connolly, Patrick; Roth, Michael; Zhang, Wendong; Piperdi, Sajida; Geller, David S.] Childrens Hosp Montefiore, Div Pediat Hematol Oncol & Blood & Marrow Cell Tr, Albert Einstein Coll Med, Bronx, NY 10467 USA; [Chung, So Hak] Kosin Univ, Coll Med, Busan, South Korea; [Hoang, Bang; Yang, Rui; Morris, Jonathan; Gorlick, Richard; Geller, David S.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Orthopaed Surg, Bronx, NY 10467 USA; [Guzik, Hillary] Albert Einstein Coll Med, Analyt Imaging Facil, Bronx, NY 10467 USA; [Gorlick, Richard] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Geller, DS (corresponding author), Childrens Hosp Montefiore, Div Pediat Hematol Oncol & Blood & Marrow Cell Tr, Albert Einstein Coll Med, Bronx, NY 10467 USA.; Geller, DS (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Orthopaed Surg, Bronx, NY 10467 USA.	dgellar@montefiore.org		Connolly, Patrick/0000-0002-9648-3670; GORLICK, RICHARD/0000-0001-8995-2929	Swim Across America; Matthew Foster Foundation; Barbara Bates Center for The Study of the History of Nursing; Barbara Epstein Foundation	Swim Across America; Matthew Foster Foundation; Barbara Bates Center for The Study of the History of Nursing; Barbara Epstein Foundation	This research was funded in part by Swim Across America, The Matthew Foster Foundation, Barbara Bates Center for The Study of the History of Nursing, and The Barbara Epstein Foundation. We would also like to thank the Pediatric Preclinical Testing Program for the use of their xenograft cell lines and Eugenie S. Kleinerman, MD who kindly provided the SaOS-LM7 cell line. We would also like to acknowledge Daewoong Pharmaceutical Co. Ltd., for graciously providing BMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayerza MA, 2010, CLIN ORTHOP RELAT R, V468, P2854, DOI 10.1007/s11999-010-1423-4; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Friedrich JB, 2008, J BONE JOINT SURG AM, V90A, P93, DOI 10.2106/JBJS.G.00551; Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1; Geller DS, 2014, CLIN CANC RES; Geng S, 2014, MOL CANCER THER, V13, P1431, DOI 10.1158/1535-7163.MCT-13-0934; Gobbi G, 2002, INT J ONCOL, V20, P143; Rici REG, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-17; Guo W, 1999, CLIN ORTHOP RELAT R, P175; GURNEY JG, 1999, CANC INCIDENCE SURVI, P99; Haydon RC, 2007, CLIN ORTHOP RELAT R, P237, DOI 10.1097/BLO.0b013e31802b683c; Hornicek FJ, 2001, CLIN ORTHOP RELAT R, P87; Houghton PJ, 2007, PEDIATR BLOOD CANCER, V49, P928, DOI 10.1002/pbc.21078; Jaffe N, 2002, CANCER-AM CANCER SOC, V95, P2202, DOI 10.1002/cncr.10944; Jia SF, 2002, ANTI-CANCER DRUG, V13, P155, DOI 10.1097/00001813-200202000-00007; Jia SF, 1999, CLIN EXP METASTAS, V17, P501, DOI 10.1023/A:1006623001465; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Mirabello L, 2009, INT J CANCER, V125, P229, DOI 10.1002/ijc.24320; SIMON MA, 1986, J BONE JOINT SURG AM, V68A, P1331, DOI 10.2106/00004623-198668090-00005; Wang L, 2011, CANCER BIOL THER, V11, P457, DOI 10.4161/cbt.11.5.14372; Yang R, 2007, INT J CANCER, V121, P943, DOI 10.1002/ijc.22749	21	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173322	10.1371/journal.pone.0173322	http://dx.doi.org/10.1371/journal.pone.0173322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264040	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300053
J	Lamurias, A; Clarke, LA; Couto, FM				Lamurias, Andre; Clarke, Luka A.; Couto, Francisco M.			Extracting microRNA-gene relations from biomedical literature using distant supervision	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; TRANSCRIPTION FACTOR; SIMILARITY; DATABASE; NETWORK; KERNEL	Many biomedical relation extraction approaches are based on supervised machine learning, requiring an annotated corpus. Distant supervision aims at training a classifier by combining a knowledge base with a corpus, reducing the amount of manual effort necessary. This is particularly useful for biomedicine because many databases and ontologies have been made available for many biological processes, while the availability of annotated corpora is still limited. We studied the extraction of microRNA-gene relations from text. MicroRNA regulation is an important biological process due to its close association with human diseases. The proposed method, IBRel, is based on distantly supervised multi-instance learning. We evaluated IBRel on three datasets, and the results were compared with a co-occurrence approach as well as a supervised machine learning algorithm. While supervised learning outperformed on two of those datasets, IBRel obtained an F-score 28.3 percentage points higher on the dataset for which there was no training set developed specifically. To demonstrate the applicability of IBRel, we used it to extract 27 miRNA-gene relations from recently published papers about cystic fibrosis. Our results demonstrate that our method can be successfully used to extract relations from literature about a biological process without an annotated corpus. The source code and data used in this study are available athttps://github.com/AndreLamurias/IBRel.	[Lamurias, Andre; Couto, Francisco M.] Univ Lisbon, LaSIGE, Fac Ciencias, Lisbon, Portugal; [Clarke, Luka A.] Univ Lisbon, BioISI Biosyst & Integrat Sci Inst, Fac Ciencias, Lisbon, Portugal	Universidade de Lisboa; BIOISI; Universidade de Lisboa	Lamurias, A (corresponding author), Univ Lisbon, LaSIGE, Fac Ciencias, Lisbon, Portugal.	alamurias@lasige.di.fc.ul.pt	Couto, Francisco M/A-4066-2010; Clarke, Luka A/E-5843-2012; Lamurias, Andre/U-9729-2017	Couto, Francisco M/0000-0003-0627-1496; Clarke, Luka A/0000-0003-3254-9121; Lamurias, Andre/0000-0001-7965-6536	Portuguese Fundacao para a Ciencia e Tecnologia [PD/BD/106083/2015, PEst-OE/BIA/U14046/2011, UID/CEC/00408/2013]	Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Portuguese Fundacao para a Ciencia e Tecnologia (https://www.fct.mctes.pt/) through the PhD Grant ref. PD/BD/106083/2015 to AL, PEst-OE/BIA/U14046/2011 (BioFIG) to LAC, and UID/CEC/00408/2013 (LaSIGE) to AL and FMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagewadi S., 2014, F1000RESEARCH, V3; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bundschus M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-207; Bunescu R., 2006, P WORKSH LINK NAT LA, P49; Bunescu R.C., 2007, P ICML, P105, DOI DOI 10.1145/1273496.1273510; Chen YJ, 2016, WORKSH 30 AAAI C ART, P105; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Chowdhary R, 2012, AM J RESP CELL MOL, V47, P112, DOI 10.1165/rcmb.2011-0419OC; Craven M, 1999, Proc Int Conf Intell Syst Mol Biol, P77; Dietterich TG, 1997, ARTIF INTELL, V89, P31, DOI 10.1016/S0004-3702(96)00034-3; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Giuliano C., 2006, P 11 C EUR CHAPT ASS, P401; Guo L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23700; Hamed M, 2015, NUCLEIC ACIDS RES, V43, pW283, DOI 10.1093/nar/gkv418; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang JS, 2015, IEEE INT C BIOINFORM, P975, DOI 10.1109/BIBM.2015.7359816; Jain S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-562; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kim JH, 2009, ARTECH HSE METH BIOE, P1, DOI 10.1109/ICIMW.2009.5324773; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krallinger M, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s1, 10.1186/gb-2008-9-S2-S4, 10.1186/gb-2008-9-s2-s4, 10.1186/gb-2008-9-S2-S1]; Lafferty John D., 2001, ICML 01, P282, DOI DOI 10.5555/645530.655813; Lamurias A, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/1758-2946-7-S1-S13; Lamurias A, 2014, J INTEGR BIOINFORMAT, V11, DOI 10.2390/biecoll-jib-2014-247; Leaman R., 2013, BIOCREATIVE CHALL EV, V2, P34; Leaman Robert, 2008, Pac Symp Biocomput, P652; Li G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004391; Li Y., 2013, NUCLEIC ACIDS RES; Liu Y, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.42; Mack GS, 2007, NAT BIOTECHNOL, V25, P631, DOI 10.1038/nbt0607-631; Manning CD, 2014, PROCEEDINGS OF 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS: SYSTEM DEMONSTRATIONS, P55, DOI 10.3115/v1/p14-5010; Min B., 2013, P 2013 C N AM CHAPT, P777, DOI [DOI 10.1186/S40537-016-0043-6, 10.1609/aaai.v33i01.33016407]; Mintz M., 2009, P JOINT C 47 ANN M A, V2, P1003, DOI DOI 10.3115/1690219.1690287; Moschitti A., 2004, P 42 ANN M ASS COMP; Murray BS, 2010, MOL BIOSYST, V6, P1853, DOI 10.1039/c003961f; Naeem Haroon, 2010, BMC Bioinformatics, V11, P135, DOI 10.1186/1471-2105-11-135; Nguyen TVT, 2011, P 5 INT JOINT C NAT, P732; Palma G, 2014, LECT NOTES COMPUT SC, V8796, P131, DOI 10.1007/978-3-319-11964-9_9; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Poon H, 2015, BIOCOMPUT-PAC SYM, P120; Powers D. M., 2012, EACL 2012 13 C EUROP, P345; Ramachandran S, 2013, AM J RESP CELL MOL, V49, P544, DOI 10.1165/rcmb.2012-0430OC; Ravikumar Ke, 2012, J Biomed Semantics, V3 Suppl 3, pS2, DOI 10.1186/2041-1480-3-S3-S2; Rosenfeld B, 2007, P 16 ACM C C INF KNO, P411, DOI DOI 10.1145/1321440.1321499; Rozenfeld B, 2006, IEEE DATA MINING, P1032; Satre R., 2007, P 2 BIOCREATIVE CHAL, P209; Segura-Bedmar I., 2013, ASS COMPUT LINGUIST, V3206, P341; Segura-Bedmar I, 2011, J BIOMED INFORM, V44, P789, DOI 10.1016/j.jbi.2011.04.005; Wahba G, 1992, SFI STUDIES SCI COMP, VXII, P95; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Zelenko D, 2003, J MACH LEARN RES, V3, P1083, DOI 10.1162/153244303322533205; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zou Q, 2016, BRIEF FUNCT GENOMICS, V15, P55, DOI 10.1093/bfgp/elv024	55	18	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0171929	10.1371/journal.pone.0171929	http://dx.doi.org/10.1371/journal.pone.0171929			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28263989	Green Submitted, Green Published, gold			2022-12-27	WOS:000396054300006
J	Lee, S; Kang, E; Yoo, KD; Choi, Y; Kim, DK; Joo, KW; Yang, SH; Kim, YL; Kang, SW; Yang, CW; Kim, NH; Kim, YS; Lee, H				Lee, Sunhwa; Kang, Eunjeong; Yoo, Kyung Don; Choi, Yunhee; Kim, Dong Ki; Joo, Kwon Wook; Yang, Seung Hee; Kim, Yong-Lim; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam Ho; Kim, Yon Su; Lee, Hajeong			Lower serum potassium associated with increased mortality in dialysis patients: A nationwide prospective observational cohort study in Korea	PLOS ONE			English	Article							AMBULATORY PERITONEAL-DIALYSIS; RESIDUAL RENAL-FUNCTION; HEMODIALYSIS-PATIENTS; PRACTICE PATTERNS; HYPOKALEMIA; ATHEROSCLEROSIS; MALNUTRITION; INFLAMMATION; SUPPLEMENTATION; NONADHERENCE	Background Abnormal serum potassium concentration has been suggested as a risk factor for mortality in patients undergoing dialysis patients. We investigated the impact of serum potassium levels on survival according to dialysis modality. Methods A nationwide, prospective, observational cohort study for end stage renal disease patients has been ongoing in Korea since August 2008. Our analysis included patients whose records contained data regarding serum potassium levels. The relationship between serum potassium and mortality was analyzed using competing risk regression. Results A total of 3,230 patients undergoing hemodialysis (HD, 64.3%) or peritoneal dialysis (PD, 35.7%) were included. The serum potassium level was significantly lower (P < 0.001) in PD (median, 4.5 mmol/L; interquartile range, 4.0-4.9 mmol/L) than in HD patients (median, 4.9 mmol/L; interquartile range, 4.5-5.4 mmol/L). During 4.4-1.7 years of follow-up, 751 patients (23.3%) died, mainly from cardiovascular events (n = 179) and infection (n = 120). In overall, lower serum potassium level less than 4.5 mmol/L was an independent risk factor for mortality after adjusting for age, comorbidities, and nutritional status (sub-distribution hazard ratio, 1.30; 95% confidence interval 1.10-1.53; P = 0.002). HD patients showed a U-shaped survival pattern, suggesting that both lower and higher potassium levels were deleterious, although insignificant. However, in PD patients, only lower serum potassium level (<4.5 mmol/L) was an independent predictor of mortality (sub-distribution hazard ratio, 1.35; 95% confidence interval 1.00-1.80; P = 0.048). Conclusion Lower serum potassium levels (<4.5 mmol/L) occur more commonly in PD than in HD patients. It represents an independent predictor of survival in overall dialysis, especially in PD patients. Therefore, management of dialysis patients should focus especially on reducing the risk of hypokalemia, not only that of hyperkalemia.	[Lee, Sunhwa; Kang, Eunjeong; Kim, Dong Ki; Joo, Kwon Wook; Kim, Yon Su; Lee, Hajeong] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Yoo, Kyung Don] Dongguk Univ, Dept Internal Med, Gyeongju Hosp, Gyeongju, South Korea; [Choi, Yunhee] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul, South Korea; [Yang, Seung Hee; Lee, Hajeong] Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea; [Kang, Shin-Wook] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Yang, Chul Woo] Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Nam Ho] Chonnam Natl Univ Hosp, Dept Internal Med, Gwangju, South Korea	Seoul National University (SNU); Seoul National University Hospital; Dongguk University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Kyungpook National University; Kyungpook National University Hospital; Yonsei University; Yonsei University Health System; Seoul St. Mary's Hospital; Chonnam National University; Chonnam National University Hospital	Lee, H (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.; Lee, H (corresponding author), Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea.	mdhjlee@gmail.com	Kim, Dong Ki/J-5389-2012; Kang, Eunjeong/ABA-3646-2021; Yoo, Kyung Don/AAK-8096-2020	Kim, Dong Ki/0000-0002-5195-7852; Kang, Eunjeong/0000-0002-2191-2784; Yoo, Kyung Don/0000-0001-6545-6517	grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HC15C1129]	grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HC15C1129).	Avram MM, 2001, AM J KIDNEY DIS, V38, P1351, DOI 10.1053/ajkd.2001.29254; Bergstrom J, 1983, Kidney Int Suppl, V16, pS153; Bielecka-Dabrowa A, 2012, INT J CARDIOL, V158, P12, DOI 10.1016/j.ijcard.2011.06.121; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; CAPPUCCIO FP, 1991, J HYPERTENS, V9, P465, DOI 10.1097/00004872-199105000-00011; Chattopadhyay J, 2014, ADV PERIT DIAL, V30; Ekundayo OJ, 2010, INT J CARDIOL, V141, P167, DOI 10.1016/j.ijcard.2008.11.195; ELLIOTT P, 1988, BRIT MED J, V297, P319; Glassock RJ, 2009, CLIN J AM SOC NEPHRO, V4, pS79, DOI 10.2215/CJN.04860709; GORDEN P, 1973, DIABETES, V22, P544, DOI 10.2337/diab.22.7.544; Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183; He FJ, 2010, HYPERTENSION, V55, P681, DOI 10.1161/HYPERTENSIONAHA.109.147488; HELFANT RH, 1986, AM J MED, V80, P13, DOI 10.1016/0002-9343(86)90336-0; HODGKIN AL, 1960, J PHYSIOL-LONDON, V153, P386, DOI 10.1113/jphysiol.1960.sp006541; Hwang JC, 2011, BLOOD PURIFICAT, V32, P254, DOI 10.1159/000325226; Jadoul M, 2012, CLIN J AM SOC NEPHRO, V7, P765, DOI 10.2215/CJN.08850811; Jansen MAM, 2002, KIDNEY INT, V62, P1046, DOI 10.1046/j.1523-1755.2002.00505.x; Khan AN, 1996, PERITON DIALYSIS INT, V16, P652; Kim Hyun-Wook, 2007, Electrolyte Blood Press, V5, P102, DOI 10.5049/EBP.2007.5.2.102; Kjeldsen K, 2010, EXP CLIN CARDIOL, V15, pE96; Kovesdy CP, 2007, CLIN J AM SOC NEPHRO, V2, P999, DOI 10.2215/CJN.04451206; Lacson E, 2015, AM J KIDNEY DIS, V66, P1056, DOI 10.1053/j.ajkd.2015.06.014; Lang SM, 2001, PERITON DIALYSIS INT, V21, P52; LINDHOLM B, 1986, ACTA MED SCAND, V219, P323; Lu XH, 2009, J RENAL NUTR, V19, P469, DOI 10.1053/j.jrn.2009.04.003; Misra M, 2001, KIDNEY INT, V59, P754, DOI 10.1046/j.1523-1755.2001.059002754.x; Moist LM, 2000, J AM SOC NEPHROL, V11, P556, DOI 10.1681/ASN.V113556; Musso Carlos G., 2004, International Urology and Nephrology, V36, P469, DOI 10.1007/s11255-004-6194-y; Noori N, 2010, AM J KIDNEY DIS, V56, P338, DOI 10.1053/j.ajkd.2010.03.022; Osadchii OE, 2010, FUND CLIN PHARMACOL, V24, P547, DOI 10.1111/j.1472-8206.2010.00835.x; Pecoits R, 2002, NEPHROL DIAL TRANSPL, V17, P28, DOI 10.1093/ndt/17.suppl_11.28; PLAVINIK FL, 1992, HYPERTENSION, V19, P26; Ribeiro SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127453; ROSTAND SG, 1983, ARCH INTERN MED, V143, P377, DOI 10.1001/archinte.143.2.377; ROWE JW, 1980, METABOLISM, V29, P498, DOI 10.1016/0026-0495(80)90074-8; Saran R, 2003, KIDNEY INT, V64, P254, DOI 10.1046/j.1523-1755.2003.00064.x; Singhi S, 1996, Indian Pediatr, V33, P9; SPITAL A, 1985, AM J KIDNEY DIS, V6, P173, DOI 10.1016/S0272-6386(85)80022-6; Stenvinkel P, 2001, PERITON DIALYSIS INT, V21, pS157; SUGIMOTO T, 1988, HYPERTENSION, V11, P579, DOI 10.1161/01.HYP.11.6.579; Szeto CC, 2005, AM J KIDNEY DIS, V46, P128, DOI 10.1053/j.ajkd.2005.03.015; TADDEI S, 1994, HYPERTENSION, V23, P485, DOI 10.1161/01.HYP.23.4.485; Torlen K, 2012, CLIN J AM SOC NEPHRO, V7, P1272, DOI 10.2215/CJN.00960112; Tziviskou Effie, 2003, International Urology and Nephrology, V35, P429, DOI 10.1023/B:UROL.0000022867.93739.03; Unruh ML, 2005, AM J KIDNEY DIS, V46, P1107, DOI 10.1053/j.ajkd.2005.09.002; Wang AYM, 2005, NEPHROL DIAL TRANSPL, V20, P1676, DOI 10.1093/ndt/gfh891; Weiner ID, 1997, J AM SOC NEPHROL, V8, P1179; Xu QD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086750; Yi Joo-Hark, 2009, Electrolyte Blood Press, V7, P25, DOI 10.5049/EBP.2009.7.1.25; Yi Joo-Hark, 2009, Electrolyte Blood Press, V7, P79, DOI 10.5049/EBP.2009.7.2.79; Zanger R, 2010, SEMIN DIALYSIS, V23, P575, DOI 10.1111/j.1525-139X.2010.00789.x	51	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0171842	10.1371/journal.pone.0171842	http://dx.doi.org/10.1371/journal.pone.0171842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264031	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300004
J	Thapa, S; Stewart, BA; Xue, QW; Chen, YQ				Thapa, Sushil; Stewart, Bob A.; Xue, Qingwu; Chen, Yuanquan			Manipulating plant geometry to improve microclimate, grain yield, and harvest index in grain sorghum	PLOS ONE			English	Article							WATER-USE EFFICIENCY; TRANSPIRATION EFFICIENCY; POPULATION-DENSITIES; CANOPY TEMPERATURE; WIDE-RANGE; DYNAMICS; GROWTH; CORN; IRRIGATION; DROUGHT	Cultivar selection, planting geometry, and plant population are the key factors determining grain sorghum yields in water deficit areas. The objective of this study was to investigate whether clump geometry (three plants clustered) improves microclimate within crop canopy when plants are grown under varying water levels. In a 2-yr sorghum (Sorghum bicolor L. Moench) greenhouse study, plants were grown at two geometries (clump and conventional evenly spaced planting, ESP), two water levels (high and low, representing well-watered and water-limited condition, respectively), and three soil surface treatments (lid covered, straw-mulched, and bare). Air temperature and relative humidity (RH) within the plant canopy were measured every five minutes at different growth stages. Mean vapor pressure deficits (VPDs) within the clumps were consistently lower than those for ESPs, indicating that clumps improved the microclimate. Clumps had significantly higher harvest index (HI) compared to ESPs (0.48 vs. 0.43), which was largely due to clumps having an average of 0.4 tillers per plant compared to 1.2 tillers per plant for ESPs. Grain yield in the current study was similar between clumps and ESPs. However, our results suggest that improved microclimate was likely a reason for clumps producing significantly higher grain yields compared to ESPs in previous studies.	[Thapa, Sushil; Stewart, Bob A.] West Texas A&M Univ, Dryland Agr Inst, Canyon, TX 79016 USA; [Thapa, Sushil; Xue, Qingwu] Texas A&M AgriLife Res & Extens Ctr, Amarillo, TX 79106 USA; [Chen, Yuanquan] China Agr Univ, Coll Agron, Beijing, Peoples R China	Texas A&M University System; West Texas A&M University; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; China Agricultural University	Thapa, S (corresponding author), West Texas A&M Univ, Dryland Agr Inst, Canyon, TX 79016 USA.; Thapa, S (corresponding author), Texas A&M AgriLife Res & Extens Ctr, Amarillo, TX 79106 USA.	sushil.thapa@ag.tamu.edu	Xue, Qingwu/AAE-2431-2020; Chen, Yuanquan/AAU-9492-2020	Xue, Qingwu/0000-0002-6470-3245				Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; ARNON I, 1975, PHYSL ASPECTS DRYLAN; ASTON AR, 1972, AGRON J, V64, P368, DOI 10.2134/agronj1972.00021962006400030034x; Badr MA, 2012, AGR WATER MANAGE, V110, P9, DOI 10.1016/j.agwat.2012.03.008; Bandaru V, 2006, AGRON J, V98, P1109, DOI 10.2134/agronj2005.0166; Ben-Gal A, 2002, PLANT SOIL, V247, P211, DOI 10.1023/A:1021556808595; Bennett T, 2006, PLANT MOL BIOL, V60, P843, DOI 10.1007/s11103-005-2763-4; BLUM A, 1970, AGRON J, V62, P333, DOI 10.2134/agronj1970.00021962006200030007x; Blum A., 2004, PHYSL BIOTECHNOLOGY, P141, DOI DOI 10.1201/9780203022030.CH4; CASAL JJ, 1985, ANN BOT-LONDON, V56, P553, DOI 10.1093/oxfordjournals.aob.a087040; CASAL JJ, 1986, ENVIRON EXP BOT, V26, P365, DOI 10.1016/0098-8472(86)90024-9; CRAUFURD PQ, 1993, EXP AGR, V29, P61, DOI 10.1017/S001447970002041X; CronkLab, 2016, CALC VAP PRESS DEF; DAVIS MH, 1994, CROP SCI, V34, P1604, DOI 10.2135/cropsci1994.0011183X003400060033x; Finlayson SA, 2010, PLANT PHYSIOL, V152, P1914, DOI 10.1104/pp.109.148833; Gallavotti A, 2013, J EXP BOT, V64, P2593, DOI 10.1093/jxb/ert141; Gardiol JM, 2003, J HYDROL, V271, P188, DOI 10.1016/S0022-1694(02)00347-5; Gautier H, 1999, ANN BOT-LONDON, V83, P423, DOI 10.1006/anbo.1998.0840; GERIK TJ, 1987, CROP SCI, V27, P1225, DOI 10.2135/cropsci1987.0011183X002700060027x; Glenn EP, 2008, SENSORS-BASEL, V8, P2136, DOI 10.3390/s8042136; Godin C, 1999, ANN BOT-LONDON, V84, P343, DOI 10.1006/anbo.1999.0923; Haefele SM, 2009, FIELD CROP RES, V111, P1, DOI 10.1016/j.fcr.2008.09.008; HAMMER GL, 1994, FIELD CROP RES, V36, P221, DOI 10.1016/0378-4290(94)90114-7; Hammer GL, 1997, AUST J AGR RES, V48, P649, DOI 10.1071/A96111; Huang JK, 2002, NATURE, V418, P678, DOI 10.1038/nature01015; Ingram DL, 1993, BULLETIN, V241, P1; JACKSON RD, 1977, WATER RESOUR RES, V13, P651, DOI 10.1029/WR013i003p00651; Jones Hamlyn G., 2003, Journal of Agricultural Meteorology, V59, P205, DOI 10.2480/agrmet.59.205; Jordan, 1987, WATER WATER POLICY W, P355; Jurik TW, 2004, FIELD CROP RES, V90, P335, DOI 10.1016/j.fcr.2004.04.002; Kapanigowda M, 2010, CROP IMPROV, V24, P271; Kapanigowda M, 2010, FIELD CROP RES, V118, P115, DOI 10.1016/j.fcr.2010.04.012; Kashif Khurshid, 2006, International Journal of Agriculture and Biology, V8, P593; Krishnareddy SR, 2009, J CROP IMPROV, V24, P1, DOI 10.1080/15427520903303808; Lafarge TA, 2002, ANN BOT-LONDON, V90, P87, DOI 10.1093/aob/mcf152; Lafarge TA, 2002, ANN BOT-LONDON, V90, P99, DOI 10.1093/aob/mcf153; LASCAR, 2008, HIGH ACC HUM TEMP DE; LIDDLE MJ, 1982, OIKOS, V38, P52, DOI 10.2307/3544567; Lin BB, 2007, AGR FOREST METEOROL, V144, P85, DOI 10.1016/j.agrformet.2006.12.009; MAAS SJ, 1987, AGRON J, V79, P739, DOI 10.2134/agronj1987.00021962007900040031x; Mahan JR, 2012, IRRIGATION SCI, V30, P127, DOI 10.1007/s00271-011-0269-1; Mantovani D, 2014, J HYDROL HYDROMECH, V62, P316, DOI 10.2478/johh-2014-0028; MITCHELL KJ, 1953, PHYSIOL PLANTARUM, V6, P21, DOI 10.1111/j.1399-3054.1953.tb08930.x; Mohammed S, 2012, J CROP IMPROV, V26, P130, DOI 10.1080/15427528.2011.618241; Ong C. K., 2007, Annals of Arid Zone, V46, P255; Pabin J., 2003, International Agrophysics, V17, P175; Prenger JJ, 2009, GREENHOUSE CONDENSAT; PRIHAR SS, 1990, AGRON J, V82, P1160, DOI 10.2134/agronj1990.00021962008200060027x; Rajan N, 2010, AGRON J, V102, P1641, DOI 10.2134/agronj2010.0076; Rooney WL, 2004, ADV AGRON, V83, P37, DOI 10.1016/S0065-2113(04)83002-5; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; SAS Institute Inc, 2009, STAT AN SYST US GUID; Shaheen A, 2010, AFR J AGR RES, V5, P2178; SHUTING D, 1993, BIOL PLANTARUM, V35, P273, DOI 10.1007/BF02925953; Sinclair T.R., 2010, PRINCIPLES ECOLOGY P; STEVENSON KR, 1971, AGRON J, V63, P327, DOI 10.2134/agronj1971.00021962006300020038x; Stewart BA, 2009, J CROP IMPROV, V23, P71, DOI 10.1080/15427520802418319; Stewart BA, 2015, AGRON J, V107, P1544, DOI 10.2134/agronj14.0038; STICKLER F. C, 1961, AGRON JOUR, V53, P187; Tanner C.B., 1983, LIMITATIONS EFFICIEN; Thapa S, 2016, J CROP IMPROV, V30, P614, DOI 10.1080/15427528.2016.1217445; Xin ZG, 2009, FIELD CROP RES, V111, P74, DOI 10.1016/j.fcr.2008.10.010; Zhang HP, 1998, PLANT SOIL, V201, P295, DOI 10.1023/A:1004328004860	63	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173511	10.1371/journal.pone.0173511	http://dx.doi.org/10.1371/journal.pone.0173511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264051	Green Published, gold, Green Submitted			2022-12-27	WOS:000396054300068
J	Buszko, M; Cardini, B; Oberhuber, R; Oberhuber, L; Jakic, B; Beierfuss, A; Wick, G; Cappellano, G				Buszko, Maja; Cardini, Benno; Oberhuber, Rupert; Oberhuber, Lukas; Jakic, Bojana; Beierfuss, Anja; Wick, Georg; Cappellano, Giuseppe			Differential depletion of total T cells and regulatory T cells and prolonged allotransplant survival in CD3. humanized mice treated with polyclonal anti human thymocyte globulin	PLOS ONE			English	Article							OKT3 MONOCLONAL-ANTIBODY; RABBIT ANTITHYMOCYTE GLOBULIN; KIDNEY-TRANSPLANT RECIPIENTS; NONOBESE DIABETIC MICE; IN-VIVO; TCR/CD3 COMPLEX; THERAPY; MECHANISMS; INDUCTION; AUTOIMMUNITY	Thymoglobulin (ATG) is a polyclonal rabbit antibody against human thymocytes used as a T cell-depleting agent to prevent or treat allotransplant rejection. The aim of the present study was to investigate the effect of low dose ATG treatment exclusively on T cells using a humanized BALB/c human CD3. transgenic mouse model expressing both human and murine T cell receptors (TCR). Mice received a single intravenous (i. v.) injection of ATG. Blood and peripheral lymphoid organs were obtained after different time points. We found a significant T cell depletion in this mouse model. In addition, regulatory T cells (Tregs) proved to be less sensitive to depletion than the rest of T cells and the Treg: non-Treg ratio was therefore increased. Finally, we also investigated the effect of ATG in a heterotopic allogenic murine model of heart transplantation. Survival and transplant function were significantly prolonged in ATG-treated mice. In conclusion, we showed (a) an immunosuppressive effect of ATG in this humanized mouse model which is exclusively mediated by reactivity against human CD3.; (b) provided evidence for a relative resistance of Tregs against this regimen; and (c) demonstrated the immunomodulatory effect of ATG under these experimental circumstances by prolongation of heart allograft survival.	[Buszko, Maja; Jakic, Bojana; Wick, Georg; Cappellano, Giuseppe] Med Univ Innsbruck, Lab Autoimmun, Div Expt Pathophysiol & Immunol, Bioctr, Innsbruck, Austria; [Cardini, Benno; Oberhuber, Rupert; Oberhuber, Lukas] Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, Ctr Operat Med, Innsbruck, Austria; [Beierfuss, Anja] Med Univ Innsbruck, Cent Lab, Anim Facil, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Cappellano, G (corresponding author), Med Univ Innsbruck, Lab Autoimmun, Div Expt Pathophysiol & Immunol, Bioctr, Innsbruck, Austria.	giuseppe.cappellano@i-med.ac.at	Cappellano, Giuseppe/ABE-4980-2020; Jakic, Bojana/AAR-8584-2020	Jakic, Bojana/0000-0002-2339-5928; Cappellano, Giuseppe/0000-0001-5193-4688	SANOFI-Genzyme	SANOFI-Genzyme	This project has been supported by SANOFI-Genzyme (to GW). This support included the salaries of one PhD student (M. Buszko), part of the salary of a senior postdoc (G. Cappellano), a part time technician and a part time animal caretaker. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOWICZ D, 1989, TRANSPLANTATION, V47, P606, DOI 10.1097/00007890-198904000-00008; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; BLANCHARD J M, 1985, Microsurgery, V6, P169, DOI 10.1002/micr.1920060308; Bouvy AP, 2014, NEPHROL DIAL TRANSPL, V29, P1587, DOI 10.1093/ndt/gfu079; Carson BD, 2007, ANN NY ACAD SCI, V1103, P167, DOI 10.1196/annals.1394.022; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; CHATENOUD L, 1982, EUR J IMMUNOL, V12, P979, DOI 10.1002/eji.1830121116; Chung DT, 2007, INT IMMUNOL, V19, P1003, DOI 10.1093/intimm/dxm078; DELAHERA A, 1991, J EXP MED, V173, P7, DOI 10.1084/jem.173.1.7; Feng XM, 2014, HAEMATOLOGICA, V99, P1433, DOI 10.3324/haematol.2014.106542; HIRSCH R, 1988, J IMMUNOL, V140, P3766; Kuhn C, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001830; Minamimura K, 2006, J IMMUNOL, V176, P4125, DOI 10.4049/jimmunol.176.7.4125; Mohty M, 2007, LEUKEMIA, V21, P1387, DOI 10.1038/sj.leu.2404683; Mohty M, 2014, DRUGS, V74, P1605, DOI 10.1007/s40265-014-0277-6; Neff KS, 2011, TRANSPLANTATION, V92, P523, DOI 10.1097/TP.0b013e31822923f7; Nishio J, 2010, J EXP MED, V207, P1879, DOI 10.1084/jem.20100205; Oberhuber R, 2014, JOVE-J VIS EXP, DOI 10.3791/50753; Penaranda C, 2011, J IMMUNOL, V187, P2015, DOI 10.4049/jimmunol.1100713; Popow I, 2013, AM J TRANSPLANT, V13, P3103, DOI 10.1111/ajt.12514; Preville X, 2001, TRANSPLANTATION, V71, P460, DOI 10.1097/00007890-200102150-00021; Qu YY, 2010, CELL MOL IMMUNOL, V7, P419, DOI 10.1038/cmi.2010.45; Rojo JM, 2014, J LEUKOCYTE BIOL, V95, P441, DOI 10.1189/jlb.1112584; Ruzek MC, 2009, TRANSPLANTATION, V88, P170, DOI 10.1097/TP.0b013e3181abc061; Sebastian M, 2016, J IMMUNOL, V196, P144, DOI 10.4049/jimmunol.1501704; SHI YF, 1991, J IMMUNOL, V146, P3340; Simon G, 2008, DIABETES, V57, P405, DOI 10.2337/db06-1384; Starzl T. E., 1967, TRANSPLANTATION, V5, P1100; Steffens S, 2006, CIRCULATION, V114, P1977, DOI 10.1161/CIRCULATIONAHA.106.627430; Tang QZ, 2012, TRANSPL INT, V25, P1257, DOI 10.1111/j.1432-2277.2012.01565.x; THISTLETHWAITE JR, 1984, TRANSPLANTATION, V38, P695, DOI 10.1097/00007890-198412000-00029; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Xia CQ, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-70	33	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173088	10.1371/journal.pone.0173088	http://dx.doi.org/10.1371/journal.pone.0173088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257450	Green Submitted, Green Published, gold			2022-12-27	WOS:000396021100056
J	Hategeka, C; Shoveller, J; Tuyisenge, L; Kenyon, C; Cechetto, DF; Lynd, LD				Hategeka, Celestin; Shoveller, Jean; Tuyisenge, Lisine; Kenyon, Cynthia; Cechetto, David F.; Lynd, Larry D.			Pediatric emergency care capacity in a low-resource setting: An assessment of district hospitals in Rwanda	PLOS ONE			English	Article							QUALITY; KENYA; INDICATORS; COUNTRIES; CHILDREN	Background Health system strengthening is crucial to improving infant and child health outcomes in low-resource countries. While the knowledge related to improving newborn and child survival has advanced remarkably over the past few decades, many healthcare systems in such settings remain unable to effectively deliver pediatric advance life support management. With the introduction of the Emergency Triage, Assessment and Treatment plus Admission care (ETAT+)-a locally adapted pediatric advanced life support management program-in Rwandan district hospitals, we undertook this study to assess the extent to which these hospitals are prepared to provide this pediatric advanced life support management. The results of the study will shed light on the resources and support that are currently available to implement ETAT+, which aims to improve care for severely ill infants and children. Methods A cross-sectional survey was undertaken in eight district hospitals across Rwanda focusing on the availability of physical and human resources, as well as hospital services organizations to provide emergency triage, assessment and treatment plus admission care for severely ill infants and children. Results Many of essential resources deemed necessary for the provision of emergency care for severely ill infants and children were readily available (e.g. drugs and laboratory services). However, only 4/8 hospitals had BVM for newborns; while nebulizer and MDI were not available in 2/8 hospitals. Only 3/8 hospitals had F-75 and ReSoMal. Moreover, there was no adequate triage system across any of the hospitals evaluated. Further, guidelines for neonatal resuscitation and management of malaria were available in 5/8 and in 7/8 hospitals, respectively; while those for child resuscitation and management of sepsis, pneumonia, dehydration and severe malnutrition were available in less than half of the hospitals evaluated. Conclusions Our assessment provides evidence to inform new strategies to enhance the capacity of Rwandan district hospitals to provide pediatric advanced life support management. Identifying key gaps in the health care system is required in order to facilitate the implementation and scale up of ETAT+ in Rwanda. These findings also highlight a need to establish an outreach/mentoring program, embedded within the ongoing ETAT+ program, to promote cross-hospital learning exchanges.	[Hategeka, Celestin; Shoveller, Jean] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Hategeka, Celestin; Lynd, Larry D.] Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, Vancouver, BC, Canada; [Tuyisenge, Lisine] Univ Teaching Hosp Kigali, Dept Pediat, Kigali, Rwanda; [Kenyon, Cynthia] London Hlth Sci Ctr, Childrens Hosp, Div Neonatal Perinatal Med, London, ON, Canada; [Cechetto, David F.] Western Univ, Dept Anat & Cell Biol, Schulich Sch Med & Dent, London, ON, Canada; [Lynd, Larry D.] Providence Hlth Res Inst, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario)	Hategeka, C (corresponding author), Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada.; Hategeka, C; Lynd, LD (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, Vancouver, BC, Canada.; Lynd, LD (corresponding author), Providence Hlth Res Inst, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada.	celestin.hategeka@alumni.ubc.ca; larry.lynd@ubc.ca		Hategeka, Celestin/0000-0001-7808-4652; Lynd, Larry/0000-0002-7622-3919	CIDA-Maternal Newborn and Child Health in Rwanda [S065358]	CIDA-Maternal Newborn and Child Health in Rwanda	DFC received a grant (CIDA-Maternal Newborn and Child Health in Rwanda, S065358) that contributed to funding the master's training for CH at the University of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe KK, 2000, AM J EMERG MED, V18, P126, DOI 10.1016/S0735-6757(00)90001-9; Aluvaala J, 2014, ARCH DIS CHILDHOOD; Association AH, 2005, PEDIATRICS, V117, pe989, DOI [10.1542/peds.2006-0219, DOI 10.1542/PEDS.2006-0219]; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Binagwaho A, 2013, NEW ENGL J MED, V369, P2054, DOI 10.1056/NEJMsr1302176; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; English M, 2004, LANCET, V364, P1622, DOI 10.1016/S0140-6736(04)17318-2; Gathara D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117048; Hategeka C., 2012, RWANDA MED J, V69, P34; Hategekimana C., 2015, EVALUATING IMPLEMENT; Hategekimana C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152882; Irimu GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039964; Khilnani P, 2010, INDIAN J CRIT CARE M, V14, P41, DOI 10.4103/0972-5229.63029; Mabey D, 2013, PRINCIPLES MED AFRIC; Maternal Newborn and Child Health in Rwanda (MNCHR), 2010, REP QUAL HLTH CAR RW; MENGE I, 1995, E AFR MED J, V72, P165; Ministry of Health of Rwanda, 2010, LIST NAT MED ESS; Ministry of Health of Rwanda, 2011, INT HLTH SYST STRENG; Ministry of Health of Rwanda, 2008, SERV PROV ASS SURV; Ministry of Health of Rwanda, 2012, RWAND ANN HLTH STAT; Ministry of Health of Rwanda, 2011, BAS PED PROT; Ministry of Health Rwanda, 2005, RWAND HLTH SECT POL; Molyneux EM, 2010, ANN TROP PAEDIATR, V30, P165, DOI 10.1179/146532810X12703902516482; Mwakyusa Sekela, 2006, BMC Int Health Hum Rights, V6, P9, DOI 10.1186/1472-698X-6-9; National Institute of Statistics of Rwanda, 2014, RWAND POP HOUS CENS; National Institute of Statistics of Rwanda (NISR) [Rwanda]; Ministry of Health (MOH) [Rwanda]; and ICF International, 2015, RWAND DEM HLTH SURV; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Ntoburi S, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-90; Ralston ME, 2013, LANCET, V381, P256, DOI 10.1016/S0140-6736(12)61191-X; Robison JA, 2012, PEDIATRICS, V130, pE676, DOI 10.1542/peds.2012-0026; Shoveller J, 2016, CRIT PUBLIC HEALTH, V26, P487, DOI 10.1080/09581596.2015.1117577; Slusher TM, 2011, SEMINARS PERINATOLOG; United Nations, MILL DEV GOALS 2000; WHO, 1987, HOSP HLTH ALL REP WH; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; World Health Organization (WHO), 2003, KANGAROO MOTHER CARE	36	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173233	10.1371/journal.pone.0173233	http://dx.doi.org/10.1371/journal.pone.0173233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257500	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100079
J	Leiser, D; Duani, N; Wagner-Egger, P				Leiser, David; Duani, Nofar; Wagner-Egger, Pascal			The conspiratorial style in lay economic thinking	PLOS ONE			English	Article							RIGHT-WING AUTHORITARIANISM; INDIVIDUAL-DIFFERENCES; BELIEF; ASSOCIATIONS; MENTALITY; SYSTEM; PERCEPTIONS; PERSONALITY; SCHIZOTYPY; IDEATION	This study investigates patterns of lay perception of economics, and in particular the place of conspiratorial thinking regarding the economic domain. We devised four types of accounts in the economic domain, over a range of questions regarding different aspects of the economy: the classical neo-liberal economic view (which we labeled Econ101), and the Conspiracy view (the destructive outcomes of economy are due to small and powerful groups who are manipulating the markets), to which we added the Government malfunction view (failures in the economy are due to the authorities), and the Bad Invisible Hand view (the invisible hand may go wrong, and the equilibrium reached by its doings may be undesirable). The last two views are the ones most strongly endorsed by our respondents, in the US, Israel and Switzer-land. The pattern of inter-correlations between the four accounts, and that between each and the psycho-social variables we examined, exhibits two clusters, Econ101 vs. the other three views of economy. This corresponds to a general opposition between people who trust the neoliberal economic system, and those opposed to it. What sets economic conspiratorial thinking apart are its links with other conspirational beliefs and with paranormal beliefs.	[Leiser, David] Ben Gurion Univ Negev, Dept Psychol, Beer Sheva, Israel; [Duani, Nofar] Ben Gurion Univ Negev, Dept Econ, Beer Sheva, Israel; [Wagner-Egger, Pascal] Univ Fribourg, Dept Psychol, Fribourg, Switzerland	Ben Gurion University; Ben Gurion University; University of Fribourg	Leiser, D (corresponding author), Ben Gurion Univ Negev, Dept Psychol, Beer Sheva, Israel.	dleiser@bgu.ac.il	Leiser, David/C-3384-2008; Leiser, David/M-9734-2019	Leiser, David/0000-0003-1619-8106; Leiser, David/0000-0003-1619-8106; Duani, Nofar/0000-0002-9928-8336; Wagner-Egger, Pascal/0000-0003-3042-4165				Abalakina-Paap M, 1999, POLIT PSYCHOL, V20, P637, DOI 10.1111/0162-895X.00160; Barron D, 2014, PERS INDIV DIFFER, V70, P156, DOI 10.1016/j.paid.2014.06.040; Brotherton R., 2013, PSYPAG Q, V88, P9; Brotherton R, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00279; Bruder M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00225; Caplan B., 2011, MYTH RATIONAL VOTER; Crocker J, 1999, PERS SOC PSYCHOL B, V25, P941, DOI 10.1177/01461672992511003; Dagnall N, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00206; Darriet E, 2015, MIND SOC, P1; Darwin H, 2011, PERS INDIV DIFFER, V50, P1289, DOI 10.1016/j.paid.2011.02.027; Davies P, 2015, J CURRICULUM STUD, V47, P300, DOI 10.1080/00220272.2014.934717; Dieguez S, 2015, PSYCHOL SCI, V26, P1762, DOI 10.1177/0956797615598740; Douglas KM, 2008, J SOC PSYCHOL, V148, P210, DOI 10.3200/SOCP.148.2.210-222; Duckitt J, 2002, J PERS SOC PSYCHOL, V83, P75, DOI 10.1037//0022-3514.83.1.75; Fornero E., 2015, BANKERS MARKETS INVE, V134, P6; Franks B, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00424; Funke F, 2005, POLIT PSYCHOL, V26, P195, DOI 10.1111/j.1467-9221.2005.00415.x; Gangl K, 2012, J SOCIO-ECON, V41, P603, DOI 10.1016/j.socec.2012.05.018; GOERTZEL T, 1994, POLIT PSYCHOL, V15, P731, DOI 10.2307/3791630; Grzesiak-Feldman M, 2008, PSYCHOL REP, V102, P884, DOI 10.2466/PR0.102.3.884-886; Grzesiak-Feldman M, 2007, PSYCHOL REP, V100, P199, DOI 10.2466/PR0.100.1.199-202; Grzesiak-Feldman M, 2009, PSYCHOL REP, V105, P389, DOI 10.2466/PR0.105.2.389-393; Imhoff R, 2014, EUR J PERSONALITY, V28, P25, DOI 10.1002/per.1930; Kahneman D., 2011, THINKING FAST SLOW; Keeley BL, 1999, J PHILOS, V96, P109, DOI 10.2307/2564659; Lantian A., 2015, ROLE FONCTIONNEL ADH; Lantian A, 2016, INT REV SOC PSYCHOL, V29, P1, DOI 10.5334/irsp.8; Leiser D., 2005, J SOCIO-ECON, V34, P179, DOI DOI 10.1016/J.S0CEC.2004.09.006; Leiser D., 2010, J SOCIO-ECON, V39, P132, DOI DOI 10.1016/J.S0CEC.2010.02.013; Leiser D, 2017, EC PSYCHOL SCI EC ME; Leiser D, 2016, J ECON PSYCHOL, V53, P154, DOI 10.1016/j.joep.2016.02.002; Leiser D, 2009, APPL PSYCHOL-INT REV, V58, P370, DOI 10.1111/j.1464-0597.2009.00396.x; Levenson H., 1981, DIFFERENTIATING INTE; Lobato E, 2014, APPL COGNITIVE PSYCH, V28, P617, DOI 10.1002/acp.3042; MOSCOVICI S, 1988, EUR J SOC PSYCHOL, V18, P211, DOI 10.1002/ejsp.2420180303; Newheiser AK, 2011, PERS INDIV DIFFER, V51, P1007, DOI 10.1016/j.paid.2011.08.011; Oliver JE, 2014, AM J POLIT SCI, V58, P952, DOI 10.1111/ajps.12084; Olmsted Kathryn S., 2008, REAL ENEMIES CONSPIR; Raab MH, 2013, FRONTIERS PSYCHOL, V4; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Roos MWM, 2008, EUR J POLIT ECON, V24, P192, DOI 10.1016/j.ejpoleco.2007.07.001; Roos MWM, 2007, PUBLIC CHOICE, V132, P291, DOI 10.1007/s11127-007-9152-2; StatSoft Inc, 2013, STATISTICA DAT AN SO; Stieger S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00297; Sullivan D, 2010, J PERS SOC PSYCHOL, V98, P434, DOI 10.1037/a0017457; Sutton R. M., 2014, POWER POLITICS PARAN; Swami V, 2016, PERS INDIV DIFFER, V99, P72, DOI 10.1016/j.paid.2016.04.084; Swami V, 2013, APPL COGNITIVE PSYCH, V27, P71, DOI 10.1002/acp.2873; Swami V, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00280; Swami V, 2011, BRIT J PSYCHOL, V102, P443, DOI 10.1111/j.2044-8295.2010.02004.x; Swami V, 2010, APPL COGNITIVE PSYCH, V24, P749, DOI 10.1002/acp.1583; van der Tempel J, 2015, PERS INDIV DIFFER, V82, P136, DOI 10.1016/j.paid.2015.03.010; van Elk M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130422; Van Prooijen JW, 2015, APPL COGNITIVE PSYCH, V29, P753, DOI 10.1002/acp.3161; van Prooijen JW, 2015, SOC PSYCHOL PERS SCI, V6, P570, DOI 10.1177/1948550614567356; Van Prooijen JW, 2013, EUR J SOC PSYCHOL, V43, P109, DOI 10.1002/ejsp.1922; Wagner W, 2002, BRIT J SOC PSYCHOL, V41, P323, DOI 10.1348/014466602760344241; Wagner W., 2005, EVERYDAY DISCOURSE C; Wagner-Egger P, 2007, REV INT PSYCHOL SOC, V20, P31; Wagner-Egger P, 2011, PUBLIC UNDERST SCI, V20, P461, DOI 10.1177/0963662510393605; Whitson JA, 2015, J EXP SOC PSYCHOL, V56, P89, DOI 10.1016/j.jesp.2014.09.002	61	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0171238	10.1371/journal.pone.0171238	http://dx.doi.org/10.1371/journal.pone.0171238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257506	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100006
J	Pan, XD; Gu, DH; Mao, JH; Zhu, H; Chen, XF; Zheng, B; Shan, YX				Pan, Xiao-dong; Gu, Dong-hua; Mao, Jia-Hui; Zhu, Hua; Chen, Xinfeng; Zheng, Bing; Shan, Yuxi			Concurrent inhibition of mTORC1 and mTORC2 by WYE-687 inhibits renal cell carcinoma cell growth in vitro and in vivo	PLOS ONE			English	Article							PRECLINICAL EVALUATION; CANCER; RAPAMYCIN; EXPRESSION; RESISTANCE; APOPTOSIS; COMPLEX; TARGET; HK-2	Mammalian target of rapamycin (mTOR) in renal cell carcinoma (RCC) represents a valuable oncotarget for treatment. We here tested the potential anti-RCC activity by a novel mTOR kinase inhibitor WYE-687 in vitro and in vivo. WYE-687 was cytotoxic and anti-proliferative to established RCC cell lines (786-O and A498) and primary human RCC cells. Yet, it was non-cytotoxic toHK-2 tubular epithelial cells. WYE-687 provoked caspase-dependent apoptosis in the RCC cells. At the molecular level, WYE-687 almost completely blocked mTORC1 (p-S6K1 and p-S6) and mTORC2 (p-Akt Ser 473) activation in both 786-Ocells and primary human RCC cells, where it downregulated both hypoxia-inducible factor (HIF)-1 alpha and HIF-2 alpha expression. Significantly, oral administration of WYE-687 potently suppressed786-O tumor xenograft growth in nude mice. mTORC1/2 activation and HIF-1 alpha/2 alpha expression were also remarkably downregulated in WYE-687-treated tumor tissues. Thus, our preclinical results imply that WYE-687 may have important translational value for the treatment of RCC.	[Pan, Xiao-dong; Gu, Dong-hua; Shan, Yuxi] Soochow Univ, Affiliated Hosp 2, Dept Urol, Suzhou, Peoples R China; [Mao, Jia-Hui] Nantong Univ, Sch Med, Dept Pathophysiol, Nantong, Peoples R China; [Zhu, Hua; Chen, Xinfeng; Zheng, Bing] Nantong Univ, Affiliated Hosp 2, Dept Urol, Nantong, Peoples R China	Soochow University - China; Nantong University; Nantong University	Shan, YX (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Urol, Suzhou, Peoples R China.; Zheng, B (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Urol, Nantong, Peoples R China.	bingzhengnantong@163.com; drshanyuxisd@163.com			Nantong City Scientific Project [2014151B1]	Nantong City Scientific Project	This study is supported by Nantong City Scientific Project (2014151B1 to B.Z.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato RJ, 2000, SEMIN ONCOL, V27, P177; Chen MB, 2015, BIOCHEM BIOPH RES CO, V463, P954, DOI 10.1016/j.bbrc.2015.06.041; Cheng F, 2016, BIOCHEM BIOPH RES CO, V470, P324, DOI 10.1016/j.bbrc.2016.01.054; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Dutcher JP, 2011, MED ONCOL, V28, P1530, DOI 10.1007/s12032-010-9649-2; Fiori E, 2002, J EXP CLIN CANC RES, V21, P229; Gomez-Pinillos A, 2012, HEMATOL ONCOL CLIN N, V26, P483, DOI 10.1016/j.hoc.2012.02.014; Hasskarl J, 2014, RECENT RESULTS CANC, V201, P373, DOI 10.1007/978-3-642-54490-3_23; Husseinzadeh HD, 2011, CURR CLIN PHARMACOL, V6, P214, DOI 10.2174/157488411797189433; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Komoike Y, 2012, ARCH TOXICOL, V86, P37, DOI 10.1007/s00204-011-0742-x; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Konings IRHM, 2009, CURR CANCER DRUG TAR, V9, P439, DOI 10.2174/156800909788166556; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Li Z, 2016, ONCOTARGET; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989; Pal SK, 2013, CANCER TREAT REV, V39, P709, DOI 10.1016/j.ctrv.2012.12.015; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Schreiber KH, 2015, AGING CELL, V14, P265, DOI 10.1111/acel.12313; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200; Uygur MC, 1999, J EXP CLIN CANC RES, V18, P397; Vilar E, 2011, MOL CANCER THER, V10, P395, DOI 10.1158/1535-7163.MCT-10-0905; Wu DY, 2013, ONCOL LETT, V5, P829, DOI 10.3892/ol.2013.1123; Yang FG, 2005, ACTA PHARMACOL SIN, V26, P753, DOI 10.1111/j.1745-7254.2005.00753.x; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005; Zhang YM, 2015, J INVEST DERMATOL, V135, P181, DOI 10.1038/jid.2014.326; Zheng B, 2014, CANC LETT; Zheng B, 2016, SCI REP-UK, V6, DOI 10.1038/srep29415; Zheng B, 2015, BIOCHEM BIOPH RES CO, V459, P234, DOI 10.1016/j.bbrc.2015.02.084; Zheng B, 2015, CANCER LETT, V357, P468, DOI 10.1016/j.canlet.2014.11.012; Zhou HY, 2012, CHIN J CANCER, V31, P8, DOI 10.5732/cjc.011.10281	41	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172555	10.1371/journal.pone.0172555	http://dx.doi.org/10.1371/journal.pone.0172555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257457	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100021
J	Galdeano, DM; Breton, MC; Lopes, JRS; Falk, BW; Machado, MA				Galdeano, Diogo Manzano; Breton, Michele Claire; Spotti Lopes, Joao Roberto; Falk, Bryce W.; Machado, Marcos Antonio			Oral delivery of double-stranded RNAs induces mortality in nymphs and adults of the Asian citrus psyllid, Diaphorina citri	PLOS ONE			English	Article							CANDIDATUS-LIBERIBACTER-ASIATICUS; SPODOPTERA-EXIGUA; CHITIN SYNTHASES; GREENING DISEASE; CATHEPSIN-D; INTERFERENCE; DSRNA; VECTOR; INJECTION; SUCKING	The Asian citrus psyllid (ACP), Diaphorina citri Kuwayama, is one of the most important citrus pests. ACP is the vector of the phloem-limited bacteria Candidatus Liberibacter americanus and Candidatus Liberibacter asiaticus, the causal agents of the devastating citrus disease huanglongbing (HLB). The management of HLB is based on the use of healthy young plants, eradication of infected plants and chemical control of the vector. RNA interference (RNAi) has proven to be a promising tool to control pests and explore gene functions. Recently, studies have reported that target mRNA knockdown in many insects can be induced through feeding with double-stranded RNA (dsRNA). In the current study, we targeted the cathepsin D, chitin synthase and inhibitor of apoptosis genes of adult and nymph ACP by feeding artificial diets mixed with dsRNAs and Murraya paniculata leaves placed in dsRNAs solutions, respectively. Adult ACP mortality was positively correlated with the amount of dsRNA used. Both nymphs and adult ACP fed dsRNAs exhibited significantly increased mortality over time compared with that of the controls. Moreover, qRT-PCR analysis confirmed the dsRNA-mediated RNAi effects on target mRNAs. These results showed that RNAi can be a powerful tool for gene function studies in ACP and perhaps for HLB control.	[Galdeano, Diogo Manzano; Breton, Michele Claire; Machado, Marcos Antonio] Inst Agron Campinas, Ctr Citricultura Sylvio Moreira, Lab Biotecnol, Cordeiropolis, SP, Brazil; [Galdeano, Diogo Manzano] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil; [Spotti Lopes, Joao Roberto] Univ Sao Paulo, Escola Super Agr Luiz De Queiroz, Piracicaba, SP, Brazil; [Falk, Bryce W.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; University of California System; University of California Davis	Machado, MA (corresponding author), Inst Agron Campinas, Ctr Citricultura Sylvio Moreira, Lab Biotecnol, Cordeiropolis, SP, Brazil.	marcos@centrodecitricultura.br	Lopes, Joao/F-3439-2012; Galdeano, Diogo M/C-3662-2019; Machado, Marcos Antonio/G-3582-2012	Lopes, Joao/0000-0002-9998-5473; Galdeano, Diogo M/0000-0002-7411-5009; Yan, Zhiyong/0000-0001-8253-0694; Machado, Marcos Antonio/0000-0001-9780-3990	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/02138-0, 2014/03925-8, 2008/57909-2]; CNPq [573848/08-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2013/02138-0, 2014/03925-8 and 2008/57909-2), and CNPq (573848/08-4).; We thank the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2008/57909-2, 2013/02138-0, 2014/03925-8) and CNPq (573848/08-4) for supporting this work. We also thank Dra. Yen-Wen Kuo, Alyssa Oslan and Tera L. Pitman for helpful discussions, advice and assistance.	Allen ML, 2012, J INSECT PHYSIOL, V58, P391, DOI 10.1016/j.jinsphys.2011.12.014; Alves AP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14122; Baum JA, 2014, ADV INSECT PHYSL; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Bove JM, 2006, J PLANT PATHOL, V88, P7; Chen X, 2008, B ENTOMOL RES, V98, P613, DOI 10.1017/S0007485308005932; Christiaens O, 2014, PEPTIDES, V53, P307, DOI 10.1016/j.peptides.2013.12.014; Coletta HD, 2004, PLANT DIS, V88, P1382, DOI 10.1094/PDIS.2004.88.12.1382C; DAGRACA JV, 1991, ANNU REV PHYTOPATHOL, V29, P109, DOI 10.1146/annurev.py.29.090191.000545; El-Shesheny I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065392; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Gui ZZ, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-49; Hajeri S, 2014, J BIOTECHNOL, V176, P42, DOI 10.1016/j.jbiotec.2014.02.010; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hoddle MS, 2014, J ECON ENTOMOL, V107, P125, DOI 10.1603/EC13318; HOUSEMAN JG, 1983, COMP BIOCHEM PHYS B, V75, P509, DOI 10.1016/0305-0491(83)90367-X; Hoy MA, 2010, FLA ENTOMOL, V93, P24, DOI 10.1653/024.093.0103; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Jarosch A, 2012, APIDOLOGIE, V43, P128, DOI 10.1007/s13592-011-0092-y; Jin SX, 2015, PLANT BIOTECHNOL J, V13, P435, DOI 10.1111/pbi.12355; Khan AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073657; Killiny N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110536; Li HC, 2015, PLANT CELL ENVIRON, V38, P2277, DOI 10.1111/pce.12546; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; Li JJ, 2015, PEST MANAG SCI, V71, P1175, DOI 10.1002/ps.3903; Li X, 2011, PLOS ONE, V6; Luan JB, 2013, INSECT BIOCHEM MOLEC, V43, P740, DOI 10.1016/j.ibmb.2013.05.012; Luo Y, 2013, INSECT MOL BIOL, V22, P574, DOI 10.1111/imb.12046; Mann RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029197; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Michaud JP, 2004, BIOCONTROL, V49, P417, DOI 10.1023/B:BICO.0000034605.53030.db; Nunes Francis M.F., 2013, Insects, V4, P90, DOI 10.3390/insects4010090; Otti MJZ, 2007, NEOTROP ENTOMOL, V44, P197; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Pridgeon JW, 2008, J MED ENTOMOL, V45, P414, DOI 10.1603/0022-2585(2008)45[414:TAADRK]2.0.CO;2; Rao KV., 2015, FRONT PHYSL, V6; Russell CW, 2015, ENTOMOL EXP APPL, V154, P171, DOI 10.1111/eea.12268; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Walker WB, 2011, ENTOMOL EXP APPL, V138, P83, DOI 10.1111/j.1570-7458.2010.01078.x; Wuriyanghan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066050; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Wynant N., 2014, INT REV CELL MOL BIO, V1st; Wynant N, 2014, INSECT BIOCHEM MOLEC, V46, P1, DOI 10.1016/j.ibmb.2013.12.008; YAMAMOTO PT, 2009, BIOASSAY, V4, P9; Yang J, 2014, J INTEGR AGR, V13, P115, DOI 10.1016/S2095-3119(13)60511-0; Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x; Zhang H, 2013, INSECT SCI, V20, P15, DOI 10.1111/j.1744-7917.2012.01513.x	57	43	45	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0171847	10.1371/journal.pone.0171847	http://dx.doi.org/10.1371/journal.pone.0171847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282380	gold, Green Published, Green Submitted			2022-12-27	WOS:000396091800004
J	Ali, J; Xu, JL; Gao, YM; Ma, XF; Meng, LJ; Wang, Y; Pang, YL; Guan, YS; Xu, MR; Revilleza, JE; Franje, NJ; Zhou, SC; Li, ZK				Ali, Jauhar; Xu, Jian-Long; Gao, Yong-Ming; Ma, Xiu-Fang; Meng, Li-Jun; Wang, Ying; Pang, Yun-Long; Guan, Yong-Sheng; Xu, Mei-Rong; Revilleza, Jastin E.; Franje, Neil J.; Zhou, Shao-Chuan; Li, Zhi-Kang			Harnessing the hidden genetic diversity for improving multiple abiotic stress tolerance in rice (Oryza sativa L.)	PLOS ONE			English	Article							BACKCROSS INTROGRESSION LINES; DROUGHT TOLERANCE; SALT TOLERANCE; SELECTION; YIELD; DISSECTION; VARIETIES; MAIZE; FLOOD; QTLS	To develop superior rice varieties with improved yield in most rainfed areas of Asia/Africa, we started an introgression-breeding program for simultaneously improving yield and tolerances of multiple abiotic stresses. Using eight BC1 populations derived from a widely adaptable recipient and eight donors plus three rounds of phenotypic selection, we developed 496 introgression lines (ILs) with significantly higher yield under drought, salt and/or non-stress conditions in 5 years. Six new varieties were released in the Philippines and Pakistan and many more are being evaluated in multi-location yield trials for releasing in several countries. Marker-facilitated genetic characterization revealed three interesting aspects of the breeding procedure: (1) the donor introgression pattern in specific BC populations was characteristic; (2) introgression frequency in different genomic regions varied considerably, resulting primarily from strong selection for the target traits; and (3) significantly lower heterozygosity was observed in BC progenies selected for drought and salinity tolerance. Applying strong phenotypic selection under abiotic stresses in early segregating generations has major advantages for not only improving multiple abiotic stress tolerance but also achieving quicker homozygosity in early generations. This breeding procedure can be easily adopted by small breeding programs in developing countries to develop high-yielding varieties tolerant of abiotic stresses. The large set of trait-specific ILs can be used for genetic mapping of genes/QTL that affect target and non-target traits and for efficient varietal development by designed QTL pyramiding and genomics-based recurrent selection in our Green Super Rice breeding technology.	[Ali, Jauhar; Ma, Xiu-Fang; Meng, Li-Jun; Wang, Ying; Pang, Yun-Long; Guan, Yong-Sheng; Xu, Mei-Rong; Revilleza, Jastin E.; Franje, Neil J.] IRRI, Los Banos, Philippines; [Xu, Jian-Long; Gao, Yong-Ming; Meng, Li-Jun; Wang, Ying; Pang, Yun-Long; Guan, Yong-Sheng; Xu, Mei-Rong; Li, Zhi-Kang] CAAS, Inst Crop Sci, Beijing, Peoples R China; [Xu, Jian-Long; Li, Zhi-Kang] CAAS, Agr Genom Inst, Shenzhen Inst Breeding Innovat, Shenzhen, Peoples R China; [Ma, Xiu-Fang] Liaoning Acad Agr Sci, Shenyang, Peoples R China; [Zhou, Shao-Chuan] Guangdong Acad Agr Sci, Guangzhou, Guangdong, Peoples R China	CGIAR; International Rice Research Institute (IRRI); Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Guangdong Academy of Agricultural Sciences	Li, ZK (corresponding author), CAAS, Inst Crop Sci, Beijing, Peoples R China.; Li, ZK (corresponding author), CAAS, Agr Genom Inst, Shenzhen Inst Breeding Innovat, Shenzhen, Peoples R China.	lizhikang@caas.cn	Ali, Jauhar Ali or A. Jauhar/E-4432-2012; meng, li/GVT-2063-2022; Xu, Jianlong/AAI-8310-2020	Ali, Jauhar Ali or A. Jauhar/0000-0002-3177-2607; 	Bill & Melinda Gates Foundation [GD1393]; National 863 High Technology Research and Development Program from the Ministry of Science and Technology of China [2014AA10A601]; Shenzhen Peacock Plan [20130415095710361]; Natural Science Foundation of China [31261140369]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National 863 High Technology Research and Development Program from the Ministry of Science and Technology of China(National High Technology Research and Development Program of China); Shenzhen Peacock Plan; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants to ZL from Bill & Melinda Gates Foundation (http://www.gatesfoundation.org) (GD1393), to JX from National 863 High Technology Research and Development Program from the Ministry of Science and Technology of China (http://www.863.gov.cn) (2014AA10A601) and to ZL from Shenzhen Peacock Plan (http://www/szsti.gov.cn) (20130415095710361), and to JX from the Natural Science (http://www.nsfc.gov.cn/) Foundation of China (31261140369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AJ, 2006, FIELD CROP RES, V97, P66, DOI 10.1016/j.fcr.2005.08.016; Ali J., 2012, P 12 SABRAO C PLANT, P16; Asaduzzaman M., 2010, BANGL FOOD SEC INV F, P26; Banziger M, 1999, CROP SCI, V39, P1035, DOI 10.2135/cropsci1999.0011183X003900040012x; Beebe SE, 2008, CROP SCI, V48, P582, DOI 10.2135/cropsci2007.07.0404; BOLANOS J, 1993, FIELD CROP RES, V31, P269, DOI 10.1016/0378-4290(93)90066-V; Cooper M, 2014, J EXP BOT, V65, P6191, DOI 10.1093/jxb/eru064; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; Gregorio GB, 2002, FIELD CROP RES, V76, P91, DOI 10.1016/S0378-4290(02)00031-X; Gregorio GB, 1997, IRRI DISCUSSION PAPE, V22, P2; Guan YS, 2010, J EXP BOT, V61, P4145, DOI 10.1093/jxb/erq212; He YX, 2010, PLANT BREEDING, V129, P167, DOI 10.1111/j.1439-0523.2009.01683.x; Ismail AM, 2013, FIELD CROP RES, V152, P83, DOI 10.1016/j.fcr.2013.01.007; Lafitte HR, 2006, FIELD CROP RES, V97, P77, DOI 10.1016/j.fcr.2005.08.017; Li Z.K., 2007, ADV MOL BREEDING DRO, P531, DOI DOI 10.1007/978-1-4020-5578-2_21; Li ZK, 2013, CURR OPIN PLANT BIOL, V16, P261, DOI 10.1016/j.pbi.2013.03.008; Li ZK, 2005, PLANT MOL BIOL, V59, P33, DOI 10.1007/s11103-005-8519-3; Meng LJ, 2013, PLANT BREEDING, V132, P604, DOI 10.1111/pbr.12097; Nagai I., 1962, JAPONICA RICE ITS BR, P843; Raman A, 2012, RICE, V5, DOI 10.1186/1939-8433-5-31; Singh R, 2016, PLANT SCI, V242, P278, DOI 10.1016/j.plantsci.2015.08.008; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Tuong TP, 2003, COMP ASSESS WAT MAN, V1, P53, DOI 10.1079/9780851996691.0053; Wang WJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0709-5; Wang Y, 2013, CROP J, V1, P134, DOI 10.1016/j.cj.2013.07.006; Wang Y, 2013, CROP SCI, V53, P430, DOI 10.2135/cropsci2012.06.0361; Wassmann R, 2009, ADV AGRON, V101, P59, DOI 10.1016/S0065-2113(08)00802-X; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Zang JP, 2008, SCI CHINA SER C, V51, P583, DOI 10.1007/s11427-008-0081-1; Zhang F, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-55; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1	31	28	32	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172515	10.1371/journal.pone.0172515	http://dx.doi.org/10.1371/journal.pone.0172515			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278154	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900120
J	Kauhl, B; Heil, J; Hoebe, CJPA; Schweikart, J; Krafft, T; Dukers-Muijrers, NHTM				Kauhl, Boris; Heil, Jeanne; Hoebe, Christian J. P. A.; Schweikart, Juergen; Krafft, Thomas; Dukers-Muijrers, Nicole H. T. M.			Is the current pertussis incidence only the results of testing? A spatial and space-time analysis of pertussis surveillance data using cluster detection methods and geographically weighted regression modelling	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; UNITED-STATES; HEALTH-CARE; VACCINATION STRATEGIES; INCREASING INCIDENCE; POISSON REGRESSION; DISEASE BURDEN; EPIDEMIOLOGY; DIAGNOSIS; OUTBREAK	Background Despite high vaccination coverage, pertussis incidence in the Netherlands is amongst the highest in Europe with a shifting tendency towards adults and elderly. Early detection of outbreaks and preventive actions are necessary to prevent severe complications in infants. Efficient pertussis control requires additional background knowledge about the determinants of testing and possible determinants of the current pertussis incidence. Therefore, the aim of our study is to examine the possibility of locating possible pertussis outbreaks using space-time cluster detection and to examine the determinants of pertussis testing and incidence using geographically weighted regression models. Methods We analysed laboratory registry data including all geocoded pertussis tests in the southern area of the Netherlands between 2007 and 2013. Socio-demographic and infrastructure-related population data were matched to the geo-coded laboratory data. The spatial scan statistic was applied to detect spatial and space-time clusters of testing, incidence and test-positivity. Geographically weighted Poisson regression (GWPR) models were then constructed to model the associations between the age-specific rates of testing and incidence and possible population-based determinants. Results Space-time clusters for pertussis incidence overlapped with space-time clusters for testing, reflecting a strong relationship between testing and incidence, irrespective of the examined age group. Testing for pertussis itself was overall associated with lower socio-economic status, multi-person-households, proximity to primary school and availability of healthcare. The current incidence in contradiction is mainly determined by testing and is not associated with a lower socioeconomic status. Discussion Testing for pertussis follows to an extent the general healthcare seeking behaviour for common respiratory infections, whereas the current pertussis incidence is largely the result of testing. More testing would thus not necessarily improve pertussis control. Detecting outbreaks using space-time cluster detection is feasible but needs to adjust for the strong impact of testing on the detection of pertussis cases.	[Kauhl, Boris; Krafft, Thomas] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Publ Hlth & Primary Care CAPHRI, Dept Hlth Eth & Soc, Maastricht, Netherlands; [Heil, Jeanne; Hoebe, Christian J. P. A.; Dukers-Muijrers, Nicole H. T. M.] South Limburg Publ Hlth Serv GGD Zuid Limburg, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [Heil, Jeanne; Hoebe, Christian J. P. A.; Dukers-Muijrers, Nicole H. T. M.] MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands; [Schweikart, Juergen] Beuth Univ Appl Sci, Dept 3, Civil Engn & Geoinformat, Berlin, Germany	Maastricht University; Maastricht University	Kauhl, B (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Sch Publ Hlth & Primary Care CAPHRI, Dept Hlth Eth & Soc, Maastricht, Netherlands.	boris.kauhl@maastrichtuniversity.nl	Dukers-Muijrers, Nicole/M-7178-2014	Krafft, Thomas/0000-0002-6164-7815; Heil, Jeanne/0000-0002-0057-9599				[Anonymous], ESRI INT EXPL REGR R; Anselin L, 2005, EXPLORING SPATIAL DA; Barlow RS, 2014, CLIN INFECT DIS, V58, P1523, DOI 10.1093/cid/ciu156; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Calugar A, 2006, CLIN INFECT DIS, V42, P981, DOI 10.1086/500321; Campbell SM, 1996, FAM PRACT, V13, P75, DOI 10.1093/fampra/13.1.75; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P216; Chen J, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-57; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Cherry JD, 2003, PEDIATRICS, V112, P405, DOI 10.1542/peds.112.2.405; Choe YJ, 2012, INT J INFECT DIS, V16, pE850, DOI 10.1016/j.ijid.2012.07.012; Choisy M, 2012, P ROY SOC B-BIOL SCI, V279, P4574, DOI 10.1098/rspb.2012.1761; Chuk LMR, 2008, COMMUN DIS INTELL, V32, P449; Coleman M., 2009, Malaria Journal, V8; Coudeville L, 2008, EPIDEMIOL INFECT, V136, P604, DOI 10.1017/S0950268807009041; Cutler DM, 2006, ED HLTH EVALUATING T; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; de Melker HE, 2000, EMERG INFECT DIS, V6, P348, DOI 10.3201/eid0604.000404; de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; Dhewantara PW, 2015, GEOSPATIAL HEALTH, V10, P255, DOI 10.4081/gh.2015.373; Dijkstra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072730; Fathima S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-48; Feldacker C, 2010, HEALTH PLACE, V16, P996, DOI 10.1016/j.healthplace.2010.06.004; Fisman DN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-694; Fotheringham A. S., 2003, GEOGRAPHICALLY WEIGH; Galanis E, 2006, CAN MED ASSOC J, V174, P451, DOI 10.1503/cmaj.050379; Gezondheidsraad, 2015, VACCINATIE TEGEN KIN; Giammanco A, 2003, VACCINE, V22, P112, DOI 10.1016/S0264-410X(03)00514-0; Greenberg DP, 2005, PEDIATR INFECT DIS J, V24, P721, DOI 10.1097/01.inf.0000172905.08606.a3; Guimaraes LM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1222-3; Haque U, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-63; He Q, 2008, FACTORS CONTRIBUTING; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Heil J, 2017, EUROSURVEIL IN PRESS; Hu MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038978; Huang B, 2010, INT J GEOGR INF SCI, V24, P383, DOI 10.1080/13658810802672469; Jenkinson D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5463; Kaczmarek MC, 2013, MED J AUSTRALIA, V198, P624, DOI 10.5694/mja13.10044; Kauhl B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135656; Kauhl B, 2015, HEALTH PLACE, V31, P111, DOI 10.1016/j.healthplace.2014.11.002; Kirkland K. B., 2007, Morbidity and Mortality Weekly Report, V56, P837; Kulldorff, 2010, SATSCAN SOFTWARE SPA; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 2013, SATSCAN TM USER GUID; Kulldorff M, 2011, SATSCAN USER GUIDE V; Lawson AB, 2000, STAT MED, V19, P2217; LOVETT A, 1989, PROF GEOGR, V41, P190, DOI 10.1111/j.0033-0124.1989.00190.x; LOVETT AA, 1986, SOC SCI MED, V23, P935, DOI 10.1016/0277-9536(86)90251-0; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Nakaya T, 2005, STAT MED, V24, P2695, DOI 10.1002/sim.2129; Nakaya T, 2012, GWR4 USER MANUAL WWW; Ndiath M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-453; Nuolivirta K, 2010, PEDIATR INFECT DIS J, V29, P1013, DOI 10.1097/INF.0b013e3181f537c6; Omer SB, 2008, AM J EPIDEMIOL, V168, P1389, DOI 10.1093/aje/kwn263; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Regidor E, 2004, SOC SCI MED, V59, P1975, DOI 10.1016/j.socscimed.2004.02.032; Robertson C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066168; Robertson C, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-16; Rozenbaum MH, 2012, EPIDEMIOL INFECT, V140, P1503, DOI 10.1017/S0950268811002354; Rozenbaum MH, 2012, VACCINE, V30, P7327, DOI 10.1016/j.vaccine.2012.06.026; Service NH, 2012, SHARP RIS WHOOP COUG; Shoff C, 2012, DEMOGR RES, V27, P377; Sizaire V, 2014, EUROSURVEILLANCE, P19; Smith SM, 2008, COCHRANE DB SYST REV, V1; Statistiek CBvd, 2010, TOEL WIJK BUURTK 201; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; te Beest DE, 2014, EPIDEMICS-NETH, V7, P1, DOI 10.1016/j.epidem.2014.02.001; Terry JB, 2015, COMMUN DIS INTELL, V39, pE27; Tozzi AE, 2005, CAN MED ASSOC J, V172, P509, DOI 10.1503/cmaj.1040766; van den Wijngaard CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010406; van der Maas NAT, 2013, VACCINE, V31, P4541, DOI 10.1016/j.vaccine.2013.07.060; van Lier A, 2013, EUR J PUBLIC HEALTH; van Lier E Alies, 2009, Ned Tijdschr Geneeskd, V153, P950; Verheij TJM, 2011, HUISARTS WET, V2011; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012; Waller L.A., 2004, APPL SPATIAL STAT PU; Wang T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-885; Ward A, 2005, INFECT CONT HOSP EP, V26, P288, DOI 10.1086/502541; Weisent J, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-45; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; Wymann MN, 2011, VACCINE, V29, P2058, DOI 10.1016/j.vaccine.2011.01.017; Ziemann A, 2012, RESUSCITATION, V83, pe30; Zouari A, 2012, CRIT REV MICROBIOL, V38, P111, DOI 10.3109/1040841X.2011.622715	86	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172383	10.1371/journal.pone.0172383	http://dx.doi.org/10.1371/journal.pone.0172383			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278180	gold, Green Submitted, Green Published			2022-12-27	WOS:000396087900118
J	Li, Y; Liu, SX; Wang, HH; Mai, HR; Yuan, XL; Li, CG; Chen, XW; Wen, FQ				Li, Yue; Liu, Sixi; Wang, Huihui; Mai, Huirong; Yuan, Xiuli; Li, Changgang; Chen, Xiaowen; Wen, Feiqiu			Methylation level of CpG islands in GGH gene promoter in pediatric acute leukemia	PLOS ONE			English	Article							GLUTAMYL HYDROLASE; DNA METHYLATION; METHOTREXATE; POLYMORPHISMS; ACCUMULATION; CHILDREN; SYNTHETASE	Background gamma-Glutamyl hydrolase (GGH) regulates intracellular folates and antifolates such as methotrexate (MTX) for proper nucleotide biosynthesis and antifolate-induced cytotoxicity, respectively. In addition to genetic polymorphism and karyotypic abnormalities, methylation of CpG island 1 (CpG1) in the promoter region is found to modulate GGH activity by reducing GGH mRNA expression in acute lymphoblastic leukemia (ALL) cells. We aim to investigate methylation status of two CpG islands (CpG1 and CpG2) in the GGH promoter region in pediatric patients with ALL and acute myelogenous leukemia (AML). Methods 70B-ALL, 29 AML, 10 ITP (idiopathic thrombocytopenic purpura) and 40 healthy children are recruited in the present study. MS-HRM (methylation-sensitive high-resolution melting) and bisulfite sequencing PCR (BSP) are used to detect methylation change and its level in CpG1 and CpG2 in the GGH promoter region. GGH mRNA expression is quantified by realtime PCR. Correlation between CpG island methylation and GGH mRNA expression is assessed by statistical software. Results Methylations of CpG1 are detected in leukemia cells samples obtained from 30.9% (21/68) of patients with ALL and 20.7% (6/29) of patients with AML. These methylations are not detected in the controls. Methylations of CpG2 are detected in leukemia cell samples obtained from 44.1% (30/68) of the ALL patients and 37.9% (11/29) of the AML patients. These percentages are significantly higher than that observed in the control cell samples: 6.0% (3/50) (Fisher's exact test, P = 0.000). The abundance of CpG1 methylation in all leukemia cell samples is classified as Grade I (methylation level is less than 10%) and the abundance of CpG2 methylation in leukemia cell samples is classified in separate grades. Our results indicate that methylation of CpG1 or hypermethylation (the methylation level is greater than 10%) of CpG2 could significantly reduce GGH mRNA expression in leukemia cells from the ALL and AML patients (ALL-CpG1: t = 4.632, P = 0.000; ALL-CpG2: t = 3.250, P = 0.006; AML-CpG1: t = -2.254, P = 0.037; AML-CpG2: t = 1.328, P = 0.202). Conclusion Either methylation of CpG1 or hypermethylation of CpG2 in GGH promoter region can significantly reduce GGH mRNA expression in pediatric patients with acute leukemia, which can improve the response to treatment.	[Li, Yue; Liu, Sixi; Wang, Huihui; Mai, Huirong; Yuan, Xiuli; Li, Changgang; Wen, Feiqiu] Shenzhen Childrens Hosp, Div Hematol & Oncol, Shenzhen, Guangdong, Peoples R China; [Chen, Xiaowen] Shenzhen Childrens Hosp, Shenzhen Inst Pediat, Shenzhen, Guangdong, Peoples R China		Wen, FQ (corresponding author), Shenzhen Childrens Hosp, Div Hematol & Oncol, Shenzhen, Guangdong, Peoples R China.; Chen, XW (corresponding author), Shenzhen Childrens Hosp, Shenzhen Inst Pediat, Shenzhen, Guangdong, Peoples R China.	13510333196@139.com; fwen62@126.com	wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022; Mai, Huirong/AAH-3768-2021	Chen, Xiaowen/0000-0002-3118-3837	Science and Technology Projects from Science Technology and Innovation Committee of Shenzhen Municipality [JCYJ20130401114111456, JCYJ20140416141331552]; Natural Science Foundation of Guangdong Province [2015A030313759]	Science and Technology Projects from Science Technology and Innovation Committee of Shenzhen Municipality; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by Science and Technology Projects (grant number JCYJ20130401114111456) from the Science Technology and Innovation Committee of Shenzhen Municipality, http://www.szsti.gov.cn/ services/plan/, XC; Science and Technology Projects (grant number JCYJ20140416141331552) from the Science Technology and Innovation Committee of Shenzhen Municipality, http://www.szst.gov.cn/ services/plan/, SL; and grant 2015A030313759 from the Natural Science Foundation of Guangdong Province, http://pro.gdstc.gov.cn/ egrantweb/, FW. ALL the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALINSKA M, 1981, CANCER RES, V41, P2751; BERTINO JR, 1993, J CLIN ONCOL, V11, P5, DOI 10.1200/JCO.1993.11.1.5; Bishop KS, 2015, NUTRIENTS, V7, P922, DOI 10.3390/nu7020922; Campa D, 2012, INT J CANCER, V131, P803, DOI 10.1002/ijc.26436; Chave KJ, 2003, GENE, V319, P167, DOI 10.1016/S0378-1119(03)00807-2; Cheng Q, 2005, NAT GENET, V37, P878, DOI 10.1038/ng1612; Cheng Q, 2004, PHARMACOGENETICS, V14, P557, DOI 10.1097/01.fpc.0000114761.78957.7e; Cheng Q, 2006, AM J HUM GENET, V79, P264, DOI 10.1086/505645; Cotton AM, 2015, HUM MOL GENET, V24, P1528, DOI 10.1093/hmg/ddu564; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; Galivan J, 2000, PHARMACOL THERAPEUT, V85, P207, DOI 10.1016/S0163-7258(99)00063-7; Hatano Y, 2015, CARCINOGENESIS, V36, P719, DOI 10.1093/carcin/bgv060; Lautner-Csorba O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069843; Masson E, 1996, J CLIN INVEST, V97, P73, DOI 10.1172/JCI118409; Moran RG, 1999, SEMIN ONCOL, V26, P24; Niedzielska E, 2013, ADV CLIN EXP MED, V22, P579; O'Donnell Anne H, 2014, J Cancer Ther, V5, P1311; Reddy KB, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0185-1; Rots MG, 1999, BLOOD, V93, P1677, DOI 10.1182/blood.V93.5.1677.405a16_1677_1683; Subspecialty Group of Hematology Diseases The Society of Pediatrics Chinese Medical Association, 2006, Zhonghua Er Ke Za Zhi, V44, P392; Tu JJ, 2015, INT J BIOCHEM CELL B, V67, P115, DOI 10.1016/j.biocel.2015.05.002; Veeck J, 2010, J MAMMARY GLAND BIOL, V15, P5, DOI 10.1007/s10911-010-9165-1; Wang SM, 2014, CANCER CHEMOTH PHARM, V74, P283, DOI 10.1007/s00280-014-2507-8; Zgheib NK, 2014, PHARMACOGENET GENOM, V24, P387, DOI 10.1097/FPC.0000000000000069	25	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173472	10.1371/journal.pone.0173472	http://dx.doi.org/10.1371/journal.pone.0173472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278270	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900099
J	Liu, T; Liu, Y; Qian, C; Qian, DP				Liu, Tao; Liu, Yi; Qian, Chen; Qian, Depei			IOPA: I/O-aware parallelism adaption for parallel programs	PLOS ONE			English	Article							EFFICIENT	With the development of multi-/many-core processors, applications need to be written as parallel programs to improve execution efficiency. For data-intensive applications that use multiple threads to read/write files simultaneously, an I/O sub-system can easily become a bottleneck when too many of these types of threads exist; on the contrary, too few threads will cause insufficient resource utilization and hurt performance. Therefore, programmers must pay much attention to parallelism control to find the appropriate number of I/O threads for an application. This paper proposes a parallelism control mechanism named IOPA that can adjust the parallelism of applications to adapt to the I/O capability of a system and balance computing resources and I/O bandwidth. The programming interface of IOPA is also provided to programmers to simplify parallel programming. IOPA is evaluated using multiple applications with both solid state and hard disk drives. The results show that the parallel applications using IOPA can achieve higher efficiency than those with a fixed number of threads.	[Liu, Tao; Liu, Yi; Qian, Chen; Qian, Depei] Beihang Univ, Sinogerman Joint Software Inst, Beijing, Peoples R China; [Liu, Yi] State Key Lab Math Engn & Adv Comp, Wuxi, Peoples R China	Beihang University	Liu, T (corresponding author), Beihang Univ, Sinogerman Joint Software Inst, Beijing, Peoples R China.	thomasball@126.com						Allen M. D., 2010, THESIS; Amdahl G.M., 1967, P APR 18 20 1967 SPR, P483, DOI [10.1145/1465482.1465560, DOI 10.1145/1465482.1465560]; Bienia C, 2008, PACT'08: PROCEEDINGS OF THE SEVENTEENTH INTERNATIONAL CONFERENCE ON PARALLEL ARCHITECTURES AND COMPILATION TECHNIQUES, P72, DOI 10.1145/1454115.1454128; Butenhof D.R., 1997, PROGRAMMING POSIX TH; Dagum L, 1998, IEEE COMPUT SCI ENG, V5, P46, DOI 10.1109/99.660313; Ding Y, 2009, J PARALLEL DISTR COM, V69, P790, DOI 10.1016/j.jpdc.2009.04.004; Gupta G, 2012, 4 USENIX WORKSH HOT; Gupta V, 2012, EVALUATING SCALABILI; Haque ME, 2015, ACM SIGPLAN NOTICES, V50, P161, DOI [10.1145/2694344.2694384, 10.1145/2775054.2694384]; Heirman W, 2014, PROCEEDINGS OF THE 4TH INTERNATIONAL WORKSHOP ON RUNTIME AND OPERATING SYSTEMS FOR SUPERCOMPUTERS, ROSS 2014, DOI 10.1145/2612262.2612268; Jones K., 2001, LOGIN MAGAZINE USENI; Lee JH, 2010, CONF PROC INT SYMP C, P270, DOI 10.1145/1816038.1815996; Matthew N., 2011, BEGINNING LINUX PROG; Nicolau A., 2010, INT WORKSH LANG COMP, P166; Raman A, 2011, ACM SIGPLAN NOTICES, V46, P26, DOI 10.1145/1993316.1993502; Reinders J., 2007, INTEL THREADING BUIL; Sridharan S., 2013, INT ACM C SUPERCOMPU, P337; Sridharan S, 2014, ACM SIGPLAN NOTICES, V49, P169, DOI [10.1145/2666356.2594292, 10.1145/2594291.2594292]; Suleman M. Aater, 2008, P 13 INT C ARCH SUPP, V42, P277; Wang YZ, 2012, INT PARALL DISTRIB P, P921, DOI 10.1109/IPDPS.2012.87; Zhang X, 2011, P INT C HIGH PERF CO, P18	21	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173038	10.1371/journal.pone.0173038	http://dx.doi.org/10.1371/journal.pone.0173038			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278236	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900135
J	Tanisawa, K; Taniguchi, H; Sun, XM; Ito, T; Kawakami, R; Sakamoto, S; Higuchi, M				Tanisawa, Kumpei; Taniguchi, Hirokazu; Sun, Xiaomin; Ito, Tomoko; Kawakami, Ryoko; Sakamoto, Shizuo; Higuchi, Mitsuru			Visceral fat area is a strong predictor of leukocyte cell-derived chemotaxin 2, a potential biomarker of dyslipidemia	PLOS ONE			English	Article							5'-AMP-ACTIVATED PROTEIN-KINASE; CARDIORESPIRATORY FITNESS; SUBUNIT EXPRESSION; SELENOPROTEIN-P; ADIPOSE-TISSUE; JAPANESE MEN; EXERCISE; LIVER; RISK; DETERMINANTS	Background Leukocyte cell-derived chemotaxin 2 (LECT2) is a hepatokine linking obesity to skeletal muscle insulin resistance. Although previous studies reported that obesity was associated with high levels of circulating LECT2 in human, the associations of detailed body fat distribution with LECT2 levels have not been examined. Furthermore, although animal study suggested that exercise decreased circulating LECT2 levels, it remains unknown whether physical fitness is associated with LECT2 levels in human. We therefore examined the relationship of plasma LECT2 levels with various adiposity indices and cardiorespiratory fitness (CRF) in middle-aged and elderly Japanese men. Furthermore, we examined the relationship of LECT2 levels with the presence of metabolic syndrome, hypertension, insulin resistance and dyslipidemia to determine the clinical significance of measuring circulating LECT2. Materials and methods This was a cross-sectional study of 143 Japanese men (age: 30-79 years). Participants' plasma LECT2 levels were measured by an enzyme-linked immunosorbent assay. To assess their abdominal fat distributions, visceral fat area (VFA) and subcutaneous fat area (SFA) were measured using magnetic resonance imaging. CRF was assessed by measuring peak oxygen uptake (VO2peak). Results All adiposity indices measured in this study were positively correlated with plasma LECT2 levels, while VO2peak was negatively correlated with LECT2 levels after adjustment for age. The correlations, except for VFA were no longer significant with further adjustment for VFA. Stepwise multiple linear regression analysis revealed that VFA was the strongest predictor of plasma LECT2 levels. Plasma LECT2 levels differed based on the presence of metabolic syndrome and dyslipidemia, but not hypertension and insulin resistance. Logistic regression analyses revealed that plasma LECT2 levels were significantly associated with dyslipidemia independently of VFA; VFA was not significantly associated with dyslipidemia after adjustment for LECT2. Conclusion VFA was the strongest predictor of plasma LECT2 that is a potential biomarker linking visceral obesity to dyslipidemia.	[Tanisawa, Kumpei] Natl Inst Biomed Innovat Hlth & Nutr, Dept Hlth Promot & Exercise, Tokyo, Japan; [Tanisawa, Kumpei] Japan Soc Promot Sci, Tokyo, Japan; [Tanisawa, Kumpei; Kawakami, Ryoko; Sakamoto, Shizuo; Higuchi, Mitsuru] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Tanisawa, Kumpei; Sakamoto, Shizuo; Higuchi, Mitsuru] Waseda Univ, Inst Adv Act Aging Res, Tokorozawa, Saitama, Japan; [Taniguchi, Hirokazu] Ryukoku Univ, Fac Agr, Otsu, Shiga, Japan; [Sun, Xiaomin] Xi An Jiao Tong Univ, Sch Publ Hlth, Xian, Shaanxi, Peoples R China; [Ito, Tomoko] Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Japan	Japan Society for the Promotion of Science; Waseda University; Waseda University; Ryukoku University; Xi'an Jiaotong University; Waseda University	Higuchi, M (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.; Higuchi, M (corresponding author), Waseda Univ, Inst Adv Act Aging Res, Tokorozawa, Saitama, Japan.	mhiguchi@waseda.jp	Kawakami, Ryoko/K-8149-2019	Kawakami, Ryoko/0000-0001-8211-1553; Tanisawa, Kumpei/0000-0002-9334-7104	Ministry of Education, Culture, Sports, Science, and Technology [14J03810, S1511017]; Grants-in-Aid for Scientific Research [16K13056] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided by the Ministry of Education, Culture, Sports, Science, and Technology [http.//www.mext.go.jp/a_menu/shinkou/hoiyo/main5_a5.html]Award #14J03810 to Kumpei Tanisawa; and by the Ministry of Education, Culture, Sports, Science, and Technology [http://www.mext.go.jp/a_menu/shinkou/holyo/main5_a5.html] Award #S1511017 to Mitsuru Higuchi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Clausen JO, 1996, J CLIN INVEST, V98, P1195, DOI 10.1172/JCI118903; Denecke B, 2003, BIOCHEM J, V376, P135, DOI 10.1042/BJ20030676; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Harrell FE, 2001, REGRESSION MODELING; Iroz A, 2015, DIABETOLOGIA, V58, P1699, DOI 10.1007/s00125-015-3634-4; Kasa-Vubu JZ, 2005, J CLIN ENDOCR METAB, V90, P849, DOI 10.1210/jc.2004-0455; Lan F, 2014, DIABETES, V63, P1649, DOI 10.2337/db13-0728; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Matsuzawa Y, 2005, J ATHEROSCLER THROMB, V12, P301, DOI 10.5551/jat.12.301; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Miyamoto L, 2012, J BIOL CHEM, V287, P40441, DOI 10.1074/jbc.M112.384545; Nielsen JN, 2003, J APPL PHYSIOL, V94, P631, DOI 10.1152/japplphysiol.00642.2002; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Okumura A, 2013, BIOSCI TRENDS, V7, P276, DOI 10.5582/bst.2013.v7.6.276; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sawada SS, 2003, DIABETES CARE, V26, P2918, DOI 10.2337/diacare.26.10.2918; Sui X, 2008, DIABETES CARE, V31, P550, DOI 10.2337/dc07-1870; Takekoshi K, 2006, METABOLISM, V55, P1122, DOI 10.1016/j.metabol.2006.04.007; Taniguchi H, 2014, J CLIN ENDOCR METAB, V99, pE1877, DOI 10.1210/jc.2014-1877; Tanisawa K, 2015, J ATHEROSCLER THROMB, V22, P379, DOI 10.5551/jat.25098; Tanisawa K, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0416-4; Tanisawa K, 2014, PHYSIOL GENOMICS, V46, P207, DOI 10.1152/physiolgenomics.00182.2013; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Wong SL, 2004, MED SCI SPORT EXER, V36, P286, DOI 10.1249/01.MSS.0000113665.40775.35; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yi XJ, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/946432	32	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173310	10.1371/journal.pone.0173310	http://dx.doi.org/10.1371/journal.pone.0173310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278265	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900071
J	Yi, JY; Kim, HJ; Chung, MS				Yi, Ji Yoon; Kim, Hui Ju; Chung, Myong-Soo			Manufacture of low-benzo(a)pyrene sesame seed (Sesamum indicum L.) oil using a self-designed apparatus	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; OXIDATIVE STABILITY; VEGETABLE-OILS; CAKE EXTRACT; SOYBEAN OILS; FOOD; PROTEIN; BENZO(A)PYRENE; MUTAGENICITY; PYROLYSIS	The aim of this study was to lower benzo(a) pyrene (BaP) contents in sesame seed oil (SSO) during manufacture by using a self-designed apparatus, to determine its optimal conditions, and to analyze antioxidants in SSO which might be related to BaP content reduction. Washing and spin-drying steps reduce exogenous BaP contamination, and the reduced moisture in seeds lowered BaP content in final SSO. A ventilation system in the roasting step inhibits BaP formation and reabsorption, followed by a controlled compression step. The optimal condition, a single washing cycle with 2-min spin-drying, 1350-rpm ventilation, and a single compression cycle, reduced the BaP content in SSO to 2.93 mu g/kg, where the raw seeds had been spiked with 10-mu g/kg BaP. Total phenolic contents showed a reversal pattern to the distribution of BaP contents. Sesamol and sesamolin were quantified by a high performance liquid chromatography-ultraviolet detector, and it was suggested that sesamol which is a strong antioxidant might have prevented BaP formation during the roasting step. This study enabled the commercial production of low-BaP SSO, and the data could be used in further investigations of the BaP content reduction mechanism with quantitative chemical analysis of the SSO composition.	[Yi, Ji Yoon; Kim, Hui Ju; Chung, Myong-Soo] Ewha Womans Univ, Dept Food Sci & Engn, Seoul, South Korea	Ewha Womans University	Chung, MS (corresponding author), Ewha Womans Univ, Dept Food Sci & Engn, Seoul, South Korea.	mschung@ewha.ac.kr		Yi, Jiyoon/0000-0002-4323-3125	Korean Ministry of Food and Drug Safety [13162MFDS051]	Korean Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This research was supported by a grant (grant number: 13162MFDS051, recipient: MSC) from the Korean Ministry of Food and Drug Safety (http://www.mfds.go.kr/eng) in 2014 and 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouGharbia HA, 1997, J AM OIL CHEM SOC, V74, P215, DOI 10.1007/s11746-997-0126-9; Anilakumar Kandangath Raghavan, 2010, Agriculturae Conspectus Scientificus, V75, P159; [Anonymous], 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.724; Bouaid A, 2007, FUEL, V86, P2596, DOI 10.1016/j.fuel.2007.02.014; Camargo MCR, 2003, FOOD CONTROL, V14, P49, DOI 10.1016/S0956-7135(02)00052-X; Chen BH, 2001, J AGR FOOD CHEM, V49, P5238, DOI 10.1021/jf0106906; Cheng WW, 2015, J AM OIL CHEM SOC, V92, P1725, DOI 10.1007/s11746-015-2734-0; Chung SY, 2011, FOOD CHEM, V129, P1420, DOI 10.1016/j.foodchem.2011.05.092; Dabrowska D, 2008, POL J ENVIRON STUD, V17, P17; Elleuch M, 2007, FOOD CHEM, V103, P641, DOI 10.1016/j.foodchem.2006.09.008; European Commission, 2006, OFFICIAL J EUROPEA L, V364, P5; FUKUDA Y, 1986, AGR BIOL CHEM TOKYO, V50, P857, DOI 10.1080/00021369.1986.10867500; Gfrerer M, 2003, J SEP SCI, V26, P1230, DOI 10.1002/jssc.200301422; Grougnet R, 2012, J AGR FOOD CHEM, V60, P108, DOI 10.1021/jf2040687; Guillen M. D., 1997, Reviews on Environmental Health, V12, P133; HOPIA A, 1986, J AM OIL CHEM SOC, V63, P889, DOI 10.1007/BF02540921; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P9; Janoszka B, 2004, ACTA CHROMATOGR, V14, P115; JOHNSON LA, 1979, J AM OIL CHEM SOC, V56, P463, DOI 10.1007/BF02671542; Kaur IP, 2000, MUTAT RES-GEN TOX EN, V470, P71, DOI 10.1016/S1383-5718(00)00096-6; Kazerouni N, 2001, FOOD CHEM TOXICOL, V39, P423, DOI 10.1016/S0278-6915(00)00158-7; KIKUGAWA K, 1983, J AM OIL CHEM SOC, V60, P1528, DOI 10.1007/BF02666577; LARSSON BK, 1987, J AM OIL CHEM SOC, V64, P365, DOI 10.1007/BF02549296; Lee JY, 2006, J FOOD SCI, V71, pC430, DOI 10.1111/j.1750-3841.2006.00137.x; Lee SW, 2010, FOOD CHEM, V118, P681, DOI 10.1016/j.foodchem.2009.05.040; McGrath TE, 2003, J ANAL APPL PYROL, V66, P51, DOI 10.1016/S0165-2370(02)00105-5; Ministry Of Food And Drug Safety, 2009, STAND SPEC EACH FOOD; Ministry Of Food And Drug Safety, 2009, COMM STAND SPEC GEN; Ministry Of Food And Drug Safety, 2009, SAMPL HANDL METH; Mohdaly AAA, 2011, IND CROP PROD, V34, P952, DOI 10.1016/j.indcrop.2011.02.018; Moret S, 2000, J CHROMATOGR A, V882, P245, DOI 10.1016/S0021-9673(00)00079-0; NAMIKI M, 1995, FOOD REV INT, V11, P281, DOI 10.1080/87559129509541043; NAMIKI M, 1990, CRIT REV FOOD SCI, V29, P273, DOI 10.1080/10408399009527528; National Toxicology Program, 2014, 13 REP CARC; NISBET ICT, 1992, REGUL TOXICOL PHARM, V16, P290, DOI 10.1016/0273-2300(92)90009-X; Orruno E, 2007, FOOD CHEM, V100, P926, DOI 10.1016/j.foodchem.2005.10.051; PEREZ G, 1986, CHEMOSPHERE, V15, P589, DOI 10.1016/0045-6535(86)90006-8; Rey-Salgueiro L, 2008, FOOD CHEM, V108, P607, DOI 10.1016/j.foodchem.2007.11.026; Camargo MCR, 2012, FOOD CHEM, V135, P937, DOI 10.1016/j.foodchem.2012.06.031; Saydut A, 2008, BIORESOURCE TECHNOL, V99, P6656, DOI 10.1016/j.biortech.2007.11.063; Sharma RK, 2006, J ANAL APPL PYROL, V75, P69, DOI 10.1016/j.jaap.2005.03.010; Shin BR, 2015, FOOD SCI BIOTECHNOL, V24, P2017, DOI 10.1007/s10068-015-0266-x; SLINKARD K, 1977, AM J ENOL VITICULT, V28, P49; Suja KP, 2005, FOOD CHEM, V91, P213, DOI 10.1016/j.foodchem.2003.09.001; Tan CP, 2002, FOOD CHEM, V76, P385, DOI 10.1016/S0308-8146(01)00272-2; Teixeira VH, 2007, FOOD CHEM, V104, P106, DOI 10.1016/j.foodchem.2006.11.007; Wu PF, 1998, MUTAT RES-FUND MOL M, V403, P29, DOI 10.1016/S0027-5107(98)00015-3; Yeo J, 2011, EUR J LIPID SCI TECH, V113, P910, DOI 10.1002/ejlt.201000553	48	3	3	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173585	10.1371/journal.pone.0173585	http://dx.doi.org/10.1371/journal.pone.0173585			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278179	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900014
J	Cardenas-Monroy, CA; Pohlmann, T; Pinon-Zarate, G; Matus-Ortega, G; Guerra, G; Feldbrugge, M; Pardo, JP				Cardenas-Monroy, Christian A.; Pohlmann, Thomas; Pinon-Zarate, Gabriela; Matus-Ortega, Genaro; Guerra, Guadalupe; Feldbruegge, Michael; Pardo, Juan Pablo			The mitochondrial alternative oxidase Aox1 is needed to cope with respiratory stress but dispensable for pathogenic development in Ustilago maydis	PLOS ONE			English	Article							CYANIDE-RESISTANT RESPIRATION; PLANT-MITOCHONDRIA; NEUROSPORA-CRASSA; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; MAGNAPORTHE-GRISEA; ELECTRON-TRANSPORT; CANDIDA-ALBICANS; IMMUNOLOGICAL IDENTIFICATION; ASPERGILLUS-FUMIGATUS	The mitochondrial alternative oxidase is an important enzyme that allows respiratory activity and the functioning of the Krebs cycle upon disturbance of the respiration chain. It works as a security valve in transferring excessive electrons to oxygen, thereby preventing potential damage by the generation of harmful radicals. A clear biological function, besides the stress response, has so far convincingly only been shown for plants that use the alternative oxidase to generate heat to distribute volatiles. In fungi it was described that the alternative oxidase is needed for pathogenicity. Here, we investigate expression and function of the alternative oxidase at different stages of the life cycle of the corn pathogen Ustilago maydis (Aox1). Interestingly, expression of Aox1 is specifically induced during the stationary phase suggesting a role at high cell density when nutrients become limiting. Studying deletion strains as well as overexpressing strains revealed that Aox1 is dispensable for normal growth, for cell morphology, for response to temperature stress as well as for filamentous growth and plant pathogenicity. However, during conditions eliciting respiratory stress yeast-like growth as well as hyphal growth is strongly affected. We conclude that Aox1 is dispensable for the normal biology of the fungus but specifically needed to cope with respiratory stress.	[Cardenas-Monroy, Christian A.; Matus-Ortega, Genaro; Pardo, Juan Pablo] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City, DF, Mexico; [Pohlmann, Thomas; Feldbruegge, Michael] Heinrich Heine Univ Dusseldorf, Dept Biol, Cluster Excellence Plant Sci, Inst Microbiol, Dusseldorf, Germany; [Pinon-Zarate, Gabriela] Univ Nacl Autonoma Mexico, Fac Med, Dept Biol Celular & Tisular, Mexico City, DF, Mexico; [Guerra, Guadalupe] Inst Politecn Nacl, Dept Microbiol, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Heinrich Heine University Dusseldorf; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico	Pardo, JP (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City, DF, Mexico.	pardov@bq.unam.mx	Piñon-Zarate, Gabriela/G-7645-2019; Feldbrügge, Michael/AAS-3939-2021	Piñon-Zarate, Gabriela/0000-0002-3080-9703; Feldbrügge, Michael/0000-0003-0046-983X; Matus, Genaro/0000-0002-4428-7299; Cardenas Monroy, Christian Adrian/0000-0002-3768-1618	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [PAPIIT IN209614]; Universidad Nacional Autonoma de Mexico (UNAM); Consejo Nacional de Ciencia y Tecnologia [CONACyT 254904]; CONACyT, Mexico [218133]; Secretaria de Investigacion y Posgrado [SIP 20150761]; Institute Politecnico Nacional (IPN); DFG/CONACyT [FOR1334]	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Investigacion y Posgrado; Institute Politecnico Nacional (IPN); DFG/CONACyT	Juan Pablo Pardo received a grant from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT IN209614), Universidad Nacional Autonoma de Mexico (UNAM) and Consejo Nacional de Ciencia y Tecnologia (CONACyT 254904). Christian A. Cardenas-Monroy received a doctoral fellowship grant from CONACyT, 218133, Mexico. Guadalupe Guerra received a grant from Secretaria de Investigacion y Posgrado (SIP 20150761), Institute Politecnico Nacional (IPN). Christian A. Cardenas-Monroy received a doctoral fellowship grant from CONACyT, Mexico. Research in the laboratory of M FeldbrUgge was supported by DFG/CONACyT FOR1334.	Affourtit C, 2002, FEBS LETT, V510, P121, DOI 10.1016/S0014-5793(01)03261-6; Akhter S, 2003, INFECT IMMUN, V71, P5794, DOI 10.1128/IAI.71.10.5794-5802.2003; Albury MS, 2009, PHYSIOL PLANTARUM, V137, P316, DOI 10.1111/j.1399-3054.2009.01270.x; Andronis EA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00132; Avila-Adame C, 2003, PEST MANAG SCI, V59, P303, DOI 10.1002/ps.638; Avila-Adame C, 2002, MOL PLANT MICROBE IN, V15, P493, DOI 10.1094/MPMI.2002.15.5.493; Baumann S, 2014, EMBO REP, V15, P94, DOI 10.1002/embr.201338037; Biriukova E N, 2008, Mikrobiologiia, V77, P448; Brachmann A, 2001, MOL MICROBIOL, V42, P1047, DOI 10.1046/j.1365-2958.2001.02699.x; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Brefort T, 2009, ANNU REV PHYTOPATHOL, V47, P423, DOI 10.1146/annurev-phyto-080508-081923; Cabrera-Orefice A, 2014, BIOCHIMIE, V102, P124, DOI 10.1016/j.biochi.2014.03.003; Capece A, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow015; Castro-Guerrero NA, 2004, J BIOENERG BIOMEMBR, V36, P459, DOI 10.1023/B:JOBB.0000047328.82733.ef; Chaudhuri M, 2005, PARASITOL RES, V96, P178, DOI 10.1007/s00436-005-1337-3; Chaudhuri M, 2006, TRENDS PARASITOL, V22, P484, DOI 10.1016/j.pt.2006.08.007; Clifton R, 2005, PLANT MOL BIOL, V58, P193, DOI 10.1007/s11103-005-5514-7; Costa JH, 2007, J PLANT PHYSIOL, V164, P718, DOI 10.1016/j.jplph.2006.04.001; Dahal K, 2016, NEW PHYTOL; DAY DA, 1994, PLANT PHYSIOL, V106, P1421, DOI 10.1104/pp.106.4.1421; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dejean L, 2000, BBA-BIOENERGETICS, V1457, P45, DOI 10.1016/S0005-2728(00)00053-0; Djamei A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002955; Dojcinovic D, 2005, PLANT MOL BIOL, V58, P159, DOI 10.1007/s11103-005-5390-1; EDWARDS DL, 1974, J BIOL CHEM, V249, P3551; ELTHON TE, 1989, PLANT PHYSIOL, V89, P1311, DOI 10.1104/pp.89.4.1311; Feldbrugge M, 2004, CURR OPIN MICROBIOL, V7, P666, DOI 10.1016/j.mib.2004.10.006; Fujita K, 2002, J APPL MICROBIOL, V92, P1035, DOI 10.1046/j.1365-2672.2002.01614.x; Fujita K, 2002, INT J FOOD MICROBIOL, V79, P193, DOI 10.1016/S0168-1605(02)00108-3; GEORGOPOULOS SG, 1970, J BACTERIOL, V103, P745, DOI 10.1128/JB.103.3.745-750.1970; Grahl N, 2012, MOL MICROBIOL, V84, P383, DOI 10.1111/j.1365-2958.2012.08034.x; Guerrero-Castillo S, 2012, BBA-BIOENERGETICS, V1817, P353, DOI 10.1016/j.bbabio.2011.11.007; Hans L., 1982, PHYSIOL PLANTARUM, V55, P478; Hernandez O, 2011, YEAST, V28, P771, DOI 10.1002/yea.1902; Ruiz OH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001353; Holliday R., 1974, HDB GENETICS, P575, DOI 10.1007/978-1-4899-1710-2_31; Honda Y, 2012, J BIOSCI BIOENG, V113, P338, DOI 10.1016/j.jbiosc.2011.10.026; Huh WK, 2001, BIOCHEM J, V356, P595, DOI 10.1042/0264-6021:3560595; Jarmuszkiewicz W, 1997, FEBS LETT, V411, P110, DOI 10.1016/S0014-5793(97)00676-5; Jarmuszkiewicz W, 2005, BBA-BIOENERGETICS, V1708, P71, DOI 10.1016/j.bbabio.2005.01.003; Johnson CH, 2003, YEAST, V20, P381, DOI 10.1002/yea.968; Joseph-Horne T, 2001, BBA-BIOENERGETICS, V1504, P179, DOI 10.1016/S0005-2728(00)00251-6; Juarez O, 2004, BBA-BIOENERGETICS, V1658, P244, DOI 10.1016/j.bbabio.2004.06.005; Juarez O, 2006, FEBS J, V273, P4603, DOI 10.1111/j.1742-4658.2006.05463.x; Kaffarnik F, 2003, EMBO J, V22, P5817, DOI 10.1093/emboj/cdg554; Kahmann R, 2004, NEW PHYTOL, V164, P31, DOI 10.1111/j.1469-8137.2004.01156.x; Kern A, 2007, MICROBIOL-SGM, V153, P1250, DOI 10.1099/mic.0.2006/001404-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBOWITZ AM, 1989, MOL CELL BIOL, V9, P1362, DOI 10.1128/MCB.9.3.1362; LAURIERE M, 1993, ANAL BIOCHEM, V212, P206, DOI 10.1006/abio.1993.1313; Leuthner B, 2005, MOL GENET GENOMICS, V272, P639, DOI 10.1007/s00438-004-1085-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magnani T, 2007, FEMS MICROBIOL LETT, V271, P230, DOI 10.1111/j.1574-6968.2007.00716.x; Martins VP, 2011, EUKARYOT CELL, V10, P237, DOI 10.1128/EC.00194-10; McDonald AE, 2009, J EXP BIOL, V212, P2627, DOI 10.1242/jeb.032151; MCINTOSH L, 1994, PLANT PHYSIOL, V105, P781, DOI 10.1104/pp.105.3.781; MICHEAHAMZEHPOUR M, 1987, EXPERIENTIA, V43, P439, DOI 10.1007/BF01940445; MILLAR AH, 1993, FEBS LETT, V329, P259, DOI 10.1016/0014-5793(93)80233-K; MINAGAWA N, 1992, FEBS LETT, V302, P217, DOI 10.1016/0014-5793(92)80444-L; MOORE AL, 1980, TRENDS BIOCHEM SCI, V5, P284, DOI 10.1016/0968-0004(80)90160-7; MOORE AL, 1992, BIOCHEM SOC T, V20, P361, DOI 10.1042/bst0200361; MOORE AL, 1991, BIOCHIM BIOPHYS ACTA, V1059, P121, DOI 10.1016/S0005-2728(05)80197-5; Moore AL, 2008, BIOCHEM SOC T, V36, P1022, DOI 10.1042/BST0361022; Moore AL, 2013, ANNU REV PLANT BIOL, V64, P637, DOI 10.1146/annurev-arplant-042811-105432; Nargang FE, 2012, G3-GENES GENOM GENET, V2, P1345, DOI 10.1534/g3.112.004218; Nihei C, 2002, BBA-MOL BASIS DIS, V1587, P234, DOI 10.1016/S0925-4439(02)00086-8; PENA A, 1969, BIOCHIM BIOPHYS ACTA, V180, P1, DOI 10.1016/0005-2728(69)90187-X; Pinon-Zarate G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/158980; Pohlmann T, 2015, ELIFE, V4, DOI 10.7554/eLife.06041; Rogov AG, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1615, DOI 10.1134/S0006297914130112; Ruy F, 2006, J BIOENERG BIOMEMBR, V38, P129, DOI 10.1007/s10863-006-9012-7; Saavedra E, 2008, FEMS YEAST RES, V8, P1313, DOI 10.1111/j.1567-1364.2008.00437.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schirawski J, 2010, SCIENCE, V330, P1546, DOI 10.1126/science.1195330; SHERALD JL, 1970, PLANT PHYSIOL, V46, P180, DOI 10.1104/pp.46.1.180; Shiba T, 2013, P NATL ACAD SCI USA, V110, P4580, DOI 10.1073/pnas.1218386110; Sierra-Campos E, 2009, MICROBIOL-SGM, V155, P604, DOI 10.1099/mic.0.020800-0; Sierra-Campos E, 2009, MITOCHONDRION, V9, P96, DOI 10.1016/j.mito.2009.01.003; Skirycz A, 2010, PLANT PHYSIOL, V152, P226, DOI 10.1104/pp.109.148965; Smith CA, 2009, PHYSIOL PLANTARUM, V137, P459, DOI 10.1111/j.1399-3054.2009.01305.x; Spellig T, 1996, MOL GEN GENET, V252, P503, DOI 10.1007/BF02172396; Terfruchte M, 2014, FUNGAL GENET BIOL, V62, P1, DOI 10.1016/j.fgb.2013.10.012; VANLERBERGHE GC, 1992, PLANT PHYSIOL, V100, P115, DOI 10.1104/pp.100.1.115; Veiga A, 2000, FEMS MICROBIOL LETT, V190, P93, DOI 10.1111/j.1574-6968.2000.tb09268.x; Veiga A, 2003, J APPL MICROBIOL, V95, P364, DOI 10.1046/j.1365-2672.2003.01992.x; Veiga A, 2003, FEMS YEAST RES, V3, P239, DOI 10.1016/S1567-1356(03)00036-9; Walker R, 2005, MOL BIOCHEM PARASIT, V139, P153, DOI 10.1016/j.molbiopara.2004.11.003; Wang J, 2011, PHYSIOL PLANTARUM, V142, P339, DOI 10.1111/j.1399-3054.2011.01471.x; Xiao M, 2010, Z NATURFORSCH C, V65, P463; Xu T, 2012, J MICROBIOL, V50, P594, DOI 10.1007/s12275-012-2015-7; Yan L, 2009, J ANTIMICROB CHEMOTH, V64, P764, DOI 10.1093/jac/dkp273; Yukioka H, 1998, BBA-GENE STRUCT EXPR, V1442, P161, DOI 10.1016/S0167-4781(98)00159-6; Zhou G., 2015, SHOCK VIB, V2015, P1, DOI DOI 10.1007/S11274-015-1877-3; Zhu Y, 2011, J INTEGR PLANT BIOL, V53, P7, DOI 10.1111/j.1744-7909.2010.01004.x	94	22	23	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173389	10.1371/journal.pone.0173389	http://dx.doi.org/10.1371/journal.pone.0173389			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273139	Green Submitted, Green Published, gold			2022-12-27	WOS:000396073700001
J	Eppler, FJ; Quast, T; Kolanus, W				Eppler, Felix J.; Quast, Thomas; Kolanus, Waldemar			Dynamin2 controls Rap1 activation and integrin clustering in human T lymphocyte adhesion	PLOS ONE			English	Article							CELL-MIGRATION; 2-DEPENDENT ENDOCYTOSIS; CR3-DEPENDENT ADHESION; IMMUNOLOGICAL SYNAPSE; RAP1-INDUCED ADHESION; ACTIN CYTOSKELETON; LEUKOCYTE ADHESION; EFFECTOR RIAM; SMALL GTPASE; RECEPTOR	Leukocyte trafficking is crucial to facilitate efficient immune responses. Here, we report that the large GTPase dynamin2, which is generally considered to have a key role in endocytosis and membrane remodeling, is an essential regulator of integrin-dependent human T lymphocyte adhesion and migration. Chemical inhibition or knockdown of dynamin2 expression significantly reduced integrin-dependent T cell adhesion in vitro. This phenotype was not observed when T cells were treated with various chemical inhibitors which abrogate endocytosis or actin polymerization. We furthermore detected dynamin2 in signaling complexes and propose that it controls T cell adhesion via FAK/Pyk2-and RapGEF1-mediated Rap1 activation. In addition, the dynamin2 inhibitor-induced reduction of lymphocyte adhesion can be rescued by Rap1a overexpression. We demonstrate that the dynamin2 effect on T cell adhesion does not involve integrin affinity regulation but instead relies on its ability to modulate integrin valency. Taken together, we suggest a previously unidentified role of dynamin2 in the regulation of integrin-mediated lymphocyte adhesion via a Rap1 signaling pathway.	[Eppler, Felix J.; Quast, Thomas; Kolanus, Waldemar] Univ Bonn, LIMES, Life & Med Sci Inst, Div Mol Immunol & Cell Biol, Bonn, Germany	University of Bonn	Kolanus, W (corresponding author), Univ Bonn, LIMES, Life & Med Sci Inst, Div Mol Immunol & Cell Biol, Bonn, Germany.	wkolanus@uni-bonn.de			DFG Collaborative Research Centers [SFB 645, SFB 704]	DFG Collaborative Research Centers	This work was funded by the DFG Collaborative Research Centers SFB 645 (to TQ and WK) and SFB 704 (to WK). FJE was a scholar of the NRW Graduate School LIMES Chemical Biology. WK is a member of the DFG Cluster of Excellence ImmunoSensation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon R, 2012, CURR OPIN CELL BIOL, V24, P670, DOI 10.1016/j.ceb.2012.06.001; ANDREW D, 1993, EUR J IMMUNOL, V23, P2217, DOI 10.1002/eji.1830230925; Arnaout M Amin, 2016, F1000Res, V5; Bazzoni G, 1998, TRENDS BIOCHEM SCI, V23, P30, DOI 10.1016/S0968-0004(97)01141-9; Beals CR, 2001, J IMMUNOL, V167, P6113, DOI 10.4049/jimmunol.167.11.6113; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bruzzaniti A, 2005, MOL BIOL CELL, V16, P3301, DOI 10.1091/mbc.e04-12-1117; Bruzzaniti A, 2009, MOL CELL BIOL, V29, P3644, DOI 10.1128/MCB.00851-08; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; Chapman NM, 2014, IMMUNOL RES, V59, P23, DOI 10.1007/s12026-014-8527-y; Chu H, 2008, J IMMUNOL, V181, P3373, DOI 10.4049/jimmunol.181.5.3373; Chung KJ, 2014, MOL BIOL CELL, V25, P2948, DOI 10.1091/mbc.E14-04-0867; de Bruyn KMT, 2002, J BIOL CHEM, V277, P29468, DOI 10.1074/jbc.M204990200; Destaing O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077956; DRANSFIELD I, 1992, J CELL BIOL, V116, P1527, DOI 10.1083/jcb.116.6.1527; Duchniewicz M, 2006, MOL CELL BIOL, V26, P643, DOI 10.1128/MCB.26.2.643-653.2006; Durand CA, 2006, EUR J IMMUNOL, V36, P2235, DOI 10.1002/eji.200535004; Ebisuno Y, 2010, BLOOD, V115, P804, DOI 10.1182/blood-2009-03-211979; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Gahmberg CG, 2009, BBA-GEN SUBJECTS, V1790, P431, DOI 10.1016/j.bbagen.2009.03.007; Ginsberg MH, 2014, BMB REP, V47, P655, DOI 10.5483/BMBRep.2014.47.12.241; Glodek AM, 2007, LEUKEMIA, V21, P1723, DOI 10.1038/sj.leu.2404769; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Ichiba T, 1997, J BIOL CHEM, V272, P22215, DOI 10.1074/jbc.272.35.22215; Ichiba T, 1999, J BIOL CHEM, V274, P14376, DOI 10.1074/jbc.274.20.14376; Iwamoto DV, 2015, CURR OPIN CELL BIOL, V36, P41, DOI 10.1016/j.ceb.2015.06.009; Jacobelli J, 2009, J IMMUNOL, V182, P2041, DOI 10.4049/jimmunol.0803267; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2004, J BIOL CHEM, V279, P11875, DOI 10.1074/jbc.M310717200; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2005, IMMUNOLOGY, V116, P164, DOI 10.1111/j.1365-2567.2005.02214.x; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Klapproth S, 2015, BLOOD, V126, P2704, DOI 10.1182/blood-2015-05-647453; Kliche S, 2012, BLOOD, V119, P777, DOI 10.1182/blood-2011-06-362269; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lagarrigue F, 2016, BLOOD, V128, P479, DOI 10.1182/blood-2015-12-638700; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Lee MY, 2014, DEVELOPMENT, V141, P1465, DOI 10.1242/dev.104539; Lefort CT, 2012, BLOOD, V119, P4275, DOI 10.1182/blood-2011-08-373118; Lek HS, 2013, J BIOL CHEM, V288, P14698, DOI 10.1074/jbc.M112.430918; Ley K, 2016, NAT REV DRUG DISCOV, V15, P173, DOI 10.1038/nrd.2015.10; Li Y, 2007, CHANNELS, V1; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Nolz JC, 2008, J CELL BIOL, V182, P1231, DOI 10.1083/jcb.200801121; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Quast T, 2011, BLOOD, V118, P1818, DOI 10.1182/blood-2010-12-326595; Raab M, 2010, IMMUNITY, V32, P541, DOI 10.1016/j.immuni.2010.03.007; Radha V, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-31; Razidlo GL, 2013, DEV CELL, V24, P573, DOI 10.1016/j.devcel.2013.02.010; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Robertson MJ, 2014, NAT PROTOC, V9, P851, DOI 10.1038/nprot.2014.046; ROBINSON MK, 1992, J IMMUNOL, V148, P1080; Rognoni E, 2016, J CELL SCI, V129, P17, DOI 10.1242/jcs.161190; Rufanova VA, 2009, J CELL PHYSIOL, V219, P45, DOI 10.1002/jcp.21649; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Stritt S, 2015, BLOOD, V125, P219, DOI 10.1182/blood-2014-08-597542; Su WJ, 2015, BLOOD, V126, P2695, DOI 10.1182/blood-2015-05-644104; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanaka M, 2016, INT J RHEUMATOL, V2016, DOI 10.1155/2016/8938916; te Boekhorst V, 2016, ANNU REV CELL DEV BI, V32, P491, DOI 10.1146/annurev-cellbio-111315-125201; Thompson HM, 2002, CURR BIOL, V12, P2111, DOI 10.1016/S0960-9822(02)01390-8; Tohyama Y, 2003, MOL BIOL CELL, V14, P2570, DOI 10.1091/mbc.E02-09-0615; Van Kolen K, 2006, CELL SIGNAL, V18, P1169, DOI 10.1016/j.cellsig.2005.09.005; Wang Y, 2011, MOL BIOL CELL, V22, P1529, DOI 10.1091/mbc.E10-09-0785; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Willinger T, 2015, P NATL ACAD SCI USA, V112, P4423, DOI 10.1073/pnas.1504279112; Willinger T, 2014, J EXP MED, V211, P685, DOI 10.1084/jem.20131343; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037	88	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172443	10.1371/journal.pone.0172443	http://dx.doi.org/10.1371/journal.pone.0172443			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273099	gold, Green Published, Green Submitted			2022-12-27	WOS:000396073700074
J	Makau, JN; Watanabe, K; Ishikawa, T; Mizuta, S; Hamada, T; Kobayashi, N; Nishida, N				Makau, Juliann Nzembi; Watanabe, Ken; Ishikawa, Takeshi; Mizuta, Satoshi; Hamada, Tsuyoshi; Kobayashi, Nobuyuki; Nishida, Noriyuki			Identification of small molecule inhibitors for influenza a virus using in silico and in vitro approaches	PLOS ONE			English	Article							STRUCTURE-BASED DISCOVERY; H1N1 2009 VIRUS; DRUG DISCOVERY; NEURAMINIDASE INHIBITORS; SEQUENCE CONSERVATION; ANTIINFLUENZA VIRUS; MUTATIONAL ANALYSIS; H5N1 NUCLEOPROTEIN; STRUCTURAL BASIS; AMINO-ACIDS	Influenza viruses have acquired resistance to approved neuraminidase-targeting drugs, increasing the need for new drug targets for the development of novel anti-influenza drugs. Nucleoprotein (NP) is an attractive target since it has an indispensable role in virus replication and its amino acid sequence is well conserved. In this study, we aimed to identify new inhibitors of the NP using a structure-based drug discovery algorithm, named Nagasaki University Docking Engine (NUDE), which has been established especially for the Destination for GPU Intensive Machine (DEGIMA) supercomputer. The hit compounds that showed high binding scores during in silico screening were subsequently evaluated for anti-influenza virus effects using a cell-based assay. A 4-hydroxyquinolinone compound, designated as NUD-1, was found to inhibit the replication of influenza virus in cultured cells. Analysis of binding between NUD-1 and NP using surface plasmon resonance assay and fragment molecular orbital calculations confirmed that NUD-1 binds to NP and could interfere with NP-NP interactions essential for virus replication. Time-of-addition experiments showed that the compound inhibited the mid-stage of infection, corresponding to assembly of the NP and other viral proteins. Moreover, NUD-1 was also effective against various types of influenza A viruses including a clinical isolate of A(H1N1)pdm09 influenza with a 50% inhibitory concentration range of 1.8-2.1 mu M. Our data demonstrate that the combined use of NUDE system followed by the cell-based assay is useful to obtain lead compounds for the development of novel anti-influenza drugs.	[Makau, Juliann Nzembi; Watanabe, Ken; Ishikawa, Takeshi; Mizuta, Satoshi; Kobayashi, Nobuyuki; Nishida, Noriyuki] Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki, Japan; [Makau, Juliann Nzembi] Nagasaki Univ, Leading Program, Grad Sch Biomed Sci, Nagasaki, Japan; [Hamada, Tsuyoshi] Nagasaki Univ, Nagasaki Adv Comp Ctr, Bunkyo Machi, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Watanabe, K (corresponding author), Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki, Japan.	kenw@nagasaki-u.ac.jp	Ishikawa, Takeshi/AAH-5802-2019	Mizuta, Satoshi/0000-0002-9023-7671; WATANABE, Ken/0000-0002-2592-3472; Ishikawa, Takeshi/0000-0002-3187-1381	Takeda Science Foundation; JSPS Next Generation World-Leading Researchers (NEXT Program) [GR082]; JSPS KAKENHI [25460125, 16K00853]; Nagasaki University Leading Program for Nurturing Global Leaders in Tropical and Emerging Communicable Diseases - Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [16K00853] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); JSPS Next Generation World-Leading Researchers (NEXT Program); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nagasaki University Leading Program for Nurturing Global Leaders in Tropical and Emerging Communicable Diseases - Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Takeda Science Foundation (NN), a grant from JSPS Next Generation World-Leading Researchers (NEXT Program), Grant Number GR082 (TH), and a grant from JSPS KAKENHI, Grant Numbers 25460125 and 16K00853 (KW). JNM was supported by the Nagasaki University Leading Program for Nurturing Global Leaders in Tropical and Emerging Communicable Diseases, funded by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, analysis, the decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; Armstrong AJ, 2013, CLIN CANCER RES, V19, P6891, DOI 10.1158/1078-0432.CCR-13-1581; Avilov S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149986; Babar MM, 2015, INFECT GENET EVOL, V34, P200, DOI 10.1016/j.meegid.2015.06.030; Bengtsson AA, 2012, ARTHRITIS RHEUM-US, V64, P1579, DOI 10.1002/art.33493; Butler J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004065; Chan WH, 2010, J VIROL, V84, P7337, DOI 10.1128/JVI.02474-09; Charyasriwong S, 2016, DRUG DISCOV THER, V10, P201, DOI 10.5582/ddt.2016.01045; Charyasriwong S, 2015, ARCH MED RES, V46, P8, DOI 10.1016/j.arcmed.2014.12.002; Cheng HM, 2012, J MED CHEM, V55, P2144, DOI 10.1021/jm2013503; Cohen NC, 2007, CHEM BIOL DRUG DES, V70, P557, DOI 10.1111/j.1747-0285.2007.00599.x; Collins PJ, 2009, VACCINE, V27, P6317, DOI 10.1016/j.vaccine.2009.07.017; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Fukuoka M, 2012, BBA-GEN SUBJECTS, V1820, P90, DOI 10.1016/j.bbagen.2011.11.003; Garcia J, 2009, INFLUENZA OTHER RESP, V3, P69, DOI 10.1111/j.1750-2659.2009.00072.x; Gerritz SW, 2011, P NATL ACAD SCI USA, V108, P15366, DOI 10.1073/pnas.1107906108; Gibbs N, 2001, PROTEINS, V43, P186, DOI 10.1002/1097-0134(20010501)43:2<186::AID-PROT1030>3.0.CO;2-L; Hagiwara K, 2010, BIOCHEM BIOPH RES CO, V394, P721, DOI 10.1016/j.bbrc.2010.03.058; Haruyama T, 2013, J NAT MED-TOKYO, V67, P636, DOI 10.1007/s11418-012-0725-0; HATADA E, 1989, J BIOCHEM-TOKYO, V105, P537, DOI 10.1093/oxfordjournals.jbchem.a122702; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hurt AC, 2011, NEW ENGL J MED, V365, P2541, DOI 10.1056/NEJMc1111078; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Inoue M, 2010, EMERG INFECT DIS, V16, P1633, DOI 10.3201/eid1610.100688; Ishibashi D, 2016, EBIOMEDICINE, V9, P238, DOI 10.1016/j.ebiom.2016.06.010; Ishii K, 2008, DRUG DISCOV THER, V2, P24; Ishikawa T, 2009, CHEM PHYS LETT, V474, P195, DOI 10.1016/j.cplett.2009.04.045; Ishikawa T, 2009, J COMPUT CHEM, V30, P2594, DOI 10.1002/jcc.21265; Kakisaka M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005062; Kaldor SW, 1997, J MED CHEM, V40, P3979, DOI 10.1021/jm9704098; Kao RY, 2010, NAT BIOTECHNOL, V28, P600, DOI 10.1038/nbt.1638; Kawakami E, 2011, J VIROL METHODS, V173, P1, DOI 10.1016/j.jviromet.2010.12.014; Kitaura K, 1999, CHEM PHYS LETT, V312, P319, DOI 10.1016/S0009-2614(99)00937-9; Kukol A, 2014, VIROLOGY, V454, P40, DOI 10.1016/j.virol.2014.01.023; Labaronne A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090247; Lackenby A, 2008, Euro Surveill, V13; Lejal N, 2013, ANTIMICROB AGENTS CH, V57, P2231, DOI 10.1128/AAC.02335-12; Li Z, 2009, J VIROL, V83, P4153, DOI 10.1128/JVI.02642-08; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Makau JN, 2013, DRUG DISCOV THER, V7, P189, DOI 10.5582/ddt.2013.v7.5.189; Marella A, 2013, SAUDI PHARM J, V21, P1, DOI 10.1016/j.jsps.2012.03.002; McCauley J, 1999, CURR BIOL, V9, pR796, DOI 10.1016/S0960-9822(99)80491-6; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Mena I, 1999, J VIROL, V73, P1186, DOI 10.1128/JVI.73.2.1186-1194.1999; Mondal A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004826; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Ng AKL, 2012, J VIROL, V86, P6758, DOI 10.1128/JVI.00073-12; Njoroge FG, 2008, ACCOUNTS CHEM RES, V41, P50, DOI 10.1021/ar700109k; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Polman C, 2005, NEUROLOGY, V64, P987, DOI 10.1212/01.WNL.0000154520.48391.69; REED L. J., 1938, AMER JOUR HYG, V27, P493; Robb NC, 2009, J GEN VIROL, V90, P1398, DOI 10.1099/vir.0.009639-0; Saito R, 2003, J CLIN MICROBIOL, V41, P2164, DOI 10.1128/JCM.41.5.2164-2165.2003; Seibert CW, 2010, J VIROL, V84, P11219, DOI 10.1128/JVI.01424-10; Shen YF, 2011, P NATL ACAD SCI USA, V108, P16515, DOI 10.1073/pnas.1113107108; Storms AD, 2012, EMERG INFECT DIS, V18, P308, DOI 10.3201/eid1802.111466; Sugaya N, 2007, CLIN INFECT DIS, V44, P197, DOI 10.1086/509925; Takashita E, 2015, ANTIMICROB AGENTS CH, V59, P2607, DOI 10.1128/AAC.04836-14; Takashita E, 2015, ANTIVIR RES, V117, P27, DOI 10.1016/j.antiviral.2015.02.003; Takizawa N, 2006, MICROBES INFECT, V8, P823, DOI 10.1016/j.micinf.2005.10.005; Talele TT, 2010, CURR TOP MED CHEM, V10, P127, DOI 10.2174/156802610790232251; TARKOWSKI A, 1986, ARTHRITIS RHEUM, V29, P1405, DOI 10.1002/art.1780291115; van Montfort RLM, 2009, TRENDS BIOTECHNOL, V27, P315, DOI 10.1016/j.tibtech.2009.02.003; VUKANOVIC J, 1993, CANCER RES, V53, P1833; WANG CC, 1976, BIOCHEM PHARMACOL, V25, P343, DOI 10.1016/0006-2952(76)90225-2; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watanabe K, 2014, ARCH MED RES, V45, P359, DOI 10.1016/j.arcmed.2014.05.006; Wlodawer A, 1998, ANNU REV BIOPH BIOM, V27, P249, DOI 10.1146/annurev.biophys.27.1.249; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379	72	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173582	10.1371/journal.pone.0173582	http://dx.doi.org/10.1371/journal.pone.0173582			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273150	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700018
J	Bartsch, MR; Bartsch, LA; Richardson, WB; Vallazza, JM; Lafrancois, BM				Bartsch, Michelle R.; Bartsch, Lynn A.; Richardson, William B.; Vallazza, Jon M.; Lafrancois, Brenda Moraska			Effects of food resources on the fatty acid composition, growth and survival of freshwater mussels	PLOS ONE			English	Article							ST-CROIX RIVER; BIOCHEMICAL TRACERS; VILLOSA-IRIS; UNIONIDAE; SEDIMENT; PHYTOPLANKTON; BIVALVES; DIETS; WEB; USA	Increased nutrient and sediment loading in rivers have caused observable changes in algal community composition, and thereby, altered the quality and quantity of food resources available to native freshwater mussels. Our objective was to characterize the relationship between nutrient conditions and mussel food quality and examine the effects on fatty acid composition, growth and survival of juvenile mussels. Juvenile Lampsilis cardium and L. siliquoidea were deployed in cages for 28 d at four riverine and four lacustrine sites in the lower St. Croix River, Minnesota/Wisconsin, USA. Mussel foot tissue and food resources (four seston fractions and surficial sediment) were analyzed for quantitative fatty acid (FA) composition. Green algae were abundant in riverine sites, whereas cyanobacteria were most abundant in the lacustrine sites. Mussel survival was high (95%) for both species. Lampsilis cardium exhibited lower growth relative to L. siliquoidea (p < 0.0001), but growth of L. cardium was not significantly different across sites (p = 0.13). In contrast, growth of L. siliquoidea was significantly greater at the most upstream riverine site compared to the lower three lacustrine sites (p = 0.002). In situ growth of Lampsilis siliquoidea was positively related to volatile solids (10 - 32 mu m fraction), total phosphorus (<10 and 10 - 32 mu m fractions), and select FA in the seston (docosapentaeonic acid, DPA, 22:5n3; 4,7,10,13,16-docosapentaenoic, 22:5n6; arachidonic acid, ARA, 20: 4n6; and 24: 0 in the <10 and 10 - 32 mu m fractions). Our laboratory feeding experiment also indicated high accumulation ratios for 22:5n3, 22:5n6, and 20:4n6 in mussel tissue relative to supplied algal diet. In contrast, growth of L. siliquiodea was negatively related to nearly all FAs in the largest size fraction (i.e., >63 mu m) of seston, including the bacterial FAs, and several of the FAs associated with sediments. Reduced mussel growth was observed in L. siliquoidea when the abundance of cyanobacteria exceeded 9% of the total phytoplankton biovolume. Areas dominated by cyanobacteria may not provide sufficient food quality to promote or sustain mussel growth.	[Bartsch, Michelle R.; Bartsch, Lynn A.; Richardson, William B.; Vallazza, Jon M.] US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI 54601 USA; [Lafrancois, Brenda Moraska] Natl Pk Serv, Ashland, WI USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior	Bartsch, MR (corresponding author), US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI 54601 USA.	mbartsch@usgs.gov		Bartsch, Michelle/0000-0002-9571-5564; Bartsch, Lynn/0000-0002-1483-4845	US National Park Service through Park-Oriented Biological Support (POBS); USGS SIR Cyclical Funds, Basis+ [3210BG4, 47]	US National Park Service through Park-Oriented Biological Support (POBS); USGS SIR Cyclical Funds, Basis+	This research was supported in part by the US National Park Service, through Park-Oriented Biological Support (POBS), USGS SIR Cyclical Funds, Basis+ number 3210BG4, Task 47.	Acker F, 2002, ANAL USGS NAWQA PROG, P87; American Public Health Association A. W. W. A. Water Environment Federation APHA AWWA and WEF, 1998, STANDARD METHODS EXA; Arts MT, 2001, CAN J FISH AQUAT SCI, V58, P122, DOI 10.1139/cjfas-58-1-122; Basen T, 2011, J N AM BENTHOL SOC, V30, P653, DOI 10.1899/10-087.1; Beck K, 2003, N AM J AQUACULT, V65, P203, DOI 10.1577/C02-031; Berntsson KM, 1997, AQUACULTURE, V154, P139, DOI 10.1016/S0044-8486(97)00041-0; Bohm M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094759; Bontes BM, 2007, HYDROBIOLOGIA, V584, P191, DOI 10.1007/s10750-007-0580-2; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Budge SM, 2001, MAR CHEM, V76, P285, DOI 10.1016/S0304-4203(01)00068-8; Carmichael WW, 2001, HUM ECOL RISK ASSESS, V7, P1393, DOI 10.1080/20018091095087; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Christian AD, 2004, J N AM BENTHOL SOC, V23, P101, DOI 10.1899/0887-3593(2004)023<0101:TPAPFS>2.0.CO;2; Dillard G. E., 2007, BIBL PHYCOL, V112, P127; Duff JH, 1998, LIMNOL OCEANOGR, V43, P1378, DOI 10.4319/lo.1998.43.6.1378; Dzialowski AR, 2011, LAKE RESERV MANAGE, V27, P6, DOI 10.1080/07438141.2011.551027; Edlund MB, 2009, J PALEOLIMNOL, V41, P641, DOI 10.1007/s10933-008-9296-1; EMERSON K, 1975, J FISH RES BOARD CAN, V32, P2379, DOI 10.1139/f75-274; Eriksson L., 2006, MULTI MEGAVARIATE DA, V2nd, DOI DOI 10.1016/j.arabjc.2013.10.006; Etti H, 1999, SUSSWASSERFLORA MITT, V2/4; Gatenby CM, 1996, J N AM BENTHOL SOC, V15, P597, DOI 10.2307/1467810; Gatenby CM, 1997, AM MALACOL BULL, V14, P57; HAGAR AF, 1986, PHYSIOL ZOOL, V59, P419, DOI 10.1086/physzool.59.4.30158595; Hanson CE, 2010, AQUAT BOT, V93, P114, DOI 10.1016/j.aquabot.2010.04.004; Heathcote AJ, 2016, INLAND WATERS, V6, P250, DOI 10.5268/IW-6.2.941; Hebert CE, 2009, OECOLOGIA, V160, P15, DOI 10.1007/s00442-009-1285-1; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hornbach DJ, 2010, AQUAT CONSERV, V20, P250, DOI 10.1002/aqc.1081; Huisman J, 2004, ECOLOGY, V85, P2960, DOI 10.1890/03-0763; Knauer J, 1997, AQUACULTURE, V154, P293, DOI 10.1016/S0044-8486(97)00056-2; Komarek J., 2005, SUSSWASSERFLORA MITT; Komarek J, 1998, SUSSWASSERFLORA MITT; Krammer K., 1991, SUBETAWASSERFLORA MI, P576; Krammer K., 1986, SUSSWASSERFLORA MITT, V2/1, P1; Krammer K., 1988, SUSSWASSERFLORA MITT, V2, P596; KRYGER J, 1988, OECOLOGIA, V77, P34, DOI 10.1007/BF00380921; Lafrancois BM, 2009, J PALEOLIMNOL, V41, P603, DOI 10.1007/s10933-008-9294-3; Larson JH, 2016, ECOL APPL, V26, P873, DOI 10.1890/15-0440; Little RC, 1996, SAS SYSTEM MIXED MOD; Magdalene S, 2013, LAKE ST CROIX NUTR L; McGoldrick DJ, 2009, J GREAT LAKES RES, V35, P137, DOI 10.1016/j.jglr.2008.11.007; Newton TJ, 2013, J SHELLFISH RES, V32, P497, DOI 10.2983/035.032.0229; Nichols SJ, 2000, CAN J ZOOL, V78, P871, DOI 10.1139/cjz-78-5-871; Nichols SJ, 2005, J GREAT LAKES RES, V31, P87, DOI 10.1016/S0380-1330(05)70240-9; Oliver R. L., 2000, ECOLOGY CYANOBACTERI, P149, DOI [10.1007/0-306-46855-7_6, DOI 10.1007/0-306-46855-7_6]; OSTROVSKY I, 1993, HYDROBIOLOGIA, V271, P49, DOI 10.1007/BF00005695; Patrick R, 1966, DIATOMS UNITED STATE, VI; Patrick R, 1975, DIATOMS UNITED STATE, VII; Prepas EE, 1997, CAN J FISH AQUAT SCI, V54, P41, DOI 10.1139/cjfas-54-1-41; Raikow DF, 2001, LIMNOL OCEANOGR, V46, P514, DOI 10.4319/lo.2001.46.3.0514; Scott JT, 2009, HYDROBIOLOGIA, V625, P61, DOI 10.1007/s10750-008-9696-2; STOKES M, 1995, CATEGORICAL DATA ANA; Strandberg U, 2014, LIPIDS, V49, P591, DOI 10.1007/s11745-014-3902-y; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; Torres-Ruiz M, 2007, J N AM BENTHOL SOC, V26, P509, DOI 10.1899/06-070.1; Triplett LD, 2009, J PALEOLIMNOL, V41, P659, DOI 10.1007/s10933-008-9290-7; VANDERPLOEG HA, 1995, CAN J FISH AQUAT SCI, V52, P63, DOI 10.1139/f95-006; von Utermohl H, 1931, VERH INT VEREIN THEO, V5, P567; Wehr J. D., 2003, FRESHWATER ALGAE N A; WOLD S, 1994, CHEMOMETR INTELL LAB, V23, P149, DOI 10.1016/0169-7439(93)E0075-F; Zhukova NV, 1998, COMP BIOCHEM PHYS B, V120, P499, DOI 10.1016/S0305-0491(98)10036-6	61	16	16	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173419	10.1371/journal.pone.0173419	http://dx.doi.org/10.1371/journal.pone.0173419			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267810	Green Submitted, gold, Green Published			2022-12-27	WOS:000396060600030
J	Chan, YM; Lee, P; Jungles, S; Morris, G; Cadaoas, J; Skrinar, A; Vellard, M; Kakkis, E				Chan, Yiumo Michael; Lee, Paul; Jungles, Steve; Morris, Gabrielle; Cadaoas, Jaclyn; Skrinar, Alison; Vellard, Michel; Kakkis, Emil			Substantial deficiency of free sialic acid in muscles of patients with GNE myopathy and in a mouse model	PLOS ONE			English	Article							INCLUSION-BODY MYOPATHY; ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE; RIMMED VACUOLES; DISTAL MYOPATHY; SKELETAL-MUSCLE; N-ACETYLMANNOSAMINE; BIFUNCTIONAL ENZYME; ALPHA-DYSTROGLYCAN; KEY ENZYME; MUTATION	GNE myopathy (GNEM), also known as hereditary inclusion body myopathy (HIBM), is a late- onset, progressive myopathy caused by mutations in the GNE gene encoding the enzyme responsible for the first regulated step in the biosynthesis of sialic acid (SA). The disease is characterized by distal muscle weakness in both the lower and upper extremities, with the quadriceps muscle relatively spared until the late stages of disease. To explore the role of SA synthesis in the disease, we conducted a comprehensive and systematic analysis of both free and total SA levels in a large cohort of GNEM patients and a mouse model. A sensitive LC/MS/MS assay was developed to quantify SA in serum and muscle homogenates. Mean serum free SA level was 0.166 pg/mL in patients and 18% lower (p<0.001) than that of age -matched control samples (0.203 pg/mL). In biopsies obtained from patients, mean free SA levels of different muscles ranged from 0.046-0.075 pg/pmol Cr and were markedly lower by 72-85% (p<0.001) than free SA from normal controls. Free SA was shown to constitute a small fraction (3-7%) of the total SA pool in muscle tissue. Differences in mean total SA levels in muscle from patients compared with normal controls were less distinct and more variable between different muscles, suggesting a small subset of sialylation targets could be responsible for the pathogenesis of GNEM. Normal quadriceps had significantly lower levels of free SA (reduced by 39%) and total SA (reduced by 53%) compared to normal gastrocnemius. A lower SA requirement for quadriceps may be linked to the reported quadriceps sparing in GNEM. Analysis of SA levels in GneM74377A4743T mutant mice corroborated the human study results. These results show that serum and muscle free SA is severely reduced in GNEM, which is consistent with the biochemical defect in SA synthesis associated with GNE mutations. These results therefore support the approach of reversing SA depletion as a potential treatment for GNEM patients.	[Chan, Yiumo Michael; Lee, Paul; Jungles, Steve; Morris, Gabrielle; Cadaoas, Jaclyn; Skrinar, Alison; Vellard, Michel; Kakkis, Emil] Ultragenyx Pharmaceut Inc, Novato, CA 94949 USA		Chan, YM (corresponding author), Ultragenyx Pharmaceut Inc, Novato, CA 94949 USA.	ychan@ultragenyx.com			Ultragenyx	Ultragenyx	The study described in the manuscript was funded by Ultragenyx. In additional to providing support in the form of salaries for authors YMC, PL, SJ, GM, JC, AS, MV, EK, Ultragenyx designed the clinical study and commissioned the SA analysis by Intertek. The investigators conducted the study and collected the biopsies and sent them to the Intertek lab for clinical specimens. For mouse model this work was done internally at Ultragenyx and samples sent to Intertek.	Amsili S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002477; [Anonymous], 2006, BOILER MANUF, DOI [DOI 10.2200/S00010ED1V01Y200508IVM003, DOI 10.1074/JBC.M604903200]; Argov Z, 2003, NEUROLOGY, V60, P1519, DOI 10.1212/01.WNL.0000061617.71839.42; ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; Broccolini A, 2005, NEUROMUSCULAR DISORD, V15, P177, DOI 10.1016/j.nmd.2004.10.001; Broccolini A, 2010, NEUROLOGY, V75, P265, DOI 10.1212/WNL.0b013e3181e8e8f1; Broccolini A, 2008, J NEUROCHEM, V105, P971, DOI 10.1111/j.1471-4159.2007.05208.x; Broccolini A, 2015, BBA-MOL BASIS DIS, V1852, P644, DOI 10.1016/j.bbadis.2014.08.007; Broccolini A, 2009, MUSCLE NERVE, V40, P340, DOI 10.1002/mus.21385; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Eisenberg I, 2001, EUR J HUM GENET, V9, P501, DOI 10.1038/sj.ejhg.5200665; Eisenberg I, 2008, HUM MOL GENET, V17, P3663, DOI 10.1093/hmg/ddn261; Eisenberg Iris, 2003, Hum Mutat, V21, P99, DOI 10.1002/humu.9100; Gagiannis D, 2007, GLYCOCONJUGATE J, V24, P125, DOI 10.1007/s10719-006-9019-7; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; Harazi A., 2016, MOL NEUROBIOL; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; Hinderlich S, 2004, FEBS LETT, V566, P105, DOI 10.1016/j.febslet.2004.04.013; Huizing M, 2004, MOL GENET METAB, V81, P196, DOI 10.1016/j.ymgme.2003.11.012; Huizing M, 2014, NEUROMUSCULAR DISORD, V24, P387, DOI 10.1016/j.nmd.2014.03.004; Huizing M, 2009, BBA-MOL BASIS DIS, V1792, P881, DOI 10.1016/j.bbadis.2009.07.001; Leoyklang P, 2014, BIOMARK MED, V8, P641, DOI [10.2217/BMM.14.2, 10.2217/bmm.14.2]; Lucka L, 1999, FEBS LETT, V454, P341, DOI 10.1016/S0014-5793(99)00837-6; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Malicdan MCV, 2012, J BIOL CHEM, V287, P2689, DOI 10.1074/jbc.M111.297051; Malicdan MCV, 2009, NAT MED, V15, P690, DOI 10.1038/nm.1956; Marini M, 2014, ACTA HISTOCHEM, V116, P926, DOI 10.1016/j.acthis.2014.03.005; MitraniRosenbaum S, 1996, HUM MOL GENET, V5, P159, DOI 10.1093/hmg/5.1.159; Niethamer TK, 2012, MOL GENET METAB, V107, P748, DOI 10.1016/j.ymgme.2012.10.011; Nishino I, 2002, NEUROLOGY, V59, P1689, DOI 10.1212/01.WNL.0000041631.28557.C6; Nishino I, 2015, J NEUROL NEUROSUR PS, V86, P385, DOI 10.1136/jnnp-2013-307051; Noguchi S, 2004, J BIOL CHEM, V279, P11402, DOI 10.1074/jbc.M313171200; Reinke SO, 2009, BIOL CHEM, V390, P591, DOI 10.1515/BC.2009.073; Ricci E, 2006, NEUROLOGY, V66, P755, DOI 10.1212/01.wnl.0000200956.76449.3f; Saito F, 2004, NEUROMUSCULAR DISORD, V14, P158, DOI 10.1016/j.nmd.2003.09.006; Salama I, 2005, BIOCHEM BIOPH RES CO, V328, P221, DOI 10.1016/j.bbrc.2004.12.157; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Sela I, 2013, NEUROMOL MED, V15, P180, DOI 10.1007/s12017-012-8209-7; Seppala R, 1999, AM J HUM GENET, V64, P1563, DOI 10.1086/302411; Tarnopolsky MA, 1999, MUSCLE NERVE, V22, P1228, DOI 10.1002/(SICI)1097-4598(199909)22:9<1228::AID-MUS9>3.0.CO;2-6; TESCH PA, 1985, EUR J APPL PHYSIOL O, V54, P237, DOI 10.1007/BF00426139; van der Ham M, 2007, J CHROMATOGR B, V848, P251, DOI 10.1016/j.jchromb.2006.10.066; Voermans NC, 2010, CLIN NEUROPATHOL, V29, P71; Yonekawa T, 2014, BRAIN, V137, P2670, DOI 10.1093/brain/awu210	45	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173261	10.1371/journal.pone.0173261	http://dx.doi.org/10.1371/journal.pone.0173261			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267778	Green Submitted, gold, Green Published			2022-12-27	WOS:000396060600017
J	van Rentergem, JAA; Murre, JMJ; Huizenga, HM				van Rentergem, Joost A. Agelink; Murre, Jaap M. J.; Huizenga, Hilde M.			Multivariate normative comparisons using an aggregated database	PLOS ONE			English	Article							INTEGRATIVE DATA-ANALYSIS; LINEAR MIXED-MODEL; MISSING DATA; MAXIMUM-LIKELIHOOD; PERFORMANCE; NORMALITY; EQUATION; TESTS	In multivariate normative comparisons, a patient's profile of test scores is compared to those in a normative sample. Recently, it has been shown that these multivariate normative comparisons enhance the sensitivity of neuropsychological assessment. However, multivariate normative comparisons require multivariate normative data, which are often unavailable. In this paper, we show how a multivariate normative database can be constructed by combining healthy control group data from published neuropsychological studies. We show that three issues should be addressed to construct a multivariate normative database. First, the database may have a multilevel structure, with participants nested within studies. Second, not all tests are administered in every study, so many data may be missing. Third, a patient should be compared to controls of similar age, gender and educational background rather than to the entire normative sample. To address these issues, we propose a multilevel approach for multivariate normative comparisons that accounts for missing data and includes covariates for age, gender and educational background. Simulations show that this approach controls the number of false positives and has high sensitivity to detect genuine deviations from the norm. An empirical example is provided. Implications for other domains than neuropsychology are also discussed. To facilitate broader adoption of these methods, we provide code implementing the entire analysis in the open source software package R.	[van Rentergem, Joost A. Agelink; Murre, Jaap M. J.; Huizenga, Hilde M.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Huizenga, Hilde M.] Univ Amsterdam, Amsterdam Brain & Cognit Ctr Amsterdam, Amsterdam, Netherlands; [Huizenga, Hilde M.] Univ Amsterdam, Res Prior Area Yield, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam	van Rentergem, JAA (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	j.a.agelink@uva.nl	Murre, Jaap MJ/A-3813-2010		Netherlands organization for scientific research [MaGW 480-12-015]; VICI grant - Netherlands organization for scientific research [453-12-005]; Netherlands organization for scientific research (NWO) [MaGW 480-12-015]; VICI grant - NWO [453-12-005]	Netherlands organization for scientific research(Netherlands Organization for Scientific Research (NWO)); VICI grant - Netherlands organization for scientific research; Netherlands organization for scientific research (NWO)(Netherlands Organization for Scientific Research (NWO)); VICI grant - NWO	JAR is supported by grant MaGW 480-12-015 awarded by the Netherlands organization for scientific research (www.nwo.nl/en). HMH is supported by a VICI grant 453-12-005 awarded by the Netherlands organization for scientific research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ben Schmand, Nathalie de Vent and Patrick Snellings for their helpful comments. JAR is supported by grant MaGW 480-12-015 awarded by the Netherlands organization for scientific research (NWO). HH is supported by a VICI grant 453-12-005 awarded by the NWO.	Bauer DJ, 2006, PSYCHOL METHODS, V11, P142, DOI 10.1037/1082-989X.11.2.142; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Broeders M, 2013, J INT NEUROPSYCH SOC, V19, P695, DOI 10.1017/S1355617713000295; Brooks BL, 2009, DEMENT GERIATR COGN, V27, P439, DOI 10.1159/000215390; Carrig MM, 2015, MULTIVAR BEHAV RES, V50, P383, DOI 10.1080/00273171.2015.1022641; Castelli L, 2010, PARKINSONISM RELAT D, V16, P115, DOI 10.1016/j.parkreldis.2009.08.010; Cohen S, 2015, CLIN INFECT DIS, V60, P1111, DOI 10.1093/cid/ciu1144; Crawford JR, 2006, NEUROPSYCHOLOGY, V20, P259, DOI 10.1037/0894-4105.20.3.259; Crawford JR, 1998, J CLIN EXP NEUROPSYC, V20, P755, DOI 10.1076/jcen.20.5.755.1132; CRAWFORD JR, 1994, BRIT J CLIN PSYCHOL, V33, P65, DOI 10.1111/j.2044-8260.1994.tb01094.x; Crawford JR, 2006, NEUROPSYCHOLOGIA, V44, P666, DOI 10.1016/j.neuropsychologia.2005.06.001; Curran PJ, 2009, PSYCHOL METHODS, V14, P81, DOI 10.1037/a0015914; Dalrymple-Alford JC, 2011, MOVEMENT DISORD, V26, P629, DOI 10.1002/mds.23592; de Vent NR, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01601; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Follmann D, 1996, J AM STAT ASSOC, V91, P854, DOI 10.2307/2291680; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Gomez-Anson B, 2007, NEUROLOGY, V68, P906, DOI 10.1212/01.wnl.0000257090.01107.2f; Graham JW, 2006, PSYCHOL METHODS, V11, P323, DOI 10.1037/1082-989X.11.4.323; Grasman RPPP, 2010, NEUROPSYCHOLOGIA, V48, P1510, DOI 10.1016/j.neuropsychologia.2009.11.016; Huba G. J., 1985, J PSYCHOEDUCATIONAL, V4, P321, DOI DOI 10.1177/073428298500300403; Huizenga HM, 2007, NEUROPSYCHOLOGIA, V45, P2534, DOI 10.1016/j.neuropsychologia.2007.03.011; Huizenga HM, 2016, J CLIN EXP NEUROPSYC, V38, P611, DOI 10.1080/13803395.2015.1132299; Hussong AM, 2013, ANNU REV CLIN PSYCHO, V9, P61, DOI 10.1146/annurev-clinpsy-050212-185522; Jacqmin-Gadda H, 2007, COMPUT STAT DATA AN, V51, P5142, DOI 10.1016/j.csda.2006.05.021; Kraemer HC, 2003, J AM ACAD CHILD PSY, V42, P1524, DOI 10.1097/00004583-200312000-00022; LOONEY SW, 1995, AM STAT, V49, P64, DOI 10.2307/2684816; Moritz S, 2005, BRIT J CLIN PSYCHOL, V44, P193, DOI 10.1348/014466505X35678; Murre JMJ, 2013, ACTA PSYCHOL, V142, P96, DOI 10.1016/j.actpsy.2012.10.005; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Oscar-Berman M, 2004, ALCOHOL CLIN EXP RES, V28, P667, DOI 10.1097/01.ALC.0000122761.09179.B9; Parmenter BA, 2010, J INT NEUROPSYCH SOC, V16, P6, DOI 10.1017/S1355617709990750; Phaf RH, 2010, EUR J COGN PSYCHOL, V22, P306, DOI 10.1080/09541440902995922; Pinheiro J, 2001, MIXED EFFECTS MODELS; Proust-Lima C, 2011, AM J EPIDEMIOL, V174, P1077, DOI 10.1093/aje/kwr243; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schafer JL, 2002, J COMPUT GRAPH STAT, V11, P437, DOI 10.1198/106186002760180608; Schmand B, 2010, J INFECTION, V61, P330, DOI 10.1016/j.jinf.2010.07.006; Smeding HMM, 2011, J NEUROL NEUROSUR PS, V82, P754, DOI 10.1136/jnnp.2007.140012; Strauss E, 2006, COMPENDIUM NEUROPSYC; Su Tanja, 2015, AIDS, V29, P547, DOI 10.1097/QAD.0000000000000573; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Testa SM, 2009, J INT NEUROPSYCH SOC, V15, P1012, DOI 10.1017/S1355617709990713; Valdes-Sosa M, 2011, NEUROIMAGE, V57, P1162, DOI 10.1016/j.neuroimage.2011.04.057; Zakzanis KK, 1998, NEUROPSY NEUROPSY BE, V11, P111	48	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173218	10.1371/journal.pone.0173218	http://dx.doi.org/10.1371/journal.pone.0173218			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5QM	28267796	gold, Green Published, Green Submitted			2022-12-27	WOS:000396060600016
J	Fokkens, BT; Mulder, DJ; Schalkwijk, CG; Scheijen, JL; Smit, AJ; Los, LI				Fokkens, Bernardina T.; Mulder, Douwe J.; Schalkwijk, Casper G.; Scheijen, Jean L.; Smit, Andries J.; Los, Leonoor I.			Vitreous advanced glycation endproducts and alpha-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls	PLOS ONE			English	Article							END-PRODUCTS; SKIN AUTOFLUORESCENCE; PROLIFERATIVE VITREORETINOPATHY; AQUEOUS FLARE; PENTOSIDINE; PLASMA; METHYLGLYOXAL; DISEASE; 3-DEOXYGLUCOSONE; IDENTIFICATION	Purpose Advanced glycation endproducts (AGEs) and their precursors alpha-dicarbonyls are implicated in the progression of diabetic retinopathy. The purpose of this study was to assess AGEs and a-dicarbonyls in the vitreous of patients with type 2 diabetes mellitus (T2DM) with early stages or absence of diabetic retinopathy. Methods We examined vitreous samples obtained during vitrectomy from 31 T2DM patients presenting themselves with rhegmatogenous retinal detachment and compared these to 62 nondiabetic rhegmatogenous retinal detachment patients, matched on age, estimated glomerular filtration rate, smoking, intra-ocular lens implantation, and proliferative vitreoretinopathy. AGEs (pentosidine, N-epsilon-(carboxymethyl) lysine, N-epsilon-(carboxyethyl) lysine, and 5-hydro-5methylimidazolone) and a-dicarbonyls (3-deoxyglucosone, methylglyoxal, and glyoxal) were measured by ultra performance liquid chromatography or high performance liquid chromatography. Skin autofluorescence was measured by the AGE Reader. Results Mean age was 64 +/- 7.6 years for T2DM patients and 63 +/- 8.1 years for controls. For T2DM patients, median diabetes duration was 2.2 (0.3-7.4) years. Non-proliferative diabetic retinopathy was present in 1 patient and classified as absent or background retinopathy in 30 patients. Vitreous levels of pentosidine (2.20 vs. 1.59 mu mol/mol lysine, p = 0.012) and 3-deoxyglucosone (809 vs. 615 nmol/L, p = 0.001) were significantly elevated in T2DM patients compared to controls. Other AGEs and a-dicarbonyls in the vitreous were not significantly different. There was a trend for increased skin autofluorescence in T2DM patients as compared to controls (p = 0.07). Conclusions Pentosidine and 3-deoxyglucosone concentrations were increased in the vitreous of rhegmatogenous retinal detachment patients with a relatively short duration of diabetes compared to non-diabetic rhegmatogenous retinal detachment patients.	[Fokkens, Bernardina T.; Mulder, Douwe J.; Smit, Andries J.] Univ Groningen, Dept Internal Med, Univ Med Ctr Groningen, Groningen, Netherlands; [Fokkens, Bernardina T.; Smit, Andries J.] Univ Groningen, Res Inst GUIDE, Grad Sch Med Sci, Univ Med Ctr Groningen, Groningen, Netherlands; [Fokkens, Bernardina T.; Los, Leonoor I.] Univ Groningen, Dept Ophthalmol, Univ Med Ctr Groningen, Groningen, Netherlands; [Schalkwijk, Casper G.; Scheijen, Jean L.] Maastricht Univ, Lab Metab & Vasc Med, Dept Expt Internal Med, Maastricht, Netherlands; [Los, Leonoor I.] Univ Groningen, WJ Kolff Inst, Grad Sch Med Sci, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; Maastricht University; University of Groningen	Fokkens, BT (corresponding author), Univ Groningen, Dept Internal Med, Univ Med Ctr Groningen, Groningen, Netherlands.; Fokkens, BT (corresponding author), Univ Groningen, Res Inst GUIDE, Grad Sch Med Sci, Univ Med Ctr Groningen, Groningen, Netherlands.; Fokkens, BT (corresponding author), Univ Groningen, Dept Ophthalmol, Univ Med Ctr Groningen, Groningen, Netherlands.	bt.fokkens@umcg.nl	Scheijen, Jean/AAY-3799-2020	Schalkwijk, Casper G/0000-0003-0190-2690	Stichting Blindenhulp, The Netherlands	Stichting Blindenhulp, The Netherlands(Netherlands Government)	BTF was supported financially by Stichting Blindenhulp, The Netherlands (http://www.blindenhulp.nl/). This organization had no role in the design or conduct of this research.	AHMED MU, 1986, J BIOL CHEM, V261, P4889; Amann T, 1997, KLIN MONATSBL AUGENH, V210, P43, DOI 10.1055/s-2008-1035012; Beisswenger PJ, 2003, BIOCHEM SOC T, V31, P1358; Bishop PN, 2004, INVEST OPHTH VIS SCI, V45, P1041, DOI 10.1167/iovs.03-1017; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Choudhuri S, 2013, MOL VIS, V19, P100; de Groot L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3538; DYER DG, 1991, J BIOL CHEM, V266, P11654; Gavin JR, 1999, DIABETES CARE, V22, pS5; Hanssen NMJ, 2013, J CLIN ENDOCR METAB, V98, pE1369, DOI 10.1210/jc.2013-1068; Komiya N, 2008, INT HEART J, V49, P681, DOI 10.1536/ihj.49.681; Lal S, 1997, ARCH BIOCHEM BIOPHYS, V342, P254, DOI 10.1006/abbi.1997.0117; Los LI, 2003, INVEST OPHTH VIS SCI, V44, P2828, DOI 10.1167/iovs.02-0588; Lu JX, 2011, CLIN BIOCHEM, V44, P307, DOI 10.1016/j.clinbiochem.2010.11.004; Lutgers HL, 2006, DIABETES CARE, V29, P2654, DOI 10.2337/dc05-2173; Maessen DE, 2015, DIABETES CARE, V38, P913, DOI 10.2337/dc14-2605; Matsumoto Y, 2002, JPN J OPHTHALMOL, V46, P406, DOI 10.1016/S0021-5155(02)00508-7; Matsumoto Y, 2002, JPN J OPHTHALMOL, V46, P510, DOI 10.1016/S0021-5155(02)00537-3; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P567, DOI 10.1196/annals.1333.065; Mulder DJ, 2006, DIABETES TECHNOL THE, V8, P523, DOI 10.1089/dia.2006.8.523; Nakamura N, 2003, DIABETES RES CLIN PR, V61, P93, DOI 10.1016/S0168-8227(03)00109-8; Nakamura T, 2010, OXID MED CELL LONGEV, V3, P304, DOI 10.4161/oxim.3.5.13069; Nakayama K, 2008, AM J NEPHROL, V28, P871, DOI 10.1159/000139653; Nowotny K, 2015, BIOMOLECULES, V5, P194, DOI 10.3390/biom5010194; Odani H, 1999, BIOCHEM BIOPH RES CO, V256, P89, DOI 10.1006/bbrc.1999.0221; Ogawa S, 2010, HYPERTENSION, V56, P471, DOI 10.1161/HYPERTENSIONAHA.110.156786; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Pachydaki SI, 2006, EXP EYE RES, V82, P807, DOI 10.1016/j.exer.2005.09.022; Peyroux J, 2006, PATHOL BIOL, V54, P405, DOI 10.1016/j.patbio.2006.07.006; Scheijen JLJM, 2014, CLIN CHEM LAB MED, V52, P85, DOI 10.1515/cclm-2012-0878; Scheijen JLJM, 2009, J CHROMATOGR B, V877, P610, DOI 10.1016/j.jchromb.2009.01.022; Schroder S, 2012, RETINA-J RET VIT DIS, V32, P38, DOI 10.1097/IAE.0b013e3182173753; SEBAG J, 1992, ARCH OPHTHALMOL-CHIC, V110, P1472, DOI 10.1001/archopht.1992.01080220134035; SELL DR, 1989, J BIOL CHEM, V264, P21597; Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074; Stinghen AEM, 2016, J AM SOC NEPHROL, V27, P354, DOI 10.1681/ASN.2014101047; Stitt AW, 1998, INVEST OPHTH VIS SCI, V39, P2517; Thompson J, 2001, PROLIFERATIVE VITREO, P2287; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Tome CC, 2005, GRAEF ARCH CLIN EXP, V243, P1272, DOI 10.1007/s00417-004-1108-3; van Deemter M, 2009, EXP EYE RES, V88, P1043, DOI 10.1016/j.exer.2009.01.004; van Deemter M, 2016, RETINA; van Eupen MGA, 2016, HYPERTENSION, V68, P956, DOI 10.1161/HYPERTENSIONAHA.116.07446; van Waateringe RP, 2016, EUR J CLIN INVEST, V46, P481, DOI 10.1111/eci.12627; Verzijl N, 2000, BIOCHEM J, V350, P381, DOI 10.1042/0264-6021:3500381; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; Xue J, 2014, BIOCHEMISTRY-US, V53, P3327, DOI 10.1021/bi500046t; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yamagishi S, 2005, CURR DIABETES REV, V1, P93, DOI 10.2174/1573399052952631	50	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173379	10.1371/journal.pone.0173379	http://dx.doi.org/10.1371/journal.pone.0173379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264049	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300060
J	Maringe, C; Fowler, H; Rachet, B; Luque-Fernandez, MA				Maringe, Camille; Fowler, Helen; Rachet, Bernard; Luque-Fernandez, Miguel Angel			Reproducibility, reliability and validity of population-based administrative health data for the assessment of cancer non-related comorbidities	PLOS ONE			English	Article							CO-MORBIDITY; CHARLSON; INDEX; SURVIVAL; IMPACT; STAGE; LUNG; MORTALITY; DIAGNOSIS	Background Patients with comorbidities do not receive optimal treatment for their cancer, leading to lower cancer survival. Information on individual comorbidities is not straightforward to derive from population-based administrative health datasets. We described the development of a reproducible algorithm to extract the individual Charlson index comorbidities from such data. We illustrated the algorithm with 1,789 laryngeal cancer patients diagnosed in England in 2013. We aimed to clearly set out and advocate the time-related assumptions specified in the algorithm by providing empirical evidence for them. Methods Comorbidities were assessed from hospital records in the ten years preceding cancer diagnosis and internal reliability of the hospital records was checked. Data were right-truncated 6 or 12 months prior to cancer diagnosis to avoid inclusion of potentially cancer-related comorbidities. We tested for collider bias using Cox regression. Results Our administrative data showed weak to moderate internal reliability to identify comorbidities (ICC ranging between 0.1 and 0.6) but a notably high external validity (86.3%). We showed a reverse protective effect of non-cancer related Chronic Obstructive Pulmonary Disease (COPD) when the effect is split into cancer and non-cancer related COPD (Age-adjusted HR: 0.95, 95% CI:0.7-1.28 for non-cancer related comorbidities). Furthermore, we showed that a window of 6 years before diagnosis is an optimal period for the assessment of comorbidities. Conclusion To formulate a robust approach for assessing common comorbidities, it is important that assumptions made are explicitly stated and empirically proven. We provide a transparent and consistent approach useful to researchers looking to assess comorbidities for cancer patients using administrative health data.	[Maringe, Camille; Fowler, Helen; Rachet, Bernard; Luque-Fernandez, Miguel Angel] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Canc Survival Grp, London, England	University of London; London School of Hygiene & Tropical Medicine	Maringe, C (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Canc Survival Grp, London, England.	Camille.Maringe@lshtm.ac.uk	FERNANDEZ, MIGUEL ANGEL LUQUE/AAZ-5017-2020; FERNANDEZ, MIGUEL ANGEL LUQUE/AAK-7183-2021; FERNANDEZ, MIGUEL ANGEL LUQUE/L-4053-2015	FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; Rachet, Bernard/0000-0001-5837-7773; Fowler, Helen/0000-0003-2233-3183; Maringe, Camille/0000-0002-8739-9565	CRUK [C7923/A18525]; Cancer Research UK [18525, 11700] Funding Source: researchfish	CRUK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This study was funded by CRUK grant number C7923/A18525. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TP, 2009, MED CARE, V47, P73, DOI 10.1097/MLR.0b013e318180913c; Ahn DH, 2013, CLIN LUNG CANCER, V14, P644, DOI 10.1016/j.cllc.2013.06.009; Akushevich Igor, 2011, ISRN Oncol, V2011, P415790, DOI 10.5402/2011/415790; [Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Bang UC, 2014, GASTROENTEROLOGY, V146, P989, DOI 10.1053/j.gastro.2013.12.033; Bannay A, 2016, MED CARE, V54, P188, DOI 10.1097/MLR.0000000000000471; Bernardini Judith, 2004, Adv Perit Dial, V20, P125; Braithwaite D, 2012, CANCER EPIDEM BIOMAR, V21, P1115, DOI 10.1158/1055-9965.EPI-11-1228; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; Brewer N, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-132; Center for Disease Control and Prevention, 1988, MMWR-MORBID MORTAL W, V37, P1; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334; Corkum M, 2012, CANCER CAUSE CONTROL, V23, P213, DOI 10.1007/s10552-011-9875-8; Crooks CJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007974; Daskivich TJ, 2015, J UROLOGY, V194, P73, DOI 10.1016/j.juro.2015.01.081; FEINSTEIN AR, 1970, J CHRON DIS, V23, P455, DOI 10.1016/0021-9681(70)90054-8; Fleming ST, 2005, MED CARE, V43, P132, DOI 10.1097/00005650-200502000-00006; Glymour MM, 2016, EPIDEMIOLOGY; Hatlen P, 2011, J THORAC ONCOL, V6, P1810, DOI 10.1097/JTO.0b013e31822a75be; Health and Social Care Information Centre, 2016, OPCS 4 CLASS; Hemmelgarn BR, 2003, AM J KIDNEY DIS, V42, P125, DOI 10.1016/S0272-6386(03)00415-3; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Howlader Nadia, 2014, Journal of the National Cancer Institute Monographs, P255, DOI 10.1093/jncimonographs/lgu022; Imamura K, 1997, J CLIN EPIDEMIOL, V50, P1011, DOI 10.1016/S0895-4356(97)00128-5; Kehl KL, 2015, J GERIATR ONCOL, V6, P202, DOI 10.1016/j.jgo.2015.01.005; Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12; Li HJ, 2012, J CANCER EPIDEMIOL, V2012, DOI 10.1155/2012/291704; Lund L, 2009, J UROLOGY, V182, P35, DOI DOI 10.1016/J.JUR0.2009.02.136; MALENKA DJ, 1994, J CLIN EPIDEMIOL, V47, P1027, DOI 10.1016/0895-4356(94)90118-X; Navid A, 2015, BRIT J HOSP MED, V76, P707, DOI 10.12968/hmed.2015.76.12.707; Newschaffer CJ, 1997, J CLIN EPIDEMIOL, V50, P725, DOI 10.1016/S0895-4356(97)00050-4; Patterson RE, 2010, BREAST CANCER RES TR, V122, P859, DOI 10.1007/s10549-010-0732-3; Porta M, 2014, DICT EPIDEMIOLOGY; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Sarfati D, 2013, ASIA PACIFIC J CLIN; Sarfati D, 2014, J CLIN EPIDEMIOL, V67, P586, DOI 10.1016/j.jclinepi.2013.11.012; Sarfati D, 2012, J CLIN EPIDEMIOL, V65, P924, DOI 10.1016/j.jclinepi.2012.02.017; Sarfati D, 2010, NEW ZEAL MED J, V123, P50; Sarfati D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-116; Shack LG, 2010, POSTGRAD MED J, V86, P73, DOI 10.1136/pgmj.2009.084566; Sogaard Mette, 2013, Clin Epidemiol, V5, P3, DOI 10.2147/CLEP.S47150; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Terret C, 2009, LANCET ONCOL, V10, P80, DOI 10.1016/S1470-2045(08)70336-X; van Doorn C, 2001, J CLIN EPIDEMIOL, V54, P694, DOI 10.1016/S0895-4356(00)00367-X; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Weiss NS, 2006, CLIN EPIDEMIOLOGY ST, VIX	48	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172814	10.1371/journal.pone.0172814	http://dx.doi.org/10.1371/journal.pone.0172814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28263996	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000396054300019
J	Vandecandelaere, I; Van Nieuwerburgh, F; Deforce, D; Coenye, T				Vandecandelaere, Ilse; Van Nieuwerburgh, Filip; Deforce, Dieter; Coenye, Tom			Metabolic activity, urease production, antibiotic resistance and virulence in dual species biofilms of Staphylococcus epidermidis and Staphylococcus aureus	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; PROTEIN-A; CAENORHABDITIS-ELEGANS; METHICILLIN RESISTANCE; DNA-BINDING; SUSCEPTIBILITY; INFECTIONS; MECHANISMS; PATHOGEN; SEQUENCE	In this paper, the metabolic activity in single and dual species biofilms of Staphylococcus epidermidis and Staphylococcus aureus isolates was investigated. Our results demonstrated that there was less metabolic activity in dual species biofilms compared to S. aureus biofilms. However, this was not observed if S. aureus and S. epidermidis were obtained from the same sample. The largest effect on metabolic activity was observed in biofilms of S. aureus Mu50 and S. epidermidis ET-024. A transcriptomic analysis of these dual species biofilms showed that urease genes and genes encoding proteins involved in metabolism were downregulated in comparison to monospecies biofilms. These results were subsequently confirmed by phenotypic assays. As metabolic activity is related to acid production, the pH in dual species biofilms was slightly higher compared to S. aureus Mu50 biofilms. Our results showed that S. epidermidis ET-024 in dual species biofilms inhibits metabolic activity of S. aureus Mu50, leading to less acid production. As a consequence, less urease activity is required to compensate for low pH. Importantly, this effect was biofilm-specific. Also S. aureus Mu50 genes encoding virulence-associated proteins (Spa, SpIF and Dps) were upregulated in dual species biofilms compared to monospecies biofilms and using Caenorhabditis elegans infection assays, we demonstrated that more nematodes survived when co-infected with S. epidermidis ET-024 and S. aureus mutants lacking functional spa, spIF or dps genes, compared to nematodes infected with S. epidermidis ET-024 and wild type S. aureus. Finally, S. epidermidis ET-024 genes encoding resistance to oxacillin, erythromycin and tobramycin were upregulated in dual species biofilms and increased resistance was subsequently confirmed. Our data indicate that both species in dual species biofilms of S. epidermidis and S. aureus influence each other's behavior, but additional studies are required necessary to elucidate the exact mechanism(s) involved.	[Vandecandelaere, Ilse; Coenye, Tom] Univ Ghent, Lab Farmaceut Microbiol, Ottergemsesteenweg, Ghent, Belgium; [Van Nieuwerburgh, Filip; Deforce, Dieter] Univ Ghent, Lab Farmaceut Biotechnol, Ottergemsesteenweg, Ghent, Belgium	Ghent University; Ghent University	Coenye, T (corresponding author), Univ Ghent, Lab Farmaceut Microbiol, Ottergemsesteenweg, Ghent, Belgium.	Tom.Coenye@UGent.be	Coenye, Tom/A-6291-2014; Van Nieuwerburgh, Filip/H-9697-2015; Deforce, Dieter LD/J-4725-2013; Coenye, Tom/Z-1928-2019	Coenye, Tom/0000-0002-6407-0601; Van Nieuwerburgh, Filip/0000-0001-8815-5485; Deforce, Dieter LD/0000-0002-0635-661X; Coenye, Tom/0000-0002-6407-0601	FWO-Vlaanderen [3G001211]; Interuniversity Attraction Poles Program initiated by the Belgian Science Policy Office [P7_28]	FWO-Vlaanderen(FWO); Interuniversity Attraction Poles Program initiated by the Belgian Science Policy Office	This research has been funded by FWO-Vlaanderen (project 3G001211, to TC and DDF) and by the Interuniversity Attraction Poles Program initiated by the Belgian Science Policy Office (grant P7_28, to TC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Becker K, 2012, GENOME ANNOUNCEMENTS, V10; Becker K, 2012, MANUAL CLIN MICROBIO, V10, P308; Becker K, 2014, INT J MED MICROBIOL, V304, P794, DOI 10.1016/j.ijmm.2014.06.007; Begun J, 2007, PLOS PATHOG, V3, P526, DOI 10.1371/journal.ppat.0030057; Bloemendaal ALA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011841; Bore E, 2007, MICROBIOL-SGM, V153, P2289, DOI 10.1099/mic.0.2007/005942-0; Bouchard D, 2012, J BACTERIOL, V194, P6292, DOI 10.1128/JB.01188-12; Brackman G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20321; Burne RA, 2000, MICROBES INFECT, V2, P533, DOI 10.1016/S1286-4579(00)00312-9; Cerca N, 2005, J ANTIMICROB CHEMOTH, V56, P331, DOI 10.1093/jac/dki217; Chatterjee Som S, 2013, Clin Epidemiol, V5, P205, DOI 10.2147/CLEP.S37071; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; COWAN ST, 1954, J GEN MICROBIOL, V10, P174, DOI 10.1099/00221287-10-1-174; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; He XS, 2014, ISME J, V8, P564, DOI 10.1038/ismej.2013.172; Heilmann C, 2011, ADV EXP MED BIOL, V715, P105, DOI 10.1007/978-94-007-0940-9_7; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Horsburgh MJ, J BACTERIOLOGY, V182, P468; Jin T, 2013, CELL PHYSIOL BIOCHEM, V32, P322, DOI 10.1159/000354440; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Martinez A, 1997, J BACTERIOL, V179, P5188, DOI 10.1128/jb.179.16.5188-5194.1997; McCarthy H, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00001; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Molina-Manso D, 2013, INT J ANTIMICROB AG, V41, P521, DOI 10.1016/j.ijantimicag.2013.02.018; Otto M, 2001, INFECT IMMUN, V69, P1957, DOI 10.1128/IAI.69.3.1957-1960.2001; Otto M, 2014, CURR OPIN MICROBIOL, V17, P32, DOI 10.1016/j.mib.2013.11.004; Otto M, 2013, BIOESSAYS, V35, P4, DOI 10.1002/bies.201200112; Otto M, 2012, SEMIN IMMUNOPATHOL, V34, P201, DOI 10.1007/s00281-011-0296-2; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Palmqvist N, 2002, MICROB PATHOGENESIS, V33, P239, DOI 10.1006/mpat.2002.0533; Peacock SJ, 2015, ANNU REV BIOCHEM, V84, P577, DOI 10.1146/annurev-biochem-060614-034516; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Perkins SD, 2010, INT J MED MICROBIOL, V300, P503, DOI 10.1016/j.ijmm.2010.02.005; Reed SB, 2001, INFECT IMMUN, V69, P1521, DOI 10.1128/IAI.69.3.1521-1527.2001; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Sachs George, 2011, Curr Gastroenterol Rep, V13, P540, DOI 10.1007/s11894-011-0226-4; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Szczuka E, 2015, FOLIA MICROBIOLOGICA; Vandecandelaere I, 2014, GENOME ANNOUNCEMENTS, V2; Vandecandelaere I, 2014, PATHOG DIS, V70, P321, DOI 10.1111/2049-632X.12133; Vandecandelaere I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038401; Wang XM, 2003, J MED MICROBIOL, V52, P989, DOI 10.1099/jmm.0.05360-0; Widaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040586; Ziebuhr W, 2006, INT J ANTIMICROB AG, V28, pS14, DOI 10.1016/j.ijantimicag.2006.05.012	47	17	17	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172700	10.1371/journal.pone.0172700	http://dx.doi.org/10.1371/journal.pone.0172700			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28263995	gold, Green Published			2022-12-27	WOS:000396054300015
J	Chen, VCH; Ng, MH; Chiu, WC; McIntyre, RS; Lee, Y; Lin, TY; Weng, JC; Chen, PC; Hsu, CY				Chen, Vincent Chin-Hung; Ng, Mei-Hing; Chiu, Wei-Che; McIntyre, Roger S.; Lee, Yena; Lin, Tsang-Yaw; Weng, Jun-Cheng; Chen, Pau-Chung; Hsu, Chung-Yao			Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; GLOBAL BURDEN; ANGLE; DISEASE; DRUGS; RISK	Background Selective serotonin reuptake inhibitors (SSRIs) are one of the most commonly prescribed classes of antidepressants. Glaucoma is the second leading cause of blindness globally and iatrogenic glaucoma has been implicated across disparate medication classes. Available studies that have sought to determine the association between SSRI exposure and glaucoma have provided mixed results. The aim of the study herein was to investigate whether an association exists between SSRI exposure and glaucoma incidence. Methods Glaucoma cases were identified from Taiwan's National Health Insurance Research Database with a new primary diagnosis of glaucoma between 1997 and 2009. The date wherein the cases were diagnosed with glaucoma was operationalized as the index date. The control group was comprised of individuals within the database who were not diagnosed with glaucoma. 15,865 glaucoma cases were compared to 77,014 sex-, age-, residence-and insurance premium-matched controls on measures of prescribed duration and dosage of SSRIs up to 365 days before index date to proxy SSRIs exposure. Results Individuals receiving SSRIs were at greater risk of glaucoma incidence (OR = 1.39; 95% CI = 1.29 - 1.50); the foregoing increased likelihood was reduced after adjusting for confounding variables (aOR = 1.09; 95% CI = 1.00,1.18). SSRI treatment of longer duration (i. e. > 365 days) and higher doses (>= 1 defined daily dose) were associated with greater risk of glaucoma incidence (aOR = 1.36; 95% CI = 1.08 - 1.71). Subgroup analysis showed that the effect of SSRIs on glaucoma was limited to individuals younger than 65 years of age (aOR = 1.37; 95% CI = 1.25 - 1.50), without diabetes (aOR = 1.39; 95% CI = 1.27 - 1.52), without hypertension (aOR = 1.46; 95% CI = 1.31 - 1.63) or hypercholesterolemia (aOR = 1.35; 95% CI = 1.23 - 1.48). Conclusion Treatment with SSRIs was associated with greater risk of having a diagnosis of glaucoma, particularly in individuals with longer duration and/or higher average dose of SSRI. Our findings suggest that individuals receiving SSRIs treatment for extended periods of time and/or at relatively higher therapeutic doses should be monitored for symptoms associated with glaucoma.	[Chen, Vincent Chin-Hung] Chiayi Chang Gung Mem Hosp, Dept Psychiat, Chang Gung Med Fdn, Chiayi, Taiwan; [Chen, Vincent Chin-Hung] Chang Gung Univ, Sch Med, Dept Psychiat, Taoyuan, Taiwan; [Ng, Mei-Hing; Lin, Tsang-Yaw] Minist Hlth & Welf, Tsaotun Psychiat Ctr, Nantou, Nantou, Taiwan; [Ng, Mei-Hing] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chiu, Wei-Che] Cathay Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Chiu, Wei-Che] Fu Jen Catholic Univ, Coll Med, Taipei, Taiwan; [McIntyre, Roger S.; Lee, Yena] Univ Toronto, Univ Hlth Network, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada; [McIntyre, Roger S.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [McIntyre, Roger S.] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada; [Weng, Jun-Cheng] Chung Shan Med Univ, Dept Med Imaging & Radiol Sci, Taichung, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan; [Hsu, Chung-Yao] Kaoshiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Hsu, Chung-Yao] Natl Taiwan Univ Hosp, Dept Environm & Occupat Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chung Shan Medical University; Cathay General Hospital; Fu Jen Catholic University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Chung Shan Medical University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Ng, MH (corresponding author), Minist Hlth & Welf, Tsaotun Psychiat Ctr, Nantou, Nantou, Taiwan.; Ng, MH (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	condensedmilk0@gmail.com	McIntyre, Roger/AAU-1000-2020; Lee, Yena/L-5505-2019; Chen, Pau-Chung/H-5686-2011; Students, MDPU/ABE-8402-2020; Lee, Yena/D-9016-2019	McIntyre, Roger/0000-0003-4733-2523; Lee, Yena/0000-0003-0629-9456; Chen, Pau-Chung/0000-0002-6242-5974; Lee, Yena/0000-0003-0629-9456; Hsu, Chung-Yao/0000-0002-9880-5944	Chang Gung Memorial Hospital [CMRPG6E0271]; Ministry of Science and Technology, Taiwan [NSC 102-2314-B- 040-004-MY3]; Tsaotun Psychiatric Center, Ministry of Health and Welfare, Taiwan [DOH103-HO-1113]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Tsaotun Psychiatric Center, Ministry of Health and Welfare, Taiwan	VC-HC has received grant (CMRPG6E0271) from Chang Gung Memorial Hospital and the Ministry of Science and Technology, Taiwan (NSC 102-2314-B- 040-004-MY3). M-HN has received a grant (DOH103-HO-1113) from Tsaotun Psychiatric Center, Ministry of Health and Welfare, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNETT NL, 1993, EXP EYE RES, V57, P209, DOI 10.1006/exer.1993.1116; Beg, 2015, INT J MED SCI PUBLIC, V4, P634; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P341, DOI 10.1111/j.1442-9071.2012.02773.x; Cazzola M, 2012, RESP MED, V106, P249, DOI 10.1016/j.rmed.2011.07.021; Chen HY, 2016, J CLIN PSYCHIAT, V77, pE692, DOI 10.4088/JCP.15m10038; Chen HY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002041; Chen V. C. H., 2015, PSYCHO-ONCOLOGY, V25, P803, DOI [10.1002/pon.3929, DOI 10.1002/P0N.3929]; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; COSTAGLIOLA C, 1993, BRIT J OPHTHALMOL, V77, P344, DOI 10.1136/bjo.77.6.344; Costagliola C, 2004, CNS DRUGS, V18, P475, DOI 10.2165/00023210-200418080-00001; Costagliola C, 2000, EXP EYE RES, V70, P551, DOI 10.1006/exer.1999.0773; Costagliola C, 2008, CURR NEUROPHARMACOL, V6, P293, DOI 10.2174/157015908787386104; Eke T, 1997, BRIT MED J, V314, P1387; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Ilyas S, 2012, BRIT J PSYCHIAT, V200, P393, DOI 10.1192/bjp.bp.111.104257; Kingman S, 2004, B WORLD HEALTH ORGAN, V82, P887; Lachkar Y, 2007, CURR OPIN OPHTHALMOL, V18, P129, DOI 10.1097/ICU.0b013e32808738d5; Lai SW, 2011, AM J GASTROENTEROL, V106, P1697, DOI 10.1038/ajg.2011.155; LIN CH, 2016, MEDICINE, V95, DOI DOI 10.1097/MD; Lin YC, 2012, J CHIN MED ASSOC, V75, P567, DOI 10.1016/j.jcma.2012.08.020; Mojtabai R, 2011, HEALTH AFFAIR, V30, P1434, DOI 10.1377/hlthaff.2010.1024; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Osborne N.N., 1982, P7; Razeghinejad MR, 2011, AM J MED, V124, P20, DOI 10.1016/j.amjmed.2010.08.011; Richa S, 2010, CNS DRUGS, V24, P501, DOI 10.2165/11533180-000000000-00000; RITCH R, 1994, ARCH OPHTHALMOL-CHIC, V112, P67, DOI 10.1001/archopht.1994.01090130077021; The Australian Adverse Drug Reactions Advisory Committee, 2001, AUSTR ADV DRUGS REAC, V20; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; WHO Collaborating Centre for Drug Statistics Methodology, 2014, GUID ATC CLASS DDD A; World Health Organization Collaborating Centre for Drug Statistics Methodology, 2014, ATC CLASS IND DDDS 2; Zelefsky JR, 2006, AM J OPHTHALMOL, V141, P1144, DOI 10.1016/j.ajo.2006.01.033	32	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173005	10.1371/journal.pone.0173005	http://dx.doi.org/10.1371/journal.pone.0173005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257449	Green Submitted, Green Published, gold			2022-12-27	WOS:000396021100049
J	Li, Y; Wei, MS; Zhang, FX; Zhao, JL				Li, Ying; Wei, Musheng; Zhang, Fengxia; Zhao, Jianli			Comparison of two SVD-based color image compression schemes	PLOS ONE			English	Article							STRUCTURE-PRESERVING METHOD; SINGULAR-VALUE DECOMPOSITION; LEAST-SQUARES PROBLEM; K-SVD; ALGORITHM	Color image compression is a commonly used process to represent image data as few bits as possible, which removes redundancy in the data while maintaining an appropriate level of quality for the user. Color image compression algorithms based on quaternion are very common in recent years. In this paper, we propose a color image compression scheme, based on the real SVD, named real compression scheme. First, we form a new real rectangular matrix C according to the red, green and blue components of the original color image and perform the real SVD for C. Then we select several largest singular values and the corresponding vectors in the left and right unitary matrices to compress the color image. We compare the real compression scheme with quaternion compression scheme by performing quaternion SVD using the real structure-preserving algorithm. We compare the two schemes in terms of operation amount, assignment number, operation speed, PSNR and CR. The experimental results show that with the same numbers of selected singular values, the real compression scheme offers higher CR, much less operation time, but a little bit smaller PSNR than the quaternion compression scheme. When these two schemes have the same CR, the real compression scheme shows more prominent advantages both on the operation time and PSNR.	[Li, Ying; Wei, Musheng; Zhang, Fengxia; Zhao, Jianli] Liaocheng Univ, Coll Math Sci, Liaocheng, Shandong, Peoples R China; [Wei, Musheng] Shanghai Normal Univ, Coll Math & Sci, Shanghai, Peoples R China	Liaocheng University; Shanghai Normal University	Li, Y (corresponding author), Liaocheng Univ, Coll Math Sci, Liaocheng, Shandong, Peoples R China.	liyingld@163.com			National Natural Science Foundation of China [11171226, 11301247]; Natural Science Foundation of Shandong [ZR2012FQ005, ZR2014FM032]; Science and Technology Project of Department of education, Shandong Province [J15LI10]; science foundation of Liaocheng University [31805, 318011318]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province); Science and Technology Project of Department of education, Shandong Province; science foundation of Liaocheng University	This work was supported by the National Natural Science Foundation of China under grants 11171226 and 11301247, the Natural Science Foundation of Shandong under grant ZR2012FQ005, ZR2014FM032, Science and Technology Project of Department of education, Shandong Province J15LI10, the science foundation of Liaocheng University under grants 31805, 318011318.	Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; ANDREWS HC, 1976, IEEE T ACOUST SPEECH, V24, P26, DOI 10.1109/TASSP.1976.1162766; Bryt O, 2008, J VIS COMMUN IMAGE R, V19, P270, DOI 10.1016/j.jvcir.2008.03.001; Chew LW, 2008, INTERNATIONAL SYMPOSIUM OF INFORMATION TECHNOLOGY 2008, VOLS 1-4, PROCEEDINGS, P2336; Ghorbel O, 2012, PROCEEDINGS OF 2012 IEEE 14TH INTERNATIONAL CONFERENCE ON COMMUNICATION TECHNOLOGY, P1363, DOI 10.1109/ICCT.2012.6511432; Golub G., 2013, MATRIX COMPUTATIONS; Gonzalez R., 2001, DIGITAL IMAGE PROCES, V2; Jia ZG, 2013, J COMPUT APPL MATH, V239, P12, DOI 10.1016/j.cam.2012.09.018; Jiang TS, 2008, COMPUT PHYS COMMUN, V178, P795, DOI 10.1016/j.cpc.2008.01.038; Jiang TS, 2007, COMPUT PHYS COMMUN, V176, P481, DOI 10.1016/j.cpc.2006.12.005; Kumar V, 2012, DEV CIRC SYST ICDCS, P447; Li Y, 2016, J COMPUT APPL MATH, V305, P82, DOI 10.1016/j.cam.2016.03.031; Li Y, 2014, APPL MATH COMPUT, V235, P157, DOI 10.1016/j.amc.2014.02.068; Ma T, 2013, IEEE COMMUN SURV TUT, V15, P963, DOI 10.1109/SURV.2012.060912.00149; Prasantha HS, 2007, INT C COMP INT MULT; Rufai AM, 2014, DIGIT SIGNAL PROCESS, V24, P117, DOI 10.1016/j.dsp.2013.09.008; Sangwine S., QUATERNION TOOLBOX M; Sangwine SJ, 1996, ELECTRON LETT, V32, P1979, DOI 10.1049/el:19961331; Shih YT, 2012, APPL MATH COMPUT, V218, P10370, DOI 10.1016/j.amc.2012.03.070; Singh SK, 2009, UKSIM EURO SYMP COMP, P235, DOI 10.1109/EMS.2009.100; Wang MH, 2008, COMPUT PHYS COMMUN, V179, P203, DOI 10.1016/j.cpc.2008.02.016; Wang MH, 2013, APPL MATH COMPUT, V223, P354, DOI 10.1016/j.amc.2013.08.026; Wang MH, 2013, COMPUT PHYS COMMUN, V184, P2182, DOI 10.1016/j.cpc.2013.05.001; Wu P, 2012, ADV INTEL SOFT COMPU, V159, P465; ZainEldin H, 2015, AIN SHAMS ENG J, V6, P481, DOI 10.1016/j.asej.2014.11.001; Zhang FZ, 1997, LINEAR ALGEBRA APPL, V251, P21, DOI 10.1016/0024-3795(95)00543-9	26	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172746	10.1371/journal.pone.0172746	http://dx.doi.org/10.1371/journal.pone.0172746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257451	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100025
J	Orban, JC; Novain, M; Cattet, F; Plattier, R; Nefzaoui, M; Hyvernat, H; Raguin, O; Kaidomar, M; Kerever, S; Ichai, C				Orban, Jean-Christophe; Novain, Michael; Cattet, Florian; Plattier, Remi; Nefzaoui, Mohamed; Hyvernat, Herve; Raguin, Olivier; Kaidomar, Michel; Kerever, Sebastien; Ichai, Carole			Association of serum lactate with outcome after out-of-hospital cardiac arrest treated with therapeutic hypothermia	PLOS ONE			English	Article							EUROPEAN-RESUSCITATION-COUNCIL; INTENSIVE-CARE MEDICINE; SURVIVORS; PREDICTION; GUIDELINES; CLEARANCE; INJURY; SHOCK; MORTALITY; SOCIETY	Aims Lactate reflects hypoxic insult in many conditions and is considered as a prognosis factor. But, after cardiac arrest, its interest is still debated. Our study aimed to assess the prognosis value of lactate in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia. Methods This retrospective observational study included out-of-hospital cardiac arrest patients treated with therapeutic hypothermia in four ICUs. Lactate levels were compared at different times during the first 24 hours according to outcome at ICU discharge and to the type of death (multiorgan or neurologic failure). Results Two hundred and seventy-two patients were included, 89 good outcome and 183 poor outcome. In the latter group, 171 patients died, from multiorgan failure in 30% and neurologic failure in 70%. Lactate levels were higher in the poor compared to the good outcome patients at admission (5.4 (3.3-9.4) vs. 2.2 (1.5-3.6) mmol/L; p<0.01), 12 hours (2.5 (1.6-4.7) vs. 1.4 (1.0-2.2) mmol/L; p<0.01) and 24 hours (1.8 (1.1-2.8) vs. 1.3 (0.9-2.1) mmol/L; p<0.01). Patients succumbing from multiorgan failure exhibited higher lactate levels compared to those dying from neurologic failure at admission (7.9 (3.9-12.0) vs. 5.2 (3.3-8.8) mmol/L; p<0.01), H12 (4.9 (2.1-8.9) vs. 2.2 (1.4-3.4) mmol/L; p<0.01) and H24 (3.3 (1.8-5.5) vs. 1.4 (1.1-2.5) mmol/L; p<0.01). Initial lactate levels showed an increasing proportion of poor outcome from the first to fourth quartile. Conclusions After out-of-hospital cardiac arrest treated with therapeutic hypothermia, lactate levels during the first 24 hours seem linked with ICU outcome. Patients dying from multiorgan failure exhibit higher initial lactate concentrations than patients succumbing from neurological failure.	[Orban, Jean-Christophe; Novain, Michael; Cattet, Florian; Plattier, Remi; Nefzaoui, Mohamed; Ichai, Carole] Nice Univ Hosp, Pasteur Hosp 2, Med Surg ICU, 30 Voie Romaine, Nice, France; [Hyvernat, Herve] Nice Univ Hosp, Med ICU, Archet Hosp, 151 Route St Antoine, Nice, France; [Raguin, Olivier] Antibes Gen Hosp, Intens Care Unit, 107 Ave Nice, Antibes, France; [Kaidomar, Michel] Frejus St Raphael Gen Hosp, Intens Care Unit, 240 Ave St Lambert, Frejus, France; [Kerever, Sebastien] Lariboisiere Univ Hosp, Dept Anesthesiol, 2 Rue Ambroise Pare, Paris, France; [Kerever, Sebastien] Lariboisiere Univ Hosp, Dept Crit Care, 2 Rue Ambroise Pare, Paris, France	CHU Nice; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Orban, JC (corresponding author), Nice Univ Hosp, Pasteur Hosp 2, Med Surg ICU, 30 Voie Romaine, Nice, France.	orban.jc@chu-nice.fr	Kerever, Sébastien/S-1620-2019	Kerever, Sébastien/0000-0003-0764-4370; Orban, Jean-Christophe/0000-0002-8004-4809				Abella BS, 2005, RESUSCITATION, V64, P181, DOI 10.1016/j.resuscitation.2004.09.014; BAKKER J, 1991, CHEST, V99, P956, DOI 10.1378/chest.99.4.956; Bougouin W, 2014, INTENS CARE MED, V40, P846, DOI 10.1007/s00134-014-3252-5; CARDEN DL, 1985, AM J EMERG MED, V3, P120, DOI 10.1016/0735-6757(85)90033-6; Chamorro C, 2010, ANESTH ANALG, V110, P1328, DOI 10.1213/ANE.0b013e3181d8cacf; Cocchi MN, 2011, MINERVA ANESTESIOL, V77, P1063; Contenti J, 2015, AM J EMERG MED, V33, P167, DOI 10.1016/j.ajem.2014.11.003; Dankiewicz J, 2014, CRIT CARE MED, V42, P2537, DOI 10.1097/CCM.0000000000000543; de Vreede-Swagemakers JJM, 1998, HEART, V79, P356, DOI 10.1136/hrt.79.4.356; Donnino MW, 2007, RESUSCITATION, V75, P229, DOI 10.1016/j.resuscitation.2007.03.021; Donnino MW, 2014, CRIT CARE MED, V42, P1804, DOI 10.1097/CCM.0000000000000332; Gasparetto N, 2014, RESUSCITATION, V85, P376, DOI 10.1016/j.resuscitation.2013.11.014; Grimaldi D, 2013, RESUSCITATION, V84, P60, DOI 10.1016/j.resuscitation.2012.06.010; Han F, 2008, CRIT CARE MED, V36, pS447, DOI 10.1097/CCM.0b013e31818a8a51; James JH, 1999, LANCET, V354, P505, DOI 10.1016/S0140-6736(98)91132-1; Kliegel A, 2004, MEDICINE, V83, P274, DOI 10.1097/01.md.0000141098.46118.4c; Korth U, 2003, RESUSCITATION, V58, P209, DOI 10.1016/S0300-9572(03)00119-9; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; Lee TR, 2013, CRIT CARE, V17, DOI 10.1186/cc13090; Lemiale V, 2013, INTENS CARE MED, V39, P1972, DOI 10.1007/s00134-013-3043-4; Levraut J, 1998, AM J RESP CRIT CARE, V157, P1021, DOI 10.1164/ajrccm.157.4.9705037; Mullner M, 1997, INTENS CARE MED, V23, P1138, DOI 10.1007/s001340050470; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; Oddo M, 2014, CRIT CARE MED, V42, P1340, DOI 10.1097/CCM.0000000000000211; Orban JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045284; Revelly JP, 2005, CRIT CARE MED, V33, P2235, DOI 10.1097/01.CCM.0000181525.99295.8F; Sandroni C, 2014, INTENS CARE MED, V40, P1816, DOI 10.1007/s00134-014-3470-x; Shinozaki K, 2011, RESUSCITATION, V82, P404, DOI 10.1016/j.resuscitation.2010.10.026; Starodub R, 2013, RESUSCITATION, V84, P1078, DOI 10.1016/j.resuscitation.2013.02.001; Wolfrum S, 2007, RESUSCITATION, V72, P207, DOI 10.1016/j.resuscitation.2006.06.033; Zellner T, 2013, RESUSCITATION, V84, P1382, DOI 10.1016/j.resuscitation.2013.03.021	35	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173239	10.1371/journal.pone.0173239	http://dx.doi.org/10.1371/journal.pone.0173239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282398	Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800024
J	Chen, D; Wan, SR; Xiang, J; Bao, FS				Chen, Duo; Wan, Suiren; Xiang, Jing; Bao, Forrest Sheng			A high-performance seizure detection algorithm based on Discrete Wavelet Transform (DWT) and EEG	PLOS ONE			English	Article							SIGNAL CLASSIFICATION; EPILEPSY DIAGNOSIS	In the past decade, Discrete Wavelet Transform (DWT), a powerful time-frequency tool, has been widely used in computer-aided signal analysis of epileptic electroencephalography (EEG), such as the detection of seizures. One of the important hurdles in the applications of DWT is the settings of DWT, which are chosen empirically or arbitrarily in previous works. The objective of this study aimed to develop a framework for automatically searching the optimal DWT settings to improve accuracy and to reduce computational cost of seizure detection. To address this, we developed a method to decompose EEG data into 7 commonly used wavelet families, to the maximum theoretical level of each mother wavelet. Wavelets and decomposition levels providing the highest accuracy in each wavelet family were then searched in an exhaustive selection of frequency bands, which showed optimal accuracy and low computational cost. The selection of frequency bands and features removed approximately 40% of redundancies. The developed algorithm achieved promising performance on two well-tested EEG datasets (accuracy > 90% for both datasets). The experimental results of the developed method have demonstrated that the settings of DWT affect its performance on seizure detection substantially. Compared with existing seizure detection methods based on wavelet, the new approach is more accurate and transferable among datasets.	[Chen, Duo; Wan, Suiren] Southeast Univ, Sch Biol Sci & Med Engn, Lab Med Elect, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China; [Xiang, Jing] Cincinnati Childrens Hosp, Div Neurol, Cincinnati, OH USA; [Bao, Forrest Sheng] Univ Akron, Dept Elect & Comp Engn, Akron, OH 44325 USA	Southeast University - China; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Akron	Wan, SR (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, Lab Med Elect, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China.; Bao, FS (corresponding author), Univ Akron, Dept Elect & Comp Engn, Akron, OH 44325 USA.	srwan@seu.edu.cn; forrest.bao@gmail.com						Acharya UR, 2012, EXPERT SYST APPL, V39, P9072, DOI 10.1016/j.eswa.2012.02.040; Adeli H, 2003, J NEUROSCI METH, V123, P69, DOI 10.1016/S0165-0270(02)00340-0; Andrzejak RG, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061907; Batista G.E., 2004, ACM SIGKDD EXPLOR NE, V6, P20, DOI 10.1145/1007730.1007735; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chapelle O, 2007, NEURAL COMPUT, V19, P1155, DOI 10.1162/neco.2007.19.5.1155; Daubechies I., 1992, 10 LECT WAVELETS, DOI [10.1137/1.9781611970104, DOI 10.1137/1.9781611970104, DOI 10.1063/1.4823127]; Faust O, 2015, SEIZURE-EUR J EPILEP, V26, P56, DOI 10.1016/j.seizure.2015.01.012; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fotiadis DI, 2016, HANDBOOK OF RESEARCH, DOI [10.4018/978-1-4666-8828-5, DOI 10.4018/978-1-4666-8828-5]; Gotman J, 2010, EPILEPSIA, V51, P63, DOI 10.1111/j.1528-1167.2009.02449.x; Guo L, 2010, J NEUROSCI METH, V193, P156, DOI 10.1016/j.jneumeth.2010.08.030; Guo L, 2010, J NEUROSCI METH, V191, P101, DOI 10.1016/j.jneumeth.2010.05.020; Jenssen S, 2010, AM J ALZHEIMERS DIS, V25, P18, DOI 10.1177/1533317508319433; Khan YU, 2003, CLIN NEUROPHYSIOL, V114, P898, DOI 10.1016/S1388-2457(03)00035-X; Knowlton RC, 2009, ANN NEUROL, V65, P716, DOI 10.1002/ana.21660; Koessler L, 2010, NEUROIMAGE, V51, P642, DOI 10.1016/j.neuroimage.2010.02.067; Lee SA, 2000, EPILEPSIA, V41, P297, DOI 10.1111/j.1528-1157.2000.tb00159.x; Lima CAM, 2011, ARTIF INTELL MED, V53, P83, DOI 10.1016/j.artmed.2011.07.003; Lima CAM, 2009, EXPERT SYST APPL, V36, P10054, DOI 10.1016/j.eswa.2009.01.022; Liu YX, 2012, IEEE T NEUR SYS REH, V20, P749, DOI 10.1109/TNSRE.2012.2206054; Magosso E, 2009, APPL MATH COMPUT, V207, P42, DOI 10.1016/j.amc.2007.10.069; MALLAT S, 1992, IEEE T PATTERN ANAL, V14, P710, DOI 10.1109/34.142909; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Nunes TM, 2014, NEUROCOMPUTING, V136, P103, DOI 10.1016/j.neucom.2014.01.020; Rankine L, 2007, MED BIOL ENG COMPUT, V45, P251, DOI 10.1007/s11517-006-0143-0; Shoeb A., 2010, 27 INT C MACH LEARN; Shoeb AH, 2009, APPLICATION OF MACHI; Tao JX, 2013, EPILEPSIA, V54, P858, DOI 10.1111/epi.12094; Ubeyli ED, 2009, DIGIT SIGNAL PROCESS, V19, P297, DOI 10.1016/j.dsp.2008.07.004; Ubeyli ED, 2008, COMPUT BIOL MED, V38, P14, DOI 10.1016/j.compbiomed.2007.06.002; Wei D., 1998, COIFLET TYPE WAVELET; who, EPILEPSY; Yi-Leh Wu, 2000, Proceedings of the Ninth International Conference on Information and Knowledge Management. CIKM 2000, P488; Zandi AS, 2010, IEEE T BIO-MED ENG, V57, P1639, DOI 10.1109/TBME.2010.2046417	36	58	60	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173138	10.1371/journal.pone.0173138	http://dx.doi.org/10.1371/journal.pone.0173138			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278203	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900048
J	Corrard, F; Copin, C; Wollner, A; Elbez, A; Derkx, V; Bechet, S; Levy, C; Boucherat, M; Cohen, R				Corrard, Francois; Copin, Christian; Wollner, Alain; Elbez, Annie; Derkx, Veronique; Bechet, Stephane; Levy, Corinne; Boucherat, Michel; Cohen, Robert			Sickness behavior in feverish children is independent of the severity of fever. An observational, multicenter study	PLOS ONE			English	Article							YOUNG-CHILDREN; IMMUNE-SYSTEM; PAIN SCALE; DEPRESSION; IBUPROFEN; PARACETAMOL; CYTOKINE; EFFICACY; IL-6; INTERLEUKIN-1-BETA	Background. Objectives Behavioral changes in a febrile child are usually considered to stem from the fever. We studied sickness behavior (SB) in terms of its clinical components and its relation to fever. Methods This observational, multicenter study included children aged 6 months to 3 years who were either febrile (fever >= 12 hours, >= 39 degrees C and >= 38 degrees C at inclusion) or non-febrile and well. The child had to have been awake for the 2 hours preceding the consultation and cared for by the parent who brought him/her to the doctor. SB was evaluated according to 6 parameters over this 2-hour period: time spent playing, distance covered, time spent seeking comfort, time spent whining or crying, time spent in a state of irritation or of anger, most distorted facial expression. Two parameters were assessed for the 24-hour period preceding the consultation: time spent sleeping and appetite. The parent reported the degree of change in these parameters compared with the usual situation, using rating scales. Results 200 febrile children (most with nonspecific upper respiratory infections) and 200 non-febrile children were included. The mean values of the 8 parameters differed significantly (p<0.001) between the 2 groups and were independent of the height of fever at inclusion in the febrile children. In the study conditions, paracetamol failed to improve SB when the child was still feverish. Conclusion The 8 parameters suggested that SB and fever are two independent manifestations that are activated simultaneously during an infection. This independence is in harmony with recommendations to treat the discomfort of SB and not the fever.	[Corrard, Francois; Copin, Christian; Wollner, Alain; Elbez, Annie; Derkx, Veronique; Bechet, Stephane; Levy, Corinne; Boucherat, Michel; Cohen, Robert] Assoc Clin & Therapeut Infantile Val de Marne, St Maur Des Fosses, France; [Corrard, Francois; Cohen, Robert] Assoc Francaise Pediat Ambulatoire, Chambery, France; [Elbez, Annie; Cohen, Robert] CHI Creteil, Dept Microbiol, Creteil, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil	Corrard, F (corresponding author), Assoc Clin & Therapeut Infantile Val de Marne, St Maur Des Fosses, France.; Corrard, F (corresponding author), Assoc Francaise Pediat Ambulatoire, Chambery, France.	francois.corrard@free.fr	LEVY, Corinne/AAM-3541-2021; Cohen, Robert/AAM-4426-2021	LEVY, Corinne/0000-0002-1927-6360; Cohen, Robert/0000-0001-6151-0686	Pfizer Sante Familiale (Paris), a pharmaceutical group that markets ibuprofen	Pfizer Sante Familiale (Paris), a pharmaceutical group that markets ibuprofen	This study was supported by a grant from Pfizer Sante Familiale (Paris), a pharmaceutical group that markets ibuprofen. The sponsor had no role in the study design, data collection or analysis, the decision to publish, or the preparation of the manuscript.	[Anonymous], 2000, Am J Psychiatry, V157, P1; Autret E, 1997, EUR J CLIN PHARMACOL, V51, P367, DOI 10.1007/s002280050215; Autret-Leca E, 2007, CURR MED RES OPIN, V23, P2205, DOI 10.1185/030079907X223323; Bennett BK, 1998, AUST NZ J PSYCHIAT, V32, P180, DOI 10.3109/00048679809062727; Carbajal R, 2007, EVALUATION DOULEUR C; Chiappini E, 2009, CLIN THER, V31, P1826, DOI 10.1016/j.clinthera.2009.08.006; Community Paediatrics Committee, 2013, FEV TEMP TAK; Corwin EJ, 2003, ANN BEHAV MED, V25, P41, DOI 10.1207/S15324796ABM2501_06; Corwin EJ, 2008, BIOL RES NURS, V10, P128, DOI 10.1177/1099800408323220; Damm J, 2013, NEUROPHARMACOLOGY, V71, P98, DOI 10.1016/j.neuropharm.2013.03.014; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Dantzer R, 2006, NEUROL CLIN, V24, P441, DOI 10.1016/j.ncl.2006.03.003; Dantzer R, 2014, TRENDS NEUROSCI, V37, P39, DOI 10.1016/j.tins.2013.10.003; Dantzer R, 2009, IMMUNOL ALLERGY CLIN, V29, P247, DOI 10.1016/j.iac.2009.02.002; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Fournier-Charriere E, 2012, PAIN, V153, P1573, DOI 10.1016/j.pain.2012.02.024; Harden LM, 2015, BRAIN BEHAV IMMUN, V50, P322, DOI 10.1016/j.bbi.2015.07.012; Hay AD, 2008, BMJ-BRIT MED J, V337; Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1; Hiles SA, 2012, BRAIN BEHAV IMMUN, V26, P1180, DOI 10.1016/j.bbi.2012.06.001; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Janicki-Deverts D, 2007, BRAIN BEHAV IMMUN, V21, P301, DOI 10.1016/j.bbi.2006.09.002; KENT S, 1992, P NATL ACAD SCI USA, V89, P9117, DOI 10.1073/pnas.89.19.9117; Konsman JP, 2000, EUR J NEUROSCI, V12, P4434, DOI 10.1046/j.0953-816X.2000.01319.x; Kramer LC, 2008, CLIN PEDIATR, V47, P907, DOI 10.1177/0009922808319967; KRAMER MS, 1991, LANCET, V337, P591, DOI 10.1016/0140-6736(91)91648-E; Luheshi GN, 2000, AUTON NEUROSCI-BASIC, V85, P127, DOI 10.1016/S1566-0702(00)00231-9; McIntyre J, 1996, ARCH DIS CHILD, V74, P164, DOI 10.1136/adc.74.2.164; National Institute for health and Clinical Excellence, 2013, FEV ILLN CHILDR FEV; Piraino B, 2012, BRAIN BEHAV IMMUN, V26, P552, DOI 10.1016/j.bbi.2011.12.009; Reichenberg A, 2002, PSYCHONEUROENDOCRINO, V27, P945, DOI 10.1016/S0306-4530(01)00101-9; Reichenberg A, 2001, ARCH GEN PSYCHIAT, V58, P445, DOI 10.1001/archpsyc.58.5.445; Sarrell EM, 2006, ARCH PEDIAT ADOL MED, V160, P197, DOI 10.1001/archpedi.160.2.197; Simon AK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3085; Sullivan JE, 2011, PEDIATRICS, V127, P580, DOI 10.1542/peds.2010-3852; Vollmer-Conna U, 2004, PSYCHOL MED, V34, P1289, DOI 10.1017/S0033291704001953	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0171670	10.1371/journal.pone.0171670	http://dx.doi.org/10.1371/journal.pone.0171670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278190	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900109
J	George, J; Ammar, ED; Hall, DG; Lapointe, SL				George, Justin; Ammar, El-Desouky; Hall, David G.; Lapointe, Stephen L.			Sclerenchymatous ring as a barrier to phloem feeding by Asian citrus psyllid: Evidence from electrical penetration graph and visualization of stylet pathways	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER ASIATICUS; DIAPHORINA-CITRI; BEHAVIOR; LIGNIFICATION; TRANSMISSION; ACQUISITION; DISEASE	Asian citrus psyllid (Diaphorina citri) feeding behaviors play a significant role in the transmission of the phloem-limited Candidatus Liberibacter asiaticus (CLas) bacterium that causes the economically devastating citrus greening disease. Sustained phloem ingestion by D. citri on CLas infected plants is required for pathogen acquisition and transmission. Recent studies have shown a fibrous ring of thick-walled sclerenchyma around the phloem in mature, fully expanded citrus leaves that is more prominent on the abaxial compared with the adaxial side. The composition and thickness of this fibrous ring may have an important role in selection of feeding sites by D. citri based on leaf age and leaf surface, which in turn can affect pathogen acquisition and transmission. We measured feeding behavior using electrical penetration graph (EPG) recordings of individual D. citri adults placed on abaxial or adaxial surfaces of young or mature Valencia orange leaves to study the role of the sclerenchymatous ring in modifying D. citri feeding behavior. Feeding sites on the same leaf tissues were then sectioned and examined by epifluorescence microscopy. The duration of phloem ingestion (E2 waveform) by psyllids was significantly reduced on mature compared with young leaves, and on abaxial compared with adaxial leaf surfaces. The longest duration of phloem ingestion was observed from psyllids placed on the adaxial side of young leaves that had the least developed sclerenchyma. Bouts of phloem salivation (E1 waveform), however, were significantly longer on mature leaves compared with young leaves. D. citri adults made consecutive phloem feeding attempts (bouts) on the abaxial side of mature leaves and those bouts resulted in unsuccessful or shorter periods of phloem ingestion. Adults also made more frequent and longer bouts of xylem ingestion on mature leaves compared with adult psyllids placed on young leaves. Epifluorescence microscopy showed that the fibrous ring in young leaves was thinner and autofluoresced in red whereas the ring in mature leaves was thicker and autofluoresced in blue, indicating changes in structure and composition (e.g., lignification) of sclerenchyma correlated with leaf age. Our results support the hypothesis that the presence of a thick, well-developed fibrous ring around phloem tissues of mature leaves acts as a barrier to frequent or prolonged phloem ingestion by D. citri from citrus leaves. This may have an important role in limiting or preventing CLas acquisition and/or transmission by D. citri, and could be used for identification and development of resistant citrus cultivars.	[George, Justin; Ammar, El-Desouky; Hall, David G.; Lapointe, Stephen L.] USDA ARS, Subtrop Insects & Hort Res Unit, US Hort Res Lab, Ft Pierce, FL 34945 USA; [Ammar, El-Desouky] Univ Florida, IFAS, Lake Alfred, FL USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Lapointe, SL (corresponding author), USDA ARS, Subtrop Insects & Hort Res Unit, US Hort Res Lab, Ft Pierce, FL 34945 USA.	Stephen.Lapointe@ars.usda.gov			USDA-ARS Project "IPM Methods for Insect Pests of Orchard Crops"; Citrus Research and Development Foundation [853]; ARS Project "IPM Methods for Insect Pests of Orchard Crops"	USDA-ARS Project "IPM Methods for Insect Pests of Orchard Crops"; Citrus Research and Development Foundation; ARS Project "IPM Methods for Insect Pests of Orchard Crops"	Funding was provided by USDA-ARS Project "IPM Methods for Insect Pests of Orchard Crops". Significant external funding was provided by the Citrus Research and Development Foundation, grant #853. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; We thank Larry Markle and Arielly Dias (USDA-ARS, Ft. Pierce, FL) for technical assistance and Anna Sara Hill (USDA-ARS, Ft. Pierce, FL) for insect rearing. Funding for this work was provided by ARS Project "IPM Methods for Insect Pests of Orchard Crops". Significant external funding was provided by the Citrus Research and Development Foundation, grant #853. There was no additional external funding received for this study. USDA is an equal opportunity provider and employer. Mention of a trademark or proprietary product does not constitute a guarantee or warranty of the product by the United States Department of Agriculture and does not imply its approval to the exclusion of other products that may also be suitable.	AKIN DE, 1992, J SCI FOOD AGR, V59, P437, DOI 10.1002/jsfa.2740590403; Ammar ED, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159594; Ammar ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110919; Ammar ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059914; BLUM A, 1968, CROP SCI, V8, P388, DOI 10.2135/cropsci1968.0011183X000800030037x; Bonani JP, 2010, ENTOMOL EXP APPL, V134, P35, DOI 10.1111/j.1570-7458.2009.00937.x; Bove JM, 2006, J PLANT PATHOL, V88, P7; Cen YJ, 2012, ENTOMOL EXP APPL, V143, P13, DOI 10.1111/j.1570-7458.2012.01222.x; Duarte MR, 2005, FITOTERAPIA, V76, P41, DOI 10.1016/j.fitote.2004.10.003; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hall DG, 2016, J EC ENTOMOL; Hewer A, 2011, J EXP BIOL, V214, P3868, DOI 10.1242/jeb.060913; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Koh EJ, 2012, PROTOPLASMA, V249, P687, DOI 10.1007/s00709-011-0312-3; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Luo XZ, 2015, FLA ENTOMOL, V98, P186, DOI 10.1653/024.098.0132; Moore R., 1998, BOTANY, V3; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Rangasamy M, 2009, J ECON ENTOMOL, V102, P432, DOI 10.1603/029.102.0156; Richter S, 2011, PLANTA, V233, P763, DOI 10.1007/s00425-010-1338-z; Setamou M, 2016, J EC ENTOMOL; Setamou M, 2017, PLOS ONE, V11; Setamou M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131917; Skelley LH, 2004, BIOL CONTROL, V29, P14, DOI 10.1016/S1049-9644(03)00129-4; TJALLINGII WF, 1978, ENTOMOL EXP APPL, V24, P721, DOI 10.1007/BF02385128; Tomaseto AF, 2016, J APPL ENTOMOL, V140, P91, DOI 10.1111/jen.12249; Wang Y, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00220, 10.3389/fpls.2013.00314]; Xu C.F., 1988, P 10 C INT ORG CITRU, P243; Yasuda K, 2005, JPN J APPL ENTOMOL Z, V49, P146, DOI 10.1303/jjaez.2005.146	31	33	34	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173520	10.1371/journal.pone.0173520	http://dx.doi.org/10.1371/journal.pone.0173520			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278248	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900004
J	Krucken, J; Blumke, J; Maaz, D; Demeler, J; Ramunke, S; Antolova, D; Schaper, R; von Samson-Himmelstjerna, G				Kruecken, Juergen; Bluemke, Julia; Maaz, Denny; Demeler, Janina; Ramuenke, Sabrina; Antolova, Daniela; Schaper, Roland; von Samson-Himmelstjerna, Georg			Small rodents as paratenic or intermediate hosts of carnivore parasites in Berlin, Germany	PLOS ONE			English	Article							ECHINOCOCCUS-MULTILOCULARIS-INFECTIONS; CENTRAL-NERVOUS-SYSTEM; TOXOPLASMA-GONDII; NEOSPORA-CANINUM; TOXOCARA-CANIS; TAENIA-MARTIS; ENVIRONMENTAL CONTAMINATION; NEGLECTED INFECTIONS; TOXASCARIS-LEONINA; BEHAVIORAL-CHANGES	Rodents are important intermediate and paratenic hosts for carnivore parasites, including the important zoonotic agents Toxoplasma, Echinococcus and Toxocara. Monitoring of such parasites in rodents can be used to detect increasing risks for human and veterinary public health. Rodents were trapped at four sites in Berlin, two near the city center, two at the periphery. PCRs were conducted to detect Coccidia (target ITS-1) and specifically Toxoplasma gondii (repetitive element) in brain and ascarids (ITS-2) in muscle or brain tissue. During necropsies, metacestodes were collected and identified using ITS-2 and 12S rRNA PCRs. An ELISA to detect antibodies against Toxocara canis ES antigens was performed. Within the 257 examined rodents, the most frequently observed parasite was Frenkelia glareoli predominantly found in Myodes glareolus. T. gondii was only detected in 12 rodents and Microtus spp. (although strongly underrepresented) had a significantly increased chance of being positive. Neither Echinococcus nor typical Taenia parasites of dogs and cats were found but Mesocestoides litteratus and Taenia martis metacestodes were identified which can cause severe peritoneal or ocular cysticercosis in dogs, primates and humans. Using PCR, the ascarids T. canis (n = 8), Toxocara cati (4) and Parascaris sp. (1) were detected predominantly in muscles. Seroprevalence of T. canis was 14.2% and ELISA was thus more sensitive than PCR to detect infection with this parasite. Non-parametric multidimensional scaling and cluster analysis revealed that parasite communities could be grouped into an urban and a peri-urban cluster with high frequency of ascarid-positive rodents in urban and high frequency of F. glareoli in peri-urban sites. Prevalence rates of parasites in rodents with potential impact for human or veterinary public health are considerable and the monitoring of transmission cycles of carnivore parasites in intermediate rodent hosts is recommended to estimate the health risks arising from wild and domesticated carnivores.	[Kruecken, Juergen; Bluemke, Julia; Maaz, Denny; Demeler, Janina; Ramuenke, Sabrina; von Samson-Himmelstjerna, Georg] Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany; [Antolova, Daniela] Slovak Acad Sci, Inst Parasitol, Kosice, Slovakia; [Schaper, Roland] Bayer Anim Hlth GmbH, Leverkusen, Germany	Free University of Berlin; Slovak Academy of Sciences; Bayer AG	von Samson-Himmelstjerna, G (corresponding author), Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany.	gvsamson@fu-berlin.de	Schaper, Roland/ABC-5752-2020; Krücken, Jürgen/AAE-3133-2021; Antolová, Daniela/AAF-6411-2020; McKay-Demeler, Janina/AAO-4336-2020; Krücken, Jürgen/B-6794-2009; Krücken, Jürgen/CAF-6903-2022	Krücken, Jürgen/0000-0002-2842-8100; Antolová, Daniela/0000-0002-9358-2163; Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100; Maaz, Denny/0000-0002-5005-4416; Ramunke, Sabrina/0000-0003-0195-4175	Bayer Animal Health, Leverkusen, Germany	Bayer Animal Health, Leverkusen, Germany(Bayer AG)	The funder Bayer Animal Health, Leverkusen, Germany provided financial support to the Freie Universitat Berlin to pay a stipend for one author [JB] and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. RS is employed by Bayer Animal Health and participated in the conceptualization of the study and supported the study by facilitating the financial support through Bayer Animal Health. He did not have any influence on the conduct of the study, the data collection and analysis and the decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Afonso C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032489; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antolova D, 2004, VET PARASITOL, V126, P317, DOI 10.1016/j.vetpar.2004.08.005; Antolova D, 2013, J HELMINTHOL, V87, P52, DOI 10.1017/S0022149X11000848; Beste C, 2014, NEUROBIOL AGING, V35, P1037, DOI 10.1016/j.neurobiolaging.2013.11.012; Bordes F, 2015, INTEGR ZOOL, V10, P424, DOI 10.1111/1749-4877.12149; BOWLES J, 1992, MOL BIOCHEM PARASIT, V54, P165, DOI 10.1016/0166-6851(92)90109-W; Brunet J, 2015, J CLIN MICROBIOL, V53, P2756, DOI 10.1128/JCM.01033-15; Brunet J, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-422; Charrad M, 2014, J STAT SOFTW, V61, P1; Chieffi PP, 2010, REV INST MED TROP SP, V52, P243, DOI 10.1590/S0036-46652010000500004; CUELLAR C, 1995, INT J PARASITOL, V25, P731, DOI 10.1016/0020-7519(94)00187-S; De Liberato C, 2014, PARASITOL INT, V63, P695, DOI 10.1016/j.parint.2014.05.008; Denzin N, 2014, TRANSBOUND EMERG DIS, V61, P239, DOI 10.1111/tbed.12026; Duscher GG, 2015, INT J PARASITOL-PAR, V4, P88, DOI 10.1016/j.ijppaw.2014.12.001; Eberwein P, 2013, EMERG INFECT DIS, V19, P1152, DOI 10.3201/eid1907.121114; Fichet-Calvet E, 2004, PARASITE, V11, P301, DOI 10.1051/parasite/2004113301; Finsterer J, 2013, J HELMINTHOL, V87, P257, DOI 10.1017/S0022149X12000600; Flegr J, 2007, SCHIZOPHRENIA BULL, V33, P757, DOI 10.1093/schbul/sbl074; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Fuehrer HP, 2010, PARASITOL RES, V107, P469, DOI 10.1007/s00436-010-1905-z; Fuhrer HP, 2010, PARASITOL RES, V106, P1001, DOI 10.1007/s00436-010-1753-x; GASSER RB, 1995, ACTA TROP, V59, P31, DOI 10.1016/0001-706X(94)00085-F; HAVASIOVA K, 1993, J HELMINTHOL, V67, P291, DOI 10.1017/S0022149X00013298; Herrmann DC, 2012, VET PARASITOL, V185, P78, DOI 10.1016/j.vetpar.2011.10.030; Ho MSY, 1996, J CLIN MICROBIOL, V34, P1203, DOI 10.1128/JCM.34.5.1203-1208.1996; Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8; Hotez PJ, 2011, INT J INFECT DIS, V15, pE611, DOI 10.1016/j.ijid.2011.05.006; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000400; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000256; Hrckova G, 2011, PARASITOLOGY, V138, P638, DOI 10.1017/S0031182011000047; Hughes JM, 2006, PARASITOLOGY, V132, P29, DOI 10.1017/S0031182005008784; Hurkova-Hofmannova L, 2014, J PARASITOL, V100, P139, DOI 10.1645/13-255.1; Ishiwata K, 2004, PARASITOL RES, V92, P50, DOI 10.1007/s00436-003-1010-7; Jin Y, 2015, J KOREAN MED SCI, V30, P549, DOI 10.3346/jkms.2015.30.5.549; Kazacos Kevin R, 2013, Handb Clin Neurol, V114, P251, DOI 10.1016/B978-0-444-53490-3.00020-0; Kunz Thomas H., 1996, P279; Lydersen S, 2009, STAT MED, V28, P1159, DOI 10.1002/sim.3531; Macpherson CNL, 2013, INT J PARASITOL, V43, P999, DOI 10.1016/j.ijpara.2013.07.004; Maenz M, 2014, PROG RETIN EYE RES, V39, P77, DOI 10.1016/j.preteyeres.2013.12.005; Meerburg BG, 2012, VET PARASITOL, V184, P317, DOI 10.1016/j.vetpar.2011.09.001; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; Morgan ER, 2013, VET PARASITOL, V193, P390, DOI 10.1016/j.vetpar.2012.12.034; MORRIS P, 1972, Mammal Review, V2, P69, DOI 10.1111/j.1365-2907.1972.tb00160.x; Ngugi AK, 2013, LANCET NEUROL, V12, P253, DOI 10.1016/S1474-4422(13)70003-6; Niethammer J., 1982, HDB SAUGETIERE EUROP; Nijsse R, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1009-9; Palmer BS, 2007, SEIZURE-EUR J EPILEP, V16, P657, DOI 10.1016/j.seizure.2007.05.010; Reischl U, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-7; Reperant LA, 2009, PARASITOLOGY, V136, P329, DOI 10.1017/S0031182008005428; Rodriguez-Caballero A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0875-5; RYZHIKOV KM, 1978, KEY HELMINTH PARASIT; Salek M, 2015, MAMMAL REV, V45, P1, DOI 10.1111/mam.12027; Scheid R, 2008, CLIN NEUROL NEUROSUR, V110, P1054, DOI 10.1016/j.clineuro.2008.06.014; Schmidt S, 2001, UNTERSUCHUNGEN ZUM V; Schnieder T, 2011, VET PARASITOL, V175, P193, DOI 10.1016/j.vetpar.2010.10.027; Staubach C, 2001, AM J TROP MED HYG, V65, P943, DOI 10.4269/ajtmh.2001.65.943; Staubach C, 2011, VET PARASITOL, V179, P77, DOI 10.1016/j.vetpar.2011.01.065; Stieger C, 2002, PARASITOLOGY, V124, P631, DOI 10.1017/S0031182002001749; Strube C, 2013, VET PARASITOL, V193, P375, DOI 10.1016/j.vetpar.2012.12.033; Sutor A, 2014, ACTA THERIOL, V59, P49, DOI 10.1007/s13364-013-0138-9; Svobodova M, 2004, ACTA PROTOZOOL, V43, P251; Thomasson D, 2011, PARASITOLOGY, V138, P1117, DOI 10.1017/S0031182011000904; von Nickisch-Rosenegk M, 1999, J MOL EVOL, V48, P586, DOI 10.1007/PL00006501; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Walsh MG, 2012, INT J PARASITOL, V42, P1159, DOI 10.1016/j.ijpara.2012.10.002; Zahabiun F, 2015, AM J TROP MED HYG, V93, P319, DOI 10.4269/ajtmh.15-0190; Zalesny G, 2012, PARASITOL RES, V110, P1055, DOI 10.1007/s00436-011-2598-7; Zibaei M, 2016, J CLIN LAB ANAL, V30, P248, DOI 10.1002/jcla.21844	69	21	21	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172829	10.1371/journal.pone.0172829	http://dx.doi.org/10.1371/journal.pone.0172829			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278269	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900129
J	Sherrard, LJ; Tai, AS; Wee, BA; Ramsay, KA; Kidd, TJ; Ben Zakour, NL; Whiley, DM; Beatson, SA; Bell, SC				Sherrard, Laura J.; Tai, Anna S.; Wee, Bryan A.; Ramsay, Kay A.; Kidd, Timothy J.; Ben Zakour, Nouri L.; Whiley, David M.; Beatson, Scott A.; Bell, Scott C.			Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis	PLOS ONE			English	Article							TRANSMISSIBLE STRAINS; PHYLOGENETIC ANALYSIS; CONVERGENT EVOLUTION; LUNG INFECTIONS; TOOL; SUSCEPTIBILITY; REGULATOR; SEQUENCE; CLASSIFICATION; ADAPTATION	A Pseudomonas aeruginosa AUST-02 strain sub-type (M3L7) has been identified in Australia, infects the lungs of some people with cystic fibrosis and is associated with antibiotic resistance. Multiple clonal lineages may emerge during treatment with mutations in chromosomally encoded antibiotic resistance genes commonly observed. Here we describe the within-host diversity and antibiotic resistance of M3L7 during and after antibiotic treatment of an acute pulmonary exacerbation using whole genome sequencing and show both variation and shared mutations in important genes. Eleven isolates from an M3L7 population (n = 134) isolated over 3 months from an individual with cystic fibrosis underwent whole genome sequencing. A phylogeny based on core genome SNPs identified three distinct phylogenetic groups comprising two groups with higher rates of mutation (hypermutators) and one nonhypermutator group. Genomes were screened for acquired antibiotic resistance genes with the result suggesting that M3L7 resistance is principally driven by chromosomal mutations as no acquired mechanisms were detected. Small genetic variations, shared by all 11 isolates, were found in 49 genes associated with antibiotic resistance including frame-shift mutations (mexA, mex7), premature stop codons (oprD, mexB) and mutations in quinolone-resistance determining regions (gyrA, parE). However, whole genome sequencing also revealed mutations in 21 genes that were acquired following divergence of groups, which may also impact the activity of antibiotics and multi-drug efflux pumps. Comparison of mutations with minimum inhibitory concentrations of anti-pseudomonal antibiotics could not easily explain all resistance profiles observed. These data further demonstrate the complexity of chronic and antibiotic resistant P. aeruginosa infection where a multitude of co-existing genotypically diverse sub-lineages might co-exist during and after intravenous antibiotic treatment.	[Sherrard, Laura J.; Tai, Anna S.; Ramsay, Kay A.; Bell, Scott C.] QIMR Berghofer Med Res Inst, Lung Bacteria Grp, Brisbane, Qld, Australia; [Tai, Anna S.; Ramsay, Kay A.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Tai, Anna S.; Bell, Scott C.] Prince Charles Hosp, Adult Cyst Fibrosis Ctr, Dept Thorac Med, Brisbane, Qld, Australia; [Tai, Anna S.] Sir Charles Gairdner Hosp, Dept Resp Med, Western Australia Adult Cyst Fibrosis Ctr, Perth, WA, Australia; [Wee, Bryan A.; Kidd, Timothy J.; Ben Zakour, Nouri L.; Beatson, Scott A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Kidd, Timothy J.] Queens Univ Belfast, Ctr Med Expt, Belfast, Antrim, North Ireland; [Kidd, Timothy J.] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Whiley, David M.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Whiley, David M.] Pathol Queensland, Dept Microbiol, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; Prince Charles Hospital; University of Queensland; Queens University Belfast; University of Queensland; University of Queensland	Bell, SC (corresponding author), QIMR Berghofer Med Res Inst, Lung Bacteria Grp, Brisbane, Qld, Australia.; Bell, SC (corresponding author), Prince Charles Hosp, Adult Cyst Fibrosis Ctr, Dept Thorac Med, Brisbane, Qld, Australia.	Scott.Bell@qimrberghofer.edu.au	Beatson, Scott/B-6985-2013; Bell, Scott/AAJ-4298-2020; Whiley, David M/E-8955-2011; ZAKOUR, Nouri L BEN/B-9338-2011; Kidd, Timothy/F-2149-2010; Bell, Scott C/A-7241-2011; Wee, Bryan/AAP-3461-2021	Beatson, Scott/0000-0002-1806-3283; Bell, Scott/0000-0001-8651-7139; Whiley, David M/0000-0001-5969-3161; ZAKOUR, Nouri L BEN/0000-0002-6949-1755; Kidd, Timothy/0000-0002-6135-6364; Bell, Scott C/0000-0001-8651-7139; Wee, Bryan/0000-0001-6135-5903	National Health and Medical Research Council [NHMRC: 455919]; Australian Infectious Diseases Research Centre (QIMRB-UQ seed grant); TPCH Foundation grant [MS2013-02]; Perpetual [AR01822]; Shelley Shephard Memorial Scholarship; NHMRC medical and dental Postgraduate Scholarship; Australian Cystic Fibrosis Research Trust Postgraduate Scholarship; Airways Infections, Inflammation & Cystic Fibrosis Group Scholarship; Queensland Health; Health Research Fellowship; NHMRC; CF Foundation Therapeutics (USA); TPCH Foundation; Childrens Health Foundation, Queensland; NHMRC [APP1090456, GNT1088448]; Australian Postgraduate Award; ERSEU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship [4571-2013]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Infectious Diseases Research Centre (QIMRB-UQ seed grant); TPCH Foundation grant; Perpetual; Shelley Shephard Memorial Scholarship; NHMRC medical and dental Postgraduate Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Australian Cystic Fibrosis Research Trust Postgraduate Scholarship; Airways Infections, Inflammation & Cystic Fibrosis Group Scholarship; Queensland Health; Health Research Fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CF Foundation Therapeutics (USA); TPCH Foundation; Childrens Health Foundation, Queensland; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); ERSEU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship	This work was supported by project grant funding from the National Health and Medical Research Council (NHMRC: 455919), Australian Infectious Diseases Research Centre (QIMRB-UQ seed grant), TPCH Foundation grant (MS2013-02) and Perpetual (AR01822). L.J.S. is the recipient of The Shelley Shephard Memorial Scholarship. A.S.T is the recipient of NHMRC medical and dental Postgraduate Scholarship, Australian Cystic Fibrosis Research Trust Postgraduate Scholarship and Airways Infections, Inflammation & Cystic Fibrosis Group Scholarship. S.C.B. is the recipient of a Queensland Health, Health Research Fellowship and receives grant support from the NHMRC, CF Foundation Therapeutics (USA), TPCH Foundation and Childrens Health Foundation, Queensland. S.A.B. is the recipient of a NHMRC Fellowship (APP1090456). K.A.R. is the recipient of an Australian Postgraduate Award, PhD Scholarship. T.J.K is the recipient of an ERSEU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship (MC RESPIRE2 first round, grant number 4571-2013) and a NHMRC Early Career Fellowship (GNT1088448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2010, JAMA-J AM MED ASSOC, V304, P2145, DOI 10.1001/jama.2010.1665; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Bruchmann S, 2013, ANTIMICROB AGENTS CH, V57, P1361, DOI 10.1128/AAC.01581-12; Caballero JD, 2015, MBIO, V6, DOI 10.1128/mBio.00981-15; Caille O, 2014, J BACTERIOL, V196, P3890, DOI 10.1128/JB.01997-14; Campbell CT, 2016, ANN PHARMACOTHER, V50, P133, DOI 10.1177/1060028015621916; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Christensen LD, 2012, J ANTIMICROB CHEMOTH, V67, P1198, DOI 10.1093/jac/dks002; Chung JCS, 2012, J BACTERIOL, V194, P4857, DOI 10.1128/JB.01050-12; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; Croucher NJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1196; Cystic Fibrosis Trust, 2015, UK CYST FIBR REG 201; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dassner AM, 2016, INFECT DIS THER; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Dettman JR, 2013, P NATL ACAD SCI USA, V110, P21065, DOI 10.1073/pnas.1307862110; Feliziani S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004651; Fothergill JL, 2012, EUR RESPIR J, V40, P227, DOI 10.1183/09031936.00204411; George PM, 2011, BMJ-BRIT MED J, V342, pd1008, DOI DOI 10.1136/BMJ; Hurley MN, 2012, J CYST FIBROS, V11, P288, DOI 10.1016/j.jcf.2012.02.006; Jones AM, 2002, THORAX, V57, P924, DOI 10.1136/thorax.57.11.924; Jorth P, 2015, CELL HOST MICROBE, V18, P307, DOI 10.1016/j.chom.2015.07.006; Kidd TJ, 2015, LANCET RESP MED, V3, P640, DOI 10.1016/S2213-2600(15)00228-3; Kidd TJ, 2013, EUR RESPIR J, V41, P1091, DOI 10.1183/09031936.00060512; Kohler T, 1999, J BACTERIOL, V181, P6300; Kos VN, 2015, ANTIMICROB AGENTS CH, V59, P427, DOI 10.1128/AAC.03954-14; Marvig RL, 2015, NAT GENET, V47, P57, DOI 10.1038/ng.3148; Marvig RL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003741; Maseda H, 2000, FEMS MICROBIOL LETT, V192, P107, DOI 10.1016/S0378-1097(00)00419-5; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; O'Carroll MR, 2004, EUR RESPIR J, V24, P101, DOI 10.1183/09031936.04.00122903; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Parkins MD, 2012, CHEST, V141, P485, DOI 10.1378/chest.11-0917; Piddock LJV, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.120, 10.1038/nmicrobiol.2016.120]; Prickett MH, 2017, THORAX, V72, P40, DOI 10.1136/thoraxjnl-2015-208027; Robinson P, 2003, J CLIN MICROBIOL, V41, P5741, DOI 10.1128/JCM.41.12.5741.2003; Rodriguez-Martinez JM, 2009, ANTIMICROB AGENTS CH, V53, P1766, DOI 10.1128/AAC.01410-08; Sanbongi Y, 2009, MICROBIOL IMMUNOL, V53, P361, DOI 10.1111/j.1348-0421.2009.00137.x; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Smith AL, 2003, CHEST, V123, P1495, DOI 10.1378/chest.123.5.1495; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Syrmis MW, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-307; Tai AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144022; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Wick Ryan R, 2015, Bioinformatics, V31, P3350, DOI 10.1093/bioinformatics/btv383; Williams D, 2015, AM J RESP CRIT CARE, V191, P775, DOI 10.1164/rccm.201409-1646OC; Wolter DJ, 2008, CLIN INFECT DIS, V46, pE137, DOI 10.1086/588484; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang HK, 2012, NUCLEIC ACIDS RES, V40, pW569, DOI 10.1093/nar/gks576; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	57	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172179	10.1371/journal.pone.0172179	http://dx.doi.org/10.1371/journal.pone.0172179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273168	Green Published, gold			2022-12-27	WOS:000396073700068
J	Walters, MS; Salit, J; Ju, JH; Staudt, MR; Kaner, RJ; Rogalski, AM; Sodeinde, TB; Rahim, R; Strulovici-Barel, Y; Mezey, JG; Almulla, AM; Sattar, H; Mahmoud, M; Crystal, RG				Walters, Matthew S.; Salit, Jacqueline; Ju, Jin Hyun; Staudt, Michelle R.; Kaner, Robert J.; Rogalski, Allison M.; Sodeinde, Teniola B.; Rahim, Riyaad; Strulovici-Barel, Yael; Mezey, Jason G.; Almulla, Ahmad M.; Sattar, Hisham; Mahmoud, Mai; Crystal, Ronald G.			Waterpipe smoking induces epigenetic changes in the small airway epithelium	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ENDOPLASMIC-RETICULUM STRESS; GENOME-WIDE METHYLATION; DNA METHYLATION; CIGARETTE-SMOKING; GENE-EXPRESSION; CARCINOGENIC PAH; TOBACCO SMOKING; LUNG; PROTEOSTASIS	Waterpipe (also called hookah, shisha, or narghile) smoking is a common form of tobacco use in the Middle East. Its use is becoming more prevalent in Western societies, especially among young adults as an alternative form of tobacco use to traditional cigarettes. While the risk to cigarette smoking is well documented, the risk to waterpipe smoking is not well defined with limited information on its health impact at the epidemiologic, clinical and biologic levels with respect to lung disease. Based on the knowledge that airway epithelial cell DNA methylation is modified in response to cigarette smoke and in cigarette smoking-related lung diseases, we assessed the impact of light-use waterpipe smoking on DNA methylation of the small airway epithelium (SAE) and whether changes in methylation were linked to the transcriptional output of the cells. Small airway epithelium was obtained from 7 nonsmokers and 7 light-use (2.6 +/- 1.7 sessions/wk) waterpipe-only smokers. Genome-wide comparison of SAE DNA methylation of waterpipe smokers to nonsmokers identified 727 probesets differentially methylated (fold-change >1.5, p<0.05) representing 673 unique genes. Dominant pathways associated with these epigenetic changes include those linked to G-protein coupled receptor signaling, aryl hydrocarbon receptor signaling and xenobiotic metabolism signaling, all of which have been associated with cigarette smoking and lung disease. Of the genes differentially methylated, 11.3% exhibited a corresponding significant (p<0.05) change in gene expression with enrichment in pathways related to regulation of mRNA translation and protein synthesis (eIF2 signaling and regulation of eIF4 and p70S6K signaling). Overall, these data demonstrate that light-use waterpipe smoking is associated with epigenetic changes and related transcriptional modifications in the SAE, the cell population demonstrating the earliest pathologic abnormalities associated with chronic cigarette smoking.	[Walters, Matthew S.; Salit, Jacqueline; Ju, Jin Hyun; Staudt, Michelle R.; Kaner, Robert J.; Rogalski, Allison M.; Sodeinde, Teniola B.; Rahim, Riyaad; Strulovici-Barel, Yael; Mezey, Jason G.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA; [Kaner, Robert J.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Almulla, Ahmad M.; Sattar, Hisham] Hamad Med Corp, Pulm Sect, Doha, Qatar; [Mahmoud, Mai] Weill Cornell Med Coll, Doha, Qatar; [Walters, Matthew S.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Pulm,Crit Care & Sleep Med, Oklahoma City, OK USA	Cornell University; Cornell University; Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Oklahoma System; University of Oklahoma Health Sciences Center	Crystal, RG (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA.; Crystal, RG (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	geneticmedicine@med.cornell.edu		Staudt, Michelle/0000-0002-3364-0894; AlMulla, Dr. Ahmad/0000-0001-6550-6879; Walters, Matthew/0000-0003-0010-8444	National Heart, Lung, and Blood Institute [HL107882, HL107882-251, P20 HL113443]; National Institutes of Health [UL1 TR000457, RR024143]; Qatar National Research Fund [NPRP 09-742-3-194]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qatar National Research Fund(Qatar National Research Fund (QNRF))	This work was supported by the National Heart, Lung, and Blood Institute through grants HL107882, HL107882-251 and P20 HL113443 to RGC, by the National Institutes of Health through grants UL1 TR000457 and RR024143 and by the Qatar National Research Fund through grant NPRP 09-742-3-194 to MSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl EA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-244; Al Rashidi M, 2008, FOOD CHEM TOXICOL, V46, P3546, DOI 10.1016/j.fct.2008.09.007; American Lung Association SCP, 2012, HOOK SMOK GROW THREA; Aslam Hafiz Muhammad, 2014, Int Arch Med, V7, P16, DOI 10.1186/1755-7682-7-16; AUERBACH O, 1957, NEW ENGL J MED, V256, P97, DOI 10.1056/NEJM195701172560301; Beane J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r201; Buro-Auriemma LJ, 2013, HUM MOL GENET, V22, P4726, DOI 10.1093/hmg/ddt326; Cervantes-Ortiz SL, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050124; Cobb CO, 2011, NICOTINE TOB RES, V13, P78, DOI 10.1093/ntr/ntq212; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Eissenberg T, 2009, AM J PREV MED, V37, P518, DOI 10.1016/j.amepre.2009.07.014; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hackett NR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-82; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Honeyman L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-16; Huang SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107055; Hukkanen J, 2002, CRIT REV TOXICOL, V32, P391, DOI 10.1080/20024091064273; Jeltsch A, 2014, TRENDS BIOCHEM SCI, V39, P310, DOI 10.1016/j.tibs.2014.05.002; Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001; Kelsen SG, 2012, PULM PHARMACOL THER, V25, P447, DOI 10.1016/j.pupt.2012.07.005; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Kim YJ, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-39; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Marcinak Stefan J, 2010, Proc Am Thorac Soc, V7, P356, DOI 10.1513/pats.201001-015AW; Maziak W, 2015, TOB CONTROL, V24, P3, DOI 10.1136/tobaccocontrol-2014-051903; Maziak W, 2011, ADDICT BEHAV, V36, P1, DOI 10.1016/j.addbeh.2010.08.030; Monzer B, 2008, FOOD CHEM TOXICOL, V46, P2991, DOI 10.1016/j.fct.2008.05.031; Moyer TP, 2002, CLIN CHEM, V48, P1460; Nicodemus-Johnson J, 2016, AM J RESP CRIT CARE, V193, P376, DOI 10.1164/rccm.201506-1243OC; Oakes SA, 2015, ANNU REV PATHOL-MECH, V10, P173, DOI 10.1146/annurev-pathol-012513-104649; Osorio F, 2013, SEMIN IMMUNOPATHOL, V35, P293, DOI 10.1007/s00281-013-0368-6; Pascual M, 2011, EPIGENETICS-US, V6, P1131, DOI 10.4161/epi.6.9.16061; Qiu WL, 2012, AM J RESP CRIT CARE, V185, P373, DOI 10.1164/rccm.201108-1382OC; Rabinovich EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033770; Raman T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-493; Roux PP, 2012, COLD SPRING HARB PER, V4; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sanders YY, 2012, AM J RESP CRIT CARE, V186, P525, DOI 10.1164/rccm.201201-0077OC; Schaal C, 2014, MOL CANCER RES, V12, P14, DOI 10.1158/1541-7786.MCR-13-0541; Schivo M, 2014, CLIN REV ALLERG IMMU, V46, P34, DOI 10.1007/s12016-013-8372-0; Schubert J, 2013, TALANTA, V115, P665, DOI 10.1016/j.talanta.2013.06.022; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Sepetdjian E, 2013, NICOTINE TOB RES, V15, P1107, DOI 10.1093/ntr/nts255; Sepetdjian E, 2010, FOOD CHEM TOXICOL, V48, P3242, DOI 10.1016/j.fct.2010.08.033; Shihadeh A, 2015, TOB CONTROL, V24, P22, DOI 10.1136/tobaccocontrol-2014-051907; Smith-Simone S, 2008, NICOTINE TOB RES, V10, P393, DOI 10.1080/14622200701825023; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Staudt MR, 2014, AM J RESP CRIT CARE, V190, P955, DOI 10.1164/rccm.201406-1167LE; Stefanowicz D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044213; Steffen KK, 2016, CELL METAB, V23, P1004, DOI 10.1016/j.cmet.2016.05.013; Steiling K, 2013, AM J RESP CRIT CARE, V187, P933, DOI 10.1164/rccm.201208-1449OC; Strulovici-Barel Y, 2016, AM J RESP CRIT CARE; Thompson RF, 2008, BIOINFORMATICS, V24, P1161, DOI 10.1093/bioinformatics/btn096; Tilley AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022798; (TobReg) WSGoTPR, 2005, WAT TOB SMOK HLTH EF; Tsaprouni LG, 2014, EPIGENETICS-US, V9, P1382, DOI 10.4161/15592294.2014.969637; van 't Wout EFA, 2014, AM J RESP CELL MOL, V50, P1005, DOI 10.1165/rcmb.2014-0019TR; Vucic EA, 2014, AM J RESP CELL MOL, V50, P912, DOI 10.1165/rcmb.2013-0304OC; Wan ES, 2015, AM J RESP CELL MOL, V53, P246, DOI 10.1165/rcmb.2014-0103OC; Wei J, 2013, CHEST, V143, P1098, DOI 10.1378/chest.12-2133; Whalen R, 1998, SEMIN LIVER DIS, V18, P345, DOI 10.1055/s-2007-1007169; Yang IV, 2014, AM J RESP CRIT CARE, V190, P1263, DOI 10.1164/rccm.201408-1452OC; Yoo S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004898; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812	66	21	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171112	10.1371/journal.pone.0171112	http://dx.doi.org/10.1371/journal.pone.0171112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273093	Green Submitted, Green Published, gold			2022-12-27	WOS:000396073700093
J	Lai, SH; Liao, SL; Tsai, MH; Hua, MC; Chiu, CY; Yeh, KW; Yao, TC; Huang, JL				Lai, Shen-Hao; Liao, Sui-Ling; Tsai, Ming-Han; Hua, Man-Chin; Chiu, Chih-Yung; Yeh, Kuo-Wei; Yao, Tsung-Chieh; Huang, Jing-Long			Low cord-serum 25-hydroxyvitamin D levels are associated with poor lung function performance and increased respiratory infection in infancy	PLOS ONE			English	Article							VITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; WHEEZE; RISK; CHILDREN; ASTHMA; BIRTH; SENSITIZATION; PREVENTION; PREGNANCY	Background Perinatal vitamin D deficiency is associated with a higher risk of wheezing in childhood. However, the relationship between vitamin D levels and lung function in infancy has not been investigated. The aim of this study was to investigate the impact of perinatal vitamin D levels on respiratory function and disease outcome in infancy. Materials and methods Full-term infants without any chronic diseases or major anomalies were enrolled in the Prediction of Allergies in Taiwanese Children cohort study. Maternal and cord blood were collected for determining the 25(OH)D level. Questionnaires were recorded at birth and 6 months of age. Infant lung function, including tidal breathing analysis, respiratory mechanics, and forced tidal expiration, was tested at 6 months of age. Results A total of 122 mother infant pairs were enrolled in this study, and 71 infants underwent lung function testing at 6 months of age. 25(OH)D levels in maternal and cord serum were highly correlated (r(2) = 0.457, p < 0.0001). Infants with lower cord serum 25(OH)D levels (< 13.7 ng/ml) had higher resistance of respiratory system (p < 0.01) and a higher risk of a respiratory tract infection before the age of 6 months (p < 0.01). Conclusion Although a high correlation was found between maternal and cord vitamin D levels, the effect on respiratory outcome was different. Our study is the first to show that low cord 25(OH)D levels significantly relationship with poorer lung function performance and higher likelihood of a respiratory tract infection before 6 months of age.	[Lai, Shen-Hao; Yeh, Kuo-Wei; Yao, Tsung-Chieh; Huang, Jing-Long] Chang Gung Mem Hosp, Dept Pediat, Linkou Branch, Taoyuan, Taiwan; [Lai, Shen-Hao; Liao, Sui-Ling; Tsai, Ming-Han; Hua, Man-Chin; Chiu, Chih-Yung; Yeh, Kuo-Wei; Yao, Tsung-Chieh; Huang, Jing-Long] Chang Gung Univ, Dept Pediat, Taoyuan, Taiwan; [Lai, Shen-Hao; Liao, Sui-Ling; Tsai, Ming-Han; Hua, Man-Chin; Chiu, Chih-Yung; Yeh, Kuo-Wei; Yao, Tsung-Chieh; Huang, Jing-Long] Predict Allergies Taiwanese Children PATCH Cohort, Keelung, Taiwan; [Liao, Sui-Ling; Tsai, Ming-Han; Hua, Man-Chin; Chiu, Chih-Yung] Chang Gung Mem Hosp, Keelung Branch, Dept Pediat, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Yao, TC; Huang, JL (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Linkou Branch, Taoyuan, Taiwan.; Yao, TC; Huang, JL (corresponding author), Chang Gung Univ, Dept Pediat, Taoyuan, Taiwan.; Yao, TC; Huang, JL (corresponding author), Predict Allergies Taiwanese Children PATCH Cohort, Keelung, Taiwan.	yaotcmail@gmail.com; hjlong0182@gmail.com	Chiu, CY/Q-4238-2019; Yeh, Kuo-Wei/V-3725-2019	Huang, Jing-Long/0000-0002-3530-7753; Huang, Jing-Long/0000-0001-9280-920X				Bailey D, 2014, CLIN BIOCHEM, V47, P816, DOI 10.1016/j.clinbiochem.2014.01.015; Bailey D, 2013, CLIN BIOCHEM, V46, P190, DOI 10.1016/j.clinbiochem.2012.10.037; Baiz N, 2014, J ALLERGY CLIN IMMUN, V133, P147, DOI 10.1016/j.jaci.2013.05.017; Bates JHT, 2000, EUR RESPIR J, V16, P1180, DOI 10.1034/j.1399-3003.2000.16f26.x; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Brehm JM, 2010, J ALLERGY CLIN IMMUN, V126, P52, DOI 10.1016/j.jaci.2010.03.043; Camargo CA, 2007, AM J CLIN NUTR, V85, P788, DOI 10.1093/ajcn/85.3.788; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; CARLSEN KH, 1994, EUR RESPIR J, V7, P2154, DOI 10.1183/09031936.94.07122154; Carroll KN, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.002; Chawes BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099856; Chiu CY, 2015, PEDIAT ALLERG IMM-UK, V26, P337, DOI 10.1111/pai.12384; Cremers E, 2011, THORAX, V66, P474, DOI 10.1136/thx.2010.151985; DUNDAS I, 1995, AM J RESP CRIT CARE, V151, P1451, DOI 10.1164/ajrccm.151.5.7735599; Emmen JMA, 2012, CLIN CHEM LAB MED, V50, P1969, DOI 10.1515/cclm-2011-0085; Frey U, 2000, EUR RESPIR J, V16, P731, DOI 10.1034/j.1399-3003.2000.16d28.x; Gappa M, 2001, EUR RESPIR J, V17, P141, DOI 10.1183/09031936.01.17101410; GAPPA M, 1993, PEDIATR PULM, V15, P304, DOI 10.1002/ppul.1950150508; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Greer FR, 2008, AM J CLIN NUTR, V88, p529S, DOI 10.1093/ajcn/88.2.529S; Gunville Cameron F., 2013, Inflammation & Allergy Drug Targets, V12, P239; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; Hammar KS, 2014, ACTA PAEDIATR, V103, P856, DOI 10.1111/apa.12666; Hendolin PH, 2000, J CLIN MICROBIOL, V38, P125; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kim DH, 2008, AM J CARDIOL, V102, P1540, DOI 10.1016/j.amjcard.2008.06.067; Kinder BW, 2011, EXPERT REV CLIN IMMU, V7, P255, DOI [10.1586/eci.11.12, 10.1586/ECI.11.12]; Koistinen A, 2014, PEDIAT ALLERG IMM-UK, V25, P834, DOI 10.1111/pai.12308; Lai SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142797; Larose TL, 2015, EUR RESPIR J, V45, P1019, DOI 10.1183/09031936.00069714; Liao SL, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8175898; Liao SL, 2014, PEDIAT ALLERG IMM-UK, V25, P456, DOI 10.1111/pai.12247; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Modl M, 2000, AM J RESP CRIT CARE, V161, P763, DOI 10.1164/ajrccm.161.3.9812063; Niruban SJ, 2014, EUR J CLIN NUTR, V68, P1334, DOI 10.1038/ejcn.2014.121; Pike KC, 2012, THORAX, V67, P950, DOI 10.1136/thoraxjnl-2012-201888; Ren CL, 2014, PEDIATR PULM, V49, P1251, DOI 10.1002/ppul.23012; Rothers J, 2011, J ALLERGY CLIN IMMUN, V128, P1093, DOI 10.1016/j.jaci.2011.07.015; Saraf R., 2015, MATERN CHILD NUTR; Sly PD, 2000, EUR RESPIR J, V16, P741, DOI 10.1034/j.1399-3003.2000.16d29.x; Stelmach I, 2015, RESP MED, V109, P38, DOI 10.1016/j.rmed.2014.10.016; Stocks J, 2005, PROG RESPIR RES, V33, P78; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; Trump DL, 2010, CANCER J, V16, P1, DOI 10.1097/PPO.0b013e3181c51ee6; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Visness CM, 2015, J ALLERGY CLIN IMMUN, V136, P1108, DOI 10.1016/j.jaci.2015.03.046; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Weisse K, 2013, ALLERGY, V68, P220, DOI 10.1111/all.12081; White JH, 2010, J STEROID BIOCHEM, V121, P234, DOI 10.1016/j.jsbmb.2010.03.034; Wu YW, 2014, PSYCHIAT DANUB, V26, P152; Yao TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099105; Young S, 2000, EUR RESPIR J, V15, P151, DOI 10.1034/j.1399-3003.2000.15a28.x; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	54	15	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173268	10.1371/journal.pone.0173268	http://dx.doi.org/10.1371/journal.pone.0173268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267792	Green Submitted, gold, Green Published			2022-12-27	WOS:000396060600018
J	Momen, NC; Ernst, A; Arendt, LH; Olsen, J; Li, J; Gissler, M; Rasmussen, F; Ramlau-Hansen, CH				Momen, Natalie C.; Ernst, Andreas; Arendt, Linn Hakonsen; Olsen, Jorn; Li, Jiong; Gissler, Mika; Rasmussen, Finn; Ramlau-Hansen, Cecilia Host			Maternal cancer and congenital anomalies in children - a Danish nationwide cohort study	PLOS ONE			English	Article							PREGNANCY-ASSOCIATED CANCER; BIRTH; MALFORMATIONS; RISK; PATIENT	Several studies on pregnancy-associated cancers have suggested an association with congenital anomalies in offspring. Previous studies have included maternal cancers diagnosed up to 2 years after pregnancy; however, long latency periods of some cancers mean that cancers diagnosed many years postpartum might have been present during pregnancy in a preclinical state. This paper considers the association between maternal cancers diagnosed from 2 years prior to pregnancy until the mother reaches 50 years of age, and congenital anomalies, as diagnosed at birth or within the first year of life. The current population-based study looks at associations of cancers in mothers with congenital anomalies in their children. Children were followed up from birth to diagnosis of a congenital anomaly, death, emigration or end of follow-up (whichever occurred first). A total of 56,016 children (2.6%) were considered exposed to a maternal cancer of any type; and they had a hazard ratio (HR) of 1.04 (95% confidence interval [CI]: 1.00, 1.09) compared with unexposed children. The greatest HR was seen among children whose mothers had been diagnosed with cancers before or during pregnancy (HR: 1.37, 95% CI: 1.07, 1.75). Similar results were seen when paternal cancers were used as a `negative control'. Statistically significant associations were seen for some specific congenital anomalies of organ systems (congenital anomalies of the musculoskeletal system [HR: 1.13, 95% CI: 1.02, 1.25]) and for some specific types of maternal cancer (leukaemia [HR: 1.31, 95% CI: 1.01, 1.61], The results of the main analyses suggest a small increase in risk of congenital anomalies in offspring of mothers diagnosed with cancer from 2 years before pregnancy, until the mother reaches 50 years of age; with the greatest increase seen for exposure in the pre-pregnancy and pregnancy period. These results may reflect shared causes for some cancers and some congenital anomalies. The similar results seen for paternal cancers indicate that the cause may be genetic or related to the families' social and environmental conditions.	[Momen, Natalie C.; Ernst, Andreas; Arendt, Linn Hakonsen; Ramlau-Hansen, Cecilia Host] Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark; [Olsen, Jorn; Li, Jiong] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA; [Gissler, Mika] THL Natl Inst Hlth & Welf, Helsinki, Finland; [Gissler, Mika] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Family Med, Stockholm, Sweden; [Rasmussen, Finn] Lund Univ, Dept Hlth Sci, Lund, Sweden	Aarhus University; Aarhus University; University of California System; University of California Los Angeles; Finland National Institute for Health & Welfare; Karolinska Institutet; Lund University	Momen, NC (corresponding author), Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark.	ncm@ph.au.dk	li, jiong/L-6534-2014; Momen, Natalie C/D-9272-2019	li, jiong/0000-0002-1716-8067; Momen, Natalie C/0000-0002-9832-8500; li, jiong/0000-0003-1125-026X; Ramlau-Hansen, Cecilia Host/0000-0003-3296-0121; Rasmussen, Finn/0000-0001-7915-7809; Ernst, Andreas/0000-0001-5533-8891; Gissler, Mika/0000-0001-8254-7525	Novo Nordisk Foundation [12535]; Nordic Cancer Union [2013_129830, 2015_176673]; European Research Council [ERC-2010-StG-260242-PROGEURO]; Danish Council for Independent Research [DFF-6110-00019]; Karen Elise Jensens Fond; Novo Nordisk Fonden [NNF14OC0012535] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Nordic Cancer Union; European Research Council(European Research Council (ERC)European Commission); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Karen Elise Jensens Fond; Novo Nordisk Fonden(Novo Nordisk Foundation)	The Novo Nordisk Foundation (http://www.novonordiskfonden.dk, 12535), the Nordic Cancer Union (http://www.ncu.nu/, 2013_129830, 2015_176673), the European Research Council (https://erc.europa.eu/, ERC-2010-StG-260242-PROGEURO), Danish Council for Independent Research (http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research, DFF-6110-00019), and Karen Elise Jensens Fond (http://www.kejfond.dk/, 2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiles J M, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS39, DOI 10.1016/j.ejon.2005.09.006; Braems G, 2011, ONCOLOGIST, V16, P1547, DOI 10.1634/theoncologist.2011-0121; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Cardonick E, 2010, AM J CLIN ONCOL-CANC, V33, P221, DOI 10.1097/COC.0b013e3181a44ca9; Chambers CD, 1998, TERATOLOGY, V58, P251, DOI 10.1002/(SICI)1096-9926(199812)58:6<251::AID-TERA6>3.0.CO;2-L; Dalberg K, 2006, PLOS MED, V3, P1597, DOI 10.1371/journal.pmed.0030336; DOUGLAS RG, 1990, BRIT J SURG, V77, P246, DOI 10.1002/bjs.1800770305; Eibye S, 2013, OBSTET GYNECOL, V122, P608, DOI 10.1097/AOG.0b013e3182a057a2; Frey HA, 2014, OBSTET GYNECOL, V124, P91, DOI 10.1097/AOG.0000000000000335; Garcia-Manero M, 2009, EJSO-EUR J SURG ONC, V35, P215, DOI 10.1016/j.ejso.2008.04.010; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Hansen D, 2000, LANCET, V356, P875, DOI 10.1016/S0140-6736(00)02676-3; HEDEGAARD M, 1993, BMJ-BRIT MED J, V307, P234, DOI 10.1136/bmj.307.6898.234; Howard J, 2013, MINIMUM LATENCY TYPE; Koren G, 1996, CANC PREGNANCY MATER; Lambe M, 1995, BRIT MED J, V311, P1607, DOI 10.1136/bmj.311.7020.1607; Langagergaard V, 2008, BRIT J CANCER, V98, P183, DOI 10.1038/sj.bjc.6604126; Langagergaard V, 2006, BRIT J CANCER, V94, P142, DOI 10.1038/sj.bjc.6602878; Langagergaard V, 2011, CLIN EPIDEMIOL, V3, P7; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Lee YY, 2012, BJOG-INT J OBSTET GY, V119, P1572, DOI 10.1111/j.1471-0528.2012.03475.x; Liew Z, 2015, INT J EPIDEMIOL, V44, P345, DOI 10.1093/ije/dyu249; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Nadler DL., 2014, ADV EPIDEMIOL, V2014, P1, DOI [10.1155/2014/746769, DOI 10.1155/2014/746769]; Navrozoglou I, 2008, EJSO-EUR J SURG ONC, V34, P837, DOI 10.1016/j.ejso.2008.01.029; Nitenberg G, 2000, CRIT REV ONCOL HEMAT, V34, P137, DOI 10.1016/S1040-8428(00)00048-2; Pavlidis NA, 2002, ONCOLOGIST, V7, P279; RCOG, 2010, TERM PREGN FET ABN E; Ryan AM, 2016, P NUTR SOC, V75, P199, DOI 10.1017/S002966511500419X; Sun YL, 2016, CANCER EPIDEMIOL, V44, P59, DOI 10.1016/j.canep.2016.07.011; TIKKANEN J, 1991, EUR J EPIDEMIOL, V7, P628; VAINIO H, 1989, SCAND J WORK ENV HEA, V15, P13, DOI 10.5271/sjweh.1889; Van Calsteren K, 2010, J CLIN ONCOL, V28, P683, DOI 10.1200/JCO.2009.23.2801; Zhu JL, 2002, BRIT J CANCER, V87, P524, DOI 10.1038/sj.bjc.6600488	34	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173355	10.1371/journal.pone.0173355	http://dx.doi.org/10.1371/journal.pone.0173355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264065	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300055
J	Parker, AM; House, JK; Hazelton, MS; Bosward, KL; Sheehy, PA				Parker, Alysia M.; House, John K.; Hazelton, Mark S.; Bosward, Katrina L.; Sheehy, Paul A.			Comparison of culture and a multiplex probe PCR for identifying Mycoplasma species in bovine milk, semen and swab samples	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; BULK-TANK MILK; IN-VITRO AMPLIFICATION; RIBOSOMAL-RNA GENES; DAIRY-CATTLE; MASTITIS; INFECTION; DISEASE; CALVES; ASSAY	Mycoplasma spp. are a major cause of mastitis, arthritis and pneumonia in cattle, and have been associated with reproductive disorders in cows. While culture is the traditional method of identification the use of PCR has become more common. Several investigators have developed PCR protocols to detect M. bovis in milk, yet few studies have evaluated other sample types or other important Mycoplasma species. Therefore the objective of this study was to develop a multiplex PCR assay to detect M. bovis, M. californicum and M. bovigenitalium, and evaluate its analytical performance against traditional culture of bovine milk, semen and swab samples. The PCR specificity was determined and the limit of detection evaluated in spiked milk, semen and swabs. The PCR was then compared to culture on 474 field samples from individual milk, bulk tank milk (BTM), semen and swab (vaginal, preputial, nose and eye) samples. Specificity analysis produced appropriate amplification for all M. bovis, M. californicum and M. bovigenitalium isolates. Amplification was not seen for any of the other Mollicutes or eubacterial isolates. The limit of detection of the PCR was best in milk, followed by semen and swabs. When all three Mycoplasma species were present in a sample, the limit of detection increased. When comparing culture and PCR, overall there was no significant difference in the proportion of culture and PCR positive samples. Culture could detect significantly more positive swab samples. No significant differences were identified for semen, individual milk or BTM samples. PCR identified five samples with two species present. Culture followed by 16S-23S rRNA sequencing did not enable identification of more than one species. Therefore, the superior method for identification of M. bovis, M. californicum and M. bovigenitalium may be dependent on the sample type being analysed, and whether the identification of multiple target species is required.	[Parker, Alysia M.; House, John K.; Hazelton, Mark S.; Bosward, Katrina L.; Sheehy, Paul A.] Univ Sydney, Sydney Sch Vet Sci, Fac Sci, Camden, NSW, Australia	University of Sydney	Parker, AM (corresponding author), Univ Sydney, Sydney Sch Vet Sci, Fac Sci, Camden, NSW, Australia.	alysia.parker@sydney.edu.au	Bosward, Katrina/ABF-5091-2020	Bosward, Katrina/0000-0002-7561-2162; House, John/0000-0002-6174-6565	Dairy Australia [C100000545]	Dairy Australia(Dairy Australia)	This work was supported by Dairy Australia, No C100000545. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayling RD, 2004, VET REC, V155, P413, DOI 10.1136/vr.155.14.413; BENNETT RH, 1977, CORNELL VET, V67, P361; Biddle MK, 2005, JAVMA-J AM VET MED A, V227, P455, DOI 10.2460/javma.2005.227.455; Bielanski A, 2000, THERIOGENOLOGY, V53, P1213, DOI 10.1016/S0093-691X(00)00266-1; Boonyayatra S, 2012, J DAIRY SCI, V95, P196, DOI 10.3168/jds.2011-4531; Boonyayatra S, 2012, J VET DIAGN INVEST, V24, P7, DOI 10.1177/1040638711425936; Brenner J, 2009, ISR J VET MED, V64, P103; Byrne W, 2005, VET REC, V156, P767, DOI 10.1136/vr.156.24.767; Clothier KA, 2010, J VET DIAGN INVEST, V22, P956, DOI 10.1177/104063871002200618; Cole HH, 2013, REPROD DOMESTIC ANIM; Dairy Australia Limited, 2014, MYC DAIR HEARDS FACT; FISH NA, 1985, CAN VET J, V26, P13; Fox LK, 2012, VET CLIN N AM-FOOD A, V28, P225, DOI 10.1016/j.cvfa.2012.03.007; Fraser BC, 2014, AM J VET RES, V75, P200, DOI 10.2460/ajvr.75.2.200; Ghanem ME, 2013, THERIOGENOLOGY, V79, P180, DOI 10.1016/j.theriogenology.2012.09.027; GONZALEZ YRC, 1995, VET MICROBIOL, V47, P183, DOI 10.1016/0378-1135(95)00058-I; HALE HH, 1962, CORNELL VET, V52, P582; Hermeyer K, 2012, J VET DIAGN INVEST, V24, P364, DOI 10.1177/1040638711435145; Hewicker-Trautwein M, 2002, VET REC, V151, P699; Higuchi H, 2011, VET REC, V169, p442B, DOI 10.1136/vr.d5331; Hirose K, 2001, J VET MED SCI, V63, P691, DOI 10.1292/jvms.63.691; Infante-Martinez F, 1999, Rev Latinoam Microbiol, V41, P117; Justice-Allen A, 2011, J DAIRY SCI, V94, P3411, DOI 10.3168/jds.2010-3940; Kirk JH, 1997, J AM VET MED ASSOC, V211, P1036; Kobayashi H, 1998, J VET MED SCI, V60, P1299, DOI 10.1292/jvms.60.1299; MACKIE DP, 1982, VET REC, V110, P578, DOI 10.1136/vr.110.25.578; Maunsell FP, 2011, J VET INTERN MED, V25, P772, DOI 10.1111/j.1939-1676.2011.0750.x; Maunsell F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044523; McVey DS, 2013, VET MICROBIOLOGY; Nicholas RAJ, 2003, RES VET SCI, V74, P105, DOI 10.1016/S0034-5288(02)00155-8; Parker AM, 2016, VET MICROBIOL, V196, P118, DOI 10.1016/j.vetmic.2016.10.010; Petit T, 2008, VET REC, V162, P792, DOI 10.1136/vr.162.24.792; Punyapornwithaya V, 2010, PREV VET MED, V93, P66, DOI 10.1016/j.prevetmed.2009.08.008; Quinn PJ, 2013, VET MICROBIOLOGY MIC; Rossetti BC, 2010, MOL CELL PROBE, V24, P321, DOI 10.1016/j.mcp.2010.05.001; Sachse K, 2010, VET J, V186, P299, DOI 10.1016/j.tvjl.2009.10.008; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Stipkovits L, 2005, RES VET SCI, V78, P207, DOI 10.1016/j.rvsc.2004.09.005; Subramaniam S, 1998, MOL CELL PROBE, V12, P161, DOI 10.1006/mcpr.1998.0160; Tang J, 2000, J MICROBIOL METH, V39, P121, DOI 10.1016/S0167-7012(99)00107-4; Trachtenberg S, 2005, CURR BIOL, V15, pR483, DOI 10.1016/j.cub.2005.06.049; Wilson DJ, 2007, JAVMA-J AM VET MED A, V230, P1519, DOI 10.2460/javma.230.10.1519	42	24	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173422	10.1371/journal.pone.0173422	http://dx.doi.org/10.1371/journal.pone.0173422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264012	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300064
J	Joesaar, M; Viggor, S; Heinaru, E; Naanuri, E; Mehike, M; Leito, I; Heinaru, A				Joesaar, Merike; Viggor, Signe; Heinaru, Eeva; Naanuri, Eve; Mehike, Maris; Leito, Ivo; Heinaru, Ain			Strategy of Pseudomonas pseudoalcaligenes C70 for effective degradation of phenol and salicylate	PLOS ONE			English	Article							PUTIDA F1; BIODEGRADATION KINETICS; NAPHTHALENE-DEGRADATION; RING-CLEAVAGE; GROWTH; TOL; BENZENE; CLONING; PATHWAY; ACCUMULATION	Phenol- and naphthalene-degrading indigenous Pseudomonas pseudoalcaligenes strain C70 has great potential for the bioremediation of polluted areas. It harbours two chromosomally located catechol meta pathways, one of which is structurally and phylogenetically very similar to the Pseudomonas sp. CF600 dmp operon and the other to the P. stutzeri AN10 nah lower operon. The key enzymes of the catechol meta pathway, catechol 2,3-dioxygenase (C23O) from strain C70, PheB and NahH, have an amino acid identity of 85%. The metabolic and regulatory phenotypes of the wild-type and the mutant strain C70 Delta pheB lacking pheB were evaluated. qRT-PCR data showed that in C70, the expression of pheB- and nahH-encoded C23O was induced by phenol and salicylate, respectively. We demonstrate that strain C70 is more effective in the degradation of phenol and salicylate, especially at higher substrate concentrations, when these compounds are present as a mixture; i.e., when both pathways are expressed. Moreover, NahH is able to substitute for the deleted PheB in phenol degradation when salicylate is also present in the growth medium. The appearance of a yellow intermediate 2-hydroxymuconic semialdehyde was followed by the accumulation of catechol in salicylate-containing growth medium, and lower expression levels and specific activities of the C23O of the sal operon were detected. However, the excretion of the toxic intermediate catechol to the growth medium was avoided when the growth medium was supplemented with phenol, seemingly due to the contribution of the second meta pathway encoded by the phe genes.	[Joesaar, Merike; Viggor, Signe; Heinaru, Eeva; Naanuri, Eve; Mehike, Maris; Heinaru, Ain] Univ Tartu, Fac Sci & Technol, Inst Mol & Cell Biol, Tartu, Estonia; [Leito, Ivo] Univ Tartu, Fac Sci & Technol, Inst Chem, Tartu, Estonia	University of Tartu; University of Tartu	Joesaar, M (corresponding author), Univ Tartu, Fac Sci & Technol, Inst Mol & Cell Biol, Tartu, Estonia.	merike.joesaar@ut.ee	Leito, Ivo/U-9463-2019	Leito, Ivo/0000-0002-3000-4964	Institute of Molecular and Cell Biology, University of Tartu; Estonian Ministry of Education and Research [SF0180026s08, IUT20-19]; Estonian Science Foundation [7827]	Institute of Molecular and Cell Biology, University of Tartu; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation	This research was supported by the Institute of Molecular and Cell Biology, University of Tartu; by the research grants SF0180026s08 (Prof. Ain Heinaru), IUT20-19, and CELMS from the Estonian Ministry of Education and Research, and by the Estonian Science Foundation grant 7827. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Isolated strains are deposited in the Collection of Environmental and Laboratory Microbial Strains (CELMS; financed by the Estonian Ministry of Education and Research), the public catalogue of which is available on the Estonian Electronic Microbial dataBase (EEMB) website hilp://eemb.ut.ee. We are grateful to Sofia Tespelevits for assistance with the HPLC analysis of the samples. This manuscript was edited for English language by American Journal Experts (AJE).	ADAMS MARK H., 1959; [Anonymous], 2000, EURACHEM CITAC GUIDE; AOKI K, 1984, AGR BIOL CHEM TOKYO, V48, P2097, DOI 10.1080/00021369.1984.10866454; BAUCHOP T, 1960, J GEN MICROBIOL, V23, P457; Bertini L, 2013, BIOCHIMIE, V95, P241, DOI 10.1016/j.biochi.2012.09.018; Bosch R, 2000, GENE, V245, P65, DOI 10.1016/S0378-1119(00)00038-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CERDAN P, 1995, EUR J BIOCHEM, V229, P113, DOI 10.1111/j.1432-1033.1995.0113l.x; Choi KY, 2007, APPL ENVIRON MICROB, V73, P1370, DOI 10.1128/AEM.02379-06; Coronado E, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00300; Diaz E, 2013, CURR OPIN BIOTECH, V24, P431, DOI 10.1016/j.copbio.2012.10.010; GARCIAVALDES E, 1988, APPL ENVIRON MICROB, V54, P2478; George KW, 2012, MICROBIOL-SGM, V158, P2781, DOI 10.1099/mic.0.058230-0; George KW, 2011, ADV APPL MICROBIOL, V74, P1, DOI 10.1016/B978-0-12-387022-3.00005-7; George KW, 2011, MICROBIOL-SGM, V157, P89, DOI 10.1099/mic.0.042531-0; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HEGEMAN GD, 1966, J BACTERIOL, V91, P1140, DOI 10.1128/JB.91.3.1140-1154.1966; Heinaru E, 2001, FEMS MICROBIOL ECOL, V37, P79; Heinaru E, 2016, GENE, V589, P90, DOI 10.1016/j.gene.2016.05.022; HUGOUVIEUXCOTTEPATTAT N, 1990, J BACTERIOL, V172, P6651, DOI 10.1128/jb.172.12.6651-6660.1990; IlKim S, 1997, J BACTERIOL, V179, P5226; Jimenez JI, 2014, ENVIRON MICROBIOL, V16, P1767, DOI 10.1111/1462-2920.12361; Joesaar M, 2010, FEMS MICROBIOL ECOL, V72, P464, DOI 10.1111/j.1574-6941.2010.00858.x; Juang RS, 2006, BIOCHEM ENG J, V31, P133, DOI 10.1016/j.bej.2006.05.025; Juhanson J, 2009, FEMS MICROBIOL ECOL, V70, P446, DOI 10.1111/j.1574-6941.2009.00754.x; Junca H, 2004, MICROBIOL-SGM, V150, P4181, DOI 10.1099/mic.0.27451-0; Jutkina J, 2011, GENES-BASEL, V2, P853, DOI 10.3390/genes2040853; KEIL H, 1985, J BACTERIOL, V163, P248, DOI 10.1128/JB.163.1.248-255.1985; Kitayama A, 1996, J FERMENT BIOENG, V82, P217, DOI 10.1016/0922-338X(96)88811-8; Lee DS, 2005, J MICROBIOL BIOTECHN, V15, P859; Lovley DR, 2003, NAT REV MICROBIOL, V1, P35, DOI 10.1038/nrmicro731; Martinez-Garcia E, 2011, ENVIRON MICROBIOL, V13, P2702, DOI 10.1111/j.1462-2920.2011.02538.x; Monero A, 2003, BIOTECHNOL PROGR, V19, P676, DOI 10.1021/bp025764s; Munoz R, 2007, CHEMOSPHERE, V68, P244, DOI 10.1016/j.chemosphere.2007.01.016; Murakami S, 1999, BIOSCI BIOTECH BIOCH, V63, P859, DOI 10.1271/bbb.63.859; ODONNELL KJ, 1991, J GEN MICROBIOL, V137, P2831, DOI 10.1099/00221287-137-12-2831; Park W, 2004, APPL MICROBIOL BIOT, V64, P429, DOI 10.1007/s00253-003-1420-6; Perez-Pantoja D, 2003, J BACTERIOL, V185, P1534, DOI 10.1128/JB.185.5.1534-1542.2003; Pessione E, 2001, BIOL CHEM, V382, P1253, DOI 10.1515/BC.2001.156; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Powlowski Justin, 1994, Biodegradation, V5, P219, DOI 10.1007/BF00696461; Reardon KF, 2000, BIOTECHNOL BIOENG, V69, P385, DOI 10.1002/1097-0290(20000820)69:4<385::AID-BIT5>3.0.CO;2-Q; ROSSELLOMORA RA, 1994, APPL ENVIRON MICROB, V60, P966; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saez Pablo B., 1993, Biodegradation, V4, P3, DOI 10.1007/BF00701451; SALATREPAT JM, 1972, EUR J BIOCHEM, V28, P347, DOI 10.1111/j.1432-1033.1972.tb01920.x; SMITH MR, 1991, APPL MICROBIOL BIOT, V34, P536, DOI 10.1007/BF00180584; Sota M, 2006, J BACTERIOL, V188, P4057, DOI 10.1128/JB.00185-06; Suenaga H, 2009, FEMS MICROBIOL ECOL, V69, P472, DOI 10.1111/j.1574-6941.2009.00719.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422; VANDERMEER JR, 1992, MICROBIOL REV, V56, P677, DOI 10.1128/MMBR.56.4.677-694.1992; Vedler E, 2013, SYST APPL MICROBIOL, V36, P525, DOI 10.1016/j.syapm.2013.07.004; Widdel F, 2001, CURR OPIN BIOTECH, V12, P259, DOI 10.1016/S0958-1669(00)00209-3; Williams Peter A., 1994, Biodegradation, V5, P195, DOI 10.1007/BF00696460; YEN KM, 1982, P NATL ACAD SCI-BIOL, V79, P874, DOI 10.1073/pnas.79.3.874; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	57	13	14	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173180	10.1371/journal.pone.0173180	http://dx.doi.org/10.1371/journal.pone.0173180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257519	Green Submitted, Green Published, gold			2022-12-27	WOS:000396021100071
J	Maurer, L; Schwarz, F; Fischer-Rosinsky, A; Schlueter, N; Brachs, S; Mohlig, M; Pfeiffer, A; Mai, K; Spranger, J; Bobbert, T				Maurer, Lukas; Schwarz, Franziska; Fischer-Rosinsky, Antje; Schlueter, Nina; Brachs, Sebastian; Moehlig, Matthias; Pfeiffer, Andreas; Mai, Knut; Spranger, Joachim; Bobbert, Thomas			Renal function is independently associated with circulating betatrophin	PLOS ONE			English	Article							ANGIOPOIETIN-LIKE PROTEIN; TYPE-2 DIABETES SUBJECTS; GLUCOSE; HORMONE; LIPASIN; LEVEL; OBESE	Objective Betatrophin has been identified as a marker linking liver with beta cell function and lipid metabolism in murine models. Until now, the regulation of circulating betatrophin in humans is not entirely clear. We here analyzed the relation of betatrophin levels to phenotypes of the metabolic syndrome and speculated that renal function might influence circulating betatrophin levels and explain age-dependent changes of betatrophin. Subjects We analyzed blood samples from 535 individuals participating in the Metabolic Syndrome Berlin Potsdam study. Results In a crude analysis we found a positive correlation between betatrophin levels and HbA1c (r = 0.24; p < 0.001), fasting glucose (r = 0.20; p < 0.001) and triglycerides (r = 0.12; p = 0.007). Furthermore betatrophin was positively correlated with age (r = 0.47; p < 0.001), systolic blood pressure (r = 0.17; p < 0.001), intima media thickness (r = 0.26; p < 0.001) and negatively correlated with CKD-EPI eGFR (r = -0.33; p < 0.001) as an estimate of renal function. Notably, eGFR remained highly associated with betatrophin after adjustment for age, waist circumference, gender, HbA1c and lipid parameters in a multivariate linear regression model (beta = -0.197, p < 0.001). Conclusions Our data suggest that circulating levels of betatrophin depend on age, gender, waist circumference, total/HDL cholesterol ratio and renal function. Especially the association to eGFR highlights the importance for future studies to address renal function as possible influence on betatrophin regulation and consider eGFR as potential confounder when analyzing the role of betatrophin in humans.	[Maurer, Lukas; Schwarz, Franziska; Fischer-Rosinsky, Antje; Schlueter, Nina; Brachs, Sebastian; Moehlig, Matthias; Pfeiffer, Andreas; Mai, Knut; Spranger, Joachim; Bobbert, Thomas] Charite, Dept Endocrinol Diabet & Nutr, Berlin, Germany; [Maurer, Lukas; Fischer-Rosinsky, Antje; Mai, Knut; Spranger, Joachim] Charite, Expt & Clin Res Ctr, Berlin, Germany; [Maurer, Lukas; Fischer-Rosinsky, Antje; Mai, Knut; Spranger, Joachim] Max Delbruck Zentrum, Berlin, Germany; [Maurer, Lukas; Schwarz, Franziska; Fischer-Rosinsky, Antje; Schlueter, Nina; Brachs, Sebastian; Spranger, Joachim] Charite, Charite Ctr Cardiovasc Res CCR, Berlin, Germany; [Schlueter, Nina; Pfeiffer, Andreas] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany; [Pfeiffer, Andreas] German Inst Human Nutr, Dept Clin Nutr, Nuthetal, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Spranger, J (corresponding author), Charite, Dept Endocrinol Diabet & Nutr, Berlin, Germany.; Spranger, J (corresponding author), Charite, Expt & Clin Res Ctr, Berlin, Germany.; Spranger, J (corresponding author), Max Delbruck Zentrum, Berlin, Germany.; Spranger, J (corresponding author), Charite, Charite Ctr Cardiovasc Res CCR, Berlin, Germany.	joachim.spranger@charite.de	Mai, Knut/W-9904-2019; Pfeiffer, Andreas F.H./AAJ-2311-2020	Mai, Knut/0000-0003-0126-3155; Pfeiffer, Andreas F.H./0000-0002-6887-0016; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Brachs, Sebastian/0000-0002-6336-3939	Deutsches Zentrum fur Herz-Kreislauf-Forschung; Berlin Institute of Health; Deutsche Diabetes Gesellschaft; Deutsche Forschungsgemeinschaft DFG [KF0218]	Deutsches Zentrum fur Herz-Kreislauf-Forschung; Berlin Institute of Health; Deutsche Diabetes Gesellschaft; Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	The study was supported by the Deutsches Zentrum fur Herz-Kreislauf-Forschung (https://dzhk.de/), the Berlin Institute of Health (https://www.bihealth.org/), the Deutsche Diabetes Gesellschaft (http://www.deutsche-diabetes-gesellschaft.de/home.html) and the Deutsche Forschungsgemeinschaft DFG KF0218 (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10949; Barja-Fernandez S, 2015, J CLIN ENDOCR METAB, V100, pE1188, DOI 10.1210/JC.2015-1595; Bobbert T, 2013, DIABETES CARE, V36, P145, DOI 10.2337/dc12-0703; Chen CC, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-015-0326-9; Chen X, 2015, J CLIN ENDOCR METAB, V100, pE96, DOI 10.1210/jc.2014-2300; Crujeiras AB, 2015, INT J OBES LOND; Ebert T, 2014, J CLIN ENDOCR METAB, V99, pE2510, DOI 10.1210/jc.2013-4349; Ebert T, 2015, EUR J ENDOCRINOL, V173, P1, DOI 10.1530/EJE-14-0815; Espes D, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/323407; Espes D, 2014, DIABETOLOGIA, V57, P50, DOI 10.1007/s00125-013-3071-1; Fenzl A, 2014, DIABETOLOGIA, V57, P1204, DOI 10.1007/s00125-014-3208-x; Fu ZY, 2014, DIABETOLOGIA, V57, P2232, DOI 10.1007/s00125-014-3346-1; Fu ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05013; Fu ZY, 2013, BIOCHEM BIOPH RES CO, V430, P1126, DOI 10.1016/j.bbrc.2012.12.025; Gao T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133640; Gokulakrishnan K, 2015, DIABETES RES CLIN PR, V109, P71, DOI 10.1016/j.diabres.2015.04.028; Gomez-Ambrosi J, 2014, J CLIN ENDOCR METAB, V99, pE2004, DOI 10.1210/jc.2014-1568; Guo KF, 2015, OBESITY, V23, P793, DOI 10.1002/oby.21038; Gusarova V, 2014, CELL, V159, P691, DOI 10.1016/j.cell.2014.09.027; Hu H, 2014, DIABETES CARE, V37, P2718, DOI 10.2337/dc14-0602; Jiao Y, 2014, DIABETES, V63, P1283, DOI 10.2337/db13-1435; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mahmood D, 2014, INT J ARTIF ORGANS, V37, P13, DOI 10.5301/ijao.5000252; Maurer L, 2016, J CLIN ENDOCR METAB, V101, P4014, DOI 10.1210/jc.2016-1788; Merabet E, 1997, J CLIN ENDOCR METAB, V82, P847, DOI 10.1210/jc.82.3.847; Organization WH, 2005, REP WHO IDF CONS DEF; Pfau D, 2010, DIABETES CARE, V33, P171, DOI 10.2337/dc09-1351; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Ren G, 2012, AM J PHYSIOL-ENDOC M, V303, pE334, DOI 10.1152/ajpendo.00084.2012; Stein S, 2009, DIABETES CARE, V32, P126, DOI 10.2337/dc08-1054; Tokumoto S, 2015, DIABETIC MED, V32, P653, DOI 10.1111/dme.12696; Trebotic LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136701; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Wu S, 2014, PEDIAT DIABETES; Yamada H, 2015, ENDOCR J, V62, P417, DOI 10.1507/endocrj.EJ14-0525; Yi P, 2017, CELL, V168, P326, DOI 10.1016/j.cell.2016.12.017; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038	38	13	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173197	10.1371/journal.pone.0173197	http://dx.doi.org/10.1371/journal.pone.0173197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257453	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000396021100073
J	Nanwa, N; Sander, B; Krahn, M; Daneman, N; Lu, H; Austin, PC; Govindarajan, A; Rosella, LC; Cadarette, SM; Kwong, JC				Nanwa, Natasha; Sander, Beate; Krahn, Murray; Daneman, Nick; Lu, Hong; Austin, Peter C.; Govindarajan, Anand; Rosella, Laura C.; Cadarette, Suzanne M.; Kwong, Jeffrey C.			A population-based matched cohort study examining the mortality and costs of patients with community-onset Clostridium difficile infection identified using emergency department visits and hospital admissions	PLOS ONE			English	Article							ELDERLY CANCER-PATIENTS; UNITED-STATES; OF-ILLNESS; CARE; SURVEILLANCE; DISEASE; EPIDEMIOLOGY; DEATH	Few studies have evaluated the mortality or quantified the economic burden of community-onset Clostridium difficile infection (CDI). We estimated the attributable mortality and costs of community-onset CDI. We conducted a population-based matched cohort study. We identified incident subjects with community-onset CDI using health administrative data (emergency department visits and hospital admissions) in Ontario, Canada between January 1, 2003 and December 31, 2010. We propensity-score matched each infected subject to one uninfected subject and followed subjects in the cohort until December 31, 2011. We evaluated all-cause mortality and costs (unadjusted and adjusted for survival) from the healthcare payer perspective (2014 Canadian dollars). During our study period, we identified 7,950 infected subjects. The mean age was 63.5 years (standard deviation = 22.0), 62.7% were female, and 45.0% were very high users of the healthcare system. The relative risk for 30-day, 180-day, and 1-year mortality were 7.32 (95% confidence interval [CI], 5.94-9.02), 3.55 (95% CI, 3.17-3.97), and 2.59 (95% CI, 2.37-2.83), respectively. Mean attributable cumulative 30-day, 180-day, and 1-year costs (unadjusted for survival) were $7,434 (95% CI, $7,122-$7,762), $12,517 (95% CI, $11,687-$ 13,366), and $13,217 (95% CI, $12,062-$ 14,388). Mean attributable cumulative 1-,2-, and 3-year costs (adjusted for survival) were $10,700 (95% CI, $9,811-$11,645), $13,312 (95% CI, $ 12,024-$14,682), and $ 15,812 (95% CI, $ 14,159-$17,571). Infected subjects had considerably higher risk of all-cause mortality and costs compared with uninfected subjects. This study provides insight on an understudied patient group. Our study findings will facilitate assessment of interventions to prevent community-onset CDI.	[Nanwa, Natasha; Krahn, Murray; Cadarette, Suzanne M.] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Nanwa, Natasha; Sander, Beate; Krahn, Murray] Toronto Hlth Econ & Technol Assessment Collaborat, Toronto, ON, Canada; [Sander, Beate; Rosella, Laura C.; Kwong, Jeffrey C.] Publ Hlth Ontario, Toronto, ON, Canada; [Sander, Beate; Krahn, Murray; Daneman, Nick; Austin, Peter C.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Sander, Beate; Krahn, Murray; Daneman, Nick; Lu, Hong; Austin, Peter C.; Govindarajan, Anand; Rosella, Laura C.; Cadarette, Suzanne M.; Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Krahn, Murray; Kwong, Jeffrey C.] Univ Hlth Network, Toronto, ON, Canada; [Krahn, Murray; Daneman, Nick] Univ Toronto, Dept Med, Toronto, ON, Canada; [Daneman, Nick; Austin, Peter C.] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Govindarajan, Anand] Mt Sinai Hosp, Toronto, ON, Canada; [Govindarajan, Anand] Univ Toronto, Dept Surg, Div Gen Surg, Toronto, ON, Canada; [Rosella, Laura C.; Kwong, Jeffrey C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Toronto; University of Toronto	Nanwa, N (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada.	natasha.nanwa@mail.utoronto.ca	Sander, Beate/P-7665-2018	Sander, Beate/0000-0003-2128-9133; Cadarette, Suzanne/0000-0002-8584-9649; Krahn, Murray/0000-0001-5836-397X	CIHR operating grant [MOP 130553]; Institute for Clinical Evaluative Sciences (ICES); Public Health Ontario (PHO); Ontario Ministry of Health and Long-Term Care (MOHLTC)	CIHR operating grant(Canadian Institutes of Health Research (CIHR)); Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Public Health Ontario (PHO); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This study was supported by a CIHR operating grant (grant number: MOP 130553, grant recipient: Beate Sander), the Institute for Clinical Evaluative Sciences (ICES), and Public Health Ontario (PHO). ICES and PHO are funded by annual grants from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results, and conclusions reported in this article do not necessarily represent the views of CIHR, ICES, PHO, or the MOHLTC. Parts of this material are based on data and information compiled and provided by the Canadian Institute of Health Information (CINI). However, the analyses, conclusions, opinions and statements expressed herein are those of the authors, and not necessarily those of CIHI.	Agresti A, 2004, STAT MED, V23, P65, DOI 10.1002/sim.1589; Austin PC, 2014, STAT MED, V33, P4306, DOI 10.1002/sim.6276; Austin PC, 2011, MED CARE, V49, P932, DOI 10.1097/MLR.0b013e318215d5e2; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Bank of Canada, 2014, ANN AV EXCH RAT; Barlow WE, 2009, MED CARE, V47, pS33, DOI 10.1097/MLR.0b013e3181a2d847; Brown ML, 1999, MED CARE, V37, P1249, DOI 10.1097/00005650-199912000-00008; Canadian Agency for Drugs and Technologies in Health (CADTH), 2017, GUID EC EV HLTH TECH; Centers for Disease Control and Prevention, 2015, CLOSTR DIFF INF TRAC; Clohessy P, 2014, INT J INFECT DIS, V29, P152, DOI 10.1016/j.ijid.2014.08.009; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Hirshon JM, 2011, EMERG INFECT DIS, V17, P1946, DOI 10.3201/eid1710.110069; Karas JA, 2010, J INFECTION, V61, P1, DOI 10.1016/j.jinf.2010.03.025; Kuntz JL, 2012, INFECT CONT HOSP EP, V33, P1031, DOI 10.1086/667733; Kutty PK, 2008, INFECT CONT HOSP EP, V29, P197, DOI 10.1086/528813; Larg A, 2011, PHARMACOECONOMICS, V29, P653, DOI 10.2165/11588380-000000000-00000; Lash TL, 2011, LUNG, V189, P27, DOI 10.1007/s00408-010-9274-z; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lipscomb J, 2009, MED CARE, V47, pS1, DOI 10.1097/MLR.0b013e3181a7e401; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; Nanwa N, 2015, AM J GASTROENTEROL, V110, P511, DOI 10.1038/ajg.2015.48; Negron M, 2011, AMERICAN JOURNAL OF, V106, pS481; Organisation for Economic Co Operation and Development, 2014, PPPS EXCH RAT; Pillai DR, 2010, CLIN INFECT DIS, V50, P1685, DOI 10.1086/653007; RILEY GF, 1995, MED CARE, V33, P828, DOI 10.1097/00005650-199508000-00007; Sammons JS, 2013, CLIN INFECT DIS, V57, P1, DOI 10.1093/cid/cit155; Su CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071055; Tan XQ, 2014, INT J ANTIMICROB AG, V43, P47, DOI 10.1016/j.ijantimicag.2013.09.011; Tarricone R, 2006, HEALTH POLICY, V77, P51, DOI 10.1016/j.healthpol.2005.07.016; Wodchis WP, 2013, WORKING PAPER SERIES; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103	33	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172410	10.1371/journal.pone.0172410	http://dx.doi.org/10.1371/journal.pone.0172410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257438	gold, Green Published, Green Submitted			2022-12-27	WOS:000396021100017
J	Pages-Monteiro, L; Marti, R; Commun, C; Alliot, N; Bardel, C; Meugnier, H; Perouse-de-Montclos, M; Reix, P; Durieu, I; Durupt, S; Vandenesch, F; Freney, J; Cournoyer, B; Doleans-Jordheim, A				Pages-Monteiro, Laurence; Marti, Romain; Commun, Carine; Alliot, Nolwenn; Bardel, Claire; Meugnier, Helene; Perouse-de-Montclos, Michele; Reix, Philippe; Durieu, Isabelle; Durupt, Stephane; Vandenesch, Francois; Freney, Jean; Cournoyer, Benoit; Doleans-Jordheim, Anne			Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa	PLOS ONE			English	Article							INTERGENIC SPACER ANALYSIS; STAPHYLOCOCCUS-AUREUS; MICROBIAL DIVERSITY; AIRWAY MICROBIOTA; STENOTROPHOMONAS-MALTOPHILIA; YOUNG-CHILDREN; LUNG-FUNCTION; COMMUNITIES; INFECTIONS; RESISTANCE	Cystic fibrosis (CF) lungs harbor a complex community of interacting microbes, including pathogens like Pseudomonas aeruginosa. Meta-taxogenomic analysis based on V5-V6 rrs PCR products of 52 P. aeruginosa-positive (Pp) and 52 P. aeruginosa-negative (Pn) pooled DNA extracts from CF sputa suggested positive associations between P. aeruginosa and Stenotrophomonas and Prevotella, but negative ones with Haemophilus, Neisseria and Burkholderia. Internal Transcribed Spacer analyses (RISA) from individual DNA extracts identified three significant genetic structures within the CF cohorts, and indicated an impact of P. aeruginosa. RISA clusters Ip and IIIp contained CF sputa with a P. aeruginosa prevalence above 93%, and of 24.2% in cluster IIp. Clusters Ip and IIIp showed lower RISA genetic diversity and richness than IIp. Highly similar cluster IIp RISA profiles were obtained from two patients harboring isolates of a same P. aeruginosa clone, suggesting convergent evolution in the structure of their microbiota. CF patients of cluster IIp had received significantly less antibiotics than patients of clusters Ip and IIIp but harbored the most resistant P. aeruginosa strains. Patients of cluster IIIp were older than those of Ip. The effects of P. aeruginosa on the RISA structures could not be fully dissociated from the above two confounding factors but several trends in these datasets support the conclusion of a strong incidence of P. aeruginosa on the genetic structure of CF lung microbiota.	[Pages-Monteiro, Laurence; Marti, Romain; Commun, Carine; Alliot, Nolwenn; Freney, Jean; Cournoyer, Benoit; Doleans-Jordheim, Anne] Univ Lyon 1, UMR CNRS Ecol Microbienne 5557, Equipe Rech Bacteries Pathogenes Opportunistes &, Villeurbanne, France; [Pages-Monteiro, Laurence; Marti, Romain; Commun, Carine; Alliot, Nolwenn; Freney, Jean; Cournoyer, Benoit; Doleans-Jordheim, Anne] VetAgro Sup, Villeurbanne, France; [Pages-Monteiro, Laurence; Vandenesch, Francois; Freney, Jean; Doleans-Jordheim, Anne] Hosp Civils Lyon HCL, Ctr Biol & Pathol Est, Lab Bacteriol, Bron, France; [Bardel, Claire] Univ Lyon 1, Equipe Rech, UMR CNRS 5558, INRA,INRIA,Lab Biometrie & Biol Evolut, Lyon, France; [Bardel, Claire] ISPB, Lyon, France; [Meugnier, Helene] Univ Lyon, Ecole Normale Super Lyon, INSERM, CIRI,Int Ctr Infectiol Res,CNRS UMR5308,U1111, Lyon, France; [Perouse-de-Montclos, Michele] Hosp Civils Lyon, Lab Bacteriol, St Genis Laval, France; [Perouse-de-Montclos, Michele; Durieu, Isabelle; Durupt, Stephane] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Ctr Ressources & Competences CRCM Adulte, Pierre Benite, France; [Reix, Philippe] Hosp Civils Lyon, Ctr Ressources & Competences CRCM Enfant, Hop Femme Mere Enfant, Lyon, France; [Vandenesch, Francois] INSERM, U851, Equipe Rech Pathogenie Staphylocoques, Bron, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); INRAE; Inria; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; CHU Lyon; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Doleans-Jordheim, A (corresponding author), Univ Lyon 1, UMR CNRS Ecol Microbienne 5557, Equipe Rech Bacteries Pathogenes Opportunistes &, Villeurbanne, France.; Doleans-Jordheim, A (corresponding author), VetAgro Sup, Villeurbanne, France.; Doleans-Jordheim, A (corresponding author), Hosp Civils Lyon HCL, Ctr Biol & Pathol Est, Lab Bacteriol, Bron, France.	anne.doleans-jordheim@univ-lyon1.fr	Marti, Romain/F-5645-2014; Vandenesch, Francois/C-7209-2014	Marti, Romain/0000-0002-2887-2201; Vandenesch, Francois/0000-0001-9412-7106	ONG Vaincre la Mucoviscidose; Association Gregory Lemarchal; ONG soroptimist european club; french GDR (Group de recherche) Pseudomonas; CNRS; Universite Lyon 1; VetAgro Sup	ONG Vaincre la Mucoviscidose; Association Gregory Lemarchal; ONG soroptimist european club; french GDR (Group de recherche) Pseudomonas; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Lyon 1; VetAgro Sup	The author received funding from ONG Vaincre la Mucoviscidose and the Association Gregory Lemarchal, from ONG soroptimist european club, french GDR (Group de recherche) Pseudomonas, CNRS, Universite Lyon 1, and VetAgro Sup. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge LP Jordheim for assistance with the preparation of the manuscript. We acknowledge the ONG VLM (Vaincre la mucoviscidose) and the association Gregory Lemarchal. Thanks are expressed to GDR Pseudomonas, and funding from CNRS, Universite Lyon 1 and VetAgro Sup. We acknowledge all members of the ONG Soroptimist International Europe club for financial contribution.	Adabi M, 2015, INFECT CHEMOTHER, V47, P98, DOI 10.3947/ic.2015.47.2.98; Ahlgren HG, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0062-7; [Anonymous], 2015, R LANG ENV STAT COMP; Baldan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089614; Ballmann M, 1998, THORAX, V53, P732, DOI 10.1136/thx.53.9.732; Barnabie PM, 2015, J BACTERIOL, V197, P2250, DOI 10.1128/JB.00303-15; Beaume M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00321; Birtel J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125356; Bonnet R, 2014, A A, P325; Brady C, 2014, J CYST FIBROS, V13, P43, DOI 10.1016/j.jcf.2013.08.002; Carmody LA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0074-9; Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC; Colinon C, 2010, ENVIRON MICROBIOL, V12, P716, DOI 10.1111/j.1462-2920.2009.02115.x; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Cuthbertson L, 2015, ISME J; Danovaro R, 2006, APPL ENVIRON MICROB, V72, P5982, DOI 10.1128/AEM.01361-06; Davenport CF, 2013, ENVIRON MICROBIOL, V15, P1, DOI 10.1111/j.1462-2920.2012.02843.x; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Flight WG, 2015, J CLIN MICROBIOL, V53, P2022, DOI 10.1128/JCM.00432-15; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Gibson RL, 2003, AM J RESP CRIT CARE, V167, P841, DOI 10.1164/rccm.200208-855OC; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Goeminne PC, 2015, J CYST FIBROS; Goss CH, 2004, THORAX, V59, P955, DOI 10.1136/thx.2003.017707; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hewson I, 2006, MICROB ECOL, V51, P147, DOI 10.1007/s00248-005-0144-9; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Ishii S, 2009, J MICROBIOL METH, V78, P344, DOI 10.1016/j.mimet.2009.07.005; Jarry TM, 2006, INFECT IMMUN, V74, P2568, DOI 10.1128/IAI.74.5.2568-2577.2006; Keravec M, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1207-0; Kiley JP, 2011, CHEST, V140, P497, DOI 10.1378/chest.11-0774; Klepac-Ceraj V, 2012, GEOBIOLOGY, V10, P223, DOI 10.1111/j.1472-4669.2012.00317.x; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lavenir R, 2007, J MICROBIOL METH, V70, P20, DOI 10.1016/j.mimet.2007.03.008; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; MACHAN ZA, 1992, J ANTIMICROB CHEMOTH, V30, P615, DOI 10.1093/jac/30.5.615; Mitchell G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-33; Moree WJ, 2012, P NATL ACAD SCI USA, V109, P13811, DOI 10.1073/pnas.1206855109; Nazaret S, 2009, J MICROBIOL METH, V76, P58, DOI 10.1016/j.mimet.2008.09.019; Parkins MD, 2015, J CYST FIBROS, V14, P293, DOI 10.1016/j.jcf.2015.03.012; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Pompilio- A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00951; Price KE, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-27; Psoter KJ, 2015, EPIDEMIOL INFECT, P1; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Raidt L, 2015, PEDIATR INFECT DIS J, V34, P700, DOI 10.1097/INF.0000000000000714; Ramsey KA, 2014, AM J RESP CRIT CARE, V190, P1111, DOI 10.1164/rccm.201407-1277OC; Renwick J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109798; Rogers GB, 2013, THORAX, V68, P731, DOI 10.1136/thoraxjnl-2012-203105; Rogers GB, 2013, TRENDS MICROBIOL, V21, P271, DOI 10.1016/j.tim.2013.03.004; ROMLING U, 1994, J INFECT DIS, V170, P1616, DOI 10.1093/infdis/170.6.1616; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sherrard LJ, 2014, LANCET, V384, P703, DOI 10.1016/S0140-6736(14)61137-5; Sibley CD, 2011, CAN J MICROBIOL, V57, P69, DOI [10.1139/W10-105, 10.1139/w10-105]; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; TODER DS, 1994, INFECT IMMUN, V62, P1320, DOI 10.1128/IAI.62.4.1320-1327.1994; Twomey KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082432; Tyrrell J, 2015, MICROBIOLOGY; van Dorst J, 2014, FEMS MICROBIOL ECOL, V89, P316, DOI 10.1111/1574-6941.12308; VandenBranden SL, 2012, PEDIATR PULM, V47, P135, DOI 10.1002/ppul.21526; Whiley RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115513; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; WOOD RE, 1987, J PEDIATR-US, V111, P841, DOI 10.1016/S0022-3476(87)80198-1; Yang L, 2011, ENVIRON MICROBIOL, V13, P1682, DOI 10.1111/j.1462-2920.2011.02459.x; Zhao JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04345; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	72	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173022	10.1371/journal.pone.0173022	http://dx.doi.org/10.1371/journal.pone.0173022			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282386	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800015
J	Vermeersch, E; Denorme, F; Maes, W; De Meyer, SF; Vanhoorelbeke, K; Edwards, J; Shevach, EM; Unutmaz, D; Fujii, H; Deckmyn, H; Tersteeg, C				Vermeersch, Elien; Denorme, Frederik; Maes, Wim; De Meyer, Simon F.; Vanhoorelbeke, Karen; Edwards, Justin; Shevach, Ethan M.; Unutmaz, Derya; Fujii, Hodaka; Deckmyn, Hans; Tersteeg, Claudia			The role of platelet and endothelial GARP in thrombosis and hemostasis	PLOS ONE			English	Article							LATENT TGF-BETA; MESSENGER-RNA EXPRESSION; REGULATORY T-CELL; IN-VIVO; GENE-EXPRESSION; TRANSGENIC MICE; MODEL; SURFACE; ACTIVATION; TGF-BETA-1	Background Glycoprotein-A Repetitions Predominant protein (GARP or LRRC32) is present on among others human platelets and endothelial cells. Evidence for its involvement in thrombus formation was suggested by full knockout of GARP in zebrafish. Objectives To evaluate the role of GARP in platelet physiology and in thrombus formation using platelet and endothelial conditional GARP knock out mice. Methods Platelet and endothelial specific GARP knockout mice were generated using the Cre-loxP recombination system. The function of platelets without GARP was measured by flow cytometry, spreading analysis and aggregometry using PAR4-activating peptide and collagen related peptide. Additionally, clot retraction and collagen-induced platelet adhesion and aggregation under flow were analyzed. Finally, in vivo tail bleeding time, occlusion time of the mesenteric and carotid artery after FeCI3-induced thrombosis were determined in platelet and endothelial specific GARP knock out mice. Results Platelet specific GARP knockout mice had normal surface GPIb, GPVI and integrin al lb glycoprotein expression. Although GARP expression was increased upon platelet activation, platelets without GARP displayed normal agonist induced activation, spreading on fibrinogen and aggregation responses. Furthermore, absence of GARP on platelets did not influence clot retraction and had no impact on thrombus formation on collagen-coated surfaces under flow. In line with this, neither the tail bleeding time nor the occlusion time in the carotidand mesenteric artery after FeCI3-induced thrombus formation in platelet or endothelial specific GARP knock out mice were affected. Conclusions Evidence is provided that platelet and endothelial GARP are not important in hemostasis and thrombosis in mice.	[Vermeersch, Elien; Denorme, Frederik; Maes, Wim; De Meyer, Simon F.; Vanhoorelbeke, Karen; Deckmyn, Hans; Tersteeg, Claudia] Katholieke Univ Leuven, IRF Life Sci, Lab Thrombosis Res, Campus Kulak Kortrijk, Kortrijk, Belgium; [Edwards, Justin; Shevach, Ethan M.] NIAID, Immunol Lab, Bldg 10, Bethesda, MD 20892 USA; [Unutmaz, Derya] Jackson Lab Genom Med, Farmington, CT USA; [Fujii, Hodaka] Osaka Univ, Chromatin Biochem Res Grp, Combined Program Microbiol & Immunol, Microbial Dis Res Inst, Osaka, Japan	KU Leuven; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Jackson Laboratory; Osaka University	Deckmyn, H (corresponding author), Katholieke Univ Leuven, IRF Life Sci, Lab Thrombosis Res, Campus Kulak Kortrijk, Kortrijk, Belgium.	Hans.Deckmyn@kuleuven.be	Fujii, Hodaka/A-2420-2008; Deckmyn, Hans/N-8932-2019; Deckmyn, Hans/L-9434-2015; Fujii, Hodaka/N-9792-2019; Tersteeg, Claudia/V-3758-2018	Fujii, Hodaka/0000-0003-1296-4256; Deckmyn, Hans/0000-0003-3952-5501; Deckmyn, Hans/0000-0003-3952-5501; Fujii, Hodaka/0000-0003-1296-4256; Tersteeg, Claudia/0000-0002-6380-6349; Vanhoorelbeke, Karen/0000-0003-2288-8277; Denorme, Frederik/0000-0003-1442-3568; Maes, Wim/0000-0002-4629-6674; Edwards, Justin/0000-0001-8936-2136; De Meyer, Simon/0000-0002-1807-5882; Vermeersch, Elien/0000-0002-1425-9561	Research Foundation Flanders (FWO), Belgium [G.0628.13]; FWO, Belgium [12N0715N]; Division of Intramural Research, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065303, ZIAAI000224] Funding Source: NIH RePORTER	Research Foundation Flanders (FWO), Belgium(FWO); FWO, Belgium(FWO); Division of Intramural Research, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	HD received funding from the Research Foundation Flanders (FWO, http://www.fwo.be), Belgium (FWO grant G.0628.13). CT is a Postdoctoral Fellow also supported by the FWO, Belgium (12N0715N). JE and EMS are supported by funds from the Division of Intramural Research, NIAID (http://www.niaid.niti.gov/about/dir). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cuende J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1983; De Meyer SF, 2008, ARTERIOSCL THROM VAS, V28, P1621, DOI 10.1161/ATVBAHA.108.168369; De Meyer Simon F, 2011, Exp Transl Stroke Med, V3, P9, DOI 10.1186/2040-7378-3-9; Denorme F, 2016, THROMB HAEMOSTASIS, V116, P597, DOI 10.1160/TH16-01-0036; Edwards JP, 2013, J IMMUNOL, V190, P5506, DOI 10.4049/jimmunol.1300199; Fridrich S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153290; GRAINGER DJ, 1995, NAT MED, V1, P932, DOI 10.1038/nm0995-932; Hofmann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115306; Kehrmann A, 2013, CANCER GENET-NY, V206, P279, DOI 10.1016/j.cancergen.2013.06.002; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kooijman S, 2015, J THROMB HAEMOST, V13, P126, DOI 10.1111/jth.12765; Korporaal SJA, 2011, ARTERIOSCL THROM VAS, V31, P34, DOI 10.1161/ATVBAHA.110.210252; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Lang MR, 2010, J THROMB HAEMOST, V8, P1159, DOI 10.1111/j.1538-7836.2010.03815.x; Lev PR, 2007, PLATELETS, V18, P35, DOI 10.1080/09537100600800743; Li Y, 2015, J IMMUNOL, V195, P2648, DOI 10.4049/jimmunol.1500139; Macaulay IC, 2007, BLOOD, V109, P3260, DOI 10.1182/blood-2006-07-036269; Meyer A, 2012, BLOOD, V119, P1064, DOI 10.1182/blood-2011-09-377648; O'Connor MN, 2009, BLOOD, V113, P4754, DOI 10.1182/blood-2008-06-162693; OLLENDORFF V, 1992, MAMM GENOME, V2, P195, DOI 10.1007/BF00302877; Roubin R, 1996, INT J DEV BIOL, V40, P545; Salles-Crawley II, 2014, BLOOD, V123, P2873, DOI 10.1182/blood-2013-10-534024; Soslau G, 1997, CYTOKINE, V9, P405, DOI 10.1006/cyto.1996.0182; Stalker TJ, 2009, J THROMB HAEMOST, V7, P1886, DOI 10.1111/j.1538-7836.2009.03606.x; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Tersteeg C, 2014, CIRC RES, V114, P780, DOI 10.1161/CIRCRESAHA.114.302361; Thijs T, 2012, BLOOD, V119, P1634, DOI 10.1182/blood-2011-10-381715; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Verhenne S, 2015, BLOOD, V126, P1715, DOI 10.1182/blood-2015-03-632901; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Weyand AC, 2014, CURR OPIN HEMATOL, V21, P418, DOI 10.1097/MOH.0000000000000075; Wu QY, 1998, J CLIN INVEST, V101, P321, DOI 10.1172/JCI1617	35	19	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173329	10.1371/journal.pone.0173329	http://dx.doi.org/10.1371/journal.pone.0173329			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278197	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900073
J	Domingues, MJ; Martinez-Sanz, J; Papon, L; Larue, L; Mouawad, L; Bonaventure, J				Domingues, Melanie J.; Martinez-Sanz, Juan; Papon, Laura; Larue, Lionel; Mouawad, Liliane; Bonaventure, Jacky			Structure-based mutational analysis of ICAT residues mediating negative regulation of beta-catenin co-transcriptional activity	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; MELANOMA-CELLS; E-CADHERIN; BINDING; ACTIVATION; COMPLEX; TCF/LEF; PROLIFERATION; METASTASIS	ICAT (Inhibitor of beta-CAtenin and TCF) is a small acidic protein that negatively regulates beta-catenin co-transcriptional activity by competing with TCF/LEF factors in their binding to beta-catenin superhelical core. In melanoma cells, ICAT competes with LEF1 to negatively regulate the M-MITF and NEDD9 target genes. The structure of ICAT consists of two domains: the 3-helix bundle N-terminal domain binds to beta-catenin Armadillo (Arm) repeats 10-12 and the C-terminal tail binds to Arm repeats 5-9. To elucidate the structural mechanisms governing ICAT/beta-catenin interactions in melanoma cells, three ICAT residues Y15, K19 and V22 in the N-terminal domain, contacting hydrophobic beta-catenin residue F660, were mutated and interaction was assessed by immunoprecipitation. Despite the moderate hydrophobicity of the contact, its removal completely abolished the interaction. In the ICAT C-terminal tail consensus sequence, neutralization of the electrostatic interactions between residues D66, E75 and beta-catenin residues K435, K312, coupled to deletion of the hydrophobic contact between F71 and beta-catenin R386, markedly reduced, but failed to abolish the ICAT-mediated negative regulation of M-MITF and NEDD9 promoters. We conclude that in melanoma cells, anchoring of ICAT N-terminal domain to beta-catenin through the hook made by residue F660, trapped in the pincers formed by ICAT residues Y15 and V22, is crucial for stabilizing the ICAT/beta-catenin complex. This is a prerequisite for binding of the consensus peptide to Arm repeats 5-9 and competition with LEF1. Differences between ICAT and LEF1 in their affinity for beta-catenin may rely on the absence in ICAT of hydrophilic residues between D66 and F71.	[Domingues, Melanie J.; Martinez-Sanz, Juan; Papon, Laura; Larue, Lionel; Mouawad, Liliane; Bonaventure, Jacky] PSL Res Univ, Inst Curie, Orsay, France; [Domingues, Melanie J.; Martinez-Sanz, Juan; Papon, Laura; Larue, Lionel; Mouawad, Liliane; Bonaventure, Jacky] Univ Paris Saclay, Univ Paris Sud, Orsay, France; [Domingues, Melanie J.; Papon, Laura; Larue, Lionel; Bonaventure, Jacky] INSERM, U1021, Normal & Pathol Dev Melanocytes, Orsay, France; [Domingues, Melanie J.; Papon, Laura; Larue, Lionel; Bonaventure, Jacky] CNRS, UMR 3347, Orsay, France; [Domingues, Melanie J.; Papon, Laura; Larue, Lionel; Bonaventure, Jacky] Equipe Labellisee Ligue Canc, Orsay, France; [Martinez-Sanz, Juan; Mouawad, Liliane] INSERM, U1196, Chem Modelling & Imaging Biol, Orsay, France; [Martinez-Sanz, Juan; Mouawad, Liliane] CNRS, UMR 9187, Orsay, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Bonaventure, J (corresponding author), PSL Res Univ, Inst Curie, Orsay, France.; Bonaventure, J (corresponding author), Univ Paris Saclay, Univ Paris Sud, Orsay, France.; Bonaventure, J (corresponding author), INSERM, U1021, Normal & Pathol Dev Melanocytes, Orsay, France.; Bonaventure, J (corresponding author), CNRS, UMR 3347, Orsay, France.; Bonaventure, J (corresponding author), Equipe Labellisee Ligue Canc, Orsay, France.	jacky.bonaventure@i2bc.paris-saclay.fr	Mouawad, Liliane/N-1945-2018; Larue, Lionel/I-6532-2016	Mouawad, Liliane/0000-0002-7155-9712; 	La Fondation ARC contre le Cancer; Ligue Nationale contre le Cancer; INCa; Pair Melanoma and Canceropole IdF; Investissements d'Avenir [ANR-11-LBX-0038, ANR-10-IDEX-0001-02 PSL]; Ministere de I'Education Nationale de la Recherche et de la Technologie (MENRT); French program "Investissements d'Avenir - Institut Carnot" [ANR-11-CARN-008-01]	La Fondation ARC contre le Cancer; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France); Pair Melanoma and Canceropole IdF; Investissements d'Avenir(French National Research Agency (ANR)); Ministere de I'Education Nationale de la Recherche et de la Technologie (MENRT); French program "Investissements d'Avenir - Institut Carnot"(French National Research Agency (ANR))	The work was supported by a grant from "La Fondation ARC contre le Cancer", Ligue Nationale contre le Cancer, INCa, Pair Melanoma and Canceropole IdF, and is under the program "lnvestissements d'Avenir" launched by the French Government and implemented by ANR Labex CelTisPhyBio (ANR-11-LBX-0038 and ANR-10-IDEX-0001-02 PSL). M.J. Domingues was the recipient of a fellowship from the Ministere de I'Education Nationale de la Recherche et de la Technologie (MENRT) and J. Martinez-Sanz was financed by the French program "Investissements d'Avenir - Institut Carnot" managed by the National Research Agency (ANR-11-CARN-008-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Domingues MJ, 2014, CANCER RES, V74, P1983, DOI 10.1158/0008-5472.CAN-13-0920; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fasolini M, 2003, J BIOL CHEM, V278, P21092, DOI 10.1074/jbc.M301781200; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gail R, 2005, J BIOL CHEM, V280, P7107, DOI 10.1074/jbc.M410215200; Gallagher SJ, 2013, ONCOGENE, V32, P2230, DOI 10.1038/onc.2012.229; Gottardi CJ, 2004, AM J PHYSIOL-CELL PH, V286, pC747, DOI 10.1152/ajpcell.00433.2003; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Graham TA, 2002, MOL CELL, V10, P563, DOI 10.1016/S1097-2765(02)00637-8; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huels DJ, 2015, EMBO J, V34, P2321, DOI 10.15252/embj.201591739; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jung HY, 2013, MOL CELL, V52, P193, DOI 10.1016/j.molcel.2013.08.028; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li Y, 2011, ABSTR APPL ANAL, V22, P1, DOI DOI 10.1371/J0URNAL.P0NE.0026656; Mao CD, 2011, CRIT REV EUKAR GENE, V21, P207, DOI 10.1615/CritRevEukarGeneExpr.v21.i3.10; Mo R, 2009, J BIOL CHEM, V284, P28222, DOI 10.1074/jbc.M109.045039; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Poy F, 2001, NAT STRUCT BIOL, V8, P1053, DOI 10.1038/nsb720; Satoh K, 2004, P NATL ACAD SCI USA, V101, P8017, DOI 10.1073/pnas.0401733101; Selzer E, 2002, CANCER RES, V62, P2098; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Tago K, 2000, GENE DEV, V14, P1741; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Williams BO, 2000, ONCOGENE, V19, P5720, DOI 10.1038/sj.onc.1203921; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Yang PT, 2012, EMBO MOL MED, V4, P1294, DOI 10.1002/emmm.201201486	38	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172603	10.1371/journal.pone.0172603	http://dx.doi.org/10.1371/journal.pone.0172603			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273108	gold, Green Published, Green Submitted			2022-12-27	WOS:000396073700081
J	Ljones, K; Ness, HO; Solvang-Garten, K; Gaustad, SE; Hoydal, MA				Ljones, Kristine; Ness, Henning Ofstad; Solvang-Garten, Karin; Gaustad, Svein Erik; Hoydal, Morten Andre			Acute exhaustive aerobic exercise training impair cardiomyocyte function and calcium handling in Sprague-Dawley rats	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; ENDURANCE EXERCISE; MITOCHONDRIAL-FUNCTION; PERMEABILIZED FIBERS; ATRIAL-FIBRILLATION; FINE-STRUCTURE; HEART; INCREASES; CONTRACTILITY; PARTICIPANTS	Introduction Recent data from long-distance endurance participants suggest that cardiac function is impaired after completion. Existing data further indicate that right ventricular function is more affected than left ventricular function. The cellular mechanisms underpinning cardiac deterioration are limited and therefore the aim of this study was to examine cardiomyocyte and molecular responses of the right and left ventricle to an acute bout of exhaustive endurance exercise. Materials and methods Male Sprague-Dawley rats were assigned to sedentary controls or acute exhaustive endurance exercise consisting of a 120 minutes long forced treadmill run. The contractile function and Ca2+ handling properties in isolated cardiomyocytes, protein expression levels of sarcoplasmic reticulum Ca2+-ATPase and phospholamban including two of its phosphorylated states (serine 16 and threonine 17), and the mitochondrial respiration in permeabilized cardiac muscle fibers were analyzed. Results The exercise group showed a significant reduction in cardiomyocyte fractional shortening (right ventricle 1 Hz and 3 Hz p<0.001; left ventricle 1 Hz p<0.05), intracellular Ca2+ amplitude (right ventricle 1 and 3 Hz p<0.001; left ventricle 1 Hz p<0.01 and 3 Hz p<0.05) and rate of diastolic Ca2+ decay (right ventricle 1 Hz p<0.001 and 3 Hz p<0.01; left ventricle 1 and 3 Hz p<0.01). Cardiomyocyte relaxation during diastole was only significantly prolonged at 3 Hz in the right ventricle (p<0.05) compared to sedentary controls. We found an increase in phosphorylation of phospholamban at serine 16 and threonine 17 in the left (p<0.05), but not the right, ventricle from exhaustively exercised animals. The protein expression levels of sarcoplasmic reticulum Ca2+-ATPase and phospholamban was not changed. Furthermore, we found a reduction in maximal oxidative phosphorylation and electron transport system capacities of mitochondrial respiration in the right (p<0.01 and p<0.05, respectively), but not the left ventricle from rats subjected to acute exhaustive treadmill exercise. Conclusion Acute exhaustive treadmill exercise is associated with impairment of cardiomyocyte Ca2+ handling and mitochondrial respiration that causes depression in both contraction and diastolic relaxation of cardiomyocytes.	[Ljones, Kristine; Ness, Henning Ofstad; Solvang-Garten, Karin; Gaustad, Svein Erik; Hoydal, Morten Andre] Norwegian Univ Technol & Sci NTNU, Dept Circulat & Med Imaging, Trondheim, Norway; [Ljones, Kristine; Ness, Henning Ofstad; Solvang-Garten, Karin; Gaustad, Svein Erik] KG Jebsen Ctr Exercise Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Hoydal, MA (corresponding author), Norwegian Univ Technol & Sci NTNU, Dept Circulat & Med Imaging, Trondheim, Norway.	morten.hoydal@ntnu.no	Høydal, Morten A/K-2806-2012	Høydal, Morten A/0000-0003-1804-2578	Norwegian Research Council; Liaison Committee	Norwegian Research Council(Research Council of NorwayEuropean Commission); Liaison Committee	The PI is funded by the Norwegian Research Council with a grant to support Young Research talents. He receives a 3 year salary as a research scientist in this grant. He also receives general running cost finances from The Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU). Hennig Ness holds a PhD student grant from The Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU). This study is a part of his thesis. The grant finances his salary during this period. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal B, 2014, BBA-BIOENERGETICS, V1837, P354, DOI 10.1016/j.bbabio.2013.11.006; Aggarwal NT, 2013, ANTIOXID REDOX SIGN, V18, P432, DOI 10.1089/ars.2011.4234; [Anonymous], 2014, THE RIGHT HEART; BANISTER EW, 1971, AM J PHYSIOL, V220, P1935, DOI 10.1152/ajplegacy.1971.220.6.1935; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; Claessen G, 2014, MED SCI SPORT EXER, V46, P1717, DOI 10.1249/MSS.0000000000000282; Delgado J, 1999, J APPL PHYSIOL, V87, P152, DOI 10.1152/jappl.1999.87.1.152; Dell'Italia L J, 1991, Curr Probl Cardiol, V16, P653; DOUGLAS PS, 1990, J AM COLL CARDIOL, V15, P64, DOI 10.1016/0735-1097(90)90176-P; DOUGLAS PS, 1987, CIRCULATION, V76, P1206, DOI 10.1161/01.CIR.76.6.1206; Elliott AD, 2015, BRIT J SPORT MED, V49, P724, DOI 10.1136/bjsports-2014-093895; Germano G, 2012, EUR HEART J, V33, P137; Gnaiger E, 1995, J BIOENERG BIOMEMBR, V27, P583, DOI 10.1007/BF02111656; Gnaiger E., 2008, DRUGINDUCED MITOCHON, V327, P325, DOI [DOI 10.1002/9780470372531.CH12, 10.1002/9780470372531.ch12pp]; Grimsmo J, 2010, EUR J CARDIOV PREV R, V17, P100, DOI 10.1097/HJR.0b013e32833226be; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; JI LL, 1994, BIOCHEM PHARMACOL, V47, P877; Kemi OJ, 2007, J MOL CELL CARDIOL, V43, P354, DOI 10.1016/j.yjmcc.2007.06.013; KING DW, 1970, AM J PHYSIOL, V218, P1150, DOI 10.1152/ajplegacy.1970.218.4.1150; Knez WL, 2006, SPORTS MED, V36, P429, DOI 10.2165/00007256-200636050-00005; Kober F, 2004, MAGN RESON MATER PHY, V17, P157, DOI 10.1007/s10334-004-0086-0; La Gerche A, 2008, HEART, V94, P860, DOI 10.1136/hrt.2006.101063; La Gerche A, 2014, PULM CIRC, V4, P407, DOI 10.1086/677355; La Gerche A, 2012, EUR HEART J, V33, P998, DOI 10.1093/eurheartj/ehr397; La Gerche A, 2011, MED SCI SPORT EXER, V43, P974, DOI 10.1249/MSS.0b013e31820607a3; LAGUENS RP, 1967, CIRC RES, V21, P271, DOI 10.1161/01.RES.21.3.271; LAGUENS RP, 1966, EXPERIENTIA, V22, P244, DOI 10.1007/BF01900936; Contarteze RVL, 2008, COMP BIOCHEM PHYS A, V151, P415, DOI 10.1016/j.cbpa.2007.03.005; Lemieux H, 2010, J GERONTOL A-BIOL, V65, P1157, DOI 10.1093/gerona/glq141; MAHER JT, 1972, AM J PHYSIOL, V222, P207, DOI 10.1152/ajplegacy.1972.222.1.207; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Molina L, 2008, EUROPACE, V10, P618, DOI 10.1093/europace/eun071; Moraska A, 2000, AM J PHYSIOL-REG I, V279, pR1321, DOI 10.1152/ajpregu.2000.279.4.R1321; Mousavi N, 2009, AM J CARDIOL, V103, P1467, DOI 10.1016/j.amjcard.2009.01.294; Neilan TG, 2006, EUR HEART J, V27, P1079, DOI 10.1093/eurheartj/ehi813; Neilan TG, 2006, CIRCULATION, V114, P2325, DOI 10.1161/CIRCULATIONAHA.106.647461; Olah A, 2015, INT J CARDIOL, V182, P258, DOI 10.1016/j.ijcard.2014.12.045; Palmer BM, 1998, J APPL PHYSIOL, V85, P2159, DOI 10.1152/jappl.1998.85.6.2159; Periasamy M, 2008, CARDIOVASC RES, V77, P265, DOI 10.1093/cvr/cvm056; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; PIERCE GN, 1984, J APPL PHYSIOL, V57, P326, DOI 10.1152/jappl.1984.57.2.326; Predel HG, 2014, EUR HEART J, V35, P3091, DOI 10.1093/eurheartj/eht502; Scharhag J, 2006, EUR J CARDIOV PREV R, V13, P388, DOI 10.1097/00149831-200606000-00015; Schoenwolf GC, 2015, LARSENS HUMAN EMBRYO; Shave R, 2010, J AM COLL CARDIOL, V56, P169, DOI 10.1016/j.jacc.2010.03.037; Silva AM, 2012, METHODS MOL BIOL, V810, P7, DOI 10.1007/978-1-61779-382-0_2; Stowe DF, 2004, ANTIOXID REDOX SIGN, V6, P439, DOI 10.1089/152308604322899512; TAYLOR PB, 1976, EUR J APPL PHYSIOL O, V35, P111, DOI 10.1007/BF02333801; Taylor RS, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003331.pub4; Terblanche SE, 2001, COMP BIOCHEM PHYS A, V128, P889, DOI 10.1016/S1095-6433(00)00344-5; TERJUNG RL, 1973, AM J PHYSIOL, V225, P300, DOI 10.1152/ajplegacy.1973.225.2.300; Trivax JE, 2010, J APPL PHYSIOL, V108, P1148, DOI 10.1152/japplphysiol.01151.2009; Urhausen A, 2004, AM J CARDIOL, V94, P696, DOI 10.1016/j.amjcard.2004.05.050; VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5; Vollaard NBJ, 2005, SPORTS MED, V35, P1045, DOI 10.2165/00007256-200535120-00004; Wei X, 2015, TRENDS CARDIOVAS MED, V25, P529, DOI 10.1016/j.tcm.2014.12.014; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Whyte GP, 2008, MED SCI SPORT EXER, V40, P1416, DOI 10.1249/MSS.0b013e318172cefd; Wilson M, 2011, J APPL PHYSIOL, V110, P1622, DOI 10.1152/japplphysiol.01280.2010; Wisloff U, 2002, CARDIOVASC RES, V54, P162, DOI 10.1016/S0008-6363(01)00565-X	63	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173449	10.1371/journal.pone.0173449	http://dx.doi.org/10.1371/journal.pone.0173449			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273177	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700003
J	Weber, L; Al-Refae, K; Ebbert, J; Jagers, P; Altmuller, J; Becker, C; Hahn, S; Gisselmann, G; Hatt, H				Weber, Lea; Al-Refae, Klaudia; Ebbert, Juliane; Jaegers, Peter; Altmueller, Janine; Becker, Christian; Hahn, Stephan; Gisselmann, Guenter; Hatt, Hanns			Activation of odorant receptor in colorectal cancer cells leads to inhibition of cell proliferation and apoptosis	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; OLFACTORY RECEPTOR; PROSTATE-CANCER; EXPRESSION; GENE; PATHWAY; FAMILY; REVEALS; MEMBERS; TARGET	The analysis and functional characterization of ectopically expressed human olfactory receptors (ORs) is becoming increasingly important, as many ORs have been identified in several healthy and cancerous tissues. OR activation has been demonstrated to have influence on cancer cell growth and progression. Here, ORs were identified using RNA-Seq analyses and RT-PCR. We demonstrated the OR protein localization in HCT116 cells using immunocytochemistry (IHC). In order to analyze the physiological role of OR51B4, we deorphanized the receptor by the use of CRE-Luciferase assays, conducted calcium imaging experiments as well as scratch-and proliferation assays. Furthermore, western blot analyses revealed the involvement of different protein kinases in the ligand-dependent signaling pathway. Receptor knockdown via shRNA was used to analyze the involvement of OR51B4. We identified OR51B4, which is highly expressed in the colon cancer cell line HCT116 and in native human colon cancer tissues. We deorphanized the receptor and identified Troenan as an effective ligand. Troenan stimulation of HCT116 cells has anti-proliferative, anti-migratory and pro-apoptotic effects, mediated by changes in the intracellular calcium level upon PLC activation. These effects cause changes in the phosphorylation levels of p38, mTor and Akt kinases. Knockdown of the receptor via shRNA confirmed the involvement of OR51B4. This study emphasizes the importance of ectopically expressed ORs in the therapy for several diseases. The findings provide the basis for alternative treatments of colorectal cancer.	[Weber, Lea; Al-Refae, Klaudia; Ebbert, Juliane; Jaegers, Peter; Gisselmann, Guenter; Hatt, Hanns] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany; [Al-Refae, Klaudia] Univ Duisburg Essen, Univ Hosp, Inst Cell Biol Canc Res, Essen, Germany; [Altmueller, Janine; Becker, Christian] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Hahn, Stephan] Ruhr Univ Bochum, Dept Mol Gastrointestinal Oncol, Bochum, Germany	Ruhr University Bochum; University of Duisburg Essen; University of Cologne; Ruhr University Bochum	Weber, L (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany.	lea.weber@gmx.de	Hahn, Stephan/E-3880-2010; Hahn, Stephan A./AAV-6062-2021	Hahn, Stephan/0000-0003-0855-9741; Hahn, Stephan A./0000-0003-0855-9741; Altmuller, Janine/0000-0003-4372-1521; Szymonowicz, Klaudia/0000-0001-8296-6738	Heinrich and Alma Vogelsang Stiftung	Heinrich and Alma Vogelsang Stiftung	LW was funded by the Heinrich and Alma Vogelsang Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; LW was funded by the Heinrich and Alma Vogelsang Stiftung.	American Cancer Society, 2015, AM CANC SOC FACTS FI; Ataee R, 2010, EUR J CANCER PREV, V19, P138, DOI 10.1097/CEJ.0b013e3283354901; Bardon S, 2002, CANCER LETT, V181, P187, DOI 10.1016/S0304-3835(02)00047-2; Birkenkamp-Demtroder K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073593; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; Breer H, 1992, Curr Opin Neurobiol, V2, P439, DOI 10.1016/0959-4388(92)90177-M; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Busse D, 2014, J INVEST DERMATOL, V134, P2823, DOI 10.1038/jid.2014.273; Camilleri M, 2009, CURR OPIN ENDOCRINOL, V16, P53, DOI 10.1097/MED.0b013e32831e9c8e; Cerchiara T, 2015, NAT PROD COMMUN, V10, P547; COMPTON SJ, 1985, ANAL BIOCHEM, V151, P369, DOI 10.1016/0003-2697(85)90190-3; Cui T, 2013, EUR J ENDOCRINOL, V168, P253, DOI 10.1530/EJE-12-0814; Deliot N, 2015, BIOCH BIOPHYS ACTA; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Garaude J, 2008, MOL IMMUNOL, V45, P3463, DOI 10.1016/j.molimm.2008.03.016; Giandomenico V, 2013, J MOL ENDOCRINOL, V51, P277, DOI 10.1530/JME-13-0144; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Gonzalez-Kristeller DC, 2013, GENET MOL RES, V12, P3479, DOI 10.4238/2013.September.10.4; Grossi V, 2014, WORLD J GASTROENTERO, V20, P9744, DOI 10.3748/wjg.v20.i29.9744; Klasen K, 2010, CELL SIGNAL, V22, P150, DOI 10.1016/j.cellsig.2009.09.026; Krautwurst D, 2008, CHEM BIODIVERS, V5, P842, DOI 10.1002/cbdv.200890099; KURANAMI M, 1995, J SURG RES, V58, P233, DOI 10.1006/jsre.1995.1036; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Manteniotis S, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2015.70; Massberg D, 2015, ARCH BIOCHEM BIOPHYS, V566, P100, DOI 10.1016/j.abb.2014.12.004; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Sanz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085110; Siddiqui E, 2005, ONCOL REP; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Veereman G, 2015, CRIT REV ONCOL HEMAT, V94, P122, DOI 10.1016/j.critrevonc.2014.12.004; Wang J. Q., 2015, SCI WORLD J, V2015, P1, DOI [DOI 10.1371/J0URNAL.P0NE.0124261, DOI 10.2118/174392-MS]; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Xu LL, 2000, CANCER RES, V60, P6568; Yun HJ, 2012, MOL CELL BIOCHEM, V363, P281, DOI 10.1007/s11010-011-1180-z; Zhang X, 2012, CYTOSKELETON, V69, P810, DOI 10.1002/cm.21055; Zhong HL, 2001, J PHARMACOL EXP THER, V297, P837; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120	49	40	41	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172491	10.1371/journal.pone.0172491	http://dx.doi.org/10.1371/journal.pone.0172491			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273117	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700076
J	Benammi, H; Erazi, H; El Hiba, O; Vinay, L; Bras, H; Viemari, JC; Gamrani, H				Benammi, Hind; Erazi, Hasna; El Hiba, Omar; Vinay, Laurent; Bras, Helene; Viemari, Jean-Charles; Gamrani, Halima			Disturbed sensorimotor and electrophysiological patterns in lead intoxicated rats during development are restored by curcumin I	PLOS ONE			English	Article							CATION-CHLORIDE COTRANSPORTERS; BODY-WEIGHT GAIN; SPINAL-CORD; LIPID-PEROXIDATION; MONOAMINE-OXIDASE; OXIDATIVE STRESS; MOUSE MODEL; EXPOSURE; SEROTONIN; BRAIN	Lead poisoning is one of the most significant health problem of environmental origin. It is known to cause different damages in the central and peripheral nervous system which could be represented by several neurophysiological and behavioral symptoms. In this study we firstly investigated the effect of lead prenatal exposure in rats to (3g/L), from neonatal to young age, on the motor/sensory performances, excitability of the spinal cord and gaits during development. Then we evaluated neuroprotective effects of curcumin I (Cur I) against lead neurotoxicity, by means of grasping and cliff avoidance tests to reveal the impairment of the sensorimotor functions in neonatal rats exposed prenatally to lead. In addition, extra cellular recordings of motor output in spinal cord revealed an hyper-excitability of spinal networks in lead treated rats. The frequency of induced fictive locomotion was also increased in treated rats. At the young age, rats exhibited an impaired locomotor gait. All those abnormalities were attenuated by Cur I treatment at a dose of 16g/kg. Based on our finding, Cur I has shown features of a potent chemical compound able to restore the neuronal and the relative locomotor behaviors disturbances induced by lead intoxication. Therefore, this chemical can be recommended as a new therapeutic trial against lead induced neurotoxicity.	[Benammi, Hind; Erazi, Hasna; El Hiba, Omar; Gamrani, Halima] Cadi Ayyad Univ, Neurosci Pharmacol & Environm Team, Fac Sci Semlalia, Marrakech, Morocco; [El Hiba, Omar] Chouaib Doukkali Univ, Dept Biol, Fac Sci, El Jadida, Morocco; [Vinay, Laurent; Bras, Helene; Viemari, Jean-Charles] Univ Aix Marseille, Inst Neurosci Timone, Unite Mixte Rech 7289, CNRS, Marseille, France	Cadi Ayyad University of Marrakech; Chouaib Doukkali University of El Jadida; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Gamrani, H (corresponding author), Cadi Ayyad Univ, Neurosci Pharmacol & Environm Team, Fac Sci Semlalia, Marrakech, Morocco.; Viemari, JC (corresponding author), Univ Aix Marseille, Inst Neurosci Timone, Unite Mixte Rech 7289, CNRS, Marseille, France.	jean-charles.viemari@univ-amu.fr; gamrani54@gmail.com	Bras, Helene/L-8915-2018	EL Hiba, Omar/0000-0002-0581-4164; Halima, GAMRANI/0000-0002-3962-7404; Viemari, Jean-Charles/0000-0001-6614-1461	Neuromed; CNRST	Neuromed; CNRST	This work was financially supported by Neuromed and CNRST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell A, 2002, BRAIN RES REV, V39, P154, DOI 10.1016/S0165-0173(02)00182-0; Ak T, 2008, CHEM-BIOL INTERACT, V174, P27, DOI 10.1016/j.cbi.2008.05.003; Amendola J, 2004, EUR J NEUROSCI, V20, P2822, DOI 10.1111/j.1460-9568.2004.03745.x; Arora V, 2011, PSYCHONEUROENDOCRINO, V36, P1570, DOI 10.1016/j.psyneuen.2011.04.012; Bachetti T, 2012, EXP CELL RES, V318, P1844, DOI 10.1016/j.yexcr.2012.06.008; Bagchi D, 2005, J INORG BIOCHEM, V99, P1155, DOI 10.1016/j.jinorgbio.2005.02.011; Basha Chand D, 2015, Interdiscip Toxicol, V8, P159, DOI 10.1515/intox-2015-0025; Basha D Chand, 2013, NEUROSCIRES; Beaudin SA, 2007, NEUROTOXICOL TERATOL, V29, P188, DOI 10.1016/j.ntt.2006.11.004; Benammi H, 2014, ACTA HISTOCHEM, V116, P920, DOI 10.1016/j.acthis.2014.03.002; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Bokara KK, 2008, BIOMETALS, V21, P9, DOI 10.1007/s10534-007-9088-5; Borodinsky LN, 2012, CURR OPIN NEUROBIOL, V22, P624, DOI 10.1016/j.conb.2012.02.004; Bouyatas MM, 2007, ACTA HISTOCHEM, V109, P421, DOI 10.1016/j.acthis.2007.05.002; Braga MFM, 1999, BRAIN RES, V826, P10, DOI 10.1016/S0006-8993(99)01193-2; Bulmus FG, 2013, TOXICOL ENVIRON CHEM, V95, P1019, DOI 10.1080/02772248.2013.829061; Canfield RL, 2003, CHILD NEUROPSYCHOL, V9, P35, DOI 10.1076/chin.9.1.35.14496; CAZALETS JR, 1992, J PHYSIOL-LONDON, V455, P187, DOI 10.1113/jphysiol.1992.sp019296; Chiodo LM, 2004, NEUROTOXICOL TERATOL, V26, P359, DOI 10.1016/j.ntt.2004.01.010; Ciftci O, 2010, IMMUNOPHARM IMMUNOT, V32, P99, DOI 10.3109/08923970903164318; Correa M, 2004, LIFE SCI, V74, P2009, DOI 10.1016/j.lfs.2003.08.042; Daniel S, 2004, J INORG BIOCHEM, V98, P266, DOI 10.1016/j.jinorgbio.2003.10.014; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; Devi CB, 2005, INT J DEV NEUROSCI, V23, P375, DOI 10.1016/j.ijdevneu.2004.11.003; Ercal N, 1996, FREE RADICAL BIO MED, V21, P157, DOI 10.1016/0891-5849(96)00020-2; Fahr M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00175; Gilbert ME, 2007, NEUROTOXICOL TERATOL, V29, P385, DOI 10.1016/j.ntt.2007.01.006; Gonzalez-Salazar A, 2011, CARDIOVASC TOXICOL, V11, P357, DOI 10.1007/s12012-011-9128-9; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Holmes A, 2008, NEUROSCI BIOBEHAV R, V32, P1293, DOI 10.1016/j.neubiorev.2008.03.006; Hornung JP, 2003, J CHEM NEUROANAT, V26, P331, DOI 10.1016/j.jchemneu.2003.10.002; Hu H, 2006, ENVIRON HEALTH PERSP, V114, P1730, DOI 10.1289/ehp.9067; Huang Z, 2011, NEUROSCI LETT, V493, P145, DOI 10.1016/j.neulet.2011.02.030; Ishida T, 2004, J HEALTH SCI, V50, P474, DOI 10.1248/jhs.50.474; Jiang J, 2016, AQUACULTURE, V463, P174, DOI 10.1016/j.aquaculture.2016.05.040; Jung KK, 2006, LIFE SCI, V79, P2022, DOI 10.1016/j.lfs.2006.06.048; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; KALA SV, 1995, J NEUROCHEM, V65, P1631; Kapoor S, 2001, BIOPHYS CHEM, V92, P119, DOI 10.1016/S0301-4622(01)00188-0; Kato K, 1998, CELL STRESS CHAPERON, V3, P152, DOI 10.1379/1466-1268(1998)003<0152:SOTSIE>2.3.CO;2; Khalki L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080013; Khan MM, 2012, NEUROTOX RES, V22, P1, DOI 10.1007/s12640-011-9295-2; Koopmans GC, 2007, PHYSIOL BEHAV, V92, P993, DOI 10.1016/j.physbeh.2007.07.018; Kulkarni SK, 2008, PSYCHOPHARMACOLOGY B, V201; LASLEY SM, 1984, NEUROCHEM RES, V9, P1675, DOI 10.1007/BF00968078; Leret ML, 2002, BRAIN RES BULL, V58, P469, DOI 10.1016/S0361-9230(02)00819-5; Li YC, 2009, PROG NEURO-PSYCHOPH, V33, P435, DOI 10.1016/j.pnpbp.2009.01.006; Lopresti AL, 2012, J PSYCHOPHARMACOL, V26, P1512, DOI 10.1177/0269881112458732; Mameli O, 2001, BRAIN RES BULL, V55, P269, DOI 10.1016/S0361-9230(01)00467-1; Marchioro M, 1996, J PHARMACOL EXP THER, V279, P143; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Mello CF, 1998, BRAZ J MED BIOL RES, V31, P943, DOI 10.1590/S0100-879X1998000700010; Merce Correaa, 2004, LIFE SCI, V74, P2009, DOI [10.1016/j.lfs.2003.08.042PMID:14967196, DOI 10.1016/J.LFS.2003.08.042]; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; Moreira EG, 2001, NEUROTOXICOL TERATOL, V23, P489, DOI 10.1016/S0892-0362(01)00159-3; Mountney A, 2013, J NEUROSCI METH, V212, P1, DOI 10.1016/j.jneumeth.2012.08.025; Mudipalli A, 2007, INDIAN J MED RES, V126, P518; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nishimaru H, 1996, J PHYSIOL-LONDON, V497, P131, DOI 10.1113/jphysiol.1996.sp021755; Ono K, 2006, J NEUROCHEM, V97, P105, DOI 10.1111/j.1471-4159.2006.03707.x; Panahi Y, 2016, BIOMED PHARMACOTHER, V82, P578, DOI 10.1016/j.biopha.2016.05.037; Pearlstein E, 2005, EUR J NEUROSCI, V21, P1338, DOI 10.1111/j.1460-9568.2005.03971.x; Pflieger JF, 2002, J NEUROSCI, V22, P5108, DOI 10.1523/JNEUROSCI.22-12-05108.2002; Plusquellec P, 2007, NEUROTOXICOL TERATOL, V29, P527, DOI 10.1016/j.ntt.2007.07.002; Priyadarsini KI, 2014, MOLECULES, V19, P20091, DOI 10.3390/molecules191220091; Pyrzanowska J, 2010, PHARMACOL BIOCHEM BE, V95, P351, DOI 10.1016/j.pbb.2010.02.013; Rajeswari A., 2008, Inflammopharmacology, V16, P96, DOI 10.1007/s10787-007-1614-0; Ramesh GT, 2001, TOXICOL LETT, V123, P195, DOI 10.1016/S0378-4274(01)00395-2; Rezende VB, 2010, SCI TOTAL ENVIRON, V408, P4955, DOI 10.1016/j.scitotenv.2010.07.039; Rueter LE, 1997, REV NEUROSCIENCE, V8, P117; Sansar W, 2012, ACTA HISTOCHEM, V114, P41, DOI 10.1016/j.acthis.2011.02.003; Sansar W, 2011, ACTA HISTOCHEM, V113, P601, DOI 10.1016/j.acthis.2010.06.005; Santillan ME, 2010, NUTRITION, V26, P423, DOI 10.1016/j.nut.2009.06.005; Shukla PK, 2003, HUM EXP TOXICOL, V22, P653, DOI 10.1191/0960327103ht411oa; SMYTHE GA, 1989, AM J PHYSIOL, V256, pE231, DOI 10.1152/ajpendo.1989.256.2.E231; Stansfield KH, 2015, TRANSL PSYCHIAT, V10, P5; Trombini TV, 2001, PHARMACOL BIOCHEM BE, V68, P743, DOI 10.1016/S0091-3057(01)00473-7; Van den Heuvel DMA, 2008, PROG NEUROBIOL, V85, P75, DOI 10.1016/j.pneurobio.2008.01.003; Vinay L, 2000, EUR J NEUROSCI, V12, P4562, DOI 10.1046/j.0953-816X.2000.01321.x; WEINREICH K, 1977, NUTR METAB, V21, P201; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706; Xiang JJ, 2010, ENVIRON POLLUT, V158, P1376, DOI 10.1016/j.envpol.2010.01.002; Xiao C, 2006, BRAIN RES, V1088, P93, DOI 10.1016/j.brainres.2006.03.005; Xu Y, 2005, EUR J PHARMACOL, V518, P40, DOI 10.1016/j.ejphar.2005.06.002; Xu Y, 2006, BRAIN RES, V1122, P56, DOI 10.1016/j.brainres.2006.09.009; Yakovenko S, 2005, J NEUROPHYSIOL, V94, P1057, DOI 10.1152/jn.00991.2004; Zhao X, 2012, NEUROPHARMACOLOGY, V62, P843, DOI 10.1016/j.neuropharm.2011.08.050; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356	89	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0172715	10.1371/journal.pone.0172715	http://dx.doi.org/10.1371/journal.pone.0172715			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267745	Green Published, Green Submitted, gold			2022-12-27	WOS:000396060600001
J	Chang, CH; Wu, CP; Wang, JD; Lee, SW; Chang, CS; Yeh, HZ; Ko, CW; Lien, HC				Chang, Chung-Hsin; Wu, Cheng-Pin; Wang, Jung-Der; Lee, Shou-Wu; Chang, Chi-Sen; Yeh, Hong-Zen; Ko, Chung-Wang; Lien, Han-Chung			Alcohol and tea consumption are associated with asymptomatic erosive esophagitis in Taiwanese men	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; HELICOBACTER-PYLORI INFECTION; GASTRIC-ACID-SECRETION; RISK-FACTORS; BARRETTS-ESOPHAGUS; ENDOSCOPIC FINDINGS; BODY-MASS; PREVALENCE; COFFEE; POPULATION	Objective Asymptomatic erosive esophagitis (AEE) is commonly found in men, and might be a risk factor of developing esophageal adenocarcinoma. We aimed to determine if specific dietary habits increase the risk of AEE in asymptomatic Taiwanese men. Methods We recruited male adults undergoing upper gastrointestinal endoscopy for health check. We excluded subjects with reflux symptoms, or taking anti-reflux medications or drugs that potentially impair lower esophageal sphincter function or cause mucosal injury. The frequency of consuming reflux-provoking diets including alcohol, tea, coffee, tomato/citric juice, chocolate, sweet food, and spicy food was assessed. The erosive esophagitis was diagnosed based on the Los Angeles Classification after endoscopy. Frequent consumption of a specific diet was defined as >= 4 days/week of consuming that diet. Results A total of 1256 participants were recruited. After excluding 424 ineligible subjects, AEE was identified in 180 (22%) among 832 asymptomatic subjects. The risk of AEE increased with the number of days per week of consuming alcohol or tea: nondrinkers (19%, 17%), occasional drinkers (<1 day/week; 19%, 15%), regular drinkers (1-3 days/week; 26%, 21%), frequent drinkers (4-6 days/week; 32%, 22%), and daily drinkers (42%, 28%), respectively (trend test P < 0.001 for both). Multivariate analysis showed that hiatus hernia (adjusted odds ratio (aOR) 5.0, 95% confidence interval (CI) 2.6-9.6), drinking alcohol >= 4 days/week (aOR 2.3, 95% CI 1.3-4.0), and drinking tea >= 4 days/week (aOR 1.6, 95% CI 1.1-2.3) are independent risk factors of AEE. The risk of AEE was 3.8 times greater for those drinking both alcohol and tea >= 4 days/week than the non-drinkers.	[Chang, Chung-Hsin; Lee, Shou-Wu; Chang, Chi-Sen; Yeh, Hong-Zen; Ko, Chung-Wang; Lien, Han-Chung] Taichung Vet Gen Hosp, Div Gastroenterol, Taichung, Taiwan; [Wu, Cheng-Pin] China Med Univ Hosp, Hlth Examinat Ctr, Taichung, Taiwan; [Wu, Cheng-Pin] China Med Univ Hosp, Prevent Med Ctr, Taichung, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Dept Publ Hlth, Coll Med, Tainan, Taiwan; [Lee, Shou-Wu; Chang, Chi-Sen] Chung Shan Med Univ, Dept Internal Med, Taichung, Taiwan; [Yeh, Hong-Zen; Ko, Chung-Wang; Lien, Han-Chung] Natl Yang Ming Univ, Dept Internal Med, Taipei, Taiwan	Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Cheng Kung University; Chung Shan Medical University; National Yang Ming Chiao Tung University	Lien, HC (corresponding author), Taichung Vet Gen Hosp, Div Gastroenterol, Taichung, Taiwan.	lhc@vghtc.gov.tw			Rong Sing Medical Foundation [RSMF-101022]	Rong Sing Medical Foundation	This study was supported by research grants from the Rong Sing Medical Foundation, RSMF-101022. CSC received the funding. No additional external funding was received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre L, 2012, DIS ESOPHAGUS, V25, P535, DOI 10.1111/j.1442-2050.2011.01285.x; BERQUIST WE, 1981, J ALLERGY CLIN IMMUN, V67, P407, DOI 10.1016/0091-6749(81)90087-7; Boekema PJ, 1999, EUR J GASTROEN HEPAT, V11, P1271, DOI 10.1097/00042737-199911000-00015; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Bujanda L, 2000, AM J GASTROENTEROL, V95, P3374, DOI 10.1111/j.1572-0241.2000.03347.x; Bytzer P, 2007, AM J GASTROENTEROL, V102, P1585, DOI 10.1111/j.1572-0241.2006.00911.x; Chen TS, 2007, J CLIN GASTROENTEROL, V41, P819, DOI 10.1097/01.mcg.0000225658.30803.79; Chen Z, 2011, ARCH SURG-CHICAGO, V146, P1164, DOI 10.1001/archsurg.2011.248; Chen ZH, 2011, ASIAN PAC J CANCER P, V12, P229; Chih PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077932; Cho JH, 2011, J GASTROEN HEPATOL, V26, P1034, DOI 10.1111/j.1440-1746.2011.06686.x; Choi JY, 2013, EUR J GASTROEN HEPAT, V25, P764, DOI 10.1097/MEG.0b013e32835f594c; Chu NF, 2005, OBES REV, V6, P271, DOI 10.1111/j.1467-789X.2005.00175.x; COHEN S, 1975, NEW ENGL J MED, V293, P897, DOI 10.1056/NEJM197510302931803; COHEN S, 1980, NEW ENGL J MED, V303, P122, DOI 10.1056/NEJM198007173030302; Dent J, 2012, CLIN GASTROENTEROL H, V10, P863, DOI 10.1016/j.cgh.2012.02.028; Du J, 2007, WORLD J GASTROENTERO, V13, P6009, DOI 10.3748/wjg.13.6009; FELDMAN M, 1995, GASTROENTEROLOGY, V108, P125, DOI 10.1016/0016-5085(95)90016-0; Gerson LB, 2002, GASTROENTEROLOGY, V123, P461, DOI 10.1053/gast.2002.34748; Goh KL, 2011, J GASTROEN HEPATOL, V26, P2, DOI 10.1111/j.1440-1746.2010.06534.x; Gudjonsson H, 1995, Laeknabladid, V81, P484; Johnson DA, 2004, GASTROENTEROLOGY, V126, P660, DOI 10.1053/j.gastro.2003.12.001; Kaltenbach T, 2006, ARCH INTERN MED, V166, P965, DOI 10.1001/archinte.166.9.965; Katz PO, 2013, AM J GASTROENTEROL, V108, P308, DOI 10.1038/ajg.2012.444; KEKKI M, 1982, SCAND J GASTROENTERO, V17, P737, DOI 10.3109/00365528209181087; Khan N, 2013, CURR PHARM DESIGN, V19, P6141, DOI 10.2174/1381612811319340008; Kim J, 2014, DIS ESOPHAGUS, V27, P311, DOI 10.1111/dote.12099; Kim N, 2008, ALIMENT PHARM THER, V27, P173, DOI 10.1111/j.1365-2036.2007.03561.x; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; Ko CW, 2002, GASTROENTEROL J TAIW, V19, P116; Kubo A, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-144; Labenz J, 2004, AM J GASTROENTEROL, V99, P1652, DOI 10.1111/j.1572-0241.2004.30390.x; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lee D, 2013, SCAND J GASTROENTERO, V48, P906, DOI 10.3109/00365521.2013.812236; Lei WY, 2015, DIGEST LIVER DIS, V47, P24, DOI 10.1016/j.dld.2014.09.017; Li YC, 2011, ADDICTION, V106, P1946, DOI 10.1111/j.1360-0443.2011.03514.x; Lien HC, 2009, J CLIN GASTROENTEROL, V43, P926, DOI 10.1097/MCG.0b013e318191e9d5; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Menon S, 2011, EUR J GASTROEN HEPAT, V23, P389, DOI 10.1097/MEG.0b013e328345d429; Menon S, 2011, EUR J GASTROEN HEPAT, V23, P133, DOI 10.1097/MEG.0b013e3283426f57; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Minatsuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069891; Moayyedi P, 2006, LANCET, V367, P2086, DOI 10.1016/S0140-6736(06)68932-0; Murao T, 2011, DIGEST DIS SCI, V56, P2857, DOI 10.1007/s10620-011-1679-x; Nazareth I, 2011, ALCOHOL ALCOHOLISM, V46, P600, DOI 10.1093/alcalc/agr078; Nilsson M, 2004, GUT, V53, P1730, DOI 10.1136/gut.2004.043265; Nilsson M, 2002, SCAND J GASTROENTERO, V37, P626, DOI 10.1080/00365520212502; Niu CY, 2012, WORLD J GASTROENTERO, V18, P7333, DOI 10.3748/wjg.v18.i48.7333; Nocon M, 2006, ALIMENT PHARM THER, V23, P169, DOI 10.1111/j.1365-2036.2006.02727.x; Nocon M, 2007, J GASTROEN HEPATOL, V22, P1728, DOI 10.1111/j.1440-1746.2006.04549.x; Nozu T, 2008, J GASTROENTEROL, V43, P27, DOI 10.1007/s00535-007-2120-2; Ou JL, 2012, J CHIN MED ASSOC, V75, P60, DOI 10.1016/j.jcma.2011.12.008; Pehl C, 1997, ALIMENT PHARM THER, V11, P483, DOI 10.1046/j.1365-2036.1997.00161.x; Peng S, 2009, ENDOSCOPY, V41, P1011, DOI 10.1055/s-0029-1215291; Pohl H, 2013, AM J GASTROENTEROL, V108, P200, DOI 10.1038/ajg.2012.387; Raghunath A, 2003, BMJ-BRIT MED J, V326, P737, DOI 10.1136/bmj.326.7392.737; Rao SSC, 2002, DIGEST DIS SCI, V47, P2763, DOI 10.1023/A:1021017524660; Ren LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16048; Ronkainen J, 2005, SCAND J GASTROENTERO, V40, P275, DOI 10.1080/00365520510011579; Ronkainen J, 2011, AM J GASTROENTEROL, V106, P1946, DOI 10.1038/ajg.2011.326; Shapiro M, 2007, ALIMENT PHARM THER, V25, P93, DOI 10.1111/j.1365-2036.2006.03170.x; Takabayashi F, 2004, J GASTROENTEROL, V39, P61, DOI 10.1007/s00535-003-1246-0; THOMAS FB, 1980, GASTROENTEROLOGY, V79, P1262; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Wang FW, 2010, DIGEST DIS SCI, V55, P1320, DOI 10.1007/s10620-009-0888-z; Wang PC, 2012, J GASTROEN HEPATOL, V27, P586, DOI 10.1111/j.1440-1746.2011.06881.x; WENDL B, 1994, ALIMENT PHARM THER, V8, P283; World Health Organization, GLOBAL STATUS REPORT; Zagari RM, 2008, GUT, V57, P1354, DOI 10.1136/gut.2007.145177; Zheng ZL, 2008, GASTROENTEROLOGY, V135, P72, DOI 10.1053/j.gastro.2008.03.039	71	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173230	10.1371/journal.pone.0173230	http://dx.doi.org/10.1371/journal.pone.0173230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264069	Green Submitted, gold, Green Published			2022-12-27	WOS:000396054300047
J	Chinthamani, S; Settem, RP; Honma, K; Kay, JG; Sharma, A				Chinthamani, Sreedevi; Settem, Rajendra P.; Honma, Kiyonobu; Kay, Jason G.; Sharma, Ashu			Macrophage inducible C-type lectin (Mincle) recognizes glycosylated surface (S)-layer of the periodontal pathogen Tannerella forsythia	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; S-LAYER; EPITHELIAL-CELLS; T-CELLS; RECEPTORS; PROTEIN; IL-10; EXPRESSION; IMMUNITY	The oral pathogen Tannerella forsythia is implicated in the development of periodontitis, a common inflammatory disease that leads to the destruction of the gum and tooth supporting tissues, often leading to tooth loss. T. forsythia is a unique Gram-negative organism endowed with an elaborate protein O-glycosylation system that allows the bacterium to express a glycosylated surface (S)-layer comprising two high molecular weight glycoproteins modified with O-linked oligosaccharides. The T. forsythia S-layer has been implicated in the modulation of cytokine responses of antigen presenting cells, such as macrophages, that play a significant role during inflammation associated with periodontitis. The macrophage-inducible C-type lectin receptor (Mincle) is an FcR(Y)-coupled pathogen recognition receptor that recognizes a wide variety of sugar containing ligands from fungal and bacterial pathogens. In this study, we aimed to determine if Mincle might be involved in the recognition of T. forsythia S-layer and modulation of cytokine response of macrophages against the bacterium. Binding studies using recombinant Mincle-Fc fusion protein indicated a specific Ca2+-dependent binding of Mincle to T. forsythia S-layer. Subsequent experiments with Mincle-expressing and Mincle-knockdown macrophages revealed a role for Mincle/S-layer interaction in the induction of both pro-and anti-inflammatory cytokine secretion in macrophages stimulated with T. forsythia as well as its S-layer. Together, these studies revealed Mincle as an important macrophage receptor involved in the modulation of cytokine responses of macrophages against T. forsythia, and thus may play a critical role in orchestrating the host immune response against the bacterium.	[Chinthamani, Sreedevi; Settem, Rajendra P.; Honma, Kiyonobu; Kay, Jason G.; Sharma, Ashu] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Sharma, A (corresponding author), SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA.	sharmaa@buffalo.edu	; Homma, Kiyonobu/K-9084-2013; Sharma, Ashu/O-3149-2016	Kay, Jason/0000-0001-8944-6612; Settem, Rajendra Prasad/0000-0002-3577-7675; Homma, Kiyonobu/0000-0003-1342-4745; Sharma, Ashu/0000-0001-9252-0668	US Public Health [DE14749]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE023526, R01DE014749] Funding Source: NIH RePORTER	US Public Health(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by US Public Health, grant DE14749. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Crump KE, 2016, INFECT IMMUN; den Dunnen J, 2010, IMMUNOL LETT, V128, P12, DOI 10.1016/j.imlet.2009.09.008; Devi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15049; Fagan RP, 2014, NATURE REV MICROBIOL; Feinberg H, 2013, J BIOL CHEM, V288, P28457, DOI 10.1074/jbc.M113.497149; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Hasturk H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00118; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Horie T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163974; Igari K, 2014, ORAL BIOL DENT, V2; Inagaki S, 2006, INFECT IMMUN, V74, P5023, DOI 10.1128/IAI.00062-06; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Krauss JL, 2010, PERIODONTOL 2000, V52, P141, DOI 10.1111/j.1600-0757.2009.00324.x; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lam RS, 2014, J IMMUNOL, V193, P2349, DOI 10.4049/jimmunol.1400853; Lee RT, 2011, GLYCOBIOLOGY, V21, P512, DOI 10.1093/glycob/cwq193; Lee SW, 2006, GENE, V371, P102, DOI 10.1016/j.gene.2005.11.027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masumoto M, 1999, J IMMUNOL, V163, P5039; Mealey BL, 1999, PERIODONTOL 2000, V21, P197, DOI 10.1111/j.1600-0757.1999.tb00176.x; Meyer-Wentrup F, 2005, IMMUNITY, V22, P399, DOI 10.1016/j.immuni.2005.04.001; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Myneni SR, 2013, IMMUNOL INVEST, V42, P519, DOI 10.3109/08820139.2013.822761; Myneni SR, 2011, J IMMUNOL, V187, P501, DOI 10.4049/jimmunol.1100683; Patin EC, 2016, INNATE IMMUN-LONDON, V22, P181, DOI 10.1177/1753425916636671; Posch G, 2013, GLYCOBIOLOGY, V23, P568, DOI 10.1093/glycob/cws172; Posch G, 2011, J BIOL CHEM, V286, P38714, DOI 10.1074/jbc.M111.284893; Rabes A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117022; Richardson MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00288; Sakakibara J, 2007, MICROBIOL-SGM, V153, P866, DOI 10.1099/mic.0.29275-0; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sekot G, 2011, J DENT RES, V90, P109, DOI 10.1177/0022034510384622; Sekot G, 2012, ARCH MICROBIOL; Settem RP, 2013, MUCOSAL IMMUNOL, V6, P415, DOI 10.1038/mi.2012.85; Sharma A, 1998, INFECT IMMUN, V66, P5703, DOI 10.1128/IAI.66.12.5703-5710.1998; Sharma A, 2010, PERIODONTOL 2000, V54, P106, DOI 10.1111/j.1600-0757.2009.00332.x; Sharma A, 2014, J INFECT DIS, V209, P1837, DOI 10.1093/infdis/jit820; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Tanner ACR, 2006, PERIODONTOL 2000, V42, P88, DOI 10.1111/j.1600-0757.2006.00184.x; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651	48	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173394	10.1371/journal.pone.0173394	http://dx.doi.org/10.1371/journal.pone.0173394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264048	Green Submitted, Green Published, gold			2022-12-27	WOS:000396054300062
J	Gupta, NJ; Kumar, V; Panda, S				Gupta, Neelu Jain; Kumar, Vinod; Panda, Satchidananda			A camera-phone based study reveals erratic eating pattern and disrupted daily eating-fasting cycle among adults in India	PLOS ONE			English	Article							NIGHT-SHIFT WORK; CIRCADIAN-RHYTHMS; RISK; HEALTH; RESISTANCE; DISEASE; IMPACT; FOOD	The daily rhythm of feeding-fasting and meal-timing are emerging as important determinants of health. Circadian rhythm research in animal models and retrospective analyses of human nutrition data have shown that reduced length of overnight fasting or increased late night eating increases risk for metabolic diseases including obesity and diabetes. However, the daily rhythm in eating pattern in humans is rarely measured. Traditional methods to collect nutrition information through food diary and food log pay little attention to the timing of eating which may also change from day to day. We adopted a novel cell-phone based approach to longitudinally record all events of food and beverage intake in adults. In a feasibility study daily food-eating patterns of 93 healthy individuals were recorded for 21 days using camera phones. Analysis of the daily eating patterns of these individuals indicates deviation from conventional assumption that people eat three meals-a-day within a 12 h interval. We found that eating events are widespread throughout the day, with <30% of calories consumed before noon and >30% consumed in evening and late night hours. There was little difference in eating pattern between weekdays and weekends. In this cohort more than 50% of people spread their caloric intake events over 15 h or longer. One decile of the cohort who were spouses of shift-workers or had flexible work schedule spread their caloric intake over 20 h. Although the nutrition quality and diversity of food consumed is different between South-East Asian and Western countries, such overall disruption of daily eating-fasting rhythm is similar. Therefore, in view of hypothesis that disrupted daily eating pattern may contribute to the global increase in metabolic diseases and modification of daily eating pattern is a potential modifiable behavior to contain these diseases, monitoring eating pattern is an important aspect of lifestyle.	[Gupta, Neelu Jain; Kumar, Vinod] Univ Delhi, Dept Zool, Delhi, India; [Gupta, Neelu Jain] Mahanand Miss Harijan Coll, Dept Zool, Ghaziabad, Uttar Pradesh, India; [Panda, Satchidananda] Salk Inst Biol Sci, La Jolla, CA 92037 USA; [Panda, Satchidananda] Univ Calif San Diego, Ctr Circadian Biol, San Diego, CA 92093 USA	University of Delhi; Salk Institute; University of California System; University of California San Diego	Gupta, NJ (corresponding author), Univ Delhi, Dept Zool, Delhi, India.; Gupta, NJ (corresponding author), Mahanand Miss Harijan Coll, Dept Zool, Ghaziabad, Uttar Pradesh, India.; Panda, S (corresponding author), Salk Inst Biol Sci, La Jolla, CA 92037 USA.; Panda, S (corresponding author), Univ Calif San Diego, Ctr Circadian Biol, San Diego, CA 92093 USA.	drneelujgupta@hotmail.com; satchin@salk.edu	Gupta, Neelu Jain/I-9900-2014; Gupta, Neelu Jain/AAF-6721-2020	Gupta, Neelu Jain/0000-0003-4885-1827	American Federation of Aging Research [M14322]; Leona M. and Harry B. Helmsley Charitable Trust's [2012-PG-MED002]; UGC research award [F-30-50/2011]; Indo-US Science and Technology Forum (IUSSTF) IUSSTF/JC- Biological Timing [JC-15- 2013/2014-15]; Glenn Center for Aging; Joe W. and Dorothy Dorsett Brown Foundation	American Federation of Aging Research; Leona M. and Harry B. Helmsley Charitable Trust's; UGC research award; Indo-US Science and Technology Forum (IUSSTF) IUSSTF/JC- Biological Timing; Glenn Center for Aging; Joe W. and Dorothy Dorsett Brown Foundation	This work was partially supported by grants from American Federation of Aging Research #M14322, Leona M. and Harry B. Helmsley Charitable Trust's grant #2012-PG-MED002, the Glenn Center for Aging, Joe W. and Dorothy Dorsett Brown Foundation to SP and UGC research award (F-30-50/2011) to NJG, and a joint grant from the Indo-US Science and Technology Forum (IUSSTF) IUSSTF/JC- Biological Timing/JC-15- 2013/2014-15 to VK (http://www.iusstf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arble DM, 2015, SLEEP; Brown DL, 2009, AM J EPIDEMIOL, V169, P1370, DOI 10.1093/aje/kwp056; Cahill LE, 2013, CIRCULATION, V128, P337, DOI 10.1161/CIRCULATIONAHA.113.001474; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; Chung H, 2016, METABOLISM, V65, P1743, DOI 10.1016/j.metabol.2016.09.006; Davis S, 2001, JNCI-J NATL CANCER I, V93, P1557, DOI 10.1093/jnci/93.20.1557; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Garaulet M, 2013, INT J OBES LOND; Gill S, 2015, CELL METAB, V22, P789, DOI 10.1016/j.cmet.2015.09.005; Gill S, 2015, SCIENCE, V347, P1265, DOI 10.1126/science.1256682; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lucassen EA, 2016, CURR BIOL, V26, P1843, DOI 10.1016/j.cub.2016.05.038; Marinac CR, 2015, CANCER EPIDEM BIOMAR, V24, P783, DOI 10.1158/1055-9965.EPI-14-1292; Marinac CR, 2016, JAMA ONCOLOGY; Narayan KMV, 2007, DIABETES CARE, V30, P1562, DOI 10.2337/dc06-2544; Rothschild J, 2014, NUTR REV, V72, P308, DOI 10.1111/nure.12104; ROZA AM, 1984, AM J CLIN NUTR, V40, P168, DOI 10.1093/ajcn/40.1.168; Sherman H, 2012, FASEB J, V26, P3493, DOI 10.1096/fj.12-208868; Shetty PS, 2002, PUBLIC HEALTH NUTR, V5, P175, DOI 10.1079/PHN2001291; Six BL, 2011, J FOOD COMPOS ANAL, V24, P1160, DOI 10.1016/j.jfca.2011.06.006; Six BL, 2010, J AM DIET ASSOC, V110, P74, DOI 10.1016/j.jada.2009.10.010; Sookoian S, 2007, J INTERN MED, V261, P285, DOI 10.1111/j.1365-2796.2007.01766.x; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Tuomi T, 2016, CELL METAB, V23, P1067, DOI 10.1016/j.cmet.2016.04.009; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Zarrinpar A, 2016, TRENDS ENDOCRIN MET, V27, P69, DOI 10.1016/j.tem.2015.11.007; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	33	56	57	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172852	10.1371/journal.pone.0172852	http://dx.doi.org/10.1371/journal.pone.0172852			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264001	Green Submitted, gold, Green Published			2022-12-27	WOS:000396054300022
J	Peng, ML; Zhao, GF; Yang, FN; Cheng, GX; Huang, J; Qin, XS; Liu, Y; Wang, QT; Li, YZ; Qin, DC				Peng, Mengle; Zhao, Guanfei; Yang, Funing; Cheng, Guixue; Huang, Jing; Qin, Xiaosong; Liu, Yong; Wang, Qingtao; Li, Yongzhe; Qin, Dongchun			NCOA1 is a novel susceptibility gene for multiple myeloma in the Chinese population: A case-control study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NON-HODGKIN-LYMPHOMA; STEROID-RECEPTOR COACTIVATOR-1; FOLLICULAR LYMPHOMA; EXPRESSION DATA; BREAST-CANCER; CLASS-I; RISK; VARIANTS; LOCI	Multiple myeloma (MM) is an incurable malignancy of mature B-lymphoid cells, and its pathogenesis is only partially understood. Previous studies have demonstrated that a number of Non-Hodgkin Lymphoma (NHL) associated genes also show susceptibility to MM, suggesting malignancies originating from B cells may share similar genetic susceptibility. Several recent large-scale genome-wide association studies (GWAS) have identified HLA-I, HLA-II, CXCR5, ETS1, LPP and NCOA1 genes as genetic risk factors associated with NHL, and this study aimed to investigate whether these genes polymorphisms confer susceptibility with MM in the Chinese Han population. In 827 MM cases and 709 healthy controls of Chinese Han, seven single nucleotide polymorphisms (SNPs) in the HLA-I region (rs6457327), the HLA-II region (rs2647012 and rs7755224), the CXCR5 gene (rs4938573), the ETS1 gene (rs4937362), the LPP gene (rs6444305), and the NCOA1 region (rs79480871) were genotyped using the Sequenom platform. Our study indicated that genotype and allele frequencies of rs79480871 showed strong associations with MM patients (p(a) = 3.5x10(-4) and p(a) = 1.5x10(-4)), and the rs6457327 genotype was more readily associated with MM patients than with controls (p(a) = 4.9x10(-3)). This study was the first to reveal the correlation between NCOA1 gene polymorphisms and MM patients, indicating that NCOA1 might be a novel susceptibility gene for MM patients in the Chinese Han population.	[Peng, Mengle; Qin, Dongchun] Zhengzhou Univ, Key Lab Lab Med Henan Prov, Affiliated Hosp 1, Dept Clin Lab, Zhengzhou, Henan, Peoples R China; [Zhao, Guanfei; Wang, Qingtao] Capital Med Univ, Beijing Chaoyang Hosp, Dept Clin Lab, Beijing, Peoples R China; [Yang, Funing; Li, Yongzhe] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing, Peoples R China; [Yang, Funing; Li, Yongzhe] Peking Union Med Coll, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing, Peoples R China; [Yang, Funing; Huang, Jing] Jilin Univ, Hosp 1, Dept Clin Lab, Changchun, Jilin, Peoples R China; [Cheng, Guixue; Qin, Xiaosong; Liu, Yong] China Med Univ, Shengjing Hosp, Dept Clin Lab, Shenyang, Liaoning, Peoples R China	Zhengzhou University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jilin University; China Medical University	Qin, DC (corresponding author), Zhengzhou Univ, Key Lab Lab Med Henan Prov, Affiliated Hosp 1, Dept Clin Lab, Zhengzhou, Henan, Peoples R China.; Li, YZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing, Peoples R China.; Li, YZ (corresponding author), Peking Union Med Coll, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing, Peoples R China.	yongzhelipumch@126.com; qindongchun@163.com	Peng, Mengle/AAZ-1751-2020	Peng, Mengle/0000-0001-8693-6923	National Natural Science Foundation of China [81172857, 81373188]; Chinese National High Technology Research and Development Program, Ministry of Science and Technology [2011AA02A113]; National Science Technology Pillar Program in the 12th 5-year Plan [2014BA107B00]; Capital Health Research and Development of Special [2014-1-4011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National High Technology Research and Development Program, Ministry of Science and Technology(National High Technology Research and Development Program of China); National Science Technology Pillar Program in the 12th 5-year Plan; Capital Health Research and Development of Special	We thank all participants in the MM study. This work was upported by grants from the National Natural Science Foundation of China Grants (81172857, 81373188), the Chinese National High Technology Research and Development Program, Ministry of Science and Technology Grants (2011AA02A113), the National Science Technology Pillar Program in the 12th 5-year Plan (2014BA107B00), and the Capital Health Research and Development of Special (2014-1-4011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daghri NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102141; Becker N, 2011, RECENT RESULTS CANC, V183, P25, DOI 10.1007/978-3-540-85772-3_2; Berglund M, 2011, BLOOD, V118, P4489, DOI 10.1182/blood-2011-06-362921; Broderick P, 2012, NAT GENET, V44, P58, DOI 10.1038/ng.993; Cerhan JR, 2014, NAT GENET, V46, P1233, DOI 10.1038/ng.3105; Chubb D, 2013, NAT GENET, V45, P1221, DOI 10.1038/ng.2733; Conde L, 2013, AM J HUM GENET, V92, P126, DOI 10.1016/j.ajhg.2012.11.009; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; Fleming FJ, 2004, J CLIN PATHOL, V57, P1069, DOI 10.1136/jcp.2004.016733; Fleming FJ, 2004, J CLIN ENDOCR METAB, V89, P375, DOI 10.1210/jc.2003-031048; Foo JN, 2013, AM J HUM GENET, V93, P167, DOI 10.1016/j.ajhg.2013.05.020; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hosgood HD, 2008, HEMATOL ONCOL, V26, P148, DOI 10.1002/hon.852; Karabon L, 2012, PATHOL ONCOL RES, V18, P219, DOI 10.1007/s12253-011-9431-6; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; Lan Q, 2007, CARCINOGENESIS, V28, P823, DOI 10.1093/carcin/bgl196; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qin L, 2015, ONCOTARGET, V6, P23890, DOI 10.18632/oncotarget.4341; Sato Y, 2011, CANCER SCI, V102, P1253, DOI 10.1111/j.1349-7006.2011.01929.x; Sayad A, 2014, TURK J HEMATOL, V31, P388, DOI 10.4274/tjh.2013.0098; Shafia S, 2013, BLOOD CELL MOL DIS, V51, P56, DOI 10.1016/j.bcmd.2013.02.001; Skibola CF, 2012, TISSUE ANTIGENS, V79, P279, DOI 10.1111/j.1399-0039.2012.01845.x; Skibola CF, 2014, AM J HUM GENET, V95, P462, DOI 10.1016/j.ajhg.2014.09.004; Skibola CF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-516; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Swaminathan B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8213; Walsh CA, 2012, INT J BIOL SCI, V8, P470, DOI 10.7150/ijbs.4125; Wang SS, 2006, HUM GENET, V120, P297, DOI 10.1007/s00439-006-0212-3; Wang SS, 2015, AM J EPIDEMIOL, V181, P406, DOI 10.1093/aje/kwu290; Wang SS, 2010, BLOOD, V115, P4820, DOI 10.1182/blood-2010-01-266775; Weinhold N, 2013, NAT GENET, V45, P522, DOI 10.1038/ng.2583; Wrench D, 2011, BLOOD, V117, P3147, DOI 10.1182/blood-2010-10-315382; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695	36	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173298	10.1371/journal.pone.0173298	http://dx.doi.org/10.1371/journal.pone.0173298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264017	gold, Green Published, Green Submitted			2022-12-27	WOS:000396054300050
J	Pollak, J; Rai, KG; Funk, CC; Arora, S; Lee, E; Zhu, J; Price, ND; Paddison, PJ; Ramirez, JM; Rostomily, RC				Pollak, Julia; Rai, Karan G.; Funk, Cory C.; Arora, Sonali; Lee, Eunjee; Zhu, Jun; Price, Nathan D.; Paddison, Patrick J.; Ramirez, Jan-Marino; Rostomily, Robert C.			Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; CANCER; GLIOMA; TRANSPORTERS; TUMORS; IDENTIFICATION; BIOLOGY; CLONING; MODELS; GENES	Ion channels and transporters have increasingly recognized roles in cancer progression through the regulation of cell proliferation, migration, and death. Glioblastoma stem-like cells (GSCs) are a source of tumor formation and recurrence in glioblastoma multiforme, a highly aggressive brain cancer, suggesting that ion channel expression may be perturbed in this population. However, little is known about the expression and functional relevance of ion channels that may contribute to GSC malignancy. Using RNA sequencing, we assessed the enrichment of ion channels in GSC isolates and non-tumor neural cell types. We identified a unique set of GSC-enriched ion channels using differential expression analysis that is also associated with distinct gene mutation signatures. In support of potential clinical relevance, expression of selected GSC-enriched ion channels evaluated in human glioblastoma databases of The Cancer Genome Atlas and Ivy Glioblastoma Atlas Project correlated with patient survival times. Finally, genetic knockdown as well as pharmacological inhibition of individual or classes of GSC-enriched ion channels constrained growth of GSCs compared to normal neural stem cells. This first-in-kind global examination characterizes ion channels enriched in GSCs and explores their potential clinical relevance to glioblastoma molecular subtypes, gene mutations, survival outcomes, regional tumor expression, and experimental responses to loss-of-function. Together, the data support the potential biological and therapeutic impact of ion channels on GSC malignancy and provide strong rationale for further examination of their mechanistic and therapeutic importance.	[Pollak, Julia; Rai, Karan G.; Ramirez, Jan-Marino] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA; [Funk, Cory C.; Price, Nathan D.] Inst Syst Biol, Seattle, WA USA; [Arora, Sonali; Paddison, Patrick J.] Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA; [Lee, Eunjee; Zhu, Jun] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Zhu, Jun] Icahn Sch Med Mt Sinai, Dept Hematol & Med Oncol, Tisch Canc Inst, New York, NY 10029 USA; [Rostomily, Robert C.] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; [Rostomily, Robert C.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Rostomily, Robert C.] Houston Methodist Res Inst, Houston, TX 77030 USA; [Rostomily, Robert C.] Houston Methodist Hosp, Dept Neurosurg, Houston, TX USA	Seattle Children's Hospital; Institute for Systems Biology (ISB); Fred Hutchinson Cancer Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Rostomily, RC (corresponding author), Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA.; Rostomily, RC (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.; Rostomily, RC (corresponding author), Houston Methodist Res Inst, Houston, TX 77030 USA.; Rostomily, RC (corresponding author), Houston Methodist Hosp, Dept Neurosurg, Houston, TX USA.	rrostomily@houstonmethodist.org	Arora, Sonali/AAE-9407-2021	Arora, Sonali/0000-0002-6661-3024; Ramirez, Jan-Marino/0000-0002-5626-3999; Price, Nathan/0000-0002-4157-0267; Rostomily, Robert/0000-0003-1431-162X	National Cancer Institute of the National Institutes of Health [F32 CA199717, R01 CA190957, R01 CA193841]; National Human Genome Research Institute of the National Institutes of Health [U01 HG008451]; American Cancer Society [ACS-RSG-14-056-01]; Seattle Children's Research Institute; NATIONAL CANCER INSTITUTE [R01CA190957, F32CA199717] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091251] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Cancer Society(American Cancer Society); Seattle Children's Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers F32 CA199717 to JP, R01 CA190957 to PJP, and R01 CA193841 to PJP. This work was also supported by the National Human Genome Research Institute of the National Institutes of Health under award number U01 HG008451 to JZ, the American Cancer Society under award number ACS-RSG-14-056-01 to PJP, and Seattle Children's Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5729, DOI 10.1111/bph.13347; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2015, IVY GAP IVY GLIOBLAS; Arcangeli A, 2009, CURR MED CHEM, V16, P66, DOI 10.2174/092986709787002835; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Becchetti A, 2011, AM J PHYSIOL-CELL PH, V301, pC255, DOI 10.1152/ajpcell.00047.2011; Besson P, 2015, BBA-BIOMEMBRANES, V1848, P2493, DOI 10.1016/j.bbamem.2015.04.013; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; Brackenbury WJ, 2012, CHANNELS, V6, P352, DOI 10.4161/chan.21910; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; CONE CD, 1974, ANN NY ACAD SCI, V238, P420, DOI 10.1111/j.1749-6632.1974.tb26808.x; Cong D, 2015, CURR MED CHEM, V22, P37; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Cuddapah VA, 2011, AM J PHYSIOL-CELL PH, V301, pC541, DOI 10.1152/ajpcell.00102.2011; Das S, 2008, NAT CLIN PRACT NEURO, V4, P427, DOI 10.1038/ncpneuro0862; Engstrom PG, 2012, GENOME MED, V4, DOI 10.1186/gm377; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Hille B, 2001, ION CHANNELS EXCITAB, P1; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Joo KM, 2013, CELL REP, V3, P260, DOI 10.1016/j.celrep.2012.12.013; Joshi AD, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-17; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Leanza L, 2016, BBA-MOL CELL RES, V1863, P1385, DOI 10.1016/j.bbamcr.2015.11.032; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lehen'kyi V, 2011, AM J PHYSIOL-CELL PH, V301, pC1281, DOI 10.1152/ajpcell.00249.2011; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Litan A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00086; Liu XJ, 2002, J NEUROSCI, V22, P1840, DOI 10.1523/JNEUROSCI.22-05-01840.2002; Liu ZG, 2013, NEURO-ONCOLOGY, V15, P1173, DOI 10.1093/neuonc/not065; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Osswald M, 2015, NATURE, V528, P93, DOI 10.1038/nature16071; Ouadid-Ahidouch H, 2015, BBA-BIOMEMBRANES, V1848, P2621, DOI 10.1016/j.bbamem.2015.02.015; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pla AF, 2012, AM J PHYSIOL-CELL PH, V302, pC9, DOI 10.1152/ajpcell.00280.2011; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Rao VR, 2015, CANCERS, V7, P849, DOI 10.3390/cancers7020813; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Simon O, 2015, J NEURO-ONCOL, V125, P225, DOI 10.1007/s11060-015-1896-9; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Sonoda Y, 2001, CANCER RES, V61, P4956; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; STILLWELL EF, 1973, NATURE-NEW BIOL, V246, P110, DOI 10.1038/newbio246110a0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Toledo CM, 2015, CELL REP, V13, P2425, DOI 10.1016/j.celrep.2015.11.021; Turner KL, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0095; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055587; Wang ZF, 2015, SCI REP-UK, V5, P1, DOI 10.1038/srep14187; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xia JZ, 2003, GENE, V313, P91, DOI 10.1016/S0378-1119(03)00633-4; Yang M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00185; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013	68	27	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172884	10.1371/journal.pone.0172884	http://dx.doi.org/10.1371/journal.pone.0172884			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264064	Green Submitted, gold, Green Published			2022-12-27	WOS:000396054300025
J	Hartwig, FP; de Mola, CL; Davies, NM; Victora, CG; Relton, CL				Hartwig, Fernando Pires; de Mola, Christian Loret; Davies, Neil Martin; Victora, Cesar Gomes; Relton, Caroline L.			Breastfeeding effects on DNA methylation in the offspring: A systematic literature review	PLOS ONE			English	Article							EPIGENOME-WIDE ASSOCIATION; HIGH-CARBOHYDRATE DIET; EPIGENETIC EPIDEMIOLOGY; MATERNAL SMOKING; BIRTH-WEIGHT; DEVELOPMENTAL ORIGINS; SOCIOECONOMIC-STATUS; PREPREGNANCY BMI; GESTATIONAL-AGE; CHILDREN	Background Breastfeeding benefits both infants and mothers. Recent research shows long-term health and human capital benefits among individuals who were breastfed. Epigenetic mechanisms have been suggested as potential mediators of the effects of early-life exposures on later health outcomes. We reviewed the literature on the potential effects of breastfeeding on DNA methylation. Methods Studies reporting original results and evaluating DNA methylation differences according to breastfeeding/breast milk groups (e. g., ever vs. never comparisons, different categories of breastfeeding duration, etc) were eligible. Six databases were searched simultaneously using Ovid, and the resulting studies were evaluated independently by two reviewers. Results Seven eligible studies were identified. Five were conducted in humans. Studies were heterogeneous regarding sample selection, age, target methylation regions, methylation measurement and breastfeeding categorisation. Collectively, the studies suggest that breastfeeding might be negatively associated with promoter methylation of LEP (which encodes an anorexigenic hormone), CDKN2A (involved in tumour suppression) and Slc2a4 genes (which encodes an insulin-related glucose transporter) and positively with promoter methylation of the Nyp (which encodes an orexigenic neuropeptide) gene, as well as influence global methylation patterns and modulate epigenetic effects of some genetic variants. Conclusions The findings from our systematic review are far from conclusive due to the small number of studies and their inherent limitations. Further studies are required to understand the actual potential role of epigenetics in the associations of breastfeeding with later health outcomes. Suggestions for future investigations, focusing on epigenome-wide association studies, are provided.	[Hartwig, Fernando Pires; de Mola, Christian Loret; Victora, Cesar Gomes] Univ Fed Pelotas, Postgrad Programme Epidemiol, Pelotas, Brazil; [Hartwig, Fernando Pires; Davies, Neil Martin; Relton, Caroline L.] Univ Bristol, MRC, Integrat Epidemiol Unit, Sch Social & Community Med, Bristol, Avon, England; [Davies, Neil Martin; Relton, Caroline L.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	Universidade Federal de Pelotas; University of Bristol; University of Bristol	Hartwig, FP (corresponding author), Univ Fed Pelotas, Postgrad Programme Epidemiol, Pelotas, Brazil.; Hartwig, FP (corresponding author), Univ Bristol, MRC, Integrat Epidemiol Unit, Sch Social & Community Med, Bristol, Avon, England.	fernandophartwig@gmail.com	Relton, Caroline/AAC-5904-2019; de Mola, Christian Loret/C-9534-2012; Hartwig, Fernando/AAG-5578-2020; Victora, Cesar Gomes/Y-2455-2019	de Mola, Christian Loret/0000-0002-5264-5914; Victora, Cesar Gomes/0000-0002-2465-2180; Relton, Caroline/0000-0003-2052-4840; Davies, Neil/0000-0002-2460-0508	Medical Research Council [MC_UU_12013/2] Funding Source: Medline; BBSRC [BB/I025263/1] Funding Source: UKRI; ESRC [ES/N000498/1] Funding Source: UKRI; MRC [MC_UU_12013/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025263/1] Funding Source: researchfish; Economic and Social Research Council [ES/N000498/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Adkins RM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-47; Alsaweed M, 2015, INT J ENV RES PUB HE, V12, P13981, DOI 10.3390/ijerph121113981; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Boddicker RL, 2016, ANIM GENET; Brion MJA, 2011, INT J EPIDEMIOL, V40, P670, DOI 10.1093/ije/dyr020; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Castillo H, 2016, EUR J CLIN NUTR, V70, P431, DOI 10.1038/ejcn.2015.232; Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003; Champagne FA, 2009, NEUROSCI BIOBEHAV R, V33, P593, DOI 10.1016/j.neubiorev.2007.10.009; Chor Dóra, 2005, Cad. Saúde Pública, V21, P1586, DOI 10.1590/S0102-311X2005000500033; Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334; Davies MN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r43; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Elshibly EM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-244; Engel SM, 2014, AM J EPIDEMIOL, V179, P834, DOI 10.1093/aje/kwt433; Fergusson DM, 1999, PAEDIATR PERINAT EP, V13, P144; Gluckman PD, 2010, GENOME MED, V2, DOI 10.1186/gm135; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; Gudsnuk K, 2012, ILAR J, V53, P279, DOI 10.1093/ilar.53.3-4.279; Han L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r79; Hannon E, 2015, EPIGENETICS-US, V10, P1024, DOI 10.1080/15592294.2015.1100786; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Heijmans BT, 2012, INT J EPIDEMIOL, V41, P74, DOI 10.1093/ije/dyr225; Herbstman JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072824; Horta BL, 2015, ACTA PAEDIATR, V104, P14, DOI 10.1111/apa.13139; Horta BL, 2001, AM J PUBLIC HEALTH, V91, P304, DOI 10.2105/AJPH.91.2.304; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Illingworth RS, 2015, NUCLEIC ACIDS RES, V43, P732, DOI 10.1093/nar/gku1305; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Jones JR, 2011, PEDIATRICS, V128, P1117, DOI 10.1542/peds.2011-0841; Joubert BR, 2016, AM J HUM GENET, V98, P680, DOI 10.1016/j.ajhg.2016.02.019; Karlsson O, 2016, EPIGENETICS; Kitano Naomi, 2016, Prev Med Rep, V3, P121, DOI 10.1016/j.pmedr.2015.12.010; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Mahmood S, 2013, J DEV ORIG HLTH DIS, V4, P479, DOI 10.1017/S2040174413000238; Markunas CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156361; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; Michels KA, 2016, FERTIL STERIL, V105, P1014, DOI 10.1016/j.fertnstert.2015.12.043; Mischke M, 2013, AM J PHYSIOL-REG I, V304, pR1065, DOI 10.1152/ajpregu.00551.2012; Mitrani P, 2007, AM J PHYSIOL-ENDOC M, V292, pE1069, DOI 10.1152/ajpendo.00477.2006; Ng JWY, 2012, GENOME BIOL, V13, DOI [10.1186/gb4029, 10.1186/gb-2012-13-6-246]; Ng SK, 2014, BMC PREGNANCY CHILDB, V14, DOI [10.1186/1471-2393-14-314, 10.1186/1471-2393-14-323]; Oakley LL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002765; Obermann-Borst SA, 2013, PEDIATR RES, V74, P344, DOI 10.1038/pr.2013.95; Paaby AB, 2013, TRENDS GENET, V29, P66, DOI 10.1016/j.tig.2012.10.010; Quillian L, 2012, AM SOCIOL REV, V77, P354, DOI 10.1177/0003122412447793; Raisanen S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-120; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Raychaudhuri N, 2014, J NUTR BIOCHEM, V25, P1066, DOI 10.1016/j.jnutbio.2014.05.011; Relton CL, 2015, INT J EPIDEMIOL, V44, P1181, DOI 10.1093/ije/dyv072; Relton CL, 2015, INT J EPIDEMIOL, V44, P1083, DOI 10.1093/ije/dyv198; Relton CL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000356; Richmond RC, 2015, HUM MOL GENET, V24, P2201, DOI 10.1093/hmg/ddu739; Rossnerova A, 2013, MUTAT RES-FUND MOL M, V741, P18, DOI 10.1016/j.mrfmmm.2013.02.003; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Sharp GC, 2015, INT J EPIDEMIOL, V44, P1288, DOI 10.1093/ije/dyv042; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Simpkin AJ, 2016, HUM MOL GENET, V25, P191, DOI 10.1093/hmg/ddv456; Simpkin AJ, 2015, HUM MOL GENET, V24, P3752, DOI 10.1093/hmg/ddv119; Soto-Ramirez N, 2013, AM J RESP CRITICAL C; Soto-Ramirez N, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-1; Srinivasan M, 2008, J ENDOCRINOL, V197, P565, DOI 10.1677/JOE-08-0021; Stoger R, 2006, EPIGENETICS-US, V1, P155; Tao MH, 2013, J DEV ORIG HLTH DIS, V4, P182, DOI 10.1017/S2040174412000694; Tow Jennifer, 2014, Breastfeed Rev, V22, P7; VADLAMUDI S, 1993, AM J PHYSIOL, V265, pE565, DOI 10.1152/ajpendo.1993.265.4.E565; Verduci E, 2014, NUTRIENTS, V6, P1711, DOI 10.3390/nu6041711; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Walton E, 2016, SCHIZOPHRENIA BULL, V42, P406, DOI 10.1093/schbul/sbv074; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x; Wojcicki JM, 2011, J WOMENS HEALTH, V20, P341, DOI 10.1089/jwh.2010.2248; Zetterstrom R, 1999, ACTA PAEDIATR, V88, P1, DOI 10.1080/080352599750029664; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	79	40	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173070	10.1371/journal.pone.0173070	http://dx.doi.org/10.1371/journal.pone.0173070			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257446	Green Published, gold			2022-12-27	WOS:000396021100055
J	Larsson, K; Baker, S; Silins, I; Guo, YF; Stenius, U; Korhonen, A; Berglund, M				Larsson, Kristin; Baker, Simon; Silins, Ilona; Guo, Yufan; Stenius, Ulla; Korhonen, Anna; Berglund, Marika			Text mining for improved exposure assessment	PLOS ONE			English	Article							BISPHENOL-A; METABOLISM; TOOL	Chemical exposure assessments are based on information collected via different methods, such as biomonitoring, personal monitoring, environmental monitoring and questionnaires. The vast amount of chemical-specific exposure information available from web-based databases, such as PubMed, is undoubtedly a great asset to the scientific community. However, manual retrieval of relevant published information is an extremely time consuming task and overviewing the data is nearly impossible. Here, we present the development of an automatic classifier for chemical exposure information. First, nearly 3700 abstracts were manually annotated by an expert in exposure sciences according to a taxonomy exclusively created for exposure information. Natural Language Processing (NLP) techniques were used to extract semantic and syntactic features relevant to chemical exposure text. Using these features, we trained a supervised machine learning algorithm to automatically classify PubMed abstracts according to the exposure taxonomy. The resulting classifier demonstrates good performance in the intrinsic evaluation. We also show that the classifier improves information retrieval of chemical exposure data compared to keyword-based PubMed searches. Case studies demonstrate that the classifier can be used to assist researchers by facilitating information retrieval and classification, enabling data gap recognition and overviewing available scientific literature using chemical-specific publication profiles. Finally, we identify challenges to be addressed in future development of the system.	[Larsson, Kristin; Silins, Ilona; Stenius, Ulla; Berglund, Marika] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Baker, Simon; Guo, Yufan; Korhonen, Anna] Univ Cambridge, Comp Lab, Cambridge, England; [Korhonen, Anna] Univ Cambridge, DTAL, Language Technol Lab, Cambridge, England	Karolinska Institutet; University of Cambridge; University of Cambridge	Larsson, K (corresponding author), Karolinska Inst, Inst Environm Med, Stockholm, Sweden.	kristin.larsson@ki.se		Baker, Simon/0000-0002-0998-438X; Larsson, Kristin/0000-0003-0398-0289	Commonwealth Scholarship Commission; Cambridge Trust; Medical Research Council UK [MR/M013049/1]; MRC [MR/M013049/1, G0601766] Funding Source: UKRI; Medical Research Council [MR/M013049/1, G0601766] Funding Source: researchfish	Commonwealth Scholarship Commission; Cambridge Trust; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	S.B. received funding from Commonwealth Scholarship Commission (http://cscuk.dfid.gov.uk/), Cambridge Trust (https://www.cambridgetrust.org/). A.K. received funding from Medical Research Council UK grant MR/M013049/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. K.L., I.S., Y.G., U.S. and M.B. received no specific funding for this work.	Alexander J, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1570; Angerer J, 2007, INT J HYG ENVIR HEAL, V210, P201, DOI 10.1016/j.ijheh.2007.01.024; Asimakopoulos AG, 2012, TOXICOL LETT, V210, P141, DOI 10.1016/j.toxlet.2011.07.032; Baker S, 2016, P COLING IN PRESS; Baker S, 2016, BIOINFORMATICS, V32, P432, DOI 10.1093/bioinformatics/btv585; Bergdahl IA, 2008, J TOXICOL ENV HEAL A, V71, P1235, DOI 10.1080/15287390802209525; Clark S, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P327; Clark S., 2002, P 6 INT WORKSH AD GR, P19; Davis AP, 2016, NUCL ACIDS RES; [FAO WHO] Food and Agriculture Organization of the United Nations World Health Organization, 1995, APPL RISK AN FOOD ST; Fleuren WWM, 2015, METHODS, V74, P97, DOI 10.1016/j.ymeth.2015.01.015; Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.200600243; Gasull M, 2011, ENVIRON INT, V37, P1226, DOI 10.1016/j.envint.2011.05.008; Guo Y, P COLING 2012, P183; Harpaz R, 2014, DRUG SAFETY, V37, P777, DOI 10.1007/s40264-014-0218-z; Hunter L, 2006, MOL CELL, V21, P589, DOI 10.1016/j.molcel.2006.02.012; IPCS, 2000, IPCS ENV HLTH CRIT; IPCS, 1997, IPCS ENV HLTH CRIT; Janjua NR, 2008, INT J ANDROL, V31, P118, DOI 10.1111/j.1365-2605.2007.00841.x; Jiang J, 2007, INFORM RETRIEVAL, V10, P341, DOI 10.1007/s10791-007-9027-7; Joachims T Thorsten, 2002, LEARNING CLASSIFY TE; Karimi S, 2015, ACM COMPUT SURV, V47, DOI 10.1145/2719920; Korhonen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033427; Le Q., 2014, 31 INT C MACH LEARN, P1188; Lee M, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0093-3; Leitner F, 2010, IEEE ACM T COMPUT BI, V7, P385, DOI 10.1109/TCBB.2010.61; Liu HB, 2012, J BIOMED SEMANT, V3, DOI 10.1186/2041-1480-3-3; Loper E., 2002, P COLING ACL INT PRE, V1, P63, DOI DOI 10.3115/1225403.1225421; LOWE HJ, 1994, JAMA-J AM MED ASSOC, V271, P1103, DOI 10.1001/jama.271.14.1103; Mattingly CJ, 2012, ENVIRON SCI TECHNOL, V46, P3046, DOI 10.1021/es2033857; NRC, 1983, RISK ASS FED GOV MAN; Renner R, 1997, ENVIRON SCI TECHNOL, V31, pA316, DOI 10.1021/es972366q; Rimell L, 2009, J BIOMED INFORM, V42, P852, DOI 10.1016/j.jbi.2008.12.004; Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283; Settles B, 2005, BIOINFORMATICS, V21, P3191, DOI 10.1093/bioinformatics/bti475; Sharma VK, 2009, J ENVIRON SCI HEAL A, V44, P423, DOI 10.1080/10934520902719704; Silins I, 2014, TOXICOL LETT, V229, pS164, DOI 10.1016/j.toxlet.2014.06.565; Simpson Matthew S, 2012, MINING TEXT DATA, P465, DOI DOI 10.1007/978-1-4614-3223-4_14; Sun L, 2009, P 2009 C EMP METH NA, V2; Swedish Chemical Agency [SCA], 2015, 415 SCA; UNEP, 2015, GLOB MON PLAN PERS O; Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x; Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Zhu F, 2013, J BIOMED INFORM, V46, P200, DOI 10.1016/j.jbi.2012.10.007	45	9	9	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173132	10.1371/journal.pone.0173132	http://dx.doi.org/10.1371/journal.pone.0173132			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257498	gold, Green Published			2022-12-27	WOS:000396021100063
J	Lu, J; Gu, BY; Wang, XL; Zhang, YH				Lu, Jing; Gu, Boyu; Wang, Xiaolin; Zhang, Yuhua			High-speed adaptive optics line scan confocal retinal imaging for human eye	PLOS ONE			English	Article							HUMAN CONE PHOTORECEPTORS; LASER OPHTHALMOSCOPE; IN-VIVO; PARAFOVEAL CAPILLARIES; DIABETIC-RETINOPATHY; LIGHT OPHTHALMOSCOPY; PERCEPTION; MOVEMENTS; TRACKING; SYSTEM	Purpose Continuous and rapid eye movement causes significant intraframe distortion in adaptive optics high resolution retinal imaging. To minimize this artifact, we developed a high speed adaptive optics line scan confocal retinal imaging system. Methods A high speed line camera was employed to acquire retinal image and custom adaptive optics was developed to compensate the wave aberration of the human eye's optics. The spatial resolution and signal to noise ratio were assessed in model eye and in living human eye. The improvement of imaging fidelity was estimated by reduction of intra-frame distor-tion of retinal images acquired in the living human eyes with frame rates at 30 frames/ second (FPS), 100 FPS, and 200 FPS. Results The device produced retinal image with cellular level resolution at 200 FPS with a digitization of 512x512 pixels/frame in the living human eye. Cone photoreceptors in the central fovea and rod photoreceptors near the fovea were resolved in three human subjects in normal chorioretinal health. Compared with retinal images acquired at 30 FPS, the intra-frame dis-tortion in images taken at 200 FPS was reduced by 50.9% to 79.7%. Conclusions We demonstrated the feasibility of acquiring high resolution retinal images in the living human eye at a speed that minimizes retinal motion artifact. This device may facilitate research involving subjects with nystagmus or unsteady fixation due to central vision loss.	[Lu, Jing; Gu, Boyu; Wang, Xiaolin; Zhang, Yuhua] Univ Alabama Birmingham, Sch Med, Dept Ophthalmol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Zhang, YH (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Ophthalmol, Birmingham, AL 35294 USA.	yuhuazhang@uabmc.edu	wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341	National Institutes of Health (NIH) [EY021903, EY024378, P30 EY003039]; National Science Foundation (NSF) [IIA-1539034]; EyeSight Foundation of Alabama; Buck Trust of Alabama; NATIONAL EYE INSTITUTE [R01EY024378, R21EY021903, P30EY003039] Funding Source: NIH RePORTER; Office Of The Director [1539034] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); EyeSight Foundation of Alabama; Buck Trust of Alabama; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by National Institutes of Health (NIH) (EY021903, EY024378, P30 EY003039); National Science Foundation (NSF) (IIA-1539034); Institutional support from Research to Prevent Blindness; EyeSight Foundation of Alabama; and Buck Trust of Alabama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, 1288 EMVA; Automated Imaging Association, 2004, SPEC CAM LINK INT ST; Bedggood Phillip, 2012, Biomed Opt Express, V3, P3264, DOI 10.1364/BOE.3.003264; Bedggood P, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907211; Burns SA, 2007, J OPT SOC AM A, V24, P1313, DOI 10.1364/JOSAA.24.001313; Carpenter RHS, 1988, MOVEMENTS EYES; Chen MF, 2015, INVEST OPHTH VIS SCI, V56, P674, DOI 10.1167/iovs.14-15936; Christoph Czeranowsky MS., 2015, WHITE PAPER DO YOU A; Chui TYP, 2012, BIOMED OPT EXPRESS, V3, P2537, DOI 10.1364/BOE.3.002537; Cooper RF, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.1.10; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Delori F. o. C., 2007, J OPT SOC AM A, V24, P1250; DITCHBURN RW, 1953, J PHYSIOL-LONDON, V119, P1; Dubra A, 2011, BIOMED OPT EXPRESS, V2, P1864, DOI 10.1364/BOE.2.001864; Dubra A, 2011, BIOMED OPT EXPRESS, V2, P1757, DOI 10.1364/BOE.2.001757; EIZENMAN M, 1985, VISION RES, V25, P1635, DOI 10.1016/0042-6989(85)90134-8; Ferguson RD, 2010, J OPT SOC AM A, V27, pA265, DOI 10.1364/JOSAA.27.00A265; Guevara-Torres A, 2016, BIOMED OPT EXPRESS, V7, P4228, DOI 10.1364/BOE.7.004228; Guevara-Torres A, 2015, BIOMED OPT EXPRESS, V6, P2106, DOI 10.1364/BOE.6.002106; Hammer DX, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2335470; Hammer DX, 2006, OPT EXPRESS, V14, P3354, DOI 10.1364/OE.14.003354; Hunter JJ, 2011, BIOMED OPT EXPRESS, V2, P139, DOI 10.1364/BOE.2.000139; Jonnal RS, 2007, OPT EXPRESS, V15, P16141, DOI 10.1364/OE.15.016141; Laser Institute of America, 2014, AM NAT STAND SAF US; Lu J, 2016, OPT LETT, V41, P3852, DOI 10.1364/OL.41.003852; Martial FP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043942; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2008, J VISION, V8, DOI [10.1167/8.14.28, 10.1167/8.14.i]; Meadway A, 2014, BIOMED OPT EXPRESS, V5, P713, DOI 10.1364/BOE.5.000713; Meadway A, 2013, OPT EXPRESS, V21, P29792, DOI 10.1364/OE.21.029792; Merino D, 2011, BIOMED OPT EXPRESS, V2, P2189, DOI 10.1364/BOE.2.002189; Morgan JIW, 2009, INVEST OPHTH VIS SCI, V50, P1350, DOI 10.1167/iovs.08-2618; Mujat M, 2009, OPT EXPRESS, V17, P10242, DOI 10.1364/OE.17.010242; Nuthmann A, 2010, PSYCHOL REV, V117, P382, DOI 10.1037/a0018924; Otero-Millan J, 2008, J VISION, V8, DOI 10.1167/8.14.21; Rha J, 2006, OPT EXPRESS, V14, P4552, DOI 10.1364/OE.14.004552; Rha J, 2009, OPT LETT, V34, P3782, DOI 10.1364/OL.34.003782; RIGGS LA, 1954, J OPT SOC AM, V44, P315, DOI 10.1364/JOSA.44.000315; Romero-Borja F, 2005, APPL OPTICS, V44, P4032, DOI 10.1364/AO.44.004032; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Roorda A, 2007, INVEST OPHTH VIS SCI, V48, P2297, DOI 10.1167/iovs.06-1450; Roorda A, 2015, ANNU REV VIS SCI, V1, P19, DOI 10.1146/annurev-vision-082114-035357; Roorda A, 2010, OPTOMETRY VISION SCI, V87, P260, DOI 10.1097/OPX.0b013e3181d39479; Scoles D, 2014, INVEST OPHTH VIS SCI, V55, P4244, DOI 10.1167/iovs.14-14542; Sheehy CK, 2012, BIOMED OPT EXPRESS, V3, P2611, DOI 10.1364/BOE.3.002611; Stevenson SB, 2005, BIOMEDICAL OPTICS, V2005; Talcott KE, 2011, INVEST OPHTH VIS SCI, V52, P2219, DOI 10.1167/iovs.10-6479; Tam J, 2012, OPTOMETRY VISION SCI, V89, pE692, DOI 10.1097/OPX.0b013e3182548b07; Tam J, 2011, INVEST OPHTH VIS SCI, V52, P9257, DOI 10.1167/iovs.11-8481; Tam J, 2011, BIOMED OPT EXPRESS, V2, P781, DOI 10.1364/BOE.2.000781; Tam J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3548880; Tam J, 2010, INVEST OPHTH VIS SCI, V51, P1691, DOI 10.1167/iovs.09-4483; Vienola KV, 2015, OPT LETT, V40, P5335, DOI 10.1364/OL.40.005335; Vogel CR, 2006, OPT EXPRESS, V14, P487, DOI 10.1364/OPEX.14.000487; Webb RH, 1996, REP PROG PHYS, V59, P427, DOI 10.1088/0034-4885/59/3/003; Webb Robert H., 1995, P55; Williams DR, 2011, VISION RES, V51, P1379, DOI 10.1016/j.visres.2011.05.002; Wilson T., 1984, THEORY PRACTICE SCAN; Yang Q, 2014, BIOMED OPT EXPRESS, V5, P3174, DOI 10.1364/BOE.5.003174; Yu YM, 2014, CHIN OPT LETT, V12, DOI [10.3788/COL201412.110602, 10.3788/COL201412.100601]; Yu YX, 2015, OPT EXPRESS, V23, P23035, DOI 10.1364/OE.23.023035; Zhang J, 2015, BIOMED OPT EXPRESS, V6, P2120, DOI 10.1364/BOE.6.002120; Zhang TJ, 2015, AM J OPHTHALMOL, V160, P290, DOI 10.1016/j.ajo.2015.04.034; Zhang YH, 2006, OPT LETT, V31, P1268, DOI 10.1364/OL.31.001268	64	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0169358	10.1371/journal.pone.0169358	http://dx.doi.org/10.1371/journal.pone.0169358			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257458	Green Submitted, gold, Green Published			2022-12-27	WOS:000396021100001
J	Pourcine, F; Dahan, K; Mihout, F; Cachanado, M; Brocheriou, I; Debiec, H; Ronco, P				Pourcine, Franck; Dahan, Karine; Mihout, Fabrice; Cachanado, Marine; Brocheriou, Isabelle; Debiec, Hanna; Ronco, Pierre			Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years	PLOS ONE			English	Article							PHOSPHOLIPASE A(2) RECEPTOR; DOMAIN-CONTAINING 7A; UNTREATED PATIENTS; NEPHROTIC SYNDROME; CONTROLLED-TRIAL; AUTOANTIBODIES; CYCLOPHOSPHAMIDE; TITER	Introduction Clinical course of membranous nephropathy (MN) is difficult to predict. Measurement of circulating anti-PLA2R autoantibodies (PLA2R-Ab) and detection in immune deposits of PLA2R antigen (PLA2R-Ag) are major advances in disease understanding. We evaluated the clinical significance of these biomarkers. Methods In this 14-year retrospective study, we collected data from 108 MN patients and assessed the relationship between clinical course, PLA2R-Ab and PLA2R-Ag. We also assessed THSD7A status. Results Eighty-five patients suffered from primary MN (PMN) and 23 patients from a secondary form. The median follow-up was 30.4 months [interquartile range, 17.7;56.7]. Among the 77 patients with PMN and available serum and/or biopsy, 69 (89.6%) had PLA2R-related disease as shown by anti-PLA2R-Ab and/or PLA2R-Ag, while 8 patients (8/77, 10.4%) were negative for both. There was no significant difference between these two groups in age at diagnosis and outcome assessed by proteinuria, serum albumin level and eGFR. Two of the 8 negative patients were positive for THSD7A. In patients with PLA2R related PMN, younger age, lower proteinuria, higher eGFR, and lower PLA2R-Ab level at baseline and after 6 months were associated with remission of proteinuria. Initial PLA2R-Ab titer <= 97.6 RU/mL and complete depletion of PLA2R-Ab within 6-months were significantly associated with spontaneous remission at the end of follow-up. In rituximab treated patients, lower PLA2R-Ab titer at initiation of treatment, and absence of PLA2R-Ab and higher serum albumin level at 3 months were significantly associated with remission. Noticeably, 81.8% of the patients who achieved remission completely cleared PLA2R-Ab. Depletion of PLA2R-Ab and increase of serum albumin level preceded the decrease of proteinuria. Conclusion Assessment of PLA2R autoimmunity is essential for patient management. Combination of PLA2R-Ab and PLA2R-Ag increases diagnosis sensitivity. PLA2R-Ab titer is a biomarker of disease severity at initial assessment, and the kinetics of the antibody are significantly correlated to disease evolution.	[Pourcine, Franck] Hop Henri Mondor, AP HP, Dept Nephrol & Transplantat, Creteil, France; [Dahan, Karine; Mihout, Fabrice; Ronco, Pierre] Hop Tenon, AP HP, Dept Nephrol & Dialysis, Paris, France; [Cachanado, Marine] Hop St Antoine, AP HP, Dept Clin Pharmacol, Paris, France; [Cachanado, Marine] Unite Rech Clin, Paris, France; [Brocheriou, Isabelle] Hop Tenon, AP HP, Dept Pathol, Paris, France; [Debiec, Hanna; Ronco, Pierre] Univ Paris, Univ Pierre & Marie Curie, Sorbonne Univ, Paris, France; [Debiec, Hanna; Ronco, Pierre] INSERM, Paris, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ronco, P (corresponding author), Hop Tenon, AP HP, Dept Nephrol & Dialysis, Paris, France.; Ronco, P (corresponding author), Univ Paris, Univ Pierre & Marie Curie, Sorbonne Univ, Paris, France.; Ronco, P (corresponding author), INSERM, Paris, France.	pierreronco@yahoo.fr	Debiec, Hanna/AAL-8144-2021; Ronco, Pierre/AAC-8390-2022	Debiec, Hanna/0000-0002-8946-8245; Franck, Pourcine/0000-0001-5601-6018	European Research Council [ERC-2012-ADG_20120314, 322947]; 7th Framework Programme of the European Community [2012-305608]	European Research Council(European Research Council (ERC)European Commission); 7th Framework Programme of the European Community	This study was funded by grants from the European Research Council ERC-2012-ADG_20120314 (Grant Agreement 322947) and from 7th Framework Programme of the European Community Contract 2012-305608 (European Consortium for High-Throughput Research in Kidney Diseases). Rituximab was provided by Hoffmann La Roche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by grants from the European Research Council ERC-2012-ADG_20120314 (Grant Agreement 322947) and from 7th Framework Programme of the European Community Contract 2012-305608 (European Consortium for High-Throughput Research in Rare Kidney Diseases). Rituximab was provided by Hoffmann-LaRoche. The authors confirm that they are not paid employees or consultants of Hoffmann-LaRoche, that no patents or products are in development in association with this study, and that no other perceivable competing interest exist between the authors and this company. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Bech AP, 2014, CLIN J AM SOC NEPHRO, V9, P1386, DOI 10.2215/CJN.10471013; Beck LH, 2011, J AM SOC NEPHROL, V22, P1543, DOI 10.1681/ASN.2010111125; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; CATTRAN DC, 1995, KIDNEY INT, V47, P1130, DOI 10.1038/ki.1995.161; Dahan K, 2016, J AM SOC NEPHROL; Debiec H, 2011, NEW ENGL J MED, V364, P689, DOI 10.1056/NEJMc1011678; DONADIO JV, 1988, KIDNEY INT, V33, P708, DOI 10.1038/ki.1988.56; Dong HR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156263; Hofstra JM, 2012, J AM SOC NEPHROL, V23, P1735, DOI 10.1681/ASN.2012030242; Hofstra JM, 2011, CLIN J AM SOC NEPHRO, V6, P1286, DOI 10.2215/CJN.07210810; Hoxha E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110681; Hoxha E, 2014, CLIN J AM SOC NEPHRO, V9, P1883, DOI 10.2215/CJN.03850414; Hoxha E, 2014, J AM SOC NEPHROL, V25, P1357, DOI 10.1681/ASN.2013040430; Jha V, 2007, J AM SOC NEPHROL, V18, P1899, DOI 10.1681/ASN.2007020166; Kanigicherla D, 2013, KIDNEY INT, V83, P940, DOI 10.1038/ki.2012.486; Polanco N, 2010, J AM SOC NEPHROL, V21, P697, DOI 10.1681/ASN.2009080861; PONTICELLI C, 1989, NEW ENGL J MED, V320, P8, DOI 10.1056/NEJM198901053200102; Ponticelli C, 2014, CLIN J AM SOC NEPHRO, V9, P609, DOI 10.2215/CJN.04160413; Qin HZ, 2016, J AM SOC NEPHROL; Radhakrishnan J, 2012, KIDNEY INT, V82, P840, DOI 10.1038/ki.2012.280; Ruggenenti P, 2015, J AM SOC NEPHROL, V26, P2545, DOI 10.1681/ASN.2014070640; SCHIEPPATI A, 1993, NEW ENGL J MED, V329, P85, DOI 10.1056/NEJM199307083290203; Stehle T, 2015, NEPHROL DIAL TRANSPL, V30, P1047, DOI 10.1093/ndt/gfv080; Svobodova B, 2013, NEPHROL DIAL TRANSPL, V28, P1839, DOI 10.1093/ndt/gfs439; Tomas NM, 2016, J CLIN INVEST, V126, P2519, DOI 10.1172/JCI85265; Tomas NM, 2014, NEW ENGL J MED, V371, P2277, DOI 10.1056/NEJMoa1409354; van den Brand JAJG, 2014, CLIN J AM SOC NEPHRO, V9, P1066, DOI 10.2215/CJN.08880813; Xie QH, 2015, AM J NEPHROL, V41, P345, DOI 10.1159/000431331	28	48	55	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173201	10.1371/journal.pone.0173201	http://dx.doi.org/10.1371/journal.pone.0173201			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257452	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100075
J	Brouns, SHA; van der Schuit, KCH; Stassen, PM; Lambooij, SLE; Dieleman, J; Vanderfeesten, ITP; Haak, HR				Brouns, Steffie H. A.; van der Schuit, Klara C. H.; Stassen, Patricia M.; Lambooij, Suze L. E.; Dieleman, Jeanne; Vanderfeesten, Irene T. P.; Haak, Harm R.			Applicability of the modified Emergency Department Work Index (mEDWIN) at a Dutch emergency department	PLOS ONE			English	Article							OUTCOMES; NEEDS; STAY; CARE	Background Emergency department (ED) crowding leads to prolonged emergency department length of stay (ED-LOS) and adverse patient outcomes. No uniform definition of ED crowding exists. Several scores have been developed to quantify ED crowding; the best known is the Emergency Department Work Index (EDWIN). Research on the EDWIN is often applied to limited settings and conducted over a short period of time. Objectives To explore whether the EDWIN as a measure can track occupancy at a Dutch ED over the course of one year and to identify fluctuations in ED occupancy per hour, day, and month. Secondary objective is to investigate the discriminatory value of the EDWIN in detecting crowding, as compared with the occupancy rate and prolonged ED-LOS. Methods A retrospective cohort study of all ED visits during the period from September 2010 to August 2011 was performed in one hospital in the Netherlands. The EDWIN incorporates the number of patients per triage level, physicians, treatment beds and admitted patients to quantify ED crowding. The EDWIN was adjusted to emergency care in the Netherlands: modified EDWIN (mEDWIN). ED crowding was defined as the 75 th percentile of mEDWIN per hour, which was >= 0.28. Results In total, 28,220 ED visits were included in the analysis. The median mEDWIN per hour was 0.15 (Interquartile range (IQR) 0.05-0.28); median mEDWIN per patient was 0.25 (IQR 0.15-0.39). The EDWIN was higher on Wednesday (0.16) than on other days (0.14-0.16, p< 0.001), and a peak in both mEDWIN (0.30-0.33) and ED crowding (52.9-63.4%) was found between 13: 00-18: 00 h. A comparison of the mEDWIN with the occupancy rate revealed an area under the curve (AUC) of 0.86 (95% CI 0.85-0.87). The AUC of mEDWIN compared with a prolonged ED-LOS (>= 4 hours) was 0.50 (95% CI 0.40-0.60). Conclusion The mEDWIN was applicable at a Dutch ED. The mEDWIN was able to identify fluctuations in ED occupancy. In addition, the mEDWIN had high discriminatory power for identification of a busy ED, when compared with the occupancy rate.	[Brouns, Steffie H. A.; van der Schuit, Klara C. H.; Lambooij, Suze L. E.; Haak, Harm R.] Maxima Med Ctr, Dept Internal Med, Eindhoven, Netherlands; [Stassen, Patricia M.; Haak, Harm R.] Maastricht Univ, Med Ctr, Dept Internal Med, Div Gen Med,Sect Acute Med, Maastricht, Netherlands; [Dieleman, Jeanne] Maxima Med Ctr, Maxima Med Ctr Acad, Eindhoven, Netherlands; [Vanderfeesten, Irene T. P.] Eindhoven Univ Technol, Sch Ind Engn, Eindhoven, Netherlands; [Haak, Harm R.] Maastricht Univ, Dept Hlth Serv Res, Maastricht, Netherlands; [Haak, Harm R.] CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [Brouns, Steffie H. A.] Maxima Med Ctr, Dept Internal Med, Veldhoven, Netherlands	Maxima Medical Center; Maastricht University; Maxima Medical Center; Eindhoven University of Technology; Maastricht University; Maastricht University; Maxima Medical Center	Brouns, SHA (corresponding author), Maxima Med Ctr, Dept Internal Med, Eindhoven, Netherlands.; Brouns, SHA (corresponding author), Maxima Med Ctr, Dept Internal Med, Veldhoven, Netherlands.	S.Brouns@mmc.nl	Vanderfeesten, Irene/B-6181-2019	Vanderfeesten, Irene/0000-0002-6670-5519				American College of Emergency Physicians (ACEP), 2013, ANN EMERG MED, V61, P726; Asplin BR, 2003, ANN EMERG MED, V42, P173, DOI 10.1067/mem.2003.302; Beniuk K, 2012, EMERG MED J, V29, P868, DOI 10.1136/emermed-2011-200646; Bernstein SL, 2003, ACAD EMERG MED, V10, P938, DOI 10.1197/S1069-6563(03)00311-7; Bernstein SL, 2009, ACAD EMERG MED, V16, P1, DOI 10.1111/j.1553-2712.2008.00295.x; Brouns SHA, 2014, NETH J MED, V72, P311; Brouns SHA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135066; Carter EJ, 2014, J NURS SCHOLARSHIP, V46, P106, DOI 10.1111/jnu.12055; Epstein SK, 2012, INTERN EMERG MED, V7, P173, DOI 10.1007/s11739-011-0702-8; Handel DA, 2010, ACAD EMERG MED, V17, P840, DOI 10.1111/j.1553-2712.2010.00814.x; Hollander JE, 2007, ANN EMERG MED, V50, P497, DOI 10.1016/j.annemergmed.2007.05.002; Holmes JL, 2010, EMERG MED AUSTRALAS, V22, P75, DOI 10.1111/j.1742-6723.2009.01259.x; Hoot NR, 2008, ANN EMERG MED, V52, P126, DOI 10.1016/j.annemergmed.2008.03.014; Hoot NR, 2007, ANN EMERG MED, V49, P747, DOI 10.1016/j.annemergmed.2007.01.017; Hwang U, 2006, J AM GERIATR SOC, V54, P270, DOI 10.1111/j.1532-5415.2005.00587.x; Hwang U, 2011, ACAD EMERG MED, V18, P526, DOI 10.1111/j.1553-2712.2011.01054.x; Jones SS, 2006, ACAD EMERG MED, V13, P1204, DOI 10.1197/j.aem.2006.05.021; Kocher KE, 2012, ACAD EMERG MED, V19, P525, DOI 10.1111/j.1553-2712.2012.01353.x; Kulstad EB, 2010, WEST J EMERG MED, V11, P324; Kulstad EB, 2009, INT J EMERG MED, V2, P149, DOI 10.1007/s12245-009-0107-x; Kulstad EB, 2010, AM J EMERG MED, V28, P304, DOI 10.1016/j.ajem.2008.12.014; Mackway-Jones K, 2005, EMERGENCY TRIAGE; McCarthy ML, 2008, ANN EMERG MED, V51, P15, DOI 10.1016/j.annemergmed.2007.09.003; Pines JM, 2011, ACAD EMERG MED, V18, P1358, DOI 10.1111/j.1553-2712.2011.01235.x; Raad voor de Volksgezondheid en Zorg, 2011, ZIEK 20 20 NIEM DROO; Richardson DB, 2006, MED J AUSTRALIA, V184, P213, DOI 10.5694/j.1326-5377.2006.tb00204.x; van der Linden C, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-41; van der Linden MC, 2014, EUR J EMERG MED, V21, P354, DOI 10.1097/MEJ.0000000000000086; Weber EJ, 2011, ANN EMERG MED, V57, P79, DOI 10.1016/j.annemergmed.2010.08.013; Weiss SJ, 2004, ACAD EMERG MED, V11, P38, DOI 10.1197/S1069-6563(03)00583-9; Wiler JL, 2011, ACAD EMERG MED, V18, P1371, DOI 10.1111/j.1553-2712.2011.01135.x	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e73387	10.1371/journal.pone.0173387	http://dx.doi.org/10.1371/journal.pone.0173387			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282406	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800033
J	Desbordes, P; Ruan, S; Modzelewski, R; Pineau, P; Vauclin, S; Gouel, P; Michel, P; Di Fiore, F; Vera, P; Gardin, I				Desbordes, Paul; Ruan, Su; Modzelewski, Romain; Pineau, Pascal; Vauclin, Sebastien; Gouel, Pierrick; Michel, Pierre; Di Fiore, Frederic; Vera, Pierre; Gardin, Isabelle			Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier	PLOS ONE			English	Article							METABOLIC TUMOR VOLUME; CT TEXTURE ANALYSIS; F-18-FDG PET; NEOADJUVANT CHEMORADIOTHERAPY; PATHOLOGICAL RESPONSE; PROGNOSTIC VALUE; HETEROGENEITY; RADIOMICS; PARAMETERS; CHEMOTHERAPY	Purpose In oncology, texture features extracted from positron emission tomography with 18-fluoro-deoxyglucose images (FDG-PET) are of increasing interest for predictive and prognostic studies, leading to several tens of features per tumor. To select the best features, the use of a random forest (RF) classifier was investigated. Methods Sixty-five patients with an esophageal cancer treated with a combined chemo-radiation therapy were retrospectively included. All patients underwent a pretreatment whole-body FDG-PET. The patients were followed for 3 years after the end of the treatment. The response assessment was performed 1 month after the end of the therapy. Patients were classified as complete responders and non-complete responders. Sixty-one features were extracted from medical records and PET images. First, Spearman's analysis was performed to eliminate correlated features. Then, the best predictive and prognostic subsets of features were selected using a RF algorithm. These results were compared to those obtained by a Mann-Whitney U test (predictive study) and a univariate Kaplan-Meier analysis (prognostic study). Results Among the 61 initial features, 28 were not correlated. From these 28 features, the best subset of complementary features found using the RF classifier to predict response was composed of 2 features: metabolic tumor volume (MTV) and homogeneity from the co-occurrence matrix. The corresponding predictive value (AUC = 0.836 +/- 0.105, Se = 82 +/- 9%, Sp = 91 +/- 12%) was higher than the best predictive results found using the Mann-Whitney test: busyness from the gray level difference matrix (P < 0.0001, AUC = 0.810, Se = 66%, Sp = 88%). The best prognostic subset found using RF was composed of 3 features: MTV and 2 clinical features (WHO status and nutritional risk index) (AUC = 0.822 +/- 0.059, Se = 79 +/- 9%, Sp = 95 +/- 6%), while no feature was significantly prognostic according to the Kaplan-Meier analysis. Conclusions The RF classifier can improve predictive and prognostic values compared to the Mann-Whitney U test and the univariate Kaplan-Meier survival analysis when applied to several tens of features in a limited patient database.	[Desbordes, Paul; Ruan, Su; Modzelewski, Romain; Vera, Pierre; Gardin, Isabelle] Univ Rouen, LITIS Quantif, EA4108, Rouen, France; [Desbordes, Paul; Pineau, Pascal; Vauclin, Sebastien] Dosisoft, Cachan, France; [Modzelewski, Romain; Gouel, Pierrick; Vera, Pierre; Gardin, Isabelle] Ctr Henri Becquerel, Dept Nucl Med, Rouen, France; [Michel, Pierre] Normandie Univ, UNIROUEN, Inserm 1245, Rouen Univ Hosp,Dept Hepatogastroenterol, Rouen, France; [Di Fiore, Frederic] Ctr Henri Becquerel, Dept Oncol, Rouen, France	Universite de Rouen Normandie; UNICANCER; Centre Henri Becquerel; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Henri Becquerel	Desbordes, P (corresponding author), Univ Rouen, LITIS Quantif, EA4108, Rouen, France.; Desbordes, P (corresponding author), Dosisoft, Cachan, France.	desbordespaul@gmail.com	Desbordes, Paul/W-6780-2019	Desbordes, Paul/0000-0002-1521-7590; Ruan, Su/0000-0001-8785-6917; Gardin, Isabelle/0000-0002-6342-6127	ANRT (French National Association for Research and Technology) under the contract ANRT [2013/1153]; Dosisoft	ANRT (French National Association for Research and Technology) under the contract ANRT(French National Research Agency (ANR)); Dosisoft	This work was partly funded by ANRT (French National Association for Research and Technology) under the contract ANRT no2013/1153. This work was also funded by Dosisoft. Dosisoft provided support in the form of salaries for authors PD, SV and PP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Altman DG, 1998, BREAST CANCER RES TR, V52, P289, DOI 10.1023/A:1006193704132; AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Blom RLGM, 2013, EUR J NUCL MED MOL I, V40, P1500, DOI 10.1007/s00259-013-2468-x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brooks FJ, 2014, J NUCL MED, V55, P37, DOI 10.2967/jnumed.112.116715; Bundschuh RA, 2014, J NUCL MED, V55, P891, DOI 10.2967/jnumed.113.127340; Chalkidou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124165; Czernin J, 2007, J NUCL MED, V48, p78S; Demsar J, 2006, J MACH LEARN RES, V7, P1; Desseroit MC, 2016, EUR J NUCL MED MOL I, V43, P1477, DOI 10.1007/s00259-016-3325-5; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Ganeshan B, 2012, CLIN RADIOL, V67, P157, DOI 10.1016/j.crad.2011.08.012; Gao X, 2015, EUR J RADIOL, V84, P312, DOI 10.1016/j.ejrad.2014.11.006; Giganti F, 2017, EUR RADIOL, V27, P1831, DOI 10.1007/s00330-016-4540-y; Giganti F, 2016, RADIOL MED, V121, P173, DOI 10.1007/s11547-015-0585-2; Giorgetti A, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003151; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Hatt M, 2013, J NUCL MED, V54, P341, DOI 10.2967/jnumed.112.108837; Hatt M, 2011, EUR J NUCL MED MOL I, V38, P1595, DOI 10.1007/s00259-011-1834-9; Hatt M, 2011, EUR J NUCL MED MOL I, V38, P1191, DOI 10.1007/s00259-011-1755-7; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hofheinz F, 2015, EUR J NUCL MED MOL I, V42, P429, DOI 10.1007/s00259-014-2953-x; Hyun SH, 2010, ANN SURG ONCOL, V17, P115, DOI 10.1245/s10434-009-0719-7; Lartizien C, 2014, IEEE J BIOMED HEALTH, V18, P946, DOI 10.1109/JBHI.2013.2283658; Leijenaar RTH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11075; Leijenaar RTH, 2013, ACTA ONCOL, V52, P1391, DOI 10.3109/0284186X.2013.812798; Lemarignier C, 2014, EUR J NUCL MED MOL I, V41, P2008, DOI 10.1007/s00259-014-2839-y; Mi HM, 2015, ARTIF INTELL MED, V64, P195, DOI 10.1016/j.artmed.2015.07.002; Orlhac F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145063; Orlhac F, 2014, J NUCL MED, V55, P414, DOI 10.2967/jnumed.113.129858; Palie O, 2013, EUR J NUCL MED MOL I, V40, P1345, DOI 10.1007/s00259-013-2450-7; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13087; Paul D, 2017, COMPUT MED IMAG GRAP, V60, P42, DOI 10.1016/j.compmedimag.2016.12.002; Raman SP, 2014, ACAD RADIOL, V21, P1587, DOI 10.1016/j.acra.2014.07.023; Tan S, 2013, MED PHYS, V40, DOI 10.1118/1.4820445; Tan S, 2013, INT J RADIAT ONCOL, V85, P1375, DOI 10.1016/j.ijrobp.2012.10.017; Thibault G., 2009, PROC PATTERN RECOGNI, P140; Tixier F, 2012, J NUCL MED, V53, P693, DOI 10.2967/jnumed.111.099127; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Vallieres M, 2015, PHYS MED BIOL, V60, P5471, DOI 10.1088/0031-9155/60/14/5471; Van de Wiele C, 2013, EUR J NUCL MED MOL I, V40, P290, DOI 10.1007/s00259-012-2280-z; van Rossum PSN, 2016, J NUCL MED, V57, P691, DOI 10.2967/jnumed.115.163766; Vauclin S, 2009, PHYS MED BIOL, V54, P6901, DOI 10.1088/0031-9155/54/22/010; Yan JH, 2015, J NUCL MED, V56, P1667, DOI 10.2967/jnumed.115.156927; Yip SSF, 2016, PHYS MED BIOL, V61, pR150, DOI 10.1088/0031-9155/61/13/R150; Yu CH, 2003, RESAMPLING METHODS C, V8; Zhang H, 2014, INT J RADIAT ONCOL, V88, P195, DOI 10.1016/j.ijrobp.2013.09.037	52	30	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173208	10.1371/journal.pone.0173208	http://dx.doi.org/10.1371/journal.pone.0173208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282392	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800021
J	Hansson, B; Rippe, C; Kotowska, D; Wasserstrom, S; Sall, J; Goransson, O; Sward, K; Stenkula, KG				Hansson, Bjorn; Rippe, Catarina; Kotowska, Dorota; Wasserstrom, Sebastian; Sall, Johanna; Goransson, Olga; Sward, Karl; Stenkula, Karin G.			Rosiglitazone drives cavin-2/SDPR expression in adipocytes in a CEBP alpha-dependent manner	PLOS ONE			English	Article							CAVIN FAMILY; INSULIN-RESISTANCE; CAVEOLAE; RECEPTOR; TRANSCRIPTION; PTRF; MUTATIONS; DYNAMICS; SURFACE; CELLS	Caveolae are abundant adipocyte surface domains involved in insulin signaling, membrane trafficking and lipid homeostasis. Transcriptional control mechanisms for caveolins and cavins, the building blocks of caveolae, are thus arguably important for adipocyte biology and studies in this area may give insight into insulin resistance and diabetes. Here we addressed the hypothesis that one of the less characterized caveolar components, cavin-2 (SDPR), is controlled by CCAAT/Enhancer Binding Protein (CEBP alpha) and Peroxisome Proliferator- Activated Receptor Gamma (PPARG). Using human mRNA expression data we found that SDPR correlated with PPARG in several tissues. This was also observed during differentiation of 3T3-L1 fibroblasts into adipocytes. Treatment of 3T3-L1-derived adipocytes with the PPAR gamma-activator Rosiglitazone increased SDPR and CEBPa expression at both the mRNA and protein levels. Silencing of CEBPa antagonized these effects. Further, adenoviral expression of PPAR gamma/CEBP alpha or Rosiglitazone-treatment increased SDPR expression in primary rat adipocytes. The myocardin family coactivator MKL1 was recently shown to regulate SDPR expression in human coronary artery smooth muscle cells. However, we found that actin depolymerization, known to inhibit MKL1 and MKL2, was without effect on SDPR mRNA levels in adipocytes, even though overexpression of MKL1 and MKL2 had the capacity to increase caveolins and cavins and to repress PPAR gamma/CEBP alpha. Altogether, this work demonstrates that CEBPa expression and PPAR gamma-activity promote SDPR transcription and further supports the emerging notion that PPAR gamma/CEBP alpha and MKL1/MKL2 are antagonistic in adipocytes.	[Hansson, Bjorn; Rippe, Catarina; Kotowska, Dorota; Wasserstrom, Sebastian; Sall, Johanna; Goransson, Olga; Sward, Karl; Stenkula, Karin G.] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Stenkula, KG (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	karin.stenkula@med.lu.se	Säll, Johanna/C-1083-2015; Rippe, Catarina/B-4110-2010	Säll, Johanna/0000-0001-7337-4140; Rippe, Catarina/0000-0001-8621-9836; Goransson, Olga/0000-0002-7209-8022; Stenkula, Karin/0000-0002-0739-1150; Wasserstrom, Sebastian/0000-0001-9755-5974	Swedish Research Council [2013-3542, K2015-65X-22662-01-3]; Novo Nordisk Foundation; Diabetes Foundation; Magnus Bergvall Foundation; Crafoord Foundation; Albert Pahlsson Foundation; Royal Physiographic Society in Lund; Novo Nordisk Fonden [NNF15OC0016472] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Diabetes Foundation; Magnus Bergvall Foundation; Crafoord Foundation; Albert Pahlsson Foundation; Royal Physiographic Society in Lund; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was financially supported by the Swedish Research Council (2013-3542 to K.St., K2015-65X-22662-01-3 to K.Sw.), The Novo Nordisk Foundation, Diabetes Foundation, Magnus Bergvall Foundation, The Crafoord Foundation, Albert Pahlsson Foundation, and the Royal Physiographic Society in Lund.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Bastiani M, 2010, J CELL SCI, V123, P3831, DOI 10.1242/jcs.070102; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Breen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034516; Burgermeister E, 2003, ONCOGENE, V22, P3888, DOI 10.1038/sj.onc.1206625; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Gustincich S, 1999, GENOMICS, V57, P120, DOI 10.1006/geno.1998.5733; Haakonsson AK, 2013, MOL ENDOCRINOL, V27, P1536, DOI 10.1210/me.2013-1080; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hansen CG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2808; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Henriksson E, 2015, J CELL SCI, V128, P472, DOI 10.1242/jcs.153932; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Karlsson M, 2004, EUR J BIOCHEM, V271, P2471, DOI 10.1111/j.1432-1033.2004.04177.x; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Kovtun O, 2015, J CELL SCI, V128, P1269, DOI 10.1242/jcs.167866; Krawczyk KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133931; Lindahl M, 2015, J LIPID RES, V56, P2248, DOI 10.1194/jlr.M054767; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; McDonald ME, 2015, CELL, V160, P105, DOI 10.1016/j.cell.2014.12.005; Mineo C, 1998, J CELL BIOL, V141, P601, DOI 10.1083/jcb.141.3.601; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Nassar ZD, 2015, INT REV CEL MOL BIO, V320, P235, DOI 10.1016/bs.ircmb.2015.07.009; Nobusue H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4368; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Oshikawa J, 2004, P NATL ACAD SCI USA, V101, P12670, DOI 10.1073/pnas.0402053101; Panigrahy D, 2002, J CLIN INVEST, V110, P923, DOI 10.1172/JCI200215634; Regazzetti C, 2015, ENDOCRINOLOGY, V156, P789, DOI 10.1210/en.2014-1656; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Stralfors P, 2012, ADV EXP MED BIOL, V729, P111, DOI 10.1007/978-1-4614-1222-9_8; Talukder MAH, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12736; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X	37	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173412	10.1371/journal.pone.0173412	http://dx.doi.org/10.1371/journal.pone.0173412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278164	gold, Green Published, Green Submitted			2022-12-27	WOS:000396087900088
J	Heissig, P; Schrimpf, W; Hadwiger, P; Wagner, E; Lamb, DC				Heissig, Philipp; Schrimpf, Waldemar; Hadwiger, Philipp; Wagner, Ernst; Lamb, Don C.			Monitoring integrity and localization of modified single-stranded RNA oligonucleotides using ultrasensitive fluorescence methods	PLOS ONE			English	Article							PULSED INTERLEAVED EXCITATION; ANTISENSE OLIGONUCLEOTIDES; CHEMICAL-MODIFICATION; SIRNA DELIVERY; THERAPEUTICS; INTERFERENCE; ANTAGOMIRS; MICRORNA; DESIGN; QUANTIFICATION	Short single-stranded oligonucleotides represent a class of promising therapeutics with diverse application areas. Antisense oligonucleotides, for example, can interfere with various processes involved in mRNA processing through complementary base pairing. Also RNA interference can be regulated by antagomirs, single-stranded siRNA and single-stranded microRNA mimics. The increased susceptibility to nucleolytic degradation of unpaired RNAs can be counteracted by chemical modification of the sugar phosphate backbone. In order to understand the dynamics of such single-stranded RNAs, we investigated their fate after exposure to cellular environment by several fluorescence spectroscopy techniques. First, we elucidated the degradation of four differently modified, dual-dye labeled short RNA oligonucleotides in HeLa cell extracts by fluorescence correlation spectroscopy, fluorescence cross-correlation spectroscopy and Forster resonance energy transfer. We observed that the integrity of the oligonucleotide sequence correlates with the extent of chemical modifications. Furthermore, the data showed that nucleolytic degradation can only be distinguished from unspecific effects like aggregation, association with cellular proteins, or intramolecular dynamics when considering multiple measurement and analysis approaches. We also investigated the localization and integrity of the four modified oligonucleotides in cultured HeLa cells using fluorescence lifetime imaging microscopy. No intracellular accumulation could be observed for unmodified oligonucleotides, while completely stabilized oligonucleotides showed strong accumulation within HeLa cells with no changes in fluorescence lifetime over 24 h. The integrity and accumulation of partly modified oligonucleotides was in accordance with their extent of modification. In highly fluorescent cells, the oligonucleotides were transported to the nucleus. The lifetime of the RNA in the cells could be explained by a balance between release of the oligonucleotides from endosomes, degradation by RNases and subsequent depletion from the cells.	[Heissig, Philipp; Wagner, Ernst] Univ Munich LMU, Dept Pharm, Pharmaceut Biotechnol, Munich, Germany; [Heissig, Philipp; Schrimpf, Waldemar; Wagner, Ernst; Lamb, Don C.] Univ Munich LMU, Ctr NanoSci CeNS, Munich, Germany; [Schrimpf, Waldemar; Lamb, Don C.] Univ Munich LMU, Dept Chem, Phys Chem, Munich, Germany; [Hadwiger, Philipp] Axolabs GmbH, Kulmbach, Germany	University of Munich; University of Munich; University of Munich	Wagner, E (corresponding author), Univ Munich LMU, Dept Pharm, Pharmaceut Biotechnol, Munich, Germany.; Wagner, E; Lamb, DC (corresponding author), Univ Munich LMU, Ctr NanoSci CeNS, Munich, Germany.; Lamb, DC (corresponding author), Univ Munich LMU, Dept Chem, Phys Chem, Munich, Germany.	ernst.wagner@cup.uni-muenchen.de; don.lamb@cup.uni-muenchen.de	Wagner, Ernst/A-7435-2012; Lamb, Don C/G-9501-2014; Wagner, Ernst/ABB-5976-2020	Wagner, Ernst/0000-0001-8413-0934; Lamb, Don C/0000-0002-0232-1903; Wagner, Ernst/0000-0001-8413-0934				Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Bramsen JB, 2009, NUCLEIC ACIDS RES, V37, P2867, DOI 10.1093/nar/gkp106; Chan JHP, 2006, CLIN EXP PHARMACOL P, V33, P533, DOI 10.1111/j.1440-1681.2006.04403.x; Chen AK, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp837; Chorn G, 2012, RNA, V18, P1796, DOI 10.1261/rna.031278.111; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; CIAFRE SA, 1995, NUCLEIC ACIDS RES, V23, P4134; Clayton AHA, 2004, J MICROSC-OXFORD, V213, P1, DOI 10.1111/j.1365-2818.2004.01265.x; Corey DR, 2007, J CLIN INVEST, V117, P3615, DOI 10.1172/JCI33483; Cortez MA, 2014, MOL THER, V22, P1494, DOI 10.1038/mt.2014.79; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Dohmen C, 2012, ACS NANO, V6, P5198, DOI 10.1021/nn300960m; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Foo YH, 2012, BIOPHYS J, V102, P1174, DOI 10.1016/j.bpj.2012.01.040; Frohlich T, 2012, J CONTROL RELEASE, V160, P532, DOI 10.1016/j.jconrel.2012.03.018; Hendrix J, 2013, BIOPHYS J, V105, P848, DOI 10.1016/j.bpj.2013.05.059; Hirsch M, 2015, NUCLEIC ACIDS RES, V43, P4650, DOI 10.1093/nar/gkv307; Juliano RL, 2016, NUCLEIC ACIDS RES, V44, P6518, DOI 10.1093/nar/gkw236; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Kopp F, 2014, ONCOTARGET, V5, P185, DOI 10.18632/oncotarget.1427; Kopp F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050469; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Lennox KA, 2011, GENE THER, V18, P1111, DOI 10.1038/gt.2011.100; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Lorenz P, 1998, MOL BIOL CELL, V9, P1007, DOI 10.1091/mbc.9.5.1007; Luhtala N, 2010, TRENDS BIOCHEM SCI, V35, P253, DOI 10.1016/j.tibs.2010.02.002; Lundin KE, 2015, HUM GENE THER, V26, P475, DOI 10.1089/hum.2015.070; Mattes J, 2007, AM J RESP CELL MOL, V36, P8, DOI 10.1165/rcmb.2006-0227TR; Muller K, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/46/464001; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Reinhard S, 2016, MACROMOL BIOSCI; Rosenberg HF, 2008, J LEUKOCYTE BIOL, V83, P1079, DOI 10.1189/jlb.1107725; Schaffert D, 2011, ANGEW CHEM INT EDIT, V50, P8986, DOI 10.1002/anie.201102165; Smart N, 2005, BIOL PROCED ONLINE, V7, P1, DOI 10.1251/bpo99; Thomson DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055214; Troiber C, 2013, BIOMATERIALS, V34, P1624, DOI 10.1016/j.biomaterials.2012.11.021; Velu Chinavenmeni S, 2012, Methods Mol Biol, V928, P185, DOI 10.1007/978-1-62703-008-3_15; Wagner E, 2012, ACCOUNTS CHEM RES, V45, P1005, DOI 10.1021/ar2002232; Wittrup A, 2015, NAT REV GENET, V16, P543, DOI 10.1038/nrg3978; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002	43	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173401	10.1371/journal.pone.0173401	http://dx.doi.org/10.1371/journal.pone.0173401			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278199	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900086
J	Alibhai, S; Jewell, Z; Evans, J				Alibhai, Sky; Jewell, Zoe; Evans, Jonah			The challenge of monitoring elusive large carnivores: An accurate and cost-effective tool to identify and sex pumas (Puma concolor) from footprints	PLOS ONE			English	Article							TIGERS PANTHERA-TIGRIS; LIONS FELIS-CONCOLOR; INDIVIDUAL TIGERS; COUGAR; IDENTIFICATION; BIOLOGY; TRACKS	Acquiring reliable data on large felid populations is crucial for effective conservation and management. However, large felids, typically solitary, elusive and nocturnal, are difficult to survey. Tagging and following individuals with VHF or GPS technology is the standard approach, but costs are high and these methodologies can compromise animal welfare. Such limitations can restrict the use of these techniques at population or landscape levels. In this paper we describe a robust technique to identify and sex individual pumas from footprints. We used a standardized image collection protocol to collect a reference database of 535 footprints from 35 captive pumas over 10 facilities; 19 females (300 footprints) and 16 males (235 footprints), ranging in age from 1-20 yrs. Images were processed in JMP data visualization software, generating one hundred and twenty three measurements from each footprint. Data were analyzed using a customized model based on a pairwise trail comparison using robust cross-validated discriminant analysis with a Ward's clustering method. Classification accuracy was consistently > 90% for individuals, and for the correct classification of footprints within trails, and > 99% for sex classification. The technique has the potential to greatly augment the methods available for studying puma and other elusive felids, and is amenable to both citizen-science and opportunistic/local community data collection efforts, particularly as the data collection protocol is inexpensive and intuitive.	[Alibhai, Sky; Jewell, Zoe] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Alibhai, Sky; Jewell, Zoe] SAS, JMP Div, Cary, NC 27513 USA; [Alibhai, Sky; Jewell, Zoe] North Carolina State Univ, Dept Mech & Aerosp Engn, Raleigh, NC 27695 USA; [Evans, Jonah] Texas Parks & Wildlife, Austin, TX USA	Duke University; University of North Carolina; North Carolina State University	Jewell, Z (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.; Jewell, Z (corresponding author), SAS, JMP Div, Cary, NC 27513 USA.; Jewell, Z (corresponding author), North Carolina State Univ, Dept Mech & Aerosp Engn, Raleigh, NC 27695 USA.	wildtrack.monitoring@gmail.com		Jewell, Zoe/0000-0002-4915-7952				Alibhai SK, 2001, ORYX, V35, P284, DOI 10.1017/S0030605300032014; Alibhai SK, 2001, J ZOOLOGY; Alibhai Sky K., 2008, Endangered Species Research, V4, P205, DOI 10.3354/esr00067; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Beausoleil R. A., 2008, P 9 MOUNT LION WORKS, P205; Beier P, 1996, WILDLIFE SOC B; Carbyn L, 2003, THE SWIFT FOX; Cattet M, 2008, J MAMMALOGY; Choate DM, 2006, WILDLIFE SOC B, V34, P782, DOI 10.2193/0091-7648(2006)34[782:EOCPEI]2.0.CO;2; Creel S., 2002, THE AFRICAN WILD DOG; Davidson GA, 2014, J WILDLIFE MANAGE, V78, P1104, DOI 10.1002/jwmg.758; Dyck MG, 2007, ECOLOGICAL COMPLEXIT; Edwards R. Y., 1959, Murrelet, V40, P14, DOI 10.2307/3534823; Elbroch LM, 2013, WILDLIFE BIOL, V19, P210, DOI 10.2981/12-114; Evans JW, 2009, J WILDLIFE MANAGEMEN; Foster RJ, 2012, J WILDLIFE MANAGEMEN; Funston PJ, 2010, J ZOOL, V281, P56, DOI 10.1111/j.1469-7998.2009.00682.x; Garcia KP, 2010, ZOOL STUD, V49, P577; Gogate MG, 1989, TIGER PUGMARK STUDIE; Grigione MM, 1999, BIOL CONSERV, V88, P25, DOI 10.1016/S0006-3207(98)00096-2; Gu J, 2014, WILDLIFE SOC B; Gu J, 2014, WILDLIFE SOC B, V38, P495, DOI 10.1002/wsb.432; Heilbrun RD, 2006, WILDLIFE SOC B; Herzog CJ, 2007, J WILDLIFE MANAGEMEN; Jewell Z., 2013, CONSERVATION BIOL; Jewell ZC, 2001, J ZOOL, V254, P1, DOI 10.1017/S0952836901000516; Jewell ZC, 2010, ENCY ANIMAL RIGHTS W; Jewell ZC, 2016, JOVE-J VIS EXP, DOI 10.3791/54034; Karanth KU, 2003, ANIM CONSERV, V6, P141, DOI 10.1017/S1367943003003184; Karanth KU, 2006, ECOLOGY; Kelly MJ, 2008, J MAMMALOGY; Klein DR, 1959, J WILDLIFE MANAGEMEN; Krausman PR, 2004, WILDLIFE SOC B; Lewison R, 2001, BIOL CONSERV, V99, P313, DOI 10.1016/S0006-3207(00)00197-X; Logan KA, 1999, WILDLIFE SOC B; Mardia KV, 1979, TESTS UNIVARIATE MUL; McBride R, 2015, SOUTHEAST NAT, V14, P351, DOI 10.1656/058.014.0215; McBride RT, 2008, SOUTHEAST NAT, V7, P381, DOI 10.1656/1528-7092-7.3.381; McDougal C., 1977, FACE TIGER; Miller CM, 2001, MEASUREMENTS JAGUAR; Milligan GW, 1978, PSYCHOMETRIKA, V45, P68; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Moorhouse TP, 2005, J APPL ECOL, V42, P91, DOI 10.1111/j.1365-2664.2005.00998.x; Murray DL, 2000, METH C CONS, P15; Panwar HS, 1979, PUBLICATIONS ASTRONO, P1063; Pimm SL, 2015, TRENDS ECOL EVOL, V30, P685, DOI 10.1016/j.tree.2015.08.008; Pirie TJ, 2016, WILDLIFE BIOL, V22, P13, DOI 10.2981/wlb.00129; Reeder DM, 2005, J MAMMALOGY; Riordan P, 1998, ANIM CONSERV, V1, P253, DOI 10.1111/j.1469-1795.1998.tb00036.x; Rosas-Rosas OC, 2003, WILDLIFE SOC B; Sagar SR, 1993, TECHNIQUE DISTINGUIS; Sankhala K., 2005, TIGER STORY INDIAN T; Sharma S, 2005, J ZOOL, V267, P9, DOI 10.1017/S0952836905007119; Sharma S, 2003, WILDLIFE SOC B, V31, P258; Shaw H.G., 2007, PUMA FIELD GUIDE; Shaw HG., 2007, IDENTIFICATION ASSES; SMALLWOOD KS, 1993, BIOL CONSERV, V65, P51, DOI 10.1016/0006-3207(93)90196-8; SMALLWOOD KS, 1995, BIOL CONSERV, V71, P251, DOI 10.1016/0006-3207(94)00034-N; Stander PE, 1997, J ZOOLOGY; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Taberlet P, 1999, BIOL J LINNEAN SOC; VANSICKLE WD, 1991, J WILDLIFE MANAGE, V55, P738; Wilson GJ, 2001, WILDLIFE RES, V28, P151, DOI 10.1071/WR00033; Wolfe ML, 2016, J WILDLIFE MANAGE, V80, P27, DOI 10.1002/jwmg.985; Wultsch C, 2014, MOL ECOLOGY RESOURCE; Zalewski A., 1973, WILDLIFE SOC B	66	16	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172065	10.1371/journal.pone.0172065	http://dx.doi.org/10.1371/journal.pone.0172065			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273159	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700066
J	Jorgensen, SB; Soraas, A; Sundsfjord, A; Liestol, K; Leegaard, TM; Jenum, PA				Jorgensen, Silje B.; Soraas, Arne; Sundsfjord, Arnfinn; Liestol, Knut; Leegaard, Truls M.; Jenum, Pal A.			Fecal carriage of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae after urinary tract infection - A three year prospective cohort study	PLOS ONE			English	Article							ESBL-PRODUCING ENTEROBACTERIACEAE; TRANSMISSION DYNAMICS; CHANGING EPIDEMIOLOGY; COLONIZATION; PREVALENCE; DURATION; TRAVEL	We have performed a prospective cohort study to investigate the duration of and risk factors for prolonged fecal carriage of ESBL-producing Escherichia coli or Klebsiella pneumoniae in patients with community acquired urinary tract infection caused by these bacteria. From 2009 to 2011, 101 Norwegian patients were recruited. Stool swabs and questionnaires were collected every three months for one year and at the end of the study in 2012. Information on antibiotic prescriptions was collected from the Norwegian Prescription Database. Stool samples were cultured directly on ChromID ESBL agar as well as in an enrichment broth, and culture positive isolates were examined by bla(CTX-M) multiplex PCR. Isolates without bla(CTX-M) were investigated for alternative ESBL-determinants with a commercial microarray system. Time to fecal clearance of ESBL producing Enterobacteriaceae was also analysed using Kaplan-Meier estimates. Uni- and multivariate logistic regression was used to compare groups according to previously described risk factors. The ESBL point prevalence of fecal carriage were 61% at 4 months, 56% at 7 months, 48% at 10 months, 39% at 13 months, 19% after two years, and 15% after three years or more. We found no correlation between duration of carriage, comorbidity, antibiotic use or travel to ESBL high-prevalence countries. Prolonged carriage was associated with E. coli isolates of phylogroup B2 or D. Importantly, comparative MLST and MLVA analyses of individual paired urine and fecal E. coli isolates revealed that ESBL production commonly occurred in diverse strains within the same host. When investigating cross-transmission of ESBL producing bacteria in health care institutions, this notion should be taken into account.	[Jorgensen, Silje B.; Soraas, Arne; Jenum, Pal A.] Vestre Viken Hosp Trust, Dept Lab Med, Sect Med Microbiol, Baerum, Norway; [Jorgensen, Silje B.; Leegaard, Truls M.] Akershus Univ Hosp, Dept Clin Microbiol & Infect Control, Lorenskog, Norway; [Soraas, Arne] Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway; [Sundsfjord, Arnfinn] Univ Hosp North Norway, Dept Microbiol & Infect Control, Norwegian Natl Advisory Unit Detect Antimicrobial, Tromso, Norway; [Sundsfjord, Arnfinn] Univ Tromso, Fac Hlth Sci, Dept Med Biol, Res Grp Host Microbe Interact, Tromso, Norway; [Liestol, Knut] Univ Oslo, Dept Informat, Oslo, Norway; [Leegaard, Truls M.; Jenum, Pal A.] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University of Oslo; University of Oslo	Jorgensen, SB (corresponding author), Vestre Viken Hosp Trust, Dept Lab Med, Sect Med Microbiol, Baerum, Norway.; Jorgensen, SB (corresponding author), Akershus Univ Hosp, Dept Clin Microbiol & Infect Control, Lorenskog, Norway.	silje.bakken.jorgensen@ahus.no	Sundsfjord, Arnfinn/F-9668-2018	Sundsfjord, Arnfinn/0000-0002-3728-2270; Jorgensen, Silje/0000-0002-3135-1431	Helse Sor-Ost RHF [2013060]; Helse Sor-Ost Regional Health Trust; Wellcome Trust [090532/Z/09/Z]	Helse Sor-Ost RHF; Helse Sor-Ost Regional Health Trust; Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by a research grant awarded to PAJ from Helse Sor-Ost RHF, grant number 2013060, www.helsesorost.no.; The inclusion group in this study is the same as the group included in a previous study by Soraas et al [8]. The study was funded by Helse Sor-Ost Regional Health Trust. Bjorn Arne Lindstedt and Inger Lobersli are acknowledged for excellent supervision of the implementation of the MLVA protocol, and Bettina Aasnes for her assistance in the microarray analysis. We thank the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust grant reference 090532/Z/09/Z) for the generation of the sequencing data.	Adler A, 2012, CLIN MICROBIOL INFEC, V18, pE497, DOI 10.1111/j.1469-0691.2012.03999.x; Birgand G, 2013, AM J INFECT CONTROL, V41, P443, DOI 10.1016/j.ajic.2012.05.015; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Blaak H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127752; Chaudhry S, 2005, MED CARE, V43, P607, DOI 10.1097/01.mlr.0000163658.65008.ec; Christiansson M, 2011, SCAND J INFECT DIS, V43, P579, DOI 10.3109/00365548.2011.568953; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; de Kraker MEA, 2013, CLIN MICROBIOL INFEC, V19, P860, DOI 10.1111/1469-0691.12028; Feldman N, 2013, CLIN MICROBIOL INFEC, V19, pE190, DOI 10.1111/1469-0691.12099; Hilty M, 2012, CLIN INFECT DIS, V55, P967, DOI 10.1093/cid/cis581; Jorgensen SB, 2014, SCAND J INFECT DIS, V46, P462, DOI 10.3109/00365548.2014.896031; Karami N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083030; Kluytmans-van den Bergh MFQ, 2015, J CLIN MICROBIOL, V53, P2709, DOI 10.1128/JCM.01251-15; Lindstedt BA, 2007, J MICROBIOL METH, V69, P197, DOI 10.1016/j.mimet.2007.01.001; Lobersli I, 2012, J MICROBIOL METH, V88, P134, DOI 10.1016/j.mimet.2011.11.003; Naseer U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041232; Nielsen KL, 2014, J MED MICROBIOL, V63, P582, DOI 10.1099/jmm.0.068783-0; O'Connell N, 2015, J HOSP INFECT, V90, P102, DOI 10.1016/j.jhin.2015.01.018; Ostholm-Balkhed A, 2013, J ANTIMICROB CHEMOTH, V68, P2144, DOI 10.1093/jac/dkt167; Oteo J, 2010, CURR OPIN INFECT DIS, V23, P320, DOI 10.1097/QCO.0b013e3283398dc1; Overdevest I, 2016, EUROSURVEILLANCE, V21, P24, DOI 10.2807/1560-7917.ES.2016.21.42.30376; Papst L, 2015, INFECT DIS LOND, P1; Peirano G, 2011, J TRAVEL MED, V18, P299, DOI 10.1111/j.1708-8305.2011.00548.x; Pitout JDD, 2010, DRUGS, V70, P313, DOI 10.2165/11533040-000000000-00000; Rodriguez-Bano J, 2008, J ANTIMICROB CHEMOTH, V62, P1142, DOI 10.1093/jac/dkn293; Ruppe E, 2015, CLIN INFECT DIS, V61, P593, DOI 10.1093/cid/civ333; Se Sakshaug, 2015, DRUG CONSUMPTION NOR; Soraas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085889; Soraas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069581; Stoesser N, 2015, J CLIN MICROBIOL; Thomsen MCF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157718; Titelman E, 2014, CLIN MICROBIOL INFEC, V20, pO508, DOI 10.1111/1469-0691.12559; Tofteland S, 2007, J CLIN MICROBIOL, V45, P199, DOI 10.1128/JCM.01319-06; Tschudin-Sutter S, 2012, CLIN INFECT DIS, V55, P1505, DOI 10.1093/cid/cis770; Valverde A, 2008, J CLIN MICROBIOL, V46, P2796, DOI 10.1128/JCM.01008-08; van Smeden M, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0267-3; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3	38	29	30	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173510	10.1371/journal.pone.0173510	http://dx.doi.org/10.1371/journal.pone.0173510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267783	gold, Green Published, Green Submitted			2022-12-27	WOS:000396060600040
J	Sarshekeh, AM; Advani, S; Overman, MJ; Manyam, G; Kee, BK; Fogelman, DR; Dasari, A; Raghav, K; Vilar, E; Manuel, S; Shureiqi, I; Wolff, RA; Patel, KP; Luthra, R; Shaw, K; Eng, C; Maru, DM; Routbort, MJ; Meric-Bernstam, F; Kopetz, S				Sarshekeh, Amir Mehrvarz; Advani, Shailesh; Overman, Michael J.; Manyam, Ganiraju; Kee, Bryan K.; Fogelman, David R.; Dasari, Arvind; Raghav, Kanwal; Vilar, Eduardo; Manuel, Shanequa; Shureiqi, Imad; Wolff, Robert A.; Patel, Keyur P.; Luthra, Raja; Shaw, Kenna; Eng, Cathy; Maru, Dipen M.; Routbort, Mark J.; Meric-Bernstam, Funda; Kopetz, Scott			Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer	PLOS ONE			English	Article							TGF-BETA; STRUCTURAL BASIS; FUNCTIONAL CONSEQUENCES; MOLECULAR SUBTYPES; MISSENSE MUTATIONS; PHOSPHORYLATION; GENE; 5-FLUOROURACIL; METASTASIS; BIOMARKERS	SMAD4 is an essential mediator in the transforming growth factor-beta pathway. Sporadic mutations of SMAD4 are present in 2.1-20.0% of colorectal cancers (CRCs) but data are limited. In this study, we aimed to evaluate clinicopathologic characteristics, prognosis, and clinical outcome associated with this mutation in CRC cases. Data for patients with metastatic or unresectable CRC who underwent genotyping for SMAD4 mutation and received treatment at The University of Texas MD Anderson Cancer Center from 2000 to 2014 were reviewed. Their tumors were sequenced using a hotspot panel predicted to cover 80% of the reported SMAD4 mutations, and further targeted resequencing that included full-length SMAD4 was performed on mutated tumors using a HiSeq sequencing system. Using The Cancer Genome Atlas data on CRC, the characteristics of SMAD4 and transforming growth factor-beta pathway mutations were evaluated according to different consensus molecular subtypes of CRC. Among 734 patients with CRC, 90 (12%) had SMAD4 mutations according to hotspot testing. SMAD4 mutation was associated with colon cancer more so than with rectal cancer (odds ratio 2.85; p<0.001), female sex (odds ratio 1.71; p = 0.02), and shorter overall survival than in wild-type SMAD4 cases (median, 29 months versus 56 months; hazard ratio 2.08; p<0.001 [log-rank test]). SMAD4 mutation was not associated with age, stage at presentation, colonic location, distant metastasis, or tumor grade. A subset of patients with metastatic CRC (n = 44) wild-type for KRAS, NRAS, and BRAF who received anti-epidermal growth factor receptor therapy with mutated SMAD4 (n = 13) had shorter progression-free survival duration than did patients wild-type for SMAD4 (n = 31) (median, 111 days versus 180 days; p = 0.003 [log-rank test]). Full-length sequencing confirmed that missense mutations at R361 and P356 in the MH2 domain were the most common SMAD4 alterations. In The Cancer Genome Atlas data, SMAD4 mutation frequently occurred with KRAS, NRAS, and BRAF mutations and was more common in patients with the consensus molecular subtype 3 of CRC than in those with the other 3 subtypes. This is one of the largest retrospective studies to date characterizing SMAD4 mutations in CRC patients and demonstrates the prognostic role and lack of response of CRC to anti-epidermal growth factor receptor therapy. Further studies are required to validate these findings and the role of SMAD4 mutation in CRC.	[Sarshekeh, Amir Mehrvarz; Advani, Shailesh; Overman, Michael J.; Manyam, Ganiraju; Kee, Bryan K.; Fogelman, David R.; Dasari, Arvind; Raghav, Kanwal; Vilar, Eduardo; Manuel, Shanequa; Shureiqi, Imad; Wolff, Robert A.; Patel, Keyur P.; Luthra, Raja; Shaw, Kenna; Eng, Cathy; Maru, Dipen M.; Routbort, Mark J.; Meric-Bernstam, Funda; Kopetz, Scott] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Kopetz, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA.	skopetz@mdanderson.org	Manyam, Ganiraju C/B-5890-2014; Kopetz, Scott/AAC-1387-2019; Manyam, Ganiraju/E-9150-2012; Shureiqi, imad/T-6214-2019; Advani, Shailesh/AAA-2812-2020	Kopetz, Scott/0000-0001-9647-3416; Manyam, Ganiraju/0000-0001-6006-8961; Advani, Shailesh/0000-0002-1446-969X; Shureiqi, Imad/0000-0003-2019-938X; Eng, Cathy/0000-0003-2335-0612	Sheikh Khalifa Al Nahyan Ben Zayed Institute for Personalized Cancer Therapy; University of Texas MD Anderson Cancer Center Support Grant [P30CA016672]; National Institutes of Health [R01CA184843]; NATIONAL CANCER INSTITUTE [R01CA184843, P30CA016672] Funding Source: NIH RePORTER	Sheikh Khalifa Al Nahyan Ben Zayed Institute for Personalized Cancer Therapy; University of Texas MD Anderson Cancer Center Support Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the Sheikh Khalifa Al Nahyan Ben Zayed Institute for Personalized Cancer Therapy and The University of Texas MD Anderson Cancer Center Support Grant No. P30CA016672 and National Institutes of Health Grant No. R01CA184843 (S.K.). There was no additional external funding received for this study.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Alazzouzi H, 2005, CLIN CANCER RES, V11, P2606, DOI 10.1158/1078-0432.CCR-04-1458; Alhopuro P, 2005, CLIN CANCER RES, V11, P6311, DOI 10.1158/1078-0432.CCR-05-0244; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chacko BM, 2001, NAT STRUCT BIOL, V8, P248, DOI 10.1038/84995; Dallol A, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0878-9; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Deschoolmeester V, 2010, ONCOLOGIST, V15, P699, DOI 10.1634/theoncologist.2010-0025; Drabsch Y, 2012, CANCER METAST REV, V31, P553, DOI 10.1007/s10555-012-9375-7; Duffy MJ, 2008, CLIN CHEM, V54, P1770, DOI 10.1373/clinchem.2008.110056; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goswami RS, 2015, CLIN CANCER RES, V21, P2644, DOI 10.1158/1078-0432.CCR-14-2391; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Han SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064271; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Iacobuzio-Donahue CA, 2004, CLIN CANCER RES, V10, P1597, DOI 10.1158/1078-0432.CCR-1121-3; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Jauhri M, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0820-2; Kuang CZ, 2004, ONCOGENE, V23, P1021, DOI 10.1038/sj.onc.1207219; Lee SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090459; Lei ZD, 2013, GASTROENTEROLOGY, V145, P554, DOI 10.1053/j.gastro.2013.05.010; Li XM, 2011, J GASTROINTEST SURG, V15, P2001, DOI 10.1007/s11605-011-1627-2; Losi L, 2007, ONCOL REP, V17, P1095; Lupini L, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1752-5; Malapelle U, 2016, J CLIN PATHOL, V69, P767, DOI 10.1136/jclinpath-2015-203403; Mamot C, 2003, BRIT J CANCER, V88, P420, DOI 10.1038/sj.bjc.6600733; Massague J, 1997, TRENDS CELL BIOL, V7, P187, DOI 10.1016/S0962-8924(97)01036-2; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Miyaki M, 1999, ONCOGENE, V18, P3098, DOI 10.1038/sj.onc.1202642; Moren A, 2000, ONCOGENE, V19, P4396, DOI 10.1038/sj.onc.1203798; Papageorgis P, 2011, CANCER RES, V71, P998, DOI 10.1158/0008-5472.CAN-09-3269; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Roth AD, 2012, JNCI-J NATL CANCER I, V104, P1635, DOI 10.1093/jnci/djs427; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Xiao DS, 2006, ACTA BIOCH BIOPH SIN, V38, P883, DOI 10.1111/j.1745-7270.2006.00233.x; Xu YF, 2007, HUM MOL GENET, V16, pR14, DOI 10.1093/hmg/ddl486; Yoshioka Y, 2015, CANCER-AM CANCER SOC, V121, P4359, DOI 10.1002/cncr.29676; Yu J, 2015, GUT, V64, P636, DOI 10.1136/gutjnl-2013-306620; Zhang B, 2014, BRIT J CANCER, V110, P946, DOI 10.1038/bjc.2013.789	49	52	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173345	10.1371/journal.pone.0173345	http://dx.doi.org/10.1371/journal.pone.0173345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267766	Green Published, gold, Green Submitted			2022-12-27	WOS:000396060600023
J	Quatremere, G; Guiguet, M; Girardi, P; Liaud, MN; Mey, C; Benkhoucha, C; Barbier, F; Cattaneo, G; Simon, A; Castro, DR				Quatremere, Guillemette; Guiguet, Marguerite; Girardi, Patricia; Liaud, Marie-Noelle; Mey, Coline; Benkhoucha, Cynthia; Barbier, Franck; Cattaneo, Graciela; Simon, Anne; Castro, Daniela Rojas			How are women living with HIV in France coping with their perceived side effects of antiretroviral therapy? Results from the EVE study	PLOS ONE			English	Article							GENDER-DIFFERENCES; POSITIVE INDIVIDUALS; ADVERSE EVENTS; IMPACT; CARE; DISCONTINUATION; HIV/AIDS; COMMUNICATION; ENGAGEMENT; ADHERENCE	Objective Side effects of antiretroviral therapy (ART) can have a negative impact on health-related quality of life threatening long-term retention in HIV care and adherence to ART. The aim of the French community-based survey EVE was to document personal experiences with side effects, the related physician-patient communication, and solutions found to deal with them. Design Cross-sectional study of women between September 2013 to September 2014 Methods An anonymous online questionnaire included the HIV Symptom Distress Module, which explores 20 symptoms. Results In all, 301 women on ART participated in the study (median age: 49 years; median duration of ART: 14 years). They reported having experienced a median of 12 symptoms (Q1-Q3: 9-15) during the previous 12 months. Overall, 56% of them reported having found at least a partial solution to dealing with their symptoms. Women reporting financial difficulties were twice less likely to have found solutions to coping with their side effects (AOR: 0.5; 95% CI: 0.3-0.8). Feeling supported by the health-care provider (AOR: 2.1; 95% CI: 1.1-3.9) and being in contact with HIV/AIDS organisations (AOR: 1.9; 95% CI: 1.2-3.2) were positively associated with coping. Seventeen percent reported having modified their ART regimen to improve tolerance, with only 2 in 3 informing their physician afterwards. Reporting financial difficulties and living with more bothersome symptoms increased the risk of ART regimen modification without health-care provider consultation. Conclusion The EVE study has called attention to the large number of side effects experienced by WLWHIV, only half of whom have found self-care strategies to manage their symptoms. Modification of ART regimen by the women themselves was not uncommon.	[Quatremere, Guillemette; Girardi, Patricia; Liaud, Marie-Noelle; Mey, Coline; Benkhoucha, Cynthia; Barbier, Franck; Cattaneo, Graciela; Castro, Daniela Rojas] AIDES, Pantin, France; [Guiguet, Marguerite] UPMC Univ Paris 06, Sorbonne Univ, INSERM, IPLESP UMRS 1136, Paris, France; [Simon, Anne] Hop La Pitie Salpetriere, AP HP, CIDAG, Dept Internal Med, Paris, France; [Castro, Daniela Rojas] Univ Lyon 2, Social Psychol Res Grp GRePS, Lyon, France; [Castro, Daniela Rojas] SESSTIM, INSERM, U912, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Lyon 2; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Quatremere, G (corresponding author), AIDES, Pantin, France.	gquatremere@aides.org	Rojas, Daniela/AAF-1591-2019; Guiguet, Marguerite/L-8480-2018	ROJAS CASTRO, Daniela/0000-0002-5379-1438				Abel Elizabeth, 2003, J Assoc Nurses AIDS Care, V14, P61, DOI 10.1177/1055329003252879; Aidala AA, 2016, AM J PUBLIC HEALTH, V106, pE1, DOI 10.2105/AJPH.2015.302905; Al-Dakkak I, 2013, AIDS CARE, V25, P400, DOI 10.1080/09540121.2012.712667; Andany N, 2011, HIV CLIN TRIALS, V12, P89, DOI 10.1310/hct1202-89; Berg KM, 2004, J GEN INTERN MED, V19, P1111, DOI 10.1111/j.1525-1497.2004.30445.x; Bernier A, 2015, REV PANAM SALUD PUBL, V38, P209; Bunupuradah T, 2016, LANCET HIV, V3, pE343, DOI 10.1016/S2352-3018(16)30010-8; Butler K, 2016, LANCET HIV, V3, pE421, DOI 10.1016/S2352-3018(16)30054-6; Castro DR, SANTE PUBLIQUE, V21, P129; Chen Wei-Ti, 2013, J AIDS Clin Res, V4, P218; Chou FY, 2004, AIDS PATIENT CARE ST, V18, P109, DOI 10.1089/108729104322802533; Curno MJ, 2016, JAIDS-J ACQ IMM DEF, V71, P181, DOI 10.1097/QAI.0000000000000842; del Amo J, 2017, AIDS, V31, P253, DOI 10.1097/QAD.0000000000001270; Demange E, 2012, COLLABORATIVE RES CO; Dray-Spira R., 2013, Bulletin Epidemiologique Hebdomadaire, P285; Erlandson KM, 2014, AIDS, V28, P1939, DOI 10.1097/QAD.0000000000000384; Fagbami Oluwakemi, 2015, Open AIDS J, V9, P45, DOI 10.2174/1874613601509010045; Fasinu PS, 2016, CURR DRUG METAB, V17, P52, DOI 10.2174/1389200216666151103115053; Flickinger TE, 2013, JAIDS-J ACQ IMM DEF, V63, P362, DOI 10.1097/QAI.0b013e318295b86a; Gantner P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164240; Greig JM, 2014, CURR OPIN INFECT DIS, V27, P46, DOI 10.1097/QCO.0000000000000033; Hoffmann C, 2017, HIV MED, V18, P56, DOI 10.1111/hiv.12468; Jonassaint CR, 2013, AIDS CARE, V25, P1185, DOI 10.1080/09540121.2012.752788; Justice AC, 2001, J CLIN EPIDEMIOL, V54, pS77, DOI 10.1016/S0895-4356(01)00449-8; Kempf MC, 2009, JAIDS-J ACQ IMM DEF, V52, P336, DOI 10.1097/QAI.0b013e3181b628be; Koole O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147309; Ladenheim D, 2008, HIV MED, V9, P653, DOI 10.1111/j.1468-1293.2008.00610.x; Leach L L, 2015, Open AIDS J, V9, P66, DOI 10.2174/1874613601509010066; Liu CL, 2009, AIDS PATIENT CARE ST, V23, P965, DOI 10.1089/apc.2009.0134; McGowan JA, 2017, HIV MED, V18, P89, DOI 10.1111/hiv.12398; Nicastri E, 2007, J ANTIMICROB CHEMOTH, V60, P724, DOI 10.1093/jac/dkm302; Preau M, 2012, AIDS CARE, V24, P434, DOI 10.1080/09540121.2011.613909; Preau M, 2008, JAIDS-J ACQ IMM DEF, V47, P467, DOI 10.1097/QAI.0b013e31815f3bdc; Reeves PM, 2000, J HEALTH COMMUN, V5, P47, DOI 10.1080/10810730050019555; Remien RH, 2015, JAIDS-J ACQ IMM DEF, V69, pS16, DOI 10.1097/QAI.0000000000000577; Robison LS, 2008, AIDS RES HUM RETROV, V24, P1347, DOI 10.1089/aid.2008.0083; Sax PE, 2005, AIDS PATIENT CARE ST, V19, P563, DOI 10.1089/apc.2005.19.563; Squires K, 2016, LANCET HIV, V3, pE410, DOI 10.1016/S2352-3018(16)30016-9; Squires KE, 2011, AIDS PATIENT CARE ST, V25, P279, DOI 10.1089/apc.2010.0228; Tesfaye M, 2016, TROP MED INT HEALTH, V21, P735, DOI 10.1111/tmi.12705; Umeh OC, 2006, EXPERT OPIN DRUG MET, V2, P273, DOI 10.1517/17425255.2.2.273; UNAIDS, AIDS NUMB AIDS IS NO; World Health Organization, 2014, FAST TRACK COMB PREV	43	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173338	10.1371/journal.pone.0173338	http://dx.doi.org/10.1371/journal.pone.0173338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5OE	28264016	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300054
J	Quistgaard, EM; Molledo, MM; Low, C				Quistgaard, Esben M.; Molledo, Maria Martinez; Loew, Christian			Structure determination of a major facilitator peptide transporter: Inward facing PepT(St) from Streptococcus thermophilus crystallized in space group P3(1)21	PLOS ONE			English	Article							CENTERED MONOCLINIC CRYSTALS; X-RAY CRYSTALLOGRAPHY; ESCHERICHIA-COLI; EXPRESSION CLONING; MEMBRANE-PROTEINS; DYNAMIC MECHANISM; POT FAMILY; PACKING; DIPEPTIDES; COMPLEXES	Major facilitator superfamily (MFS) peptide transporters (typically referred to as PepT, POT or PTR transporters) mediate the uptake of di- and tripeptides, and so play an important dietary role in many organisms. In recent years, a better understanding of the molecular basis for this process has emerged, which is in large part due to a steep increase in structural information. Yet, the conformational transitions underlying the transport mechanism are still not fully understood, and additional data is therefore needed. Here we report in detail the detergent screening, crystallization, experimental MIRAS phasing, and refinement of the peptide transporter PepT(St) from Streptococcus thermophilus. The space group is P3(1)21, and the protein is crystallized in a monomeric inward facing form. The binding site is likely to be somewhat occluded, as the lobe encompassing transmembrane helices 10 and 11 is markedly bent towards the central pore of the protein, but the extent of this potential occlusion could not be determined due to disorder at the apex of the lobe. Based on structural comparisons with the seven previously determined P2(1)2(1)2(1) and C222(1) structures of inward facing PepTSt, the structural flexibility as well as the conformational changes mediating transition between the inward open and inward facing occluded states are discussed. In conclusion, this report improves our understanding of the structure and conformational cycle of PepTSt, and can furthermore serve as a case study, which may aid in supporting future structure determinations of additional MFS transporters or other integral membrane proteins.	[Quistgaard, Esben M.; Molledo, Maria Martinez; Loew, Christian] DESY, CSSB, Hamburg, Germany; [Quistgaard, Esben M.; Molledo, Maria Martinez; Loew, Christian] European Mol Biol Lab Hamburg, Hamburg, Germany; [Quistgaard, Esben M.; Loew, Christian] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Helmholtz-Center for Infection Research; European Molecular Biology Laboratory (EMBL); Karolinska Institutet	Low, C (corresponding author), DESY, CSSB, Hamburg, Germany.; Low, C (corresponding author), European Mol Biol Lab Hamburg, Hamburg, Germany.; Low, C (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	christian.loew@embl-hamburg.de	Molledo, Maria Martinez/AAB-6902-2021	Molledo, Maria Martinez/0000-0002-2948-0891; Quistgaard, Esben/0000-0002-1381-3364; Loew, Christian/0000-0003-0764-7483	European Union under BioStruct-X [N783]; Horizon 2020 programme of the European Union (iNEXT grant) [653706]; Swedish Research Council [621-2013-5905]	European Union under BioStruct-X; Horizon 2020 programme of the European Union (iNEXT grant); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This research was funded by the European Union's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (grant agreement N783), by the Horizon 2020 programme of the European Union (iNEXT grant, project no. 653706) and the Swedish Research Council (grant number 621-2013-5905).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrec M, 2007, PROTEINS, V69, P449, DOI 10.1002/prot.21507; Banatao DR, 2006, P NATL ACAD SCI USA, V103, P16230, DOI 10.1073/pnas.0607674103; Boggavarapu R, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0167-8; Boll M, 1996, P NATL ACAD SCI USA, V93, P284, DOI 10.1073/pnas.93.1.284; Brandsch M, 2013, CURR OPIN PHARMACOL, V13, P881, DOI 10.1016/j.coph.2013.08.004; Brandsch M, 2009, EXPERT OPIN DRUG MET, V5, P887, DOI 10.1517/17425250903042292; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Buschmann S, 2014, PROTEIN SCI, V23, P411, DOI 10.1002/pro.2423; Caffrey M, 2015, ACTA CRYSTALLOGR F, V71, P3, DOI 10.1107/S2053230X14026843; Carugo O, 1997, PROTEIN SCI, V6, P2261; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chaptal V, 2016, DATA BRIEF, V7, P726, DOI 10.1016/j.dib.2016.03.031; Chaptal V, 2016, BBA-BIOMEMBRANES, V1858, P326, DOI 10.1016/j.bbamem.2015.11.021; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daniel H, 2006, PHYSIOLOGY, V21, P93, DOI 10.1152/physiol.00054.2005; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doki S, 2013, P NATL ACAD SCI USA, V110, P11343, DOI 10.1073/pnas.1301079110; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eyal E, 2005, J MOL BIOL, V351, P431, DOI 10.1016/j.jmb.2005.05.066; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; Fernandez PAA, 2004, CURR MICROBIOL, V49, P361, DOI 10.1007/s00284-004-4367-7; Fowler PW, 2015, STRUCTURE, V23, P290, DOI 10.1016/j.str.2014.12.012; Fukuda M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8097; Guettou F, 2014, NAT STRUCT MOL BIOL, V21, P728, DOI 10.1038/nsmb.2860; Guettou F, 2013, EMBO REP, V14, P804, DOI 10.1038/embor.2013.107; HENDERSON PJF, 1990, PHILOS T ROY SOC B, V326, P391, DOI 10.1098/rstb.1990.0020; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang CY, 2016, ACTA CRYSTALLOGR D, V72, P93, DOI 10.1107/S2059798315021683; Huang CY, 2015, ACTA CRYSTALLOGR D, V71, P1238, DOI 10.1107/S1399004715005210; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; JESSENMARSHALL AE, 1995, J BIOL CHEM, V270, P16251, DOI 10.1074/jbc.270.27.16251; Jiang DH, 2013, P NATL ACAD SCI USA, V110, P14664, DOI 10.1073/pnas.1308127110; JUILLARD V, 1995, APPL ENVIRON MICROB, V61, P3024, DOI 10.1128/AEM.61.8.3024-3030.1995; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Komarova NY, 2008, PLANT PHYSIOL, V148, P856, DOI 10.1104/pp.108.123844; LIU W, 1995, BBA-BIOMEMBRANES, V1235, P461, DOI 10.1016/0005-2736(95)80036-F; Low C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077984; Low C, 2013, BBA-GEN SUBJECTS, V1830, P3497, DOI 10.1016/j.bbagen.2013.02.001; Lyons JA, 2014, EMBO REP, V15, P886, DOI 10.15252/embr.201338403; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Newstead S, 2015, BBA-GEN SUBJECTS, V1850, P488, DOI 10.1016/j.bbagen.2014.05.011; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Parker JL, 2016, ADV EXP MED BIOL, V922, P61, DOI 10.1007/978-3-319-35072-1_5; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; Pike ACW, 2016, ACTA CRYSTALLOGR D, V72, P303, DOI 10.1107/S2059798316000401; Quistgaard EM, 2016, NAT REV MOL CELL BIO, V17, P123, DOI 10.1038/nrm.2015.25; Quistgaard EM, 2013, J STRUCT BIOL, V184, P375, DOI 10.1016/j.jsb.2013.09.009; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Rapp CS, 2005, PROTEINS, V60, P103, DOI 10.1002/prot.20492; RONG LA, 1995, J BIOL CHEM, V270, P6456, DOI 10.1074/jbc.270.12.6456; Schulz GE, 2011, J MOL BIOL, V407, P640, DOI 10.1016/j.jmb.2011.02.003; Sikic Kresimir, 2010, Open Biochem J, V4, P83, DOI 10.2174/1874091X01004010083; Smith DE, 2013, MOL ASPECTS MED, V34, P323, DOI 10.1016/j.mam.2012.11.003; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; Song G, 2007, J MOL BIOL, V369, P880, DOI 10.1016/j.jmb.2007.03.059; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; STROUD RM, 1995, PROTEIN SCI, V4, P2392, DOI 10.1002/pro.5560041118; Tate CG, 2010, METHODS MOL BIOL, V601, P187, DOI 10.1007/978-1-60761-344-2_12; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WEBB KE, 1990, J ANIM SCI, V68, P3011; YAMAGUCHI A, 1992, J BIOL CHEM, V267, P19155; Yan N, 2015, ANNU REV BIOPHYS, V44, P257, DOI 10.1146/annurev-biophys-060414-033901; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhao Y, 2014, STRUCTURE, V22, P1152, DOI 10.1016/j.str.2014.06.008	67	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173126	10.1371/journal.pone.0173126	http://dx.doi.org/10.1371/journal.pone.0173126			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264013	Green Submitted, Green Published, gold			2022-12-27	WOS:000396054300041
J	Reid, KM; Patel, S; Robinson, AJ; Bu, LJ; Jarungsriapisit, J; Moore, LJ; Salinas, I				Reid, Kristin M.; Patel, Sonal; Robinson, Aaron J.; Bu, Lijing; Jarungsriapisit, Jiraporn; Moore, Lindsey J.; Salinas, Irene			Salmonid alphavirus infection causes skin dysbiosis in Atlantic salmon (Salmo salar L.) post-smolts	PLOS ONE			English	Article							1ST LABORATORY CONFIRMATION; DISEASE-VIRUS SDV; SLEEPING-DISEASE; GUT MICROBIOTA; FRESH-WATER; COMMUNITY; PATHOGENESIS; CHALLENGE; SPAIN	Interactions among host, microbiota and viral pathogens are complex and poorly understood. The goal of the present study is to assess the changes in the skin microbial community of Atlantic salmon (Salmo salar L.) in response to experimental infection with salmonid alphavirus (SAV). The salmon skin microbial community was determined using 16S rDNA pyrosequencing in five different experimental groups: control, 7 days after infection with low-dose SAV, 14 days after infection with low-dose SAV, 7 days after infection with high-dose SAV, and 14 days after infection with high-dose SAV. Both infection treatment and time after infection were strong predictors of the skin microbial community composition. Skin samples from SAV3 infected fish showed an unbalanced microbiota characterized by a decreased abundance of Proteobacteria such as Oleispira sp. and increased abundances of opportunistic taxa including Flavobacteriaceae, Streptococcaceae and Tenacibaculum sp. These results demonstrate that viral infections can result in skin dysbiosis likely rendering the host more susceptible to secondary bacterial infections.	[Reid, Kristin M.; Robinson, Aaron J.; Bu, Lijing; Salinas, Irene] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Patel, Sonal; Jarungsriapisit, Jiraporn; Moore, Lindsey J.] Inst Marine Res, Bergen, Norway	University of New Mexico; Institute of Marine Research - Norway	Salinas, I (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	isalinas@unm.edu		Robinson, Aaron/0000-0002-1406-5636; Bu, Lijing/0000-0001-8625-2732; Patel, Sonal/0000-0003-4107-0497	NIH [P20GM103452]; Research Council of Norway [224885/E40]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110907] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Norway(Research Council of Norway); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grant P20GM103452, and Research Council of Norway, Research grant # 224885/E40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by NIH grant P20GM103452, and Research Council of Norway, Research grant # 224885/E40. We also thank the UNM Center for Advanced Research Computing for computational resources used in this work and Dr. Darrell Dinwiddie for sharing the Illumina MiSeq. Authors thank Stig Maehle, and Ann Cathrine B. Einen at Institute of Marine Research, Norway, for help during sampling, and processing of skin samples for DNA isolation and quality assurance.	Andersen L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-198; Avadhanula V, 2006, J VIROL, V80, P1629, DOI 10.1128/JVI.80.4.1629-1636.2006; Bergmann SM, 2008, B EUR ASSOC FISH PAT, V28, P148; Borzym E, 2014, B VET I PULAWY, V58, P341, DOI 10.2478/bvip-2014-0053; Boutin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102649; Boutin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084772; Boutin S, 2012, VET MICROBIOL, V155, P355, DOI 10.1016/j.vetmic.2011.09.002; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cipriano R, 2011, HLTH DIS AQUATIC ORG, P156; Cosseau C, 2016, ONE HEALTH, V2, P33, DOI 10.1016/j.onehlt.2016.02.002; David R, 2011, NAT REV MICROBIOL, V9, P831, DOI 10.1038/nrmicro2691; Deriu E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005572; Derome N, 2016, ADV ENV MICROBIOLOGY, V3, P81, DOI 10.1007/978-3-319-28170-4_4; Eggset G, 1997, AQUACULTURE, V158, P179, DOI 10.1016/S0044-8486(97)00178-6; Eichmiller JJ, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0190-1; Gaulke CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154632; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Graham DA, 2007, J FISH DIS, V30, P569, DOI 10.1111/j.1365-2761.2007.00826.x; Graham DA, 2012, J FISH DIS, V35, P949, DOI 10.1111/j.1365-2761.2012.01427.x; Graham DA, 2011, J FISH DIS, V34, P273, DOI 10.1111/j.1365-2761.2010.01234.x; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Hennersdorf P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151594; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Jansen MD, 2010, J FISH DIS, V33, P391, DOI 10.1111/j.1365-2761.2009.01131.x; Jarungsriapisit J, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0520-8; Jarungsriapisit J, 2016, VET RES, V47, DOI 10.1186/s13567-016-0385-2; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Larsen A, 2013, FEMS MICROBIOL ECOL, V85, P483, DOI 10.1111/1574-6941.12136; Llewellyn MS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00207; Lokesh J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19707; Lowrey L, 2015, APPL ENVIRON MICROB, V81, P6915, DOI 10.1128/AEM.01826-15; McLoughlin MF, 2007, J FISH DIS, V30, P511, DOI 10.1111/j.1365-2761.2007.00848.x; Mesa MG, 1999, AQUACULTURE, V174, P25, DOI 10.1016/S0044-8486(99)00012-5; Mitchell KR, 2008, J IND MICROBIOL BIOT, V35, P1139, DOI 10.1007/s10295-008-0393-y; Olsen AB, 2011, DIS AQUAT ORGAN, V94, P189, DOI 10.3354/dao02324; Rahman T, 2015, FISH PATHOL, V50, P44, DOI 10.3147/jsfp.50.44; Robinson CM, 2014, ANNU REV VIROL, V1, P55, DOI 10.1146/annurev-virology-031413-085550; Schmidt V, 2016, APPL ENVIRON MICROB, V82, P4470, DOI 10.1128/AEM.00902-16; Schmidt-Posthaus H, 2014, DIS AQUAT ORGAN, V111, P165, DOI 10.3354/dao02766; Smrzlic IV, 2013, B EUR ASSOC FISH PAT, V33, P78; Sylvain FE, 2016, SCI REP-UK, V6, DOI 10.1038/srep32032; Teramoto M, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00644-16; TORANZO AE, 1993, AQUACULTURE, V114, P189, DOI 10.1016/0044-8486(93)90295-A; Vujkovic-Cvijin I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006438; Wilks J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002681	46	36	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172856	10.1371/journal.pone.0172856	http://dx.doi.org/10.1371/journal.pone.0172856			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264056	Green Published, gold, Green Submitted			2022-12-27	WOS:000396054300023
J	Wang, X; Cao, JG; Dai, XL; Xiao, JB; Wu, YH; Wang, QX				Wang, Xin; Cao, Jianguo; Dai, Xiling; Xiao, Jianbo; Wu, Yuhuan; Wang, Quanxi			Total flavonoid concentrations of bryophytes from Tianmu Mountain, Zhejiang Province (China): Phylogeny and ecological factors	PLOS ONE			English	Article							ACETYLCHOLINESTERASE INHIBITION-ACTIVITY; MARCHANTIN-C; ANTIOXIDANT ACTIVITY; NATURAL POLYPHENOLS; DIETARY POLYPHENOLS; EXTRACTS; LIVERWORT; ANTIBACTERIAL; FERNS; ANTIFUNGAL	The flavonoids in bryophytes may have great significance in phylogeny and metabolism research. However, to date there has been little research on bryophyte metabolites, especially flavonoids. To redress this somewhat, we determined flavonoid concentrations of bryophytes from Tianmu Mountain through a colorimetric assay and considered the factors influencing the results. This is the first time that the flavonoid contents of bryophytes have been examined in detail. The results revealed a range of total flavonoid concentrations in 90 samples collected from Tianmu Mountain from 1.8 to 22.3 mg/g (w/w). The total flavonoid contents of liverworts were generally higher than those of mosses; acrocarpous mosses had generally higher values than that of pleurocarpous mosses. The total flavonoid contents of bryophytes growing at lower light levels were general higher than those growing in full-sun. The total flavonoid contents of epiphytic bryophytes were highest, while those of aquatic bryophytes were the lowest. Total flavonoid contents of species growing at low-latitudes were much higher than those at high-latitude individuals. In conclusion, total flavonoid contents of bryophytes have some connection with plant phylogeny; more flavonoids might be contained in relatively primitive bryophytes. Meanwhile, the effects of ecological factors on total flavonoid contents of bryophytes exist; light and habitat (especially tree habitat and river habitat) might be representative factor.	[Wang, Xin; Cao, Jianguo; Dai, Xiling; Xiao, Jianbo; Wang, Quanxi] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China; [Wang, Xin] Chinese Acad Sci, Insititute Appl Ecol, Shenyang, Peoples R China; [Xiao, Jianbo] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China; [Wu, Yuhuan] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	Shanghai Normal University; Chinese Academy of Sciences; University of Macau; Hangzhou Normal University	Wang, QX (corresponding author), Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China.; Wu, YH (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	yuhuanwu@hznu.edu.cn; wangqx@shnu.edu.cn	Xiao, Jian/GYU-4351-2022; Xiao, Jianbo/C-7323-2012	Xiao, Jianbo/0000-0003-3311-770X	National Natural Science Foundation of China [41571049]; Shanghai Gaofeng & Gaoyuan Project for University Academic Program Development; Ministry of Science and Technology, China [2015FY110200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Gaofeng & Gaoyuan Project for University Academic Program Development; Ministry of Science and Technology, China(Ministry of Science and Technology, China)	National Natural Science Foundation of China: No. 41571049, Yuhuan Wu; Shanghai Gaofeng & Gaoyuan Project for University Academic Program Development:Quanxi Wang; Basic Research Project of Ministry of Science and Technology, China: 2015FY110200, Yuhuan Wu.	Agati G, 2002, PHOTOCHEM PHOTOBIOL, V76, P350, DOI 10.1562/0031-8655(2002)076&lt;0350:FDITOP&gt;2.0.CO;2; Andrae-Marobela K, 2013, CURR DRUG METAB, V14, P392, DOI 10.2174/13892002113149990095; Atanassova M., 2011, J U CHEM TECHNOL MET, V46, P81; Beckert S, 1999, PLANT SYST EVOL, V218, P179, DOI 10.1007/BF01089226; BOTTOMLE.W, 1965, NATURE, V207, P1211; Caldwell CR, 2005, J AGR FOOD CHEM, V53, P1125, DOI 10.1021/jf0355351; Cao JG, 2015, IND CROP PROD, V75, P135, DOI 10.1016/j.indcrop.2015.04.064; CRAWFORD DJ, 1978, BOT REV, V44, P431, DOI 10.1007/BF02860846; Delmas D, 2012, ANTI-CANCER AGENT ME, V12, P835, DOI 10.2174/187152012802650093; EDWARDS D, 1995, NATURE, V374, P635, DOI 10.1038/374635a0; Fu B, 2016, J PHOTOCH PHOTOBIO B, V162, P544, DOI 10.1016/j.jphotobiol.2016.07.016; GIANNASI DE, 1978, BOT REV, V44, P339; GORNALL RJ, 1978, SYST BOT, V3, P353, DOI 10.2307/2418744; He-Nygren X, 2006, CLADISTICS, V22, P1, DOI 10.1111/j.1096-0031.2006.00089.x; Hyvonen J, 2004, MOL PHYLOGENET EVOL, V31, P915, DOI 10.1016/j.ympev.2003.10.003; Ivanova V, 2007, PREP BIOCHEM BIOTECH, V37, P343, DOI 10.1080/10826060701593241; Lee JM, 2001, J KOREAN SOC FOOD CU, V16, P504; Lin JY, 2007, FOOD CHEM, V101, P140, DOI 10.1016/j.foodchem.2006.01.014; Liu HK, 2016, J FUNCT FOODS, V25, P459, DOI 10.1016/j.jff.2016.06.028; Majuakim L, 2014, SEPILOK BULL, V19, P23; Manoj G. S., 2012, Indian Journal of Natural Products and Resources, V3, P173; Marinova D., 2005, J U CHEM TECHNOL MET, V40, P255; Mitre GB, 2004, J NAT PROD, V67, P31, DOI [10.1021/np030074z, 10.1021/np03007z]; Neves CRSS, 2016, IJSRST, V2, P1; Niu C, 2006, CHEM BIODIVERS, V3, P34, DOI 10.1002/cbdv.200690004; Niu Xiao-dong, 2016, Yingyong Shengtai Xuebao, V27, P1; NORO T, 1969, YAKUGAKU ZASSHI, V89, P851, DOI 10.1248/yakushi1947.89.6_851; Panickar KS, 2013, MOL NUTR FOOD RES, V57, P34, DOI 10.1002/mnfr.201200431; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Qiu YL, 1998, NATURE, V394, P671, DOI 10.1038/29286; Ramamoorthy PK, 2007, J ENG SCI TECHNOL, V2, P70; Saeed N, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-221; SHAW J, 1988, AM J BOT, V75, P1019, DOI 10.2307/2443770; Shen J, 2010, CANCER BIOL THER, V9, P33, DOI 10.4161/cbt.9.1.10279; Shi YQ, 2008, CANCER LETT, V262, P173, DOI 10.1016/j.canlet.2007.12.014; Shi YQ, 2009, CANCER LETT, V276, P160, DOI 10.1016/j.canlet.2008.11.004; Skrzypczak-Pietraszek E, 2014, CHEM BIODIVERS, V11, P562, DOI 10.1002/cbdv.201300148; Spitaler R, 2006, PHYTOCHEMISTRY, V67, P409, DOI 10.1016/j.phytochem.2005.11.018; Stanojevic L, 2009, SENSORS-BASEL, V9, P5702, DOI 10.3390/s90705702; Veljic M, 2010, ARCH BIOL SCI, V62, P381, DOI 10.2298/ABS1002381V; Wang Daihua, 2013, Shengwu Duoyangxing, V21, P170, DOI 10.3724/SP.J.1003.2013.07193; Wang X, 2017, IND CROP PROD, V97, P137, DOI 10.1016/j.indcrop.2016.12.013; Wang X, 2016, MOLECULES, V21, DOI 10.3390/molecules21030360; Woo HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075604; [吴玉环 Wu Yuhuan], 2004, [生态学杂志, Chinese Journal of Ecology], V23, P218; Xia X, 2014, IND CROP PROD, V58, P91, DOI 10.1016/j.indcrop.2014.04.005; Xiao JB, 2015, CURR MED CHEM, V22, P23; Xiao JB, 2015, J AGR FOOD CHEM, V63, P1547, DOI 10.1021/jf505514d; Xiao JB, 2014, BIOTECHNOL ADV, V32, P1145, DOI 10.1016/j.biotechadv.2014.04.006; Xie CF, 2009, CHEM BIODIVERS, V6, P303, DOI 10.1002/cbdv.200700450	50	10	11	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							E173003	10.1371/journal.pone.0173003	http://dx.doi.org/10.1371/journal.pone.0173003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28263997	gold, Green Published, Green Submitted			2022-12-27	WOS:000396054300032
J	Bard, AM; Main, DCJ; Haase, AM; Whay, HR; Roe, EJ; Reyher, KK				Bard, Alison M.; Main, David C. J.; Haase, Anne M.; Whay, Helen R.; Roe, Emma J.; Reyher, Kristen K.			The future of veterinary communication: Partnership or persuasion? A qualitative investigation of veterinary communication in the pursuit of client behaviour change	PLOS ONE			English	Article							PHYSICIAN-PATIENT COMMUNICATION; ENGLAND; PATTERNS; FARMS	Client behaviour change is at the heart of veterinary practice, where promoting animal health and welfare is often synonymous with engaging clients in animal management practices. In the medical realm, extensive research points to the link between practitioner communication and patient behavioural outcomes, suggesting that the veterinary industry could benefit from a deeper understanding of veterinarian communication and its effects on client motiva-tion. Whilst extensive studies have quantified language components typical of the veterinary consultation, the literature is lacking in-depth qualitative analysis in this context. The objective of this study was to address this deficit, and offer new critical insight into veterinary com-munication strategies in the pursuit of client behaviour change. Role-play interactions (n = 15) between UK cattle veterinarians and an actress experienced in medical and veterinary education were recorded, transcribed and analysed thematically. Analysis revealed that, overall, veterinarians tend to communicate in a directive style (minimal eliciting of client opin-ion, dominating the consultation agenda, prioritising instrumental support), reflecting a paternalistic role in the consultation interaction. Given this finding, recommendations for progress in the veterinary industry are made; namely, the integration of evidence-based medical communication methodologies into clinical training. Use of these types of methodol-ogies may facilitate the adoption of more mutualistic, relationship-centred communication in veterinary practice, supporting core psychological elements of client motivation and resul-tant behaviour change.	[Bard, Alison M.; Main, David C. J.; Whay, Helen R.; Reyher, Kristen K.] Univ Bristol, Sch Vet Sci, Bristol BS8 1TH, Avon, England; [Haase, Anne M.] Univ Bristol, Sch Policy Studies, Bristol BS8 1TH, Avon, England; [Roe, Emma J.] Univ Southampton, Geog & Environm, Southampton SO9 5NH, Hants, England	University of Bristol; University of Bristol; University of Southampton	Bard, AM (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS8 1TH, Avon, England.	alison.bard@bristol.ac.uk	Roe, Emma/D-3617-2009	Roe, Emma/0000-0003-4674-2133; Haase, Anne M/0000-0001-8556-2165	British Veterinary Association Animal Welfare foundation, Norman Hayward Fund [NHF_2013_10_KR]	British Veterinary Association Animal Welfare foundation, Norman Hayward Fund	Funding was provided by the British Veterinary Association Animal Welfare foundation, Norman Hayward Fund (ref: NHF_2013_10_KR). Funding has been received by The University of Bristol (KKR, DCJM, AMH, HRW), The University of Southampton (EJR) and studentship stipend paid to AMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abood SK, 2007, VET CLIN N AM-SMALL, V37, P151, DOI 10.1016/j.cvsm.2006.09.011; AHDB Dairy, 2016, AHDB DAIR MAST CONTR; AHDB Dairy, 2016, AHDB DAIRY; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; American Animal Hospital Association, 2003, VET CLIN N AM SMALL; [Anonymous], 2011, APPL CONVERSATION AN; Barker ZE, 2010, J DAIRY SCI, V93, P932, DOI 10.3168/jds.2009-2309; Bradley AJ, 2007, VET REC, V160, P253, DOI 10.1136/vr.160.8.253; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Dillard JP, 2005, COMMUN MONOGR, V72, P144, DOI 10.1080/03637750500111815; Everitt S, 2013, J SMALL ANIM PRACT, V54, P453, DOI 10.1111/jsap.12115; Gray C., 2010, HDB VET COMMUNICATIO; Holloway L, 2001, J RURAL STUD, V17, P293, DOI 10.1016/S0743-0167(00)00045-0; Jansen J, 2010, J DAIRY SCI, V93, P1296, DOI 10.3168/jds.2009-2794; Jansen J., 2010, MASTITIS FARMER MIND; Jorge R, 2013, RCVS POSITION PAPER; LeBlanc SJ, 2006, J DAIRY SCI, V89, P1267, DOI 10.3168/jds.S0022-0302(06)72195-6; LEVINSON W, 1994, JAMA-J AM MED ASSOC, V272, P1619, DOI 10.1001/jama.272.20.1619; Lupton Deborah, 2012, MED CULTURE ILLNESS, V3rd ed, DOI DOI 10.4135/9781446254530; Maille V, 2013, J BUS RES, V66, P141, DOI 10.1016/j.jbusres.2012.09.006; McArthur ML, 2013, AUST VET J, V91, P374, DOI 10.1111/avj.12083; McGlone MS, 2003, J COMMUN, V53, P251, DOI 10.1093/joc/53.2.251; Miller B, 2013, IEEE INT CONF BIG DA; Mossop L, 2015, VET REC, V177, P122, DOI [10.1136/vr.h425, 10.1136/vr.h4033]; Pan Q, 2013, THEORY PRACTICE LANG, V3; Alan R, 2006, J VET MED EDUC, V33, P38, DOI 10.3138/jvme.33.1.38; Robinson NJ, 2014, VET REC, V175, DOI 10.1136/vr.102713; Roter D, 2000, PATIENT EDUC COUNS, V39, P5, DOI 10.1016/S0738-3991(99)00086-5; Roter DL, 1997, JAMA-J AM MED ASSOC, V277, P350, DOI 10.1001/jama.277.4.350; Ryan RM, 2000, CONTEMP EDUC PSYCHOL, V25, P54, DOI 10.1006/ceps.1999.1020; Seale Clive, 2007, Commun Med, V4, P177, DOI 10.1515/CAM.2007.021; Semmer NK, 2008, INT J STRESS MANAGE, V15, P235, DOI 10.1037/1072-5245.15.3.235; Shaw JR, 2006, JAVMA-J AM VET MED A, V228, P714, DOI 10.2460/javma.228.5.714; Shaw JR, 2004, JAVMA-J AM VET MED A, V225, P222, DOI 10.2460/javma.2004.225.222; Silverman J, 2013, SKILLS COMMUNICATING, V3rd; Skelton JR, 2002, FAM PRACT, V19, P484, DOI 10.1093/fampra/19.5.484; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Vet Futures Project Board, 2015, VET FUT TAK CHARG OU; Whay H. R., 2010, IMPROVING ANIMAL WEL	39	71	71	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0171380	10.1371/journal.pone.0171380	http://dx.doi.org/10.1371/journal.pone.0171380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257511	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000396021100007
J	Requena-Mullor, JM; Lopez, E; Castro, AJ; Alcaraz-Segura, D; Castro, H; Reyes, A; Cabello, J				Requena-Mullor, Juan M.; Lopez, Enrique; Castro, Antonio J.; Alcaraz-Segura, Domingo; Castro, Hermelindo; Reyes, Andres; Cabello, Javier			Remote-sensing based approach to forecast habitat quality under climate change scenarios	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; BADGERS MELES-MELES; LANDSCAPE-SCALE; EUROPEAN BADGER; DISTRIBUTIONS; SELECTION; HETEROGENEITY; DIVERSITY; GRADIENT; IMPACTS	As climate change is expected to have a significant impact on species distributions, there is an urgent challenge to provide reliable information to guide conservation biodiversity policies. In addressing this challenge, we propose a remote sensing-based approach to forecast the future habitat quality for European badger, a species not abundant and at risk of local extinction in the arid environments of southeastern Spain, by incorporating environmental variables related with the ecosystem functioning and correlated with climate and land use. Using ensemble prediction methods, we designed global spatial distribution models for the distribution range of badger using presence-only data and climate variables. Then, we constructed regional models for an arid region in the southeast Spain using EVI (Enhanced Vegetation Index) derived variables and weighting the pseudo-absences with the global model projections applied to this region. Finally, we forecast the badger potential spatial distribution in the time period 2071-2099 based on IPCC scenarios incorporating the uncertainty derived from the predicted values of EVI-derived variables. By including remotely sensed descriptors of the temporal dynamics and spatial patterns of ecosystem functioning into spatial distribution models, results suggest that future forecast is less favorable for European badgers than not including them. In addition, change in spatial pattern of habitat suitability may become higher than when forecasts are based just on climate variables. Since the validity of future forecast only based on climate variables is currently questioned, conservation policies supported by such information could have a biased vision and overestimate or underestimate the potential changes in species distribution derived from climate change. The incorporation of ecosystem functional attributes derived from remote sensing in the modeling of future forecast may contribute to the improvement of the detection of ecological responses under climate change scenarios.	[Requena-Mullor, Juan M.; Lopez, Enrique; Castro, Antonio J.; Alcaraz-Segura, Domingo; Castro, Hermelindo; Reyes, Andres; Cabello, Javier] Univ Almeria, Andalusian Ctr Assessment & Monitoring Global Cha, Almeria, Spain; [Lopez, Enrique] Univ Almeria, Dept Educ, Didact Expt Sci Area, Almeria, Spain; [Castro, Antonio J.] Idaho State Univ, Dept Biol Sci, Gale Life Sci Bldg Rm 207,8th Ave,Mail Stop, Pocatello, ID 83209 USA; [Alcaraz-Segura, Domingo] Univ Granada, Dept Bot, Granada, Spain; [Castro, Hermelindo; Cabello, Javier] Univ Almeria, Dept Biol & Geol, Almeria, Spain	Universidad de Almeria; Universidad de Almeria; Idaho; Idaho State University; University of Granada; Universidad de Almeria	Requena-Mullor, JM (corresponding author), Univ Almeria, Andalusian Ctr Assessment & Monitoring Global Cha, Almeria, Spain.	juanmir@ual.es	Castro Martínez, Antonio J./Z-2469-2019; Alcaraz-Segura, Domingo/B-8063-2008; Cabello, Javier/N-5799-2014	Castro Martínez, Antonio J./0000-0003-1587-8564; Alcaraz-Segura, Domingo/0000-0001-8988-4540; Cabello, Javier/0000-0002-5123-964X; Requena-Mullor, Juan Miguel/0000-0002-5120-7947	Andalusian Center for the Assessment and Monitoring of Global Change (CAESCG); Andalusian Government (Project SEGALERT) [P09-RNM-5048]; Andalusian Government (Project GLOCHARID); ERDF; Ministry of Science and Innovation [CGL2010-22314]; National Science Foundation Idaho EPSCoR program [IIA-1301792]	Andalusian Center for the Assessment and Monitoring of Global Change (CAESCG); Andalusian Government (Project SEGALERT); Andalusian Government (Project GLOCHARID); ERDF(European Commission); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Science Foundation Idaho EPSCoR program	JRM received funding from the Andalusian Center for the Assessment and Monitoring of Global Change (CAESCG) (http://www.caescg.org/). Funding was also received from the Andalusian Government (http:/www.juntadeandalucia.es/medioambiente/site/portalweb/)(Projects GLOCHARID and SEGALERT P09-RNM-5048), the ERDF (http://ec.europa.eu/regional_policy/es/funding/erdf/), and the Ministry of Science and Innovation (http://www.idi.mineco.gob.es/portal/site/MICINN/) (Project CGL2010-22314, subprogram BOS, National Plant I+D+I 2010). AJC was partially funded by the National Science Foundation Idaho EPSCoR program under award no. IIA-1301792. (http://www.isu.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz-Segura D, 2006, GLOBAL ECOL BIOGEOGR, V15, P200, DOI 10.1111/j.1466-822x.2006.00215.x; Alcaraz-Segura D, 2013, REMOTE SENS-BASEL, V5, P127, DOI 10.3390/rs5010127; [Anonymous], 2006, GEN CLIM CHANG SCEN; [Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Beale CM, 2008, P NATL ACAD SCI USA, V105, P14908, DOI 10.1073/pnas.0803506105; Booth G. D., 1994, IDENTIFYING PROXY SE; Buermann W, 2008, J BIOGEOGR, V35, P1160, DOI 10.1111/j.1365-2699.2007.01858.x; Cabello J, 2012, J ARID ENVIRON, V79, P76, DOI 10.1016/j.jaridenv.2011.12.006; Cabello J, 2012, BIODIVERS CONSERV, V21, P3287, DOI 10.1007/s10531-012-0370-7; Castro AJ, 2013, EARTH OBSERVATION EC, P105, DOI DOI 10.1201/B15628; Davidowitz G, 1998, J BIOGEOGR, V25, P553, DOI 10.1046/j.1365-2699.1998.2530553.x; Fischer C, 2005, J ZOOL, V266, P121, DOI 10.1017/S0952836905006576; Fryxell JM, 2005, ECOL LETT, V8, P328, DOI 10.1111/j.1461-0248.2005.00727.x; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Huete AR, 2012, REMOTE SENS ENVIRON, V83, P195; Lara-Romero C, 2012, J ARID ENVIRON, V76, P43, DOI 10.1016/j.jaridenv.2011.08.004; Legendre P., 2012, NUMERICAL ECOLOGY; Macdonald DW, 2010, GLOBAL CHANGE BIOL, V16, P2913, DOI 10.1111/j.1365-2486.2010.02208.x; Maiorano L, 2011, PHILOS T R SOC B, V366, P2681, DOI 10.1098/rstb.2011.0121; Martonne E., 1926, GEOGR REV, V17, P397; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; Nouvellet P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068116; Palomo LJ., 2007, ATLAS LIBRO ROJO MAM; Parry M. L., 2007, CLIMATE CHANGE 2007; Paruelo JM, 1999, ECOSYSTEMS, V2, P64, DOI 10.1007/s100219900058; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Piquer-Rodriguez M, 2012, J NAT CONSERV, V20, P326, DOI 10.1016/j.jnc.2012.07.001; Quintas-Soriano C, 2014, LANDSCAPE ECOL, V29, P1069, DOI 10.1007/s10980-014-0032-0; Requena-Mullor J, 2016, MAMMAL RES, V61, P197, DOI 10.1007/s13364-016-0269-x; Requena-Mullor JM, 2014, LANDSCAPE ECOL, V29, P843, DOI 10.1007/s10980-014-0020-4; Revilla E, 2001, J ZOOL, V255, P291, DOI 10.1017/S0952836901001388; Ruimy A, 1994, J GEOPHYS RES-ATMOS, V99, P5263, DOI 10.1029/93JD03221; Thuiller W, 2014, BIOMOD2 ENSEMBLE PLA, P1; Verburg PH, 2015, ANTHROPOCENE, V12, P29, DOI 10.1016/j.ancene.2015.09.004; Virgos E, 1999, J BIOGEOGR, V26, P559, DOI 10.1046/j.1365-2699.1999.00320.x; Virgos Emilio, 2005, P283; Wenger SJ, 2013, GLOBAL CHANGE BIOL, V19, P3343, DOI 10.1111/gcb.12294; Whittaker RJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P76, DOI 10.1111/j.1466-8238.2006.00268.x; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Wilby RL, 1998, WATER RESOUR RES, V34, P2995, DOI 10.1029/98WR02577; Wilson PD, 2011, METHODS ECOL EVOL, V2, P623, DOI 10.1111/j.2041-210X.2011.00115.x; Zaccarelli N, 2013, ECOL INDIC, V28, P22, DOI 10.1016/j.ecolind.2011.07.008	46	9	9	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172107	10.1371/journal.pone.0172107	http://dx.doi.org/10.1371/journal.pone.0172107			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257501	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100012
J	Blundon, EG; Rumak, SP; Ward, LM				Blundon, Elizabeth G.; Rumak, Samuel P.; Ward, Lawrence M.			Sequential search asymmetry: Behavioral and psychophysiological evidence from a dual oddball task	PLOS ONE			English	Article							OPEN-SOURCE TOOLBOX; MISMATCH NEGATIVITY; ELECTROPHYSIOLOGICAL EVIDENCE; SELECTIVE ATTENTION; P300 LATENCY; STIMULUS; AMPLITUDE; P3A; IDENTIFICATION; ORGANIZATION	We conducted five experiments in order to explore the generalizability of a new type of search asymmetry, which we have termed sequential search asymmetry, across sensory modalities, and to better understand its origin. In all five experiments rare oddballs occurred randomly within longer sequences of more frequent standards. Oddballs and standards all consisted of rapidly-presented runs of five pure tones (Experiments 1 and 5) or five colored annuli (Experiments 2 through 4) somewhat analogous to simultaneously-presented feature-present and feature-absent stimuli in typical visual search tasks. In easy tasks fea-turepresent reaction times and P300 latencies were shorter than feature-absent ones, similar to findings in search tasks with simultaneously-presented stimuli. Moreover the P3a subcom-ponent of the P300 ERP was strongly apparent only in the feature-present condition. In more difficult tasks requiring focused attention, however, RT and P300 latency differences disappeared but the P300 amplitude difference was significant. Importantly in all five experi-ments d for feature-present targets was larger than that for feature-absent targets. These results imply that sequential search asymmetry arises from discriminability differences between feature-present and feature-absent targets. Response time and P300 latency differences can be attributed to the use of different attention strategies in search for featurepresent and feature-absent targets, indexed by the presence of a dominant P3a subcompo-nent in the feature-present target-evoked P300s that is lacking in the P300s to the feature-absent targets.	[Blundon, Elizabeth G.; Rumak, Samuel P.; Ward, Lawrence M.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Ward, Lawrence M.] Univ British Columbia, Brain Res Ctr, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Ward, LM (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.; Ward, LM (corresponding author), Univ British Columbia, Brain Res Ctr, Vancouver, BC, Canada.	lward@psych.ubc.ca		Ward, Lawrence/0000-0003-4431-5015	Natural Sciences and Engineering Research Council (NSERC) of Canada [A9958]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by grant A9958 from the Natural Sciences and Engineering Research Council (NSERC) of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) to LMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Bishop DVM, 2005, COGNITIVE BRAIN RES, V24, P177, DOI 10.1016/j.cogbrainres.2004.12.007; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; COWAN N, 1993, J EXP PSYCHOL LEARN, V19, P909, DOI 10.1037/0278-7393.19.4.909; Cusack R, 2003, J EXP PSYCHOL HUMAN, V29, P713, DOI 10.1037/0096-1523.29.3.713; Czigler I, 2014, COGN AFFECT BEHAV NE, V14, P278, DOI 10.3758/s13415-013-0193-3; Dell'Acqua R, 2015, J COGNITIVE NEUROSCI, V27, P720, DOI 10.1162/jocn_a_00752; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Garrido MI, 2008, NEUROIMAGE, V42, P936, DOI 10.1016/j.neuroimage.2008.05.018; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; LUCK SJ, 1990, PERCEPT PSYCHOPHYS, V48, P603, DOI 10.3758/BF03211606; Macmillan NA, 2005, DETECTION THEORY USE; MAGLIERO A, 1984, PSYCHOPHYSIOLOGY, V21, P171, DOI 10.1111/j.1469-8986.1984.tb00201.x; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; MOCKS J, 1988, PSYCHOPHYSIOLOGY, V25, P217; NEISSER U, 1963, AM J PSYCHOL, V76, P376, DOI 10.2307/1419778; Overvliet KE, 2008, ACTA PSYCHOL, V127, P51, DOI 10.1016/j.actpsy.2007.01.001; Pickles J. O, 1988, INTRO PHYSL HEARING; Plaisier MA, 2008, ACTA PSYCHOL, V128, P368, DOI 10.1016/j.actpsy.2008.03.011; Polich J, 2003, BRAIN TOPOGR, V15, P141, DOI 10.1023/A:1022637732495; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; SATHIAN K, 1991, PERCEPT PSYCHOPHYS, V50, P237, DOI 10.3758/BF03206747; Sussman E, 1998, BRAIN RES, V789, P130, DOI 10.1016/S0006-8993(97)01443-1; Sussman E, 2002, COGNITIVE BRAIN RES, V13, P393, DOI 10.1016/S0926-6410(01)00131-8; Sussman ES, 2005, NEUROREPORT, V16, P1519, DOI 10.1097/01.wnr.0000177002.35193.4c; Timm J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00189; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; TREISMAN A, 1985, J EXP PSYCHOL GEN, V114, P285, DOI 10.1037/0096-3445.114.3.285; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Viola FC, 2009, CLIN NEUROPHYSIOL, V120, P868, DOI 10.1016/j.clinph.2009.01.015; Walhovd KB, 2008, PSYCHOPHYSIOLOGY, V45, P545, DOI 10.1111/j.1469-8986.2008.00661.x; WHANG KC, 1991, PERCEPT PSYCHOPHYS, V50, P157, DOI 10.3758/BF03212216; WOODY CD, 1967, MED BIOL ENG, V5, P539, DOI 10.1007/BF02474247; Wright R.D, 2008, ORIENTING ATTENTION	40	4	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173237	10.1371/journal.pone.0173237	http://dx.doi.org/10.1371/journal.pone.0173237			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278202	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900056
J	Borschmann, KN; Rewell, SS; Iuliano, S; Ghasem-Zadeh, A; Davey, RA; Ho, HD; Skeers, PN; Bernhardt, J; Howells, DW				Borschmann, Karen N.; Rewell, Sarah S.; Iuliano, Sandra; Ghasem-Zadeh, Ali; Davey, Rachel A.; Ho, Heidi; Skeers, Peta N.; Bernhardt, Julie; Howells, David W.			Reduced bone formation markers, and altered trabecular and cortical bone mineral densities of non-paretic femurs observed in rats with ischemic stroke: A randomized controlled pilot study	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; MICRO-COMPUTED TOMOGRAPHY; PHYSICAL-ACTIVITY; OCCLUSION; MODEL; GUIDELINES; INJURY; MASS	Background Immobility and neural damage likely contribute to accelerated bone loss after stroke, and subsequent heightened fracture risk in humans. Objective To investigate the skeletal effect of middle cerebral artery occlusion (MCAo) stroke in rats and examine its utility as a model of human post-stroke bone loss. Methods Twenty 15-week old spontaneously hypertensive male rats were randomized to MCAo or sham surgery controls. Primary outcome: group differences in trabecular bone volume fraction (BV/TV) measured by Micro-CT (10.5 micron istropic voxel size) at the ultra-distal femur of stroke affected left legs at day 28. Neurological impairments (stroke behavior and foot faults) and physical activity (cage monitoring) were assessed at baseline, and days 1 and 27. Serum bone turnover markers (formation: N-terminal propeptide of type 1 procollagen, PINP; resorption: C-terminal telopeptide of type 1 collagen, CTX) were assessed at baseline, and days 7 and 27. Results No effect of stroke was observed on BV/TV or physical activity, but PINP decreased by -24.5% (IQR-34.1,-10.5, p= 0.046) at day 27. In controls, cortical bone volume (5.2%, IQR 3.2, 6.9) and total volume (6.4%, IQR 1.2, 7.6) were higher in right legs compared to left legs, but these side-to-side differences were not evident in stroke animals. Conclusion MCAo may negatively affect bone formation. Further investigation of limb use and physical activity patterns after MCAo is required to determine the utility of this current model as a representation of human post-stroke bone loss.	[Borschmann, Karen N.; Bernhardt, Julie] La Trobe Univ, Sch Allied Hlth, Bundoora, Vic, Australia; [Borschmann, Karen N.; Rewell, Sarah S.; Ho, Heidi; Skeers, Peta N.; Bernhardt, Julie; Howells, David W.] Florey Inst Neurosci & Mental Hlth, Stroke Div, Heidelberg, Vic, Australia; [Borschmann, Karen N.; Bernhardt, Julie] NHMRC Ctr Res Excellence Stroke Rehabil & Recover, Melbourne, Vic, Australia; [Iuliano, Sandra; Ghasem-Zadeh, Ali] Univ Melbourne, Austin Hlth, Dept Endocrinol, Heidelberg, Vic, Australia; [Iuliano, Sandra; Ghasem-Zadeh, Ali; Davey, Rachel A.] Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic, Australia; [Howells, David W.] Univ Tasmania, Sch Med, Fac Hlth, Hobart, Tas, Australia	La Trobe University; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Tasmania	Borschmann, KN (corresponding author), La Trobe Univ, Sch Allied Hlth, Bundoora, Vic, Australia.; Borschmann, KN (corresponding author), Florey Inst Neurosci & Mental Hlth, Stroke Div, Heidelberg, Vic, Australia.; Borschmann, KN (corresponding author), NHMRC Ctr Res Excellence Stroke Rehabil & Recover, Melbourne, Vic, Australia.	karen.borschmann@florey.edu.au	; Bernhardt, Julie/F-9538-2015; Borschmann, Karen/I-3692-2016	DAVEY, RACHEL A/0000-0001-5121-0209; Bernhardt, Julie/0000-0002-2787-8484; Howells, David/0000-0002-2512-7724; Borschmann, Karen/0000-0001-5364-2718				Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Batchelor PE, 2010, J NEUROTRAUM, V27, P1357, DOI 10.1089/neu.2010.1360; Bernhardt J, 2016, INT J STROKE; Bolton DAE, 2006, BEHAV BRAIN RES, V168, P272, DOI 10.1016/j.bbr.2005.11.017; BORLONGAN CV, 1995, PHYSIOL BEHAV, V58, P909, DOI 10.1016/0031-9384(95)00103-P; Borschmann K, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/103697; Borschmann K, 2012, INT J STROKE, V7, P330, DOI 10.1111/j.1747-4949.2011.00645.x; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chiang C, 2009, J BONE MINER RES, V24, P621, DOI 10.1359/JBMR.081217; Dion N, 2011, OSTEOPOROSIS RESEARCH: ANIMAL MODELS, P37, DOI 10.1007/978-0-85729-293-3_4; Driessler F, 2010, J MOL ENDOCRINOL, V45, P175, DOI 10.1677/JME-10-0015; English C, 2014, PHYS THER, V94, P185, DOI 10.2522/ptj.20130175; Erben R, 2003, HDB HISTOLOGY METHOD; Erben RG, 2000, J BONE MINER RES, V15, P1085, DOI 10.1359/jbmr.2000.15.6.1085; Fisher A, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/641943; FOX KM, 1995, ANAT RECORD, V241, P284, DOI 10.1002/ar.1092410215; Freret T, 2006, BEHAV NEUROSCI, V120, P1285, DOI 10.1037/0735-7044.120.6.1285; HUGHES PCR, 1970, J ANAT, V106, P371; Jamsa T, 1999, J BONE MINER RES, V14, P1708, DOI 10.1359/jbmr.1999.14.10.1708; Jorgensen L, 2001, CALCIFIED TISSUE INT, V68, P11, DOI 10.1007/BF02684997; Jorgensen L, 2001, BONE, V28, P655, DOI 10.1016/S8756-3282(01)00434-3; Jorgensen L, 2000, OSTEOPOROSIS INT, V11, P381, DOI 10.1007/s001980070103; Kanis J, 2001, STROKE, V32, P702, DOI 10.1161/01.STR.32.3.702; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Laib A, 2000, MED BIOL ENG COMPUT, V38, P326, DOI 10.1007/BF02347054; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee JI, 2005, BRAIN INJURY, V19, P1207, DOI 10.1080/02699050500309338; Metz GA, 2009, J VIS EXP; Miklyaeva EI, 1997, BEHAV BRAIN RES, V88, P143, DOI 10.1016/S0166-4328(97)00043-0; Pang MYC, 2007, OSTEOPOROSIS INT, V18, P1243, DOI 10.1007/s00198-007-0372-6; Petullo D, 1999, LIFE SCI, V64, P1099, DOI 10.1016/S0024-3205(99)00038-7; Quinn LP, 2005, BRAIN RES, V1031, P118, DOI 10.1016/j.brainres.2004.10.036; Rewell SSJ, 2010, J CEREBR BLOOD F MET, V30, P729, DOI 10.1038/jcbfm.2009.273; Roach HI, 2003, J HISTOCHEM CYTOCHEM, V51, P373, DOI 10.1177/002215540305100312; Snow LM, 2012, AM J PHYS MED REHAB, V91, P965, DOI 10.1097/PHM.0b013e31825f18e1; Stryjek R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066055; Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1; Vignaux G, 2015, J BONE MINER RES, V30, P1103, DOI 10.1002/jbmr.2426; Vignaux G, 2013, J BONE MINER RES, V28, P2136, DOI 10.1002/jbmr.1940; Windle V, 2005, BRAIN RES, V1044, P25, DOI 10.1016/j.brainres.2005.02.060; Wong IPL, 2008, SEMIN CELL DEV BIOL, V19, P452, DOI 10.1016/j.semcdb.2008.08.001; Zebaze R, 2013, BONE, V54, P8, DOI 10.1016/j.bone.2013.01.007	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172889	10.1371/journal.pone.0172889	http://dx.doi.org/10.1371/journal.pone.0172889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278253	gold, Green Published, Green Accepted			2022-12-27	WOS:000396087900131
J	Dai, Q; Geng, LL; Lu, MJ; Jin, WB; Nan, XY; He, PA; Yao, YH				Dai, Qi; Geng, Lili; Lu, Minjia; Jin, Weibo; Nan, Xuying; He, Ping-an; Yao, Yuhua			Comparative transcriptome analysis of the different tissues between the cultivated and wild tomato	PLOS ONE			English	Article							RNA-SEQ; FRUIT; TOPHAT; GENE	Although domesticated tomato is cultivated by wild tomato, there are a lot of differences between cultivated tomato and wild tomato, such as shape, physiological function and life history. Many studies show that wild tomato has better salt resistance and drought resistance. In addition to, domesticated tomato's fruit is bigger and has more nutritious than wild tomato. The different features are closely related to differentially expressed genes. We identified 126 up-regulated differentially expressed genes and 87 down-regulated differentially expressed genes in cultivated tomato and wild tomato by RNA-Seq. These differentially expressed genes may be associated with salt resistance, drought resistance and fruit nutrition. These differentially expressed genes also further highlight the large-scale reconstruction between wild and cultivated species. In this paper, we mainly study GO enrichment analysis and pathway analysis of the differentially expressed genes. After GO and pathway enrichment analysis, a set of significantly enriched GO annotations and pathways were identified for the differentially expressed genes. What's more, we also identified long non-coding RNAs and mRNAs in the two species and analyzed its essential features. In addition to, we construct a co-expression network of long non-coding RNAs and mRNAs, and annotate mRNAs associated with long non-coding RNAs as target genes, and speculate the regulation function of long non-coding RNAs. In total, our results reveal the effects of artificial and natural selection on tomato's transcript, providing scientific basis for tomato's research in the future.	[Dai, Qi; Geng, Lili; Lu, Minjia; Jin, Weibo; Nan, Xuying; He, Ping-an; Yao, Yuhua] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang Sci-Tech University	Yao, YH (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	yaoyuhua2288@163.com			National Natural Science Foundation of China [61272312, 61170316, 31372075]; 521 Talent Cultivation Plan of Zhejiang Sci-Tech University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 521 Talent Cultivation Plan of Zhejiang Sci-Tech University	This work was supported by financial grants from the National Natural Science Foundation of China (Nos. 61272312 and 61170316) and the 521 Talent Cultivation Plan of Zhejiang Sci-Tech University.r This work was supported by financial grants from the National Natural Science Foundation of China (Nos. 61272312, 31372075 and 61170316) and the 521 Talent Cultivation Plan of Zhejiang Sci-Tech University.	Chen HY, 2015, BIOCHEM BIOPH RES CO, V464, P768, DOI 10.1016/j.bbrc.2015.07.029; Correia A F K, 2015, Int J Food Sci, V2015, P970724, DOI 10.1155/2015/970724; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; George S, 2011, FOOD CHEM, V1624, P1633; Ghosh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076029; Izawa T, 2009, CURR OPIN PLANT BIOL, V12, P185, DOI 10.1016/j.pbi.2009.01.004; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Khachik F, 2002, EXP BIOL MED, V227, P845, DOI 10.1177/153537020222701002; Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kroll KW, 2014, CANCER INFORM, V13, P7, DOI 10.4137/CIN.S14022; Kumar S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21597; Li KQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149352; Li PY, 2016, FOOD CHEM, V202, P125, DOI 10.1016/j.foodchem.2016.01.142; Liu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050785; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munir S, 2016, PLANT PHYSIOL BIOCH, V102, P167, DOI 10.1016/j.plaphy.2016.02.020; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Ruiu F, 2015, PLANT MOL BIOL, V89, P263, DOI 10.1007/s11103-015-0367-1; Sacilik Kamil, 2007, Agriculturae Conspectus Scientificus, V72, P343; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shi J, 2000, CRIT REV BIOTECHNOL, V20, P293, DOI 10.1080/07388550091144212; Souza JS, 2002, THESIS; Tal M, 1978, ZPFLANZENPHYSIOL, V86, P9; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu X, 2015, INT J CLIN EXP PATHO, V8, P2625	34	11	11	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172411	10.1371/journal.pone.0172411	http://dx.doi.org/10.1371/journal.pone.0172411			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278186	Green Submitted, gold, Green Published			2022-12-27	WOS:000396087900119
J	Grigg, J; Miyashita, L; Suri, R				Grigg, Jonathan; Miyashita, Lisa; Suri, Reetika			Pneumococcal infection of respiratory cells exposed to welding fumes; Role of oxidative stress and HIF-1 alpha	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; STREPTOCOCCUS-PNEUMONIAE; IN-VITRO; RECEPTOR	Welders are more susceptible to pneumococcal pneumonia. The mechanisms are yet unclear. Pneumococci co-opt the platelet activating factor receptor (PAFR) to infect respiratory epithelial cells. We previously reported that exposure of respiratory cells to welding fumes (WF), upregulates PAFR-dependent pneumococcal infection. The signaling pathway for this response is unknown, however, in intestinal cells, hypoxia-inducible factor-1 alpha (HIF 1 alpha) is reported to mediate PAFR-dependent infection. We sought to assess whether oxidative stress plays a role in susceptibility to pneumococcal infection via the platelet activating factor receptor. We also sought to evaluate the suitability of nasal epithelial PAFR expression in welders as a biomarker of susceptibility to infection. Finally, we investigated the generalisability of the effect of welding fumes on pneumococcal infection and growth using a variety of different welding fume samples. Nasal epithelial PAFR expression in welders and controls was analysed by flow cytometry. WF were collected using standard methodology. The effect of WF on respiratory cell reactive oxygen species production, HIF-1 alpha expression, and pneumococcal infection was determined using flow cytometry, HIF-1 alpha knockdown and overexpression, and pneumococcal infection assays. We found that nasal PAFR expression is significantly increased in welders compared with controls and that WF significantly increased reactive oxygen species production, HIF-1 alpha and PAFR expression, and pneumococcal infection of respiratory cells. In unstimulated cells, HIF-1 alpha knockdown decreased PAFR expression and HIF-1 alpha overexpression increased PAFR expression. However, in knockdown cells pneumococcal infection was paradoxically increased and in over-expressing cells infection was unaffected. Nasal epithelial PAFR expression may be used as a biomarker of susceptibility to pneumococcal infection in order to target individuals, particularly those at high risk such as welders, for the pneumococcal vaccine. Expression of HIF-1 alpha in unexposed respiratory cells inhibits basal pneumococcal infection via PAFR-independent mechanisms.	[Grigg, Jonathan; Miyashita, Lisa; Suri, Reetika] Blizard Inst Cell & Mol Sci, Ctr Genom & Child Hlth, London, England	University of London; Queen Mary University London	Suri, R (corresponding author), Blizard Inst Cell & Mol Sci, Ctr Genom & Child Hlth, London, England.	r.suri@qmul.ac.uk		Grigg, Jonathan/0000-0003-3109-6028; Suri, Reetika/0000-0001-5509-2502	Colt Foundation [CF/05/12]	Colt Foundation	The study was supported by a grant from the Colt Foundation: CF/05/12. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badding MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101310; COGGON D, 1994, LANCET, V344, P41, DOI 10.1016/S0140-6736(94)91056-1; Coggon D, 2016, THORAX; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Daijo H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34424; Grigg J, 2012, THORAX, V67, P908, DOI 10.1136/thoraxjnl-2011-200835; Heath and Safety Executive, FUM FACTS WHAT IS IT; Hedmer M, 2013, INT ARCH OCCUP ENV H; Keely S, 2010, MOL BIOL CELL, V21, P538, DOI 10.1091/mbc.E09-07-0573; Kelly CJ, 2013, MUCOSAL IMMUNOL; Lin AE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004818; Lin Y-F, 2015, BIOMED CENTRAL, V13, P52, DOI DOI 10.1186/s12989-016-0163-3; Liu Wei, 2012, Int J Biochem Mol Biol, V3, P165; Marongiu A, 2016, THORAX; McNeilly JD, 2004, TOXICOL APPL PHARM, V196, P95, DOI 10.1016/j.taap.2003.11.021; Movafagh S, 2014, J CELL BIOCH; Mushtaq N, 2011, J ALLERGY CLIN IMMUN, V127, P1236, DOI 10.1016/j.jaci.2010.11.039; Palmer KT, 2009, THORAX, V64, P983, DOI 10.1136/thx.2009.114280; Palmer KT, 2003, AM J EPIDEMIOL, V157, P227, DOI 10.1093/aje/kwf188; Patterson L, 2015, OUTBREAK INVASIVE PN, P3; Phalen RF, 2006, TOXICOL SCI, V92, P126, DOI 10.1093/toxsci/kfj182; Smani Y, 2012, J BIOL CHEM; Suri R, 2016, J ALLERGY CLIN IMMUN, V137, P527, DOI 10.1016/j.jaci.2015.06.033; Swords WE, 2000, MOL MICROBIOL, V37, P13, DOI 10.1046/j.1365-2958.2000.01952.x; Taylor MD, 2003, TOXICOL SCI, V75, P181, DOI 10.1093/toxsci/kfg173; Toren K, 2011, THORAX, V66, DOI 10.1136/thoraxjnl-2011-200707; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Wang T, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-35; Wergeland E, 2001, SCAND J WORK ENV HEA, V27, P353, DOI 10.5271/sjweh.625; Yu Y, 2014, BRIT J CANCER, V111, P515, DOI 10.1038/bjc.2014.323	30	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173569	10.1371/journal.pone.0173569	http://dx.doi.org/10.1371/journal.pone.0173569			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278175	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900013
J	Masuda, Y; Nakayama, Y; Tanaka, A; Naito, K; Konishi, M				Masuda, Yuki; Nakayama, Yoshiaki; Tanaka, Akihiro; Naito, Kenta; Konishi, Morichika			Antitumor activity of orally administered maitake alpha-glucan by stimulating antitumor immune response in murine tumor	PLOS ONE			English	Article							ENZYMATICALLY SYNTHESIZED GLYCOGEN; NUCLEAR-MAGNETIC-RESONANCE; GRIFOLA-FRONDOSA MAITAKE; MACROPHAGE ACTIVATION; FRUIT BODY; CANCER; CELLS; POLYSACCHARIDE; COMBINATION; SYSTEM	Maitake alpha-glucan, YM-2A, isolated from Grifola frondosa, has been characterized as a highly alpha-1,6-branched alpha-1,4 glucan. YM-2A has been shown to possess an anti-virus effect in mice; however, it does not directly inhibit growth of the virus in vitro, indicating that the anti-virus effect of YM-2A might be associated with modulation of the host immune system. In this study, we found that oral administration of YM-2A could inhibit tumor growth and improve survival rate in two distinct mouse models of colon-26 carcinoma and B16 melanoma. Orally administered YM-2A enhanced antitumor immune response by increasing INF-gamma-expressing CD4(+) and CD8(+) cells in the spleen and INF-gamma-expressing CD8(+) cells in tumor-draining lymph nodes. In vitro study showed that YM-2A directly activated splenic CD11b(+) myeloid cells, peritoneal macrophages and bone marrow-derived dendritic cells, but did not affect splenic CD11b -lymphocytes or colon-26 tumor cells. YM-2A is more slowly digested by pancreatic alpha-amylase than are amylopectin and rabbit liver glycogen, and orally administered YM-2A enhanced the expression of MHC class II and CD86 on dendritic cells and the expression of MHC class II on macrophages in Peyer's patches. Furthermore, in vitro stimulation of YM-2A increased the expression of pro-inflammatory cytokines in Peyer's patch CD11c(+) cells. These results suggest that orally administered YM-2A can activate dendritic cells and macrophages in Peyer's patches, inducing systemic antitumor T-cell response. Thus, YM-2A might be a candidate for an oral therapeutic agent in cancer immunotherapy.	[Masuda, Yuki; Nakayama, Yoshiaki; Konishi, Morichika] Kobe Pharmaceut Univ, Dept Microbial Chem, Kobe, Hyogo, Japan; [Tanaka, Akihiro; Naito, Kenta] Yukiguni Maitake Co Ltd, Dept Res & Dev, Niigata, Japan	Kobe Pharmaceutical University	Masuda, Y (corresponding author), Kobe Pharmaceut Univ, Dept Microbial Chem, Kobe, Hyogo, Japan.	organic@kobepharma-u.ac.jp			Yukiguni Maitake Co., Ltd.	Yukiguni Maitake Co., Ltd.	Yukiguni Maitake Co., Ltd. provided research materials and a research grant for consumables, but did not have any input into the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Bittencourt VCB, 2006, J BIOL CHEM, V281, P22614, DOI 10.1074/jbc.M511417200; BOCK K, 1984, ADV CARBOHYD CHEM BI, V42, P193, DOI 10.1016/S0065-2318(08)60125-0; Furuyashiki T, 2011, FOOD FUNCT, V2, P183, DOI 10.1039/c0fo00171f; Geurtsen J, 2009, J IMMUNOL, V183, P5221, DOI 10.4049/jimmunol.0900768; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grohmann U, 1998, IMMUNITY, V9, P315, DOI 10.1016/S1074-7613(00)80614-7; Hayashi K, 2013, J BREW SOC JAPAN, V108, P401; Kakutani R, 2007, CARBOHYD RES, V342, P2371, DOI 10.1016/j.carres.2007.07.024; Kakutani R, 2012, INT IMMUNOPHARMACOL, V12, P80, DOI 10.1016/j.intimp.2011.10.017; Kakutani R, 2012, GLYCOBIOLOGY, V22, P146, DOI 10.1093/glycob/cwr122; KUBO K, 1994, BIOL PHARM BULL, V17, P1106, DOI 10.1248/bpb.17.1106; Kubo K, 1997, BIOL PHARM BULL, V20, P781, DOI 10.1248/bpb.20.781; Kushner BH, 2014, CLIN CANCER RES, V20, P1375, DOI 10.1158/1078-0432.CCR-13-1012; Lo TCT, 2011, J AGR FOOD CHEM, V59, P11997, DOI 10.1021/jf202457r; Masuda Y, 2015, J LEUKOCYTE BIOL, V98, P1015, DOI 10.1189/jlb.1A0814-415RR; Masuda Y, 2013, INT J CANCER, V133, P108, DOI 10.1002/ijc.27999; Masuda Y, 2010, CANCER IMMUNOL IMMUN, V59, P1531, DOI 10.1007/s00262-010-0880-7; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; NANBA H, 1987, CHEM PHARM BULL, V35, P1162; NISHIJIMA M, 1985, P NATL ACAD SCI USA, V82, P282, DOI 10.1073/pnas.82.2.282; Ryoyama K, 2004, BIOSCI BIOTECH BIOCH, V68, P2332, DOI 10.1271/bbb.68.2332; SAITO H, 1977, BIOCHEMISTRY-US, V16, P908, DOI 10.1021/bi00624a015; Sun L, 2012, GLYCOCONJUGATE J, V29, P357, DOI 10.1007/s10719-012-9403-4; Takaya Y, 1998, J MAR BIOTECHNOL, V6, P208; Tsoni SV, 2008, ANN NY ACAD SCI, V1143, P45, DOI 10.1196/annals.1443.019; Tsung K, 1997, J IMMUNOL, V158, P3359; Wesa KM, 2015, CANCER IMMUNOL IMMUN, V64, P237, DOI 10.1007/s00262-014-1628-6; Wojtowicz ME, 2016, SEMIN ONCOL, V43, P161, DOI 10.1053/j.seminoncol.2015.11.001; Yang YP, 2015, J CLIN INVEST, V125, P3335, DOI 10.1172/JCI83871; Yasuda M, 2013, FOOD FUNCT, V4, P1387, DOI 10.1039/c3fo60035a; Yoon YD, 2004, INT IMMUNOPHARMACOL, V4, P1477, DOI 10.1016/j.intimp.2004.06.012; Zhang YJ, 2002, J AGR FOOD CHEM, V50, P7581, DOI 10.1021/jf0257648	33	21	23	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173621	10.1371/journal.pone.0173621	http://dx.doi.org/10.1371/journal.pone.0173621			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278221	gold, Green Published, Green Submitted			2022-12-27	WOS:000396087900018
J	Stone, MR; Thomas, K; Wilkinson, M; Stevenson, E; Gibson, AS; Jones, AM; Thompson, KG				Stone, Mark R.; Thomas, Kevin; Wilkinson, Michael; Stevenson, Emma; Gibson, Alan St Clair; Jones, Andrew M.; Thompson, Kevin G.			Exploring the performance reserve: Effect of different magnitudes of power output deception on 4,000 m cycling time-trial performance	PLOS ONE			English	Article							INTEROCEPTIVE SENSITIVITY; ENERGY-EXPENDITURE; PACING STRATEGIES; MAXIMAL WORK; EXERCISE; FATIGUE; PERCEPTION; AWARENESS; DURATION; DISTANCE	Purpose The aim of the present study was to investigate whether a magnitude of deception of 5% in power output would lead to a greater reduction in the amount of time taken for participants to complete a 4000 m cycling TT than a magnitude of deception of 2% in power output, which we have previously shown can lead to a small change in 4000 m cycling TT performance. Methods Ten trained male cyclists completed four, 4000 m cycling TTs. The first served as a habituation and the second as a baseline for future trials. During trials three and four participants raced against a pacer which was set, in a randomized order, at a mean power output equal to 2% (+2% TT) or 5% (+5% TT) higher than their baseline performance. However participants were misled into believing that the power output of the pacer was an accurate representation of their baseline performance on both occasions. Cardiorespiratory responses were recorded throughout each TT, and used to estimate energy contribution from aerobic and anaerobic metabolism. Results Participants were able to finish the +2% TT in a significantly shorter duration than at baseline ( p = 0.01), with the difference in performance likely attributable to a greater anaerobic contribution to total power output ( p = 0.06). There was no difference in performance between the +5% TT and +2% TT or baseline trials. Conclusions Results suggest that a performance reserve is conserved, involving anaerobic energy contribution, which can be utilised given a belief that the exercise will be sustainable however there is an upper limit to how much deception can be tolerated. These findings have implications for performance enhancement in athletes and for our understanding of the nature of fatigue during high-intensity exercise.	[Stone, Mark R.] Buckinghamshire New Univ, Ctr Human Performance Hlth & Wellbeing, High Wycombe, Bucks, England; [Thomas, Kevin; Wilkinson, Michael] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Stevenson, Emma] Newcastle Univ, Inst Cellular Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Gibson, Alan St Clair] Univ Waikato, Sch Hlth Sport & Human Performance, Hamilton, New Zealand; [Jones, Andrew M.] Univ Exeter, Sch Sport & Hlth Sci, Exeter, Devon, England; [Thompson, Kevin G.] Univ Canberra, Res Inst Sport & Exercise UCRISE, Canberra, ACT, Australia	Buckinghamshire New University; Northumbria University; Newcastle University - UK; University of Waikato; University of Exeter; University of Canberra	Thompson, KG (corresponding author), Univ Canberra, Res Inst Sport & Exercise UCRISE, Canberra, ACT, Australia.	kevin.thompson@canberra.edu.au	Wilkinson, Michael/AAY-2686-2021	Wilkinson, Michael/0000-0002-1174-5185; Stone, Mark/0000-0003-0735-287X; Thomas, Kevin/0000-0003-2973-5337; Thompson, Kevin/0000-0003-3985-1622	Faculty of Health and Life Sciences, Northumbria University, UK; English Institute of Sport; English Institute of Sport, Northumbria University, UK	Faculty of Health and Life Sciences, Northumbria University, UK; English Institute of Sport; English Institute of Sport, Northumbria University, UK	Funding was provided by the English Institute of Sport and the Faculty of Health and Life Sciences, Northumbria University, UK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the English Institute of Sport for supporting this research. The authors declare that there are no conflicts of interest.	Amann M, 2009, J PHYSIOL-LONDON, V587, P271, DOI 10.1113/jphysiol.2008.163303; Baron B, 2011, BRIT J SPORT MED, V45, P511, DOI 10.1136/bjsm.2009.059964; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cohen J.E., 1988, STAT POWER ANAL BEHA; Corbett J, 2009, BRIT J SPORT MED, V43, P770, DOI 10.1136/bjsm.2008.056416; de Koning J J, 1999, J Sci Med Sport, V2, P266, DOI 10.1016/S1440-2440(99)80178-9; Edwards AM, 2013, SPORTS MED, V43, P1057, DOI 10.1007/s40279-013-0091-4; Flyger N., 2008, ISN B, V1, P27; Foster C, 2004, INT J SPORTS MED, V25, P198, DOI 10.1055/s-2003-45260; Foster C, 2003, MED SCI SPORT EXER, V35, P826, DOI 10.1249/01.MSS.0000065001.17658.68; Foster C, 2009, BRIT J SPORT MED, V43, P765, DOI 10.1136/bjsm.2008.054841; Gibson AS, 2004, BRIT J SPORT MED, V38, P797, DOI 10.1136/bjsm.2003.009852; HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304; Herbert BM, 2007, INT J PSYCHOPHYSIOL, V65, P214, DOI 10.1016/j.ijpsycho.2007.04.007; Herbert BM, 2007, PSYCHOPHYSIOLOGY, V44, P194, DOI 10.1111/j.1469-8986.2007.00493.x; Hettinga FJ, 2012, BRIT J SPORT MED, V46, P30, DOI 10.1136/bjsm.2009.064261; Hettinga FJ, 2006, MED SCI SPORT EXER, V38, P1484, DOI 10.1249/01.mss.0000228956.75344.91; Lambert EV, 2005, BRIT J SPORT MED, V39, P52, DOI 10.1136/bjsm.2003.011247; Mauger AR, 2009, MED SCI SPORT EXER, V41, P451, DOI 10.1249/MSS.0b013e3181854957; Micklewright D, 2010, BRIT J SPORT MED, V44, P952, DOI 10.1136/bjsm.2009.057315; Morton RH, 2009, J SCI MED SPORT, V12, P332, DOI 10.1016/j.jsams.2007.11.006; Noakes TD, 2004, BRIT J SPORT MED, V38, P648, DOI 10.1136/bjsm.2003.009761; Noakes TD, 2004, J APPL PHYSIOL, V96, P1571, DOI 10.1152/japplphysiol.01124.2003; Noordhof DA, 2011, INT J SPORTS MED, V32, P422, DOI 10.1055/s-0031-1271676; Perreault S, 1998, J SPORT EXERCISE PSY, V20, P421, DOI 10.1123/jsep.20.4.421; Pires FD, 2012, BRIT J SPORT MED, V46, P18, DOI 10.1136/bjsm.2010.079053; Pohl J, 1997, DIABETES CARE, V20, P796, DOI 10.2337/diacare.20.5.796; Renfree A, 2014, SPORTS MED, V44, P147, DOI 10.1007/s40279-013-0107-0; SERRESSE O, 1988, INT J SPORTS MED, V9, P456, DOI 10.1055/s-2007-1025051; SERRESSE O, 1991, INT J SPORTS MED, V12, P543, DOI 10.1055/s-2007-1024731; Shei RJ, 2016, INT J SPORTS MED, V37, P341, DOI 10.1055/s-0035-1565139; Stone MR, 2011, EUR J APPL PHYSIOL, V111, P1807, DOI 10.1007/s00421-010-1818-7; Stone MR, 2012, MED SCI SPORT EXER, V44, P534, DOI 10.1249/MSS.0b013e318232cf77; Swart J, 2009, BRIT J SPORT MED, V43, P782, DOI 10.1136/bjsm.2008.055889; Taylor D, 2014, PHYSIOL BEHAV, V133, P45, DOI 10.1016/j.physbeh.2014.05.002; Tucker R, 2009, BRIT J SPORT MED, V43, P392, DOI 10.1136/bjsm.2008.050799; Williams EL, 2015, J SCI MED SPORT, V18, P486, DOI 10.1016/j.jsams.2014.07.003	37	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173120	10.1371/journal.pone.0173120	http://dx.doi.org/10.1371/journal.pone.0173120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278174	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000396087900044
J	Kendall, EA; Azman, AS; Cobelens, FG; Dowdy, DW				Kendall, Emily A.; Azman, Andrew S.; Cobelens, Frank G.; Dowdy, David W.			MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TREATMENT OUTCOMES; FOLLOW-UP; MATHEMATICAL-MODEL; DRUG-RESISTANCE; SOUTH-AFRICA; METAANALYSIS; TRANSMISSION; DISEASE; REINFECTION	Background In 2013, approximately 480,000 people developed active multidrug-resistant tuberculosis (MDR-TB), while only 97,000 started MDR-TB treatment. We sought to estimate the impact of improving access to MDR-TB diagnosis and treatment, under multiple diagnostic algorithm and treatment regimen scenarios, on ten-year projections of MDR-TB incidence and mortality. Methods We constructed a dynamic transmission model of an MDR-TB epidemic in an illustrative East/Southeast Asian setting. Using approximate Bayesian computation, we investigated a wide array of potential epidemic trajectories consistent with current notification data and known TB epidemiology. Results Despite an overall projected decline in TB incidence, data-consistent simulations suggested that MDR-TB incidence is likely to rise between 2015 and 2025 under continued 2013 treatment practices, although with considerable uncertainty (median 17% increase, 95% Uncertainty Range [UR] -38% to + 137%). But if, by 2017, all identified active TB patients with previously-treated TB could be tested for drug susceptibility, and 85% of those with MDR-TB could initiate MDR-appropriate treatment, then MDR-TB incidence in 2025 could be reduced by 26% (95% UR 4-52%) relative to projections under continued current practice. Also expanding this drug-susceptibility testing and appropriate MDR-TB treatment to treatment-naive as well as previously-treated TB cases, by 2020, could reduce MDR-TB incidence in 2025 by 29% (95% UR 6-55%) compared to continued current practice. If this diagnosis and treatment of all MDR-TB in known active TB cases by 2020 could be implemented via a novel second-line regimen with similar effectiveness and tolerability as current first-line therapy, a 54% (95% UR 20-74%) reduction in MDR-TB incidence compared to current-practice projections could be achieved by 2025. Conclusions Expansion of diagnosis and treatment of MDR-TB, even using current sub-optimal second-line regimens, is expected to significantly decrease MDR-TB incidence at the population level. Focusing MDR diagnostic efforts on previously-treated cases is an efficient first-step approach.	[Kendall, Emily A.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; [Azman, Andrew S.; Dowdy, David W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Cobelens, Frank G.] Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Amsterdam; Academic Medical Center Amsterdam	Kendall, EA (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA.	ekendal2@jhmi.edu		Kendall, Emily/0000-0002-0083-422X; Cobelens, Frank/0000-0002-4367-1133; Azman, Andrew/0000-0001-8662-9077	NIH [T32 AI007291-24]; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007291] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH T32 AI007291-24 (to EAK; www.nih.gov) and by Bill and Melinda Gates Foundation Work Order 10 (to DWD; www.gatesfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Cegielski JP, 2014, CLIN INFECT DIS, V59, P1049, DOI 10.1093/cid/ciu572; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Falzon D, 2015, EUR RESPIR J, V45, P150, DOI 10.1183/09031936.00101814; Falzon D, 2013, LANCET INFECT DIS, V13, P690, DOI 10.1016/S1473-3099(13)70130-0; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Gosling RD, 2011, CLIN MICROBIOL INFEC, V17, P1617, DOI 10.1111/j.1469-0691.2011.03660.x; Grandjean L, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001843; Hoa NB, 2014, TROP MED INT HEALTH, V19, P1076, DOI 10.1111/tmi.12347; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Korenromp EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038816; Kruk ME, 2008, TROP MED INT HEALTH, V13, P703, DOI 10.1111/j.1365-3156.2008.02042.x; MacPherson P, 2014, B WORLD HEALTH ORGAN, V92, P126, DOI 10.2471/BLT.13.124800; Mak A, 2008, AM J RESP CRIT CARE, V178, P306, DOI 10.1164/rccm.200802-240OC; Marx FM, 2014, CLIN INFECT DIS, V58, P1676, DOI 10.1093/cid/ciu186; Mayer Kenneth, 2013, J Int Assoc Provid AIDS Care, V12, P208, DOI 10.1177/2325957413475839; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Mehra M, 2013, INT J TUBERC LUNG D, V17, P1186, DOI 10.5588/ijtld.12.0959; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Millet JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064898; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Okada K, 2012, INT J TUBERC LUNG D, V16, P1619, DOI 10.5588/ijtld.12.0201; Palmero DJ, 2004, INT J TUBERC LUNG D, V8, P778; Reid A, 2015, INT J TUBERC LUNG D, V19, P5, DOI 10.5588/ijtld.14.0078; Sachdeva KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131438; Schnippel K, 2013, TROP MED INT HEALTH, V18, P109, DOI 10.1111/tmi.12018; Shrestha S, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu073; Sloot R, 2014, AM J RESP CRIT CARE, V190, P1044, DOI 10.1164/rccm.201406-1159OC; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Hoang TTT, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2338-5; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Trauer JM, 2014, J THEOR BIOL, V358, P74, DOI 10.1016/j.jtbi.2014.05.023; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Wares Fraser, 2014, Indian J Tuberc, V61, P298; Weiss P, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-333; WHO, 2014, GLOB TUB REP 2014	50	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172748	10.1371/journal.pone.0172748	http://dx.doi.org/10.1371/journal.pone.0172748			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273116	Green Submitted, Green Published, gold			2022-12-27	WOS:000396073700028
J	Perumal, N; Manicam, C; Steinicke, M; Funke, S; Pfeiffer, N; Grus, FH				Perumal, Natarajan; Manicam, Caroline; Steinicke, Matthias; Funke, Sebastian; Pfeiffer, Norbert; Grus, Franz H.			Characterization of the human aqueous humour proteome: A comparison of the genders	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; OPEN-ANGLE GLAUCOMA; PROSTAGLANDIN D SYNTHASE; MACULAR DEGENERATION; MASS-SPECTROMETRY; COMPUTATIONAL PLATFORM; TEAR PROTEOME; AGE; IDENTIFICATION; ANGIOGENESIS	Aqueous humour (AH) is an important biologic fluid that maintains normal intraocular pressure and contains proteins that regulate the homeostasis of ocular tissues. Any alterations in the protein compositions are correlated to the pathogenesis of various ocular disorders. In recent years, gender-based medicine has emerged as an important research focus considering the prevalence of certain diseases, which are higher in a particular sex. Nevertheless, the inter-gender variations in the AH proteome are unknown. Therefore, this study endeavoured to characterize the AH proteome to assess the differences between genders. Thirty AH samples of patients who underwent cataract surgery were categorized according to their gender. Label-free quantitative discovery mass spectrometry-based proteomics strategy was employed to characterize the AH proteome. A total of 147 proteins were identified with a false discovery rate of less than 1% and only the top 10 major AH proteins make up almost 90% of the total identified proteins. A large number of proteins identified were correlated to defence, immune and inflammatory mechanisms, and response to wounding. Four proteins were found to be differentially abundant between the genders, comprising SERPINF1, SERPINA3, SERPING1 and PTGDS. The findings emerging from our study provide the first insight into the gender-based proteome differences in the AH and also highlight the importance in considering potential sex-dependent changes in the proteome of ocular pathologies in future studies employing the AH.	[Perumal, Natarajan; Manicam, Caroline; Steinicke, Matthias; Funke, Sebastian; Pfeiffer, Norbert; Grus, Franz H.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Expt & Translat Ophthalmol, Mainz, Germany	Johannes Gutenberg University of Mainz	Grus, FH (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Expt & Translat Ophthalmol, Mainz, Germany.	grus@eye-research.org	Pfeiffer, Norbert/AAO-7586-2020	Perumal, Natarajan/0000-0002-2612-5907				Abe R, 2004, AM J PATHOL, V164, P1225, DOI 10.1016/S0002-9440(10)63210-5; ANDO H, 1993, INVEST OPHTH VIS SCI, V34, P3541; Badock V, 2001, ELECTROPHORESIS, V22, P2856, DOI 10.1002/1522-2683(200108)22:14<2856::AID-ELPS2856>3.0.CO;2-U; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; BECERRA SP, 1995, J BIOL CHEM, V270, P25992, DOI 10.1074/jbc.270.43.25992; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Bouck N, 2002, TRENDS MOL MED, V8, P330, DOI 10.1016/S1471-4914(02)02362-6; Bouhenni RA, 2011, EXP EYE RES, V92, P67, DOI 10.1016/j.exer.2010.11.004; Chelbi ST, 2012, HUM MOL GENET; Cheng JW, 2013, J GLAUCOMA, V22, P301, DOI 10.1097/IJG.0b013e31824083ca; Chowdhury UR, 2010, INVEST OPHTH VIS SCI, V51, P4921, DOI 10.1167/iovs.10-5531; Cox J, 2014, MOL CELLULAR PROTEOM; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davis AE, 2008, MOL IMMUNOL, V45, P4057, DOI 10.1016/j.molimm.2008.06.028; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Drabovich AP, 2015, BBA-PROTEINS PROTEOM, V1854, P677, DOI 10.1016/j.bbapap.2014.09.006; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Duan X, 2008, PROTEOMIC ANAL AQUEO; Duan XM, 2010, MOL VIS, V16, P2839; Escoffier P, 2010, J PROTEOME RES, V9, P789, DOI 10.1021/pr9006602; Fan BJ, 2008, INVEST OPHTH VIS SCI, V49, P1886, DOI 10.1167/iovs.07-0414; Filleur S, 2009, J CELL BIOCHEM, V106, P769, DOI 10.1002/jcb.22072; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Funatsu H, 2006, OPHTHALMOLOGY, V113, P294, DOI 10.1016/j.ophtha.2005.10.030; Funding M, 2005, ACTA OPHTHALMOL SCAN, V83, P31, DOI 10.1111/j.1600-0420.2005.00381.x; Funke S, 2012, J PROTEOMICS, V75, P3177, DOI 10.1016/j.jprot.2012.03.018; GABELT BT, 1990, EXP EYE RES, V51, P87, DOI 10.1016/0014-4835(90)90174-S; Gerashchenko DY, 1998, INVEST OPHTH VIS SCI, V39, P198; Granger J, 2005, PROTEOMICS, V5, P4713, DOI 10.1002/pmic.200401331; Grus F, 2008, TRANSTHYRETIN COMPLE; Grus FH, 2007, PROTEOM CLIN APPL, V1, P876, DOI 10.1002/prca.200700105; Gunther R, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-14; Herbert B, 2000, ELECTROPHORESIS, V21, P3639, DOI 10.1002/1522-2683(200011)21:17<3639::AID-ELPS3639>3.0.CO;2-V; Hohenstein-Blaul NVU, 2013, EXP EYE RES, V117, P126, DOI 10.1016/j.exer.2013.07.015; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huttenhain R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003989; Izzotti A, 2010, J PROTEOME RES, V9, P4831, DOI 10.1021/pr1005372; Ji YH, 2015, CLIN BIOCHEM, V48, P1304, DOI 10.1016/j.clinbiochem.2015.08.006; Kalsheker NA, 1996, INT J BIOCHEM CELL B, V28, P961, DOI 10.1016/1357-2725(96)00032-5; Kim TW, 2012, J PROTEOME RES, V11, P4034, DOI 10.1021/pr300080s; Kliuchnikova A, 2016, PROTEOMICS; Kramer M, 2005, OCUL IMMUNOL INFLAMM, V13, P305, DOI 10.1080/09273940590950990; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Miike K, 2010, PROTEOMICS, V10, P2678, DOI 10.1002/pmic.200900496; Munoz E, 1999, NEUROLOGY, V52, P297, DOI 10.1212/WNL.52.2.297; Murthy KR, 2015, OMICS, V19, P283, DOI 10.1089/omi.2015.0029; Nahnsen S, 2013, MOL CELL PROTEOMICS, V12, P549, DOI 10.1074/mcp.R112.025163; NAKAMURA M, 1988, J BIOL CHEM, V263, P19218; Nobl M, 2016, EXP EYE RES, V146, P107, DOI 10.1016/j.exer.2016.01.001; Ogata N, 2005, AM J OPHTHALMOL, V140, P937, DOI 10.1016/j.ajo.2005.05.037; Ohno-Matsui K, 2001, J CELL PHYSIOL, V189, P323, DOI 10.1002/jcp.10026; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Perumal N, 2016, SCI REPORTS, V6; Perumal N, 2014, PROTEOMICS, V14, P1698, DOI 10.1002/pmic.201300039; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Pieragostino D, 2015, PROTEOM CLIN APPL, V9, P169, DOI 10.1002/prca.201400084; Pike RN, 2005, FEBS J, V272, P4842, DOI 10.1111/j.1742-4658.2005.04880.x; Pluskal MG, 2002, PROTEOMICS, V2, P145, DOI 10.1002/1615-9861(200202)2:2<145::AID-PROT145>3.0.CO;2-Y; Richardson MR, 2009, MOL VIS, V15, P2740; Rudnicka AR, 2006, INVEST OPHTH VIS SCI, V47, P4254, DOI 10.1167/iovs.06-0299; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; Rychli K, 2009, EXPERT OPIN THER TAR, V13, P1295, DOI 10.1517/14728220903241641; Sacca SC, 2012, INVEST OPHTH VIS SCI, V53, P4242, DOI 10.1167/iovs.11-8902; Smith W, 1997, AUST NZ J OPHTHALMOL, V25, pS13; Soria J, 2015, MOL VIS, V21, P451; Stastna M, 2007, PROTEOMICS, V7, P4358, DOI 10.1002/pmic.200700300; Stoermer KA, 2011, VIROLOGY, V411, P362, DOI 10.1016/j.virol.2010.12.045; Tombran-Tink J, 2003, TRENDS MOL MED, V9, P244, DOI 10.1016/S1471-4914(03)00074-1; Tong HP, 2006, CLIN BIOCHEM, V39, P267, DOI 10.1016/j.clinbiochem.2005.11.013; Tsiligiannis SE, 2012, REPROD SCI; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; Vajaranant TS, 2010, CURR OPIN OPHTHALMOL, V21, P91, DOI 10.1097/ICU.0b013e3283360b7e; Wang XY, 2002, HUM GENET, V110, P356, DOI 10.1007/s00439-002-0697-3; Yang HY, 2013, INT J LEGAL MED, V127, P1065, DOI 10.1007/s00414-013-0848-1; Yang Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158611; Yang SM, 2011, J CLIN ENDOCR METAB, V96, P831, DOI 10.1210/jc.2010-2140; Yao JQ, 2013, INT J MOL MED, V32, P1421, DOI 10.3892/ijmm.2013.1509; Yao JQ, 2013, PROTEOM CLIN APPL, V7, P550, DOI 10.1002/prca.201200012; Zhang QB, 2013, J EXP MED, V210, P191, DOI 10.1084/jem.20111843; Zhou L, 2012, PROG RETIN EYE RES, V31, P527, DOI 10.1016/j.preteyeres.2012.06.002; Zurbig P, 2012, ELECTROPHORESIS, V33, P3617, DOI 10.1002/elps.201200360	84	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172481	10.1371/journal.pone.0172481	http://dx.doi.org/10.1371/journal.pone.0172481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273097	Green Submitted, Green Published, gold			2022-12-27	WOS:000396073700075
J	Del Mistro, A; Frayle, H; Rizzi, M; Fantin, G; Ferro, A; Angeletti, PM; Rossi, PG; Altobelli, E				Del Mistro, Annarosa; Frayle, Helena; Rizzi, Martina; Fantin, Gianpiero; Ferro, Antonio; Angeletti, Paolo Matteo; Rossi, Paolo Giorgi; Altobelli, Emma			Methylation analysis and HPV genotyping of self-collected cervical samples from women not responding to screening invitation and review of the literature	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS DNA; INCREASE PARTICIPATION; SOCIOECONOMIC GROUPS; FOLLOW-UP; CANCER; TRIAGE; SPECIFICITY; CYTOLOGY; PROGRAM; VALIDATION	Aim of the study To assess the feasibility of partial HPV genotyping and methylation analysis of CADM1, MAL, and miR124-2 genes as triage tests in assaying self-collected cervical samples positive for high-risk HPV on primary screening, and to review the literature regarding host cellular gene methylation analysis of self-collected cervical samples. Material and methods Women residing in North-East Italy who had failed to respond to the invitation to participate in an organized population-based program were invited to provide a self-sample. Their stored baseline (self-collected) and follow-up (clinician-collected) cervical samples were included in the study. DNA was extracted from HPV-positive (Qiagen's Hybrid Capture 2, HC2) samples. Partial genotyping with separate detection of HPV types 16 and 18 was performed with a hybrid capture-based method and a quantitative PCR assay. Methylation was assayed with a quantitative methylation-specific PCR. Results High-risk HPV infection was detected in 48% of baseline and 71% of follow-up HC2-positive samples. Methylation was demonstrated respectively in 15% and 23.5% of baseline and follow- up samples and chiefly involved a single gene (miR124-2). Invalid quantitative PCR results were recorded in 5% of self-collected samples. The specificity of miR124-1, MAL, and CADM1 methylation was 84%, 94%, and 98%, respectively, and the specificity of the three markers combined was 84%. Sensitivity was not estimated due to the lack of CIN2+ samples. The systematic review showed that different methylation assays yield different accuracy values. Conclusion Self-collected samples are suitable for methylation assays included in reflex triage testing. The reproducibility and accuracy of the methylation tests described in the literature should be improved.	[Del Mistro, Annarosa; Frayle, Helena; Rizzi, Martina] Veneto Inst Oncol IOV IRCCS, Immunol & Diagnost Mol Oncol Unit, Padua, Italy; [Fantin, Gianpiero] Local Hlth Unit 7, Maternal & Child Dept, Treviso, Italy; [Ferro, Antonio] Local Hlth Unit 17, Prevent Dept, Padua, Italy; [Angeletti, Paolo Matteo] Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Rossi, Paolo Giorgi] Local Hlth Author, Interinst Epidemiol Unit, Reggio Emilia, Italy; [Rossi, Paolo Giorgi] IRCCS, Arcispedale S Maria Nuova Res Hosp, Reggio Emilia, Italy; [Altobelli, Emma] Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Altobelli, Emma] Univ Aquila, AUSL Teramo, Epidemiol & Biostat Unit, Laquila, Italy	IRCCS Istituto Oncologico Veneto (IOV); University of L'Aquila; University of L'Aquila; University of L'Aquila	Altobelli, E (corresponding author), Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy.; Altobelli, E (corresponding author), Univ Aquila, AUSL Teramo, Epidemiol & Biostat Unit, Laquila, Italy.	emma.altobelli@cc.univaq.it	Rossi, Paolo Giorgi/K-6367-2016; Frayle, Helena/S-7496-2018	Rossi, Paolo Giorgi/0000-0001-9703-2460; Frayle, Helena/0000-0002-4906-3075				Ahmadipour H, 2016, ASIAN PAC J CANC PRE, V17; Altobelli E, 2016, LANCET ONCOL; Altobelli E, 2016, MOL CLIN ONCOL, V5, P348, DOI 10.3892/mco.2016.909; Altobelli E, 2015, INT J GYNECOL CANCER, V25, P474, DOI 10.1097/IGC.0000000000000374; Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Boers A, 2014, BRIT J CANCER, V111, P1095, DOI 10.1038/bjc.2014.392; Bogler T, 2015, CAN FAM PHYSICIAN, V61, pE459; Camilloni L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-464; Carozzi F, 2008, LANCET ONCOL, V9, P937, DOI 10.1016/S1470-2045(08)70208-0; Carrasquillo O, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-299; Castle PE, 2008, J CLIN MICROBIOL, V46, P2595, DOI 10.1128/JCM.00824-08; Chang CC, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1411-x; De Strooper LMA, 2016, GYNECOL ONCOL, V141, P341, DOI 10.1016/j.ygyno.2016.02.012; De Strooper LMA, 2014, J CLIN PATHOL, V67, P1067, DOI 10.1136/jclinpath-2014-202616; Del Mistro A, 2010, GYNECOL ONCOL, V117, P77, DOI 10.1016/j.ygyno.2010.01.003; Dijkstra MG, 2014, ANN ONCOL, V25, P927, DOI 10.1093/annonc/mdt538; Duke P, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0206-1; Ebisch RMF, 2016, INT J CANCER, V139, P691, DOI 10.1002/ijc.30090; Eijsink JJH, 2011, GYNECOL ONCOL, V120, P280, DOI 10.1016/j.ygyno.2010.10.029; Gillio-Tos A, 2013, J CLIN MICROBIOL, V51, P2901, DOI 10.1128/JCM.01047-13; Giorgi-Rossi P, 2012, INT J CANCER, V130, P1387, DOI 10.1002/ijc.26147; Hesselink AT, 2014, INT J CANCER, V135, P880, DOI 10.1002/ijc.28723; Hesselink AT, 2014, J CLIN MICROBIOL, V52, P890, DOI 10.1128/JCM.03195-13; Hillemanns P, 2016, ONCOL RES TREAT, V39, P501, DOI 10.1159/000448385; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Overmeer RM, 2009, J PATHOL, V219, P327, DOI 10.1002/path.2598; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Rossi PG, 2015, BRIT J CANCER, V112, P667, DOI 10.1038/bjc.2015.11; Sancho-Garnier H, 2013, INT J CANCER, V133, P2681, DOI 10.1002/ijc.28283; Schiffman M, 2015, J CLIN MICROBIOL, V53, P52, DOI 10.1128/JCM.02116-14; Schiffman M, 2015, CANCER EPIDEM BIOMAR, V24, P1304, DOI 10.1158/1055-9965.EPI-14-1353; Serraino D, 2015, PREV MED, V75, P56, DOI 10.1016/j.ypmed.2015.01.034; Tamalet C, 2016, J CLIN VIROL, V78, P102, DOI 10.1016/j.jcv.2016.02.027; Vaccarella S, 2016, LANCET ONCOL; Verdoodt F, 2015, EUR J CANCER, V51, P2375, DOI 10.1016/j.ejca.2015.07.006; Verhoef VMJ, 2014, GYNECOL ONCOL, V135, P58, DOI 10.1016/j.ygyno.2014.08.003; Verhoef VMJ, 2014, LANCET ONCOL, V15, P315, DOI 10.1016/S1470-2045(14)70019-1; Virtanen A, 2015, INT J CANCER, V136, pE677, DOI 10.1002/ijc.29176; Zorzi M, 2013, BJOG-INT J OBSTET GY, V120, P1260, DOI 10.1111/1471-0528.12272	40	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172226	10.1371/journal.pone.0172226	http://dx.doi.org/10.1371/journal.pone.0172226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28263992	gold, Green Submitted, Green Published			2022-12-27	WOS:000396054300008
J	Wessels, D; Lusche, DF; Voss, E; Kuhl, S; Buchele, EC; Klemme, MR; Russell, KB; Ambrose, J; Soll, BA; Bossler, A; Milhem, M; Goldman, C; Soll, DR				Wessels, Deborah; Lusche, Daniel F.; Voss, Edward; Kuhl, Spencer; Buchele, Emma C.; Klemme, Michael R.; Russell, Kanoe B.; Ambrose, Joseph; Soll, Benjamin A.; Bossler, Aaron; Milhem, Mohammed; Goldman, Charles; Soll, David R.			Melanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44	PLOS ONE			English	Article							CD44 SPLICE VARIANTS; MOTION ANALYSIS; TUMOR-GROWTH; 3-DIMENSIONAL RECONSTRUCTION; FLUORESCENCE MICROSCOPY; MONOCLONAL-ANTIBODIES; MALIGNANT-MELANOMA; HUMAN FIBROBLASTS; NEURAL CREST; S100 PROTEIN	Using unique computer-assisted 3D reconstruction software, it was previously demonstrated that tumorigenic cell lines derived from breast tumors, when seeded in a 3D Matrigel model, grew as clonal aggregates which, after approximately 100 hours, underwent coalescence mediated by specialized cells, eventually forming a highly structured large spheroid. Non-tumorigenic cells did not undergo coalescence. Because histological sections of melanomas forming in patients suggest that melanoma cells migrate and coalesce to form tumors, we tested whether they also underwent coalescence in a 3D Matrigel model. Melanoma cells exiting fragments of three independent melanomas or from secondary cultures derived from them, and cells from the melanoma line HTB-66, all underwent coalescence mediated by specialized cells in the 3D model. Normal melanocytes did not. However, coalescence of melanoma cells differed from that of breast-derived tumorigenic cell lines in that they 1) coalesced immediately, 2) underwent coalescence as individual cells as well as aggregates, 3) underwent coalescence far faster and 4) ultimately formed long, flat, fenestrated aggregates that were extremely dynamic. A screen of 51 purified monoclonal antibodies (mAbs) targeting cell surface-associated molecules revealed that two mAbs, anti-beta 1 integrin/(CD29) and anti-CD44, blocked melanoma cell coalescence. They also blocked coalescence of tumorigenic cells derived from a breast tumor. These results add weight to the commonality of coalescence as a characteristic of tumorigenic cells, as well as the usefulness of the 3D Matrigel model and software for both investigating the mechanisms regulating tumorigenesis and screening for potential anti-tumorigenesis mAbs.	[Wessels, Deborah; Lusche, Daniel F.; Voss, Edward; Kuhl, Spencer; Buchele, Emma C.; Klemme, Michael R.; Russell, Kanoe B.; Ambrose, Joseph; Soll, Benjamin A.; Soll, David R.] Univ Iowa, Dept Biol, Dev Studies Hybridoma Bank, Iowa City, IA 52242 USA; [Bossler, Aaron] Univ Iowa Hosp & Clin, Dept Mol Pathol, Iowa City, IA 52242 USA; [Milhem, Mohammed] Univ Iowa Hosp & Clin, Dept Internal Med, Iowa City, IA 52242 USA; [Goldman, Charles] Mercy Hosp Syst Des Moines, Des Moines, IA USA	University of Iowa; University of Iowa; University of Iowa	Soll, DR (corresponding author), Univ Iowa, Dept Biol, Dev Studies Hybridoma Bank, Iowa City, IA 52242 USA.	david-soll@uiowa.edu		Bossler, Aaron/0000-0002-8748-2510; Milhem, Mohammed/0000-0003-4663-6824; Lusche, Daniel Felix/0000-0002-8848-4198	Monoclonal Antibody Research Institute; Developmental Studies Hybridoma Bank; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	Monoclonal Antibody Research Institute; Developmental Studies Hybridoma Bank; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Monoclonal Antibody Research Institute and the Developmental Studies Hybridoma Bank, the latter a National Resource created by the National Institutes of Health (NIH) housed at the University of Iowa.	Ahrens T, 2001, ONCOGENE, V20, P3399, DOI 10.1038/sj.onc.1204435; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ambrose J, 2015, AM J CANCER RES, V5, P3485; Aung PP, 2015, J CLIN PATHOL, V68, P963, DOI 10.1136/jclinpath-2015-202887; Babapoor S, 2016, MODERN PATHOL, V29, P461, DOI 10.1038/modpathol.2016.44; Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; BELITSOS PC, 1990, J IMMUNOL, V144, P1661; Blessing K, 1998, HISTOPATHOLOGY, V32, P139; Boyd DD, 2003, AM J PATHOL, V162, P619, DOI 10.1016/S0002-9440(10)63855-2; BRINSTER RL, 1984, CELL, V37, P367, DOI 10.1016/0092-8674(84)90367-2; BRONNERFRASER M, 1980, J COMP NEUROL, V193, P423, DOI 10.1002/cne.901930209; Cabezon T, 2013, MOL CELL PROTEOMICS, V12, P381, DOI 10.1074/mcp.M112.019786; Chen YF, 2014, J INVEST DERMATOL, V134, P335, DOI 10.1038/jid.2013.327; Cheon DJ, 2011, ANNU REV PATHOL-MECH, V6, P95, DOI 10.1146/annurev.pathol.3.121806.154244; Chu TY, 1999, GENE CHROMOSOME CANC, V24, P127, DOI 10.1002/(SICI)1098-2264(199902)24:2<127::AID-GCC5>3.0.CO;2-8; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Costa S, 2016, AM J SURG PATHOL, V40, P368, DOI 10.1097/PAS.0000000000000568; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dixit R, 2003, PLANT J, V36, P280, DOI 10.1046/j.1365-313X.2003.01868.x; Dobrucki JW, 2007, BIOPHYS J, V93, P1778, DOI 10.1529/biophysj.106.096636; Doganer BA, 2016, TRENDS CELL BIOL, V26, P262, DOI 10.1016/j.tcb.2015.11.002; Ertao Z., 2016, J EXP CLIN CANC RES, V35, P1, DOI DOI 10.1186/s13046-016-0336-9; Ezin AM, 2009, DEV BIOL, V330, P221, DOI 10.1016/j.ydbio.2009.03.018; Facista Alexander, 2012, Genome Integr, V3, P3, DOI 10.1186/2041-9414-3-3; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Franklin WA, 1997, J CLIN INVEST, V100, P2417, DOI DOI 10.1172/JCI119782; FRIDMAN R, 1991, JNCI-J NATL CANCER I, V83, P769, DOI 10.1093/jnci/83.11.769; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; GLASGOW BJ, 1987, J CUTAN PATHOL, V14, P223, DOI 10.1111/j.1600-0560.1987.tb01337.x; GOODFELLOW PN, 1982, EUR J IMMUNOL, V12, P659, DOI 10.1002/eji.1830120807; Gov NS, 2007, P NATL ACAD SCI USA, V104, P15970, DOI 10.1073/pnas.0708037104; GOWN AM, 1986, AM J PATHOL, V123, P195; Guida S, 2016, BRIT J DERMATOL, V174, P610, DOI 10.1111/bjd.14286; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; GUO YJ, 1994, CANCER RES, V54, P1561; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heaphy CM, 2009, BREAST CANCER RES TR, V118, P229, DOI 10.1007/s10549-009-0504-0; HeroldMende C, 1996, J PATHOL, V179, P66, DOI 10.1002/(SICI)1096-9896(199605)179:1<66::AID-PATH544>3.0.CO;2-5; HERRMANN LR, 1976, J ENG MECH DIV-ASCE, V102, P749; Im Sungbin, 1992, Yonsei Medical Journal, V33, P344; Jensen EC, 2012, ANAT REC, V295, P2031, DOI 10.1002/ar.22602; Jones TD, 2005, CLIN CANCER RES, V11, P6512, DOI 10.1158/1078-0432.CCR-05-0891; Jothy S, 1996, TUMOR BIOL, V17, P58, DOI 10.1159/000217967; Jungbauer S, 2004, CHEMPHYSCHEM, V5, P85, DOI 10.1002/cphc.200300868; Kadara H, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju004; Kerosuo L, 2012, SEMIN CELL DEV BIOL, V23, P320, DOI 10.1016/j.semcdb.2012.03.010; Kibbey Maura C., 1994, Journal of Tissue Culture Methods, V16, P227, DOI 10.1007/BF01540656; Kirfel G, 2004, PROTOPLASMA, V223, P67, DOI 10.1007/s00709-003-0031-5; KOZLOWSKI JM, 1984, J NATL CANCER I, V72, P913; Kuhl S, 2016, CHEMOTAXIS METHODS P; Kutzner H, 2012, MODERN PATHOL, V25, P838, DOI 10.1038/modpathol.2012.35; Leotlela PD, 2007, ONCOGENE, V26, P3846, DOI 10.1038/sj.onc.1210155; Ley K, 2016, NAT REV DRUG DISCOV, V15, P173, DOI 10.1038/nrd.2015.10; Li X, 2015, CANCER GENET-NY, V208, P25, DOI 10.1016/j.cancergen.2014.11.005; Lochhead P, 2014, ETIOLOGIC FIELD EFFE; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; LOWE SW, 1994, COLD SPRING HARB SYM, V59, P419, DOI 10.1101/SQB.1994.059.01.047; Lynch SP, 2013, ONCOLOGIST, V18, P1167, DOI 10.1634/theoncologist.2013-0167; Ma Q, 2012, ONCOL LETT, V3, P797, DOI 10.3892/ol.2012.558; MIHM MC, 1971, NEW ENGL J MED, V284, P1078, DOI 10.1056/NEJM197105132841907; Moody G, 2016, INT J CANCER, V139, P1340, DOI 10.1002/ijc.30180; MOORE GE, 1971, SURG GYNECOL OBSTETR, V132, P427; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; NERI A, 1982, J NATL CANCER I, V68, P507; Nonaka D, 2008, J CUTAN PATHOL, V35, P1014, DOI 10.1111/j.1600-0560.2007.00953.x; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Omelchenko T, 2003, P NATL ACAD SCI USA, V100, P10788, DOI 10.1073/pnas.1834401100; Pampaloni F, 2014, INTEGR BIOL-UK, V6, P988, DOI 10.1039/c4ib00121d; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Perona Rosario, 2006, Clin Transl Oncol, V8, P77, DOI 10.1007/s12094-006-0162-1; Piotrowicz RS, 2011, MOL CANCER THER, V10, P2072, DOI 10.1158/1535-7163.MCT-11-0351; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Poston T, 1998, COMPUT GRAPH FORUM, V17, pC137, DOI 10.1111/1467-8659.00261; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; PRICE JE, 1990, CANCER RES, V50, P717; Provance DW, 1996, P NATL ACAD SCI USA, V93, P14554, DOI 10.1073/pnas.93.25.14554; Raso-Barnett L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053883; RODECK U, 1993, CANCER METAST REV, V12, P219, DOI 10.1007/BF00665954; Russ J.C, 1992, IMAGE PROCESSING HDB; Saalbach A, 1998, ARCH DERMATOL RES, V290, P360, DOI 10.1007/s004030050318; Scherer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118628; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Seiter S, 1996, CLIN CANCER RES, V2, P447; Seiter S, 1996, VIRCHOWS ARCH, V428, P141; Siiskonen Hanna, 2013, BMC Cancer, V13, P181, DOI 10.1186/1471-2407-13-181; Sironen RK, 2011, EXP CELL RES, V317, P383, DOI 10.1016/j.yexcr.2010.11.017; Sixma JJ, 1997, THROMB HAEMOSTASIS, V78, P434; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Smoller BR, 2006, MODERN PATHOL, V19, pS34, DOI 10.1038/modpathol.3800508; Soll DR, 2009, EUKARYOT CELL, V8, P1381, DOI 10.1128/EC.00121-09; Soll David R, 2003, ScientificWorldJournal, V3, P827; Soll DR, 1999, COMPUT MED IMAG GRAP, V23, P3, DOI 10.1016/S0895-6111(98)00058-5; Soll DR, 1995, INT REV CYTOL, V163, P43; Soll DR, 2000, SCANNING, V22, P249, DOI 10.1002/sca.4950220404; Soll DR, 2001, METH MOL B, V161, P45; Soll DR, 1998, TECH MOD B, P25; Song PI, 2002, J INVEST DERMATOL, V119, P424, DOI 10.1046/j.1523-1747.2002.01847.x; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Sung Myong-Hee, 2013, Cells, V2, P284, DOI 10.3390/cells2020284; SWEENEY TM, 1991, CANCER METAST REV, V10, P245, DOI 10.1007/BF00050795; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Wang YG, 2012, EXP MOL MED, V44, P387, DOI 10.3858/emm.2012.44.6.044; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; WESSELS D, 1994, CELL MOTIL CYTOSKEL, V27, P1, DOI 10.1002/cm.970270102; Wessels DJ, 2016, METHODS MOL BIOL, V1365, P265, DOI 10.1007/978-1-4939-3124-8_14; Wong PP, 2014, ONCOGENE, V33, P4579, DOI 10.1038/onc.2014.45; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; ZAMBRUNO G, 1993, J CELL SCI, V105, P179	117	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173400	10.1371/journal.pone.0173400	http://dx.doi.org/10.1371/journal.pone.0173400			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264026	Green Published, gold, Green Submitted			2022-12-27	WOS:000396054300063
J	Inzaugarat, ME; De Matteo, E; Baz, P; Lucero, D; Garcia, CC; Ballerga, EG; Daruich, J; Sorda, JA; Wald, MR; Chernavsky, AC				Eugenia Inzaugarat, Maria; De Matteo, Elena; Baz, Placida; Lucero, Diego; Claudia Garcia, Cecilia; Ballerga, Esteban Gonzalez; Daruich, Jorge; Sorda, Juan Antonio; Wald, Miriam Ruth; Claudia Chernavsky, Alejandra			New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans	PLOS ONE			English	Article							OXIDATIVE STRESS; NADPH OXIDASE; LEPTIN; STEATOHEPATITIS; INFLAMMATION; ACTIVATION; MECHANISMS; CELLS; EXPRESSION; SIGNATURE	Introduction The immune system acts on different metabolic tissues that are implicated in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Leptin and linoleic acid have the ability to potentially affect immune cells, whereas curcumin is a known natural polyphenol with antioxidant and anti-inflammatory properties. Aims This study was designed to evaluate the pro-inflammatory and pro-oxidant effects of leptin and linoleic acid on immune cells from patients with NAFLD and to corroborate the modulatory effects of curcumin and its preventive properties against the progression of NAFLD using a high-fat diet (HFD)-induced NAFLD/nonalcoholic steatohepatitis mouse model. Results The ex vivo experiments showed that linoleic acid increased the production of reactive oxygen species in monocytes and liver macrophages, whereas leptin enhanced tumor necrosis factor-alpha (TNF-alpha) production in monocytes and interferon-gamma production in circulating CD4(+) cells. Conversely, oral administration of curcumin prevented HFD-induced liver injury, metabolic alterations, intrahepatic CD4(+) cell accumulation and the linoleic acid-and leptin-induced pro-inflammatory and pro-oxidant effects on mouse liver macrophages. Conclusion Our findings provide new evidence for the therapeutic potential of curcumin to treat human NAFLD. However, the development of a preventive treatment targeting human circulating monocytes and liver macrophages as well as peripheral and hepatic CD4(+) cells requires additional research.	[Eugenia Inzaugarat, Maria; Baz, Placida; Claudia Garcia, Cecilia; Claudia Chernavsky, Alejandra] Univ Buenos Aires, CONICET, Inst Inmunol Genet & Metab, Buenos Aires, DF, Argentina; [De Matteo, Elena] Hosp Ninos Dr R Gutierrez, Serv Patol, Buenos Aires, DF, Argentina; [Lucero, Diego] Univ Buenos Aires, Fac Farm & Bioquim, Dept Bioquim Clin, Lab Lipidos & Arterioesclerosis, Buenos Aires, DF, Argentina; [Ballerga, Esteban Gonzalez; Daruich, Jorge; Sorda, Juan Antonio] Univ Buenos Aires, Hosp Clin Jose de San Martin, Div Gastroenterol, Buenos Aires, DF, Argentina; [Wald, Miriam Ruth] Univ Catolica Argentina, Consejo Nacl Invest Cient & Tecn, Inst Invest Biomed BIOMED, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Pontifical Catholic University of Argentina	Chernavsky, AC (corresponding author), Univ Buenos Aires, CONICET, Inst Inmunol Genet & Metab, Buenos Aires, DF, Argentina.	alejandra.cher@yahoo.com.ar		Lucero, Diego/0000-0003-2833-5681; Wald, Miriam/0000-0001-9216-2880; Garcia, Cecilia/0000-0001-7120-2038	University of Buenos Aires [CM05]; National Council for Scientific and Technological Investigation [PIP0051]; National Agency for the Promotion of Technology and Science [PICT 2012-2598]	University of Buenos Aires(University of Buenos Aires); National Council for Scientific and Technological Investigation; National Agency for the Promotion of Technology and Science	ACCH received the following fundings: Grant CM05 from the University of Buenos Aires, PIP0051 from the National Council for Scientific and Technological Investigation, PICT 2012-2598 from the National Agency for the Promotion of Technology and Science.	Abe Y, 1999, PHARMACOL RES, V39, P41, DOI 10.1006/phrs.1998.0404; Aggarwal BB, 2010, ANNU REV NUTR, V30, P173, DOI 10.1146/annurev.nutr.012809.104755; Alkhouri N, 2014, DIGEST DIS SCI, V59, P1617, DOI 10.1007/s10620-014-3031-8; [Anonymous], 2013, J BUILD CONSTR PLAN, DOI DOI 10.4236/JBCPR.2013.11001; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Balteau M, 2011, CARDIOVASC RES, V92, P237, DOI 10.1093/cvr/cvr230; Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727; Cassano S, 2014, METABOLISM, V63, P1272, DOI 10.1016/j.metabol.2014.06.010; Chatterjee S, 2013, J HEPATOL, V58, P778, DOI 10.1016/j.jhep.2012.11.035; De Almeida IT, 2002, CLIN NUTR, V21, P219, DOI 10.1054/clnu.2001.0529; Farrell GC, 2014, LIVER INT, V34, P1084, DOI 10.1111/liv.12335; Feldstein AE, 2010, J LIPID RES, V51, P3046, DOI 10.1194/jlr.M007096; Huang XD, 2008, WORLD J GASTROENTERO, V14, P2888, DOI 10.3748/wjg.14.2888; Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421; Lam QLK, 2007, CELL MOL IMMUNOL, V4, P1; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Meli R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00177; Oner-Iyidogan Y, 2014, CAN J PHYSIOL PHARM, V92, P805, DOI 10.1139/cjpp-2014-0174; Polyzos SA, 2015, METABOLISM, V64, P60, DOI 10.1016/j.metabol.2014.10.012; Procaccini C, 2015, METABOLISM, V64, P92, DOI 10.1016/j.metabol.2014.10.014; Procaccini C, 2012, J IMMUNOL, V189, P2941, DOI 10.4049/jimmunol.1200935; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; Sanchez-Margalet V, 2003, CLIN EXP IMMUNOL, V133, P11, DOI 10.1046/j.1365-2249.2003.02190.x; Sellmayer A, 1996, CELL SIGNAL, V8, P397, DOI 10.1016/0898-6568(96)00077-0; Shapiro H, 2005, NUTR RES REV, V18, P212, DOI 10.1079/NRR2005106; Shishodia S, 2013, BIOFACTORS, V39, P37, DOI 10.1002/biof.1041; Sutti S, 2014, HEPATOLOGY, V59, P886, DOI 10.1002/hep.26749; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Vonghia L, 2013, INT J MOL SCI, V14, P19867, DOI 10.3390/ijms141019867; Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001	34	38	42	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172900	10.1371/journal.pone.0172900	http://dx.doi.org/10.1371/journal.pone.0172900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257515	gold, Green Published, Green Submitted			2022-12-27	WOS:000396021100038
J	Mootien, S; Kaplan, PM				Mootien, Saraspadee; Kaplan, Paul M.			Monoclonal antibodies specific for Bacteroides fragilis enterotoxins BFT1 and BFT2 and their use in immunoassays	PLOS ONE			English	Article							METALLOPROTEASE TOXIN GENE; HELICOBACTER-PYLORI INFECTION; INFLAMMATORY-BOWEL-DISEASE; DIARRHEAL DISEASE; COLORECTAL-CANCER; GASTRIC-CANCER; TUMORIGENESIS; COMMENSAL; CHILDREN	We have developed 22 mouse IgG(1) monoclonal antibodies (mAbs) against Bacteroides fragilis zinc metalloprotease toxins 1 and 2 (BFT1 and BFT2). Mice were immunized with recombinant BFT1 or BFT2 proteins with metalloprotease activity. Eight of the mAbs bind specifically to BFT1. One mAb, 2H6, binds specifically to BFT2. The remaining 13 mAbs bind to both BFT1 and BFT2. The eight BFT1-specific mAbs recognize at least five different epitopes on the toxin. Four of the BFT1-specific mAbs neutralized rBFT1 metalloprotease activity. Only one of these four mAbs, 1D9, neutralizes the cytotoxic effect of BFT1. Here, we describe the development of enzyme-linked immunosorbent assays (ELISAs) to detect BFT1 or BFT2 toxin in an isotype-specific manner. The sandwich ELISAs have a detection limit of 20 to 40 ng/ml when purified recombinant BFT protein is diluted into PBS. The sandwich ELISA can be used to distinguish and quantify levels of rBFT1 and rBFT2 in stool. This ELISA can be an important tool to investigate the association between BFT expression by enterotoxigenic B. fragilis and diseases such as diarrhea, inflammatory bowel disease and colorectal cancer.	[Mootien, Saraspadee; Kaplan, Paul M.] L2 Diagnost LLC, New Haven, CT 06511 USA		Mootien, S (corresponding author), L2 Diagnost LLC, New Haven, CT 06511 USA.	smootien@l2dx.com			NIH SBIR Grant [1 R43 A1092976-01A1]; L2 Diagnostics LLC	NIH SBIR Grant; L2 Diagnostics LLC	This study was funded by an NIH SBIR Grant awarded to SM: Grant Number 1 R43 A1092976-01A1. L2 Diagnostics LLC provided support in the form of salaries for authors SM and PMK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Asaka M, 2002, INTERNAL MED, V41, P1, DOI 10.2169/internalmedicine.41.1; Basset C, 2004, DIGEST DIS SCI, V49, P1425, DOI 10.1023/B:DDAS.0000042241.13489.88; Basset Christelle, 2002, Science Progress, V85, P13, DOI 10.3184/003685002783238898; Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787; Chung GT, 1999, INFECT IMMUN, V67, P4945, DOI 10.1128/IAI.67.9.4945-4949.1999; Delzenne NM, 2015, DIABETOLOGIA; Demarest SJ, 2010, MABS-AUSTIN, V2, P190, DOI 10.4161/mabs.2.2.11220; Durmaz B, 2005, ANAEROBE, V11, P318, DOI 10.1016/j.anaerobe.2005.06.001; Franco AA, 2005, INFECT IMMUN, V73, P5273, DOI 10.1128/IAI.73.8.5273-5277.2005; Franco AA, 1997, INFECT IMMUN, V65, P1007, DOI 10.1128/IAI.65.3.1007-1013.1997; Gharaibeh DN, 2013, J MICROBIOL METH, V94, P125, DOI 10.1016/j.mimet.2013.05.009; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Kato N, 2000, FEMS MICROBIOL LETT, V182, P171, DOI 10.1111/j.1574-6968.2000.tb08892.x; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P591; MYERS LL, 1987, AM J VET RES, V48, P774; MYERS LL, 1984, INFECT IMMUN, V44, P241, DOI 10.1128/IAI.44.2.241-244.1984; Nguyen TV, 2005, J CLIN MICROBIOL, V43, P755, DOI 10.1128/JCM.43.2.755-760.2005; Nishizawa T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/794378; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Pathela P, 2005, J INFECT DIS, V191, P1245, DOI 10.1086/428947; Prindiville TP, 2000, EMERG INFECT DIS, V6, P171, DOI 10.3201/eid0602.000210; Qin HY, 2014, WORLD J GASTROENTERO, V20, P14126, DOI 10.3748/wjg.v20.i39.14126; Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08; Robizadeh S, 2007, INFLAMM BOWEL DIS, V13, P1475, DOI 10.1002/ibd.20265; SANJOAQUIN VH, 1995, SCAND J INFECT DIS, V27, P211, DOI 10.3109/00365549509019011; Sears CL, 2001, TOXICON, V39, P1737, DOI 10.1016/S0041-0101(01)00160-X; Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08; Shiryaev SA, 2014, FEBS J, V281, P2487, DOI 10.1111/febs.12804; Slyepchenko A, 2014, CNS NEUROL DISORD-DR, V13, P1770; Terada S, 1993, Kansenshogaku Zasshi, V67, P772; Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x; VANTASSELL RL, 1994, CLIN DIAGN LAB IMMUN, V1, P578, DOI 10.1128/CDLI.1.5.578-584.1994; Viljoen KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119462; WEIKEL CS, 1992, INFECT IMMUN, V60, P321, DOI 10.1128/IAI.60.2.321-327.1992; Wick EC, 2010, CURR OPIN INFECT DIS, V23, P470, DOI 10.1097/QCO.0b013e32833da1eb; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Wu SG, 2003, GASTROENTEROLOGY, V124, P392, DOI 10.1053/gast.2003.50047; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yong X, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0111-0; Zhou LH, 2015, NEUROPSYCH DIS TREAT, V11, P715, DOI 10.2147/NDT.S61997	40	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173128	10.1371/journal.pone.0173128	http://dx.doi.org/10.1371/journal.pone.0173128			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257448	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100062
J	Ojo, OB; Lougue, S; Woldegerima, WA				Ojo, Oluwatobi Blessing; Lougue, Siaka; Woldegerima, Woldegebriel Assefa			Bayesian generalized linear mixed modeling of Tuberculosis using informative priors	PLOS ONE			English	Article								TB is rated as one of the world's deadliest diseases and South Africa ranks 9th out of the 22 countries with hardest hit of TB. Although many pieces of research have been carried out on this subject, this paper steps further by inculcating past knowledge into the model, using Bayesian approach with informative prior. Bayesian statistics approach is getting popular in data analyses. But, most applications of Bayesian inference technique are limited to situations of non-informative prior, where there is no solid external information about the distribution of the parameter of interest. The main aim of this study is to profile people living with TB in South Africa. In this paper, identical regression models are fitted for classical and Bayesian approach both with non-informative and informative prior, using South Africa General Household Survey (GHS) data for the year 2014. For the Bayesian model with informative prior, South Africa General Household Survey dataset for the year 2011 to 2013 are used to set up priors for the model 2014.	[Ojo, Oluwatobi Blessing; Woldegerima, Woldegebriel Assefa] AIMS Cameroon, African Inst Math Sci, Math Sci, Limbe, Cameroon; [Lougue, Siaka] Univ Kwazulu Natal, Sch Math Stat & Comp Sci, Durban, South Africa; [Woldegerima, Woldegebriel Assefa] Mekelle Univ, Dept Math, Mekelle, Ethiopia; [Ojo, Oluwatobi Blessing] Lagos State Polytech, Dept Math & Stat, Lagos, Nigeria	University of Kwazulu Natal; Mekelle University	Lougue, S (corresponding author), Univ Kwazulu Natal, Sch Math Stat & Comp Sci, Durban, South Africa.	siaka@aims.ac.za	Woldegerima, Woldegebriel Assefa/HGB-5068-2022	Woldegerima, Woldegebriel Assefa/0000-0002-0336-7831				Bernardo J. M., 2009, WILEY SERIES PROBABI; Centers for Disease Control and Prevention, TUB DAT STAT; Dale M Needham, 2011, TROP MED INT HEALTH, V6, P256; Gelman A., 2007, DATA ANAL USING REGR; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Getoor L, 2004, ARTIF INTELL MED, V30, P233, DOI 10.1016/j.artmed.2003.11.003; Hilbe JM, 2009, CH CRC TEXT STAT SCI, P1; Hosmer D.W., 2013, WILEY SERIES PROBABI, DOI DOI 10.1002/0471722146; Hosmer D. W., 2015, SPRINGER SERIES STAT; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Millet JP, 2013, EUR SPINE J, V22, P539, DOI 10.1007/s00586-012-2334-8; Ntzoufras I., 2011, WILEY SERIES COMPUTA; R Core Team, 2013, R LANG ENV STAT COMP; Ryan KJ., 2004, SHERRIS MED MICROBIO; Statistics South Africa (SSA), 2016, GEN HOUS SURV 2014 R	16	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172580	10.1371/journal.pone.0172580	http://dx.doi.org/10.1371/journal.pone.0172580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257437	Green Submitted, gold, Green Published			2022-12-27	WOS:000396021100022
J	Jacques, A; Laurent, M; Ribiere-Chabert, M; Saussac, M; Bougeard, S; Budge, GE; Hendrikx, P; Chauzat, MP; de Graaf, D; Meroc, E; Nguyen, BK; Roelandt, S; Roels, S; Van der Stede, Y; Tonnersen, T; Kryger, P; Jaarma, K; Kuus, M; Raie, A; Heinikainen, S; Pelkonen, S; Vahanikkila, N; Andrieux, C; Ballis, A; Barrieu, G; Bendali, F; Brugoux, C; Franco, S; Fuentes, AM; Joel, A; Layec, Y; Lopez, J; Lozach, A; Malherbe, DL; Mariau, V; Meziani, F; Monod, D; Mutel, S; Oesterle, E; Orlowski, M; Petit, M; Pillu, P; Poret, F; Viry, A; Berg, S; Buchler, R; de Craigher, D; Genersch, E; Kaatz, HH; Meixner, MD; von der Ohe, W; Otten, C; Rosenkranz, P; Schaefer, MO; Schroeder, A; Agianiotaki, E; Arfara, S; Boutsini, S; Giannoulopoulou, M; Hondrou, V; Karipidou, S; Katsaros, D; Katzagiannakis, A; Kiriakopoulos, A; Oureilidis, K; Panteli, A; Pantoleon, F; Papagianni, Z; Papalexiou, E; Perdikaris, S; Prapas, A; Siana, P; Skandalakis, I; Stougiou, D; Tomazinakis, I; Tsali, E; Tseliou, E; Tsiplakidis, A; Tsompanellis, E; Vamvakas, G; Varvarouta, V; Vourvidis, D; Dan, A; Daroczi, G; Lang, M; Papp, M; Paulus, PD; Pupp, E; Szalo, M; Toth, A; Zseli, S; Bressan, G; Cerrone, A; Formato, G; Granato, A; Lavazza, A; Macellari, P; Marcello, P; Ghittino, C; Maroni, PA; Possidente, R; Mutinelli, F; Nassuato, C; Pintore, A; Ricchiuti, L; Ruocco, L; Salvaggio, A; Troiano, P; Voltini, B; Avsejenko, J; Ciekure, E; Deksne, G; Eglite, I; Granta, R; Olsevski, E; Rodze, I; Stinka, M; Sirutkaityte, R; Siriukaitis, S; Bober, A; Jazdzewski, K; Pohorecka, K; Skubida, M; Zdanska, D; Amador, MRR; Freitas, S; Quintans, S; Santos, PT; Brezinova, N; Brtkova, A; Cuvalova, Z; Filipova, M; Jurovcikova, J; Kantikova, M; Kubicova, Z; Papiernikova, E; Sulejova, L; Toporcak, J; Ares, CCM; Ariza, J; Berna, SN; Cabeza, NA; Casasempere, CJ; Cid, GC; Corzan, RJM; De Abajo, DMA; Diaz, RR; Esteban, RA; Fernandez, SP; Garcia, PA; Gonzalez, BC; Minguez, GO; Onate, ML; Oteiza, OP; Perez, CI; Plaza, PM; Puy, PDJR; Riol, GR; Romero, GLJ; Soldevilla, YJF; Barrasus, MSI; Soriano, GM; Vigo, LV; Villarta, RJL; Fabricius-Kristiansen, L; Forsgren, E; Brown, M; Budge, G; Grant, R; Marris, G; Powell, M; Wattam, A; Whiting, I; Cauquil, L; Riviere, MP; Garin, E				Jacques, Antoine; Laurent, Marion; Ribiere-Chabert, Magali; Saussac, Mathilde; Bougeard, Stephanie; Budge, Giles E.; Hendrikx, Pascal; Chauzat, Marie-Pierre; de Graaf, Dirk; Meroc, Estelle; Nguyen, Bach Kim; Roelandt, Stefan; Roels, Stefan; Van der Stede, Yves; Tonnersen, Tina; Kryger, Per; Jaarma, Kart; Kuus, Merle; Raie, Arvi; Heinikainen, Sirpa; Pelkonen, Sinikka; Vahanikkila, Nella; Andrieux, Christophe; Ballis, Alexis; Barrieu, Guy; Bendali, Fatah; Brugoux, Corinne; Franco, Stephanie; Fuentes, Anne-Marie; Joel, Alain; Layec, Yves; Lopez, Jacqueline; Lozach, Andre; Malherbe, Duluc Laure; Mariau, Viviane; Meziani, Faycal; Monod, Denis; Mutel, Sebastien; Oesterle, Eric; Orlowski, Muriel; Petit, Manuel; Pillu, Patricia; Poret, Florence; Viry, Alain; Berg, Stefan; Buechler, Ralph; de Craigher, Doris; Genersch, Elke; Kaatz, Hans-Hinrich; Meixner, Marina D.; von der Ohe, Werner; Otten, Christoph; Rosenkranz, Peter; Schaefer, Marc O.; Schroeder, Annette; Agianiotaki, Eirini; Arfara, Stamatia; Boutsini, Sofia; Giannoulopoulou, Marianthi; Hondrou, Varvara; Karipidou, Sonia; Katsaros, Dimitrios; Katzagiannakis, Aristomenis; Kiriakopoulos, Antonios; Oureilidis, Konstantinos; Panteli, Aspasia; Pantoleon, Fotis; Papagianni, Zoi; Papalexiou, Eleni; Perdikaris, Socrates; Prapas, Athanasios; Siana, Panagiota; Skandalakis, Ioannis; Stougiou, Despoina; Tomazinakis, Ioannis; Tsali, Eleftheria; Tseliou, Evgenia; Tsiplakidis, Achillefs; Tsompanellis, Efstratios; Vamvakas, Giorgos; Varvarouta, Vasiliki; Vourvidis, Dimitris; Dan, Adam; Daroczi, Gyongyi; Lang, Maria; Papp, Melitta; Paulus, Petra-Deakne; Pupp, Eszter; Szalo, Marta; Toth, Adam; Zseli, Szilvia; Bressan, Gianluigi; Cerrone, Anna; Formato, Giovanni; Granato, Anna; Lavazza, Antonio; Macellari, Piero; Marcello, Paola; Ghittino, Claudio; Maroni, Ponti Andrea; Possidente, Rosaria; Mutinelli, Franco; Nassuato, Claudia; Pintore, Antonio; Ricchiuti, Luciano; Ruocco, Luigi; Salvaggio, Antonio; Troiano, Pasquale; Voltini, Barbara; Avsejenko, Jelena; Ciekure, Elina; Deksne, Gunita; Eglite, Ineta; Granta, Rita; Olsevski, Edvins; Rodze, Ieva; Stinka, Madara; Sirutkaityte, Rasa; Siriukaitis, Sigitas; Bober, Andrzej; Jazdzewski, Krzysztof; Pohorecka, Krystyna; Skubida, Marta; Zdanska, Dagmara; Amador, Maria Rita Ramos; Freitas, Susana; Quintans, Sofia; Santos, Patricia Tavares; Brezinova, Nicole; Brtkova, Andrea; Cuvalova, Zuzana; Filipova, Miriam; Jurovcikova, Julia; Kantikova, Miriam; Kubicova, Zuzana; Papiernikova, Erika; Sulejova, Lucia; Toporcak, Juraj; Ares, Cenador Carmen Maria; Ariza, Javier; Berna, Serna Nieves; Cabeza, Nunez Amparo; Casasempere, Cascales Jorge; Cid, Gonzalez Carlos; Corzan, Ripoll Jose Manuel; De Abajo, Domingo Miguel Angel; Diaz, Rey Roberto; Esteban, Royo Angel; Fernandez, Somalo Pilar; Garcia, Pascualvaca Alejandra; Gonzalez, Brena Carlos; Minguez, Gonzalez Olga; Onate, Maria Luisa; Oteiza, Orradre Pedro; Perez, Cobo Iratxe; Plaza, Perez Margarita; Puy, Pitarque D. Juan Ramon; Riol, Guinea Ruben; Romero, Gonzalez Luis Jose; Soldevilla, Yanguas Jose Fernando; Soler i Barrasus, Merce; Soriano, Gonzalez Mario; Vigo, Lopez Virginia; Villarta, Rivas Jose Luis; Fabricius-Kristiansen, Lotta; Forsgren, Eva; Brown, Mike; Budge, Giles; Grant, Ruth; Marris, Gay; Powell, Michelle; Wattam, Andy; Whiting, Ilex; Cauquil, Laura; Riviere, Marie-Pierre; Garin, Emmanuel		EPILOBEE Consortium	A pan-European epidemiological study reveals honey bee colony survival depends on beekeeper education and disease control	PLOS ONE			English	Article							POLLINATORS; LOSSES	Reports of honey bee population decline has spurred many national efforts to understand the extent of the problem and to identify causative or associated factors. However, our collective understanding of the factors has been hampered by a lack of joined up trans-national effort. Moreover, the impacts of beekeeper knowledge and beekeeping management practices have often been overlooked, despite honey bees being a managed pollinator. Here, we established a standardised active monitoring network for 5 798 apiaries over two consecutive years to quantify honey bee colony mortality across 17 European countries. Our data demonstrate that overwinter losses ranged between 2% and 32%, and that high summer losses were likely to follow high winter losses. Multivariate Poisson regression models revealed that hobbyist beekeepers with small apiaries and little experience in beekeeping had double the winter mortality rate when compared to professional beekeepers. Furthermore, honey bees kept by professional beekeepers never showed signs of disease, unlike apiaries from hobbyist beekeepers that had symptoms of bacterial infection and heavy Varroa infestation. Our data highlight beekeeper background and apicultural practices as major drivers of honey bee colony losses. The benefits of conducting trans-national monitoring schemes and improving beekeeper training are discussed.	[Jacques, Antoine; Saussac, Mathilde; Hendrikx, Pascal; Chauzat, Marie-Pierre] ANSES, Sci Affairs Dept Labs, Unit Coordinat & Support Surveillance, Maisons Alfort, France; [Jacques, Antoine; Laurent, Marion; Ribiere-Chabert, Magali; Chauzat, Marie-Pierre] ANSES, Unit Honey Bee Pathol, European Union & Natl Reference Lab Honey Bee Hlt, Sophia Antipolis, France; [Bougeard, Stephanie] ANSES, Unit Epidemiol & Welf Pork, Ploufragan, France; [Budge, Giles E.] Fera, York, N Yorkshire, England; [Budge, Giles E.] Newcastle Univ, Inst Agri Food Res & Innovat, Newcastle Upon Tyne, Tyne & Wear, England; [de Graaf, Dirk] Univ Ghent, Dept Physiol, Lab Zoophysiol, B-9000 Ghent, Belgium; [Meroc, Estelle; Roelandt, Stefan] Natl Ref Lab Honeybee Dis CODA CERVA VAR, Brussels, Belgium; [Nguyen, Bach Kim] Ulg, Fac Gembloux Agro Bio Tech, Gembloux, Belgium; [Roels, Stefan; Van der Stede, Yves] CODA CERVA VAR, Brussels, Belgium; [Tonnersen, Tina; Kryger, Per] Univ Aarhus, Natl Reference Lab Honeybee Dis, DK-8000 Aarhus C, Denmark; [Jaarma, Kart; Raie, Arvi] Estonian Vet & Food Board, Tallinn, Estonia; [Kuus, Merle] Estonian Vet & Food Lab, Tallinn, Estonia; [Heinikainen, Sirpa; Pelkonen, Sinikka] Finnish Food Safety Author EVIRA, Vet Bacteriol Res Unit, Kuopio, Finland; [Andrieux, Christophe; Pillu, Patricia] DDPP Cantal, Aurillac, France; [Ballis, Alexis] Chambre Agr Haut Rhin, Sainte Croix Plaine, France; [Barrieu, Guy] DDPP Bouches Rhone, Marseille, France; [Bendali, Fatah; Meziani, Faycal] Direct Gen Alimentat, Paris, France; [Brugoux, Corinne; Poret, Florence] Groupement Defense Sanitaire Cantal, Aurillac, France; Anses, Natl Reference Lab Honeybee Dis, Sophia Antipolis, France; [Fuentes, Anne-Marie] Groupement Defense Sanitaire Drome, Bourg Les Valence, France; [Joel, Alain; Petit, Manuel] DDPP Finistere, Quimper, France; [Malherbe, Duluc Laure; Oesterle, Eric] Groupement Defense Sanitaire Indre & Loire, Tours, France; [Layec, Yves; Lozach, Andre] Groupement Defense Sanitaire Apicole Finistere, Quimper, France; [Lopez, Jacqueline; Mariau, Viviane] DDPP Indre & Loire, Tours, France; [Monod, Denis] Groupement Defense Sanitaire Apicole Bouches Rhon, Marseille, France; [Mutel, Sebastien] DDCSPP Haut-Rhin, Colmar, France; [Orlowski, Muriel] DDPP Drome, Valence, France; [Viry, Alain] Lab Anal Jura, Poligny, France; [Berg, Stefan] Bavarian State Inst Viticulture & Horticulture, Bee Res Ctr, Veitshochheim, Germany; [Buechler, Ralph; Meixner, Marina D.] LLH Bieneninst Kirchhain, Kirchhain, Germany; [de Craigher, Doris; Rosenkranz, Peter; Schroeder, Annette] Univ Hohenheim, Apicultural State Inst, Stuttgart, Germany; [Genersch, Elke] Inst Bee Res, Hohen Neuendorf, Germany; [Kaatz, Hans-Hinrich] Univ Halle Wittenberg, Dept Zool, Halle, Germany; [von der Ohe, Werner] LAVES Inst Bienenkunde, Celle, Germany; [Otten, Christoph] Dienstleistungszentrum Landlicher Raum, Fachzentrum Bienen Imkerei Mayen, Mainz, Germany; [Agianiotaki, Eirini; Arfara, Stamatia; Boutsini, Sofia; Panteli, Aspasia; Papagianni, Zoi; Papalexiou, Eleni; Perdikaris, Socrates; Prapas, Athanasios; Stougiou, Despoina] Ctr Vet Inst Athens, Athens, Greece; [Giannoulopoulou, Marianthi; Katzagiannakis, Aristomenis; Varvarouta, Vasiliki] Regional Vet Lab Heraclio, Iraklion, Greece; [Hondrou, Varvara; Kiriakopoulos, Antonios; Tsompanellis, Efstratios] Reg Vet Lab Mytilini, Mitilini, Greece; [Karipidou, Sonia; Vamvakas, Giorgos] Reg Vet Lab Kozani, Kozani, Greece; [Katsaros, Dimitrios] Reg Vet Lab Chalkis, Chalkis, Greece; [Oureilidis, Konstantinos; Tsiplakidis, Achillefs] Reg Vet Lab Kavala, Kavala, Greece; [Pantoleon, Fotis; Siana, Panagiota] Reg Vet Lab Tripoli, Tripoli, Greece; [Perdikaris, Socrates; Vourvidis, Dimitris] Minist Rural Dev & Food, Thessaloniki, Greece; [Skandalakis, Ioannis; Tomazinakis, Ioannis] Reg Vet Lab Chania, Khania, Greece; [Tsali, Eleftheria] Reg Vet Lab Larisa, Larisa, Greece; [Tseliou, Evgenia] Reg Vet Lab Kerkyra, Kerkyra, Greece; [Dan, Adam; Daroczi, Gyongyi; Lang, Maria; Papp, Melitta; Paulus, Petra-Deakne; Pupp, Eszter] Vet Diagnost Directorate NRL Bee Hlth, Natl Food Chain Safety Off, Budapest, Hungary; [Szalo, Marta] Minist of Agr, Food Chain Control Dept, Budapest, Hungary; [Toth, Adam; Zseli, Szilvia] NRL Bee Hlth, Budapest, Hungary; [Bressan, Gianluigi] Ulss22, Bussolengo, Italy; [Cerrone, Anna] IZS Mezzogiorno, Naples, Italy; [Formato, Giovanni] IZS Reg Lazio & Toscana, Rome, Italy; [Granato, Anna; Mutinelli, Franco] IZS Venezie, Legnaro, Italy; [Lavazza, Antonio] IZS Lombardia & Emilia Romagna, Brescia, Italy; [Macellari, Piero] Asl Umbria, Perugia, Italy; [Marcello, Paola] ASL Sassari, Sassari, Italy; [Ghittino, Claudio] IZS Umbria & Marche, Perugia, Italy; [Maroni, Ponti Andrea; Ruocco, Luigi] Ministero Salute, Rome, Italy; [Possidente, Rosaria] IZS Piemonte Liguria & Valle Aosta, Imperia, Italy; [Nassuato, Claudia] Reg Lombardia, Milan, Italy; [Pintore, Antonio] IZS Sardegna, Cagliari, Italy; [Ricchiuti, Luciano] IZS Abruzzo & Molise, Teramo, Italy; [Salvaggio, Antonio] IZS Sicilia, Palermo, Italy; [Troiano, Pasquale] IZS Puglia & Basilicata, Foggia, Italy; [Voltini, Barbara] Reg Toscana, Pisa, Italy; [Avsejenko, Jelena; Ciekure, Elina; Deksne, Gunita] BIOR, Inst Food Safety Anim Hlth & Environm, Riga, Latvia; [Eglite, Ineta] Latvian Beekeepers Assoc, Jelgava, Latvia; [Granta, Rita; Rodze, Ieva] BIOR, Riga, Latvia; [Olsevski, Edvins; Stinka, Madara] Food & Vet Serv Republ Latvia, Riga, Latvia; [Sirutkaityte, Rasa; Siriukaitis, Sigitas] State Food & Vet Serv, Anim Hlth & Welfare Dept, Vilnius, Lithuania; [Bober, Andrzej; Pohorecka, Krystyna; Skubida, Marta; Zdanska, Dagmara] Natl Vet Res Inst, Pulawy, Poland; [Jazdzewski, Krzysztof] Gen Vet Inspectorate, Warsaw, Poland; [Amador, Maria Rita Ramos; Freitas, Susana; Quintans, Sofia; Santos, Patricia Tavares] Direcao Geral Alimentacao & Vet, Lisbon, Portugal; [Brezinova, Nicole; Brtkova, Andrea; Cuvalova, Zuzana; Filipova, Miriam; Jurovcikova, Julia; Kantikova, Miriam; Kubicova, Zuzana; Sulejova, Lucia] State Vet & Food Inst, Dolny Kubin, Slovakia; [Papiernikova, Erika] State Vet & Food Adm Slovak Republ, Bratislava, Slovakia; [Toporcak, Juraj] Univ Vet Med & Pharm Kosice, Kosice, Slovakia; [Ares, Cenador Carmen Maria] Consejeria Agroganaderia & Recursos Autoctonos Pr, Gijon, Spain; [Ariza, Javier; Villarta, Rivas Jose Luis] Consejeria Agr Junta Comunidades Castill La Manch, Guadalajara, Spain; [Berna, Serna Nieves; Casasempere, Cascales Jorge] Consejeria Presidencia Agr Pesca Alimentac & Agua, Valencia, Spain; [Cabeza, Nunez Amparo; Garcia, Pascualvaca Alejandra] Consejeria Agr & Pesca Junta Andalucia, Seville, Spain; [Cid, Gonzalez Carlos; Diaz, Rey Roberto] Subdirec Xeral Ganderia Conselleria Medio Rural, Vilanova De Arousa, Spain; [Corzan, Ripoll Jose Manuel; Esteban, Royo Angel; Onate, Maria Luisa] Consejeria Agr & Ganaderia & Medio Ambiente Diput, Zaragoza, Spain; [De Abajo, Domingo Miguel Angel; Minguez, Gonzalez Olga; Riol, Guinea Ruben] Consejeria Agr & Ganaderia Junta Castilla & Leon, Valladolid, Spain; [Fernandez, Somalo Pilar; Perez, Cobo Iratxe; Romero, Gonzalez Luis Jose] M Agr Alim & Medio Ambiente, SG Sanidad Higiene Anim & Trazabilidad, Madrid, Spain; [Gonzalez, Brena Carlos] Consejeria Agr Desarrollo Rural, Medio Ambiente & Energia J Extremadura, Merida, Spain; [Oteiza, Orradre Pedro] Diputac Foral Navarra, Dpto Desarrollo Rural Ind Empleo & Medio Ambiente, Madrid, Spain; [Plaza, Perez Margarita] Consejeria Agr & Agua Reg Murcia, Murcia, Spain; [Puy, Pitarque D. Juan Ramon] Pesca & Alimentac Gobierno Vasco, Dept Agr, Madrid, Spain; [Soldevilla, Yanguas Jose Fernando] Consejeria Agr Ganaderia & Medio Ambiente, Comunidad Autonoma Rioja, La Rioja, Spain; [Soler i Barrasus, Merce] Generalitat Catalunya, Dept Agr Ramaderia Pesca Alimentacio & Medi Nat, Barcelona, Spain; [Soriano, Gonzalez Mario] Generalitat Valenciana, Consejeria Presidencia Agr Pesca Alim & Agua, Valencia, Spain; [Vigo, Lopez Virginia] Consejeria Agr Ganaderia Pesca & Aguas Gobierno, Las Palmas Gran Canaria, Spain; [Forsgren, Eva] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Brown, Mike; Budge, Giles; Grant, Ruth; Marris, Gay; Powell, Michelle; Wattam, Andy; Whiting, Ilex] Food & Environm Res Agcy, NBU, York, N Yorkshire, England; [Cauquil, Laura; Riviere, Marie-Pierre] Unit Honey Bee Pathol, Sophia Antipolis, France; [Garin, Emmanuel] Unit Coordinat & Support Surveillance, Maisons Alfort, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Food & Environment Research Agency; Newcastle University - UK; Ghent University; University of Liege; Aarhus University; Finnish Food Authority; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); University Hohenheim; Martin Luther University Halle Wittenberg; IZS del Mezzogiorno; IZS Lazio e Toscana; IZS delle Venezie; IZS Lombardia e Emilia; IZS Umbria e Marche; IZS Piemonte Liguria e Valle D'aosta; IZS Della Sardegna; IZS Sicilia; IZS Puglia e Basilicata; Institute of Food Safety, Animal Health & Environment "BIOR"; Institute of Food Safety, Animal Health & Environment "BIOR"; National Veterinary Institute - National Research Institute; University of Veterinary Medicine Kosice; Swedish University of Agricultural Sciences; Food & Environment Research Agency; Ecole Nationale Veterinaire d'Alfort (ENVA)	Chauzat, MP (corresponding author), ANSES, Sci Affairs Dept Labs, Unit Coordinat & Support Surveillance, Maisons Alfort, France.; Chauzat, MP (corresponding author), ANSES, Unit Honey Bee Pathol, European Union & Natl Reference Lab Honey Bee Hlt, Sophia Antipolis, France.	marie-pierre.chauzat@anses.fr	Skubida, Marta/Y-3172-2018; Formato, Giovanni/ABA-6990-2021; de Graaf, Dirk C./HGD-4017-2022; Büchler, Ralph/AAI-3540-2020; MUTINELLI, FRANCO/K-7525-2018; Kryger, Per/H-4600-2019; Meixner, Marina/ABD-6400-2021; Dán, Ádám/G-6018-2012; Bober, Andrzej/AAW-1046-2020	Skubida, Marta/0000-0002-9959-443X; Formato, Giovanni/0000-0002-1202-5745; MUTINELLI, FRANCO/0000-0003-2903-9390; Kryger, Per/0000-0001-5306-3230; Meixner, Marina/0000-0002-7785-4894; Dán, Ádám/0000-0001-7849-7721; Chauzat, Marie-Pierre/0000-0001-8842-741X	EFSA; Fera; Welsh Government; EURL for honey bee health; European Commission; EU Reference Laboratory	EFSA; Fera; Welsh Government; EURL for honey bee health; European Commission(European CommissionEuropean Commission Joint Research Centre); EU Reference Laboratory	The financers of EPILOBEE were the European Commission, the Member States and the EU Reference Laboratory. The statistical analysis was co-funded by EFSA together with the EURL for honey bee health. GB acknowledges support from Fera and the Welsh Government (and MB, RG, GM, MP AW and IW in the Epilobee consortium) but did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. The specific role of these authors rare articulated in author contribution section.	Aizen MA, 2009, CURR BIOL, V4; Budge GE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133228; Burkle LA, 2013, SCIENCE, P1; Chauzat MP, 2016, APIDOLOGIE, V47, P348, DOI 10.1007/s13592-016-0440-z; EU (European Union), 2010, OFF J EUR UNION, VL073, P1; EURL, 2013, AM GUID EUR PROJ HON; EURL, 2011, GUID EUR PROJ HON CO; Forister ML, 2010, P NATL ACAD SCI USA, V107, P2088, DOI 10.1073/pnas.0909686107; Garibaldi LA, 2013, SCIENCE, P1; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Garratt MPD, 2014, BIOL CONSERV, V169, P128, DOI 10.1016/j.biocon.2013.11.001; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Henry M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2110; Henry M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5359; Husson F, 2015, EXPLORATORY DATA ANA; Jacques A, 2016, EFSA SUPP PUBL; Josse J, 2012, J CLASSIF, V29, P91, DOI 10.1007/s00357-012-9097-0; Lee K, 2015, CURR OPIN INSECT SCI, V10, P37, DOI 10.1016/j.cois.2015.04.009; Lee KV, 2015, APIDOLOGIE, V46, P292, DOI 10.1007/s13592-015-0356-z; Marghitas L. A., 2008, Lucrari Stiintifice - Zootehnie si Biotehnologii, Universitatea de Stiinte Agricole si Medicina Veterinara a Banatului Timisoara, V41, P309; Meixner M, 2015, CURRENT OPINION INSE, V10, P8; Meixner MD, 2014, J APICULT RES, V53, P215, DOI 10.3896/IBRA.1.53.2.04; Mill AC, 2014, ENVIRON MICROBIOL, V16, P3753, DOI 10.1111/1462-2920.12292; Moritz RFA, 2016, AGR ECOSYST ENVIRON, V216, P44, DOI 10.1016/j.agee.2015.09.027; Muli E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094459; Pirk CWW, 2014, J APICULT RES, V53, P35, DOI 10.3896/IBRA.1.53.1.03; Porrini C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155411; Simone-Finstrom M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32023; Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01; van der Zee R, 2014, J APICULT RES, V53, P19, DOI 10.3896/IBRA.1.53.1.02; Van Oldenborgh GJ, 2015, MILD WEATHER EUROPE, P707; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; vanEngelsdorp D, 2013, PREV VET MED, V108, P225, DOI 10.1016/j.prevetmed.2012.08.004; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011	34	99	104	8	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172591	10.1371/journal.pone.0172591	http://dx.doi.org/10.1371/journal.pone.0172591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278255	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900124
J	Knopf, AS; McNealy, KR; Al-Khattab, H; Carter-Harris, L; Oruche, UM; Naanyu, V; Draucker, CB				Knopf, Amelia S.; McNealy, Kim R.; Al-Khattab, Halima; Carter-Harris, Lisa; Oruche, Ukamaka Marian; Naanyu, Violet; Draucker, Claire Burke			Sexual learning among East African adolescents in the context of generalized HIV epidemics: A systematic qualitative meta-synthesis	PLOS ONE			English	Article							OF-SCHOOL ADOLESCENTS; PREVENTION PROGRAMS; PARENTS MATTER; YOUNG-WOMEN; NON-ORPHANS; CONDOM USE; RISK; EXPERIENCES; PREGNANCY; COMMUNICATION	Background AIDS-related illness is the leading cause of mortality for adolescents in sub-Saharan Africa. Together, Kenya, Tanzania, and Uganda account for 21% of HIV-infected adolescents in sub-Saharan Africa. The United Nations framework for addressing the epidemic among adolescents calls for comprehensive sexual and reproductive health education. These HIV prevention efforts could be informed by a synthesis of existing research about the formal and informal sexual education of adolescents in countries experiencing generalized epidem-ics. The purpose of this study was to describe the process of sexual learning among East African adolescents living in the context of generalized HIV epidemics. Methods Qualitative metasynthesis, a systematic procedure for integrating the results of multiple qualitative studies addressing a similar phenomenon, was used. Thirty-two research reports met study inclusion criteria. The reports were assessed in a four-step analytic process: appraisal, classification of findings, synthesis of findings, and construction of a framework depicting the process of sexual learning in this population. Results The framework includes three phases of sexual learning: 1) being primed for sex, 2) making sense of sex, and 3) having sexual experiences. Adolescents were primed for sex through gender norms, cultural practices, and economic structures as well as through conversations and formal instruction. They made sense of sex by acquiring information about sexual inter-course, reproduction and pregnancy, sexually transmitted infections, and relationships and by developing a variety of beliefs and attitudes about these topics. Some adolescents described having sexual experiences that met wants or needs, but many experienced sex that was coerced or violent. Whether sex was wanted, coerced, or violent, adolescents experienced worry about sexually transmitted infections or premarital pregnancy. Conclusions The three phases of sexual learning interact to shape adolescents' sexual lives and their risk for HIV infection. This framework will contribute to the development of sexual education programs that address HIV risk within the broader context of sexual learning.	[Knopf, Amelia S.; McNealy, Kim R.; Al-Khattab, Halima; Carter-Harris, Lisa; Oruche, Ukamaka Marian; Draucker, Claire Burke] Indiana Univ, Sch Nursing, Indianapolis, IN 46204 USA; [Naanyu, Violet] Moi Univ, Sch Med, Eldoret, Rift Valley Pro, Kenya	Indiana University System; Indiana University-Purdue University Indianapolis; Moi University	Knopf, AS (corresponding author), Indiana Univ, Sch Nursing, Indianapolis, IN 46204 USA.	asknopf@iu.edu	Naanyu, Violet/AAL-6106-2020; Naanyu, Violet/GNM-8783-2022; Alizadeh/AAK-1398-2021; , M/AAD-2633-2019	Naanyu, Violet/0000-0003-0182-1719; Naanyu, Violet/0000-0003-0182-1719; Knopf, Amelia/0000-0003-2557-4556	National Institute of Nursing Research [F31NR013135, T32NR007066, F31NR013864]; Indiana University Clinical and Translational Sciences Institute [KL2TR001106, UL1TR001108]; NATIONAL INSTITUTE OF NURSING RESEARCH [T32NR015433, T32NR007066] Funding Source: NIH RePORTER	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Indiana University Clinical and Translational Sciences Institute; NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work expands and builds upon doctoral work that was funded by the National Institute of Nursing Research (https://www.ninr.nih.gov/) F31NR013135 (Knopf). The authors wish to acknowledge financial support from the National Institute of Nursing Research (https://www.ninr.nih.gov/) T32NR007066 (Knopf, Carter-Harris) and F31NR013864 (Al-Khattab), and the Indiana University Clinical and Translational Sciences Institute (https://www.indianactsi.org/) KL2TR001106 and UL1TR001108 (Oruche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work expands and builds upon doctoral work that was funded by F31NR013135 (Knopf). The authors wish to acknowledge the following sources of support: T32NR007066 (Knopf, Carter-Harris), F31NR013864 (Al-Khattab), KL2TR001106 and UL1TR001108 (Oruche).	Abuya B.A., 2012, J SCH VIOLENCE, V11, P323, DOI [10.1080/15388220.2012.706874, DOI 10.1080/15388220.2012.706874]; [Anonymous], 2015, UN JOINT PROGRAMME H; Bastien S, 2009, CULT HEALTH SEX, V11, P751, DOI 10.1080/13691050903362632; Baumgartner JN, 2010, AIDS CARE, V22, P1153, DOI 10.1080/09540121003615095; Belita A, 2011, CHILD HLTH ED INTERD, V3; Bell SA, 2014, J YOUTH STUD, V17, P814, DOI 10.1080/13676261.2013.878797; Birungi Ruth, 2011, Afr J AIDS Res, V10, P487, DOI 10.2989/16085906.2011.646664; Chacko S, 2007, J HEALTH POPUL NUTR, V25, P319; Conn C, 2013, AIDS CARE, V25, P273, DOI 10.1080/09540121.2012.712659; Crichton J, 2012, J ADOLESCENCE, V35, P21, DOI 10.1016/j.adolescence.2011.06.008; Fortenberry JD, 2014, NEW DIR CHILD ADOLES, V144, P71, DOI 10.1002/cad.20061; Gallant M, 2004, SOC SCI MED, V58, P1337, DOI 10.1016/S0277-9536(03)00331-9; Hayer Manvir Kaur, 2010, J Health Organ Manag, V24, P498; Heaton LM, 2015, SEX TRANSM INFECT, V91, P615, DOI 10.1136/sextrans-2014-051991; Juma M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-84; Kajula LJ, 2014, AIDS BEHAV, V18, pS69, DOI 10.1007/s10461-013-0634-6; Kamau A., 2006, HLTH SOCIOL REV, V15, P305, DOI 10.5172/hesr.2006.15.3.305; Kenya National Bureau of Statistics MoH National AIDS Control Council Kenya Medical Research Institute National Council for Population Health and Development and the DHS Program ICF International, 2014, KEN DEP HLTH SURV; Lo NC, 2016, HEALTH AFFAIR, V35, P856, DOI 10.1377/hlthaff.2015.0828; Lofgren J, 2009, AJAR-AFR J AIDS RES, V8, P193, DOI 10.2989/AJAR.2009.8.2.7.859; Maticka-Tyndale E, 2010, INT J SEX HEALTH, V22, P234, DOI 10.1080/19317611.2010.491377; Miller KS, 2013, AM J PUBLIC HEALTH, V103, pE16, DOI 10.2105/AJPH.2013.301417; Miller KS, 2011, AIDS EDUC PREV, V23, P550, DOI 10.1521/aeap.2011.23.6.550; Mitchell EMH, 2006, CULT HEALTH SEX, V8, P515, DOI 10.1080/13691050600888400; Mmari K, 2009, CULT HEALTH SEX, V11, P799, DOI 10.1080/13691050902919085; Mojola SA, 2011, STUD FAMILY PLANN, V42, P29, DOI 10.1111/j.1728-4465.2011.00262.x; Muhanguzi FK, 2011, CULT HEALTH SEX, V13, P713, DOI 10.1080/13691058.2011.571290; Njue C., 2011, SEX EDUC-SEX SOC LEA, V11, P459, DOI DOI 10.1080/14681811.2011.595271; Njue C, 2009, AIDS, V23, P505, DOI 10.1097/QAD.0b013e32832605d0; Nobelius A.-M., 2010, SEX EDUC-SEX SOC LEA, V10, P91, DOI DOI 10.1080/14681810903491438; Nobelius AM, 2012, J SEX RES, V49, P88, DOI 10.1080/00224499.2011.568126; Nobelius AM, 2011, AIDS CARE, V23, P252, DOI 10.1080/09540121.2010.507736; Nobelius AM, 2010, J SEX RES, V47, P490, DOI 10.1080/00224499.2010.494776; Nzioka C, 2004, CULT HEALTH SEX, V6, P31, DOI 10.1080/1369105031000106365; Pfeiffer C, 2014, REPROD HEALTH MATTER, V22, P178, DOI 10.1016/S0968-8080(14)43756-X; Poulsen MN, 2010, AIDS EDUC PREV, V22, P273, DOI 10.1521/aeap.2010.22.4.273; Puffer ES, 2012, J RES ADOLESCENCE, V22, P1, DOI 10.1111/j.1532-7795.2011.00760.x; Sandelowski M., 2007, HDB SYNTHESIZING QUA; Sekiwunga Richard, 2009, Afr J Reprod Health, V13, P113; Sommer M, 2009, CULT HEALTH SEX, V11, P383, DOI 10.1080/13691050902722372; Tanzania Commission for AIDS ZAC National Bureau of Statistics Office of Chief Government Statistician and ICF International, 2013, TANZ AIDS IND SURV 2; Tolley Elizabeth E, 2014, J Int AIDS Soc, V17, P19149, DOI 10.7448/IAS.17.3.19149; Uganda Ministry of Health and ICF International, 2012, UG AIDS IND SURV 201; Unicef, 2016, 7 STOCKT REP 2016 HI; United Nations Joint Programme on HIV/AIDS, 2016, UNAIDS PREV TOOLK 20; Wagman J, 2009, J INTERPERS VIOLENCE, V24, P2073, DOI 10.1177/0886260508327707	46	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173225	10.1371/journal.pone.0173225	http://dx.doi.org/10.1371/journal.pone.0173225			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278210	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900054
J	Linc, G; Gaal, E; Molnar, I; Icso, D; Badaeva, E; Molnar-Lang, M				Linc, Gabriella; Gaal, Eszter; Molnar, Istvan; Icso, Diana; Badaeva, Ekaterina; Molnar-Lang, Marta			Molecular cytogenetic (FISH) and genome analysis of diploid wheatgrasses and their phylogenetic relationship	PLOS ONE			English	Article							THINOPYRUM-BESSARABICUM; KARYOTYPE ANALYSIS; SALT TOLERANCE; DNA-SEQUENCES; RIBOSOMAL-RNA; COMMON WHEAT; BREAD WHEAT; CHROMOSOMES; TRITICEAE; IDENTIFICATION	This paper reports detailed FISH-based karyotypes for three diploid wheatgrass species Agropyron cristatum (L.) Beauv., Thinopyrum bessarabicum (Savul.& Rayss) A. Love, Pseudoroegneria spicata (Pursh) A. Love, the supposed ancestors of hexaploid Thinopyrum intermedium (Host) Barkworth & D.R. Dewey, compiled using DNA repeats and comparative genome analysis based on COS markers. Fluorescence in situ hybridization (FISH) with repetitive DNA probes proved suitable for the identification of individual chromosomes in the diploid JJ, StSt and PP genomes. Of the seven microsatellite markers tested only the (GAA) n trinucleotide sequence was appropriate for use as a single chromosome marker for the P. spicata A(S) chromosome. Based on COS marker analysis, the phylogenetic relationship between diploid wheatgrasses and the hexaploid bread wheat genomes was established. These findings confirmed that the J and E genomes are in neighbouring clusters.	[Linc, Gabriella; Gaal, Eszter; Molnar, Istvan; Icso, Diana; Molnar-Lang, Marta] Hungarian Acad Sci, Inst Agr, Dept Plant Genet Resources, Agr Res Ctr, Martonvasar, Hungary; [Badaeva, Ekaterina] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Russian Academy of Sciences; Vavilov Institute of General Genetics	Linc, G (corresponding author), Hungarian Acad Sci, Inst Agr, Dept Plant Genet Resources, Agr Res Ctr, Martonvasar, Hungary.	linc.gabriella@agrar.mta.hu	Badaeva, Ekaterina D./N-4368-2017; Molnar, istvan/L-9779-2019	Badaeva, Ekaterina D./0000-0001-7101-9639; Molnar, Istvan/0000-0002-7167-9319	National Science Foundation Grants [OTKA K108555, K104382]; Hungarian Academy of Sciences [MTA KEP 5/2016]; Janos Bolyai Research Fellowship	National Science Foundation Grants(National Science Foundation (NSF)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Janos Bolyai Research Fellowship(Hungarian Academy of Sciences)	This work was financed by grants from the National Science Foundation Grants (OTKA K108555 to GL and K104382 to MML), the Hungarian Academy of Sciences (MTA KEP 5/2016 to GL), and by a Janos Bolyai Research Fellowship to IM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adonina IG, 2015, COMP CYTOGENET, V9, P533, DOI 10.3897/CompCytogen.v9i4.5120; Badaeva ED, 1996, GENOME, V39, P1150, DOI 10.1139/g96-145; Badaeva ED, 1996, GENOME, V39, P293, DOI 10.1139/g96-040; Badaeva ED, 2015, CYTOGENET GENOME RES, V146, P71, DOI 10.1159/000433458; Badaeva ED, 2010, CHROMOSOME RES, V18, P697, DOI 10.1007/s10577-010-9151-x; BEDBROOK JR, 1980, CELL, V19, P545, DOI 10.1016/0092-8674(80)90529-2; Burt C, 2011, THEOR APPL GENET, V123, P1387, DOI 10.1007/s00122-011-1674-9; Ceoloni C., 2015, ALIEN INTROGRESSION, P273, DOI DOI 10.1007/978-3-319-23494-6_11; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; DEVOS KM, 1993, THEOR APPL GENET, V85, P673, DOI 10.1007/BF00225004; Dewey D.R., 1984, GENE MANIPULATION PL, P209, DOI DOI 10.1007/978-1-4613-2429-4_9; DVORAK J, 1981, CAN J GENET CYTOL, V23, P481; DVORAK J, 1984, CAN J GENET CYTOL, V26, P628; ENDO TR, 1984, CHROMOSOMA, V89, P361, DOI 10.1007/BF00331253; Fedak G, 2005, CYTOGENET GENOME RES, V109, P360, DOI 10.1159/000082420; FEDAK G, 1985, EUPHYTICA, V34, P673, DOI 10.1007/BF00035403; Fominaya A, 1997, GENOME, V40, P689, DOI 10.1139/g97-791; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; GERLACH WL, 1979, NUCL ACIDS RES, V7; Howard T, 2011, J EXP BOT, V62, P2217, DOI 10.1093/jxb/erq423; HSIAO C, 1995, GENOME, V38, P211, DOI 10.1139/g95-026; HSIAO C, 1986, CAN J GENET CYTOL, V28, P109, DOI 10.1139/g86-015; Hu LJ, 2012, GENES GENOM, V34, P67, DOI 10.1007/s13258-011-0153-7; JAUHAR PP, 1990, GENOME, V33, P944, DOI 10.1139/g90-143; JIANG J, 1993, THEOR APPL GENET, V86, P41, DOI 10.1007/BF00223806; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Juchimiuk-Kwasniewska J, 2011, J APPL GENET, V52, P23, DOI 10.1007/s13353-010-0017-x; Kellogg EA, 1996, SYST BOT, V21, P321, DOI 10.2307/2419662; Kosman E, 2005, MOL ECOL, V14, P415, DOI 10.1111/j.1365-294X.2005.02416.x; Le HT, 1989, PLANT MOL BIO REP, V7, P150, DOI DOI 10.1007/BF02669631; Li DY, 2002, ANN BOT-LONDON, V90, P445, DOI 10.1093/aob/mcf213; Linc G, 2012, CYTOGENET GENOME RES, V136, P138, DOI 10.1159/000334835; Linc G, 1999, GENOME, V42, P497, DOI 10.1139/gen-42-3-497; Love A., 1984, Feddes Repertorium, V95, P425; Mahelka V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-127; Mason-Gamer RJ, 2005, AM J BOT, V92, P1045, DOI 10.3732/ajb.92.6.1045; McIntosh R. A., 1988, Proceedings of the seventh international wheat genetics symposium, held at Cambridge, UK, 13-19 July 1988., P1225; Megyeri M., 2012, Acta Agronomica Hungarica, V60, P87, DOI 10.1556/AAgr.60.2012.2.1; Molnar I, 2016, PLANT J; Molnar I, 2014, THEOR APPL GENET, V127, P1091, DOI 10.1007/s00122-014-2282-2; Molnar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070844; Molnar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027708; Murphy KM, 2007, J SUSTAIN AGR, V31, P137, DOI 10.1300/J064v31n01_11; NAGAKI K, 1995, GENOME, V38, P479, DOI 10.1139/g95-063; OMIELAN JA, 1991, GENOME, V34, P961, DOI 10.1139/g91-149; Parida SK, 2006, THEOR APPL GENET, V112, P808, DOI 10.1007/s00122-005-0182-1; Pedersen C, 1997, GENOME, V40, P589, DOI 10.1139/g97-077; Quraishi UM, 2009, FUNCT INTEGR GENOMIC, V9, P473, DOI 10.1007/s10142-009-0129-8; RAYBURN AL, 1987, AM J BOT, V74, P574, DOI 10.2307/2443837; RAYBURN AL, 1986, J HERED, V77, P253, DOI 10.1093/oxfordjournals.jhered.a110231; Said M, 2014, PLANT MOL CYTOGENETI; Schneider A, 2005, GENOME, V48, P1070, DOI 10.1139/G05-062; SCHULZSCHAEFFER J, 1962, AM J BOT, V49, P940, DOI 10.2307/2439206; SCHULZSCHAEFFER J, 1987, CROP SCI, V27, P822, DOI 10.2135/cropsci1987.0011183X002700040058x; SCHWARZACHER T, 1989, ANN BOT-LONDON, V64, P315, DOI 10.1093/oxfordjournals.aob.a087847; Schwarzacher T, 2000, ANN BOT, V86, P433; Sepsi A, 2008, THEOR APPL GENET, V116, P825, DOI 10.1007/s00122-008-0716-4; TAEB M, 1993, GENOME, V36, P825, DOI 10.1139/g93-110; Vrana J, 2000, GENETICS, V156, P2033; Wang RRC, 2014, J SYST EVOL, V52, P697, DOI 10.1111/jse.12084; Wang RRC, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P77, DOI 10.1007/978-3-642-14228-4_2; WANG RRC, 1989, GENOME, V32, P802, DOI 10.1139/g89-514; WANG RRC, 1985, CAN J GENET CYTOL, V27, P722, DOI 10.1139/g85-108; Yang CT, 2014, CARYOLOGIA, V67, P234, DOI 10.1080/0144235X.2014.974351; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhang H, 1998, THEOR APPL GENET, V96, P69, DOI 10.1007/s001220050710	66	27	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173623	10.1371/journal.pone.0173623	http://dx.doi.org/10.1371/journal.pone.0173623			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278169	Green Accepted, Green Published, gold			2022-12-27	WOS:000396087900019
J	Lulic, T; El-Sayes, J; Fassett, HJ; Nelson, AJ				Lulic, Tea; El-Sayes, Jenin; Fassett, Hunter J.; Nelson, Aimee J.			Physical activity levels determine exercise-induced changes in brain excitability	PLOS ONE			English	Article							PAIRED ASSOCIATIVE STIMULATION; HUMAN MOTOR CORTEX; AEROBIC EXERCISE; NEUROTROPHIC FACTOR; INTRACORTICAL INHIBITION; SINGLE BOUT; MAGNETIC STIMULATION; INDUCED INCREASE; NO INFLUENCE; FITNESS	Emerging evidence suggests that regular physical activity can impact cortical function and facilitate plasticity. In the present study, we examined how physical activity levels influence corticospinal excitability and intracortical circuitry in motor cortex following a single session of moderate intensity aerobic exercise. We aimed to determine whether exercise-induced short-term plasticity differed between high versus low physically active individuals. Participants included twenty-eight young, healthy adults divided into two equal groups based on physical activity level determined by the International Physical Activity Questionnaire: lowto-moderate (LOW) and high (HIGH) physical activity. Transcranial magnetic stimulation was used to assess motor cortex excitability via motor evoked potential (MEP) recruitment curves for the first dorsal interosseous (FDI) muscle at rest (MEPREST) and during tonic contraction (MEPACTIVE), short-interval intracortical inhibition (SICI) and facilitation (SICF), and intracortical facilitation (ICF). All dependent measures were obtained in the resting FDI muscle, with the exception of AMT and MEPACTIVE recruitment curves that were obtained during tonic FDI contraction. Dependent measures were acquired before and following moderate intensity aerobic exercise (20 mins, similar to 60% of the age-predicted maximal heart rate) performed on a recumbent cycle ergometer. Results indicate that MEPREST recruitment curve amplitudes and area under the recruitment curve (AURC) were increased following exercise in the HIGH group only (p = 0.002 and p = 0.044, respectively). SICI and ICF were reduced following exercise irrespective of physical activity level (p = 0.007 and p = 0.04, respectively). MEPACTIVE recruitment curves and SICF were unaltered by exercise. These findings indicate that the propensity for exercise-induced plasticity is different in high versus low physically active individuals. Additionally, these data highlight that a single session of aerobic exercise can transiently reduce inhibition in the motor cortex regardless of physical activity level, potentially priming the system for plasticity induction.	[Lulic, Tea; El-Sayes, Jenin; Fassett, Hunter J.; Nelson, Aimee J.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	McMaster University	Nelson, AJ (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	nelsonaj@mcmaster.ca		Lulic, Tea/0000-0002-7501-3493	Natural Sciences and Engineering Research Council of Canada [NSERC RGPIN-2015-06309]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC RGPIN-2015-06309).; The authors thank the Natural Sciences and Engineering Research Council for funding to AJN.	Bailey AZ, 2016, TRANSLATIONAL NEUROS, V6; Bergen JL, 2002, NEUROREHABILITATION, V17, P161; Bestmann S, 2015, EXP BRAIN RES, V233, P679, DOI 10.1007/s00221-014-4183-7; Bos I, 2011, NEUROSCI LETT, V500, P129, DOI 10.1016/j.neulet.2011.06.019; Brunig I, 2001, EUR J NEUROSCI, V13, P1320, DOI 10.1046/j.0953-816x.2001.01506.x; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; Chaddock L, 2010, BRAIN RES, V1358, P172, DOI 10.1016/j.brainres.2010.08.049; Chang WH, 2016, CLIN NEUROPHYSIOL, V127, P2892, DOI 10.1016/j.clinph.2016.04.001; Chen R, 1998, J NEUROPHYSIOL, V80, P2870, DOI 10.1152/jn.1998.80.6.2870; Cho HC, 2012, NEUROSCI LETT, V519, P78, DOI 10.1016/j.neulet.2012.05.025; Cirillo J, 2009, J PHYSIOL-LONDON, V587, P5831, DOI 10.1113/jphysiol.2009.181834; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; CONOVER WJ, 1982, BIOMETRICS, V38, P715, DOI 10.2307/2530051; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crizzle AM, 2006, CLIN J SPORT MED, V16, P422, DOI 10.1097/01.jsm.0000244612.55550.7d; Currie J, 2009, NEUROSCI LETT, V451, P152, DOI 10.1016/j.neulet.2008.12.043; Cuypers K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086380; D Kuipers S, 2006, CURR OPIN DRUG DISC, V9, P580; Dai W, 2016, NEUROSCIENCE, V336, P114, DOI 10.1016/j.neuroscience.2016.08.053; Di Lazzaro V, 1998, EXP BRAIN RES, V119, P265; Ding YH, 2006, CURR NEUROVASC RES, V3, P15, DOI 10.2174/156720206775541787; Doeltgen SH, 2011, EXP BRAIN RES, V215, P199, DOI 10.1007/s00221-011-2886-6; Erickson KI, 2009, HIPPOCAMPUS, V19, P1030, DOI 10.1002/hipo.20547; Floel A, 2010, NEUROIMAGE, V49, P2756, DOI 10.1016/j.neuroimage.2009.10.043; Frederiksen KS, 2015, INT J GERIATR PSYCH, V30, P744, DOI 10.1002/gps.4220; Goekint M, 2008, MED SCI SPORT EXER, V40, P1990, DOI 10.1249/MSS.0b013e31817eee85; Goekint M, 2012, J APPL PHYSIOL, V112, P535, DOI 10.1152/japplphysiol.00306.2011; Goekint M, 2011, NEUROSCI LETT, V494, P150, DOI 10.1016/j.neulet.2011.03.001; Goldsworthy MR, 2016, NEUROSCIENCE, V320, P205, DOI 10.1016/j.neuroscience.2016.02.012; Gomez-Merino D, 2001, NEUROSCI LETT, V301, P143, DOI 10.1016/S0304-3940(01)01626-3; Gordon BA, 2008, PSYCHOPHYSIOLOGY, V45, P825, DOI 10.1111/j.1469-8986.2008.00676.x; Griffin EW, 2011, PHYSIOL BEHAV, V104, P934, DOI 10.1016/j.physbeh.2011.06.005; Hanajima R, 1998, J PHYSIOL-LONDON, V509, P607, DOI 10.1111/j.1469-7793.1998.607bn.x; HATTORI S, 1994, BRAIN RES BULL, V35, P41, DOI 10.1016/0361-9230(94)90214-3; Herting MM, 2013, J COGNITIVE NEUROSCI, V25, P595, DOI 10.1162/jocn_a_00344; Heyman E, 2012, PSYCHONEUROENDOCRINO, V37, P844, DOI 10.1016/j.psyneuen.2011.09.017; Huang T, 2014, SCAND J MED SCI SPOR, V24, P1, DOI 10.1111/sms.12069; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Jovanovic JN, 2004, BRAIN DERIVED NEUROT; Killgore WDS, 2013, SCI REP-UK, V3, DOI 10.1038/srep03457; Kitaoka R, 2010, J NUTR SCI VITAMINOL, V56, P185, DOI 10.3177/jnsv.56.185; Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000; Korchounov A, 2007, J NEURAL TRANSM, V114, P223, DOI 10.1007/s00702-006-0523-5; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Leon-Sarmiento FE, 2013, ARCH MED RES, V44, P221, DOI 10.1016/j.arcmed.2013.03.003; Liepert J, 1997, J NEURAL TRANSM, V104, P1207, DOI 10.1007/BF01294721; Maddock RJ, 2016, J NEUROSCI, V36, P2449, DOI 10.1523/JNEUROSCI.3455-15.2016; Maddock RJ, 2011, NEUROIMAGE, V57, P1324, DOI 10.1016/j.neuroimage.2011.05.048; Mang CS, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6797928; Mang CS, 2014, J APPL PHYSIOL, V117, P1325, DOI 10.1152/japplphysiol.00498.2014; McAllister SM, 2009, CLIN NEUROPHYSIOL, V120, P820, DOI 10.1016/j.clinph.2009.02.003; McDonnell MN, 2013, J APPL PHYSIOL, V114, P1174, DOI 10.1152/japplphysiol.01378.2012; Meeusen R, 1997, INT J SPORTS MED, V18, P571, DOI 10.1055/s-2007-972683; MEEUSEN R, 1995, SPORTS MED, V20, P160, DOI 10.2165/00007256-199520030-00004; Mooney R.A., 2016, EXP BRAIN RES; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Ni Z, 2013, NEUROLOGY, V80, P1746, DOI 10.1212/WNL.0b013e3182919029; Nofuji Y, 2012, J SPORT SCI MED, V11, P83; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ortu E, 2013, CLIN NEUROPHYSIOL, V124, P1381, DOI 10.1016/j.clinph.2013.02.005; Petriz BA, 2017, J CELL PHYSIOL, V232, P257, DOI 10.1002/jcp.25477; Ploughman M, 2007, EUR J NEUROSCI, V25, P3453, DOI 10.1111/j.1460-9568.2007.05591.x; Prakash RS, 2010, BRAIN RES, V1341, P41, DOI 10.1016/j.brainres.2009.06.063; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Schmidt S, 2009, CLIN NEUROPHYSIOL, V120, P987, DOI 10.1016/j.clinph.2009.02.164; Schmolesky MT, 2013, J SPORT SCI MED, V12, P502; Schwenkreis P, 1999, NEUROSCI LETT, V270, P137, DOI 10.1016/S0304-3940(99)00492-9; Singh AM, 2014, EXP BRAIN RES, V232, P3675, DOI 10.1007/s00221-014-4049-z; Singh AM, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-23; Smith AE, 2014, EXP BRAIN RES, V232, P1875, DOI 10.1007/s00221-014-3879-z; Snow NP, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150039, 10.1371/journal.pone.0146712]; Stagg CJ, 2011, J PHYSIOL-LONDON, V589, P5845, DOI 10.1113/jphysiol.2011.216978; Sutoo D, 2003, NEUROBIOL DIS, V13, P1, DOI 10.1016/S0969-9961(03)00030-5; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Tang SW, 2008, NEUROSCI LETT, V431, P62, DOI 10.1016/j.neulet.2007.11.019; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Tergau F, 2000, MED SCI SPORT EXER, V32, P1942, DOI 10.1097/00005768-200011000-00019; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; Thirugnanasambandam N, 2015, J NEUROPHYSIOL, V114, P1102, DOI 10.1152/jn.00791.2014; van de Ruit M, 2015, BRAIN STIMUL, V8, P231, DOI 10.1016/j.brs.2014.10.020; Vega SR, 2012, INT J SPORTS MED, V33, P8, DOI 10.1055/s-0031-1285929; Vega SR, 2006, BRAIN RES, V1121, P59, DOI 10.1016/j.brainres.2006.08.105; Vega SR, 2011, PSYCHONEUROENDOCRINO, V36, P220, DOI 10.1016/j.psyneuen.2010.07.012; Veniero D, 2013, J NEUROSCI, V33, P13773, DOI 10.1523/JNEUROSCI.1777-13.2013; Wang GJ, 2000, J NUCL MED, V41, P1352; Warburton DER, 2011, APPL PHYSIOL NUTR ME, V36, pS266, DOI [10.1139/H11-062, 10.1139/h11-062]; Wilmore JH, 2001, MED SCI SPORT EXER, V33, P99; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003; Ziemann U, 1998, NEUROLOGY, V51, P1320, DOI 10.1212/WNL.51.5.1320; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306; Ziemann U, 1998, ELECTROMYOGR MOTOR C, V109, P321, DOI 10.1016/S0924-980X(98)00023-X; Ziemann U, 2015, CLIN NEUROPHYSIOL, V126, P1847, DOI 10.1016/j.clinph.2014.08.028; Zouhal H, 2008, SPORTS MED, V38, P401, DOI 10.2165/00007256-200838050-00004	94	55	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173672	10.1371/journal.pone.0173672	http://dx.doi.org/10.1371/journal.pone.0173672			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278300	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900027
J	Noah, JA; Dravida, S; Zhang, X; Yahil, S; Hirsch, J				Noah, J. Adam; Dravida, Swethasri; Zhang, Xian; Yahil, Shaul; Hirsch, Joy			Neural correlates of conflict between gestures and words: A domain-specific role for a temporal-parietal complex	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; DIFFUSE OPTICAL TOMOGRAPHY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; COGNITIVE CONTROL MECHANISMS; HUMAN BRAIN; PREFRONTAL CORTEX; FUNCTIONAL BRAIN; RESPONSE-INHIBITION; FNIRS DATA; FMRI	The interpretation of social cues is a fundamental function of human social behavior, and resolution of inconsistencies between spoken and gestural cues plays an important role in successful interactions. To gain insight into these underlying neural processes, we compared neural responses in a traditional color/word conflict task and to a gesture/word conflict task to test hypotheses of domain-general and domain-specific conflict resolution. In the gesture task, recorded spoken words ("yes" and "no") were presented simultaneously with video recordings of actors performing one of the following affirmative or negative gestures: thumbs up, thumbs down, head nodding (up and down), or head shaking (side-to-side), thereby generating congruent and incongruent communication stimuli between gesture and words. Participants identified the communicative intent of the gestures as either positive or negative. In the color task, participants were presented the words "red" and "green" in either red or green font and were asked to identify the color of the letters. We observed a classic "Stroop" behavioral interference effect, with participants showing increased response time for incongruent trials relative to congruent ones for both the gesture and color tasks. Hemodynamic signals acquired using functional near-infrared spectroscopy (fNIRS) were increased in the right dorsolateral prefrontal cortex (DLPFC) for incongruent trials relative to congruent trials for both tasks consistent with a common, domain-general mechanism for detecting conflict. However, activity in the left DLPFC and frontal eye fields and the right temporal-parietal junction (TPJ), superior temporal gyrus (STG), supramarginal gyrus (SMG), and primary and auditory association cortices was greater for the gesture task than the color task. Thus, in addition to domain-general conflict processing mechanisms, as suggested by common engagement of right DLPFC, socially specialized neural modules localized to the left DLPFC and right TPJ including adjacent homologous receptive language areas were engaged when processing conflicting communications. These findings contribute to an emerging view of specialization within the TPJ and adjacent areas for interpretation of social cues and indicate a role for the region in processing social conflict.	[Noah, J. Adam; Dravida, Swethasri; Zhang, Xian; Hirsch, Joy] Yale Sch Med, Dept Psychiat, Brain Funct Lab, New Haven, CT 06510 USA; [Dravida, Swethasri] Yale Sch Med, Med Scientist Training Program, New Haven, CT USA; [Yahil, Shaul] Washington Univ, Dept Neurosci, St Louis, MO USA; [Hirsch, Joy] Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Hirsch, Joy] Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA; [Hirsch, Joy] Yale Sch Med, Dept Comparat Med, New Haven, CT 06510 USA; [Hirsch, Joy] UCL, Dept Med Phys & Bioengn, London, England	Yale University; Yale University; Washington University (WUSTL); Yale University; Yale University; Yale University; University of London; University College London	Hirsch, J (corresponding author), Yale Sch Med, Dept Psychiat, Brain Funct Lab, New Haven, CT 06510 USA.; Hirsch, J (corresponding author), Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA.; Hirsch, J (corresponding author), Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA.; Hirsch, J (corresponding author), Yale Sch Med, Dept Comparat Med, New Haven, CT 06510 USA.; Hirsch, J (corresponding author), UCL, Dept Med Phys & Bioengn, London, England.	joyhirsch@yahoo.com		Hirsch, Joy/0000-0002-1418-6489; Noah, J. Adam/0000-0001-9773-2790	NIH Medical Scientist Training Program Training Grant [T32GM007205]; National Institute of Mental Health of the National Institutes of Health [R01MH107513]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107513, R01MH111629] Funding Source: NIH RePORTER	NIH Medical Scientist Training Program Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was partially supported by NIH Medical Scientist Training Program Training Grant T32GM007205. The work also received partial supported by the National Institute of Mental Health of the National Institutes of Health under award number R01MH107513 (PI JH).	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; Boehme S, 2015, SOC COGN AFFECT NEUR, V10, P856, DOI 10.1093/scan/nsu128; Caldwell M, 2016, NEUROIMAGE; Carter RM, 2013, TRENDS COGN SCI, V17, P328, DOI 10.1016/j.tics.2013.05.007; Carter RM, 2012, SCIENCE, V337, P109, DOI 10.1126/science.1219681; Casey BJ, 1997, J AM ACAD CHILD PSY, V36, P374, DOI 10.1097/00004583-199703000-00016; Chen K, 2016, ADV MATER INTERFACES, V3, DOI 10.1002/admi.201600115; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Eggebrecht AT, 2014, NAT PHOTONICS, V8, P448, DOI 10.1038/nphoton.2014.107; Eggebrecht AT, 2012, NEUROIMAGE, V61, P1120, DOI 10.1016/j.neuroimage.2012.01.124; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2008, TRENDS COGN SCI, V12, P374, DOI 10.1016/j.tics.2008.07.001; Egner T, 2007, NEUROIMAGE, V35, P940, DOI 10.1016/j.neuroimage.2006.11.061; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Etkin A, 2006, NEURON, V52, P1121, DOI 10.1016/j.neuron.2006.12.003; Ferradal SL, 2014, NEUROIMAGE, V85, P117, DOI 10.1016/j.neuroimage.2013.03.069; Franceschini MA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363365; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; HAZEKI O, 1988, J APPL PHYSIOL, V64, P796, DOI 10.1152/jappl.1988.64.2.796; Hellendoorn A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00850; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hoshi Y, 2003, PSYCHOPHYSIOLOGY, V40, P511, DOI 10.1111/1469-8986.00053; Iwanaga R, 2013, PSYCHIAT CLIN NEUROS, V67, P203, DOI 10.1111/pcn.12052; Keehn B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00444; Keller E, 2007, LECT NOTES COMPUT SC, V4775, P85; Kelly SD, 2010, PSYCHOL SCI, V21, P260, DOI 10.1177/0956797609357327; Kelly SD, 2010, J COGNITIVE NEUROSCI, V22, P683, DOI 10.1162/jocn.2009.21254; Kikuchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056087; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Kita Y, 2011, BRAIN DEV-JPN, V33, P494, DOI 10.1016/j.braindev.2010.11.007; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lotze M, 2006, NEUROPSYCHOLOGIA, V44, P1787, DOI 10.1016/j.neuropsychologia.2006.03.016; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MATCHER SJ, 1995, ANAL BIOCHEM, V227, P54, DOI 10.1006/abio.1995.1252; McNeill David., 1994, RES LANG SOC INTERAC, V27, P223, DOI [10.1207/s15327973rlsi2703_4, DOI 10.1207/S15327973RLSI2703_4]; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Noah JA, 2015, JOVE-J VIS EXP, DOI 10.3791/52116; Okamoto M, 2005, NEUROIMAGE, V26, P18, DOI 10.1016/j.neuroimage.2005.01.018; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ono Y, 2014, NEUROIMAGE, V85, P461, DOI 10.1016/j.neuroimage.2013.05.071; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Sato H, 2013, NEUROIMAGE, V83, P158, DOI 10.1016/j.neuroimage.2013.06.043; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tachibana A, 2011, NEUROSCI LETT, V503, P125, DOI 10.1016/j.neulet.2011.08.023; Tachtsidis Ilias, 2016, Neurophotonics, V3, P030401, DOI 10.1117/1.NPh.3.3.030401; Tachtsidis I, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031405; Tak S, 2014, NEUROIMAGE, V85, P72, DOI 10.1016/j.neuroimage.2013.06.016; Wible CG, 2012, SCHIZOPHR RES TREAT, V2012, DOI 10.1155/2012/920485; Xiao T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046569; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yasumura A, 2014, BRAIN DEV-JPN, V36, P97, DOI 10.1016/j.braindev.2013.01.005; Zaki J, 2010, J NEUROSCI, V30, P8481, DOI 10.1523/JNEUROSCI.0382-10.2010; Zhang X, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.1.015004	64	11	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173525	10.1371/journal.pone.0173525	http://dx.doi.org/10.1371/journal.pone.0173525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278240	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900005
J	Lim, LM; McStea, M; Chung, WW; Azmi, NN; Aziz, SAA; Alwi, S; Kamarulzaman, A; Kamaruzzaman, SB; Chua, SS; Rajasuriar, R				Lim, Li Min; McStea, Megan; Chung, Wen Wei; Azmi, Nuruljannah Nor; Aziz, Siti Azdiah Abdul; Alwi, Syireen; Kamarulzaman, Adeeba; Kamaruzzaman, Shahrul Bahyah; Chua, Siew Siang; Rajasuriar, Reena			Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multi-ethnic Malaysia	PLOS ONE			English	Article							QUALITY-OF-LIFE; DRUG-DRUG INTERACTIONS; ALTERNATIVE MEDICINE USE; DIABETES-MELLITUS; ELDERLY-PATIENTS; MEDICATION USE; UNITED-STATES; INAPPROPRIATE MEDICATION; EXCESSIVE POLYPHARMACY; CONTROLLED-TRIAL	Background Polypharmacy has been associated with increased morbidity and mortality in the older population. Objectives The aim of this study was to determine the prevalence, risk factors and health outcomes associated with polypharmacy in a cohort of urban community-dwelling older adults receiving chronic medications in Malaysia. Methods This was a baseline study in the Malaysian Elders Longitudinal Research cohort. The inclusion criteria were individuals aged >= 55years and taking at least one medication chronically (>= 3 months). Participants were interviewed using a structured questionnaire during home visits where medications taken were reviewed. Health outcomes assessed were frequency of falls, functional disability, potential inappropriate medication use (PIMs), potential drugdrug interactions (PDDIs), healthcare utilisation and quality of life (QoL). Risk factors and health outcomes associated with polypharmacy (>= 5 medications including dietary supplements) were determined using multivariate regression models. Results A total of 1256 participants were included with a median (interquartile range) age of 69(63-74) years. The prevalence of polypharmacy was 45.9% while supplement users made up 56.9% of the cohort. The risk factors associated with increasing medication use were increasing age, Indian ethnicity, male, having a higher number of comorbidities specifically those diagnosed with cardiovascular, endocrine and gastrointestinal disorders, as well as supplement use. Health outcomes significantly associated with polypharmacy were PIMS, PDDIs and increased healthcare utilisation. Conclusion A significant proportion of older adults on chronic medications were exposed to polypharmacy and use of dietary supplements contributed significantly to this. Medication reviews are warranted to reduce significant polypharmacy related issues in the older population.	[Lim, Li Min; Alwi, Syireen; Chua, Siew Siang; Rajasuriar, Reena] Univ Malaya, Dept Pharm, Fac Med, Kuala Lumpur, Malaysia; [McStea, Megan; Kamaruzzaman, Shahrul Bahyah] Univ Malaya, Fac Med, Malaysian Elders Longitudinal Res MELOR Grp, Kuala Lumpur, Malaysia; [McStea, Megan; Azmi, Nuruljannah Nor; Aziz, Siti Azdiah Abdul; Kamarulzaman, Adeeba; Rajasuriar, Reena] Univ Malaya, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia; [Chung, Wen Wei] Univ Malaya, Med Ctr, Dept Pharm, Kuala Lumpur, Malaysia; [Aziz, Siti Azdiah Abdul] Natl Univ Malaysia UKM, Fac Pharm, Kuala Lumpur, Malaysia; [Kamarulzaman, Adeeba; Kamaruzzaman, Shahrul Bahyah] Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, Malaysia; [Rajasuriar, Reena] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Kebangsaan Malaysia; Universiti Malaya; University of Melbourne	Rajasuriar, R (corresponding author), Univ Malaya, Dept Pharm, Fac Med, Kuala Lumpur, Malaysia.	reena@um.edu.my	McStea, Megan/M-7721-2019; ALWI, SYIREEN/B-9895-2010; Kamaruzzaman, Shahrul Bahyah/B-9728-2010; Rajasuriar, Reena/B-9569-2010; Chua, Siew Siang/AAH-9218-2021; McStea, Megan/Q-4851-2017; Kamaruzzaman, Shahrul Bahyah/Q-3189-2019; Abdul Aziz, Siti Azdiah/H-6527-2018; KAMARULZAMAN, ADEEBA/B-5216-2010	McStea, Megan/0000-0002-1241-7845; ALWI, SYIREEN/0000-0001-7887-3328; Rajasuriar, Reena/0000-0003-3756-0629; Abdul Aziz, Siti Azdiah/0000-0003-0846-3598; 	University of Malaya (UM) High Impact Research (HIR) Grant from Department of Higher Education, Ministry of Education, Malaysia [UM.C/625/1/HIR/MOHE/ASH/02]; University Malaya Research Grant from UM [UMRG RP029-14HTM]	University of Malaya (UM) High Impact Research (HIR) Grant from Department of Higher Education, Ministry of Education, Malaysia; University Malaya Research Grant from UM	This work was supported by the University of Malaya (UM) High Impact Research (HIR) Grant from the Department of Higher Education, Ministry of Education, Malaysia [UM.C/625/1/HIR/MOHE/ASH/02] to SBK and the University Malaya Research Grant from UM [UMRG RP029-14HTM] to RR.; We would like to acknowledge the contribution of the staff and participants of the MELoR study. This work was supported by the University of Malaya (UM) High Impact Research (HIR) Grant from the Department of Higher Education, Ministry of Education, Malaysia [UM.C/625/1/HIR/MOHE/ASH/02] and the University Malaya Research Grant from UM [UMRG RP029-14HTM].	[Anonymous], 2012, DIABETES CARE S1, V35, pS4, DOI DOI 10.2337/DC12-S004; Ataie-Jafari A, 2013, CLIN NUTR, V32, P911, DOI 10.1016/j.clnu.2013.01.012; Bjorkman IK, 2002, ANN PHARMACOTHER, V36, P1675, DOI 10.1345/aph.1A484; Blenkinsopp A, 2012, BRIT J CLIN PHARMACO, V74, P573, DOI 10.1111/j.1365-2125.2012.04331.x; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Briggs S, 2015, EMERG MED AUSTRALAS, V27, P419, DOI 10.1111/1742-6723.12451; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Cashion W, 2015, ANN EPIDEMIOL, V25, P433, DOI 10.1016/j.annepidem.2015.01.018; Chan DC, 2009, DRUG AGING, V26, P345, DOI 10.2165/00002512-200926040-00005; Chan DC, 2009, PHARMACOEPIDEM DR S, V18, P327, DOI 10.1002/pds.1712; Charlesworth CJ, 2015, J GERONTOL A-BIOL, V70, P989, DOI 10.1093/gerona/glv013; Chen LL, 2012, INT J CLIN PHARM-NET, V34, P596, DOI 10.1007/s11096-012-9651-1; Chen TF, 2016, DRUG AGING, V33, P199, DOI 10.1007/s40266-016-0357-2; Chia HS, 2015, SINGAP MED J, V56, P493, DOI 10.11622/smedj.2015133; Cooper JA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009235; Crotty M, 2004, AGE AGEING, V33, P612, DOI 10.1093/ageing/afh213; Crotty Maria, 2004, Am J Geriatr Pharmacother, V2, P257, DOI 10.1016/j.amjopharm.2005.01.001; Cullinan S, 2016, INT J CLIN PHARM-NET, V38, P374, DOI 10.1007/s11096-016-0254-0; Dhanoa A, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-404; Duggan J, 2001, AIDS PATIENT CARE ST, V15, P159, DOI 10.1089/108729101750123661; Firouzi S, 2016, EUROPEAN JOURNAL OF; Fried TR, 2014, J AM GERIATR SOC, V62, P2261, DOI 10.1111/jgs.13153; Gan GG, 2015, SUPPORT CARE CANCER, V23, P2399, DOI 10.1007/s00520-015-2614-z; Gaskin Darrell J, 2006, Am J Geriatr Pharmacother, V4, P96, DOI 10.1016/j.amjopharm.2006.06.008; Ghazali E, 2006, ADV GLOBAL BUSINESS, P43; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Harugeri A, 2010, AM J GERIATR PHARMAC, V8, P271, DOI 10.1016/j.amjopharm.2010.06.004; Hassan N., 2005, INT MED J, V12, p251 257; Hayashi Y, 2016, GERIATRICS GERONTOLO; Hor J Y, 2008, Med J Malaysia, V63, P125; Hovstadius B, 2013, HEALTH POLICY, V109, P166, DOI 10.1016/j.healthpol.2012.09.005; Huang ES, 2014, JAMA INTERN MED, V174, P251, DOI 10.1001/jamainternmed.2013.12956; Huri HZ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1192; Huri HZ, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-2; Hyde M, 2003, AGING MENT HEALTH, V7, P186, DOI 10.1080/1360786031000101157; Iihara N, 2016, J CLIN PHARM THER, V41, P273, DOI 10.1111/jcpt.12381; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; John GM, 2016, JOURNAL OF CANCER SU; Johnson CL, 2013, VITAL HLTH STAT, V2, P1; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Jyrkka J, 2009, DRUG AGING, V26, P493, DOI 10.2165/00002512-200926060-00006; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kilcup M, 2013, J AM PHARM ASSOC, V53, P78, DOI 10.1331/JAPhA.2013.11250; Kim HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098043; Laiteerapong N, 2011, DIABETES CARE, V34, P1749, DOI 10.2337/dc10-2424; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lipska KJ, 2015, JAMA INTERN MED, V175, P356, DOI 10.1001/jamainternmed.2014.7345; Lis CG, 2006, SUPPORT CARE CANCER, V14, P193, DOI 10.1007/s00520-005-0876-6; Loya AM, 2009, DRUG AGING, V26, P423, DOI 10.2165/00002512-200926050-00006; Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660; Mahfudz A S, 2005, Med J Malaysia, V60, P454; Mamun K, 2004, ANN ACAD MED SINGAP, V33, P49; Mangoni AA, 2004, BRIT J CLIN PHARMACO, V57, P6, DOI 10.1046/j.1365-2125.2003.02007.x; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Ministry of Health Malaysia, 2013, CLINICAL PRACTICE GU, P35; Ministry of Health Malaysia, 2015, CLINICAL PRACTICE GU, P80; Olivier P, 2009, DRUG AGING, V26, P475, DOI 10.2165/00002512-200926060-00004; Palgi Y, 2015, QUAL LIFE RES, V24, P1835, DOI 10.1007/s11136-015-0918-6; Paltiel O, 2001, J CLIN ONCOL, V19, P2439, DOI 10.1200/JCO.2001.19.9.2439; Cabello AJP, 2016, EUR J CLIN PHARMACOL, V72, P731, DOI 10.1007/s00228-016-2026-0; Pumthong G, 2015, COMPLEMENT THER MED, V23, P617, DOI 10.1016/j.ctim.2015.01.016; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Raschi E, 2015, BRIT J CLIN PHARMACO, V80, P1411, DOI 10.1111/bcp.12754; Rautiainen S, 2016, NATURE REVIEWS ENDOC; Richardson K, 2014, PHARMACOEPIDEM DR S, V23, P656, DOI 10.1002/pds.3590; Rondanelli M, 2011, CLIN NUTR, V30, P571, DOI 10.1016/j.clnu.2011.04.005; Sathasivam J, 2015, ASIA-PAC J PUBLIC HE, V27, p52S, DOI 10.1177/1010539515583332; Senik S, 2006, INT MED J, V13, P121; Shim JM, 2016, ASIA-PAC J PUBLIC HE, V28, P51, DOI 10.1177/1010539515613411; Stuijt CCM, 2008, DRUG AGING, V25, P947, DOI 10.2165/0002512-200825110-00005; Tan Mun Chieng, 2015, Clin Nutr Res, V4, P18, DOI 10.7762/cnr.2015.4.1.18; Tey NP, 2015, GERONTOLOGIST; Tinetti ME, 2014, JAMA INTERN MED, V174, P588, DOI 10.1001/jamainternmed.2013.14764; United Nations Department of Economic and Social Affairs, 2015, REPORT NO ST ESA SER; Walckiers D, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0095-7; Wang R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142123; Weng MC, 2013, QJM-INT J MED, V106, P1009, DOI 10.1093/qjmed/hct141; WHO Collaborating Center for Drug Statistics Methodology, 2014, GUIDELINES FOR ATC C; Zia A, 2016, GERIATRICS GERONTOLO	80	75	76	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173466	10.1371/journal.pone.0173466	http://dx.doi.org/10.1371/journal.pone.0173466			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273128	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700007
J	Dhayat, SA; Mirgorod, P; Lenschow, C; Senninger, N; Anthoni, C; Vowinkel, T				Dhayat, Sameer A.; Mirgorod, Philip; Lenschow, Christina; Senninger, Norbert; Anthoni, Christoph; Vowinkel, Thorsten			Challenges in pancreatic adenocarcinoma surgery - National survey and current practice guidelines	PLOS ONE			English	Article							LENGTH-OF-STAY; LIVER METASTASES; CLINICAL PATHWAYS; CANCER; RESECTION; PANCREATICODUODENECTOMY; IMPACT; COSTS	Background Pancreatic ductal adenocarcinoma (PDAC) remains one of the most deadly cancers in Europe and the USA. There is consensus that radical tumor surgery is the only viable option for any long-term survival in patients with PDAC. So far, limited data are available regarding the routine surgical management of patients with advanced PDAC in the light of surgical guidelines. Methods A national survey on perioperative management of patients with PDAC and currently applied criteria on their tumor resectability in German university and community hospitals was carried out. Results With a response rate of 81.6% (231/283) a total of 95 (41.1%) participating departments practicing pancreatic surgery in Germany are certified as competence and reference centers for surgical diseases of the pancreas in 2016. More than 95% of them indicate to carry out structured and interdisciplinary therapies along with an interdisciplinary pre-and postoperative tumor board. The majority of survey respondents prefer the pylorus-preserving partial pancreatoduodenectomy (93.1%) with standard lymphadenectomy for cancer of the pancreatic head. Intraoperative histological evaluation of the resection margins is used regularly by 99% of the survey respondents. 98.7% of survey respondents carry out partial or complete vein resection, 126 respondents (54.5%) would resect tumor adjacent arteries, and 102 respondents (44.2%) would perform metastasectomy if complete PDAC resection (R0) is possible. Conclusion Evidence-based and standardized pancreatic surgery is practiced by a large number of hospitals in Germany. However, a significant number of survey respondents support an extended radical tumor resection in patients with advanced PDAC even when not indicated by current clinical guidelines.	[Dhayat, Sameer A.; Mirgorod, Philip; Lenschow, Christina; Senninger, Norbert; Anthoni, Christoph; Vowinkel, Thorsten] Univ Hosp Muenster, Dept Gen & Visceral Surg, Munster, Germany	University of Munster	Dhayat, SA (corresponding author), Univ Hosp Muenster, Dept Gen & Visceral Surg, Munster, Germany.	sameer.dhayat@ukmuenster.de						Bellon E, 2016, UPDATES SURG, V68, P247, DOI 10.1007/s13304-016-0407-7; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Bockhorn M, 2014, SURGERY, V155, P977, DOI 10.1016/j.surg.2014.02.001; Buc E, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-347; Callery MP, 2009, ANN SURG ONCOL, V16, P1727, DOI 10.1245/s10434-009-0408-6; Conroy T, 2016, EUR J CANCER, V57, P10, DOI 10.1016/j.ejca.2015.12.026; Crippa S, 2016, EJSO-EUR J SURG ONC, V42, P1533, DOI 10.1016/j.ejso.2016.06.398; Crippa S, 2016, EUR J SURG ONCOL; Doi R, 2008, SURG TODAY, V38, P1021, DOI 10.1007/s00595-007-3745-8; Ducreux M, 2015, ANN ONCOL, V26, pV56, DOI 10.1093/annonc/mdv295; Evans DB, 2009, ANN SURG ONCOL, V16, P1736, DOI 10.1245/s10434-009-0416-6; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hackert T, 2016, EUR J SURG ONCOL; Kelly KJ, 2013, J GASTROINTEST SURG, V17, P1209, DOI 10.1007/s11605-013-2178-5; Kruger S, 2016, PANCREATOLOGY, V16, P593, DOI 10.1016/j.pan.2016.03.016; Malvezzi M., 2015, ANN ONCOL, V2015, P1, DOI DOI 10.1093/ANN0NC/MDV001; Meguid RA, 2008, J AM COLL SURGEONS, V206, P622, DOI 10.1016/j.jamcollsurg.2007.11.011; Michalski CW, 2008, DIGEST SURG, V25, P473, DOI 10.1159/000184739; Muller MK, 2009, LANGENBECK ARCH SURG, V394, P31, DOI 10.1007/s00423-008-0352-0; Rotter T, 2012, EVAL HEALTH PROF, V35, P3, DOI 10.1177/0163278711407313; Seufferlein T, 2013, Z GASTROENTEROL, V51, P1395, DOI 10.1055/s-0033-1356220; Shaib WL, 2016, ONCOLOGIST, V21, P178, DOI 10.1634/theoncologist.2015-0316; Shrikhande SV, 2007, ANN SURG ONCOL, V14, P118, DOI 10.1245/s10434-006-9131-8; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tachezy M, 2016, SURGERY, V160, P136, DOI 10.1016/j.surg.2016.02.019; Tang KZ, 2016, PANCREATOLOGY, V16, P28, DOI 10.1016/j.pan.2015.11.007; Tempero MA, 2014, J NATL COMPR CANC NE, V12, P1083, DOI 10.6004/jnccn.2014.0106; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wagner M, 2004, BRIT J SURG, V91, P586, DOI 10.1002/bjs.4484; Wong JC, 2008, CLIN GASTROENTEROL H, V6, P1301, DOI 10.1016/j.cgh.2008.09.014; Yoshioka R, 2014, BRIT J SURG, V101, P523, DOI 10.1002/bjs.9420; Yu XZ, 2014, EJSO-EUR J SURG ONC, V40, P371, DOI 10.1016/j.ejso.2014.01.010; Zanini N, 2015, UPDATES SURG-ITALY, V67, P19, DOI 10.1007/s13304-015-0283-6; Zhou YM, 2012, WORLD J SURG, V36, P884, DOI 10.1007/s00268-012-1461-z	34	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173374	10.1371/journal.pone.0173374	http://dx.doi.org/10.1371/journal.pone.0173374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267771	Green Published, gold, Green Submitted			2022-12-27	WOS:000396060600027
J	Fauvelle, C; Diepstraten, R; Jessen, T				Fauvelle, Catherine; Diepstraten, Rianne; Jessen, Tyler			A meta-analysis of home range studies in the context of trophic levels: Implications for policy-based conservation	PLOS ONE			English	Article							MOVEMENT PATTERNS; BERGMANNS RULE; CASCADES; MAMMALS; MODELS; WOLVES; SIZE	Home ranges have been widely-used as ecological tools, though using home range estimates in decision-support for conservation biology is a relatively new idea. However, trophic levels are rarely taken into consideration when estimating home range. This lapse could present issues when interpreting past studies, especially in policy-based conservation. The objectives of this study were to survey the current literature, to critically analyse published articles with home range analyses, and to compare home range size by species' trophic level. We predicted that animals residing in higher trophic levels would have significantly larger home ranges than animals occupying lower trophic levels. We found that terrestrial carnivores had larger home ranges than terrestrial herbivores, though terrestrial mesocarnivores had the largest home ranges. We also found that aquatic herbivores had larger home ranges than both aquatic carnivores and aquatic mesocarnivores. Our results are important to consider for planning and management sectors, to avoid the implementation of ineffective conservation policies.	[Fauvelle, Catherine; Diepstraten, Rianne] Univ Calgary, Fac Environm Design, Calgary, AB, Canada; [Jessen, Tyler] Univ Calgary, Fac Vet Med, Calgary, AB, Canada	University of Calgary; University of Calgary	Fauvelle, C (corresponding author), Univ Calgary, Fac Environm Design, Calgary, AB, Canada.	cxfauvelle@gmail.com						[Anonymous], [No title captured]; Ashton KG, 2000, AM NAT, V156, P390, DOI 10.1086/303400; Berger KM, 2008, ECOLOGY, V89, P818, DOI 10.1890/07-0193.1; Beschta RL, 2008, ECOHYDROLOGY, V1, P118, DOI 10.1002/eco.12; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Collins AB, 2007, J FISH BIOL, V71, P1159, DOI 10.1111/j.1095-8649.2007.01590.x; Cramer PC, 2001, ECOL MODEL, V140, P51, DOI 10.1016/S0304-3800(01)00268-X; Graham K, 2005, BIOL CONSERV, V122, P159, DOI 10.1016/j.biocon.2004.06.006; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Herfindal I, 2005, J ZOOL, V265, P63, DOI 10.1017/S0952836904006053; Komers PE, 2013, GLOBAL CHANGE BIOL, V19, P2916, DOI 10.1111/gcb.12266; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; McCann K, 1997, P ROY SOC B-BIOL SCI, V264, P1249, DOI 10.1098/rspb.1997.0172; MCNAB BK, 1971, ECOLOGY, V52, P845, DOI 10.2307/1936032; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; Myers N, 1979, SINKING ARK NEW LOOK; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; Roemer GW, 2009, BIOSCIENCE, V59, P165, DOI 10.1525/bio.2009.59.2.9; Svancara LK, 2005, BIOSCIENCE, V55, P989, DOI 10.1641/0006-3568(2005)055[0989:PVECAR]2.0.CO;2; Toigo C, 2006, ECOGRAPHY, V29, P301, DOI 10.1111/j.2006.0906-7590.04394.x; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3	24	14	14	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173361	10.1371/journal.pone.0173361	http://dx.doi.org/10.1371/journal.pone.0173361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267759	Green Published, Green Submitted, gold			2022-12-27	WOS:000396060600025
J	Hu, HC; Chen, JKC; Tsai, CM; Chen, HY; Tung, TH; Li, LPH				Hu, Hao-Chun; Chen, Joshua Kuang-Chao; Tsai, Chia-Mi; Chen, Hsing-Yi; Tung, Tao-Hsin; Li, Lieber Po-Hung			Evolution of impedance field telemetry after one day of activation in cochlear implant recipients	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; ELECTRODE IMPEDANCE; PITCH PERCEPTION; INSERTION; POSTIMPLANTATION; FEASIBILITY; CHILDREN; DESIGN; SAFETY; SYSTEM	Objectives Changes in impedance between 24 hours and one month after cochlear implantation have never been explored due to the inability to switch on within one day. This study examined the effect of early activation (within 24 hours) on the evolution of electrode impedance with the aim of providing information on the tissue-to-electrode interface when electrical stimulation was commenced one day post implantation. Methods We performed a retrospective review at a single institution. Patients who received a Nucleus 24RECA implant system (Cochlear, Sydney, Australia) and underwent initial switch-on within 24 hours postoperatively were included. Impedance measurements were obtained intraoperatively and postoperatively at 1 day, 1 week, 4 weeks, and 8 weeks. Results A significant drop in impedance was noted 1 day after an initial activation within 24 hours followed by a significant rise in impedance in all channels until 1 week, after which the impedance behaved differently in different segments. Basal and mid-portion electrodes revealed a slight increase while apical electrodes showed a slight decrease in impedance from 1 week to 8 weeks postoperatively. Impedance was relatively stable 4 weeks after surgery. Conclusions This is the first study to report the evolution of impedance in all channels between initial mapping 1 day and 1 month after cochlear implantation. The underlying mechanism for the differences in behavior between different segments of the electrode may be associated with the combined effect of dynamics among the interplay of cell cover formation, electrical stimulation, and fibrotic reaction.	[Hu, Hao-Chun; Tsai, Chia-Mi; Li, Lieber Po-Hung] Cheng Hsin Gen Hosp, Dept Otolaryngol, Taipei, Taiwan; [Hu, Hao-Chun] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Chen, Joshua Kuang-Chao] Far Eastern Mem Hosp, Cochlear Implant Ctr, New Taipei, Taiwan; [Chen, Joshua Kuang-Chao; Li, Lieber Po-Hung] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Tsai, Chia-Mi] Natl Taipei Univ Nursing & Hlth Sci, Dept Speech Language Pathol & Audiol, Taipei, Taiwan; [Chen, Hsing-Yi] Lotung Poh Ai Hosp, Dept Otolaryngol, Yilan, Taiwan; [Tung, Tao-Hsin] Cheng Hsin Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Tung, Tao-Hsin] Fu Jen Catholic Univ, Sch Med, Fac Publ Hlth, Taipei, Taiwan	Cheng Hsin General Hospital; National Yang Ming Chiao Tung University; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; National Taipei University of Nursing & Health Science (NTUNHS); Cheng Hsin General Hospital; Fu Jen Catholic University	Li, LPH (corresponding author), Cheng Hsin Gen Hosp, Dept Otolaryngol, Taipei, Taiwan.	lieber.chgh@gmail.com	Li, Lieber/AAG-7397-2022; Li, Lieber/AFL-7454-2022					Alsabellha RM, 2014, OTOL NEUROTOL, V35, pE130, DOI 10.1097/MAO.0000000000000266; BRUMMER SB, 1977, IEEE T BIO-MED ENG, V24, P59, DOI 10.1109/TBME.1977.326218; Busby P A, 2002, Cochlear Implants Int, V3, P87, DOI 10.1179/cim.2002.3.2.87; Chen JKC, 2016, OTOLARYNG HEAD NECK, V154, P771, DOI 10.1177/0194599816631514; Chen JKC, 2015, ACTA OTO-LARYNGOL, V135, P592, DOI 10.3109/00016489.2015.1006335; Chen JKC, 2014, OTOL NEUROTOL, V35, P1409, DOI 10.1097/MAO.0000000000000407; Chen JKC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071929; Chen JKC, 2010, PEDIATRICS, V125, pE793, DOI 10.1542/peds.2008-3620; Friedland David R, 2009, Trends Amplif, V13, P124, DOI 10.1177/1084713809336422; Gajadeera EA, 2017, EAR HEAR; Hagr A, 2015, INT J AUDIOL, V54, P323, DOI 10.3109/14992027.2014.996824; Hughes ML, 2001, EAR HEARING, V22, P471, DOI 10.1097/00003446-200112000-00004; Jia H, 2011, ANN OTO RHINOL LARYN, V120, P529, DOI 10.1177/000348941112000807; Joseph J, 2010, J MATER SCI-MATER M, V21, P1665, DOI 10.1007/s10856-010-4015-7; Mangus B, 2012, OTOLARYNG CLIN N AM, V45, P69, DOI 10.1016/j.otc.2011.08.017; Marsella P, 2014, OTOL NEUROTOL, V35, P277, DOI 10.1097/MAO.0000000000000259; Molisz A, 2015, AUDIOL NEURO-OTOL, V20, P222, DOI 10.1159/000377615; Nadol JB, 2001, ANN OTO RHINOL LARYN, V110, P883, DOI 10.1177/000348940111000914; Newbold C, 2004, J NEURAL ENG, V1, P218, DOI 10.1088/1741-2560/1/4/005; Newbold Carrie, 2014, Cochlear Implants Int, V15, P191, DOI 10.1179/1754762813Y.0000000050; Paasche G, 2006, OTOL NEUROTOL, V27, P639, DOI 10.1097/01.mao.0000227662.88840.61; Rebscher SJ, 2008, J REHABIL RES DEV, V45, P731, DOI 10.1682/JRRD.2007.08.0119; Roland JT, 2005, LARYNGOSCOPE, V115, P1325, DOI 10.1097/01.mlg.0000167993.05007.35; Sennaroglu Levent, 2010, Cochlear Implants Int, V11, P4, DOI 10.1002/cii.416; Somdas MA, 2007, AUDIOL NEURO-OTOL, V12, P277, DOI 10.1159/000103208; Stadelmann WK, 1998, AM J SURG, V176, p39S, DOI 10.1016/S0002-9610(98)00184-6; Tykocinski M, 2005, OTOL NEUROTOL, V26, P948, DOI 10.1097/01.mao.0000185056.99888.f3; Wilk M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147552; Wolf-Magele A, 2015, CLIN OTOLARYNGOL, V40, P527, DOI 10.1111/coa.12391; Zadrozniak Marek, 2011, Otolaryngol Pol, V65, P214, DOI 10.1016/S0030-6657(11)70678-3; Zeng FG, 2015, HEARING RES, V322, P188, DOI 10.1016/j.heares.2014.09.013	31	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173367	10.1371/journal.pone.0173367	http://dx.doi.org/10.1371/journal.pone.0173367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264044	Green Published, gold, Green Submitted			2022-12-27	WOS:000396054300056
J	Puttkammer, N; Domercant, JW; Adler, M; Yuhas, K; Myrtil, M; Young, P; Francois, K; Grand'Pierre, R; Lowrance, D				Puttkammer, Nancy; Domercant, Jean Wysler; Adler, Michelle; Yuhas, Krista; Myrtil, Martine; Young, Paul; Francois, Kesner; Grand'Pierre, Reynold; Lowrance, David			ART attrition and risk factors among Option B plus patients in Haiti: A retrospective cohort study	PLOS ONE			English	Article							POISSON REGRESSION APPROACH; CLUSTER RANDOMIZED-TRIAL; TO-CHILD-TRANSMISSION; ANTIRETROVIRAL THERAPY; MALAWI; CARE; HIV; RETENTION; IMPACT; PROGRAM	Objectives In October 2012, the Haitian Ministry of Health endorsed the "Option B+" strategy to eliminate mother-to-child transmission of HIV and achieve HIV epidemic control. The objective of this paper is to assess and identify risk factors for attrition from the national ART program among Option B+ patients in the 12 months after ART initiation. Design This retrospective cohort study included patients newly initiating ART from October 2012-August 2013 at 68 ART sites covering 45% of all newly enrolled ART patients in all regions of Haiti. Methods With data from electronic medical records, we carried out descriptive analysis of sociodemographic, clinical, and pregnancy-related correlates of ART attrition, and used a modified Poisson regression approach to estimate relative risks in a multivariable model. Results There were 2,166 Option B+ patients who initiated ART, of whom 1,023 were not retained by 12 months (47.2%). One quarter (25.3%) dropped out within 3 months of ART initiation. Protective factors included older age, more advanced HIV disease progression, and any adherence counseling prior to ART initiation, while risk factors included starting ART late in gestation, starting ART within 7 days of HIV testing, and using an atypical ART regimen. Discussion Our study demonstrates early ART attrition among Option B+ patients and contributes evidence on the characteristics of women who are most at risk of attrition in Haiti. Our findings highlight the importance of targeted strategies to support retention among Option B+ patients.	[Puttkammer, Nancy] Univ Washington, Dept Global Hlth, Int Training & Educ Ctr Hlth I TECH, Seattle, WA 98195 USA; [Domercant, Jean Wysler; Lowrance, David] US Ctr Dis Control & Prevent, Port Au Prince, Haiti; [Adler, Michelle] US Ctr Dis Control & Prevent, Kampala, Uganda; [Yuhas, Krista] Univ Washington, Ctr AIDS Res, Seattle, WA 98195 USA; [Myrtil, Martine] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Young, Paul] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Francois, Kesner; Grand'Pierre, Reynold] Govt Haiti, Minist Publ Hlth & Populat, Port Au Prince, Haiti	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA	Puttkammer, N (corresponding author), Univ Washington, Dept Global Hlth, Int Training & Educ Ctr Hlth I TECH, Seattle, WA 98195 USA.	nputt@uw.edu		Puttkammer, Nancy/0000-0002-6693-9278	Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Health Resources and Services Administration [U91HA0680]; US Centers for Disease Control and Prevention [NU2GGH001130-04-00]; International Training and Education Center for Health (I-TECH) at the University of Washington; NIAID of the National Institute of Health; NCI of the National Institute of Health; NIMH of the National Institute of Health; NIDA of the National Institute of Health; NICHD of the National Institute of Health; NHLBI of the National Institute of Health; NIA of the National Institute of Health; NIGMS of the National Institute of Health; NIDDK of the National Institute of Health [AI027757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Health Resources and Services Administration; US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); International Training and Education Center for Health (I-TECH) at the University of Washington; NIAID of the National Institute of Health; NCI of the National Institute of Health; NIMH of the National Institute of Health; NIDA of the National Institute of Health; NICHD of the National Institute of Health; NHLBI of the National Institute of Health; NIA of the National Institute of Health; NIGMS of the National Institute of Health; NIDDK of the National Institute of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research has been supported by the Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Health Resources and Services Administration, under award number U91HA0680, and the US Centers for Disease Control and Prevention (https://www.cdc.gov/), under award number NU2GGH001130-04-00, to the International Training and Education Center for Health (I-TECH) at the University of Washington. Research reported in this publication was also supported by NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, NIDDK of the National Institutes of Health (https://www.nih.gov/) under award number AI027757 to the University of Washington Center for AIDS Research (CFAR). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, the National Institutes of Health, or the Health Resources and Services Administration.	Cataldo F, 2016, J ACQUIR IMMUNE DEFI; Cayemittes M, 2013, ENQUETE MORTALITE MO; Chan AK, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20672; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Desinor O, 2011, B EPIDEMIOLOGIQUE PR; Dionne-Odom J, 2016, AIDS RES TREAT, V2016, DOI 10.1155/2016/6284290; Domercant J, 2015, ATTRITION ANTIRETROV; Domercant JW, 2015, MMWR-MORBID MORTAL W, V64, P137; Ebuy H, 2015, INT J INFECT DIS, V33, P123, DOI 10.1016/j.ijid.2014.12.026; Ford D, 2016, J ACQUIRED IMMUNE DE; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Herce ME, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1065-y; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kieffer MP, 2014, JAIDS-J ACQ IMM DEF, V67, pS188, DOI 10.1097/QAI.0000000000000372; Kim MH, 2015, JAIDS-J ACQ IMM DEF, V68, pE77, DOI 10.1097/QAI.0000000000000517; Kim MH, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17389; Kim MH, 2015, WHY DID I STOP BARRI; Llenas-Garcia J, 2015, RETENTION CARE HIV I; Lober William B, 2008, AMIA Annu Symp Proc, P434; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Matheson AI, 2012, INT J MED INFORM, V81, P244, DOI 10.1016/j.ijmedinf.2012.01.011; Moga T, 2015, TAKING LESSONS LEARN; (MSPP) M.d.l.S.P.e.d.l.P., 2015, ET OP DEP CAS CASC P; Mukherjee JS, 2006, JAIDS-J ACQ IMM DEF, V43, pS123, DOI 10.1097/01.qai.0000248348.25630.74; Mutede BR, 2015, IMPROVING RETENTION; Ortblad KF, 2013, AIDS, V27, P2003, DOI 10.1097/QAD.0b013e328362ba67; [PNLS MSPP], 2014, DECL ENG VIH SIDA; Price AJ, 2014, SEX TRANSM INFECT, V90, P309, DOI 10.1136/sextrans-2013-051336; Rosenberg NE, 2015, LANCET HIV, V2, pE483, DOI 10.1016/S2352-3018(15)00182-4; Rosenberg NE, 2014, JAIDS-J ACQ IMM DEF, V67, pS114, DOI 10.1097/QAI.0000000000000319; Sam-Agudu NA, 2014, JAIDS-J ACQ IMM DEF, V67, pS132, DOI 10.1097/QAI.0000000000000331; Schmitz K, 2015, RETAINING MOTHER BAB; Sherr K, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-55; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2014, THE GAP REP; UNICEF, 2014, UNICEF DAT MON HLTH; van Lettow M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18994; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; World Health Organization, 2015, GUIDELINE ON WHEN TO; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	42	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173123	10.1371/journal.pone.0173123	http://dx.doi.org/10.1371/journal.pone.0173123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264045	Green Published, gold, Green Submitted			2022-12-27	WOS:000396054300039
J	Kim, D; Jung, YG; Roh, S				Kim, Daehwan; Jung, Yeon-Gil; Roh, Sangho			Microarray analysis of embryo-derived bovine pluripotent cells: The vulnerable state of bovine embryonic stem cells	PLOS ONE			English	Article							SELF-RENEWAL; CULTURE-CONDITIONS; REGULATES PLURIPOTENCY; NUCLEAR TRANSFER; MOUSE EMBRYOS; IN-VITRO; BLASTOCYSTS; LINES; EXPRESSION; DIFFERENTIATION	Although there are many studies about pluripotent stem cells, little is known about pluripotent pathways and the difficulties of maintaining the pluripotency of bovine cells in vitro. Here, we investigated differently expressed genes (DEG) in bovine embryo-derived stem like cells (eSLCs) from various origins to validate their distinct characteristics of pluripotency and differentiation. We identified core pluripotency markers and additional markers which were not determined as pluripotency markers yet in bovine eSLCs. Using the KEGG database, TGF beta, WNT, and LIF signaling were related to the maintenance of pluripotency. In contrast, some DEGs related to the LIF pathway were down-regulated, suggesting that reactivation of the pathway may be required for the establishment of true bovine embryonic stem cells (ESCs). Interestingly, oncogenes were co-down-regulated, while tumor suppressor genes were co-up-regulated in eSLCs, implying that this pattern may induce abnormal teratomas. These data analyses of signaling pathways provide essential information on authentic ESCs in addition to providing evidence for pluripotency in bovine eSLCs.	[Kim, Daehwan; Roh, Sangho] Seoul Natl Univ, Cellular Reprogramming & Embryo Biotechnol Lab, Sch Dent, Dent Res Inst, Seoul, South Korea; [Jung, Yeon-Gil] ET Biotech Co Ltd, Jangsu, South Korea	Seoul National University (SNU)	Roh, S (corresponding author), Seoul Natl Univ, Cellular Reprogramming & Embryo Biotechnol Lab, Sch Dent, Dent Res Inst, Seoul, South Korea.	sangho@snu.ac.kr		Roh, Sangho/0000-0001-8082-6459	National Research Foundation of Korea (NRF) through the Oromaxillofacial Dysfunction Research Center [2015048003]; Technology Development Program for Agriculture and Forestry, Ministry of Agriculture, Food and Rural Affairs (MAFRA), Republic of Korea [111160-04]; ET Biotech Co. Ltd.	National Research Foundation of Korea (NRF) through the Oromaxillofacial Dysfunction Research Center; Technology Development Program for Agriculture and Forestry, Ministry of Agriculture, Food and Rural Affairs (MAFRA), Republic of Korea; ET Biotech Co. Ltd.	This study was supported by a grant from the National Research Foundation of Korea (NRF, No. 2015048003 through the Oromaxillofacial Dysfunction Research Center for the Elderly at Seoul National University) and the Technology Development Program for Agriculture and Forestry, Ministry of Agriculture, Food and Rural Affairs (MAFRA; 111160-04), Republic of Korea. ET Biotech Co. Ltd. provided support in the form of salaries for author YGJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballabeni A, 2011, P NATL ACAD SCI USA, V108, P19252, DOI 10.1073/pnas.1116794108; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cao SB, 2009, J EXP ZOOL PART A, V311A, P368, DOI 10.1002/jez.535; Carter MG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r61; Chang G, 2009, GENOMICS, V93, P112, DOI 10.1016/j.ygeno.2008.09.011; Chiou SH, 2013, J EXP MED, V210, P85, DOI 10.1084/jem.20121044; Christophorou MA, 2014, NATURE, V507, P104, DOI 10.1038/nature12942; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Donald CD, 2003, LAB INVEST, V83, P501, DOI 10.1097/01.LAB.0000063929.61760.F6; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Farifteh F, 2014, CELL J, V15, P316; FISHEL, 1994, CELL, V77, pU17; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Furusawa T, 2004, BIOL REPROD, V70, P1452, DOI 10.1095/biolreprod.103.024190; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gong GC, 2010, CELL REPROGRAM, V12, P151, DOI 10.1089/cell.2009.0049; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; Jin MZ, 2012, CYTOTECHNOLOGY, V64, P379, DOI 10.1007/s10616-011-9408-z; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kawaguchi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135403; Khaled WT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6987; Kim D, 2016, REPROD FERT DEVELOP, V28, P1762, DOI 10.1071/RD14071; Komiya T, 2006, ONCOGENE, V25, P6128, DOI 10.1038/sj.onc.1209627; Laner-Plamberger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075317; Li P, 2013, STEM CELL REV REP, V9, P709, DOI 10.1007/s12015-013-9452-5; Li Y -M, 2005, NO FRUITS, V3, P3, DOI DOI 10.1182/BL00D-2004-07-2681; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Mai QY, 2007, CELL RES, V17, P1008, DOI 10.1038/cr.2007.102; Mitalipov SM, 2006, REPROD FERT DEVELOP, V18, P817, DOI 10.1071/RD06112; Mitalipova M, 2001, Cloning, V3, P59, DOI 10.1089/15204550152475563; Moustakas A, 2001, J CELL SCI, V114, P4359; Munoz M, 2008, REPROD DOMEST ANIM, V43, P32, DOI 10.1111/j.1439-0531.2008.01229.x; Munoz M, 2008, THERIOGENOLOGY, V69, P1159, DOI 10.1016/j.theriogenology.2008.02.014; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Panarace M, 2007, THERIOGENOLOGY, V67, P142, DOI 10.1016/j.theriogenology.2006.09.036; Park S, 2015, ANIM REPROD SCI, V161, P47, DOI 10.1016/j.anireprosci.2015.08.003; Perez-Iratxeta C, 2005, FEBS LETT, V579, P1795, DOI 10.1016/j.febslet.2005.02.020; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Robert C, 2011, MOL REPROD DEV, V78, P651, DOI 10.1002/mrd.21364; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SAITO S, 1992, ROUX ARCH DEV BIOL, V201, P134, DOI 10.1007/BF00188711; Saito S, 2002, FEBS LETT, V531, P389, DOI 10.1016/S0014-5793(02)03550-0; Saito Shigeo, 2004, Hum Cell, V17, P107; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Sharov AA, 2010, METHOD ENZYMOL, V477, P511, DOI 10.1016/S0076-6879(10)77025-7; Stranzinger GF, 1996, INT J EXP PATHOL, V77, P263; TALBOT NC, 1995, MOL REPROD DEV, V42, P35, DOI 10.1002/mrd.1080420106; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ushizawa Koichi, 2004, Reprod Biol Endocrinol, V2, P77; Verma V, 2013, STEM CELLS DEV, V22, P1728, DOI 10.1089/scd.2012.0481; Walker EJ, 2012, CANCER RES, V72, P636, DOI 10.1158/0008-5472.CAN-11-2266; Wang L, 2005, BIOL REPROD, V73, P149, DOI 10.1095/biolreprod.104.037150; Wang LL, 2012, CELL RES, V22, P1082, DOI 10.1038/cr.2012.77; Wang SW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.420; Wu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep28343; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Yang SH, 2014, CELL REP, V7, P1968, DOI 10.1016/j.celrep.2014.05.037; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang M, 2014, NAT GENET, V46, P1170, DOI 10.1038/ng.3116; Zheng XF, 2012, STEM CELLS, V30, P910, DOI 10.1002/stem.1070	71	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173278	10.1371/journal.pone.0173278	http://dx.doi.org/10.1371/journal.pone.0173278			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257460	gold, Green Published, Green Submitted			2022-12-27	WOS:000396021100082
J	Nakaoka, T; Iga, M; Yamada, T; Koujima, I; Takeshima, M; Zhou, XY; Suzuki, Y; Ogihara, MH; Kataoka, H				Nakaoka, Takayoshi; Iga, Masatoshi; Yamada, Tetsuya; Koujima, Ikumi; Takeshima, Mika; Zhou, Xiangying; Suzuki, Yutaka; Ogihara, Mari H.; Kataoka, Hiroshi			Deep sequencing of the prothoracic gland transcriptome reveals new players in insect ecdysteroidogenesis	PLOS ONE			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; DROSOPHILA-MELANOGASTER; NAD KINASE; CYTOCHROME-P450 ENZYME; ECDYSONE SYNTHESIS; MOLTING HORMONE; BOMBYX-MORI; P450 ENZYME; BIOSYNTHESIS; GENE	Ecdysteroids are steroid hormones that induce molting and determine developmental timing in arthropods. In insect larva, the prothoracic gland (PG) is a major organ for ecdysone synthesis and release. Released ecdysone is converted into the active form, 20-hydroxyecdysone (20E) in the peripheral tissues. All processes from ecdysone synthesis and release from the PG to its conversion to 20E are called ecdysteroidogenesis and are under the regulation of numerous factors expressed in the PG and peripheral tissues. Classical genetic approaches and recent transcriptomic screening in the PG identified several genes responsible for ecdysone synthesis and release, whereas the regulatory mechanism remains largely unknown. We analyzed RNA-seq data of the silkworm Bombyx mori PG and employed the fruit fly Drosophila melanogaster GAL4/UAS binary RNAi system to comprehensively screen for genes involved in ecdysone synthesis and/or release. We found that the genes encoding delta-aminolevulinic acid synthase (CG3017/alas) and putative NAD kinase (CG33156) were highly expressed in the PG of both B. mori and D. melanogaster. Neither alas nor CG33156 RNAi-induced larvae could enter into the pupal stage, and they had a lower abundance of the active form ecdysteroids in their prolonged larval stage. These results demonstrated that alas and CG33156 are indispensable for ecdysteroidogenesis.	[Nakaoka, Takayoshi; Iga, Masatoshi; Yamada, Tetsuya; Koujima, Ikumi; Takeshima, Mika; Zhou, Xiangying; Ogihara, Mari H.; Kataoka, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Suzuki, Yutaka] Univ Tokyo, Dept Computat Biol & Med Sci, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan	University of Tokyo; University of Tokyo	Kataoka, H (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	kataoka@k.u-tokyo.ac.jp			Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Japan Society for the Promotion of Science [25252023]	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to H.K. (Grant# 25252023). https://www.jsps.go.jp/english/e-grants/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISHOP DF, 1981, ARCH BIOCHEM BIOPHYS, V206, P380, DOI 10.1016/0003-9861(81)90105-3; BISHOP DF, 1990, GENOMICS, V7, P207, DOI 10.1016/0888-7543(90)90542-3; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Danielsen ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004343; de Mena IR, 1999, J BIOL CHEM, V274, P37321, DOI 10.1074/jbc.274.52.37321; Gilbert LI, 2005, VITAM HORM, V73, P31, DOI 10.1016/S0083-6729(05)73002-8; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Huang X, 2005, DEVELOPMENT, V132, P5115, DOI 10.1242/dev.02079; Iga M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103239; Iga M, 2012, BIOL PHARM BULL, V35, P838, DOI 10.1248/bpb.35.838; Komura-Kawa T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005712; Lavrynenko O, 2015, DEVELOPMENT, V142, P3758, DOI 10.1242/dev.124982; Lerner F, 2001, BIOCHEM BIOPH RES CO, V288, P69, DOI 10.1006/bbrc.2001.5735; Love NR, 2015, P NATL ACAD SCI USA, V112, P1386, DOI 10.1073/pnas.1417290112; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Niwa R, 2005, INSECT MOL BIOL, V14, P563, DOI 10.1111/j.1365-2583.2005.00587.x; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Ogihara MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124953; Ohashi K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2262; Okano S, 2010, GENES CELLS, V15, P77, DOI 10.1111/j.1365-2443.2009.01366.x; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; WATANABE N, 1983, BIOCHEM BIOPH RES CO, V113, P377, DOI 10.1016/0006-291X(83)91737-0; Yamanaka N, 2015, CELL, V163, P907, DOI 10.1016/j.cell.2015.10.022; Yin CL, 2016, NUCLEIC ACIDS RES, V44, pD801, DOI 10.1093/nar/gkv1204; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428	32	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172951	10.1371/journal.pone.0172951	http://dx.doi.org/10.1371/journal.pone.0172951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257485	gold, Green Published, Green Submitted			2022-12-27	WOS:000396021100045
J	Ross, I; Mejia, C; Melendez, J; Chan, PA; Nunn, AC; Powderly, W; Goodenberger, K; Liu, JX; Mayer, KH; Patel, RR				Ross, Ian; Mejia, Carlos; Melendez, Johanna; Chan, Philip A.; Nunn, Amy C.; Powderly, William; Goodenberger, Katherine; Liu, Jingxia; Mayer, Kenneth H.; Patel, Rupa R.			Awareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: Implications for country-wide implementation	PLOS ONE			English	Article							HEALTH-CARE PROVIDERS; RANDOMIZED CLINICAL-TRIAL; ANTIRETROVIRAL PROPHYLAXIS; DRUG-RESISTANCE; UNITED-STATES; HIGH-RISK; MEN; INFECTION; WOMEN; PREP	Introduction HIV continues to be a major health concern with approximately 2.1 million new infections occurring worldwide in 2015. In Central America, Guatemala had the highest incident number of HIV infections (3,700) in 2015. Antiretroviral pre-exposure prophylaxis (PrEP) was recently recommended by the World Health Organization (WHO) as an efficacious intervention to prevent HIV transmission. PrEP implementation efforts are underway in Guatemala and success will require providers that are knowledgeable and willing to prescribe PrEP. We sought to explore current PrEP awareness and prescribing attitudes among Guatemalan physicians in order to inform future PrEP implementation efforts. Methods We conducted a cross-sectional survey of adult internal medicine physicians at the main teaching hospital in Guatemala City in March 2015. The survey included demographics, medical specialty, years of HIV patient care, PrEP awareness, willingness to prescribe PrEP, previous experience with post-exposure prophylaxis, and concerns about PrEP. The primary outcome was willingness to prescribe PrEP, which was assessed using a 5-point Likert scale for different at-risk population scenarios. Univariate and multivariate logistic regression was performed to identify predictors for willingness to prescribe PrEP. Results Eighty-seven physicians completed the survey; 66% were male, 64% were internal medicine residency trainees, and 10% were infectious disease (ID) specialists. Sixty-nine percent of physicians were PrEP aware, of which 9% had previously prescribed PrEP. Most (87%) of respondents were willing to prescribe PrEP to men who have sex with men (MSM), sex workers, injection drug users, or HIV-uninfected persons having known HIV-positive sexual partners. Concerns regarding PrEP included development of resistance (92%), risk compensation (90%), and cost (64%). Univariate logistic regression showed that younger age, being a resident trainee, and being a non-ID specialist were significant predictors for willingness to prescribe PrEP. In multivariate logistic regression, being a non-ID specialist was a significant predictor. Conclusions Guatemalan physicians at an urban public hospital were PrEP aware and willing to prescribe, but few have actually done so yet. Future education programs should address the concerns identified, including the low potential for the development of antiretroviral resistance. These findings can aid PrEP implementation efforts in Guatemala.	[Ross, Ian; Powderly, William; Goodenberger, Katherine; Patel, Rupa R.] Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA; [Mejia, Carlos; Melendez, Johanna] Roosevelt Hosp, Div Infect Dis, Guatemala City, Guatemala; [Chan, Philip A.] Brown Univ, Div Infect Dis, Providence, RI 02912 USA; [Nunn, Amy C.] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA; [Liu, Jingxia] Washington Univ, Sch Med, Div Publ Hlth Sci, St Louis, MO USA; [Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Mayer, Kenneth H.] Harvard Med Sch, Div Infect Dis, Boston, MA USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA	Washington University (WUSTL); Brown University; Brown University; Washington University (WUSTL); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Fenway Health	Patel, RR (corresponding author), Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA.	rupapatel@email.wustl.edu		Chan, Philip/0000-0003-0964-5895; Powderly, William/0000-0001-7808-3086	Washington University in St. Louis Mentors in Medicine International Grant; Washington University Institute of Clinical and Translational Sciences [UL1TR000448]; National Center for Advancing Translational Sciences of the National Institutes of Health [KL2TR000450]; National Institute of Allergy And Infectious Diseases [1K23AI096923]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000450, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH083620] Funding Source: NIH RePORTER	Washington University in St. Louis Mentors in Medicine International Grant; Washington University Institute of Clinical and Translational Sciences; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	IR is supported by the Washington University in St. Louis Mentors in Medicine International Grant. RRP is supported by the Washington University Institute of Clinical and Translational Sciences grant UL1TR000448, sub-award KL2TR000450, from the National Center for Advancing Translational Sciences of the National Institutes of Health. PAC is supported by the National Institute of Allergy And Infectious Diseases (1K23AI096923). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews CD, 2015, CURR OPIN HIV AIDS, V10, P258, DOI 10.1097/COH.0000000000000161; [Anonymous], 2014, PREEXP PROPH PREV HI; Auerbach JD, 2015, J INT AIDS SOC, V18, P30, DOI 10.7448/IAS.18.4.19983; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten J.M., 2016, N ENGL J MED; Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Caceres CF, 2015, J INT AIDS SOC S3, V18; Chakrapani V, 2015, AIDS PATIENT CARE ST, V29, P569, DOI 10.1089/apc.2015.0143; Chan PA, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20903; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hankins C, 2015, J INT AIDS SOC, V18, P71, DOI 10.7448/IAS.18.4.19973; Karris MY, 2014, CLIN INFECT DIS, V58, P704, DOI 10.1093/cid/cit796; Krakower D, 2014, AIDS BEHAV, V18, P1712, DOI 10.1007/s10461-014-0839-3; Krakower D, 2012, CURR OPIN HIV AIDS, V7, P593, DOI 10.1097/COH.0b013e3283590446; Lehman DA, 2015, J INFECT DIS, V211, P1211, DOI 10.1093/infdis/jiu677; Liegler T, 2014, J INFECT DIS, V210, P1217, DOI 10.1093/infdis/jiu233; Liu AY, 2013, JAIDS-J ACQ IMM DEF, V64, P87, DOI 10.1097/QAI.0b013e31828f097a; Marcus JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081997; Marrazzo JM, 2014, JAMA-J AM MED ASSOC, V312, P390, DOI 10.1001/jama.2014.7999; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Mimiaga MJ, 2014, AIDS CARE, V26, P684, DOI 10.1080/09540121.2013.845289; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Mugo NR, 2016, CURR OPIN HIV AIDS, V11, P80, DOI 10.1097/COH.0000000000000224; Mugwanya KK, 2015, JAMA INTERN MED, V175, P246, DOI 10.1001/jamainternmed.2014.6786; Nel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147743; Puro V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-217; Schackman BR, 2012, CURR OPIN HIV AIDS, V7, P587, DOI 10.1097/COH.0b013e3283582c8b; Tang EC, 2014, AIDS RES HUM RETROV, V30, P416, DOI [10.1089/aid.2013.0212, 10.1089/AID.2013.0212]; Tellalian D, 2013, AIDS PATIENT CARE ST, V27, P553, DOI 10.1089/apc.2013.0173; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tripathi A, 2012, SOUTH MED J, V105, P199, DOI 10.1097/SMJ.0b013e31824f1a1b; UNAIDS and Stop AIDS Alliance, 2015, COMM DEL, P23; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; White JM, 2012, AIDS PATIENT CARE ST, V26, P395, DOI 10.1089/apc.2012.0030; WHO, 2014, CONSOLIDATED GUIDELI; Wolitski R., 2004, AIDS OTHER MANIFESTA, P997; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2005, GUAT SUMM COUNTR PRO	41	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173057	10.1371/journal.pone.0173057	http://dx.doi.org/10.1371/journal.pone.0173057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257475	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100053
J	Bell, SM; Wendt, DJ; Zhang, YH; Taylor, TW; Long, SN; Tsuruda, L; Zhao, B; Laipis, P; Fitzpatrick, PA				Bell, Sean M.; Wendt, Dan J.; Zhang, Yanhong; Taylor, Timothy W.; Long, Shinong; Tsuruda, Laurie; Zhao, Bin; Laipis, Phillip; Fitzpatrick, Paul A.			Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria	PLOS ONE			English	Article							POLYETHYLENE-GLYCOL; ENZYME-REACTORS; MANAGEMENT; CLEARANCE; FORMS	Phenylketonuria (PKU) is a genetic metabolic disease in which the decrease or loss of phenylalanine hydroxylase (PAH) activity results in elevated, neurotoxic levels of phenylalanine (Phe). Due to many obstacles, PAH enzyme replacement therapy is not currently an option. Treatment of PKU with an alternative enzyme, phenylalanine ammonia lyase (PAL), was first proposed in the 1970s. However, issues regarding immunogenicity, enzyme production and mode of delivery needed to be overcome. Through the evaluation of PAL enzymes from multiple species, three potential PAL enzymes from yeast and cyanobacteria were chosen for evaluation of their therapeutic potential. The addition of polyethylene glycol (PEG, MW=20,000), at a particular ratio to modify the protein surface, attenuated immunogenicity in an animal model of PKU. All three PEGylated PAL candidates showed efficacy in a mouse model of PKU (BTBR Pah(enu2)) upon subcutaneous injection. However, only PEGylated Anabaena variabilis (Av) PAL-treated mice demonstrated sustained low Phe levels with weekly injection and was the only PAL evaluated that maintained full enzymatic activity upon PEGylation. A PEGylated recombinant double mutant version of AvPAL (Cys503Ser/Cys565Ser), rAvPAL-PEG, was selected for drug development based on its positive pharmacodynamic profile and favorable expression titers. PEGylation was shown to be critical for rAvPAL-PEG efficacy as under PEGylated rAvPAL had a lower pharmacodynamic effect. rAvPAL and rAvPAL-PEG had poor stability at 4 degrees C. L-Phe and trans-cinnamate were identified as activity stabilizing excipients. rAvPAL-PEG is currently in Phase 3 clinical trials to assess efficacy in PKU patients.	[Bell, Sean M.; Wendt, Dan J.; Zhang, Yanhong; Taylor, Timothy W.; Long, Shinong; Tsuruda, Laurie; Zhao, Bin; Fitzpatrick, Paul A.] BioMarin Pharmaceut, Novato, CA USA; [Laipis, Phillip] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Zhao, Bin] BioZ Consulting, San Ramon, CA USA	BioMarin Pharmaceutical Inc.; State University System of Florida; University of Florida	Bell, SM (corresponding author), BioMarin Pharmaceut, Novato, CA USA.	sbell@bmrn.com			BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.	This study was funded by BioMarin Pharmaceutical Inc. the employer of all the authors except Phillip Laipis.	ABELL CW, 1972, CANCER RES, V32, P285; Alunni S, 2003, ARCH BIOCHEM BIOPHYS, V412, P170, DOI 10.1016/S0003-9861(03)00007-9; AMBRUS CM, 1983, J PHARMACOL EXP THER, V224, P598; AMBRUS CM, 1978, SCIENCE, V201, P837, DOI 10.1126/science.567372; [Anonymous], 2001, METABOLIC MOL BASES, DOI DOI 10.1036/OMMBID.97; Belanger-Quintana A, 2011, MOL GENET METAB, V104, pS19, DOI 10.1016/j.ymgme.2011.08.009; Blau N, 2013, EXPERT OPIN DRUG MET, V9, P1207, DOI 10.1517/17425255.2013.804064; Blau N, 2009, MOL GENET METAB, V96, P158, DOI 10.1016/j.ymgme.2009.01.002; BOURGET L, 1989, BIOMATER ARTIF CELL, V17, P161, DOI 10.3109/10731198909118278; Bowersox J, 2001, PEDIATRICS, V108, P972; Calabrese JC, 2004, BIOCHEMISTRY-US, V43, P11403, DOI 10.1021/bi049053+; Cui JD, 2014, CRIT REV BIOTECHNOL, V34, P258, DOI 10.3109/07388551.2013.791660; Fisch RO, 2000, EUR J PEDIATR, V159, pS142, DOI 10.1007/PL00014378; Gamez A, 2005, MOL THER, V11, P986, DOI 10.1016/j.ymthe.2005.02.013; Gamez A, 2004, MOL THER, V9, P124, DOI 10.1016/j.ymthe.2003.11.002; Gamez A, 2007, MOL GENET METAB, V91, P325, DOI 10.1016/j.ymgme.2007.04.015; HOSKINS JA, 1982, RES COMMUN CHEM PATH, V35, P275; HOSKINS JA, 1980, LANCET, V1, P392; Ikeda K, 2005, AMINO ACIDS, V29, P283, DOI 10.1007/s00726-005-0218-5; INOUE S, 1986, BIOCHEM BIOPH RES CO, V141, P165, DOI 10.1016/S0006-291X(86)80349-7; Jingzhong L, 1998, Chin J Biotechnol, V14, P227; Kim W, 2004, MOL THER, V10, P220, DOI 10.1016/j.ymthe.2004.05.001; Longo N, 2014, LANCET; Martynyuk AE, 2007, EPILEPSIA, V48, P1143, DOI 10.1111/j.1528-1167.2007.01115.x; Mima Y, 2015, MOL PHARMACEUT, V12, P2429, DOI 10.1021/acs.molpharmaceut.5b00144; Mitchell JJ, 2011, GENET MED, V13, P697, DOI 10.1097/GIM.0b013e3182141b48; Moffitt MC, 2007, BIOCHEMISTRY-US, V46, P1004, DOI 10.1021/bi061774g; Poppe L, 2005, ANGEW CHEM INT EDIT, V44, P3668, DOI 10.1002/anie.200461377; Rauk AP, 2014, J PHARM SCI-US, V103, P2278, DOI 10.1002/jps.24063; ROBERTS J, 1976, CANCER TREAT REP, V60, P261; Sarkissian CN, 2008, P NATL ACAD SCI USA, V105, P20894, DOI 10.1073/pnas.0808421105; Sarkissian CN, 1999, P NATL ACAD SCI USA, V96, P2339, DOI 10.1073/pnas.96.5.2339; SCHULZ W, 1989, FEBS LETT, V258, P335, DOI 10.1016/0014-5793(89)81687-4; SHEDLOVSKY A, 1993, GENETICS, V134, P1205; SHEN RS, 1979, CANCER TREAT REP, V63, P1063; SHEN RS, 1977, CANCER RES, V37, P1051; Walter JH, 2002, LANCET, V360, P55, DOI 10.1016/S0140-6736(02)09334-0; Wang L, 2005, MOL GENET METAB, V86, P134, DOI 10.1016/j.ymgme.2005.05.012; Wang L, 2008, J MOL BIOL, V380, P623, DOI 10.1016/j.jmb.2008.05.025; WIEDER KJ, 1979, J BIOL CHEM, V254, P2579; Yang Q, 2015, WIRES NANOMED NANOBI, V7, P655, DOI 10.1002/wnan.1339; ZUCKER M, 1969, PLANT PHYSIOL, V44, P912, DOI 10.1104/pp.44.6.912; Zurfluh MR, 2008, HUM MUTAT, V29, P167, DOI 10.1002/humu.20637	43	42	45	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173269	10.1371/journal.pone.0173269	http://dx.doi.org/10.1371/journal.pone.0173269			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282402	Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800026
J	Adams, LC; Boker, SM; Bender, YY; Diederichs, G; Fallenberg, EM; Wagner, M; Hamm, B; Makowski, MR				Adams, Lisa C.; Boeker, Sarah M.; Bender, Yvonne Y.; Diederichs, Gerd; Fallenberg, Eva M.; Wagner, Moritz; Hamm, Bernd; Makowski, Marcus R.			Diagnostic accuracy of susceptibility-weighted magnetic resonance imaging for the evaluation of pineal gland calcification	PLOS ONE			English	Article							INTRACRANIAL CALCIFICATIONS; COMPUTED-TOMOGRAPHY; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; FIELD-STRENGTH; MAPPING QSM; IN-VIVO; MELATONIN; MICROBLEEDS; LESIONS	Objectives To determine the diagnostic performance of susceptibility-weighted magnetic resonance imaging (SWMR) for the detection of pineal gland calcifications (PGC) compared to conventional magnetic resonance imaging (MRI) sequences, using computed tomography (CT) as a reference standard. Methods 384 patients who received a 1.5 Tesla MRI scan including SWMR sequences and a CT scan of the brain between January 2014 and October 2016 were retrospectively evaluated. 346 patients were included in the analysis, of which 214 showed PGC on CT scans. To assess correlation between imaging modalities, the maximum calcification diameter was used. Sensitivity and specificity and intra-and interobserver reliability were calculated for SWMR and conventional MRI sequences. Results SWMR reached a sensitivity of 95% (95% CI: 91%-97%) and a specificity of 96% (95% CI: 91%-99%) for the detection of PGC, whereas conventional MRI achieved a sensitivity of 43% (95% CI: 36%-50%) and a specificity of 96% (95% CI: 91%-99%). Detection rates for calcifications in SWMR and conventional MRI differed significantly (95% versus 43%, p< 0.001). Diameter measurements between SWMR and CT showed a close correlation (R-2 = 0.85, p< 0.001) with a slight but not significant overestimation of size (SWMR: 6.5 mm +/- 2.5; CT: 5.9 mm +/- 2.4, p = 0.02). Interobserver-agreement for diameter measurements was excellent on SWMR (ICC = 0.984, p < 0.0001). Conclusions Combining SWMR magnitude and phase information enables the accurate detection of PGC and offers a better diagnostic performance than conventional MRI with CT as a reference standard.	[Adams, Lisa C.; Boeker, Sarah M.; Bender, Yvonne Y.; Diederichs, Gerd; Fallenberg, Eva M.; Wagner, Moritz; Hamm, Bernd; Makowski, Marcus R.] Charite, Dept Radiol, Berlin, Germany; [Makowski, Marcus R.] Charite, Dept Radiol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Adams, LC (corresponding author), Charite, Dept Radiol, Berlin, Germany.	lisa.adams@charite.de	Adams, Lisa C./AAC-7163-2021; Fallenberg, Eva Maria/C-7069-2014; Makowski, Marcus R/Q-7957-2018	Adams, Lisa C./0000-0001-5836-4542; Fallenberg, Eva Maria/0000-0001-8060-0468; 	Deutsche Forschungsgesellschaft (DFG); GIF (German Israel Research Foundation)	Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG)); GIF (German Israel Research Foundation)	MRM has received grants from the Deutsche Forschungsgesellschaft (DFG) and GIF (German Israel Research Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admassie Daniel, 2009, Ethiop Med J, V47, P55; Awa R, 2014, NEURORADIOLOGY, V56, P525, DOI 10.1007/s00234-014-1369-4; Bai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053237; Barbosa Jeam Haroldo Oliveira, 2015, Radiol Bras, V48, P93, DOI 10.1590/0100-3984.2014.0010; Buch S, 2016, NMR BIOMEDICINE; Chen WW, 2014, RADIOLOGY, V270, P496, DOI 10.1148/radiol.13122640; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; CICCHETTI DV, 1994, J CLIN EXP NEUROPSYC, V16, P155, DOI 10.1080/01688639408402625; Daghighi M. H., 2007, Folia Morphologica, V66, P115; Deistung A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057924; Deistung A, 2013, NEUROIMAGE, V65, P299, DOI 10.1016/j.neuroimage.2012.09.055; Del Brutto OH, 2015, CLIN NEUROL NEUROSUR, V130, P91, DOI 10.1016/j.clineuro.2014.12.019; Dumrongpisutikul N, 2012, AM J NEURORADIOL, V33, P550, DOI 10.3174/ajnr.A2806; Fang AS, 2013, INSIGHTS IMAGING, V4, P369, DOI 10.1007/s13244-013-0248-6; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2015, MAGN RESON IMAGING, V33, P1, DOI 10.1016/j.mri.2014.09.004; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Ide S, 2015, EUR RADIOL, V25, P710, DOI 10.1007/s00330-014-3472-7; Kitkhuandee A, 2014, J STROKE CEREBROVASC, V23, P249, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.009; Langkammer C, 2013, RADIOLOGY, V267, P551, DOI 10.1148/radiol.12120707; Liebrich LS, 2014, J MAGN RESON IMAGING, V40, P966, DOI 10.1002/jmri.24449; Liu CL, 2015, J MAGN RESON IMAGING, V42, P23, DOI [10.3969/j.issn.1001-2400.2015.01.004, 10.1002/jmri.24768]; Liu RY, 1999, J CLIN ENDOCR METAB, V84, P323, DOI 10.1210/jc.84.1.323; Mahlberg R, 2008, NEUROBIOL AGING, V29, P203, DOI 10.1016/j.neurobiolaging.2006.10.003; Mahlberg R, 2009, SLEEP MED, V10, P439, DOI 10.1016/j.sleep.2008.05.003; Maslinska D, 2010, FOLIA NEUROPATHOL, V48, P276; Mayo JC, 2005, ENDOCRINE, V27, P169, DOI 10.1385/ENDO:27:2:169; McCollough CH, 2007, RADIOLOGY, V243, P527, DOI 10.1148/radiol.2432050808; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Norenberg D, 2016, RADIOLOGY, V278, P475, DOI 10.1148/radiol.2015150034; Nolte I, 2010, CLIN NEUROL NEUROSUR, V112, P204, DOI 10.1016/j.clineuro.2009.11.010; NORMAN D, 1978, J COMPUT ASSIST TOMO, V2, P61, DOI 10.1097/00004728-197801000-00009; Pandi-Perumal SR, 2006, FEBS J, V273, P2813, DOI 10.1111/j.1742-4658.2006.05322.x; Rocha CS, 2015, CURR MOL MED, V15, P299, DOI 10.2174/1566524015666150505155530; Schweser F, 2010, MED PHYS, V37, P5165, DOI 10.1118/1.3481505; Sigurdardottir LG, 2016, J BIOL RHYTHM, V31, P461, DOI 10.1177/0748730416656948; Smith AB, 2010, RADIOGRAPHICS, V30, P2001, DOI 10.1148/rg.307105131; Srinivasan V, 2011, RECENT PATENTS ENDOC, V5, P109, DOI 10.2174/187221411799015408; Straub S, 2016, J MAGN RESON IMAGING; Tuntapakul S, 2016, ASIA-PAC J CLIN ONCO, V12, pE405, DOI 10.1111/ajco.12519; Turgut Ahmet Tuncay, 2008, Pathophysiology, V15, P41, DOI 10.1016/j.pathophys.2008.02.001; Yalcin A, 2016, J CHEM NEUROANAT, V78, P20, DOI 10.1016/j.jchemneu.2016.07.008; Yang Q, 2009, J MAGN RESON IMAGING, V30, P357, DOI 10.1002/jmri.21859; Zhou JN, 2003, J PINEAL RES, V34, P11, DOI 10.1034/j.1600-079X.2003.01897.x; Zhu WZ, 2008, CHINESE MED J-PEKING, V121, P2021, DOI 10.1097/00029330-200810020-00014; Zulfiqar M, 2012, AM J NEURORADIOL, V33, P858, DOI 10.3174/ajnr.A2862	47	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172764	10.1371/journal.pone.0172764	http://dx.doi.org/10.1371/journal.pone.0172764			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278291	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900128
J	Choi, WS; Cowling, BJ; Noh, JY; Song, JY; Wie, SH; Lee, JS; Seo, YB; Lee, J; Jeong, HW; Kim, YK; Kim, SW; Park, KH; Lee, SH; Cheong, HJ; Kim, WJ				Choi, Won Suk; Cowling, Benjamin J.; Noh, Ji Yun; Song, Joon Young; Wie, Seong-Heon; Lee, Jin Soo; Seo, Yu Bin; Lee, Jacob; Jeong, Hye Won; Kim, Young Keun; Kim, Shin-Woo; Park, Kyong-Hwa; Lee, Sun Hee; Cheong, Hee Jin; Kim, Woo Joo			Disease burden of 2013-2014 seasonal influenza in adults in Korea	PLOS ONE			English	Article							RESPIRATORY-INFECTIONS; PATTERNS	Background This study was performed to investigate the disease burden of seasonal influenza in adults >= 20 years of age in Korea, based on surveillance data from the Hospital-based Influenza Morbidity & Mortality Surveillance (HIMM) network. Materials and methods The HIMM network is composed of two surveillance systems: emergency room-based and inpatients-based surveillance. A total of ten university hospitals all over the country are included in the surveillance network. The adult catchment population of the HIMM network was calculated by using the data of each hospital and the database of the Health Insurance Review and Assessment Service (HIRA) of Korea. The incidence rates of laboratory-confirmed medically-attended influenza, laboratory-confirmed influenza-related admission and laboratory-confirmed influenza-related death were calculated based on the catchment population. The socioeconomic burden of influenza was estimated using the human capital approach. Results During the 2013-2014 influenza season, the calculated adult catchment population of the HIMM network was 1,380,000. The incidence of medically-attended laboratory-confirmed influenza infection was 242.8 per 100,000 adults. The incidence of laboratory-confirmed influenza-related admission was 57.9 per 100,000 adults. The incidence of laboratory-confirmed influenza-related death was 3.1 per 100,000 adults. The total socioeconomic cost of 2013-2014 seasonal influenza in Korean adult population was estimated as 125 million USD (1 USD = 1,100 KRW). Conclusion The disease burden of 2013-2014 seasonal influenza in Korean adult population is very high and indicates that more active prevention and control policies will be needed to decrease the burden. Additional researches will be needed to assess the burden of seasonal influenza in the Korean child population.	[Choi, Won Suk; Noh, Ji Yun; Song, Joon Young; Cheong, Hee Jin; Kim, Woo Joo] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Cowling, Benjamin J.] Univ Hong Kong, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Pokfulam, Hong Kong, Peoples R China; [Wie, Seong-Heon] Catholic Univ Korea, Coll Med, St Vincents Hosp, Div Infect Dis,Dept Internal Med, Seoul, South Korea; [Lee, Jin Soo] Inha Univ, Sch Med, Inha Univ Hosp, Div Infect Dis,Dept Internal Med, Incheon, South Korea; [Seo, Yu Bin; Lee, Jacob] Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Div Infect Dis,Dept Internal Med, Seoul, South Korea; [Jeong, Hye Won] Chungbuk Natl Univ, Coll Med, Chungbuk Univ Hosp, Div Infect Dis,Dept Internal Med, Cheongju, South Korea; [Kim, Young Keun] Yonsei Univ, Wonju Coll Med, Wonju Christian Hosp, Div Infect Dis,Dept Internal Med, Wonju, South Korea; [Kim, Shin-Woo] Kyungpook Natl Univ, Coll Med, Dept Internal Med, Daegu, South Korea; [Park, Kyong-Hwa] Chonnam Natl Univ, Sch Med, Div Infect Dis, Gwangju, South Korea; [Lee, Sun Hee] Pusan Natl Univ, Coll Med, Dept Internal Med, Busan, South Korea; [Kim, Woo Joo] Transgovt Enterprise Pandem Influenza Korea, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); University of Hong Kong; World Health Organization; Catholic University of Korea; Inha University; Inha University Hospital; Hallym University; Chungbuk National University; Yonsei University; Kyungpook National University; Chonnam National University; Pusan National University	Kim, WJ (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea.; Kim, WJ (corresponding author), Transgovt Enterprise Pandem Influenza Korea, Seoul, South Korea.	wjkim@korea.ac.kr	Choi, Won Suk/V-2730-2017; Cowling, Benjamin/C-4263-2009	Choi, Won Suk/0000-0001-5874-4764; Song, Joon Young/0000-0002-0148-7194; Cowling, Benjamin/0000-0002-6297-7154; Cheong, Hee Jin/0000-0002-2532-1463	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A103001]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (Grant No.: A103001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, WKLY EPIDEMIOL REC, V89, P245; [Anonymous], 2012, WKLY EPIDEMIOL REC, V87, P461; Choi WS, 2010, J CLIN VIROL, V47, P325, DOI 10.1016/j.jcv.2010.01.003; Fedson DS, 2005, VACCINE, V23, P5133, DOI 10.1016/j.vaccine.2005.06.010; He DH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11013; Jung Young-Ho, 2006, J Prev Med Public Health, V39, P499; Kee SY, 2007, J INFECTION, V55, P273, DOI 10.1016/j.jinf.2007.04.354; Kim YW, 2013, SCAND J INFECT DIS, V45, P390, DOI 10.3109/00365548.2012.749423; Lai PL, 2011, HUM VACCINES, V7, P217, DOI 10.4161/hv.7.0.14607; MoEa Labor, 2014, 2013 SURVEY REPORT L; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; No IC, 1997, SOCIOECONOMIC COSTS; Office KNS, KOR STAT INF SERV; Park M, 2015, AM J PREVENTIVE MED; Pitman RJ, 2007, J INFECTION, V54, P530, DOI 10.1016/j.jinf.2006.09.017; Seo NG, 2013, REPORT KOREA HLTH PA; Song JY, 2013, J MED VIROL, V85, P910, DOI 10.1002/jmv.23548; Suh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084121; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; YSea Shin, 2010, REPORT DAILY NURSING; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552	22	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172012	10.1371/journal.pone.0172012	http://dx.doi.org/10.1371/journal.pone.0172012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278158	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900114
J	Lim, GXY; Yeo, ML; Koh, YY; Winarni, TI; Rajan-Babu, IS; Chong, SS; Faradz, SMH; Guan, M				Lim, Grace X. Y.; Yeo, Minli; Koh, Yvonne Y.; Winarni, Tri Indah; Rajan-Babu, Indhu-Shree; Chong, Samuel S.; Faradz, Sultana M. H.; Guan, Ming			Validation of a commercially available test that enables the quantification of the numbers of CGG trinucleotide repeat expansion in FMR1 gene	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; EXPANDED ALLELES; PRIMED PCR; FULL MUTATIONS; GUIDELINES; IDENTIFICATION; DISORDERS; DIAGNOSIS; NEWBORN; ASSAY	In the present study, we evaluated a commercially available TP-PCR-based assay, the FastFraX(TM) FMR1 Sizing kit, as a test in quantifying the number of CGG repeats in the FMR1 gene. Based on testing with well characterized DNA samples from Coriell, the kit yielded size results within 3 repeats of those obtained by common consensus (n = 14), with the exception of one allele. Furthermore, based on data obtained using all Coriell samples with or without common consensus (n = 29), the Sizing kit was 97.5% in agreement with existing approaches. Additionally, the kit generated consistent size information in repeatability and reproducibility studies (CV 0.39% to 3.42%). Clinical performance was established with 198 archived clinical samples, yielding results of 100% sensitivity (95% CI, 91.03% to 100%) and 100% specificity (95% CI, 97.64% to 100%) in categorizing patient samples into the respective normal, intermediate, premutation and full mutation genotypes.	[Lim, Grace X. Y.; Yeo, Minli; Koh, Yvonne Y.; Guan, Ming] BioFactory Pte Ltd, Singapore, Singapore; [Winarni, Tri Indah; Faradz, Sultana M. H.] Diponegoro Univ, Div Human Genet, Ctr Biomed Res, Fac Med, Semarang, Indonesia; [Rajan-Babu, Indhu-Shree; Chong, Samuel S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore; [Chong, Samuel S.] Natl Univ Hlth Syst, Khoo Teck Puat Natl Univ Childrens Med Inst, Singapore, Singapore; [Chong, Samuel S.] Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore	Diponegoro University; National University of Singapore; National University of Singapore; National University of Singapore	Lim, GXY (corresponding author), BioFactory Pte Ltd, Singapore, Singapore.	grace@thebiofactory.com	Faradz/AAI-4583-2020; Chong, Samuel S./D-8098-2015	Chong, Samuel S./0000-0002-1872-5937; Rajan Babu, Indhu Shree/0000-0002-5614-5212; Winarni, Tri/0000-0001-5450-2813	Biofactory Ptd Ltd	Biofactory Ptd Ltd	The authors received no specific funding for this work. The Biofactory Ptd Ltd provided support in the form of salaries for authors GXYL, MY, YYK and MG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Biancalana V, 2015, EUR J HUM GENET, V23, P417, DOI 10.1038/ejhg.2014.185; Chen LJ, 2010, J MOL DIAGN, V12, P589, DOI 10.2353/jmoldx.2010.090227; Filipovic-Sadic S, 2010, CLIN CHEM, V56, P399, DOI 10.1373/clinchem.2009.136101; Fu YH, 1991, CELL, P67; Haddad LA, 1996, HUM GENET, V97, P808; Hantash FM, 2010, GENET MED, V12, P162, DOI 10.1097/GIM.0b013e3181d0d40e; Juusola JS, 2012, J MOL DIAGN, V14, P476, DOI 10.1016/j.jmoldx.2012.03.005; Lim GXY, 2015, J MOL DIAGN, V17, P302, DOI 10.1016/j.jmoldx.2014.12.005; Lyon E, 2010, J MOL DIAGN, V12, P505, DOI 10.2353/jmoldx.2010.090229; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Monaghan KG, 2013, GENET MED, V15, P575, DOI 10.1038/gim.2013.61; Mundhofir FE, 2014, WORLD J MED GENET, DOI 25278957; OOSTRA BA, 1993, J MED GENET, V30, P410, DOI 10.1136/jmg.30.5.410; Pretto D, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00318; Rajan-Babu IS, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.5; Rajan-Babu IS, 2015, EXPERT REV MOL DIAGN, V15, P431, DOI 10.1586/14737159.2015.1001749; Tassone F, 2008, J MOL DIAGN, V10, P43, DOI 10.2353/jmoldx.2008.070073; Teo CRL, 2012, CLIN CHEM, V58, P568, DOI 10.1373/clinchem.2011.174615; Warner JP, 1996, J MED GENET, V33, P1022, DOI 10.1136/jmg.33.12.1022; Wilson JA, 2008, J MOL DIAGN, V10, P2, DOI 10.2353/jmoldx.2008.070105	20	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173279	10.1371/journal.pone.0173279	http://dx.doi.org/10.1371/journal.pone.0173279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278294	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900065
J	Park, SH; Lee, L; Shearston, JA; Weitzman, M				Park, Su Hyun; Lee, Lily; Shearston, Jenni A.; Weitzman, Michael			Patterns of electronic cigarette use and level of psychological distress	PLOS ONE			English	Article							MENTAL-HEALTH; TOBACCO SMOKING; NATIONAL-SURVEY; ASSOCIATION; ILLNESS; K6; ADULTS; RISK; SURVEILLANCE; PERFORMANCE	Background Psychological distress has been correlated with higher levels of nicotine dependence. To date, the possible association between individuals' levels of psychological distress and e-cigarette use has not been investigated, despite the dramatic growth of e-cigarette use in the US. We examined this possible association using a nationally representative sample of US adults. Methods A total of 36,697 adults from the 2014 National Health Interview Survey (NHIS) were included. The Kessler 6 scale was used to measure psychological distress. Multivariate logistic regression analysis was conducted to assess the association between level of psychological distress and e-cigarette use. Results Both e-cigarette and cigarette use varied according to level of psychological distress as well as multiple socio-demographic characteristics. In a multivariate model, psychological distress was significantly associated with the following groups: (a) exclusive e-cigarette everuse (aOR = 3.7; 95% CI = 1.6, 8.6), (b) current dual use of e-cigarettes and cigarettes (aOR = 4.6; 95% CI = 3.1, 6.7), (c) former cigarette use and ever use of e-cigarette (aOR = 3.2; 95% CI = 2.2, 4.8) and (d) current use of cigarettes only (aOR = 2.1; 95% CI = 1.7, 2.6). Conclusion These are the first data to demonstrate that, as is true for cigarettes, e-cigarette use is associated with increased levels of psychological distress. Further large-scale, longitudinal studies are needed to determine the direction of this relationship and to evaluate the long-term positive and negative consequences of such use.	[Park, Su Hyun; Lee, Lily; Weitzman, Michael] NYU, Sch Med, Dept Pediat, New York, NY USA; [Park, Su Hyun; Shearston, Jenni A.] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Lee, Lily; Weitzman, Michael] Brooklyn Coll, New York, NY 11210 USA; [Shearston, Jenni A.] NYU, Coll Global Publ Hlth, New York, NY USA; [Shearston, Jenni A.; Weitzman, Michael] New York Univ, Abu Dhabi Publ Hlth Res Ctr, Abu Dhabi, U Arab Emirates; [Weitzman, Michael] NYU, Dept Environm Med, New York, NY 10016 USA	New York University; New York University; City University of New York (CUNY) System; Brooklyn College (CUNY); New York University; New York University	Weitzman, M (corresponding author), NYU, Sch Med, Dept Pediat, New York, NY USA.	michael.weitzman@nyumc.org	Lee, Lily/GWZ-7968-2022	Shearston, Jenni/0000-0002-3277-9958; Park, Su Hyun/0000-0002-5527-7520; Lee, Lily/0000-0001-9716-1983	NIH/NCI [3P30 CA016087-3351]; Abu Dhabi Institute, New York University/Abu Dhabi	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Abu Dhabi Institute, New York University/Abu Dhabi	This work was supported by NIH/NCI 3P30 CA016087-3351 (LL and MW) and the Abu Dhabi Institute, New York University/Abu Dhabi (JS and MW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; Bell K, 2012, INT J DRUG POLICY, V23, P242, DOI 10.1016/j.drugpo.2012.01.006; Bell S, 2015, JAMA PSYCHIAT, V72, P1254, DOI 10.1001/jamapsychiatry.2015.2107; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Bullen C, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0538-8; Burnette D, 2016, PSYCHO-ONCOLOGY, V26; CDC, 2013, 5 CDC; CDC, 2016, TRENDS CURR CIG SMOK; Centers for Disease Control (CDC), 2014, NAT HLTH INT SURV NH; Coleman BN, 2015, NICOTINE TOB RES, V17, P212, DOI 10.1093/ntr/ntu211; Cummins S. E., 2014, Tobacco Control, V23, piii48, DOI 10.1136/tobaccocontrol-2013-051511; Cummins SE, 2014, TOBACCO CONTROL; Cunningham Timothy J, 2015, Sleep Disord, V2015, P172064, DOI 10.1155/2015/172064; Degenhardt L, 2001, Nicotine Tob Res, V3, P225; DELEON J, 1995, AM J PSYCHIAT, V152, P453; Domingo AK, 2015, SAMJ S AFR MED J, V105, P1057, DOI [10.7196/SAMJ.2015.v105i12.9843, 10.7196/samj.2015.v105i12.9843]; Dutra LM, 2014, JAMA PEDIATR, V168, P684, DOI 10.1001/jamapediatrics.2013.5488; el-Guebaly N, 2002, PSYCHIATR SERV, V53, P1166, DOI 10.1176/appi.ps.53.9.1166; Fluharty M, 2016, NICOTINE TOB RES; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Gindi R.M., 2015, ELECT CIGARETTE USE; Hagman BT, 2008, ADDICT BEHAV, V33, P582, DOI 10.1016/j.addbeh.2007.11.007; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Healton CG, 2016, AM J PUBLIC HEALTH, V106, P1164, DOI 10.2105/AJPH.2016.303209; HEDEGAARD M, 1993, BMJ-BRIT MED J, V307, P234, DOI 10.1136/bmj.307.6898.234; Hefner K, 2016, J DUAL DIAGN, V12, P109, DOI 10.1080/15504263.2016.1172895; Henry AD, 1996, AM J OCCUP THER, V50, P171, DOI 10.5014/ajot.50.3.171; Hickman NJ, 2014, TOB CONTROL, V23, P7, DOI 10.1136/tobaccocontrol-2012-050479; Hrywna M, 2014, AM J HEALTH BEHAV, V38, P570, DOI 10.5993/AJHB.38.4.10; Hwang J, 2015, J BUS RES, V68, P2189, DOI 10.1016/j.jbusres.2015.03.019; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 1999, J HEALTH SOC BEHAV, V40, P208, DOI 10.2307/2676349; Kisely S, 2013, JAMA PSYCHIAT, V70, P209, DOI 10.1001/jamapsychiatry.2013.278; Kobau R, 2014, EPILEPSY BEHAV, V41, P66, DOI 10.1016/j.yebeh.2014.08.002; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Lawrence D, 2016, NICOTINE TOB RES, V18, P1463, DOI 10.1093/ntr/ntv272; Le Cook B, 2014, JAMA-J AM MED ASSOC, V311, P172, DOI 10.1001/jama.2013.284985; Leung J, 2012, PSYCHOL MED, V42, P1273, DOI 10.1017/S0033291711002261; Leung J, 2011, AUST NZ J PSYCHIAT, V45, P170, DOI 10.3109/00048674.2010.534070; Marshall L.T., 2006, YOUTH TOBACCO SURVEI; Matzka M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154496; Mitchell CM, 2011, PSYCHOL ASSESSMENT, V23, P752, DOI 10.1037/a0023288; Olive LS, 2016, J BEHAV MED, V39, P587, DOI 10.1007/s10865-016-9723-0; Orr KK, 2014, ANN PHARMACOTHER, V48, P1502, DOI 10.1177/1060028014547076; Piane GM, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140211; Pratt LA, 2009, ANN EPIDEMIOL, V19, P202, DOI 10.1016/j.annepidem.2008.12.005; Pratt SI, 2016, ADDICT BEHAV, V59, P30, DOI 10.1016/j.addbeh.2016.03.009; Primack BA, 2015, JAMA PEDIATR, V169, P1018, DOI 10.1001/jamapediatrics.2015.1742; Prochaska JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113013; Rahman MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122544; Ratschen E, 2014, PSYCHIATR BULL, V38, P226, DOI 10.1192/pb.bp.114.047431; Reeves William C., 2011, Morbidity and Mortality Weekly Report, V60, P1; Samet JM, 2013, THORAC SURG CLIN, V23, P103, DOI 10.1016/j.thorsurg.2013.01.009; SAMHSA-HRSA Center for Integrated Health Solutions, SCREEN TOOLS SAMHSA2; Schluger NW, 2014, PSYCHIATR BULL, V38, P201, DOI 10.1192/pb.bp.114.048439; Singh T, 2016, TOBACCO USE MIDDLE H; Sorsdahl K, 2016, J HLTH PSYCHOL; Sung HY, 2011, NICOTINE TOB RES, V13, P1183, DOI 10.1093/ntr/ntr148; Surtees PG, 2008, NEUROLOGY, V70, P788, DOI 10.1212/01.wnl.0000304109.18563.81; Taylor G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1151; van der Deen FS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-598; Willis E, 2017, HEALTH COMMUN, V32, P372, DOI 10.1080/10410236.2016.1138388; Zhao GX, 2009, INT J PUBLIC HEALTH, V54, P30, DOI 10.1007/s00038-009-0004-3; Ziedonis D, 2008, NICOTINE TOB RES, V10, P1691, DOI 10.1080/14622200802443569	65	45	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173625	10.1371/journal.pone.0173625	http://dx.doi.org/10.1371/journal.pone.0173625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278239	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900020
J	Sidana, S; Narkhede, M; Elson, P; Hastings, D; Faiman, B; Valent, J; Samaras, C; Hamilton, K; Liu, HK; Smith, MR; Reu, FJ				Sidana, Surbhi; Narkhede, Mayur; Elson, Paul; Hastings, Debbie; Faiman, Beth; Valent, Jason; Samaras, Christy; Hamilton, Kimberly; Liu, Hien K.; Smith, Mitchell R.; Reu, Frederic J.			Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis	PLOS ONE			English	Article							ORAL PROTEASOME INHIBITOR; RANDOMIZED PHASE-III; PERIPHERAL NEUROPATHY; INTRAVENOUS BORTEZOMIB; DEXAMETHASONE; LENALIDOMIDE; COMBINATION; IXAZOMIB; SAFETY; CRITERIA	Introduction Randomized studies have shown that bortezomib (BTZ) can be given weekly via intravenous (IV) route or twice weekly via subcutaneous (SC) route with lower neuropathy risk and no loss of anti-myeloma efficacy compared to original standard IV twice weekly schedule. Weekly SC should therefore yield the best therapeutic index and is widely used but has not been compared to established administration schedules in the context of a clinical trial. Methods Comprehensive electronic medical record review was done for disease control and neuropathy symptoms of 344 consecutive patients who received their first BTZ-containing regimen for myeloma or AL amyloidosis before or after we changed to SC weekly in December 2010. Univariate and multivariable analyses were carried out that adjusted for age, underlying disease, concurrently used anticancer agents, underlying conditions predisposing to neuropathy, and number of prior regimens compared SC weekly to other schedules. Results Fifty-three patients received BTZ SC weekly, 17 SC twice weekly, 127 IV weekly and 147 IV twice weekly. Risk for neuropathy of any grade was higher with other schedules compared to SC weekly (44.3% vs. 26.9%, p = 0.001) while response rate was similar (72.1% vs. 76.6%, respectively, p = 0.15). Multivariable analyses upheld higher neuropathy risk (Odds ratio 2.45, 95% CI 1.26-4.76, p = 0.008) while the likelihood of not achieving a response (= partial response or better) was comparable (Odds ratio 1.25, 95% CI 0.58-2.71, p = 0.56) for other schedules compared to SC weekly, respectively. Lower neuropathy risk translated into longer treatment duration when BTZ was started SC weekly (p = 0.001). Conclusions Weekly SC BTZ has activity comparable to other schedules and causes low rates of neuropathy.	[Sidana, Surbhi; Narkhede, Mayur] Cleveland Clin, Dept Internal Med, Cleveland, OH 44106 USA; [Elson, Paul] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Hastings, Debbie] Cleveland Clin, Dept Canc Ctr Res, Cleveland, OH 44106 USA; [Faiman, Beth; Valent, Jason; Samaras, Christy; Hamilton, Kimberly; Liu, Hien K.; Smith, Mitchell R.; Reu, Frederic J.] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Oncol, Cleveland, OH 44106 USA; [Sidana, Surbhi] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN USA; [Narkhede, Mayur] Georgetown Univ, Dept Hematol & Med Oncol, Washington, DC USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Mayo Clinic; Georgetown University	Reu, FJ (corresponding author), Cleveland Clin, Taussig Canc Inst, Dept Hematol & Oncol, Cleveland, OH 44106 USA.	reuf@ccf.org		Sidana, Surbhi/0000-0003-3288-7614; Reu, Frederic/0000-0003-1160-8030				Argyriou AA, 2014, ARCH TOXICOL, V88, P1669, DOI 10.1007/s00204-014-1316-5; Arnulf B, 2012, HAEMATOL-HEMATOL J, V97, P1925, DOI 10.3324/haematol.2012.067793; Barbee MS, 2013, ANN PHARMACOTHER, V47, P1136, DOI 10.1177/1060028013503122; Bringhen S, 2010, BLOOD, V116, P4745, DOI 10.1182/blood-2010-07-294983; Broyl A, 2012, SEMIN HEMATOL, V49, P249, DOI 10.1053/j.seminhematol.2012.04.001; Burnette BL, 2013, CANCER-AM CANCER SOC, V119, P4308, DOI 10.1002/cncr.28340; Dispenzieri A, 2005, BEST PRACT RES CL HA, V18, P673, DOI 10.1016/j.beha.2005.01.024; Harousseau JL, 2006, HAEMATOLOGICA, V91, P1498; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jagannath S, 2005, BRIT J HAEMATOL, V129, P776, DOI 10.1111/j.1365-2141.2005.05540.x; Jakubowiak AJ, 2012, BLOOD, V120, P1801, DOI 10.1182/blood-2012-04-422683; Kastritis E, 2010, J CLIN ONCOL, V28, P1031, DOI 10.1200/JCO.2009.23.8220; Kumar SK, 2014, LANCET ONCOL, V15, P1503, DOI 10.1016/S1470-2045(14)71125-8; Kumar SK, 2014, BLOOD, V124, P1047, DOI 10.1182/blood-2014-01-548941; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; Landowski TH, 2005, CANCER RES, V65, P3828, DOI 10.1158/0008-5472.CAN-04-3684; Merlini G, 2011, J CLIN ONCOL, V29, P1924, DOI 10.1200/JCO.2010.32.2271; Minarik J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123866; Moreau P, 2016, NEW ENGL J MED, V374, P1621, DOI 10.1056/NEJMoa1516282; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; National Comprehensive Cancer Network (NCCN), 2015, NCCN CLIN PRACT GUID; (NCCN) NCCN, 2016, NCCN CLIN PRACT GUID; Palladini G, 2012, J CLIN ONCOL, V30, P4541, DOI 10.1200/JCO.2011.37.7614; Poruchynsky MS, 2008, CELL CYCLE, V7, P940, DOI 10.4161/cc.7.7.5625; Reece DE, 2011, BLOOD, V118, P865, DOI 10.1182/blood-2011-02-334227; Richardson PG, 2006, J CLIN ONCOL, V24, P3113, DOI 10.1200/JCO.2005.04.7779; Richardson PG, 2009, J CLIN ONCOL, V27, P3518, DOI 10.1200/JCO.2008.18.3087; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Sonneveld P, 2012, J CLIN ONCOL, V30, P2946, DOI 10.1200/JCO.2011.39.6820; Straka C V M, 2015, J CLIN ONCOL; Takamatsu Y, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.5382.5382; Wang Liang, 2015, Asian Pac J Cancer Prev, V16, P2093	32	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172996	10.1371/journal.pone.0172996	http://dx.doi.org/10.1371/journal.pone.0172996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278302	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900134
J	Trimarchi, MP; Yan, P; Groden, J; Bundschuh, R; Goodfellow, PJ				Trimarchi, Michael P.; Yan, Pearlly; Groden, Joanna; Bundschuh, Ralf; Goodfellow, Paul J.			Identification of endometrial cancer methylation features using combined methylation analysis methods	PLOS ONE			English	Article							WIDE DNA METHYLATION; MICROSATELLITE INSTABILITY; PROMOTER HYPERMETHYLATION; COLORECTAL-CANCER; METHYLOME ANALYSIS; COLON-CANCER; PHENOTYPE; MLH1; CARCINOMAS; MARKERS	Background DNA methylation is a stable epigenetic mark that is frequently altered in tumors. DNA meth-ylation features are attractive biomarkers for disease states given the stability of DNA methylation in living cells and in biologic specimens typically available for analysis. Widespread accumulation of methylation in regulatory elements in some cancers (specifically the CpG island methylator phenotype, CIMP) can play an important role in tumorigenesis. High reso-lution assessment of CIMP for the entire genome, however, remains cost prohibitive and requires quantities of DNA not available for many tissue samples of interest. Genome-wide scans of methylation have been undertaken for large numbers of tumors, and higher resolu-tion analyses for a limited number of cancer specimens. Methods for analyzing such large datasets and integrating findings from different studies continue to evolve. An approach for comparison of findings from a genome-wide assessment of the methylated component of tumor DNA and more widely applied methylation scans was developed. Methods Methylomes for 76 primary endometrial cancer and 12 normal endometrial samples were gen-erated using methylated fragment capture and second generation sequencing, MethylCapseq. Publically available Infinium HumanMethylation 450 data from The Cancer Genome Atlas (TCGA) were compared to MethylCap-seq data. Results Analysis of methylation in promoter CpG islands (CGIs) identified a subset of tumors with a methylator phenotype. We used a two-stage approach to develop a 13-region methylation signature associated with a "hypermethylator state" High level methylation for the 13-region methylation signatures was associated with mismatch repair deficiency, high mutation rate, and low somatic copy number alteration in the TCGA test set. In addition, the signature devised showed good agreement with previously described methylation clusters devised by TCGA. Conclusion We identified a methylation signature for a "hypermethylator phenotype" in endometrial can-cer and developed methods that may prove useful for identifying extreme methylation phe-notypes in other cancers.	[Trimarchi, Michael P.; Groden, Joanna] Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Yan, Pearlly] Ohio State Univ, Coll Med, Dept Internal Med, Columbus, OH 43210 USA; [Bundschuh, Ralf] Ohio State Univ, Dept Phys, Ctr RNA Biol, Dept Chem & Biochem, 174 W 18th Ave, Columbus, OH 43210 USA; [Bundschuh, Ralf] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Bundschuh, Ralf] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Goodfellow, Paul J.] Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Goodfellow, PJ (corresponding author), Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA.	Paul.Goodfellow@osumc.edu			National Center for Advancing Translational Sciences [TL1TR001069]; National Science Foundation [HRD-0833561]; National Cancer Institute [P30 CA016058]; James Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R50CA211524, P30CA016058] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); James Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MPT was supported by Award Number Grant TL1TR001069 from the National Center for Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. MPT received an Ohio STEM Ability Alliance award from the National Science Foundation under NSF Award Number HRD-0833561. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect those of the National Science Foundation. This work was supported by The National Cancer Institute (P30 CA016058 supporting the Genomics shared resources at the Ohio State University Comprehensive Cancer Center), and funds from the James Comprehensive Cancer Center.	Arai E, 2012, CARCINOGENESIS, V33, P1487, DOI 10.1093/carcin/bgs177; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Buchanan DD, 2014, J CLIN ONCOL, V32, P90, DOI 10.1200/JCO.2013.51.2129; Cottrell S, 2007, J UROLOGY, V177, P1753, DOI 10.1016/j.juro.2007.01.010; Esteller M, 1998, ONCOGENE, V17, P2413, DOI 10.1038/sj.onc.1202178; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Goodfellow PJ, 2015, J CLIN ONCOL, V33, P4301, DOI 10.1200/JCO.2015.63.9518; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hsu YT, 2013, CLIN CANCER RES, V19, P6272, DOI 10.1158/1078-0432.CCR-13-1734; Hughes LAE, 2013, CANCER RES, V73, P5858, DOI 10.1158/0008-5472.CAN-12-4306; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Issa JP, 2008, CLIN CANCER RES, V14, P5939, DOI 10.1158/1078-0432.CCR-08-1596; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Jithesh PV, 2013, BRIT J CANCER, V108, P370, DOI 10.1038/bjc.2012.568; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kolbe DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032941; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Langner C, 2015, DIGEST DIS, V33, P28, DOI 10.1159/000366032; Li H, 2012, ONCOL REP, V28, P99, DOI 10.3892/or.2012.1779; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; REIS RJS, 1983, J BIOL CHEM, V258, P9078; Rhee JK, 2013, NUCLEIC ACIDS RES, V41, P8464, DOI 10.1093/nar/gkt643; Rodriguez BAT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S14; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Simpkins SB, 1999, HUM MOL GENET, V8, P661, DOI 10.1093/hmg/8.4.661; Sproul D, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R84, 10.1186/gb-2012-13-10-r84]; Tost J, 2010, MOL BIOTECHNOL, V44, P71, DOI 10.1007/s12033-009-9216-2; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Trimarchi MP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S6; Turcan S, 2013, ONCOTARGET, V4, P1729, DOI 10.18632/oncotarget.1412; Whitcomb BP, 2003, CLIN CANCER RES, V9, P2277; Zhang B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-868; Zhang QY, 2011, GYNECOL OBSTET INVES, V72, P183, DOI 10.1159/000324496; Zighelboim I, 2007, J CLIN ONCOL, V25, P2042, DOI 10.1200/JCO.2006.08.2107; Zouridis H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004504	43	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173242	10.1371/journal.pone.0173242	http://dx.doi.org/10.1371/journal.pone.0173242			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278225	gold, Green Published, Green Submitted			2022-12-27	WOS:000396087900058
J	Tudor, D; Nenu, I; Filip, GA; Olteanu, D; Cenariu, M; Tabaran, F; Ion, RM; Gligor, L; Baldea, I				Tudor, Diana; Nenu, Iuliana; Filip, Gabriela Adriana; Olteanu, Diana; Cenariu, Mihai; Tabaran, Flaviu; Ion, Rodica Mariana; Gligor, Lucian; Baldea, Ioana			Combined regimen of photodynamic therapy mediated by Gallium phthalocyanine chloride and Metformin enhances anti-melanoma efficacy	PLOS ONE			English	Article							IN-VITRO; PHOTOPHYSICAL PROPERTIES; ALUMINUM-PHTHALOCYANINE; NITRIC-OXIDE; CANCER-CELLS; TNF-ALPHA; KAPPA-B; ALA-PDT; MELANOMA; APOPTOSIS	Background Melanoma therapy is challenging, especially in advanced cases, due to multiple developed tumor defense mechanisms. Photodynamic therapy (PDT) might represent an adjuvant treatment, because of its bimodal action: tumor destruction and immune system awakening. In this study, a combination of PDT mediated by a metal substituted phthalocyanine-Gal-lium phthalocyanine chloride (GaPc) and Metformin was used against melanoma. The study aimed to: (1) find the anti-melanoma efficacy of GaPc-PDT, (2) assess possible bene-ficial effects of Metformin addition to PDT, (3) uncover some of the mechanisms underlining cell killing and anti-angiogenic effects. Methods Two human lightly pigmented melanoma cell lines: WM35 and M1/15 subjected to previous Metformin exposure were treated by GaPc-PDT. Cell viability, death mechanism, cytoskele-ton alterations, oxidative damage, were assessed by means of colorimetry, flowcytometry, confocal microscopy, spectrophotometry, ELISA, Western Blotting. Results GaPc proved an efficient photosensitizer. Metformin addition enhanced cell killing by mech-anisms dependent on the cell line, namely apoptosis in the metastatic M1/15 and necrosis in the radial growth phase, WM35. Cell death mechanism relied on the inhibition of nuclear transcription factor (NF)-kappa B activation and tumor necrosis factor (TNF) D related apoptosis-inducing ligand (TRAIL) sensitization, leading to TRAIL and TNF-alpha induced apoptosis. Met-formin diminished the anti-angiogenic effect of PDT. Conclusions Metformin addition to GaPc-PDT increased tumor cell killing through enhanced oxidative damage and induction of proapoptotic mechanisms, but altered PDT anti-angiogenic effects. General significance Combination of Metformin and PDT might represent a solution to enhance the efficacy, lead-ing to a potential adjuvant role of PDT in melanoma therapy.	[Tudor, Diana; Nenu, Iuliana; Filip, Gabriela Adriana; Olteanu, Diana; Baldea, Ioana] Univ Med & Pharm, Dept Physiol, Cluj Napoca, Romania; [Cenariu, Mihai] Univ Agr Sci & Vet Med, Dept Biochem, Cluj Napoca, Romania; [Tabaran, Flaviu] Univ Agr Sci & Vet Med, Dept Pathol, Cluj Napoca, Romania; [Ion, Rodica Mariana] Natl Inst Res & Dev Chem & Petrochem ICECHIM, Nanomed Res Grp, Bucharest, Romania; [Gligor, Lucian] OSRAM Romania, OSRAM Opto Semicond, Global City Business Pk, Voluntari, Ilfov, Romania	Iuliu Hatieganu University of Medicine & Pharmacy; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; National Institute Research & Development in Chemistry & Petrochemistry; Osram	Filip, GA (corresponding author), Univ Med & Pharm, Dept Physiol, Cluj Napoca, Romania.	adrianafilip33@yahoo.com	Ion, Rodica-Mariana/B-2839-2008; Adriana, Filip Gabriela/AAB-7418-2019; Cenariu, Mihai Cosmin/C-2558-2012; Tudor, Diana/ABB-8826-2020; Tudor, Diana Valentina/O-5516-2017; Ioana, Baldea/Y-6129-2019; Tabaran, Flaviu/D-8562-2011; Olteanu, Elena Diana/A-4750-2017; Baldea, Ioana/C-4360-2011	Ion, Rodica-Mariana/0000-0002-9842-3321; Adriana, Filip Gabriela/0000-0002-7447-4925; Cenariu, Mihai Cosmin/0000-0001-6501-0128; Tudor, Diana Valentina/0000-0002-5997-8586; Tabaran, Flaviu/0000-0001-5744-0451; Olteanu, Elena Diana/0000-0002-3034-3659; Baldea, Ioana/0000-0003-4046-7310	University of Medicine and Pharmacy, Cluj-Napoca, Romania [1493/4/28.01.2014, 4945/4/08.03.2016]; OSRAM Opto Semiconductors, OSRAM Romania;  [PN-III-P2-2.1-PED-2016-1521]	University of Medicine and Pharmacy, Cluj-Napoca, Romania; OSRAM Opto Semiconductors, OSRAM Romania; 	This paper was supported by 1493/4/28.01.2014, 4945/4/08.03.2016 Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania and National Grant PN-III-P2-2.1-PED-2016-1521. We also affirm that the paper doesn't have any grants or contracts from a government agency, a non profit foundation, or a company supporting the preparation of the manuscript or the described research. The OSRAM Opto Semiconductors, OSRAM Romania provided support in the form of salaries for authors [LG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.77; Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Ali H, 1999, CHEM REV, V99, P2379, DOI 10.1021/cr980439y; Baldea I, 2012, J PHYSIOL PHARMACOL, V63, P109; Baldea I, 2016, J PHOTOCH PHOTOBIO B, V161, P402, DOI 10.1016/j.jphotobiol.2016.06.012; Baldea Ioana, 2015, Clujul Med, V88, P175, DOI 10.15386/cjmed-419; Baldea I, 2015, J PHOTOCH PHOTOBIO B, V151, P142, DOI 10.1016/j.jphotobiol.2015.07.019; Baldea I, 2013, J DERMATOL SCI, V72, P168, DOI 10.1016/j.jdermsci.2013.06.004; Berwick M, MELANOMA 2016, P17; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonnett R, 2001, TETRAHEDRON, V57, P9513, DOI 10.1016/S0040-4020(01)00952-8; Bro?yna AA, 2016, J CUTANEOUS PATHOLOG; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2016, ONCOTARGET, V7, P17844, DOI 10.18632/oncotarget.7528; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Cerezo M, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12267; Cerezo M, 2013, MOL CANCER THER, V12, P1605, DOI 10.1158/1535-7163.MCT-12-1226-T; Chen B, 2006, CRITICAL REV EUKARVO, V16; Collins-Gold L., 2000, MOD DRUG DISCOVERY, V3, P44; Cretney E, 2006, IMMUNOL CELL BIOL, V84, P87, DOI 10.1111/j.1440-1711.2005.01413.x; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Eggermont AMM, 2014, LANCET, V383, P816, DOI 10.1016/S0140-6736(13)60802-8; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Filip A, 2011, J MED FOOD, V14, P761, DOI 10.1089/jmf.2010.0142; Alvarez MG, 2004, PHOTODIAGN PHOTODYN, V1, P335, DOI 10.1016/S1572-1000(04)00068-7; Gorlach Agnes, 2008, Biochem J, V412, pe17, DOI 10.1042/BJ20080920; Griffith TS, 1998, J IMMUNOL, V161, P2833; Guldi DM, 2000, J AM CHEM SOC, V122, P8289, DOI 10.1021/ja001578b; Hegyesi H, 2001, J INVEST DERMATOL, V117, P151, DOI 10.1046/j.0022-202x.2001.01406.x; Hirsch HA, 2009, CANCER RES, V69, P8832, DOI 10.1158/0008-5472.CAN-09-3869; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Jakubowska M, 2013, NITRIC OXIDE-BIOL CH, V35, P79, DOI 10.1016/j.niox.2013.08.004; Janjetovic K, 2011, EUR J PHARMACOL, V668, P373, DOI 10.1016/j.ejphar.2011.07.004; Kleemann B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103762; Kumar R, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-27; Lang K, 2004, COORDIN CHEM REV, V248, P321, DOI 10.1016/j.ccr.2004.02.004; Leanne B J, 2008, METAL BASED DRUGS, V2008; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; LINSKY JP, 1980, INORG CHEM, V19, P3131, DOI 10.1021/ic50212a061; Liu F, 2009, J INVEST DERMATOL, V129, P422, DOI 10.1038/jid.2008.255; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Maduray K, 2013, J PHOTOCH PHOTOBIO B, V128, P58, DOI 10.1016/j.jphotobiol.2013.08.003; Martin MJ, 2012, CANCER DISCOV, V2, P344, DOI 10.1158/2159-8290.CD-11-0280; Medina VA, 2010, BRIT J PHARMACOL, V161, P755, DOI 10.1111/j.1476-5381.2010.00961.x; Meier F, 2000, AM J PATHOL, V156, P193, DOI 10.1016/S0002-9440(10)64719-0; Menendez JA, 2015, CELL CYCLE, V14, P3801, DOI 10.1080/15384101.2015.1022697; Moiseeva O, 2013, AGING-US, V5, P330, DOI 10.18632/aging.100556; Monge-Fuentes V, 2014, NANO REV EXP, V5, DOI 10.3402/nano.v5.24381; Muehlmann LA, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0095-3; Muehlmann LA, 2014, INT J NANOMED, V9, P1199, DOI 10.2147/IJN.S57420; Nenu I, 2015, TUMOR BIOL, V36, P6589, DOI 10.1007/s13277-015-3639-0; Nenu I, 2014, J PHOTOCH PHOTOBIO B, V138, P80, DOI 10.1016/j.jphotobiol.2014.04.027; Niehr F, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-76; Nombona N, 2012, J PHOTOCH PHOTOBIO B, V107, P35, DOI 10.1016/j.jphotobiol.2011.11.007; Nyman ES, 2004, J PHOTOCH PHOTOBIO B, V73, P1, DOI 10.1016/j.jphotobiol.2003.10.002; Ochoa-Gonzalez F, 2016, PLOS ONE, V11; OHKURA T, 1984, ARCH BIOCHEM BIOPHYS, V235, P63, DOI 10.1016/0003-9861(84)90255-8; Oleinick NL, 2002, PHOTOCH PHOTOBIO SCI, V1, P1, DOI 10.1039/b108586g; Olteanu D, 2014, J PHOTOCH PHOTOBIO B, V136, P54, DOI 10.1016/j.jphotobiol.2014.04.018; Pan XB, 2015, COLLOID SURFACE B, V130, P292, DOI 10.1016/j.colsurfb.2015.04.028; Plonka PM, 2003, EXP DERMATOL, V12, P356, DOI 10.1034/j.1600-0625.2002.120401.x; Pluskalova M, 2006, J PHOTOCH PHOTOBIO B, V83, P205, DOI 10.1016/j.jphotobiol.2006.01.003; Popescu T, 2014, LIFE SCI, V117, P75, DOI 10.1016/j.lfs.2014.09.022; Pustelny K, 2007, NITRIC OXIDE-BIOL CH, V16, P202, DOI 10.1016/j.niox.2006.10.002; Raghunath Arathi, 2015, BMC Res Notes, V8, P170, DOI 10.1186/s13104-015-1128-6; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Salani B, 2014, ENDOCR-RELAT CANCER, V21, pR461, DOI 10.1530/ERC-14-0284; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; Sharma KV, 2012, PHOTODIAGN PHOTODYN, V9, P156, DOI 10.1016/j.pdpdt.2011.09.003; Sharma SK, RESISTANCE PHOTODYNA, P229; Slattery ML, 2010, CARCINOGENESIS; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; SLOMINSKI A, 1985, ANTICANCER RES, V5, P403; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362; Spagnolo F, 2012, ARCH DERMATOL RES, V304, P177, DOI 10.1007/s00403-012-1223-7; SPIKES JD, 1986, PHOTOCHEM PHOTOBIOL, V43, P691, DOI 10.1111/j.1751-1097.1986.tb05648.x; Swavey S., 2013, RECENT ADV BIOL THER; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Uzdensky A, 2005, BBA-GEN SUBJECTS, V1722, P43, DOI 10.1016/j.bbagen.2004.11.011; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Wolnicka-Glubisz A, 2015, ARCH DERMATOL RES, V307, P89, DOI 10.1007/s00403-014-1523-1; Wood JM, 2004, BIOCHEM BIOPH RES CO, V325, P1412, DOI 10.1016/j.bbrc.2004.10.185; Yuan CY, 2015, TISSUE ENG PT A, V21, P1163, DOI [10.1089/ten.tea.2014.0058, 10.1089/ten.TEA.2014.0058]; Zabierowski SE, 2008, J CLIN ONCOL, V26, P2890, DOI 10.1200/JCO.2007.15.5465; Zhuang LQ, 2006, HUM PATHOL, V37, P1286, DOI 10.1016/j.humpath.2006.04.026	91	20	20	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173241	10.1371/journal.pone.0173241	http://dx.doi.org/10.1371/journal.pone.0173241			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278159	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900057
J	Htun, NM; Magliano, DJ; Zhang, ZY; Lyons, J; Petit, T; Nkuipou-Kenfack, E; Ramirez-Torres, A; von zur Muhlen, C; Maahs, D; Schanstra, JP; Pontillo, C; Pejchinovski, M; Snell-Bergeon, JK; Delles, C; Mischak, H; Staessen, JA; Shaw, JE; Koeck, T; Peter, K				Htun, Nay M.; Magliano, Dianna J.; Zhang, Zhen-Yu; Lyons, Jasmine; Petit, Thibault; Nkuipou-Kenfack, Esther; Ramirez-Torres, Adela; von zur Muhlen, Constantin; Maahs, David; Schanstra, Joost P.; Pontillo, Claudia; Pejchinovski, Martin; Snell-Bergeon, Janet K.; Delles, Christian; Mischak, Harald; Staessen, Jan A.; Shaw, Jonathan E.; Koeck, Thomas; Peter, Karlheinz			Prediction of acute coronary syndromes by urinary proteome analysis	PLOS ONE			English	Article							MASS-SPECTROMETRY; EXTRACELLULAR-MATRIX; MYOCARDIAL-INFARCTION; BIOMARKER DISCOVERY; CLINICAL PROTEOMICS; GENERAL-POPULATION; PLAQUE RUPTURE; ARTERY-DISEASE; ATHEROSCLEROSIS; PROGRESSION	Identification of individuals who are at risk of suffering from acute coronary syndromes (ACS) may allow to introduce preventative measures. We aimed to identify ACS-related urinary peptides, that combined as a pattern can be used as prognostic biomarker. Proteomic data of 252 individuals enrolled in four prospective studies from Australia, Europe and North America were analyzed. 126 of these had suffered from ACS within a period of up to 5 years post urine sampling (cases). Proteomic analysis of 84 cases and 84 matched controls resulted in the discovery of 75 ACS-related urinary peptides. Combining these to a peptide pattern, we established a prognostic biomarker named Acute Coronary Syndrome Predictor 75 (ACSP75). ACSP75 demonstrated reasonable prognostic discrimination (c-statistic = 0.664), which was similar to Framingham risk scoring (c-statistics = 0.644) in a validation cohort of 42 cases and 42 controls. However, generating by a composite algorithm named Acute Coronary Syndrome Composite Predictor (ACSCP), combining the biomarker pattern ACSP75 with the previously established urinary proteomic biomarker CAD238 characterizing coronary artery disease as the underlying aetiology, and age as a risk factor, further improved discrimination (c-statistic = 0.751) resulting in an added prognostic value over Framingham risk scoring expressed by an integrated discrimination improvement of 0.273 +/- 0.048 (P < 0.0001) and net reclassification improvement of 0.405 +/- 0.113 (P = 0.0007). In conclusion, we demonstrate that urinary peptide biomarkers have the potential to predict future ACS events in asymptomatic patients. Further large scale studies are warranted to determine the role of urinary biomarkers in clinical practice.	[Htun, Nay M.; Peter, Karlheinz] Baker IDI Heart & Diabet Inst, Atherothrombosis & Vasc Biol, Melbourne, Vic, Australia; [Htun, Nay M.; Peter, Karlheinz] Monash Univ, Dept Med, Melbourne, Vic, Australia; [Magliano, Dianna J.; Lyons, Jasmine; Shaw, Jonathan E.] Baker IDI Heart & Diabet Inst, Clin Diabet & Epidemiol, Melbourne, Vic, Australia; [Zhang, Zhen-Yu; Petit, Thibault; Staessen, Jan A.] Univ Leuven, Dept Cardiovasc Sci, KU Leuven, Studies Coordinating Ctr,Res Unit Hypertens & Car, Leuven, Belgium; [Nkuipou-Kenfack, Esther; Ramirez-Torres, Adela; Pontillo, Claudia; Pejchinovski, Martin; Mischak, Harald; Koeck, Thomas] Mosaiques Diagnost GmbH, Hannover, Germany; [Ramirez-Torres, Adela] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA; [von zur Muhlen, Constantin] Univ Heart Ctr Freiburg, Dept Cardiol, Freiburg, Germany; [Maahs, David] Stanford Sch Med, Dept Paediat, Stanford, CA USA; [Maahs, David; Snell-Bergeon, Janet K.] Univ Colorado, Sch Med, Barbara Davis Ctr Diabet, Aurora, CO USA; [Schanstra, Joost P.] INSERM, U1048, Inst Cardiovasc & Metab Dis, Toulouse, France; [Schanstra, Joost P.] Univ Toulouse III Paul Sabatier, Toulouse, France; [Delles, Christian; Mischak, Harald] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Staessen, Jan A.] Maastricht Univ, R&D VitaK Grp, Maastricht, Netherlands	Baker Heart and Diabetes Institute; Monash University; Baker Heart and Diabetes Institute; KU Leuven; Mosaiques Diagnostics GmbH (MOS); Sanford Burnham Prebys Medical Discovery Institute; Universitats Herzzentrum Freiburg; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Glasgow; Maastricht University	Peter, K (corresponding author), Baker IDI Heart & Diabet Inst, Atherothrombosis & Vasc Biol, Melbourne, Vic, Australia.; Peter, K (corresponding author), Monash Univ, Dept Med, Melbourne, Vic, Australia.	Karlheinz.Peter@bakeridi.edu.au	/S-2765-2019; Staessen, Jan A/A-1065-2011; Zhang, Zhenyu/GZL-8479-2022; Schanstra, Joost P/X-7724-2018	/0000-0002-8040-2258; Staessen, Jan A/0000-0002-3026-1637; Zhang, Zhenyu/0000-0002-3785-7417; Schanstra, Joost P/0000-0002-7471-372X; Maahs, David/0000-0002-4602-7909; Magliano, Dianna/0000-0002-9507-6096; Snell-Bergeon, Janet/0000-0002-9337-3740; Mischak, Harald/0000-0003-0323-0306	European Union grant EU-MASCARA [HEALTH-FP7-278249]; European Union grant HOMAGE [HEALTH-FP7-305507]; European Union grant SYSVASC [HEALTH-FP7-603288]; European Research Council Advanced Researcher Grant EXPLORE [2011-294713]; National Health and Medical Research Council of Australia (NHMRC) - European Union Collaborative Research Grant [GNT1102158]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium [G.0881.13, G.0880.13]; Cardiac Society of Australia and New Zealand (CSANZ); NHMRC, Australia; NHMRC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	European Union grant EU-MASCARA; European Union grant HOMAGE; European Union grant SYSVASC; European Research Council Advanced Researcher Grant EXPLORE; National Health and Medical Research Council of Australia (NHMRC) - European Union Collaborative Research Grant; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium(FWO); Cardiac Society of Australia and New Zealand (CSANZ); NHMRC, Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project was partly supported by the European Union grants EU-MASCARA (HEALTH-FP7-278249), HOMAGE (HEALTH-FP7-305507), SYSVASC (HEALTH-FP7-603288), the European Research Council Advanced Researcher Grant EXPLORE (2011-294713) and the National Health and Medical Research Council of Australia (NHMRC) - European Union Collaborative Research Grant GNT1102158. The Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0881.13 and G.0880.13) supported the FLEMENGHO study. N. M. Htun was supported by scholarships from the Cardiac Society of Australia and New Zealand (CSANZ) and NHMRC, Australia. D. J. Magliano, J. E. Shaw and K. Peter are supported by research fellowships from the NHMRC. The funders provided support in the form of salaries for authors [NMH, DJM, ENK, JPS, CD, HM, JAS, JES, TK, KP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Adiguzel E, 2009, VASC MED, V14, P73, DOI 10.1177/1358863X08094801; Amabile N, 2014, EUR HEART J, V35, P2972, DOI 10.1093/eurheartj/ehu153; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown CE, 2015, PROTEOM CLIN APPL, V9, P610, DOI 10.1002/prca.201400195; Chen YC, 2013, CIRC RES, V113, P252, DOI 10.1161/CIRCRESAHA.113.301562; Chistiakov DA, 2013, CARDIOL REV, V21, P270, DOI 10.1097/CRD.0b013e31828c5ced; Coon JJ, 2008, PROTEOM CLIN APPL, V2, P964, DOI 10.1002/prca.200800024; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dakna M, 2009, J CHROMATOGR B, V877, P1250, DOI 10.1016/j.jchromb.2008.10.048; Delles C, 2010, J HYPERTENS, V28, P2316, DOI 10.1097/HJH.0b013e32833d81b7; Duner P, 2015, ATHEROSCLEROSIS, V240, P26, DOI 10.1016/j.atherosclerosis.2015.02.043; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Girolami Mark, 2006, Drug Discov Today Technol, V3, P13, DOI 10.1016/j.ddtec.2006.03.010; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; Hoefer IE, 2015, EUR HEART J, V36, P2635, DOI 10.1093/eurheartj/ehv236; Hong SN, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000307; Kong CH, 2013, INTERACT CARDIOV TH, V16, P11, DOI 10.1093/icvts/ivs421; Laiho K, 1998, CLIN RHEUMATOL, V17, P234, DOI 10.1007/BF01451054; Lan TH, 2013, CARDIOVASC PATHOL, V22, P401, DOI 10.1016/j.carpath.2013.01.003; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Neisius U, 2012, J HYPERTENS, V30, P67, DOI 10.1097/HJH.0b013e32834e12d8; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; Newby AC, 2014, CURR OPIN LIPIDOL, V25, P358, DOI 10.1097/MOL.0000000000000111; Nkuipou-Kenfack E, 2014, AGEING RES REV, V18, P74, DOI 10.1016/j.arr.2014.09.002; Pejchinovski M, 2015, PROTEOM CLIN APPL, V9, P453, DOI 10.1002/prca.201400113; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Ponticos M, 2014, J BIOMED RES, V28, P25, DOI 10.7555/JBR.27.20130064; R Core Team, 2018, R LANG ENV STAT COMP; Rocchiccioli S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-260; Rossing K, 2008, J AM SOC NEPHROL, V19, P1283, DOI 10.1681/ASN.2007091025; Schanstra JP, 2015, J AM SOC NEPHROL, V26, P1999, DOI 10.1681/ASN.2014050423; Seidelmann SB, 2016, CIRCULATION, V134, P1328, DOI 10.1161/CIRCULATIONAHA.116.023425; Shami A, 2014, CURR OPIN LIPIDOL, V25, P394, DOI 10.1097/MOL.0000000000000112; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Van der Donckt C, 2015, EUR HEART J, V36, P1049, DOI 10.1093/eurheartj/ehu041; Vassiliadis E, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-140; Vivanco F, 2008, BIOMARK INSIGHTS, V3, P101; von zur Muhlen C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013847; von zur Muhlen C, 2009, J PROTEOME RES, V8, P335, DOI 10.1021/pr800615t; Wittke S, 2005, ELECTROPHORESIS, V26, P1476, DOI 10.1002/elps.200410140; Yayan J, 2013, VASC HEALTH RISK MAN, V9, P435, DOI 10.2147/VHRM.S45704; Yin XY, 2014, ARTERIOSCL THROM VAS, V34, P939, DOI 10.1161/ATVBAHA.113.302918; Zhang ZY, 2015, HYPERTENSION, V66, P52, DOI 10.1161/HYPERTENSIONAHA.115.05296; Zhang ZY, 2014, INT J CARDIOL, V176, P158, DOI 10.1016/j.ijcard.2014.07.014; Zimmerli LU, 2008, MOL CELL PROTEOMICS, V7, P290, DOI 10.1074/mcp.M700394-MCP200; Zurbig Petra, 2009, Methods Mol Biol, V564, P105, DOI 10.1007/978-1-60761-157-8_6	47	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172036	10.1371/journal.pone.0172036	http://dx.doi.org/10.1371/journal.pone.0172036			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273075	Green Published, Green Accepted, gold			2022-12-27	WOS:000396073700065
J	Meda, SA; Gueorguieva, RV; Pittman, B; Rosen, RR; Aslanzadeh, F; Tennen, H; Leen, S; Hawkins, K; Raskin, S; Wood, RM; Austad, CS; Dager, A; Fallahi, C; Pearlson, GD				Meda, Shashwath A.; Gueorguieva, Ralitza V.; Pittman, Brian; Rosen, Rivkah R.; Aslanzadeh, Farah; Tennen, Howard; Leen, Samantha; Hawkins, Keith; Raskin, Sarah; Wood, Rebecca M.; Austad, Carol S.; Dager, Alecia; Fallahi, Carolyn; Pearlson, Godfrey D.			Longitudinal influence of alcohol and marijuana use on academic performance in college students	PLOS ONE			English	Article							CANNABIS USE; PRESCRIPTION STIMULANTS; HEAVY DRINKING; NONMEDICAL USE; ADULT RATS; HEALTH; DEPRESSION; OUTCOMES; SCHOOL; TRAJECTORIES	Background Alcohol and marijuana are the two most abused substances in US colleges. However, research on the combined influence (cross sectional or longitudinal) of these substances on academic performance is currently scant. Methods Data were derived from the longitudinal 2-year Brain and Alcohol Research in College Students (BARCS) study including 1 142 freshman students who completed monthly marijuana use and alcohol consumption surveys. Subjects were classified into data-driven groups based on their alcohol and marijuana consumption. A linear mixed-model (LMM) was employed using this grouping factor to predict grade point average (GPA), adjusted for a variety of socio-demographic and clinical factors. Results Three data-driven clusters emerged: 1) No/low users of both, 2) medium-high alcohol/nolow marijuana, and 3) medium-high users of both substances. Individual cluster derivations between consecutive semesters remained stable. No significant interaction between clusters and semester (time) was noted. Post-hoc analysis suggest that at the outset, compared to sober peers, students using moderate to high levels of alcohol and low marijuana demonstrate lower GPAs, but this difference becomes non-significant over time. In contrast, students consuming both substances at moderate-to-high levels score significantly lower at both the outset and across the 2-year investigation period. Our follow-up analysis also indicate that when students curtailed their substance use over time they had significantly higher academic GPA compared to those who remained stable in their substance use patterns over the two year period. Conclusions Overall, our study validates and extends the current literature by providing important implications of concurrent alcohol and marijuana use on academic achievement in college.	[Meda, Shashwath A.; Rosen, Rivkah R.; Aslanzadeh, Farah; Leen, Samantha; Dager, Alecia; Pearlson, Godfrey D.] Hartford HealthCare Corp, Olin Neuropsychiat Res Ctr, Hartford, CT 06103 USA; [Gueorguieva, Ralitza V.] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Gueorguieva, Ralitza V.; Pittman, Brian; Hawkins, Keith; Dager, Alecia; Pearlson, Godfrey D.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Tennen, Howard] Trinity Coll, Dept Psychol & Neurosci, Hartford, CT USA; [Raskin, Sarah] Univ Connecticut, Sch Med, Dept Community Med, Farmington, CT USA; [Wood, Rebecca M.; Austad, Carol S.; Fallahi, Carolyn] Cent Connecticut State Univ, Dept Psychol, New Britain, CT 06050 USA; [Pearlson, Godfrey D.] Yale Univ, Dept Neurobiol, New Haven, CT USA	Yale University; Yale University; Trinity College; University of Connecticut; Connecticut State University System; Central Connecticut State University; Yale University	Meda, SA (corresponding author), Hartford HealthCare Corp, Olin Neuropsychiat Res Ctr, Hartford, CT 06103 USA.	shashwath.meda@hhchealth.org	Raskin, Sarah/T-1420-2019; Dager, Alecia D/V-5798-2017; Aslanzadeh, Farah/AAO-8846-2020	Raskin, Sarah/0000-0002-4310-4278; Gueorguieva, Ralitza/0000-0003-0944-5973	National Institute on Alcohol Abuse and Alcoholism [AA016599, AA19036]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016599, RC1AA019036] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was made possible by grant support from the National Institute on Alcohol Abuse and Alcoholism (AA016599 and AA19036, Pearlson).	Agosti V, 2002, AM J DRUG ALCOHOL AB, V28, P645, DOI 10.1081/ADA-120015873; AKAIKE H, 1992, No To Hattatsu, V24, P127; Arria AM, 2015, PSYCHOL ADDICT BEHAV, V29, P564, DOI 10.1037/adb0000108; Arria AM, 2013, ADDICT BEHAV, V38, P1643, DOI 10.1016/j.addbeh.2012.10.002; Arria AM, 2013, J STUD ALCOHOL DRUGS, V74, P71, DOI 10.15288/jsad.2013.74.71; Arria AM, 2008, J DRUG ISSUES, V38, P1045, DOI 10.1177/002204260803800406; Bacher J, 2013, SPSS TWOSTEP CLUSTER; Barron Susan, 2005, Alcohol Clin Exp Res, V29, P1720, DOI 10.1097/01.alc.0000179220.79356.e5; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Caldeira KM, 2012, NICOTINE TOB RES, V14, P777, DOI 10.1093/ntr/nts131; Carletta J, 1996, COMPUT LINGUIST, V22, P249; Dager AD, 2013, ALCOHOL CLIN EXP RES, V37, pE161, DOI 10.1111/j.1530-0277.2012.01879.x; Ehrenreich H, 1999, PSYCHOPHARMACOLOGY, V142, P295, DOI 10.1007/s002130050892; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; Fontes MA, 2011, BRIT J PSYCHIAT, V198, P442, DOI 10.1192/bjp.bp.110.077479; Frey MC, 2004, PSYCHOL SCI, V15, P373, DOI 10.1111/j.0956-7976.2004.00687.x; Frojd SA, 2008, J ADOLESCENCE, V31, P485, DOI 10.1016/j.adolescence.2007.08.006; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Hollingshead ADB, 1975, FOUR FACTOR INDEX OF, P18; Humensky J, 2010, J SCH NURS, V26, P377, DOI 10.1177/1059840510376515; Jacobus J, 2015, DEV COGN NEUROS-NETH, V16, P101, DOI 10.1016/j.dcn.2015.04.006; Jacobus J, 2015, NEUROPSYCHOLOGY, V29, P829, DOI 10.1037/neu0000203; Johnston L. D., 2012, MONITORING FUTURE NA, VII; Kessler RC, 2003, ACTA PSYCHIAT SCAND, V108, P19, DOI 10.1034/j.1600-0447.108.s417.2.x; LaBrie JW, 2010, ADDICT BEHAV, V35, P721, DOI 10.1016/j.addbeh.2010.03.009; Martinez JA, 2008, PSYCHOL ADDICT BEHAV, V22, P450, DOI 10.1037/0893-164X.22.3.450; Meier MH, 2015, DRUG ALCOHOL DEPEN, V156, P207, DOI 10.1016/j.drugalcdep.2015.09.010; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; MELCHIOR CL, 1981, J PHARMACOL EXP THER, V219, P175; Moss HB, 2014, DRUG ALCOHOL DEPEN, V136, P51, DOI 10.1016/j.drugalcdep.2013.12.011; NEWLIN DB, 1990, PSYCHOL BULL, V108, P383, DOI 10.1037/0033-2909.108.3.383; OVIEDO A, 1993, BRAIN RES, V616, P293, DOI 10.1016/0006-8993(93)90220-H; Pope HG, 2003, DRUG ALCOHOL DEPEN, V69, P303, DOI 10.1016/S0376-8716(02)00334-4; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Reisbig AMJ, 2012, J VET MED EDUC, V39, P341, DOI 10.3138/jvme.0712-065R; Rubino T, 2008, NEUROPSYCHOPHARMACOL, V33, P2760, DOI 10.1038/sj.npp.1301664; Schneider M, 2003, NEUROPSYCHOPHARMACOL, V28, P1760, DOI 10.1038/sj.npp.1300225; SCHUCKIT MA, 1988, ARCH GEN PSYCHIAT, V45, P211; Schweinsburg Alecia D, 2008, Curr Drug Abuse Rev, V1, P99; Singleton RA, 2009, J STUD ALCOHOL DRUGS, V70, P355, DOI 10.15288/jsad.2009.70.355; Solowij N, 2011, PSYCHOPHARMACOLOGY, V216, P131, DOI 10.1007/s00213-011-2203-x; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stein MB, 2000, AM J PSYCHIAT, V157, P1606, DOI 10.1176/appi.ajp.157.10.1606; Suerken CK, 2016, DRUG ALCOHOL DEPEN, V162, P137, DOI 10.1016/j.drugalcdep.2016.02.041; Takagi M, 2011, J STUD ALCOHOL DRUGS, V72, P96, DOI 10.15288/jsad.2011.72.96; Thombs DL, 2009, J STUD ALCOHOL DRUGS, V70, P776, DOI 10.15288/jsad.2009.70.776; Wechsler H, 1998, J AM COLL HEALTH, V47, P57, DOI 10.1080/07448489809595621; Weitzman E. R., 2009, J STUDIES ALCOHOL S, P12, DOI DOI 10.15288/JSADS.2009.S16.12; White Aaron M, 2005, Recent Dev Alcohol, V17, P161, DOI 10.1007/0-306-48626-1_8; Williams J, 2004, HEALTH ECON, V13, P825, DOI 10.1002/hec.859; Wolaver AM, 2002, CONTEMP ECON POLICY, V20, P415, DOI 10.1093/cep/20.4.415; Zeigler DW, 2005, PREV MED, V40, P23, DOI 10.1016/j.ypmed.2004.04.044	53	57	58	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172213	10.1371/journal.pone.0172213	http://dx.doi.org/10.1371/journal.pone.0172213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273162	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700069
J	Soma, M; Iwama, M				Soma, Masayo; Iwama, Midori			Mating success follows duet dancing in the Java sparrow	PLOS ONE			English	Article							FEMALE CHOICE; COURTSHIP DISPLAY; BENGALESE FINCHES; SEXUAL SELECTION; SONG PERFORMANCE; MAGPIE-LARKS; BIRDS; COORDINATION; PREFERENCES; COMPLEXITY	Mutual interactions between sexes have multiple signalling functions. Duet singing in songbirds is related to mutual mate guarding, joint resource defence, and signalling commitment. Coordinated visual displays of mating pairs are thought to perform similar functions, but are less well understood. The current study evaluated mutual interactions in an Estrildid species to explore the relative importance of duet dancing and male singing in mating success of pairs in a first encounter. When Java sparrows (Lonchura oryzivora) court prospective mates, only males sing. However, both males and females perform courtship dances, often in a duet-like manner. These dances are typically terminated by female copulation solicitation displays (CSDs). In the current study, we observed higher mating success when courtship dances were mutually exchanged, and when males sang. However, the sex initiating the courtship did not affect mating success. Most females produced CSDs after duet dancing but before hearing the entire song, indicating that duet dancing played a crucial role in mating. This finding highlights an unexplored aspect of duetting behaviour in the process of mutual mate choice. These results conflict with the majority of past songbird research, which has interpreted songs as primary behavioural sexual signals.	[Soma, Masayo] Hokkaido Univ, Fac Sci, Dept Biol, Behav Neurobiol Grp,Kita Ku, Kita 10,Nishi 8, Sapporo, Hokkaido, Japan; [Iwama, Midori] Hokkaido Univ, Behav Neurobiol Grp, Biosystems Sci Course, Grad Sch Life Sci,Kita Ku, Kita 10,Nishi 8, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Soma, M (corresponding author), Hokkaido Univ, Fac Sci, Dept Biol, Behav Neurobiol Grp,Kita Ku, Kita 10,Nishi 8, Sapporo, Hokkaido, Japan.	masayo.soma@sci.hokudai.ac.jp		Soma, Masayo/0000-0002-8596-1956	Japan Society for the Promotion of Science [23680027, 16H06177]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Young Scientists (Nos. 23680027, 16H06177) received by MS, http://www.jsps.go.jp/english/ index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; ARROWOOD PC, 1988, BEHAVIOUR, V106, P129, DOI 10.1163/156853988X00133; Barske J, 2011, P ROY SOC B-BIOL SCI, V278, P3523, DOI 10.1098/rspb.2011.0382; Borgia G, 1998, ANIM BEHAV, V56, P1121, DOI 10.1006/anbe.1998.0908; Byers J, 2010, ANIM BEHAV, V79, P771, DOI 10.1016/j.anbehav.2010.01.009; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; CATCHPOLE CK, 1987, TRENDS ECOL EVOL, V2, P94, DOI 10.1016/0169-5347(87)90165-0; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Clutton-Brock T, 2009, ANIM BEHAV, V77, P3, DOI 10.1016/j.anbehav.2008.08.026; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; Dalziell AH, 2013, CURR BIOL, V23, P1132, DOI 10.1016/j.cub.2013.05.018; Dunn AM, 1996, ETHOLOGY, V102, P529; Dunning JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089438; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; Elie JE, 2010, ANIM BEHAV, V80, P597, DOI 10.1016/j.anbehav.2010.06.003; Funghi C, 2015, BEHAV PROCESS, V115, P74, DOI 10.1016/j.beproc.2015.03.010; Fusani L, 1997, BEHAVIOUR, V134, P321, DOI 10.1163/156853997X00566; Fusani L, 2014, NEUROSCI BIOBEHAV R, V46, P534, DOI 10.1016/j.neubiorev.2014.07.017; Geberzahn N, 2013, J COMP PSYCHOL, V127, P352, DOI 10.1037/a0033154; Goodwin, 1982, ESTRILDID FINCHES WO; Hall ML, 2007, CURR BIOL, V17, pR406, DOI 10.1016/j.cub.2007.04.022; Hall ML, 2004, BEHAV ECOL SOCIOBIOL, V55, P415, DOI 10.1007/s00265-003-0741-x; Hall ML, 2000, ANIM BEHAV, V60, P667, DOI 10.1006/anbe.2000.1517; Hasegawa A, 2011, ORNITHOL SCI, V10, P73, DOI 10.2326/osj.10.73; Hoepfner AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065525; HUNTER FM, 1993, TRENDS ECOL EVOL, V8, P21, DOI 10.1016/0169-5347(93)90126-A; Kagawa H, 2013, BEHAV PROCESS, V99, P138, DOI 10.1016/j.beproc.2013.07.012; Konter A, 2014, WILSON J ORNITHOL, V126, P140, DOI 10.1676/13-161.1; Langmore NE, 1998, TRENDS ECOL EVOL, V13, P136, DOI 10.1016/S0169-5347(97)01241-X; MALACARNE G, 1991, ETHOL ECOL EVOL, V3, P207, DOI 10.1080/08927014.1991.9525369; Marshall-Ball L, 2006, ANIM BEHAV, V71, P823, DOI 10.1016/j.anbehav.2005.05.021; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Morisaka Tadamichi, 2008, Ornithological Science, V7, P75, DOI 10.2326/1347-0558(2008)7[75:VIPFCS]2.0.CO;2; NUECHTERLEIN GL, 1982, CONDOR, V84, P350; O'Loghlen AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036130; Ota N, BIOASOUSTIC IN PRESS; Ota N, 2015, SCI REP-UK, V5, DOI 10.1038/srep16614; Ota N, 2014, J AVIAN BIOL, V45, P566, DOI 10.1111/jav.00383; Patricelli GL, 2006, ANIM BEHAV, V71, P49, DOI 10.1016/j.anbehav.2005.03.029; PETRIE M, 1992, ANIM BEHAV, V44, P790, DOI 10.1016/S0003-3472(05)80309-4; Rek P, 2016, ANIM BEHAV, V117, P35, DOI 10.1016/j.anbehav.2016.04.024; Restall R., 1996, MUNIAS AND MANNIKINS; Riebel K, 2009, ADV STUD BEHAV, V40, P197, DOI 10.1016/S0065-3454(09)40006-8; SEARCY WA, 1992, AM ZOOL, V32, P71; Servedio MR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3020; SOMA M, 2015, FRONT ECOL EVOL, V3, DOI DOI 10.3389/FEV0.2015.00004; Soma M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124876; Soma M, 2011, BEHAV ECOL, V22, P363, DOI 10.1093/beheco/arq219; Torres R, 2003, BEHAV ECOL SOCIOBIOL, V55, P65, DOI 10.1007/s00265-003-0669-1; Ullrich R, 2016, ANIM BEHAV, V112, P285, DOI 10.1016/j.anbehav.2015.11.012; Wachtmeister CA, 2001, ANIM BEHAV, V61, P861, DOI 10.1006/anbe.2001.1684; Woolley SMN, 1997, J NEUROSCI, V17, P6380; Zanollo V, 2013, ETHOLOGY, V119, P344, DOI 10.1111/eth.12071	53	18	19	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172655	10.1371/journal.pone.0172655	http://dx.doi.org/10.1371/journal.pone.0172655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273111	Green Published, gold			2022-12-27	WOS:000396073700084
J	Wang, Z; Fan, GQ; Dong, YP; Zhai, XQ; Deng, MJ; Zhao, ZL; Liu, WS; Cao, YB				Wang, Zhe; Fan, Guoqiang; Dong, Yanpeng; Zhai, Xiaoqiao; Deng, Minjie; Zhao, Zhenli; Liu, Wenshan; Cao, Yabing			Implications of polyploidy events on the phenotype, microstructure, and proteome of Paulownia australis	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; STRESS; GENE; PLANTS; MECHANISMS; GLYCINEBETAINE; PHOTOSYNTHESIS; TRANSCRIPTOME; LIGNIFICATION; PHYSIOLOGY	Polyploidy events are believed to be responsible for increasing the size of plant organs and enhancing tolerance to environmental stresses. Autotetraploid Paulownia australis plants exhibit superior traits compared with their diploid progenitors. Although some transcriptomics studies have been performed and some relevant genes have been revealed, the molecular and biological mechanisms regulating the predominant characteristics and the effects of polyploidy events on P. australis remain unknown. In this study, we compared the phenotypes, microstructures, and proteomes of autotetraploid and diploid P. australis plants. Compared with the diploid plant, the leaves of the autotetraploid plant were longer and wider, and the upper epidermis, lower epidermis, and palisade layer of the leaves were thicker, the leaf spongy parenchyma layer was thinner, the leaf cell size was bigger, and cell number was lower. In the proteome analysis, 3,010 proteins were identified and quantified, including 773 differentially abundant proteins. These results may help to characterize the P. australis proteome profile. Differentially abundant proteins related to cell division, glutathione metabolism, and the synthesis of cellulose, chlorophyll, and lignin were more abundant in the autotetraploid plants. These results will help to enhance the understanding of variations caused by polyploidy events in P. australis. The quantitative real-time PCR results provided details regarding the expression patterns of the proteins at mRNA level. We observed a limited correlation between transcript and protein levels. These observations may help to clarify the molecular basis for the predominant autotetraploid characteristics and be useful for plant breeding in the future.	[Wang, Zhe; Fan, Guoqiang; Dong, Yanpeng; Deng, Minjie; Zhao, Zhenli; Liu, Wenshan; Cao, Yabing] Henan Agr Univ, Inst Paulownia, Zhengzhou, Henan, Peoples R China; [Wang, Zhe; Fan, Guoqiang; Dong, Yanpeng; Deng, Minjie; Zhao, Zhenli; Liu, Wenshan; Cao, Yabing] Henan Agr Univ, Coll Forestry, Zhengzhou, Henan, Peoples R China; [Zhai, Xiaoqiao] Forestry Acad Henan, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University	Fan, GQ (corresponding author), Henan Agr Univ, Inst Paulownia, Zhengzhou, Henan, Peoples R China.; Fan, GQ (corresponding author), Henan Agr Univ, Coll Forestry, Zhengzhou, Henan, Peoples R China.	zlxx64@126.com		Wang, Zhe/0000-0001-6671-694X	Key Science and Technology Program of Henan Province of China [152107000097]; Natural Science Foundation of Henan Province of China [162300410158]; Distinguished Talents Foundation of Henan Province of China [174200510001]	Key Science and Technology Program of Henan Province of China; Natural Science Foundation of Henan Province of China; Distinguished Talents Foundation of Henan Province of China	This work was supported by the Key Science and Technology Program of Henan Province of China (152107000097), the Natural Science Foundation of Henan Province of China (162300410158), and the Distinguished Talents Foundation of Henan Province of China (174200510001).	Allario T, 2011, J EXP BOT, V62, P2507, DOI 10.1093/jxb/erq467; Ates S, 2008, AFR J BIOTECHNOL, V7, P4153; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Boudet AM, 2000, PLANT PHYSIOL BIOCH, V38, P81, DOI 10.1016/S0981-9428(00)00166-2; Chao DY, 2013, SCIENCE, V341, P658, DOI 10.1126/science.1240561; Chen THH, 2011, PLANT CELL ENVIRON, V34, P1, DOI 10.1111/j.1365-3040.2010.02232.x; Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003; Dai FW, 2015, INT J MOL SCI, V16, P22938, DOI 10.3390/ijms160922938; Deng BL, 2012, PLANT GROWTH REGUL, V66, P37, DOI 10.1007/s10725-011-9626-6; [邓敏捷 Deng Minjie], 2013, [河南农业大学学报, Journal of Henan Agricultural University], V47, P698; Dong YP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00892; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Dudits D, 2016, PLANT PHYSIOL, V170, P1504, DOI 10.1104/pp.15.01679; Fan GQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149617; Fan GuoQiang, 2010, Journal of Northeast Forestry University, V38, P22; Fan GuoQiang, 2009, Journal of Northwest A & F University - Natural Science Edition, V37, P83; [范国强 Fan Guoqiang], 2007, [林业科学, Scientia Silvae Sinicae], V43, P31; [范国强 FAN GuoQiang], 2007, [植物生理学通讯, Plant Physiology Communications], V43, P109; Giri J, 2011, PLANT SIGNAL BEHAV, V6, P1746, DOI 10.4161/psb.6.11.17801; Giribaldi M, 2010, J PROTEOMICS, V73, P1647, DOI 10.1016/j.jprot.2010.05.002; Gonzalez LMG, 2012, PLANT CELL ENVIRON, V35, P682, DOI 10.1111/j.1365-3040.2011.02444.x; Guerfel M, 2009, SCI HORTIC-AMSTERDAM, V119, P257, DOI 10.1016/j.scienta.2008.08.006; Hall T, 2008, TREES LIFE J, V3, P3; Hartmann MD, 2006, J MOL BIOL, V364, P411, DOI 10.1016/j.jmb.2006.09.001; HELL R, 1988, PHYSIOL PLANTARUM, V72, P70, DOI 10.1111/j.1399-3054.1988.tb06624.x; Henkes S, 2001, PLANT CELL, V13, P535, DOI 10.1105/tpc.13.3.535; Herrmann K, 2001, ENCY LIFE SCI; Hou QC, 2015, ANN BOT-LONDON, V115, P465, DOI 10.1093/aob/mcu152; Ipekci Z, 2003, PLANT CELL REP, V22, P16, DOI 10.1007/s00299-003-0650-5; JAWORSKI EG, 1972, J AGR FOOD CHEM, V20, P1195, DOI 10.1021/jf60184a057; Jiang ZF, 2012, ECOTOXICOLOGY, V21, P759, DOI 10.1007/s10646-011-0836-5; Koh J, 2012, NEW PHYTOL, V196, P292, DOI 10.1111/j.1469-8137.2012.04251.x; Kong F, 2011, PLANT MOL BIOL REP, V29, P927, DOI 10.1007/s11105-011-0301-x; Lackner DH, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r25; Lan P, 2012, MOL CELL PROTEOMICS, V11, P1156, DOI 10.1074/mcp.M112.020461; Li WL, 1996, AM J BOT, V83, P15, DOI 10.2307/2445949; Li XD, 2012, PLANTA, V236, P579, DOI 10.1007/s00425-012-1629-7; Ma JJ, 2012, SCI CHINA LIFE SCI, V55, P68, DOI 10.1007/s11427-012-4268-0; Marenco RA, 2009, PHOTOSYNTHETICA, V47, P184, DOI 10.1007/s11099-009-0031-6; Marmagne A, 2010, NEW PHYTOL, V186, P216, DOI 10.1111/j.1469-8137.2009.03139.x; May MJ, 1998, J EXP BOT, V49, P649, DOI 10.1093/jexbot/49.321.649; Nassar NMA, 2008, GENET MOL RES, V7, P276, DOI 10.4238/vol7-2gmr399; Ng DWK, 2012, HEREDITY, V108, P419, DOI 10.1038/hdy.2011.92; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Qian CT, 2005, PLANT BREEDING, V124, P272, DOI 10.1111/j.1439-0523.2005.01066.x; Qiao JJ, 2012, J PROTEOME RES, V11, P5286, DOI 10.1021/pr300504w; Sahashi Norio, 1995, Annals of the Phytopathological Society of Japan, V61, P481, DOI 10.3186/jjphytopath.61.481; Shen YY, 2015, J PROTEOMICS, V112, P274, DOI 10.1016/j.jprot.2014.10.006; Song Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29843; Sugiyama SI, 2005, ANN BOT-LONDON, V96, P931, DOI 10.1093/aob/mci245; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Tal M, 1979, Basic Life Sci, V13, P61; Tan FQ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0450-4; Tian XX, 2013, J PROTEOMICS, V78, P326, DOI 10.1016/j.jprot.2012.10.002; Tsukaya H, 2008, PLOS BIOL, V6, P1373, DOI 10.1371/journal.pbio.0060174; Wang SZ, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0891-4; Wang Yang, 2013, Acta Agriculturae Jiangxi, V25, P39; Wang Y, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00220, 10.3389/fpls.2013.00314]; Xu EK, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0828-8; Yu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115153; [张晓申 Zhang Xiaoshen], 2013, [河南农业大学学报, Journal of Henan Agricultural University], V47, P543; [张晓申 Zhang Xiaoshen], 2012, [河南农业大学学报, Journal of Henan Agricultural University], V46, P646	62	18	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172633	10.1371/journal.pone.0172633	http://dx.doi.org/10.1371/journal.pone.0172633			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273106	gold, Green Published, Green Submitted			2022-12-27	WOS:000396073700083
J	Zhou, BX; Li, J; Liang, XL; Yang, ZF; Jiang, ZH				Zhou, Beixian; Li, Jing; Liang, Xiaoli; Yang, Zifeng; Jiang, Zhihong			Transcriptome profiling of influenza A virus-nfected lung epithelial (A549) cells with lariciresinol-4-beta-D-glucopyranoside treatment	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; DNA-DAMAGE-RESPONSE; ISATIS-INDIGOTICA; TELOMERE LENGTH; CYCLE ARREST; ANTIVIRAL ACTIVITY; I INTERFERON; IKK-EPSILON; INFECTION; EXPRESSION	The influenza A virus is an acute contagious pathogen that affects the human respiratory system and can cause severe lung disease and even death. Lariciresino1-4-beta-D-glucopyranoside is a lignan that is extracted from Isatis indigotica, which is a medicinal herb plant that was commonly applied to treat infections, the common cold, fever and inflammatory diseases. Our previous study demonstrated that lariciresino1-4-beta-D-glucopyranoside possesses anti-viral and anti-inflammatory properties. However, the comprehensive and detailed mechanisms that underlie the effect of lariciresino1-4-beta-D-glucopyranoside interventions against influenza virus infection remain to be elucidated. In this study, we employed high-throughput RNA sequencing (RNA-seq) to investigate the transcriptomic responses of influenza A virus-infected lung epithelial (A549) cells with lariciresino1-4-beta-D-glucopyranoside treatment. The transcriptome data show that infection with influenza A virus prompted the activation of 368 genes involved in RIG-I signalling, the inflammatory response, interferon a/beta signalling and gene expression that was not affected by lariciresino1-4-beta-D-glucopyranoside treatment. Lariciresino1-4-beta-D-glucopyranoside exerted its pharmacological actions on the immune system, signal transduction, cell cycle and metabolism, which may be an underlying defense mechanism against influenza virus infection. In addition, 166 differentially expressed genes (DEGs) were uniquely expressed in lariciresino1-4-beta-D-glucopyranoside-treated cells, which were concentrated in the cell cycle, DNA repair, chromatin organization, gene expression and biosynthesis domains. Among them, six telomere-associated genes were up-regulated by lariciresino1-4-beta-D-glucopyranoside treatment, which have been implicated in telomere regulation and stability. Collectively, we employed RNAseq analysis to provide comprehensive insight into the mechanism of lariciresino1-4-beta-D-glucopyranoside against influenza virus infection.	[Zhou, Beixian; Yang, Zifeng; Jiang, Zhihong] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China; [Li, Jing; Liang, Xiaoli; Yang, Zifeng] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Ctr Resp Dis, State Key Lab Resp Dis,Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China	Macau University of Science & Technology; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Yang, ZF; Jiang, ZH (corresponding author), Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China.; Yang, ZF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Ctr Resp Dis, State Key Lab Resp Dis,Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China.	jeffyah@163.com; zhjiang@must.edu.mo		Jiang, Zhi-Hong/0000-0002-7956-2481	National Natural Science Foundation of China [U1201227, 81428024]; Science and Technology Development Fund in Macao Special Administrative Region [019/2013/A1]; Ministry of Science and Technology of China [2015DFM30010]; Guangzhou Postdoctoral Research Foundation, China [2015LJ]; Natural Science Foundation of Guangdong Province, China [2014A030310115]; Scientific Research Project of College Directly Under the Guangzhou Education Bureau [1201430183]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Fund in Macao Special Administrative Region; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Guangzhou Postdoctoral Research Foundation, China(China Postdoctoral Science Foundation); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Scientific Research Project of College Directly Under the Guangzhou Education Bureau	This study was supported by the National Natural Science Foundation of China (Grant no. U1201227) (http://www.nsfc.gov.cn/publish/portal1/); the Science and Technology Development Fund in Macao Special Administrative Region (Grant no. 019/2013/A1) (http://www.fdct.gov.mo/about); the National Natural Science Foundation of China (Grant no. 81428024) (http://www.nsfc.gov.cn/publish/portal1/); the Ministry of Science and Technology of China (Grant no. 2015DFM30010) (http://www.most.gov.cn/index.htm); the Guangzhou Postdoctoral Research Foundation, China (Grant no. 2015LJ) (http://www.hrssgz.gov.cn/gzbsh/); the Natural Science Foundation of Guangdong Province, China (Grant no. 2014A030310115) (http://www.gdstc.gov.cn/); and the Scientific Research Project of College Directly Under the Guangzhou Education Bureau (Grant no. 1201430183) (http://www.gzedu.gov.cn/).	Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; Billharz R, 2009, J VIROL, V83, P10557, DOI 10.1128/JVI.00330-09; Chakrabarti AK, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-219; Challacombe JF, 2004, PHYSIOL GENOMICS, V18, P51, DOI 10.1152/physiolgenomics.00155.2003; Chan RWY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051057; Chen JF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-857; Chen MH, 2012, J NAT PROD, V75, P1167, DOI 10.1021/np3002833; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Coulombe F, 2014, IMMUNITY, V40, P554, DOI 10.1016/j.immuni.2014.02.013; Davies C, 2015, J VIROL, V89, P6057, DOI 10.1128/JVI.03673-14; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Deng Z, 2014, CELL REP, V9, P2263, DOI 10.1016/j.celrep.2014.11.019; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Di Pietro A, 2013, J VIROL, V87, P4523, DOI 10.1128/JVI.02548-12; Dixit E, 2013, ADV IMMUNOL, V117, P99, DOI 10.1016/B978-0-12-410524-9.00004-9; Fernandes HS, 2016, EXPERT OPINION THERA, P1; Fox JM, 2013, J GEN VIROL, V94, P1451, DOI 10.1099/vir.0.053124-0; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hai R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3854; Hale BG, 2010, FUTURE MICROBIOL, V5, P23, DOI [10.2217/fmb.09.108, 10.2217/FMB.09.108]; Hayase Y, 2003, INTERVIROLOGY, V46, P319, DOI 10.1159/000073211; Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Huang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066546; Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x; Izumi Y, 2007, NEUROSCI LETT, V426, P54, DOI 10.1016/j.neulet.2007.08.054; Jiang W, 2013, J VIROL, V87, P3039, DOI 10.1128/JVI.03176-12; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; KATZE MG, 1986, J VIROL, V60, P1027, DOI 10.1128/JVI.60.3.1027-1039.1986; Kaufer BB, 2011, J EXP MED, V208, P605, DOI 10.1084/jem.20101402; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Kumar V, 2010, ROBBINS COTRAN PATHO, P43; Lam WY, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-554; Lamontagne J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005438; Lee TKW, 2003, CARCINOGENESIS, V24, P1729, DOI 10.1093/carcin/bgg145; Li G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-59; Li J, 2015, J ETHNOPHARMACOL, V174, P379, DOI 10.1016/j.jep.2015.08.037; Li N, 2015, CELL MOL LIFE SCI, V72, P2973, DOI 10.1007/s00018-015-1879-1; Li YT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-398; Maines TR, 2012, J INFECT DIS, V205, P474, DOI 10.1093/infdis/jir768; Marjuki H, 2015, J VIROL, V89, P5419, DOI 10.1128/JVI.03513-14; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; O'Bryan JM, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-37; Oguin TH, 2014, J BIOL CHEM, V289, P25405, DOI 10.1074/jbc.M114.558817; Onomoto K, 2014, TRENDS IMMUNOL, V35, P420, DOI 10.1016/j.it.2014.07.006; Park SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16512; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Prakash A, 2005, J BIOL CHEM, V280, P18651, DOI 10.1074/jbc.M501289200; Quan R, 2016, SCI REP-UK, V6, DOI 10.1038/srep27917; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Sanda C, 2006, J INTERF CYTOK RES, V26, P462, DOI 10.1089/jir.2006.26.462; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Sprenger H, 1996, J EXP MED, V184, P1191, DOI 10.1084/jem.184.3.1191; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Tang J., 2010, KAOGU, V2010, P9, DOI DOI 10.1016/J.JP0WS0UR.2009.11.036; van der Sluijs KF, 2006, J INFECT DIS, V193, P214, DOI 10.1086/498911; Vijayakumar P, 2015, GENE, V559, P77, DOI 10.1016/j.gene.2015.01.016; Vijayan M, 2014, SCIENTIFICA CAIRO, V2014; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Wang XY, 2006, PHYTOTHER RES, V20, P335, DOI 10.1002/ptr.1892; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei-yang YE., 2011, AFRICAN J PHARM PHAR, V5; Yang Q, 2000, J BIOL CHEM, V275, P36892, DOI 10.1074/jbc.M005319200; Yang ZF, 2015, SCIENCE, V347, pS35; Zhu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep22243; Zou W, 2013, SCI REP-UK, V3, DOI 10.1038/srep01601	72	17	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173058	10.1371/journal.pone.0173058	http://dx.doi.org/10.1371/journal.pone.0173058			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273165	gold, Green Published, Green Submitted			2022-12-27	WOS:000396073700037
J	Santos, NW; Yoshimura, EH; Mareze-Costa, CE; Machado, E; Agustinho, BC; Pereira, LM; Brito, MN; Brito, NA; Zeoula, LM				Santos, Nadine W.; Yoshimura, Emerson H.; Mareze-Costa, Cecilia E.; Machado, Erica; Agustinho, Bruna C.; Pereira, Lucelia M.; Brito, Marcia N.; Brito, Nilton A.; Zeoula, Lucia M.			Supplementation of cow milk naturally enriched in polyunsaturated fatty acids and polyphenols to growing rats	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; DAIRY-COWS; ANTIOXIDANT CAPACITY; METABOLISM; EXPRESSION; EXTRACT; PLASMA	This study investigated whether intake of cow milk, naturally enriched with polyunsaturated fatty acids (PUFA, omega-3) and polyphenols (from propolis extract and vitamin E), from manipulation of cow's diet, would result in positive metabolic effects in rats from weaning until adulthood. Male Wistar rats were fed a standard chow diet or a hypercaloric diet (metabolically disturbed rats, obese) which was supplemented with either whole common milk, milk enriched with PUFA (PUFA-M) or milk enriched with PUFA and polyphenols (PUFA/P-M), at 5mL/kg body weight,having water as control. Whole milk supplementation increased initial weight gain and reduced gain in the adulthood of rats. Intake of common milk reduced cholesterol levels in non-obese rats and reduced insulin resistance in obese rats. PUFA-milk showed a decreasing effect on plasma triacylglycerol and VLDL concentrations, increasing plasma HDL concentration and reducing adipocyte size of non-obese rats, but no effect was observed in obese rats. PUFA/P-milk in obese rats resulted in greater deposition of muscle mass and mesenteric fat, with a tendency to lower LDL levels, and resulted a visceral fat accumulation in non-obese rats. Thus, whole common milk and PUFA-rich milk have shown to be beneficial in a normal metabolic condition, whereas common milk and milk enriched with PUFA and polyphenols improve metabolic effects of obesity.	[Santos, Nadine W.; Yoshimura, Emerson H.; Machado, Erica; Agustinho, Bruna C.; Pereira, Lucelia M.; Zeoula, Lucia M.] Univ Estadual Maringa, Dept Zootecnia, Maringa, Parana, Brazil; [Mareze-Costa, Cecilia E.; Brito, Marcia N.; Brito, Nilton A.] Univ Estadual Maringa, Dept Ciencias Fisiol, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	Santos, NW (corresponding author), Univ Estadual Maringa, Dept Zootecnia, Maringa, Parana, Brazil.	nadine@zootecnista.com.br		Woruby Santos, Nadine/0000-0003-0996-8213	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Brasilia, DF, Brazil) [482858/2011-7]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Brasilia, DF, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) is acknowledged for the financial support (482858/2011-7, Brasilia, DF, Brazil).	Aguiar SC, 2014, ANIM FEED SCI TECH, V193, P148, DOI 10.1016/j.anifeedsci.2014.04.006; [Anonymous], [No title captured]; AOAC, 2007, OFFICIAL METHODS ANA, V18th; Azain MJ, 2000, J NUTR, V130, P1548; Bauman DE, 2006, J DAIRY SCI, V89, P1235, DOI 10.3168/jds.S0022-0302(06)72192-0; BERNARDIS LL, 1968, J ENDOCRINOL, V40, P527, DOI 10.1677/joe.0.0400527; Bernstein AM, 2012, METAANALYSIS SHOWS D, P1; Brazilian Institute of Geography and Statistics, 2008, ANTHR NUTR STAT CHIL; Brazilian Ministry of Health, 2008, FEED GUID BRAZ POP P; Bu DP, 2007, J DAIRY SCI, V90, P998, DOI 10.3168/jds.S0022-0302(07)71585-0; Choi SS, 2011, BIOCHEM PHARMACOL, V81, P925, DOI 10.1016/j.bcp.2011.01.002; Connor WE, 2000, AM J CLIN NUTR, V71, p171S, DOI 10.1093/ajcn/71.1.171S; Crichton GE, 2011, OBES REV, V12, pe190, DOI 10.1111/j.1467-789X.2010.00837.x; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Faure P, 1995, ANAL FREE RADICALS B, P238; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foletto MD, 2015, ACTA SCI-HEALTH SCI, V37, P19, DOI 10.4025/actascihealthsci.v37i1.18614; Gagnon N, 2009, BRIT J NUTR, V102, P1015, DOI 10.1017/S0007114509344104; Harris S, 1997, FATTY ACIDS SERUMLIP, P65; Hartman L, 1973, Lab Pract, V22, P475; Hu FB, 2016, OPTIMAL DIETS PREVEN, V288, P2569; Ikeda R, 2011, BBA-GEN SUBJECTS, V1810, P695, DOI 10.1016/j.bbagen.2011.04.007; Kim TN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115407; Kiokias SN, 2006, FOOD BIOPHYS, V1, P115, DOI 10.1007/s11483-006-9015-2; Landi F, 2014, CURR OPIN CLIN NUTR, V17, P25, DOI 10.1097/MCO.0000000000000018; Lima DC, 2008, METAB BRAIN DIS, V23, P361, DOI [10.1007/s11011-008-9101-x, DOI 10.1007/S11011-008-9101-X]; Monika P, 2015, PHYTOMEDICINE, V22, P939, DOI 10.1016/j.phymed.2015.07.001; Noakes M, 1996, AM J CLIN NUTR, V63, P42, DOI 10.1093/ajcn/63.1.42; Rainer L, 2004, J AM DIET ASSOC, V104, P963, DOI 10.1016/j.jada.2004.03.016; RODBELL M, 1964, J BIOL CHEM, V239, P375; Roza NAV, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.28536; Santos NW, 2014, LIVEST SCI, V159, P37, DOI 10.1016/j.livsci.2013.11.015; Santos NW, 2016, LIVEST SCI, V191, P132, DOI 10.1016/j.livsci.2016.07.012; Simionato JI, 2010, J BRAZIL CHEM SOC, V21, P520, DOI 10.1590/S0103-50532010000300018; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Stancliffe RA, 2011, AM J CLIN NUTR AM SO; VYNCKE W, 1970, FETTE SEIFEN ANSTRICHM, V72, P1084, DOI 10.1002/lipi.19700721218; Zhao XW, 2013, ANIM FEED SCI TECH, V185, P35, DOI 10.1016/j.anifeedsci.2013.06.009; Zhu QY, 2002, J AGR FOOD CHEM, V50, P6929, DOI 10.1021/jf0206163; Zulueta A, 2009, INT DAIRY J, V19, P380, DOI 10.1016/j.idairyj.2009.02.003	40	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0172909	10.1371/journal.pone.0172909	http://dx.doi.org/10.1371/journal.pone.0172909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267800	Green Published, Green Submitted, gold			2022-12-27	WOS:000396060600005
J	Sun, YY; Zhang, JQ; Qin, L; Yan, C; Zhang, XJ; Liu, DD				Sun, Yuying; Zhang, Jiquan; Qin, Lei; Yan, Cui; Zhang, Xiaojun; Liu, Dandan			Identification and validation of sRNAs in Edwardsiella tarda S08	PLOS ONE			English	Article							SMALL NONCODING RNAS; VI SECRETION SYSTEM; ESCHERICHIA-COLI; BACTERIAL GENOMES; REGULATORY RNAS; VIBRIO-CHOLERAE; OUTER-MEMBRANE; HOST INFECTION; III SECRETION; VIRULENCE	Bacterial small non-coding RNAs (sRNAs) are known as novel regulators involved in virulence, stress responsibility, and so on. Recently, a lot of new researches have highlighted the critical roles of sRNAs in fine-tune gene regulation in both prokaryotes and eukaryotes. Edwardsiella tarda (E. tarda) is a gram-negative, intracellular pathogen that causes edward-siellosis in fish. Thus far, no sRNA has been reported in E. tarda. The present study represents the first attempt to identify sRNAs in E. tarda S08. Ten sRNAs were validated by RNA sequencing and quantitative PCR (qPCR). ET_sRNA_1 and ET_sRNA_2 were homolous to tmRNA and GcvB, respectively. However, the other candidate sRNAs have not been reported till now. The cellular abundance of 10 validated sRNA was detected by qPCR at different growth phases to monitor their biosynthesis. Nine candidate sRNAs were expressed in the late-stage of exponential growth and stationary stages of growth (36 similar to 60 h). And the expression of the nine sRNAs was growth phase-dependent. But ET_sRNA_10 was almost expressed all the time and reached the highest peak at 48 h. Their targets were predicted by TargetRNA2 and each sRNA target contains some genes that directly or indirectly relate to virulence. These results preliminary showed that sRNAs probably play a regulatory role of virulence in E. tarda.	[Sun, Yuying; Qin, Lei; Yan, Cui; Zhang, Xiaojun; Liu, Dandan] Huaihai Inst Technol, Coll Marine Life & Fisheries, Lianyungang, Peoples R China; [Sun, Yuying] Jiangsu Marine Resources Dev Res Inst, Lianyungang, Peoples R China; [Sun, Yuying] Huaihai Inst Technol, Coinnovat Ctr Jiangsu Marine Bioind Technol, Lianyungang, Peoples R China; [Zhang, Jiquan] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China	Jiangsu Ocean University; Jiangsu Ocean University; Chinese Academy of Sciences; Institute of Oceanology, CAS	Zhang, JQ (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	zhangjiquan@qdio.ac.cn	zhang, jin/GXV-9154-2022	zhang, Jiquan/0000-0001-5063-339X	National Natural Science Foundation of China [41306165]; Natural Science Foundation of Jiangsu Province [BK20140442]; Priority Academic Program Development of Jiangsu Higher Education Institutions, China Postdoctoral Foundation Fund [2011M501169]; 521 High-Level Talent Education Project of Lianyungang	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions, China Postdoctoral Foundation Fund; 521 High-Level Talent Education Project of Lianyungang	The project was supported by The National Natural Science Foundation of China (41306165), The Natural Science Foundation of Jiangsu Province (BK20140442), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, China Postdoctoral Foundation Funding (2011M501169) and the fifth-batch "521 High-Level Talent Education Project of Lianyungang".	Abu-Qatouseh LF, 2010, J MOL MED, V88, P565, DOI 10.1007/s00109-010-0597-2; Acebo P, 2012, RNA, V18, P530, DOI 10.1261/rna.027359.111; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altuvia S, 2007, CURR OPIN MICROBIOL, V10, P257, DOI 10.1016/j.mib.2007.05.003; Busi F, 2010, BIOCHIMIE, V92, P1458, DOI 10.1016/j.biochi.2010.06.020; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Gao DQ, 2014, FEMS MICROBIOL LETT, V353, P132, DOI 10.1111/1574-6968.12420; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Guillier M, 2006, MOL MICROBIOL, V59, P231, DOI 10.1111/j.1365-2958.2005.04929.x; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Lenz DH, 2005, MOL MICROBIOL, V58, P1186, DOI 10.1111/j.1365-2958.2005.04902.x; Li Wuju, 2012, Genomics Proteomics & Bioinformatics, V10, P276, DOI 10.1016/j.gpb.2012.09.004; Liu EF, 2014, J BASIC MICROB, V54, P678, DOI 10.1002/jobm.201300622; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livny J, 2005, NUCLEIC ACIDS RES, V33, P4096, DOI 10.1093/nar/gki715; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Morohoshi T, 2004, J BIOSCI BIOENG, V98, P274, DOI 10.1016/S1389-1723(04)00281-6; Mraheil MA, 2010, MICROB BIOTECHNOL, V3, P658, DOI 10.1111/j.1751-7915.2010.00171.x; Papenfort K, 2015, FEMS MICROBIOL REV, V39, P362, DOI 10.1093/femsre/fuv016; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Papenfort K, 2009, RES MICROBIOL, V160, P278, DOI 10.1016/j.resmic.2009.03.004; Patenge N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-550; Pichon C, 2012, NUCLEIC ACIDS RES, V40, P2846, DOI 10.1093/nar/gkr1141; Pichon C, 2008, BIOINFORMATICS, V24, P2807, DOI 10.1093/bioinformatics/btn560; Pulvermacher SC, 2009, MICROBIOL-SGM, V155, P106, DOI 10.1099/mic.0.023598-0; Raabe CA, 2011, RNA, V17, P1357, DOI 10.1261/rna.2682311; Rao PSS, 2003, MICROBIOL-SGM, V149, P2635, DOI 10.1099/mic.0.26478-0; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Romby P, 2010, CELL MOL LIFE SCI, V67, P217, DOI 10.1007/s00018-009-0162-8; Sahr T, 2012, RNA BIOL, V9, P503, DOI 10.4161/rna.20270; Sakai T, 2009, MICROBIOL IMMUNOL, V53, P131, DOI 10.1111/j.1348-0421.2009.00108.x; Schroeder CLC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2293-7; Shioya K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023948; Soutourina OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003493; Sridhar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011970; Stauffer Lorraine T, 2012, ISRN Microbiol, V2012, P697308, DOI 10.5402/2012/697308; Sun Y, 2012, INFECT IMMUN, V80, P2948, DOI 10.1128/IAI.00063-12; Tan YP, 2005, MICROBIOL-SGM, V151, P2301, DOI 10.1099/mic.0.28005-0; Tjaden B, 2008, J MATH BIOL, V56, P183, DOI 10.1007/s00285-007-0079-5; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Tu KC, 2007, GENE DEV, V21, P221, DOI 10.1101/gad.1502407; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; Vecerek B, 2007, EMBO J, V26, P965, DOI 10.1038/sj.emboj.7601553; Wang LM, 2014, VET MICROBIOL, V171, P165, DOI 10.1016/j.vetmic.2014.03.030; Wang X, 2010, FISH SHELLFISH IMMUN, V29, P1082, DOI 10.1016/j.fsi.2010.08.025; Wang YF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00164; Warrier I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100147; Williams KP, 2000, NUCLEIC ACIDS RES, V28, P168, DOI 10.1093/nar/28.1.168; Xiao JF, 2009, APPL MICROBIOL BIOT, V83, P151, DOI 10.1007/s00253-009-1924-9; Xie HX, 2014, INFECT IMMUN, V82, P3436, DOI 10.1128/IAI.01065-13; Xu T, 2014, J APPL MICROBIOL, V116, P236, DOI 10.1111/jam.12357; Zhang M, 2008, MICROBIOL-SGM, V154, P2060, DOI 10.1099/mic.0.2008/017343-0; Zhang M, 2009, APPL ENVIRON MICROB, V75, P3882, DOI 10.1128/AEM.02690-08; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zheng WJ, 2011, FISH SHELLFISH IMMUN, V31, P985, DOI 10.1016/j.fsi.2011.08.018	57	3	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0172783	10.1371/journal.pone.0172783	http://dx.doi.org/10.1371/journal.pone.0172783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267754	Green Submitted, Green Published, gold			2022-12-27	WOS:000396060600003
J	Chen, A; Leith, M; Tu, R; Tahim, G; Sudra, A; Bhargava, S				Chen, Aaron; Leith, Matthew; Tu, Roger; Tahim, Gurpreet; Sudra, Anish; Bhargava, Swapnil			Effects of diluents on cell culture viability measured by automated cell counter	PLOS ONE			English	Article							ANIMAL-CELLS; SHEAR SENSITIVITY; PLURONIC F68; BIOREACTOR; MECHANISMS; REDUCTION; SERUM	Commercially available automated cell counters based on trypan blue dye-exclusion are widely used in industrial cell culture process development and manufacturing to increase throughput and eliminate inherent variability in subjective interpretation associated with manual hemocytometers. When using these cell counters, sample dilution is often necessary to stay within the assay measurement range; however, the effect of time and diluents on cell culture is not well understood. This report presents the adverse effect of phosphate buffered saline as a diluent on cell viability when used in combination with an automated cell counter. The reduced cell viability was attributed to shear stress introduced by the automated cell counter. Furthermore, length of time samples were incubated in phosphate buffered saline also contributed to the observed drop in cell viability. Finally, as erroneous viability measurements can severely impact process decisions and product quality, this report identifies several alternative diluents that can maintain cell culture viability over time in order to ensure accurate representation of cell culture conditions.	[Chen, Aaron; Leith, Matthew; Tu, Roger; Tahim, Gurpreet; Bhargava, Swapnil] Seattle Genet Inc, BioProc Dev, Bothell, WA 98021 USA; [Sudra, Anish] Seattle Genet Inc, Clin Mfg, Bothell, WA USA	Seattle Genetics; Seattle Genetics	Chen, A (corresponding author), Seattle Genet Inc, BioProc Dev, Bothell, WA 98021 USA.	cwchen@seagen.com		Tu, Roger/0000-0002-7899-1604	Seattle Genetics, Inc.	Seattle Genetics, Inc.	The funder, Seattle Genetics, Inc., provided support in the form of salaries for authors AC, ML, RT, GT, AS and SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALRUBEAI M, 1995, BIOTECHNOL BIOENG, V45, P463, DOI 10.1002/bit.260450602; Amanullah A, 2010, BIOTECHNOL BIOENG, V106, P57, DOI 10.1002/bit.22664; Chen A, 2009, BIOTECHNOL BIOENG, V102, P148, DOI 10.1002/bit.22031; Evans HM, 1914, SCIENCE, V39, P443, DOI 10.1126/science.39.1004.443; GARCIABRIONES M, 1992, ANN NY ACAD SCI, V665, P219, DOI 10.1111/j.1749-6632.1992.tb42586.x; GRAMER MJ, 1993, BIOTECHNOL PROGR, V9, P366, DOI 10.1021/bp00022a003; Hsu WT, 2012, CYTOTECHNOLOGY, V64, P667, DOI 10.1007/s10616-012-9446-1; Huang YM, 2010, BIOTECHNOL PROGR, V26, P1400, DOI 10.1002/btpr.436; JORDAN M, 1994, BIOTECHNOL BIOENG, V43, P446, DOI 10.1002/bit.260430603; Keane JT, 2003, BIOTECHNOL BIOENG, V81, P211, DOI 10.1002/bit.10472; Kostov Y, 2001, BIOTECHNOL BIOENG, V72, P346, DOI 10.1002/1097-0290(20010205)72:3<346::AID-BIT12>3.0.CO;2-X; Koterba KL, 2012, J BIOTECHNOL, V157, P261, DOI 10.1016/j.jbiotec.2011.11.009; KRETZMER G, 1991, APPL MICROBIOL BIOT, V34, P613, DOI 10.1007/BF00167909; Legmann R, 2009, BIOTECHNOL BIOENG, V104, P1107, DOI 10.1002/bit.22474; Lew C, INSTRUMENT TO INSTRU; MICHAELS JD, 1991, BIOTECHNOL BIOENG, V38, P169, DOI 10.1002/bit.260380209; Pappenheimer AM, 1917, J EXP MED, V25, P633, DOI 10.1084/jem.25.5.633; RAMIREZ OT, 1990, BIOTECHNOL BIOENG, V36, P911, DOI 10.1002/bit.260360906; Shukla AA, 2010, TRENDS BIOTECHNOL, V28, P253, DOI 10.1016/j.tibtech.2010.02.001; Szabo S E, 2004, Lab Hematol, V10, P109, DOI 10.1532/LH96.04020; Trexler-Schmidt M, 2010, BIOTECHNOL BIOENG, V106, P452, DOI 10.1002/bit.22699; VANDERPOL LA, 1993, BIOTECHNOL PROGR, V9, P504, DOI 10.1021/bp00023a009	22	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173375	10.1371/journal.pone.0173375	http://dx.doi.org/10.1371/journal.pone.0173375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264018	gold, Green Published			2022-12-27	WOS:000396054300058
J	Verhage, L; Severing, EI; Bucher, J; Lammers, M; Busscher-Lange, J; Bonnema, G; Rodenburg, N; Proveniers, MCG; Angenent, GC; Immink, RGH				Verhage, Leonie; Severing, Edouard I.; Bucher, Johan; Lammers, Michiel; Busscher-Lange, Jacqueline; Bonnema, Guusje; Rodenburg, Nicole; Proveniers, Marcel C. G.; Angenent, Gerco C.; Immink, Richard G. H.			Splicing-related genes are alternatively spliced upon changes in ambient temperatures in plants	PLOS ONE			English	Article							PRE-MESSENGER-RNA; CIRCADIAN CLOCK; SR45 PROTEIN; ARABIDOPSIS; EXPRESSION; RESPONSES; GROWTH; QUANTIFICATION; IDENTIFICATION; TRANSCRIPTS	Plants adjust their development and architecture to small variations in ambient temperature. In a time in which temperatures are rising world-wide, the mechanism by which plants are able to sense temperature fluctuations and adapt to it, is becoming of special interest. By performing RNA-sequencing on two Arabidopsis accession and one Brassica species exposed to temperature alterations, we showed that alternative splicing is an important mechanism in ambient temperature sensing and adaptation. We found that amongst the differentially alternatively spliced genes, splicing related genes are enriched, suggesting that the splicing machinery itself is targeted for alternative splicing when temperature changes. Moreover, we showed that many different components of the splicing machinery are targeted for ambient temperature regulated alternative splicing. Mutant analysis of a splicing related gene that was differentially spliced in two of the genotypes showed an altered flowering time response to different temperatures. We propose a two-step mechanism where temperature directly influences alternative splicing of the splicing machinery genes, followed by a second step where the altered splicing machinery affects splicing of downstream genes involved in the adaptation to altered temperatures.	[Verhage, Leonie; Angenent, Gerco C.; Immink, Richard G. H.] Wageningen Univ & Res, Mol Biol Lab, Pb Wageningen, Netherlands; [Verhage, Leonie; Severing, Edouard I.; Lammers, Michiel; Busscher-Lange, Jacqueline; Angenent, Gerco C.; Immink, Richard G. H.] Wageningen Univ & Res, Wageningen Plant Res, Biosci, Pb Wageningen, Netherlands; [Severing, Edouard I.] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Bucher, Johan; Bonnema, Guusje] Wageningen Univ & Res, Wageningen UR Plant Breeding, Pb Wageningen, Netherlands; [Rodenburg, Nicole; Proveniers, Marcel C. G.] Univ Utrecht, Inst Environm Biol, Mol Plant Physiol, Utrecht, Netherlands	Wageningen University & Research; Wageningen University & Research; Max Planck Society; Wageningen University & Research; Utrecht University	Immink, RGH (corresponding author), Wageningen Univ & Res, Mol Biol Lab, Pb Wageningen, Netherlands.; Immink, RGH (corresponding author), Wageningen Univ & Res, Wageningen Plant Res, Biosci, Pb Wageningen, Netherlands.	richard.immink@wur.nl	Immink, Richard G.H./A-9825-2011; Proveniers, Marcel C. G./B-7919-2011	Immink, Richard/0000-0002-0182-4138; Proveniers, Marcel/0000-0001-7896-6049; Verhage, Leonie/0000-0001-6402-3605	NWO-ALW/TTI-GG project (Dutch Scientific Organisation/Technological Top Institute Green Genetics, the Netherlands) [828.11.005]; Syngenta; Bejo Seeds B.V.; Rijk Zwaan Breeding B.V.; Netherlands Genomics Initiative (NGI) [40-41009-98-8003]	NWO-ALW/TTI-GG project (Dutch Scientific Organisation/Technological Top Institute Green Genetics, the Netherlands); Syngenta(Syngenta); Bejo Seeds B.V.; Rijk Zwaan Breeding B.V.; Netherlands Genomics Initiative (NGI)	This work was funded by a NWO-ALW/TTI-GG project (Dutch Scientific Organisation/Technological Top Institute Green Genetics, the Netherlands) entitled Thermoflow: Flowering time regulation in Brassica species by ambient temperatures (828.11.005), together with Syngenta, Bejo Seeds B.V. and Rijk Zwaan Breeding B.V. Part of the RNAseq analyses have been performed in the framework of a Horizon Breakthrough project of the Netherlands Genomics Initiative (NGI), entitled Role of alternative splicing in plants adaptation to a changing environment (40-41009-98-8003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126516; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Barta A, 2008, CURR TOP MICROBIOL, V326, P83; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; BOOIJ R, 1987, NETH J AGR SCI, V35, P435; Carvalho RF, 2010, PLANT PHYSIOL, V154, P772, DOI 10.1104/pp.110.155523; Cho S, 2015, P NATL ACAD SCI USA, V112, P9926, DOI 10.1073/pnas.1500639112; David CJ, 2011, GENE DEV, V25, P972, DOI 10.1101/gad.2038011; Ding F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-431; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Forment J, 2002, PLANT J, V30, P511, DOI 10.1046/j.1365-313X.2002.01311.x; Gu L, 2014, PLANT PHYSIOL BIOCH, V82, P309, DOI 10.1016/j.plaphy.2014.07.006; Gu XF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2947; HOFFMAN BE, 1992, GENE DEV, V6, P2554, DOI 10.1101/gad.6.12b.2554; Huang XY, 2013, PLANT CELL, V25, P637, DOI 10.1105/tpc.112.107896; James AB, 2012, PLANT CELL, V24, P961, DOI 10.1105/tpc.111.093948; Kalyna M, 2003, MOL BIOL CELL, V14, P3565, DOI 10.1091/mbc.E03-02-0109; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Koini MA, 2009, CURR BIOL, V19, P408, DOI 10.1016/j.cub.2009.01.046; Leviatan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066511; Ling ZH, 2015, PLANT J, V84, P228, DOI 10.1111/tpj.12997; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pose D, 2013, NATURE, V503, P414, DOI 10.1038/nature12633; Reddy ASN, 2013, PLANT CELL, V25, P3657, DOI 10.1105/tpc.113.117523; Rosloski SM, 2013, PLANT MOL BIOL, V81, P57, DOI 10.1007/s11103-012-9982-2; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Seo PJ, 2012, PLANT CELL, V24, P2427, DOI 10.1105/tpc.112.098723; Streitner C, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24638; Streitner C, 2012, NUCLEIC ACIDS RES, V40, P11240, DOI 10.1093/nar/gks873; Sureshkumar S, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.55, 10.1038/nplants.2016.55]; Syed NH, 2012, TRENDS PLANT SCI, V17, P616, DOI 10.1016/j.tplants.2012.06.001; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vitulo N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-99; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang BB, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r102; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243; Zhang XN, 2009, PLANT PHYSIOL, V150, P1450, DOI 10.1104/pp.109.138180	42	36	38	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172950	10.1371/journal.pone.0172950	http://dx.doi.org/10.1371/journal.pone.0172950			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257507	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100044
J	Aljanaki, A; Yang, YH; Soleymani, M				Aljanaki, Anna; Yang, Yi-Hsuan; Soleymani, Mohammad			Developing a benchmark for emotional analysis of music	PLOS ONE			English	Article							PERCEIVED EMOTION	Music emotion recognition (MER) field rapidly expanded in the last decade. Many new methods and new audio features are developed to improve the performance of MER algorithms. However, it is very difficult to compare the performance of the new methods because of the data representation diversity and scarcity of publicly available data. In this paper, we address these problems by creating a data set and a benchmark for MER. The data set that we release, a MediaEval Database for Emotional Analysis in Music (DEAM), is the largest available data set of dynamic annotations (valence and arousal annotations for 1,802 songs and song excerpts licensed under Creative Commons with 2Hz time resolution). Using DEAM, we organized the 'Emotion in Music'task at MediaEval Multimedia Evaluation Campaign from 2013 to 2015. The benchmark attracted, in total, 21 active teams to participate in the challenge. We analyze the results of the benchmark: the winning algorithms and feature-sets. We also describe the design of the benchmark, the evaluation procedures and the data cleaning and transformations that we suggest. The results from the benchmark suggest that the recurrent neural network based approaches combined with large feature-sets work best for dynamic MER.	[Aljanaki, Anna] Univ Utrecht, Utrecht, Netherlands; [Aljanaki, Anna; Soleymani, Mohammad] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Yang, Yi-Hsuan] Acad Sinica, Taipei, Taiwan	Utrecht University; University of Geneva; Academia Sinica - Taiwan	Aljanaki, A (corresponding author), Univ Utrecht, Utrecht, Netherlands.; Aljanaki, A (corresponding author), Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland.	aljanaki@gmail.com			COMMIT/project; Ambizione program of the Swiss National Science Foundation [PZ00P2_154981]	COMMIT/project; Ambizione program of the Swiss National Science Foundation	AA's work was supported by COMMIT/project (commit-nl.nl). MS was supported by Ambizione program of the Swiss National Science Foundation (Grant number PZ00P2_154981).	Aljanaki A., 2013, P MEDIAEVAL 2013 WOR; Aljanaki A., 2014, P 15 C INT SOC MUSIC, P373; Aljanaki A., 2015, P MEDIAEVAL 2015 WOR; Aljanaki A, 2015, P INT SOC MUS INF RE; Aljanaki A, 2016, INFORM PROCESS MANAG, V52, P115, DOI 10.1016/j.ipm.2015.03.004; [Anonymous], 2008, P 9 INT C MUSIC INFO; Bachorik JP, 2009, MUSIC PERCEPT, V26, P355, DOI 10.1525/MP.2009.26.4.355; Barthet M., 2012, P 9 INT S COMP MUS M, P492; Bittner R. M., 2014, P INT SOC MUS INF RE, V14, P155; Cabrera D, 1999, P AUSTR AC SOC C, V24, P47; Cai K, 2015, P MEDIAEVAL 2015 WOR; Chen YA, 2015, INT CONF ACOUST SPEE, P693, DOI 10.1109/ICASSP.2015.7178058; Chen YA, 2014, INT CONF ACOUST SPEE, DOI 10.1109/ICASSP.2014.6853979; Chmulik M, 2015, P MEDIAEVAL 2015 WOR; Collier G.L., 2007, PSYCHOL MUSIC, V35, P110, DOI [10.1177/0305735607068890, DOI 10.1177/0305735607068890]; Coutinho E, 2015, P MEDIAEVAL 2015 WOR; Coutinho E, 2014, IEEE IJCNN, P3592, DOI 10.1109/IJCNN.2014.6889814; Coutinho Eduardo, 2014, P MEDIAEVAL 2014 WOR, V1263, P1; Eerola T., 2014, P AES INT C; Eyben F., 2013, P 21 ACM INT C MULT, P835, DOI 10.1145/2502081.2502224; Fan Y., 2014, P MEDIAEVAL 2014 WOR; Geringer JM, 2004, B COUN RES MUSIC ED, P1; Gupta R, 2015, P MEDIAEVAL 2015 WOR; He L., P 5 INT WORKSH AUD V, P73; Hu X, 2017, IEEE T AFFECT COMPUT, V8, P228, DOI 10.1109/TAFFC.2016.2523503; Huq A, 2010, J NEW MUSIC RES, V39, P227, DOI 10.1080/09298215.2010.513733; Imbrasaite V, 2014, IEEE INT CON MULTI; Imbrasaite V, 2013, IEEE INT CONF MULTI; Inskip C, 2012, INT J DIGIT LIBRARIE, V12, P137, DOI 10.1007/s00799-012-0084-1; Koelstra S, 2012, IEEE T AFFECT COMPUT, V3, P18, DOI 10.1109/T-AFFC.2011.15; Korhonen MD, 2006, IEEE T SYST MAN CY B, V36, P588, DOI 10.1109/TSMCB.2005.862491; Kumar Naveen, 2014, P MEDIAEVAL 2014 WOR; Laurier C., 2009, P 7 TRIENN C EUR SOC, DOI 10.3389/conf.neuro.09.2009.02.033; Laurier C., 2009, P INT C MUS INF RETR, P381; Laurier Cyril, 2007, MIREX TASK AUDIO MOO, P2; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Liu Y, 2015, P MEDIAEVAL 2015 WOR; Markov K, 2013, MEDIAEVAL; Markov K, 2014, P MEDIAEVAL 2014 WOR; McKeown G, 2012, IEEE T AFFECT COMPUT, V3, P5, DOI 10.1109/T-AFFC.2011.20; McKeown GJ, 2014, PSYCHOL METHODS, V19, P155, DOI 10.1037/a0034282; Morris JD, 1995, J ADVERTISING RES, V35, P63; Nicolaou MA, 2011, IEEE T AFFECT COMPUT, V2, P92, DOI 10.1109/T-AFFC.2011.9; Panda R., 2011, 130 AUD ENG SOC CONV; Panda R., 2013, P INT S COMP MUS MOD; Patra B.G., 2015, P MEDIAEVAL 2015 WOR; Pellegrini T, 2015, P MEDIAEVAL 2015 WOR; Ringeval F., 2013, AUT FAC GEST REC FG, P1, DOI [DOI 10.1109/FG.2013.6553805, 10.1109/FG.2013.6553805]; Ringeval F, 2015, MM'15: PROCEEDINGS OF THE 2015 ACM MULTIMEDIA CONFERENCE, P1335, DOI 10.1145/2733373.2806408; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schmidt E. M., 2010, 2010 Ninth International Conference on Machine Learning and Applications (ICMLA 2010), P655, DOI 10.1109/ICMLA.2010.101; Schmidt E. M., 2011, ISMIR, P777; Schmidt E. M., 2013, P INT SOC MUS INF RE, P21; Schubert E, 2004, MUSIC PERCEPT, V21, P561, DOI 10.1525/mp.2004.21.4.561; Schubert E, 2003, PERCEPT MOTOR SKILL, V96, P1117, DOI 10.2466/PMS.96.4.1117-1122; Schubert E., 1996, P 4 INT C MUS PERC C, P263; Schubert E, 2013, PSYCHOL MUSIC, V41, P350, DOI 10.1177/0305735611430079; Schuller B, 2012, ICMI '12: PROCEEDINGS OF THE ACM INTERNATIONAL CONFERENCE ON MULTIMODAL INTERACTION, P449; Schuller B, 2011, LECT NOTES COMPUT SC, V6975, P415, DOI 10.1007/978-3-642-24571-8_53; Soleymani M., 2010, SIGIR WORKSH; Soleymani M., 2013, P MEDIAEVAL 2013 WOR; Soleymani M, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P1161, DOI 10.1145/2647868.2655019; Soleymani M, 2014, IEEE T MULTIMEDIA, V16, P1075, DOI 10.1109/TMM.2014.2305573; Speck J.A., 2011, P 12 INT SOC MUS INF, P24; Su D., 2012, P ACM INT WORKSH MUS, P51; Thayer R. E, 1990, BIOPSYCHOLOGY MOOD A; Valstar M., 2014, PROC 4 ACM INT WORKS, P3, DOI [10.1109/FG.2015.7284874, DOI 10.1109/FG.2015.7284874, DOI 10.1145/2661806.2661807]; Valstar M., 2013, P 3 ACM INT WORKSHOP, P3, DOI DOI 10.1145/2512530.2512533; Vuoskoski JK, 2011, MUSIC SCI, V15, P159, DOI 10.1177/1029864911403367; Wang J.C., 2012, P 20 ACM INT C MULT, P89, DOI [10.1145/2393347.2393367, DOI 10.1145/2393347.2393367, 10.1145/2393347.2396494]; Wang JC, 2015, IEEE T AFFECT COMPUT, V6, P56, DOI 10.1109/TAFFC.2015.2397457; Weber M, 2015, P MEDIAEVAL 2015 WOR; Weninger F., 2013, P MEDIAEVAL 2013 WOR; Xu M, 2015, MEDIAEVAL 2015 WORKS; Yang W., 2014, P MEDIAEVAL 2014 WOR; Yang Y.-H., 2014, P MEDIAEVAL 2014 WOR; Yang YH, 2008, IEEE T AUDIO SPEECH, V16, P448, DOI 10.1109/TASL.2007.911513; Yi-Hsuan Yang, 2012, ACM T INTEL SYST TEC, V3, P1, DOI DOI 10.1145/2168752.2168754	79	64	64	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e73392	10.1371/journal.pone.0173392	http://dx.doi.org/10.1371/journal.pone.0173392			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EN6CJ	28282400	Green Submitted, gold, Green Published			2022-12-27	WOS:000396091800035
J	Nam, KW; Kim, CK; Kim, TJ; An, SJ; Oh, K; Mo, H; Kang, MK; Han, MK; Demchuk, AM; Ko, SB; Yoon, BW				Nam, Ki-Woong; Kim, Chi Kyung; Kim, Tae Jung; An, Sang Joon; Oh, Kyungmi; Mo, Heejung; Kang, Min Kyoung; Han, Moon-Ku; Demchuk, Andrew M.; Ko, Sang-Bae; Yoon, Byung-Woo			Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke	PLOS ONE			English	Article							SURVIVAL	Background Stroke in cancer patients is not rare but is a devastating event with high mortality. However, the predictors of mortality in stroke patients with cancer have not been well addressed. D-dimer could be a useful predictor because it can reflect both thromboembolic events and advanced stages of cancer. Aim In this study, we evaluate the possibility of D-dimer as a predictor of 30-day mortality in stroke patients with active cancer. Methods We included 210 ischemic stroke patients with active cancer. The 30-day mortality data were collected by reviewing medical records. We also collected follow-up D-dimer levels in 106 (50%) participants to evaluate the effects of treatment response on D-dimer levels. Results Of the 210 participants, 30-day mortality occurred in 28 (13%) patients. Higher initial NIHSS scores, D-dimer levels, and CRP levels as well as frequent cryptogenic mechanism, systemic metastasis, multiple vascular territory lesion, hemorrhagic transformation, and larger infarct volume were related to 30-day mortality. In the multivariate analysis, D-dimer [adjusted OR (aOR) = 2.19; 95% CI, 1.46-3.28, P < 0.001] predicted 30-day mortality after adjusting for confounders. The initial NIHSS score (aOR = 1.07; 95% CI, 1.00-1.14, P = 0.043) and hemorrhagic transformation (aOR = 3.02; 95% CI, 1.10-8.29, P = 0.032) were also significant independent of D-dimer levels. In the analysis of D-dimer changes after treatment, the mortality group showed no significant decrease in D-dimer levels, despite treatment, while the survivor group showed the opposite response. Conclusions D-dimer levels may predict 30-day mortality in acute ischemic stroke patients with active cancer.	[Nam, Ki-Woong; Kim, Tae Jung; An, Sang Joon; Mo, Heejung; Kang, Min Kyoung; Ko, Sang-Bae; Yoon, Byung-Woo] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Kim, Chi Kyung; Oh, Kyungmi] Korea Univ, Dept Neurol, Guro Hosp, Seoul, South Korea; [Kim, Chi Kyung; Oh, Kyungmi] Korea Univ, Coll Med, Seoul, South Korea; [Kim, Chi Kyung; Demchuk, Andrew M.] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci & Radiol, Calgary Stroke Program, Calgary, AB, Canada; [Han, Moon-Ku] Seoul Natl Univ, Dept Neurol, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); University of Calgary; Seoul National University (SNU)	Yoon, BW (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea.	bwyoon@snu.ac.kr	Kim, Chi Kyung/AAR-9819-2020; Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Oh, Kyungmi/0000-0002-7304-0308; Ko, Sang-Bae/0000-0002-9429-9597; Nam, Ki-Woong/0000-0001-7514-6264	R&D support grant of Korea University Guro Hospital, Republic of Korea [01600161]; Ministry of Health and Welfare, Republic of Korea [HI16C1078]; Alberta Innovates [201300690] Funding Source: researchfish	R&D support grant of Korea University Guro Hospital, Republic of Korea; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Alberta Innovates	This work was funded by the R&D support grant (01600161) of Korea University Guro Hospital, Republic of Korea.; This work was supported by the R&D support grant (01600161) of Korea University Guro Hospital, Republic of Korea and by the Ministry of Health and Welfare (HI16C1078), Republic of Korea. The funding organization had no role in the design, conduct, or analyses conducted during this study or the preparation of this report.	Bang OY, 2011, J CLIN NEUROL, V7, P53, DOI 10.3988/jcn.2011.7.2.53; Dirix LY, 2002, BRIT J CANCER, V86, P389, DOI 10.1038/sj.bjc.6600069; el-Shami K, 2007, ONCOLOGIST, V12, P518, DOI 10.1634/theoncologist.12-5-518; Fonarow GC, 2012, J AM HEART ASSOC, V1, P42, DOI 10.1161/JAHA.111.000034; GRAUS F, 1985, MEDICINE, V64, P16, DOI 10.1097/00005792-198501000-00002; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Jeong HG, 2015, STROKE, V46, P687, DOI 10.1161/STROKEAHA.114.007466; Kim SG, 2010, STROKE, V41, P798, DOI 10.1161/STROKEAHA.109.571356; Lee AY, 2002, CANCER TREAT REV, V28, P137, DOI 10.1016/S0305-7372(02)00044-0; Lee MJ, 2016, STROKE, V5, P7; Oya M, 2001, JPN J CLIN ONCOL, V31, P388, DOI 10.1093/jjco/hye075; Saposnik G, 2008, STROKE, V39, P2318, DOI 10.1161/STROKEAHA.107.510362; Schwarzbach CJ, 2012, STROKE, V43, P3029, DOI 10.1161/STROKEAHA.112.658625; Schwarzbach CJ, 2015, CEREBROVASC DIS EXTR, V5, P139, DOI 10.1159/000439549; Seok JM, 2010, ANN NEUROL, V68, P213, DOI 10.1002/ana.22050; SILVER FL, 1984, STROKE, V15, P492, DOI 10.1161/01.STR.15.3.492; Szczudiik A, 2000, Med Sci Monit, V6, P75; Taccone Fabio Silvio, 2008, J Stroke Cerebrovasc Dis, V17, P169, DOI 10.1016/j.jstrokecerebrovasdis.2008.01.007; Zi WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086465	19	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0172793	10.1371/journal.pone.0172793	http://dx.doi.org/10.1371/journal.pone.0172793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282388	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800012
J	Parulekar, NN; Kolekar, P; Jenkins, A; Kleiven, S; Utkilen, H; Johansen, A; Sawant, S; Kulkarni-Kale, U; Kale, M; Saebo, M				Parulekar, Niranjan Nitin; Kolekar, Pandurang; Jenkins, Andrew; Kleiven, Synne; Utkilen, Hans; Johansen, Anette; Sawant, Sangeeta; Kulkarni-Kale, Urmila; Kale, Mohan; Saebo, Mona			Characterization of bacterial community associated with phytoplankton bloom in a eutrophic lake in South Norway using 16S rRNA gene amplicon sequence analysis	PLOS ONE			English	Article							SP-NOV.; HETEROTROPHIC BACTERIA; CYANOBACTERIAL BLOOMS; PROKARYOTIC DIVERSITY; METAGENOMIC ANALYSIS; ORGANIC-CARBON; ABUNDANT GROUP; GROWTH-RATES; WATER; BACTERIOPLANKTON	Interactions between different phytoplankton taxa and heterotrophic bacterial communities within aquatic environments can differentially support growth of various heterotrophic bacterial species. In this study, phytoplankton diversity was studied using traditional microscopic techniques and the bacterial communities associated with phytoplankton bloom were studied using High Throughput Sequencing ((HTS) analysis of 16S rRNA gene amplicons from the V1-V3 and V3-V4 hypervariable regions. Samples were collected from Lake Akersvannet, a eutrophic lake in South Norway, during the growth season from June to August 2013. Microscopic examination revealed that the phytoplankton community was mostly represented by Cyanobacteria and the dinoflagellate Ceratium hirundinella. The HTS results revealed that Proteobacteria ((Alpha, Beta, and Gamma), Bacteriodetes, Cyanobacteria, Actinobacteria and Verrucomicrobia dominated the bacterial community, with varying relative abundances throughout the sampling season. Species level identification of Cyanobacteria showed a mixed population of Aphanizomenon flos-aquae, Microcystis aeruginosa and Woronichinia naegeliana. A significant proportion of the microbial community was composed of unclassified taxa which might represent locally adapted freshwater bacterial groups. Comparison of cyanobacterial species composition from HTS and microscopy revealed quantitative discrepancies, indicating a need for cross validation of results. To our knowledge, this is the first study that uses HTS methods for studying the bacterial community associated with phytoplankton blooms in a Norwegian lake. The study demonstrates the value of considering results from multiple methods when studying bacterial communities.	[Parulekar, Niranjan Nitin; Jenkins, Andrew; Kleiven, Synne; Utkilen, Hans; Johansen, Anette; Saebo, Mona] Univ Coll Southeast Norway, Fac Technol Nat Sci & Maritime Sci, Dept Nat Sci & Environm Hlth, Bo I Telemark, Norway; [Kolekar, Pandurang; Sawant, Sangeeta; Kulkarni-Kale, Urmila] Savitribai Phule Pune Univ, Bioinformat Ctr, Pune, Maharashtra, India; [Kale, Mohan] Savitribai Phule Pune Univ, Dept Stat, Pune, Maharashtra, India	University College of Southeast Norway; Savitribai Phule Pune University; Savitribai Phule Pune University	Parulekar, NN (corresponding author), Univ Coll Southeast Norway, Fac Technol Nat Sci & Maritime Sci, Dept Nat Sci & Environm Hlth, Bo I Telemark, Norway.	niranjan.n.parulekar@usn.no	Kolekar, Pandurang/ABF-7389-2020; Kulkarni-Kale, Urmila/G-6946-2011	Kolekar, Pandurang/0000-0003-0044-0076; Jenkins, Andrew/0000-0003-2588-8483	SIU, Norway; UGC, India; Indo-Norwegian Cooperation Program	SIU, Norway; UGC, India(University Grants Commission, India); Indo-Norwegian Cooperation Program	We acknowledge funding from SIU, Norway and UGC, India under the Indo-Norwegian Cooperation Program (INCP-2014). None of the funds received from the Indo-Norwegian Cooperation Program were used specifically for this study.; The authors would like to thank Karin Brekke Li for technical assistance and guidance and Brett Neilan (University of New South Wales, Australia) for providing the DNA extraction protocol. We acknowledge funding from SIU, Norway and UGC, India under the Indo-Norwegian Cooperation Program (INCP-2014). None of the funds received from the Indo-Norwegian Cooperation Program were used specifically for this study.	Albertsen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132783; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Bagatini IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085950; Berg KA, 2009, ISME J, V3, P314, DOI 10.1038/ismej.2008.110; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bertilsson S., 2003, AQUATIC ECOSYSTEMS I, P3, DOI DOI 10.1016/B978-012256371-3/50002-0; Blaha Ludek, 2009, Interdiscip Toxicol, V2, P36, DOI 10.2478/v10102-009-0006-2; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Brettar I, 2006, INT J SYST EVOL MICR, V56, P2177, DOI 10.1099/ijs.0.64172-0; Brettum P., 2004, 4818 SNO NORW I WAT, V4818, P33; Brooks JP, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0351-6; Cai HY, 2013, MICROB ECOL, V66, P73, DOI 10.1007/s00248-013-0224-1; Cai M, 2002, J BACTERIOL, V184, P4672, DOI 10.1128/JB.184.17.4672-4680.2002; Cao Y, 1998, LIMNOL OCEANOGR, V43, P1403, DOI 10.4319/lo.1998.43.7.1403; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardman Z, 2014, APPL ENVIRON MICROB, V80, P3749, DOI 10.1128/AEM.00899-14; Chen C, 2011, PROCEDIA ENGINEER, V18, DOI 10.1016/j.proeng.2011.11.054; Chen WM, 2013, INT J SYST EVOL MICR, V63, P1457, DOI 10.1099/ijs.0.043836-0; Chorus EI, 1999, TOXIC CYANOBACTERIA, P1; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; COLE JJ, 1982, LIMNOL OCEANOGR, V27, P1080, DOI 10.4319/lo.1982.27.6.1080; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Dai GZ, 2012, GLOBAL CHANGE BIOL, V18, P1571, DOI 10.1111/j.1365-2486.2012.02638.x; Pinto PD, 2010, OIKOS, V119, P567, DOI 10.1111/j.1600-0706.2009.17924.x; Dokulil MT, 2000, HYDROBIOLOGIA, V438, P1, DOI 10.1023/A:1004155810302; Dolman Andrew M, 2012, PLoS One, V7, pe38757, DOI 10.1371/journal.pone.0038757; Dziallas C, 2011, ENVIRON MICROBIOL, V13, P1632, DOI 10.1111/j.1462-2920.2011.02479.x; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Eiler A, 2007, APPL ENVIRON MICROB, V73, P3511, DOI 10.1128/AEM.02534-06; Eiler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053516; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; Falconer Ian R, 2005, Int J Environ Res Public Health, V2, P43, DOI 10.3390/ijerph2005010043; Feng XH, 1997, APPL ENVIRON MICROB, V63, P1332, DOI 10.1128/AEM.63.4.1332-1337.1997; Ferguson HW, 2004, J FISH DIS, V27, P249, DOI 10.1111/j.1365-2761.2004.00537.x; Fisher J, 2013, ACTA PROTOZOOL, V52, P203, DOI 10.4467/16890027AP.13.0018.1115; Fujii K, 2003, INT J SYST EVOL MICR, V53, P47, DOI 10.1099/ijs.0.02301-0; Fussel H-M, 2012, CLIM CHANG IMP VULN, P1725; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Harris TD, 2016, INLAND WATERS, V6, P199, DOI 10.5268/IW-6.2.938; Henriksen A, 1998, AMBIO, V27, P80; Imai H., 2009, INTERDISCIPLINARY ST, P269; Jiang LJ, 2007, HYDROBIOLOGIA, V581, P161, DOI 10.1007/s10750-006-0518-0; Jin L, 2014, INT J SYST EVOL MICR, V64, P762, DOI 10.1099/ijs.0.057240-0; Jin L, 2013, INT J SYST EVOL MICR, V63, P2559, DOI 10.1099/ijs.0.048884-0; Jochimsen EM, 1998, NEW ENGL J MED, V338, P873, DOI 10.1056/NEJM199803263381304; Jones SE, 2009, ENVIRON MICROBIOL, V11, P2463, DOI 10.1111/j.1462-2920.2009.01977.x; Karl David M., 1998, P29; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Kielak A, 2010, FEMS MICROBIOL ECOL, V71, P23, DOI 10.1111/j.1574-6941.2009.00785.x; Kim MK, 2007, INT J SYST EVOL MICR, V57, P1527, DOI 10.1099/ijs.0.64579-0; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kolmonen E, 2004, AQUAT MICROB ECOL, V36, P201, DOI 10.3354/ame036201; Kormas KA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/463894; Louati I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140614; Mao DP, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-66; Martinez-Garcia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035314; Martinez-Garcia M, 2012, ISME J, V6, P113, DOI 10.1038/ismej.2011.84; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Miguens D, 2015, LIMNETICA, V34, P215; Miller TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074933; Miller TR, 2011, FEMS MICROBIOL ECOL, V78, P336, DOI 10.1111/j.1574-6941.2011.01162.x; Mou XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061890; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Newton RJ, 2007, APPL ENVIRON MICROB, V73, P7169, DOI 10.1128/AEM.00794-07; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Olenina I., 2006, HELCON BALTIC SEA EN, P144; Oliver R. L., 2000, ECOLOGY CYANOBACTERI, P149, DOI [10.1007/0-306-46855-7_6, DOI 10.1007/0-306-46855-7_6]; Paerl H W, 2001, ScientificWorldJournal, V1, P76; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; PICK FR, 1987, NEW ZEAL J MAR FRESH, V21, P425, DOI 10.1080/00288330.1987.9516238; Pinhassi J, 2003, APPL ENVIRON MICROB, V69, P199, DOI 10.1128/AEM.69.1.199-211.2003; Pope PB, 2008, FEMS MICROBIOL ECOL, V64, P9, DOI 10.1111/j.1574-6941.2008.00448.x; Rapala J, 2005, INT J SYST EVOL MICR, V55, P1563, DOI 10.1099/ijs.0.63599-0; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Riemann L, 2001, MICROB ECOL, V42, P274, DOI 10.1007/s00248-001-0018-8; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; ROBARTS RD, 1987, NEW ZEAL J MAR FRESH, V21, P391, DOI 10.1080/00288330.1987.9516235; Salcher MM, 2010, LIMNOL OCEANOGR, V55, P846, DOI 10.4319/lo.2009.55.2.0846; Sangwan P, 2005, APPL ENVIRON MICROB, V71, P8402, DOI 10.1128/AEM.71.12.8402-8410.2005; Schartau AK, 2013, MILJOOVERVAKING VANN; Schirrmeister BE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-177; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Shatwell T, 2008, GLOBAL CHANGE BIOL, V14, P2194, DOI 10.1111/j.1365-2486.2008.01630.x; Shi LM, 2012, ENV MICROBIOL REP, V4, P669, DOI 10.1111/1758-2229.12001; Sime Ngando T., 1991, Archiv fuer Protistenkunde, V140, P109; Simek K, 2005, APPL ENVIRON MICROB, V71, P2381, DOI 10.1128/AEM.71.5.2381-2390.2005; Simek K, 2006, ENVIRON MICROBIOL, V8, P1613, DOI 10.1111/j.1462-2920.2006.01053.x; Simek K, 2011, APPL ENVIRON MICROB, V77, P7307, DOI 10.1128/AEM.05107-11; Simek K, 2010, APPL ENVIRON MICROB, V76, P631, DOI 10.1128/AEM.02203-09; Sinha R, 2012, WATER RES, V46, P1408, DOI 10.1016/j.watres.2011.12.019; SMITH VH, 1983, SCIENCE, V221, P669, DOI 10.1126/science.221.4611.669; Suchankova P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076431, 10.1371/journal.pone.0071284]; Tikkanen T, 1992, VAXTPLANKTONFLORA ST; Tillett D, 2000, J PHYCOL, V36, P251, DOI 10.1046/j.1529-8817.2000.99079.x; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Tremblay Julien, 2015, Front Microbiol, V6, P771, DOI 10.3389/fmicb.2015.00771; Tsujimura Shigeo, 2001, Phycological Research, V49, P275, DOI 10.1111/j.1440-1835.2001.tb00257.x; Utkilen H., 1996, Phycologia, V35, P189, DOI 10.2216/i0031-8884-35-6S-189.1; Vareli K, 2009, J ENVIRON MONITOR, V11, P1506, DOI 10.1039/b903093j; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Vinas M, 2005, CAN J MICROBIOL, V51, P897, DOI 10.1139/w05-090; Wang HJ, 2008, FRESHWATER BIOL, V53, P935, DOI 10.1111/j.1365-2427.2007.01950.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wehr J. D., 2003, FRESHWATER ALGAE N A; Wilhelm LJ, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-27; Winsley T, 2012, APPL ENVIRON MICROB, V78, P5938, DOI 10.1128/AEM.01299-12; Wu LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101837; Wu WJ, 2010, FRESEN ENVIRON BULL, V19, P846; Xiao X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106510; Xie LQ, 2003, WATER RES, V37, P2073, DOI 10.1016/S0043-1354(02)00532-8; YABUUCHI E, 1990, MICROBIOL IMMUNOL, V34, P99, DOI 10.1111/j.1348-0421.1990.tb00996.x; Yamamoto Yoko, 1993, Japanese Journal of Phycology, V41, P215; Zarauz L, 2008, J PLANKTON RES, V30, P1297, DOI 10.1093/plankt/fbn084; Zheng W, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0110-9; Zhu L, 2014, APPL ENVIRON MICROB, V80, P1874, DOI 10.1128/AEM.02972-13; Zwart G, 2003, APPL ENVIRON MICROB, V69, P5875, DOI 10.1128/AEM.69.10.5875-5883.2003; Zwart G, 1998, SYST APPL MICROBIOL, V21, P546, DOI 10.1016/S0723-2020(98)80067-2; Zwisler W, 2003, AQUAT MICROB ECOL, V31, P211, DOI 10.3354/ame031211	123	50	55	7	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e173408	10.1371/journal.pone.0173408	http://dx.doi.org/10.1371/journal.pone.0173408			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282404	Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800038
J	Matsumoto, T; Tabara, Y; Murase, K; Takahashi, Y; Setoh, K; Kawaguchi, T; Muro, S; Kadotani, H; Kosugi, S; Sekine, A; Yamada, R; Nakayama, T; Mishima, M; Matsuda, F; Chin, KZ				Matsumoto, Takeshi; Tabara, Yasuharu; Murase, Kimihiko; Takahashi, Yoshimitsu; Setoh, Kazuya; Kawaguchi, Takahisa; Muro, Shigeo; Kadotani, Hiroshi; Kosugi, Shinji; Sekine, Akihiro; Yamada, Ryo; Nakayama, Takeo; Mishima, Michiaki; Matsuda, Fumihiko; Chin, Kazuo			Combined association of clinical and lifestyle factors with non-restorative sleep: The Nagahama Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; NONRESTORATIVE SLEEP; INSOMNIA SYMPTOMS; DURATION; RISK; MORTALITY; QUALITY; HEART; PREVALENCE; WOMEN	Background Non-restorative sleep (NRS) was suggested to be associated with cardiovascular outcomes. However, causative factors for NRS have not been fully elucidated. This study aimed to clarify factors and their relationships with NRS to better understand the clinical and epidemiological implications of NRS and to develop a score that can objectively evaluate NRS status. Methods Study subjects consisted of 9,788 community residents (age 53.6 +/- 13.4 y). Subjective NRS as well as possible clinical and lifestyle factors for NRS were investigated by questionnaires. Other clinical parameters were obtained from personal records of information obtained at the baseline examination. Results A total of 3,261 participants complained of NRS. Factors independently associated with subjective NRS were younger age (odds ratio = 1.43), use of a hypnotic drug (2.04), irregular sleep schedule (2.02), short sleep duration (< 5 h, 11.7; 5-6 h, 4.81; 6-7 h, 2.40), frequent sleepiness (2.33), routine stress (4.63), no habitual exercise (1.61), nocturia symptoms (1.43), symptoms of gastroesophageal reflux disease (1.44), and depression (1.46) (all P < 0.001). The NRS score comprised of these 10 factors was linearly associated with the frequency of subjective NRS (P-trend < 0.001). Frequency of individuals with a high NRS score was greater in women (52.3%) than in men (42.1%, P<0.001), while no clear association was observed with common risk factors for cardiovascular diseases. Conclusions NRS was a phenomenon representing various clinical and lifestyle features. Careful attention should be paid to individuals with a high NRS score who might be at risk for mental fatigue and have unfavorable lifestyle factors.	[Matsumoto, Takeshi; Murase, Kimihiko; Muro, Shigeo; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Tabara, Yasuharu; Setoh, Kazuya; Kawaguchi, Takahisa; Yamada, Ryo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Takahashi, Yoshimitsu; Nakayama, Takeo] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan; [Kadotani, Hiroshi] Shiga Univ Med Sci, Dept Sleep & Behav Sci, Shiga, Japan; [Kosugi, Shinji] Kyoto Univ, Sch Publ Hlth, Dept Med Eth & Med Genet, Kyoto, Japan; [Sekine, Akihiro] Chiba Univ, Ctr Prevent Med Sci, Chiba, Japan; [Chin, Kazuo] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Shiga University of Medical Science; Kyoto University; Chiba University; Kyoto University	Chin, KZ (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan.	chink@kuhp.kyoto-u.ac.jp	KOSUGI, Shinji/HCH-0631-2022; Kadotani, Hiroshi/A-7908-2015; TAKAHASHI, Yoshimitsu/GZB-2656-2022; Matsumoto, Takeshi/AAR-4323-2020; NAKAYAMA, Takeo/HCH-0537-2022; KOSUGI, Shinji/GYR-2946-2022	Kadotani, Hiroshi/0000-0001-7474-3315; 	Ministry of Education, Culture, Sports, Science & Technology in Japan; Takeda Science Foundation; Japanese Ministry of Education, Culture, Sports, Science and Technology; Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare of Japan; Japan Vascular Disease Research Foundation; Health, Labour and Welfare Sciences Research Grants, Research on Region Medical	Ministry of Education, Culture, Sports, Science & Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Vascular Disease Research Foundation(Japan Vascular Disease Research Foundation); Health, Labour and Welfare Sciences Research Grants, Research on Region Medical	This study was supported by a University Grant, a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science & Technology in Japan, a research grant from the Takeda Science Foundation, grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare of Japan, the Japan Vascular Disease Research Foundation, and Health, Labour and Welfare Sciences Research Grants, Research on Region Medical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Chandola T, 2010, SLEEP, V33, P739, DOI 10.1093/sleep/33.6.739; Doi Y, 2003, SLEEP, V26, P467, DOI 10.1093/sleep/26.4.467; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Hasan A, 2012, SLEEP BREATH, V16, P111, DOI 10.1007/s11325-010-0463-z; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Ikehara S, 2009, SLEEP, V32, P295, DOI 10.1093/sleep/32.3.295; Jackson CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-552; Jordan AS, 2014, LANCET, V383, P736, DOI 10.1016/S0140-6736(13)60734-5; Kim CW, 2015, ARTERIOSCL THROM VAS, V35, P2238, DOI 10.1161/ATVBAHA.115.306110; Kusano M, 2004, J GASTROENTEROL, V39, P888, DOI 10.1007/s00535-004-1417-7; Laugsand LE, 2014, EUR HEART J, V35, P1382, DOI 10.1093/eurheartj/eht019; Laugsand LE, 2014, SLEEP, V37, P1776, DOI 10.5665/sleep.4170; Leineweber C, 2003, J PSYCHOSOM RES, V54, P121, DOI 10.1016/S0022-3999(02)00475-0; Li YP, 2014, CIRCULATION, V129, P737, DOI 10.1161/CIRCULATIONAHA.113.004500; Murase K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140058; Murase K, 2014, SLEEP, V37, P1810, DOI 10.5665/sleep.4176; Ohayon MM, 2005, ARCH INTERN MED, V165, P35, DOI 10.1001/archinte.165.1.35; Ohayon MM, 2002, J SLEEP RES, V11, P339, DOI 10.1046/j.1365-2869.2002.00317.x; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P593, DOI 10.1016/S0022-3999(02)00449-X; Phillips B, 2005, J CLIN SLEEP MED, V1, P277; Prather AA, 2013, J PSYCHIATR RES, V47, P1228, DOI 10.1016/j.jpsychires.2013.05.004; Sarsour K, 2010, SLEEP MED, V11, P965, DOI 10.1016/j.sleep.2010.08.007; Shakeel N, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-014-0420-0; Sutherland K, 2015, SLEEP BIOL RHYTHMS, V13, P26, DOI 10.1111/sbr.12098; United Nations, 2015, STESASERA390 UN; Vernon MK, 2010, SLEEP MED REV, V14, P205, DOI 10.1016/j.smrv.2009.10.002; Wakasugi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108718; Walsh JK, 2011, SLEEP, V34, P997, DOI 10.5665/SLEEP.1150; Whinnery J, 2014, SLEEP, V37, P601, DOI 10.5665/sleep.3508; Williams ED, 2015, PSYCHOL MED, V45, P1861, DOI 10.1017/S0033291714002967; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yamazaki Shin, 2005, Health Qual Life Outcomes, V3, P48; Zhang JH, 2012, SLEEP MED, V13, P570, DOI 10.1016/j.sleep.2011.12.012	35	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0171849	10.1371/journal.pone.0171849	http://dx.doi.org/10.1371/journal.pone.0171849			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278155	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900112
J	Raaijmakers, A; Jacobs, L; Rayyan, M; van Tienoven, TP; Ortibus, E; Levtchenko, E; Staessen, JA; Allegaert, K				Raaijmakers, Anke; Jacobs, Lotte; Rayyan, Maissa; van Tienoven, Theun Pieter; Ortibus, Els; Levtchenko, Elena; Staessen, Jan A.; Allegaert, Karel			Catch-up growth in the first two years of life in Extremely Low Birth Weight (ELBW) infants is associated with lower body fat in young adolescence	PLOS ONE			English	Article							CHILDREN BORN; PRETERM INFANTS; DEVELOPMENTAL-DISABILITY; BIOELECTRICAL-IMPEDANCE; POSTNATAL-GROWTH; PUBERTAL CHANGES; RESISTANT RULES; BLOOD-PRESSURE; AGE; PREMATURITY	Aim To investigate growth patterns and anthropometrics in former extremely low birth weight (ELBW, <1000 g) children and link these outcomes to neurocognition and body composition in childhood. Methods ELBW children were examined at birth (n = 140), at 9 and 24 months (n >= 96) and at approximately 11 years within the framework of the PREMATCH (PREMATurity as predictor children's of Cardiovascular and renal Health) case control (n = 93-87) study. Regional growth charts were used to convert anthropometrics into Z scores. Catch up growth in the first two years of life was qualified as present if Delta Z score >0.67 SDS. At 11 years, anthropometrics, neurocognitive performance, body composition, grip strength and puberty scores were assessed. Results ELBW neonates displayed extra uterine growth restriction with mean Z scores for height, weight and head circumference of 0.77, 0.93 and 0.46 at birth, 1.61, 1.67 and 0.72 at 9 months, 1.22, 1.61 and 0.84 at 24 months, and 0.42, 0.49 and 1.09 at 11 years. ELBW children performed consistently worse on neurocognitive testing with an average intelligence quotient equivalent at 11 years of 92.5 (SD 13.1). Catch up growth was not associated with neurocognitive performance. Compared to controls, ELBW cases had lower grip strength (13.6 vs. 15.9 kg) and percentage lean body weight (75.1 vs. 80.5%), but higher body fat (24.6 vs. 19.2%) and advanced puberty scores at 11 years (all P<0.025). Catch-up growth for weight and height in the first two years of life in cases was associated with a lower percentage body fat compared to cases without catch-up growth (16.8% catchup growth for weight vs. 25.7%, P<0.001; 20.9% catch-up for height vs. 25.8%, P= 0.049). Conclusions In young adolescence, former ELBW children still have difficulties to reach their target height. Compared to normal birth weight controls, ELBW adolescents show lower neurocognitive performance and grip strength and a higher percentage body fat, a potential risk factor for adverse health outcomes in adulthood. Our key finding is that catch-up growth in ELBW children in the first two years of life is associated with a lower percentage body fat and is therefore likely to be beneficial.	[Raaijmakers, Anke; Rayyan, Maissa; Ortibus, Els; Levtchenko, Elena] Univ Hosp Leuven, Dept Pediat & Neonatol, Leuven, Belgium; [Raaijmakers, Anke; Rayyan, Maissa; Levtchenko, Elena; Allegaert, Karel] Univ Leuven, KU Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Jacobs, Lotte] Univ Leuven, KU Leuven, Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, Leuven, Belgium; [van Tienoven, Theun Pieter] Vrije Univ Brussel, Dept Sociol, Brussels, Belgium; [Staessen, Jan A.] Maastricht Univ, R&D Grp VitaK, Maastricht, Netherlands; [Allegaert, Karel] Erasmus MC, Sophia Childrens Hosp, Intens Care, Rotterdam, Netherlands; [Allegaert, Karel] Erasmus MC, Sophia Childrens Hosp, Dept Pediat Surg, Rotterdam, Netherlands	KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; Vrije Universiteit Brussel; Maastricht University; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Raaijmakers, A (corresponding author), Univ Hosp Leuven, Dept Pediat & Neonatol, Leuven, Belgium.; Raaijmakers, A (corresponding author), Univ Leuven, KU Leuven, Dept Dev & Regenerat, Leuven, Belgium.	anke.raaijmakers@uzleuven.be	Staessen, Jan A/A-1065-2011; Ortibus, Els/GYJ-3215-2022; Levtchenko, Elena/AAO-7125-2020; allegaert, karel/C-3611-2016	Staessen, Jan A/0000-0002-3026-1637; allegaert, karel/0000-0001-9921-5105; Rayyan, Maissa/0000-0001-5718-6887; van Tienoven, Theun Pieter/0000-0003-1532-254X	"Agency for Innovation by Science and Technology in Flanders (IWT)" through the 'SAFE-PEDRUG' project [IWT/SBO 130033]; EURenOmics consortium [305608]; European Union [HEALTH-FP7-278249-EUMASCARA, HEALTH-F7-305507 HOMAGE]; European Research Council Advanced Researcher Grant [2011-294713-EXPLORE]; Fund for Scientific Research Flanders [G.0881.13, G.088013]	"Agency for Innovation by Science and Technology in Flanders (IWT)" through the 'SAFE-PEDRUG' project(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); EURenOmics consortium; European Union(European Commission); European Research Council Advanced Researcher Grant(European Research Council (ERC)); Fund for Scientific Research Flanders(FWO)	This study was supported by the "Agency for Innovation by Science and Technology in Flanders (IWT)" through the 'SAFE-PEDRUG' project (IWT/SBO 130033). K.A. and E.L. are senior clinical investigators of the Fund for Scientific Research, Flanders (Fundamental Clinical lnvestigatorship, 1800214N and 1801110N) and E.L. is also supported by the EURenOmics consortium (grant agreement 305608). The European Union (HEALTH-FP7-278249-EUMASCARA, HEALTH-F7-305507 HOMAGE and the European Research Council Advanced Researcher Grant-2011-294713-EXPLORE) and the Fund for Scientific Research Flanders (G.0881.13 and G.088013) currently support the Studies Coordinating Centre in Leuven. J.A.S. is affiliated to R&D Group VitaK, part of Maastricht University, J. A.S. is not funded in any way by this affiliation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; Bonamy AKE, 2007, J INTERN MED, V262, P635, DOI 10.1111/j.1365-2796.2007.01868.x; Breij LM, 2016, PEDIAT OBESITY; Clemm HH, 2015, ACTA PAEDIATR, V104, P1174, DOI 10.1111/apa.13080; Cole TJ, 2014, ARCH DIS CHILD-FETAL, V99, pF34, DOI 10.1136/archdischild-2012-303536; de Zegher F, 2016, PEDIAT OBESITY; de Zegher F, 2006, FERTIL STERIL, V86, pS4, DOI 10.1016/j.fertnstert.2006.03.013; DEVLIEGER H, 1993, CLIN NUTR, V12, P282, DOI 10.1016/0261-5614(93)90047-8; Embleton ND, 2016, ARCH DIS CHILDHOOD; Euser AM, 2008, HORM RES, V70, P319, DOI 10.1159/000161862; Euser AM, 2005, AM J CLIN NUTR, V81, P480; Feigin VL, 2016, LANCET NEUROLOGY; Fricke O, 2010, HORM RES PAEDIAT, V73, P390, DOI 10.1159/000308173; George I, 2011, PEDIATR NEPHROL, V26, P1843, DOI 10.1007/s00467-011-1883-0; Gianni ML, 2016, PEDIATR RES, V79, P710, DOI 10.1038/pr.2015.273; Guellec I, 2015, J PEDIATR-US, V167, P975, DOI 10.1016/j.jpeds.2015.08.025; HOAGLIN DC, 1986, J AM STAT ASSOC, V81, P991, DOI 10.2307/2289073; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Ibanez L, 2006, MOL CELL ENDOCRINOL, V254, P22, DOI 10.1016/j.mce.2006.04.010; Ibanez L, 2011, FERTIL STERIL, V96, P220, DOI 10.1016/j.fertnstert.2011.03.107; Jarjour IT, 2015, PEDIATR NEUROL, V52, P143, DOI 10.1016/j.pediatrneurol.2014.10.027; Kerkhof GF, 2012, NAT REV ENDOCRINOL, V8, P689, DOI 10.1038/nrendo.2012.168; Lapillonne A, 2013, J PEDIATR-US, V162, pS7, DOI 10.1016/j.jpeds.2012.11.048; Lewandowski AJ, 2015, HYPERTENSION, V65, P607, DOI 10.1161/HYPERTENSIONAHA.114.04662; Ligi I, 2010, SEMIN PERINATOL, V34, P188, DOI 10.1053/j.semperi.2010.02.002; Lowe J, 2016, PAEDIAT RESP REV; Luo ZC, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.6.e72; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; McGorrian C, 2011, EUR HEART J, V32, P581, DOI 10.1093/eurheartj/ehq448; Ong KK, 2015, ACTA PAEDIATR, V104, P974, DOI 10.1111/apa.13128; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Paul Alexandra, 2011, Int J Adolesc Med Health, V23, P175; Raaijmakers A, 2015, BLOOD PRESSURE, V24, P275, DOI 10.3109/08037051.2015.1053220; Ranke MB, 2015, DEV MED CHILD NEUROL, V57, P23, DOI 10.1111/dmcn.12582; Roelants M, 2009, ANN HUM BIOL, V36, P680, DOI 10.3109/03014460903049074; SEGAL KR, 1991, AM J CLIN NUTR, V54, P26, DOI 10.1093/ajcn/54.1.26; Simeoni U, 2011, PEDIATR NEPHROL, V26, P493, DOI 10.1007/s00467-010-1648-1; Simon D, 2008, BEST PRACT RES CL EN, V22, P525, DOI 10.1016/j.beem.2008.03.003; Sniderman AD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003665; STEWART SP, 1993, BRIT J NUTR, V69, P645, DOI 10.1079/BJN19930066; Tanner J M, 1970, Arch Dis Child, V45, P819; Uthaya S, 2005, PEDIATR RES, V57, P211, DOI 10.1203/01.PDR.0000148284.58934.1C; VANDERMEULEN BF, 2002, BSID II NL DUTCH MAN; Vasquez-Garibay EM, 2014, NUTR HOSP, V30, P410, DOI 10.3305/nh.2014.30.2.7373; Wechsler D., 2008, WECHSLER NONVERBAL S; Wells GD, 2014, PEDIATR PULM, V49, P878, DOI 10.1002/ppul.22928; Welsh L, 2010, THORAX, V65, P165, DOI 10.1136/thx.2008.107474; Wit JM, 2002, J PEDIATR ENDOCR MET, V15, P1229; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601; Yamakawa T, 2016, EARLY HUM DEV, V92, P7, DOI 10.1016/j.earlhumdev.2015.10.019; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	54	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173349	10.1371/journal.pone.0173349	http://dx.doi.org/10.1371/journal.pone.0173349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278233	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900075
J	Zhou, L; Yang, S; Wang, SG; Xiong, LY				Zhou, Lei; Yang, Shan; Wang, Shuguang; Xiong, Liyang			Ownership reform and the changing manufacturing landscape in Chinese cities: The case of Wuxi	PLOS ONE			English	Article							INTRA-METROPOLITAN LEVEL; INDUSTRIAL-LOCATION; ECONOMIC TRANSITION; FOREIGN-INVESTMENT; LAND-DEVELOPMENT; URBAN CHINA; SHANGHAI; MODEL; STATE; CITY	Since the economic transition, manufacturing in China has undergone profound changes not only in number of enterprises, but also in ownership structure and intra-urban spatial distribution. Investigating the changing manufacturing landscape from the perspective of ownership structure is critical to a deep understanding of the changing role of market and government in re-shaping manufacturing location behavior. Through a case study of Wuxi, a city experiencing comprehensive ownership reform, this paper presents a detailed analysis of the intra-urban spatial shift of manufacturing, identifies the location discrepancies, and examines the underlying forces responsible for the geographical differentiations. Through zone-and district-based analysis, a distinctive trend of decentralization and suburbanization, as well as an uneven distribution of manufacturing, is unveiled. The results of Location Quotient analysis show that the distribution of manufacturing by ownership exhibits distinctive spatial patterns, which is characterized by a historically-based, market-led, and institutionally- created spatial variation. By employing Hot Spot analysis, the role of development zones in attracting manufacturing enterprises of different ownerships is established. Overall, the location behavior of the diversified manufacturing has been increasingly based on the forces of market since the land marketization began. A proactive role played by local governments has also guided the enterprise location decision through spatial planning and regulatory policies.	[Zhou, Lei] Nanjing Univ Posts & Telecommun, Sch Geog & Biol Informat, Nanjing, Jiangsu, Peoples R China; [Zhou, Lei; Yang, Shan; Xiong, Liyang] Nanjing Normal Univ, Sch Geog, Nanjing, Jiangsu, Peoples R China; [Zhou, Lei; Wang, Shuguang] Ryerson Univ, Dept Geog, Toronto, ON, Canada; [Xiong, Liyang] Univ Wisconsin, Dept Geog, Madison, WI 53706 USA; [Xiong, Liyang] Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing, Jiangsu, Peoples R China	Nanjing University of Posts & Telecommunications; Nanjing Normal University; Toronto Metropolitan University; University of Wisconsin System; University of Wisconsin Madison	Xiong, LY (corresponding author), Nanjing Normal Univ, Sch Geog, Nanjing, Jiangsu, Peoples R China.; Xiong, LY (corresponding author), Univ Wisconsin, Dept Geog, Madison, WI 53706 USA.; Xiong, LY (corresponding author), Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing, Jiangsu, Peoples R China.	xiongliyang@163.com	XIONG, Li-Yang/U-3882-2017	XIONG, Li-Yang/0000-0001-7930-3319; Wang, Shuguang/0000-0002-7706-0621	Jiangsu Natural Science Foundation of Youth [BK20160893]; Natural Science Foundation of Jiangsu Higher Education Institutions [16KJB170012]; Philosophy and Social Science Foundation of Jiangsu Higher Education Institutions [2016SJB630001]; Humanities and Social Sciences Foundation of Nanjing University of Posts and Telecommunications [NYY215017]; National Natural Science Foundation of China [41471135, 41601411]; Priority Academic Program Development of Jiangsu Higher Education Institutions-PAPD	Jiangsu Natural Science Foundation of Youth; Natural Science Foundation of Jiangsu Higher Education Institutions; Philosophy and Social Science Foundation of Jiangsu Higher Education Institutions; Humanities and Social Sciences Foundation of Nanjing University of Posts and Telecommunications; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions-PAPD	The authors acknowledge the financial support of Project BK20160893 of Jiangsu Natural Science Foundation of Youth, Project 16KJB170012 of Natural Science Foundation of Jiangsu Higher Education Institutions, Project 2016SJB630001 of Philosophy and Social Science Foundation of Jiangsu Higher Education Institutions, Project NYY215017 of Humanities and Social Sciences Foundation of Nanjing University of Posts and Telecommunications, Project 41471135 and 41601411 of the National Natural Science Foundation of China, and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions-PAPD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arauzo-Carod JM, 2009, REG STUD, V43, P545, DOI 10.1080/00343400701874172; Berkoz L, 2008, TIJDSCHR ECON SOC GE, V99, P94, DOI 10.1111/j.1467-9663.2008.00442.x; Bevan A., 2004, INT BUSINESS REV, V13, P43, DOI [DOI 10.1016/J.IBUSREV.2003.05.005, 10.1016/j.ibusrev.2003.05.005]; Bradshaw M J, 1996, GLOBAL EC TRANSITION; Burt J.E., 2009, ELEMENTARY STAT GEOG; Duckett J., 1998, ENTREPRENEURIAL STAT; Feng J, 2008, REG STUD, V42, P83, DOI 10.1080/00343400701654160; Gao BY, 2014, LAND USE POLICY, V36, P1, DOI 10.1016/j.landusepol.2013.06.007; Graham E, 2004, INT EC EC POLICY, VI, P87, DOI DOI 10.1007/s10368-003-0003-4; HANSEN ER, 1987, REG SCI URBAN ECON, V17, P89, DOI 10.1016/0166-0462(87)90070-6; He CF, 2008, REG STUD, V42, P923, DOI 10.1080/00343400701543272; He CF, 2007, EURASIAN GEOGR ECON, V48, P603, DOI 10.2747/1538-7216.48.5.603; [贺灿飞 He Canfei], 2005, [地理学报, Acta Geographica Sinica], V60, P122; Heady Christopher, 1995, FISCAL MANAGEMENT EC; HEALEY MJ, 1990, LOCATION CHANGE PERS; HUallachain BO, 2009, URBAN GEOGR, V30, P898, DOI 10.2747/0272-3638.30.8.898; Jones C., 1996, REG STUD, V30, P797; Lejpras A, 2011, ANN REGIONAL SCI, V46, P543, DOI 10.1007/s00168-009-0356-x; Lever WF, 1996, GLOBAL EC TRANSITION; Lin GCS, 2005, ANN ASSOC AM GEOGR, V95, P411, DOI 10.1111/j.1467-8306.2005.00467.x; Lin GCS, 1999, INT J URBAN REGIONAL, V23, P670, DOI 10.1111/1468-2427.00222; Lin GCS, 2011, URBAN GEOGR, V32, P50, DOI 10.2747/0272-3638.32.1.50; [吕卫国 LU Weiguo], 2009, [地理学报, Acta Geographica Sinica], V64, P142; MacLachlan I, 1998, PROF GEOGR, V50, P315, DOI 10.1111/0033-0124.00123; Mitchell A., 2005, ESRI GUIDE GIS ANAL, V2; Nakata C., 1997, INT MARKET REV, V14, P461, DOI [https://doi.org/10.1108/02651339710192993, DOI 10.1108/02651339710192993]; Oman C., 2000, POLICY COMPETITION F; SCOTT AJ, 1982, URBAN STUD, V19, P111, DOI 10.1080/00420988220080261; Shan Y., 2000, ACTA GEOGRAPHIC SINI, V6, P671; Shen XP, 2005, GEOFORUM, V36, P761, DOI 10.1016/j.geoforum.2005.01.005; Sit VFS, 2000, ANN ASSOC AM GEOGR, V90, P653, DOI 10.1111/0004-5608.00216; STAFFORD HA, 1985, ANN ASSOC AM GEOGR, V75, P227, DOI 10.1111/j.1467-8306.1985.tb00083.x; The municipal government of Wuxi, 2012, DEV PROC IND WUX EC; Tian L, 2009, LAND USE POLICY, V26, P599, DOI 10.1016/j.landusepol.2008.08.012; Wang SG, 2005, GROWTH CHANGE, V36, P41, DOI 10.1111/j.1468-2257.2005.00266.x; Warr P., 1990, EXPORT PROMOTION STR; Wei YHD, 2008, URBAN GEOGR, V29, P639, DOI 10.2747/0272-3638.29.7.639; Wei YHD, 2010, PROF GEOGR, V62, P264, DOI 10.1080/00330120903546684; Wei YHD, 2007, ECON GEOGR, V83, P421; Wei YD, 2013, PROF GEOGR, V65, P247, DOI 10.1080/00330124.2012.679443; Wei YHD, 2005, GROWTH CHANGE, V36, P16, DOI 10.1111/j.1468-2257.2005.00265.x; WILL RA, 1964, LAND ECON, V40, P49, DOI 10.2307/3144460; Wu FL, 2002, URBAN STUD, V39, P1071, DOI 10.1080/00420980220135491; Wu FL, 1999, ANN REGIONAL SCI, V33, P535, DOI 10.1007/s001680050120; Wu JP, 2005, CITIES, V22, P275, DOI 10.1016/j.cities.2005.05.005; Yuan F, 2014, HABITAT INT, V42, P58, DOI 10.1016/j.habitatint.2013.10.008; Zhang XP, 2013, CHINESE GEOGR SCI, V23, P249, DOI 10.1007/s11769-012-0581-6	47	1	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173607	10.1371/journal.pone.0173607	http://dx.doi.org/10.1371/journal.pone.0173607			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278284	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900015
J	Miroshnichenko, D; Chaban, I; Chernobrovkina, M; Dolgov, S				Miroshnichenko, Dmitry; Chaban, Inna; Chernobrovkina, Mariya; Dolgov, Sergey			Protocol for efficient regulation of in vitro morphogenesis in einkorn (Triticum monococcum L.), a recalcitrant diploid wheat species	PLOS ONE			English	Article							PLANT-REGENERATION; SOMATIC EMBRYOGENESIS; IMMATURE EMBRYOS; CALLUS INDUCTION; MATURE EMBRYOS; AESTIVUM L; DIVERSE SET; DURUM DESF.; BARLEY; THIDIAZURON	Einkorn (Triticum monococcum L.) is A-genome diploid wheat that has a potential to become a useful model for understanding the biology and genomics in Triticeae. Unfortunately, the application of modern technologies such as genetic engineering, RNAi-based gene silencing and genome editing is not available for einkorn as there is no efficient in vitro tissue culture and plant regeneration system. In the present study an efficient and simple protocol for plant regeneration via direct or indirect somatic embryogenesis and organogenesis has been developed. Various auxins used as sole inductors in einkorn displayed low effect for morphogenesis (0-8%) and plant regeneration (1-2 shoots per explant). The addition of Daminozide, the inhibitor of biosynthesis of gibberellins, together with auxin significantly improved the formation of morphogenic structures, especially when Dicamba (51.4%) and Picloram (56.6%) were used for combination; furthermore, the simultaneous addition of cytokinin into induction medium significantly promoted in vitro performance. Among the tested cytokinins, the urea-type substances, such as TDZ and CPPU were more effective than the adenine type ones, BA and Zeatin, for the regulation of morphogenesis; especially, TDZ was more effective than CPPU for shoot formation (11.73 vs. 7.04 per regenerating callus). The highest morphogenic response of 90.2% with the production of more than 10 shoots per initial explant was observed when 3.0 mg/L Dicamba, 50.0 mg/L Daminozide and 0.25 mg/L TDZ were combined together. Along with the identification of appropriate induction medium, the optimal developmental stage for einkorn was found as partially transparent immature embryo in size of around 1.0 mm. Although in the present study the critical balance between plant growth regulators was established for einkorn only, we assume that further the proposed strategy could be successfully applied to other recalcitrant cereal species and genotypes.	[Miroshnichenko, Dmitry] RAS, Inst Basic Biol Problems, Pushchino, Moscow Region, Russia; [Miroshnichenko, Dmitry; Dolgov, Sergey] RAS, Branch Shemyakin & Ovchinnikov Inst Bioorgan Chem, Pushchino, Moscow Region, Russia; [Chaban, Inna; Chernobrovkina, Mariya; Dolgov, Sergey] All Russia Res Inst Agr Biotechnol, Moscow, Russia	Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; All-Russia Research Institute of Agricultural Biotechnology	Miroshnichenko, D (corresponding author), RAS, Inst Basic Biol Problems, Pushchino, Moscow Region, Russia.; Miroshnichenko, D (corresponding author), RAS, Branch Shemyakin & Ovchinnikov Inst Bioorgan Chem, Pushchino, Moscow Region, Russia.	miroshnichenko@bibch.ru	Inna, Chaban/ABE-4287-2020; Miroshnichenko, Dmitry/U-7330-2017; Chernobrovkina, Mariya/L-4713-2017; Dolgov, Sergey/AAV-3465-2021	Miroshnichenko, Dmitry/0000-0003-3975-7484; dolgov, sergey/0000-0003-1399-3235	Russian Science Foundation [16-14-10155]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation, Grant number: 16-14-10155 (http:rscf.ru/en/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikina O, 2016, CROP BREED APPL BIOT, V16, P307, DOI 10.1590/1984-70332016v16n4a46; Bakos F, 2009, SEX PLANT REPROD, V22, P15, DOI 10.1007/s00497-008-0087-7; Barro F, 1999, EUPHYTICA, V108, P161, DOI 10.1023/A:1003676830857; Biesaga-Koscielniak J, 2010, ACTA PHYSIOL PLANT, V32, P1047, DOI 10.1007/s11738-010-0495-9; Bouamama B, 2011, IN VITRO CELL DEV-PL, V47, P321, DOI 10.1007/s11627-011-9357-4; BROWN C, 1989, J PLANT PHYSIOL, V133, P727, DOI 10.1016/S0176-1617(89)80080-X; Brown RGS, 1997, PHYSIOL PLANTARUM, V101, P309, DOI 10.1034/j.1399-3054.1997.1010208.x; CARMAN JG, 1987, PLANT CELL TISS ORG, V10, P115, DOI 10.1007/BF00035909; Chang Y, 2003, PLANT CELL REP, V21, P733, DOI 10.1007/s00299-003-0607-8; Chauhan H, 2007, PLANT CELL TISS ORG, V91, P191, DOI 10.1007/s11240-007-9285-5; Delporte F, 2014, PROTOPLASMA, V251, P1455, DOI 10.1007/s00709-014-0647-7; Delporte F, 2012, PLANT SIGNAL BEHAV, V7, P1608, DOI 10.4161/psb.22424; Elhiti M, 2011, METHODS MOL BIOL, V710, P229, DOI 10.1007/978-1-61737-988-8_17; Eudes F, 2003, PLANT CELL TISS ORG, V73, P147, DOI 10.1023/A:1022800512708; Fernandez S, 1999, PLANT GROWTH REGUL, V28, P147, DOI 10.1023/A:1006142504577; Fu FL, 2011, AFR J BIOTECHNOL, V10, P2618; Ganeshan S, 2006, PLANT CELL TISS ORG, V85, P63, DOI 10.1007/s11240-005-9049-z; Guo B, 2011, AFR J BIOTECHNOL, V10, P8984; GUSSMAN CD, 1993, PLANT GROWTH REGUL, V12, P149, DOI 10.1007/BF00144596; Haliloglu K, 2005, J PLANT BIOCHEM BIOT, V14, P155, DOI 10.1007/BF03263244; Harlan J.R., 1981, WHEAT SCI TODAY TOMO, P1; HE DG, 1986, PLANT SCI, V45, P119, DOI 10.1016/0168-9452(86)90047-6; He GY, 2001, EUPHYTICA, V119, P369, DOI 10.1023/A:1017587628995; Hess JR, 1998, CROP SCI, V38, P249, DOI 10.2135/cropsci1998.0011183X003800010042x; Jha AK, 2007, PLANT CELL REP, V26, P285, DOI 10.1007/s00299-006-0252-0; JOHANSSON L, 1986, POTATO RES, V29, P179, DOI 10.1007/BF02357649; Konieczny R, 2003, PLANT CELL TISS ORG, V73, P177, DOI 10.1023/A:1022877807237; Kothari SL, 1998, J PLANT BIOCHEM BIOT, V7, P93, DOI 10.1007/BF03263042; Kumar S, 2005, BIOL PLANTARUM, V49, P629, DOI 10.1007/s10535-005-0064-z; Leon E, 2006, PLANT BREEDING, V125, P580, DOI 10.1111/j.1439-0523.2006.01262.x; Li BC, 2003, IN VITRO CELL DEV-PL, V39, P20, DOI 10.1079/IVP2002356; Longin CFH, 2016, TRENDS PLANT SCI, V21, P731, DOI 10.1016/j.tplants.2016.05.005; MESSENS E, 1990, P NATL ACAD SCI USA, V87, P4368, DOI 10.1073/pnas.87.11.4368; Miroshnichenko D., 2009, Australian Journal of Crop Science, V3, P83; Miroshnichenko D. N., 2013, Russian Agricultural Sciences, V39, P24, DOI 10.3103/S1068367413010175; Miroshnichenko D, 2016, PLANT CELL TISS ORG, V125, P495, DOI 10.1007/s11240-016-0965-x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murthy BNS, 1998, IN VITRO CELL DEV-PL, V34, P267, DOI 10.1007/BF02822732; Ozgen M, 2017, PLANT GENET RESOUR-C, V15, P45, DOI 10.1017/S1479262115000350; OZIASAKINS P, 1982, PROTOPLASMA, V110, P95, DOI 10.1007/BF01281535; Pellegrineschi A, 2002, GENOME, V45, P421, DOI 10.1139/G01-154; Przetakiewicz A, 2003, PLANT CELL TISS ORG, V73, P245, DOI 10.1023/A:1023030511800; Pullman GS, 2005, PLANT CELL REP, V23, P596, DOI 10.1007/s00299-004-0880-1; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; Rasco-Gaunt S, 2001, J EXP BOT, V52, P865, DOI 10.1093/jexbot/52.357.865; Rawat N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-205; Running Bi, 2008, Frontiers of Agriculture in China, V2, P262, DOI 10.1007/s11703-008-0038-y; Schulze J, 2007, FRUIT VEG CEREAL SCI, V1, P64; Seldimirova OA, 2016, IN VITRO CELL DEV-PL, V52, P251, DOI 10.1007/s11627-016-9767-4; Shan He, 2014, Journal of Northeast Agricultural University (English Edition), V21, P12; Shan XY, 2000, IN VITRO CELL DEV-PL, V36, P207, DOI 10.1007/s11627-000-0038-y; She MY, 2013, MOL BIOTECHNOL, V54, P451, DOI 10.1007/s12033-012-9583-y; Takumi S, 1997, GENES GENET SYST, V72, P63, DOI 10.1266/ggs.72.63; Viertel K, 1998, J PLANT PHYSIOL, V152, P167, DOI 10.1016/S0176-1617(98)80128-4; Ward KA, 2001, IN VITRO CELL DEV-PL, V37, P361; Yang S, 2015, ACTA PHYSIOL PLANT, V37, P1; Yin N, 2012, PLANT MOL BIOL REP, V30, P949, DOI 10.1007/s11105-011-0403-5; Zaharieva M, 2014, GENET RESOUR CROP EV, V61, P677, DOI 10.1007/s10722-014-0084-7; Zale JM, 2004, PLANT CELL TISS ORG, V76, P277, DOI 10.1023/B:TICU.0000009248.32457.4c	59	17	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173533	10.1371/journal.pone.0173533	http://dx.doi.org/10.1371/journal.pone.0173533			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273182	Green Submitted, Green Published, gold			2022-12-27	WOS:000396073700014
J	Zhang, XY; Wu, Y; Xiao, G; Tang, ZP; Wang, MY; Liu, FC; Zhu, XF				Zhang, Xinying; Wu, Yan; Xiao, Gao; Tang, Zhenping; Wang, Meiyin; Liu, Fuchang; Zhu, Xuefeng			Simultaneous photocatalytic and microbial degradation of dye-containing wastewater by a novel g-C3N4-P-25/photosynthetic bacteria composite	PLOS ONE			English	Article							TIO2-COATED BIOFILM CARRIER; BRILLIANT RED X-3B; VISIBLE-LIGHT; AZO-DYE; DECOLORIZATION; ALGINATE; REMOVAL; BIODEGRADATION; NANOPARTICLES; COMBINATION	Azo dyes are very resistant to light-induced fading and biodegradation. Existing advanced oxidative pre-treatment methods based on the generation of non-selective radicals cannot efficiently remove these dyes from wastewater streams, and post-treatment oxidative dye removal is problematic because it may leave many byproducts with unknown toxicity profiles in the outgoing water, or cause expensive complete mineralization. These problems could potentially be overcome by combining photocatalysis and biodegradation. A novel visible-light-responsive hybrid dye removal agent featuring both photocatalysts (g-C3N4-P-25) and photosynthetic bacteria encapsulated in calcium alginate beads was prepared by self-assembly. This system achieved a removal efficiency of 94% for the dye reactive brilliant red X-3b and also reduced the COD of synthetic wastewater samples by 84.7%, successfully decolorized synthetic dye-contaminated wastewater and reduced its COD, demonstrating the advantages of combining photocatalysis and biocatalysis for wastewater purification. The composite apparently degrades X-3b by initially converting the dye into aniline and phenol derivatives whose aryl moieties are then attacked by free radicals to form alkyl derivatives, preventing the accumulation of aromatic hydrocarbons that might suppress microbial activity. These alkyl intermediates are finally degraded by the photosynthetic bacteria.	[Zhang, Xinying; Wu, Yan; Xiao, Gao; Tang, Zhenping; Wang, Meiyin; Liu, Fuchang] Fuzhou Univ, Coll Environm & Resources, Fuzhou, Fujian, Peoples R China; [Zhang, Xinying] Fuzhou Univ, Res Inst Photocatalysis, State Key Lab Photocatalysis Energy & Environm, Fuzhou, Peoples R China; [Zhu, Xuefeng] Delft Univ Technol, Fac Civil Engn & GeoSci, Sect Sanit Engn, Dept Water Management, Delft, Netherlands	Fuzhou University; Fuzhou University; Delft University of Technology	Zhang, XY (corresponding author), Fuzhou Univ, Coll Environm & Resources, Fuzhou, Fujian, Peoples R China.; Zhang, XY (corresponding author), Fuzhou Univ, Res Inst Photocatalysis, State Key Lab Photocatalysis Energy & Environm, Fuzhou, Peoples R China.; Zhu, XF (corresponding author), Delft Univ Technol, Fac Civil Engn & GeoSci, Sect Sanit Engn, Dept Water Management, Delft, Netherlands.	xyz_8471@163.com; X.Zhu-1@tudelft.nl	xiao, gao/K-1226-2014; Xiao, Gao/D-8205-2019; xuefeng, zhu/AAJ-9371-2020	xiao, gao/0000-0002-6166-8771; Xiao, Gao/0000-0002-6166-8771; xuefeng, zhu/0000-0002-1910-629X	State Key Laboratory of Photocatalysis on Energy and Environment [2014C05]; Fujian Provincial Department of Science and Technology [2015R1004-3]; Environmental Protection Department of Fujian Province [2015R024]	State Key Laboratory of Photocatalysis on Energy and Environment; Fujian Provincial Department of Science and Technology; Environmental Protection Department of Fujian Province	This work was financially supported by the State Key Laboratory of Photocatalysis on Energy and Environment (2014C05), the Fujian Provincial Department of Science and Technology (CN) (2015R1004-3) and by Environmental Protection Department of Fujian Province (2015R024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarelli JQ, 2009, WATER SCI TECHNOL, V60, P1081, DOI 10.2166/wst.2009.459; An TC, 2003, J CHEM TECHNOL BIOT, V78, P1142, DOI 10.1002/jctb.915; Banat IM, 1996, BIORESOURCE TECHNOL, V58, P217, DOI 10.1016/S0960-8524(96)00113-7; Benzaquen TB, 2016, J CHEM TECHNOL BIOT, V91, P718, DOI 10.1002/jctb.4635; Brosillon S, 2008, DESALINATION, V222, P331, DOI 10.1016/j.desal.2007.01.153; Cao CH, 2013, APPL SURF SCI, V271, P105, DOI 10.1016/j.apsusc.2013.01.135; Chemlal R, 2014, ECOL ENG, V73, P281, DOI 10.1016/j.ecoleng.2014.09.043; Chen CY, 2014, CHEMOSPHERE, V117, P494, DOI 10.1016/j.chemosphere.2014.08.069; Cui D, 2014, BIORESOURCE TECHNOL, V163, P254, DOI 10.1016/j.biortech.2014.03.165; Daneshvar N, 2007, BIORESOURCE TECHNOL, V98, P1176, DOI 10.1016/j.biortech.2006.05.025; dos Santos AB, 2007, BIORESOURCE TECHNOL, V98, P2369, DOI 10.1016/j.biortech.2006.11.013; Gnanapragasam G, 2011, BIORESOURCE TECHNOL, V102, P627, DOI 10.1016/j.biortech.2010.08.012; Hao RR, 2016, APPL CATAL B-ENVIRON, V187, P47, DOI 10.1016/j.apcatb.2016.01.026; Hayat H, 2015, SEP PURIF TECHNOL, V154, P149, DOI 10.1016/j.seppur.2015.09.025; Kumar AN, 2015, BIORESOURCE TECHNOL, V188, P56, DOI 10.1016/j.biortech.2015.01.098; Kumar M, 2016, ARCH BIOCHEM BIOPHYS, V605, P41, DOI 10.1016/j.abb.2016.03.026; Kumar M, 2015, SCRIPTA MATER, V105, P46, DOI 10.1016/j.scriptamat.2015.04.030; Kumar M, 2013, J ENVIRON BIOL, V34, P1; Laera G, 2011, BIORESOURCE TECHNOL, V102, P7012, DOI 10.1016/j.biortech.2011.04.056; Li GZ, 2012, WATER RES, V46, P6489, DOI 10.1016/j.watres.2012.09.029; Li GZ, 2012, BIOTECHNOL BIOENG, V109, P884, DOI 10.1002/bit.24366; Li GZ, 2011, ENVIRON SCI TECHNOL, V45, P8359, DOI 10.1021/es2016523; Li JH, 2016, J PHOTOCH PHOTOBIO A, V317, P151, DOI 10.1016/j.jphotochem.2015.11.008; Liu W, 2012, CHEM ENG J, V209, P386, DOI 10.1016/j.cej.2012.08.033; Lotito AM, 2012, CHEM ENG J, V195, P261, DOI 10.1016/j.cej.2012.05.006; Marsolek MD, 2008, BIOTECHNOL BIOENG, V101, P83, DOI 10.1002/bit.21889; Montazerozohori M, 2013, ENVIRON PROG SUSTAIN, V32, P1061, DOI 10.1002/ep.11709; Ozdemir S, 2013, BIORESOURCE TECHNOL, V146, P135, DOI 10.1016/j.biortech.2013.07.066; Pawar RC, 2014, APPL CATAL B-ENVIRON, V144, P57, DOI 10.1016/j.apcatb.2013.06.022; Saratale RG, 2011, J TAIWAN INST CHEM E, V42, P138, DOI 10.1016/j.jtice.2010.06.006; Sarkar S, 2015, ECOTOX ENVIRON SAFE, V121, P263, DOI 10.1016/j.ecoenv.2015.02.035; Tian X, 2009, INT J HYDROGEN ENERG, V34, P4708, DOI 10.1016/j.ijhydene.2009.03.042; Wang XN, 2015, ULTRASON SONOCHEM, V23, P93, DOI 10.1016/j.ultsonch.2014.10.005; Wei S, 2014, POLYM COMPOSITE, V08, P1292; Xiao HH, 2015, APPL SURF SCI, V358, P313, DOI 10.1016/j.apsusc.2015.07.213; Xie YB, 2003, J MOL CATAL A-CHEM, V206, P419, DOI 10.1016/S1381-1169(03)00454-0; Yurtsever A, 2015, BIORESOURCE TECHNOL, V192, P564, DOI 10.1016/j.biortech.2015.06.024; Zhao KY, 2014, CATAL TODAY, V236, P127, DOI 10.1016/j.cattod.2014.03.041; Zhou DD, 2015, ENVIRON SCI TECHNOL, V49, P7776, DOI 10.1021/acs.est.5b00989; Zhuang Y, 2016, J ENVIRON CHEM ENG, V4, P147, DOI 10.1016/j.jece.2015.11.014	40	22	23	4	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172747	10.1371/journal.pone.0172747	http://dx.doi.org/10.1371/journal.pone.0172747			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273118	Green Submitted, Green Published, gold			2022-12-27	WOS:000396073700087
J	Chu, CS; Sun, IW; Begum, A; Liu, SI; Chang, CJ; Chiu, WC; Chen, CH; Tang, HS; Yang, CL; Lin, YC; Chiu, CC; Stewart, R				Chu, Chung-Shiang; Sun, I-Wen; Begum, Aysha; Liu, Shen-Ing; Chang, Ching-Jui; Chiu, Wei-Che; Chen, Chin-Hsin; Tang, Hwang-Shen; Yang, Chia-Li; Lin, Ying-Chin; Chiu, Chih-Chiang; Stewart, Robert			The association between subjective memory complaint and objective cognitive function in older people with previous major depression	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; ALZHEIMERS-DISEASE; EXECUTIVE DYSFUNCTION; GERIATRIC DEPRESSION; APOE GENOTYPE; RISK-FACTORS; GOSPEL OAK; IMPAIRMENT; COMMUNITY; PERFORMANCE	The goal of this study is to investigate associations between subjective memory complaint and objective cognitive performance in older people with previous major depression a high risk sample for cognitive impairment and later dementia. A cross-sectional study was carried out in people aged 60 or over with previous major depression but not fulfilling current major depression criteria according to DSM-IV-TR. People with dementia or Mini-Mental State Examination score less than 17 were excluded. Subjective memory complaint was defined on the basis of a score on the subscale of Geriatric Mental State schedule, a maximum score of >= 4 Older people aged equal or over 60 without any psychiatric diagnosis were enrolled as healthy controls. Cognitive function was evaluated using a series of cognitive tests assessing verbal memory, attention/speed, visuospatial function, verbal fluency, and cognitive flexibility in all participants. One hundred and thirteen older people with previous major depression and forty-six healthy controls were enrolled. Subjective memory complaint was present in more than half of the participants with depression history (55.8%). Among those with major depression history, subjective memory complaint was associated with lower total immediate recall and delayed verbal recall scores after adjustment. The associations between subjective memory complaint and worse memory performance were stronger in participants with lower depressive symptoms (Hamilton Depression Rating Scale score <7). The results suggest subjective memory complaint may be a valid appraisal of memory performance in older people with previous major depression and consideration should be given to more proactive assessment and follow-up in these clinical samples.	[Chu, Chung-Shiang] Cardinal Tien Hosp, Dept Psychiat, New Taipei, Taiwan; [Sun, I-Wen; Liu, Shen-Ing] Mackay Mem Hosp, Dept Psychiat, Taipei, Taiwan; [Begum, Aysha; Stewart, Robert] Kings Coll London, Inst Psychiat, Dept Psychol Med, London, England; [Chang, Ching-Jui; Chiu, Wei-Che] Cathay Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Chiu, Wei-Che] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Chen, Chin-Hsin; Chiu, Chih-Chiang] Taipei Med Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Chen, Chin-Hsin] Taipei Med Univ, Dept Psychiat, Wan Fang Hosp, Taipei, Taiwan; [Tang, Hwang-Shen; Chiu, Chih-Chiang] Taipei City Hosp, Songde Branch, Dept Psychiat, Taipei, Taiwan; [Yang, Chia-Li] Taipei City Hosp, Zhongxing Branch, Dept Family Med, Taipei, Taiwan; [Lin, Ying-Chin] Taipei Med Univ, Shuang Ho Hosp, Dept Family Med, New Taipei, Taiwan; [Lin, Ying-Chin] Taipei Med Univ, Sch Med, Dept Family Med, Coll Med, Taipei, Taiwan	Mackay Memorial Hospital; University of London; King's College London; Cathay General Hospital; Fu Jen Catholic University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei City Hospital; Taipei City Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University	Chiu, CC (corresponding author), Taipei Med Univ, Sch Med, Dept Psychiat, Taipei, Taiwan.; Chiu, CC (corresponding author), Taipei City Hosp, Songde Branch, Dept Psychiat, Taipei, Taiwan.	eric.ccchiu@gmail.com	Stewart, Robert/B-1667-2010	Stewart, Robert/0000-0002-4435-6397	Taipei City Hospital; National Science Council of Taiwan [NSC 98-2314-B-532-001-MY3, MOST 105-2314-B-532-003-MY3]; National Institute for Health Research (NIHR) Biomedical Research Centre; Dementia Biomedical Research Unit at South London; Maudsley NHS Foundation Trust; King's College London	Taipei City Hospital; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Dementia Biomedical Research Unit at South London; Maudsley NHS Foundation Trust; King's College London(General Electric)	This work is supported by Taipei City Hospital and the National Science Council of Taiwan (NSC 98-2314-B-532-001-MY3 and MOST 105-2314-B-532-003-MY3). RS is part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London.	Abdulrab K, 2008, EUR PSYCHIAT, V23, P321, DOI 10.1016/j.eurpsy.2008.02.004; Alexopoulos GS, 2000, ARCH GEN PSYCHIAT, V57, P285, DOI 10.1001/archpsyc.57.3.285; Amariglio RE, 2011, J AM GERIATR SOC, V59, P1612, DOI 10.1111/j.1532-5415.2011.03543.x; Balash Y, 2013, ACTA NEUROL SCAND, V127, P344, DOI 10.1111/ane.12038; Bartley M, 2012, INT J GERIATR PSYCH, V27, P836, DOI 10.1002/gps.2794; BASSETT SS, 1993, J GERIATR PSYCH NEUR, V6, P105, DOI 10.1177/089198879300600207; Begum A, 2012, INT J GERIATR PSYCH, V27, P612, DOI 10.1002/gps.2760; Burmester B, 2016, NEUROPSYCHOL REV, V26, P376, DOI 10.1007/s11065-016-9332-2; Butters MA, 2004, ARCH GEN PSYCHIAT, V61, P587, DOI 10.1001/archpsyc.61.6.587; Butters MA, 2000, AM J PSYCHIAT, V157, P1949, DOI 10.1176/appi.ajp.157.12.1949; Butters Meryl A, 2008, Dialogues Clin Neurosci, V10, P345; Chen CH, 2005, ALCOHOL CLIN EXP RES, V29, P602, DOI 10.1097/01.ALC.0000159189.56671.EC; Chiu CC, 2012, AM J CLIN NUTR, V95, P420, DOI 10.3945/ajcn.111.015784; Minett TSC, 2008, INT J GERIATR PSYCH, V23, P49, DOI 10.1002/gps.1836; COPELAND JRM, 1976, PSYCHOL MED, V6, P439, DOI 10.1017/S0033291700015889; de Groot JC, 2001, NEUROLOGY, V56, P1539, DOI 10.1212/WNL.56.11.1539; Dufouil C, 2005, J AM GERIATR SOC, V53, P616, DOI 10.1111/j.1532-5415.2005.53209.x; Estevez-Gonzalez A, 2003, INT J GERIATR PSYCH, V18, P1021, DOI 10.1002/gps.1010; GAGNON M, 1994, NEUROEPIDEMIOLOGY, V13, P145, DOI 10.1159/000110373; Geerlings MI, 1999, AM J PSYCHIAT, V156, P531; Jadoon A, 2012, J AFFECT DISORDERS, V136, P918, DOI 10.1016/j.jad.2011.09.007; Jessen F, 2006, NEUROBIOL AGING, V27, P1751, DOI 10.1016/j.neurobiolaging.2005.10.010; Jonker C, 1996, J AM GERIATR SOC, V44, P44, DOI 10.1111/j.1532-5415.1996.tb05636.x; Jorm AF, 2004, PSYCHOL MED, V34, P1495, DOI 10.1017/S0033291704003162; Jorm AF, 2001, PSYCHOL MED, V31, P441, DOI 10.1017/S0033291701003245; Jorm AF, 2000, GERONTOLOGY, V46, P219, DOI 10.1159/000022163; Jungwirth S, 2004, J AM GERIATR SOC, V52, P263, DOI 10.1111/j.1532-5415.2004.52066.x; Kim JM, 2006, AM J GERIAT PSYCHIAT, V14, P949, DOI 10.1097/01.JGP.0000214857.66638.ed; Lam LCW, 2005, INT J GERIATR PSYCH, V20, P876, DOI 10.1002/gps.1370; Lim JK, 2003, OR SPECTRUM, V25, P25, DOI 10.1007/s00291-002-0116-0; Lockwood KA, 2002, AM J PSYCHIAT, V159, P1119, DOI 10.1176/appi.ajp.159.7.1119; Molinuevo JL, 2016, ALZHEIMERS DEMENT; O'Brien JT, 2004, AM J PSYCHIAT, V161, P2081, DOI 10.1176/appi.ajp.161.11.2081; OCONNOR DW, 1990, ARCH GEN PSYCHIAT, V47, P224; Paradise MB, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-108; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Prince MJ, 1997, PSYCHOL MED, V27, P323, DOI 10.1017/S0033291796004485; Rapp MA, 2005, AM J PSYCHIAT, V162, P691, DOI 10.1176/appi.ajp.162.4.691; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; Rush AJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1841, DOI 10.1038/sj.npp.1301131; Stewart R, 2008, NEUROLOGY, V70, P1601, DOI 10.1212/01.wnl.0000310982.99438.54; Stewart R, 2001, PSYCHOL MED, V31, P431, DOI 10.1017/S0033291701003257; Stewart R, 2011, BRIT J PSYCHIAT, V198, P199, DOI 10.1192/bjp.bp.110.078683; Tabert MH, 2006, ARCH GEN PSYCHIAT, V63, P916, DOI 10.1001/archpsyc.63.8.916; TOBIANSKY R, 1995, PSYCHOL MED, V25, P779, DOI 10.1017/S0033291700035029; van der Flier WM, 2004, J NEUROL, V251, P671, DOI 10.1007/s00415-004-0390-7; Waldorff FB, 2012, INT J GERIATR PSYCH, V27, P1180, DOI 10.1002/gps.3765; Wang PN, 2000, J AM GERIATR SOC, V48, P295, DOI 10.1111/j.1532-5415.2000.tb02649.x; Yeh YC, 2011, AM J GERIAT PSYCHIAT, V19, P923, DOI 10.1097/JGP.0b013e318202clc6; Zivelin A, 1997, CLIN CHEM, V43, P1657; Zlatar ZZ, 2014, J GERIATR PSYCH NEUR, V27, P181, DOI 10.1177/0891988714524628; Zwan MD, 2016, J ALZHEIMERS DIS, V49, P1115, DOI 10.3233/JAD-150446	53	23	23	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173027	10.1371/journal.pone.0173027	http://dx.doi.org/10.1371/journal.pone.0173027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5QM	28267772	Green Published, gold, Green Submitted			2022-12-27	WOS:000396060600008
J	Grabchak, M; Marcon, E; Lang, G; Zhang, ZY				Grabchak, Michael; Marcon, Eric; Lang, Gabriel; Zhang, Zhiyi			The generalized Simpson's entropy is a measure of biodiversity	PLOS ONE			English	Article							SPECIES-DIVERSITY; DISCOVERY RATES; RICHNESS; EVENNESS	Modern measures of diversity satisfy reasonable axioms, are parameterized to produce diversity profiles, can be expressed as an effective number of species to simplify their interpretation, and come with estimators that allow one to apply them to real-world data. We introduce the generalized Simpson's entropy as a measure of diversity and investigate its properties. We show that it has many useful features and can be used as a measure of biodiversity. Moreover, unlike most commonly used diversity indices, it has unbiased estimators, which allow for sound estimation of the diversity of poorly sampled, rich communities.	[Grabchak, Michael; Zhang, Zhiyi] Univ North Carolina Charlotte, Dept Math & Stat, Charlotte, NC 28223 USA; [Marcon, Eric] Univ Guyane, Univ Antilles, AgroParisTech, UMR EcoFoG,CNRS,CIRAD,INRA, BP 709, F-97310 Kourou, France; [Lang, Gabriel] Univ Paris Saclay, INRA, AgroParisTech, UMR Mia 518, F-75015 Paris, France	University of North Carolina; University of North Carolina Charlotte; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; INRAE; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Marcon, E (corresponding author), Univ Guyane, Univ Antilles, AgroParisTech, UMR EcoFoG,CNRS,CIRAD,INRA, BP 709, F-97310 Kourou, France.	eric.marcon@ecofog.gf	Marcon, Eric/B-5631-2009	Marcon, Eric/0000-0002-5249-321X	Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-25-01]	Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR))	This work has benefited from an "Investissement d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-25-01).	Beck J, 2010, METHODS ECOL EVOL, V1, P38, DOI 10.1111/j.2041-210X.2009.00003.x; Brose U, 2003, ECOLOGY, V84, P2364, DOI 10.1890/02-0558; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Cao L, 2014, ENTROPYESTIMATION ES; Chao A, 2015, METHODS ECOL EVOL, V6, P873, DOI 10.1111/2041-210X.12349; Chao AN, 2013, METHODS ECOL EVOL, V4, P1091, DOI 10.1111/2041-210X.12108; Corona P, 2015, BIODIVERSIT IN PRESS; Dalton H, 1920, ECON J, V30, P348, DOI 10.2307/2223525; DAROCZY Z, 1970, INFORM CONTROL, V16, P36, DOI 10.1016/S0019-9958(70)80040-7; Dauby G, 2012, ECOGRAPHY, V35, P661, DOI 10.1111/j.1600-0587.2011.06860.x; FADDEEV D. K., 1956, USP MAT NAUK, V11, P227; Gourlet-Fleury S., 2004, ECOLOGY MANAGEMENT N; Gregorius HR, 2014, WEB ECOL, V14, P51, DOI 10.5194/we-14-51-2014; GREGORIUS HR, 1991, THEOR POPUL BIOL, V40, P269, DOI 10.1016/0040-5809(91)90056-L; Harvda J, 1967, KYBERNETIKA, V3, P30; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Marcon E., 2015, PRACTICAL ESTIMATION; Marcon E, 2015, J STAT SOFTW, V67, P1; Marcon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090289; Olszewski TD, 2004, OIKOS, V104, P377, DOI 10.1111/j.0030-1299.2004.12519.x; PATIL GP, 1982, J AM STAT ASSOC, V77, P548, DOI 10.2307/2287709; R Development Core Team, 2016, R LANG ENV STAT COMP; Renyi A., 1961, 4 BERK S MATH STAT P, V1; Ricotta C, 2005, ACTA BIOTHEOR, V53, P29, DOI 10.1007/s10441-005-7001-6; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; TOTHMERESZ B, 1995, J VEG SCI, V6, P283, DOI 10.2307/3236223; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Zhang ZY, 2016, J NONPARAMETR STAT, V28, P563, DOI 10.1080/10485252.2016.1190357; Zhang ZY, 2010, J STAT PLAN INFER, V140, P1731, DOI 10.1016/j.jspi.2009.12.023	33	16	16	3	149	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173305	10.1371/journal.pone.0173305	http://dx.doi.org/10.1371/journal.pone.0173305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267765	Green Published, Green Submitted, gold			2022-12-27	WOS:000396060600021
J	Piedra, FA; Mei, MH; Avadhanula, V; Mehta, R; Aideyan, L; Garofalo, RP; Piedra, PA				Piedra, Felipe-Andres; Mei, Minghua; Avadhanula, Vasanthi; Mehta, Reena; Aideyan, Letisha; Garofalo, Roberto P.; Piedra, Pedro A.			The interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitis	PLOS ONE			English	Article							ANTIBODY-MEDIATED RESTRICTION; DISEASE SEVERITY; G-PROTEIN; HOSPITALIZED INFANTS; INFECTION; PATHOGENESIS; REPLICATION; MULTICENTER; MACROPHAGES; COMMUNITY	Respiratory syncytial virus (RSV) causes significant infant morbidity and mortality. For decades severe RSV-induced disease was thought to result from an uncontrolled host response to viral replication, but recent work suggests that a strong innate immune response early in infection is protective. To shed light on host-virus interactions and the viral determinants of disease, copy numbers of five RSV genes (NS1, NS2, N, G, F) were measured by quantitative real-time polymerase chain reaction (qPCR) in nasal wash samples from children with RSV-associated bronchiolitis. Correlations were sought with host cytokines/chemokines and biomarkers. Associations with disposition from the emergency department (hospitalized or sent home) and pulse oximetry 02 saturation levels were also sought. Additionally, RNase P copy number was measured and used to normalize nasal wash data. RSV gene copy numbers were found to significantly correlate with both cytokine/chemokine and biomarker levels; and RNase P-normalized viral gene copy numbers (NS1, NS2, N and G) were significantly higher in infants with less severe disease. Moreover, three of the normalized viral gene copy numbers (NS1, NS2, and N) correlated significantly with arterial O-2 saturation levels. The data support a model where a higher viral load early in infection can promote a robust innate immune response that protects against progression into hypoxic RSV-induced lower respiratory tract illness.	[Piedra, Felipe-Andres; Mei, Minghua; Avadhanula, Vasanthi; Aideyan, Letisha; Piedra, Pedro A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Mehta, Reena] Allergy & Asthma Specialists PC, Saddle River, NJ USA; [Garofalo, Roberto P.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Piedra, Pedro A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Mei, Minghua] Eli Lilly & Co, Statist Oncol, Indianapolis, IN 46285 USA	Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; Eli Lilly	Piedra, PA (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Piedra, PA (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	ppiedra@bcm.edu	, VA/AAO-6566-2020; Garofalo, Roberto P./AAF-7385-2022; Garofalo, Roberto P./ABL-2322-2022	Piedra, Pedro/0000-0002-5839-0879	Department of Defense; Postdoctoral Fellowship from the National Institute of Environmental Health Sciences [T32-07254]	Department of Defense(United States Department of Defense); Postdoctoral Fellowship from the National Institute of Environmental Health Sciences	This work was supported by the Department of Defense (https://urldefense.proofpoint.com/v2/url?u=http-3A_www.defense.gov_&d=DwIGaQ&c=ZQs-KZ8oxEw0p81sqgiaRA&r=8HfluFGqdfRYRuWe3HyiMA&m=PYV_85UrZLaXMsZpeX6cRhl19l8q2G5RutrxhnOWcMk&s=W5VY_4LzMqd1U6ND2m5hHnonN4l5-HBG7ygLctfsPEQ&e=) [W81XWH1010146 to RPG] and a Postdoctoral Fellowship from the National Institute of Environmental Health Sciences (https://urldefense.proofpoint.com/v2/url?u=http-3A_www.niehs.nih.gov_&d=DwIGaQ&c=ZQs-KZ8oxEw0p81sqgiaRA&r=8HfluFGqdfRYRuWe3HyiMA&m=PYV_85UrZLaXMsZpeX6cRhl19l8q2G5RutrxhnOWcMk&s=egZ4Nl6jAxKtJFK-tBHFo3Gy0OMiA1Q5EeZ72qgW7SM&e=) [T32-07254 to RM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, DATA ANAL ABI PRISM; Avadhanula V, 2015, J INFECT DIS, V211, P582, DOI 10.1093/infdis/jiu473; Bennett BL, 2007, J INFECT DIS, V195, P1532, DOI 10.1086/515575; Buckingham SC, 2000, PEDIATR INFECT DIS J, V19, P113, DOI 10.1097/00006454-200002000-00006; Bukreyev A, 2012, J VIROL, V86, P10880, DOI 10.1128/JVI.01162-12; Bukreyev A, 2008, J VIROL, V82, P12191, DOI 10.1128/JVI.01604-08; Chirkova T, 2013, J VIROL, V87, P13466, DOI 10.1128/JVI.01741-13; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; DeVincenzo JP, 2005, J INFECT DIS, V191, P1861, DOI 10.1086/430008; Fodha I, 2007, J MED VIROL, V79, P1951, DOI 10.1002/jmv.21026; FULGINITI VA, 1969, AM J EPIDEMIOL, V89, P435, DOI 10.1093/oxfordjournals.aje.a120956; Fuller JA, 2013, J MED VIROL, V85, P924, DOI 10.1002/jmv.23455; Graham BS, 2000, IMMUNOPHARMACOLOGY, V48, P237, DOI 10.1016/S0162-3109(00)00233-2; Harcourt JL, 2004, J INFECT DIS, V190, P1936, DOI 10.1086/425516; Hasegawa K, 2015, J INFECT DIS, V211, P1550, DOI 10.1093/infdis/jiu658; Hasegawa K, 2014, PEDIATR INFECT DIS J, V33, P11, DOI 10.1097/INF.0b013e3182a5f324; Houben ML, 2010, J MED VIROL, V82, P1266, DOI 10.1002/jmv.21771; JOHNSON KM, 1961, JAMA-J AM MED ASSOC, V176, P663; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Krathwohl MD, 2006, VACCINE, V24, P2987, DOI 10.1016/j.vaccine.2005.11.032; Laham FR, 2010, PEDIATRICS, V125, pE225, DOI 10.1542/peds.2009-0411; Laham FR, 2004, J INFECT DIS, V189, P2047, DOI 10.1086/383350; Legg JP, 2003, AM J RESP CRIT CARE, V168, P633, DOI 10.1164/rccm.200210-1148OC; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Lopez CB, 2014, J VIROL, V88, P8720, DOI 10.1128/JVI.00707-14; Mansbach JM, 2012, ARCH PEDIAT ADOL MED, V166, P700, DOI 10.1001/archpediatrics.2011.1669; McLellan JS, 2013, CURR TOP MICROBIOL, V372, P83, DOI 10.1007/978-3-642-38919-1_4; Mehta R, 2014, INFLUENZA OTHER RESP, V8, P617, DOI 10.1111/irv.12276; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nicholson EG, 2016, J INFECT DIS; Openshaw PJM, 2005, CLIN MICROBIOL REV, V18, P541, DOI 10.1128/CMR.18.3.541-555.2005; Pathak KB, 2009, VIRUSES-BASEL, V1, P895, DOI 10.3390/v1030895; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; Scagnolari C, 2012, MED MICROBIOL IMMUN, V201, P311, DOI 10.1007/s00430-012-0233-6; Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004; Sun Y, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005122; Swedan S, 2009, J VIROL, V83, P9682, DOI 10.1128/JVI.00715-09; Tapia LI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090786; Tripp RA, 2004, VIRAL IMMUNOL, V17, P165, DOI 10.1089/0882824041310513; Wright PF, 2002, J INFECT DIS, V185, P1011, DOI 10.1086/339822; Yang P, 2015, VIROLOGY, V485, P223, DOI 10.1016/j.virol.2015.07.016; Yokota S, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/184328; Zheng JM, 2015, DISCRETE DYN NAT SOC, V2015, DOI 10.1155/2015/782630; Zorc JJ, 2010, PEDIATRICS, V125, P342, DOI 10.1542/peds.2009-2092	46	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0172953	10.1371/journal.pone.0172953	http://dx.doi.org/10.1371/journal.pone.0172953			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267794	Green Submitted, gold, Green Published			2022-12-27	WOS:000396060600006
J	Antunes, ACL; Jensen, D; Halasa, T; Toft, N				Antunes, Ana Carolina Lopes; Jensen, Dan; Halasa, Tariq; Toft, Nils			A simulation study to evaluate the performance of five statistical monitoring methods when applied to different time-series components in the context of control programs for endemic diseases	PLOS ONE			English	Article							SYNDROMIC SURVEILLANCE; ALGORITHMS; CATTLE	Disease monitoring and surveillance play a crucial role in control and eradication programs, as it is important to track implemented strategies in order to reduce and/or eliminate a specific disease. The objectives of this study were to assess the performance of different statistical monitoring methods for endemic disease control program scenarios, and to explore what impact of variation (noise) in the data had on the performance of these monitoring methods. We simulated 16 different scenarios of changes in weekly sero-prevalence. The changes included different combinations of increases, decreases and constant sero-prevalence levels (referred as events). Two space-state models were used to model the time series, and different statistical monitoring methods (such as univariate process control algorithms-Shewart Control Chart, Tabular Cumulative Sums, and the V-mask-and monitoring of the trend component-based on 99% confidence intervals and the trend sign) were tested. Performance was evaluated based on the number of iterations in which an alarm was raised for a given week after the changes were introduced. Results revealed that the Shewhart Control Chart was better at detecting increases over decreases in sero-prevalence, whereas the opposite was observed for the Tabular Cumulative Sums. The trend-based methods detected the first event well, but performance was poorer when adapting to several consecutive events. The V-Mask method seemed to perform most consistently, and the impact of noise in the baseline was greater for the Shewhart Control Chart and Tabular Cumulative Sums than for the V-Mask and trend-based methods. The performance of the different statistical monitoring methods varied when monitoring increases and decreases in disease sero-prevalence. Combining two of more methods might improve the potential scope of surveillance systems, allowing them to fulfill different objectives due to their complementary advantages.	[Antunes, Ana Carolina Lopes; Halasa, Tariq; Toft, Nils] Natl Vet Inst DTU, Div Diagnost & Sci Advice Epidemiol, Bulowsvej 27, Frederiksberg C, Denmark; [Jensen, Dan] Dept Large Anim Sci KU, Sect Prod & Hlth, Gronnegardsvej 8, Frederiksberg C, Denmark	Technical University of Denmark	Antunes, ACL (corresponding author), Natl Vet Inst DTU, Div Diagnost & Sci Advice Epidemiol, Bulowsvej 27, Frederiksberg C, Denmark.	aclan@vet.dtu.dk	Jensen, Dan/M-1714-2019	Jensen, Dan/0000-0002-9437-0605; Halasa, Tariq/0000-0003-1112-0254; Lopes-Antunes, Ana-Carolina/0000-0001-8142-8241	Danish Food and Agriculture Administration	Danish Food and Agriculture Administration	The authors would like to thank the Pig Research Centre - SEGES for providing part of the data used in this study, and the Danish Food and Agriculture Administration for funding the project.	[Anonymous], 2014, R LANG ENV STAT COMP; Antunes ACL, 2016, PREV VET MED, V127, P15, DOI 10.1016/j.prevetmed.2016.03.005; Buckeridge David L, 2005, MMWR Suppl, V54, P109; Cao PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092945; Carslake D, 2011, PHILOS T R SOC B, V366, P1975, DOI 10.1098/rstb.2010.0396; Christensen J., 2003, Animal disease surveillance and survey systems: methods and applications, P15, DOI 10.1002/9780470344866.ch2; Cornou C, 2008, LIVEST SCI, V118, P262, DOI 10.1016/j.livsci.2008.02.004; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; Doherr MG, 2001, PHILOS T R SOC B, V356, P1097, DOI 10.1098/rstb.2001.0898; Dorea FC, 2014, PREV VET MED, V116, P313, DOI 10.1016/j.prevetmed.2014.04.001; Dorea FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057334; Dorea FC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0114; Dupuy C, 2015, EPIDEMIOL INFECT, V143, P2559, DOI 10.1017/S0950268814003495; Elbert Y, 2009, STAT MED, V28, P3226, DOI 10.1002/sim.3708; Jensen D.B., 2015, 7 EUR C PREC LIV FAR, P503; Kristensen AR, 2010, ADV TOPICS STAT HERD, P331; Kvisgaard L, 2011, PRRSV OUTBREAK HIGH, P60; Lombardo Joseph S, 2004, MMWR Suppl, V53, P159; Madsen TN, 2005, COMPUT ELECTRON AGR, V48, P138, DOI 10.1016/j.compag.2005.02.014; Montgomery D.C., 2011, INTRO STAT QUALITY C, V6th; Ostersen T, 2010, COMPUT ELECTRON AGR, V74, P51, DOI 10.1016/j.compag.2010.06.003; Reddy TA, 2011, APPLIED DATA ANALYSIS AND MODELING FOR ENERGY ENGINEERS AND SCIENTISTS, P1, DOI 10.1007/978-1-4419-9613-8; Reis BY, 2003, P NATL ACAD SCI USA, V100, P1961, DOI 10.1073/pnas.0335026100; Rodriguez-Prieto V, 2014, EPIDEMIOL INFECT, V143, P1; Salman MD., 2003, SURVEILLANCE MONITOR, P3; SMITH AFM, 1983, BIOMETRICS, V39, P867, DOI 10.2307/2531322; THYSEN I, 1993, ACTA AGR SCAND A-AN, V43, P58, DOI 10.1080/09064709309410145; Wagner MM, 2006, HDB BIOSURVEILLANCE, P217; West M, 1997, BIOMETRIKA, V84, P489, DOI 10.1093/biomet/84.2.489; West M., 2006, BAYESIAN FORECASTING; Yahav I, 2007, LECT NOTES COMPUT SC, V4506, P91	32	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173099	10.1371/journal.pone.0173099	http://dx.doi.org/10.1371/journal.pone.0173099			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264002	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300038
J	Bhattarai, A; Pant, ND; Nepal, K; Adhikari, S; Sharma, M; Parajuli, P				Bhattarai, Anupama; Pant, Narayan Dutt; Nepal, Krishus; Adhikari, Sailaja; Sharma, Mukunda; Parajuli, Pramila			Anti Japanese encephalitis virus IgM positivity among patients with acute encephalitic syndrome admitted to different hospitals from all over Nepal	PLOS ONE			English	Article								The Japanese encephalitis virus (JEV) infection is one of the major public health problems in Nepal because of its increasing disease morbidity and mortality. The main purpose of this study was to determine the anti-JEV IgM positivity among acute encephalitis syndromic cases from all over Nepal. The present study was conducted at National Public Health Laboratory, Kathmandu, Nepal from April 2015 to October 2015. A total of 671 (418 CSF and 253 serum) samples were collected from 625 patients with acute encephalitic syndrome, admitted to different hospitals from all over Nepal. IgM antibody capture enzyme linked immunosorbent assay (ELISA) was used for the detection of anti-JEV IgM positive cases. The rate of anti-JEV IgM positivity was found to be 21.12%. The majority of positive cases (50%) were from the age group below 15 years, with the highest numbers of cases occurring in September (55.30%). Among all the anti-JEV IgM positive cases, higher numbers of cases were males. Geographically, the highest numbers of anti-JEV IgM positive cases were recorded from Terai region. Similarly, largest numbers of anti-JEV IgM positive cases were reported from Kailai district followed by those from Kanchanpur. However, anti-JEV IgM positive cases were also reported from hill districts. Continuation of active surveillance and vector control measures, proper management of diagnostic facilities and expanded program of immunization in JE endemic areas should be strongly emphasized to reduce the endemicity of the disease.	[Bhattarai, Anupama; Parajuli, Pramila] St Xaviers Coll, Dept Microbiol, Kathmandu, Nepal; [Pant, Narayan Dutt] Grande Int Hosp, Dept Microbiol, Kathmandu, Nepal; [Nepal, Krishus] GoldenGate Int Coll, Dept Microbiol, Kathmandu, Nepal; [Adhikari, Sailaja; Sharma, Mukunda] Natl Publ Hlth Lab, Kathmandu, Nepal		Pant, ND (corresponding author), Grande Int Hosp, Dept Microbiol, Kathmandu, Nepal.	ndpant1987@gmail.com						[Anonymous], 2010, WEEKLY EPIDEMIOLOGIC; Batchelor Patricia, 2015, Trop Dis Travel Med Vaccines, V1, P11, DOI 10.1186/s40794-015-0013-6; Bista M B, 2005, JNMA J Nepal Med Assoc, V44, P51; Brahma B, 2015, J EVIDENCE BASED MED, V2, P8637; EDCD, 2005, ANN REP 2002 2003; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Halstead SB, 2010, CLIN INFECT DIS, V50, P1155, DOI 10.1086/651271; Kakoti G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/152656; National Immunization Program Reaching Every Child, 2011, COMPR MULT PLAN 2063; Pandey B, 2003, EPIDEMIOL INFECT, V131, P881, DOI 10.1017/S0950268803008835; Pant S. D., 2009, Journal of Nepal Paediatric Society, V29, P35, DOI 10.3126/jnps.v29i1.1600; Partridge J, 2007, AM J TROP MED HYG, V77, P1146, DOI 10.4269/ajtmh.2007.77.1146; Priyanka Srivastava, 2014, Epidemiology: Open Access, V4, P161; Ram ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099999; Tiwari S, 2012, BRAZ J INFECT DIS, V16, P564, DOI 10.1016/j.bjid.2012.10.004	15	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173434	10.1371/journal.pone.0173434	http://dx.doi.org/10.1371/journal.pone.0173434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264024	Green Submitted, Green Published, gold			2022-12-27	WOS:000396054300065
J	Euesden, J; Danese, A; Lewis, CM; Maughan, B				Euesden, Jack; Danese, Andrea; Lewis, Cathryn M.; Maughan, Barbara			A bidirectional relationship between depression and the autoimmune disorders - New perspectives from the National Child Development Study	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; MENTAL-DISORDERS; RISK-FACTORS; INFLAMMATION; DISEASES; EPIDEMIOLOGY; SCHIZOPHRENIA; SMOKING; ANXIETY; STRESS	Background Depression and the autoimmune disorders are comorbid-the two classes of disorders overlap in the same individuals at a higher frequency than chance. The immune system may influence the pathological processes underlying depression; understanding the origins of this comorbidity may contribute to dissecting the mechanisms underlying these disorders. Method We used population cohort data from the 1958 British birth cohort study (the National Child Development Study) to investigate the ages at onset of depression and 23 autoimmune disorders. We used self-report data to ascertain life-time history of depression, autoimmune disorders and their ages at onset. We modelled the effect of depression onset on subsequent autoimmune disorder onset, and vice versa, and incorporated polygenic risk scores for depression and autoimmune disorder risk. Results In our analytic sample of 8174 individuals, 315 reported ever being diagnosed with an autoimmune disorder (3.9%), 1499 reported ever experiencing depression (18.3%). There was significant comorbidity between depression and the autoimmune disorders (OR = 1.66, 95% CI = 1.27-2.15). Autoimmune disorder onset associated with increased subsequent hazard of depression onset (HR = 1.39, 95% CI = 1.11-1.74, P = 0.0037), independently of depression genetic risk. Finally, depression increased subsequent hazard of autoimmune disorder onset (HR = 1.40, 95% CI = 1.09-1.80, P = 0.0095), independently of autoimmune disorder genetic risk. Discussion Our results point to a bidirectional relationship between depression and the autoimmune disorders. This suggests that shared risk factors may contribute to this relationship, including both common environmental exposures that increase baseline inflammation levels, and shared genetic factors.	[Euesden, Jack; Danese, Andrea; Lewis, Cathryn M.; Maughan, Barbara] Kings Coll London, MRC, SGDP Ctr, Inst Psychiat Psychol & Neurosci, London, England; [Euesden, Jack] Univ Bristol, Integrat Epidemiol Unit, Bristol, Avon, England; [Danese, Andrea] Kings Coll London, Dept Child & Adolescent Psychiat, Inst Psychiat Psychol & Neurosci, London, England; [Lewis, Cathryn M.] Kings Coll London, Div Genet & Mol Med, London, England	University of London; King's College London; University of Bristol; University of London; King's College London; University of London; King's College London	Euesden, J (corresponding author), Kings Coll London, MRC, SGDP Ctr, Inst Psychiat Psychol & Neurosci, London, England.	jack.euesden@kcl.ac.uk	Danese, Andrea/ABF-1471-2020; Lewis, Cathryn/A-5225-2010	Danese, Andrea/0000-0001-8718-5412; Euesden, Jack/0000-0002-6790-1925; Maughan, Barbara/0000-0002-8887-3484; Lewis, Cathryn/0000-0002-8249-8476	Medical Research Council; Wellcome Trust [076113, 085475, 090355]; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre, South London and the Maudsley NHS Foundation Trust; King's College London; MRC [G1001799, MR/N01104X/1, MR/N01104X/2] Funding Source: UKRI; Medical Research Council [MR/N01104X/2, 1242800, MR/N01104X/1, G1001799] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre, South London and the Maudsley NHS Foundation Trust; King's College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council PhD Studentship to JE. Funding for the project was provided by the Wellcome Trust Agreement under award 076113, 085475 and 090355. This study was also supported by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre, South London and the Maudsley NHS Foundation Trust and King's College London.	Andersson NW, 2015, PSYCHOL MED, V45, P3559, DOI 10.1017/S0033291715001488; BEISER M, 1993, AM J PSYCHIAT, V150, P1349; Benros ME, 2011, AM J PSYCHIAT, V168, P1303, DOI 10.1176/appi.ajp.2011.11030516; Bjorngaard JH, 2013, PSYCHOL MED, V43, P711, DOI 10.1017/S0033291712001274; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; BURKE KC, 1990, ARCH GEN PSYCHIAT, V47, P511; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Danese A, 2011, MOL PSYCHIATR, V16, P244, DOI 10.1038/mp.2010.5; Danese A, 2008, ARCH GEN PSYCHIAT, V65, P409, DOI 10.1001/archpsyc.65.4.409; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Di Giuseppe D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4498; Dickens C, 2002, PSYCHOSOM MED, V64, P52, DOI 10.1097/00006842-200201000-00008; Dube SR, 2009, PSYCHOSOM MED, V71, P243, DOI 10.1097/PSY.0b013e3181907888; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Euesden JM, PSYCHOSOM M IN PRESS; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; HOLLAND PW, 1986, J AM STAT ASSOC, V81, P945, DOI 10.2307/2289064; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Kohler O, 2014, JAMA PSYCHIAT, V71, P1381, DOI 10.1001/jamapsychiatry.2014.1611; Kurina LM, 2001, J EPIDEMIOL COMMUN H, V55, P716, DOI 10.1136/jech.55.10.716; Lu MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep20647; Martin J, 2016, AM J EPIDEMIOL, V183, P1149, DOI 10.1093/aje/kww009; Matthews KA, 2010, BRAIN BEHAV IMMUN, V24, P96, DOI 10.1016/j.bbi.2009.08.005; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Moffitt TE, 2010, PSYCHOL MED, V40, P899, DOI 10.1017/S0033291709991036; Musselman DL, 2001, NEW ENGL J MED, V344, P961, DOI 10.1056/NEJM200103293441303; Nanni V, 2012, AM J PSYCHIAT, V169, P141, DOI 10.1176/appi.ajp.2011.11020335; Nissen HA, 1936, NEW ENGL J MED, V214, P576, DOI 10.1056/NEJM193603192141205; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Patten SB, 2003, NEUROLOGY, V61, P1524, DOI 10.1212/01.WNL.0000095964.34294.B4; Pedersen M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2022; Peyrot WJ, 2014, BRIT J PSYCHIAT, V205, P113, DOI 10.1192/bjp.bp.113.143081; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; R Development Core Team, 2008, R A LANGUAGE AND ENV; Raison Charles L, 2013, Cerebrum, V2013, P10; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Sheehy C, 2006, RHEUMATOLOGY, V45, P1325, DOI 10.1093/rheumatology/kel231; Smith DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075362; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Van de Velde S, 2010, SOC SCI MED, V71, P305, DOI 10.1016/j.socscimed.2010.03.035; WEISSMAN MM, 1977, ARCH GEN PSYCHIAT, V34, P98; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277	48	47	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							E0173015	10.1371/journal.pone.0173015	http://dx.doi.org/10.1371/journal.pone.0173015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5OE	28264010	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300033
J	Hayashi, K; Furuya, A; Sakamaki, Y; Akagi, T; Shinoda, Y; Sadakata, T; Hashikawa, T; Shimizu, K; Minami, H; Sano, Y; Nakayama, M; Furuichi, T				Hayashi, Kanehiro; Furuya, Asako; Sakamaki, Yuriko; Akagi, Takumi; Shinoda, Yo; Sadakata, Tetsushi; Hashikawa, Tsutomu; Shimizu, Kazuki; Minami, Haruka; Sano, Yoshitake; Nakayama, Manabu; Furuichi, Teiichi			The brain-specific RasGEF very-KIND is required for normal dendritic growth in cerebellar granule cells and proper motor coordination	PLOS ONE			English	Article							EXCHANGE FACTOR; MICE LACKING; C-LOBE; PROTEIN; CAPS2	Very-KIND/Kndc1/KIAA1768 (v-KIND) is a brain-specific Ras guanine nucleotide exchange factor carrying two sets of the kinase non-catalytic C-lobe domain (KIND), and is predominantly expressed in cerebellar granule cells. Here, we report the impact of v-KIND deficiency on dendritic and synaptic growth in cerebellar granule cells in v-KIND knockout (KO) mice. Furthermore, we evaluate motor function in these animals. The gross anatomy of the cerebellum, including the cerebellar lobules, layered cerebellar cortex and densely-packed granule cell layer, in KO mice appeared normal, and was similar to wild-type (WT) mice. However, KO mice displayed an overgrowth of cerebellar granule cell dendrites, compared with WT mice, resulting in an increased number of dendrites, dendritic branches and terminals. Immunoreactivity for vGluT2 (a marker for excitatory presynapses of mossy fiber terminals) was increased in the cerebellar glomeruli of KO mice, compared with WT mice. The postsynaptic density around the terminals of mossy fibers was also increased in KO mice. Although there were no significant differences in locomotor ability between KO and WT animals in their home cages or in the open field, young adult KO mice had an increased grip strength and a tendency to exhibit better motor performance in balance-related tests compared with WT animals. Taken together, our results suggest that v-KIND is required for compact dendritic growth and proper excitatory synaptic connections in cerebellar granule cells, which are necessary for normal motor coordination and balance.	[Hayashi, Kanehiro; Furuya, Asako; Shinoda, Yo; Sadakata, Tetsushi; Furuichi, Teiichi] RIKEN Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama, Japan; [Hayashi, Kanehiro] Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, Tokyo, Japan; [Furuya, Asako] RIKEN Brain Sci Inst, Lab Mental Biol, Wako, Saitama, Japan; [Sakamaki, Yuriko; Akagi, Takumi; Hashikawa, Tsutomu] RIKEN Brain Sci Inst, Res Resource Ctr, Wako, Saitama, Japan; [Sakamaki, Yuriko] Tokyo Med & Dent Univ, Res Ctr Med & Dent Sci, Bunkyo Ku, Tokyo, Japan; [Akagi, Takumi] Nippon Med Sch, Dept Physiol, Bunkyo Ku, Tokyo, Japan; [Shinoda, Yo] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo, Japan; [Sadakata, Tetsushi] Gunma Univ, Adv Sci Res Leaders Dev Unit, Maebashi, Gunma, Japan; [Shimizu, Kazuki; Minami, Haruka; Sano, Yoshitake; Furuichi, Teiichi] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba, Japan; [Nakayama, Manabu] Kazusa DNA Res Inst, Dev Technol Dept, Chromosome Engn Team, Kisarazu, Chiba, Japan	RIKEN; Keio University; RIKEN; RIKEN; Tokyo Medical & Dental University (TMDU); Nippon Medical School; Tokyo University of Pharmacy & Life Sciences; Gunma University; Tokyo University of Science; Kazusa DNA Research Institute	Furuichi, T (corresponding author), RIKEN Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama, Japan.; Furuichi, T (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba, Japan.	tfuruichi@rs.tus.ac.jp	Furuichi, Teiichi/B-5086-2014; Shinoda, Yo/H-3091-2019; Sadakata, Tetsushi/W-9324-2018	Furuichi, Teiichi/0000-0002-9676-1888; Shinoda, Yo/0000-0003-3253-2194; Sadakata, Tetsushi/0000-0003-0276-4162; Sano, Yoshitake/0000-0001-5188-3104	Japan Society for the Promotion of Science (KAKENHI) [20300134, 23300137, 26290026, 15K14356, 15K06745]; Hamaguchi Foundation for the Advancement of Biochemistry; Tokyo University of Science; Grants-in-Aid for Scientific Research [15K14356] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Tokyo University of Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants from the Japan Society for the Promotion of Science (KAKENHI 20300134, 23300137, 26290026, 15K14356, 15K06745), the Hamaguchi Foundation for the Advancement of Biochemistry, and Tokyo University of Science.	Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Ceccarelli M, 2015, DEV BIOL, V408, P109, DOI 10.1016/j.ydbio.2015.10.007; Ciccarelli FD, 2003, TRENDS BIOCHEM SCI, V28, P349, DOI 10.1016/S0968-0004(03)00116-6; Delvendahl I, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00093; Eccles JC, 1967, CEREBELLUM NEURONAL; Galliano E, 2013, CELL REP, V3, P1239, DOI 10.1016/j.celrep.2013.03.023; Gan WB, 2009, COLD SPRING HARB PRO, V4, P1; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Huang J, 2007, J CELL BIOL, V179, P539, DOI 10.1083/jcb.200702036; Huang JH, 2011, FEBS J, V278, P1651, DOI 10.1111/j.1742-4658.2011.08085.x; Ito M, 2000, BRAIN RES, V886, P237, DOI 10.1016/S0006-8993(00)03142-5; Ito M, 1997, INT REV NEUROBIOL, V41, P475, DOI 10.1016/S0074-7742(08)60366-9; Kadotani H, 1996, J NEUROSCI, V16, P7859; Ma QL, 2014, J NEUROSCI, V34, P7124, DOI 10.1523/JNEUROSCI.3439-13.2014; Mees A, 2005, GENE EXPR PATTERNS, V6, P79, DOI 10.1016/j.modgep.2005.04.015; Nakayama M, 2006, FASEB J, V20, P1718, DOI 10.1096/fj.06-5952fje; PALKOVIT.M, 1972, BRAIN RES, V45, P15, DOI 10.1016/0006-8993(72)90213-2; Ramon, 1909, HISTOLOGIE SYSTEME N; Rieff HI, 2006, EUR J NEUROSCI, V23, P2225, DOI 10.1111/j.1460-9568.2006.04727.x; Rylkova D, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0075-15.2015; Sadakata T, 2007, J CLIN INVEST, V117, P931, DOI 10.1172/JCI29031; Sadakata T, 2007, J NEUROSCI, V27, P2472, DOI 10.1523/JNEUROSCI.2279-06.2007; Shinoda Y, 2011, P NATL ACAD SCI USA, V108, P373, DOI 10.1073/pnas.1012220108; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1	24	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173175	10.1371/journal.pone.0173175	http://dx.doi.org/10.1371/journal.pone.0173175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264072	gold, Green Published, Green Submitted			2022-12-27	WOS:000396054300043
J	Helluy, X; Sauter, M; Ye, YX; Lykowsky, G; Kreutner, J; Yilmaz, A; Jahns, R; Boivin, V; Kandolf, R; Jakob, PM; Hiller, KH; Klingel, K				Helluy, Xavier; Sauter, Martina; Ye, Yu-Xiang; Lykowsky, Gunthard; Kreutner, Jakob; Yilmaz, Ali; Jahns, Roland; Boivin, Valerie; Kandolf, Reinhard; Jakob, Peter M.; Hiller, Karl-Heinz; Klingel, Karin			In vivo T2*weighted MRI visualizes cardiac lesions in murine models of acute and chronic viral myocarditis	PLOS ONE			English	Article							COXSACKIEVIRUS B3-INDUCED MYOCARDITIS; ADENINE-NUCLEOTIDE TRANSLOCATOR; RESONANCE; CARDIOMYOPATHY; SUSCEPTIBILITY; REPLICATION; EXPRESSION; INFARCTION; INFECTION; DIAGNOSIS	Objective Acute and chronic forms of myocarditis are mainly induced by virus infections. As a consequence of myocardial damage and inflammation dilated cardiomyopathy and chronic heart failure may develop. The gold standard for the diagnosis of myocarditis is endomyocardial biopsies which are required to determine the etiopathogenesis of cardiac inflammatory processes. However, new non-invasive MRI techniques hold great potential in visualizing cardiac non-ischemic inflammatory lesions at high spatial resolution, which could improve the investigation of the pathophysiology of viral myocarditis. Results Here we present the discovery of a novel endogenous T2* MRI contrast of myocardial lesions in murine models of acute and chronic CVB3 myocarditis. The evaluation of infected hearts ex vivo and in vivo by 3D T2w and T2*w MRI allowed direct localization of virus-induced myocardial lesions without any MRI tracer or contrast agent. T2* w weighted MRI is able to detect both small cardiac lesions of acute myocarditis and larger necrotic areas at later stages of chronic myocarditis, which was confirmed by spatial correlation of MRI hypointensity in myocardium with myocardial lesions histologically. Additional in vivo and ex vivo MRI analysis proved that the contrast mechanism was due to a strong paramagnetic tissue alteration in the vicinity of myocardial lesions, effectively pointing towards iron deposits as the primary contributor of contrast. The evaluation of the biological origin of the MR contrast by specific histological staining and transmission electron microscopy revealed that impaired iron metabolism primarily in mitochondria caused iron deposits within necrotic myocytes, which induces strong magnetic susceptibility in myocardial lesions and results in strong T2* contrast. Conclusion This T2*w MRI technique provides a fast and sensitive diagnostic tool to determine the patterns and the severity of acute and chronic enteroviral myocarditis and the precise localization of tissue damage free of MR contrast agents.	[Helluy, Xavier; Ye, Yu-Xiang] Univ Wurzburg, Inst Phys, Dept Expt Phys V, Wurzburg, Germany; [Sauter, Martina; Kandolf, Reinhard; Klingel, Karin] Univ Hosp Tuebingen, Inst Pathol & Neuropathol, Dept Mol Pathol, Tubingen, Germany; [Ye, Yu-Xiang] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Ye, Yu-Xiang] Harvard Med Sch, Boston, MA USA; [Lykowsky, Gunthard; Kreutner, Jakob; Jakob, Peter M.; Hiller, Karl-Heinz] Res Ctr Magnet Resonance Bavaria MRB, Wurzburg, Germany; [Yilmaz, Ali] Univ Hosp Munster, Dept Cardiol & Angiol, Munster, Germany; [Jahns, Roland] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Jahns, Roland] Univ Hosp Wurzburg, Interdisziplinary Bank Biomat & Data Ibdw, Wurzburg, Germany; [Boivin, Valerie] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany; [Hiller, Karl-Heinz] Fraunhofer Inst Integrated Circuits, Magnet Resonance & XRay Imaging Dept, Wurzburg, Germany	University of Wurzburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Wurzburg; University of Munster; University of Wurzburg; University of Wurzburg; University of Wurzburg; Fraunhofer Gesellschaft	Klingel, K (corresponding author), Univ Hosp Tuebingen, Inst Pathol & Neuropathol, Dept Mol Pathol, Tubingen, Germany.	Karin.Klingel@med.uni-tuebingen.de			German Federal Ministry of Education and Research [01EZ0818, 13EZ0817]; Deutsche Herzstiftung e.V.	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Herzstiftung e.V.	This work was financially supported by a grant from the German Federal Ministry of Education and Research (WN; grant-ID 01EZ0818 and 13EZ0817), and in part by the Deutsche Herzstiftung e.V. (Ye, Y-X).	Brunner S, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-43; Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Dorner A, 2000, J AM COLL CARDIOL, V35, P1778, DOI 10.1016/S0735-1097(00)00644-6; Ebermann L, 2012, LAB INVEST, V92, P125, DOI 10.1038/labinvest.2011.145; Grant SC, 2001, IEEE T MAGN, V37, P2989, DOI 10.1109/20.947051; Gruhle S, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0287-z; Jacoby C, 2014, MAGN RESON MATER PHY, V27, P101, DOI 10.1007/s10334-013-0391-6; Khan FA, 2007, INT J INFECT DIS, V11, P482, DOI 10.1016/j.ijid.2007.04.007; KLINGEL K, 1992, P NATL ACAD SCI USA, V89, P314, DOI 10.1073/pnas.89.1.314; Klingel K, 2014, IMAGE MONTH ASS IRON; Moon JC, 2007, REV ESP CARDIOL, V60, P1, DOI 10.1016/S0300-8932(07)74976-X; Pankuweit S, 2013, HEART FAIL REV, V18, P683, DOI 10.1007/s10741-012-9357-4; POSSE S, 1990, J MAGN RESON, V88, P473, DOI 10.1016/0022-2364(90)90282-E; Reichenbach JR, 2011, SUSCEPTIBILITY WEIGH, P1; Sagar S, 2012, LANCET, V379, P738, DOI 10.1016/S0140-6736(11)60648-X; Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854; Schulze K, 1999, CARDIOVASC RES, V44, P91, DOI 10.1016/S0008-6363(99)00204-7; Szalay G, 2009, CIRC RES, V104, P851, DOI 10.1161/CIRCRESAHA.109.193805; Thorek DLJ, 2006, ANN BIOMED ENG, V34, P23, DOI 10.1007/s10439-005-9002-7; Ursu ON, 2014, CELL PHYSIOL BIOCHEM, V33, P52, DOI 10.1159/000356649; Weinstein JS, 2010, J CEREBR BLOOD F MET, V30, P15, DOI 10.1038/jcbfm.2009.192; Ye Y, 2012, CIRCULATION; Ye YX, 2013, CIRCULATION, V128, P1878, DOI 10.1161/CIRCULATIONAHA.113.000731; Yilmaz A, 2013, EUR HEART J, V34, P462, DOI 10.1093/eurheartj/ehs366	25	7	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172084	10.1371/journal.pone.0172084	http://dx.doi.org/10.1371/journal.pone.0172084			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264039	Green Submitted, Green Published, gold			2022-12-27	WOS:000396054300007
J	Lennerz, C; Vrazic, H; Haller, B; Braun, S; Petzold, T; Ott, I; Lennerz, A; Michel, J; Blazek, P; Deisenhofer, I; Whittaker, P; Kolb, C				Lennerz, Carsten; Vrazic, Hrvoje; Haller, Bernhard; Braun, Siegmund; Petzold, Tobias; Ott, Ilka; Lennerz, Agnes; Michel, Jonathan; Blazek, Patrick; Deisenhofer, Isabel; Whittaker, Peter; Kolb, Christof			Biomarker-based diagnosis of pacemaker and implantable cardioverter defibrillator pocket infections: A prospective, multicentre, case control evaluation	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ELECTRONIC DEVICE INFECTIONS; CARDIAC RESYNCHRONIZATION THERAPY; RISK-FACTORS; PERMANENT PACEMAKER; BINDING-PROTEIN; PROCALCITONIN; MANAGEMENT; PREVENTION; MORTALITY	Background The use of cardiac implantable electronic devices (CIED) has risen steadily, yet the rate of cardiac device infections (CDI) has disproportionately increased. Amongst all cardiac device infections, the pocket infection is the most challenging diagnosis. Therefore, we aimed to improve diagnosis of such pocket infection by identifying relevant biomarkers. Methods We enrolled 25 consecutive patients with invasively and microbiologically confirmed pocket infection. None of the patients had any confounding conditions. Pre-operative levels of 14 biomarkers were compared in infected and control (n = 50) patients. Our selected biomarkers included white blood cell count (WBC), C-reactive protein (CRP), procalcitonin (PCT), lipopolysaccharide binding protein, high-sensitivity C-reactive protein (HS-CRP), polymorphonuclear-elastase, presepsin, various interleukins, tumor necrosis factor a (TNF-a), and granulocyte macrophage colony-stimulating factor (GM-CSF). Results Of the 25 patients with isolated pocket infection (70 13years, 76% male, 40% ICDs), none presented with leukocytosis. In contrast, they had higher serum levels of HS-CRP (p = 0.019) and PCT (p = 0.010) than control patients. Median PCT-level was 0.06 ng/mL (IQR 0.03-0.07 ng/mL) in the study group versus 0.03 ng/mL (IQR 0.02-0.04 ng/mL) in controls. An optimized PCT cut-off value of 0.05 ng/mL suggests pocket infection with a sensitivity of 60% and specificity of 82%. In addition TNF-alpha- and GM-CSF-levels were lower in the study group. Other biomarkers did not differ between groups. Conclusion Diagnosis of isolated pocket infections requires clinical awareness, physical examination, evaluation of blood cultures and echocardiography assessment. Nevertheless, measurement of PCT- and HS-CRP-levels can aid diagnosis. However, no conclusion can be drawn from normal WBC-values.	[Lennerz, Carsten; Lennerz, Agnes; Blazek, Patrick; Deisenhofer, Isabel; Kolb, Christof] Tech Univ Munich, Deutsch Herzzentrum Munchen, Abt Elektrophysiol, Klin Herz & Kreislauferkrankungen, Munich, Germany; [Vrazic, Hrvoje] Univ Zagreb, Univ Hosp Dubrava, Sch Med, Dept Internal Med,Div Cardiol, Zagreb, Croatia; [Haller, Bernhard] Tech Univ Munich, Klinikum Rechts Isar, Inst Med Stat & Epidemiol, Munich, Germany; [Braun, Siegmund] Tech Univ Munich, Fac Med, Deutsch Herzzentrum Munchen, Inst Lab Med, Munich, Germany; [Petzold, Tobias] Klinikum Univ Munchen, Med Klin & Poliklin 1, Munich, Germany; [Michel, Jonathan] Tech Univ Munich, Deutsch Herzzentrum Munchen, Klin Herz & Kreislauferkrankungen, Munich, Germany; [Whittaker, Peter] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI USA; [Whittaker, Peter] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA	German Heart Centre Munich; Technical University of Munich; University of Zagreb; Technical University of Munich; German Heart Centre Munich; Technical University of Munich; University of Munich; German Heart Centre Munich; Technical University of Munich; Wayne State University; Wayne State University	Lennerz, C (corresponding author), Tech Univ Munich, Deutsch Herzzentrum Munchen, Abt Elektrophysiol, Klin Herz & Kreislauferkrankungen, Munich, Germany.	Lennerz@dhm.mhn.de	Haller, Bernhard/I-1943-2019; Whittaker, Peter/F-1234-2011	Haller, Bernhard/0000-0002-9723-393X; Whittaker, Peter/0000-0002-5627-2166; Deisenhofer, Isabel/0000-0001-5826-6846; Lennerz, Carsten/0000-0002-1693-6474; Blazek, Patrick/0000-0002-3335-8645	Biotronik GmbH	Biotronik GmbH	The German Heart Centre received an unearmarked grant of 10,000 EUR by Biotronik GmbH to support research activities in the broad field of cardiac rhythm management and cardiac devices. The funder had no role in selection of the research topic, study design, datacollection and analysis, decision to publish, or preparation of the manuscript. This research grant was used to purchase the required reagent kits for processing the blood samples and analysing the biomarkers.	Al-Nawas B, 1996, Eur J Med Res, V1, P331; Baddour LM, 2012, NEW ENGL J MED, V367, P842, DOI 10.1056/NEJMcp1107675; Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Birnie DH, 2013, NEW ENGL J MED, V368, P2084, DOI 10.1056/NEJMoa1302946; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Cabell CH, 2004, AM HEART J, V147, P582, DOI 10.1016/j.ahj.2003.06.005; Chamis AL, 2001, CIRCULATION, V104, P1029, DOI 10.1161/hc3401.095097; Christ-Crain M, 2005, SWISS MED WKLY, V135, P451; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; ENDO S, 1995, J INFLAMM, V45, P136; Fjell CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079207; Greenspon AJ, 2011, J AM COLL CARDIOL, V58, P1001, DOI 10.1016/j.jacc.2011.04.033; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Hogevik H, 1997, INFECTION, V25, P82, DOI 10.1007/BF02113580; Hohn A, 2015, INFECTION, V43, P405, DOI [10.1007/s15010-014-0718-x, 10.1007/]; Johansen JB, 2011, EUR HEART J, V32, P991, DOI 10.1093/eurheartj/ehq497; KERN WV, 1993, INFECT IMMUN, V61, P5413, DOI 10.1128/IAI.61.12.5413-5416.1993; Kirkfeldt RE, 2014, EUR HEART J, V35, P1186, DOI 10.1093/eurheartj/eht511; Klug D, 2004, HEART, V90, P882, DOI 10.1136/hrt.2003.010595; Klug D, 2007, CIRCULATION, V116, P1349, DOI 10.1161/CIRCULATIONAHA.106.678664; Knudsen JB, 2010, AM J MED, V123, P1121, DOI 10.1016/j.amjmed.2010.07.018; Le KY, 2011, HEART RHYTHM, V8, P1678, DOI 10.1016/j.hrthm.2011.05.015; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Li ZG, 2015, PATHOGENS, V4, P793, DOI 10.3390/pathogens4040793; Lindstrom ST, 2014, INTERN MED J, V44, P390, DOI 10.1111/imj.12374; Margey R, 2010, EUROPACE, V12, P64, DOI 10.1093/europace/eup362; Mierzchala M, 2011, CLIN BIOCHEM, V44, P357, DOI 10.1016/j.clinbiochem.2011.01.012; Mittal S, 2014, HEART RHYTHM, V11, P595, DOI 10.1016/j.hrthm.2013.12.013; Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Mueller C, 2004, CIRCULATION, V109, P1707, DOI 10.1161/01.CIR.0000126281.52345.52; Mulpuru SK, 2013, CIRCULATION, V128, P1031, DOI 10.1161/CIRCULATIONAHA.113.000763; Myerburg RJ, 2008, NEW ENGL J MED, V359, P2245, DOI 10.1056/NEJMra0803409; Nielsen JC, 2015, EUR HEART J, V36, P2484, DOI 10.1093/eurheartj/ehv060; Nof E, 2013, EUR HEART J, V34, P229, DOI 10.1093/eurheartj/ehs352; O'Dwyer MJ, 2008, INTENS CARE MED, V34, P683, DOI 10.1007/s00134-007-0968-5; Ohlow MA, 2012, INT J CARDIOL, V159, P177, DOI 10.1016/j.ijcard.2011.02.042; Prutkin JM, 2014, CIRCULATION, V130, P1037, DOI 10.1161/CIRCULATIONAHA.114.009081; Rawczynska-Englert I, 2000, J HEART VALVE DIS, V9, P705; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Romeyer-Bouchard C, 2010, EUR HEART J, V31, P203, DOI 10.1093/eurheartj/ehp421; Sandoe JAT, 2015, J ANTIMICROB CHEMOTH, V70, P325, DOI 10.1093/jac/dku383; Sarrazin JF, 2012, J AM COLL CARDIOL, V59, P1616, DOI 10.1016/j.jacc.2011.11.059; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Sohail MR, 2007, J AM COLL CARDIOL, V49, P1851, DOI 10.1016/j.jacc.2007.01.072; Sohail MR, 2011, ARCH INTERN MED, V171, P1821, DOI 10.1001/archinternmed.2011.441; Tarakji KG, 2014, EUROPACE, V16, P1490, DOI 10.1093/europace/euu147; Tarakji KG, 2010, HEART RHYTHM, V7, P1043, DOI 10.1016/j.hrthm.2010.05.016; Tompkins C, 2013, AM J CARDIOL, V111, P1608, DOI 10.1016/j.amjcard.2013.01.334; Uslan DZ, 2007, ARCH INTERN MED, V167, P669, DOI 10.1001/archinte.167.7.669; Viola GM, 2010, CIRCULATION, V121, P2085, DOI 10.1161/CIRCULATIONAHA.110.936708; Voigt A, 2006, J AM COLL CARDIOL, V48, P590, DOI 10.1016/j.jacc.2006.05.016; Vollmer T, 2009, CLIN CHEM, V55, P295, DOI 10.1373/clinchem.2008.106195; Watkin RW, 2007, J INFECTION, V55, P220, DOI 10.1016/j.jinf.2007.05.174; Wilkoff BL, 2009, HEART RHYTHM, V6, P1085, DOI 10.1016/j.hrthm.2009.05.020; Zhang X, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1032-4	57	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172384	10.1371/journal.pone.0172384	http://dx.doi.org/10.1371/journal.pone.0172384			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264059	gold, Green Published, Green Submitted			2022-12-27	WOS:000396054300011
J	Fernandez-Garcia, JC; Alcaide, J; Santiago-Fernandez, C; Roca-Rodriguez, MM; Aguera, Z; Banos, R; Botella, C; de la Torre, R; Fernandez-Real, JM; Fruhbeck, G; Gomez-Ambrosi, J; Jimenez-Murcia, S; Menchon, JM; Casanueva, FF; Fernandez-Aranda, F; Tinahones, FJ; Garrido-Sanchez, L				Fernandez-Garcia, Jose Carlos; Alcaide, Juan; Santiago-Fernandez, Concepcion; Roca-Rodriguez, M. M.; Aguera, Zaida; Banos, Rosa; Botella, Cristina; de la Torre, Rafael; Fernandez-Real, Jose M.; Fruhbeck, Gema; Gomez-Ambrosi, Javier; Jimenez-Murcia, Susana; Menchon, Jose M.; Casanueva, Felipe F.; Fernandez-Aranda, Fernando; Tinahones, Francisco J.; Garrido-Sanchez, Lourdes			An increase in visceral fat is associated with a decrease in the taste and olfactory capacity (vol 12, e0171204, 2017)	PLOS ONE			English	Correction													AGÜERA, ZAIDA/K-9771-2014; JIMENEZ-MURCIA, SUSANA/L-9786-2014; BAÑOS, ROSA MARIA/C-6077-2011; Fernández-Real, Jose Manuel/AGH-3599-2022; Fernandez-Aranda, Fernando/L-9762-2014; Fernandez-Garcia, Jose Carlos/B-5312-2013; Tinahones, Francisco José/AAB-2882-2020; Botella, Cristina/F-9230-2010; de la Torre, Rafael/D-3561-2018; Menchon, Jose/A-5242-2009	AGÜERA, ZAIDA/0000-0003-4453-4939; JIMENEZ-MURCIA, SUSANA/0000-0002-3596-8033; BAÑOS, ROSA MARIA/0000-0003-0626-7665; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Fernandez-Aranda, Fernando/0000-0002-2968-9898; Fernandez-Garcia, Jose Carlos/0000-0003-2229-8488; Botella, Cristina/0000-0001-8783-6959; de la Torre, Rafael/0000-0002-6765-1866; Santiago Fernandez, Conchi/0000-0003-4439-6863; Menchon, Jose/0000-0002-6231-6524	Instituto de Salud Carlos III [FIS PI15/01114]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This study was supported by the project Instituto de Salud Carlos III (FIS PI15/01114).	Fernandez-Garcia JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171204	1	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173588	10.1371/journal.pone.0173588	http://dx.doi.org/10.1371/journal.pone.0173588			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257495	gold, Green Published, Green Submitted			2022-12-27	WOS:000396021100097
J	Sato, T; Sugawara, J; Aizawa, N; Iwama, N; Takahashi, F; Nakamura-Kurakata, M; Saito, M; Sugiyama, T; Kunikata, H; Nakazawa, T; Yaegashi, N				Sato, Takahiro; Sugawara, Junichi; Aizawa, Naoko; Iwama, Noriyuki; Takahashi, Fumiaki; Nakamura-Kurakata, Michiyo; Saito, Masatoshi; Sugiyama, Takashi; Kunikata, Hiroshi; Nakazawa, Toru; Yaegashi, Nobuo			Longitudinal changes of ocular blood flow using laser speckle flowgraphy during normal pregnancy	PLOS ONE			English	Article							RETINAL MICROVASCULAR CALIBER; OPHTHALMIC ARTERY DOPPLER; PREECLAMPSIA; CIRCULATION; VELOCIMETRY; PRESSURE; VELOCITY; WOMEN	Purpose Innovative laser speckle flowgraphy (LSFG) enables noninvasive evaluation of retinal microcirculation and the usefulness has been reported in the field of ophthalmology. LSFG has allowed us to measure the real time changes of retinal blood flow without pupillary dilatations and contrast media. Herein, we investigated the change of retinal blood flow in normal pregnant women during gestation using LSFG. Methods A prospective cohort study was conducted in 53 pregnant women who visited our institution between January, 2013 and July, 2014. Finally, a total of 41 participants without any obstetric complications were available for evaluation. Retinal blood flow was measured with LSFG in a total of 4 times during pregnancy (T1. 11-13 weeks, T2. 19-21 weeks, T3. 28-30 weeks, T4. 34-36 weeks) and mean blur rate (MBR), blowout score (BOS), flow acceleration index (FAI), and resistive index (RI) are analyzed from these measurements. Relations between LSFG parameters and mean arterial blood pressure (MAP) are determined throughout pregnancy. Results MBR showed no significant changes throughout pregnancy. BOS showed a tendency to increase in the 3rd trimester. FAI values showed a slight increase from the 1st to 2nd trimester while a significant decrease was noted in the 3rd trimester. RI exhibited no changes between the 1st and 2nd trimesters, values decreased significantly after the 3rd trimester. MAP was positively correlated with BOS, and negatively correlated with FAI and RI. Conclusion The present study clearly demonstrated that profiles of LSFG parameters demonstrated a decrease of resistance in retinal blood vessels. These changes in indices provide a highly sensitive reflection of physiological changes in vascular resistance due to pregnancy. Thus, LSFG may be useful, as a non-invasive, diagnostic tool to detect pregnancy related disorders such as preeclampsia.	[Sato, Takahiro; Sugawara, Junichi; Iwama, Noriyuki; Takahashi, Fumiaki; Nakamura-Kurakata, Michiyo; Saito, Masatoshi; Yaegashi, Nobuo] Tohoku Univ, Dept Obstet & Gynecol, Grad Sch Med, Sendai, Miyagi, Japan; [Sugawara, Junichi] Tohoku Univ, Tohoku Med Megabank Org, Div Fetomaternal Med Sci, Sendai, Miyagi, Japan; [Aizawa, Naoko; Kunikata, Hiroshi; Nakazawa, Toru] Tohoku Univ, Dept Ophthalmol, Grad Sch Med, Sendai, Miyagi, Japan; [Sugiyama, Takashi] Ehime Univ, Grad Sch Med, Dept Obstet & Gynecol, Matsuyama, Ehime, Japan	Tohoku University; Tohoku University; Tohoku University; Ehime University	Sugawara, J (corresponding author), Tohoku Univ, Dept Obstet & Gynecol, Grad Sch Med, Sendai, Miyagi, Japan.; Sugawara, J (corresponding author), Tohoku Univ, Tohoku Med Megabank Org, Div Fetomaternal Med Sci, Sendai, Miyagi, Japan.	jsugawara@med.tohoku.ac.jp	Sugawara, Junichi/O-2190-2013	Iwama, Noriyuki/0000-0002-6808-0911; Sugiyama, Takashi/0000-0002-3715-0075	JST grant from JSPS KAKENHI [26861306]; Grants-in-Aid for Scientific Research [26861306] Funding Source: KAKEN	JST grant from JSPS KAKENHI; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a JST grant from JSPS KAKENHI Grants-in-Aid for Scientific Research (B) (M.K. 26861306). The funder had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Aizawa N, 2011, CLIN OPHTHALMOL, V5, P1171, DOI 10.2147/OPTH.S22093; Alm A., 1992, ADLERS PHYSL EYE, P198; Belfort MA, 1999, AM J OBSTET GYNECOL, V180, P601, DOI 10.1016/S0002-9378(99)70261-9; Correa-Silva EP, 2012, INT J GYNECOL OBSTET, V117, P251, DOI 10.1016/j.ijgo.2012.01.012; Diniz ALD, 2008, INT J GYNECOL OBSTET, V100, P216, DOI 10.1016/j.ijgo.2007.07.013; Duvekot J J, 1994, Obstet Gynecol Surv, V49, pS1, DOI 10.1097/00006254-199412011-00001; FUJII H, 1994, MED BIOL ENG COMPUT, V32, P302, DOI 10.1007/BF02512526; Hata T, 1997, AM J OBSTET GYNECOL, V177, P174, DOI 10.1016/S0002-9378(97)70458-7; Isono H, 2003, ARCH OPHTHALMOL-CHIC, V121, P225; Konishi N, 2002, OPT REV, V9, P163, DOI 10.1007/s10043-002-0163-4; KYLE PM, 1993, BRIT J OBSTET GYNAEC, V100, P85, DOI 10.1111/j.1471-0528.1993.tb12957.x; Liu LX, 2014, CARDIOVASC RES, V101, P545, DOI 10.1093/cvr/cvu009; Lupton SJ, 2013, HYPERTENSION, V62, P899, DOI 10.1161/HYPERTENSIONAHA.113.01890; Lupton SJ, 2013, HYPERTENSION, V61, P880, DOI 10.1161/HYPERTENSIONAHA.111.00698; Mahendru AA, 2014, J HYPERTENS, V32, P849, DOI 10.1097/HJH.0000000000000090; Matias DS, 2012, J CLIN ULTRASOUND, V40, P576, DOI 10.1002/jcu.21949; Nitta F, 2014, CLIN OPHTHALMOL, V8, P1119, DOI 10.2147/OPTH.S62022; Riskin-Mashiah S, 2002, AM J OBSTET GYNECOL, V187, P1667, DOI 10.1067/mob.2002.127594; Takata M, 2002, OBSTET GYNECOL, V100, P931, DOI 10.1016/S0029-7844(02)02244-5; TAMAKI Y, 1995, EXP EYE RES, V60, P373, DOI 10.1016/S0014-4835(05)80094-6; Tsuda S, 2014, CURR EYE RES, V39, P1207, DOI 10.3109/02713683.2014.905608; Williams KP, 2004, ULTRASOUND OBST GYN, V23, P254, DOI 10.1002/uog.955	22	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173127	10.1371/journal.pone.0173127	http://dx.doi.org/10.1371/journal.pone.0173127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257508	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100061
J	Wu, L; Lei, YP; Lan, SB; Hu, CX				Wu, Li; Lei, Yaping; Lan, Shubin; Hu, Chunxiang			Photosynthetic recovery and acclimation to excess light intensity in the rehydrated lichen soil crusts	PLOS ONE			English	Article							THERMAL-ENERGY DISSIPATION; PHOTOSYSTEM-II; CO2 EXCHANGE; WATER RELATIONS; CHLOROPHYLL FLUORESCENCE; SUCCESSIONAL STAGES; REACTION CENTERS; CYANOBACTERIUM; DESERT; ACTIVATION	As an important successional stage and main type of biological soil crusts (BSCs) in Shapotou region of China (southeastern edge of Tengger Desert), lichen soil crusts (LSCs) often suffer from many stresses, such as desiccation and excess light intensity. In this study, the chlorophyll fluorescence and CO2 exchange in the rehydrated LSCs were detected under a series of photosynthetically active radiation (PAR) gradients to study the photosynthetic acclimation of LSCs. The results showed that although desiccation leaded to the loss of photosynthetic activity in LSCs, the fluorescence parameters including Fo, Fv and Fv/Fm of LSCs could be well recovered after rehydration. After the recovery of photosynthetic activity, the effective photosynthetic efficiency phi(PSII) detected by Imaging PAM had declined to nearly 0 within both the lichen thallus upper and lower layers when the PAR increased to 200 mu E m(-2) s(-1), however the net photosynthesis detected by the CO2 gas analyzer in the LSCs still appeared when the PAR increased to 1000 mu E m(-2) s(-1). Our results indicate that LSCs acclimating to high PAR, on the one hand is ascribed to the special structure in crust lichens, making the incident light into the lichen thallus be weakened; on the other hand the massive accumulation of photosynthetic pigments in LSCs also provides a protective barrier for the photosynthetic organisms against radiation damage. Furthermore, the excessive light energy absorbed by crust lichens is also possibly dissipated by the increasing non-photochemical quenching, therefore to some extent providing some protection for LSCs.	[Wu, Li; Lei, Yaping] Wuhan Univ Technol, Sch Resources & Environm Engn, Wuhan, Peoples R China; [Lan, Shubin; Hu, Chunxiang] Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Peoples R China	Wuhan University of Technology; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Lan, SB (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Peoples R China.	shblan@ihb.ac.cn			National Natural Science Foundation of China [31300100, 31300322, 31670456]; Youth Innovation Promotion Association CAS [2017385]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association CAS	This study was kindly supported by grants from the National Natural Science Foundation of China (Nos. 31300100, 31300322 and 31670456) and Youth Innovation Promotion Association CAS (2017385). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Belnap J., 2001, BIOL SOIL CRUSTS STR, DOI [10.1639/0007-2745(2002)105[0500:]2.0.co;2, DOI 10.1639/0007-2745(2002)105[0500:]2.0.CO;2]; BILGER W, 1989, J PLANT PHYSIOL, V134, P261, DOI 10.1016/S0176-1617(89)80240-8; Bukhov NG, 2004, PLANTA, V219, P110, DOI 10.1007/s00425-003-1195-0; Cabrajic AVJ, 2010, PLANT CELL ENVIRON, V33, P840, DOI 10.1111/j.1365-3040.2009.02110.x; ELDRIDGE DJ, 1994, AUST J SOIL RES, V32, P389, DOI 10.1071/SR9940389; Gao K, 2007, J PHOTOCH PHOTOBIO B, V89, P117, DOI 10.1016/j.jphotobiol.2007.09.006; GARCIAPICHEL F, 1991, J PHYCOL, V27, P395, DOI 10.1111/j.0022-3646.1991.00395.x; GARCIAPICHEL F, 1992, PHOTOCHEM PHOTOBIOL, V56, P17, DOI 10.1111/j.1751-1097.1992.tb09596.x; Harel Y, 2004, PLANT PHYSIOL, V136, P3070, DOI 10.1104/pp.104.047712; Heber U, 2006, J EXP BOT, V57, P2993, DOI 10.1093/jxb/erl058; Heber U, 2010, NEW PHYTOL, V185, P459, DOI 10.1111/j.1469-8137.2009.03064.x; Housman DC, 2006, J ARID ENVIRON, V66, P620, DOI 10.1016/j.jaridenv.2005.11.014; Hu CX, 2003, ACTA BOT SIN, V45, P917; Kranner I, 2008, BRYOLOGIST, V111, P576, DOI 10.1639/0007-2745-111.4.576; Lan SB, 2012, PLANT SOIL, V351, P325, DOI 10.1007/s11104-011-0966-9; Lan SB, 2012, ENVIRON EARTH SCI, V65, P77, DOI 10.1007/s12665-011-1066-0; Lan SB, 2010, EUR J SOIL BIOL, V46, P381, DOI 10.1016/j.ejsobi.2010.08.002; Lange OL, 1998, FUNCT ECOL, V12, P195, DOI 10.1046/j.1365-2435.1998.00192.x; Lange OL, 2004, LICHENOLOGIST, V36, P329, DOI 10.1017/S0024282904014392; LANGE OL, 1992, FUNCT ECOL, V6, P519, DOI 10.2307/2390048; LANGE OL, 1994, FUNCT ECOL, V8, P253, DOI 10.2307/2389909; Lange OL, 2006, FLORA, V201, P268, DOI 10.1016/j.flora.2005.08.003; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Nishiyama Y, 2001, EMBO J, V20, P5587, DOI 10.1093/emboj/20.20.5587; Ohad I, 2011, PHYSIOL PLANTARUM, V142, P79, DOI 10.1111/j.1399-3054.2011.01466.x; Ohad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011000; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; Wu L, 2013, EUR J SOIL BIOL, V55, P77, DOI 10.1016/j.ejsobi.2012.12.006; Wu L, 2011, MICROB ECOL, V62, P715, DOI 10.1007/s00248-011-9828-5; Zaady E, 2000, SOIL BIOL BIOCHEM, V32, P959, DOI 10.1016/S0038-0717(00)00004-3; Zhao XM, 2008, J ARID ENVIRON, V72, P370, DOI 10.1016/j.jaridenv.2007.07.002	32	6	7	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172537	10.1371/journal.pone.0172537	http://dx.doi.org/10.1371/journal.pone.0172537			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257469	Green Submitted, Green Published, gold			2022-12-27	WOS:000396021100019
J	Moo, EK; Peterson, DR; Leonard, TR; Kaya, M; Herzog, W				Moo, Eng Kuan; Peterson, Daniel R.; Leonard, Timothy R.; Kaya, Motoshi; Herzog, Walter			In vivo muscle force and muscle power during near-maximal frog jumps	PLOS ONE			English	Article							MEDIAL GASTROCNEMIUS; HINDLIMB MUSCLES; SARCOMERE-LENGTH; TENDON UNIT; PERFORMANCE; SOLEUS; STRAIN; OUTPUT; CAT; CONTRACTION	Frogs' outstanding jumping ability has been associated with a high power output from the leg extensor muscles. Two main theories have emerged to explain the high power output of the frog leg extensor muscles, either (i) the contractile conditions of all leg extensor muscles are optimized in terms of muscle length and speed of shortening, or (ii) maximal power is achieved through a dynamic catch mechanism that uncouples fibre shortening from the corresponding muscle-tendon unit shortening. As in vivo instantaneous power generation in frog hind limb muscles during jumping has never been measured directly, it is hard to distinguish between the two theories. In this study, we determined the instantaneous variable power output of the plantaris longus (PL) of Lithobates pipiens (also known as Rana pipiens), by directly measuring the in vivo force, length change, and speed of muscle and fibre shortening in near maximal jumps. Fifteen near maximal jumps (> 50cm in horizontal distance) were analyzed. High instantaneous peak power in PL (536 +/- 47 W/kg) was achieved by optimizing the contractile conditions in terms of the force-length but not the force-velocity relationship, and by a dynamic catch mechanism that decouples fascicle shortening from muscle-tendon unit shortening. We also found that the extra-muscular free tendon likely amplifies the peak power output of the PL by modulating fascicle shortening length and shortening velocity for optimum power output, but not by releasing stored energy through recoiling as the tendon only started recoiling after peak PL power had been achieved.	[Moo, Eng Kuan; Peterson, Daniel R.; Leonard, Timothy R.; Kaya, Motoshi; Herzog, Walter] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada	University of Calgary	Herzog, W (corresponding author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.	wherzog@ucalgary.ca	Herzog, Walter/AAG-7188-2020	Herzog, Walter/0000-0002-5341-0033; Moo, Eng Kuan/0000-0001-6363-6063	Natural Sciences and Engineering Research Council (NSERC) of Canada; Alberta Innovates [201500764] Funding Source: researchfish	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates	The work was supported by Natural Sciences and Engineering Research Council (NSERC) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; [Anonymous], 1977, SCALE EFFECTS ANIMAL; Astley HC, 2011, BIOL LETT; Astley HC, 2014, J EXP BIOL, V217, P4372, DOI 10.1242/jeb.110296; Azizi E, 2008, P NATL ACAD SCI USA, V105, P1745, DOI 10.1073/pnas.0709212105; Azizi E, 2010, P ROY SOC B-BIOL SCI, V277, P1523, DOI 10.1098/rspb.2009.2051; Azizi E, 2009, J PHYSIOL-LONDON, V587, P4309, DOI 10.1113/jphysiol.2009.173690; BENNETCLARK HC, 1975, J EXP BIOL, V63, P53; Biewener A A, 2000, Exerc Sport Sci Rev, V28, P99; Butterfield TA, 2005, J APPL PHYSIOL, V99, P1352, DOI 10.1152/japplphysiol.00481.2005; CALOW LJ, 1973, J ZOOL, V171, P293; Fontana HD, 2014, J ELECTROMYOGR KINES, V24, P934, DOI 10.1016/j.jelekin.2014.06.010; Galantis A, 2003, P ROY SOC B-BIOL SCI, V270, P1493, DOI 10.1098/rspb.2003.2403; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Grieve D. W., 1978, INT SERIES BIOMECH A, V4, P405; GRIFFITHS RI, 1989, J EXP BIOL, V147, P439; HERZOG W, 1993, J BIOMECH, V26, P945, DOI 10.1016/0021-9290(93)90056-K; HERZOG W, 1991, J BIOMECH, V24, P31, DOI 10.1016/0021-9290(91)90375-W; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; HILL AV, 1949, PROC R SOC SER B-BIO, V136, P399, DOI 10.1098/rspb.1949.0033; HIRANO M, 1984, J EXP BIOL, V108, P429; Kargo WJ, 2002, J EXP BIOL, V205, P1683; Kawakami Y, 1998, J APPL PHYSIOL, V85, P398, DOI 10.1152/jappl.1998.85.2.398; Kaya M, 2002, J BIOMECH, V35, P893, DOI 10.1016/S0021-9290(02)00043-X; Kaya M, 2008, J R SOC INTERFACE, V5, P415, DOI 10.1098/rsif.2007.1158; LIEBER RL, 1991, AM J PHYSIOL, V261, pC86, DOI 10.1152/ajpcell.1991.261.1.C86; LUTZ GJ, 1994, SCIENCE, V263, P370, DOI 10.1126/science.8278808; LYNN R, 1994, J APPL PHYSIOL, V77, P1439, DOI 10.1152/jappl.1994.77.3.1439; Maganaris CN, 1998, J PHYSIOL-LONDON, V512, P603, DOI 10.1111/j.1469-7793.1998.603be.x; MAI MT, 1990, J BIOMECH, V23, P271, DOI 10.1016/0021-9290(90)90017-W; MARSH RL, 1994, J EXP BIOL, V188, P131; Mayfield DL, 2016, J EXP BIOL; Olson JM, 1998, J EXP BIOL, V201, P2763; Patek SN, 2004, NATURE, V428, P819, DOI 10.1038/428819a; Peplowski MM, 1997, J EXP BIOL, V200, P2861; Richards CT, 2007, J EXP BIOL, V210, P3147, DOI 10.1242/jeb.005207; Roberts TJ, 2003, J EXP BIOL, V206, P2567, DOI 10.1242/jeb.00452; Roberts TJ, 1997, SCIENCE, V275, P1113, DOI 10.1126/science.275.5303.1113; Sawicki GS, 2015, J EXP BIOL, V218, P3700, DOI 10.1242/jeb.126235; WALMSLEY B, 1978, J NEUROPHYSIOL, V41, P1203, DOI 10.1152/jn.1978.41.5.1203; ZUURBIER CJ, 1994, J BIOMECH, V27, P445, DOI 10.1016/0021-9290(94)90020-5	41	19	19	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e173415	10.1371/journal.pone.0173415	http://dx.doi.org/10.1371/journal.pone.0173415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282405	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800040
J	Chapman, R; Jongwe, TI; Douglass, N; Chege, G; Williamson, AL				Chapman, Ros; Jongwe, Tsungai Ivai; Douglass, Nicola; Chege, Gerald; Williamson, Anna-Lise			Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice	PLOS ONE			English	Article							T-CELL RESPONSES; RHESUS-MONKEYS; IMMUNE-RESPONSES; TYPE-1; PROTEINS; ANTIGENS; EFFICACY; PLASMID; REGIMEN; BREADTH	In an effort to make affordable vaccines suitable for the regions most affected by HIV-1, we have constructed stable vaccines that express an HIV-1 subtype C mosaic Gag immunogen (BCG-Gag(M), MVA-Gag(M) and DNA-Gag(M)). Mosaic immunogens have been designed to address the tremendous diversity of this virus. Here we have shown that Gag(M) buds from cells infected and transfected with MVA-Gag(M) and DNA-Gag(M) respectively and forms virus like particles. Previously we showed that a BCG-Gag(M) prime MVA-Gag(M) boost generated strong cellular immune responses in mice. In this study immune responses to the DNAGag(M) and MVA-Gag(M) vaccines were evaluated in homologous and heterologous prime boost vaccinations. The DNA homologous prime boost vaccination elicited predominantly CD8+ T cells while the homologous MVA vaccination induced predominantly CD4+ T cells. A heterologous DNA-Gag(M) prime MVA-Gag(M) boost induced strong, more balanced Gag CD8+ and CD4+ T cell responses and that were predominantly of an effector memory phenotype. The immunogenicity of the mosaic Gag (Gag(M)) was compared to a naturally occurring subtype C Gag (Gag(N)) using a DNA homologous vaccination regimen. DNA-Gag(N) expresses a natural Gag with a sequence that was closest to the consensus sequence of subtype C viruses sampled in South Africa. DNA-Gag(M) homologous vaccination induced cumulative HIV-1 Gag-specific IFN-y ELISPOT responses that were 6.5-fold higher than those induced by the DNA-Gag(N) vaccination. Similarly, DNA-Gag(M) vaccination generated 7-fold higher levels of cytokine-positive CD8+ T cells than DNA-Gag(N) indicating that this subtype C mosaic Gag elicits far more potent immune responses than a consensus type Gag. Cells transfected and infected with DNA-Gag(M) and MVA-Gag(M) respectively, expressed high levels of Gag(M) and produced budding virus-like particles. Our data indicates that a heterologous prime boost regimen using DNA and MVA vaccines expressing HIV-1 subtype C mosaic Gag is highly immunogenic in mice and warrants further investigation in non-human primates.	[Chapman, Ros; Jongwe, Tsungai Ivai; Douglass, Nicola; Chege, Gerald; Williamson, Anna-Lise] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Chapman, Ros; Jongwe, Tsungai Ivai; Douglass, Nicola; Chege, Gerald; Williamson, Anna-Lise] Univ Cape Town, Fac Hlth Sci, Dept Pathol, Div Med Virol, Cape Town, South Africa; [Williamson, Anna-Lise] Groote Schuur Hosp, Natl Hlth Lab Serv, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town	Chapman, R (corresponding author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Cape Town, South Africa.; Chapman, R (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Pathol, Div Med Virol, Cape Town, South Africa.	Ros.Chapman@uct.ac.za	Chapman, Rosamund/AAJ-6490-2020; Chege, Gerald/HIK-1573-2022	Chege, Gerald/0000-0003-3986-9638; Douglass, Nicola/0000-0002-8929-6279; Chapman, Rosamund/0000-0001-9162-2099; Williamson, Anna-Lise/0000-0002-5467-1200	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	This work is also based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation. Tsungai Jongwe received bursaries from the Schlumberger Foundation and the Poliomyelitis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Jawad S, 2016, MOL THER, V24, P375, DOI 10.1038/mt.2015.210; Asbach B, 2016, J VIROL, V90, P4133, DOI 10.1128/JVI.03135-15; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Burgers WA, 2006, J GEN VIROL, V87, P399, DOI 10.1099/vir.0.81379-0; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; Chapman R, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071601, 10.1371/journal.pone.0076584]; Columb MO, 2006, CURR ANAESTH CRIT CA, V17, P233, DOI DOI 10.1016/J.CACC.2006.03.005; Datta SAK, 2016, J VIROL, V90, P1773, DOI 10.1128/JVI.02061-15; Ellenberger D, 2005, VIROLOGY, V340, P21, DOI 10.1016/j.virol.2005.06.014; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; Gray GE, 2016, CLIN VACCINE IMMUNOL, V23, P496, DOI 10.1128/CVI.00717-15; Hanke T, 1998, VACCINE, V16, P426, DOI 10.1016/S0264-410X(97)00296-X; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Joachim A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118486; Jongwe TI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159141; Kardani K, 2016, VACCINE, V34, P413, DOI 10.1016/j.vaccine.2015.11.062; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Mascola JR, 2005, J VIROL, V79, P771, DOI 10.1128/JVI.79.2.771-779.2005; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; Ndhlovu ZM, 2011, J IMMUNOL, V186, P6914, DOI 10.4049/jimmunol.1004231; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rueda P, 2004, J GEN VIROL, V85, P563, DOI 10.1099/vir.0.19525-0; Saade F, 2012, EXPERT REV VACCINES, V11, P189, DOI [10.1586/erv.11.188, 10.1586/ERV.11.188]; Santra S, 2010, J MED PRIMATOL, V39, P282; Smith JM, 2004, AIDS RES HUM RETROV, V20, P1335, DOI 10.1089/aid.2004.20.1335; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tanzer FL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-51; Williamson AL, 2016, EXPERT REV VACCINES, V15, P585, DOI 10.1586/14760584.2016.1129904; Williamson C, 2003, AIDS RES HUM RETROV, V19, P133, DOI 10.1089/088922203762688649	31	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173352	10.1371/journal.pone.0173352	http://dx.doi.org/10.1371/journal.pone.0173352			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278263	gold, Green Submitted, Green Published			2022-12-27	WOS:000396087900076
J	Raihan, MJ; Farzana, FD; Sultana, S; Haque, MA; Rahman, AS; Waid, JL; McCormick, B; Choudhury, N; Ahmed, T				Raihan, Mohammad Jyoti; Farzana, Fahmida Dil; Sultana, Sabiha; Haque, Md Ahshanul; Rahman, Ahmed Shafiqur; Waid, Jillian L.; McCormick, Ben; Choudhury, Nuzhat; Ahmed, Tahmeed			Examining the relationship between socio-economic status, WASH practices and wasting	PLOS ONE			English	Article							CHILD UNDERNUTRITION; ACUTE MALNUTRITION; WATER; INTERVENTION; ENTEROPATHY; PREVENTION; DIARRHEA; DISINFECTION; PREVALENCE; SANITATION	Childhood wasting is a global problem and is significantly more pronounced in low and middle income countries like Bangladesh. Socio Economic Status (SES) and Water, Sanitation and Hygiene (WASH) practices may be significantly associated with wasting. Most previous research is consistent about the role of SES, but the significance of WASH in the context of wasting remains ambiguous. The effect of SES and WASH on weight for length (WHZ) is examined using a Structural Equation Model (SEM) to explicitly describe the direct and indirect role of WASH in the context of SES. A nationally representative survey of 10,478 Bangladeshi children under 5 were examined. An expert defined SEM was used to construct latent variables for SES and WASH. The SEM included a direct pathway from SES to WHZ and an indirect pathway from SES to WHZ via WASH along with regression of relevant covariates on the outcome WHZ and the latent variables. Both SES (p<0.01) and WASH (p<0.05) significantly affect WHZ. SES (p<0.01) also significantly affects WASH. Other structural components showed that child's age (p<0.01) affects WHZ and types of residence (p<0.01) affects SES. WASH practices at least partially mediate the association between SES and wasting status. WASH and SES are both significantly associated with WHZ.	[Raihan, Mohammad Jyoti; Farzana, Fahmida Dil; Haque, Md Ahshanul; Rahman, Ahmed Shafiqur; Choudhury, Nuzhat; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Sultana, Sabiha; Ahmed, Tahmeed] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Waid, Jillian L.] Helen Keller Int, Dhaka, Bangladesh; [McCormick, Ben] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA	International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Rural Advancement Committee BRAC; BRAC University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Ahmed, T (corresponding author), Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh.; Ahmed, T (corresponding author), BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh.	tahmeed@icddrb.org		McCormick, Ben/0000-0002-8060-0502	European Commission; EU	European Commission(European CommissionEuropean Commission Joint Research Centre); EU(European Commission)	This study was made possible by the committed contribution and partnership of James P Grant School of Public Health (JPGSPH), BRAC University and icddr,b. This project itself is a joint partnership between JPGSPH, BRAC University, Bangladesh Bureau of Statistics and Helen Keller International (HKI), Bangladesh and funded by European Commission.; This manuscript was made possible by the committed contribution and partnership of James P Grant School of Public Health (JPGSPH), BRAG University (BU) and icddr,b. The manuscript is based on data collected and shared by FSNSP, implemented by JPGSPH, BU, Helen Keller International, Bangladesh and Bangladesh Bureau of Statistics and funded by EU. This manuscript has been reviewed by FSNSP technical reviewers for scientific content and consistency of data interpretation with previous FSNSP publications and significant comments have been incorporated prior to submission for publication. We acknowledge the following donors for providing unrestricted support to icddr,b's effort and advancement to its strategic plan: Government of the People's Republic of Bangladesh; Canada (Global Affairs, Canada-GAC), Sweden (Sida), and the United Kingdom (DFID).	Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Arnold B, 2009, INT J EPIDEMIOL, V38, P1651, DOI 10.1093/ije/dyp241; Arnold BF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003476; Banda K, 2007, T ROY SOC TROP MED H, V101, P1124, DOI 10.1016/j.trstmh.2007.05.004; BLACK RE, 1980, J INFECT DIS, V142, P660, DOI 10.1093/infdis/142.5.660; Bloss E, 2004, J TROP PEDIATRICS, V50, P260, DOI 10.1093/tropej/50.5.260; Chavance M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-37; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Cogill B, 2003, ANTHROPOMETRIC INDIC; Dangour AD, 2013, COCHRANE DATABASE SY, V8; de Pee S, 2015, FOOD NUTR BULL, V36, pS24, DOI 10.1177/15648265150361S104; du Preez M, 2011, ENVIRON SCI TECHNOL, V45, P9315, DOI 10.1021/es2018835; Ehiri J, 2003, HAND WASHING PREVENT; Frozanfar MK, 2016, NAGOYA J MED SCI, V78, P41; Fuchs C, 2014, INT J PEDIAT, V2014, DOI 10.1155/2014/267806; Gross R, 2006, LANCET, V367, P1209, DOI 10.1016/S0140-6736(06)68509-7; Gunzler Douglas, 2013, Shanghai Arch Psychiatry, V25, P390, DOI 10.3969/j.issn.1002-0829.2013.06.009; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Helen Keller International B, 2014, FSNSP HIST; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Imdad A, 2011, CURR OPIN CLIN NUTR, V14, P276, DOI 10.1097/MCO.0b013e328345364a; Isunju JB, 2011, PUBLIC HEALTH, V125, P368, DOI 10.1016/j.puhe.2011.03.008; Kennedy E, 2015, FOOD NUTR BULL, V36, pS9, DOI 10.1177/15648265150361S102; Khan NZ, 2009, J TROP PEDIATRICS, V55, P177, DOI 10.1093/tropej/fmn108; Langford R, 2011, AM J HUM BIOL, V23, P621, DOI 10.1002/ajhb.21189; Lin A, 2013, AM J TROP MED HYG, V89, P130, DOI 10.4269/ajtmh.12-0629; LOWBURY EJL, 1964, BMJ-BRIT MED J, V2, P230, DOI 10.1136/bmj.2.5403.230; Luby SP, 2004, JAMA-J AM MED ASSOC, V291, P2547, DOI 10.1001/jama.291.21.2547; Luby SP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001052; Manary MJ, 2008, BMJ, V337; MITTERMAYER H, 1975, ZBL BAKT MIK HYG B, V160, P163; Mohsena M, 2010, PUBLIC HEALTH NUTR, V13, P1498, DOI 10.1017/S1368980010001758; Ngure FM, 2014, ANN NY ACAD SCI, V1308, P118, DOI 10.1111/nyas.12330; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Pelletier David L., 2002, COMMON UNDERSTANDING; Psaki SR, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-8; Rayhan MI, 2006, PAK J NUTR, V5, P558, DOI [DOI 10.3923/PJN.2006.558.562, 10.3923/pjn.2006.558.562]; Schofield C, 1996, B WORLD HEALTH ORGAN, V74, P223; Sharma K, 2012, JOURNAL OF NEPAL HEA; Shekar M, 2006, REPOSITIONING NUTR C; Siddiqi M.N.A., 2011, ASIAN J MED SCI, V2, P113, DOI [10.3126/ajms.v2i2.3662, DOI 10.3126/AJMS.V2I2.3662]; Smith LC, 2005, WORLD DEV, V33, P1285, DOI 10.1016/j.worlddev.2005.03.002; VanderWeele TJ, 2012, AM J EPIDEMIOL; Vidal M, 2005, J CLIN MICROBIOL, V43, P5362, DOI 10.1128/JCM.43.10.5362-5365.2005; Waddington H., 2009, WATER SANITATION HYG; Walker JE, 1925, J INFECT DIS, V37, P181, DOI 10.1093/infdis/37.2.181; Wang YF, 2006, FOOD NUTR BULL, V27, pS175, DOI 10.1177/15648265060274S502; WHO, 2015, CHILD GROWTH IND THE; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA	49	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172134	10.1371/journal.pone.0172134	http://dx.doi.org/10.1371/journal.pone.0172134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278161	Green Published, gold			2022-12-27	WOS:000396087900115
J	Figueiredo, PHS; Lima, MMO; Costa, HS; Gomes, RT; Neves, CDC; de Oliveira, ES; Alves, FL; Rodrigues, VGB; Maciel, EHB; Balthazar, CH				Scheidt Figueiredo, Pedro Henrique; Oliveira Lima, Marcia Maria; Costa, Henrique Silveira; Gomes, Rosalina Tossige; Cunha Neves, Camila Danielle; de Oliveira, Evandro Silveira; Alves, Frederico Lopes; Brandao Rodrigues, Vanessa Gomes; Barroso Maciel, Emilio Henrique; Balthazar, Claudio Heitor			The role of the inspiratory muscle weakness in functional capacity in hemodialysis patients	PLOS ONE			English	Article							SHUTTLE WALK TEST; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; EXERCISE CAPACITY; REFERENCE VALUES; HEART-FAILURE; MORTALITY; STRENGTH; DISEASE; CKD	Introduction Inspiratory muscle function may be affected in patients with End-Stage Renal Disease (ESRD), further worsening the functional loss in these individuals. However, the impact of inspiratory muscle weakness (IMW) on the functional capacity (FC) of hemodialysis patients remains unknown. Thus, the present study aimed to evaluate the impact of IMW on FC in ESRD patients undergoing hemodialysis. Materials and methods ESRD patients on hemodialysis treatment for more than six months were evaluated for inspiratory muscle strength and FC. Inspiratory muscle strength was evaluated based on maximal inspiratory pressure (MIP). IMW was defined as MIP values less than 70% of the predicted value. FC was evaluated using the Incremental Shuttle Walk test (ISWT). Patients whose predicted peak oxygen uptake (VO(2)peak) over the distance walked during the ISWT was less than 16mL/kg/min were considered to have FC impairment. Associations between variables were assessed by linear and logistic regression, with adjustment for age, sex, body mass index (BMI), presence of diabetes and hemoglobin level. Receiver-operating characteristic (ROC) analysis was used to determine different cutoff values of the MIP for normal inspiratory muscle strength and FC. Results Sixty-five ERSD patients (67.7% male), aged 48.2 (44.5-51.9) years were evaluated. MIP was an independent predictor of the distance walked during the ISWT (R (2) = 0.44). IMW was an independent predictor of VO(2)peak < 16mL/kg/min. (OR = 5.7; p = 0.048) in adjusted logistic regression models. ROC curves showed that the MIP cutoff value of 82cmH(2)O had a sensitivity of 73.5% and specificity of 93.7% in predicting normal inspiratory strength and a sensitivity and specificity of 76.3% and 70.4%, respectively, in predicting VO(2)peak >= 16mL/ kg/min. Conclusions IMW is associated with reduced FC in hemodialysis patients. Evaluation of the MIP may be important to functional monitoring in clinical practice and can help in the stratification of patients eligible to perform exercise testing.	[Scheidt Figueiredo, Pedro Henrique] Univ Fed Vales Jequitinhonha & Mucuri, Postgrad Course Physiol Sci, Multicentr Program Physiol Sci, Diamantina, MG, Brazil; [Scheidt Figueiredo, Pedro Henrique; Oliveira Lima, Marcia Maria; Gomes, Rosalina Tossige; Cunha Neves, Camila Danielle; de Oliveira, Evandro Silveira; Balthazar, Claudio Heitor] Univ Fed Vales Jequitinhonha & Mucuri, Phys Therapy Sch, Cardiovasc Rehabil Lab LABCAR, Diamantina, MG, Brazil; [Costa, Henrique Silveira] Univ Fed Minas Gerais, Sch Med, Postgrad Program Infect Dis & Trop Med, Belo Horizonte, MG, Brazil; [Alves, Frederico Lopes; Brandao Rodrigues, Vanessa Gomes; Barroso Maciel, Emilio Henrique] Santa Casa Caridade Diamantina Hosp, Hemodialysis Unit, Diamantina, MG, Brazil; [Scheidt Figueiredo, Pedro Henrique; Balthazar, Claudio Heitor] Rodovia MGT 367,Km 583,5000,Alto da Jacuba,39, Diamantina, MG, Brazil	Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Minas Gerais	Figueiredo, PHS (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, Postgrad Course Physiol Sci, Multicentr Program Physiol Sci, Diamantina, MG, Brazil.; Figueiredo, PHS (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, Phys Therapy Sch, Cardiovasc Rehabil Lab LABCAR, Diamantina, MG, Brazil.; Figueiredo, PHS (corresponding author), Rodovia MGT 367,Km 583,5000,Alto da Jacuba,39, Diamantina, MG, Brazil.	phsfig@yahoo.com.br	Figueiredo, Pedro Henrique/AAP-2158-2020; Costa, Henrique Silveira/H-8286-2014	Costa, Henrique Silveira/0000-0002-1426-7246				Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Alves R, 2016, EUR J PHYS REHAB MED, V52, P20; Axelsson J, 2004, AM J CLIN NUTR, V80, P1222, DOI 10.1093/ajcn/80.5.1222; Cahalin LP, 2015, HEART FAIL CLIN, V11, P149, DOI 10.1016/j.hfc.2014.09.002; Carrero JJ, 2008, CLIN NUTR, V27, P557, DOI 10.1016/j.clnu.2008.04.007; Chen CT, 2013, SCI WORLD J, DOI 10.1155/2013/643954; Cury JL, 2010, BRAZ J PHYS THER, V14, P91, DOI 10.1590/S1413-35552010005000008; Dempsey JA, 2006, RESP PHYSIOL NEUROBI, V151, P242, DOI 10.1016/j.resp.2005.12.015; Dipp T, 2010, REV BRAS MED ESPORTE, V16, P246, DOI 10.1590/S1517-86922010000400002; Dourado VZ, 2013, J BRAS PNEUMOL, V39, P190, DOI 10.1590/S1806-37132013000200010; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; Fassbinder Tânia Regina Cavinatto, 2015, Braz. J. Nephrol., V37, P47, DOI 10.5935/0101-2800.20150008; Finkelstein FO, 2009, KIDNEY INT, V76, P946, DOI 10.1038/ki.2009.307; Fragoso CAV, 2014, J AM GERIATR SOC, V62, P622, DOI 10.1111/jgs.12738; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Hart N, 2002, AM J RESP CRIT CARE, V165, P1265, DOI 10.1164/rccm.2110016; Hill K, 2012, RESPIROLOGY, V17, P278, DOI 10.1111/j.1440-1843.2011.02089.x; Ikizler TA, 2002, AM J PHYSIOL-ENDOC M, V282, pE107, DOI 10.1152/ajpendo.2002.282.1.E107; Iyasere O, 2014, POSTGRAD MED J, V90, P340, DOI 10.1136/postgradmedj-2013-132251; Johansen KL, 2010, KIDNEY INT, V78, P1164, DOI 10.1038/ki.2010.312; Johansen KL, 2012, CLIN J AM SOC NEPHRO; Kaminski DM, 2011, CLIN AUTON RES, V21, P29, DOI 10.1007/s10286-010-0087-1; Katayama A, 2014, ENVIRON HEALTH PREV, V19, P220, DOI 10.1007/s12199-014-0380-z; Kovelis Demetria, 2008, J. bras. pneumol., V34, P907, DOI 10.1590/S1806-37132008001100004; Kutner NG, 2015, AM J KIDNEY DIS, V66, P297, DOI 10.1053/j.ajkd.2015.01.024; Moreno AM, 2014, BRAZ J MED BIOL RES, V47, P972, DOI 10.1590/1414-431X20143896; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P719, DOI 10.1590/S0100-879X1999000600007; Neves CDC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117563; Painter P, 2012, CLIN J AM SOC NEPHRO; Painter P, 2009, ADV CHRONIC KIDNEY D, V16, P437, DOI 10.1053/j.ackd.2009.09.002; Parreira VF, 2014, CHEST, V145, P1357, DOI 10.1378/chest.13-2071; Petchey WG, 2011, CLIN J AM SOC NEPHRO, V6, P512, DOI 10.2215/CJN.06880810; Pinheiro MB, 2014, EUR J PHYS REHAB MED, V50, P301; Polkey MI, 2016, AM J RESP CRITICAL C; Pomidori L, 2016, J NEPHROL, P1; Reis MS, 2014, PHYSIOTHER RES INT, V19, P16, DOI 10.1002/pri.1552; Reis MS, 2010, CLINICS, V65, P369, DOI 10.1590/S1807-59322010000400004; Rosa CSC, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0183-5; Silva Vanessa Giendruczak da, 2011, Braz. J. Nephrol., V33, P62; Singer J, 2011, J CARDIOPULM REHABIL, V31, P111, DOI 10.1097/HCR.0b013e3182033663; SINGH SJ, 1992, THORAX, V47, P1019, DOI 10.1136/thx.47.12.1019; Stack AG, 2005, AM J KIDNEY DIS, V45, P690, DOI 10.1053/j.ajkd.2004.12.013; Tavana Sasan, 2015, Tanaffos, V14, P128; Torino C, 2014, KIDNEY BLOOD PRESS R, V39, P205, DOI 10.1159/000355798; van der Palen J, 2004, THORAX, V59, P1063, DOI 10.1136/thx.2004.021915; WEBER KT, 1985, AM J CARDIOL, V55, pA22, DOI 10.1016/0002-9149(85)90792-1; Weiner DE, 2006, AM J KIDNEY DIS, V48, P392, DOI 10.1053/j.ajkd.2006.05.021; Yamada K, 2016, J CARD FAIL, V22, P38, DOI 10.1016/j.cardfail.2015.10.010	48	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173159	10.1371/journal.pone.0173159	http://dx.doi.org/10.1371/journal.pone.0173159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278163	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900051
J	Hildebrandt, W; Schwarzbach, H; Pardun, A; Hannemann, L; Bogs, B; Konig, AM; Mahnken, AH; Hildebrandt, O; Koehler, U; Kinscherf, R				Hildebrandt, Wulf; Schwarzbach, Hans; Pardun, Anita; Hannemann, Lena; Bogs, Bjoern; Koenig, Alexander M.; Mahnken, Andreas H.; Hildebrandt, Olaf; Koehler, Ulrich; Kinscherf, Ralf			Age-related differences in skeletal muscle microvascular response to exercise as detected by contrast-enhanced ultrasound (CEUS)	PLOS ONE			English	Article							LIMB VASCULAR CONDUCTANCE; BLOOD-FLOW; HEALTHY HUMANS; CAPILLARY RECRUITMENT; GLUCOSE-UPTAKE; ENDOTHELIAL DYSFUNCTION; REGIONAL SPECIFICITY; INSULIN-RESISTANCE; OLDER MEN; IN-VIVO	Background Aging involves reductions in exercise total limb blood flow and exercise capacity. We hypothesized that this may involve early age-related impairments of skeletal muscle microvascular responsiveness as previously reported for insulin but not for exercise stimuli in humans. Methods Using an isometric exercise model, we studied the effect of age on contrast-enhanced ultrasound (CEUS) parameters, i.e. microvascular blood volume (MBV), flow velocity (MFV) and blood flow (MBF) calculated from replenishment of Sonovue contrast-agent microbubbles after their destruction. CEUS was applied to the vastus lateralis (VLat) and intermedius (VInt) muscle in 15 middle-aged (MA, 43.6 +/- 1.5 years) and 11 young (YG, 24.1 +/- 0.6 years) healthy males before, during, and after 2 min of isometric knee extension at 15% of peak torque (PT). In addition, total leg blood flow as recorded by femoral artery Doppler-flow. Moreover, fibertype-specific and overall capillarisation as well as fiber composition were additionally assessed in Vlat biopsies obtained from CEUS site. MA and YG had similar quadriceps muscle MRT-volume or PT and maximal oxygen uptake as well as a normal cardiovascular risk factors and intima-media-thickness. Results During isometric exercise MA compared to YG reached significantly lower levels in MFV (0.123 +/- 0.016 vs. 0.208 +/- 0.036 a.u.) and MBF (0.007 +/- 0.001 vs. 0.012 +/- 0.002 a.u.). In the VInt the (post-occlusive hyperemia) post-exercise peaks in MBV and MBF were significantly lower in MA vs. YG. Capillary density, capillary fiber contacts and femoral artery Doppler were similar between MA and YG. Conclusions In the absence of significant age-related reductions in capillarisation, total leg blood flow or muscle mass, healthy middle-aged males reveal impaired skeletal muscle microcirculatory responses to isometric exercise. Whether this limits isometric muscle performance remains to be assessed.	[Hildebrandt, Wulf; Schwarzbach, Hans; Pardun, Anita; Hannemann, Lena; Bogs, Bjoern; Kinscherf, Ralf] Univ Marburg, Inst Anat & Cell Biol, Dept Med Cell Biol, Marburg, Germany; [Koenig, Alexander M.; Mahnken, Andreas H.] Univ Hosp Giessen, Dept Diagnost & Intervent Radiol, Baldingerstr, Marburg, Germany; [Koenig, Alexander M.; Mahnken, Andreas H.] Marburg UKGM Univ, Baldingerstr, Marburg, Germany; [Hildebrandt, Olaf; Koehler, Ulrich] Univ Hosp Giessen & Marburg UKGM, Div Pneumol, Internal Med, Dept Sleep Med, Baldingerstr, Marburg, Germany	Philipps University Marburg; University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg	Hildebrandt, W (corresponding author), Univ Marburg, Inst Anat & Cell Biol, Dept Med Cell Biol, Marburg, Germany.	Wulf.Hildebrandt@staff.uni-marburg.de	Kinscherf, Ralf/AAV-7164-2021	Mahnken, Andreas H./0000-0001-8077-9306	von Behring Rontgen Stiftung [580071]	von Behring Rontgen Stiftung	WH received a grant of the von Behring Rontgen Stiftung (Grant number 580071). The funders had no role in study design, data collection and anaylsis, decission to publish, or preparation of the mansucript.	BARON AD, 1994, AM J PHYSIOL, V266, pE248, DOI 10.1152/ajpendo.1994.266.2.E248; Barrett EJ, 2013, REV ENDOCR METAB DIS, V14, P21, DOI 10.1007/s11154-012-9232-6; Beere PA, 1999, CIRCULATION, V100, P1085, DOI 10.1161/01.CIR.100.10.1085; Behnke BJ, 2005, RESP PHYSIOL NEUROBI, V146, P259, DOI 10.1016/j.resp.2004.12.009; Budui SL, 2015, CLIN CASES MINER BON, V12, P22, DOI 10.11138/ccmbm/2015.12.1.022; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; Clark Michael G, 2002, Semin Vasc Med, V2, P21, DOI 10.1055/s-2002-23506; Clerk LH, 2006, DIABETES, V55, P1436, DOI 10.2337/db05-1373; Clerk LH, 2004, DIABETES-METAB RES, V20, P3, DOI 10.1002/dmrr.414; Credeur DP, 2015, J APPL PHYSIOL, V118, P455, DOI 10.1152/japplphysiol.00785.2014; Dawson D, 2002, AM J PHYSIOL-ENDOC M, V282, pE714, DOI 10.1152/ajpendo.00373.2001; Degens H., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P246; DEHN MM, 1972, J APPL PHYSIOL, V33, P805, DOI 10.1152/jappl.1972.33.6.805; DeSouza CA, 2000, CIRCULATION, V102, P1351, DOI 10.1161/01.CIR.102.12.1351; Dinenno FA, 1999, CIRCULATION, V100, P164, DOI 10.1161/01.CIR.100.2.164; Dinenno FA, 2001, J PHYSIOL-LONDON, V534, P287, DOI 10.1111/j.1469-7793.2001.00287.x; Dinenno FA, 2000, AM J PHYSIOL-HEART C, V278, pH1205, DOI 10.1152/ajpheart.2000.278.4.H1205; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Donato AJ, 2006, AM J PHYSIOL-HEART C, V290, pH272, DOI 10.1152/ajpheart.00405.2005; Durham WJ, 2010, FASEB J, V24, P4117, DOI 10.1096/fj.09-150177; Frisbee JC, 2014, J PHYSL, P1, DOI [10.1113/jphysiol.2013.268060_1, DOI 10.1113/JPHYSIOL.2013.268060_1]; Frisbee JC, 2014, AM J PHYSIOL-HEART C, V307, pH1714, DOI 10.1152/ajpheart.00605.2014; Gavin TP, 2007, J PHYSIOL-LONDON, V585, P231, DOI 10.1113/jphysiol.2007.143198; Groen BBL, 2014, J APPL PHYSIOL, V116, P998, DOI 10.1152/japplphysiol.00919.2013; HIGGINBOTHAM MB, 1986, AM J CARDIOL, V57, P1374, DOI 10.1016/0002-9149(86)90221-3; Hirai DM, 2012, AM J PHYSIOL-HEART C, V303, pH1076, DOI 10.1152/ajpheart.00477.2012; Hirai DM, 2011, J APPL PHYSIOL, V111, P989, DOI 10.1152/japplphysiol.00490.2011; Hofmann MA, 2001, J CLIN INVEST, V107, P675, DOI 10.1172/JCI10588; IRION GL, 1987, J GERONTOL, V42, P660, DOI 10.1093/geronj/42.6.660; JASPERSE JL, 1994, J PHYSIOL-LONDON, V474, P353, DOI 10.1113/jphysiol.1994.sp020027; Keske MA, 2016, J PHYSIOL-LONDON, V594, P2223, DOI 10.1113/jphysiol.2014.283549; Krix M, 2010, EUR J RADIOL, V76, P110, DOI 10.1016/j.ejrad.2009.05.007; LAAKSO M, 1990, J CLIN INVEST, V85, P1844, DOI 10.1172/JCI114644; LIND L, 1993, AM HEART J, V125, P1494, DOI 10.1016/0002-8703(93)90446-G; MARTIN WH, 1991, CIRCULATION, V84, P654, DOI 10.1161/01.CIR.84.2.654; McDaniel J, 2010, J PHYSIOL-LONDON, V588, P4507, DOI 10.1113/jphysiol.2010.198770; Mitchell WK, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.119; Musch TI, 2004, J APPL PHYSIOL, V96, P81, DOI 10.1152/japplphysiol.00729.2003; Phillips BE, 2015, J PHYSIOL-LONDON, V593, P2721, DOI 10.1113/JP270343; Poole DC, 2014, J PHYSIOL-LONDON, V592, P5133, DOI 10.1113/jphysiol.2014.282145; Poole DC, 2013, EXP PHYSIOL, V98, P1645, DOI 10.1113/expphysiol.2013.073874; Porsch-Ozcurumez MK, 1997, THESIS JUSTUS LIEBIG; Proctor DN, 2006, MICROCIRCULATION, V13, P325, DOI 10.1080/10739680600618967; Proctor DN, 2005, J APPL PHYSIOL, V98, P193, DOI 10.1152/japplphysiol.00704.2004; Proctor DN, 1998, J APPL PHYSIOL, V85, P68, DOI 10.1152/jappl.1998.85.1.68; Richards JC, 2014, J PHYSIOL-LONDON, V592, P4775, DOI 10.1113/jphysiol.2014.278358; Ridout SJ, 2005, J APPL PHYSIOL, V99, P2067, DOI 10.1152/japplphysiol.00825.2005; Roth GA, 2011, B WORLD HEALTH ORGAN, V89, P92, DOI 10.2471/BLT.10.079947; Ryan NA, 2006, J APPL PHYSIOL, V100, P178, DOI 10.1152/japplphysiol.00827.2005; Seals DR, 2006, EXP GERONTOL, V41, P501, DOI 10.1016/j.exger.2006.01.001; Sinkler SY, 2014, AM J PHYSIOL-HEART C, V307, pH830, DOI 10.1152/ajpheart.00368.2014; Sjoberg KA, 2011, AM J PHYSIOL-HEART C, V301, pH450, DOI 10.1152/ajpheart.01174.2010; Skilton MR, 2005, AM J PHYSIOL-HEART C, V288, pH1404, DOI 10.1152/ajpheart.00484.2004; Solomon TPJ, 2011, J CLIN ENDOCR METAB, V96, P1377, DOI 10.1210/jc.2010-2069; Steinberg HO, 1997, CIRCULATION, V96, P3287; Vincent MA, 2004, DIABETES, V53, P1418, DOI 10.2337/diabetes.53.6.1418; Vincent MA, 2002, DIABETES, V51, P42, DOI 10.2337/diabetes.51.1.42; Vincent MA, 2006, AM J PHYSIOL-ENDOC M, V290, pE1191, DOI 10.1152/ajpendo.00497.2005; Wagenmakers AJM, 2016, J PHYSIOL-LONDON, V594, P2207, DOI 10.1113/jphysiol.2014.284513; WAHREN J, 1974, SCAND J CLIN LAB INV, V33, P79, DOI 10.3109/00365517409114201; Weber MA, 2007, J MOL MED, V85, P887, DOI 10.1007/s00109-007-0220-3; Wei K, 1998, CIRCULATION, V97, P473; Womack L, 2009, J AM COLL CARDIOL, V53, P2175, DOI 10.1016/j.jacc.2009.02.042; YANG YJ, 1989, J CLIN INVEST, V84, P1620, DOI 10.1172/JCI114339; Zhang L, 2004, DIABETES, V53, P447, DOI 10.2337/diabetes.53.2.447	65	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172771	10.1371/journal.pone.0172771	http://dx.doi.org/10.1371/journal.pone.0172771			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273102	Green Submitted, gold, Green Published			2022-12-27	WOS:000396073700030
J	Lee, CW; Fang, SY; Tsai, DC; Huang, N; Hsu, CC; Chen, SY; Chiu, AWH; Liu, CJL				Lee, Chia-Wei; Fang, Shao-You; Tsai, Der-Chong; Huang, Nicole; Hsu, Chih-Chien; Chen, Shing-Yi; Chiu, Allen Wen-Hsiang; Liu, Catherine Jui-Ling			Prevalence and association of refractive anisometropia with near work habits among young schoolchildren: The evidence from a population-based study	PLOS ONE			English	Article							CILIARY MUSCLE THICKNESS; OCULAR AXIAL LENGTH; SCHOOL-CHILDREN; MYOPIA; ERROR; ACCOMMODATION; NEARWORK; DESIGN; AGE; EYE	Background Lifestyle behaviour may play a role in refractive error among children, but the association between near work habits and refractive anisometropia remains unclear. Methods We estimated the prevalence of refractive anisometropia and examined its association with near work activities among 23,114 children in the Myopia Investigation Study in Taipei who were grade 2 elementary school students at baseline in 2013 and 2014. Baseline data on demographics, medical history, parental history and near work habits were collected by parent-administered questionnaire survey. Refractive status was determined by cycloplegic autorefraction. Refractive anisometropia was defined as the spherical equivalent difference >= 1.0 diopter between eyes. Results The prevalence of refractive anisometropia was 5.3% (95% confidence interval [CI], 5.0% to 5.6%). The prevalence and severity of refractive anisometropia increased with both myopic and hyperopic refractive error. Multivariate logistic regression analysis revealed that refractive anisometropia was significantly associated with myopia (odds ratio [OR], 2.98; 95% CI, 2.53-3.51), hyperopia (OR, 2.37; 95% CI, 1.98-2.83), degree of astigmatism (OR, 1.005; 95% CI, 1.005-1.006), amblyopia (OR, 2.54; 95% CI, 2.06-3.12), male gender (OR, 0.88; 95% CI, 0.78-0.99) and senior high school level of maternal education (OR, 0.69; 95% CI, 0.52-0.92). Though anisometropic children were more likely to spend more time on near work (crude OR, 1.15; 95% CI, 1.02-1.29) and to have less eye-to-object distance in doing near work (crude OR, 1.15; 95% CI, 1.01-1.30), these associations became insignificant after additional adjustment for ocular, demographic and parental factors. Conclusions The present study provides large-scale, population-based evidence showing no independent association between refractive anisometropia and near work habits, though myopia is associated with refractive anisometropia.	[Lee, Chia-Wei; Hsu, Chih-Chien; Liu, Catherine Jui-Ling] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Fang, Shao-You] Natl Taiwan Univ, Children & Family Res Ctr, Taipei, Taiwan; [Tsai, Der-Chong; Chiu, Allen Wen-Hsiang; Liu, Catherine Jui-Ling] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Tsai, Der-Chong] Natl Yang Ming Univ Hosp, Dept Ophthalmol, Yilan, Taiwan; [Huang, Nicole] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan; [Hsu, Chih-Chien] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Chen, Shing-Yi] Taipei City Govt, Dept Hlth, Taipei, Taiwan	Taipei Veterans General Hospital; National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Liu, CJL (corresponding author), Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.; Tsai, DC; Liu, CJL (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Tsai, DC (corresponding author), Natl Yang Ming Univ Hosp, Dept Ophthalmol, Yilan, Taiwan.	11803@ymuh.ym.edu.tw; jlliu@vghtpe.gov.tw		Huang, Nicole/0000-0002-6629-1176	Taipei City Government [H10237, P10303]	Taipei City Government	The present study was supported by grants H10237 and P10303 from the Taipei City Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afsari S, 2013, BRIT J OPHTHALMOL, V97, P1095, DOI 10.1136/bjophthalmol-2012-302637; Bailey MD, 2008, INVEST OPHTH VIS SCI, V49, P4353, DOI 10.1167/iovs.08-2008; Borchert M, 2010, OPHTHALMOLOGY, V117, P148, DOI 10.1016/j.ophtha.2009.06.008; Deng L, 2012, INVEST OPHTH VIS SCI, V53, P3782, DOI 10.1167/iovs.11-8727; GEE SS, 1988, OPHTHALMOLOGY, V95, P1276; Ghosh A, 2014, OPTOMETRY VISION SCI, V91, P322, DOI 10.1097/OPX.0000000000000166; Giordano L, 2009, OPHTHALMOLOGY, V116, P739, DOI 10.1016/j.ophtha.2008.12.030; Guzowski M, 2003, AM J OPHTHALMOL, V136, P551, DOI 10.1016/S0002-9394(03)00246-0; Hsu CC, 2016, J CHIN MED ASS, P30078; Hu YY, 2016, INVEST OPHTH VIS SCI, V57, P979, DOI 10.1167/iovs.15-18647; Huang HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140419; Huang Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114910, 10.1371/journal.pone.0131053]; Huynh SC, 2006, BRIT J OPHTHALMOL, V90, P597, DOI 10.1136/bjo.2005.083154; Kuchem MK, 2013, OPTOMETRY VISION SCI, V90, P1312, DOI 10.1097/OPX.0000000000000070; Lewis HA, 2012, OPTOMETRY VISION SCI, V89, P727, DOI 10.1097/OPX.0b013e318253de7e; Lin Z, 2013, OPHTHAL PHYSL OPT, V33, P311, DOI 10.1111/opo.12049; Mallen EAH, 2006, INVEST OPHTH VIS SCI, V47, P1251, DOI 10.1167/iovs.05-1086; Mutti DO, 2002, INVEST OPHTH VIS SCI, V43, P3633; O'Donoghue L, 2013, INVEST OPHTH VIS SCI, V54, P602, DOI 10.1167/iovs.12-11066; Ojaimi E, 2005, OPHTHAL EPIDEMIOL, V12, P59, DOI 10.1080/09286580490921296; PARSSINEN O, 1990, OPTOMETRY VISION SCI, V67, P256, DOI 10.1097/00006324-199004000-00005; Qin XJ, 2005, INVEST OPHTH VIS SCI, V46, P4024, DOI 10.1167/iovs.05-0120; Read SA, 2010, INVEST OPHTH VIS SCI, V51, P6262, DOI 10.1167/iovs.10-5457; Saw SM, 2002, ARCH OPHTHALMOL-CHIC, V120, P620, DOI 10.1001/archopht.120.5.620; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P332; Sherwin JC, 2012, OPHTHALMOLOGY, V119, P2141, DOI 10.1016/j.ophtha.2012.04.020; SORSBY A, 1962, VISION RES, V2, P43, DOI 10.1016/0042-6989(62)90062-7; Swarbrick HA, 2015, OPHTHALMOLOGY, V122, P620, DOI 10.1016/j.ophtha.2014.09.028; Tong L, 2006, INVEST OPHTH VIS SCI, V47, P3247, DOI 10.1167/iovs.05-0906; Tsai DC, 2015, CLIN EXP OPHTHALMOL, V43, P612, DOI 10.1111/ceo.12532; VONNOORDEN GK, 1987, INVEST OPHTH VIS SCI, V28, P750; Weale RA, 2002, OPHTHALMIC RES, V34, P389, DOI 10.1159/000067040; Woodman EC, 2011, BRIT J OPHTHALMOL, V95, P652, DOI 10.1136/bjo.2010.180323; Yamashita T, 1999, OPHTHAL PHYSL OPT, V19, P30, DOI 10.1046/j.1475-1313.1998.00407.x; Yekta A, 2010, CLIN EXP OPHTHALMOL, V38, P242, DOI 10.1111/j.1442-9071.2010.02247.x	35	9	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173519	10.1371/journal.pone.0173519	http://dx.doi.org/10.1371/journal.pone.0173519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273153	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700012
J	Lee, DH; Seubert, S; Huhn, K; Brecht, L; Rotger, C; Waschbisch, A; Schlachetzki, J; Klausmeyer, A; Melms, A; Wiese, S; Winkler, J; Linker, RA				Lee, De-Hyung; Seubert, Silvia; Huhn, Konstantin; Brecht, Lukas; Roetger, Caroline; Waschbisch, Anne; Schlachetzki, Johannes; Klausmeyer, Alice; Melms, Arthur; Wiese, Stefan; Winkler, Juergen; Linker, Ralf A.			Fingolimod effects in neuroinflammation: Regulation of astroglial glutamate transporters?	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; OLIGODENDROCYTE PROGENITOR CELLS; MULTIPLE-SCLEROSIS LESIONS; CENTRAL-NERVOUS-SYSTEM; 1-PHOSPHATE RECEPTOR 1; RAT MODEL; FTY720; SPHINGOSINE; PROLIFERATION; EXPRESSION	Fingolimod is an oral sphingosine-1-phosphate-receptor modulator which reduces the recirculation of immune cells and may also directly target glial cells. Here we investigate effects of fingolimod on expression of astroglial glutamate transporters under pro-inflammatory conditions. In astrocyte cell culture, the addition of pro-inflammatory cytokines led to a significant downregulation of glutamate transporters glutamate transporter-1 ( slc1a2/SLC1A2) and glutamate aspartate transporter ( slc1a3/SLC1A3) expression on the mRNA or protein level. In this setting, the direct application of fingolimod-1 phosphate ( F1P) on astrocytes did not change expression levels of slc1a2 and slc1a3 mRNA. The analysis of both transporters on the protein level by Western Blot and immunocytochemistry did also not reveal any effect of F1P. On a functional level, the addition of conditioned supernatants from F1P treated astrocytes to neuronal cell culture did not result in increased neurite growth. In experimental autoimmune encephalomyelitis as a model of multiple sclerosis, fingolimod treatment reduced T cell and macrophages/microglia mediated inflammation and also diminished astrocyte activation. At the same time, fingolimod restored the reduced expression of slc1a2 and slc1a3 in the inflamed spinal cord on the mRNA level and of SLC1A2 and SLC1A3 on the protein level, presumably via indirect, anti-inflammatory mechanisms. These findings provide further evidence for a predominantly peripheral effect of the compound in neuroinflammation.	[Lee, De-Hyung; Seubert, Silvia; Huhn, Konstantin; Brecht, Lukas; Roetger, Caroline; Waschbisch, Anne; Melms, Arthur; Linker, Ralf A.] Friedrich Alexander Univ, Dept Neurol, Erlangen, Germany; [Schlachetzki, Johannes; Winkler, Juergen] Friedrich Alexander Univ, Dept Mol Neurol, Erlangen, Germany; [Klausmeyer, Alice; Wiese, Stefan] Ruhr Univ, Inst Mol Neurobiol, Bochum, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Ruhr University Bochum	Lee, DH (corresponding author), Friedrich Alexander Univ, Dept Neurol, Erlangen, Germany.	de-hyung.lee@uk-erlangen.de	Linker, Ralf/AAD-8884-2020	Winkler, Jurgen/0000-0003-0630-9204	Deutsche Forschungsgemeinschaft (DFG); Novartis Pharma Germany; Novartis Pharma	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Novartis Pharma Germany; Novartis Pharma	The microscope used in this study was funded by the Deutsche Forschungsgemeinschaft (DFG). Novartis Pharma Germany supported previous research on fingolimod and provided fingolimod-1 phosphate for the present study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Katrin Bitterer, the Department of Neurology, University Hospital Erlangen, for expert technical assistance. RAL holds an endowed professorship supported by Novartis Pharma.	Al-Izki S, 2011, MULT SCLER J, V17, P939, DOI 10.1177/1352458511400476; Balatoni B, 2007, BRAIN RES BULL, V74, P307, DOI 10.1016/j.brainresbull.2007.06.023; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Brunkhorst R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070124; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Colombo E, 2014, ANN NEUROL, V76, P325, DOI 10.1002/ana.24217; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Ettle B, 2014, MOL CELL NEUROSCI, V62, P68, DOI 10.1016/j.mcn.2014.06.012; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; Foster CA, 2009, BRAIN PATHOL, V19, P254, DOI 10.1111/j.1750-3639.2008.00182.x; Fujino M, 2003, J PHARMACOL EXP THER, V305, P70, DOI 10.1124/jpet.102.045658; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Herrero-Herranz E, 2007, AM J PATHOL, V171, P589, DOI 10.2353/ajpath.2007.061241; Kanno T, 2011, LIFE SCI, V89, P137, DOI 10.1016/j.lfs.2011.05.021; Kataoka H, 2005, CELL MOL IMMUNOL, V2, P439; Korn T, 2005, FASEB J, V19, P1878, DOI 10.1096/fj.05-3748fje; Korn T, 2007, NEUROMOL MED, V9, P1, DOI 10.1385/NMM:9:1:1; Kraft P, 2013, STROKE, V44, P3202, DOI 10.1161/STROKEAHA.113.002880; Linker RA, 2010, BRAIN, V133, P2248, DOI 10.1093/brain/awq179; Liu Jing, 2013, J Toxicol, V2013, P967029, DOI 10.1155/2013/967029; Lublin F, 2016, LANCET, V387, P1075, DOI 10.1016/S0140-6736(15)01314-8; Mandolesi G, 2013, J NEUROSCI, V33, P12105, DOI 10.1523/JNEUROSCI.5369-12.2013; Miron VE, 2008, ANN NEUROL, V63, P61, DOI 10.1002/ana.21227; Mullershausen F, 2007, J NEUROCHEM, V102, P1151, DOI 10.1111/j.1471-4159.2007.04629.x; Newcombe J, 2008, BRAIN PATHOL, V18, P52, DOI 10.1111/j.1750-3639.2007.00101.x; Papadopoulos D, 2010, J NEUROSCI RES, V88, P346, DOI 10.1002/jnr.22196; Pitt D, 2003, NEUROLOGY, V61, P1113, DOI 10.1212/01.WNL.0000090564.88719.37; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Rolland WB, 2013, EXP NEUROL, V241, P45, DOI 10.1016/j.expneurol.2012.12.009; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Van Doorn R, 2010, GLIA, V58, P1465, DOI 10.1002/glia.21021; Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; Woodcock JM, 2010, CELL SIGNAL, V22, P1291, DOI 10.1016/j.cellsig.2010.04.004; Yan XS, 2014, GLIA, V62, P1093, DOI 10.1002/glia.22665; Zhang J, 2015, NEUROBIOL DIS, V76, P57, DOI 10.1016/j.nbd.2015.01.006	37	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171552	10.1371/journal.pone.0171552	http://dx.doi.org/10.1371/journal.pone.0171552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273090	gold, Green Published, Green Submitted			2022-12-27	WOS:000396073700058
J	Li, R; Wang, H; Pan, XH; Ma, QQ; Chen, L; Zhou, X; Jiang, TT; He, L; Chen, JF; Zhang, XL; Luo, Y; Xi, SJ; Lv, X; Xia, SC				Li, Runhua; Wang, Hui; Pan, Xiaohong; Ma, Qiaoqin; Chen, Lin; Zhou, Xin; Jiang, Tingting; He, Lin; Chen, Junfang; Zhang, Xingliang; Luo, Yan; Xi, Shengjun; Lv, Xin; Xia, Shichang			Prevalence of condomless anal intercourse and recent HIV testing and their associated factors among men who have sex with men in Hangzhou, China: A respondent-driven sampling survey	PLOS ONE			English	Article							RISK BEHAVIOR; SOCIAL SUPPORT; HUNAN PROVINCE; BLACK-MEN; PREVENTION; INFECTION; TRANSMISSION; METAANALYSIS; MSM; PROBABILITY	Men who have sex with men (MSM) are a large high-risk population for HIV infection in recent years in China. A cross-sectional survey was conducted in Hangzhou, China, to determine rates of condomless anal intercourse (CAI), recent HIV testing (in the recent year) and associated factors using respondent-driven sampling. Questionnaires using face-to-face interviews were employed to collect data on sexual risk behaviors and HIV testing. Five hundred eleven MSM were recruited, of which 459 (89.8%) had anal intercourse in the past 6 months. Of these 459 participants, 457 (99.6%) answered whether they had taken an HIV test in the recent year, so only their data were analyzed. Weighted data were analyzed using bivariate and multivariate logistic regression analysis. The CAI rate with male partners in the past 6 months was 43.7% (95% confidence interval [CI], 34.0-51.5%), while the rate of condomless vaginal intercourse (CVI) was 21.6% (95% CI, 15.6-32.3%). The prevalence of recent HIV testing was 56.8% (95% CI, 48.7-66.5%), while the prevalence of HIV and syphilis were 8.8% and 6.5%, respectively. Multivariate analysis indicated that CAI was associated with earlier homosexual debut, suicidal inclinations, childhood sexual abuse, HIV testing in the recent year, and lower estimate of HIV prevalence. Recent HIV testing was associated with homosexual debut age, engaging in CAI with male partners in the past 6 months, having oral sex in the past 6 months, self-perceived higher likelihood of HIV infection, knowing about antiretroviral therapy for HIV/AIDS, receiving AIDS/sexually transmitted infection (STI) interventions in the past year, and syphilis infection. Given high prevalence of HIV and syphilis, high levels of CAI and CVI, and low HIV testing rate, the results indicated high risk of HIV infection and transmission among MSM. HIV prevention interventions should target MSM with early homosexual debut and psychosocial health problems, while HIV/AIDS education among MSM should focus on increasing knowledge of HIV risk, estimated HIV prevalence and antiretroviral therapy, and improving risk perception of HIV acquisition.	[Li, Runhua; Wang, Hui; Pan, Xiaohong; Ma, Qiaoqin; Chen, Lin; Zhou, Xin; Jiang, Tingting; He, Lin; Xia, Shichang] Zhejiang Prov Ctr Dis Control & Prevent, Dept HIV AIDS & STDs Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Li, Runhua] Ningbo Univ, Sch Med, Dept Epidemiol & Hlth Stat, Ningbo, Zhejiang, Peoples R China; [Chen, Junfang; Zhang, Xingliang; Luo, Yan] Ctr Dis Control & Prevent Hangzhou City, Hangzhou, Zhejiang, Peoples R China; [Xi, Shengjun; Lv, Xin] Ctr Dis Control & Prevent Xiacheng Dist, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Ningbo University	Xia, SC (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept HIV AIDS & STDs Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	shchxia@cdc.zj.cn		Li, Runhua/0000-0003-1971-0726	Special Project of Major Science and Technology of Zhejiang Province, China [2013C03047-1]	Special Project of Major Science and Technology of Zhejiang Province, China	The study was funded by Special Project of Major Science and Technology of Zhejiang Province, China (2013C03047-1 (http://www.zjkjt.gov.cn/news/node01/detail0101/2013/010148798.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D, 2012, LANCET, V380, P439, DOI 10.1016/S0140-6736(12)60920-9; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Balthasar H, 2009, ARCH SEX BEHAV, V38, P1000, DOI 10.1007/s10508-008-9382-5; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; BROWNE A, 1986, PSYCHOL BULL, V99, P66, DOI 10.1037/0033-2909.99.1.66; Buttram ME, 2013, J COMMUN HEALTH, V38, P62, DOI 10.1007/s10900-012-9582-8; Center for Disease Control and Prevention of Zhejiang Province, 2013, ANN REP HIV EP SURV; Centers for Disease Control and Prevention, 2013, COND STDS FACT SHEET; Chow EPF, 2015, AIDS CARE, V27, P1332, DOI 10.1080/09540121.2015.1058892; Chow EPF, 2010, JAIDS-J ACQ IMM DEF, V55, pE32, DOI 10.1097/QAI.0b013e3181f3d3c1; Clark JL, 2008, SEX TRANSM INFECT, V84, P449, DOI 10.1136/sti.2008.031310; Darbes LA, 2005, HEALTH PSYCHOL, V24, P617, DOI 10.1037/0278-6133.24.6.617; Darbes LA, 2012, AIDS BEHAV, V16, P159, DOI 10.1007/s10461-010-9868-8; Fonner VA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001224.pub4; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; Horth RZ, 2015, AIDS BEHAV, V19, P1978, DOI 10.1007/s10461-015-1044-8; Huang Qin, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P1297; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Johnson WD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001230.pub2; Kelly JA, 2010, AIDS EDUC PREV, V22, P483, DOI 10.1521/aeap.2010.22.6.483; Kendall C, 2008, AIDS BEHAV, V12, pS97, DOI 10.1007/s10461-008-9390-4; Lee E, 2013, GAY COMMUNITY PERIOD, P1; Li R, 2016, HEALTH PSYCHOL, V35, P148, DOI 10.1037/hea0000265; Li XF, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000124; Ma QQ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2591-7; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V51, P340, DOI 10.1097/QAI.0b013e3181a24b38; National Health and Family Planning Commission of the People's Republic of China, 2015, 2015 CHIN AIDS RESP; Outlaw AY, 2011, AIDS PATIENT CARE ST, V25, pS23, DOI 10.1089/apc.2011.9879; Pan XH, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008466; Paz-Bailey G, 2013, MMWR-MORBID MORTAL W, V62, P958; Smith DK, 2015, JAIDS-J ACQ IMM DEF, V68, P337, DOI 10.1097/QAI.0000000000000461; State Council AIDS Working Committee Office (SCAWCO), 2012, 2012 CHIN AIDS RESP, P1; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Tang WM, 2013, AIDS BEHAV, V17, P1415, DOI 10.1007/s10461-013-0413-4; Trapence G, 2012, LANCET, V380, P400, DOI 10.1016/S0140-6736(12)60834-4; Valdiserri RO, 2007, PLOS MED, V4, P975, DOI 10.1371/journal.pmed.0040200; van Kesteren NMC, 2007, PATIENT EDUC COUNS, V65, P5, DOI 10.1016/j.pec.2006.09.003; Volz E, 2008, J OFF STAT, V24, P79; Wei CY, 2012, SEX TRANSM INFECT, V88, P622, DOI 10.1136/sextrans-2012-050619; Wejnert C, 2009, SOCIOL METHODOL, V39, P73, DOI 10.1111/j.1467-9531.2009.01216.x; Williamson LM, 2009, SEX TRANSM INFECT, V85, P550, DOI 10.1136/sti.2008.033886; World Health Organization, 2011, PREVENTION TREATMENT; World Health Organization (WHO), 2010, COND HIV PREV; Xing JM, 2008, CHINESE MED J-PEKING, V121, P2342, DOI 10.1097/00029330-200811020-00023; Xu JJ, 2011, SEX TRANSM DIS, V38, P89, DOI 10.1097/OLQ.0b013e3181f0bc5e; Zhao YJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000534; Zhong F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103136; Zhu YX, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3076-z; Zou HC, 2012, AIDS BEHAV, V16, P1717, DOI 10.1007/s10461-012-0225-y	52	19	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0167730	10.1371/journal.pone.0167730	http://dx.doi.org/10.1371/journal.pone.0167730			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273077	gold, Green Published, Green Submitted			2022-12-27	WOS:000396073700089
J	van Ravenzwaaij, D; Ioannidis, JPA				van Ravenzwaaij, Don; Ioannidis, John P. A.			A simulation study of the strength of evidence in the recommendation of medications based on two trials with statistically significant results	PLOS ONE			English	Article							P-VALUES; CONFIDENCE-INTERVALS; RANDOMIZED-TRIALS; CLINICAL-TRIALS; HYPOTHESIS; TESTS	A typical rule that has been used for the endorsement of new medications by the Food and Drug Administration is to have two trials, each convincing on its own, demonstrating effectiveness. "Convincing" may be subjectively interpreted, but the use of p-values and the focus on statistical significance (in particular with p < .05 being coined significant) is pervasive in clinical research. Therefore, in this paper, we calculate with simulations what it means to have exactly two trials, each with p < .05, in terms of the actual strength of evidence quantified by Bayes factors. Our results show that different cases where two trials have a p-value below .05 have wildly differing Bayes factors. Bayes factors of at least 20 in favor of the alternative hypothesis are not necessarily achieved and they fail to be reached in a large proportion of cases, in particular when the true effect size is small (0.2 standard deviations) or zero. In a non-trivial number of cases, evidence actually points to the null hypothesis, in particular when the true effect size is zero, when the number of trials is large, and when the number of participants in both groups is low. We recommend use of Bayes factors as a routine tool to assess endorsement of new medications, because Bayes factors consistently quantify strength of evidence. Use of p-values may lead to paradoxical and spurious decision-making regarding the use of new medications.	[van Ravenzwaaij, Don] Univ Groningen, Dept Psychol, Groningen, Netherlands; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA	University of Groningen; Stanford University; Stanford University; Stanford University; Stanford University	van Ravenzwaaij, D (corresponding author), Univ Groningen, Dept Psychol, Groningen, Netherlands.	d.van.ravenzwaaij@rug.nl	Ioannidis, John P. A./G-9836-2011	Ioannidis, John P./0000-0003-3118-6859; van Ravenzwaaij, Don/0000-0002-5030-4091				[Anonymous], 2016, JASP COMP PROGR VERS; Campbell G, 2011, J BIOPHARM STAT, V21, P871, DOI 10.1080/10543406.2011.589638; Cassey P, 2016, PSYCHON B REV; Chavalarias D, 2016, JAMA-J AM MED ASSOC, V315, P1141, DOI 10.1001/jama.2016.1952; FDA, 2016, TETR; Food and Drug Administration, 1998, GUID IND PROV CLIN E; Gamalo MA, 2016, STAT METHODS MED RES, V25, P221, DOI 10.1177/0962280212448723; Gamalo-Siebers M, 2016, J BIOPHARM STAT, V26, P1; Gamerman D, 2006, MARKOV CHAIN MONTE C; Gigerenzer G., 2004, J SOCIO-ECON, V33, P587, DOI DOI 10.1016/J.SOCEC.2004.09.033; GOODMAN SN, 1993, AM J EPIDEMIOL, V137, P485, DOI 10.1093/oxfordjournals.aje.a116700; Goodman SN, 1999, ANN INTERN MED, V130, P1005, DOI 10.7326/0003-4819-130-12-199906150-00019; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Hobbs BP, 2008, J BIOPHARM STAT, V18, P54, DOI 10.1080/10543400701668266; Hoekstra R, 2014, PSYCHON B REV, V21, P1157, DOI 10.3758/s13423-013-0572-3; Ioannidis JPA, 2011, SCIENCE, V334, P1230, DOI 10.1126/science.1211811; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jeffreys H., 1998, THEORY PROBABILITY; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katz Russell, 2004, NeuroRx, V1, P307, DOI 10.1007/BF03206615; Monden R, 2016, INT J METHODS PSYCHI; Mueller PS, 2007, ANN INTERN MED, V146, P878, DOI 10.7326/0003-4819-146-12-200706190-00009; O'Hagan A., 2004, KENDALLS ADV THEOR B, V2B; Pennello G, 2008, J BIOPHARM STAT, V18, P81, DOI 10.1080/10543400701668274; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Schiller P, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-214; Scott JA, 2011, J BIOPHARM STAT, V21, P1030, DOI 10.1080/10543406.2011.590924; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Zaslavsky BG, 2013, BIOMETRICS, V69, P157, DOI 10.1111/j.1541-0420.2012.01806.x	34	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173184	10.1371/journal.pone.0173184	http://dx.doi.org/10.1371/journal.pone.0173184			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273140	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700043
J	Zinni, M; Zuena, AR; Marconi, V; Petrella, C; Fusco, I; Giuli, C; Canu, N; Severini, C; Broccardo, M; Theodorou, V; Lattanzi, R; Casolini, P				Zinni, Manuela; Zuena, Anna Rita; Marconi, Veronica; Petrella, Carla; Fusco, Ilaria; Giuli, Chiara; Canu, Nadia; Severini, Cinzia; Broccardo, Maria; Theodorou, Vassilia; Lattanzi, Roberta; Casolini, Paola			Maternal exposure to low levels of corticosterone during lactation protects adult rat progeny against TNBS-induced colitis: A study on GR-mediated anti-inflammatory effect and prokineticin system	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INDUCED LEUCINE-ZIPPER; NF-KAPPA-B; PSYCHOSOCIAL STRESS; ULCERATIVE-COLITIS; LIFE EVENTS; INTESTINAL INFLAMMATION; RELAPSE; ACTIVATION; HORMONE	The early phase of life represents a critical period for the development of an organism. Interestingly, early life experiences are able to influence the development of the gastrointestinal tract and the reactivity to colonic inflammatory stress. We recently demonstrated that adult male rats exposed to low doses of corticosterone during lactation (CORT-nursed rats) are protected against experimental colitis induced by the intracolonic infusion of 2,4,6-trinitrobenzenesulfonic acid (TNBS). Based on these interesting results, we wanted to better investigate which cellular actors could be involved in the protection of CORT-nursed rats from TNBS-induced experimental colitis. Therefore, in the present work, we focused our attention on different factors implicated in GR-mediated anti-inflammatory effect. To address this issue, colonic tissues, collected from control and CORT-nursed healthy animals and from control and CORT-nursed colitic rats, were processed and the following inflammatory factors were evaluated: the expression of (i) glucocorticoid receptors (GR), (ii) glucocorticoid-induced leucine zipper (GILZ), (iii) phospho-p65NF-kappa B, (iv) the pro-inflammatory cytokines IL-1 beta and TNF-alpha, (v) the prokineticins PK2 and PK2L and (vi) their receptors PKR1 and PKR2. We found that adult CORT-nursed rats, in comparison to controls, showed increased expression of colonic GR and reduced expression of pro-inflammatory molecules (IL-1 beta, TNF-alpha, PK2 and PK2L) in response to inflammatory colitis. The observed changes were associated with an increase in GILZ colonic expression and with a reduction in phospo-p65NF-kappa B colonic expression.	[Zinni, Manuela; Zuena, Anna Rita; Marconi, Veronica; Fusco, Ilaria; Giuli, Chiara; Broccardo, Maria; Lattanzi, Roberta; Casolini, Paola] Univ Roma La Sapienza, Dept Physiol & Pharmacol Vittorio Erspamer, Rome, Italy; [Petrella, Carla; Canu, Nadia; Severini, Cinzia] CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Canu, Nadia] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Theodorou, Vassilia] INRA, UMR TOXALIM Neurogastroenterol & Nutr Team, El Purpan, Toulouse, France	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); University of Rome Tor Vergata; INRAE	Casolini, P (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol Vittorio Erspamer, Rome, Italy.	paola.casolini@uniroma1.it	Petrella, Carla/AAX-1265-2020; Severini, Cinzia/AAX-3569-2020	Petrella, Carla/0000-0003-0651-1816; Severini, Cinzia/0000-0002-6932-704X; FUSCO, Ilaria/0000-0002-8175-6939	 [000126_14_Ateneo 2014 Casolini]		This work was supported by the "000126_14_Ateneo 2014 Casolini" grant.	Ahmad T, 2004, GASTROENTEROLOGY, V126, P1533, DOI 10.1053/j.gastro.2004.01.061; ANGELUCCI L, 1985, NEUROBEH TOXICOL TER, V7, P511; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Bach O, 1990, Z Gesamte Hyg, V36, P442; Barreau F, 2004, GUT, V53, P501, DOI 10.1136/gut.2003.024174; Bereshchenko O, 2014, CELL REP, V7, P464, DOI 10.1016/j.celrep.2014.03.004; BIFULCO A, 1991, BRIT J PSYCHIAT, V159, P115, DOI 10.1192/bjp.159.1.115; Bitton A, 2008, GUT, V57, P1386, DOI 10.1136/gut.2007.134817; Bitton A, 2003, AM J GASTROENTEROL, V98, P2203, DOI 10.1016/S0002-9270(03)00750-0; Cannarile L, 2009, GASTROENTEROLOGY, V136, P530, DOI 10.1053/j.gastro.2008.09.024; Casolini P, 2007, J NEUROSCI, V27, P7041, DOI 10.1523/JNEUROSCI.1074-07.2007; Catalani A, 2011, NEUROSCI BIOBEHAV R, V35, P1502, DOI 10.1016/j.neubiorev.2010.10.017; Chen JC, 2005, MOL PHARMACOL, V67, P2070, DOI 10.1124/mol.105.011619; Collins SM, 2001, AM J PHYSIOL-GASTR L, V280, pG315, DOI 10.1152/ajpgi.2001.280.3.G315; DUFFY LC, 1991, BEHAV MED, V17, P101, DOI 10.1080/08964289.1991.9937553; Ergang P, 2008, DIGEST DIS SCI, V53, P2160, DOI 10.1007/s10620-007-0125-6; FAVA GA, 1977, PSYCHOTHER PSYCHOSOM, V27, P93; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; GARRETT VD, 1991, J BEHAV MED, V14, P87, DOI 10.1007/BF00844770; Giannini E, 2009, P NATL ACAD SCI USA, V106, P14646, DOI 10.1073/pnas.0903720106; GREENE BR, 1994, BEHAV RES THER, V32, P217, DOI 10.1016/0005-7967(94)90114-7; Gue M, 1997, AM J PHYSIOL-GASTR L, V272, pG84, DOI 10.1152/ajpgi.1997.272.1.G84; Inman CF, 2005, J IMMUNOL METHODS, V302, P156, DOI 10.1016/j.jim.2005.05.005; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kisliouk T, 2005, ANN ANAT, V187, P529, DOI 10.1016/j.aanat.2005.07.005; Lattanzi R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/301292; Levenstein S, 2000, AM J GASTROENTEROL, V95, P1213, DOI 10.1111/j.1572-0241.2000.02012.x; Li J, 2004, AM J GASTROENTEROL, V99, P1129, DOI 10.1111/j.1572-0241.2004.04155.x; Maccari S, 2014, J NEUROENDOCRINOL, V26, P707, DOI 10.1111/jne.12175; Maftei D, 2014, BRIT J PHARMACOL, V171, P4850, DOI 10.1111/bph.12793; Marsango S, 2009, PEPTIDES, V30, P2182, DOI 10.1016/j.peptides.2009.09.007; Milde AM, 2004, PHYSIOL BEHAV, V81, P71, DOI 10.1016/j.physbeh.2004.01.002; MORTEAU O, 1994, DIGEST DIS SCI, V39, P1239, DOI 10.1007/BF02093789; Negri L, 2011, CURR PHARM BIOTECHNO, V12, P1720, DOI 10.2174/138920111798357410; NORTH CS, 1991, ANN INTERN MED, V114, P381, DOI 10.7326/0003-4819-114-5-381; PAAR GH, 1988, PSYCHOTHER PSYCH MED, V38, P376; Petrella C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113389; Qiu BS, 1999, NAT MED, V5, P1178, DOI 10.1038/13503; Reber SO, 2006, ENDOCRINOLOGY, V147, P4968, DOI 10.1210/en.2006-0347; Riccardi C, 2001, ADV EXP MED BIOL, V495, P31; RILEY SA, 1990, GUT, V31, P179, DOI 10.1136/gut.31.2.179; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Ronchetti S, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00170; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; SCHULMAN G, 1994, AM J PHYSIOL, V266, pC729, DOI 10.1152/ajpcell.1994.266.3.C729; Shanahan F, 2001, GASTROENTEROLOGY, V120, P622, DOI 10.1053/gast.2001.22122; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Targownik LE, 2015, AM J GASTROENTEROL, V110, P1001, DOI 10.1038/ajg.2015.147; vanTol EAF, 1996, GUT, V39, P385, DOI 10.1136/gut.39.3.385; Veenema AH, 2008, ENDOCRINOLOGY, V149, P2727, DOI 10.1210/en.2007-1469; Vidal A, 2006, AM J GASTROENTEROL, V101, P775, DOI 10.1111/j.1572-0241.2006.00476.x; VONWIETERSHEIM J, 1992, PSYCHOTHER PSYCHOSOM, V58, P103, DOI 10.1159/000288617; Watson RP, 2012, NEUROGASTROENT MOTIL, V24, P65, DOI 10.1111/j.1365-2982.2011.01804.x; Watson RP, 2012, NEUROGASTROENT MOTIL, V24, pe12, DOI DOI 10.1111/J.1365-2982.2011.01804.X; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Yorty JL, 2004, AM J PHYSIOL-REG I, V287, pR1316, DOI 10.1152/ajpregu.00685.2003	58	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173484	10.1371/journal.pone.0173484	http://dx.doi.org/10.1371/journal.pone.0173484			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5QM	28267767	Green Published, gold, Green Submitted			2022-12-27	WOS:000396060600035
J	Drummond, NM; Hayduk-Costa, G; Leguerrier, A; Carlsen, AN				Drummond, Neil M.; Hayduk-Costa, Gabrielle; Leguerrier, Alexandra; Carlsen, Anthony N.			Effector-independent reduction in choice reaction time following bi-hemispheric transcranial direct current stimulation over motor cortex	PLOS ONE			English	Article							VOLUNTARY MOVEMENT; TDCS; FACILITATION; EXCITABILITY	Increased reaction times (RT) during choice-RT tasks stem from a requirement for additional processing as well as reduced motor-specific preparatory activation. Transcranial direct current stimulation (tDCS) can modulate primary motor cortex excitability, increasing (anodal stimulation) or decreasing (cathodal stimulation) excitability in underlying cortical tissue. The present study investigated whether lateralized differences in choice-RT would result from the concurrent modulation of left and right motor cortices using bi-hemispheric tDCS. Participants completed a choice-RT task requiring either a left or right wrist extension. In forced-choice trials an illuminated target indicated the required response, whereas in free-choice trials participants freely selected either response upon illumination of a central fixation. Following a pre-test trial block, offline bi-hemispheric tDCS (1 mA) was applied over the left and right motor cortices for 10 minutes, which was followed by a post-tDCS block of RT trials. Twelve participants completed three experimental sessions, two with real tDCS (anode right, anode left), as well as a sham tDCS session. Post-tDCS results showed faster RTs for both right and left responses irrespective of tDCS polarity during forced-choice trials, while sham tDCS had no effect. In contrast, no stimulation-related RT or response selection differences were observed in free-choice trials. The present study shows evidence of an effector-independent speeding of response initiation in a forced-choice RT task following bihemispheric tDCS and yields novel information regarding the functional effect of bi-hemispheric tDCS.	[Drummond, Neil M.; Hayduk-Costa, Gabrielle; Leguerrier, Alexandra; Carlsen, Anthony N.] Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON, Canada	University of Ottawa	Carlsen, AN (corresponding author), Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON, Canada.	tony.carlsen@uottawa.ca		Carlsen, Anthony/0000-0001-6015-8991; Drummond, Neil/0000-0003-1161-4334	Natural Sciences and Engineering Research Council of Canada Discovery Grant [RGPIN: 418361-2012]; Ontario Ministry of Research and Innovation (CA) [ER14-10-133]	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Research and Innovation (CA)	This research was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant awarded to ANC (RGPIN: 418361-2012; www.nserc-crsng.gc.ca/index_eng.asp). This research is also supported by Ontario Ministry of Research and Innovation (CA), grant no. ER14-10-133 to ANC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Bolognini N, 2011, NEUROREHAB NEURAL RE, V25, P819, DOI 10.1177/1545968311411056; Bolzoni F, 2013, J PHYSIOL-LONDON, V591, P3381, DOI 10.1113/jphysiol.2012.244764; Carlsen AN, 2015, BEHAV BRAIN RES, V279, P68, DOI 10.1016/j.bbr.2014.11.009; Carlsen AN, 2012, CLIN NEUROPHYSIOL, V123, P21, DOI 10.1016/j.clinph.2011.04.028; Datta Abhishek, 2012, Front Psychiatry, V3, P91, DOI 10.3389/fpsyt.2012.00091; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hayduk-Costa G, 2013, BEHAV BRAIN RES, V257, P208, DOI 10.1016/j.bbr.2013.09.030; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; Jentzsch I, 2004, PSYCHOPHYSIOLOGY, V41, P231, DOI 10.1111/j.1469-8986.2004.00155.x; Kabakov AY, 2012, J NEUROPHYSIOL, V107, P1881, DOI 10.1152/jn.00715.2011; KLAPP ST, 1995, J EXP PSYCHOL HUMAN, V21, P1015, DOI 10.1037/0096-1523.21.5.1015; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Kumru H, 2006, NEUROSCI LETT, V406, P66, DOI 10.1016/j.neulet.2006.07.012; Kuo HI, 2013, BRAIN STIMUL, V6, P644, DOI 10.1016/j.brs.2012.09.010; Leuthold H, 2004, J PSYCHOPHYSIOL, V18, P77, DOI 10.1027/0269-8803.18.23.77; McCambridge AB, 2014, J NEUROPHYSIOL, V111, P2187, DOI 10.1152/jn.00879.2013; Molinuevo JL, 2000, CLIN NEUROPHYSIOL, V111, P2008, DOI 10.1016/S1388-2457(00)00443-0; Mordillo-Mateos L, 2012, BRAIN STIMUL, V5, P214, DOI 10.1016/j.brs.2011.05.001; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; Paquette C, 2011, J CEREBR BLOOD F MET, V31, P2086, DOI 10.1038/jcbfm.2011.72; Sehm B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00183; Sommer MA, 2003, CURR OPIN NEUROBIOL, V13, P663, DOI 10.1016/j.conb.2003.10.014; Vines BW, 2006, NEUROREPORT, V17, P671, DOI 10.1097/00001756-200604240-00023; Waters-Metenier S, 2014, J NEUROSCI, V34, P1037, DOI 10.1523/JNEUROSCI.2282-13.2014; Williams JA, 2010, PHYS THER, V90, P398, DOI 10.2522/ptj.20090075	29	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172714	10.1371/journal.pone.0172714	http://dx.doi.org/10.1371/journal.pone.0172714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28263998	Green Submitted, Green Published, gold			2022-12-27	WOS:000396054300016
J	Kebede, HK; Gesesew, HA; Woldehaimanot, TE; Goro, KK				Kebede, Hafte Kahsay; Gesesew, Hailay Abrha; Woldehaimanot, Tewodros Eyob; Goro, Kabaye Kumela			Antimicrobial use in paediatric patients in a teaching hospital in Ethiopia	PLOS ONE			English	Article							ANTIBIOTIC USE; PRESCRIPTIONS; SURVEILLANCE; CHILDREN; EUROPE	Background Antibiotics use in in children are different from adults due to a lack of data on pharmacokinetics, pharmacodynamics, efficacy and safety of drugs, different physiological spectrum, pediatrics populations being vulnerable to the majority of the illnesses, and the adverse effect of their irrational use is more serious. However, antibiotic use is not explored much in a paediatric population. The current study focused on antibiotic use among pediatric population using data from a tertiary hospital in Ethiopia. Methods A retrospective cross-sectional study collated data from 614 pediatrics patients admitted in pediatrics ward at Jimma University Teaching Hospital, Southwest Ethiopia. Descriptive analyses were performed to describe the type and pattern of antibiotics. The number of prescriptions per a patient was also compared with the WHO standard. Data analysis was carried out using SPSS version 20 for mackintosh. Results Antimicrobials were prescribed for 407(86.4%) patients of which 85.9% were in the form of injectables. A total of 1241 (90%) medicines were administered parenterally followed by oral 110 (8%). The maximum number of medicines per prescription was eight for all types of drugs in general, and five for antimicrobials in particular. All antimicrobials were prescribed empirically without any microbiological evidence. Pneumonia, sepsis and meningitis were the main reasons for antimicrobial use in the ward. Out of the total of 812 antibiotics prescribed; Penicillin G crystalline was the most (20%) frequently prescribed, followed by gentamicin (19%) and ampicillin (16). Conclusions Majority of the prescribed antibiotics were antimicrobials, and was in the form of injectables. Antimicrobials were over prescribed and the number of drugs per prescription was also far from WHO recommendation. Strict prescribing standard guidelines and treatment habits should be developed in the country, to prevent antimicrobial resistance.	[Kebede, Hafte Kahsay] Filtu Hosp, Somali, Ethiopia; [Gesesew, Hailay Abrha] Jimma Univ, Dept Epidemiol, Coll Hlth Sci, Jimma, Ethiopia; [Gesesew, Hailay Abrha] Flinders Univ S Australia, Discipline Publ Hlth, Fac Med Nursing & Hlth Sci, Adelaide, SA, Australia; [Woldehaimanot, Tewodros Eyob; Goro, Kabaye Kumela] Jimma Univ, Dept Clin Pharm, Coll Hlth Sci, Jimma, Ethiopia	Jimma University; Flinders University South Australia; Jimma University	Gesesew, HA (corresponding author), Jimma Univ, Dept Epidemiol, Coll Hlth Sci, Jimma, Ethiopia.; Gesesew, HA (corresponding author), Flinders Univ S Australia, Discipline Publ Hlth, Fac Med Nursing & Hlth Sci, Adelaide, SA, Australia.	hailushepi@gmail.com	Gesesew, Hailay/AAF-6486-2020	Gesesew, Hailay/0000-0002-3531-4400	Jimma University	Jimma University	This research was funded by Jimma University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulgafar O J, 2011, J CLIN DIAGNOSTIC RE, V5, P566; Abula T., 1999, Ethiopian Journal of Health Development, V13, P135; Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P47, DOI 10.1093/jac/dkr457; Ansam S, 2006, AN NAJAH U J RES, V20, P191; Bozic B, 2015, ARCH DIS CHILD, V100, P966, DOI 10.1136/archdischild-2015-308274; Buccellato E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139097; Cars O, 2001, LANCET, V357, P1851, DOI 10.1016/S0140-6736(00)04972-2; Ceyhan M, 2010, INT J INFECT DIS, V14, pE55, DOI 10.1016/j.ijid.2009.03.013; Desta Z, 1997, E AFR MED J, V74, P758; DiPiro JT, 2002, PHARMACOTHERAPY PATH; FDRE, 2010, HLTH SECT DEV PROGR; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Isah AO, 2004, DEV STANDARD VALUES; Jan D, 2001, HLTH ISSUES, V69, P1; Katzung B G, 2001, BASIC CLIN PHARMACOL, P200; Majed A-A, 2015, EUROPEAN SCI J, V11, P253; Mathew B, 2013, IRJIPS, V1; Menassie K, 2004, CROSS SECTIONAL SURV; Mestawot F, 2013, INT J BASIC CLIN PHA, V2, P718; Minyahil A., 2013, J APPL PHARM SCI, V3, P93; Mukonzo JK, 2013, J MULTIDISCIP HEALTH, V6, P303, DOI 10.2147/JMDH.S49075; Nwolisa CE, 2006, J TROP PEDIATRICS, V52, P197, DOI 10.1093/tropej/fmi095; Palikhe N, 2004, Kathmandu Univ Med J (KUMJ), V2, P6; Paruk F, 2012, SAMJ S AFR MED J, V102, P613, DOI 10.7196/SAMJ.5833; Raveh D, 2001, QJM-INT J MED, V94, P141, DOI 10.1093/qjmed/94.3.141; Resi D, 2003, J ANTIMICROB CHEMOTH, V52, P282, DOI 10.1093/jac/dkg302; SCHOLLENBERG E, 1980, CAN MED ASSOC J, V122, P49; Thrane N, 1999, PEDIATR INFECT DIS J, V18, P333, DOI 10.1097/00006454-199904000-00004; [WHO MoH], 2003, BAS ASS PHARM SECT E; [WHO AHO], 2016, AFR HLTH OBS WHO AN; WHO, 1985, C EXP NAIR 25 29 NOV; WHO. World Health Organization, 2010, MED RAT US MED; Wubante Y, 2005, S W ETHIOPIA ETHIOPI, V15, P147	33	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173290	10.1371/journal.pone.0173290	http://dx.doi.org/10.1371/journal.pone.0173290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264021	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300049
J	Lu, S; Mirchevska, G; Phatak, SS; Li, DM; Luka, J; Calderone, RA; Fonzi, WA				Lu, Sha; Mirchevska, Gordana; Phatak, Sayali S.; Li, Dongmei; Luka, Janos; Calderone, Richard A.; Fonzi, William A.			Dynamic time warping assessment of high-resolution melt curves provides a robust metric for fungal identification	PLOS ONE			English	Article							ACCURATE IDENTIFICATION; MEDICALLY IMPORTANT; TRANSCRIBED SPACER; DNA; REGION; PCR; SPP.; ALIGNMENTS; VALIDATION; SIMULATION	Fungal infections are a global problem imposing considerable disease burden. One of the unmet needs in addressing these infections is rapid, sensitive diagnostics. A promising molecular diagnostic approach is high-resolution melt analysis (HRM). However, there has been little effort in leveraging HRM data for automated, objective identification of fungal species. The purpose of these studies was to assess the utility of distance methods developed for comparison of time series data to classify HRM curves as a means of fungal species identification. Dynamic time warping (DTW), first introduced in the context of speech recognition to identify temporal distortion of similar sounds, is an elastic distance measure that has been successfully applied to a wide range of time series data. Comparison of HRM curves of the rDNA internal transcribed spacer (ITS) region from 51 strains of 18 fungal species using DTW distances allowed accurate classification and clustering of all 51 strains. The utility of DTW distances for species identification was demonstrated by matching HRM curves from 243 previously identified clinical isolates against a database of curves from standard reference strains. The results revealed a number of prior misclassifications, discriminated species that are not resolved by routine phenotypic tests, and accurately identified all 243 test strains. In addition to DTW, several other distance functions, Edit Distance on Real sequence (EDR) and Shape-based Distance (SBD), showed promise. It is concluded that DTW-based distances provide a useful metric for the automated identification of fungi based on HRM curves of the ITS region and that this provides the foundation for a robust and automatable method applicable to the clinical setting.	[Lu, Sha] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou, Guangdong, Peoples R China; [Mirchevska, Gordana] Univ Sts Cyril & Methodius, Inst Microbiol & Parasitol, Skopje, Macedonia; [Phatak, Sayali S.; Li, Dongmei; Calderone, Richard A.; Fonzi, William A.] Georgetown Univ, Dept Microbiol & Immunol, Washington, DC 20057 USA; [Luka, Janos] Walter Reed Army Inst Res, Silver Spring, MD USA	Sun Yat Sen University; Saints Cyril & Methodius University of Skopje; Georgetown University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Fonzi, WA (corresponding author), Georgetown Univ, Dept Microbiol & Immunol, Washington, DC 20057 USA.	fonziw@georgetown.edu						Alnuaimi AD, 2014, MOL ORAL MICROBIOL, V29, P117, DOI 10.1111/omi.12050; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arancia S, 2011, DIAGN MICR INFEC DIS, V69, P283, DOI 10.1016/j.diagmicrobio.2010.10.003; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bergman A, 2007, EUR J CLIN MICROBIOL, V26, P813, DOI 10.1007/s10096-007-0369-2; Blake RD, 1999, BIOINFORMATICS, V15, P370, DOI 10.1093/bioinformatics/15.5.370; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Chen L., 2004, P 30 INT C VER LARG, V30, P792, DOI DOI 10.1016/B978-012088469-8/50070-X; Chen L., 2005, P 2005 ACM SIGMOD IN, P491, DOI DOI 10.1145/1066157.1066213; Costa JM, 2010, J MICROBIOL METH, V80, P306, DOI 10.1016/j.mimet.2010.01.002; Decat E, 2013, RES MICROBIOL, V164, P110, DOI 10.1016/j.resmic.2012.10.017; Ding H, 2008, PROC VLDB ENDOW, V1, P1542; Dunyach C, 2008, DIAGN MICR INFEC DIS, V60, P263, DOI 10.1016/j.diagmicrobio.2007.09.014; Dwight Z, 2011, BIOINFORMATICS, V27, P1019, DOI 10.1093/bioinformatics/btr065; Erali M, 2008, EXP MOL PATHOL, V85, P50, DOI 10.1016/j.yexmp.2008.03.012; Erali M, 2010, METHODS, V50, P250, DOI 10.1016/j.ymeth.2010.01.013; Ferrari MD, 2013, J CLIN MICROBIOL, V51, P3826, DOI 10.1128/JCM.01050-13; Fraley SI, 2016, SCI REP-UK, V6, DOI 10.1038/srep19218; Gago S, 2014, MED MYCOL, V52, P470, DOI 10.1093/mmy/myu009; Gago S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-13; Gago S, 2011, J CLIN MICROBIOL, V49, P3663, DOI 10.1128/JCM.01091-11; Gee SF, 2002, J CLIN MICROBIOL, V40, P556, DOI 10.1128/JCM.40.2.556-574.2002; Giorgino T, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i07; Gundry CN, 2008, NUCLEIC ACIDS RES, V36, P3401, DOI 10.1093/nar/gkn204; Hrncirova K, 2010, J CLIN MICROBIOL, V48, P3392, DOI 10.1128/JCM.01109-10; Jackson AP, 2009, GENOME RES, V19, P2231, DOI 10.1101/gr.097501.109; Jaumot J, 2005, CHEMOMETR INTELL LAB, V76, P101, DOI 10.1016/j.chemolab.2004.12.007; Keogh E, 2003, DATA MIN KNOWL DISC, V7, P349, DOI 10.1023/A:1024988512476; Keogh E., 2006, P 32 INT C VER LARG, P882, DOI DOI 10.5555/1182635.1164203; Maechler M., 2015, CLUSTER CLUSTER ANAL; Mandviwala T, 2010, J MOL DIAGN, V12, P91, DOI 10.2353/jmoldx.2010.090085; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; Merenstein D, 2013, AIDS RES HUM RETROV, V29, P30, DOI [10.1089/aid.2012.0269, 10.1089/AID.2012.0269]; Merseguel KB, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0793-3; Meyer D., 2015, PROXY DISTANCE SIMIL; Mori U., 2016, TSDIST DISTANCE MEAS; Nemcova E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116940; Paparrizos J, 2016, SIGMOD REC, V45, P69, DOI 10.1145/2949741.2949758; Pasligh J, 2010, J MICROBIOL IMMUNOL, V43, P147, DOI 10.1016/S1684-1182(10)60023-0; Plachy R, 2005, J MICROBIOL METH, V60, P107, DOI 10.1016/j.mimet.2004.09.003; Rabiner LR, 1993, FUNDAMENTALS SPEECH, pxxxv; Rasmussen JP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-107; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Reja V, 2010, METHODS, V50, pS10, DOI 10.1016/j.ymeth.2010.02.006; Ripley B. D, 2016, GGDENDRO CREATE DEND; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sarda-Espinosa A, 2016, DTWCLUST TIME SERIES; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Somogyvari F, 2012, IN VIVO, V26, P979; STEGER G, 1994, NUCLEIC ACIDS RES, V22, P2760, DOI 10.1093/nar/22.14.2760; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Team RC, 2015, R LANG ENV STAT COMP; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Trtkova J, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-234; Venables WN, 2002, MODERN APPL STAT S, pxi; Vlachos M, 2002, PROC INT CONF DATA, P673, DOI 10.1109/ICDE.2002.994784; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	60	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173320	10.1371/journal.pone.0173320	http://dx.doi.org/10.1371/journal.pone.0173320			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264030	gold, Green Submitted, Green Published			2022-12-27	WOS:000396054300052
J	Harms, J; Liket, K; Protzko, J; Scholmerich, V				Harms, Job; Liket, Kellie; Protzko, John; Scholmerich, Vera			Free to help? An experiment on free will belief and altruism	PLOS ONE			English	Article							DICTATOR GAMES; DEPLETION; AMERICAN; RELIGION; PEOPLE; GOD	How does belief in free will affect altruistic behavior? In an online experiment we undermine subjects' belief in free will through a priming task. Subjects subsequently conduct a series of binary dictator games in which they can distribute money between themselves and a charity that supports low-income people in developing countries. In each decision task, subjects choose between two different distributions, one of which is more generous towards the charity. In contrast to previous experiments that report a negative effect of undermining free will on honest behavior and self-reported willingness to help, we find an insignificant average treatment effect. However, we do find that our treatment reduces charitable giving among non-religious subjects, but not among religious subjects. This could be explained by our finding that religious subjects associate more strongly with social norms that prescribe helping the poor, and might therefore be less sensitive to the effect of reduced belief in free will. Taken together, these findings indicate that the effects of free will belief on prosocial behavior are more nuanced than previously suggested.	[Harms, Job; Liket, Kellie] Erasmus Univ, Dept Econ, Rotterdam, Netherlands; [Protzko, John] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Scholmerich, Vera] Erasmus Univ, Erasmus Univ Coll, Dept Social & Behav Sci, Rotterdam, Netherlands	Erasmus University Rotterdam; University of California System; University of California Santa Barbara; Erasmus University Rotterdam	Harms, J (corresponding author), Erasmus Univ, Dept Econ, Rotterdam, Netherlands.	harms@ese.eur.nl	Protzko, John/AAL-4594-2020	Protzko, John/0000-0001-5710-8635	Giving for Impact Foundation	Giving for Impact Foundation	The authors gratefully acknowledge financial support from the Giving for Impact Foundation.	Aquinas T., 1981, SUMMA THEOLOGIAE; Aristotle M, 1933, 1045A 8 10 ARISTOTLE, V17; Aristotle M, 1933, 1045A 8 10 ARISTOTLE, V18; Arnett JJ, 2008, AM PSYCHOL, V63, P602, DOI 10.1037/0003-066X.63.7.602; Batson C. D., 1985, ADV PSYCHOL RELIG, P185, DOI [10.1016/B978-0-08-027948-0.50019-0, DOI 10.1016/B978-0-08-027948-0.50019-0]; Baumeister RF, 1994, LOSING CONTROL WHY P, Vxi; Baumeister RF, 2007, SOC PERSONAL PSYCHOL, V1, P115, DOI 10.1111/j.1751-9004.2007.00001.x; Baumeister RF, 2014, ADV EXP SOC PSYCHOL, V50, P1, DOI 10.1016/B978-0-12-800284-1.00001-1; Baumeister RF, 2009, PERS SOC PSYCHOL B, V35, P260, DOI 10.1177/0146167208327217; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Bekkers R, 2011, VOLUNT SECT REV, V2, P337, DOI 10.1332/204080511X6087712; Bekkers R, 2011, QUAL QUANT, V45, P1369, DOI 10.1007/s11135-010-9341-9; Benson P. L., 1989, RES SOCIAL SCI STUDY, V1, P153; Bourget D, 2014, PHILOS STUD, V170, P465, DOI 10.1007/s11098-013-0259-7; Branas-Garza P, 2013, ECON PHILOS, V29, P199, DOI 10.1017/S0266267113000199; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Dennett DC, 2015, ELBOW ROOM: THE VARIETIES OF FREE WILL WORTH WANTING, P1; Duhaime EP, 2015, JUDGM DECIS MAK, V10, P593; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; Fong CM, 2007, ECON J, V117, P1008, DOI 10.1111/j.1468-0297.2007.02076.x; Harris S., 2012, FREE WILL; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Horton J., 2011, EXP ECON, V14, P1; Krajbich I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8455; Krueger F, 2014, SOC COGN AFFECT NEUR, V9, P1143, DOI 10.1093/scan/nst092; Kushnir T, 2012, ADV CHILD DEV BEHAV, V43, P193, DOI 10.1016/B978-0-12-397919-3.00007-1; Libet Benjamin., 1993, NEUROPHYSIOLOGY CONS, DOI [10.1007/978-1-4612-0355-1_16, DOI 10.1007/978-1-4612-0355-1_16]; MacKenzie MJ, 2014, PERS SOC PSYCHOL B; Mazar N, 2008, J MARKETING RES, V45, P633, DOI 10.1509/jmkr.45.6.633; McKay R, 2011, P ROY SOC B-BIOL SCI, V278, P1858, DOI 10.1098/rspb.2010.2125; Monroe AE, 2016, SOC PSYCHOL PERS SCI; Montague RR, 2008, CURR BIOL, V18, pR584, DOI 10.1016/j.cub.2008.04.053; Nahmias E, 2014, COGNITION, V133, P502, DOI 10.1016/j.cognition.2014.07.009; Paolacci G, 2010, JUDGM DECIS MAK, V5, P5, DOI DOI 10.1111/NTWE.12038; Phillips JW, 2011, JSTOR; Pronin E, 2010, P NATL ACAD SCI USA, V107, P22469, DOI 10.1073/pnas.1012046108; Raihani NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073131; Raihani NJ, 2012, P R SOC B; RITZEMA RJ, 1979, J PSYCHOL THEOL, V7, P105; Sarkissian H, 2010, MIND LANG, V25, P346, DOI 10.1111/j.1468-0017.2010.01393.x; Schopenhauer A., 1839, PRIZE ESSAY FREEDOM; Schulz JF, 2014, J ECON PSYCHOL, V41, P77, DOI 10.1016/j.joep.2012.08.007; Shariff AF, 2014, PSYCHOL SCI; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Smilansky S, 2000, FREE WILL ILLUSION; Stillman TF, 2010, SOC PSYCHOL PERS SCI, V1, P43, DOI 10.1177/1948550609351600; Twenge JM, 2004, PERS SOC PSYCHOL REV, V8, P308, DOI 10.1207/s15327957pspr0803_5; Vohs KD, 2008, PSYCHOL SCI, V19, P49, DOI 10.1111/j.1467-9280.2008.02045.x; Vohs KD, 2000, PSYCHOL SCI, V11, P249, DOI 10.1111/1467-9280.00250; Youniss J, 1999, J ADOLESCENCE, V22, P243, DOI 10.1006/jado.1999.0214	52	9	9	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173193	10.1371/journal.pone.0173193	http://dx.doi.org/10.1371/journal.pone.0173193			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6CJ	28282393	Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800019
J	Shakiba, E; Edwards, JD; Jodari, F; Duke, SE; Baldo, AM; Korniliev, P; McCouch, SR; Eizenga, GC				Shakiba, Ehsan; Edwards, Jeremy D.; Jodari, Farman; Duke, Sara E.; Baldo, Angela M.; Korniliev, Pavel; McCouch, Susan R.; Eizenga, Georgia C.			Genetic architecture of cold tolerance in rice (Oryza sativa) determined through high resolution genome-wide analysis	PLOS ONE			English	Article							QUANTITATIVE-TRAIT LOCI; LOW-TEMPERATURE GERMINABILITY; YIELD COMPONENTS; SEEDLING STAGE; CHILLING TOLERANCE; COMPLEX TRAITS; BOOTING STAGE; ASSOCIATION; QTLS; STRESS	Cold temperature is an important abiotic stress which negatively affects morphological development and seed production in rice (Oryza sativa L.). At the seedling stage, cold stress causes poor germination, seedling injury and poor stand establishment; and at the reproductive stage cold decreases seed yield. The Rice Diversity Panel 1 (RDP1) is a global collection of over 400 O. sativa accessions representing the five major subpopulations from the INDICA and JAPONICA varietal groups, with a genotypic dataset consisting of 700,000 SNP markers. The objectives of this study were to evaluate the RDP1 accessions for the complex, quantitatively inherited cold tolerance traits at the germination and reproductive stages, and to conduct genome-wide association (GWA) mapping to identify SNPs and candidate genes associated with cold stress at these stages. GWA mapping of the germination index (calculated as percent germination in cold divided by warm treatment) revealed 42 quantitative trait loci (QTLs) associated with cold tolerance at the seedling stage, including 18 in the panel as a whole, seven in temperate japonica, six in tropical japonica, 14 in JAPONICA, and nine in INDICA, with five shared across all subpopulations. Twenty-two of these QTLs co-localized with 32 previously reported cold tolerance QTLs. GWA mapping of cold tolerance at the reproductive stage detected 29 QTLs, including seven associated with percent sterility, ten with seed weight per panicle, 14 with seed weight per plant and one region overlapping for two traits. Fifteen co-localized with previously reported QTLs for cold tolerance or yield components. Candidate gene ontology searches revealed these QTLs were associated with significant enrichment for genes related to with lipid metabolism, response to stimuli, response to biotic stimuli (suggesting cross-talk between biotic and abiotic stresses), and oxygen binding. Overall the JAPONICA accessions were more tolerant to cold stress than INDICA accessions.	[Shakiba, Ehsan] Univ Arkansas, Rice Res & Extens Ctr, Stuttgart, AK USA; [Edwards, Jeremy D.; Baldo, Angela M.; Eizenga, Georgia C.] Dale Bumpers Natl Rice Res Ctr, USDA ARS, Stuttgart, AR 72160 USA; [Jodari, Farman] RES, Biggs, CA USA; [Duke, Sara E.] USDA ARS, Plains Area, College Stn, TX USA; [Korniliev, Pavel] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [McCouch, Susan R.] Cornell Univ, Sch Integrat Plant Sci, Plant Breeding & Genet Sect, Ithaca, NY USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Cornell University; Cornell University	Eizenga, GC (corresponding author), Dale Bumpers Natl Rice Res Ctr, USDA ARS, Stuttgart, AR 72160 USA.	georgia.eizenga@ars.usda.gov		Edwards, Jeremy/0000-0002-0237-0932	National Science Foundation-Plant Genome Project: "The Genetic Basis of Transgressive Variation in Rice" [1026555]; U.S. Department of Agriculture/Agricultural Research Service CRIS [6028-21220-005-00D]; California Cooperative Rice Research Foundation (CCRRF) [501(c)(5)]	National Science Foundation-Plant Genome Project: "The Genetic Basis of Transgressive Variation in Rice"; U.S. Department of Agriculture/Agricultural Research Service CRIS(United States Department of Agriculture (USDA)); California Cooperative Rice Research Foundation (CCRRF)	This research was supported by the National Science Foundation-Plant Genome Project: "The Genetic Basis of Transgressive Variation in Rice" (Award no. 1026555) to SRM and GCE in support of ES and PK; U.S. Department of Agriculture/Agricultural Research Service CRIS project 6028-21220-005-00D "Using Genetic Approaches to Reduce Crop Losses in Rice Due to Biotic and Abiotic Stress" in support of JDE, SED, AMB and GCE and the California Cooperative Rice Research Foundation (CCRRF), a private nonprofit research foundation [501(c)(5)], supporting breeding and genetics research and foundation seed production in support of FJ to collect the data at the reproductive stage. There was no additional external funding received for this study.	Alexandrov N, 2015, NUCLEIC ACIDS RES, V43, pD1023, DOI 10.1093/nar/gku1039; Andaya V, 2003, THEOR APPL GENET, V113, P467; Andaya VC, 2003, J EXP BOT, V54, P2579, DOI 10.1093/jxb/erg243; Andaya VC, 2003, THEOR APPL GENET, V106, P1084, DOI 10.1007/s00122-002-1126-7; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Badea C, 2009, PLANT OMICS, V2, P78; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Browse J, 2001, CURR OPIN PLANT BIOL, V4, P241, DOI 10.1016/S1369-5266(00)00167-9; Cai HW, 2002, THEOR APPL GENET, V104, P1217, DOI 10.1007/s00122-001-0819-7; Chen Y, 2013, PLANT MOL BIOL REP, V31, P87, DOI 10.1007/s11105-012-0481-z; Counce PA, 2000, CROP SCI, V40, P436, DOI 10.2135/cropsci2000.402436x; Cui D, 2013, EUPHYTICA, V193, P369, DOI 10.1007/s10681-013-0935-x; Cui KH, 2002, THEOR APPL GENET, V105, P745, DOI 10.1007/s00122-002-0908-2; Cui SX, 2005, PROTEOMICS, V5, P3162, DOI 10.1002/pmic.200401148; Cruz Renata Pereira da, 2010, Braz. J. Plant Physiol., V22, P199, DOI 10.1590/S1677-04202010000300007; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Edwards JD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw107; Eizenga GC, 2014, J PLANT REGIST, V8, P109, DOI 10.3198/jpr2013.03.0013crmp; Fujino K, 2004, THEOR APPL GENET, V108, P794, DOI 10.1007/s00122-003-1509-4; Fujino K, 2015, BREEDING SCI, V65, P403, DOI 10.1270/jsbbs.65.403; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; GLASZMANN JC, 1990, EUPHYTICA, V45, P95; Greening P, 1992, CROP SCI, P660; Greening P, 1998, CROP SCI, V38, P660; He CiXin, 2000, Scientia Agricultura Sinica, V33, P24; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huang J, 2013, J INTEGR PLANT BIOL, V55, P735, DOI 10.1111/jipb.12051; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Jacobs BC, 1999, J AGRON CROP SCI, V182, P79, DOI 10.1046/j.1439-037x.1999.00259.x; Jiang L, 2006, FIELD CROP RES, V98, P68, DOI 10.1016/j.fcr.2005.12.015; Kim SI, 2011, BIOCHEM J, V435, P373, DOI 10.1042/BJ20101610; Kissoudis C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00207; Koseki M, 2010, MOL GENET GENOMICS, V284, P45, DOI 10.1007/s00438-010-0548-1; Li ZK, 1997, GENETICS, V145, P453; Liu FX, 2013, MOL PLANT, V6, P757, DOI 10.1093/mp/sss161; Lou QJ, 2007, EUPHYTICA, V158, P87, DOI 10.1007/s10681-007-9431-5; Lv Y, 2016, PLANT CELL ENVIRON, V39, P556, DOI 10.1111/pce.12635; Ma Y, 2015, CELL, V160, P1209, DOI 10.1016/j.cell.2015.01.046; McCouch S, 2004, PLOS BIOL, V2, P1507, DOI 10.1371/journal.pbio.0020347; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; Ming F, 2001, J PLANT NUTR, V24, P1399, DOI 10.1081/PLN-100106990; Monaco MK, 2014, NUCLEIC ACIDS RES, V42, pD1193, DOI 10.1093/nar/gkt1110; Morsy MR, 2005, GENE, V344, P171, DOI 10.1016/j.gene.2004.09.033; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Murai M, 1991, JPN J BREED, V41, P601; Nakagahra M, 1997, PLANT MOL BIOL, V35, P69, DOI 10.1023/A:1005784431759; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Nguyen NV, 2006, PADDY WATER ENVIRON, V4, P1, DOI 10.1007/s10333-005-0031-5; NISHIMURA M, 1993, JPN J CROP SCI, V62, P242, DOI 10.1626/jcs.62.242; Obara M, 2001, J EXP BOT, V52, P1209, DOI 10.1093/jexbot/52.359.1209; Pan YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120590; R Core Team, 2016, R A LANGUAGE AND ENV; Ranawake AL, 2014, BIOTECHNOL BIOTEC EQ, V28, P989, DOI 10.1080/13102818.2014.978539; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Saito K, 2001, THEOR APPL GENET, V103, P862, DOI 10.1007/s001220100661; SAS Institute Inc, 2012, THE SAS SYSTEM FOR W; SAS Institute Inc, 2015, JMP 12 SPECIALIZED M; SATAKE T, 1989, JPN J CROP SCI, V58, P240, DOI 10.1626/jcs.58.240; Shaik R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077261; Shinozaki K, 1996, CURR OPIN BIOTECH, V7, P161, DOI 10.1016/S0958-1669(96)80007-3; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Su CF, 2010, PLANT PHYSIOL, V153, P145, DOI 10.1104/pp.110.153015; Suh JP, 2010, THEOR APPL GENET, V120, P985, DOI 10.1007/s00122-009-1226-8; Takeuchi Y, 2001, BREEDING SCI, V51, P191, DOI 10.1270/jsbbs.51.191; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Vaughan DA, 2008, RICE, V1, P16, DOI 10.1007/s12284-008-9000-0; Venu RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095178; Visioni A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-424; Wang D, 2016, RICE, V9, DOI 10.1186/s12284-016-0133-2; Xiao J., 1996, NATURE, V384, P356; Xing Yong-Zhong, 2001, Acta Genetica Sinica, V28, P439; Yamaya T, 2002, J EXP BOT, V53, P917, DOI 10.1093/jexbot/53.370.917; Yan C, 1998, CHINESE J RICE SCI, V13, P134; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhu YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145704; Zhuang JY, 1997, THEOR APPL GENET, V95, P799, DOI 10.1007/s001220050628	81	74	77	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0172133	10.1371/journal.pone.0172133	http://dx.doi.org/10.1371/journal.pone.0172133			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282385	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800008
J	Khatun, M; Al Mamun, A; Scott, J; William, GM; Clavarino, A; Najman, JM				Khatun, Mohsina; Al Mamun, Abdullah; Scott, James; William, Gail M.; Clavarino, Alexandra; Najman, Jake M.			Do children born to teenage parents have lower adult intelligence? A prospective birth cohort study	PLOS ONE			English	Article							ADOLESCENT PREGNANCY; PATERNAL AGE; LIFE-COURSE; OUTCOMES; ASSOCIATION; CHILDHOOD; RISK; MOTHERS; CHILDBEARING; DEPRESSION	Teenage motherhood has been associated with a wide variety of negative offspring outcomes including poorer cognitive development. In the context of limitations of previous research, this paper assesses the contemporary relevance of this finding. In this study we investigate the long-term cognitive status (IQ) among 21 year adult offspring born to teenage parents using the Mater University Study of Pregnancy- a prospective birth cohort study, which recruited all pregnant mothers attending a large obstetrical hospital in Brisbane, Australia, from 1981 to 1983. The analyses were restricted to a sub-sample of 2643 mother-offspring pair. Offspring IQ was measured using the Peabody Picture Vocabulary Test at 21 year. Parental age was reported at first clinic visit. Offspring born to teenage mothers (<20 years) have -3.0 (95% Confidence Interval (CI): -4.3, -1.8) points lower IQ compared to children born to mothers >= 20 years and were more likely to have a low IQ (Odds Ratio (OR) 1.7; 95% CI: 1.3, 2.3). Adjustment for a range of confounding and mediating factors including parental socioeconomic status, maternal IQ, maternal smoking and binge drinking in pregnancy, birthweight, breastfeeding and parenting style attenuates the association, though the effect remains statistically significant (-1.4 IQ points; 95% CI: -2.8,-0.1). Similarly the risk of offspring having low IQ remained marginally significantly higher in those born to teenage mothers (OR 1.3; 95% CI: 1.0, 1.9). In contrast, teenage fatherhood is not associated with adult offspring IQ, when adjusted for maternal age. Although the reduction in IQ is quantitatively small, it is indicative of neurodevelopmental disadvantage experienced by the young adult offspring of teenage mothers. Our results suggest that public policy initiatives should be targeted not only at delaying childbearing in the population but also at supporting early life condition of children born to teenage mothers to minimize the risk for disadvantageous outcomes of the next generation.	[Khatun, Mohsina; Al Mamun, Abdullah; William, Gail M.; Najman, Jake M.] Univ Queensland, Fac Med & Biomed Sci, Sch Publ Hlth, Brisbane, Qld, Australia; [Scott, James] Univ Queensland, Fac Med & Biomed Sci, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Scott, James] Royal Brisbane & Womens Hosp, Metro North Mental Hlth Serv, Queensland, Australia; [Clavarino, Alexandra] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Najman, Jake M.] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; University of Queensland	Khatun, M (corresponding author), Univ Queensland, Fac Med & Biomed Sci, Sch Publ Hlth, Brisbane, Qld, Australia.	m.khatun@uq.edu.au	Scott, James G/D-5900-2012; Mamun, Abdullah/HHM-9898-2022; Najman, Jackob M./B-1527-2008; Mamun, Abdullah A/A-4673-2011; Clavarino, Alexandra/F-1411-2010	Scott, James G/0000-0002-0744-0688; Najman, Jackob M./0000-0001-7079-2080; Mamun, Abdullah A/0000-0002-1535-8086; Clavarino, Alexandra/0000-0002-1145-5946	National Health and Medical Research Council (NHMRC) [1026598]; Australian Research Council (ARC) [DP150100162]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	AAM received a National Health and Medical Research Council (NHMRC) Career Development Fellowship (#1026598). JMN received an Australian Research Council (ARC) Discovery Project (DP150100162). ULRs for NHMRC and ARC https://www.nhmrc.gov.au/grants-funding; http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank all women and their offspring who voluntarily participated in the study, the MUSP data collection team, data manger and research team, The University of Queensland. AAM is supported by a National Health and Medical Research Council (NHMRC) Career Development Fellowship (#1026598). JMN is supported by an Australian Research Council (ARC) Discovery Project (DP150100162). The authors thank Greg Shuttlewood of the University of Queensland for help with data management.	AUROUX MR, 1989, HUM REPROD, V4, P794, DOI 10.1093/oxfordjournals.humrep.a136988; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Batty GD, 2004, BMJ-BRIT MED J, V329, P585, DOI 10.1136/bmj.329.7466.585; Bedford A., 1978, DELUSIONS SYMPTOMS S; BEITCHMAN JH, 1986, J SPEECH HEAR DISORD, V51, P98, DOI 10.1044/jshd.5102.98; Bilder DA, 2013, AJIDD-AM J INTELLECT, V118, P156, DOI 10.1352/1944-7558-118.2.156; BROOKSGUNN J, 1986, DEV REV, V6, P224, DOI 10.1016/0273-2297(86)90013-4; Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190; Carlsen KCL, 1997, EUR RESPIR J, V10, P1774, DOI 10.1183/09031936.97.10081774; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; Chin HB, 2012, AM J PREV MED, V42, P272, DOI 10.1016/j.amepre.2011.11.006; Conde-Agudelo A, 2005, AM J OBSTET GYNECOL, V192, P342, DOI 10.1016/j.ajog.2004.10.593; Cornelius MD, 2010, J DEV BEHAV PEDIATR, V31, P405, DOI 10.1097/DBP.0b013e3181e121d2; Cunnington AJ, 2001, J FAM PLAN REPROD H, V27, P36, DOI 10.1783/147118901101194877; Doi SAR, 2015, EPIDEMIOLOGY, V26, pE42, DOI 10.1097/EDE.0000000000000289; Dunn L.M., 2007, PEABODY PICTURE VOCA; Eckenrode J, 2010, ARCH PEDIAT ADOL MED, V164, P9, DOI 10.1001/archpediatrics.2009.240; Edwards RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012157; Eriksen HLF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079200; Fall CHD, 2015, LANCET GLOB HEALTH, V3, pE366, DOI 10.1016/S2214-109X(15)00038-8; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Harden A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4254; Hardy JB, 1998, DEV PSYCHOL, V34, P1220, DOI 10.1037/0012-1649.34.6.1220; Hasan SS, 2013, ASIAN J PSYCHIATR, V6, P460, DOI 10.1016/j.ajp.2013.09.008; Hillis SD, 2004, PEDIATRICS, V113, P320, DOI 10.1542/peds.113.2.320; Hofferth SL, 1987, CHILDREN TEEN CHILDB, VII; Hoffman D. Saul, 2008, KIDS HAVING KIDS EC; Jeha D, 2015, J NEONATAL PERINATAL; KEEPING JD, 1989, BRIT J OBSTET GYNAEC, V96, P289, DOI 10.1111/j.1471-0528.1989.tb02388.x; Kohler U, 2011, STATA J, V11, P420, DOI 10.1177/1536867X1101100306; Lawlor DA, 2005, J EPIDEMIOL COMMUN H, V59, P656, DOI 10.1136/jech.2004.030205; Malaspina D, 2005, PSYCHIAT GENET, V15, P117, DOI 10.1097/00041444-200506000-00008; McGrath J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077444; Miller LL, 2014, CHEST, V145, P1213, DOI 10.1378/chest.13-1371; MOLLBORN S, 2011, POPULATION RES POLIC, V31, P31; Morinis J, 2013, ARCH DIS CHILD, V98, P959, DOI 10.1136/archdischild-2012-302525; Myrskyla M, 2013, AM J EPIDEMIOL, V177, P649, DOI 10.1093/aje/kws237; NAGLIERI JA, 1983, J CLIN PSYCHOL, V39, P965, DOI 10.1002/1097-4679(198311)39:6<965::AID-JCLP2270390624>3.0.CO;2-9; Najman JM, 2005, INT J EPIDEMIOL, V34, P992, DOI 10.1093/ije/dyi119; Najman JM, 2000, SOC PSYCH PSYCH EPID, V35, P19, DOI 10.1007/s001270050004; Najman JM, 2014, INT J EPIDEMIOLOGY; OLDS DL, 1988, AM J PUBLIC HEALTH, V78, P1436, DOI 10.2105/AJPH.78.11.1436; Saha S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000040; Shaw M, 2006, SOC SCI MED, V62, P2526, DOI 10.1016/j.socscimed.2005.10.007; Shearer DL, 2002, PERSPECT SEX REPRO H, V34, P236, DOI 10.2307/3097822; Sipsma H, 2010, AM J PUBLIC HEALTH, V100, P517, DOI 10.2105/AJPH.2009.177600; Stevens-Simon C, 2001, ARCH PEDIAT ADOL MED, V155, P1298, DOI 10.1001/archpedi.155.12.1298; Taylor JL, 2009, J FAM ISSUES, V30, P484, DOI 10.1177/0192513X08329601; Tong S, 2007, J PEDIATR-US, V151, P284, DOI 10.1016/j.jpeds.2007.03.020; van der Klis KAM, 2002, AUST NZ J PUBL HEAL, V26, P125, DOI 10.1111/j.1467-842X.2002.tb00904.x; Victora CG, 2015, LANCET GLOB HEALTH, V3, pE199, DOI 10.1016/S2214-109X(15)70002-1; Woodward L, 2001, J MARRIAGE FAM, V63, P1170, DOI 10.1111/j.1741-3737.2001.01170.x	52	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0167395	10.1371/journal.pone.0167395	http://dx.doi.org/10.1371/journal.pone.0167395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278227	gold, Green Published			2022-12-27	WOS:000396087900104
J	Kolbel, H; Hauffa, BP; Wudy, SA; Bouikidis, A; Della Marina, A; Schara, U				Koelbel, Heike; Hauffa, Berthold P.; Wudy, Stefan A.; Bouikidis, Anastasios; Della Marina, Adela; Schara, Ulrike			Hyperleptinemia in children with autosomal recessive spinal muscular atrophy type I-III	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; PUBERTAL CHANGES; MOUSE MODEL; LEPTIN; DISEASE; METABOLISM; GROWTH; RESISTANCE; SURVIVAL; INFANTS	Background Autosomal-recessive proximal spinal muscular atrophies (SMA) are disorders characterized by a ubiquitous deficiency of the survival of motor neuron protein that leads to a multisystemic disorder, which mostly affects alpha motor neurons. Disease progression is clinically associated with failure to thrive or weight loss, mainly caused by chewing and swallowing difficulties. Although pancreatic involvement has been described in animal models, systematic endocrinological evaluation of the energy metabolism in humans is lacking. Methods In 43 patients with SMA type I-III (8 type I; 22 type II; 13 type III), aged 0.6-21.8 years, auxological parameters, pubertal stage, motor function (Motor Function Measurement 32- MFM32) as well as levels of leptin, insulin glucose, hemoglobin A1c, Homeostasis Model Assessment index and an urinary steroid profile were determined. Results Hyperleptinemia was found in 15/35 (43%) of our patients; 9/15 (60%) of the hyperleptinemic patients were underweight, whereas 1/15 (7%) was obese. Hyperleptinemia was associated with SMA type (p = 0.018). There was a significant association with decreased motor function (MFM32 total score in hyperleptinemia 28.5%, in normoleptinemia 54.7% p = 0.008, OR 0.969; 95%-CI: 0.946-0.992). In addition, a higher occurrence of hirsutism, premature pub-arche and a higher variability of the urinary steroid pattern were found. Conclusion Hyperleptinemia is highly prevalent in underweight children with SMA and is associated with disease severity and decreased motor function. Neuronal degradation of hypothalamic cells or an increase in fat content by muscle remodeling could be the cause of hyperleptinemia.	[Koelbel, Heike; Della Marina, Adela; Schara, Ulrike] Univ Duisburg Essen, Childrens Hosp 1, Dept Neuropediat Dev Neurol & Social Pediat, Essen, Germany; [Hauffa, Berthold P.] Univ Duisburg Essen, Childrens Hosp 2, Dept Pediat Endocrinol, Essen, Germany; [Wudy, Stefan A.] Justus Liebig Univ, Ctr Child & Adolescent Med, Div Pediat Endocrinol & Diabetol, Steroid Res & Mass Spectrometry Unit, Giessen, Germany; [Bouikidis, Anastasios] Univ Duisburg Essen, Childrens Hosp 3, Dept Pediat Pulmonol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; Justus Liebig University Giessen; University of Duisburg Essen	Kolbel, H (corresponding author), Univ Duisburg Essen, Childrens Hosp 1, Dept Neuropediat Dev Neurol & Social Pediat, Essen, Germany.	heike.koelbel@uk-essen.de	Wudy, Stefan/ABC-7173-2020					Bach JR, 2007, AM J PHYS MED REHAB, V86, P349, DOI 10.1097/PHM.0b013e31804b1d66; Badoud F, 2015, FASEB J, V29, P748, DOI 10.1096/fj.14-263913; Bluher M, 2015, METABOLISM, V64, P131, DOI 10.1016/j.metabol.2014.10.016; Blum WF, 1997, J CLIN ENDOCR METAB, V82, P2904, DOI 10.1210/jc.82.9.2904; Bonda DJ, 2014, J NEUROCHEM, V128, P162, DOI 10.1111/jnc.12380; Bottai D, 2013, BRAIN PATHOL, V23, P613, DOI 10.1111/bpa.12071; Bowerman M, 2012, ANN NEUROL, V72, P256, DOI 10.1002/ana.23582; Butchbach MER, 2010, BIOCHEM BIOPH RES CO, V391, P835, DOI 10.1016/j.bbrc.2009.11.148; Cano SJ, 2014, MUSCLE NERVE, V49, P422, DOI 10.1002/mus.23937; Clark NM, 2014, REPROD SCI, V21, P1034, DOI 10.1177/1933719114522525; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Crawford TO, 1999, ANN NEUROL, V45, P337, DOI 10.1002/1531-8249(199903)45:3<337::AID-ANA9>3.0.CO;2-U; Araujo APDC, 2009, J PEDIATR-US, V155, P292, DOI 10.1016/j.jpeds.2009.01.071; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440; Fredriks AM, 2005, EUR J PEDIATR, V164, P216, DOI 10.1007/s00431-004-1586-7; Fuller HR, 2016, NEUROMUSCULAR DISORD, V26, P560, DOI 10.1016/j.nmd.2016.06.004; Ito Y, 2004, BRAIN DEV-JPN, V26, P53, DOI 10.1016/S0387-7604(03)00075-5; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; LaMarca NH, 2013, J CHILD NEUROL, V28, P1517, DOI 10.1177/0883073812460096; Lim MA, 2014, HUM MOL GENET, V23, P4995, DOI 10.1093/hmg/ddu214; Mannaa Mohannad M, 2009, J Clin Neuromuscul Dis, V10, P85, DOI 10.1097/CND.0b013e318190310f; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moore GE, 2016, NEUROMUSCULAR DISORD, V26, P395, DOI 10.1016/j.nmd.2016.05.005; Rudnik-Schoneborn S, 2008, J MED GENET, V45, P635, DOI 10.1136/jmg.2008.057950; Rudnik-Schoneborn S, 2010, MUSCLE NERVE, V42, P144, DOI 10.1002/mus.21654; Sainz N, 2015, METABOLISM, V64, P35, DOI 10.1016/j.metabol.2014.10.015; Sproule DM, 2012, J CHILD NEUROL, V27, P845, DOI 10.1177/0883073811415680; Sproule DM, 2011, J CHILD NEUROL, V26, P1252, DOI 10.1177/0883073811405053; Sproule DM, 2011, J CHILD NEUROL, V26, P309, DOI 10.1177/0883073810380457; Sproule DM, 2009, NEUROMUSCULAR DISORD, V19, P391, DOI 10.1016/j.nmd.2009.03.009; Stojanovic VR, 2010, ACTA NEUROL SCAND, V121, P94, DOI 10.1111/j.1600-0404.2009.01237.x; Vitte JM, 2004, AM J PATHOL, V165, P1731, DOI 10.1016/S0002-9440(10)63428-1; Wang CH, 2007, J CHILD NEUROL, V22, P1027, DOI 10.1177/0883073807305788; Welt CK, 2013, J CLIN ENDOCR METAB, V98, P4629, DOI 10.1210/jc.2013-2375; Willers SM, 2015, ANN NUTR METAB, V66, P63, DOI 10.1159/000369979; Wishart TM, 2010, HUM MOL GENET, V19, P4216, DOI 10.1093/hmg/ddq340; Wudy SA, 2004, HORM METAB RES, V36, P415, DOI 10.1055/s-2004-814565; Yildiz BO, 2010, HUM REPROD UPDATE, V16, P51, DOI 10.1093/humupd/dmp024	41	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173144	10.1371/journal.pone.0173144	http://dx.doi.org/10.1371/journal.pone.0173144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278160	gold, Green Published, Green Submitted			2022-12-27	WOS:000396087900049
J	Liu, P; Li, C; Zheng, N; Xu, Q; Yu, SB; Sui, HJ				Liu, Pei; Li, Chan; Zheng, Nan; Xu, Qiang; Yu, Sheng-Bo; Sui, Hong-Jin			The myodural bridge existing in the Nephocaena phocaenoides	PLOS ONE			English	Article							POSTERIOR MINOR MUSCLE; CONNECTIVE-TISSUE; SPINAL DURA; ATTACHMENTS; MICROSCOPY; INTERSPACE; ANEURYSMS; COLLAGEN; MATER	Recent studies have identified that the myodural bridge (MDB) between the rectus capitis posterior minor (RCPmi) and the cervical spinal dura mater in the posterior atlanto-occipital interspace in humans. And it was supposed that the MDB may play essential physiological roles. As a result, the MDB is possibly a highly conserved structure in the evolution of mammals. However, there is little confirmative description about the existence of the MDB in marine mammals. The objective of this study was to explore the existence and the fiber property of the MDB in the Neophocaena phocaenoides. Six cadavers of the Neophocaena phocaenoides with formalin fixation were used in this study. One was used for head and neck CT scanning and three-dimensional (3D) reconstruction and suboccipital region dissection, two were for sectional observation by P45 plastinated sheets of head and neck, and three were for histological analysis of suboccipial structures. This is the first study to demonstrate the existence of the MDB in the aquatic mammals. The rectus capitis dorsal minor (RCDmi) originated from the inferior border of the occiput and inserted into the cervical spinal dura mater. At the ventral aspect of the RCDmi, the MDB directly extended through the posterior atlanto-occipital interspace and connected with the cervical spinal dura mater which was consisted of type. collagen. In addition, the dorsal atlanto-occipital membrane was not found in the Neophocaena phocaenoides. The tendinous myodural bridge extended from the RCDmi to the spinal dura mater through the posterior atlanto-occipital interspace in the Neophocaena phocaenoides.	[Liu, Pei] Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China; [Li, Chan; Zheng, Nan; Yu, Sheng-Bo; Sui, Hong-Jin] Dalian Med Univ, Dept Anat, Coll Basic Med, Dalian, Peoples R China; [Xu, Qiang] Chinese Peoples Liberat Army Gen Hosp, Dept Radiol, Affiliated Hosp 403, Dalian, Peoples R China; [Sui, Hong-Jin] Dalian Hoffen Preservat Inst, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University; Chinese People's Liberation Army General Hospital	Yu, SB; Sui, HJ (corresponding author), Dalian Med Univ, Dept Anat, Coll Basic Med, Dalian, Peoples R China.; Sui, HJ (corresponding author), Dalian Hoffen Preservat Inst, Dalian, Peoples R China.	ysbdmu@126.com; suihj@hotmail.com		Liu, Pei/0000-0002-1761-8339	Natural Science Foundation of China [NSFC31571234, NSFC31600972]; Liaoning province natural science funds [2014023017]; Liaoning province department of education funds [L2015156, L2016012]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning province natural science funds; Liaoning province department of education funds	This study was supported by the Natural Science Foundation of China (NSFC31571234), http://www.nsfc.gov.cn/, recipient HJS; Liaoning province natural science funds (2014023017), http://kjjh.Ininfo.gov.cn/, HJS; Liaoning province department of education funds (L2015156), http:// kjc.sie.edu.cn/, SBY; Natural Science Foundation of China (NSFC31600972) and Liaoning province department of education funds (L2016012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnautovic KI, 1997, J NEUROSURG, V86, P252, DOI 10.3171/jns.1997.86.2.0252; Canham PB, 1999, NEUROL RES, V21, P618, DOI 10.1080/01616412.1999.11740986; Connor Richard C, 1994, DM PETERSON LIVES WH; ECKENHOFF JE, 1970, SURG GYNECOL OBSTETR, V131, P72; Enix Dennis E, 2014, J Can Chiropr Assoc, V58, P184; HACK GD, 1995, SPINE, V20, P2484, DOI 10.1097/00007632-199512000-00003; Hamada J, 2000, J NEUROSURG, V92, P1023, DOI 10.3171/jns.2000.92.6.1023; Harrison SRR, 1999, HDB MARINE MAMMALS 2, V6, P411; Humphreys BK, 2003, CLIN ANAT, V16, P152, DOI 10.1002/ca.10109; KAHN JL, 1992, ACTA ANAT, V144, P65; Mitchell BS, 1998, J MANIP PHYSIOL THER, V21, P145; Nash L, 2005, SPINE, V30, P1359, DOI 10.1097/01.brs.0000166159.31329.92; Reed JZ, 2000, J COMP PHYSIOL B, V170, P1, DOI 10.1007/s003600050001; Ruiz DS, 2002, AM J NEURORADIOL, V23, P1500; Scali F, 2013, SPINE J, V13, P558, DOI 10.1016/j.spinee.2013.01.015; Scali F, 2013, CLIN ANAT, V26, P444, DOI 10.1002/ca.22094; Scali F, 2011, SPINE, V36, pE1612, DOI 10.1097/BRS.0b013e31821129df; Sui HJ, 2006, China patent, Patent No. [ZL 031341098, 031341098]; [隋鸿锦 Sui Hongjin], 2013, [中国临床解剖学杂志, Chinese Journal of Clinical Anatomy], V31, P489; Takahashi S, 2015, EUROPEAN RADIOLOGY, V15, P1694; WOLMAN M, 1986, HISTOCHEMISTRY, V85, P41, DOI 10.1007/BF00508652; Wurtz Maurizio, 2003, NADIA REPETTO DOLPHI; Xu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep31787; Yuan XY, 2016, ANAT SCI INT, V91, P175, DOI 10.1007/s12565-015-0282-1; Zheng N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103451; Zumpano MP, 2006, CLIN ANAT, V19, P522, DOI 10.1002/ca.20220	26	12	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173630	10.1371/journal.pone.0173630	http://dx.doi.org/10.1371/journal.pone.0173630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278181	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900022
J	Rosner, SR; Pascoe, CD; Blankman, E; Jensen, CC; Krishnan, R; James, AL; Elliot, JG; Green, FH; Liu, JC; Seow, CY; Park, JA; Beckerle, MC; Pare, PD; Fredberg, JJ; Smith, MA				Rosner, Sonia R.; Pascoe, Christopher D.; Blankman, Elizabeth; Jensen, Christopher C.; Krishnan, Ramaswamy; James, Alan L.; Elliot, John G.; Green, Francis H.; Liu, Jeffrey C.; Seow, Chun Y.; Park, Jin-Ah; Beckerle, Mary C.; Pare, Peter D.; Fredberg, Jeffrey J.; Smith, Mark A.			The actin regulator zyxin reinforces airway smooth muscle and accumulates in airways of fatal asthmatics	PLOS ONE			English	Article							CUT LUNG SLICE; DEEP INSPIRATION; TIDAL STRETCHES; FOCAL ADHESIONS; INTACT AIRWAYS; MYOSIN BINDING; LIVING CELL; HYPERRESPONSIVENESS; BRONCHOCONSTRICTION; LENGTH	Bronchospasm induced in non-asthmatic human subjects can be easily reversed by a deep inspiration (DI) whereas bronchospasm that occurs spontaneously in asthmatic subjects cannot. This physiological effect of a DI has been attributed to the manner in which a DI causes airway smooth muscle (ASM) cells to stretch, but underlying molecular mechanisms-and their failure in asthma-remain obscure. Using cells and tissues from wild type and zyxin(-/-) mice we report responses to a transient stretch of physiologic magnitude and duration. At the level of the cytoskeleton, zyxin facilitated repair at sites of stress fiber fragmentation. At the level of the isolated ASM cell, zyxin facilitated recovery of contractile force. Finally, at the level of the small airway embedded with a precision cut lung slice, zyxin slowed airway dilation. Thus, at each level zyxin stabilized ASM structure and contractile properties at current muscle length. Furthermore, when we examined tissue samples from humans who died as the result of an asthma attack, we found increased accumulation of zyxin compared with non-asthmatics and asthmatics who died of other causes. Together, these data suggest a biophysical role for zyxin in fatal asthma.	[Rosner, Sonia R.; Park, Jin-Ah; Fredberg, Jeffrey J.] Harvard Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Pascoe, Christopher D.; Liu, Jeffrey C.; Pare, Peter D.] Univ British Columbia, Ctr Heart Lung Innovat, St Paul Hosp, Vancouver, BC, Canada; [Blankman, Elizabeth; Jensen, Christopher C.; Beckerle, Mary C.; Smith, Mark A.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Krishnan, Ramaswamy] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [James, Alan L.; Elliot, John G.] Sir Charles Gairdner Hosp, Dept Pulm Physiol & Sleep Med, West Australian Sleep Disorders Res Inst, Nedlands, WA, Australia; [James, Alan L.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA, Australia; [Green, Francis H.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Beckerle, Mary C.; Smith, Mark A.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of British Columbia; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Harvard University; Beth Israel Deaconess Medical Center; University of Western Australia; University of Western Australia; University of Calgary; Utah System of Higher Education; University of Utah	Smith, MA (corresponding author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA.; Smith, MA (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	mark.smith@hci.utah.edu	Pare, Peter D/C-7425-2011; Seow, Chun/AAQ-4099-2020; Fredberg, Jeffrey/M-9877-2019; Pascoe, Christopher/I-7876-2019	Pascoe, Christopher/0000-0002-5229-9927	NIH [R01HL102373, T32HL007118, P01HL120839, R01 GM50877]; Canadian Institutes of Health Research (CIHR) [MOP-13271, MOP-4725]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL120839, T32HL007118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050877] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01HL102373, NIH T32HL007118, NIH P01HL120839 and NIH R01 GM50877 and grants from Canadian Institutes of Health Research (CIHR; MOP-13271, MOP-4725).	An SS, 2002, AM J PHYSIOL-CELL PH, V283, pC792, DOI 10.1152/ajpcell.00425.2001; BENDIXEN HH, 1964, J APPL PHYSIOL, V19, P195, DOI 10.1152/jappl.1964.19.2.195; Bergner A, 2002, J GEN PHYSIOL, V119, P187, DOI 10.1085/jgp.119.2.187; Brown RH, 1998, J APPL PHYSIOL, V85, P2012, DOI 10.1152/jappl.1998.85.6.2012; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Chin LYM, 2012, EUR RESPIR J, V40, P45, DOI 10.1183/09031936.00065411; Donovan GM, 2016, WIRES SYST BIOL MED, V8, P459, DOI 10.1002/wsbm.1349; Donovan GM, 2011, PULM PHARMACOL THER, V24, P533, DOI 10.1016/j.pupt.2011.01.003; Dowie J, 2016, RESP PHYSIOL NEUROBI, V220, P25, DOI 10.1016/j.resp.2015.09.006; Fredberg JJ, 2000, J ALLERGY CLIN IMMUN, V106, P615, DOI 10.1067/mai.2000.109429; Fredberg JJ, 1997, AM J RESP CRIT CARE, V156, P1752, DOI 10.1164/ajrccm.156.6.9611016; Fredberg JJ, 1996, J APPL PHYSIOL, V81, P2703, DOI 10.1152/jappl.1996.81.6.2703; Fredberg JJ, 1999, AM J RESP CRIT CARE, V159, P959, DOI 10.1164/ajrccm.159.3.9804060; Gump A, 2001, J APPL PHYSIOL, V90, P2306, DOI 10.1152/jappl.2001.90.6.2306; Gunst SJ, 2003, J APPL PHYSIOL, V95, P413, DOI 10.1152/japplphysiol.00277.2003; GUNST SJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1267, DOI 10.1152/ajpcell.1995.268.5.C1267; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Hiorns JE, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00309; Hoffman LM, 2012, MOL BIOL CELL, V23, P1846, DOI 10.1091/mbc.E11-12-1057; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Hoffman LM, 2003, MOL CELL BIOL, V23, P70, DOI 10.1128/MCB.23.1.70-79.2003; HUGHES JMB, 1972, J APPL PHYSIOL, V32, P25, DOI 10.1152/jappl.1972.32.1.25; Ijpma G, 2015, AM J RESP CRITICAL C; James AL, 2012, AM J RESP CRIT CARE, V185, P1058, DOI 10.1164/rccm.201110-1849OC; Jensen A, 2001, J APPL PHYSIOL, V91, P506, DOI 10.1152/jappl.2001.91.1.506; King GG, 1999, AM J RESP CRIT CARE, V160, P454, DOI 10.1164/ajrccm.160.2.9804012; King GG, 2001, AM J RESP CRIT CARE, V164, P216, DOI 10.1164/ajrccm.164.2.2006101; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Lambert RK, 1997, J APPL PHYSIOL, V83, P140, DOI 10.1152/jappl.1997.83.1.140; LaPrad AS, 2010, J APPL PHYSIOL, V109, P295, DOI 10.1152/japplphysiol.00107.2010; Laprad AS, 2011, J APPL PHYSL; Lauzon, 2016, F1000 RES, P5; Lauzon AM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00191; Lavoie TL, 2012, AM J RESP CRIT CARE, V186, P225, DOI 10.1164/rccm.201202-0368OC; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; LIM TK, 1987, AM REV RESPIR DIS, V135, P591; Ma XF, 2002, AM J PHYSIOL-LUNG C, V283, pL1181, DOI 10.1152/ajplung.00389.2001; Macklem PT, 1996, AM J RESP CRIT CARE, V153, P83, DOI 10.1164/ajrccm.153.1.8542167; Mijailovich SM, 2000, BIOPHYS J, V79, P2667, DOI 10.1016/S0006-3495(00)76505-2; Mijailovich SM, 1996, BIOPHYS J, V71, P1475, DOI 10.1016/S0006-3495(96)79348-7; NADEL JA, 1961, J APPL PHYSIOL, V16, P717, DOI 10.1152/jappl.1961.16.4.717; Noble PB, 2013, J APPL PHYSIOL, V114, P1460, DOI 10.1152/japplphysiol.01489.2012; Oliver MN, 2007, AM J RESP CELL MOL, V37, P264, DOI 10.1165/rcmb.2006-0418OC; Pascoe CD, 2014, J APPL PHYSIOL, V117, P1502, DOI 10.1152/japplphysiol.00713.2014; PRATUSEVICH VR, 1995, J GEN PHYSIOL, V105, P73, DOI 10.1085/jgp.105.1.73; Puig-de-Morales M, 2004, AM J PHYSIOL-CELL PH, V287, pC643, DOI 10.1152/ajpcell.00070.2004; RAY DW, 1988, J APPL PHYSIOL, V65, P934, DOI 10.1152/jappl.1988.65.2.934; Rosner SR, 2014, AM J RESP CELL MOL, V50, P876, DOI 10.1165/rcmb.2013-0166MA; Salter HH, 1868, ASTHMA ITS PATHOLOGY; Sanderson MJ, 2011, PULM PHARMACOL THER, V24, P452, DOI 10.1016/j.pupt.2011.05.001; Scichilone N, 2000, AM J RESP CRIT CARE, V162, P910, DOI 10.1164/ajrccm.162.3.9907048; Seow CY, 2000, J APPL PHYSIOL, V89, P869, DOI 10.1152/jappl.2000.89.3.869; SKLOOT G, 1995, J CLIN INVEST, V96, P2393, DOI 10.1172/JCI118296; Smith MA, 2010, DEV CELL, V19, P365, DOI 10.1016/j.devcel.2010.08.008; STIRLING DR, 1983, J APPL PHYSIOL, V54, P934, DOI 10.1152/jappl.1983.54.4.934; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Wang L, 2000, J APPL PHYSIOL, V88, P2246, DOI 10.1152/jappl.2000.88.6.2246; WHEATLEY JR, 1989, EUR RESPIR J, V2, P331; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018	61	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0171728	10.1371/journal.pone.0171728	http://dx.doi.org/10.1371/journal.pone.0171728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278518	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900110
J	Weiss, O; Dorfman, A; Ram, T; Zadicario, P; Eilam, D				Weiss, Omri; Dorfman, Alex; Ram, Tamar; Zadicario, Pazit; Eilam, David			Rats do not eat alone in public: Food-deprived rats socialize rather than competing for baits	PLOS ONE			English	Article							MALE WISTAR RATS; RECIPROCAL ALTRUISM; PROSOCIAL CHOICE; SUCROSE-PELLETS; BEHAVIOR; DOMINANCE; COOPERATION; EVOLUTION; DEPENDS; BENEFIT	Limited resources result in competition among social animals. Nevertheless, social animals also have innate preferences for cooperative behavior. In the present study, 12 dyads of food-deprived rats were tested in four successive trials, and then re-tested as eight triads of food-deprived rats that were unfamiliar to each other. We found that the food-deprived dyads or triads of rats did not compete for the food available to them at regular spatially-marked locations that they had previously learnt. Rather, these rats traveled together to collect the baits. One rat, or two rats in some triads, lead (ran ahead) to collect most of the baits, but "leaders" differed across trials so that, on average, each rat ultimately collected similar amounts of baits. Regardless of which rat collected the baits, the rats traveled together with no substantial difference among them in terms of their total activity. We suggest that rats, which are a social species that has been found to display reciprocity, have evolved to travel and forage together and to share limited resources. Consequently, they displayed a sort of 'peace economy' that on average resulted in equal access to the baits across trials. For social animals, this type of dynamics is more relaxed, tolerant, and effective in the management of conflicts. Rather than competing for the limited available food, the food-deprived rats socialized and coexisted peacefully.	[Weiss, Omri; Dorfman, Alex; Ram, Tamar; Zadicario, Pazit; Eilam, David] Tel Aviv Univ, Dept Zool, Ramat Aviv, Israel	Tel Aviv University	Eilam, D (corresponding author), Tel Aviv Univ, Dept Zool, Ramat Aviv, Israel.	eilam@post.tau.ac.il	Eilam, David/GOV-6655-2022	Eilam, David/0000-0002-4494-6928	Israel Science Foundation (ISF) grant [230/13]	Israel Science Foundation (ISF) grant	This study was supported by the Israel Science Foundation (ISF) grant # 230/13 to David Eilam.	ADAMS N, 1983, J COMP PSYCHOL, V97, P24, DOI 10.1037/0735-7036.97.1.24; BARNETT SA, 1968, RAT STUDY BEHAV; Barta Z, 2011, P ROY SOC B-BIOL SCI, V278, P843, DOI 10.1098/rspb.2010.1634; Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Bednekoff PA, 1998, TRENDS ECOL EVOL, V13, P284, DOI 10.1016/S0169-5347(98)01327-5; BLANCHARD DC, 1990, NEUROSCI BIOBEHAV R, V14, P455, DOI 10.1016/S0149-7634(05)80068-5; Brown MF, 2011, COMP COGN BEHAV REV, V6, P5, DOI 10.3819/ccbr.2011.60003; Bruce RH, 1941, J COMP PSYCHOL, V31, P395, DOI 10.1037/h0056901; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Corman AM, 2016, ECOL EVOL, V6, P974, DOI 10.1002/ece3.1884; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0077; Dolivo V, 2016, LEARN BEHAV, V44, P223, DOI 10.3758/s13420-016-0236-z; Dolivo V, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0959; Dorfman A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146137; Ewer RF, 1971, ANIM BEHAV MONOGR, V4, P125, DOI DOI 10.1016/S0066-1856(71)80002-X; Gavrilets S, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1067; GENTSCH C, 1988, BEHAV BRAIN RES, V27, P37, DOI 10.1016/0166-4328(88)90107-6; GENTSCH C, 1988, PROG NEURO-PSYCHOPH, V12, P639, DOI 10.1016/0278-5846(88)90009-7; Hernandez-Lallement J, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00443; Hodge SJ, 2009, BEHAV ECOL, V20, P930, DOI 10.1093/beheco/arp071; Lehner SR, 2011, ETHOLOGY, V117, P949, DOI 10.1111/j.1439-0310.2011.01962.x; Lima SL, 1999, BEHAV ECOL SOCIOBIOL, V46, P110, DOI 10.1007/s002650050599; Marquez C, 2015, CURR BIOL, V25, P1736, DOI 10.1016/j.cub.2015.05.018; Mason P, 2016, HELPING ANOTHER DIST, P177; Palagi E, 2016, BEHAVIOUR IN PRESS, P153; Price ME, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00363; Pronk R, 2010, J EXP BIOL, V213, P1035, DOI 10.1242/jeb.040675; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rutte C, 2008, BEHAV ECOL SOCIOBIOL, V62, P499, DOI 10.1007/s00265-007-0474-3; Rutte C, 2007, PLOS BIOL, V5, P1421, DOI 10.1371/journal.pbio.0050196; Sato N, 2015, ANIM COGN, V18, P1039, DOI 10.1007/s10071-015-0872-2; Schneeberger K, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-41; Silberberg A, 2014, ANIM COGN, V17, P609, DOI [10.1007/s10071-013-0623-1, 10.1007/s10071-013-0692-1]; Smith JE, 2016, TRENDS ECOL EVOL, V31, P54, DOI 10.1016/j.tree.2015.09.013; SYME GJ, 1974, ANIM BEHAV, V22, P931, DOI 10.1016/0003-3472(74)90016-5; SYME GJ, 1974, ANIM BEHAV, V22, P486, DOI 10.1016/S0003-3472(74)80048-5; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Vugt M, 2006, PERS SOC PSYCHOL REV, V10, P354, DOI 10.1207/s15327957pspr1004_5; Vasconcelos M, 2012, BIOL LETTERS, V8, P910, DOI 10.1098/rsbl.2012.0554; Weiss O, 2015, ANIM COGN, V18, P39, DOI 10.1007/s10071-014-0775-7; Zentall TR, 2016, LEARN BEHAV, V44, P7, DOI 10.3758/s13420-015-0201-2	43	13	13	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173302	10.1371/journal.pone.0173302	http://dx.doi.org/10.1371/journal.pone.0173302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278246	Green Submitted, gold, Green Published			2022-12-27	WOS:000396087900069
J	Pankow, JF; Kim, K; McWhirter, KJ; Luo, W; Escobedo, JO; Strongin, RM; Duell, AK; Peyton, DH				Pankow, James F.; Kim, Kilsun; McWhirter, Kevin J.; Luo, Wentai; Escobedo, Jorge O.; Strongin, Robert M.; Duell, Anna K.; Peyton, David H.			Benzene formation in electronic cigarettes	PLOS ONE			English	Article							CONVERSION; SMOKE	Background/Objective The heating of the fluids used in electronic cigarettes ("e-cigarettes") used to create "vaping" aerosols is capable of causing a wide range of degradation reaction products. We investigated formation of benzene (an important human carcinogen) from e-cigarette fluids containing propylene glycol (PG), glycerol (GL), benzoic acid, the flavor chemical benzaldehyde, and nicotine. Methods/Main results Three e-cigarette devices were used: the JUUL (TM) "pod" system (provides no user accessible settings other than flavor cartridge choice), and two refill tank systems that allowed a range of user accessible power settings. Benzene in the e-cigarette aerosols was determined by gas chromatography/mass spectrometry. Benzene formation was ND (not detected) in the JUUL system. In the two tank systems benzene was found to form from propylene glycol (PG) and glycerol (GL), and from the additives benzoic acid and benzaldehyde, especially at high power settings. With 50:50 PG+GL, for tank device 1 at 6W and 13W, the formed benzene concentrations were 1.9 and 750 mu g/m(3). For tank device 2, at 6W and 25W, the formed concentrations were ND and 1.8 mu g/m(3). With benzoic acid and benzaldehyde at similar to 10 mg/mL, for tank device 1, values at 13W were as high as 5000 mu g/m(3). For tank device 2 at 25W, all values were <=-100 mu g/m(3). These values may be compared with what can be expected in a conventional (tobacco) cigarette, namely 200,000 pg/m3. Thus, the risks from benzene will be lower from e cigarettes than from conventional cigarettes. However, ambient benzene air concentrations in the U.S. have typically been 1 mu g/m(3), so that benzene has been named the largest single known cancer-risk air toxic in the U.S. For non-smokers, chronically repeated exposure to benzene from e-cigarettes at levels such as 100 or higher mu g/m(3) will not be of negligible risk.	[Pankow, James F.; Kim, Kilsun; Luo, Wentai; Escobedo, Jorge O.; Strongin, Robert M.; Duell, Anna K.; Peyton, David H.] Portland State Univ, Dept Chem, Portland, OR 97207 USA; [Pankow, James F.; McWhirter, Kevin J.; Luo, Wentai] Portland State Univ, Dept Civil & Environm Engn, Portland, OR 97207 USA	Portland State University; Portland State University	Pankow, JF (corresponding author), Portland State Univ, Dept Chem, Portland, OR 97207 USA.; Pankow, JF (corresponding author), Portland State Univ, Dept Civil & Environm Engn, Portland, OR 97207 USA.	pankowj@pdx.edu	Escobedo, Jorge O/F-1735-2010; Kim, Kilsun/AAM-7581-2021; Strongin, Robert M./F-1026-2010	Escobedo, Jorge O/0000-0001-8858-663X; Peyton, David/0000-0001-5828-055X; /0000-0001-5855-5162	NIH; FDA [R01ES025257]; NIEHS; FDA Center for Tobacco Products (CTP); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025257] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FDA(United States Department of Health & Human Services); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); FDA Center for Tobacco Products (CTP)(United States Department of Health & Human Services); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	NIH and FDA supported this work via award R01ES025257. In particular, the work reported in this publication was supported by NIEHS and the FDA Center for Tobacco Products (CTP) (https://www.nih.gov/). The funders had no role in study design, data collection and analysis, ecision to publish, or preparation of the manuscript.	BAKER RR, 1974, NATURE, V247, P404; Borgerding MF, 2000, 1999 MASSACHUSETTS B; George BJ, 2011, ATMOS ENVIRON, V45, P3301, DOI 10.1016/j.atmosenv.2011.03.031; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Hoang TQ, 2010, ENERG FUEL, V24, P3804, DOI 10.1021/ef100160y; Hua M, 2013, TOB CONTROL, V22, P103, DOI 10.1136/tobaccocontrol-2011-050226; International Agency for Research on Cancer (IARC), 2012, MON EV CARC RISK H F, V100-F; Jensen RP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42549; Jensen RP, 2015, NEW ENGL J MED, V372, P392, DOI 10.1056/NEJMc1413069; Kim YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16383; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; McAuley TR, 2012, INHAL TOXICOL, V24, P850, DOI 10.3109/08958378.2012.724728; Nef J. U., 1904, LIEBIGS ANN CHEM, V335, P247; OPRIS I, 1981, REV CHIM-BUCHAREST, V32, P234; Pankow JF, 2007, CANCER EPIDEM BIOMAR, V16, P584, DOI 10.1158/1055-9965.EPI-06-0762; Pankow JF, 2017, J AEROSOL SCI, V107, P9, DOI 10.1016/j.jaerosci.2017.02.003; Pankow JF, 2004, CHEM RES TOXICOL, V17, P805, DOI 10.1021/tx0342316; Sleiman M, 2016, ENVIRON SCI TECHNOL, V50, P9644, DOI 10.1021/acs.est.6b01741; Tierney P. A, 2015, TOB CONTROL; U.S. Environmental Protection Agency, 2003, EPAS REP ENV AMB CON	20	118	120	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173055	10.1371/journal.pone.0173055	http://dx.doi.org/10.1371/journal.pone.0173055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273096	Green Submitted, gold, Green Published			2022-12-27	WOS:000396073700036
J	Zhang, W; Lu, MZ; Zhang, CL; Zhang, RW; Ou, XF; Zhou, JJ; Li, Y; Kang, Y				Zhang, Wei; Lu, Meizhu; Zhang, Chenlong; Zhang, Ruwen; Ou, Xiaofeng; Zhou, Jianju; Li, Yan; Kang, Yan			Therapeutic hypothermia increases the risk of cardiac arrhythmia for perinatal hypoxic ischaemic encephalopathy: A meta-analysis	PLOS ONE			English	Article							SYSTEMIC HYPOTHERMIA; NEONATAL ENCEPHALOPATHY; MILD HYPOTHERMIA; NEWBORN-INFANTS; ASPHYXIA; SETTINGS	Objective To determine whether therapeutic hypothermia after hypoxic ischaemic encephalopathy (HIE) in neonates increases the risk of cardiac arrhythmia during intervention. Design A meta-analysis was conducted using a fixed-effect model. Risk ratios, risk differences, and 95% confidence intervals, were measured. Data sources Studies identified from the Cochrane Central Register of Controlled Trials, MEDLI NE, EMBASE, Google Scholar, previous reviews, and abstracts from onset to August, 2016. Review methods Reports that compared therapeutic hypothermia with normal care for neonates with HIE and that included data on safety or cardiac arrhythmia, which is of interest to patients and clinicians, were selected. Results We found seven trials, encompassing 1322 infants that included information on safety or cardiac arrhythmia during intervention. Therapeutic hypothermia considerably increased the combined rate of cardiac arrhythmia in the seven trials (risk ratio 2.42, 95% confidence interval 1.23 to 4.76. p = 0.01; risk difference 0.02, 95% CI 0.01 to 0.04) during intervention. Conclusions In infants with hypoxic ischaemic encephalopathy, therapeutic hypothermia is associated with a consistent increase in cardiac arrhythmia during intervention.	[Zhang, Wei; Lu, Meizhu; Zhang, Chenlong; Zhang, Ruwen; Ou, Xiaofeng; Kang, Yan] Sichuan Univ, West China Med Ctr, Dept Crit Care Med, Chengdu, Sichuan, Peoples R China; [Zhang, Wei; Zhou, Jianju] Zunyi Med Coll, Clin Hosp 3, Peoples Hosp Zunyi Guizhou Prov 1, Dept Crit Care Med, Zunyi, Guizhou, Peoples R China; [Li, Yan] Peoples Hosp Yishui Cty, Dept Neurol, Yishui, Shandong, Peoples R China	Sichuan University; Zunyi Medical University	Kang, Y (corresponding author), Sichuan Univ, West China Med Ctr, Dept Crit Care Med, Chengdu, Sichuan, Peoples R China.	kangyan_hxicu@163.com						Akisu M, 2003, PROSTAG LEUKOTR ESS, V69, P45, DOI 10.1016/S0952-3278(03)00055-3; Akula V, 2014, J INVEST MED, V62, P210; Al Faleh K, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-38; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Battin MR, 2001, PEDIATRICS, V107, P480, DOI 10.1542/peds.107.3.480; Bharadwaj SK, 2012, J TROP PEDIATRICS, V58, P382, DOI 10.1093/tropej/fms005; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gunn AJ, 1998, PEDIATRICS, V102, P885, DOI 10.1542/peds.102.4.885; Hassell KJ, 2015, ARCH DIS CHILD-FETAL, V100, pF541, DOI 10.1136/archdischild-2014-306284; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Joy R, 2013, J TROP PEDIATRICS, V59, P17, DOI 10.1093/tropej/fms036; Li Tongchuan, 2009, Hosp Pract (1995), V37, P147, DOI 10.3810/hp.2009.12.269; Lin ZL, 2006, J PERINATOL, V26, P180, DOI 10.1038/sj.jp.7211412; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Moler FW, 2015, NEW ENGL J MED, V372, P1898, DOI 10.1056/NEJMoa1411480; Mourvillier B, 2013, JAMA-J AM MED ASSOC, V310, P2174, DOI 10.1001/jama.2013.280506; Robertson NJ, 2008, LANCET, V372, P801, DOI 10.1016/S0140-6736(08)61329-X; Roka A, 2010, EARLY HUM DEV, V86, P361, DOI 10.1016/j.earlhumdev.2010.05.013; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Simbruner G, 2010, PEDIATRICS, V126, pE771, DOI 10.1542/peds.2009-2441; Zhou WH, 2010, J PEDIATR-US, V157, P367, DOI 10.1016/j.jpeds.2010.03.030	23	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173006	10.1371/journal.pone.0173006	http://dx.doi.org/10.1371/journal.pone.0173006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273115	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700035
J	Wang, Y; Stewart, E; Desjardins, L; Hadway, J; Morrison, L; Crukley, C; Lee, TY				Wang, Yong; Stewart, Errol; Desjardins, Lise; Hadway, Jennifer; Morrison, Laura; Crukley, Cathie; Lee, Ting-Yim			Assessment of intratumor hypoxia by integrated F-18-FDG PET/perfusion CT in a liver tumor model	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ADVANCED BREAST-CANCER; BLOOD-FLOW; METABOLISM; MARKERS; PIMONIDAZOLE; SURROGATE; THERAPY; CERVIX; FDG	Objectives Hypoxia in solid tumors occurs when metabolic demands in tumor cells surpass the delivery of oxygenated blood. We hypothesize that the F-18-fluorodeoxyglucose (F-18-FDG) metabolism and tumor blood flow mismatch would correlate with tumor hypoxia. Methods Liver perfusion computed tomography (CT) and F-18-FDG positron emission tomography (PET) imaging were performed in twelve rabbit livers implanted with VX2 carcinoma. Under CT guidance, a fiber optic probe was inserted into the tumor to measure the partial pressure of oxygen (pO(2)). Tumor blood flow (BF) and standardized uptake value (SUV) were measured to calculate flow-metabolism ratio (FMR). Tumor hypoxia was further identified using pimonidazole immunohistochemical staining. Pearson correlation analysis was performed to determine the correlation between the imaging parameters and pO(2) and pimonidazole staining. Results Weak correlations were found between blood volume (BV) and pO(2) level (r = 0.425, P = 0.004), SUV and pO2 (r = -0.394, P = 0.007), FMR and pimonidazole staining score (r = -0.388, P = 0.031). However, there was stronger correlation between tumor FMR and pO(2) level (r = 0.557, P < 0.001). Conclusions FMR correlated with tumor oxygenation and pimonidazole staining suggesting it may be a potential hypoxic imaging marker in liver tumor.	[Wang, Yong] Huazhong Univ Sci & Technol, Union Hosp, Dept Radiol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Wang, Yong; Lee, Ting-Yim] Western Univ, Schulich Sch Med & Dent, Dept Med Biophys, London, ON, Canada; [Stewart, Errol; Desjardins, Lise; Hadway, Jennifer; Morrison, Laura; Lee, Ting-Yim] Lawson Hlth Res Inst, Imaging Program, London, ON, Canada; [Crukley, Cathie; Lee, Ting-Yim] Robarts Res Inst, Imaging Res Labs, London, ON, Canada	Huazhong University of Science & Technology; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Lee, TY (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Med Biophys, London, ON, Canada.	tlee@imaging.robarts.ca	Stewart, Errol/AAO-5739-2020; Lee, Ting-Yim/M-1721-2013; Lee, Ting-Yim/J-3947-2019	Lee, Ting-Yim/0000-0001-7605-9752	Ontario Institute of Cancer Research (Wester REB) [103184]	Ontario Institute of Cancer Research (Wester REB)	TYL was funded by Ontario Institute of Cancer Research (Wester REB #103184) http://oicr.on.ca./.	ARTEEL GE, 1995, BRIT J CANCER, V72, P889, DOI 10.1038/bjc.1995.429; Busk M, 2008, INT J CANCER, V122, P2726, DOI 10.1002/ijc.23449; Busk M, 2009, RADIOTHER ONCOL, V92, P429, DOI 10.1016/j.radonc.2009.08.026; Cherk MH, 2006, J NUCL MED, V47, P1921; Christian N, 2010, RADIOTHER ONCOL, V97, P183, DOI 10.1016/j.radonc.2010.02.020; Dierckx RA, 2008, EUR J NUCL MED MOL I, V35, P1544, DOI 10.1007/s00259-008-0758-5; Dunnwald LK, 2008, J CLIN ONCOL, V26, P4449, DOI 10.1200/JCO.2007.15.4385; Enjilela E, 2015, COMPRESSED SENSING B; Fleming IN, 2015, BRIT J CANCER, V112, P238, DOI 10.1038/bjc.2014.610; Goh V, 2012, J NUCL MED, V53, P687, DOI 10.2967/jnumed.111.098525; Jankovic B, 2006, CYTOM PART B-CLIN CY, V70B, P45, DOI 10.1002/cyto.b.20086; Jensen NKG, 2013, ACAD RADIOL, V20, P414, DOI 10.1016/j.acra.2012.09.027; Komar G, 2009, CLIN CANCER RES, V15, P5511, DOI 10.1158/1078-0432.CCR-09-0414; Mandeville HC, 2012, RADIOLOGY, V264, P581, DOI 10.1148/radiol.12111505; Mankoff DA, 2002, J NUCL MED, V43, P500; Mankoff DA, 2009, CLIN CANCER RES, V15, P5294, DOI 10.1158/1078-0432.CCR-09-1448; Miles KA, 2008, CANCER IMAGING, V8, P81, DOI 10.1102/1470-7330.2008.0011; Nordsmark M, 2001, INT J RADIAT ONCOL, V49, P581, DOI 10.1016/S0360-3016(00)01493-0; Olive PL, 2001, ACTA ONCOL, V40, P917; Semple SIK, 2004, EUR RADIOL, V14, P2038, DOI 10.1007/s00330-004-2454-6; SHANBHAG AG, 1994, CVGIP-GRAPH MODEL IM, V56, P414, DOI 10.1006/cgip.1994.1037; Stewart EE, 2008, PHYS MED BIOL, V53, P4249, DOI 10.1088/0031-9155/53/16/003; Stewart EE, 2006, RADIOLOGY, V239, P740, DOI 10.1148/radiol.2393041382; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Zimny M, 2006, EUR J NUCL MED MOL I, V33, P1426, DOI 10.1007/s00259-006-0175-6	25	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173016	10.1371/journal.pone.0173016	http://dx.doi.org/10.1371/journal.pone.0173016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264009	Green Submitted, Green Published, gold			2022-12-27	WOS:000396054300034
J	Norelli, JL; Wisniewski, M; Fazio, G; Burchard, E; Gutierrez, B; Levin, E; Droby, S				Norelli, John L.; Wisniewski, Michael; Fazio, Gennaro; Burchard, Erik; Gutierrez, Benjamin; Levin, Elena; Droby, Samir			Genotyping-by-sequencing markers facilitate the identification of quantitative trait loci controlling resistance to Penicillium expansum in Malus sieversii	PLOS ONE			English	Article							X DOMESTICA-BORKH.; FIRE BLIGHT RESISTANCE; BLUE MOLD; DISEASE RESISTANCE; CULTIVATED APPLE; QTL ANALYSIS; VALIDATION; GERMPLASM; SELECTION; GENOME	Blue mold caused by Penicillium expansum is the most important postharvest disease of apple worldwide and results in significant financial losses. There are no defined sources of resistance to blue mold in domesticated apple. However, resistance has been described in wild Malus sieversii accessions, including plant introduction (PI) 613981. The objective of the present study was to identify the genetic loci controlling resistance to blue mold in this accession. We describe the first quantitative trait loci (QTL) reported in the Rosaceae tribe Maleae conditioning resistance to P. expansum on genetic linkage group 3 (qM-Pe3.1) and linkage group 10 (qM-Pe10.1). These loci were identified in a M. x domestica 'Royal Gala' X M. sieversii PI613981 family (GMAL4593) based on blue mold lesion diameter seven days post-inoculation in mature, wounded apple fruit inoculated with P. expansum. Phenotypic analyses were conducted in 169 progeny over a four year period. PI613981 was the source of the resistance allele for qM-Pe3.1, a QTL with a major effect on blue mold resistance, accounting for 27.5% of the experimental variability. The QTL mapped from 67.3 to 74 cM on linkage group 3 of the GMAL4593 genetic linkage map. qM-Pe10.1 mapped from 73.6 to 81.8 cM on linkage group 10. It had less of an effect on resistance, accounting for 14% of the experimental variation. 'Royal Gala' was the primary contributor to the resistance effect of this QTL. However, resistance-associated alleles in both parents appeared to contribute to the least square mean blue mold lesion diameter in an additive manner at qM-Pe10.1. A GMAL4593 genetic linkage map composed of simple sequence repeats and 'Golden Delicious' single nucleotide polymorphism markers was able to detect qM-Pe10.1, but failed to detect qM-Pe3.1. The subsequent addition of genotyping-by-sequencing markers to the linkage map provided better coverage of the PI613981 genome on linkage group 3 and facilitated discovery of qM-Pe3.1. A DNA test for qM-Pe3.1 has been developed and is currently being evaluated for its ability to predict blue mold resistance in progeny segregating for qMPe3.1. Due to the long juvenility of apple, the availability of a DNA test to screen for the presence of qM-Pe3.1 at the seedling stage will greatly improve efficiency of breeding apple for blue mold resistance.	[Norelli, John L.; Wisniewski, Michael; Burchard, Erik] ARS, Appalachian Fruit Res Stn, USDA, Kearneysville, WV 25430 USA; [Fazio, Gennaro; Gutierrez, Benjamin] ARS, Plant Genet Resources Res, USDA, Geneva, NY USA; [Levin, Elena; Droby, Samir] Agr Res Org, Dept Postharvest Sci, Volcani Ctr, Bet Dagan, Israel	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Norelli, JL (corresponding author), ARS, Appalachian Fruit Res Stn, USDA, Kearneysville, WV 25430 USA.	jay.norelli@ars.usda.gov		Gutierrez, Benjamin/0000-0002-9706-7521; Fazio, Gennaro/0000-0001-6929-3751; Wisniewski, Michael/0000-0002-7481-5590	BARD [US-4774-14C]; United States Israel Binational Agricultural Research and Development Fund; Washington Tree Fruit Research Commission [AP-08-804, CP-10-101]; USDA National Institute of Food and Agriculture Specialty Crop Research Initiative [2014-51181-22378]	BARD(US-Israel Binational Science Foundation); United States Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); Washington Tree Fruit Research Commission; USDA National Institute of Food and Agriculture Specialty Crop Research Initiative	This research was funded in large-part by Research Grant No. US-4774-14C from BARD, The United States Israel Binational Agricultural Research and Development Fund (https://www.bard-isus.com/); and additionally by the Washington Tree Fruit Research Commission (http://www.treefruitresearch.com/) project numbers AP-08-804 and CP-10-101; and the USDA National Institute of Food and Agriculture Specialty Crop Research Initiative (https://nifa.usda.gov/funding-opportunity/specialty-crop-research-initiative-scri) research-initiative-scri) project RosBREED: Combining disease resistance with horticultural quality in new Rosaceous cultivars (2014-51181-22378). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen B, 2004, J AGR FOOD CHEM, V52, P2421, DOI 10.1021/jf035406k; [Anonymous], 2014, R LANG ENV STAT COMP; Bassett CL, 2011, HORTSCIENCE, V46, P1079, DOI 10.21273/HORTSCI.46.8.1079; Baumgartner IO, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-0994-y; Bianco L, 2016, PLANT J, V86, P62, DOI 10.1111/tpj.13145; Bianco L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110377; Blanpied G. D., 1992, INFORM B, V221; Boocock J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2096-x; Bus VGM, 2005, NEW PHYTOL, V166, P1035, DOI 10.1111/j.1469-8137.2005.01395.x; CAPPELLINI RA, 1987, PLANT DIS, V71, P852; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; CHEVREAU E, 1987, THEOR APPL GENET, V75, P90, DOI 10.1007/BF00249147; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cornille A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002703; Costa F, 2010, J EXP BOT; Cowey R, 2014, BREEDING SCI, V64, P83, DOI 10.1270/jsbbs.64.83; CROSBY JA, 1992, FRUIT VARIETIES J, V46, P145; Droby S, 2016, POSTHARVEST BIOL TEC, V122, P22, DOI 10.1016/j.postharvbio.2016.04.006; Ellis ML, 2012, CROP SCI, V52, P2224, DOI 10.2135/cropsci2011.11.0624; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fahrentrapp J, 2013, TREE GENET GENOMES, V9, P237, DOI 10.1007/s11295-012-0550-3; Flachowsky H, 2007, PLANT BREEDING, V126, P137, DOI 10.1111/j.1439-0523.2007.01344.x; Flachowsky H, 2011, NEW PHYTOL, V192, P364, DOI 10.1111/j.1469-8137.2011.03813.x; Forsline P. L., 2003, Horticultural Reviews, V29, P1, DOI 10.1002/9780470650868.ch1; Gardner KM, 2014, G3, V4, P1691; Gianfranceschi L, 1998, THEOR APPL GENET, V96, P1069, DOI 10.1007/s001220050841; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Hyma KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134880; Janisiewicz WJ, 2002, ANNU REV PHYTOPATHOL, V40, P411, DOI 10.1146/annurev.phyto.40.120401.130158; JANISIEWICZ WJ, 1992, PHYTOPATHOLOGY, V82, P1364, DOI 10.1094/Phyto-82-1364; Janisiewicz WJ, 2008, HORTSCIENCE, V43, P420, DOI 10.21273/HORTSCI.43.2.420; JANSEN RC, 1994, GENETICS, V138, P871; JANSEN RC, 1994, GENETICS, V136, P1447; Jurick WM, 2011, PLANT BREEDING, V130, P481, DOI 10.1111/j.1439-0523.2011.01849.x; Kamphuis LG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-30; Konstantinou S, 2011, PLANT DIS, V95, P666, DOI 10.1094/PDIS-11-10-0856; Korban SS, 2009, GENOME, V52, P148, DOI [10.1139/G08-109, 10.1139/g08-109]; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kumar S, 2014, PLANT GENET RESOUR-C, V12, P330, DOI 10.1017/S1479262114000136; LANDER ES, 1989, GENETICS, V121, P185; Le Roux PM, 2012, MOL BREEDING, V30, P857, DOI 10.1007/s11032-011-9669-4; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; LIEBHARD R, 2004, MOL BREEDING, V10, P217; Luby J, 2001, HORTSCIENCE, V36, P225, DOI 10.21273/HORTSCI.36.2.225; Maliepaard C, 1998, THEOR APPL GENET, V97, P60, DOI 10.1007/s001220050867; McClure KA, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.43; McCouch S, 2004, PLOS BIOL, V2, P1507, DOI 10.1371/journal.pbio.0020347; Micheletti D, 2011, TREE GENET GENOMES, V7, P857, DOI 10.1007/s11295-011-0380-8; Noiton DAM, 1996, J AM SOC HORTIC SCI, V121, P773, DOI 10.21273/JASHS.121.5.773; Norelli JL, 2014, ACTA HORTIC, V1053, P199; Olmstead J, GENOME DATABASE ROSA; Parravicini G, 2011, MOL PLANT PATHOL, V12, P493, DOI 10.1111/j.1364-3703.2010.00690.x; Peace CP, 2014, TREE GENET GENOMES, V10, P1679, DOI 10.1007/s11295-014-0788-z; PHIPPS JB, 1991, SYST BOT, V16, P303, DOI 10.2307/2419283; Pindo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-12; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Richards CM, 2009, J AM SOC HORTIC SCI, V134, P228, DOI 10.21273/JASHS.134.2.228; Richards CM, 2009, TREE GENET GENOMES, V5, P339, DOI 10.1007/s11295-008-0190-9; Robinson JP, 2001, PLANT SYST EVOL, V226, P35, DOI 10.1007/s006060170072; Rosenberger D, 1997, ENG SERV PUBL, V112; Rosenberger D.A., 1990, COMPENDIUM APPLE PEA, P54; Ru S, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0834-5; Silfverberg-Dilworth E, 2006, TREE GENET GENOMES, V2, P202, DOI 10.1007/s11295-006-0045-1; Spotts RA, 1999, PLANT DIS, V83, P1051, DOI 10.1094/PDIS.1999.83.11.1051; Tahir II, 2015, EUR J HORTIC SCI, V80, P117, DOI 10.17660/eJHS.2015/80.3.4; Tobler AR, 2005, J BIOMOL TECH, V16, P389; USDA-ARS, 2000, PLANT MAT INTR 2000, P223; Van Ooijen JW, 2013, GENETIC MAPPING IN EXPERIMENTAL POPULATIONS, P101; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vilanova L, 2014, POSTHARVEST BIOL TEC, V88, P54, DOI 10.1016/j.postharvbio.2013.09.009; Volk GM, 2015, AM J BOT, V102, P1198, DOI 10.3732/ajb.1500095; Volk GM, 2013, HORTSCIENCE, V48, P1440, DOI 10.21273/HORTSCI.48.12.1440; Volk GM, 2014, GENET RESOURCES CROP; Wan YZ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0839-2; Wang AD, 2012, MOL BREEDING, V29, P379, DOI 10.1007/s11032-011-9554-1; Wisniewski M, 2016, POSTHARVEST BIOL TEC, V122, P3, DOI 10.1016/j.postharvbio.2016.05.012; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Zhang W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00161	81	33	35	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172949	10.1371/journal.pone.0172949	http://dx.doi.org/10.1371/journal.pone.0172949			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257442	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100043
J	Winkler, M; Gartner, S; Wrensch, F; Krawczak, M; Sauermann, U; Poehlmann, S				Winkler, Michael; Gaertner, Sabine; Wrensch, Florian; Krawczak, Michael; Sauermann, Ulrike; Poehlmann, Stefan			Rhesus macaque IFITM3 gene polymorphisms and SIV infection	PLOS ONE			English	Article							INDUCED TRANSMEMBRANE PROTEIN-3; HOST-CELL ENTRY; SYNONYMOUS MUTATIONS; VIRUS-REPLICATION; SEVERE INFLUENZA; DENGUE VIRUS; HIV-1; RESTRICTION; RESISTANCE; GENOME	Interferon-induced transmembrane proteins (IFITMs) have been recognized as important antiviral effectors of the innate immune system, both in cell culture and in infected humans. In particular, polymorphisms of the human IFITM3 gene have been shown to affect disease severity and progression in influenza A virus (FLUAV) and human immunodeficiency virus (HIV) infection, respectively. Rhesus macaques (Macaca mulatta) are commonly used to model human infections and the experimental inoculation of these animals with simian immunodeficiency virus (SIV) is one of the best models for HIV/AIDS in humans. However, information on the role of IFITM3 in SIV infection of rhesus macaques is currently lacking. We show that rhesus macaque (rh) IFITM3 inhibits SIV and FLUAV entry in cell culture, although with moderately reduced efficiency as compared to its human counterpart. We further report the identification of 16 polymorphisms in the rhIFITM3 gene, three of which were exonic and synonymous while the remainder was located in non-coding regions. Employing previously characterized samples from two cohorts of SIV-infected rhesus macaques, we investigated the relationship between these rhIFITM3 polymorphisms and both AIDS-free survival time and virus load. In cohort 1, several intronic polymorphisms were significantly associated with virus load or survival. However, an association with both parameters was not observed and significance was lost in most cases when animals were stratified for the presence of MHC allele Mamu-A1*001. Moreover, no significant genotype-phenotype associations were detected in cohort 2. These results suggest that, although IFITM3 can inhibit SIV infection in cell culture, genetic variation in rhIFITM3 might have only a minor impact on the course of SIV infection in experimentally infected animals.	[Winkler, Michael; Gaertner, Sabine; Wrensch, Florian; Poehlmann, Stefan] Leibniz Inst Primate Res, Infect Biol Unit, Deutsch Primatenzentrum, Gottingen, Germany; [Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany; [Sauermann, Ulrike] Leibniz Inst Primate Res, Infect Models Unit, Deutsch Primatenzentrum, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); University of Kiel; Deutsches Primatenzentrum (DPZ)	Winkler, M; Poehlmann, S (corresponding author), Leibniz Inst Primate Res, Infect Biol Unit, Deutsch Primatenzentrum, Gottingen, Germany.	MWinkler@dpz.eu; SPoehlmann@dpz.eu	Krawczak, Michael/A-8964-2010; Pöhlmann, Stefan/H-2395-2011	Krawczak, Michael/0000-0003-2603-1502; Pöhlmann, Stefan/0000-0001-6086-9136; Wrensch, Florian/0000-0002-7258-5453; Winkler, Michael/0000-0002-6198-554X	Leibniz foundation (Graduate School Emerging Infectious Diseases)	Leibniz foundation (Graduate School Emerging Infectious Diseases)	The study was supported by the Leibniz foundation (Graduate School Emerging Infectious Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031961; Bailey CC, 2013, J BIOL CHEM, V288, P32184, DOI 10.1074/jbc.M113.514356; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Bertram S, 2013, J VIROL, V87, P6150, DOI 10.1128/JVI.03372-12; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chutiwitoonchai N, 2013, MICROBES INFECT, V15, P280, DOI 10.1016/j.micinf.2012.12.003; Compton AA, 2016, EMBO REP, V17, P1657, DOI 10.15252/embr.201642771; Compton AA, 2014, CELL HOST MICROBE, V16, P736, DOI 10.1016/j.chom.2014.11.001; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Diederichs S, 2016, EMBO MOL MED, V8, P442, DOI 10.15252/emmm.201506055; Ding SL, 2014, VIROLOGY, V454, P11, DOI 10.1016/j.virol.2014.01.020; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Foster TL, 2016, CELL HOST MICROBE, V20, P429, DOI 10.1016/j.chom.2016.08.006; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Hens J, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0099-6; Hickford D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-155; Hofmann-Winkler H, 2015, J INFECT DIS, V212, pS172, DOI 10.1093/infdis/jiv101; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Hunt RC, 2014, TRENDS GENET, V30, P308, DOI 10.1016/j.tig.2014.04.006; Javed A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142086; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Ling SL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24029; Lu J., 2011, J WIREL COMMUN NETWO, V1, P1, DOI DOI 10.1128/JVI.01531-10; Mills TC, 2014, J INFECT DIS, V209, P1028, DOI 10.1093/infdis/jit468; Narayana SK, 2015, J BIOL CHEM, V290, P25946, DOI 10.1074/jbc.M115.657346; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Qian J, 2015, VIROLOGY, V474, P10, DOI 10.1016/j.virol.2014.10.015; Sauermann Ulrike, 2001, Current Molecular Medicine (Hilversum), V1, P515; Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074; Siddiqui RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025474; Smith SE, 2014, CURR OPIN VIROL, V4, P71, DOI 10.1016/j.coviro.2013.11.004; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Tartour K, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0103-y; Wang Y P Q, 2017, J VIROLOGY; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Weston S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104341; Wilkins J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156739; Williams DEJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110096; Wrensch F, 2014, VIRUSES-BASEL, V6, P3683, DOI 10.3390/v6093683; Xie MR, 2015, J VIROL, V89, P3049, DOI 10.1128/JVI.03416-14; Xuan Y, 2015, EPIDEMIOL INFECT, V143, P2975, DOI 10.1017/S0950268815000278; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yu JY, 2015, CELL REP, V13, P145, DOI 10.1016/j.celrep.2015.08.055; Zhang Y., 2015, J NANOMATER, V2015, P1, DOI DOI 10.1080/10298436.2015.1019502; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433; Zhang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049265; Zhao XS, 2014, P NATL ACAD SCI USA, V111, P6756, DOI 10.1073/pnas.1320856111; Zimin AV, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-20	48	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172847	10.1371/journal.pone.0172847	http://dx.doi.org/10.1371/journal.pone.0172847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257482	Green Published, gold			2022-12-27	WOS:000396021100031
J	Esposito, G; Hernandez, P; van Bavel, R; Vila, JA				Esposito, Gabriele; Hernandez, Penelope; van Bavel, Rene; Vila, Jose A.			Nudging to prevent the purchase of incompatible digital products online: An experimental study	PLOS ONE			English	Article							WORD-OF-MOUTH; GENDER-DIFFERENCES; DECISION-MAKING; TECHNOLOGY; CONSUMERS; BEHAVIOR; AGE; DISAPPOINTMENT; UNCERTAINTY; EMOTIONS	Ensuring safe and satisfactory online shopping activity, especially among vulnerable consumers such as elderly and less educated citizens, is part of a larger set of consumer policy objectives seeking to strengthen trust in the electronic marketplace. This article contributes to that goal by testing the effectiveness of nudges intended to prevent the purchase of 'incompatible' digital products (i.e., those which cannot be used with the devices owned by consumers or the systems they operate). We ran a computerised lab experiment (n = 626) examining three types of nudges, the effects of age and education, and interaction effects between these variables and the nudges. Results show that emotive warning messages and placing incompatibility information at the checkout page rather than earlier in the purchasing process were effective in reducing the purchase of incompatible goods. Age was also a relevant factor: older participants were more likely to purchase incompatible goods. In addition, there was an interaction effect between all nudges and age: two nudges exacerbated the effect of age, while another mitigated it. These results suggest nudges can be an effective policy tool, confirm a generational gap in online behaviour, and highlight how nudges can moderate the effect of socio-demographic variables.	[Esposito, Gabriele; van Bavel, Rene] European Commiss, Joint Res Ctr, Seville, Spain; [Hernandez, Penelope; Vila, Jose A.] Univ Valencia, Ctr Res Social & Econ Behav ERI CES, Valencia, Spain	University of Valencia	van Bavel, R (corresponding author), European Commiss, Joint Res Ctr, Seville, Spain.	rene.van-bavel@ec.europa.eu	Vila, Jose/AAA-2706-2019	Vila, Jose/0000-0002-5841-1115	European Commission's Directorate-General for Justice and Consumers; Spain's Ministerio de Economia y Competitividad [CO201346550-R]; Valencian Community's Conselleria d'Educacio, Cultura i Sport [PROMETEO 2009/068, 2013/019, ISIC 2012/021]	European Commission's Directorate-General for Justice and Consumers; Spain's Ministerio de Economia y Competitividad; Valencian Community's Conselleria d'Educacio, Cultura i Sport	This work was part of Consumer Information in the Digital Online Market (CIDOM), a project funded by the European Commission's Directorate-General for Justice and Consumers. They were involved in the study's design to increase its policy relevance. It was also partially supported by Spain's Ministerio de Economia y Competitividad under project CO201346550-R and the Valencian Community's Conselleria d'Educacio, Cultura i Sport under projects PROMETEO 2009/068, 2013/019, and ISIC 2012/021. These funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichholzer G, 2016, PUB ADMIN INF TECH, V19, P47, DOI 10.1007/978-3-319-25403-6_3; Bagozzi RP, 1999, J ACAD MARKET SCI, V27, P184, DOI 10.1177/0092070399272005; BELL DE, 1985, OPER RES, V33, P1, DOI 10.1287/opre.33.1.1; Berg L, 2015, INT J CONSUM STUD, V39, P284, DOI 10.1111/ijcs.12182; Bower G.H., 1981, THEORIES LEARNING; Burke RR, 2002, J ACAD MARKET SCI, V30, P411, DOI 10.1177/009207002236914; Burkolter D., 2011, J BUSINESS MEDIA PSY, V2, P20; Cameron AM, 2015, J LEGAL MED, V36, P39, DOI 10.1080/01947648.2015.1049916; Chevalier JA, 2006, J MARKETING RES, V43, P345, DOI 10.1509/jmkr.43.3.345; Choe EK, 2013, LECT NOTES COMPUT SC, V8119, P74; Cowart K.O., 2007, INT J CONSUM STUD, V31, P639, DOI DOI 10.1111/J.1470-6431.2007.00615.X; Cunningham S., 1967, RISK TAKING INFORM H; Duan W, 2008, J RETAILING, V84, P233, DOI 10.1016/j.jretai.2008.04.005; European Commission, EUROPE; Gao J, 2012, DECIS SUPPORT SYST, V53, P772, DOI 10.1016/j.dss.2012.05.011; Garbarino E, 2004, J BUS RES, V57, P768, DOI 10.1016/S0148-2963(02)00363-6; Garschagen M., 2015, WORLD DEV REP 2015 M, P68; Hasan B, 2010, COMPUT HUM BEHAV, V26, P597, DOI 10.1016/j.chb.2009.12.012; Hernandez B, 2011, ONLINE INFORM REV, V35, P113, DOI 10.1108/14684521111113614; HILL RP, 1987, ADV CONSUM RES, V14, P408; IGBARIA M, 1989, J MANAGE, V15, P373, DOI 10.1177/014920638901500302; Jacoby J., 1972, P 3 ANN C ASS CONS R, P382; Jansen BJ, 2012, ELECTRON COMMER RES, V12, P429, DOI 10.1007/s10660-012-9101-0; Kahneman D., 2011, THINKING FAST SLOW; Kraft-Todd G, 2015, CURR OPIN BEHAV SCI, V3, P96, DOI 10.1016/j.cobeha.2015.02.006; Lightner NJ, 2003, ERGONOMICS, V46, P153, DOI 10.1080/00140130303530; Lix LM, 1996, REV EDUC RES, V66, P579, DOI 10.3102/00346543066004579; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; LOOMES G, 1986, REV ECON STUD, V53, P271, DOI 10.2307/2297651; Lunn P, 2010, BEHAV EC VULNERABLE; Lunn P., 2014, REGULATORY POLICY BE; Lyon P, 2015, INT J CONSUM STUD, V39, P283, DOI 10.1111/ijcs.12212; Nikou S, 2015, INT J CONSUM STUD, V39, P294, DOI 10.1111/ijcs.12187; Norum PS, 2008, FAM CONSUM SCI RES J, V36, P373, DOI 10.1177/1077727X08318705; Obama B., 2015, 13707 WHIT HOUS; Perea T, 2004, INT J SERV IND MANAG, V15, P102, DOI 10.1108/09564230410523358; Perugini M, 2001, BRIT J SOC PSYCHOL, V40, P79, DOI 10.1348/014466601164704; Richardson PS, 1996, J RETAILING, V72, P159, DOI 10.1016/S0022-4359(96)90012-3; Seock YK, 2008, INT J CONSUM STUD, V32, P113, DOI 10.1111/j.1470-6431.2007.00647.x; Sheeran P, 2014, PSYCHOL BULL, V140, P511, DOI 10.1037/a0033065; Sherman E, 2001, PSYCHOL MARKET, V18, P1073, DOI 10.1002/mar.1044; Shukla P, 2013, J CONSUM BEHAV, V12, P423, DOI 10.1002/cb.1441; SOUSA LOURENCO J., 2016, 27726 EUR EN; Spiekermann S., 2002, Electronic Commerce Research, V2, P255, DOI 10.1023/A:1016062632182; Stevens J. P., 2012, APPL MULTIVARIATE ST; Suki NM., 2011, COMMUN IBIMA; Sunstein CR, 2014, J CONSUM POLICY, V37, P583, DOI 10.1007/s10603-014-9273-1; Thaler R.H., 2021, NUDGE FINAL EDITION; Thompson DV, 2005, J MARKETING RES, V42, P431, DOI 10.1509/jmkr.2005.42.4.431; van Bavel Rene, 2013, JRC SCI POLICY REPOR; Vartorella William, 1990, ADVERTISING AGE, V61, P31; Venkatesh V, 2000, MIS QUART, V24, P115, DOI 10.2307/3250981; Walther JB, 2001, SOC SCI COMPUT REV, V19, P324, DOI 10.1177/089443930101900307	54	10	11	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173333	10.1371/journal.pone.0173333	http://dx.doi.org/10.1371/journal.pone.0173333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6CJ	28282401	Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800030
J	Hatzirodos, N; Glister, C; Hummitzsch, K; Irving-Rodgers, HF; Knight, PG; Rodgers, RJ				Hatzirodos, Nicholas; Glister, Claire; Hummitzsch, Katja; Irving-Rodgers, Helen F.; Knight, Philip G.; Rodgers, Raymond J.			Transcriptomal profiling of bovine ovarian granulosa and theca interna cells in primary culture in comparison with their in vivo counterparts	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; ANCHORAGE-INDEPENDENT CULTURE; BONE MORPHOGENETIC PROTEINS; ANDROGEN PRODUCTION; ANTRAL FOLLICLES; INITIATE INFLAMMATION; MOLECULAR-PATTERNS; GENE-EXPRESSION; MENSTRUAL-CYCLE; CORPUS-LUTEUM	In vitro culture of ovarian granulosa cells and theca cells has been very important for our understanding of their function and regulation. One of the most eagerly sought attributes of cell culture is the use of chemically-defined conditions. However, even under such in vitro conditions cell behaviour could differ from the in vivo situation because of differences in oxygen tension, nutrients, adhesion matrix and other factors. To examine this further we compared the transcriptomes of both granulosa cells and cells from the theca interna that were cultured in what are arguably the best in vitro conditions for maintaining the 'follicular' phenotypes of both tissue types, as displayed by their respective freshly-isolated counterparts. The array data analysed are from recently published data and use the same sizes of bovine follicles (small antral 3-6 mm) and the same Affymetrix arrays. We conducted analysis using Partek, Ingenuity Pathway Analysis and GOEAST. Principal Component Analysis (PCA) and hierarchical clustering clearly separated the in vivo from the in vitro groups for both cells types and transcriptomes were more homogeneous upon culture. In both cell cultures behaviours associated with cell adhesion, migration and interaction with matrix or substrate were more abundant. However, the pathways involved generally differed between the two cell types. With the thecal cultures a gene expression signature of an immune response was more abundant, probably by leukocytes amongst the cells cultured from the theca interna. These results indicate differences between in vivo and in vitro that should be considered when interpreting in vitro data.	[Hatzirodos, Nicholas; Hummitzsch, Katja; Irving-Rodgers, Helen F.; Rodgers, Raymond J.] Univ Adelaide, Robinson Res Inst, Sch Med, Discipline Obstet & Gynaecol, Adelaide, SA, Australia; [Glister, Claire; Knight, Philip G.] Univ Reading, Sch Biol Sci, Hopkins Bldg, Reading, Whiteknights, England; [Irving-Rodgers, Helen F.] Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia	Robinson Research Institute; University of Adelaide; University of Reading; Griffith University	Rodgers, RJ (corresponding author), Univ Adelaide, Robinson Res Inst, Sch Med, Discipline Obstet & Gynaecol, Adelaide, SA, Australia.	ray.rodgers@adelaide.edu.au	Irving-Rodgers, Helen/E-3660-2010; Hummitzsch, Katja/K-6940-2013; Rodgers, Raymond J/C-3476-2009	Hummitzsch, Katja/0000-0001-5023-2668; knight, philip/0000-0003-0300-1554	United Kingdom Biotechnology and Biological Sciences Research Council [BB/G017174/1]; National Health and Medical Research Council of Australia; Australian Research Council; University of Adelaide; Biotechnology and Biological Sciences Research Council [BB/G017174/1] Funding Source: researchfish; BBSRC [BB/G017174/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); University of Adelaide; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the United Kingdom Biotechnology and Biological Sciences Research Council (grant no. BB/G017174/1 to PGK and CG and Underwood Fellowship award to RJR) and by the National Health and Medical Research Council of Australia and the Australian Research Council and the University of Adelaide.	ALILA HW, 1984, BIOL REPROD, V31, P1015, DOI 10.1095/biolreprod31.5.1015; Best CL, 1996, HUM REPROD, V11, P790; BRANNSTROM M, 1994, FERTIL STERIL, V61, P488; Brannstrom M, 1992, BIOL REPROD S1; Campbell BK, 1998, J REPROD FERTIL, V112, P69, DOI 10.1530/jrf.0.1120069; CHANNING CP, 1981, MOL CELL ENDOCRINOL, V22, P359, DOI 10.1016/0303-7207(81)90044-7; Desai N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-119; EIERMAN DF, 1989, J IMMUNOL, V142, P1970; ERICKSON GF, 1983, MOL CELL ENDOCRINOL, V29, P21, DOI 10.1016/0303-7207(83)90003-5; Glister C, 2005, ENDOCRINOLOGY, V146, P1883, DOI 10.1210/en.2004-1303; Glister C, 2004, REPRODUCTION, V127, P239, DOI 10.1530/rep.1.00090; Glister C, 2001, BIOL REPROD, V65, P1020, DOI 10.1095/biolreprod65.4.1020; Glister C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-72; Glister C, 2013, P NATL ACAD SCI USA, V110, pE1426, DOI 10.1073/pnas.1222216110; Gutierrez CG, 1997, BIOL REPROD, V56, P608, DOI 10.1095/biolreprod56.3.608; Hatzirodos N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099706; Hatzirodos N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097489; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-40; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-24, 10.1186/1471-2164-15-40]; Havelock JC, 2004, MOL CELL ENDOCRINOL, V228, P67, DOI 10.1016/j.mce.2004.04.018; Irving-Rodgers HF, 2001, REPRODUCTION, V122, P761, DOI 10.1530/rep.0.1220761; KERR JFR, 1995, METHOD CELL BIOL, V46, P1; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; LAVRANOS TC, 1994, EXP CELL RES, V211, P245, DOI 10.1006/excr.1994.1084; LISCIA DS, 1988, IN VITRO CELL DEV B, V24, P183, DOI 10.1007/BF02623544; Price JC, 2013, ENDOCRINOLOGY, V154, P3377, DOI 10.1210/en.2013-1102; Price JC, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110965; RODGERS HF, 1995, CELL TISSUE RES, V282, P463; Rodgers RJ, 2010, REPRODUCTION, V139, P309, DOI 10.1530/REP-09-0177; Spanel-Borowski K, 1997, J REPROD FERTIL, V111, P197, DOI 10.1530/jrf.0.1110197; Van Wezel IL, 1999, ENDOCRINOLOGY, V140, P2602, DOI 10.1210/en.140.6.2602; vanWezel IL, 1996, BIOL REPROD, V55, P1003, DOI 10.1095/biolreprod55.5.1003; Wickenheisser JK, 2006, TRENDS ENDOCRIN MET, V17, P63, DOI 10.1016/j.tem.2006.01.003; Woodruff Teresa K, 2007, Reprod Sci, V14, P6, DOI 10.1177/1933719107309818; Yamada S, 1999, MOL HUM REPROD, V5, P607, DOI 10.1093/molehr/5.7.607; ZHOU X, 1992, AM J PHYSIOL, V262, pL600, DOI 10.1152/ajplung.1992.262.5.L600	36	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e73391	10.1371/journal.pone.0173391	http://dx.doi.org/10.1371/journal.pone.0173391			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282394	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000396091800034
J	Balthasar, AJR; van Geffen, GJ; van der Voort, M; Lucassen, GW; Roggeveen, S; Bruaset, IJ; Bruhn, J				Balthasar, Andrea J. R.; van Geffen, Geert-Jan; van der Voort, Marjolein; Lucassen, Gerald W.; Roggeveen, Stefan; Bruaset, Ivar J.; Bruhn, Joergen			Spectral tissue sensing to identify intra-and extravascular needle placement - A randomized single-blind controlled trial	PLOS ONE			English	Article							ULTRASOUND GUIDANCE; OPTICAL-PROPERTIES; COMPLICATIONS; ANESTHESIA; ACCESS; PLEXUS; RANGE; BLOCK	Safe vascular access is a prerequisite for intravenous drug admission. Discrimination between intra-and extravascular needle position is essential for procedure safety. Spectral tissue sensing (STS), based on optical spectroscopy, can provide tissue information directly from the needle tip. The primary objective of the trial was to investigate if STS can reliably discriminate intra-vascular (venous) from non-vascular punctures. In 20 healthy volunteers, a needle with an STS stylet was inserted, and measurements were performed for two intended locations: the first was subcutaneous, while the second location was randomly selected as either subcutaneous or intravenous. The needle position was assessed using ultrasound (US) and aspiration. The operators who collected the data from the spectral device were blinded to the insertion and ultrasonographic visualization procedure and the physician was blinded to the spectral data. Following offline spectral analysis, a prediction of intravascular or subcutaneous needle placement was made and compared with the "true" needle tip position as indicated by US and aspiration. Data for 19 volunteers were included in the analysis. Six out of 8 intended vascular needle placements were defined as intravascular according to US and aspiration. The remaining two intended vascular needle placements were negative for aspiration. For the other 11 final needle locations, the needle was clearly subcutaneous according to US examination and no blood was aspirated. The MannWhitney U test yielded a p-value of 0.012 for the between-group comparison. The differences between extra-and intravascular were in the within-group comparison computed with the Wilcoxon signed-rank test was a p-value of 0.022. In conclusion, STS is a promising method for discriminating between intravascular and extravascular needle placement. The information provided by this method may complement current methods for detecting an intravascular needle position.	[Balthasar, Andrea J. R.] Maastricht Univ, Med Ctr, Dept Anesthesiol & Pain Med, Maastricht, Netherlands; [van Geffen, Geert-Jan; Bruhn, Joergen] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol, Nijmegen, Netherlands; [van der Voort, Marjolein; Lucassen, Gerald W.; Roggeveen, Stefan] Philips Healthcare, Best, Netherlands; [Bruaset, Ivar J.] Sint Maartensklin, Dept Anesthesiol, Nijmegen, Netherlands	Maastricht University; Radboud University Nijmegen; Philips; Philips Healthcare; Sint Maartens Clinic	Balthasar, AJR (corresponding author), Maastricht Univ, Med Ctr, Dept Anesthesiol & Pain Med, Maastricht, Netherlands.	a.balthasar@mumc.nl	Balthasar, Andrea/P-3095-2019; Bruhn, Jörgen/H-3703-2012; van Geffen, Geert-Jan/A-7075-2015	Balthasar, Andrea/0000-0001-9828-9372; 	Radboud University Medical Center; Philips Research	Radboud University Medical Center; Philips Research	Philips Research provided support in the form of salary for MV and GWL, consultancy fees for GJG and AJRB, and provided funding to the Radboud University Medical Center to carry out this study. The funder had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of each author are articulated in the 'author contributions' section.	Ball RD, 2013, J CLIN ANESTH, V25, P115, DOI 10.1016/j.jclinane.2012.06.018; Balthasar A, 2012, REGION ANESTH PAIN M, V37, P277, DOI 10.1097/AAP.0b013e31824a57c2; Bashkatov AN, 2005, OPT SPECTROSC+, V99, P836, DOI 10.1134/1.2135863; Bashkatov AN, 2005, J PHYS D APPL PHYS, V38, P2543, DOI 10.1088/0022-3727/38/15/004; Berk D, 2013, J CLIN MONIT COMPUT, V27, P319, DOI 10.1007/s10877-013-9437-6; Blaivas M, 2003, ACAD EMERG MED, V10, P1307, DOI 10.1197/S1069-6563(03)00534-7; Brynolf M, 2011, REGION ANESTH PAIN M, V36, P350, DOI 10.1097/AAP.0b013e318220f15a; Chan ED, 2013, RESP MED, V107, P789, DOI 10.1016/j.rmed.2013.02.004; Chien GCC, 2014, PAIN PHYSICIAN, V17, pE413; COHEN SM, 1948, LANCET, V252, P409, DOI 10.1016/S0140-6736(48)90986-6; Desjardins AE, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3598852; Desjardins AE, 2011, BIOMED OPT EXPRESS, V2, P1452, DOI 10.1364/BOE.2.001452; Dufour E, 2012, ANESTH ANALG, V115, P728, DOI 10.1213/ANE.0b013e31825fa37d; Furman MB, 2003, SPINE, V28, P21, DOI 10.1097/00007632-200301010-00007; Hadzic A, 2008, ANESTHESIOLOGY, V108, P557, DOI 10.1097/ALN.0b013e318168efa1; Jasper Joseph F, 2003, Pain Physician, V6, P369; Jenkins JG, 2005, INT J OBSTET ANESTH, V14, P37, DOI 10.1016/j.ijoa.2004.07.009; KENEPP NB, 1981, ANESTHESIOLOGY, V54, P172; Lamperti M, 2012, INTENS CARE MED, V38, P1105, DOI 10.1007/s00134-012-2597-x; Levin PD, 2004, BRIT J ANAESTH, V92, P865, DOI 10.1093/bja/aeh154; Lim DY, 2012, KOREAN J ANESTHESIOL, V62, P225, DOI 10.4097/kjae.2012.62.3.225; Nachabe R, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3454392; Neal JM, 2010, REGION ANESTH PAIN M, V35, P335, DOI 10.1097/AAP.0b013e3181e8a3bb; Patel RY, 2010, J MED IMAG RADIAT ON, V54, P35, DOI 10.1111/j.1754-9485.2010.02143.x; Sen S, 2005, MAYO CLIN PROC, V80, P783; Stone MB, 2010, AM J EMERG MED, V28, P343, DOI 10.1016/j.ajem.2008.11.022; Togashi K, 2013, ANESTH ANALG, V116, P1018, DOI 10.1213/ANE.0b013e31828a6e53; Weiner MM, 2013, J CARDIOTHOR VASC AN, V27, P345, DOI 10.1053/j.jvca.2012.07.007; Wu SY, 2013, ANESTHESIOLOGY, V118, P361, DOI 10.1097/ALN.0b013e31827bd172; Zetlaoui PJ, 2008, ANESTHESIOLOGY, V108, P761, DOI 10.1097/ALN.0b013e3181684c0f	30	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172662	10.1371/journal.pone.0172662	http://dx.doi.org/10.1371/journal.pone.0172662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278194	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900125
J	Beard, E; Brown, J; Kaner, E; West, R; Michie, S				Beard, Emma; Brown, Jamie; Kaner, Eileen; West, Robert; Michie, Susan			Predictors of and reasons for attempts to reduce alcohol intake: A population survey of adults in England	PLOS ONE			English	Article							PRIMARY-HEALTH-CARE; DRINKING; INTERVENTIONS; CONSUMPTION; READINESS; PATTERNS; BEHAVIOR; SUPPORT; IMPACT	Objective This study aimed to assess the predictors among high-risk drinkers in England of attempts to reduce alcohol consumption, the reasons given for these attempts and the association between the various reasons and alcohol consumption. Method Data came from 2,800 high-risk drinkers taking part in the Alcohol Toolkit Study (ATS) between March 2014 and November 2016 who were attempting to reduce their alcohol consumption. Participants completed the Alcohol Use Disorders Identification Test (AUDIT) and were asked questions regarding their socio-demographic characteristics, attempts to cut down and reasons for doing so. Results Those cutting down were significantly older (OR 1.01, p<0.001), were more likely to be female (OR 1.32, p<0.05), had higher AUDIT-C scores (OR 1.12, p<0.001), were less likely to be of white ethnicity (OR 0.64, p<0.001), and were more likely to reside in the South of England (OR 1.34, p<0.001). They were also more likely to be of higher occupationally-based social-grades (p<0.001). The main reported reasons for reducing consumption were: fitness (22.5%), weight loss (20.4%), future health (20.4%), advice from a health-care professional (7.9%) and cost (7.6%). Those reporting the followings reasons for cutting down had higher AUDIT-C scores than those who did not report these reasons: a concern about further health problems (beta 0.20, p<0.05), advice from a doctor/health worker (beta 0.38, p<0.05), that drinking was too expensive (beta 0.42, p<0.01) and detoxification (beta 0.42, p<0.01). Lower AUDIT-C scores were noted among those who reported that they knew someone who was cutting down (beta -0.67, p<0.05), that there was no reason (beta -0.36, p<0.05), or they didn't know why they were cutting down (beta -0.25, p<0.05). Conclusions Around a fifth of high-risk drinkers in England report trying to reduce their drinking, particularly older, high-socioeconomic female drinkers from the south of England. Attempts to cut down appear to be driven by a desire to improve health, advice from others and cutting down on the cost of drinking.	[Beard, Emma; Brown, Jamie; Michie, Susan] UCL, Res Dept Clin Educ & Hlth Psychol, London WC1E 6BT, England; [Beard, Emma; Brown, Jamie; West, Robert] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Kaner, Eileen] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England	University of London; University College London; University of London; University College London; Newcastle University - UK	Beard, E (corresponding author), UCL, Res Dept Clin Educ & Hlth Psychol, London WC1E 6BT, England.; Beard, E (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England.	e.beard@ucl.ac.uk	Brown, Jamie/F-4413-2011; Kaner, Eileen/ABF-2444-2020; West, Robert/B-5414-2009	Brown, Jamie/0000-0002-2797-5428; West, Robert/0000-0001-6398-0921	National Institute for Health Research (NIHR)'s School for Public Health Research (SPHR); Cancer Research UK [22962] Funding Source: researchfish; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K02325X/1, MR/K023195/1] Funding Source: researchfish	National Institute for Health Research (NIHR)'s School for Public Health Research (SPHR)(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The ATS is funded by the National Institute for Health Research (NIHR)'s School for Public Health Research (SPHR). The views are those of the authors(s) and not necessarily those of the NHS, the NIHR or the Department of Health. SPHR is a partnership between the Universities of Sheffield; Bristol; Cambridge; Exeter; UCL; The London School for Hygiene and Tropical Medicine; the LiLaC collaboration between the Universities of Liverpool and Lancaster and Fuse; The Centre for Translational Research in Public Health, a collaboration between Newcastle, Durham, Northumbria, Sunderland and Teesside Universities.	Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1111/j.1530-0277.1997.tb03811.x; Alley ES, 2014, SUBST USE MISUSE, V49, P253, DOI 10.3109/10826084.2013.825920; Beard E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1542-7; Beck F, 2014, PLOS ONE, V9; Brennan A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5452; British Heart Foundation, 2013, ALC HEART DIS OUR EX; Brown J, 2015, BRIT J GEN PRACTICE; Casswell S, 2012, ALCOHOL CLIN EXP RES, V36, P1462, DOI 10.1111/j.1530-0277.2012.01738.x; Caviness CM, 2009, J STUD ALCOHOL DRUGS, V70, P50, DOI 10.15288/jsad.2009.70.50; Collins RL, 2001, HEALTH PSYCHOL, V20, P351, DOI 10.1037//0278-6133.20.5.351; Department of Health, 2013, RED HARMF DRINK; DiClemente CC, 2009, ALCOHOL CLIN EXP RES, V33, P879, DOI 10.1111/j.1530-0277.2009.00905.x; Drinkaware, 2013, DRINK MOT HALF VIS S; Ellison J, 2013, ELL J HARMF DRINK; Ely M, METHODS ESTIMATING I; Gefou-Madianou Dimitra, 2002, ALCOHOL GENDER CULTU; Global Drug Survey, 2015, GLOB DRUG SURV 2015; Hacking JM, 2011, TRENDS MORTALITY 196, V23, P41; Hajema KJ, 1998, ADDICTION, V93, P1717, DOI 10.1046/j.1360-0443.1998.931117179.x; Harrison C, 2014, W J EMERGENCY MED, V15; Hasking P, 2005, J DRUG EDUC, V35, P95, DOI 10.2190/9Y34-F5XR-AQV5-KEL8; HAYS RD, 1995, BEHAV RES METH INSTR, V27, P277, DOI 10.3758/BF03204745; Health and Social Care Information Centre, 2010, INF FEED SURV UK; HERMOS JA, 1988, J STUD ALCOHOL, V49, P363, DOI 10.15288/jsa.1988.49.363; HM Treasury, 2014, BUDG 2014; Holmes J, 2014, LANCET, V383, P1655, DOI 10.1016/S0140-6736(13)62417-4; Home Office, 2014, GUIDANCE BANNING SAL; Home Office, 2013, NEXT STEPS FOLLOWING; Horton R, 2012, LANCET, V380, P2053, DOI 10.1016/S0140-6736(12)62133-3; Institute of Alcohol Studies, 2015, ALC HLTH IN HARM PAR; Ipsos, 2009, SOC GRAD CLASS TOOL; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Kobayashi K, 2005, JAPAN J NURSING SCI, V2, P95; Leeman R, 2011, ALCOHOLISM CLIN EXPT; Lifestyle Statistics Health and Social Care Information Centre, 2014, STAT ALC ENGL 2014; McVeigh Tracy, 2015, GUARDIAN; Milton A., 2011, EVIDENCE BASE UNPUB; Moore AA, 2005, AM J PUBLIC HEALTH, V95, P458, DOI 10.2105/AJPH.2003.019471; Mulia N, 2008, ADDICTION, V103, P1283, DOI 10.1111/j.1360-0443.2008.02234.x; National Institute on Alcohol Abuse and Alcoholism, 2007, HELP PAT WHO DRINK T; Netmums, 2015, GLASS WIN AN; O'Donnell A, 2014, ALCOHOL ALCOHOLISM, V49, P66, DOI 10.1093/alcalc/agt170; Ritterband LM, 2003, PROF PSYCHOL-RES PR, V34, P527, DOI 10.1037/0735-7028.34.5.527; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SAUNDERS JB, 1993, ADDICTION, V88, P349, DOI 10.1111/j.1360-0443.1993.tb00822.x; Schober R, 1996, ADDICT BEHAV, V21, P81, DOI 10.1016/0306-4603(95)00041-0; Sieminska A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-274; Sim F., 2015, ALCOHOLIC DRINKS CON, V22, P31; Smith L, 2009, DRINKING UK EXPLORAT; SOBELL LC, 1993, ALCOHOL CLIN EXP RES, V17, P217, DOI 10.1111/j.1530-0277.1993.tb00752.x; Walker G, 2015, GOVT DEV NEW TOBACCO; Weisner C, 2003, J STUD ALCOHOL, V64, P862, DOI 10.15288/jsa.2003.64.862; Wells Claudia, 2008, Health Stat Q, P6; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilson GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071792; WINICK C, 1962, B NARCOTICS, V14, P1	57	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173458	10.1371/journal.pone.0173458	http://dx.doi.org/10.1371/journal.pone.0173458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278218	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900095
J	Hair, PS; Sass, LA; Vazifedan, T; Shah, TA; Krishna, NK; Cunnion, KM				Hair, Pamela S.; Sass, Laura A.; Vazifedan, Turaj; Shah, Tushar A.; Krishna, Neel K.; Cunnion, Kenji M.			Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity	PLOS ONE			English	Article							IN-VITRO; ACTIVATION; SPUTUM; INFLAMMATION; ELASTASE; RECEPTOR; BLOOD	In cystic fibrosis (CF), lung damage is mediated by a cycle of obstruction, infection, inflammation and tissue destruction. The complement system is a major mediator of inflammation for many diseases with the effectors C5a and C3a often playing important roles. We have previously shown in a small pilot study that CF sputum soluble fraction concentrations of C5a and C3a were associated with clinical measures of CF disease. Here we report a much larger study of 34 CF subjects providing 169 testable sputum samples allowing longitudinal evaluation comparing C5a and C3a with clinical markers. Levels of the strongly pro-inflammatory C5a correlated negatively with FEV1% predicted (P < 0.001), whereas the often anti-inflammatory C3a correlated positively with FEV1% predicted (P = 0.01). C5a concentrations correlated negatively with BMI percentile (P = 0.017), positively with worsening of an acute pulmonary exacerbation score (P = 0.007) and positively with P. aeruginosa growth in sputum (P = 0.002). C5a levels also correlated positively with concentrations of other sputum markers associated with worse CF lung disease including neutrophil elastase (P < 0.001), myeloperoxidase activity (P = 0.006) and DNA concentration (P < 0.001). In contrast to C5a, C3a levels correlated negatively with worse acute pulmonary exacerbation score and correlated negatively with sputum concentrations of neutrophil elastase, myeloperoxidase activity and DNA concentration. In summary, these data suggest that in CF sputum, increased C5a is associated with increased inflammation and poorer clinical measures, whereas increased C3a appears to be associated with less inflammation and improved clinical measures.	[Hair, Pamela S.; Sass, Laura A.; Vazifedan, Turaj; Shah, Tushar A.; Krishna, Neel K.; Cunnion, Kenji M.] Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA; [Sass, Laura A.; Shah, Tushar A.; Cunnion, Kenji M.] Childrens Specialty Grp, Norfolk, VA 23507 USA; [Sass, Laura A.; Vazifedan, Turaj; Shah, Tushar A.; Cunnion, Kenji M.] Childrens Hosp Kings Daughters, Norfolk, VA 23507 USA; [Shah, Tushar A.; Krishna, Neel K.; Cunnion, Kenji M.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA	Eastern Virginia Medical School; Eastern Virginia Medical School	Cunnion, KM (corresponding author), Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA.; Cunnion, KM (corresponding author), Childrens Specialty Grp, Norfolk, VA 23507 USA.; Cunnion, KM (corresponding author), Childrens Hosp Kings Daughters, Norfolk, VA 23507 USA.; Cunnion, KM (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA.	cunniokm@EVMS.EDU		Vazifedan, Turaj/0000-0002-8319-7499; Cunnion, Kenji/0000-0001-8604-348X; Shah, Tushar/0000-0001-5962-1838	Cystic Fibrosis Foundation [CUNNIO1510]	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by a grant from the Cystic Fibrosis Foundation, CUNNIO1510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the Cystic Fibrosis Foundation, CUNNIO15I0.	Bosmann M, 2012, ADV EXP MED BIOL, V946, P147, DOI 10.1007/978-1-4614-0106-3_9; Coulthard LG, 2015, J IMMUNOL, V194, P3542, DOI 10.4049/jimmunol.1403068; Davies JR, 1999, BIOCHEM J, V344, P321, DOI 10.1042/0264-6021:3440321; Dwyer M, 2014, J INNATE IMMUNITY; FICK RB, 1986, PEDIATR RES, V20, P1258, DOI 10.1203/00006450-198612000-00014; Frank MM, 2001, SAMTERS IMMUNOLOGIC, P281; Gharib SA, 2009, J PROTEOME RES, V8, P3020, DOI 10.1021/pr900093j; Gifford AH, 2014, J CYST FIBROS, V13, P311, DOI 10.1016/j.jcf.2013.11.004; Gifford AM, 2014, CURR OPIN HEMATOL, V21, P16, DOI 10.1097/MOH.0000000000000009; HODSON ME, 1995, AM J RESP CRIT CARE, V151, pS70, DOI 10.1164/ajrccm/151.3_Pt_2.S70; LAMBRIS JD, 1998, HUMAN COMPLEMENT SYS, P83; Laursen NS, 2012, CURR MOL MED, V12, P1083; Le Gars M, 2013, AM J RESP CRIT CARE, V187, P170, DOI 10.1164/rccm.201205-0875OC; Mollnes TE, 2002, BLOOD, V100, P1869; Pfeifer PH, 1999, CLIN CHEM, V45, P1190; Pfeifer PH, 2000, IMMUNOPHARMACOLOGY, V46, P163, DOI 10.1016/S0162-3109(99)00167-8; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sagel SD, 2012, AM J RESP CRIT CARE, V186, P857, DOI 10.1164/rccm.201203-0507OC; Sass LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144723; SCHIOTZ PO, 1979, ACTA PATH MICRO IM C, V87, P1; Schmudde I, 2013, MUCOSAL IMMUNOL, V6, P807, DOI 10.1038/mi.2012.119; Shinjyo N, 2009, STEM CELLS, V27, P2824, DOI 10.1002/stem.225; Smailhodzic D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112682; Tralau T, 2004, EXP DERMATOL, V13, P316, DOI 10.1111/j.0906-6705.2004.00145.x	25	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173257	10.1371/journal.pone.0173257	http://dx.doi.org/10.1371/journal.pone.0173257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278205	gold, Green Published, Green Submitted			2022-12-27	WOS:000396087900062
J	Harris, AJL; de Moliere, L; Soh, M; Hahn, U				Harris, Adam J. L.; de Moliere, Laura; Soh, Melinda; Hahn, Ulrike			Unrealistic comparative optimism: An unsuccessful search for evidence of a genuinely motivational bias	PLOS ONE			English	Article							FUTURE LIFE-EVENTS; PERCEIVED VULNERABILITY; EFFECTIVE CONTRACEPTION; RISK JUDGMENTS; PROBABILITY; EGOCENTRISM; HEALTH; PERCEPTIONS; SELF; INFORMATION	One of the most accepted findings across psychology is that people are unrealistically optimistic in their judgments of comparative risk concerning future life events D they judge negative events as less likely to happen to themselves than to the average person. Harris and Hahn (2011), however, demonstrated how unbiased (non-optimistic) responses can result in data patterns commonly interpreted as indicative of optimism due to statistical artifacts. In the current paper, we report the results of 5 studies that control for these statistical confounds and observe no evidence for residual unrealistic optimism, even observing a 'severity effect' whereby severe outcomes were overestimated relative to neutral ones (Studies 3 & 4). We conclude that there is no evidence supporting an optimism interpretation of previous results using the prevalent comparison method.	[Harris, Adam J. L.; de Moliere, Laura; Soh, Melinda] UCL, Dept Expt Psychol, London, England; [Hahn, Ulrike] Univ London, Birkbeck Coll, Dept Psychol Sci, London, England	University of London; University College London; University of London; Birkbeck University London	Harris, AJL (corresponding author), UCL, Dept Expt Psychol, London, England.	adam.harris@ucl.ac.uk	Harris, Adam J L/H-3506-2011; Hahn, Ulrike/A-8947-2010	Harris, Adam J L/0000-0002-9041-6290; Hahn, Ulrike/0000-0002-7744-8589				Bar-Hillel M, 2008, PSYCHON B REV, V15, P278, DOI 10.3758/PBR.15.2.278; Bilgin B., 2012, ORGAN BEHAV HUM DECI; Budescu D., 1995, THINK REASONING, V1, P71, DOI [10.1080/13546789508256906, DOI 10.1080/13546789508256906]; BURGER JM, 1988, PERS SOC PSYCHOL B, V14, P264, DOI 10.1177/0146167288142005; Campbell J, 2007, COMPUT HUM BEHAV, V23, P1273, DOI 10.1016/j.chb.2004.12.005; Chambers JR, 2004, PSYCHOL BULL, V130, P813, DOI 10.1037/0033-2909.130.5.813; Chambers JR, 2003, PERS SOC PSYCHOL B, V29, P1343, DOI 10.1177/0146167203256870; Chang EC, 2001, J PERS SOC PSYCHOL, V81, P476, DOI 10.1037/0022-3514.81.3.476; Covey JA, 2004, BRIT J HEALTH PSYCH, V9, P39, DOI 10.1348/135910704322778713; de Moliere L, 2016, J EXP PSYCHOL GEN, V145, pE13, DOI 10.1037/xge0000124; DUNNING D, 1991, J PERS SOC PSYCHOL, V61, P521, DOI 10.1037/0022-3514.61.4.521; Fox CR, 2006, JUDGM DECIS MAK, V1, P159; Hahn U, 2014, PSYCHOL LEARN MOTIV, V61, P41, DOI 10.1016/B978-0-12-800283-4.00002-2; Hardman D., 2009, JUDGMENT DECISION MA; Harris AJL, 2011, J EXP PSYCHOL LEARN, V37, P1571, DOI 10.1037/a0024195; Harris AJL, 2011, PSYCHOL REV, V118, P135, DOI 10.1037/a0020997; Harris AJL, 2009, COGNITION, V110, P51, DOI 10.1016/j.cognition.2008.10.006; Harris AJL, CONSCIOUS COGN; HARRIS DM, 1979, J HEALTH SOC BEHAV, V20, P17, DOI 10.2307/2136475; HARRIS P, 1994, BRIT J SOC PSYCHOL, V33, P369, DOI 10.1111/j.2044-8309.1994.tb01035.x; Hart W, 2009, PSYCHOL BULL, V135, P555, DOI 10.1037/a0015701; Hertwig R, 2004, PSYCHOL SCI, V15, P534, DOI 10.1111/j.0956-7976.2004.00715.x; Hevey D, 2012, PSYCHOL HEALTH MED, V17, P417, DOI 10.1080/13548506.2011.613940; Hoorens V, 2008, BRIT J SOC PSYCHOL, V47, P441, DOI 10.1348/014466607X236023; Howell DC., 1997, STATISTICAL METHODS; Joshi MS, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00006; KAHNEMAN D, 1973, PSYCHOL REV, V80, P237, DOI 10.1037/h0034747; Kahneman D., 2011, THINKING FAST SLOW; Klar Y, 2004, J EXP SOC PSYCHOL, V40, P805, DOI 10.1016/j.jesp.2004.04.006; Klar Y, 1996, ORGAN BEHAV HUM DEC, V67, P229, DOI 10.1006/obhd.1996.0076; KLAYMAN J, 1987, PSYCHOL REV, V94, P211, DOI 10.1037/0033-295X.94.2.211; Klein CTF, 2002, PSYCHOL HEALTH, V17, P437, DOI 10.1080/0887044022000004920; Krizan Z, 2007, PSYCHOL BULL, V133, P95, DOI 10.1037/0033-2909.133.1.95; Kruger J, 2004, J EXP SOC PSYCHOL, V40, P332, DOI 10.1016/j.jesp.2003.06.002; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; LEK YY, 1995, PSYCHOL HEALTH, V10, P205, DOI 10.1080/08870449508401950; LORCH RF, 1990, J EXP PSYCHOL LEARN, V16, P149, DOI 10.1037/0278-7393.16.1.149; MILLER LC, 1981, J PERS SOC PSYCHOL, V41, P397, DOI 10.1037/0022-3514.41.2.397; Moore D. A., 2008, RATIONALITY SOCIAL R, P141; Morey RD, 2011, PSYCHOL METHODS, V16, P406, DOI 10.1037/a0024377; Nelson JD, 2005, PSYCHOL REV, V112, P979, DOI 10.1037/0033-295X.112.4.979; OAKSFORD M, 1994, PSYCHOL REV, V101, P608, DOI 10.1037/0033-295X.101.4.608; Otten W, 1996, J SOC CLIN PSYCHOL, V15, P80, DOI 10.1521/jscp.1996.15.1.80; Peck J, 2009, J CONSUM RES, V36, P434, DOI 10.1086/598614; PERLOFF LS, 1986, J PERS SOC PSYCHOL, V50, P502, DOI 10.1037/0022-3514.50.3.502; Price PC, 2002, J EXP SOC PSYCHOL, V38, P242, DOI 10.1006/jesp.2001.1509; PYSZCZYNSKI T, 1987, J PERS SOC PSYCHOL, V52, P994, DOI 10.1037/0022-3514.52.5.994; REGAN PC, 1995, PERS SOC PSYCHOL B, V21, P1073, DOI 10.1177/01461672952110008; Risen JL, 2007, J PERS SOC PSYCHOL, V93, P12, DOI 10.1037/0022-3514.93.1.12; Rose JP, 2008, PERS SOC PSYCHOL B, V34, P1236, DOI 10.1177/0146167208319764; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Sample I., 2012, HARVARD U SAYS IT CA; Sharot T., 2012, PSYCHIATRIST, V36, P439, DOI [10.1192/pb.bp.111.038182, DOI 10.1192/PB.BP.111.038182, 10.1192/Pb.bp.111.038182]; Shepperd JA, 2013, PERSPECT PSYCHOL SCI, V8, P395, DOI 10.1177/1745691613485247; Statistics O for N, 2000, HEAL STAT Q, V7, P71; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Ungemach C, 2009, PSYCHOL SCI, V20, P473, DOI 10.1111/j.1467-9280.2009.02319.x; van der Veide F, 1992, PSYCHOL HEALTH, V6, P23, DOI DOI 10.1080/08870449208402018; Vosgerau J, 2010, J EXP PSYCHOL GEN, V139, P32, DOI 10.1037/a0018144; Walter FM, 2006, FAM PRACT, V23, P472, DOI 10.1093/fampra/cml006; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806; WEINSTEIN ND, 1982, PERS SOC PSYCHOL B, V8, P195, DOI 10.1177/0146167282082002; WEINSTEIN ND, 1995, HEALTH PSYCHOL, V14, P132, DOI 10.1037/0278-6133.14.2.132; WEINSTEIN ND, 1982, J BEHAV MED, V5, P441, DOI 10.1007/BF00845372; WEINSTEIN ND, 1984, HEALTH PSYCHOL, V3, P431, DOI 10.1037/0278-6133.3.5.431; Weinstein ND, 1987, INT J BEHAV MED, V10, P481, DOI DOI 10.1007/BF00846146; Welkenhuysen M, 1996, PSYCHOL HEALTH, V11, P479, DOI 10.1080/08870449608401984; WHITLEY BE, 1991, PERS SOC PSYCHOL B, V17, P104, DOI 10.1177/0146167291171016; Windschitl PD, 2008, J PERS SOC PSYCHOL, V95, P253, DOI 10.1037/0022-3514.95.2.253; Zakay D, 1996, ACTA PSYCHOL, V93, P121, DOI 10.1016/0001-6918(96)00025-X; ZAKAY D, 1984, PSYCHOL REC, V34, P233, DOI 10.1007/BF03394867	73	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173136	10.1371/journal.pone.0173136	http://dx.doi.org/10.1371/journal.pone.0173136			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278200	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000396087900047
J	Respondek, D; Voss, M; Kuhlewindt, I; Klingel, K; Kruger, E; Beling, A				Respondek, Dorota; Voss, Martin; Kuehlewindt, Ina; Klingel, Karin; Krueger, Elke; Beling, Antje			PA28 modulates antigen processing and viral replication during coxsackievirus B3 infection	PLOS ONE			English	Article							PROTEASOME ACTIVATOR PA28; INTERFERON-GAMMA; HEART-FAILURE; MICE LACKING; REG PA28; 11S REG; IMMUNOPROTEASOME; INHIBITION; REGULATOR; MYOCARDITIS	The function of the proteasome is modulated at the level of subunit expression and by association with its regulatory complexes. During coxsackievirus B3 (CVB3) myocarditis, IFN-induced formation of immunoproteasomes (ip) is known to be critical for regulating immune modulating molecules. The function of the IFN-gamma-inducible proteasome regulator subunits PA28 alpha and beta, however, in this context was unknown. During viral myocarditis, we found an increased abundance of PA28 beta subunits in heart tissue. PA28 alpha/beta exists in PA28-20S-PA28 and PA700-20S-PA28 hybrid proteasome complexes in cells both with either predominant ip and standard proteasome (sp) expression. Being in line with reduced proteasome activity in PA28 alpha/beta-deficient cells, we observed increased levels of oxidized and poly-ubiquitinated proteins upon TLR3-activation in these cells. Moreover, PA28 alpha/beta is capable to interfere directly with viral replication of CVB3 and facilitates the generation of CVB3-derived MHC class I epitopes by the proteasome. In contrast to a distinct function of PA28 alpha/beta in vitro, gene ablation of PA28 alpha/beta in mice being on a genetic background with resistance towards the development of severe infection had no significant impact on disease progression. Other than reported for the ip, in this host PA28 alpha/beta is dispensable to meet the demand of increased peptide hydrolysis capacity by the proteasome during viral myocarditis.	[Respondek, Dorota; Voss, Martin; Kuehlewindt, Ina; Krueger, Elke; Beling, Antje] Charite Univ Med Berlin, Inst Biochem, Berlin, Germany; [Respondek, Dorota; Voss, Martin; Beling, Antje] DZHK German Ctr Cardiovasc Res, Partner Side Berlin, Berlin, Germany; [Klingel, Karin] Univ Klinikum Tubingen, Inst Mol Pathol, Tubingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Beling, A (corresponding author), Charite Univ Med Berlin, Inst Biochem, Berlin, Germany.; Beling, A (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Side Berlin, Berlin, Germany.	antje.beling@charite.de	Beling, Antje/AAW-5380-2020; Krueger, Elke/B-1462-2012	Krueger, Elke/0000-0002-2551-242X; Beling, Antje/0000-0002-1826-5248	Foundation for Experimental Biomedicine Zurich, Switzerland; Sonnenfeld foundation Berlin; DFG [VO 1602/2-1, KR 1915/6-1, SFB740]; COST BM1307 Proteostasis	Foundation for Experimental Biomedicine Zurich, Switzerland; Sonnenfeld foundation Berlin; DFG(German Research Foundation (DFG)); COST BM1307 Proteostasis	AB is supported by the Foundation for Experimental Biomedicine Zurich, Switzerland. DR was supported by a PhD scholarship from Sonnenfeld foundation Berlin. This project was granted by DFG VO 1602/2-1 to AB, KR 1915/6-1, SFB740 B3 and COST BM1307 Proteostasis to EK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Berkers CR, 2012, MOL PHARMACEUT, V9, P1126, DOI 10.1021/mp2004143; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Cascio P, 2014, BIOMOLECULES, V4, P566, DOI 10.3390/biom4020566; Cornell CT, 2007, J VIROL, V81, P6785, DOI 10.1128/JVI.00198-07; Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185; Dantuma NP, 2010, CARDIOVASC RES, V85, P263, DOI 10.1093/cvr/cvp255; de Graaf N, 2011, EUR J IMMUNOL, V41, P926, DOI 10.1002/eji.201041040; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Ersching J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005698; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Gao G, 2008, AM J PHYSIOL-HEART C, V295, pH401, DOI 10.1152/ajpheart.00292.2008; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hernebring M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01381; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Jakel S, 2009, AM J PATHOL, V175, P510, DOI 10.2353/ajpath.2009.090033; Keller M, 2015, EUR J IMMUNOL, V45, P3257, DOI 10.1002/eji.201445243; Kemball CC, 2008, J VIROL, V82, P4331, DOI 10.1128/JVI.02639-07; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Kirschner F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153847; Klingel K, 2003, AM J PATHOL, V162, P1709, DOI 10.1016/S0002-9440(10)64305-2; KLINGEL K, 1992, P NATL ACAD SCI USA, V89, P314, DOI 10.1073/pnas.89.1.314; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kuehn L, 1996, ARCH BIOCHEM BIOPHYS, V329, P87, DOI 10.1006/abbi.1996.0195; Li J, 2001, BIOCHIMIE, V83, P373, DOI 10.1016/S0300-9084(01)01236-6; Li J, 2011, FASEB J, V25, P883, DOI 10.1096/fj.10-160895; Luo HL, 2003, AM J PATHOL, V163, P381, DOI 10.1016/S0002-9440(10)63667-X; MA CP, 1992, J BIOL CHEM, V267, P10515; Macagno A, 2001, EUR J IMMUNOL, V31, P3271, DOI 10.1002/1521-4141(200111)31:11<3271::AID-IMMU3271>3.0.CO;2-2; Mishto M, 2014, EUR J IMMUNOL, V44, P3508, DOI 10.1002/eji.201444902; Murata S, 2001, EMBO J, V20, P5898, DOI 10.1093/emboj/20.21.5898; Opitz E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002233; Otoda T, 2013, DIABETES, V62, P811, DOI 10.2337/db11-1652; Paeschke A, 2016, EUR J IMMUNOL, V46, P619, DOI 10.1002/eji.201545892; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Rahnefeld A, 2014, CIRCULATION, V130, P1589, DOI 10.1161/CIRCULATIONAHA.114.009847; Raule M, 2014, CHEM BIOL, V21, P470, DOI 10.1016/j.chembiol.2014.02.006; Rechsteiner M, 2000, BIOCHEM J, V345, P1, DOI 10.1042/0264-6021:3450001; Schwarz K, 2000, J IMMUNOL, V165, P768, DOI 10.4049/jimmunol.165.2.768; Seeger M, 1997, J BIOL CHEM, V272, P8145, DOI 10.1074/jbc.272.13.8145; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Si XN, 2005, J VIROL, V79, P8014, DOI 10.1128/JVI.79.13.8014-8023.2005; Spur EM, 2016, TOXICOLOGY, V353, P34, DOI 10.1016/j.tox.2016.04.010; Stohwasser R, 2003, BIOL CHEM, V384, P39, DOI 10.1515/BC.2003.005; Stohwasser R, 2000, EUR J BIOCHEM, V267, P6221, DOI 10.1046/j.1432-1327.2000.01706.x; Strehl B, 2008, J BIOL CHEM, V283, P17891, DOI 10.1074/jbc.M710042200; Sun Y, 2002, CANCER RES, V62, P2875; Szalay G, 2006, AM J PATHOL, V168, P1542, DOI 10.2353/ajpath.2006.050865; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Verdoes M, 2006, CHEM BIOL, V13, P1217, DOI 10.1016/j.chembiol.2006.09.013; Voigt A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00042; Voigt A, 2010, AMINO ACIDS, V39, P243, DOI 10.1007/s00726-009-0434-5; Wessely R, 2001, CIRCULATION, V103, P756; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Whitton JL, 2005, NAT REV MICROBIOL, V3, P765, DOI 10.1038/nrmicro1284; Yajima T, 2009, CIRCULATION, V119, P2615, DOI 10.1161/CIRCULATIONAHA.108.766022; Zhang ZG, 1999, BIOCHEMISTRY-US, V38, P5651, DOI 10.1021/bi990056+	60	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173259	10.1371/journal.pone.0173259	http://dx.doi.org/10.1371/journal.pone.0173259			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278207	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900063
J	Dellicour, S; Gerard, M; Prunier, JG; Dewulf, A; Kuhlmann, M; Michez, D				Dellicour, Simon; Gerard, Maxence; Prunier, Jerome G.; Dewulf, Alexandre; Kuhlmann, Michael; Michez, Denis			Distribution and predictors of wing shape and size variability in three sister species of solitary bees	PLOS ONE			English	Article							IN-FLIGHT MORPHOLOGY; BODY-SIZE; PHENOTYPIC PLASTICITY; MORPHOMETRIC-ANALYSIS; GEOGRAPHIC-VARIATION; GENETIC-VARIATION; R-PACKAGE; HYMENOPTERA; POPULATIONS; EVOLUTION	Morphological traits can be highly variable over time in a particular geographical area. Different selective pressures shape those traits, which is crucial in evolutionary biology. Among these traits, insect wing morphometry has already been widely used to describe phenotypic variability at the inter-specific level. On the contrary, fewer studies have focused on intraspecific wing morphometric variability. Yet, such investigations are relevant to study potential convergences of variation that could highlight micro-evolutionary processes. The recent sampling and sequencing of three solitary bees of the genus Melitta across their entire species range provides an excellent opportunity to jointly analyse genetic and morphometric variability. In the present study, we first aim to analyse the spatial distribution of the wing shape and centroid size (used as a proxy for body size) variability. Secondly, we aim to test different potential predictors of this variability at both the intra- and inter-population levels, which includes genetic variability, but also geographic locations and distances, elevation, annual mean temperature and precipitation. The comparison of spatial distribution of intrapopulation morphometric diversity does not reveal any convergent pattern between species, thus undermining the assumption of a potential local and selective adaptation at the population level. Regarding intra-specific wing shape differentiation, our results reveal that some tested predictors, such as geographic and genetic distances, are associated with a significant correlation for some species. However, none of these predictors are systematically identified for the three species as an important factor that could explain the intra-specific morphometric variability. As a conclusion, for the three solitary bee species and at the scale of this study, our results clearly tend to discard the assumption of the existence of a common pattern of intra-specific signal/structure within the intra-specific wing shape and body size variability.	[Dellicour, Simon] Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Minderbroedersstaat 10, Leuven, Belgium; [Gerard, Maxence; Dewulf, Alexandre; Michez, Denis] Univ Mons, Res Inst Biosci, Lab Zool, Pl Parc 23, Mons, Belgium; [Prunier, Jerome G.] Univ Toulouse, CNRS, Stn Ecol Theor & Expt, Moulis, France; [Kuhlmann, Michael] Univ Kiel, Zool Museum, Hegewischstr 3, Kiel, Germany; [Kuhlmann, Michael] Nat Hist Museum, Dept Life Sci, Cromwell Rd, London, England	KU Leuven; University of Mons; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Kiel; Natural History Museum London	Dellicour, S (corresponding author), Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Minderbroedersstaat 10, Leuven, Belgium.	simon.dellicour@kuleuven.be	Prunier, Jérôme G./H-4332-2019; Dellicour, Simon/AAE-9054-2020; Michez, Denis/L-1370-2019	Prunier, Jérôme G./0000-0003-4110-2567; Dellicour, Simon/0000-0001-9558-1052; Michez, Denis/0000-0001-8880-1838; Gerard, Maxence/0000-0002-2485-0662	Belgian Fonds pour la Recherche Scientifique (FRS-FNRS) [FRFC 2.4613.10]; Fonds Wetenschappelijk Onderzoek (FWO, Flanders, Belgium); Belgian Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA)	Belgian Fonds pour la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds Wetenschappelijk Onderzoek (FWO, Flanders, Belgium)(FWO); Belgian Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS)	This research project was funded by the Belgian Fonds pour la Recherche Scientifique (FRS-FNRS; FRFC 2.4613.10). SD is a postdoctoral research fellow funded by the Fonds Wetenschappelijk Onderzoek (FWO, Flanders, Belgium) and MG is supported by a grant from the Belgian Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Allen J. A., 1877, Radical Review, Vi, P108; Angilletta MJ, 2003, AM NAT, V162, P332; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Berwaerts K, 2002, FUNCT ECOL, V16, P484, DOI 10.1046/j.1365-2435.2002.00650.x; Bitner-Mathe BC, 1999, HEREDITY, V83, P688, DOI 10.1038/sj.hdy.6886060; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bots J, 2009, CAN J ZOOL, V87, P86, DOI 10.1139/Z08-141; Cardini A, 2007, J BIOGEOGR, V34, P1663, DOI 10.1111/j.1365-2699.2007.01731.x; Cassel-Lundhagen A, 2009, ECOGRAPHY, V32, P591, DOI 10.1111/j.1600-0587.2008.05685.x; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Clemente-Carvalho RBG, 2011, MOL PHYLOGENET EVOL, V61, P79, DOI 10.1016/j.ympev.2011.05.017; May-Itza WD, 2010, CONSERV GENET, V11, P2079, DOI 10.1007/s10592-010-0087-7; Dellicour S, 2015, MOL ECOL, V24, P1074, DOI 10.1111/mec.13085; Dellicour S, 2014, MOL ECOL RESOUR, V14, P647, DOI 10.1111/1755-0998.12200; Dellicour S, 2014, MOL PHYLOGENET EVOL, V70, P412, DOI 10.1016/j.ympev.2013.08.013; Demirci B, 2012, J VECTOR ECOL, V37, P197, DOI 10.1111/j.1948-7134.2012.00217.x; Dillon ME, 2006, INTEGR COMP BIOL, V46, P49, DOI 10.1093/icb/icj007; Dinca V, 2011, MOL ECOL, V20, P3921, DOI 10.1111/j.1365-294X.2011.05223.x; Fields Development Team, 2006, FIELDS TOOLS SPATIAL; Francuski L, 2013, ANN ZOOL FENN, V50, P262, DOI 10.5735/085.050.0502; Frankino WA, 2005, SCIENCE, V307, P718, DOI 10.1126/science.1105409; Frazier MR, 2008, J EXP BIOL, V211, P2116, DOI 10.1242/jeb.019422; Garnier S, 2005, J EVOLUTION BIOL, V18, P269, DOI 10.1111/j.1420-9101.2004.00854.x; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Grimaldi David, 2005, pi; Habel JC, 2012, J INSECT CONSERV, V16, P571, DOI 10.1007/s10841-011-9442-3; Harrison JF, 2000, ANNU REV PHYSIOL, V62, P179, DOI 10.1146/annurev.physiol.62.1.179; Hartl DL, 2007, PRINCIPLES POPULATIO, P565; HAWKINS BA, 1995, ECOL ENTOMOL, V20, P195, DOI 10.1111/j.1365-2311.1995.tb00446.x; HAWKINS BA, 1995, OECOLOGIA, V102, P31, DOI 10.1007/BF00333307; HEINRICH B, 1974, SCIENCE, V185, P747, DOI 10.1126/science.185.4153.747; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2002, EVOLUTION, V56, P1068, DOI 10.1111/j.0014-3820.2002.tb01418.x; Johansson F, 2009, BIOL J LINN SOC, V97, P362, DOI 10.1111/j.1095-8312.2009.01211.x; Klepsatel P, 2014, EVOLUTION, V68, P1385, DOI 10.1111/evo.12351; Kolliker-Ott UM, 2003, OIKOS, V100, P563, DOI 10.1034/j.1600-0706.2003.12063.x; Lima CBS, 2014, SOCIOBIOLOGY, V61, P478; Loh R, 2005, GENETICA, V125, P271, DOI 10.1007/s10709-005-0367-1; Loh R, 2008, J GENET, V87, P209, DOI 10.1007/s12041-008-0034-2; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Matta BP, 2004, HEREDITY, V93, P330, DOI 10.1038/sj.hdy.6800508; Merckx T, 2006, OIKOS, V113, P226, DOI 10.1111/j.2006.0030-1299.14501.x; Michez D, 2009, ZOOL SCR, V38, P171, DOI 10.1111/j.1463-6409.2008.00362.x; Michez D, 2007, ANN SOC ENTOMOL FR, V43, P379, DOI 10.1080/00379271.2007.10697535; Milankov V, 2009, ZOOL J LINN SOC-LOND, V155, P819, DOI 10.1111/j.1096-3642.2008.00462.x; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Miller MP, 2006, MOL ECOL, V15, P145, DOI 10.1111/j.1365-294X.2005.02765.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NEWTON RG, 1967, APPLIED STATISTICS, V16, P51; Nimon K, 2008, BEHAV RES METHODS, V40, P457, DOI 10.3758/BRM.40.2.457; Oleksa A, 2015, APIDOLOGIE, V46, P49, DOI 10.1007/s13592-014-0300-7; Outomuro D, 2013, J EVOLUTION BIOL, V26, P1866, DOI 10.1111/jeb.12203; Outomuro D, 2011, BIOL J LINN SOC, V102, P263, DOI 10.1111/j.1095-8312.2010.01591.x; Peat J, 2005, FUNCT ECOL, V19, P145, DOI 10.1111/j.0269-8463.2005.00946.x; Perrard A, 2014, J EVOLUTION BIOL, V27, P2665, DOI 10.1111/jeb.12523; Pizzo A, 2006, BIOL J LINN SOC, V89, P197, DOI 10.1111/j.1095-8312.2006.00674.x; Prunier JG, 2015, MOL ECOL, V24, P263, DOI 10.1111/mec.13029; Ray RP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10851; Ray-Mukherjee J, 2014, METHODS ECOL EVOL, V5, P320, DOI 10.1111/2041-210X.12166; Ricklefs RE, 2004, NATURE, V430, P338, DOI 10.1038/nature02700; Roggero A., 2005, SHILAP Revista de Lepidopterologia, V33, P101; Rohlf F.J., 2013, TPS SMALL VERSION 1; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rohlf FJ, 2013, TPS DIG 2 17; Rohlf FJ, 2013, TPS UTIL PROGRAM VER; Shelomi M, 2012, AM NAT, V180, P511, DOI 10.1086/667595; Sota T, 2000, POPUL ECOL, V42, P279, DOI 10.1007/PL00012006; Stillwell RC, 2008, EVOLUTION, V62, P2534, DOI 10.1111/j.1558-5646.2008.00467.x; Stillwell RC, 2007, AM NAT, V170, P358, DOI 10.1086/520118; Tynkkynen K, 2004, J EVOLUTION BIOL, V17, P759, DOI 10.1111/j.1420-9101.2004.00733.x; Vargas REM, 2010, INFECT GENET EVOL, V10, P580, DOI 10.1016/j.meegid.2010.01.004; Wainwright PC, 2007, ANNU REV ECOL EVOL S, V38, P381, DOI 10.1146/annurev.ecolsys.38.091206.095706; Wakeling JM, 1997, J EXP BIOL, V200, P543; Wang IJ, 2013, EVOLUTION, V67, P3403, DOI 10.1111/evo.12134; WATSON DF, 1985, GEO-PROCESSING, V2, P315; Watson DF, 1992, CONTOURING GUIDE ANA; WOOTTON RJ, 1992, ANNU REV ENTOMOL, V37, P113, DOI 10.1146/annurev.en.37.010192.000553; Wright S, 1943, GENETICS, V28, P114; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	80	22	22	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173109	10.1371/journal.pone.0173109	http://dx.doi.org/10.1371/journal.pone.0173109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273178	gold, Green Submitted, Green Published			2022-12-27	WOS:000396073700039
J	Dias, IR; Haddad, CFB; Argolo, AJS; Orrico, VGD				Dias, Iuri Ribeiro; Baptista Haddad, Celio Fernando; Suzart Argolo, Antonio Jorge; Dill Orrico, Victor Goyannes			The 100th: An appealing new species of Dendropsophus (Amphibia: Anura: Hylidae) from northeastern Brazil	PLOS ONE			English	Article							ATLANTIC RAIN-FOREST; SOUTHERN BAHIA; PHYLOGENETIC-RELATIONSHIPS; ELEGANS ANURA; AMAZON BASIN; TREEFROG; FROGS; STATE	We describe a new species of the Dendropsophus leucophyllatus Group from the Atlantic Forest of the southern region of State of Bahia, Brazil. It can be distinguished from all species of the D. leucophyllatus Group on the basis of morphological characters (especially its unique dorsal pattern and snout in dorsal view), advertisement calls and divergence in mitochondrial DNA gene sequences. The inclusion of D. anceps on the group remains controversial but our phylogenetic analyses do not recover the new species as sister to syntopic species of the D. leucophyllatus Group (with or without D. anceps). These results also highlight the palimpsest that is past relation between the Atlantic and Amazon forests.	[Dias, Iuri Ribeiro; Suzart Argolo, Antonio Jorge] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil; [Dias, Iuri Ribeiro; Dill Orrico, Victor Goyannes] Univ Estadual Santa Cruz, Programa Posgrad Zool, Ilheus, BA, Brazil; [Baptista Haddad, Celio Fernando] Univ Estadual Paulista, Dept Zool, Inst Biociencias, Campus Rio Claro, Sao Paulo, Brazil; [Baptista Haddad, Celio Fernando] Ctr Aquicultura CAUNESP, Campus Rio Claro, Sao Paulo, Brazil	Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz; Universidade de Sao Paulo; Universidade Estadual Paulista	Dias, IR (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil.; Dias, IR (corresponding author), Univ Estadual Santa Cruz, Programa Posgrad Zool, Ilheus, BA, Brazil.	iurirdias@hotmail.com	Haddad, Célio F. B./C-4267-2012; Dias, Iuri Ribeiro/AAC-8099-2019; Argolo, Antônio/AAQ-3403-2021; Orrico, Victor G. D./G-9796-2012; Fapesp, Biota/F-8655-2017	Haddad, Célio F. B./0000-0002-7044-5764; Dias, Iuri Ribeiro/0000-0002-2825-3494; Orrico, Victor G. D./0000-0002-4560-4006; Fapesp, Biota/0000-0002-9887-8449	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [404417/2015-9, 150372/2016-7]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP [2007/57067-9, 2012/12500-5, 2008/50928-1, 2013/50741-7]; Fundacao o Boticario de Protecao a Natureza [0991_20132]; CNPq; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/57067-9, 2012/12500-5]; FAPESP [2008/50928-1, 2013/50741-7]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao o Boticario de Protecao a Natureza; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Scholarships were provided by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Project: 404417/2015-9 and Process: #150372/2016-7) to IRD and by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP-#2007/57067-9; #2012/12500-5; #2008/50928-1 and #2013/50741-7 (P.I. Cello F. B. Haddad) and Fundacao o Boticario de Protecao a Natureza (0991_20132) partially funded this study. Cello Haddad thanks to CNPq for a research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank J.D. Lynch (ICN), J.M. Daza (MHUA), S. Ron (QCAZ), L.B. Nascimento (MCNAM), H. da Silva (UFRRJ), U. Caramaschi and J.P. Pombal jr (MNRJ), T. Grant and H. Zaher (MZUSP), and R.W. Heyer (USNM) for access to collections under their care. To P. Taucce, Maria Lucia Del-Grande and C. Cassini for help during the development of this manuscript. To Antonio L. A. Neto, Juliana A. de Jesus, Marcelo Sena, Marcos V. Nova and Tadeu T. Medeiros for the field assistance. To J. Faivovich, Juan M. Guayasamin and an anonymous reviewer for invaluable comments on previous versions of this manuscript. Scholarships were provided by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to IRD and by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP #2007/57067-9 and # 2012/12500-5) to VGDO. Grants by FAPESP #2008/50928-1, #2013/50741-7 (P.I. Celio Haddad) and Fundacao o Boticario de Protecao a Natureza (0991_20132) partially funded this study. Celio Haddad thanks to CNPq for a research fellowship.	Bastos Rogerio Pereira, 1995, Naturalia (Rio Claro), V20, P165; Bastos RP, 1996, J HERPETOL, V30, P355, DOI 10.2307/1565172; Batista A, 2014, ZOOTAXA, V3826, P449, DOI 10.11646/zootaxa.3826.3.2; BOKERMANN W. C. A., 1966, REV BRASIL BIOL, V26, P15; Caldwell JP, 2005, OCCASIONAL PAPERS SA, V16, P1; Camurugi F, 2010, BIOTA NEOTROP, V10, P305, DOI 10.1590/S1676-06032010000200032; Canedo C, 2004, HERPETOLOGICA, V60, P495, DOI 10.1655/03-66; Canedo C, 2012, MOL PHYLOGENET EVOL, V65, P610, DOI 10.1016/j.ympev.2012.07.016; Caramaschi U, 2013, HERPETOLOGICA, V69, P480; Caramaschi U, 2012, ZOOLOGIA-CURITIBA, V29, P343, DOI 10.1590/S1984-46702012000400007; Carcerelli LC, 1992, REV BRAS BIOL, V52, P415; Carvalho-e-Silva Sergio Potsch, 2003, Rev. Bras. Zool., V20, P553, DOI 10.1590/S0101-81752003000300029; Cochran D.M., 1970, B US NATL MUSEUM, V288, P1, DOI DOI 10.5962/BHL.PART.6346; Conte CE, 2010, BIOTA NEOTROP, V10, P201, DOI 10.1590/S1676-06032010000200024; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Cruz Carlos Alberto Goncalves, 2007, South American Journal of Herpetology, V2, P47, DOI 10.2994/1808-9798(2007)2[47:ANSOCA]2.0.CO;2; da Silva Muniz Sergio Luiz, 2016, Herpetology Notes, V9, P99; De La Riva Ignacio, 1997, Amphibia-Reptilia, V18, P433, DOI 10.1163/156853897X00486; de Sa RO, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-241; Dias Iuri Ribeiro, 2014, Herpetology Notes, V7, P627; Dias IR, 2014, ZOOKEYS, P105, DOI 10.3897/zookeys.449.7494; DUELLMAN W E, 1978, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Duellman W. E., 1966, University of Kansas Publications of the Museum of Natural History, V17, P263; Duellman W.E., 1970, Monograph Mus nat Hist Univ Kans, V1, P1; Duellman W. E., 2001, MONOGRAPHS MUSEUM NA, V1-2, P1; Duellman W. E., 1986, BIOL AMPHIBIANS; DUELLMAN WE, 1983, COPEIA, P639, DOI 10.2307/1444328; DUELLMAN WILLIAM E., 1967, HERPETOLOGICA, V23, P169; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Fernandes DS, 2004, HERPETOLOGICA, V60, P245, DOI 10.1655/02-85; Ferreira RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142893; Fouquet A, 2011, ZOOTAXA, P59, DOI 10.11646/zootaxa.3035.1.3; Fouquet A, 2014, J BIOGEOGR, V41, P855, DOI 10.1111/jbi.12250; Fouquet A, 2012, MOL PHYLOGENET EVOL, V65, P547, DOI 10.1016/j.ympev.2012.07.012; Frost D. R., 2016, AMPHIBIANS SPECIES W; Gehara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103958; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gomes F.B.R., 2006, CHECK LIST, V2, P22; HEYER W R, 1990, Arquivos de Zoologia (Sao Paulo), V31, P231; IZECKSOHN E, 1981, Revista Brasileira de Biologia, V41, P19; Izecksohn E, 2001, ANFIBIOS MUNICIPIO R; Junca FA, 2008, ZOOTAXA, P61, DOI 10.11646/zootaxa.1907.1.4; Jungfer KH, 2010, SALAMANDRA, V46, P204; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lescure J, 2000, PATRIMOINES NATURELS, V45, P1; Lutz B., 1973, pi; MARQUEZ R, 1993, BIOTROPICA, V25, P426, DOI 10.2307/2388866; Martins I. A., 2003, Braz. J. Biol., V63, P507, DOI 10.1590/S1519-69842003000300017; Miller M.A., 2010, P GAT COMP ENV WORKS; Morais AR, 2012, HERPETOL J, V22, P249; Motta AP, 2012, ZOOTAXA, P18, DOI 10.11646/zootaxa.3249.1.2; MYERS C W, 1982, American Museum Novitates, P1; Napoli M., 1998, B MUS NAC NOVA SER Z, V391, P1; Napoli MF, 2011, ZOOTAXA, P37; Napoli MF, 2011, ZOOTAXA, P33, DOI 10.11646/zootaxa.2739.1.3; Orrico VGD, 2014, ZOOTAXA, V3881, P341, DOI 10.11646/zootaxa.3881.4.3; Orrico VGD, 2013, J HERPETOL, V47, P615, DOI 10.1670/12-208; Peloso PLV, 2016, S AM J HERPETOL, V11, P66, DOI 10.2994/SAJH-D-16-00003.1; Rambaut A., 2014, TRACER V1 6; Recoder RS, 2010, ZOOTAXA, P36; Rivera-Correa M, 2013, ZOOTAXA, V3686, P447, DOI 10.11646/zootaxa.3686.4.3; Rodriguez LO., 1994, GUIDE FROGS IQUITOS; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SAVAGE J M, 1967, Beitraege zur Neotropischen Fauna, V5, P111; Savage Jay M., 1997, Herpetological Review, V28, P131; Savage Jay M., 2002, pi; Silvano DL, 2003, CORREDOR BIODIVERSID; Teixeira M, 2012, ZOOTAXA, P25; Teixeira M, 2013, ZOOTAXA, V3702, P459, DOI 10.11646/zootaxa.3702.5.5; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WELLS KD, 1981, COPEIA, P615; Zina J, 2014, BRAZ J BIOL, V74, P146, DOI 10.1590/1519-6984.22912	73	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171678	10.1371/journal.pone.0171678	http://dx.doi.org/10.1371/journal.pone.0171678			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273092	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700059
J	Matsubara, Y; Kimachi, M; Fukuma, S; Onishi, Y; Fukuhara, S				Matsubara, Yukiko; Kimachi, Miho; Fukuma, Shingo; Onishi, Yoshihiro; Fukuhara, Shunichi			Development of a new risk model for predicting cardiovascular events among hemodialysis patients: Population-based hemodialysis patients from the Japan Dialysis Outcome and Practice Patterns Study (J-DOPPS)	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CONGESTIVE-HEART-FAILURE; CORONARY-ARTERY DISEASE; MORTALITY RISK; MINERAL METABOLISM; UNITED-STATES; ATHEROSCLEROSIS; ASSOCIATION; CALCIUM; ANEMIA	Background Cardiovascular (CV) events are the primary cause of death and becoming bedridden among hemodialysis (HD) patients. The Framingham risk score (FRS) is useful for predicting incidence of CV events in the general population, but is considerd to be unsuitable for the prediction of the incidence of CV events in HD patients, given their characteristics due to atypical relationships between conventional risk factors and outcomes. We therefore aimed to develop a new prognostic prediction model for prevention and early detection of CV events among hemodialysis patients. Methods We enrolled 3,601 maintenance HD patients based on their data from the Japan Dialysis Outcomes and Practice Patterns Study (J-DOPPS), phases 3 and 4. We longitudinaly assessed the association between several potential candidate predictors and composite CV events in the year after study initiation. Potential candidate predictors included the component factors of FRS and other HD-specific risk factors. We used multivariable logistic regression with backward stepwise selection to develop our new prediction model and generated a calibration plot. Additinially, we performed bootstrapping to assess the internal validity. Results We observed 328 composite CV events during 1-year follow-up. The final prediction model contained six variables: age, diabetes status, history of CV events, dialysis time per session, and serum phosphorus and albumin levels. The new model showed significantly better discrimination than the FRS, in both men (c-statistics: 0.76 for new model, 0.64 for FRS) and women (c-statistics: 0.77 for new model, 0.60 for FRS). Additionally, we confirmed the consistency between the observed results and predicted results using the calibration plot. Further, we found similar discrimination and calibration to the derivation model in the boot-strapping cohort. Conclusions We developed a new risk model consisting of only six predictors. Our new model predicted CV events more accurately than the FRS.	[Matsubara, Yukiko] Akane Fdn Omachi Tsuchiya Clin, Dept Artificial Organs, Hiroshima, Japan; [Matsubara, Yukiko] Hiroshima Med Univ, Hiroshima, Japan; [Kimachi, Miho; Fukuma, Shingo; Fukuhara, Shunichi] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan; [Kimachi, Miho; Fukuma, Shingo; Onishi, Yoshihiro] IHope Int, Inst Hlth Outcomes & Proc Evaluat Res, Kyoto, Japan; [Fukuma, Shingo; Fukuhara, Shunichi] Fukushima Med Univ, Ctr Innovat Res Communities & Clin Excellence, Fukushima, Japan	Hiroshima University; Kyoto University; Fukushima Medical University	Fukuma, S (corresponding author), Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan.	fukuma.shingo.3m@kyoto-u.ac.jp	Fukuma, Shingo/S-6584-2019	Fukuma, Shingo/0000-0002-8379-8761				Akdag I, 2008, NEPHRON CLIN PRACT, V108, pC99, DOI 10.1159/000113526; Beddhu S, 2004, J AM SOC NEPHROL, V15, P733, DOI 10.1097/01.ASN.0000113319.57131.28; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Canaud B, 2011, CLIN J AM SOC NEPHRO, V6, P1651, DOI 10.2215/CJN.03530410; Cavanaugh KL, 2008, AM J KIDNEY DIS, V52, P118, DOI 10.1053/j.ajkd.2008.02.001; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; DEGOULET P, 1982, NEPHRON, V31, P103, DOI 10.1159/000182627; Floege J, 2015, KIDNEY INT, V87, P996, DOI 10.1038/ki.2014.419; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Frank H, 2004, KIDNEY INT, V66, P832, DOI 10.1111/j.1523-1755.2004.00810.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goodkin DA, 2004, AM J KIDNEY DIS, V44, pS16, DOI 10.1053/j.akjd.2004.08.006; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Herzog CA, 2011, KIDNEY INT, V80, P572, DOI 10.1038/ki.2011.223; Huang JC, 2013, NEPHROLOGY, V18, P510, DOI 10.1111/nep.12094; Iaina A, 2005, NAT CLIN PRACT CARD, V2, P95, DOI 10.1038/ncpcardio0094; Johansen KL, 2015, BLOOD PURIFICAT, V40, P288, DOI 10.1159/000441575; Joki N, 1997, NEPHROL DIAL TRANSPL, V12, P718, DOI 10.1093/ndt/12.4.718; Jurkovitz C, 2006, CURR OPIN NEPHROL HY, V15, P117, DOI 10.1097/01.mnh.0000214769.11609.2d; KNOTTNERUS JA, 1995, PRIMARY CARE, V22, P341; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Murtagh FEM, 2007, NEPHROL DIAL TRANSPL, V22, P1955, DOI 10.1093/ndt/gfm153; Ohtake T, 2005, J AM SOC NEPHROL, V16, P1141, DOI 10.1681/ASN.2004090765; Okwuosa TM, 2011, J AM COLL CARDIOL, V57, P1838, DOI 10.1016/j.jacc.2010.11.053; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Shoji T, 2011, CLIN J AM SOC NEPHRO, V6, P1112, DOI 10.2215/CJN.09961110; Silverberg DS, 2003, KIDNEY INT, V64, pS40, DOI 10.1046/j.1523-1755.64.s87.7.x; Silverberg DS, 2003, NEPHROL DIAL TRANSPL, V18, P141, DOI 10.1093/ndt/18.1.141; Stack AG, 2001, J AM SOC NEPHROL, V12, P1516, DOI 10.1681/ASN.V1271516; Steyerberg EW, 2005, J CLIN EPIDEMIOL, V58, P383, DOI 10.1016/j.jclinepi.2004.07.008; Steyerberg EW, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.2005.07.008; Steyerberg EW, 1999, J CLIN EPIDEMIOL, V52, P935, DOI 10.1016/S0895-4356(99)00103-1; Sumida K, 2016, NEPHROL DIAL TRANSPL, V31, P298, DOI 10.1093/ndt/gfv402; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Wang JL, 2012, NEPHRON CLIN PRACT, V121, pC102, DOI 10.1159/000345159; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Xiao JB, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0089097, 10.1155/2014/584164, 10.1371/journal.pone.0093842]; Young EW, 2000, KIDNEY INT, V57, pS74, DOI 10.1046/j.1523-1755.2000.07413.x; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x	45	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173468	10.1371/journal.pone.0173468	http://dx.doi.org/10.1371/journal.pone.0173468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273175	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700008
J	Tornbom, K; Sunnerhagen, KS; Danielsson, A				Tornbom, Karin; Sunnerhagen, Katharina S.; Danielsson, Anna			Perceptions of physical activity and walking in an early stage after stroke or acquired brain injury	PLOS ONE			English	Article							QUALITATIVE CONTENT-ANALYSIS; PERCEIVED BARRIERS; REHABILITATION; EXERCISE; SURVIVORS; FACILITATORS; INDIVIDUALS; PERFORMANCE; POPULATION; INTERVIEWS	Background Physical activity has been established as being highly beneficial for health after stroke. There are considerable global efforts to find rehabilitation programs that encourage increased physical activity for persons with stroke. However, many persons with stroke or acquired brain injury do not reach recommended levels of physical activity and increased knowledge about why is needed. We aimed to explore views and experiences of physical activity and walking among persons with stroke or acquired brain injury. Method A qualitative study was conducted, among persons with stroke (n = 8) or acquired brain injury (n = 2) from a rehabilitation unit at Sahlgrenska University Hospital in Sweden. Semi-structured in-depth interviews were held about perceptions and experiences of walking and physical activity in general. Data were analyzed using qualitative content analysis, with categories that were determined inductively. Results Physical activity in general and walking ability more specifically were considered very important by the participants. However, physical activity was, regardless of exercising habits pre-injury, associated with different kinds of negative feelings and experiences. Commonly reported internal barriers in the current study were; fatigue, fear of falling or getting hurt in traffic, lack of motivation and depression. Reported external barriers were mostly related to walking, for example; bad weather, uneven ground, lack of company or noisy or too busy surroundings. Conclusion Persons with stroke or acquired brain injury found it difficult to engage in and sustain an eligible level of physical activity. Understanding individual concerns about motivators and barriers surrounding physical activity may facilitate the work of forming tailor-made rehabilitation for these groups, so that the levels of physical activity and walking can increase.	[Tornbom, Karin; Sunnerhagen, Katharina S.; Danielsson, Anna] Univ Gothenburg, Sahlgrenska Acad, Res Grp Rehabil Med, Inst Neurosci & Physiol,Dept Clin Neurosci, Gothenburg, Sweden; [Tornbom, Karin; Sunnerhagen, Katharina S.] Univ Gothenburg, Ctr Person Ctr Care GPCC, Gothenburg, Sweden; [Danielsson, Anna] Univ Gothenburg, Dept Hlth & Rehabil, Unit Physiotherapy, Inst Neurosci & Physiol,Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Tornbom, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Res Grp Rehabil Med, Inst Neurosci & Physiol,Dept Clin Neurosci, Gothenburg, Sweden.; Tornbom, K (corresponding author), Univ Gothenburg, Ctr Person Ctr Care GPCC, Gothenburg, Sweden.	karin.tornbom@neuro.gu.se	Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400; Danielsson, Anna/0000-0002-6496-4066	John and Brit Wennerstrom foundation for Neurological Research; Norrbacka-Eugenia foundation [808-12]; Rune and Ulla Amlovs foundation for Neurological Research; Swedish Stroke association; Hjalmar Svensson foundation [HJSV2012056]; Swedish Stroke Centre West	John and Brit Wennerstrom foundation for Neurological Research; Norrbacka-Eugenia foundation; Rune and Ulla Amlovs foundation for Neurological Research; Swedish Stroke association; Hjalmar Svensson foundation; Swedish Stroke Centre West	John and Brit Wennerstrom foundation for Neurological Research; The Norrbacka-Eugenia foundation, 808-12; Rune and Ulla Amlovs foundation for Neurological Research; The Swedish Stroke association; Hjalmar Svensson foundation, HJSV2012056; and The Swedish Stroke Centre West. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billinger SA, 2014, STROKE, V45, P2532, DOI 10.1161/STR.0000000000000022; BOHANNON RW, 1988, INT J REHABIL RES, V11, P181, DOI 10.1097/00004356-198806000-00012; Bonner NS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164120; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Combs SA, 2013, DISABIL REHABIL, V35, P860, DOI 10.3109/09638288.2012.717575; Damush TM, 2007, REHABIL NURS, V32, P253, DOI 10.1002/j.2048-7940.2007.tb00183.x; Danielsson A, 2014, PM&R, V6, P139, DOI 10.1016/j.pmrj.2013.08.593; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Duncan PW, 2005, STROKE, V36, pE100, DOI 10.1161/01.STR.0000180861.54180.FF; English C, 2016, TOP STROKE REHABIL, V23, P62, DOI 10.1179/1945511915Y.0000000009; English C, 2016, PHYS THER, V96, P193, DOI 10.2522/ptj.20140522; Evenson KR, 2014, J CARDIOPULM REHABIL, V34, P406, DOI 10.1097/HCR.0000000000000064; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gallagher Patti, 2011, Can J Neurosci Nurs, V33, P24; Galvin R, 2009, INT J REHABIL RES, V32, P238, DOI 10.1097/MRR.0b013e32832b083c; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hankey GJ, 2003, CEREBROVASC DIS, V16, P14, DOI 10.1159/000069936; Harris Jocelyn E, 2004, Physiother Can, V56, P171, DOI 10.2310/6640.2004.00017; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Idowu OA, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.274.6669; Ivey FM, 2008, J CARDIOPULM REHABIL, V28, P2, DOI 10.1097/01.HCR.0000311501.57022.a8; Jaracz K, 2014, NEUROL NEUROCHIR POL, V48, P280, DOI 10.1016/j.pjnns.2014.07.004; Kirkevold Marit, 2014, BMC Psychol, V2, P4, DOI 10.1186/2050-7283-2-4; Kucukdeveci AA, 2011, J REHABIL MED, V43, P661, DOI 10.2340/16501977-0844; Luker J, 2015, ARCH PHYS MED REHAB, V96, P1698, DOI 10.1016/j.apmr.2015.03.017; Maclean N, 2000, SOC SCI MED, V50, P495; Maclean N, 2000, BMJ-BRIT MED J, V321, P1051, DOI 10.1136/bmj.321.7268.1051; Mead GE, 2007, J AM GERIATR SOC, V55, P892, DOI 10.1111/j.1532-5415.2007.01185.x; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Mossberg KA, 2010, J HEAD TRAUMA REHAB, V25, P173, DOI 10.1097/HTR.0b013e3181dc98ff; Nadeau SE, 2016, NEUROREHAB NEURAL RE, V30, P615, DOI 10.1177/1545968315613851; Nicholson S, 2013, INT J STROKE, V8, P357, DOI 10.1111/j.1747-4949.2012.00880.x; Nicholson SL, 2014, DISABIL REHABIL, V36, P1857, DOI 10.3109/09638288.2013.874506; Ohman A, 2005, J REHABIL MED, V37, P273, DOI 10.1080/16501970510040056; Patterson S, 2009, INT J THER REHABIL, V16, P659, DOI 10.12968/ijtr.2009.16.12.45422; Peters K, 2015, NURSE RES, V22, P6, DOI 10.7748/nr.22.4.6.s2; Resnick B, 2008, TOP STROKE REHABIL, V15, P494, DOI 10.1310/tsr1505-494; Riks-Stroke, 2015, RIKS STROK YEARL RAP; Rimmer JH, 2008, J REHABIL RES DEV, V45, P315, DOI 10.1682/JRRD.2007.02.0042; Rimmer JH, 2010, AM J PHYS MED REHAB, V89, P249, DOI 10.1097/PHM.0b013e3181c9fa9d; Robison J, 2009, DISABIL REHABIL, V31, P1555, DOI 10.1080/09638280802639327; Salbach NM, 2009, PHYS THER, V89, P556, DOI 10.2522/ptj.20080249; Sunnehagen KS, 2000, SCAND J REHABIL MED, V32, P159; Vanroy C, 2016, TOP STROKE REHABIL, V23, P98, DOI 10.1080/10749357.2015.1116227; Veluswamy SK, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-27; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Witte US, 1997, SCAND J REHABIL MED, V29, P161; World Health Organization (WHO), 2016, PHYS ACTIVITY	48	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173463	10.1371/journal.pone.0173463	http://dx.doi.org/10.1371/journal.pone.0173463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273158	Green Published, gold			2022-12-27	WOS:000396073700005
J	Chang, LC; Chen, YC; Liao, LL; Wu, FL; Hsieh, PL; Chen, HJ				Chang, Li-Chun; Chen, Yu-Chi; Liao, Li-Ling; Wu, Fei Ling; Hsieh, Pei-Lin; Chen, Hsiao-Jung			Validation of the instrument of health literacy competencies for Chinese-speaking health professionals	PLOS ONE			English	Article							PERCEPTIONS; KNOWLEDGE; COMMUNICATION; PHYSICIANS	The study aimed to illustrate the constructs and test the psychometric properties of an instrument of health literacy competencies (IOHLC) for health professionals. A multi-phase questionnaire development method was used to develop the scale. The categorization of the knowledge and practice domains achieved consensus through a modified Delphi process. To reduce the number of items, the 92-item IOHLC was psychometrically evaluated through internal consistency, Rasch modeling, and two-stage factor analysis. In total, 736 practitioners, including nurses, nurse practitioners, health educators, case managers, and dieticians completed the 92-item IOHLC online from May 2012 to January 2013. The final version of the IOHLC covered 9 knowledge items and 40 skill items containing 9 dimensions, with good model fit, and explaining 72% of total variance. All domains had acceptable internal consistency and discriminant validity. The tool in this study is the first to verify health literacy competencies rigorously. Moreover, through psychometric testing, the 49-item IOHLC demonstrates adequate reliability and validity. The IOHLC may serve as a reference for the theoretical and in-service training of Chinese-speaking individuals' health literacy competencies.	[Chang, Li-Chun; Wu, Fei Ling; Hsieh, Pei-Lin; Chen, Hsiao-Jung] Chang Gung Univ Sci & Technol, Sch Nursing, Gui Shan Town, Tao Yuan County, Taiwan; [Chen, Yu-Chi] Natl Yang Ming Univ, Inst Clin Nursing, Taipei, Taiwan; [Liao, Li-Ling] I Shou Univ, Dept Hlth Management, Kaohsiung, Taiwan	Chang Gung University of Science & Technology; National Yang Ming Chiao Tung University; I Shou University	Chen, HJ (corresponding author), Chang Gung Univ Sci & Technol, Sch Nursing, Gui Shan Town, Tao Yuan County, Taiwan.	chen4885@gmail.com		Chen, Yu-Chi/0000-0003-4144-3265	Ministry of Science and Technology, Taiwan [NSC 100-2511-S-255-001-MY2]; Chang Gung Memorial Hospital [BMRP 978]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This project was funded by the Ministry of Science and Technology, Taiwan (NSC 100-2511-S-255-001-MY2) and received financial assistance from Chang Gung Memorial Hospital (BMRP 978).	Ali NK, 2014, J COMMUNITY HOSP INT, V4, DOI 10.3402/jchimp.v4.22893; ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Cafiero M, 2013, J HEALTH COMMUN, V18, P70, DOI 10.1080/10810730.2013.825665; Carmona RH, 2006, J GEN INTERN MED, V21, P803, DOI 10.1111/j.1525-1497.2006.00569.x; Chang LC, 2016, BMJ OPEN, V10, pe3120; Chang W.H, 2011, WRITE SUBMIT ACAD PA; Coleman C, 2011, NURS OUTLOOK, V59, P70, DOI 10.1016/j.outlook.2010.12.004; Coleman CA, 2013, J HEALTH COMMUN, V18, P82, DOI 10.1080/10810730.2013.829538; DeVellis R.F, 1998, SCALE DEV THEORY APP; [Education and Communications Health Education and Health Promotion Unit Division of Health Promotion World Health Organization], 1998, ED COMM HLTH ED HLTH; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Hair J.F., 2010, MULTIVARIANT DATA AN, V7th; Heijmans M, 2015, PATIENT EDUC COUNS, V98, P41, DOI 10.1016/j.pec.2014.10.006; Howard T, 2013, J HEALTH COMMUN, V18, P991, DOI 10.1080/10810730.2012.757398; Institute of Medicine, 2004, HLTH LITERACY PRESCR; Jukkala A, 2009, J CONTIN EDUC NURS, V40, P298, DOI 10.3928/00220124-20090623-01; Kutner M, 2006, 2006483 NCES US DEP; Lambert M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0614-1; Linacre J. M., 2009, USERS GUIDE WINSTEPS; Macabasco-O'Connell A, 2011, J HEALTH COMMUN, V16, P295, DOI 10.1080/10810730.2011.604389; Mackert M, 2011, HEALTH COMMUN, V26, P525, DOI 10.1080/10410236.2011.556084; Mantwill S, 2015, PATIENT EDUC COUNS, V98, P1625, DOI 10.1016/j.pec.2015.07.006; Nutbeam D, 2010, HEALTH PROMOT INT, V15, P259; Pagels Patti, 2015, Int J Family Med, V2015, P129187, DOI 10.1155/2015/129187; Parnell T.A, 2015, HLTH LITERACY NURSIN; Peng J, 2015, CANADIAN GERIATRICS, V5, P1; Schlichting JA, 2007, PATIENT EDUC COUNS, V69, P114, DOI 10.1016/j.pec.2007.08.003; Schulz PJ, 2013, PATIENT EDUC COUNS, V90, P4, DOI 10.1016/j.pec.2012.09.006; Schumacker R. E, 2004, BEGINNERS GUIDE STRU, V2nd, DOI DOI 10.4135/9781412973380.N17; Schwartzberg JG, 2007, AM J HEALTH BEHAV, V31, pS96; Turner Teri, 2009, Pediatrics, V124 Suppl 3, pS299, DOI 10.1542/peds.2009-1162F; Zhang NJ, 2014, ANN PHARMACOTHER, V48, P741, DOI 10.1177/1060028014526562	33	6	6	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172859	10.1371/journal.pone.0172859	http://dx.doi.org/10.1371/journal.pone.0172859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5OE	28264036	Green Submitted, Green Published, gold			2022-12-27	WOS:000396054300024
J	Matsubayashi, M; Shimada, Y; Li, YY; Harada, H; Kubota, K				Matsubayashi, Miri; Shimada, Yusuke; Li, Yu-You; Harada, Hideki; Kubota, Kengo			Phylogenetic diversity and in situ detection of eukaryotes in anaerobic sludge digesters	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; HYBRIDIZATION; COMMUNITY; DNA; MICROORGANISMS; IDENTIFICATION; AMPLIFICATION; BACTERIA; ARCHAEA; TOOLS	Eukaryotic communities in aerobic wastewater treatment processes are well characterized, but little is known about them in anaerobic processes. In this study, abundance, diversity and morphology of eukaryotes in anaerobic sludge digesters were investigated by quantitative real-time PCR (qPCR), 18S rRNA gene clone library construction and catalyzed reporter deposition-fluorescence in situ hybridization (CARD-FISH). Samples were taken from four different anaerobic sludge digesters in Japan. Results of qPCR of rRNA genes revealed that Eukarya accounted from 0.1% to 1.4% of the total number of microbial rRNA gene copy numbers. The phylogenetic affiliations of a total of 251 clones were Fungi, Alveolata, Viridiplantae, Amoebozoa, Rhizaria, Stramenopiles and Metazoa. Eighty-five percent of the clones showed less than 97.0% sequence identity to described eukaryotes, indicating most of the eukaryotes in anaerobic sludge digesters are largely unknown. Clones belonging to the uncultured lineage LKM11 in Cryptomycota of Fungi were most abundant in anaerobic sludge, which accounted for 50% of the total clones. The most dominant OTU in each library belonged to either the LKM11 lineage or the uncultured lineage A31 in Alveolata. Principal coordinate analysis indicated that the eukaryotic and prokaryotic community structures were related. The detection of anaerobic eukaryotes, including the members of the LKM11 and A31 lineages in anaerobic sludge digesters, by CARD-FISH revealed their sizes in the range of 2-8 mu m. The diverse and uncultured eukaryotes in the LKM11 and the A31 lineages are common and ecologically relevant members in anaerobic sludge digester.	[Matsubayashi, Miri; Li, Yu-You; Kubota, Kengo] Tohoku Univ, Dept Civil & Environm Engn, Sendai, Miyagi, Japan; [Shimada, Yusuke] Tohoku Univ, Dept Frontier Sci Adv Environm, Sendai, Miyagi, Japan; [Harada, Hideki] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University	Kubota, K (corresponding author), Tohoku Univ, Dept Civil & Environm Engn, Sendai, Miyagi, Japan.	kengo.kubota.a7@tohoku.ac.jp	Li, Yu-You/A-1735-2017; li, Yu/HCI-9086-2022; li, yu/HGL-9518-2022; Kubota, Kengo/C-8870-2009	Kubota, Kengo/0000-0002-1913-272X; Li, Yu-You/0000-0002-3659-5005	JSPS KAKENHI Grant [JP26289179]; Strategic Funds for the Promotion of Science & Technology, Ministry of Education, Culture, Sports, Sciences and Technology, Japan (MEXT)	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Strategic Funds for the Promotion of Science & Technology, Ministry of Education, Culture, Sports, Sciences and Technology, Japan (MEXT)	This research was supported by JSPS KAKENHI Grant Number JP26289179 and the Strategic Funds for the Promotion of Science & Technology, Ministry of Education, Culture, Sports, Sciences and Technology, Japan (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Brad T, 2008, APPL ENVIRON MICROB, V74, P3959, DOI 10.1128/AEM.02820-07; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Capo E, 2015, MICROB ECOL, V70, P865, DOI 10.1007/s00248-015-0627-2; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599; Ishii K, 2004, FEMS MICROBIOL ECOL, V50, P203, DOI 10.1016/j.femsec.2004.06.015; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Kubota K, 2006, APPL ENVIRON MICROB, V72, P5311, DOI 10.1128/AEM.03039-05; Kubota K, 2006, J MICROBIOL METH, V66, P521, DOI 10.1016/j.mimet.2006.02.002; Kubota K, 2013, MICROBES ENVIRON, V28, P3, DOI 10.1264/jsme2.ME12107; Lasken RS, 2007, CURR OPIN MICROBIOL, V10, P510, DOI 10.1016/j.mib.2007.08.005; Leis S, 2014, ANAEROBE, V29, P34, DOI 10.1016/j.anaerobe.2013.12.002; Lepere C, 2007, FEMS MICROBIOL ECOL, V61, P483, DOI 10.1111/j.1574-6941.2007.00359.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luo QW, 2005, APPL ENVIRON MICROB, V71, P6175, DOI 10.1128/AEM.71.10.6175-6184.2005; Matsunaga K, 2014, MICROBES ENVIRON, V29, P401, DOI 10.1264/jsme2.ME14112; Monchy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039924; Musat N, 2012, FEMS MICROBIOL REV, V36, P486, DOI 10.1111/j.1574-6976.2011.00303.x; Nagahama T, 2011, ENVIRON MICROBIOL, V13, P2359, DOI 10.1111/j.1462-2920.2011.02507.x; Ntougias S, 2011, J HAZARD MATER, V186, P1862, DOI 10.1016/j.jhazmat.2010.12.099; Okabe S, 2004, MICROB ENV, V19, P83, DOI DOI 10.1264/JSME2.19.83; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stoddard SF, 2015, NUCLEIC ACIDS RES, V43, pD593, DOI 10.1093/nar/gku1201; Sundberg C, 2013, FEMS MICROBIOL ECOL, V85, P612, DOI 10.1111/1574-6941.12148; WEBSTER CE, 1987, J MED VET MYCOL, V25, P47; Yamaguchi T, 2015, ENVIRON MICROBIOL, V17, P2532, DOI 10.1111/1462-2920.12745; Yilmaz LS, 2011, APPL ENVIRON MICROB, V77, P1118, DOI 10.1128/AEM.01733-10; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	32	25	27	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172888	10.1371/journal.pone.0172888	http://dx.doi.org/10.1371/journal.pone.0172888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264042	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300027
J	Zhang, YH; Liu, QP; Zhang, SY				Zhang, YunHong; Liu, QiPeng; Zhang, SiYing			Opinion formation with time-varying bounded confidence	PLOS ONE			English	Article							NETWORKS; DYNAMICS	When individuals in social groups communicate with one another and are under the influence of neighbors' opinions, they typically revise their own opinions to adapt to such peer opinions. The individual threshold of bounded confidence will thus be affected by both a change in individual confidence and by neighbor influence. Individuals thus update their own opinions with new bounded confidence, while their updated opinions also influence their neighbors' opinions. Based on this reasoned factual assumption, we propose an opinion dynamics model with time-varying bounded confidence. A directed network is formed by the rule of the individual bounded confidence threshold. The threshold of individual bounded confidence involves both confidence variation and the in/out degree of the individual node. When the confidence variation is greater, an individual's confidence in persisting in his own opinion in interactions is weaker, and the individual is more likely to adopt neighbors' opinions. In networks, the in/out degree is determined by individual neighbors. Our main research involves the process of opinion evolution and the basic laws of opinion cluster formation. Group opinions converge exponentially to consensus with stable neighbors. An individual opinion evolution is determined by the average neighbor opinion effect strength. We also explore the conditions involved in forming a stable neighbor relationship and the influence of the confidence variation in the convergence of the threshold of bounded confidence. The results show that the influence on opinion evolution is greater with increased confidence variation.	[Zhang, YunHong; Liu, QiPeng; Zhang, SiYing] Qingdao Univ, Inst Complex Sci, Qingdao, Peoples R China; [Zhang, YunHong] Qingdao Univ, Coll Comp Sci & Technol, Qingdao, Peoples R China	Qingdao University; Qingdao University	Zhang, YH (corresponding author), Qingdao Univ, Inst Complex Sci, Qingdao, Peoples R China.; Zhang, YH (corresponding author), Qingdao Univ, Coll Comp Sci & Technol, Qingdao, Peoples R China.	zyh_qdu@126.com	Liu, Qipeng/GZK-7138-2022	Liu, Qipeng/0000-0002-6546-3773	National Natural Science Foundation of China [61503207, 61572267]; Natural Science Foundation of Shandong Province [ZR2015PF003]; China Postdoctoral Science Foundation [2015M571996]; Qingdao Postdoctoral Application Research Project [2015123]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Qingdao Postdoctoral Application Research Project	This work was supported by the National Natural Science Foundation of China under Grants No. 61503207 and No. 61572267, the Natural Science Foundation of Shandong Province (ZR2015PF003), the Project Funded by the China Postdoctoral Science Foundation (2015M571996), and the Qingdao Postdoctoral Application Research Project/(2015123)/Dr. QiPeng Liu.	[Anonymous], 2012, INT C COMPL SCI; Baron J., 2000, THINKING DECIDING; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; CLIFFORD P, 1973, BIOMETRIKA, V60, P581, DOI 10.2307/2335008; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; Galam S, 2002, EUR PHYS J B, V25, P403, DOI 10.1140/epjb/e20020045; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P3; GLAUBER RJ, 1963, J MATH PHYS, V4, P294, DOI 10.1063/1.1703954; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; Iniguez G, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066119; Kou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043507; Kozma B, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016102; Li K, 2016, SCI REP-UK, V6, DOI 10.1038/srep21104; Li K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05491; Liu QP, 2014, ASIAN J CONTROL, V16, P1342, DOI 10.1002/asjc.816; Liu QP, 2013, PHYSICA A, V392, P2368, DOI 10.1016/j.physa.2013.01.007; Lorenz J, 2007, ARXIV07083293; Lorenz J, 2009, COMPLEXITY; Lorenz J, 2007, INT J MOD PHYS C, V18, P1819, DOI 10.1142/S0129183107011789; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Ma JY, 2016, AUTOMATICA, V73, P200, DOI 10.1016/j.automatica.2016.07.005; Mirtabatabaei A, 2012, SIAM J CONTROL OPTIM, V50, P2763, DOI 10.1137/11082751X; Moussaid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078433; Moussaid M, 2009, TOP COGN SCI, V1, P469, DOI 10.1111/j.1756-8765.2009.01028.x; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; NOWAK A, 1990, PSYCHOL REV, V97, P362, DOI 10.1037/0033-295X.97.3.362; Proskurnikov AV, 2014, IEEE INT SYMP INTELL, P849, DOI 10.1109/ISIC.2014.6967611; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Zheng Y., 2017, AIN SHAMS ENG J; Zheng YS, 2016, IEEE T CIRCUITS-II, V63, P314, DOI 10.1109/TCSII.2015.2482138	33	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172982	10.1371/journal.pone.0172982	http://dx.doi.org/10.1371/journal.pone.0172982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264038	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300030
J	Dijkstra, H; Wolff, D; van Melle, JP; Bartelds, B; Willems, TP; Oudkerk, M; Hillege, H; van den Berg, AP; Ebels, T; Berger, RMF; Sijens, PE				Dijkstra, Hildebrand; Wolff, Djoeke; van Melle, Joost P.; Bartelds, Beatrijs; Willems, Tineke P.; Oudkerk, Matthijs; Hillege, Hans; van den Berg, Aad P.; Ebels, Tjark; Berger, Rolf M. F.; Sijens, Paul E.			Diminished liver microperfusion in Fontan patients: A biexponential DWI study	PLOS ONE			English	Article							INTRAVOXEL INCOHERENT MOTION; DIFFUSION-WEIGHTED MRI; CHRONIC PASSIVE CONGESTION; CONGENITAL HEART-DISEASE; CHRONIC HEPATITIS-C; TRICUSPID-ATRESIA; HEPATOCELLULAR-CARCINOMA; PERFUSION MEASUREMENT; INITIAL-EXPERIENCE; CARDIAC CIRRHOSIS	It has been demonstrated that hepatic apparent diffusion coefficients (ADC) are decreasing in patients with a Fontan circulation. It remains however unclear whether this is a true decrease of molecular diffusion, or rather reflects decreased microperfusion due to decreased portal blood flow. The purpose of this study was therefore to differentiate diffusion and microperfusion using intravoxel incoherent motion (IVIM) modeled diffusion-weighted imaging (DWI) for different liver segments in patients with a Fontan circulation, compare to a control group, and relate with liver function, chronic hepatic congestion and hepatic disease. For that purpose, livers of 59 consecutively included patients with Fontan circulation (29 men; mean-age, 19.1 years) were examined (Oct 2012-Dec 2013) with 1.5T MRI and DWI (b = 0,50,100,250,500, 750,1500,1750 s/mm(2)). IVIM (D-slow,D-fast,f(fast)) and ADC were calculated for eight liver segments, compared to a control group (19 volunteers; 10 men; mean-age, 32.9 years), and correlated to follow-up duration, clinical variables, and laboratory measurements associated with liver function. The results demonstrated that microperfusion was reduced (p < 0.001) in Fontan livers compared to controls with -38.1% for D-fast and -32.6% for f(fast). Molecular diffusion (D-slow) was similar between patients and controls, while ADC was significantly lower (-14.3%) in patients (p < 0.001). ADC decreased significantly with follow-up duration after Fontan operation (r = -0.657). D-slow showed significant inverse correlations (r = -0.591) with follow-up duration whereas D-fast and f(fast) did not. From these results it was concluded that the decreasing ADC values in Fontan livers compared with controls reflect decreases in hepatic microperfusion rather than any change in molecular diffusion. However, with the time elapsed since the Fontan operation molecular diffusion and ADC decreased while microperfusion remained stable. This indicates that after Fontan operation initial blood flow effects on the liver are followed by intracellular changes preceding the formation of fibrosis and cirrhosis.	[Dijkstra, Hildebrand] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Ctr Med Imaging North East Netherlands, Groningen, Netherlands; [Wolff, Djoeke; Bartelds, Beatrijs; Berger, Rolf M. F.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Ctr Congenital Heart Dis,Dept Pediat Cardiol, Groningen, Netherlands; [van Melle, Joost P.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Ctr Congenital Heart Dis, Groningen, Netherlands; [Willems, Tineke P.; Sijens, Paul E.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [Oudkerk, Matthijs] Univ Groningen, Univ Med Ctr Groningen, Ctr Med Imaging North East Netherlands, Groningen, Netherlands; [Hillege, Hans] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van den Berg, Aad P.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol, Groningen, Netherlands; [Ebels, Tjark] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiothorac Surg, Ctr Congenital Heart Dis, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Dijkstra, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Ctr Med Imaging North East Netherlands, Groningen, Netherlands.	h.dijkstra01@umcg.nl		Oudkerk, Matthijs/0000-0003-2800-4110; Ebels, Tjark/0000-0002-7124-0058; Dijkstra, Hildebrand/0000-0001-6664-902X	Sebald Foundation	Sebald Foundation	This work was supported by the Sebald Foundation (to RMFB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano Y, 1998, ACTA RADIOL, V39, P440; Asrani SK, 2013, NEW ENGL J MED, V368, P1756, DOI 10.1056/NEJMc1214222; Asrani SK, 2012, HEPATOLOGY, V56, P1160, DOI 10.1002/hep.25692; Bakan AA, 2012, EUR RADIOL, V22, P682, DOI 10.1007/s00330-011-2295-z; BISMUTH H, 1982, WORLD J SURG, V6, P3, DOI 10.1007/BF01656368; Boulanger Y, 2003, NMR BIOMED, V16, P132, DOI 10.1002/nbm.818; Cornel M., 2017, VOLKSGEZONDHEID TOEK; Couinaud C, 1957, FOIE ETUDES ANATOMIQ; Dijkstra H, 2012, EUR RADIOL, V22, P891, DOI 10.1007/s00330-011-2313-1; DUNN GD, 1973, AM J MED SCI, V265, P175, DOI 10.1097/00000441-197303000-00001; FONTAN F, 1971, THORAX, V26, P240, DOI 10.1136/thx.26.3.240; Fredenburg TB, 2011, RADIOGRAPHICS, V31, P453, DOI 10.1148/rg.312105027; Ghaferi AA, 2005, J THORAC CARDIOV SUR, V129, P1348, DOI 10.1016/j.jtcvs.2004.10.005; Greenway SC, 2015, J HEART LUNG TRANSPL; Hagiwara M, 2008, RADIOLOGY, V246, P926, DOI 10.1148/radiol.2463070077; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Johnson JA, 2013, J THORAC CARDIOV SUR, V146, P140, DOI 10.1016/j.jtcvs.2012.09.005; Kanda T, 2012, EUR J RADIOL, V81, P2470, DOI 10.1016/j.ejrad.2011.10.009; Kandpal H, 2009, AM J ROENTGENOL, V192, P915, DOI 10.2214/AJR.08.1260; Kiesewetter CH, 2007, HEART, V93, P579, DOI 10.1136/hrt.2006.094516; Koh DM, 2006, EUR RADIOL, V16, P1898, DOI 10.1007/s00330-006-0201-x; KREUTZER G, 1973, J THORAC CARDIOV SUR, V66, P613, DOI 10.1016/s0022-5223(19)40598-9; Kwee TC, 2009, MAGN RESON MATER PHY, V22, P319, DOI 10.1007/s10334-009-0183-1; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEBIHAN D, 1991, JMRI-J MAGN RESON IM, V1, P7, DOI 10.1002/jmri.1880010103; LEMMER JH, 1983, J THORAC CARDIOV SUR, V86, P757; Leporq B, 2012, J MAGN RESON IMAGING, V35, P1380, DOI 10.1002/jmri.23594; Lewin M, 2007, HEPATOLOGY, V46, P658, DOI 10.1002/hep.21747; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; MULLER MF, 1994, RADIOLOGY, V190, P475; Namimoto T, 1997, RADIOLOGY, V204, P739, DOI 10.1148/radiology.204.3.9280252; Nasu Katsuhiro, 2006, Radiat Med, V24, P438, DOI 10.1007/s11604-006-0053-y; Ozkurt H, 2014, IRAN J RADIOL, V11, DOI 10.5812/iranjradiol.3555; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Pundi K, 2015, AM J CARDIOL; Ronot M, 2010, RADIOLOGY, V256, P135, DOI 10.1148/radiol.10091295; Rychik J, 2012, PEDIATR CARDIOL, V33, P1001, DOI 10.1007/s00246-012-0315-7; SAFRAN AP, 1967, AM J PATHOL, V50, P447; Sandrasegaran K, 2009, AM J ROENTGENOL, V193, P1556, DOI 10.2214/AJR.09.2436; SHERLOCK S, 1951, BRIT HEART J, V13, P273; Shinagawa H, 2008, CIRC J, V72, P364, DOI 10.1253/circj.72.364; TURNER R, 1990, RADIOLOGY, V177, P407, DOI 10.1148/radiology.177.2.2217777; Van Beers BE, 2001, AM J ROENTGENOL, V176, P667, DOI 10.2214/ajr.176.3.1760667; Wang X, 2013, EUR J RADIOL, V82, P220, DOI 10.1016/j.ejrad.2012.09.015; Wang Yi, 2011, AJR Am J Roentgenol, V196, P553, DOI 10.2214/AJR.10.4580; Wolff D, 2016, INT J CARDIOL, V202, P595, DOI 10.1016/j.ijcard.2015.09.088; Wolff D, 2014, EUR J CARDIO-THORAC, V45, P602, DOI 10.1093/ejcts/ezt461	47	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173149	10.1371/journal.pone.0173149	http://dx.doi.org/10.1371/journal.pone.0173149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257439	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100067
J	Majeed, M; Bani, S; Natarajan, S; Pandey, A; Naveed, S				Majeed, Muhammed; Bani, Sarang; Natarajan, Sankaran; Pandey, Anjali; Naveed, S.			Evaluation of 90 day repeated dose oral toxicity and reproductive/developmental toxicity of 3 '-hydroxypterostilbene in experimental animals	PLOS ONE			English	Article							APOPTOSIS-INDUCING AGENTS; SPHAEROPHYSA-SALSULA; ANTIOXIDANT; PTEROSTILBENE	3'-Hydroxypterostilbene (3'-HPT) is one of the active constituents of Sphaerophysa salsula and Pterocarpus marsupium. Despite many proposed therapeutic applications, the safety profile of 3'-HPT has not been established. The present work investigated 90 day repeated oral dose and reproductive (developmental) toxicity of 3'-HPT as a test substance in rats as per OECD guidelines. 90 day toxicity was conducted in sixty Sprague Dawley rats of each sex (120 rats), grouped into six dosage groups of 0 (control), 0 (control recovery), 20 (low dose), 80 (mid dose), 200 (high dose) and 200 (high dose recovery) mg/kg bwt/day (body weight/day) respectively. For the reproductive toxicity study forty Wistar rats of each sex (80 rats) divided into four dosage groups received 0 (vehicle control), 20 (low dose), 100 (mid dose) and 200 (high dose) mg/kg bwt/day of 3'-HPT respectively for a period of two weeks while pre-mating, mating, on the day before sacrifice, in females during pregnancy and four days of lactation period. Results showed no significant differences in body weight, food intake, absolute organ weight, haematology, with no adverse effects (toxicity) on biochemical values nor any abnormal clinical signs or behavioural changes were observed in any of the control/treatment groups, including reproductive and developmental parameters, gross and histopathological changes. In conclusion, the results suggested a No-Observed-Adverse-Effect-Level (NOAEL) of 200 mg/kg bwt/day in rats after oral administration, implying 3'-HPT did not exhibit any toxicity under the study conditions employed.	[Majeed, Muhammed] Sami Labs Ltd, Bangalore, Karnataka, India; [Bani, Sarang; Pandey, Anjali] Sami Labs Ltd, Dept Biol Res, Bangalore, Karnataka, India; [Natarajan, Sankaran] Sami Labs Ltd, Ctr Res & Dev, Bangalore, Karnataka, India; [Naveed, S.] ClinWorld Private Ltd, ClinWorld, Bangalore, Karnataka, India		Naveed, S (corresponding author), ClinWorld Private Ltd, ClinWorld, Bangalore, Karnataka, India.	naveed@clinworld.org			Sami Labs Limited; ClinWorld (P) Limited	Sami Labs Limited; ClinWorld (P) Limited	This work was sponsored by Sami Labs Limited. There was no external funding involved. The funder provided support in the form of salaries for authors of both Sami Labs Limited and ClinWorld (P) Limited [MM, SB, AP, SN and NVS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors affiliated to Sami Labs or ClinWorld are articulated in the 'author contributions' section.	GILL MT, 1987, J NAT PROD, V50, P36, DOI 10.1021/np50049a006; Ma ZJ, 2002, FITOTERAPIA, V73, P313, DOI 10.1016/S0367-326X(02)00074-6; Majeed M, 2015, United States patent US, Patent No. [9050284 B2, 9050284]; Majeed M, 2016, United States Patent US, Patent No. [9458075 B1, 9458075]; Monagas M, 2006, J AGR FOOD CHEM, V54, P319, DOI 10.1021/jf051807j; Nagabhushanam K., 2009, PharmaChem, V8, P2; OECD, 1995, OECD GUID TEST CHEM; OECD (Organization for Economic Co-operation and Development), 1998, FISH SHORT TERM TOX; Roberti M, 2003, J MED CHEM, V46, P3546, DOI 10.1021/jm030785u; Roupe KA, 2006, CURR CLIN PHARMACOL, V1, P81, DOI 10.2174/157488406775268246; Shao X, 2010, RAPID COMMUN MASS SP, V24, P1770, DOI 10.1002/rcm.4579; Takemotoa JK, 2015, J PHARM PHARM SCI, V18, P713, DOI 10.18433/J33W4C; Tolomeo M, 2005, INT J BIOCHEM CELL B, V37, P1709, DOI 10.1016/j.biocel.2005.03.004; Venkateswarlu S, 2003, BIOSCI BIOTECH BIOCH, V67, P2463, DOI 10.1271/bbb.67.2463	14	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172770	10.1371/journal.pone.0172770	http://dx.doi.org/10.1371/journal.pone.0172770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257483	Green Submitted, gold, Green Published			2022-12-27	WOS:000396021100026
J	Pettersson, K; Yousaf, K; Ranstam, J; Westgren, M; Ajne, G				Pettersson, Kristina; Yousaf, Khurram; Ranstam, Jonas; Westgren, Magnus; Ajne, Gunilla			Predictive value of traction force measurement in vacuum extraction: Development of a multivariate prognostic model	PLOS ONE			English	Article							NEONATAL SUBGALEAL HEMATOMA; RISK-FACTORS; DELIVERY; FETAL; TERM; COMPLICATIONS; HEMORRHAGE; INJURIES; NEWBORN; INFANTS	Objective To enable early prediction of strong traction force vacuum extraction. Design Observational cohort. Setting Karolinska University Hospital delivery ward, tertiary unit. Population and sample size Term mid and low metal cup vacuum extraction deliveries June 2012 D February 2015, n = 277. Methods Traction forces during vacuum extraction were collected prospectively using an intelligent handle. Levels of traction force were analysed pairwise by subjective category strong versus non-strong extraction, in order to define an objective predictive value for strong extraction. Statistical analysis A logistic regression model based on the shrinkage and selection method lasso was used to identify the predictive capacity of the different traction force variables. Predictors Total (time force integral, Newton minutes) and peak traction (Newton) force in the first to third pull; difference in traction force between the second and first pull, as well as the third and first pull respectively. Accumulated traction force at the second and third pull. Outcome Subjectively categorized extraction as strong versus non-strong. Results The prevalence of strong extraction was 26%. Prediction including the first and second pull: AUC 0,85 (CI 0,80-0,90); specificity 0,76; sensitivity 0,87; PPV 0,56; NPV 0,94. Prediction including the first to third pull: AUC 0,86 (CI 0,80-0,91); specificity 0,87; sensitivity 0,70; PPV 0,65; NPV 0,89. Conclusion Traction force measurement during vacuum extraction can help exclude strong category extraction from the second pull. From the third pull, two-thirds of strong extractions can be predicted.	[Pettersson, Kristina; Westgren, Magnus; Ajne, Gunilla] Karolinska Univ Hosp, Obstet & Gynecol, Stockholm, Sweden; [Pettersson, Kristina; Yousaf, Khurram; Westgren, Magnus; Ajne, Gunilla] Karolinska Inst, Clintec, Stockholm, Sweden; [Yousaf, Khurram] Royal Inst Technol, Sch Technol & Hlth, Stockholm, Sweden; [Ranstam, Jonas] Swedish Patient Insurance, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Royal Institute of Technology	Pettersson, K (corresponding author), Karolinska Univ Hosp, Obstet & Gynecol, Stockholm, Sweden.	kristina.a.pettersson@karolinska.se	Ranstam, Jonas/A-4386-2009	Ranstam, Jonas/0000-0002-8287-7273; Ajne, Gunilla/0000-0003-2276-3212	Swedish Patient Insurance (LOF); VINNOVA Swedish Innovations Agency; Karolinska Institute, Dept. of Obstetrics and Gynecology; Stockholm County Council (Agreement for Research and Education of Doctors) [551176]; Stockholm County Council (Combined Clinical Residency and PhD Training Program)	Swedish Patient Insurance (LOF); VINNOVA Swedish Innovations Agency; Karolinska Institute, Dept. of Obstetrics and Gynecology; Stockholm County Council (Agreement for Research and Education of Doctors); Stockholm County Council (Combined Clinical Residency and PhD Training Program)	This study was supported by grants provided by the Swedish Patient Insurance (LOF), VINNOVA Swedish Innovations Agency, the Karolinska Institute, Dept. of Obstetrics and Gynecology, the Stockholm County Council (Agreement for Research and Education of Doctors, 551176, and KP was supported by the Stockholm County Council (Combined Clinical Residency and PhD Training Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, A CODE OF PRACTICE F; [Anonymous], 1998, GUIDE TO THE MEASURE; [Anonymous], 2009, THE ELEMENTS OF STAT; Bailit JL, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.007; Baskett TF, 2008, J OBSTET GYNAECOL CA, V30, P573, DOI 10.1016/S1701-2163(16)32890-0; Boo NY, 2005, BJOG-INT J OBSTET GY, V112, P1516, DOI 10.1111/j.1471-0528.2005.00732.x; Chadwick LM, 1996, J PAEDIATR CHILD H, V32, P228, DOI 10.1111/j.1440-1754.1996.tb01559.x; Colditz MJ, 2015, J PAEDIATR CHILD H, V51, P140, DOI 10.1111/jpc.12698; Doumouchtsis SK, 2006, CURR OPIN OBSTET GYN, V18, P129, DOI 10.1097/01.gco.0000192983.76976.68; Ekeus C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-36; Eskander R, 2012, J MATERN-FETAL NEO M, V25, P2039, DOI 10.3109/14767058.2012.675374; European Police Office (Europol), 2015, THB FIN BUS MOD ASS; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; ISSEL EP, 1977, ZBL GYNAKOL, V99, P487; Kilani RA, 2006, AM J PERINAT, V23, P41, DOI 10.1055/s-2005-923438; Macfarlane AJ, 2016, BJOG-INT J OBSTET GY, V123, P559, DOI 10.1111/1471-0528.13284; Martin J. A., 2013, NATL VITAL STA REP, V64, P1; MOOLGAOKER AS, 1979, OBSTET GYNECOL, V54, P299; O'Mahony F, 2005, BJOG-INT J OBSTET GY, V112, P619, DOI 10.1111/j.1471-0528.2004.00508.x; Peaceman AM, 2015, OBSTET GYNECOL, V126, pE56, DOI 10.1097/AOG.0000000000001147; Pettersson K, 2015, BJOG-INT J OBSTET GY, V122, P1809, DOI 10.1111/1471-0528.13222; PLAUCHE WC, 1979, OBSTET GYNECOL, V53, P750; Royal College of Obstetricians and Gynaecologists, 2011, GREEN GUID; StataCorp, 2013, STATA STATISTICAL SO; Steyerberg EW, 2016, J CLIN EPIDEMIOL, V69, P245, DOI 10.1016/j.jclinepi.2015.04.005; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Towner D, 1999, NEW ENGL J MED, V341, P1709, DOI 10.1056/NEJM199912023412301; Tutschek B, 2011, BJOG-INT J OBSTET GY, V118, P62, DOI 10.1111/j.1471-0528.2010.02775.x; Vacca A, 2006, AUST NZ J OBSTET GYN, V46, P124, DOI 10.1111/j.1479-828X.2006.00540.x; Walsh CA, 2013, OBSTET GYNECOL, V121, P122, DOI [10.1097/AOG.0b013e3182749ac9, http://10.1097/AOG.0b013e3182749ac9]	30	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0171938	10.1371/journal.pone.0171938	http://dx.doi.org/10.1371/journal.pone.0171938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257459	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100010
J	Hemat, H; Shah, S; Isaakidis, P; Das, M; Kyaw, NTT; Zaheer, S; Qasemy, AQ; Zakir, M; Mahama, G; Van Overloop, C; Dominguez, L				Hemat, Hamayoun; Shah, Safieh; Isaakidis, Petros; Das, Mrinalini; Kyaw, Nang Thu Thu; Zaheer, Sattar; Qasemy, Abdul Qayeum; Zakir, Mutallib; Mahama, Gbane; Van Overloop, Catherine; Dominguez, Lynette			Before the bombing: High burden of traumatic injuries in Kunduz Trauma Center, Kunduz, Afghanistan	PLOS ONE			English	Article								Background Me A decins Sans Frontieres (MSF) has been providing healthcare in Afghanistan since 1981 including specialized health services for trauma patients in Kunduz Trauma Center (KTC) from 2011. On October 3 rd, 2015, a US airstrike hit the KTC, killing 42 people including 14 MSF staff. This study aims to demonstrate the impact on healthcare provision, after hospital destruction, by assessing the extent of care provided for trauma and injuries by the MSF KTC and to report on treatment outcomes from January 2014 to June 2015, three months prior to the bombing. Methods This is a descriptive, retrospective review of hospital records. All patients with traumatic injuries registered in the Emergency Department (ED) or hospitalized in In-Patients Department (IPD) and/ or Intensive Care Unit (ICU) of KTC between January 2014 and June 2015 were included in the study. Results A total of 35647 patients were registered in KTC during the study period. 3199 patients registered in the ED were children aged < 5 years and 310 of them were admitted including 47 to the ICU. 77.5% patients were from Kunduz province and the remaining were from other provinces. The average length of stay was 7.3 days and 3.3 days while the bed occupancy rate was an average 91.1% and 75.8% in IPD and ICU, respectively. Of 4605 IPD patients, 105 (2.3%) developed complications. Among those admitted to the ICU, 12.6% patients died. About one-third surgical interventions were carried out on an urgent basis and the major proportion (45.8%) of surgical procedures was wound surgery followed by orthopedic surgery (27.0%). Conclusions This study highlights the high burden of traumatic injuries in Kunduz province and MSF Trauma Center's contribution to saving lives, preventing disabilities and alleviating suffering among adults and children within the region. The bombing and destruction of KTC has resulted in a specific gap in critical healthcare services for the local communities in the health system of this war-ravaged region. This suggests the urgent need for reconstruction and re-opening of the center.	[Hemat, Hamayoun; Mahama, Gbane] Medecins Sans Frontieres, Operat Ctr Brussels, Kabul, Afghanistan; [Shah, Safieh; Isaakidis, Petros] Medecins Sans Frontieres, Operat Res Unit, Luxembourg, Luxembourg; [Kyaw, Nang Thu Thu] Int Union TB & Lung Dis, Mandalay, Myanmar; [Zaheer, Sattar; Qasemy, Abdul Qayeum; Zakir, Mutallib] Medecins Sans Frontieres, Operat Ctr Brussels, Kunduz, Afghanistan; [Van Overloop, Catherine; Dominguez, Lynette] Medecins Sans Frontieres, Operat Ctr Brussels, Brussels, Belgium	Doctors Without Borders; Doctors Without Borders	Hemat, H (corresponding author), Medecins Sans Frontieres, Operat Ctr Brussels, Kabul, Afghanistan.	msf-afghanistan-medcopdep@msf.org	Shah, Safieh/Z-2078-2018; Shah, Safieh/AAK-3257-2020; Shah, Safieh/ABB-4201-2021	Shah, Safieh/0000-0001-5358-9240; Shah, Safieh/0000-0001-5358-9240; Isaakidis, Petros/0000-0002-7881-1554	Department for International Development (DFID), UK	Department for International Development (DFID), UK	The programme was funded by the Department for International Development (DFID), UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, MISS HAITI TAB 2014, P5; [Anonymous], 2004, WOM CHILDR VULN ESC; [Anonymous], 1864, TREATIES STATES PART; [Anonymous], 2010, VIOLANCE INJURIES FA; Esmatia S, 2014, INDICATORS EVALUATIN, P1; Ghaferi AA, 2010, J AM COLL SURGEONS, V211, P325, DOI 10.1016/j.jamcollsurg.2010.04.025; Lucchi E, 2010, DISASTERS, V34, P973, DOI 10.1111/j.1467-7717.2010.01178.x; Meara JG, 2015, SURGERY, V158, P3, DOI [10.1016/j.surg.2015.04.011, 10.1016/S0140-6736(15)60160-X]; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120	9	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0165270	10.1371/journal.pone.0165270	http://dx.doi.org/10.1371/journal.pone.0165270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282377	Green Published, gold			2022-12-27	WOS:000396091800001
J	Chen, SJ; Huang, L; Qiu, HT; Nebel, MB; Mostofsky, SH; Pekar, JJ; Lindquist, MA; Eloyan, A; Caffo, BS				Chen, Shaojie; Huang, Lei; Qiu, Huitong; Nebel, Mary Beth; Mostofsky, Stewart H.; Pekar, James J.; Lindquist, Martin A.; Eloyan, Ani; Caffo, Brian S.			Parallel group independent component analysis for massive fMRI data sets	PLOS ONE			English	Article							BLIND SEPARATION; ALGORITHM; SUBJECT; PCA; ICA	Independent component analysis (ICA) is widely used in the field of functional neuroimaging to decompose data into spatio-temporal patterns of co-activation. In particular, ICA has found wide usage in the analysis of resting state fMRI (rs-fMRI) data. Recently, a number of large-scale data sets have become publicly available that consist of rs-fMRI scans from thousands of subjects. As a result, efficient ICA algorithms that scale well to the increased number of subjects are required. To address this problem, we propose a two-stage likelihood-based algorithm for performing group ICA, which we denote Parallel Group Independent Component Analysis (PGICA). By utilizing the sequential nature of the algorithm and parallel computing techniques, we are able to efficiently analyze data sets from large numbers of subjects. We illustrate the efficacy of PGICA, which has been implemented in R and is freely available through the Comprehensive R Archive Network, through simulation studies and application to rs-fMRI data from two large multi-subject data sets, consisting of 301 and 779 subjects respectively.	[Chen, Shaojie; Huang, Lei; Qiu, Huitong; Lindquist, Martin A.; Caffo, Brian S.] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Mostofsky, Stewart H.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Nebel, Mary Beth; Mostofsky, Stewart H.; Pekar, James J.] Kennedy Krieger Inst, Baltimore, MD USA; [Pekar, James J.] Johns Hopkins Univ, Dept Radiol & Radiol Sci, Baltimore, MD USA; [Nebel, Mary Beth] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Eloyan, Ani] Brown Univ, Dept Biostat, Providence, RI 02912 USA	Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University; Brown University	Chen, SJ (corresponding author), Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA.	schen89@jhu.edu	Huang, Lei/J-2139-2017; Nebel, Mary Beth/D-3305-2015	Huang, Lei/0000-0001-9571-9082; Nebel, Mary Beth/0000-0003-0185-3382; Pekar, James/0000-0002-9830-0655	NIH from National Institute of Biomedical Imaging And Bioengineering [R01 EB012547, P41 EB015909, RO1 EB012547]; NIH from National Institute of Neurological Disorders and Stroke [R01 NS060910, RO1 NS060910]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016061, R01EB012547, R01EB022911, P41EB015909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060910] Funding Source: NIH RePORTER	NIH from National Institute of Biomedical Imaging And Bioengineering; NIH from National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant R01 EB012547 from the National Institute of Biomedical Imaging And Bioengineering (BC); NIH grant R01 NS060910 from the National Institute of Neurological Disorders and Stroke (BC); and NIH grant P41 EB015909 from the National Institute of Biomedical Imaging And Bioengineering (BC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project was supported by the NIH grant RO1 EB012547 from the National Institute of Biomedical Imaging And Bioengineering.; The project was supported by the NIH grant RO1 NS060910 from the National Institute of Neurological Disorders and Stroke.; This research was supported by the NIH grant P41 EB015909 from the National Institute of Biomedical Imaging And Bioengineering.	Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Amdahl G.M., 1967, P APR 18 20 1967 SPR, P483, DOI [10.1145/1465482.1465560, DOI 10.1145/1465482.1465560]; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bode D, 2012, RSGE INTERFACE SGE Q; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2015, NEUROIMAGE, V118, P662, DOI 10.1016/j.neuroimage.2015.05.047; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Du YH, 2016, HUM BRAIN MAPP, V37, P1005, DOI 10.1002/hbm.23086; Du YH, 2013, NEUROIMAGE, V69, P157, DOI 10.1016/j.neuroimage.2012.11.008; Eloyan A, 2011, J NONPARAMETR STAT, V23, P513, DOI 10.1080/10485252.2010.532554; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; FLYNN MJ, 1972, IEEE T COMPUT, VC 21, P948, DOI 10.1109/TC.1972.5009071; Guo Y, 2008, NEUROIMAGE, V42, P1078, DOI 10.1016/j.neuroimage.2008.05.008; Halko N, 2011, SIAM J SCI COMPUT, V33, P2580, DOI 10.1137/100804139; Harman H. H., 1976, MODERN FACTOR ANAL; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Joel SE, 2011, MAGN RESON MED, V66, P644, DOI 10.1002/mrm.22818; JUTTEN C, 1991, SIGNAL PROCESS, V24, P1, DOI 10.1016/0165-1684(91)90079-X; Koch W, 2010, NEUROIMAGE, V51, P280, DOI 10.1016/j.neuroimage.2009.12.008; Mattson T. G., 2004, PATTERNS PARALLEL PR, V1st; Michael AM, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00106; Nebel MB, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00080; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2014, NEUROIMAGE, V101, P738, DOI 10.1016/j.neuroimage.2014.07.051; Tierney L, 2012, SNOW SIMPLE NETWORK	29	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173496	10.1371/journal.pone.0173496	http://dx.doi.org/10.1371/journal.pone.0173496			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278208	gold, Green Submitted, Green Published			2022-12-27	WOS:000396087900003
J	Duque, A; Vinader-Caerols, C; Monleon, S				Duque, Aranzazu; Vinader-Caerols, Concepcion; Monleon, Santiago			Indomethacin counteracts the effects of chronic social defeat stress on emotional but not recognition memory in mice	PLOS ONE			English	Article							PASSIVE-AVOIDANCE TASK; ADULT MALE RATS; ANIMAL-MODELS; OBJECT RECOGNITION; SPATIAL MEMORY; HIPPOCAMPAL NEUROGENESIS; IMMUNE DYSREGULATION; POSTTRAUMATIC STRESS; ALZHEIMERS-DISEASE; BEHAVIORAL-CHANGES	We have previously observed the impairing effects of chronic social defeat stress (CSDS) on emotional memory in mice. Given the relation between stress and inflammatory pro-cesses, we sought to study the effectiveness of the anti-inflammatory indomethacin in reversing the detrimental effects of CSDS on emotional memory in mice. The effects of CSDS and indomethacin on recognition memory were also evaluated. Male CD1 mice were randomly divided into four groups: non-stressed + saline (NS+ SAL); non-stressed + indo-methacin (NS+ IND); stressed + saline (S+ SAL); and stressed + indomethacin (S+ IND). Stressed animals were exposed to a daily 10 min agonistic confrontation (CSDS) for 20 days. All subjects were treated daily with saline or indomethacin (10 mg/kg, i. p.). 24 h after the CSDS period, all the mice were evaluated in a social interaction test to distinguish between those that were resilient or susceptible to social stress. All subjects (n = 10-12 per group) were then evaluated in inhibitory avoidance (IA), novel object recognition (NOR), ele-vated plus maze and hot plate tests. As in control animals (NS+ SAL group), IA learning was observed in the resilient groups, as well as in the susceptible mice treated with indomethacin (S+ IND group). Recognition memory was observed in the non-stressed and the resilient mice, but not in the susceptible animals. Also, stressed mice exhibited higher anxiety levels. No significant differences were observed in locomotor activity or analgesia. In conclusion, CSDS induces anxiety in post-pubertal mice and impairs emotional and recognition memory in the susceptible subjects. The effects of CSDS on emotional memory, but not on recogni-tion memory and anxiety, are reversed by indomethacin. Moreover, memory impairment is not secondary to the effects of CSDS on locomotor activity, emotionality or pain sensitivity.	[Duque, Aranzazu; Vinader-Caerols, Concepcion; Monleon, Santiago] Univ Valencia, Dept Psychobiol, Valencia, Spain	University of Valencia	Monleon, S (corresponding author), Univ Valencia, Dept Psychobiol, Valencia, Spain.	santiago.monleon@uv.es		Monleon, Santiago/0000-0001-8766-5969	Ministerio de Economia y Competitividad [PSI2013-44491-P]; Generalitat Valenciana, Spain [PROMETEOII/2015/020]	Ministerio de Economia y Competitividad(Spanish Government); Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF))	This work was supported by the "Ministerio de Economia y Competitividad" (Grant PSI2013-44491-P) and "Generalitat Valenciana" (Grant PROMETEOII/2015/020), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047218; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Azzinnari D, 2014, NEUROPHARMACOLOGY, V85, P328, DOI 10.1016/j.neuropharm.2014.05.039; Bahi A, 2013, STRESS, V16, P441, DOI 10.3109/10253890.2012.754419; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Blanchard RJ, 2001, PHYSIOL BEHAV, V73, P261, DOI 10.1016/S0031-9384(01)00449-8; Boehme M, 2014, NEUROSCI LETT, V572, P7, DOI 10.1016/j.neulet.2014.04.043; Borniger JC, 2014, PHYSIOL BEHAV, V133, P99, DOI 10.1016/j.physbeh.2014.05.012; Buller KM, 1998, J NEUROENDOCRINOL, V10, P519; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; Campeau S, 2011, STRESS, V14, P503, DOI 10.3109/10253890.2011.596864; Campos AC, 2013, REV BRAS PSIQUIATR, V35, pS101, DOI 10.1590/1516-4446-2013-1139; Castro P, 2009, BIOCHEM PHARMACOL, V77, P1029, DOI 10.1016/j.bcp.2008.12.012; Charney Dennis S, 2004, Sci STKE, V2004, pre5, DOI 10.1126/stke.2252004re5; Cordero MI, 2003, HORM BEHAV, V44, P338, DOI 10.1016/S0018-506X(03)00160-0; Costa-Nunes J, 2014, STRESS, V17, P108, DOI 10.3109/10253890.2013.872619; Craig K.D., 2006, WALL MELLZACKS TXB P, V5th, P231; de Quervain D, 2017, NAT REV NEUROSCI, V18, P7, DOI 10.1038/nrn.2016.155; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Duque A, 2016, ACTA NEUROBIOL EXP, V76, P225, DOI 10.21307/ane-2017-022; Eagle AL, 2013, BEHAV BRAIN RES, V256, P591, DOI 10.1016/j.bbr.2013.09.014; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Fagundes CP, 2013, BRAIN BEHAV IMMUN, V27, P8, DOI 10.1016/j.bbi.2012.06.014; Fan JH, 2017, BEHAV BRAIN RES, V316, P136, DOI 10.1016/j.bbr.2016.09.011; FILE SE, 1978, BRIT J PHARMACOL, V62, P19, DOI 10.1111/j.1476-5381.1978.tb07001.x; Finsterwald C, 2015, J NEUROSCI, V35, P15903, DOI 10.1523/JNEUROSCI.0771-15.2015; Fuertig R, 2016, BRAIN BEHAV IMMUN, V54, P59, DOI 10.1016/j.bbi.2015.12.020; Furtado M, 2015, PSYCHIAT RES, V229, P37, DOI 10.1016/j.psychres.2015.05.036; GOLD PE, 1986, BEHAV NEURAL BIOL, V46, P87, DOI 10.1016/S0163-1047(86)90927-1; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; HEISE GA, 1981, TRENDS PHARMACOL SCI, V2, P158, DOI 10.1016/0165-6147(81)90297-2; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Holder MK, 2014, FRONT NEUROENDOCRIN, V35, P89, DOI 10.1016/j.yfrne.2013.10.004; HOLSCHER C, 1995, EUR J NEUROSCI, V7, P1360, DOI 10.1111/j.1460-9568.1995.tb01127.x; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Huang GB, 2016, PROG NEURO-PSYCHOPH, V66, P73, DOI 10.1016/j.pnpbp.2015.12.002; IBM Corp, 2010, IBM SPSS STAT WIND V; Imbe H, 2006, FRONT BIOSCI-LANDMRK, V11, P2179, DOI 10.2741/1960; Iniguez SD, 2014, STRESS, V17, P247, DOI 10.3109/10253890.2014.910650; Ishida T, 2007, J PSYCHOPHARMACOL, V21, P757, DOI 10.1177/0269881107076369; Izquierdo I, 1997, PSYCHOBIOLOGY, V25, P1; Jaremka LM, 2013, PSYCHONEUROENDOCRINO, V38, P1310, DOI 10.1016/j.psyneuen.2012.11.016; Jung SH, 2015, BRAIN BEHAV IMMUN, V44, P195, DOI 10.1016/j.bbi.2014.09.015; Kanno T, 2012, J CELL PHYSIOL, V227, P919, DOI 10.1002/jcp.22800; Kenney JW, 2011, PSYCHOPHARMACOLOGY, V217, P353, DOI 10.1007/s00213-011-2283-7; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Krishnan V, 2014, EXP NEUROL, V261, P412, DOI 10.1016/j.expneurol.2014.05.012; KUDRYAVTSEVA NN, 1991, PHARMACOL BIOCHEM BE, V38, P315, DOI 10.1016/0091-3057(91)90284-9; Kumar S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5537; Larauche M, 2012, EXP NEUROL, V233, P49, DOI 10.1016/j.expneurol.2011.04.020; Lawlor PA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-11; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lee S, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00129; Lehmann ML, 2013, J NEUROSCI, V33, P2961, DOI 10.1523/JNEUROSCI.3878-12.2013; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Lukas M, 2011, NEUROPSYCHOPHARMACOL, V36, P2159, DOI 10.1038/npp.2011.95; Lupien SJ, 1999, REV NEUROSCIENCE, V10, P117; Martinez M, 1998, AGGRESSIVE BEHAV, V24, P241; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Meduri JD, 2013, BEHAV BRAIN RES, V256, P580, DOI 10.1016/j.bbr.2013.09.009; Mesa-Gresa P, 2016, PHYSIOL BEHAV, V158, P6, DOI 10.1016/j.physbeh.2016.02.027; Mesa-Gresa P, 2013, AGGRESSIVE BEHAV, V39, P269, DOI 10.1002/ab.21481; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monleon S, 2016, BEHAV PROCESS, V124, P23, DOI 10.1016/j.beproc.2015.12.002; Monleon S, 2015, BEHAV PROCESS, V115, P64, DOI 10.1016/j.beproc.2015.03.003; Morrissey MD, 2011, NEUROBIOL LEARN MEM, V95, P46, DOI 10.1016/j.nlm.2010.10.007; Narenji Somayeh Assadian, 2012, Iranian Biomedical Journal, V16, P145, DOI 10.6091/IBJ.1046.2012; Negron-Oyarzo I, 2014, BEHAV BRAIN RES, V259, P342, DOI 10.1016/j.bbr.2013.11.001; Ohl F, 1999, COGNITIVE BRAIN RES, V7, P379, DOI 10.1016/S0926-6410(98)00042-1; Ohl F, 1998, NEUROSCI BIOBEHAV R, V23, P319, DOI 10.1016/S0149-7634(98)00033-5; Okada R, 2015, NEUROSCIENCE, V299, P134, DOI 10.1016/j.neuroscience.2015.04.064; Panksepp J, 2004, BRAIN RES, V1025, P75, DOI 10.1016/j.brainres.2004.07.076; Patki G, 2013, BRAIN RES, V1539, P73, DOI 10.1016/j.brainres.2013.09.033; Perez-Tejada J, 2013, NEUROENDOCRINOLOGY, V98, P73, DOI 10.1159/000353620; Pfau ML, 2016, TRENDS NEUROSCI, V39, P353, DOI 10.1016/j.tins.2016.04.004; Powell ND, 2013, P NATL ACAD SCI USA, V110, P16574, DOI 10.1073/pnas.1310655110; Quan N, 2001, J NEUROIMMUNOL, V115, P36, DOI 10.1016/S0165-5728(01)00273-9; Razzoli M, 2011, PHARMACOL BIOCHEM BE, V97, P566, DOI 10.1016/j.pbb.2010.09.010; Reger ML, 2009, DEV PSYCHOBIOL, V51, P672, DOI 10.1002/dev.20402; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Rothwell NJ, 1999, J PHYSIOL-LONDON, V514, P3, DOI 10.1111/j.1469-7793.1999.003af.x; Sato T, 2007, EUR J PHARMACOL, V560, P36, DOI 10.1016/j.ejphar.2007.01.011; Schroeder A, 2015, BEHAV BRAIN RES, V287, P304, DOI 10.1016/j.bbr.2015.03.063; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Silvers JM, 2007, J NEUROSCI METH, V166, P99, DOI 10.1016/j.jneumeth.2007.06.032; Smith FG, 2011, CLIN EXP PHARMACOL P, V38, P494, DOI 10.1111/j.1440-1681.2011.05536.x; Snedecor GW, 1980, STAT METHODS, V7th; Sorrells SF, 2014, NEUROENDOCRINOLOGY, V100, P129, DOI 10.1159/000367849; Stackman RW, 2003, EXP NEUROL, V184, P510, DOI 10.1016/S0014-4886(03)00399-6; Stankiewicz AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142195; Stephan A, 2003, EUR J NEUROSCI, V17, P1921, DOI 10.1046/j.1460-9568.2003.02610.x; Suleyman H, 2007, PHARMACOL REP, V59, P247; Teather LA, 2002, LEARN MEMORY, V9, P41, DOI 10.1101/lm.43602; Toth I, 2013, CELL TISSUE RES, V354, P107, DOI 10.1007/s00441-013-1636-4; Touyarot K, 2004, PSYCHONEUROENDOCRINO, V29, P290, DOI 10.1016/S0306-4530(03)00031-3; Uchoa ET, 2014, J NEUROENDOCRINOL, V26, P557, DOI 10.1111/jne.12157; Van Kampen M, 2000, PHARMACOL BIOCHEM BE, V65, P539, DOI 10.1016/S0091-3057(99)00190-2; Vinader-Caerols C, 2006, ACTA NEUROBIOL EXP, V66, P23; Vinader-Caerols C, 2012, EFFECTS ANTIDEPRESSA, P23; Wang J.A., 2013, METAL MINE, V10, P8, DOI DOI 10.1371/J0URNAL.P0NE.0064929; Wang XD, 2011, NEUROBIOL DIS, V42, P300, DOI 10.1016/j.nbd.2011.01.020; Watt MJ, 2009, BEHAV NEUROSCI, V123, P564, DOI 10.1037/a0015752; Wolf OT, 2008, ACTA PSYCHOL, V127, P513, DOI 10.1016/j.actpsy.2007.08.002; Yang L, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-015-0181-3; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	107	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173182	10.1371/journal.pone.0173182	http://dx.doi.org/10.1371/journal.pone.0173182			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278165	gold, Green Published, Green Submitted			2022-12-27	WOS:000396087900052
J	Jimenez-Sanchez, C; Olivares-Vicente, M; Rodriguez-Perez, C; Herranz-Lopez, M; Lozano-Sanchez, J; Segura-Carretero, A; Fernandez-Gutierrez, A; Encinar, JA; Micol, V				Jimenez-Sanchez, Cecilia; Olivares-Vicente, Marilo; Rodriguez-Perez, Celia; Herranz-Lopez, Maria; Lozano-Sanchez, Jesus; Segura-Carretero, Antonio; Fernandez-Gutierrez, Alberto; Antonio Encinar, Jose; Micol, Vicente			AMPK modulatory activity of olive-tree leaves phenolic compounds: Bioassay-guided isolation on adipocyte model and in silico approach	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PLANT-DERIVED POLYPHENOLS; SIGNALING PATHWAY; ALTERNATE BEARING; PEEL EXTRACT; ADIPOGENESIS; QUERCETIN; OIL; DIFFERENTIATION; IDENTIFICATION	Scope Olive-tree polyphenols have demonstrated potential for the management of obesity-related pathologies. We aimed to explore the capacity of Olive-tree leaves extract to modulate triglyceride accumulation and AMP-activated protein kinase activity (AMPK) on a hypertrophic adipocyte model. Methods Intracellular triglycerides and AMPK activity were measured on the hypertrophic 3T3-L1 adipocyte model by AdipoRed and immunofluorescence microscopy, respectively. Reverse phase high performance liquid chromatography coupled to time-of-flight mass detection with electrospray ionization (RP-HPLC-ESI-TOF/MS) was used for the fractionation of the extract and the identification of the compounds. In-silico molecular docking of the AMPK alpha-2, beta and gamma subunits with the identified compounds was performed. Results Olive-tree leaves extract decreased the intracellular lipid accumulation through AMPK-dependent mechanisms in hypertrophic adipocytes. Secoiridoids, cinnamic acids, phenylethanoids and phenylpropanoids, flavonoids and lignans were the candidates predicted to account for this effect. Molecular docking revealed that some compounds may be AMPK-gamma modulators. The modulatory effects of compounds over the alpha and beta AMPK subunits appear to be less probable. Conclusions Olive-tree leaves polyphenols modulate AMPK activity, which may become a therapeutic aid in the management of obesity-associated disturbances. The natural occurrence of these compounds may have important nutritional implications for the design of functional ingredients.	[Jimenez-Sanchez, Cecilia; Rodriguez-Perez, Celia; Lozano-Sanchez, Jesus; Segura-Carretero, Antonio; Fernandez-Gutierrez, Alberto] Univ Granada, Dept Analyt Chem, Granada, Spain; [Jimenez-Sanchez, Cecilia; Rodriguez-Perez, Celia; Lozano-Sanchez, Jesus; Segura-Carretero, Antonio; Fernandez-Gutierrez, Alberto] PTS, Res & Dev Funct Food Ctr CIDAF, Granada, Spain; [Olivares-Vicente, Marilo; Herranz-Lopez, Maria; Antonio Encinar, Jose; Micol, Vicente] UMH, IBMC, Alicante, Spain; [Micol, Vicente] Inst Salud Carlos III, CIBER CB12 03 30038, Fisiopatol Obesidad & Nutr, CIBERobn, Palma De Mallorca, Spain	University of Granada; Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Micol, V (corresponding author), UMH, IBMC, Alicante, Spain.; Micol, V (corresponding author), Inst Salud Carlos III, CIBER CB12 03 30038, Fisiopatol Obesidad & Nutr, CIBERobn, Palma De Mallorca, Spain.	vmicol@umh.es	Encinar, José A/F-2946-2013; Herranz-Lopez, Maria/AAB-1933-2020; Rodríguez-Pérez, Celia/R-7378-2019; Carretero, Antonio Segura/B-6867-2014; Encinar, José Antonio/AAE-9141-2020; Fernandez-Gutierrez, Alberto/M-8512-2014; Micol, Vicente/K-6841-2014	Encinar, José A/0000-0002-7219-3863; Herranz-Lopez, Maria/0000-0002-1819-7978; Rodríguez-Pérez, Celia/0000-0002-7233-6481; Carretero, Antonio Segura/0000-0002-5564-5338; Encinar, José Antonio/0000-0002-7219-3863; Fernandez-Gutierrez, Alberto/0000-0003-3647-2598; Micol, Vicente/0000-0001-8089-0696	Spanish Ministry of Science and Innovation [BFU2014-52433-C3-2-R, AGL2011-29857-C03-02]; Spanish Ministry of Economy and Competitiveness (MINECO) [AGL2015-67995-C3-1-R, AGL2015-67995-C3-2-R, PTQ-13-06429, PTQ-14-07243, FPU AP2010-2793]; Andalusian Regional Government Council of Innovation and Science [P09-CTS-4564, P10-FQM-6563, P11-CTS-7625]; Generalitat Valenciana [PROMETEO/2016/006, ACIF/2016/230]; GIBER (Fisiopatologia de la Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III) [CB12/03/30038]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Andalusian Regional Government Council of Innovation and Science; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); GIBER (Fisiopatologia de la Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III)	This work was supported by the projects BFU2014-52433-C3-2-R, AGL2011-29857-C03-02 (Spanish Ministry of Science and Innovation); projects AGL2015-67995-C3-1-R, AGL2015-67995-C3-2-R, Torres Quevedo grants PTQ-13-06429 and PTQ-14-07243 and scholarship FPU AP2010-2793 from the Spanish Ministry of Economy and Competitiveness (MINECO); P09-CTS-4564, P10-FQM-6563 and P11-CTS-7625 grants from Andalusian Regional Government Council of Innovation and Science; PROMETEO/2016/006, and ACIF/2016/230 from Generalitat Valenciana; GIBER (CB12/03/30038, Fisiopatologia de la Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III).	[Anonymous], COLD SPRING HARB PRO; Encinar JA, 2015, DRUG DES DEV THER, V9, P5877, DOI 10.2147/DDDT.S93449; Barbier O, 2003, J BIOL CHEM, V278, P13975, DOI 10.1074/jbc.M300749200; Barrajon-Catalan E, 2014, ADV EXP MED BIOL, V824, P141, DOI 10.1007/978-3-319-07320-0_11; Bijland S, 2013, CLIN SCI, V124, P491, DOI 10.1042/CS20120536; BORJA R, 1992, PROCESS BIOCHEM, V27, P231, DOI 10.1016/0032-9592(92)80023-V; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Casado-Diaz A, 2016, J NUTR BIOCHEM, V32, P151, DOI 10.1016/j.jnutbio.2016.03.005; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Corominas-Faja B, 2014, AGING-US, V6, P731, DOI 10.18632/aging.100691; Dundar E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-219; Fu SP, 2010, ANAL BIOANAL CHEM, V397, P643, DOI 10.1007/s00216-010-3604-0; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Goodger JQD, 2009, PHYTOCHEMISTRY, V70, P1187, DOI 10.1016/j.phytochem.2009.06.004; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Guinda A, 2015, LWT-FOOD SCI TECHNOL, V64, P431, DOI 10.1016/j.lwt.2015.05.001; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Herranz-Lopez M, 2015, PHYTOMEDICINE, V22, P605, DOI 10.1016/j.phymed.2015.03.015; Herranz-Lopez M, 2012, PHYTOMEDICINE, V19, P253, DOI 10.1016/j.phymed.2011.12.001; Hosny M, 2009, PHARMACOGN RES, V1, P91; Joven J, 2012, BBA-GEN SUBJECTS, V1820, P894, DOI 10.1016/j.bbagen.2012.03.020; Kalupahana NS, 2012, MOL ASPECTS MED, V33, P26, DOI 10.1016/j.mam.2011.10.011; Kang SI, 2012, BIOL PHARM BULL, V35, P223, DOI 10.1248/bpb.35.223; Kim J, 2010, PHYTOTHER RES, V24, P1543, DOI 10.1002/ptr.3186; Klen TJ, 2015, J AGR FOOD CHEM, V63, P3859, DOI 10.1021/jf506345q; Ko HJ, 2015, J FUNCT FOODS, V17, P271, DOI 10.1016/j.jff.2015.05.033; Kwon B, 2015, BIOCHIMIE, V118, P141, DOI 10.1016/j.biochi.2015.09.006; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Lozano-Sanchez J, 2010, J AGR FOOD CHEM, V58, P9942, DOI 10.1021/jf101502q; Ma SZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07633; Gonzalez-Barroso MM, 2012, BBA-BIOENERGETICS, V1817, P1768, DOI 10.1016/j.bbabio.2012.02.019; MEAKINS GD, 1959, J CHEM SOC, P1044, DOI 10.1039/jr9590001044; Melguizo-Melguizo D, 2014, J FUNCT FOODS, V10, P192, DOI 10.1016/j.jff.2014.05.019; Menendez JA, 2013, CELL CYCLE, V12, P555, DOI 10.4161/cc.23756; Michel T, 2015, PHYTOCHEM LETT, V11, P424, DOI 10.1016/j.phytol.2014.12.020; Moon J, 2013, FOOD CHEM TOXICOL, V58, P347, DOI 10.1016/j.fct.2013.05.006; Novikova DS, 2015, BIOCHEMISTRY-MOSCOW+, V80, P127, DOI 10.1134/S0006297915020017; Ono M, 2011, J AGR FOOD CHEM, V59, P13346, DOI 10.1021/jf203490a; Peralbo-Molina A, 2012, J AGR FOOD CHEM, V60, P11542, DOI 10.1021/jf302896m; Perez-Bonilla M, 2011, FOOD CHEM, V124, P36, DOI 10.1016/j.foodchem.2010.05.099; Quirantes-Pine R, 2013, PHYTOCHEM ANALYSIS, V24, P213, DOI 10.1002/pca.2401; Rigacci S, 2015, ONCOTARGET, V6, P35344, DOI 10.18632/oncotarget.6119; Russo GL, 2013, BIOCHEM PHARMACOL, V86, P339, DOI 10.1016/j.bcp.2013.05.023; Saimaru H, 2010, J NAT MED-TOKYO, V64, P139, DOI 10.1007/s11418-009-0383-z; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Seo MJ, 2015, J NUTR BIOCHEM, V26, P1308, DOI 10.1016/j.jnutbio.2015.06.005; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; She GM, 2008, J FOOD SCI, V73, pC476, DOI 10.1111/j.1750-3841.2008.00830.x; Siriwardhana N, 2013, J NUTR BIOCHEM, V24, P613, DOI 10.1016/j.jnutbio.2012.12.013; Strobel P, 2005, BIOCHEM J, V386, P471, DOI 10.1042/BJ20040703; Sung J, 2016, J FUNCT FOODS, V20, P148, DOI 10.1016/j.jff.2015.10.024; Taamalli A, 2012, J AGR FOOD CHEM, V60, P791, DOI 10.1021/jf204233u; Taha MO, 2015, MED CHEM RES, V24, P616, DOI 10.1007/s00044-014-1168-9; Talhaoui N, 2015, J AGR FOOD CHEM, V63, P1722, DOI 10.1021/jf5058205; Talhaoui N, 2014, LWT-FOOD SCI TECHNOL, V58, P28, DOI 10.1016/j.lwt.2014.03.014; Toth G, 2015, IND CROP PROD, V67, P432, DOI 10.1016/j.indcrop.2015.01.077; Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xiao N, 2014, PLANTA MED, V80, P993, DOI 10.1055/s-0034-1382864; Yanik H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-10; Yuan HD, 2011, INT J MOL MED, V27, P531, DOI 10.3892/ijmm.2011.620	64	21	21	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173074	10.1371/journal.pone.0173074	http://dx.doi.org/10.1371/journal.pone.0173074			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278224	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900043
J	Zhang, B; Huang, GY; Wang, YQ; He, HT; Ren, JD				Zhang, Bing; Huang, Guoyan; Wang, Yuqian; He, Haitao; Ren, Jiadong			Mining dynamic noteworthy functions in software execution sequences	PLOS ONE			English	Article							COMPLEX NETWORK; RANKING; NODES	As the quality of crucial entities can directly affect that of software, their identification and protection become an important premise for effective software development, management, maintenance and testing, which thus contribute to improving the software quality and its attack-defending ability. Most analysis and evaluation on important entities like codes-based static structure analysis are on the destruction of the actual software running. In this paper, from the perspective of software execution process, we proposed an approach to mine dynamic noteworthy functions (DNFM) in software execution sequences. First, accord-ing to software decompiling and tracking stack changes, the execution traces composed of a series of function addresses were acquired. Then these traces were modeled as execution sequences and then simplified so as to get simplified sequences (SFS), followed by the extraction of patterns through pattern extraction (PE) algorithm from SFS. After that, evalu-ating indicators inner-importance and inter-importance were designed to measure the note-worthiness of functions in DNFM algorithm. Finally, these functions were sorted by their noteworthiness. Comparison and contrast were conducted on the experiment results from two traditional complex network-based node mining methods, namely PageRank and DegreeRank. The results show that the DNFM method can mine noteworthy functions in software effectively and precisely.	[Zhang, Bing; Huang, Guoyan; Wang, Yuqian; He, Haitao; Ren, Jiadong] Yanshan Univ, Coll Informat Sci & Engn, Qinhuangdao, Hebei, Peoples R China; [Zhang, Bing; Huang, Guoyan; Wang, Yuqian; He, Haitao; Ren, Jiadong] Key Lab Comp Virtual Technol & Syst Integrat Hebe, Qinhuangdao, Hebei, Peoples R China	Yanshan University	Huang, GY (corresponding author), Yanshan Univ, Coll Informat Sci & Engn, Qinhuangdao, Hebei, Peoples R China.; Huang, GY (corresponding author), Key Lab Comp Virtual Technol & Syst Integrat Hebe, Qinhuangdao, Hebei, Peoples R China.	hgy@ysu.edu.cn		Zhang, Bing/0000-0002-9867-8439	National Natural Science Foundation of China [61472341, 61572420]; Natural Science Foundation of Hebei Province [F2014203152, F2016203330]; Graduate innovative Foundation of Hebei Province [2016SJBS010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Graduate innovative Foundation of Hebei Province	This work was supported by National Natural Science Foundation of China Award Number: 61472341, Recipient: Guoyan Huang; National Natural Science Foundation of China Award Number: 61572420, Recipient: Jiadong Ren; Natural Science Foundation of Hebei Province Award Number: F2014203152, Recipient: Jiadong Ren; Natural Science Foundation of Hebei Province Award Number: F2016203330, Recipient: Haitao He; and Graduate innovative Foundation of Hebei Province Award Number: 2016SJBS010, Recipient: Bing Zhang.; This work is supported by the National Natural Science Foundation of China under Grant No. 61472341, No. 61572420, the Natural Science Foundation of Hebei Province P. R. China under Grant No. F2014203152, No. F2016203330 and the Graduate innovative Foundation of Hebei Province under Grant No. 2016SJBS010. The authors are grateful to the valuable comments and suggestions of the reviewers.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alsayed A, 2015, CHAOS SOLITON FRACT, V72, P35, DOI 10.1016/j.chaos.2014.12.009; Bae J, 2014, PHYSICA A, V395, P549, DOI 10.1016/j.physa.2013.10.047; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Basaras P, 2013, COMPUTER, V46, P24, DOI 10.1109/MC.2013.75; Bhattacharya P, 2012, PROC INT CONF SOFTW, P419, DOI 10.1109/ICSE.2012.6227173; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Cai KY, 2009, INFORM SCIENCES, V179, P1903, DOI 10.1016/j.ins.2009.01.011; Chen DB, 2012, PHYSICA A, V391, P1777, DOI 10.1016/j.physa.2011.09.017; Du YX, 2015, CHAOS, V25, DOI 10.1063/1.4916215; Gao S, 2014, PHYSICA A, V403, P130, DOI 10.1016/j.physa.2014.02.032; Gao ZK, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500058; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Hou G, 2012, WOR CONG SOFTW ENG, P9, DOI 10.1109/WCSE.2012.10; Huang GY, 2015, J COMPUTATIONAL INFO, V11, P1109; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Lan W, 2010, RES SOFTWARE CASCADI, P310, DOI [10.1109/MINES.2010.214, DOI 10.1109/MINES.2010.214]; Liu JG, 2013, PHYSICA A, V392, P4154, DOI 10.1016/j.physa.2013.04.037; Liu Y, 2016, CHAOS SOLITON FRACT, V86, P1, DOI 10.1016/j.chaos.2016.01.030; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ren JD, 2015, J COMPUTATIONAL INFO, V11, P3059; Ren JD, 2016, INT J INNOV COMPUT I, V12, P581; Wang B, 2014, ACTA METALL SIN, V50, P685, DOI 10.3724/SP.J.1037.2013.00733; Wang L, 2016, ONCOTARGET, V7, P7, DOI DOI 10.3389/FMICB.2016.00593; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xizhe Zhang, 2012, Information Computing and Applications. Proceedings of the Third International Conference, ICICA 2012, P59, DOI 10.1007/978-3-642-34062-8_8; Zhang XZ, 2011, COMPUTER SCI, V38, P242	32	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173244	10.1371/journal.pone.0173244	http://dx.doi.org/10.1371/journal.pone.0173244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278276	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900059
J	Gunnell, GF; Smith, R; Smith, T				Gunnell, Gregg F.; Smith, Richard; Smith, Thierry			33 million year old Myotis (Chiroptera, Vespertilionidae) and the rapid global radiation of modern bats	PLOS ONE			English	Article							MOLECULAR SYSTEMATICS; LOWERMOST OLIGOCENE; LATE PLIOCENE; EARLY EOCENE; MAMMALIA; EVOLUTION; PHYLOGENY; ECHOLOCATION; BIOGEOGRAPHY; ORIGIN	The bat genus Myotis is represented by 120+ living species and 40+ extinct species and is found on every continent except Antarctica. The time of divergence of Myotis has been contentious as has the time and place of origin of its encompassing group the Vespertilionidae, the most diverse (450+ species) and widely distributed extant bat family. Fossil Myotis species are common, especially in Europe, beginning in the Miocene but earlier records are poor. Recent study of new specimens from the Belgian early Oligocene locality of Boutersem reveals the presence of a relatively large vespertilionid. Morphological comparison and phylogenetic analysis confirms that the new, large form can be confidently assigned to the genus Myotis, making this record the earliest known for that taxon and extending the temporal range of this extant genus to over 33 million years. This suggests that previously published molecular divergence dates for crown myotines (Myotis) are too young by at least 7 million years. Additionally, examination of first fossil appearance data of 1,011 extant placental mammal genera indicates that only 13 first occurred in the middle to late Paleogene (48 to 33 million years ago) and of these, six represent bats, including Myotis. Paleogene members of both major suborders of Chiroptera (Yangochiroptera and Yinpterochiroptera) include extant genera indicating early establishment of successful and long-term adaptive strategies as bats underwent an explosive radiation near the beginning of the Early Eocene Climatic Optimum in the Old World. A second bat adaptive radiation in the New World began coincident with the Mid-Miocene Climatic Optimum.	[Gunnell, Gregg F.] Duke Univ, Lemur Ctr, Div Fossil Primates, Durham, NC 27708 USA; [Smith, Richard; Smith, Thierry] Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, Brussels, Belgium	Duke University; Royal Belgian Institute of Natural Sciences	Gunnell, GF (corresponding author), Duke Univ, Lemur Ctr, Div Fossil Primates, Durham, NC 27708 USA.	gregg.gunnell@duke.edu		Gunnell, Gregg F/0000-0003-3504-409X; Smith, Thierry/0000-0002-1795-2564	Federal Science Policy Office of Belgium [BR/121/A3/PALEURAFRICA]	Federal Science Policy Office of Belgium	Field and laboratory research was supported by the Federal Science Policy Office of Belgium under project BR/121/A3/PALEURAFRICA to TS and GFG.r We thank Annelise Folie, Wim Wouters, and Wim Van Neer (Royal Belgian Institute of Natural Sciences, Brussels), for giving access to comparative material, providing casts, and pictures or discussions about fossil bats. We thank Philip Myers and Priscilla Tucker (University of Michigan Museum of Zoology, Ann Arbor), Nancy B. Simmons and Eileen Westwig (American Museum of Natural History, New York) and Gerhard Storch, Irina Ruf and Katrin Krohmann (Senckenberg Forschungsinstitut, Frankfurt am Main) for access to extant bat specimens. SEM pictures were made at RBINS by Julien Cillis and Eric De Bast. Floreal Sole was instrumental in performing the phylogenetic analyses. We also thank two anonymous reviewers who improved the content of this paper. This research was funded by project BR/121/A3/PALEURAFRICA of the Federal Science Policy Office of Belgium. This is Duke Lemur Center Publication 1341.	Aguilar J-P., 1997, MEMOIRES TRAVAUX ECO, V21, P769; Amador L. I., 2016, J MAMMAL EVOL; Butler P.M., 1978, P56; Cirranello A, 2016, ACTA CHIROPTEROL, V18, P39, DOI 10.3161/15081109ACC2016.18.1.002; CZAPLEWSKI N J, 1987, Contributions to Geology University of Wyoming, V25, P133; Czaplewski NJ, 2012, CAM STUD MORPHOL MOL, P162; Czaplewski Nicholas J., 2010, P240; CZAPLEWSKI NJ, 1993, SOUTHWEST NAT, V38, P111, DOI 10.2307/3672062; CZAPLEWSKI NJ, 1991, J MAMMAL, V72, P715, DOI 10.2307/1381832; de Bonis L., 1973, Bulletin Mus natn Hist nat Paris (Sci Terre), VNo. 28, P105; Dumont ER, 2012, P ROY SOC B-BIOL SCI, V279, P1797, DOI 10.1098/rspb.2011.2005; Eick GN, 2005, MOL BIOL EVOL, V22, P1869, DOI 10.1093/molbev/msi180; FINDLEY JS, 1972, SYST ZOOL, V21, P31, DOI 10.2307/2412256; Ghazali M, 2017, J MAMM EVOL, V24, P475, DOI 10.1007/s10914-016-9351-z; GINGERICH PD, 2001, U MICHIGAN PAPERS PA, V33, P1; Gingerich PD, 2006, TRENDS ECOL EVOL, V21, P246, DOI 10.1016/j.tree.2006.03.006; Glibert M., 1952, B I ROYAL SCI NATURE, V28, P1; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Guilday J. E., 1969, Palaeovertebrata, V2, P25; Gunnell GF, 2002, PALAEONTOL ELECT, V5; Gunnell GF, 2008, J VERTEBR PALEONTOL, V28, P1, DOI 10.1671/0272-4634(2008)28[1:NBMCFT]2.0.CO;2; Gunnell GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086712; Gunnell GF, 2012, CAM STUD MORPHOL MOL, P252; Gunnell Gregg F., 2010, P581; Gunnell GF, 2011, NEUES JAHRB GEOL P-A, V260, P55, DOI 10.1127/0077-7749/2011/0128; Habersetzer J., 1987, Courier Forschungsinstitut Senckenberg, V91, P117; HAND S, 1994, J VERTEBR PALEONTOL, V14, P375, DOI 10.1080/02724634.1994.10011565; Hand SJ, 2016, PALAEOVERTEBRATA; Hoofer SR, 2003, ACTA CHIROPTEROL, V5, P1, DOI 10.3161/001.005.s101; HORACEK I, 1976, Lynx (Prague), V18, P35; Horacek I, 2001, B AKIYOSHI DAI MUS N, V32, P123; Horacek Ivan, 2001, Lynx (Prague), V32, P123; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Koopman Karl P., 1993, P137; KOWALSKI KAZIMIERZ, 1962, ACTA ZOOL CRACOVIENSIA, V7, P39; KOWALSKI KAZIMIREZ, 1956, ACTA PALEONTOL POLONICA, V1, P331; Lack JB, 2010, J MAMMAL, V91, P976, DOI 10.1644/09-MAMM-A-192.1; LEGENDRE S, 1984, CR ACAD SCI II, V298, P715; Legendre S., 1988, Journal of Vertebrate Paleontology, V8, P278; Maitre Elodie, 2014, Swiss Journal of Palaeontology, V133, P141, DOI 10.1007/s13358-014-0069-3; MARTIN RA, 1972, AM MIDL NAT, V87, P326, DOI 10.2307/2423565; McKenna MC, 1997, CLASSIFICATION MAMMA; Miller-Butterworth CM, 2007, MOL BIOL EVOL, V24, P1553, DOI 10.1093/molbev/msm076; Morgan GS, 2012, CAM STUD MORPHOL MOL, P105; MORGAN GS, 1985, BRIMLEYANA, P97; Morgan GS, 2002, SM C PALEOB, P15; MORGAN GS, 1991, B AM MUS NAT HIST, P176; Nowak RM, 1994, WALKERS BATS WORLD; OLeary M. A., 2012, MORPHOBANK 3 0 WEB A; Qiu Zhuding, 2000, Senckenbergiana Lethaea, V80, P173; QUINET GE, 1965, B I ROYAL SCI NATURE, V41, P1; Ravel A, 2016, GEODIVERSITAS, V38, P355, DOI 10.5252/g2016n3a3; Ravel A, 2011, NATURWISSENSCHAFTEN, V98, P397, DOI 10.1007/s00114-011-0785-0; Revilliod P., 1922, Abh Schweiz Pal Ges Geneve, V45, P133; Rojas D, 2016, SYST BIOL, V65, P432, DOI 10.1093/sysbio/syw011; Ruedi M, 2001, MOL PHYLOGENET EVOL, V21, P436, DOI 10.1006/mpev.2001.1017; Ruedi M, 2013, MOL PHYLOGENET EVOL, V69, P437, DOI 10.1016/j.ympev.2013.08.011; Samonds KE, 2007, ACTA CHIROPTEROL, V9, P39, DOI 10.3161/1733-5329(2007)9[39:LPBFFA]2.0.CO;2; SEVILLA P, 1990, GEOBIOS-LYON, V23, P173, DOI 10.1016/S0016-6995(06)80050-1; SIGE B, 1988, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V205, P69; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; Simmons Nancy B., 1998, Bulletin of the American Museum of Natural History, V235, P1; Simmons NB, 2005, SCIENCE, V307, P527, DOI 10.1126/science.1108871; Smith R., 2006, Strata Series 1 Communications, V13, P229; Smith R, 2004, NETH J GEOSCI, V83, P187, DOI 10.1017/S0016774600020254; Smith R, 2003, COLOQUIOS PALEONTOLO, V1, P647; Smith R, 2007, BULL INST R SC N B-S, V77, P159; Smith R, 2006, ACTA PALAEONTOL POL, V51, P381; Smith Richard, 2012, Spanish Journal of Palaeontology, V27, P105; Smith T, 2007, NATURWISSENSCHAFTEN, V94, P1003, DOI 10.1007/s00114-007-0280-9; Smith T, 2012, CAM STUD MORPHOL MOL, P23; Spaulding M, 2012, J SYST PALAEONTOL, V10, P653, DOI 10.1080/14772019.2011.630681; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Stadelmann B, 2004, ACTA CHIROPTEROL, V6, P177, DOI 10.3161/001.006.0201; Stadelmann B, 2004, J MAMMAL, V85, P133, DOI 10.1644/1545-1542(2004)085<0133:MSOTFB>2.0.CO;2; Storch Gerhard, 1999, P81; Tate GHH, 1941, B AM MUS NAT HIST, V48, P537; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Vandenberghe N, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P855, DOI 10.1016/B978-0-444-59425-9.00028-7; Ziegler R, 2003, GEOBIOS-LYON, V36, P447, DOI 10.1016/S0016-6995(03)00043-3; Ziegler Reinhard, 1993, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V33, P119; Ziegler Reinhard, 1994, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V26, P97; Ziegler Reinhard, 2000, Senckenbergiana Lethaea, V80, P647	84	12	12	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172621	10.1371/journal.pone.0172621	http://dx.doi.org/10.1371/journal.pone.0172621			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273112	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700082
J	da Silva, EZM; Freitas, EG; de Souza, DA; DaSilva, LLP; Jamur, MC; Oliver, C				Marcelino da Silva, Elaine Zayas; Freitas-Filho, Edismauro Garcia; de Souza-Junior, Devandir Antonio; Pinto DaSilva, Luis Lamberti; Jamur, Maria Celia; Oliver, Constance			Adaptor protein-3: A key player in RBL-2H3 mast cell mediator release	PLOS ONE			English	Article							HERMANSKY-PUDLAK-SYNDROME; LYSOSOMAL MEMBRANE-PROTEINS; REGULATED SECRETORY PATHWAY; BASOPHILIC LEUKEMIA-CELLS; EICOSANOID MEDIATORS; GOLGI NETWORK; AP-3 ADAPTER; COMPLEX; GRANULES; BIOGENESIS	Mast cell (MC) secretory granules are Lysosome-Related Organelles (LROs) whose biogenesis is associated with the post-Golgi secretory and endocytic pathways in which the sorting of proteins destined for a specific organelle relies on the recognition of sorting signals by adaptor proteins that direct their incorporation into transport vesicles. The adaptor protein 3 (AP-3) complex mediates protein trafficking between the trans-Golgi network (TGN) and late endosomes, lysosomes, and LROs. AP-3 has a recognized role in LROs biogenesis and regulated secretion in several cell types, including many immune cells such as neutrophils, natural killer cells, and cytotoxic T lymphocytes. However, the relevance of AP-3 for these processes in MCs has not been previously investigated. AP-3 was found to be expressed and distributed in a punctate fashion in rat peritoneal mast cells ex vivo. The rat MC line RBL-2H3 was used as a model system to investigate the role of AP-3 in mast cell secretory granule biogenesis and mediator release. By immunofluorescence and immunoelectron microscopy, AP-3 was localized both to the TGN and early endosomes indicating that AP-3 dependent sorting of proteins to MC secretory granules originates in these organ-elles. ShRNA mediated depletion of the AP-3 delta subunit was shown to destabilize the AP-3 complex in RBL-2H3 MCs. AP-3 knockdown significantly affected MC regulated secretion of beta-hexosaminidase without affecting total cellular enzyme levels. Morphometric evaluation of MC secretory granules by electron microscopy revealed that the area of MC secretory granules in AP-3 knockdown MCs was significantly increased, indicating that AP-3 is involved in MC secretory granule biogenesis. Furthermore, AP-3 knockdown had a selective impact on the secretion of newly formed and newly synthesized mediators. These results show for the first time that AP-3 plays a critical role in secretory granule biogenesis and mediator release in MCs.	[Marcelino da Silva, Elaine Zayas; Freitas-Filho, Edismauro Garcia; de Souza-Junior, Devandir Antonio; Pinto DaSilva, Luis Lamberti; Jamur, Maria Celia; Oliver, Constance] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol & Pathogen Bioagents, Sao Paulo, Brazil	Universidade de Sao Paulo	Oliver, C (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol & Pathogen Bioagents, Sao Paulo, Brazil.	coliver@fmrp.usp.br	daSilva, Luis LP/AAD-5657-2019; Da Silva, Elaine Z/O-5535-2015; LP daSilva, Luis/A-9949-2010; Filho, Edismauro G Freitas/F-8219-2012; Oliver, Constance/L-9904-2017	daSilva, Luis LP/0000-0003-3558-0087; Da Silva, Elaine Z/0000-0002-2749-6275; LP daSilva, Luis/0000-0003-3558-0087; Filho, Edismauro G Freitas/0000-0002-1910-1085; Oliver, Constance/0000-0002-8633-4612	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/07363-0, 2013/12861-0, 2009/54013-0, 2014/11396-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [161304/2011-7, 502429/2014-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA)	This work was supported by research grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, www.fapesp.br; EZMS: 2012/07363-0; EGFF: 2013/12861-0; MCJ: 2009/54013-0; CO: 2014/11396-5), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, www.cripq.br; EZMS: 161304/2011-7; DASJ: 502429/2014-3), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes, www.capes.gov.br), and Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA, www.faepa.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Artuc M, 1999, EXP DERMATOL, V8, P1, DOI 10.1111/j.1600-0625.1999.tb00342.x; Asensio CS, 2013, DEV CELL, V27, P425, DOI 10.1016/j.devcel.2013.10.007; Asensio CS, 2010, J CELL BIOL, V191, P1173, DOI 10.1083/jcb.201006131; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Blank U, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00453; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; BONIFACINO JS, 1989, J CELL SCI, V92, P701; Bonifacino JS, 2004, ANN NY ACAD SCI, V1038, P103, DOI 10.1196/annals.1315.018; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Boyce JA, 2005, CHEM IMMUNOL ALLERGY, V87, P59, DOI 10.1159/000087571; Boyce JA, 2007, IMMUNOL REV, V217, P168, DOI 10.1111/j.1600-065X.2007.00512.x; Bozza PT, 2011, PROSTAG LEUKOTR ESS, V85, P205, DOI 10.1016/j.plefa.2011.04.020; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Dragonetti A, 2000, J CELL SCI, V113, P3289; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Enders A, 2006, BLOOD, V108, P81, DOI 10.1182/blood-2005-11-4413; Feng LJ, 2002, BLOOD, V99, P1651, DOI 10.1182/blood.V99.5.1651.h8001651_1651_1658; Fontana S, 2006, BLOOD, V107, P4857, DOI 10.1182/blood-2005-11-4398; Freitas EG, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9160540; Galli SJ, 1999, IMMUNOLOGY, P1137; Grabner CP, 2006, P NATL ACAD SCI USA, V103, P10035, DOI 10.1073/pnas.0509844103; Grimberg E, 2003, J CELL SCI, V116, P145, DOI 10.1242/jcs.00186; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Henz BM, 2008, EXP DERMATOL, V17, P91, DOI 10.1111/j.1600-0625.2007.00658.x; Hiromatsu Y, 2003, MICROSC RES TECHNIQ, V60, P64, DOI 10.1002/jemt.10244; Ihrke G, 2004, TRAFFIC, V5, P946, DOI 10.1111/j.1600-0854.2004.00236.x; Jamur MC, 2005, BLOOD, V105, P4282, DOI 10.1182/blood-2004-02-0756; Jamur MC, 2014, J HISTOCHEM CYTOCHEM; Jedlitschky G, 2002, VITAM HORM, V64, P153, DOI 10.1016/S0083-6729(02)64005-1; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Karnovsky MJ, 1971, 11 ANN M AM SOC CELL; Kent HM, 2012, DEV CELL, V22, P979, DOI 10.1016/j.devcel.2012.01.018; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; Luzio JP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016840; Marks MS, 2013, CURR OPIN CELL BIOL, V25, P495, DOI 10.1016/j.ceb.2013.04.008; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Meng RH, 2015, BLOOD, V125, P1623, DOI 10.1182/blood-2014-07-586727; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Moon TC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00569; Nakatsu F, 2003, CELL STRUCT FUNCT, V28, P419, DOI 10.1247/csf.28.419; Newell-Litwa K, 2010, J NEUROSCI, V30, P820, DOI 10.1523/JNEUROSCI.3400-09.2010; NOVAK EK, 1984, BLOOD, V63, P536; OLIVER C, 1992, J CELL BIOL, V116, P635, DOI 10.1083/jcb.116.3.635; Oliver C, 2010, METHODS MOL BIOL, V588, P353, DOI 10.1007/978-1-59745-324-0_37; Olszewski MB, 2006, EUR J IMMUNOL, V36, P997, DOI 10.1002/eji.200535323; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Reid G, 2003, MOL PHARMACOL, V63, P1094, DOI 10.1124/mol.63.5.1094; Rius M, 2008, J PHARMACOL EXP THER, V324, P86, DOI 10.1124/jpet.107.131342; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shirasaka Y, 2013, J ENDOCRINOL, V217, P265, DOI 10.1530/JOE-12-0339; Souza AMMS, 2008, EXP CELL RES, V314, P2515, DOI 10.1016/j.yexcr.2008.05.014; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; Starcevic M, 2002, SEMIN CELL DEV BIOL, V13, P271, DOI 10.1016/S1084952102000563; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Traub LM, 1997, CURR OPIN CELL BIOL, V9, P527, DOI 10.1016/S0955-0674(97)80029-4; Tsai M, 2011, ADV EXP MED BIOL, V716, P186, DOI 10.1007/978-1-4419-9533-9_11; Woska JR, 2011, SCAND J IMMUNOL, V73, P8, DOI 10.1111/j.1365-3083.2010.02471.x; Woska JR, 2011, J CELL MOL MED	70	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173462	10.1371/journal.pone.0173462	http://dx.doi.org/10.1371/journal.pone.0173462			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273137	Green Submitted, gold, Green Published			2022-12-27	WOS:000396073700004
J	Van Breda, LK; Dhungyel, OP; Ginn, AN; Iredell, JR; Ward, MP				Van Breda, Lechelle K.; Dhungyel, Om P.; Ginn, Andrew N.; Iredell, Jonathan R.; Ward, Michael P.			Pre- and post-weaning scours in southeastern Australia: A survey of 22 commercial pig herds and characterisation of Escherichia coli isolates	PLOS ONE			English	Article							VIRULENCE GENES; HOUSING SYSTEMS; WEANLING PIGS; WEANED PIGS; GUT HEALTH; PERFORMANCE; DIARRHEA; DISEASES; SWINE; ANIMALS	Diarrhoeal diseases in piglets caused by Escherichia coli are responsible for substantial losses each year in the Australian pig industry. A cross-sectional survey was conducted (September 2013-May 2014) across 22 commercial pig herds located in southeastern Australia: NSW (n = 9); VIC (n = 10); and SA (n = 3), to estimate the prevalence of E. coli associated diarrhoea in pre-and post-weaned piglets and to identify key risk factors associated with E. coli disease. A questionnaire on management and husbandry practices was included. Faecal samples (n = 50 from each herd) were tested for the presence of beta-haemolytic E. coli. Species level identification was confirmed by matrix-assisted laser desorption / ionisation time-of-flight mass spectrometry (MALDI-TOF/MS). ETEC virulence and enterotoxin genes (F4, F5, F6, F18, F41, STa, STb and LT) were screened for by multiplex PCR. This study assessed 60 potential risk factors for E. coli disease in post-weaned piglets, with 2 key factors-recent disease events and the presence of bedding, statistically associated with the presence of post-weaning scours. The prevalence of diarrhea in pre-weaned pens was 17% (16/93), compared with 24% (24/102) in post-weaned pens. The most prevalent beta-haemolytic ETEC genes were F18 (32%) and STb (32%) but isolates were more likely to contain F4: STb (11 of 22 herds, 23%), than F18:STb (5 of 22 herds, 6%). These findings indicate that recent disease events that have occurred within the last 12 months, and by the use of bedding or not maintaining fresh bedding can have significant impacts on piglet diarrhoea.	[Van Breda, Lechelle K.; Dhungyel, Om P.; Ward, Michael P.] Univ Sydney, Fac Vet Sci, Camden, NSW, Australia; [Ginn, Andrew N.; Iredell, Jonathan R.] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol, Westmead Millennium Inst Med Res, Westmead, NSW, Australia; [Ginn, Andrew N.] Pathol West, Ctr Infect Dis & Microbiol Lab Serv, Antimicrobial Resistance Reference Lab, Westmead, NSW, Australia	University of Sydney; University of Sydney	Ward, MP (corresponding author), Univ Sydney, Fac Vet Sci, Camden, NSW, Australia.	michael.ward@sydney.edu.au	Dhungyel, Om/AEC-8041-2022; Ward, Michael/C-5758-2009; Ward, Michael Patrick/W-1897-2019; Ward, Michael Patrick/GRX-1851-2022	Ward, Michael/0000-0002-9921-4986; Ward, Michael Patrick/0000-0002-9921-4986	Cooperative Research Centre for High Integrity Pork [A2-106]	Cooperative Research Centre for High Integrity Pork(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was funded by the Cooperative Research Centre for High Integrity Pork (Project A2-106).; This work was funded by the Cooperative Research Centre for High Integrity Pork (Project A2-106). We thank swine veterinaries Dr. Bernie Gleeson, Dr. Peter MacKenzie, Dr. Trish Holyoake and Dr. Ross Cutler; and Chris van Diessel and Tom Weaver for their assistance. Pig producers in southeastern Australia are thanked for participating. Associate Professor Darren Trott, David Wakeham and Justine Gibson provided reference strains. Associate Professor Peter Thomson and Dr. Benjamin McCormick provided statistical assistance, Associate Professor Sally Partridge and Dr. Karen Plain critically reviewed the manuscript and Andrew McPherson and Matthew Cieslak provided technical assistance.	Alali WQ, 2008, APPL ENVIRON MICROB, V74, P3672, DOI 10.1128/AEM.02624-07; Bosi P, 2004, J ANIM SCI, V82, P1764; Buddle JR, 1997, AUST VET J, V75, P274, DOI 10.1111/j.1751-0813.1997.tb10097.x; Chapman TA, 2006, APPL ENVIRON MICROB, V72, P4782, DOI 10.1128/AEM.02885-05; DAF, 2010, PIGL SCOURS GEN INF; Do T, 2005, AUST VET J, V83, P293, DOI 10.1111/j.1751-0813.2005.tb12745.x; Dohoo I., 2009, VET EPIDEMIOLOGIC RE, P335; DRIESEN SJ, 1993, AUST VET J, V70, P259, DOI 10.1111/j.1751-0813.1993.tb08044.x; Fahy V. A., 1987, Manipulating pig production I. Proceedings of the Inaugural Conference of the Australasian Pig Science Association (APSA) Nov 23-25, 1987, Albury, NSW.., P189; Fairbrother JM, 2006, REV SCI TECH OIE, V25, P555, DOI 10.20506/rst.25.2.1682; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Hammerum AM, 2014, J ANTIMICROB CHEMOTH, V69, P2650, DOI 10.1093/jac/dku180; Lalles JP, 2007, P NUTR SOC, V66, P260, DOI 10.1017/S0029665107005484; LIM CH, 1989, J APPL BACTERIOL, V66, P559, DOI 10.1111/j.1365-2672.1989.tb04578.x; MADEC F, 1983, ANN RECH VET, V14, P456; MADEC F, 1994, VET RES, V25, P92; MULLAN BP, 1994, AUST VET J, V71, P151, DOI 10.1111/j.1751-0813.1994.tb03370.x; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Nagy B, 1999, VET RES, V30, P259; Pedersen KS, 2011, PREV VET MED, V98, P288, DOI 10.1016/j.prevetmed.2010.11.016; Pluske JR, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-1; Pluske JR, 2002, NUTR RES REV, V15, P333, DOI 10.1079/NRR200242; Pluske JR, 1997, LIVEST PROD SCI, V51, P215, DOI 10.1016/S0301-6226(97)00057-2; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; Scott K, 2006, LIVEST SCI, V103, P104, DOI 10.1016/j.livsci.2006.01.008; Skirrow SZ, 1997, AUST VET J, V75, P282, DOI 10.1111/j.1751-0813.1997.tb10098.x; Stege H, 2001, PREV VET MED, V50, P153, DOI 10.1016/S0167-5877(01)00194-5; Taylor G. A., 2006, P 2006 IEEE PES GEN, P1; Torrallardona D, 2003, J ANIM SCI, V81, P1220; Tuyttens FAM, 2005, APPL ANIM BEHAV SCI, V92, P261, DOI 10.1016/j.applanim.2005.05.007; van de Weerd HA, 2009, APPL ANIM BEHAV SCI, V116, P1, DOI 10.1016/j.applanim.2008.08.001; Voyles R, 2006, 652 AS IOW STAT U AN; WEINSTEIN DL, 1988, J BACTERIOL, V170, P4223, DOI 10.1128/jb.170.9.4223-4230.1988; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Wu XY, 2007, APPL ENVIRON MICROB, V73, P83, DOI 10.1128/AEM.00990-06; Zhang WP, 2006, INFECT IMMUN, V74, P3107, DOI 10.1128/IAI.01338-05	36	9	9	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172528	10.1371/journal.pone.0172528	http://dx.doi.org/10.1371/journal.pone.0172528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273152	Green Submitted, Green Published, gold			2022-12-27	WOS:000396073700078
J	Li, XM; Wang, JR; Shen, T; Gao, SS; He, XS; Li, JN; Yang, TY; Zhang, S; Gan, WJ; Li, JM; Wu, H				Li, Xiu-Ming; Wang, Jing-Ru; Shen, Tong; Gao, Shang-Shang; He, Xiao-Shun; Li, Jiang-Nan; Yang, Tian-Yu; Zhang, Shen; Gan, Wen-Juan; Li, Jian-Ming; Wu, Hua			Nur77 deficiency in mice accelerates tumor invasion and metastasis by facilitating TNF alpha secretion and lowering CSF-1R expression (vol 12, e0171347, 2017)	PLOS ONE			English	Correction									[Li, Jian-Ming] Soochow Univ, Pathol Ctr, Suzhou, Peoples R China; [Li, Jian-Ming] Soochow Univ, Dept Pathol, Suzhou, Peoples R China	Soochow University - China; Soochow University - China								Li XM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171347	1	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173838	10.1371/journal.pone.0173838	http://dx.doi.org/10.1371/journal.pone.0173838			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267797	Green Published, Green Submitted, gold			2022-12-27	WOS:000396060600050
J	Song, N; Dai, QQ; Zhu, BT; Wu, YX; Xu, M; Voegele, RT; Gao, XN; Kang, ZS; Huang, LL				Song, Na; Dai, Qingqing; Zhu, Baitao; Wu, Yuxing; Xu, Ming; Voegele, Ralf Thomas; Gao, Xiaoning; Kang, Zhensheng; Huang, Lili			G alpha proteins Gvm2 and Gvm3 regulate vegetative growth, asexual development, and pathogenicityon apple in Valsa mali	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; GENE-EXPRESSION; SIGNALING PATHWAYS; SUBUNIT; CAMP; VIRULENCE; GERMINATION; COLONIZATION; INFECTION; YEAST	In fungi, heterotrimeric guanine-nucleotide binding proteins (G-proteins) are key elements of signal transduction pathways, which control growth, asexual and sexual development, as well as virulence. In this study, we have identified two genes encoding heterotrimeric G protein alpha subunits, named Gvm2 and Gvm3, from Valsa malt, the causal agent of apple Valsa canker. Characterization of Gvm2 and Gvm3 mutants indicates that Gvm3 may be a crucial regulator of vegetative growth. Deletion of the corresponding gene results in a 20% reduction in growth rate. Besides, Gvm2 and Gvm3 seem to be involved in asexual reproduction, and mutants are hypersensitive to oxidative and cell membrane stresses. Interestingly, both G protein alpha subunits were most probably involved in V. mali virulence. In infection assays using Malus domestica cv. 'Fuji' leaves and twigs, the size of lesions caused by deletion mutants Delta Gvm2, or Delta Gvm3 are significantly reduced. Furthermore, many genes encoding hydrolytic enzymes important virulence factors in V. mali are expressed at a lower level in these deletion mutants. Our results suggest that Gvm2 and Gvm3 play an important role in virulence probably by regulation of expression of cell wall degrading enzymes. Delta Gvm2, and Delta Gvm3 mutants were further analyzed with respect to their impact on the transcript levels of genes in the cAMP/PKA pathway. The expression of the genes encoding adenylate cyclase VmAC, protein kinase A (PKA) regulatory subunit VmPKR, and PKA catalytic subunit VmPKA1 are down-regulated in both mutants. Further analyses indicated that intracellular cAMP level and PKA activity are down-regulated in the Delta Gvm3 mutant, but are basically unchanged in the Delta Gvm2 mutant. Overall, our findings indicate that both Gvm2 and Gvm3 play diverse roles in the modulation of vegetative growth, asexual development, and virulence in V. mali.	[Song, Na; Dai, Qingqing; Zhu, Baitao; Wu, Yuxing; Xu, Ming; Gao, Xiaoning; Kang, Zhensheng; Huang, Lili] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China; [Song, Na; Dai, Qingqing; Zhu, Baitao; Wu, Yuxing; Xu, Ming; Gao, Xiaoning; Kang, Zhensheng; Huang, Lili] Northwest A&F Univ, Coll Plant Protect, Yangling, Peoples R China; [Voegele, Ralf Thomas] Univ Hohenheim, Inst Phytomed, Fachgebiet Phytopathol, Stuttgart, Germany	Northwest A&F University - China; Northwest A&F University - China; University Hohenheim	Huang, LL (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China.; Huang, LL (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Peoples R China.	huanglili@nwsuaf.edu.cn		Kang, Zhensheng/0000-0001-5575-0122	National Natural Science Foundation of China [31471732, 31671982]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (No. 31471732; 31671982).	Abe K, 2007, PLANT BREEDING, V126, P449, DOI 10.1111/j.1439-0523.2007.01379.x; Abe K, 2011, TREE GENET GENOMES, V7, P363, DOI 10.1007/s11295-010-0337-3; Alspaugh JA, 2002, EUKARYOT CELL, V1, P75, DOI 10.1128/EC.1.1.75-84.2002; Alspaugh JA, 1997, GENE DEV, V11, P3206, DOI 10.1101/gad.11.23.3206; Beer SV., 1990, COMPENDIUM APPLE PEA, P61; Bolker M, 1998, FUNGAL GENET BIOL, V25, P143, DOI 10.1006/fgbi.1998.1102; Bruno KS, 2004, EUKARYOT CELL, V3, P1525, DOI 10.1128/EC.3.6.1525-1532.2004; BUSS JE, 1987, P NATL ACAD SCI USA, V84, P7493, DOI 10.1073/pnas.84.21.7493; [曹克强 Cao Keqiang], 2009, [植物保护, Plant Protection], V35, P114; Chang MH, 2004, GENETICS, V167, P1305, DOI 10.1534/genetics.103.025379; Chen C., 1987, ACTA PHYTOPATHOL SIN, V17, P3; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; D'Souza CA, 2001, FEMS MICROBIOL REV, V25, P349, DOI 10.1111/j.1574-6976.2001.tb00582.x; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; Doehlemann G, 2006, MOL MICROBIOL, V59, P821, DOI 10.1111/j.1365-2958.2005.04991.x; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Duan Y., 2013, THESIS, P88; Fang L, 2005, THESIS; Gao Jing, 2011, Weishengwu Xuebao, V51, P1194; Gao SJ, 1996, P NATL ACAD SCI USA, V93, P14122, DOI 10.1073/pnas.93.24.14122; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hallen HE, 2003, MYCOL RES, V107, P969, DOI 10.1017/S0953756203008190; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Jain S, 2005, FEMS MICROBIOL LETT, V243, P165, DOI 10.1016/j.femsle.2004.12.009; Kays AM, 2004, MYCOTA, V3, P175; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; Ke XW, 2014, FUNGAL GENET BIOL, V68, P31, DOI 10.1016/j.fgb.2014.04.004; Ke XW, 2013, AUSTRALAS PLANT PATH, V42, P85, DOI 10.1007/s13313-012-0158-y; Kruger J, 1998, MOL GEN GENET, V260, P193, DOI 10.1007/s004380050885; Krystofova S, 2005, EUKARYOT CELL, V4, P365, DOI 10.1128/EC.4.2.365-378.2005; Kubler E, 1997, J BIOL CHEM, V272, P20321, DOI 10.1074/jbc.272.33.20321; Lafon A, 2005, GENETICS, V171, P71, DOI 10.1534/genetics.105.040584; Lee DH, 2007, PLANT PATHOLOGY J, V23, P37, DOI 10.5423/PPJ.2007.23.2.037; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Li L, 2007, MOL BIOL CELL, V18, P4201, DOI 10.1091/mbc.E07-02-0136; Liu SH, 1997, MOL PLANT MICROBE IN, V10, P1075, DOI 10.1094/MPMI.1997.10.9.1075; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz MC, 1997, EMBO J, V16, P7008, DOI 10.1093/emboj/16.23.7008; Malbon CC, 2005, NAT REV MOL CELL BIO, V6, P689, DOI 10.1038/nrm1716; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; Regenfelder E, 1997, EMBO J, V16, P1934, DOI 10.1093/emboj/16.8.1934; Schmoll M, 2009, EUKARYOT CELL, V8, P410, DOI 10.1128/EC.00256-08; Seibel C, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-58; Servin JA., 2012, BIOCOMMUNICATION FUN, P21; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Studt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058185; TURNER GE, 1993, J BIOL CHEM, V268, P14805; Wang L., 2005, J NW SCI TECH U AGR, V33, P98, DOI [DOI 10.13207/J.CNKI.JNWAFU.2005.S1.027, 10.13207/j.cnki.jnwafu.2005.s1.027]; WANG P, 1995, P NATL ACAD SCI USA, V92, P11529, DOI 10.1073/pnas.92.25.11529; Wei JieLing, 2010, Acta Phytopathologica Sinica, V40, P14; WEST RE, 1985, J BIOL CHEM, V260, P4428; [许春景 Xu Chunjing], 2016, [中国农业科学, Scientia Agricultura Sinica], V49, P1489; Yin ZY, 2015, NEW PHYTOL, V208, P1202, DOI 10.1111/nph.13544; Yin ZY, 2013, WORLD J MICROB BIOT, V29, P1563, DOI 10.1007/s11274-013-1320-6; You FH, 2007, THESIS; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhou XY, 2011, METHODS MOL BIOL, V722, P199, DOI 10.1007/978-1-61779-040-9_15	59	11	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173141	10.1371/journal.pone.0173141	http://dx.doi.org/10.1371/journal.pone.0173141			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267786	Green Published, Green Submitted, gold			2022-12-27	WOS:000396060600010
J	Abate, KH; Belachew, T				Abate, Kalkidan Hassen; Belachew, Tefera			Women's autonomy and men's involvement in child care and feeding as predictors of infant and young child anthropometric indices in coffee farming households of Jimma Zone, South West of Ethiopia	PLOS ONE			English	Article							NUTRITIONAL-STATUS; MATERNAL AUTONOMY; UNDERNUTRITION; HEALTH; MALNUTRITION; IMPACT	Background Most of child mortality and under nutrition in developing world were attributed to suboptimal childcare and feeding, which needs detailed investigation beyond the proximal factors. This study was conducted with the aim of assessing associations of women's autonomy and men's involvement with child anthropometric indices in cash crop livelihood areas of South West Ethiopia. Methods Multi-stage stratified sampling was used to select 749 farming households living in three coffee producing sub-districts of Jimma zone, Ethiopia. Domains of women's Autonomy were measured by a tool adapted from demographic health survey. A model for determination of paternal involvement in childcare was employed. Caring practices were assessed through the WHO Infant and young child feeding practice core indicators. Length and weight measurements were taken in duplicate using standard techniques. Data were analyzed using SPSS for windows version 21. A multivariable linear regression was used to predict weight for height Z-scores and length for age Z-scores after adjusting for various factors. Results The mean (sd) scores of weight for age (WAZ), height for age (HAZ), weight for height (WHZ) and BMI for age (BAZ) was -0.52(1.26), -0.73(1.43), -0.13(1.34) and -0.1(1.39) respectively. The results of multi variable linear regression analyses showed that WHZ scores of children of mothers who had autonomy of conducting big purchase were higher by 0.42 compared to children's whose mothers had not. In addition, a child whose father was involved in childcare and feeding had higher HAZ score by 0.1. Regarding age, as for every month increase in age of child, a 0.04 point decrease in HAZ score and a 0.01 point decrease in WHZ were noted. Similarly, a child living in food insecure households had lower HAZ score by 0.29 compared to child of food secured households. As family size increased by a person a WHZ score of a child is decreased by 0.08. WHZ and HAZ scores of male child was found lower by 0.25 and 0.38 respectively compared to a female child of same age. Conclusion Women's autonomy and men's involvement appeared in tandem with better child anthropometric outcomes. Nutrition interventions in such setting should integrate enhancing women's autonomy over resource and men's involvement in childcare and feeding, in addition to food security measures.	[Abate, Kalkidan Hassen; Belachew, Tefera] Jimma Univ, Coll Hlth Sci, Dept Populat & Family Hlth, Jimma, Ethiopia	Jimma University	Abate, KH (corresponding author), Jimma Univ, Coll Hlth Sci, Dept Populat & Family Hlth, Jimma, Ethiopia.	kalkidan.hassen@ju.edu.et	Abate, Kalkidan Hassen/ABA-9014-2020; Belachew, Tefera/AAO-5877-2020	Abate, Kalkidan Hassen/0000-0001-9752-5417; 	Jimma University, Jimma, Ethiopia [RPGC/4064/2016]; Jimma University	Jimma University, Jimma, Ethiopia; Jimma University	I (the corresponding author) have received a limited funding from my host institution, Jimma University, Jimma, Ethiopia grant number RPGC/4064/2016. This funding is part of doctoral students support program which covers only travel and data collection expenses. As I am one of the eligible candidate for the support stated, I received the limited funding and my mentor and coauthor Professor Tefera Belachew received none. Details of the funder institution is available here: https://www.ju.edu.et/cphms/node/26. We declare the funding or sources of support we received during this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to present our deepest gratitude to Jimma University for financing this study. We also thank Dr. Yimam Workneh, a lecturer in the department of Foreign Language and Literature, Jimma University, for his support in editing this manuscript. Our appreciation also goes to the data collectors and supervisors. Lastly, our special thanks extend to children's mothers who participated in the study.	Ajao KO, 2010, AFRICAN J REPROD HLT, V14; Allen S., 2007, EFFECTS FATHER INVOL; Amamo A.A., 2014, EUR J BUS MANAGE, V6, P109; Anderman TL, 2014, FOOD SECUR, V6, P541, DOI 10.1007/s12571-014-0360-6; [Anonymous], 2008, SUMM STAT REP 2007 P; Ares Segura Susana, 2016, An Pediatr (Barc), V84, DOI 10.1016/j.anpedi.2015.07.024; BAQUI AH, 1994, EUR J CLIN NUTR, V48, P349; Belachew T, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-55; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Tran BH, 2008, FOOD NUTR BULL, V29, P59, DOI 10.1177/156482650802900107; Bindon JR, 2002, SOC SCI MED, V54, P1299, DOI 10.1016/S0277-9536(01)00097-1; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bronte-Tinkew J, 2004, SOC SCI MED, V58, P499, DOI 10.1016/j.socscimed.2003.09.017; Brunson EK, 2009, AM J HUM BIOL, V21, P55, DOI 10.1002/ajhb.20815; Burchi F, 2012, DEMOGR RES, V27, P681, DOI 10.4054/DemRes.2012.27.23; Carlson GJ, 2015, MATERN CHILD NUTR, V11, P452, DOI 10.1111/mcn.12113; Central Statistical Agency, 2016, DEM HLTH SURV; Central Statistical Agency [Ethiopia] and ICF International, 2011, ETH DEM HLTH SURV; Charmarbagwala R, 2004, DETERMINANTS CHILD H; Clark Gracia, 1985, FIGHTING AFRICAN FOO; Cyril S, 2016, HEALTH PROMOT INT, V31, P809, DOI 10.1093/heapro/dav059; Dancer D, 2009, INDIAN GROWTH DEV RE, V2, P18, DOI 10.1108/17538250910953444; Onis M, 2006, ACTA PAEDIATR, V95, P7, DOI 10.1080/08035320500495407; de Pee S, 2009, FOOD NUTR BULL, V30, pS434, DOI 10.1177/15648265090303S305; Dearden K, 2013, MATERN CHILD NUTR, V9, P143, DOI 10.1111/j.1740-8709.2011.00347.x; DeJong J, 2000, SOC SCI MED, V51, P941, DOI 10.1016/S0277-9536(00)00073-3; FANTA II, 2010, IND ASS INF YOUNG 3; Filmer D, 2009, WORLD BANK ECON REV, V23, P371, DOI 10.1093/wber/lhp009; Gebreyesus S.H., 2015, BMC NUTR, V1, P2, DOI [DOI 10.1186/2055-0928-1-1, 10.1186/2055-0928-1-2]; Headey D., 2014, ANAL TRENDS DETERMIN; Hindin MJ, 2000, SOC SCI MED, V51, P1517, DOI 10.1016/S0277-9536(00)00051-4; Hosegood Victoria, 2010, J Int AIDS Soc, V13 Suppl 2, pS5, DOI 10.1186/1758-2652-13-S2-S5; Kanyamurwa JM, 2013, AFR HEALTH SCI, V13, P829, DOI 10.4314/ahs.v13i3.44; Kassa T, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0675-x; Kiyak Nejat, 2014, ASSESSMENT ANTHROPOM; Lamb M.E., 1987, PARENTING LIFESPAN B, P111, DOI DOI 10.4324/9781315126005-7; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Madhavan S, 2007, SCAND J PUBLIC HEALT, V35, P107, DOI 10.1080/14034950701355700; Malhotra A., 2005, MEASURING EMPOWERMEN, DOI DOI 10.1596/0-8213-6057-4; Mei ZG, 2007, B WORLD HEALTH ORGAN, V85, P441, DOI 10.2471/BLT.06.034421; Milas S, 2004, 4 ETHIOPIAS REGIONAL; Njuki J, 2011, EUR J DEV RES, V23, P426, DOI 10.1057/ejdr.2011.8; Ntoimo LFC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1145; Owusu-Addo E, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0295-4; Paolisso MJ, 2002, ECON DEV CULT CHANGE, V50, P313, DOI 10.1086/322881; Petit N, 2007, J AGRAR CHANGE, V7, P225, DOI 10.1111/j.1471-0366.2007.00145.x; Phiri T., 2014, GRAND CHALLENGES CAN, V2014; Rahman MM, 2015, ASIA-PAC J PUBLIC HE, V27, P509, DOI 10.1177/1010539514568710; Rajaram R, 2016, INT J PUBLIC HEALTH, P1; RAMALINGASWAMI V, 1997, MALNUTRITION S ASIA, P11; Renzaho AMN, 2010, NUTRITION, V26, P1, DOI 10.1016/j.nut.2009.05.001; Ross-Suits H, 2010, 99 GEORG STAT U; Roushdy R, 041011 POP COUNC W A, P306; Sachs JD, 2012, LANCET, V379, P2206, DOI 10.1016/S0140-6736(12)60685-0; Sarah M. Allen, 2007, EFFECTS FATHER INVOL; Shroff M, 2009, MATERN CHILD NUTR, V5, P64, DOI 10.1111/j.1740-8709.2008.00161.x; Smith L., 2003, IFPRI REPORTS; Swindale A, 2007, HOUSEHOLD FOOD INSEC; UNICEF, UNICEF CONC FRAM; *UNICEF, STAT WORLDS CHILDR 2; United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH; Wamani H., 2007, BMC Pediatrics, V7; [World Bank Joint Group WHO UNICEF], 2015, LEV TRENDS CHILD MAN; World Health Organization, 2007, IND ASS INT YOUNG CH; World Health Organization, 2010, IND ASS INF YOUNG CH; Zulfiqar A Bhutta, 2013, LANCET	67	30	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172885	10.1371/journal.pone.0172885	http://dx.doi.org/10.1371/journal.pone.0172885			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5OE	28264008	Green Submitted, Green Published, gold			2022-12-27	WOS:000396054300026
J	Abu-Farha, M; Cherian, P; Al-Khairi, I; Madhu, D; Tiss, A; Warsam, S; Alhubail, A; Sriraman, D; Al-Refaei, F; Abubaker, J				Abu-Farha, Mohamed; Cherian, Preethi; Al-Khairi, Irina; Madhu, Dhanya; Tiss, Ali; Warsam, Samia; Alhubail, Asma; Sriraman, Devarajan; Al-Refaei, Faisal; Abubaker, Jehad			Plasma and adipose tissue level of angiopoietin-like 7 (ANGPTL7) are increased in obesity and reduced after physical exercise	PLOS ONE			English	Article							METABOLIC SYNDROME; OXIDATIVE STRESS; BETATROPHIN/ANGPTL8 LEVEL; TRIGLYCERIDE-METABOLISM; CALORIC RESTRICTION; HEMATOPOIETIC STEM; LIPOPROTEIN-LIPASE; LIPID-METABOLISM; PROTEINS 3; INFLAMMATION	Objective ANGPTL7 is a member of the Angiopoietin- like (ANGPTL) protein family that is composed of eight proteins (1-8). Increasing evidence is associating ANGPTL proteins to obesity and insulin resistance. The biological role of ANGPTL7 is yet to be understood except for a recently proposed role in the pathophysiology of glaucoma. This study was designed to shed light on the function of ANGPTL7 in obesity and its modulation by physical exercise as well as its potential association with lipid profile. Methods A total of 144 subjects were enrolled in this study and finished three months of physical exercise. The participants were classified based on their BMI, 82 subjects were non-obese and 62 obese. ANGPTL7 levels in plasma and adipose tissue were measured by ELISA, RTPCR and immunohistochemistry. Results In this study, we showed that ANGPTL7 level was increased in the plasma of obese subjects (1249.05 +/- 130.39 pg/mL) as compared to non-obese (930.34 +/- 87.27 pg/mL) (p-Value = 0.032). ANGPTL7 Gene and protein expression levels in adipose tissue also showed over two fold increase. Physical exercise reduced circulating level of ANGPTL7 in the obese subjects to 740.98 +/- 127.18 pg/mL, (p-Value = 0.007). ANGPTL7 expression in adipose tissue was also reduced after exercise. Finally, ANGPTL7 circulating level showed significant association with TG level in the obese subjects (R-2 = 0.183, p-Value = 0.03). Conclusion In conclusion, our data shows for the first time that obesity increases the level of ANGPTL7 in both plasma and adipose tissue. Increased expression of ANGPTL7 might play a minor role in the regulation of TG level in obese subjects either directly or through interaction with other ANGPTL protein members. Physical exercise reduced the level of ANGPTL7 highlighting the potential for targeting this protein as a therapeutic target for regulating dyslipidemia.	[Abu-Farha, Mohamed; Cherian, Preethi; Al-Khairi, Irina; Madhu, Dhanya; Tiss, Ali; Warsam, Samia; Abubaker, Jehad] Dasman Diabet Inst, Biochem & Mol Biol Unit, Kuwait, Kuwait; [Alhubail, Asma; Al-Refaei, Faisal] Dasman Diabet Inst, Clin Serv Dept, Kuwait, Kuwait; [Sriraman, Devarajan] Dasman Diabet Inst, Tissue Banking Unit, Kuwait, Kuwait		Abubaker, J (corresponding author), Dasman Diabet Inst, Biochem & Mol Biol Unit, Kuwait, Kuwait.	mohamed.abufarha@dasmaninstitute.org; jehad.abubakr@dasmaninstitute.org	Tiss, Ali/L-6656-2019	Tiss, Ali/0000-0002-3024-5370; Abu-Farha, Mohamed/0000-0001-8357-1252; Abubaker, Jehad/0000-0003-0681-7305	Kuwait Foundation for the Advancement of Sciences (KFAS) [RA-2016-025]	Kuwait Foundation for the Advancement of Sciences (KFAS)(Kuwait Foundation for the Advancement of Sciences (KFAS))	This work was supported by Kuwait Foundation for the Advancement of Sciences (KFAS).; We are grateful to Clinical Laboratory and the Tissue Bank Core Facility at DDI for their contribution in handling samples. We are also indebted to Kuwait Foundation for the Advancement of Sciences (KFAS) for financial support of this research project (RA-2016-025). The funding agency was not involved in data collection, analysis, or interpretation; trial design; patient recruitment; or any aspect pertinent to the study. Special thanks to Dr. Veeramani Marimuthu for his help in accessing journal articles used in this study. The corresponding authors had full access to all the data in the study and had final responsibility for the decision to submit for publication. None of the authors have been paid to write this article by a pharmaceutical company or other agency. Due to institute policy as well as the ethical review board where they restrict sharing such data in a public domain, data are available upon request. This data will be available through direct requisition by contacting Dr. Mohamed Abu-Farha or Dr. Jehad Abubaker. Approval to access data is to be addressed to the Chairman of the Ethical Review Committee Dr. Abdullah Bennakhi, (abdullah.bennakhi@dasmaninstitute.org).	Abu-Farha M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147367; Abu-Farha M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14448; Abu-Farha M, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0277-1; Abu-Farha M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10949; Abu-Farha M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075342; Abubaker J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069217; Ahmadi N, 2011, AM J MED, V124, P978, DOI 10.1016/j.amjmed.2011.02.032; Aldhahi Waleed, 2003, Curr Diab Rep, V3, P293, DOI 10.1007/s11892-003-0020-2; Baturcam E, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/627150; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Carrel AL, 2009, J PEDIATR ENDOCR MET, V22, P409; Chiang J, 2009, EUR J PHARMACOL, V610, P119, DOI 10.1016/j.ejphar.2009.03.035; Comes N, 2011, GENES CELLS, V16, P243, DOI 10.1111/j.1365-2443.2010.01483.x; Essalmani R, 2013, J BIOL CHEM, V288, P26410, DOI 10.1074/jbc.M113.501304; Fu ZY, 2013, BIOCHEM BIOPH RES CO, V430, P1126, DOI 10.1016/j.bbrc.2012.12.025; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; Gray SR, 2009, PREV MED, V48, P39, DOI 10.1016/j.ypmed.2008.10.013; Haridas PAN, 2015, J CLIN ENDOCR METAB, V100, pE1299, DOI 10.1210/jc.2015-1254; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Huijgen R, 2012, HUM MUTAT, V33, P448, DOI 10.1002/humu.21660; Jonker JT, 2013, AM J CLIN NUTR, V97, P255, DOI 10.3945/ajcn.112.043687; Kadomatsu T, 2011, FEBS J, V278, P559, DOI 10.1111/j.1742-4658.2010.07979.x; Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013; Kersten S, 2009, ARTERIOSCL THROM VAS, V29, P969, DOI 10.1161/ATVBAHA.108.182147; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Kuchtey J, 2008, INVEST OPHTH VIS SCI, V49, P3438, DOI 10.1167/iovs.07-1347; Lee EC, 2009, J BIOL CHEM, V284, P13735, DOI 10.1074/jbc.M807899200; Legry V, 2009, J CLIN ENDOCR METAB, V94, P5070, DOI 10.1210/jc.2009-0769; Li C, 2006, CURR OPIN LIPIDOL, V17, P152, DOI 10.1097/01.mol.0000217896.67444.05; Li YC, 2014, J DRUG TARGET, V22, P679, DOI 10.3109/1061186X.2014.928715; Lim SY, 2015, HEPATOLOGY, V62, P521, DOI 10.1002/hep.27838; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Manns PJ, 2005, ARCH PHYS MED REHAB, V86, P1176, DOI 10.1016/j.apmr.2004.11.020; Marcinko K, 2014, EXP PHYSIOL, V99, P1581, DOI 10.1113/expphysiol.2014.082255; Mattijssen F, 2012, BBA-MOL CELL BIOL L, V1821, P782, DOI 10.1016/j.bbalip.2011.10.010; Mehta N, 2014, ARTERIOSCL THROM VAS, V34, P1057, DOI 10.1161/ATVBAHA.113.302802; Montero D, 2012, OBES REV, V13, P441, DOI 10.1111/j.1467-789X.2011.00956.x; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Namkung J, 2011, METABOLISM, V60, P564, DOI 10.1016/j.metabol.2010.05.013; Nehme A, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-58; Oike Y, 2005, TRENDS MOL MED, V11, P473, DOI 10.1016/j.molmed.2005.08.002; Oike Y, 2004, INT J HEMATOL, V80, P21, DOI 10.1532/ijh97.04034; Oike Y, 2009, CIRC J, V73, P2192, DOI 10.1253/circj.CJ-09-0710; Otarod Jila Kaberi, 2004, Curr Atheroscler Rep, V6, P335, DOI 10.1007/s11883-004-0043-4; Puthanveetil P, 2015, CRIT REV CL LAB SCI, V52, P138, DOI 10.3109/10408363.2014.997931; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Ren G, 2012, AM J PHYSIOL-ENDOC M, V303, pE334, DOI 10.1152/ajpendo.00084.2012; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Roberts CK, 2006, J APPL PHYSIOL, V100, P1657, DOI 10.1152/japplphysiol.01292.2005; Rozsa FW, 2006, MOL VIS, V12, P125; Santulli G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00004; Schernthaner GH, 2005, SCAND J CLIN LAB INV, V65, P30, DOI 10.1080/00365510500236119; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; Sonnenburg WK, 2009, J LIPID RES, V50, P2421, DOI 10.1194/jlr.M900145-JLR200; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Wang LL, 2015, MOL MED REP, V11, P2789, DOI 10.3892/mmr.2014.3029; Wang Y, 2015, J LIPID RES, V56, P1296, DOI 10.1194/jlr.M054882; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Xiao YR, 2015, HAEMATOLOGICA, V100, P585, DOI 10.3324/haematol.2014.118612; Xiao YR, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-014-0102-4; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zhang R, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0133-8; Zhang R, 2013, BIOCHEM BIOPH RES CO, V432, P401, DOI 10.1016/j.bbrc.2013.01.129; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038	67	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173024	10.1371/journal.pone.0173024	http://dx.doi.org/10.1371/journal.pone.0173024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264047	gold, Green Published, Green Submitted			2022-12-27	WOS:000396054300035
J	Long, XJ; Chen, LF; Jiang, CX; Zhang, LJ				Long, Xiaojing; Chen, Lifang; Jiang, Chunxiang; Zhang, Lijuan		Alzheimer's Dis Neuroimaging	Prediction and classification of Alzheimer disease based on quantification of MRI deformation	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VOXEL-BASED MORPHOMETRY; SURFACE-BASED ANALYSIS; BRAIN ATROPHY; CEREBROSPINAL-FLUID; CORTICAL THICKNESS; ENTORHINAL CORTEX; EARLY-DIAGNOSIS; MCI PATIENTS; SHAPE	Detecting early morphological changes in the brain and making early diagnosis are important for Alzheimer's disease (AD). High resolution magnetic resonance imaging can be used to help diagnosis and prediction of the disease. In this paper, we proposed a machine learning method to discriminate patients with AD or mild cognitive impairment (MCI) from healthy elderly and to predict the AD conversion in MCI patients by computing and analyzing the regional morphological differences of brain between groups. Distance between each pair of subjects was quantified from a symmetric diffeomorphic registration, followed by an embedding algorithm and a learning approach for classification. The proposed method obtained accuracy of 96.5% in differentiating mild AD from healthy elderly with the whole-brain gray matter or temporal lobe as region of interest (ROI), 91.74% in differentiating progressive MCI from healthy elderly and 88.99% in classifying progressive MCI versus stable MCI with amygdala or hippocampus as ROI. This deformation-based method has made full use of the pair-wise macroscopic shape difference between groups and consequently increased the power for discrimination.	[Long, Xiaojing; Jiang, Chunxiang; Zhang, Lijuan] Chinese Acad Sci, Shenzhen Inst Adv Technol, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Guangdong, Peoples R China; [Chen, Lifang] Shenzhen Univ, Affiliated Hosp 1, Dept Neurol, Shenzhen Peoples Hosp 2, Shenzhen, Guangdong, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Shenzhen University	Zhang, LJ (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Guangdong, Peoples R China.	lj.zhang@siat.ac.cn			National Natural Science Foundation of China [81301285, 81371359]; Scientific Research Program of the Shenzhen Science and Technology Innovation Committee [JCYJ20150521094519463, JCYJ20140415090443270]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Food and Drug Administration; Canadian Institutes of Health Research; National Institutes of Health [P30 AG010129, K01 AG030514]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Program of the Shenzhen Science and Technology Innovation Committee; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Food and Drug Administration(United States Department of Health & Human Services); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was partly supported by the National Natural Science Foundation of China (Grant No. 81301285 and 81371359) and the Scientific Research Program of the Shenzhen Science and Technology Innovation Committee (JCYJ20150521094519463, JCYJ20140415090443270). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, the Food and Drug Administration, and through generous contributions from the following: Abbott; Alzheimers Association; Alzheimers Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimers Disease Cooperative Study at the University of California San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California Los Angeles. This research was also supported by National Institutes of Health grants P30 AG010129 and K01 AG030514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaszewski S, 2013, NEUROBIOL AGING, V34, P2815, DOI 10.1016/j.neurobiolaging.2013.06.015; Aguilar C, 2013, PSYCHIAT RES-NEUROIM, V212, P89, DOI 10.1016/j.pscychresns.2012.11.005; Barnes J, 2004, NEUROIMAGE, V23, P574, DOI 10.1016/j.neuroimage.2004.06.028; Beheshti I, 2016, MAGN RESON IMAGING, V34, P252, DOI 10.1016/j.mri.2015.11.009; Bengio Y., 2004, ADV NEURAL INFORM PR; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bozzali M, 2006, NEUROLOGY, V67, P453, DOI 10.1212/01.wnl.0000228243.56665.c2; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Busatto GF, 2003, NEUROBIOL AGING, V24, P221, DOI 10.1016/S0197-4580(02)00084-2; Casanova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077949; Casanova Ramon, 2011, Front Neuroinform, V5, P22, DOI 10.3389/fninf.2011.00022; Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015; Cho H, 2014, J ALZHEIMERS DIS, V40, P285, DOI 10.3233/JAD-132072; Chupin M, 2009, HIPPOCAMPUS, V19, P579, DOI 10.1002/hipo.20626; Colliot O, 2008, RADIOLOGY, V248, P194, DOI 10.1148/radiol.2481070876; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Duchesne S, 2008, IEEE T MED IMAGING, V27, P509, DOI 10.1109/TMI.2007.908685; Eskildsenemail S, 2013, ALZHEIMERS DEMENTI S, V9, P102; Ewers M, 2012, NEUROBIOL AGING, V33, P1203, DOI 10.1016/j.neurobiolaging.2010.10.019; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fletcher PT, 2003, PROC CVPR IEEE, P95; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Fox NC, 1999, NEUROLOGY, V52, P1687, DOI 10.1212/WNL.52.8.1687; Gerardin E, 2009, NEUROIMAGE, V47, P1476, DOI 10.1016/j.neuroimage.2009.05.036; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Gutman B, 2009, HIPPOCAMPUS, V19, P572, DOI 10.1002/hipo.20627; Harvey PD, 2005, ALZ DIS ASSOC DIS, V19, P186, DOI 10.1097/01.wad.0000189034.43203.60; Hirata Y, 2005, NEUROSCI LETT, V382, P269, DOI 10.1016/j.neulet.2005.03.038; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Koikkalainen J, 2011, NEUROIMAGE, V56, P1134, DOI 10.1016/j.neuroimage.2011.03.029; Lao ZQ, 2004, NEUROIMAGE, V21, P46, DOI 10.1016/j.neuroimage.2003.09.027; Lerch JP, 2005, CEREB CORTEX, V15, P995, DOI 10.1093/cercor/bhh200; Lillemark L, 2014, BMC MED IMAGING, V14, DOI 10.1186/1471-2342-14-21; Magnin B, 2009, NEURORADIOLOGY, V51, P73, DOI 10.1007/s00234-008-0463-x; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Moradi E, 2015, NEUROIMAGE, V104, P398, DOI 10.1016/j.neuroimage.2014.10.002; Musiek ES, 2012, ALZHEIMERS DEMENT, V8, P51, DOI 10.1016/j.jalz.2011.06.003; Nho Kwangsik, 2010, AMIA Annu Symp Proc, V2010, P542; Petrella JR, 2003, RADIOLOGY, V226, P315, DOI 10.1148/radiol.2262011600; Poulin SP, 2011, PSYCHIAT RES-NEUROIM, V194, P7, DOI 10.1016/j.pscychresns.2011.06.014; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Scahill RI, 2002, P NATL ACAD SCI USA, V99, P4703, DOI 10.1073/pnas.052587399; Shaffer JL, 2013, RADIOLOGY, V266, P583, DOI 10.1148/radiol.12120010; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Spulber G, 2013, J INTERN MED, V273, P396, DOI 10.1111/joim.12028; Tapiola T, 2008, NEUROBIOL AGING, V29, P31, DOI 10.1016/j.neurobiolaging.2006.09.007; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tiraboschi P, 2004, NEUROLOGY, V62, P1984, DOI 10.1212/01.WNL.0000129697.01779.0A; Varol E, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P146, DOI 10.1109/ISBI.2012.6235505; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Vercauteren T, 2008, LECT NOTES COMPUT SC, V5241, P754, DOI 10.1007/978-3-540-85988-8_90; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056; Willette AA, 2014, PSYCHIAT RES-NEUROIM, V224, P81, DOI 10.1016/j.pscychresns.2014.08.005; Wolz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025446; Xu Y, 2000, NEUROLOGY, V54, P1760, DOI 10.1212/WNL.54.9.1760; Yang WL, 2011, J ALZHEIMERS DIS, V24, P775, DOI 10.3233/JAD-2011-101371; Zhang DQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033182; Zhou Q, 2014, IEEE T BIO-MED ENG, V61, P2245, DOI 10.1109/TBME.2014.2310709	67	60	63	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173372	10.1371/journal.pone.0173372	http://dx.doi.org/10.1371/journal.pone.0173372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264071	Green Published, gold, Green Submitted			2022-12-27	WOS:000396054300057
J	Almand, EA; Moore, MD; Outlaw, J; Jaykus, LA				Almand, Erin A.; Moore, Matthew D.; Outlaw, Janie; Jaykus, Lee-Ann			Human norovirus binding to select bacteria representative of the human gut microbiota	PLOS ONE			English	Article							BLOOD GROUP ANTIGENS; REVERSE TRANSCRIPTION-PCR; TULANE VIRUS RECOGNIZES; ENTERIC BACTERIA; STRUCTURAL BASIS; REPLICATION; DIVERSITY; CALICIVIRUS; INHIBITION; CELLS	Recent reports describe the ability of select bacterial strains to bind human norovirus, although the specificity of such interactions is unknown. The purpose of this work was to determine if a select group of bacterial species representative of human gut microbiota bind to human norovirus, and if so, to characterize the intensity and location of that binding. The bacteria screened included naturally occurring strains isolated from human stool (Klebsiella spp., Citrobacter spp., Bacillus spp., Enterococcus faecium and Hafnia alvei) and select reference strains (Staphylococcus aureus and Enterobacter cloacae). Binding in PBS was evaluated to three human norovirus strains (GII. 4 New Orleans 2009 and Sydney 2012, GI. 6) and two surrogate viruses (Tulane virus and Turnip Crinkle Virus (TCV)) using a suspension assay format linked to RT-qPCR for quantification. The impact of different overnight culture media prior to washing on binding efficiency in PBS was also evaluated, and binding was visualized using transmission electron microscopy. All bacteria tested bound the representative human norovirus strains with high efficiency (< 1 log(10) of input virus remained unbound or < 10% unbound and > 90% binding efficiency) (p> 0.05); there was selective binding for Tulane virus and no binding observed for TCV. Binding efficiency was highest when bacteria were cultured in minimal media (< 1 log(10) of input virus remained unbound, so > 90% bound), but notably decreased when cultured in enriched media (1 - 3 log(10) unbound or 0.01 - < 90% bound)) (p< 0.05). The norovirus-bacteria binding occurred around the outer cell surfaces and pili structures, without apparent localization. The findings reported here further elucidate and inform the dynamics between human noroviruses and enteric bacteria with implications for norovirus pathogenesis.	[Almand, Erin A.; Jaykus, Lee-Ann] North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC USA; [Moore, Matthew D.; Outlaw, Janie; Jaykus, Lee-Ann] North Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Moore, MD (corresponding author), North Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA.	mdmoore5@ncsu.edu	Moore, Matthew/H-9345-2019	Moore, Matthew/0000-0002-5393-0733	National Institute of Food and Agriculture, U.S. Department of Agriculture under the NoroCORE project [1111-2011-0494, 2011-68003-30395]; US Air Force Institute of Technology Civilian Institute Program Scholarship	National Institute of Food and Agriculture, U.S. Department of Agriculture under the NoroCORE project; US Air Force Institute of Technology Civilian Institute Program Scholarship	This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 1111-2011-0494 and 2011-68003-30395, under the NoroCORE project. Support was provided by an US Air Force Institute of Technology Civilian Institute Program Scholarship (EAA). The views expressed in this article are those of the author and do not reflect the official policy or position of the United States Air Force, Department of Defense, or the U.S. Government, https://nifa.usda.gov/grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Amarasiri M, 2016, WATER RES; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; Farkas T, 2008, J VIROL, V82, P5408, DOI 10.1128/JVI.00070-08; Farkas T, 2010, J VIROL, V84, P8617, DOI 10.1128/JVI.00630-10; Gentry-Shields J, 2015, FOOD RES INT; Han L, 2014, J AM CHEM SOC, V136, P12631, DOI 10.1021/ja505272n; Hansman GS, 2012, J VIROL, V86, P284, DOI 10.1128/JVI.05909-11; Harrington PR, 2004, J VIROL, V78, P3035, DOI 10.1128/JVI.78.6.3035-3045.2004; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P1870, DOI 10.1128/AEM.71.4.1870-1875.2005; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Kleerebezem M, 2009, ANNU REV MICROBIOL, V63, P269, DOI 10.1146/annurev.micro.091208.073341; Kolawole AO, 2016, ANTIVIR RES, V132, P46, DOI 10.1016/j.antiviral.2016.05.011; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Li D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00659; Macfarlane S, 2008, J CLIN GASTROENTEROL, V42, pS142, DOI 10.1097/MCG.0b013e31816207df; Manuel CS, 2015, APPL ENVIRON MICROB, V81, P4940, DOI 10.1128/AEM.00388-15; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Miura T, 2013, J VIROL, V87, P9441, DOI 10.1128/JVI.01060-13; MOODY MR, 1969, APPL MICROBIOL, V18, P262, DOI 10.1128/AEM.18.2.262-267.1969; PRASAD BVV, 1994, J MOL BIOL, V240, P256, DOI 10.1006/jmbi.1994.1439; Robinson CM, 2014, CELL HOST MICROBE, V15, P36, DOI 10.1016/j.chom.2013.12.004; Rydell GE, 2009, GLYCOBIOLOGY, V19, P309, DOI 10.1093/glycob/cwn139; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scharff RL., 2012, INT ASS FOOD PROTECT, V75, P123, DOI [10.4315/0362-028X.JFP-11-058, DOI 10.4315/0362-028X.JFP-11-058]; Sestak K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037973; SPRINGER GF, 1961, J EXP MED, V113, P1077, DOI 10.1084/jem.113.6.1077; Stevens KA, 2004, J APPL MICROBIOL, V97, P1115, DOI 10.1111/j.1365-2672.2004.02393.x; Tan M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11784; Thorne LG, 2014, J GEN VIROL, V95, P278, DOI 10.1099/vir.0.059634-0; Zhang DS, 2015, J VIROL, V89, P1419, DOI 10.1128/JVI.02595-14	36	65	65	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173124	10.1371/journal.pone.0173124	http://dx.doi.org/10.1371/journal.pone.0173124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257478	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100060
J	Del Coso, J; Valero, M; Salinero, JJ; Lara, B; Gallo-Salazar, C; Areces, F				Del Coso, Juan; Valero, Marjorie; Jose Salinero, Juan; Lara, Beatriz; Gallo-Salazar, Cesar; Areces, Francisco			Optimum polygenic profile to resist exertional rhabdomyolysis during a marathon	PLOS ONE			English	Article							INDUCED MUSCLE DAMAGE; ACTN3 GENOTYPE; EXERCISE; POLYMORPHISMS; PERFORMANCE; INJURY	Purpose Exertional rhabdomyolysis can occur in individuals performing various types of exercise but it is unclear why some individuals develop this condition while others do not. Previous investigations have determined the role of several single nucleotide polymorphisms (SNPs) to explain inter-individual variability of serum creatine kinase (CK) concentrations after exertional muscle damage. However, there has been no research about the interrelationship among these SNPs. The purpose of this investigation was to analyze seven SNPs that are candidates for explaining individual variations of CK response after a marathon competition (ACE = 287bp Ins/Del, ACTN3 = p. R577X, CKMM = NcoI, IGF2 = C13790G, IL6 = 174G> C, MLCK = C37885A, TNFa = 308G> A). Methods Using Williams and Folland's model, we determined the total genotype score from the accumulated combination of these seven SNPs for marathoners with a low CK response (n = 36; serum CK < 400 U.L-1) vs. marathoners with a high CK response (n = 31; serum CK >= 400 U.L-1). Results At the end of the race, low CK responders had lower serum CK (290 +/- 65 vs. 733 +/- 405 U.L-1; P< 0.01) and myoglobin concentrations (443 +/- 328 vs. 1009 +/- 971 ng.mL(-1), P< 0.01) than high CK responders. Although the groups were similar in age, anthropometric characteristics, running experience and training habits, total genotype score was higher in low CK responders than in high CK responders (5.2 +/- 1.4 vs. 4.4 +/- 1.7 point, P = 0.02). Conclusion Marathoners with a lower CK response after the race had a more favorable polygenic profile than runners with high serum CK concentrations. This might suggest a significant role of genetic polymorphisms in the levels of exertional muscle damage and rhabdomyolysis. Yet other SNPs, in addition to exercise training, might also play a role in the values of CK after damaging exercise.	[Del Coso, Juan; Valero, Marjorie; Jose Salinero, Juan; Lara, Beatriz; Gallo-Salazar, Cesar; Areces, Francisco] Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain	Camilo Jose Cela University	Del Coso, J (corresponding author), Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain.	jdelcoso@ucjc.edu	Areces, Francisco/ABH-3023-2020; Del Coso, Juan/AAC-7117-2020; MARTÍN, JUAN JOSÉ JJ SALINERO/I-4212-2012; Salinero, Juan J./GLT-1243-2022; GALLO, CESAR/O-4823-2019; Lara, Beatriz/AAQ-5269-2021	Areces, Francisco/0000-0003-2996-4156; Del Coso, Juan/0000-0002-5785-984X; MARTÍN, JUAN JOSÉ JJ SALINERO/0000-0003-4153-5100; Salinero, Juan J./0000-0003-4153-5100; GALLO, CESAR/0000-0001-8676-4658; Lara, Beatriz/0000-0001-5516-4852	ViceRectorate of Research and Science at the Camilo Jose Cela University	ViceRectorate of Research and Science at the Camilo Jose Cela University	The study was part of the DAMUS project supported by a Grant-in-aid from the ViceRectorate of Research and Science, at the Camilo Jose Cela University (http://www.ucjc.edu/la-universidad/estructura-academica/vicerrectorados/vicerrectorado-de-innovacion/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areces F, 2015, J ORTHOP SPORT PHYS, V45, P462, DOI 10.2519/jospt.2015.5863; Baumert P, 2016, EUR J APPL PHYSIOL, V116, P1595, DOI 10.1007/s00421-016-3411-1; Bosch X, 2009, NEW ENGL J MED, V361, P62, DOI 10.1056/NEJMra0801327; Chen YM, 2008, EUR J APPL PHYSIOL, V104, P579, DOI 10.1007/s00421-008-0728-4; Childers MK, 2004, MUSCLE NERVE, V29, P313, DOI 10.1002/mus.10517; Clarkson PM, 2006, MED SCI SPORT EXER, V38, P623, DOI 10.1249/01.mss.0000210192.49210.fc; Clarkson PM, 2005, J APPL PHYSIOL, V99, P564, DOI 10.1152/japplphysiol.00130.2005; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; Clarkson PM, 2007, SPORTS MED, V37, P361, DOI 10.2165/00007256-200737040-00022; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collins M, 2003, MED SCI SPORT EXER, V35, P1524, DOI 10.1249/01.MSS.0000084522.14168.49; Del Coso J, 2016, SCAND J MED SCI SPOR, V26, P1036, DOI 10.1111/sms.12542; Del Coso J, 2017, EUROPEAN JOURNAL OF; Del Coso J, 2017, EUR J APPL PHYSIOL, V117, P151, DOI 10.1007/s00421-016-3507-7; Del Coso J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160053; Del Coso J, 2013, AMINO ACIDS, V44, P1511, DOI 10.1007/s00726-013-1473-5; Del Coso J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057602; Del Coso J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043280; Deuster PA, 2013, EUR J APPL PHYSIOL, V113, P1997, DOI 10.1007/s00421-013-2622-y; Devaney JM, 2007, J APPL PHYSIOL, V102, P1815, DOI 10.1152/japplphysiol.01165.2006; Duan CM, 2010, GEN COMP ENDOCR, V167, P344, DOI 10.1016/j.ygcen.2010.04.009; Efstratiadis G, 2007, Hippokratia, V11, P129; Head SI, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004862; Heled Y, 1985, J APPL PHYSIOL, V103, P504; Hubal MJ, 2010, J APPL PHYSIOL, V108, P1651, DOI 10.1152/japplphysiol.00361.2009; Landau Mark E, 2012, J Clin Neuromuscul Dis, V13, P122, DOI 10.1097/CND.0b013e31822721ca; Ling PR, 1997, AM J PHYSIOL-ENDOC M, V272, pE333, DOI 10.1152/ajpendo.1997.272.3.E333; Ma F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054685; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; NEWHAM DJ, 1983, MUSCLE NERVE, V6, P380, DOI 10.1002/mus.880060507; Pimenta EM, 2012, EUR J APPL PHYSIOL, V112, P1495, DOI 10.1007/s00421-011-2109-7; Riedl I, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12314; Ruiz JR, 2009, J PHYSIOL-LONDON, V587, P1527, DOI 10.1113/jphysiol.2008.166645; Santos J Jr, 1999, JAAPA, V12, P46; Santos Jr J ., 1999, JAAPA-J AM ACAD PHYS, V12, P53; Sauret JM, 2002, AM FAM PHYSICIAN, V65, P907; Singh D, 2005, METHOD FIND EXP CLIN, V27, P39, DOI 10.1358/mf.2005.27.1.875435; Stewart CEH, 2004, J CELL PHYSIOL, V198, P237, DOI 10.1002/jcp.10387; Totsuka M, 2002, J APPL PHYSIOL, V93, P1280, DOI 10.1152/japplphysiol.01270.2001; Vincent B, 2010, J APPL PHYSIOL, V109, P564, DOI 10.1152/japplphysiol.01007.2009; Williams AG, 2008, J PHYSIOL-LONDON, V586, P113, DOI 10.1113/jphysiol.2007.141887; Yamin C, 2014, PEDIATR ENDOCR REV P, V11, P400; Yamin C, 2007, J APPL PHYSIOL, V103, P2057, DOI 10.1152/japplphysiol.00867.2007; Yamin C, 2009, EUR J APPL PHYSIOL, V107, P375, DOI 10.1007/s00421-009-1137-z; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002	46	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172965	10.1371/journal.pone.0172965	http://dx.doi.org/10.1371/journal.pone.0172965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257486	gold, Green Published, Green Submitted			2022-12-27	WOS:000396021100047
J	Kawai, E; Nakahara, H; Ueda, SY; Manabe, K; Miyamoto, T				Kawai, Eriko; Nakahara, Hidehiro; Ueda, Shin-ya; Manabe, Kou; Miyamoto, Tadayoshi			A novel approach for evaluating the effects of odor stimulation on dynamic cardiorespiratory functions	PLOS ONE			English	Article							OLFACTORY STIMULATION; GRAPEFRUIT OIL; BLOOD-PRESSURE; INHALATION; HUMANS; SYSTEM; SCENT; RATS	We aimed to develop a novel method to quantitatively evaluate the effects of odor stimulation on cardiorespiratory functions over time, and to examine the potential usefulness of clinical aromatherapy. Eighteen subjects participated. Nine people were assigned to each of the two resting protocols. Protocol 1: After resting for 2 min in a sitting position breathing room air, the subject inhaled either air or air containing sweet marjoram essential oil from the Douglas bag for 6 min, Protocol 2: After resting for 5 min in a supine position, the subject inhaled the essential oil for 10 min, and then recovered for 10 min breathing room air. All subjects inhaled the essential oil through a face mask attached to one-way valve, and beat-to-beat heart rate (HR) and arterial blood pressure (BP) as well as breath-by-breath respiratory variables were continuously recorded. In both protocols, during fragrance inhalation of the essential oil, time-dependent decrease in mean BP and HR were observed (P< 0.05). During post-inhalation recovery, the significant fragrance-induced bradycardic effect lasted at least 5 min (-3.1 +/- 3.9% vs. pre-inhalation baseline value, p< 0.05). The mean BP response at the start of odor stimulation was approximated by a first-order exponential model. However, such fragrance-induced changes were not observed in the respiratory variables. We established a novel approach to quantitatively and accurately evaluate the effects of quantitative odor stimulation on dynamic cardiorespiratory functions, and the duration of the effect. This methodological approach may be useful for scientific evaluation of aromatherapy as an approach to integrated medicine, and the mechanisms of action of physiological effects in fragrance compounds.	[Kawai, Eriko; Nakahara, Hidehiro; Ueda, Shin-ya; Manabe, Kou; Miyamoto, Tadayoshi] Morinomiya Univ Med Sci, Grad Sch Hlth Sci, Osaka, Osaka, Japan		Kawai, E (corresponding author), Morinomiya Univ Med Sci, Grad Sch Hlth Sci, Osaka, Osaka, Japan.	kawai@respiratorycontrol.com		miyamoto, tadayoshi/0000-0001-5504-6119	Research Project for Improving Quality in Healthcare and Collecting Scientific Evidence on Integrative Medicine from Japan Agency for Medical Research and Development, AMED	Research Project for Improving Quality in Healthcare and Collecting Scientific Evidence on Integrative Medicine from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This research was partially supported by the Research Project for Improving Quality in Healthcare and Collecting Scientific Evidence on Integrative Medicine from Japan Agency for Medical Research and Development, AMED.	Asano K, 2009, INFLUENCE ODOR STIMU, V8, P17; Cha JH, 2013, J KOREAN ACAD NURS, V40, P705; Dalton P, 1996, PERCEPT PSYCHOPHYS, V58, P781, DOI 10.3758/BF03213109; Goes TC, 2012, J ALTERN COMPLEM MED, V18, P798, DOI 10.1089/acm.2011.0551; Haze S, 2002, JPN J PHARMACOL, V90, P247, DOI 10.1254/jjp.90.247; Hongratanaworakit T, 2009, NAT PROD COMMUN, V4, P291; Ilmberger J, 2001, CHEM SENSES, V26, P239, DOI 10.1093/chemse/26.3.239; Ito A, 2010, PROMOTION SALIVATION, V14, P134; Niijima A, 2003, EXP BIOL MED, V228, P1190, DOI 10.1177/153537020322801014; Peng SM, 2009, J ALTERN COMPLEM MED, V15, P53, DOI 10.1089/acm.2008.0243; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Sayorwan Winai, 2012, Journal of the Medical Association of Thailand, V95, P598; Shen J, 2005, NEUROSCI LETT, V380, P289, DOI 10.1016/j.neulet.2005.01.058; Shiina Y, 2008, INT J CARDIOL, V129, P193, DOI 10.1016/j.ijcard.2007.06.064; Tanida M, 2006, NEUROSCI LETT, V398, P155, DOI 10.1016/j.neulet.2005.12.076; Umeno K, 2008, BRIT J CLIN PHARMACO, V65, P188, DOI 10.1111/j.1365-2125.2007.02992.x; VieIllard S, 2008, COGNITION EMOTION, V22, P720, DOI 10.1080/02699930701503567; Yamamoto Y., 2003, J JPN SOC PHYSL ANTH, V8, P25	19	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172841	10.1371/journal.pone.0172841	http://dx.doi.org/10.1371/journal.pone.0172841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257441	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100030
J	Ono, N; Murakami, K; Chan, O; Hall, H; Elford, AR; Yen, P; Calzascia, T; Spencer, DM; Ohashi, PS; Dhanji, S				Ono, Nobuyuki; Murakami, Kiichi; Chan, Olivia; Hall, Hakan; Elford, Alisha R.; Yen, Patty; Calzascia, Thomas; Spencer, David M.; Ohashi, Pamela S.; Dhanji, Salim			Exposure to sequestered self-antigens in vivo is not sufficient for the induction of autoimmune diabetes	PLOS ONE			English	Article							REGULATORY T-CELLS; APOPTOTIC CELLS; DENDRITIC CELLS; CROSS-PRESENTATION; TOLERANCE; BETA; MATURATION; CLEARANCE; DEATH; NECROPTOSIS	Although the role of T cells in autoimmunity has been explored for many years, the mechanisms leading to the initial priming of an autoimmune T cell response remain enigmatic. The `hit and run' model suggests that self-antigens released upon cell death can provide the initial signal for a self-sustaining autoimmune response. Using a novel transgenic mouse model where we could induce the release of self-antigens via caspase-dependent apoptosis. We tracked the fate of CD8+ T cells specific for the self-antigen. Our studies demonstrated that antigens released from apoptotic cells were cross-presented by CD11c+ cells in the draining lymph node. This cross-presentation led to proliferation of self-antigen specific T cells, followed by a transient ability to produce IFN-gamma,but did not lead to the development of autoimmune diabetes. Using this model we examined the consequences on T cell immunity when apoptosis was combined with dendritic cell maturation signals, an autoimmune susceptible genetic background, and the deletion of Tregs. The results of our study demonstrate that autoimmune diabetes cannot be initiated by the presentation of antigens released from apoptotic cells in vivo even in the presence of factors known to promote autoimmunity.	[Ono, Nobuyuki] Saga Univ, Fac Med, Dept Rheumatol, Saga, Japan; [Ono, Nobuyuki; Murakami, Kiichi; Chan, Olivia; Hall, Hakan; Elford, Alisha R.; Yen, Patty; Calzascia, Thomas; Ohashi, Pamela S.; Dhanji, Salim] Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Dept Med Biophys, Toronto, ON, Canada; [Ono, Nobuyuki; Murakami, Kiichi; Chan, Olivia; Hall, Hakan; Elford, Alisha R.; Yen, Patty; Calzascia, Thomas; Ohashi, Pamela S.; Dhanji, Salim] Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Dept Immunol, Toronto, ON, Canada; [Spencer, David M.] Baylor Coll Med, Texas Med Ctr, Dept Pathol & Immunol, Houston, TX 77030 USA; [Spencer, David M.] Bellicum Pharmaceut Inc, Houston, TX USA	Saga University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Ohashi, PS (corresponding author), Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Dept Med Biophys, Toronto, ON, Canada.; Ohashi, PS (corresponding author), Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Dept Immunol, Toronto, ON, Canada.	pohashi@uhnresearch.ca	Ono, Nobuyuki/T-7414-2019	Ohashi, Pamela S./0000-0003-2915-9317; ONO, NOBUYUKI/0000-0003-0709-4858; Calzascia, Thomas/0000-0001-8225-6744	NCIC; Canadian Cancer Society [17506]; CIHR fellowship; Uehara Memorial Foundation; Canada Research Chair in Autoimm unity and Tumor Immunity [950-200562]; NIH Tetramer Core Facility [HHSN272201300006C]; CANVAC Network Centres of Excellence (CANVAC TD1.5)	NCIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Cancer Society(Canadian Cancer Society (CCS)); CIHR fellowship(Canadian Institutes of Health Research (CIHR)); Uehara Memorial Foundation(Uehara Memorial Foundation); Canada Research Chair in Autoimm unity and Tumor Immunity; NIH Tetramer Core Facility(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CANVAC Network Centres of Excellence (CANVAC TD1.5)	This work was supported by the CANVAC Network Centres of Excellence (CANVAC TD1.5: http://www.nce.rce.gc.ca) and the NCIC with funds from the Canadian Cancer Society (17506: http://www.cancer.ca/research). NO is supported by a CIHR fellowship (http://www.cihr-irsc.gc.ca), Uehara Memorial Foundation (http:/www.ueharazaidan.or.jp), SD holds a CIHR fellowship and PSO holds a Canada Research Chair in Autoimm unity and Tumor Immunity (950-200562: http://www.chairs-chaires.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Caiying Guo (UConn Health Center) for generating the transgenic lines. We acknowledge the NIH Tetramer Core Facility (contract HHSN272201300006C) for provision of gp33-41, gp276-286 and np396-404 tetramers.	Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Bachmann MF, 1997, J VIROL, V71, P5764, DOI 10.1128/JVI.71.8.5764-5768.1997; Bluestone JA, 2008, J CLIN IMMUNOL, V28, P677, DOI 10.1007/s10875-008-9242-z; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Coppieters KT, 2012, APMIS, V120, P941, DOI 10.1111/apm.12011; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Ferris ST, 2014, IMMUNITY, V41, P657, DOI 10.1016/j.immuni.2014.09.012; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; George SK, 2004, J AUTOIMMUN, V23, P151, DOI 10.1016/j.jaut.2004.06.006; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Griffith TS, 2007, J IMMUNOL, V178, P2679, DOI 10.4049/jimmunol.178.5.2679; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Hugues S, 2002, IMMUNITY, V16, P169, DOI 10.1016/S1074-7613(02)00273-X; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Mallet VO, 2002, NAT BIOTECHNOL, V20, P1234, DOI 10.1038/nbt762; Melli K, 2009, J IMMUNOL, V182, P2590, DOI 10.4049/jimmunol.0803543; O'Brien BA, 2006, J AUTOIMMUN, V26, P104, DOI 10.1016/j.jaut.2005.11.006; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Parish IA, 2009, BLOOD, V113, P4575, DOI 10.1182/blood-2008-10-185223; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schildknecht A, 2010, P NATL ACAD SCI USA, V107, P199, DOI 10.1073/pnas.0910620107; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Tisch R, 2009, DIABETES, V58, P12, DOI 10.2337/db08-1341; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Wallet MA, 2008, J EXP MED, V205, P219, DOI 10.1084/jem.20062293; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Zelenay S, 2013, TRENDS IMMUNOL, V34, P329, DOI 10.1016/j.it.2013.03.005	46	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173176	10.1371/journal.pone.0173176	http://dx.doi.org/10.1371/journal.pone.0173176			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257518	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100070
J	Tardy, F; Damour, G; Dorel, M; Moreau, D				Tardy, Florence; Damour, Gaelle; Dorel, Marc; Moreau, Delphine			Trait-based characterisation of soil exploitation strategies of banana, weeds and cover plant species	PLOS ONE			English	Article							PHOSPHORUS ACQUISITION EFFICIENCY; FUNCTIONAL TRAITS; ECONOMICS SPECTRUM; ROOT ARCHITECTURE; CROPPING SYSTEMS; COMPETITION	Cover plants can be introduced in cropping systems to provide agroecosystem services, including weed control via competition for resources. There is currently no consensus on how to identify the best cover plant species, while trait-based approaches are promising for screening plant species due to their agroecosystem service provision potential. This study was carried out to characterize soil exploitation strategies of cover plant species in banana agroecosystems using a trait-based approach, and in turn identify cover plant species with a high weed control potential via competition for soil resources in banana cropping systems. A field experiment was conducted on 17 cover plant species, two weed species and two banana cultivars grown individually. Four functional traits were measured. Two of them (i. e., the size of the zone explored by roots and the root impact density) were used to characterize root system soil exploration patterns. Two other traits (i. e., specific root length and root diameter) were used to characterize resource acquisition within the soil zone explored by the roots. All studied traits exhibited marked variations among species. The findings suggested a trade-off between the abilities of species to develop a limited number of large diameter roots exploring a large soil zone versus many thin roots exploring a smaller soil zone. Three soil-resource exploitation strategies were identified among species: (i) with large diameter roots that explore a large soil zone; (ii) with small diameter roots and a high specific length that explore a smaller soil zone; and (iii) with a high total root-impact density and an intermediate specific root length that explore the uppermost soil layers. Interestingly, in our panel of species, no correlations with regard to belowground and aboveground strategies were noted: species with an acquisitive belowground strategy could display an acquisitive or a conservative aboveground strategy. The findings of this study illustrated that a trait-based approach could be used to identify plant species with potential for competing with weeds, while minimising competition with banana. Six of the 17 studied cover crop species were identified as having this potential. The next step will be to assess them for their weed control performances in banana cropping systems with low reliance on herbicides.	[Tardy, Florence; Damour, Gaelle; Dorel, Marc] CIRAD, UPR GECO, Capesterre Belle Eau, Guadeloupe, France; [Moreau, Delphine] Univ Bourgogne Franche Comte, INRA, AgroSup Dijon, Agroecol, Dijon, France	CIRAD; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Tardy, F; Damour, G (corresponding author), CIRAD, UPR GECO, Capesterre Belle Eau, Guadeloupe, France.; Moreau, D (corresponding author), Univ Bourgogne Franche Comte, INRA, AgroSup Dijon, Agroecol, Dijon, France.	florence.tardyfevrier@gmail.com; gaelle.damour@cirad.fr; delphine.moreau@inra.fr	Moreau, Delphine/C-5968-2014	Moreau, Delphine/0000-0003-2640-9931; DAMOUR, Gaelle/0000-0001-6080-7306	FEDER Guadeloupe Project "Agroecologie des systemes multi-especes pour le developpement d'une agriculture durable en milieu tropical"; CIRAD; INRA	FEDER Guadeloupe Project "Agroecologie des systemes multi-especes pour le developpement d'une agriculture durable en milieu tropical"; CIRAD; INRA	This work was supported by the FEDER Guadeloupe Project "Agroecologie des systemes multi-especes pour le developpement d'une agriculture durable en milieu tropical," lead by the consortium CIRAD/INRA/UA. FT was supported by grants from CIRAD and INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1999, J EXP BOT, V50, P29, DOI 10.1093/jexbot/50.330.29; Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; [Anonymous], 2014, R LANG ENV STAT COMP; BERNTSON GM, 1994, NEW PHYTOL, V127, P483, DOI 10.1111/j.1469-8137.1994.tb03966.x; Chanteloup P, 2013, THESIS; Chapman N, 2012, TRENDS PLANT SCI, V17, P701, DOI 10.1016/j.tplants.2012.08.001; Cornelissen JHC, 1997, OECOLOGIA, V111, P460, DOI 10.1007/s004420050259; Damour G, 2015, ADV AGRON, V134, P81, DOI 10.1016/bs.agron.2015.06.004; de Mendiburu F., 2019, AGRICOLAE STAT PROCE; Dunbabin VM, 2013, PLANT SOIL, V372, P93, DOI 10.1007/s11104-013-1769-y; Ehrmann J, 2014, PLANT SOIL, V376, P1, DOI 10.1007/s11104-013-1921-8; EISSENSTAT DM, 1992, J PLANT NUTR, V15, P763, DOI 10.1080/01904169209364361; Fort F, 2013, J PLANT ECOL, V6, P211, DOI 10.1093/jpe/rts034; Gahoonia TS, 2004, PLANT SOIL, V262, P55, DOI 10.1023/B:PLSO.0000037020.58002.ac; Gardarin A, 2011, ECOL MODEL, V222, P626, DOI 10.1016/j.ecolmodel.2010.10.005; Ge ZY, 2000, PLANT SOIL, V218, P159, DOI 10.1023/A:1014987710937; Hishi T, 2007, J FOREST RES-JPN, V12, P126, DOI 10.1007/s10310-006-0260-5; Hodge A, 1999, PLANT CELL ENVIRON, V22, P811, DOI 10.1046/j.1365-3040.1999.00454.x; Hunt MA, 2006, FOREST ECOL MANAG, V233, P260, DOI 10.1016/j.foreco.2006.05.017; Jungk AO, 2002, DYNAMICS NUTR MOVEME; Koohafkan P, 2012, INT J AGR SUSTAIN, V10, P61, DOI 10.1080/14735903.2011.610206; Lu YC, 2000, FOOD REV INT, V16, P121, DOI 10.1081/FRI-100100285; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Lynch JP, 2001, PLANT SOIL, V237, P225, DOI 10.1023/A:1013324727040; Maire V, 2009, FUNCT ECOL, V23, P668, DOI 10.1111/j.1365-2435.2009.01557.x; Malezieux E, 2009, AGRON SUSTAIN DEV, V29, P43, DOI 10.1051/agro:2007057; Martin AR, 2015, J APPL ECOL, V52, P1425, DOI 10.1111/1365-2664.12526; Mokany K, 2008, J VEG SCI, V19, P119, DOI 10.3170/2007-8-18340; Osone Y, 2005, FUNCT ECOL, V19, P460, DOI 10.1111/j.1365-2435.2005.00970.x; Pages L, 2014, ECOL MODEL, V290, P76, DOI 10.1016/j.ecolmodel.2013.11.014; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Roumet C, 2006, NEW PHYTOL, V170, P357, DOI 10.1111/j.1469-8137.2006.01667.x; Roumet C, 2016, NEW PHYTOL, V210, P815, DOI 10.1111/nph.13828; STEWART AJA, 1982, OECOLOGIA, V52, P269, DOI 10.1007/BF00363848; Tardy F, 2015, EUR J AGRON, V71, P10, DOI 10.1016/j.eja.2015.08.002; Tribouillois H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122156; Vandermeer J.H., 1989, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Wood SA, 2015, TRENDS ECOL EVOL, V30, P531, DOI 10.1016/j.tree.2015.06.013; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zhu JM, 2004, FUNCT PLANT BIOL, V31, P949, DOI 10.1071/FP04046	43	7	7	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173066	10.1371/journal.pone.0173066	http://dx.doi.org/10.1371/journal.pone.0173066			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257454	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100054
J	Teferi, WM; Desaulniers, MA; Noyce, RS; Shenouda, M; Umer, B; Evans, DH				Teferi, Wondimagegnehu M.; Desaulniers, Megan A.; Noyce, Ryan S.; Shenouda, Mira; Umer, Brittany; Evans, David H.			The vaccinia virus K7 protein promotes histone methylation associated with heterochromatin formation	PLOS ONE			English	Article							CONSTITUTIVE HETEROCHROMATIN; REPRESSIVE CHROMATIN; VIRULENCE FACTOR; IMMUNE-RESPONSE; INFECTED CELLS; MYXOMA VIRUS; BEN-DOMAIN; KAPPA-B; GENE; DNA	It has been well established that many vaccinia virus proteins suppress host antiviral pathways by targeting the transcription of antiviral proteins, thus evading the host innate immune system. However, whether viral proteins have an effect on the host's overall cellular transcription is less understood. In this study we investigated the regulation of heterochromatin during vaccinia virus infection. Heterochromatin is a highly condensed form of chromatin that is less transcriptionally active and characterized by methylation of histone proteins. We examined the change in methylation of two histone proteins, H3 and H4, which are major markers of heterochromatin, during the course of viral infection. Using immunofluorescence microscopy and flow cytometry we were able to track the overall change in the methylated levels of H3K9 and H4K20. Our results suggest that there is significant increase in methylation of H3K9 and H4K20 during Orthopoxviruses infection compared to mock-infected cells. However, this effect was not seen when we infected cells with Leporipoxviruses. We further screened several vaccinia virus single and multi-gene deletion mutant and identified the vaccinia virus gene K7R as a contributor to the increase in cellular histone methylation during infection.	[Teferi, Wondimagegnehu M.; Desaulniers, Megan A.; Noyce, Ryan S.; Shenouda, Mira; Umer, Brittany; Evans, David H.] Univ Alberta, Li Ka Shing Inst Virol, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Teferi, Wondimagegnehu M.] Albert Einstein Coll Med, Jacobi Med Ctr, Dept Med, Bronx, NY 10467 USA	University of Alberta; Jacobi Medical Center; Yeshiva University; Albert Einstein College of Medicine	Evans, DH (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.	devans@ualberta.ca	Evans, David/M-1912-2016	Evans, David/0000-0001-5871-299X	NSERC; CIHR; Canada Foundation for Innovation; Faculty of Medicine AMP; Dentistry Imaging and Flow Cytometry; Alberta Innovates [201600021] Funding Source: researchfish	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Faculty of Medicine AMP; Dentistry Imaging and Flow Cytometry; Alberta Innovates	This work was supported by NSERC and CIHR operating grants to DHE along with infrastructure awards from the Canada Foundation for Innovation.r We thank Dr. Steve Ogg and Dr. Aja Rieger for their advice and the support provided by the Faculty of Medicine & Dentistry Imaging and Flow Cytometry research cores. We also thank Ms. Nicole Favis for excellent technical assistance.	Abhiman S, 2008, BIOINFORMATICS, V24, P458, DOI 10.1093/bioinformatics/btn007; Ayrapetov MK, 2014, P NATL ACAD SCI USA, V111, P9169, DOI 10.1073/pnas.1403565111; Benfield CTO, 2013, J GEN VIROL, V94, P1647, DOI 10.1099/vir.0.052670-0; Benfield CTO, 2011, J BIOL CHEM, V286, P20727, DOI 10.1074/jbc.M111.231381; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Blanie S, 2009, VET RES, V40, DOI 10.1051/vetres:2008049; Broyles SS, 2003, J GEN VIROL, V84, P2293, DOI 10.1099/vir.0.18942-0; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Ciabrelli F, 2015, J MOL BIOL, V427, P608, DOI 10.1016/j.jmb.2014.09.013; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; Dai Q, 2013, GENE DEV, V27, P602, DOI 10.1101/gad.213314.113; Dambacher S, 2013, CELL CYCLE, V12, P2925, DOI 10.4161/cc.26179; Ember SWJ, 2012, J GEN VIROL, V93, P2098, DOI 10.1099/vir.0.045070-0; ENNIS HL, 1964, SCIENCE, V146, P1474, DOI 10.1126/science.146.3650.1474; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fahy AS, 2008, J GEN VIROL, V89, P2377, DOI 10.1099/vir.0.2008/004895-0; FALKNER FG, 1988, J VIROL, V62, P1849, DOI 10.1128/JVI.62.6.1849-1854.1988; Ferguson BJ, 2013, J GEN VIROL, V94, P2070, DOI 10.1099/vir.0.054114-0; Gammon DB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000984; Gonzalez JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-59; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guerra S, 2003, J VIROL, V77, P6493, DOI 10.1128/JVI.77.11.6493-6506.2003; Kalverda AP, 2009, J MOL BIOL, V385, P843, DOI 10.1016/j.jmb.2008.09.048; Knipe DM, 2013, VIROLOGY, V435, P141, DOI 10.1016/j.virol.2012.09.023; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kroetz DN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005338; KUFE DW, 1980, J BIOL CHEM, V255, P8997; Liu SW, 2015, CELL HOST MICROBE, V17, P320, DOI 10.1016/j.chom.2015.02.002; Murcia-Nicolas A, 1999, VIRUS RES, V59, P1, DOI 10.1016/S0168-1702(98)00114-2; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Oda S, 2009, STRUCTURE, V17, P1528, DOI 10.1016/j.str.2009.09.005; OPGENORTH A, 1992, J VIROL, V66, P4720, DOI 10.1128/JVI.66.8.4720-4731.1992; Ramsey-Ewing A, 1998, VIROLOGY, V242, P138, DOI 10.1006/viro.1997.8985; Regha K, 2007, MOL CELL, V27, P353, DOI 10.1016/j.molcel.2007.06.024; Rintoul JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024643; Rochester SC, 1998, J VIROL, V72, P2917, DOI 10.1128/JVI.72.4.2917-2926.1998; Rubins KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015615; Saksouk N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-3; Sathyan KM, 2011, J CELL SCI, V124, P3149, DOI 10.1242/jcs.086603; Schliehe C, 2015, NAT IMMUNOL, V16, P67, DOI 10.1038/ni.3046; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Senkevich TG, 2011, VIROLOGY, V417, P334, DOI 10.1016/j.virol.2011.06.017; Simoes M, 2015, VIRUSES-BASEL, V7, P4978, DOI 10.3390/v7092858; TADDIE JA, 1993, J VIROL, V67, P4323, DOI 10.1128/JVI.67.7.4323-4336.1993; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; Wasilenko ST, 2003, P NATL ACAD SCI USA, V100, P14345, DOI 10.1073/pnas.2235583100; Werden SJ, 2009, J VIROL, V83, P12068, DOI 10.1128/JVI.00963-09; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Xiao-Dan Yao, 2004, VACCINIA VIRUS POXVI, pxix; Yang ZL, 2011, J VIROL, V85, P9899, DOI 10.1128/JVI.05446-11; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Yoza BK, 2011, CYTOKINE, V53, P145, DOI 10.1016/j.cyto.2010.10.007; YUWEN H, 1993, VIROLOGY, V195, P732, DOI 10.1006/viro.1993.1424	57	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173056	10.1371/journal.pone.0173056	http://dx.doi.org/10.1371/journal.pone.0173056			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257484	Green Submitted, gold, Green Published			2022-12-27	WOS:000396021100052
J	Weng, CC; Chen, ZA; Chao, KT; Ee, TW; Lin, KJ; Chan, MH; Hsiao, IT; Yen, TC; Kung, MP; Hsu, CH; Wey, SP				Weng, Chi-Chang; Chen, Zi-An; Chao, Ko-Ting; Ee, Ting-Wei; Lin, Kun-Ju; Chan, Ming-Huan; Hsiao, Ing-Tsung; Yen, Tzu-Chen; Kung, Mei-Ping; Hsu, Ching-Han; Wey, Shiaw-Pyng			Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo F-18-9fluoropropyl-(+)-dihydrotetrabenazine PET imaging	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; VESICULAR MONOAMINE TRANSPORTER; DOPAMINE TRANSPORTER; F-18-FP-(+)-DTBZ F-18-AV-133; NEURONS; AUTORADIOGRAPHY; DEGENERATION; DIHYDROTETRABENAZINE; NEURODEGENERATION; DERIVATIVES	F-18-9-Fluoropropyl-(+)-dihydrotetrabenazine [F-18-FP-(+)-DTBZ] positron emission tomography (PET) has been shown to detect dopaminergic neuron loss associated with Parkinson's disease (PD) in human and neurotoxin-induced animal models. A polyphenol compound, magnolol, was recently proposed as having a potentially restorative effect in 1 methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- or 6-hydroxydopamine-treated animal models. In this study, 18F-FP-(+)-DTBZ PET was used to determine the therapeutic efficacy of magnolol in an MPTP PD mouse model that was prepared by giving an intraperitoneally (i.p.) daily dose of 25 mg/kg MPTP to male C57BU6 mice for 5 consecutive days. Twenty minute static 18F-FP-(+)-DTBZ PET scans were performed before MPTP treatment and 5 days after the termination of MPTP treatment to set up the baseline control. Half of the MPTP-treated mice then received a daily dose of magnolol (10 mg/kg dissolved in corn oil, i.p.) for 6 days. 18F-FP-(+)-DTBZ PET imaging was performed the day after the final treatment. All F-18-FP-(+)-DTBZ PET images were analysed and the specific uptake ratio (SUr) was calculated. Ex vivo autoradiography (ARG) and corresponding immunohistochemistry (IHC) studies were conducted to confirm the distribution of dopaminergic terminals in the striatum. The striatal SUr ratios of 18F-FP-(+)-DTBZ PET images for the Sham, the MPTP, and the MPTP + Magnolol-treated groups were 1.25 0.05, 0.75 0.06, and 1.00 0.11, respectively (n = 4 for each group). The ex vivo 18F-FP-(+)-DTBZ ARG and IHC results correlated favourably with the PET imaging results. F-18-FP-(+)-DTBZ PET imaging suggested that magnolol post-treatment may reverse the neuronal damage in the MPTP-lesioned PD mice. In vivo imaging of the striatal vesicular monoamine transporter type 2 (VMAT2) distribution using F-18-FP-(+)-DTBZ animal PET is a useful method to evaluate the efficacy of therapeutic drugs i.e., magnolol, for the management of PD.	[Weng, Chi-Chang; Chen, Zi-An; Ee, Ting-Wei; Hsiao, Ing-Tsung; Wey, Shiaw-Pyng] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Weng, Chi-Chang; Hsu, Ching-Han] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Chao, Ko-Ting; Lin, Kun-Ju; Hsiao, Ing-Tsung; Yen, Tzu-Chen; Wey, Shiaw-Pyng] Chang Gung Mem Hosp, Dept Nucl Med, Ctr Adv Mol Imaging & Translat, Taoyuan, Taiwan; [Lin, Kun-Ju; Hsiao, Ing-Tsung] Chang Gung Mem Hosp, Neurosci Res Ctr, Taoyuan, Taiwan; [Chan, Ming-Huan] Natl Chengchi Univ, Inst Neurosci, Taipei, Taiwan; [Kung, Mei-Ping] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Wey, Shiaw-Pyng] Chang Gung Univ, Inst Radiol Res, Taoyuan, Taiwan; [Wey, Shiaw-Pyng] Chang Gung Mem Hosp, Taoyuan, Taiwan	Chang Gung University; National Tsing Hua University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Chengchi University; University of Pennsylvania; Chang Gung University; Chang Gung Memorial Hospital	Wey, SP (corresponding author), Chang Gung Univ, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan.; Hsu, CH (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.; Wey, SP (corresponding author), Chang Gung Mem Hosp, Dept Nucl Med, Ctr Adv Mol Imaging & Translat, Taoyuan, Taiwan.; Wey, SP (corresponding author), Chang Gung Univ, Inst Radiol Res, Taoyuan, Taiwan.; Wey, SP (corresponding author), Chang Gung Mem Hosp, Taoyuan, Taiwan.	cghsu@mx.nthu.edu.tw; spwey@mail.cgu.edu.tw	; Hsu, Ching-Han/G-6029-2010	Hsiao, Ing-Tsung/0000-0002-5255-7498; Hsu, Ching-Han/0000-0003-2351-2052; CHAN, MING-HUAN/0000-0003-3206-8731	Ministry of Science and Technology, Taiwan [NSC 100-2314-B-182A-092-MY3, 102-2221-E-007-021-MY2, 102-2314-B-182-049-MY3, 1032623-E-182-001-NU]; Research Fund of Chang Gung Memorial Hospital [CMRPG3A0513, CMRPG391514]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Research Fund of Chang Gung Memorial Hospital	This study was carried out with financial support from the Ministry of Science and Technology, Taiwan (Grant NSC 100-2314-B-182A-092-MY3 for KJL, 102-2221-E-007-021-MY2 for CHH, 102-2314-B-182-049-MY3 and 1032623-E-182-001-NU for SPW), and grants from the Research Fund of Chang Gung Memorial Hospital (CMRPG3A0513 and CMRPG391514 for KJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RJE, 2001, LANCET, V358, P1174, DOI 10.1016/S0140-6736(01)06260-2; BARBEAU A, 1969, UNION MED CAN, V98, P183; Bohnen NI, 2006, J CEREBR BLOOD F MET, V26, P1198, DOI 10.1038/sj.jcbfm.9600276; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Chao KT, 2012, SYNAPSE, V66, P823, DOI 10.1002/syn.21572; Chen HH, 2011, NEURODEGENER DIS, V8, P364, DOI 10.1159/000323872; Chen IJ, 2013, THE 11TH INTERNATION; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Cotzias G C, 1968, Trans Assoc Am Physicians, V81, P171; COTZIAS GC, 1967, NEW ENGL J MED, V276, P374, DOI 10.1056/NEJM196702162760703; COTZIAS GC, 1969, NEW ENGL J MED, V280, P337, DOI 10.1056/NEJM196902132800701; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de la Fuente-Fernandez R, 2011, ANN NEUROL, V69, P803, DOI 10.1002/ana.22284; Fornai F, 2000, BRAIN RES, V887, P110, DOI 10.1016/S0006-8993(00)02999-1; Frey KA, 1996, ANN NEUROL, V40, P873, DOI 10.1002/ana.410400609; Frey KA, 2001, ADV NEUROL, V86, P237; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Goswami R, 2006, NUCL MED BIOL, V33, P685, DOI 10.1016/j.nucmedbio.2006.05.006; HALLMAN H, 1985, J NEUROCHEM, V44, P117, DOI 10.1111/j.1471-4159.1985.tb07120.x; Hsiao IT, 2014, JAMA NEUROL, V71, P758, DOI 10.1001/jamaneurol.2014.290; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jakowec MW, 2004, J NEUROSCI RES, V76, P539, DOI 10.1002/jnr.20114; Jankovic Joseph, 2008, Neuropsychiatr Dis Treat, V4, P743; Jenner P, 2006, NEUROLOGY, V66, pS24, DOI 10.1212/WNL.66.10_suppl_4.S24; Jenner P, 2008, ANN NEUROL, V64, pS16, DOI 10.1002/ana.21489; JOHNSTON RF, 1990, ELECTROPHORESIS, V11, P355, DOI 10.1002/elps.1150110503; Kilbourn M, 1996, EUR J PHARMACOL, V307, P227, DOI 10.1016/0014-2999(96)00252-X; Kilbourn MR, 2007, NUCL MED BIOL, V34, P233, DOI 10.1016/j.nucmedbio.2007.01.007; Kung MP, 2007, NUCL MED BIOL, V34, P239, DOI 10.1016/j.nucmedbio.2006.12.005; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee CS, 2004, ARCH NEUROL-CHICAGO, V61, P1920, DOI 10.1001/archneur.61.12.1920; Lin KJ, 2011, NUCL MED BIOL, V38, P1149, DOI 10.1016/j.nucmedbio.2011.05.010; Lin KJ, 2010, J NUCL MED, V51, P1480, DOI 10.2967/jnumed.110.078196; Lin SC, 2014, J NUCL MED, V55, P73, DOI 10.2967/jnumed.113.121897; Lin YR, 2006, EUR J PHARMACOL, V537, P64, DOI 10.1016/j.ejphar.2006.03.035; Liu KY, 2013, NEUROCHEM RES, V38, P201, DOI 10.1007/s11064-012-0909-8; Ma KH, 2009, NEUROIMAGE, V45, P687, DOI 10.1016/j.neuroimage.2008.12.060; Matsui N, 2005, BIOL PHARM BULL, V28, P1762, DOI 10.1248/bpb.28.1762; Matsui N, 2009, BRAIN RES, V1305, P108, DOI 10.1016/j.brainres.2009.09.107; MOTOJI N, 1995, BIOL PHARM BULL, V18, P89; Muroyama A, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/985157; Okamura N, 2010, J NUCL MED, V51, P223, DOI 10.2967/jnumed.109.070094; Schmidt KC, 2005, NUCL MED BIOL, V32, P719, DOI 10.1016/j.nucmedbio.2005.04.020; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; Toomey JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039041; Tsao HH, 2010, NUCL MED BIOL, V37, P413, DOI 10.1016/j.nucmedbio.2010.01.002; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; VanderBorght T, 1995, EUR J PHARMACOL, V294, P577; Wilson JM, 1996, J NEUROSCI, V16, P3507; Yahr M D, 1968, Trans Am Neurol Assoc, V93, P56	51	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173503	10.1371/journal.pone.0173503	http://dx.doi.org/10.1371/journal.pone.0173503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257461	gold, Green Published, Green Submitted			2022-12-27	WOS:000396021100094
J	Bilardi, JE; Walker, SM; Temple-Smith, MJ; McNair, RP; Mooney-Somers, J; Vodstrcil, LA; Bellhouse, CE; Fairley, CK; Bradshaw, CS				Bilardi, Jade E.; Walker, Sandra M.; Temple-Smith, Meredith J.; McNair, Ruth P.; Mooney-Somers, Julie; Vodstrcil, Lenka A.; Bellhouse, Clare E.; Fairley, Christopher K.; Bradshaw, Catriona S.			Women view key sexual behaviours as the trigger for the onset and recurrence of bacterial vaginosis	PLOS ONE			English	Article							PEROXIDE-PRODUCING LACTOBACILLI; RISK-FACTORS; ORAL METRONIDAZOLE; PRETERM DELIVERY; COLONIZATION; CIRCUMCISION; ASSOCIATION; EXPERIENCES; PREVALENCE; PREVENTION	Background Bacterial vaginosis (BV) affects a third of women of reproductive age in the US and there is increasing evidence to suggest it may be sexually transmitted. This study aimed to extend and validate the findings of our earlier smaller qualitative study by exploring in detail women's views and experiences of the triggering factors associated with BV onset and recurrence. Methods Women aged 20-49, who had experienced one or more symptomatic episode of BV within 6 months, were opportunistically recruited to complete a 38-item questionnaire on their experience of BV. Results 103 women completed the questionnaire. Women were significantly more likely to report sexual than lifestyle factors triggered BV onset and recurrence (p< 0.001). The top 3 factors women attributed to both BV onset and recurrence were identical-and all sexual. They included, in order: 1) unprotected sex; 2) sex with a new male partner; and 3) sex in general. The main lifestyle factors nominated included stress, diet, menstruation and the use of feminine hygiene products. While many women felt their BV had been transmitted through sexual contact (54%) and developed as a result of sexual activity (59%), few considered BV a sexually transmitted infection (STI) (10%). Despite this 57% felt partners should also be treated for BV. Conclusion These data concur with our earlier qualitative findings that women believe BV is triggered by sexual activity. While many women felt BV was sexually transmitted and supported partner treatment, they did not consider BV an STI. This contradiction is likely due to information conveyed to women based on current guidelines. In the absence of highly effective BV treatments, this study highlights the need for guidelines to indicate there is scientific uncertainty around the pathogenesis of BV and to contain clear health messages regarding the evidence for practices shown to be associated with a reduced risk of BV ( i.e. consistent condom use.	[Bilardi, Jade E.; Walker, Sandra M.; Vodstrcil, Lenka A.; Fairley, Christopher K.; Bradshaw, Catriona S.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Bilardi, Jade E.; Walker, Sandra M.; Vodstrcil, Lenka A.; Bellhouse, Clare E.; Fairley, Christopher K.; Bradshaw, Catriona S.] Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Bilardi, Jade E.; Temple-Smith, Meredith J.; McNair, Ruth P.] Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia; [Mooney-Somers, Julie] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW, Australia; [Bellhouse, Clare E.] Monash Univ, Dept Epidemiol & Preventat Med, Melbourne, Vic, Australia; [Bradshaw, Catriona S.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Sydney; Monash University; University of Melbourne	Bilardi, JE (corresponding author), Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia.; Bilardi, JE (corresponding author), Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.; Bilardi, JE (corresponding author), Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia.	jbilardi@mshc.org.au	Vodstrcil, Lenka/AAF-8722-2020; McNair, Ruth P/B-3027-2012; Vodstrcil, Lenka/AAC-1896-2019	Vodstrcil, Lenka/0000-0003-3679-9195; Christopher, Fairley/0000-0001-9081-1664; Bilardi, Jade/0000-0003-0461-2605; bradshaw, catriona/0000-0002-6643-5678; McNair, Ruth/0000-0002-4738-8781	NHMRC Early Career Fellowship [1013135]	NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Dr Jade Bilardi is in receipt of an NHMRC Early Career Fellowship no 1013135.	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; Amaya-Guio J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011701.pub2; Bailey JV, 2004, SEX TRANSM DIS, V31, P691, DOI 10.1097/01.olq.0000143093.70899.68; Bilardi J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151794; Bilardi J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150272; Bilardi JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074378; Boskey ER, 2005, ALTERN THER HEALTH M, V11, P38; Bradshaw CS, 2016, J INFECT DIS, V214, pS14, DOI 10.1093/infdis/jiw159; Bradshaw CS, 2014, J INFECT DIS, V209, P1562, DOI 10.1093/infdis/jit664; Bradshaw CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057688; Bradshaw CS, 2013, CLIN INFECT DIS, V56, P777, DOI 10.1093/cid/cis1030; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Bradshaw CS, 2005, OBSTET GYNECOL, V106, P105, DOI 10.1097/01.AOG.0000163247.78533.7b; Calzolari E, 2000, INT J GYNECOL OBSTET, V70, P341, DOI 10.1016/S0020-7292(00)00217-4; Chapple A, 2000, J REPROD INFANT PSYC, V18, P309, DOI 10.1080/713683045; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Collins D, 2003, QUAL LIFE RES, V12, P229, DOI 10.1023/A:1023254226592; Culhane Jennifer F, 2006, Curr Infect Dis Rep, V8, P459, DOI 10.1007/s11908-006-0020-x; EASMON CSF, 1992, GENITOURIN MED, V68, P134; Eschenbach DA, 2007, CLIN INFECT DIS, V44, P220, DOI 10.1086/509584; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Fethers KA, 2009, J INFECT DIS, V200, P1662, DOI 10.1086/648092; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Gray RH, 2009, J INFECT DIS, V199, P1, DOI 10.1086/595568; Guedou FA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Holzman C, 2001, AM J PUBLIC HEALTH, V91, P1664, DOI 10.2105/AJPH.91.10.1664; Hood JE, 2011, SEX HEALTH, V8, P159, DOI 10.1071/SH10070; Hutchinson KB, 2007, SEX TRANSM DIS, V34, P671, DOI 10.1097/01.olq.0000258435.34879.da; Irving G, 1998, SEX TRANSM INFECT, V74, P334, DOI 10.1136/sti.74.5.334; Johnson SR, 2010, J LOW GENIT TRACT DI, V14, P287, DOI 10.1097/LGT.0b013e3181d85bb7; Karasz A, 2003, SOC SCI MED, V56, P1013, DOI 10.1016/S0277-9536(02)00092-8; Klebanoff MA, 2010, SEX TRANSM DIS, V37, P94, DOI 10.1097/OLQ.0b013e3181bc063c; Liu CM, 2015, MBIO, V6, DOI 10.1128/mBio.00589-15; Liu CM, 2013, MBIO, V4, DOI 10.1128/mBio.00076-13; Marrazzo JM, 2010, SEX TRANSM DIS, V37, P335, DOI 10.1097/OLQ.0b013e3181ca3cac; McClelland RS, 2008, SEX TRANSM DIS, V35, P617, DOI 10.1097/OLQ.0b013e31816907fa; Mehta SD, 2012, SEX TRANSM DIS, V39, P822, DOI 10.1097/OLQ.0b013e3182631d89; Melbourne Sexual Health Centre, 2016, BACT VAG BV FACTSH; Miller K, 2003, AM J HEALTH BEHAV, V27, pS264; Mitchell C, 2011, SEX TRANSM DIS, V38, P1137, DOI 10.1097/OLQ.0b013e31822e6121; Nansel TR, 2006, AM J OBSTET GYNECOL, V194, P381, DOI 10.1016/j.ajog.2005.07.047; Ness RB, 2002, OBSTET GYNECOL, V100, P765, DOI 10.1016/S0029-7844(02)02184-1; Newton Danielle C, 2005, Sex Health, V2, P63, DOI 10.1071/SH04015; Nyirjesy P, 1997, OBSTET GYNECOL, V90, P50, DOI 10.1016/S0029-7844(97)00242-1; ODowd T, 1996, BRIT J GEN PRACT, V46, P415; Parma M, 2014, ALTERN THER HEALTH M, V20, P52; Payne SC, 2010, J AM ACAD NURSE PRAC, V22, P101, DOI 10.1111/j.1745-7599.2009.00474.x; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Royce RA, 1999, SEX TRANSM DIS, V26, P96, DOI 10.1097/00007435-199902000-00007; Schwebke JR, 2005, SEX TRANSM DIS, V32, P654, DOI 10.1097/01.olq.0000175396.10304.62; Sewankambo N, 1997, LANCET, V350, P546, DOI 10.1016/S0140-6736(97)01063-5; Smart S, 2004, SEX TRANSM INFECT, V80, P58, DOI 10.1136/sti.2003.004978; Sobel JD, 1997, NEW ENGL J MED, V337, P1896, DOI 10.1056/NEJM199712253372607; SOBEL JD, 1993, J INFECT DIS, V167, P783, DOI 10.1093/infdis/167.3.783; Spark MJ, 2014, RES SOC ADMIN PHARM, V10, P469, DOI 10.1016/j.sapharm.2013.06.007; Verstraelen H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-148; Verstraelen H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-81; Vodstrcil LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073055; Willis GB, 1999 M AM STAT ASS; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	63	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173637	10.1371/journal.pone.0173637	http://dx.doi.org/10.1371/journal.pone.0173637			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278277	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900023
J	Masuda, H; Shimochi, E; Hamada, T; Senoura, T; Kobayashi, T; Aung, MS; Ishimaru, Y; Ogo, Y; Nakanishi, H; Nishizawa, NK				Masuda, Hiroshi; Shimochi, Erika; Hamada, Tatsuro; Senoura, Takeshi; Kobayashi, Takanori; Aung, May Sann; Ishimaru, Yasuhiro; Ogo, Yuko; Nakanishi, Hiromi; Nishizawa, Naoko K.			A new transgenic rice line exhibiting enhanced ferric iron reduction and phytosiderophore production confers tolerance to low iron availability in calcareous soil	PLOS ONE			English	Article							ORYZA-SATIVA L.; REGULATED METAL TRANSPORTER; GRAMINEOUS PLANTS; HORDEUM-VULGARE; MUGINEIC ACID; BARLEY GENES; NICOTIANAMINE AMINOTRANSFERASE; 2'-DEOXYMUGINEIC ACID; CHELATE REDUCTASE; SYNTHASE GENES	Iron (Fe) deficiency is a critical agricultural problem, especially in calcareous soil, which is distributed worldwide. Rice plants take up Fe(II) from soil through a OsIRT1 transporter (Strategy I-related system) and also take up Fe(III) via a phytosiderophore-based system (Strategy II system). However, rice plants are susceptible to low-Fe conditions because they have low Fe(III) reduction activity and low-level phytosiderophore secretion. Previously, we produced transgenic rice plants expressing a mutationally reconstructed yeast ferric chelate reductase, refre1/372, under the control of the OsIRT1 promoter. This transgenic rice line exhibited higher Fe(III) chelate reductase activity and tolerance to Fe deficiency. In addition, we produced transgenic rice overexpressing the Fe deficiency-inducible transcription factor, OsIRO2, which regulates the expression of various genes involved in the strategy II Fe(III) uptake system, including OsNAS1, OsNAAT1, OsDMAS1, OsYSL15, and TOM1. This transgenic rice exhibited improved phytosiderophore secretion ability and tolerance to Fe deficiency. In the present research, transgenic rice plants that possess both the OsIRT1 promoter-refre1/372 and the 35S promoter-OsIRO2 (RI lines) were produced to enhance both Strategy I Fe(II) reductase ability and Strategy II phytosiderophore productivity. RI lines exhibited enhanced tolerance to Fe-deficient conditions at the early and middle-late stages of growth in calcareous soil, compared to both the non-transgenic line and lines harboring either OsIRT1 promoter-refre1/372 or 35S promoter-OsIRO2 alone. RI lines also exhibited a 9-fold higher yield than the non-transgenic line. Moreover, we successfully produced Fe-deficiency-tolerant Tachisugata rice, which is a high-biomass variety used as fodder. Collectively, our results demonstrate that combined enhancement of two Fe uptake systems in rice is highly effective in conferring tolerance to low Fe availability in calcareous soil.	[Masuda, Hiroshi; Shimochi, Erika; Hamada, Tatsuro; Senoura, Takeshi; Kobayashi, Takanori; Aung, May Sann; Nishizawa, Naoko K.] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa, Japan; [Ishimaru, Yasuhiro] Tohoku Univ, Grad Sch Sci, Aoba Ku, Sendai, Miyagi, Japan; [Ogo, Yuko] Natl Inst Agrobiol Sci, Funct Plant Res Unit, Tsukuba, Ibaraki, Japan; [Nakanishi, Hiromi] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan	Ishikawa Prefecture University; Tohoku University; National Institute of Agrobiological Sciences - Japan; University of Tokyo	Nishizawa, NK (corresponding author), Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa, Japan.	kz-naoko@ishikawa-pu.ac.jp	ISHIMARU, Yasuhiro/AAS-5947-2020	ISHIMARU, Yasuhiro/0000-0003-4723-8844	Advanced Low Carbon Technology Research and Development Program (ALGA) of the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Sciences (JSPS)	Advanced Low Carbon Technology Research and Development Program (ALGA) of the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Sciences (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Advanced Low Carbon Technology Research and Development Program (ALGA) of the Japan Science and Technology Agency (JST) to NK Nishizawa and a Grant-in-Aid for Scientific Research (A) from the Japan Society for the Promotion of Sciences (JSPS) to NK Nishizawa.	Araki R, 2015, PLANT J, V81, P233, DOI 10.1111/tpj.12722; Bashir K, 2006, J BIOL CHEM, V281, P32395, DOI 10.1074/jbc.M604133200; Briat JF, 2015, TRENDS PLANT SCI, V20, P33, DOI 10.1016/j.tplants.2014.07.005; Bughio N, 2002, J EXP BOT, V53, P1677, DOI 10.1093/jxb/erf004; Connolly EL, 2003, PLANT PHYSIOL, V133, P1102, DOI 10.1104/pp.103.025122; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Horita M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-014-0192-9; Inoue H, 2009, J BIOL CHEM, V284, P3470, DOI 10.1074/jbc.M806042200; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Ishimaru Y, 2007, P NATL ACAD SCI USA, V104, P7373, DOI 10.1073/pnas.0610555104; Ishimaru Y, 2011, J BIOL CHEM, V286, P24649, DOI 10.1074/jbc.M111.221168; Kobayashi T, 2005, J EXP BOT, V56, P1305, DOI 10.1093/jxb/eri131; Kobayashi T, 2001, PLANTA, V212, P864, DOI 10.1007/s004250000453; Kobayashi T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3792; Kobayashi T, 2009, PLANT J, V60, P948, DOI 10.1111/j.1365-313X.2009.04015.x; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; Lee S, 2009, PLANT PHYSIOL, V150, P786, DOI 10.1104/pp.109.135418; Ma JF, 1999, PLANTA, V207, P590, DOI 10.1007/s004250050522; MARSCHNER H, 1986, J PLANT NUTR, V9, P695, DOI 10.1080/01904168609363475; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Masuda H, 2013, RICE, V6, DOI 10.1186/1939-8433-6-40; Masuda H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00132; Masuda H, 2009, RICE, V2, P155, DOI 10.1007/s12284-009-9031-1; Masuda H, 2008, RICE, V1, P100, DOI 10.1007/s12284-008-9007-6; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; MORI S, 1987, PLANT CELL PHYSIOL, V28, P1081; Murata Y, 2006, PLANT J, V46, P563, DOI 10.1111/j.1365-313X.2006.02714.x; Nakanishi H, 2000, PLANT MOL BIOL, V44, P199, DOI 10.1023/A:1006491521586; Nishiyama R, 2012, PLANT CELL PHYSIOL, V53, P381, DOI 10.1093/pcp/pcr188; Nozoye T, 2014, PLANT J, V77, P246, DOI 10.1111/tpj.12383; Nozoye T, 2011, J BIOL CHEM, V286, P5446, DOI 10.1074/jbc.M110.180026; Ogo Y, 2007, PLANT J, V51, P366, DOI 10.1111/j.1365-313X.2007.03149.x; Ogo Y, 2006, J EXP BOT, V57, P2867, DOI 10.1093/jxb/erl054; Ogo Y, 2011, PLANT MOL BIOL, V75, P593, DOI 10.1007/s11103-011-9752-6; Ohta H., 2010, B NATL I CROP SCI, V11, P67; Oki H, 2004, SOIL SCI PLANT NUTR, V50, P1159, DOI 10.1080/00380768.2004.10408589; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; ROMHELD V, 1986, PLANT PHYSIOL, V80, P175, DOI 10.1104/pp.80.1.175; Sallaud C, 2003, THEOR APPL GENET, V106, P1396, DOI 10.1007/s00122-002-1184-x; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; Suzuki M, 2008, SOIL SCI PLANT NUTR, V54, P77, DOI 10.1111/j.1747-0765.2007.00205.x; TAKAGI SI, 1976, SOIL SCI PLANT NUTR, V22, P423, DOI 10.1080/00380768.1976.10433004; Takahashi M, 1999, PLANT PHYSIOL, V121, P947, DOI 10.1104/pp.121.3.947; Takahashi M, 2003, PLANT CELL, V15, P1263, DOI 10.1105/tpc.010256; Takahashi M, 2001, NAT BIOTECHNOL, V19, P466, DOI 10.1038/88143; Terada R, 2004, PLANT CELL REP, V22, P653, DOI 10.1007/s00299-003-0752-0; THOMSON D, 1995, BIOTECHNIQUES, V19, P394	50	18	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173441	10.1371/journal.pone.0173441	http://dx.doi.org/10.1371/journal.pone.0173441			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278216	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900093
J	Wold, JP; Veiseth-Kent, E; Host, V; Lovland, A				Wold, Jens Petter; Veiseth-Kent, Eva; Host, Vibeke; Lovland, Atle			Rapid on-line detection and grading of wooden breast myopathy in chicken fillets by near-infrared spectroscopy	PLOS ONE			English	Article							IMAGING SPECTROSCOPY; SPECTRA; MUSCLE; WATER	The main objective of this work was to develop a method for rapid and non-destructive detection and grading of wooden breast (WB) syndrome in chicken breast fillets. Near-infrared (NIR) spectroscopy was chosen as detection method, and an industrial NIR scanner was applied and tested for large scale on-line detection of the syndrome. Two approaches were evaluated for discrimination of WB fillets: 1) Linear discriminant analysis based on NIR spectra only, and 2) a regression model for protein was made based on NIR spectra and the estimated concentrations of protein were used for discrimination. A sample set of 197 fillets was used for training and calibration. A test set was recorded under industrial conditions and contained spectra from 79 fillets. The classification methods obtained 99.5-100% correct classification of the calibration set and 100% correct classification of the test set. The NIR scanner was then installed in a commercial chicken processing plant and could detect incidence rates of WB in large batches of fillets. Examples of incidence are shown for three broiler flocks where a high number of fillets (9063, 6330 and 10483) were effectively measured. Prevalence of WB of 0.1%, 6.6% and 8.5% were estimated for these flocks based on the complete sample volumes. Such an on-line system can be used to alleviate the challenges WB represents to the poultry meat industry. It enables automatic quality sorting of chicken fillets to different product categories. Manual laborious grading can be avoided. Incidences of WB from different farms and flocks can be tracked and information can be used to understand and point out main causes for WB in the chicken production. This knowledge can be used to improve the production procedures and reduce today's extensive occurrence of WB.	[Wold, Jens Petter; Veiseth-Kent, Eva; Host, Vibeke] Nofima AS, Norwegian Inst Food & Fisheries Res, Muninbakken 9-13, Tromso, Norway; [Lovland, Atle] Nortura SA, Lorenveien 37, Oslo, Norway	Nofima	Wold, JP (corresponding author), Nofima AS, Norwegian Inst Food & Fisheries Res, Muninbakken 9-13, Tromso, Norway.	jens.petter.wold@nofima.no		Veiseth-Kent, Eva/0000-0002-8432-6010	Norwegian Agricultural Food Research Foundation [225347/F40, 224820/F40]; Norwegian company Nortura SA	Norwegian Agricultural Food Research Foundation; Norwegian company Nortura SA	This work was partially funded by the Norwegian Agricultural Food Research Foundation through the projects Food Imaging (project number 225347/F40) and Impact of protein composition for predictable food quality (224820/F40) and by the Norwegian company Nortura SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially funded by the Norwegian Agricultural Food Research Foundation through the projects Food Imaging (project number 225347/F40) and Impact of protein composition for predictable food quality (224820/F40) and by the Norwegian company Nortura SA. Karen Wahlstrom Sanden and Bjorg Narum are thanked for skilled technical assistance. We are grateful to Dr. Ragni Ofstad, Dr. Ingrid Mage and Dr. Ingunn Berget for valuable discussions.	Abasht B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153750; BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; Chung SH, 2008, PHYS MED BIOL, V53, P6713, DOI 10.1088/0031-9155/53/23/005; Cozzolino D., 1996, Journal of Near Infrared Spectroscopy, V4, P213; Duda R. O., 1973, PATTERN CLASSIFICATI; Gee K., 2016, WALL STREET J; Kuttappan VA, 2016, POULTRY SCI, V95, P2724, DOI 10.3382/ps/pew216; LIBNAU FO, 1994, VIB SPECTROSC, V7, P243, DOI 10.1016/0924-2031(94)85014-3; MACGREGOR JF, 1995, CONTROL ENG PRACT, V3, P403, DOI 10.1016/0967-0661(95)00014-L; Martens H, 1993, MULIVARIATE CALIBRAT; Porep JU, 2015, TRENDS FOOD SCI TECH, V46, P211, DOI 10.1016/j.tifs.2015.10.002; Segtnan VH, 2009, J NEAR INFRARED SPEC, V17, P247, DOI 10.1255/jnirs.851; Sihvo HK, 2014, VET PATHOL, V51, P619, DOI 10.1177/0300985813497488; Soglia F, 2016, FOOD RES INT, V89, P1071, DOI 10.1016/j.foodres.2016.04.042; Solland GH, 2004, MEAT SCI, V66, P543, DOI [10.1016/50309-1740(03)00157-8, DOI 10.1016/50309-1740(03)00157-8]; Trocino A, 2015, POULTRY SCI, V94, P2996, DOI 10.3382/ps/pev296; Velleman SG, 2015, AVIAN DIS, V59, P410, DOI 10.1637/11097-042015-Reg.1; Wold JP, 2011, MEAT SCI, V89, P317, DOI 10.1016/j.meatsci.2011.05.001; Wold JP, 2010, APPL SPECTROSC, V64, P691, DOI 10.1366/000370210791666273; Wold JP, 2006, J NEAR INFRARED SPEC, V14, P59, DOI 10.1255/jnirs.587; Wold JP., 2016, FLEISCHWIRTSCHAFT, V31, P69	21	53	56	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173384	10.1371/journal.pone.0173384	http://dx.doi.org/10.1371/journal.pone.0173384			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278170	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000396087900083
J	Arenas, A; Roces, F				Arenas, Andres; Roces, Flavio			Avoidance of plants unsuitable for the symbiotic fungus in leaf-cutting ants: Learning can take place entirely at the colony dump	PLOS ONE			English	Article							DIVISION-OF-LABOR; ATTA-SEXDENS-RUBROPILOSA; WASTE MANAGEMENT; MIDDEN WORKERS; ACROMYRMEX; HYMENOPTERA; BEHAVIOR; MEMORY; PERFORMANCE; SELECTION	Plants initially accepted by foraging leaf-cutting ants are later avoided if they prove unsuitable for their symbiotic fungus. Plant avoidance is mediated by the waste produced in the fungus garden soon after the incorporation of the unsuitable leaves, as foragers can learn plant odors and cues from the damaged fungus that are both present in the recently produced waste particles. We asked whether avoidance learning of plants unsuitable for the symbiotic fungus can take place entirely at the colony dump. In order to investigate whether cues available in the waste chamber induce plant avoidance in naive subcolonies, we exchanged the waste produced by subcolonies fed either fungicide-treated privet leaves or untreated leaves and measured the acceptance of untreated privet leaves before and after the exchange of waste. Second, we evaluated whether foragers could perceive the avoidance cues directly at the dump by quantifying the visits of labeled foragers to the waste chamber. Finally, we asked whether foragers learn to specifically avoid untreated leaves of a plant after a confinement over 3 hours in the dump of subcolonies that were previously fed fungicide-treated leaves of that species. After the exchange of the waste chambers, workers from subcolonies that had access to waste from fungicide-treated privet leaves learned to avoid that plant. One-third of the labeled foragers visited the dump. Furthermore, naive foragers learned to avoid a specific, previously unsuitable plant if exposed solely to cues of the dump during confinement. We suggest that cues at the dump enable foragers to predict the unsuitable effects of plants even if they had never been experienced in the fungus garden.	[Arenas, Andres; Roces, Flavio] Univ Wurzburg, Dept Behav Physiol & Sociobiol, Biozentrum, Wurzburg, Germany; [Arenas, Andres] IFIBYNE CONICET, Lab Insectos Sociales, Dept Biodiversidad & Biol Expt, Fac Ciencias Exactas & Nat, Pabellon II,Ciudad Univ, Buenos Aires, DF, Argentina	University of Wurzburg; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Arenas, A (corresponding author), Univ Wurzburg, Dept Behav Physiol & Sociobiol, Biozentrum, Wurzburg, Germany.; Arenas, A (corresponding author), IFIBYNE CONICET, Lab Insectos Sociales, Dept Biodiversidad & Biol Expt, Fac Ciencias Exactas & Nat, Pabellon II,Ciudad Univ, Buenos Aires, DF, Argentina.	aarenas@bg.fcen.uba.ar	Arenas, Andres/ABC-4886-2021	Roces, Flavio/0000-0001-9258-3079	University of Wurzburg [SFB 1047 TP C1]; German Academic Exchange Service (Deutscher Akademischer Austauschdienst, DAAD) [A/11/81698]	University of Wurzburg; German Academic Exchange Service (Deutscher Akademischer Austauschdienst, DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by University of Wurzburg in the funding program Open Access Publishing German Research Foundation (DFG), SFB 1047 TP C1German Academic Exchange Service (Deutscher Akademischer Austauschdienst, DAAD) (ref. no.: A/11/81698).	[Anonymous], 2010, ANT ENCOUNTERS INTER; Arenas A, 2016, J EXP BIOL, V219, P2490, DOI 10.1242/jeb.139568; Arenas A, 2016, ANIM BEHAV, V115, P167, DOI 10.1016/j.anbehav.2016.03.016; Ballari S, 2007, J INSECT BEHAV, V20, P87, DOI 10.1007/s10905-006-9065-9; BASS M, 1995, PHYSIOL ENTOMOL, V20, P1, DOI 10.1111/j.1365-3032.1995.tb00793.x; Bollazzi M, 2012, INSECT SOC, V59, P487, DOI 10.1007/s00040-012-0243-9; Bonetto AA, 1959, HORMIGAS CORTADOERAS, P77; Bot ANM, 2001, ETHOL ECOL EVOL, V13, P225, DOI 10.1080/08927014.2001.9522772; Camargo RS, 2003, SOCIOBIOLOGY, V42, P93; Cherrett J. M., 1989, ECOSYSTEMS WORLD B, P473; Elliot SL, 2010, ECOLOGY, V91, P65, DOI 10.1890/09-0424.1; Falibene A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00084; Farji-Brener AG, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0625; Fowler HG, 1996, BIOL RHYTHM RES, V27, P148, DOI 10.1076/brhm.27.2.148.12944; FOWLER HG, 1985, DEUT ENTOMOL Z, V32, P19, DOI 10.1002/mmnd.19850320105; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Gould J.L., 1984, Life Sciences Research Report, P149; HAINES B, 1983, Tropical Ecology, V24, P85; Hart AG, 2002, BEHAV ECOL, V13, P224, DOI 10.1093/beheco/13.2.224; Hart AG, 2002, NATURWISSENSCHAFTEN, V89, P275, DOI 10.1007/s00114-002-0316-0; Hart AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P387, DOI 10.1007/s002650000312; Herz H, 2008, BEHAV ECOL, V19, P575, DOI 10.1093/beheco/arn016; Herz H, 2007, BIOTROPICA, V39, P476, DOI 10.1111/j.1744-7429.2007.00283.x; Holldobler B., 1990, pi; HUBBELL SP, 1983, OECOLOGIA, V60, P321, DOI 10.1007/BF00376846; Jaffe K., 1982, Social insects in the tropics. Proceedings of the First International Symposium organized by the International Union for the Study of Social Insects and the Sociedad Mexicana de Entomologia. Cocoyoc, Morelos, Mexico, November 1980. Volume 2, P165; Jarau S, 1982, FOOD EXPLOITATION SO; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P217; JUTSUM AR, 1979, ANIM BEHAV, V27, P839, DOI 10.1016/0003-3472(79)90021-6; KNAPP JJ, 1990, WESTV STUD, P382; Kost C, 2005, J TROP ECOL, V21, P677, DOI 10.1017/S0266467405002592; Kost C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022340; Lacerda FG, 2014, ITAL J ZOOL, V81, P298, DOI 10.1080/11250003.2014.911369; Lacerda FG, 2013, J INSECT BEHAV, V26, P873, DOI 10.1007/s10905-013-9403-7; Langridge EA, 2008, BEHAV ECOL SOCIOBIOL, V62, P447, DOI 10.1007/s00265-007-0472-5; LINDAUER M, 1970, NATURWISSENSCHAFTEN, V57, P463, DOI 10.1007/BF00593072; North RD, 1999, PHYSIOL ENTOMOL, V24, P127, DOI 10.1046/j.1365-3032.1999.00122.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ridley P, 1996, EXPERIENTIA, V52, P631, DOI 10.1007/BF01969745; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROCES F, 1994, OECOLOGIA, V97, P1, DOI 10.1007/BF00317902; ROCES F, 1990, OECOLOGIA, V83, P261, DOI 10.1007/BF00317762; ROCES F, 1994, INSECT SOC, V41, P235, DOI 10.1007/BF01242294; Saverschek N, 2011, ANIM BEHAV, V82, P453, DOI 10.1016/j.anbehav.2011.05.015; Saverschek N, 2010, ANIM BEHAV, V79, P689, DOI 10.1016/j.anbehav.2009.12.021; Saverschek N, 2010, THESIS; Seeley T., 1995, WISDOM HIVE SOCIAL P; Stahel G, 1943, J NEW YORK BOT GARDE, V44, P245; STAHEL GEROLD, 1941, REV ENT [RIO DE JANEIRO], V12, P243; Stahel Gerold, 1939, REV ENT [RIO DE JANEIRO], V10, P27; Thiele T, 2014, J CHEM ECOL, V40, P617, DOI 10.1007/s10886-014-0460-y; Verza SS, 2007, INSECT SOC, V54, P303, DOI 10.1007/s00040-007-0943-8; Waddington SJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1219, DOI 10.1007/s00265-010-0936-x; Weber N. A., 1972, GARDENING ANTS ATTIN; Wirth R, 2003, HERBIVORY LEAF CUTTI	55	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171388	10.1371/journal.pone.0171388	http://dx.doi.org/10.1371/journal.pone.0171388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273083	Green Submitted, Green Published, gold			2022-12-27	WOS:000396073700094
J	De Lombaerde, S; Neyt, S; Kersemans, K; Verhoeven, J; Devisscher, L; Van Vlierberghe, H; Vanhove, C; De Vos, F				De Lombaerde, Stef; Neyt, Sara; Kersemans, Ken; Verhoeven, Jeroen; Devisscher, Lindsey; Van Vlierberghe, Hans; Vanhove, Christian; De Vos, Filip			Synthesis, in vitro and in vivo evaluation of 3 beta-[F-18]fluorocholic acid for the detection of drug-induced cholestasis in mice	PLOS ONE			English	Article							WHOLE-BODY DISTRIBUTION; INDUCED LIVER-INJURY; BILE-ACIDS; HEPATOBILIARY TRANSPORTERS; OATP; POLYPEPTIDE; RECEPTOR; BOSENTAN; BIODISTRIBUTION; RADIOSYNTHESIS	Introduction Drug-induced cholestasis is a liver disorder that might be caused by interference of drugs with the hepatobiliary bile acid transporters. It is important to identify this interference early on in drug development. In this work, Positron Emission Tomography (PET)-imaging with a F-18 labeled bile acid analogue was introduced to detect disturbed hepatobiliary transport of bile acids. Methods 3 beta-[F-18]fluorocholic acid ([F-18]FCA) was prepared by nucleophilic substitution of a mesylated precursor with [F-18]fluoride, followed by deprotection with sodium hydroxide. Transport of [F-18]FCA was assessed in vitro using CHO-NTCP, HEK-OATP1B1, HEK-OATP1B3 transfected cells and BSEP & MRP2 membrane vesicles. Investigation of [F-18]FCA metabolites was performed with primary mouse hepatocytes. Hepatobiliary transport of [F-18]FCA was evaluated in vivo in wild-type, rifampicin and bosentan pretreated FVB-mice by dynamic mu PET scanning. Results Radiosynthesis of [F-18] FCA was achieved in a moderate radiochemical yield (8.11-1.94%; non-decay corrected; n = 10) and high radiochemical purity (>99%). FCA was transported by the basolateral bile acid uptake transporters NTCP, OATP1B1 and OATP1B3. For canalicular efflux, BSEP and MRP2 are the relevant bile acid transporters. [F-18]FCA was found to be metabolically stable. In vivo, [F-18]FCA showed fast hepatic uptake (4.5-0.5 min to reach 71.8-1.2% maximum % ID) and subsequent efflux to the gallbladder and intestines (93.3-6.0% ID after 1 hour). Hepatobiliary transport of [F-18]FCA was significantly inhibited by both rifampicin and bosentan. Conclusion A F-18 labeled bile acid analogue, [F-18]FCA, has been developed that shows transport by NTCP, OATP, MRP2 and BSEP. [F-18]FCA can be used as a probe to monitor disturbed hepatobiliary transport in vivo and accumulation of bile acids in blood and liver during drug development.	[De Lombaerde, Stef; Neyt, Sara; Verhoeven, Jeroen; De Vos, Filip] Univ Ghent, Fac Pharmaceut Sci, Lab Radiopharm, Ghent, Belgium; [Kersemans, Ken] Ghent Univ Hosp, Nucl Med, Ghent, Belgium; [Devisscher, Lindsey; Van Vlierberghe, Hans] Ghent Univ Hosp, Gastroenterol & Hepatol, Ghent, Belgium; [Vanhove, Christian] Univ Ghent, IBiTech MEDISIP INFINITY, Ghent, Belgium	Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University	De Lombaerde, S (corresponding author), Univ Ghent, Fac Pharmaceut Sci, Lab Radiopharm, Ghent, Belgium.	stef.delombaerde@ugent.be	Devisscher, Lindsey/AAD-5969-2021; Vanhove, Christian/I-2095-2019	Devisscher, Lindsey/0000-0003-4862-9580; Vanhove, Christian/0000-0002-3988-5980; Van Vlierberghe, Hans/0000-0003-0647-9238; De Lombaerde, Stef/0000-0002-5307-3575; Verhoeven, Jeroen/0000-0002-6641-7760				Baringhaus KH, 1999, J LIPID RES, V40, P2158; Bleibel W, 2007, DIGEST DIS SCI, V52, P2463, DOI 10.1007/s10620-006-9472-y; Chen X, 2009, TOXICOL APPL PHARM, V240, P26, DOI 10.1016/j.taap.2009.06.022; Dong ZQ, 2015, INT J PHARMACEUT, V478, P88, DOI 10.1016/j.ijpharm.2014.11.022; Fattinger K, 2001, CLIN PHARMACOL THER, V69, P223, DOI 10.1067/mcp.2001.114667; Frisch K, 2014, NUCL MED BIOL, V41, P775, DOI 10.1016/j.nucmedbio.2014.07.001; Frisch K, 2012, J NUCL MED, V53, P772, DOI 10.2967/jnumed.111.098731; Ghibellini G, 2008, PHARM RES-DORDR, V25, P1851, DOI 10.1007/s11095-008-9597-0; Gonzalez PM, 2014, MOL PHARMACEUT, V11, P588, DOI 10.1021/mp400575t; Hartman JC, 2010, CAN J PHYSIOL PHARM, V88, P682, DOI 10.1139/Y10-060; He JK, 2014, MOL PHARMACEUT, V11, P2745, DOI 10.1021/mp500027c; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Jia LN, 2014, NUCL MED BIOL, V41, P495, DOI 10.1016/j.nucmedbio.2014.03.016; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Leslie EM, 2007, J PHARMACOL EXP THER, V321, P1170, DOI 10.1124/jpet.106.119073; Moerman L, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-12; Neyt S, 2016, NUCL MED BIOL, V43, P642, DOI 10.1016/j.nucmedbio.2016.07.001; Neyt S, 2013, J NUCL MED, V54, P624, DOI 10.2967/jnumed.112.108233; Padda MS, 2011, HEPATOLOGY, V53, P1377, DOI 10.1002/hep.24229; Pauli-Magnus C, 2006, HEPATOLOGY, V44, P778, DOI 10.1002/hep.21359; Regev A, 2014, SEMIN LIVER DIS, V34, P227, DOI 10.1055/s-0034-1375962; RODA A, 1990, J LIPID RES, V31, P1433; Schacht AC, 2016, J NUCL MED, V57, P628, DOI 10.2967/jnumed.115.161711; Seo JW, 2007, NUCL MED BIOL, V34, P383, DOI 10.1016/j.nucmedbio.2007.01.010; Severgnini M, 2012, CYTOTECHNOLOGY, V64, P187, DOI 10.1007/s10616-011-9407-0; Shimizu K, 2012, NUCL MED BIOL, V39, P847, DOI 10.1016/j.nucmedbio.2012.01.008; Shingaki T, 2013, J PHARMACOL EXP THER, V347, P193, DOI 10.1124/jpet.113.206425; Takashima T, 2012, J NUCL MED, V53, P741, DOI 10.2967/jnumed.111.098681; Testa A, 2015, MOL PHARMACEUT, V12, P2203, DOI 10.1021/acs.molpharmaceut.5b00059; Vieira MDT, 2014, EXPERT OPIN DRUG MET, V10, P581, DOI 10.1517/17425255.2014.884069; Tournier N, 2013, AAPS J, V15, P1082, DOI 10.1208/s12248-013-9514-2; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Vavricka SR, 2002, HEPATOLOGY, V36, P164, DOI 10.1053/jhep.2002.34133	33	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173529	10.1371/journal.pone.0173529	http://dx.doi.org/10.1371/journal.pone.0173529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273180	gold, Green Published, Green Submitted			2022-12-27	WOS:000396073700013
J	Dube, CE; Merciere, A; Vermeij, MJA; Planes, S				Dube, Caroline E.; Merciere, Alexandre; Vermeij, Mark J. A.; Planes, Serge			Population structure of the hydrocoral Millepora platyphylla in habitats experiencing different flow regimes in Moorea, French Polynesia	PLOS ONE			English	Article							CORAL-REEFS; SCLERACTINIAN CORALS; COLONY SIZE; ENVIRONMENTAL GRADIENTS; SPATIAL-DISTRIBUTION; COMMUNITY STRUCTURE; JUVENILE CORALS; CARIBBEAN CORAL; VIRGIN-ISLANDS; ST-JOHN	While the fire coral Millepora platyphylla is an important component of Indo-Pacific reefs, where it thrives in a wide range of environments, the ecological and biological processes driving its distribution and population structure are not well understood. Here, we quantified this species' population structure in five habitats with contrasting hydrodynamic regimes in Moorea, French Polynesia; two in the fore reef: mid and upper slopes, and three in the lagoon: back, fringing and patch reefs. A total of 3651 colonies of fire corals were mapped and measured over 45,000 m(2) of surveyed reef. Due to the species' sensitivity to fragmentation in response to strong water movement, hydrodynamic conditions (e.g. waves, pass and lagoonal circulation) corresponded to marked differences in colony size distributions, morphology and recruitment dynamics among habitats. The size structure varied among reef habitats with higher proportions of larger colonies in calm nearshore reefs (fringing and patch reefs), while populations were dominated by smaller colonies in the exposed fore reefs. The highest densities of fire corals were recorded in fore reef habitats (0.12-0.20 n.m(-2)) where the proportion of recruits and juveniles was higher at mid slope populations (49.3%) than on the upper slope near where waves break (29.0%). In the latter habitat, most colonies grew as vertical sheets on encrusting bases making them more vulnerable to colony fragmentation, whereas fire corals were encrusting or massive in all other habitats. The lowest densities of M. platyphylla occurred in lagoonal habitats (0.02-0.04 n.m(-2)) characterized by a combination of low water movement and other physical and biological stressors. This study reports the first evidence of population structure of fire corals in two common reef environments and illustrates the importance of water flow in driving population dynamic processes of these reef-building species.	[Dube, Caroline E.; Planes, Serge] PSL Res Univ, EPHE, UPVD CNRS, USR CRIOBE 3278, Perpignan, France; [Dube, Caroline E.; Merciere, Alexandre; Planes, Serge] PSL Res Univ, Lab Excellence CORAIL, EPHE, UPVD CNRS,USR CRIOBE 3278, Papetoai, Moorea, France; [Vermeij, Mark J. A.] CARMABI Fdn, Willemstad, Curacao; [Vermeij, Mark J. A.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Aquat Microbiol, Amsterdam, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); University of Amsterdam	Dube, CE (corresponding author), PSL Res Univ, EPHE, UPVD CNRS, USR CRIOBE 3278, Perpignan, France.	caroline.dube.qc@gmail.com	Dubé, Caroline/AAD-9029-2019; Vermeij, Mark/B-2752-2013; PLANES, Serge/ABF-1360-2021; Vermeij, Mark/AAR-6757-2020	Dubé, Caroline/0000-0002-8990-8597; Vermeij, Mark/0000-0001-9612-9527; Vermeij, Mark/0000-0001-9612-9527	Fonds Quebecois de Recherche sur la Nature et les Technologies	Fonds Quebecois de Recherche sur la Nature et les Technologies(FQRNT)	CED is supported by a graduate scholarship from the Fonds Quebecois de Recherche sur la Nature et les Technologies.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adjeroud M, 2007, HYDROBIOLOGIA, V589, P117, DOI 10.1007/s10750-007-0726-2; Adjeroud M, 2015, MAR ENVIRON RES, V112, P131, DOI 10.1016/j.marenvres.2015.10.004; Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; Andrefouet S, 2014, CORAL REEFS, V33, P463, DOI 10.1007/s00338-014-1133-6; Aranceta-Garza F, 2012, CORAL REEFS, V31, P1157, DOI 10.1007/s00338-012-0941-9; Attalla TM, 2011, EGYPT J AQUAT BIOL F, V15, P1; Baird AH, 2000, J EXP MAR BIOL ECOL, V251, P117, DOI 10.1016/S0022-0981(00)00209-4; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; BENDEL RB, 1989, OECOLOGIA, V78, P394, DOI 10.1007/BF00379115; Bivand R. S., 2013, APPL SPATIAL DATA AN, V10, P1, DOI DOI 10.1007/978-0-387-78171-6; Bosserelle P, 2014, GUIDE IDENTIFICATION; Bourmaud CAF, 2013, MAR ECOL-EVOL PERSP, V34, P14, DOI 10.1111/maec.12024; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Brown D, 2013, J EXP MAR BIOL ECOL, V441, P62, DOI 10.1016/j.jembe.2013.01.013; Chiappone M, 1996, B MAR SCI, V58, P555; Chindapol N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002849; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Coma R, 1997, BIOL BULL-US, V193, P20, DOI 10.2307/1542733; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; Denny M., 2014, BIOL MECH WAVE SWEPT; DEWEERDT WH, 1981, BIJDR DIERKD, V51, P1; Dollar S.J., 1982, Coral Reefs, V1, P71, DOI 10.1007/BF00301688; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; Doropoulos C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128535; Dube CE, 2017, PEERJ, V5, DOI 10.7717/peerj.2936; Dube CE, 2016, MAR BIODIVERS, V46, P329, DOI 10.1007/s12526-015-0392-y; Edmunds PJ, 2010, MAR ECOL PROG SER, V414, P75, DOI 10.3354/meps08728; Edmunds PJ, 1999, CORAL REEFS, V18, P133, DOI 10.1007/s003380050167; Edmunds PJ, 2000, MAR ECOL PROG SER, V202, P113, DOI 10.3354/meps202113; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Ferrario F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4794; Fichez R, 2005, AQUAT LIVING RESOUR, V18, P125, DOI 10.1051/alr:2005015; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Galzin R., 1985, P 5 INT COR REEF C T, V1, P73; Gili JM, 1995, OCEANOGR MAR BIOL, V33, P351; Gilmour J, 1999, MAR BIOL, V135, P451, DOI 10.1007/s002270050645; Gleason DF, 2011, J EXP MAR BIOL ECOL, V408, P42, DOI 10.1016/j.jembe.2011.07.025; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Harris A, 2014, AQUAT CONSERV, V24, P667, DOI 10.1002/aqc.2464; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Hearn CJ, 1999, J GEOPHYS RES-OCEANS, V104, P30007, DOI 10.1029/1999JC900262; Hench JL, 2008, LIMNOL OCEANOGR, V53, P2681, DOI 10.4319/lo.2008.53.6.2681; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Hoogenboom MO, 2009, ECOLOGY, V90, P767, DOI 10.1890/07-2010.1; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jackson J.B.C., 1979, Systematics Association Special Volume Series, P499; Kaandorp JA, 1999, MAR BIOL, V134, P295, DOI 10.1007/s002270050547; Kaandorp JA, 2001, J THEOR BIOL, V209, P257, DOI 10.1006/jtbi.2001.2261; Kayal M, 2016, MAR BIODIV, V1-4; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; Koehl MAR, 2004, J MARINE SYST, V49, P75, DOI 10.1016/j.jmarsys.2003.06.003; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Leichter JJ, 2013, OCEANOGRAPHY, V26, P52, DOI 10.5670/oceanog.2013.45; Lenihan HS, 2015, ECOLOGY, V96, P1540, DOI 10.1890/14-1115.1; Lewis JB, 2006, ADV MAR BIOL, V50, P1, DOI 10.1016/S0065-2881(05)50001-4; Madin JS, 2006, NATURE, V444, P477, DOI 10.1038/nature05328; Madin JS, 2006, CORAL REEFS, V25, P635, DOI 10.1007/s00338-006-0137-2; Madin JS, 2014, ECOL LETT, V17, P1008, DOI 10.1111/ele.12306; Madin JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046637; Madin JS, 2012, J EXP BIOL, V215, P968, DOI 10.1242/jeb.061002; Meesters EH, 2001, MAR ECOL PROG SER, V209, P43, DOI 10.3354/meps209043; Monismith SG, 2007, ANNU REV FLUID MECH, V39, P37, DOI 10.1146/annurev.fluid.38.050304.092125; Nagelkerken I, 2004, B MAR SCI, V74, P213; Penin L, 2007, B MAR SCI, V80, P379; Penin L, 2013, MAR ECOL PROG SER, V473, P149, DOI 10.3354/meps10101; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; Price N, 2010, OECOLOGIA, V163, P747, DOI 10.1007/s00442-010-1578-4; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RICHMOND RH, 1993, AM ZOOL, V33, P524; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Roth MS, 2009, MAR ECOL PROG SER, V376, P133, DOI 10.3354/meps07787; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SOONG K, 1993, CORAL REEFS, V12, P77, DOI 10.1007/BF00302106; Storlazzi C, 2002, OCEAN WAVE MEAS ANAL, P784, DOI DOI 10.1061/40604(273)80; Storlazzi CD, 2005, CORAL REEFS, V24, P43, DOI 10.1007/s00338-004-0430-x; Swierts T, 2016, PEERJ, V4, DOI 10.7717/peerj.1984; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; Tsounis G, 2016, PEERJ, V4, DOI 10.7717/peerj.2544; Urban DL, 2000, SPATIAL ANAL ECOLOGY; Vermeij MJA, 2007, MAR ECOL PROG SER, V351, P91, DOI 10.3354/meps07085; Vermeij MJA, 2008, ECOLOGY, V89, P1994, DOI 10.1890/07-1296.1; Vermeij MJA, 2002, MAR ECOL PROG SER, V233, P105, DOI 10.3354/meps233105; Veron J.E.N., 2000, CORALS WORLD, V1-3; WALLACE CC, 1985, MAR BIOL, V88, P217, DOI 10.1007/BF00392585; Wilkinson C, 2008, STATUS CORAL REEFS W; Williams GJ, 2013, PEERJ, V1, DOI 10.7717/peerj.81; WITMAN JD, 1992, AM ZOOL, V32, P641	92	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173513	10.1371/journal.pone.0173513	http://dx.doi.org/10.1371/journal.pone.0173513			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273119	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700010
J	Jain, S; Rai, N; Kumar, G; Pruthi, PA; Thangaraj, K; Bajpai, S; Pruthi, V				Jain, Sonal; Rai, Niraj; Kumar, Giriraj; Pruthi, Parul Aggarwal; Thangaraj, Kumarasamy; Bajpai, Sunil; Pruthi, Vikas			Ancient DNA Reveals Late Pleistocene Existence of Ostriches in Indian Sub-Continent	PLOS ONE			English	Article							EGGSHELLS; AFRICA; MATRIX	Ancient DNA (aDNA) analysis of extinct ratite species is of considerable interest as it provides important insights into their origin, evolution, paleogeographical distribution and vicariant speciation in congruence with continental drift theory. In this study, DNA hotspots were detected in fossilized eggshell fragments of ratites (dated >= 25000 years B.P. by radiocarbon dating) using confocal laser scanning microscopy (CLSM). DNA was isolated from five eggshell fragments and a 43 base pair (bp) sequence of a 16S rRNA mitochondrial-conserved region was successfully amplified and sequenced from one of the samples. Phylogenetic analysis of the DNA sequence revealed a 92% identity of the fossil eggshells to Struthio camelus and their position basal to other palaeognaths, consistent with the vicariant speciation model. Our study provides the first molecular evidence for the presence of ostriches in India, complementing the continental drift theory of biogeographical movement of ostriches in India, and opening up a new window into the evolutionary history of ratites.	[Jain, Sonal; Pruthi, Parul Aggarwal; Pruthi, Vikas] Indian Inst Technol, Dept Biotechnol, Roorkee, Uttar Pradesh, India; [Rai, Niraj; Thangaraj, Kumarasamy] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Kumar, Giriraj] Dayalbagh Educ Inst, Agra, Uttar Pradesh, India; [Bajpai, Sunil] Indian Inst Technol, Dept Earth Sci, Roorkee, Uttar Pradesh, India; [Bajpai, Sunil] Birbal Sahni Inst Palaeosci, Lucknow, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Dayalbagh Educational Institute (DEI); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP)	Jain, S (corresponding author), Indian Inst Technol, Dept Biotechnol, Roorkee, Uttar Pradesh, India.	jainsonal20@gmail.com	Rai, Niraj/AAO-7618-2021	Rai, Niraj/0000-0002-1251-9390; Jain, Sonal/0000-0003-0439-6797; Pruthi, Vikas/0000-0002-3666-5552	Council for Scientific and Industrial Research (CSIR); University Grants Commission (UGC), New Delhi	Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC), New Delhi(University Grants Commission, India)	For the financial support, we would like to acknowledge the Council for Scientific and Industrial Research (CSIR) and University Grants Commission (UGC), New Delhi.; We acknowledge the much-needed help received from the All India Institute of Medical Sciences (AIIMS), New Delhi in conducting Confocal Laser Scanning Microscopy imaging. We are thankful to CCMB Director Ch. Mohan Rao, to allow us to perform experiments in his Ancient DNA laboratory. For the financial support, we would like to acknowledge the Council for Scientific and Industrial Research and University Grants Commission (UGC), New Delhi. We would like to thank Mr. Om Prakash Sharma for helping in procuring samples from Bundi site.	Badam G.L., 2005, MAN ENV, V30, P97; BEDNARIK RG, 1994, ANTIQUITY, V68, P68, DOI 10.1017/S0003598X00046202; Bednarik RG, 1993, B INDOPACIFIC PREHIS, V13, P34; Bednarik RG., 1993, MAN ENV, V18, P33; Blinkhom J, 2015, PALAEOGEOGR PALAEOCL, V417, P80, DOI 10.1016/j.palaeo.2014.10.026; Carrino DA, 1996, CONNECT TISSUE RES, V35, P325, DOI 10.3109/03008209609029207; Cooper A, 2000, SCIENCE, V289, P1139; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; Davies W., 1880, GEOL MAG, V7, P18, DOI [10.1017/S0016756800146904, DOI 10.1017/S0016756800146904]; Dawkins R, 2004, NY TIMES BK REV, P688; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng QL, 2001, J CRYST GROWTH, V233, P548, DOI 10.1016/S0022-0248(01)01611-6; Fink D, 2006, SOL ENERG MAT SOL C, V90, P1458, DOI 10.1016/j.solmat.2005.10.022; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Harrison T, 2005, J AFR EARTH SCI, V41, P303, DOI 10.1016/j.jafrearsci.2005.07.001; Hincke MT, 2000, MATRIX BIOL, V19, P443, DOI 10.1016/S0945-053X(00)00095-0; Johnson BJ, 1997, PALAEOGEOGR PALAEOCL, V136, P121, DOI 10.1016/S0031-0182(97)00043-6; Kumar G, 1983, THESIS, P227; Kumar G, 1988, ROCK ART RES, V5, P43; Leakey MG, 2003, LOTHAGAM DAWN HUMANI; Manegold Albrecht, 2013, P135; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; MILLER GH, 1992, PHILOS T ROY SOC B, V337, P149, DOI 10.1098/rstb.1992.0092; Miller GH, 2000, PERSPECTIVES AMINO A, P161; Mitchell KJ, 2014, SCIENCE, V344, P898, DOI 10.1126/science.1251981; MOHABEY DM, 1989, J GEOL SOC INDIA, V33, P477; Mourer-Chauvire C, 2005, 6S INT SOC AV PAL EV, V7, P169; Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002; Oskam CL, 2012, METHODS MOL BIOL, V840, P65, DOI 10.1007/978-1-61779-516-9_9; Oskam CL, 2010, P ROY SOC LOND B BIO, P277; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Patnaik R, 2009, CURR SCI INDIA, V96, P1485; Pickford M, 2000, GEOLOGY PALAEOBIOLOG; Rai N, 2014, MITOCHONDRION, V14, P1, DOI 10.1016/j.mito.2013.12.002; Roberts P, 2014, P NATL ACAD SCI USA, V111, P5848, DOI 10.1073/pnas.1323465111; Sahn A., 1989, Journal of the Palaeontological Society of India, V34, P91; Sahni A., 1990, MAN ENV, V15, P41; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauer EG, 1978, PALAEONTOGR ABT A, P1; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; STERN LA, 1994, GEOLOGY, V22, P419, DOI 10.1130/0091-7613(1994)022<0419:CISOEC>2.3.CO;2; Stidham TA, 2004, J HUM EVOL, V46, P489, DOI 10.1016/j.jhevol.2004.02.002; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wellman-Labadie O, 2008, BRIT POULTRY SCI, V49, P133, DOI 10.1080/00071660802001722; Wellman-Labadie O, 2008, FEBS LETT, V582, P699, DOI 10.1016/j.febslet.2008.01.043	46	7	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0164823	10.1371/journal.pone.0164823	http://dx.doi.org/10.1371/journal.pone.0164823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273082	gold, Green Submitted, Green Published			2022-12-27	WOS:000396073700088
J	Ramalingam, K; Vuthaluru, S; Srivastava, A; Dinda, AK; Dhar, A				Ramalingam, Kirithiga; Vuthaluru, Seenu; Srivastava, Anurag; Dinda, Amit Kumar; Dhar, Anita			Ultra structural changes occurring in duct ectasia and periductal mastitis and their significance in etiopathogenesis	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; PULMONARY-FIBROSIS	Introduction Duct ectasia (DE) and periductal mastitis (PDM) are the most common benign breast conditions seen in women. The etiopathogenesis of these entities is still not clear and most of the theories regarding the causation are based on the histological features as seen on light microscopy. The ultramicroscopic features associated with these conditions that may give more insight to the etiopathogenesis are unknown. Aim To study the ultrastructural changes occurring in mammary duct cones in patients with DE and PDM using Transmission Electron Microscopic (TEM). Method Major ducts removed by radical duct excision from 21 patients with final histopathological diagnosis of DE and PDM were subjected to TEM study with 2 normal duct samples as controls. Results The TEM features of DE were denudation of the epithelial cells with focal loss of microvilli, widening of the inter-epithelial junctions with focal disruption of the T bars, periductal collagenisation without inflammation, and features suggestive of Epithelial Mesenchymal Transition (EMT). PDM features are intact epithelial lining with proliferative epithelium and periductal collagenisation with inflammation. Conclusions Based on the TEM findings, we suggest that DE and PDM are two different entities. EMT a novel finding observed in DE in this study.	[Ramalingam, Kirithiga; Vuthaluru, Seenu; Srivastava, Anurag; Dhar, Anita] All India Inst Med Sci, Dept Surg Disciplines, New Delhi, India; [Dinda, Amit Kumar] All India Inst Med Sci, Dept Pathol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Ramalingam, K (corresponding author), All India Inst Med Sci, Dept Surg Disciplines, New Delhi, India.	kirithigaramalingam@gmail.com						Burns WC, 2006, J AM SOC NEPHROL, V17, P2484, DOI 10.1681/ASN.2006050525; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Dudas PL, 2009, NEPHROL DIAL TRANSPL, V24, P1406, DOI 10.1093/ndt/gfn662; HAAGENSEN CD, 1951, CANCER, V4, P749, DOI 10.1002/1097-0142(195107)4:4<749::AID-CNCR2820040413>3.0.CO;2-F; Jenkins RH, 2011, AM J PATHOL, V178, P964, DOI 10.1016/j.ajpath.2010.12.010; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Li F, 2005, MED MOL MORPHOL, V38, P216, DOI [10.1007/s00795-005-0300-9, DOI 10.1007/S00795-005-0300-9]; Mansel R, 2009, MANSEL WEBSTERS BENI; Ozzello L, 1971, PATHOLOGY ANN, V6; Stirling John W., VIRCHOWS ARCH, V373, P119; TSUCHIYA S, 1983, ACTA PATHOL JAPON, V33, P97; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	13	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173216	10.1371/journal.pone.0173216	http://dx.doi.org/10.1371/journal.pone.0173216			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273122	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700045
J	Winiewska, M; Bugajska, E; Poznanski, J				Winiewska, Maria; Bugajska, Ewa; Poznanski, Jaroslaw			ITC-derived binding affinity may be biased due to titrant (nano)-aggregation. Binding of halogenated benzotriazoles to the catalytic domain of human protein kinase CK2	PLOS ONE			English	Article							G-QUADRUPLEX DNA; SITE; INHIBITORS; THERMODYNAMICS; AGGREGATION; DERIVATIVES; PARAMETERS; FEATURES	The binding of four bromobenzotriazoles to the catalytic subunit of human protein kinase CK2 was assessed by two complementary methods: Microscale Thermophoresis (MST) and Isothermal Titration Calorimetry (ITC). New algorithm proposed for the global analysis of MST pseudo-titration data enabled reliable determination of binding affinities for two distinct sites, a relatively strong one with the K-d of the order of 100 nM and a substantially weaker one (K-d > 1 mu M). The affinities for the strong binding site determined for the same protein-ligand systems using ITC were in most cases approximately 10-fold underestimated. The discrepancy was assigned directly to the kinetics of ligand nano-aggregates decay occurring upon injection of the concentrated ligand solution to the protein sample. The binding affinities determined in the reverse ITC experiment, in which ligands were titrated with a concentrated protein solution, agreed with the MST-derived data. Our analysis suggests that some ITC-derived Kd values, routinely reported together with PDB structures of protein-ligand complexes, may be biased due to the uncontrolled ligand (nano)-aggregation, which may occur even substantially below the solubility limit.	[Winiewska, Maria; Bugajska, Ewa; Poznanski, Jaroslaw] Polish Acad Sci, Inst Biochem & Biophys, Dept Biophys, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Winiewska, M; Poznanski, J (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Dept Biophys, Warsaw, Poland.	mwin@ibb.waw.pl; jarek@ibb.waw.pl	Winiewska, Maria/ABF-4317-2021; Poznanski, Jaroslaw/F-7705-2014	Poznanski, Jaroslaw/0000-0003-2684-1775; Marzec nee Bugajska, Ewa/0000-0002-2564-4959; Winiewska-Szajewska, Maria/0000-0003-0986-6882	Polish National Science Center [2012/07/B/ST4/01334, 2015/19/B/ST4/02156]; Centre for Preclinical Research and Technology (CePT); European Regional Development Fund and Innovative Economy; National Cohesion Strategy of Poland	Polish National Science Center; Centre for Preclinical Research and Technology (CePT); European Regional Development Fund and Innovative Economy; National Cohesion Strategy of Poland	This work was supported by Polish National Science Center (https://nen.gov.p1/?language=en) grants 2012/07/B/ST4/01334 (JP) and 2015/19/B/ST4/02156 (JP). The equipment used was sponsored in part by the Centre for Preclinical Research and Technology (CePT), a project co-sponsored by European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland (http://ec.europa.eu/regional_policy/en/projects/poland/a-biomedical-research-centre-for-central-europe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu P, 2013, J PHOTOCH PHOTOBIO B, V129, P57, DOI 10.1016/j.jphotobiol.2013.09.011; Battistutta R, 2005, HANDB EXP PHARM, V167, P125; Battistutta R, 2001, PROTEIN SCI, V10, P2200, DOI 10.1110/ps.19601; Battistutta R, 2007, CHEMBIOCHEM, V8, P1804, DOI 10.1002/cbic.200700307; Cozza G, 2013, CURR MED CHEM, V20, P671, DOI 10.2174/092986713804999312; Dam TK, 2002, BIOCHEMISTRY-US, V41, P1359, DOI 10.1021/bi015829k; Desiraju GR, 2013, PURE APPL CHEM, V85, P1711, DOI 10.1351/PAC-REC-12-05-10; Ferguson AD, 2011, FEBS LETT, V585, P104, DOI 10.1016/j.febslet.2010.11.019; FREIRE E, 1990, ANAL CHEM, V62, pA950, DOI 10.1021/ac00217a002; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902; HEIRWEGH KPM, 1992, BIOCHEM EDUC, V20, P36, DOI 10.1016/0307-4412(92)90018-H; Herrera I, 2016, J PHYS CHEM B, V120, P2077, DOI 10.1021/acs.jpcb.5b09202; Huang RX, 2016, BBA-GEN SUBJECTS, V1860, P945, DOI 10.1016/j.bbagen.2016.01.027; Kinoshita T, 2011, MOL CELL BIOCHEM, V356, P97, DOI 10.1007/s11010-011-0960-9; Kitchens RL, 1998, J IMMUNOL, V160, P1920; Klein T, 2014, ACS MED CHEM LETT, V5, P166, DOI 10.1021/ml4004205; Leavitt S, DIRECT MEASUREMENT P; Maluf NK, 2011, BIOPHYS CHEM, V154, P82, DOI 10.1016/j.bpc.2011.01.004; Mashalidis EH, 2013, NAT PROTOC, V8, P2309, DOI 10.1038/nprot.2013.130; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; McGovern SL, 2003, J MED CHEM, V46, P1478, DOI 10.1021/jm020427b; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Moll D, 2007, BIOL CHEM, V388, P163, DOI 10.1515/BC.2007.018; Nienberg C, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9030036; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Pilch DS, 2008, BIOCHIMIE, V90, P1233, DOI 10.1016/j.biochi.2008.03.011; Poznanski J, 2006, J THERM ANAL CALORIM, V83, P565, DOI 10.1007/s10973-005-7394-0; Raaf J, 2008, CHEM BIOL, V15, P111, DOI 10.1016/j.chembiol.2007.12.012; Reille-Seroussi M, 2015, BIOCHEMISTRY-US, V54, P5147, DOI 10.1021/acs.biochem.5b00722; Rossetti L, 2005, BIOORG MED CHEM LETT, V15, P413, DOI 10.1016/j.bmcl.2004.10.061; Sarno S, 2005, BBA-PROTEINS PROTEOM, V1754, P263, DOI 10.1016/j.bbapap.2005.07.043; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Wasik R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048898; Wasik R, 2012, J PHYS CHEM B, V116, P7259, DOI 10.1021/jp301561x; Wasik R, 2010, J PHYS CHEM B, V114, P10601, DOI 10.1021/jp102848y; Winiewska M, 2015, BBA-PROTEINS PROTEOM, V1854, P1708, DOI 10.1016/j.bbapap.2015.04.004; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zielenkiewicz W., 2002, THEORY CALORIMETRY	42	23	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173260	10.1371/journal.pone.0173260	http://dx.doi.org/10.1371/journal.pone.0173260			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273138	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700050
J	Rinker, T; Shafer, VL; Kiefer, M; Vidal, N; Yu, YH				Rinker, Tanja; Shafer, Valerie L.; Kiefer, Markus; Vidal, Nancy; Yu, Yan H.			T-complex measures in bilingual Spanish-English and Turkish-German children and monolingual peers	PLOS ONE			English	Article							AUDITORY-EVOKED POTENTIALS; EVENT-RELATED POTENTIALS; SYSTEM ACTIVITY; LANGUAGE; BRAIN; MATURATION; PERCEPTION; DISCRIMINATION; EXPERIENCE; EXPOSURE	Background Lateral temporal neural measures (Na and T-complex Ta and Tb) of the auditory evoked potential (AEP) index maturation of auditory/speech processing. These measures are also sensitive to language experience in adults. This paper examined neural responses to a vowel sound at temporal electrodes in four-to five-year-old Spanish-English bilinguals and English monolinguals and in five- to six-year-old Turkish-German bilinguals and German monolinguals. The goal was to determine whether obligatory AEPs at temporal electrode sites were modulated by language experience. Language experience was defined in terms of monolingual versus bilingual status as well as the amount and quality of the bilingual language experience. Method AEPs were recorded at left and right temporal electrode sites to a 250-ms vowel [epsilon] from 20 monolingual (American)-English and 18 Spanish-English children from New York City, and from 11 Turkish-German and 13 monolingual German children from Ulm, Germany. Language background information and standardized verbal and non-verbal test scores were obtained for the children. Results The results revealed differences in temporal AEPs (Na and Ta of the T-complex) between monolingual and bilingual children. Specifically, bilingual children showed smaller and/or later peak amplitudes than the monolingual groups. Ta-amplitude distinguished monolingual and bilingual children best at right electrode sites for both the German and American groups. Amount of experience and type of experience with the target language (English and German) influenced processing. Conclusions The finding of reduced amplitudes at the Ta latency for bilingual compared to monolingual children indicates that language specific experience, and not simply maturational factors, influences development of the neural processes underlying the Ta AEP, and suggests that lateral temporal cortex has an important role in language- specific speech perception development.	[Rinker, Tanja] Univ Konstanz, Dept Linguist Zukunftskolleg, Constance, Germany; [Shafer, Valerie L.; Vidal, Nancy] CUNY, Grad Ctr, New York, NY USA; [Kiefer, Markus] Univ Ulm, Ulm, Germany; [Yu, Yan H.] St Johns Univ, New York, NY USA	University of Konstanz; City University of New York (CUNY) System; Ulm University; Saint John's University	Rinker, T (corresponding author), Univ Konstanz, Dept Linguist Zukunftskolleg, Constance, Germany.	tanja.rinker@uni-konstanz.de	YU, YAN/Y-8898-2018	YU, YAN/0000-0001-6322-4800; Rinker, Tanja/0000-0002-3107-2598; Shafer, Valerie/0000-0001-8551-1878	NIH [HD46193]; Zukunftskolleg of the University of Konstanz	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zukunftskolleg of the University of Konstanz	Funded by NIH HD46193 to Valerie L. Shafer (www.nichd.nih.gov/Pages/index.aspx). Funding for this research collaboration was also provided by the Zukunftskolleg of the University of Konstanz to Tanja Rinker and Valerie Shafer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1995, CATEGORICAL DATA ANA; Albrecht R, 2000, CLIN NEUROPHYSIOL, V111, P2268, DOI 10.1016/S1388-2457(00)00464-8; Alku P, 1999, CLIN NEUROPHYSIOL, V110, P1329, DOI 10.1016/S1388-2457(99)00088-7; BAKER C, 1998, ENCY BILINGUALISM BI; Baker W, 2002, PROC ANN BUCLD, P36; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bishop DVM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035851; Bishop DVM, 2007, DEVELOPMENTAL SCI, V10, P576, DOI 10.1111/j.1467-7687.2007.00620.x; Bosch L, 2003, LANG SPEECH, V46, P217, DOI 10.1177/00238309030460020801; Bruneau N, 1999, CLIN NEUROPHYSIOL, V110, P1927, DOI 10.1016/S1388-2457(99)00149-2; Ceponiene R, 1998, EVOKED POTENTIAL, V108, P345, DOI 10.1016/S0168-5597(97)00081-6; Cheour M, 2002, NEUROSCI LETT, V325, P187, DOI 10.1016/S0304-3940(02)00269-0; Datta H, 2010, J SPEECH LANG HEAR R, V53, P757, DOI 10.1044/1092-4388(2009/08-0123); Dunn L. M., 1986, TEST VOCABULARIO IM; Dunn L.M., 1981, PEABODY PICTURE VOCA; Dunn MA, 2005, J AUTISM DEV DISORD, V35, P361, DOI 10.1007/s10803-005-3304-3; EULITZ C, 1995, J NEUROSCI, V15, P2748; Flege JE, 1997, J PHONETICS, V25, P437, DOI 10.1006/jpho.1997.0052; Fox J., 2018, R COMPANION APPL REG, VThird; Grimm H, 1991, HEIDELBERGER SPRACHE; Groen MA, 2008, BIOL PSYCHOL, V79, P148, DOI 10.1016/j.biopsycho.2008.04.003; Hisagi M, 2014, ERP INDICES VOWEL PR; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Mahajan Y, 2013, INT J DEV NEUROSCI, V31, P1, DOI 10.1016/j.ijdevneu.2012.10.002; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Parra M, 2011, J EXP CHILD PSYCHOL, V108, P113, DOI 10.1016/j.jecp.2010.07.011; Peltola MS, 2005, NEUROSCI LETT, V388, P121, DOI 10.1016/j.neulet.2005.06.037; Ponton C, 2002, CLIN NEUROPHYSIOL, V113, P407, DOI 10.1016/S1388-2457(01)00733-7; R Core Team, 2021, R LANGUAGE ENV STAT; Ramon-Casas M, 2009, COGNITIVE PSYCHOL, V59, P96, DOI 10.1016/j.cogpsych.2009.02.002; Raven JC, 2002, COLOURED PROGR MATRI; Rinker T, 2010, BRAIN LANG, V113, P90, DOI 10.1016/j.bandl.2010.01.007; Sebastian-Galles N, 2006, J COGNITIVE NEUROSCI, V18, P1277, DOI 10.1162/jocn.2006.18.8.1277; Shafer VL, 2015, INT J PSYCHOPHYSIOL, V95, P77, DOI 10.1016/j.ijpsycho.2014.08.1390; Shafer VL, 2012, NEUROSCI LETT, V526, P10, DOI 10.1016/j.neulet.2012.07.064; Shafer VL, 2011, J PHONETICS, V39, P527, DOI 10.1016/j.wocn.2010.11.010; Shafer VL, 2011, CLIN NEUROPHYSIOL, V122, P1137, DOI 10.1016/j.clinph.2010.10.046; Tonnquist-Uhlen I, 2003, CLIN NEUROPHYSIOL, V114, P685, DOI 10.1016/S1388-2457(03)00005-1; TonnquistUhlen I, 1996, ACTA OTO-LARYNGOL, V116, P680, DOI 10.3109/00016489609137907; Tse L., 2001, WHY DONT THEY LEARN; Vidal N., 2015, NEUROPHYSIOLOGICAL C; Videsott G, 2010, BRAIN LANG, V113, P103, DOI [10.1016/j.bandl.2010.01.006, 10.1016/j.band1.2010.01.006]; Wagner M, 2013, BRAIN RES, V1522, P31, DOI 10.1016/j.brainres.2013.04.045; WOLPAW JR, 1975, ELECTROEN CLIN NEURO, V39, P609, DOI 10.1016/0013-4694(75)90073-5; Yeni-Komshian G. H., 2000, BILING-LANG COGN, V3, P131, DOI [10.1017/S1366728900000225, DOI 10.1017/S1366728900000225]; Zimmerman I.L., 2002, PRESCHOOL LANGUAGE S	48	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0171992	10.1371/journal.pone.0171992	http://dx.doi.org/10.1371/journal.pone.0171992			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5QM	28267801	gold, Green Published			2022-12-27	WOS:000396060600054
J	Athanassiou, CG; Kavallieratos, NG; Campbell, JF				Athanassiou, Christos G.; Kavallieratos, Nickolas G.; Campbell, James F.			Competition of three species of Sitophilus on rice and maize	PLOS ONE			English	Article							UNBAITED PROBE TRAPS; ZEAMAIS MOTSCH; GRAIN TRIER; COLEOPTERA; CURCULIONIDAE; INSECTS; WEEVIL; RESISTANCE; MITES	Laboratory tests were carried out in order to examine competition among three congeneric species on rice and maize: the granary weevil, Sitophilus granarius, the rice weevil, Sitophilus oryzae and the maize weevil, Sitophilus zeamais. For this purpose, a total of 30 adults were placed in vials that contained 50 g or either rice or maize: 30 adults of S. granarius, 30 adults of S. oryzae, 30 adults of S. zeamais, 15 adults of S. granarius+ 15 adults of S. oryzae, 15 adults of S. granarius+ 15 adults of S. zeamais, 15 adults of S. oryzae + 15 adults of S. zeamais, and 10 adults of S. granarius+ 10 adults of S. oryzae+ 10 adults of S. zeamais. After 62 days at 30 degrees C and 65% relative humidity the number of individuals of each species were counted. Insect damaged kernels (IDK), weight of frass and grain weight were measured. When each species was alone, S. granarius had the lowest numbers of adults in both grains, which did not exceed 34 adults/vial, and S. oryzae numbers were always higher than other species. For S. oryzae and S. zeamais, the numbers of adults were considerably higher on rice than on maize. On rice, S. oryzae numbers ranged between 281 and 563 adults per vial, while for S. zeamais between 137 and 372 adults per vial. At the same time, for both species on maize, adult numbers did not exceed 54 adults per vial. The number of S. oryzae adults were constantly higher than the other species in all combinations tested. Moreover, for rice, IDK in the vials that contained S. oryzae, either alone or in combination with other species, was higher than all the other combinations. Similarly, grain weight was lower in the vials that contained S. oryzae compared to the other species combinations. In general, for S. oryzae and S. zeamais progeny production was increased with the increase of the number of the initial adults that had been placed inside the vials. At the same time, progeny production of all three species was not affected by the presence of another species inside the vial. Given that the coexistence of congeneric species in the same stored product ecosystem is often reported, our results highlight some of the inferences that are necessary in order to predict the potential outcome of competition patterns. Apart from its ecological significance, the prediction of the superior species in mixed species communities, can guide and time any control measures, on a more species-targeted basis.	[Athanassiou, Christos G.] Univ Thessaly, Dept Agr Crop Prod & Rural Dev, Lab Entomol & Agr Zool, Nea Ionia, Magnissia, Greece; [Athanassiou, Christos G.; Kavallieratos, Nickolas G.; Campbell, James F.] ARS, USDA, CGAHR, Manhattan, KS 66502 USA; [Kavallieratos, Nickolas G.] Univ Agr, Lab Agr Zool & Entomol, Dept Crop Sci, Athens, Attica, Greece	University of Thessaly; United States Department of Agriculture (USDA); Agricultural University of Athens	Kavallieratos, NG (corresponding author), ARS, USDA, CGAHR, Manhattan, KS 66502 USA.; Kavallieratos, NG (corresponding author), Univ Agr, Lab Agr Zool & Entomol, Dept Crop Sci, Athens, Attica, Greece.	nick_kaval@hotmail.com	Kavallieratos, Nickolas G./AAB-7500-2022; Athanassiou, Christos/ABE-8867-2020	Kavallieratos, Nickolas G./0000-0001-5851-5013; Kavallieratos, Nickolas/0000-0003-4342-1289	Fulbright Foundation (Greece)	Fulbright Foundation (Greece)	CGA received support from Fulbright Foundation (Greece) (http://www.fulbright.gr/en/) (Fulbright Visiting Scholar Grant for Research, academic year 2015-2016). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken AD, 1975, USDA TECHNICAL B, V31; Athanassiou C. G., 2001, Annales de l'Institut Phytopathologique Benaki, V19, P140; Athanassiou CG, 2005, J ECON ENTOMOL, V98, P1058, DOI 10.1603/0022-0493-98.3.1058; Athanassiou CG, 2003, APPL ENTOMOL ZOOL, V38, P413, DOI 10.1303/aez.2003.413; Athanassiou CG, 2001, ENTOMOL EXP APPL, V98, P67, DOI 10.1023/A:1018741310337; Athanassiou CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102867; Birch L. C., 1945, Transactions of the Royal Society of South Australia, V69, P140; BIRCH LC, 1945, AUST J EXP BIOL MED, V23, P29, DOI 10.1038/icb.1945.5; BIRCH LC, 1945, AUST J EXP BIOL MED, V23, P141, DOI 10.1038/icb.1945.23; Buchelos CT, 1999, J STORED PROD RES, V35, P397, DOI 10.1016/S0022-474X(99)00024-7; Campbell JF, 2002, J INSECT BEHAV, V15, P429, DOI 10.1023/A:1016225427886; Cordeiro EMG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100990; Correa AS, 2017, B ENTOMOL RES, V107, P9, DOI 10.1017/S0007485316000687; CROMBIE AC, 1945, PROC R SOC SER B-BIO, V132, P362, DOI 10.1098/rspb.1945.0003; Danho M, 2002, J STORED PROD RES, V38, P259, DOI 10.1016/S0022-474X(01)00027-3; DOBIE P, 1974, J STORED PROD RES, V10, P183, DOI 10.1016/0022-474X(74)90006-X; Edde PA, 2012, J STORED PROD RES, V48, P1, DOI 10.1016/j.jspr.2011.08.007; Garcia-Lara S, 2004, CROP SCI, V44, P1546, DOI 10.2135/cropsci2004.1546; GIGA DP, 1993, J STORED PROD RES, V29, P63, DOI 10.1016/0022-474X(93)90023-W; GIGA DP, 1991, J APPL ECOL, V28, P918, DOI 10.2307/2404217; Gokce A, 2004, J AGR FAC GAZIOSMANP, V21, P9; Guedes NMP, 2010, ANIM BEHAV, V79, P281, DOI 10.1016/j.anbehav.2009.10.022; Hill DS., 2003, PESTS STORAGE FOODST; KIRITANI K., 1965, Journal of Stored Products Research, V1, P169, DOI 10.1016/0022-474X(65)90017-2; LONGSTAFF BC, 1981, PROT ECOL, V3, P83; MADRID FJ, 1990, CAN ENTOMOL, V122, P515, DOI 10.4039/Ent122515-5; Mason LJ., 2012, STORED PRODUCT PROTE, P7; Mutters RG., 2009, RICE QUALITY HDB; Nansen C, 2004, ECOL RES, V19, P197, DOI 10.1111/j.1440-1703.2003.00624.x; Nansen C, 2009, J STORED PROD RES, V45, P254, DOI 10.1016/j.jspr.2009.04.005; Nicholson AJ, 1954, AUST J ZOOL, V2, P695; Nwosu LC, 2015, INT J TROP INSECT SC, V35, P185, DOI 10.1017/S1742758415000193; Obata H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014785; RICHARDS OW, 1947, P ZOOL SOC LOND, V117, P1; Robinson W.H., 2005, HDB URBAN INSECTS AR; RYOO MI, 1988, J STORED PROD RES, V24, P79, DOI 10.1016/0022-474X(88)90034-3; SEGROVE F, 1951, J EXP BIOL, V28, P281; SERRATOS A, 1987, J CHEM ECOL, V13, P751, DOI 10.1007/BF01020157; SHARIFI S, 1971, J ECON ENTOMOL, V64, P1114, DOI 10.1093/jee/64.5.1114; SINHA RN, 1995, BOOK SOIL P, P1; Soderstrom E. L., 1966, Journal of the Kansas Entomological Society, V29, P32; SUBRAMANYAM B, 1990, J ECON ENTOMOL, V83, P1102, DOI 10.1093/jee/83.3.1102; THRONE J E, 1989, Journal of Agricultural Entomology, V6, P183; THRONE J E, 1991, Journal of Agricultural Entomology, V8, P93; THRONE JE, 1994, ENVIRON ENTOMOL, V23, P1459, DOI 10.1093/ee/23.6.1459; TIPPING PW, 1988, J KANSAS ENTOMOL SOC, V61, P237; WHITE NDG, 1995, BOOK SOIL P, P123	47	21	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173377	10.1371/journal.pone.0173377	http://dx.doi.org/10.1371/journal.pone.0173377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264050	Green Published, gold, Green Submitted			2022-12-27	WOS:000396054300059
J	Camprasse, ECM; Cherel, Y; Arnould, JPY; Hoskins, AJ; Bost, CA				Camprasse, Elodie C. M.; Cherel, Yves; Arnould, John P. Y.; Hoskins, Andrew J.; Bost, Charles-Andre			Combined bio-logging and stable isotopes reveal individual specialisations in a benthic coastal seabird, the Kerguelen shag	PLOS ONE			English	Article							REARING CROZET SHAGS; FORAGING SPECIALIZATION; BEHAVIOR; DIET; CONSISTENCY; REPEATABILITY; CORMORANTS; PATTERNS; NICHE; FOOD	Individual specialisations, which involve the repetition of specific behaviours or dietary choices over time, have been suggested to benefit animals by avoiding competition with conspecifics and increasing individual foraging efficiency. Among seabirds, resident and benthic species are thought to be good models to study inter-individual variation as they repetitively exploit the same environment. We investigated foraging behaviour, isotopic niche and diet in the Kerguelen shag Phalacrocorax verrucosus during both the incubation and chick-rearing periods for the same individuals to determine the effect of sex, breeding stage, body mass and morphometrics on mean foraging metrics and their consistency. There were large differences between individuals in foraging behaviour and consistency, with strong individual specialisations in dive depths and heading from the colony. Stable isotopes revealed specialisations in feeding strategies, across multiple temporal scales. Specifically, individuals showed medium term specialisations in feeding strategies during the breeding season, as well as long-term consistency. A clustering analysis revealed 4 different foraging strategies displaying significantly different delta N-15 values and body masses. There were no sex or stage biases to clusters and individuals in different clusters did not differ in their morphology. Importantly, the results suggest that the different strategies emphasized were related to individual prey preferences rather than intrinsic characteristics.	[Camprasse, Elodie C. M.; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood Campus, Geelong, Vic, Australia; [Cherel, Yves; Bost, Charles-Andre] Univ La Rochelle, CNRS, CEBC, UMR 7372, Villiers En Bois, Deux Sevres, France; [Hoskins, Andrew J.] CSIRO Land & Water, Canberra, ACT, Australia	Deakin University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Camprasse, ECM (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood Campus, Geelong, Vic, Australia.	elodie.camprasse@gmail.com	Hoskins, Andrew/T-2694-2019; Camprasse, Elodie/X-1832-2019	Hoskins, Andrew/0000-0001-8907-6682; 	French Polar Institute Paul-Emile Victor [394]; Holsworth Wildlife Research Endowment [RM27086]	French Polar Institute Paul-Emile Victor; Holsworth Wildlife Research Endowment	The French Polar Institute Paul-Emile Victor (www.ipev.fr) provided funding (Prog. 394, resp. CAB) used for field expenses. The Holsworth Wildlife Research Endowment (https://equrtytrustees.smartygrants.com au/holmorth, grant #RM27086) provided funding for the purchase data loggers.	Annett CA, 1999, ECOLOGY, V80, P288, DOI 10.1890/0012-9658(1999)080[0288:LTROIW]2.0.CO;2; Baylis AMM, 2015, MAR BIOL, V162, P99, DOI 10.1007/s00227-014-2561-0; Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; Beaudoin CP, 1999, OECOLOGIA, V120, P386, DOI 10.1007/s004420050871; Bivand R, 2005, R NEWS, V5; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; BOST CA, 1992, J ZOOL, V226, P135, DOI 10.1111/j.1469-7998.1992.tb06132.x; Bretz F, 2002, R NEWS, V2, P14; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Casaux R, 2006, ANTARCT SCI, V18, P3, DOI 10.1017/S0954102006000010; Ceia FR, 2015, MAR BIOL, V162, P1923, DOI 10.1007/s00227-015-2735-4; Ceia FR, 2012, MAR BIOL, V159, P1581, DOI 10.1007/s00227-012-1946-1; Cherel Y, 2008, MAR ECOL PROG SER, V366, P281, DOI 10.3354/meps07587; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Cherel Y, 2010, LIMNOL OCEANOGR, V55, P324, DOI 10.4319/lo.2010.55.1.0324; Cook TR, 2007, ANTARCT SCI, V19, P55, DOI 10.1017/S0954102007000089; Cook TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056297; Cook TR, 2006, POLAR BIOL, V29, P562, DOI 10.1007/s00300-005-0089-y; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Duhamel G., 2005, POISSONS ILES KERGUE; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Furness RW, 2006, ARDEA, V94, P631; GODIN JGJ, 1995, ANIM BEHAV, V49, P1427, DOI 10.1016/0003-3472(95)90063-2; Laich AG, 2012, J ORNITHOL, V153, P139, DOI 10.1007/s10336-011-0714-1; Green K, 1997, EMU, V97, P76, DOI 10.1071/MU97008; Gremillet D, 2005, BIOL LETTERS, V1, P469, DOI 10.1098/rsbl.2005.0356; Gremillet D, 2003, J APPL ECOL, V40, P266, DOI 10.1046/j.1365-2664.2003.00806.x; Gremillet D, 1998, IBIS, V140, P113, DOI 10.1111/j.1474-919X.1998.tb04547.x; Hamel S, 2009, OECOLOGIA, V161, P421, DOI 10.1007/s00442-009-1377-y; Harris S, 2016, MAR ECOL-EVOL PERSP, V37, P419, DOI 10.1111/maec.12327; Harris S, 2014, IBIS, V156, P523, DOI 10.1111/ibi.12159; Harris S, 2013, MAR BIOL, V160, P1249, DOI 10.1007/s00227-013-2177-9; HECHT T, 1986, S AFR J ZOOL, V21, P294; Jaeger A, 2010, MAR ECOL PROG SER, V401, P269, DOI 10.3354/meps08380; Janzen FJ, 2001, ANIM BEHAV, V62, P73, DOI 10.1006/anbe.2000.1732; Kato A, 2000, AUK, V117, P718, DOI 10.1642/0004-8038(2000)117[0718:VIFAPB]2.0.CO;2; Kaufman L., 2005, FINDING GROUPS DATA; Kernaleguen L, 2016, OECOLOGIA, V180, P657, DOI 10.1007/s00442-015-3407-2; Kernaleguen L, 2015, J ANIM ECOL, V84, P1081, DOI 10.1111/1365-2656.12347; Lack D., 1968, pvii; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Michalik A, 2013, J ORNITHOL, V154, P239, DOI 10.1007/s10336-012-0890-7; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patrick SC, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0630; Patrick SC, 2014, OIKOS, V123, P33, DOI 10.1111/j.1600-0706.2013.00406.x; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Quillfeldt P, 2011, MAR ECOL PROG SER, V428, P271, DOI 10.3354/meps09058; Quintana F, 2011, OIKOS, V120, P350, DOI 10.1111/j.1600-0706.2010.18387.x; R Core Team, 2013, R LANG ENV STAT COMP; Ratcliffe N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079107; SELANDER RK, 1966, CONDOR, V68, P113, DOI 10.2307/1365712; SIEGELCAUSEY D, 1988, CONDOR, V90, P885, DOI 10.2307/1368846; Stephens D.W., 1986, pi; Sumner MD, 2013, TRIP SPATIAL ANAL AN, P1; Tranquilla LAM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090583; van Tets G.F., 1976, P 16 INT ORN C, P121; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; WANLESS S, 1992, POLAR BIOL, V12, P713; Watanabe YY, 2011, J EXP BIOL, V214, P412, DOI 10.1242/jeb.050161; WATANUKI Y, 1992, CONDOR, V94, P159, DOI 10.2307/1368805; WERNER TK, 1987, P NATL ACAD SCI USA, V84, P5506, DOI 10.1073/pnas.84.15.5506; Williams R., 1990, ANARE RES NOTES, V75, P1; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050; Woo KJ, 2008, J ANIM ECOL, V77, P1082, DOI 10.1111/j.1365-2656.2008.01429.x	67	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172278	10.1371/journal.pone.0172278	http://dx.doi.org/10.1371/journal.pone.0172278			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264057	gold, Green Submitted, Green Published			2022-12-27	WOS:000396054300010
J	Miller, AP; Shah, AS; Aperi, BV; Kurpad, SN; Stemper, BD; Glavaski-Joksimovic, A				Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra			Acute death of astrocytes in blast-exposed rat organotypic hippocampal slice cultures	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; FIBRILLARY ACIDIC PROTEIN; IN-VITRO MODEL; AMYOTROPHIC-LATERAL-SCLEROSIS; AUTOPHAGIC ASTROGLIAL DEATH; GLUTAMATE TRANSPORTER GLT-1; EXCITATORY AMINO-ACIDS; CLOSED-HEAD INJURY; CELL-DEATH	Blast traumatic brain injury (bTBI) affects civilians, soldiers, and veterans worldwide and presents significant health concerns. The mechanisms of neurodegeneration following bTBI remain elusive and current therapies are largely ineffective. It is important to better characterize blast-evoked cellular changes and underlying mechanisms in order to develop more effective therapies. In the present study, our group utilized rat organotypic hippocampal slice cultures (OHCs) as an in vitro system to model bTBI. OHCs were exposed to either 138 +/- 22 kPa (low) or 273 +/- 23 kPa (high) overpressures using an open-ended helium-driven shock tube, or were assigned to sham control group. At 2 hours (h) following injury, we have characterized the astrocytic response to a blast overpressure. Immunostaining against the astrocytic marker glial fibrillary acidic protein (GFAP) revealed acute shearing and morphological changes in astrocytes, including clasmatodendrosis. Moreover, overlap of GFAP immunostaining and propidium iodide (PI) indicated astrocytic death. Quantification of the number of dead astrocytes per counting area in the hippocampal cornu Ammonis 1 region (CA1), demonstrated a significant increase in dead astrocytes in the low- and high-blast, compared to sham control OHCs. However only a small number of GFAP-expressing astrocytes were co-labeled with the apoptotic marker Annexin V, suggesting necrosis as the primary type of cell death in the acute phase following blast exposure. Moreover, western blot analyses revealed calpain mediated breakdown of GFAP. The dextran exclusion additionally indicated membrane disruption as a potential mechanism of acute astrocytic death. Furthermore, although blast exposure did not evoke significant changes in glutamate transporter 1 (GLT-1) expression, loss of GLT-1-expressing astrocytes suggests dysregulation of glutamate uptake following injury. Our data illustrate the profound effect of blast overpressure on astrocytes in OHCs at 2 h following injury and suggest increased calpain activity and membrane disruption as potential underlying mechanisms.	[Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Miller, Anna P.; Kurpad, Shekar N.; Glavaski-Joksimovic, Aleksandra] Med Coll Wisconsin, Dept Cell Biol, Milwaukee, WI 53226 USA; [Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin	Glavaski-Joksimovic, A (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA.	aglavaski@mcw.edu	Kurpad, Shekar/V-2188-2019; Stemper, Brian/AAX-7611-2020	Miller, Anna/0000-0002-6823-0852	Department of Neurosurgery, Medical College of Wisconsin; VA Medical Research	Department of Neurosurgery, Medical College of Wisconsin; VA Medical Research(US Department of Veterans Affairs)	This work was supported by the Department of Neurosurgery, Medical College of Wisconsin and the VA Medical Research.	Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Arun P, 2012, NEUROREPORT, V23, P342, DOI 10.1097/WNR.0b013e328351b58d; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; BAHR BA, 1995, J NEUROSCI RES, V42, P294, DOI 10.1002/jnr.490420303; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Benediktsson AM, 2012, GLIA, V60, P175, DOI 10.1002/glia.21249; Benediktsson AM, 2005, J NEUROSCI METH, V141, P41, DOI 10.1016/j.jneumeth.2004.05.013; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bi Dan, 2015, Yichuan, V37, P140, DOI 10.16288/j.yczz.14-207; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bralic M, 2012, MED HYPOTHESES, V79, P358, DOI 10.1016/j.mehy.2012.05.034; BUCHS PA, 1993, DEV BRAIN RES, V71, P81, DOI 10.1016/0165-3806(93)90108-M; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Burda JE, 2015, EXP NEUROL; Campbell SL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00425; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chechneva O, 2005, NEUROSCIENCE, V136, P343, DOI 10.1016/j.neuroscience.2005.07.058; Chen JL, 2013, CELL BIOCHEM BIOPHYS, V67, P1015, DOI 10.1007/s12013-013-9597-5; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00117; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cimarosti H, 2009, NEUROPHARMACOLOGY, V56, P1088, DOI 10.1016/j.neuropharm.2009.03.007; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336, DOI 10.1152/physrev.1956.36.3.336; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Collin C, 1997, J NEUROPHYSIOL, V77, P1614, DOI 10.1152/jn.1997.77.3.1614; Coltman BW, 1996, INT J DEV NEUROSCI, V14, P707, DOI 10.1016/S0736-5748(96)00071-8; Conti AC, 1998, J NEUROSCI, V18, P5663; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Cummings Brian S, 2004, Curr Protoc Pharmacol, VChapter 12, DOI 10.1002/0471141755.ph1208s25; Czapiga M, 1999, J NEUROSCI RES, V56, P644, DOI 10.1002/(SICI)1097-4547(19990615)56:6<644::AID-JNR10>3.0.CO;2-9; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Effgen GB, 2016, JOURNAL OF NEUROTRAU; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fahlenkamp AV, 2011, INFLAMM RES, V60, P379, DOI 10.1007/s00011-010-0281-6; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Foraker JE, 2011, J NEUROCHEM, V119, P1052, DOI 10.1111/j.1471-4159.2011.07511.x; Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444; Furness DN, 2008, NEUROSCIENCE, V157, P80, DOI 10.1016/j.neuroscience.2008.08.043; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Giffard RG, 2005, GLIA, V50, P299, DOI 10.1002/glia.20167; Glavaski-Joksimovic A, 2009, NEUROSCIENCE, V162, P472, DOI 10.1016/j.neuroscience.2009.04.070; Glavaski-Joksimovic A, 2008, CLONING STEM CELLS, V10, P75, DOI 10.1089/clo.2007.0065; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heales SJR, 2004, NEUROCHEM RES, V29, P513, DOI 10.1023/B:NERE.0000014822.69384.0f; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hlavac Nora, 2015, Biomed Sci Instrum, V51, P439; Hoffer Michael E, 2009, Int Tinnitus J, V15, P115; Huang QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061345; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Hulse RE, 2001, GLIA, V33, P169, DOI 10.1002/1098-1136(200102)33:2<169::AID-GLIA1016>3.0.CO;2-B; Humpel C, 2015, NEUROSCIENCE, V305, P86, DOI 10.1016/j.neuroscience.2015.07.086; Ibolja Cernak FAA, 2010, MEDICAL DATA, V2, P297; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Jeftinija SD, 1996, J NEUROCHEM, V66, P676; Jeremic A, 2001, J NEUROCHEM, V77, P664, DOI 10.1046/j.1471-4159.2001.00272.x; Johnson EA, 2005, EXP BRAIN RES, V167, P17, DOI 10.1007/s00221-005-2362-2; Castejon OJ, 2015, FOLIA NEUROPATHOL, V53, P173, DOI 10.5114/fn.2015.54419; Jurado-Arjona J, 2015, BRAIN RES, V1611, P84, DOI 10.1016/j.brainres.2015.03.016; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kodama T, 1998, ULTRASOUND MED BIOL, V24, P1459, DOI 10.1016/S0301-5629(98)00094-5; Krishnamurthy K, 2016, TRANSLATIONAL RESEAR; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lee JY, 2015, J KOREAN NEUROSURG S, V58, P93, DOI 10.3340/jkns.2015.58.2.93; Lee YB, 2000, BRAIN RES, V864, P220, DOI 10.1016/S0006-8993(00)02180-6; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Levine J, 2015, GLIA; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lim YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125130; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Macdonald CL, 2014, JOURNAL OF NEUROTRAU; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Mari C, 2004, EUR J NUCL MED MOL I, V31, P733, DOI 10.1007/s00259-004-1473-5; Matute C, 2002, EUR J PHARMACOL, V447, P239, DOI 10.1016/S0014-2999(02)01847-2; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Mennerick S, 1998, J NEUROSCI, V18, P4490; Mewes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045017; Miller AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00020; MILLER LDP, 1994, NEUROSCIENCE, V63, P471, DOI 10.1016/0306-4522(94)90544-4; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Morin-Brureau M, 2011, J NEUROSCI, V31, P10677, DOI 10.1523/JNEUROSCI.5692-10.2011; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Ralay R. H., 2011, J NEUROTRAUM, V28, P1757, DOI DOI 10.1089/NEU.2011.1799; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; Rossi D, 2008, CELL DEATH DIFFER, V15, P1691, DOI 10.1038/cdd.2008.99; Rossi D, 2005, J BIOL CHEM, V280, P42088, DOI 10.1074/jbc.M504124200; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rytter A, 2003, J CEREBR BLOOD F MET, V23, P23, DOI 10.1097/01.WCB.0000034361.37277.1B; Ryu HJ, 2011, BRAIN RES BULL, V85, P368, DOI 10.1016/j.brainresbull.2011.05.007; Ryu HJ, 2011, CELL MOL NEUROBIOL, V31, P1071, DOI 10.1007/s10571-011-9706-1; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Sakai K, 2013, BRAIN INJURY, V27, P1692, DOI 10.3109/02699052.2013.837198; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Sarnowska A, 2009, EXP NEUROL, V215, P317, DOI 10.1016/j.expneurol.2008.10.023; Sawyer TW, 2016, JOURNAL OF NEUROTRAU; Schousboe Arne, 2013, Front Endocrinol (Lausanne), V4, P102, DOI 10.3389/fendo.2013.00102; Shah AS, 2012, BIOMED SCI INSTRUM, V48, P1; Shah AS, 2011, THE AMERICAN SOCIETY, P17; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Su T, 2011, BRAIN RES, V1385, P68, DOI 10.1016/j.brainres.2011.01.115; Suh EC, 2008, NEUROTOXICOLOGY, V29, P691, DOI 10.1016/j.neuro.2008.04.001; SUNESON A, 1989, J TRAUMA, V29, P10, DOI 10.1097/00005373-198901000-00003; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Tanielian T., 2008, INVISIBLE WOUNDS OF; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tilleux S, 2007, J NEUROSCI RES, V85, P2059, DOI 10.1002/jnr.21325; Valiyaveettil M, 2014, BRAIN RES, V1549, P32, DOI 10.1016/j.brainres.2013.12.031; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang Ke-Wan, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P687; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Willoughby KA, 2004, J NEUROCHEM, V91, P1284, DOI 10.1111/j.1471-4159.2004.02812.x; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yang ZH, 2014, J CEREBR BLOOD F MET, V34, P1444, DOI 10.1038/jcbfm.2014.105; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yi JH, 2005, GLIA, V49, P121, DOI 10.1002/glia.20099; Yong-Ming Z, 2012, AFR HEALTH SCI, V12, P552, DOI 10.4314/ahs.v12i4.24; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhou SD, 2011, BIOTECHNOL J, V6, P513, DOI 10.1002/biot.201000254; Zhu F, 2015, CHIN J TRAUMATOL, V18, P10, DOI 10.1016/j.cjtee.2014.10.001; Zimmer J, 2000, AMINO ACIDS, V19, P7, DOI 10.1007/s007260070029; Zou J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00077; Zuo HY, 2014, INT J MED SCI, V11, P426, DOI 10.7150/ijms.6540	193	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173167	10.1371/journal.pone.0173167	http://dx.doi.org/10.1371/journal.pone.0173167			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5OE	28264063	Green Published, gold, Green Submitted			2022-12-27	WOS:000396054300042
J	Amini, S; Holstege, FCP; Kemmeren, P				Amini, Saman; Holstege, Frank C. P.; Kemmeren, Patrick			Growth condition dependency is the major cause of non-responsiveness upon genetic perturbation	PLOS ONE			English	Article							M(7)GPPPX PYROPHOSPHATASE ACTIVITY; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ANALYSIS; YEAST; GENOME; NETWORKS; EPISTASIS; ROBUSTNESS; MECHANISMS; EXPRESSION	Investigating the role and interplay between individual proteins in biological processes is often performed by assessing the functional consequences of gene inactivation or removal. Depending on the sensitivity of the assay used for determining phenotype, between 66% (growth) and 53% (gene expression) of Saccharomyces cerevisiae gene deletion strains show no defect when analyzed under a single condition. Although it is well known that this non -responsive behavior is caused by different types of redundancy mechanisms or by growth condition/cell type dependency, it is not known what the relative contribution of these different causes is. Understanding the underlying causes of and their relative contribution to non -responsive behavior upon genetic perturbation is extremely important for designing efficient strategies aimed at elucidating gene function and unraveling complex cellular systems. Here, we provide a systematic classification of the underlying causes of and their relative contribution to non-responsive behavior upon gene deletion. The overall contribution of redundancy to non-responsive behavior is estimated at 29%, of which approximately 17% is due to homology-based redundancy and 12% is due to pathway-based redundancy. The major determinant of non-responsiveness is condition dependency (71%). For approximately 14% of protein complexes, just-in-time assembly can be put forward as a potential mechanistic explanation for how proteins can be regulated in a condition dependent manner. Taken together, the results underscore the large contribution of growth condition requirement to non-responsive behavior, which needs to be taken into account for strategies aimed at determining gene function. The classification provided here, can also be further harnessed in systematic analyses of complex cellular systems.	[Amini, Saman; Holstege, Frank C. P.; Kemmeren, Patrick] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [Amini, Saman; Kemmeren, Patrick] Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Kemmeren, P (corresponding author), Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands.; Kemmeren, P (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands.	p.kemmeren@prinsesmaximacentrum.nl	Holstege, Frank/AAM-9944-2021	Kemmeren, Patrick/0000-0003-2237-7354	Dutch Organization for Scientific Research (NWO) [864.11.010]	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Financial support was provided by the Dutch Organization for Scientific Research (NWO), grant 864.11.010 (SA & PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benschop JJ, 2010, MOL CELL, V38, P916, DOI 10.1016/j.molcel.2010.06.002; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Conant GC, 2002, NUCLEIC ACIDS RES, V30, P3378, DOI 10.1093/nar/gkf449; Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Dean EJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000113; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giaever G, 2014, GENETICS, V197, P451, DOI 10.1534/genetics.114.161620; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hsiao TL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000014; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kemmeren P, 2014, CELL, V157, P740, DOI 10.1016/j.cell.2014.02.054; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Li JJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001187; Liberali P, 2015, NAT REV GENET, V16, P18, DOI 10.1038/nrg3768; Liu HD, 2002, EMBO J, V21, P4699, DOI 10.1093/emboj/cdf448; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Malys N, 2004, NUCLEIC ACIDS RES, V32, P3590, DOI 10.1093/nar/gkh687; Malys N, 2006, J MOL BIOL, V363, P370, DOI 10.1016/j.jmb.2006.08.015; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Musso G, 2008, GENOME RES, V18, P1092, DOI 10.1101/gr.076174.108; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Pitre S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-365; Plata G, 2013, NUCLEIC ACIDS RES; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sameith K, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0222-5; Santt O, 2008, MOL BIOL CELL, V19, P3323, DOI 10.1091/mbc.E08-03-0328; Shen S, 2009, MOL BIOL CELL, V20, P2438, DOI 10.1091/mbc.E08-10-0987; Stillman DJ, 2010, BBA-GENE REGUL MECH, V1799, P175, DOI 10.1016/j.bbagrm.2009.11.010; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Usaj MM, 2016, TRENDS CELL BIOL, V26, P598, DOI 10.1016/j.tcb.2016.03.008; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021; Vik A, 2001, MOL CELL BIOL, V21, P6395, DOI 10.1128/MCB.21.19.6395-6405.2001; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yao YH, 2010, RNA, V16, P1007, DOI 10.1261/rna.2012310; Zhang JZ, 2012, ADV EXP MED BIOL, V751, P279, DOI 10.1007/978-1-4614-3567-9_13	56	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173432	10.1371/journal.pone.0173432	http://dx.doi.org/10.1371/journal.pone.0173432			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257504	gold, Green Published, Green Submitted			2022-12-27	WOS:000396021100091
J	Ares, MA; Fernandez-Vazquez, JL; Pacheco, S; Martinez-Santos, VI; Jarillo-Quijada, MD; Torres, J; Alcantar-Curiel, MD; Gonzalez-y-Merchand, JA; De la Cruz, MA				Ares, Miguel A.; Fernandez-Vazquez, Jose L.; Pacheco, Sabino; Martinez-Santos, Veronica I.; Dolores Jarillo-Quijada, Ma.; Torres, Javier; Alcantar-Curiel, Maria D.; Gonzalez-y-Merchand, Jorge A.; De la Cruz, Miguel A.			Additional regulatory activities of MrkH for the transcriptional expression of the Klebsiella pneumoniae mrk genes: Antagonist of H-NS and repressor	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; BIOFILM FORMATION; TYPE-3 FIMBRIAE; DEPENDENT REPRESSION; VIBRIO-CHOLERAE; LIVER-ABSCESS; FOREIGN DNA; IDENTIFICATION; BACTERIA; GENOME	Klebsiella pneumoniae is a common opportunistic pathogen causing nosocomial infections. One of the main virulence determinants of K. pneumoniae is the type 3 pilus (T3P). T3P helps the bacterial interaction to both abiotic and biotic surfaces and it is crucial for the biofilm formation. T3P is genetically organized in three transcriptional units: the mrkABCDF polycistronic operon, the mrkHI bicistronic operon and the mrkJ gene. MrkH is a regulatory protein encoded in the mrkHI operon, which positively regulates the mrkA pilin gene and its own expression. In contrast, the H-NS nucleoid protein represses the transcriptional expression of T3P. Here we reported that MrkH and H-NS positively and negatively regulate mrkJ expression, respectively, by binding to the promoter of mrkJ. MrkH protein recognized a sequence located at position -63.5 relative to the transcriptional start site of mrkJ gene. Interestingly, our results show that, in addition to its known function as classic transcriptional activator, MrkH also positively controls the expression of mrk genes by acting as an anti-repressor of H-NS; moreover, our results support the notion that high levels of MrkH repress T3P expression. Our data provide new insights about the complex regulatory role of the MrkH protein on the transcriptional control of T3P in K. pneumoniae.	[Ares, Miguel A.; Torres, Javier; De la Cruz, Miguel A.] Ctr Med Nacl Siglo XXI IMSS, Hosp Pediat, Unidad Invest Med Enfermedades Infecciosas & Para, Ciudad De Mexico, Mexico; [Ares, Miguel A.; Gonzalez-y-Merchand, Jorge A.] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Microbiol, Ciudad De Mexico, Mexico; [Fernandez-Vazquez, Jose L.; Dolores Jarillo-Quijada, Ma.; Alcantar-Curiel, Maria D.] Univ Nacl Autonoma Mexico, Fac Med, Unidad Invest Med Expt, Ciudad De Mexico, Mexico; [Pacheco, Sabino] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Microbiol Mol, Cuernavaca, Morelos, Mexico; [Martinez-Santos, Veronica I.] Univ Autonoma Guerrero, Unidad Acad Ciencias Quim Biol, Chilpancingo, Guerrero, Mexico	Instituto Mexicano del Seguro Social; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	De la Cruz, MA (corresponding author), Ctr Med Nacl Siglo XXI IMSS, Hosp Pediat, Unidad Invest Med Enfermedades Infecciosas & Para, Ciudad De Mexico, Mexico.	miguel_angel_81@live.com	Pacheco, Sabino/AFJ-9017-2022	Martinez-Santos, Veronica/0000-0002-0157-5696; Ares, Miguel/0000-0003-2574-958X; De la Cruz, Miguel A./0000-0001-6909-2941; Pacheco, Sabino/0000-0002-0208-0046; Jarillo-Quijada, Ma Dolores/0000-0003-4510-9707				Alcantar-Curiel MD, 2013, VIRULENCE, V4, P129, DOI 10.4161/viru.22974; ALLEN BL, 1991, J BACTERIOL, V173, P916, DOI 10.1128/jb.173.2.916-920.1991; Ares MA, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00013; Ayala JC, 2015, MOL MICROBIOL, V97, P630, DOI 10.1111/mmi.13058; Berdichevsky T, 2005, J BACTERIOL, V187, P349, DOI 10.1128/JB.187.1.349-357.2005; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Bustamante VH, 2001, MOL MICROBIOL, V39, P664, DOI 10.1046/j.1365-2958.2001.02209.x; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Chang CM, 2008, INFECTION, V36, P328, DOI 10.1007/s15010-008-7272-3; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De la Cruz MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003827; De la Cruz MA, 2007, MOL MICROBIOL, V66, P727, DOI 10.1111/j.1365-2958.2007.05958.x; Dorman CJ, 2007, NAT REV MICROBIOL, V5, P157, DOI 10.1038/nrmicro1598; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Gallego-Hernandez AL, 2012, J BACTERIOL, V194, P2254, DOI 10.1128/JB.06164-11; GERLACH GF, 1989, J BACTERIOL, V171, P1262, DOI 10.1128/jb.171.3.1262-1270.1989; HAN SHB, 1995, WESTERN J MED, V162, P220; HORNICK DB, 1995, INFECT IMMUN, V63, P2026, DOI 10.1128/IAI.63.5.2026-2032.1995; Huang YJ, 2009, RES MICROBIOL, V160, P71, DOI 10.1016/j.resmic.2008.10.009; Jagnow J, 2003, MICROBIOL-SGM, V149, P2397, DOI 10.1099/mic.0.26434-0; Jahn CE, 2008, J MICROBIOL METH, V75, P318, DOI 10.1016/j.mimet.2008.07.004; Johnson JG, 2011, J BACTERIOL, V193, P3453, DOI 10.1128/JB.00286-11; Johnson JG, 2010, J BACTERIOL, V192, P3944, DOI 10.1128/JB.00304-10; Langstraat J, 2001, INFECT IMMUN, V69, P5805, DOI 10.1128/IAI.69.9.5805-5812.2001; Lithgow JK, 2007, MOL MICROBIOL, V66, P685, DOI 10.1111/j.1365-2958.2007.05950.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAYER MP, 1995, GENE, V163, P41, DOI 10.1016/0378-1119(95)00389-N; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Schelenz S, 2007, JOINT BONE SPINE, V74, P275, DOI 10.1016/j.jbspin.2006.08.007; Schroll C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-179; SCHURTZ TA, 1994, INFECT IMMUN, V62, P4186, DOI 10.1128/IAI.62.10.4186-4191.1994; Sebghati TAS, 1998, INFECT IMMUN, V66, P2887, DOI 10.1128/IAI.66.6.2887-2894.1998; Stoebel DM, 2008, MICROBIOL-SGM, V154, P2533, DOI 10.1099/mic.0.2008/020693-0; Struve C, 2009, INFECT IMMUN, V77, P5016, DOI 10.1128/IAI.00585-09; Tan JWH, 2015, J BACTERIOL, V197, P1659, DOI 10.1128/JB.02615-14; Tarkkanen AM, 1997, INFECT IMMUN, V65, P1546, DOI 10.1128/IAI.65.4.1546-1549.1997; Tendeng C, 2003, TRENDS MICROBIOL, V11, P511, DOI 10.1016/j.tim.2003.09.005; Tsai FC, 2008, EMERG INFECT DIS, V14, P1592, DOI 10.3201/eid1410.071254; Wilksch JJ, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002204, 10.1371/journal.ppat.1002179]; Wu CC, 2012, MICROBIOL-SGM, V158, P1045, DOI 10.1099/mic.0.053801-0; Yang JJ, 2013, J GERIATR CARDIOL, V10, P10, DOI [10.3969/j.issn.1671-5411.2013.01.003, 10.3724/SP.J.1263.2012.12191]; Zamorano-Sanchez D, 2015, J BACTERIOL, V197, P1221, DOI 10.1128/JB.02439-14	45	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173285	10.1371/journal.pone.0173285	http://dx.doi.org/10.1371/journal.pone.0173285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278272	gold, Green Published, Green Submitted			2022-12-27	WOS:000396087900067
J	Hanemaaijer, M; Olivier, BG; Roling, WFM; Bruggeman, FJ; Teusink, B				Hanemaaijer, Mark; Olivier, Brett G.; Roling, Wilfred F. M.; Bruggeman, Frank J.; Teusink, Bas			Model-based quantification of metabolic interactions from dynamic microbial-community data	PLOS ONE			English	Article							CLOSTRIDIUM-ACETOBUTYLICUM; GENE-EXPRESSION; MIXED-CULTURE; NITRATE; GROWTH; FERMENTATION; NITROGEN; GLUCOSE; BIOLOGY; NITRITE	An important challenge in microbial ecology is to infer metabolic-exchange fluxes between growing microbial species from community-level data, concerning species abundances and metabolite concentrations. Here we apply a model-based approach to integrate such experi-mental data and thereby infer metabolic-exchange fluxes. We designed a synthetic anaero-bic co-culture of Clostridium acetobutylicum and Wolinella succinogenes that interact via interspecies hydrogen transfer and applied different environmental conditions for which we expected the metabolic-exchange rates to change. We used stoichiometric models of the metabolism of the two microorganisms that represents our current physiological under-standing and found that this understanding -the model -is sufficient to infer the identity and magnitude of the metabolic-exchange fluxes and it suggested unexpected interactions. Where the model could not fit all experimental data, it indicates specific requirement for fur-ther physiological studies. We show that the nitrogen source influences the rate of interspe-cies hydrogen transfer in the co-culture. Additionally, the model can predict the intracellular fluxes and optimal metabolic exchange rates, which can point to engineering strategies. This study therefore offers a realistic illustration of the strengths and weaknesses of model-based integration of heterogenous data that makes inference of metabolic-exchange fluxes possible from community-level experimental data.	[Hanemaaijer, Mark; Olivier, Brett G.; Bruggeman, Frank J.; Teusink, Bas] Vrije Univ Amsterdam, Amsterdam Insititute Mol Med & Syst, Syst Bioinformat, Amsterdam, Netherlands; [Hanemaaijer, Mark; Roling, Wilfred F. M.] Vrije Univ Amsterdam, Amsterdam Insititute Mol Med & Syst, Mol Cell Physiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Teusink, B (corresponding author), Vrije Univ Amsterdam, Amsterdam Insititute Mol Med & Syst, Syst Bioinformat, Amsterdam, Netherlands.	b.teusink@vu.nl	Bruggeman, Frank/AAS-8371-2020; Olivier, Brett G/A-2800-2008	Bruggeman, Frank/0000-0002-0255-4766; Olivier, Brett G/0000-0002-5293-5321; Teusink, Bas/0000-0003-3929-0423	ZonMW; Netherlands Genomics Initiative via a Zenith Horizon grant [40-41009-98-10038]; BE-Basic Foundation grant [F08.005.001]	ZonMW(Netherlands Organization for Health Research and Development); Netherlands Genomics Initiative via a Zenith Horizon grant; BE-Basic Foundation grant	This work is financially supported by ZonMW and the Netherlands Genomics Initiative via a Zenith Horizon grant 40-41009-98-10038. BGO is supported by a BE-Basic Foundation grant F08.005.001.	Akesson M, 2004, METAB ENG, V6, P285, DOI 10.1016/j.ymben.2003.12.002; Avila M, 2014, INT J FOOD MICROBIOL, V172, P70, DOI 10.1016/j.ijfoodmicro.2013.12.002; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Berry D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00219; BOKRANZ M, 1983, ARCH MICROBIOL, V135, P36, DOI 10.1007/BF00419479; Chen JS, 2001, J IND MICROBIOL BIOT, V27, P281, DOI 10.1038/sj.jim.7000083; CHUNG KT, 1976, APPL ENVIRON MICROB, V31, P342, DOI 10.1128/AEM.31.3.342-348.1976; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; De Vuyst L, 2005, TRENDS FOOD SCI TECH, V16, P43, DOI 10.1016/j.tifs.2004.02.012; Embree M, 2015, P NATL ACAD SCI USA, V112, P15450, DOI 10.1073/pnas.1506034112; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Hanemaaijer M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00213; Hanly TJ, 2011, BIOTECHNOL BIOENG, V108, P376, DOI 10.1002/bit.22954; Heinken A, 2013, GUT MICROBES, V4, P28, DOI 10.4161/gmic.22370; Jones E., 2001, SCIPY OPEN SOURCE SC; Kelk SM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00580; Khandelwal RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064567; Klitgord N, 2011, CURR OPIN BIOTECH, V22, P541, DOI 10.1016/j.copbio.2011.04.018; Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002; Kraft B, 2014, SCIENCE, V345, P676, DOI 10.1126/science.1254070; Lee J, 2008, APPL MICROBIOL BIOT, V80, P849, DOI 10.1007/s00253-008-1654-4; Lee SM, 2010, APPL BIOCHEM BIOTECH, V161, P75, DOI 10.1007/s12010-009-8788-4; Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110; Maarleveld TR, 2014, PLANT PHYSIOL, P113; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Moller S, 1998, APPL ENVIRON MICROB, V64, P721; Olivier BG, 2015, J INTEGR BIOINFORMAT, V12, DOI 10.2390/biecoll-jib-2015-269; Patle S, 2007, BIOTECHNOL LETT, V29, P1839, DOI 10.1007/s10529-007-9493-4; Pawelczyk S, 2008, J MICROBIOL METH, V75, P117, DOI 10.1016/j.mimet.2008.05.018; Reed JL, 2006, NAT REV GENET, V7, P130, DOI 10.1038/nrg1769; Roling WFM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00125; ROSENBLUM ED, 1949, J BACTERIOL, V57, P413, DOI 10.1128/JB.57.4.413-414.1949; Salimi F, 2010, BIOTECHNOL J, V5, P726, DOI 10.1002/biot.201000159; SCHUMACHER W, 1992, ARCH MICROBIOL, V158, P287, DOI 10.1007/BF00245247; Senger RS, 2008, BIOTECHNOL BIOENG, V101, P1036, DOI 10.1002/bit.22010; STAMS AJM, 1994, ANTON LEEUW INT J G, V66, P271, DOI 10.1007/BF00871644; Stolyar S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100131; Teusink B, 2006, J BIOL CHEM, V281, P40041, DOI 10.1074/jbc.M606263200; VANANDEL JG, 1985, APPL MICROBIOL BIOT, V23, P21, DOI 10.1007/BF02660113; Wilson PW, 1930, J BACTERIOL, V19, P231, DOI 10.1128/JB.19.4.231-260.1930; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Yang JE, 1998, SOIL SCI SOC AM J, V62, P1108, DOI 10.2136/sssaj1998.03615995006200040036x; Yizhak K, 2010, BIOINFORMATICS, V26, pi255, DOI 10.1093/bioinformatics/btq183; Zengler K, 2012, NAT REV MICROBIOL, V10, P366, DOI 10.1038/nrmicro2763; Zhou JZ, 2011, MBIO, V2, DOI 10.1128/mBio.00122-11; Zhuang K, 2011, ISME J, V5, P305, DOI 10.1038/ismej.2010.117	47	30	30	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173183	10.1371/journal.pone.0173183	http://dx.doi.org/10.1371/journal.pone.0173183			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278266	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900053
J	Koehler-McNicholas, SR; Nickel, EA; Medvec, J; Barrons, K; Mion, S; Hansen, AH				Koehler-McNicholas, Sara R.; Nickel, Eric A.; Medvec, Joseph; Barrons, Kyle; Mion, Spencer; Hansen, Andrew H.			The influence of a hydraulic prosthetic ankle on residual limb loading during sloped walking	PLOS ONE			English	Article							INCLINED SURFACES; FOOT; GAIT; ALIGNMENT; AMPUTEES; ADAPTATION; KINEMATICS; USERS	In recent years, numerous prosthetic ankle-foot devices have been developed to address the demands of sloped walking for individuals with lower-limb amputation. The goal of this study was to compare the performance of a passive, hydraulic ankle-foot prosthesis to two related, non-hydraulic ankles based on their ability to minimize the socket reaction moments of individuals with transtibial amputation during a range of sloped walking tasks. After a two-week accommodation period, kinematic data were collected on seven subjects with a transtibial amputation walking on an instrumented treadmill set at various slopes. Overall, this study was unable to find significant differences in the torque at the distal end of the prosthetic socket between an ankle-foot prosthesis with a hydraulic range-of-motion and other related ankle-foot prosthesis designs (rigid ankle, multiaxial ankle) during the single-support phase of walking. In addition, socket comfort and perceived exertion were not significantly different for any of the ankle-foot prostheses tested in this study. These results suggest the need for further work to determine if more advanced designs (e.g., those with microprocessor control of hydraulic features, powered ankle-foot designs) can provide more biomimetic function to prosthesis users.	[Koehler-McNicholas, Sara R.; Nickel, Eric A.; Medvec, Joseph; Barrons, Kyle; Mion, Spencer; Hansen, Andrew H.] Minneapolis Dept Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA; [Hansen, Andrew H.] Univ Minnesota, Dept Rehabil Med, Program Rehabil Sci, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Koehler-McNicholas, SR (corresponding author), Minneapolis Dept Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA.	sara.koehler@va.gov		Koehler-McNicholas, Sara/0000-0002-7201-3607	United States Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service [A6568R]	United States Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service	This work was supported by Merit Review Award #A6568R (awarded to AHH) from the United States Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	De Asha AR, 2014, CLIN BIOMECH, V29, P728, DOI 10.1016/j.clinbiomech.2014.06.009; De Asha AR, 2013, CLIN BIOMECH, V28, P218, DOI 10.1016/j.clinbiomech.2012.11.013; Hansen AH, 2004, HUM MOVEMENT SCI, V23, P807, DOI 10.1016/j.humov.2004.08.023; Hansen AH, 2006, PROSTHET ORTHOT INT, V30, P286, DOI 10.1080/03093640600816982; Hanspal RS, 2003, DISABIL REHABIL, V25, P1278, DOI 10.1080/09638280310001603983; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kendrick DB, 2005, AM J EMERG MED, V23, P828, DOI 10.1016/j.ajem.2005.07.009; Klodd E, 2010, J REHABIL RES DEV, V47, P899, DOI 10.1682/JRRD.2009.10.0166; Koehler SR, 2014, J BIOMECH, V47, P1542, DOI 10.1016/j.jbiomech.2014.01.048; Leroux A, 2002, GAIT POSTURE, V15, P64, DOI 10.1016/S0966-6362(01)00181-3; Nickel E, 2014, J REHABIL RES DEV, V51, P803, DOI 10.1682/JRRD.2013.08.0177; Noble JW, 2008, EXP BRAIN RES, V189, P249, DOI 10.1007/s00221-008-1464-z; Owen E, 2010, PROSTHET ORTHOT INT, V34, P254, DOI 10.3109/03093646.2010.485597; Pinzur MS, 1995, J REHABIL RES DEV, V32, P373; Portnoy S, 2012, GAIT POSTURE, V35, P121, DOI 10.1016/j.gaitpost.2011.08.021; Portnoy S, 2010, MED ENG PHYS, V32, P312, DOI 10.1016/j.medengphy.2009.12.006; Ries Andrew L, 2005, COPD, V2, P105; Schmalz T, 2002, GAIT POSTURE, V16, P255, DOI 10.1016/S0966-6362(02)00008-5; Sedki I, 2013, PROSTHET ORTHOT INT, V37, P250, DOI 10.1177/0309364612458448; Seelen HAM, 2003, CLIN REHABIL, V17, P787, DOI 10.1191/0269215503cr678oa; Vrieling AH, 2008, GAIT POSTURE, V28, P235, DOI 10.1016/j.gaitpost.2007.12.006; Wells R P, 1981, Bull Prosthet Res, V10-35, P15	22	10	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173423	10.1371/journal.pone.0173423	http://dx.doi.org/10.1371/journal.pone.0173423			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278172	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900091
J	Libert, X; Packeu, A; Bureau, F; Roosens, NH; De Keersmaecker, SCJ				Libert, Xavier; Packeu, Ann; Bureau, Fabrice; Roosens, Nancy H.; De Keersmaecker, Sigrid C. J.			Development and performance assessment of a luminex xMAP (R) direct hybridization assay for the detection and identification of indoor air fungal contamination	PLOS ONE			English	Article							REAL-TIME PCR; INTERNAL TRANSCRIBED SPACER; ASPERGILLUS-FUMIGATUS; AIRBORNE FUNGI; DNA; TECHNOLOGY; VALIDATION; BUILDINGS; PATHOGENS; ASTHMA	Considered as a public health problem, indoor fungal contamination is generally monitored using classical protocols based on culturing. However, this culture dependency could influence the representativeness of the fungal population detected in an analyzed sample as this includes the dead and uncultivable fraction. Moreover, culture-based protocols are often time-consuming. In this context, molecular tools are a powerful alternative, especially those allowing multiplexing. In this study a Luminex xMAP (R) assay was developed for the simultaneous detection of 10 fungal species which are most frequently in indoor air and that may cause health problems. This xMAP (R) assay was found to be sensitive, i.e. its limit of detection is ranging between 0.05 and 0.01 ng of gDNA. The assay was subsequently tested with environmental air samples which were also analyzed with a classical protocol. All the species identified with the classical method were also detected with the xMAP (R) assay, however in a shorter time frame. These results demonstrate that the Luminex xMAP (R) fungal assay developed in this study could contribute to the improvement of public health and specifically to the indoor fungal contamination treatment.	[Libert, Xavier; Roosens, Nancy H.; De Keersmaecker, Sigrid C. J.] Sci Inst Publ Hlth WIV ISP, Platform Biotechnol & Mol Biol, Brussels, Belgium; [Libert, Xavier; Bureau, Fabrice] Univ Liege ULg, GIGA, Cellular & Mol Immunol, Sart Tilman Par Liege, Belgium; [Packeu, Ann] Sci Inst Publ Hlth WIV ISP, Mycol & Aerobiol, Brussels, Belgium		De Keersmaecker, SCJ (corresponding author), Sci Inst Publ Hlth WIV ISP, Platform Biotechnol & Mol Biol, Brussels, Belgium.	sigrid.dekeersmaecker@wiv-isp.be	De Keersmaecker, Sigrid/ABB-5332-2021	De Keersmaecker, Sigrid/0000-0003-4198-4133; Roosens, Nancy H C J/0000-0001-9218-078X	RP/PJ WIV-ISP (rechtspersoonlijkheid / personnalite juridique Wetenschappelijk Instituut Volksgezondheid - Institut Scientifique de Sante Publique) (mycoMOLAIR)	RP/PJ WIV-ISP (rechtspersoonlijkheid / personnalite juridique Wetenschappelijk Instituut Volksgezondheid - Institut Scientifique de Sante Publique) (mycoMOLAIR)	This work was supported by RP/PJ WIV-ISP (rechtspersoonlijkheid / personnalite juridique Wetenschappelijk Instituut Volksgezondheid - Institut Scientifique de Sante Publique) (mycoMOLAIR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni S., 2014, XMAP COOKBOOK, V2nd; Barbau-Piednoir E, 2013, APPL MICROBIOL BIOT, V97, P4021, DOI [10.1007/s00253-012-4477-2, 10.1007/s00253-013-5234-x]; Beguin H, 1994, AEROBIOLOGIA, V10, P157, DOI DOI 10.1007/BF02459231; Bellanger AP, 2009, LETT APPL MICROBIOL, V49, P260, DOI 10.1111/j.1472-765X.2009.02653.x; Betancourt DA, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01114-15; Black Jonathan, 2013, J Biomol Tech, V24, P32, DOI 10.7171/jbt.13-2401-004; Christopher-Hennings J, 2013, J VET DIAGN INVEST, V25, P671, DOI 10.1177/1040638713507256; Costa C, 2001, J MICROBIOL METH, V44, P263, DOI 10.1016/S0167-7012(01)00212-3; Crameri R, 2011, CLIN EXP ALLERGY, V41, P302, DOI 10.1111/j.1365-2222.2011.03703.x; Dean TR, 2004, J MICROBIOL METH, V56, P431, DOI 10.1016/j.mimet.2003.11.015; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; DUNBAR SA, 2007, CLIN MICROBIOLOGY NE, V29, P79; Etienne KA, 2009, J CLIN MICROBIOL, V47, P1096, DOI 10.1128/JCM.01899-08; European Aviation Safety Agency, 2015, DEC 2015 027 R, P1, DOI DOI 10.1002/9783527678679.DG02483; Gurvich OL, 2011, METHODS MOL BIOL, V784, P1, DOI 10.1007/978-1-61779-289-2_1; Haugland RA, 2004, SYST APPL MICROBIOL, V27, P198, DOI 10.1078/072320204322881826; Herrera ML, 2009, J CLIN MICROBIOL, V47, P1325, DOI 10.1128/JCM.02073-08; Heseltine E., 2009, WHO GUID IND AIR QUA; HORNER WE, 1995, CLIN MICROBIOL REV, V8, P161, DOI 10.1128/CMR.8.2.161; Iwen PC, 2002, MED MYCOL, V40, P87, DOI 10.1080/mmy.40.1.87.109; Johnson GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040022; Knutsen A.P., 2011, CLIN REV ALLERG IMMU, V129, P280; Landlinger C, 2009, J CLIN MICROBIOL, V47, P1063, DOI 10.1128/JCM.01558-08; Lezar S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-87; Libert X, 2016, APPL MICROBIOL BIOT, V100, P1377, DOI 10.1007/s00253-015-7175-z; Libert X, 2015, APPL MICROBIOL BIOT, V99, P7267, DOI 10.1007/s00253-015-6785-9; Libert X, DISCRIMINATION 3 CLO; Lin A, 2011, J MICROBIOL METH, V87, P105, DOI 10.1016/j.mimet.2011.07.019; Meheust D, 2014, CRIT REV MICROBIOL, V40, P248, DOI 10.3109/1040841X.2013.777687; Mendell MJ, 2011, ENVIRON HEALTH PERSP, V119, P748, DOI 10.1289/ehp.1002410; Mohanta TK, 2015, BIOL PROCED ONLINE, V17, DOI 10.1186/s12575-015-0020-z; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Nolard N, 2004, VALIDATION METHODES; Pieckova E, 2004, ANN AGR ENV MED, V11, P67; Pitkaranta M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-235; Prevost-Boure NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024166; Puckeu A, 2012, B-ENT, V8, P73; Reboux G, 2010, REV MAL RESPIR, V27, P169, DOI 10.1016/j.rmr.2009.09.003; Rosenbaum PF, 2010, J EXPO SCI ENV EPID, V20, P503, DOI 10.1038/jes.2009.27; Roussel S, 2013, ENVIRON INT, V55, P20, DOI 10.1016/j.envint.2013.02.002; Schell WA, 2012, EUR J CLIN MICROBIOL, V31, P2237, DOI 10.1007/s10096-012-1561-6; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; United States Environmental Protection Agency, EPA TECHNOLOGY FOR M; Van den Bulcke M, 2010, ANAL BIOANAL CHEM, V396, P2113, DOI 10.1007/s00216-009-3286-7; Vesper S, 2011, CRIT REV MICROBIOL, V37, P15, DOI 10.3109/1040841X.2010.506177; White TJ, 1990, PCR PROTOCOLS GUIDE, DOI [DOI 10.1016/B978-0-12-372180-8.50042-1, 10.1016/B978-0-12-372180-8.50042-1]; Wuyst V, 2015, BIOMED RES INT	49	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173390	10.1371/journal.pone.0173390	http://dx.doi.org/10.1371/journal.pone.0173390			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278219	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900085
J	Stenger, M; Behr-Rasmussen, C; Klein, K; Gronnemose, RB; Andersen, TE; Klitgaard, JK; Kolmos, HJ; Lindholt, JS				Stenger, Michael; Behr-Rasmussen, Carsten; Klein, Kasper; Gronnemose, Rasmus B.; Andersen, Thomas Emil; Klitgaard, Janne K.; Kolmos, Hans Jorn; Lindholt, Jes S.			Systemic thioridazine in combination with dicloxacillin against early aortic graft infections caused by Staphylococcus aureus in a porcine model: In vivo results do not reproduce the in vitro synergistic activity	PLOS ONE			English	Article							EFFLUX PUMP; RESISTANCE; ANTIBIOTICS; ENANTIOMERS; METABOLISM; PREVENTION; MANAGEMENT; POLYESTER; DIAGNOSIS; EFFICACY	Introduction Conservative treatment solutions against aortic prosthetic vascular graft infection (APVGI) for inoperable patients are limited. The combination of antibiotics with antibacterial helper compounds, such as the neuroleptic drug thioridazine (TDZ), should be explored. Aim To investigate the efficacy of conservative systemic treatment with dicloxacillin (DCX) in combination with TDZ (DCX+TDZ), compared to DCX alone, against early APVGI caused by methicillin-sensitive Staphylococcus aureus (MSSA) in a porcine model. Methods The synergism of DCX+TDZ against MSSA was initially assessed in vitro by viability assay. Thereafter, thirty-two pigs had polyester grafts implanted in the infrarenal aorta, followed by inoculation with 10(6) CFU of MSSA, and were randomly administered oral systemic treatment with either 1) DCX or 2) DCX+TDZ. Treatment was initiated one week postoperatively and continued for a further 21 days. Weight, temperature, and blood samples were collected at predefined intervals. By termination, bacterial quantities from the graft surface, graft material, and perigraft tissue were obtained. Results Despite in vitro synergism, the porcine experiment revealed no statistical differences for bacteriological endpoints between the two treatment groups, and none of the treatments eradicated the APVGI. Accordingly, the mixed model analyses of weight, temperature, and blood samples revealed no statistical differences. Conclusion Conservative systemic treatment with DCX+TDZ did not reproduce in vitro results against APVGI caused by MSSA in this porcine model. However, unexpected severe adverse effects related to the planned dose of TDZ required a considerable reduction to the administered dose of TDZ, which may have compromised the results.	[Stenger, Michael; Klein, Kasper; Gronnemose, Rasmus B.; Andersen, Thomas Emil; Klitgaard, Janne K.; Kolmos, Hans Jorn] Univ Southern Denmark, Res Unit Clin Microbiol, Odense, Denmark; [Stenger, Michael; Lindholt, Jes S.] Odense Univ Hosp, Dept Cardiothorac & Vasc Surg, Odense, Denmark; [Behr-Rasmussen, Carsten] Viborg Hosp, Dept Vasc Surg, Viborg, Denmark; [Klitgaard, Janne K.] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Aarhus University; University of Southern Denmark	Stenger, M (corresponding author), Univ Southern Denmark, Res Unit Clin Microbiol, Odense, Denmark.; Stenger, M (corresponding author), Odense Univ Hosp, Dept Cardiothorac & Vasc Surg, Odense, Denmark.	mstenger@health.sdu.dk	Andersen, Thomas/GPT-3151-2022; Klitgaard, Janne Kudsk/F-8952-2010; Lindholt, Jes/J-2907-2014	Andersen, Thomas/0000-0001-9453-1141; Klitgaard, Janne Kudsk/0000-0001-5255-2980; Klein, Kasper/0000-0003-2767-0760; Lindholt, Jes/0000-0001-9536-4488; Gronnemose, Rasmus Birkholm/0000-0001-6411-9981	Research Council at Odense University Hospital; Danish Heart Foundation [14-R97-A5266]	Research Council at Odense University Hospital; Danish Heart Foundation	The study was financially supported by grants form the Research Council at Odense University Hospital received by MS, TEA, JKK, HJK, JSL (no grant number; http://www.ouh.dk/wm379847) and the Danish Heart Foundation (grant number: 14-R97-A5266; https://www.hjerteforeningen.dk) received by MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyk Dennis F, 2002, Semin Vasc Surg, V15, P268, DOI 10.1053/svas.2002.36262; Bonde M, 2011, FEMS MICROBIOL LETT, V318, P168, DOI 10.1111/j.1574-6968.2011.02255.x; Chambers ST, 2005, INTERN MED J, V35, pS72, DOI 10.1111/j.1444-0903.2005.00981.x; Christensen JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057493; Daniel WA, 1999, TOXICOL APPL PHARM, V158, P115, DOI 10.1006/taap.1999.8688; Dasgupta A, 2010, INT J ANTIMICROB AG, V35, P174, DOI 10.1016/j.ijantimicag.2009.09.027; Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]; Fukumoto A, 2008, J ANTIBIOT, V61, P7, DOI 10.1038/ja.2008.102; Fux CA, 2004, J BACTERIOL, V186, P4486, DOI 10.1128/JB.186.14.4486-4491.2004; Gao H, 2008, EUR J VASC ENDOVASC, V35, P41, DOI 10.1016/j.ejvs.2007.07.005; Gao H, 2012, EUR J VASC ENDOVASC, V43, P582, DOI 10.1016/j.ejvs.2012.02.011; Gao H, 2010, EUR J VASC ENDOVASC, V39, P472, DOI 10.1016/j.ejvs.2009.11.023; Hahn BL, 2014, IN VIVO, V28, P33; Harry DD, 2011, COMP ASSESSMENT PIG, P323; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Jensen AS, 2015, EUR J PHARMACOL, V747, P7, DOI 10.1016/j.ejphar.2014.11.015; JORTANI SA, 1994, FORENSIC SCI INT, V64, P165, DOI 10.1016/0379-0738(94)90227-5; Klitgaard JK, 2008, J ANTIMICROB CHEMOTH, V62, P1215, DOI 10.1093/jac/dkn417; Koyama N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048981; KRISTIANSEN JE, 1988, APMIS, V96, P1079, DOI 10.1111/j.1699-0463.1988.tb00984.x; Kristiansen Malthe M, 2006, In Vivo, V20, P361; Kristiansen MM, 2003, INT J ANTIMICROB AG, V22, P250, DOI 10.1016/S0924-8579(03)00200-0; Kvist M, 2008, APPL ENVIRON MICROB, V74, P7376, DOI 10.1128/AEM.01310-08; Lawrence PF, 2011, SEMIN VASC SURG, V24, P199, DOI 10.1053/j.semvascsurg.2011.10.014; Martins M, 2004, IN VIVO, V18, P787; Martins M, 2007, IN VIVO, V21, P771; Mussa FF, 2007, EXPERT REV ANTI-INFE, V5, P305, DOI 10.1586/14787210.5.2.305; NIEDZWIECKI DM, 1984, J PHARMACOL EXP THER, V228, P636; O'Connor S, 2006, J VASC SURG, V44, P38, DOI 10.1016/j.jvs.2006.02.053; Perera Ganesha B, 2006, Vasc Endovascular Surg, V40, P1, DOI 10.1177/153857440604000101; Pottegard A, 2015, JAMA-J AM MED ASSOC, V314, P296, DOI 10.1001/jama.2015.6669; Poulsen MO, 2013, RES MICROBIOL, V164, P181, DOI 10.1016/j.resmic.2012.10.007; Poulsen MO, 2014, JOURNAL OF MEDICAL M; Robertshaw D., 2004, DUKES PHYSL DOMESTIC; Roy D, 2000, J INFECTION, V40, P184, DOI 10.1016/S0163-4453(00)80014-6; Sabatini S, 2013, J MED CHEM, V56, P4975, DOI 10.1021/jm400262a; Saleem BR, 2010, AM J SURG, V200, P47, DOI 10.1016/j.amjsurg.2009.05.018; Stenger M, 2016, J CONTROL RELEASE, V241, P125, DOI 10.1016/j.jconrel.2016.09.018; Stenger M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135571; Swain Timothy W 3rd, 2004, Vasc Endovascular Surg, V38, P75, DOI 10.1177/153857440403800110; Thorn HA, 2011, EUR J PHARM SCI, V43, P89, DOI 10.1016/j.ejps.2011.03.008; Thorsing M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064518; Wojcikowski J, 2006, DRUG METAB DISPOS, V34, P471, DOI 10.1124/dmd.105.006445; Yasuda K, 2008, DRUG METAB DISPOS, V36, P1689, DOI 10.1124/dmd.108.020701; Yeager R A, 1996, Adv Surg, V29, P33	45	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173362	10.1371/journal.pone.0173362	http://dx.doi.org/10.1371/journal.pone.0173362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278183	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900077
J	Bryant, J; Winer, ES; Salem, T; Nadorff, MR				Bryant, Jessica; Winer, E. Samuel; Salem, Taban; Nadorff, Michael R.			Struggling toward reward: Recent experience of anhedonia interacts with motivation to predict reward pursuit in the face of a stressful manipulation	PLOS ONE			English	Article							ACTION ORIENTATION; STATE ORIENTATION; SUICIDAL IDEATION; MAJOR DEPRESSION; INDIVIDUALS; MODELS; INFORMATION; VALIDATION; DOPAMINE; DISORDER	Anhedonia, or the loss of interest and/or pleasure, is a core symptom of depression. Individuals experiencing anhedonia have difficulty motivating themselves to pursue rewarding stimuli, which can result in dysfunction. Action orientation is a motivational factor that might interact with anhedonia to potentially buffer against this dysfunction, as action-oriented individuals upregulate positive affect to quickly motivate themselves to complete goals in the face of stress. The Effort-Expenditure for Rewards Task (EEfRT) is a promising new method for examining differences in motivation in individuals experiencing anhedonia. In the EEfRT, participants choose either easier tasks associated with smaller monetary rewards or harder tasks associated with larger monetary rewards. We examined the relationship between action orientation and EEfRT performance following a negative mood induction in a sample with varying levels of anhedonia. There were two competing hypotheses: (1) action orientation would act as a buffer against anhedonia such that action-oriented individuals, regardless of anhedonic symptoms, would be motivated to pursue greater rewards despite stress, or (2) anhedonia would act as a debilitating factor such that individuals with elevated anhedonic symptoms, regardless of action orientation, would not pursue greater rewards. We examined these hypotheses via Generalized Estimating Equations and found an interaction between anhedonia and action orientation. At low levels of anhedonia, action orientation was associated with effort for reward, but this relationship was not present at high levels of anhedonia. Thus, at low levels of anhedonia, action orientation acted as a buffer against stress, but at high levels, anhedonia debilitated action orientation so that it was no longer a promotive factor.	[Bryant, Jessica; Winer, E. Samuel; Salem, Taban; Nadorff, Michael R.] Mississippi State Univ, Dept Psychol, Starkville, MS 39759 USA; [Nadorff, Michael R.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Mississippi State University; Baylor College of Medicine	Bryant, J (corresponding author), Mississippi State Univ, Dept Psychol, Starkville, MS 39759 USA.	jcs579@msstate.edu	Nadorff, Michael/AFL-6299-2022	Nadorff, Michael/0000-0002-8107-7514; Winer, E. Samuel/0000-0002-3817-874X				Admon R, 2015, BIOL PSYCHIAT, V78, P67, DOI 10.1016/j.biopsych.2014.09.019; [Anonymous], 2000, INT J EDUC RES, DOI [10.1016/S0883-0355(00)00045-8, DOI 10.1016/S0883-0355(00)00045-8]; Bartoszek G., 2016, COGNITION EMOTION, V7, P1, DOI DOI 10.1080/02699931.2016.1225004; Bartoszek G, 2015, J BEHAV THER EXP PSY, V46, P1, DOI 10.1016/j.jbtep.2014.07.012; BECKMANN J, 1984, J RES PERS, V18, P224, DOI 10.1016/0092-6566(84)90031-X; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Blunt A, 1998, PERS INDIV DIFFER, V24, P837, DOI 10.1016/S0191-8869(98)00018-X; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; Diefendorff JM, 2000, J APPL PSYCHOL, V85, P250, DOI 10.1037/0021-9010.85.2.250; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Gard DE, 2006, J RES PERS, V40, P1086, DOI 10.1016/j.jrp.2005.11.001; Geaney JT, 2015, TRAIT ANTICIPATORY P, V10, DOI [10.1371/journal.pone.0131357, DOI 10.1371/JOURNAL.PONE.0131357]; Gotlib IH, 1988, COGNITION EMOTION, V2, P185, DOI 10.1080/02699938808410923; Hardin JW, 2012, GEN ESTIMATING EQUAT; Joiner TE, 2003, PSYCHIAT RES, V119, P243, DOI 10.1016/S0165-1781(03)00131-8; Jostmann NB, 2006, PERS SOC PSYCHOL B, V32, P1716, DOI 10.1177/0146167206292595; Kazen M, 2008, J RES PERS, V42, P693, DOI 10.1016/j.jrp.2007.09.005; Koole SL, 2011, COGNITION EMOTION, V25, P440, DOI 10.1080/02699931.2010.544891; Kuhl J., 1994, VOLITION PERSONALITY, P47; Kuhl J., 2004, HDB EXPT EXISTENTIAL, P411; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; MENEC VH, 1995, J EXP EDUC, V63, P281, DOI 10.1080/00220973.1995.9943465; Pizzagalli DA, 2005, BIOL PSYCHIAT, V57, P319, DOI 10.1016/j.biopsych.2004.11.026; SALAMONE JD, 1994, PHARMACOL BIOCHEM BE, V49, P25, DOI 10.1016/0091-3057(94)90452-9; Tabachnick B. G.., 2012, USING MULTIVARIATE S; Treadway MT, 2015, SCHIZOPHR RES, V161, P382, DOI 10.1016/j.schres.2014.11.024; Treadway MT, 2013, CURR DIR PSYCHOL SCI, V22, P244, DOI 10.1177/0963721412474460; Treadway MT, 2012, J ABNORM PSYCHOL, V121, P553, DOI 10.1037/a0028813; Treadway MT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006598; Wardle MC, 2011, J NEUROSCI, V31, P16597, DOI 10.1523/JNEUROSCI.4387-11.2011; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whitton AE, 2015, CURR OPIN PSYCHIATR, V28, P7, DOI 10.1097/YCO.0000000000000122; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Winer ES, 2016, J CLIN PSYCHOL, V72, P947, DOI 10.1002/jclp.22298; Winer ES, 2016, ARCH SUICIDE RES, V20, P265, DOI 10.1080/13811118.2015.1025119; Winer ES, 2016, PSYCHOL BULL, V142, P18, DOI 10.1037/bul0000022; Winer ES, 2014, PSYCHIAT RES, V218, P124, DOI 10.1016/j.psychres.2014.04.016; Winer ES, 2014, J AFFECT DISORDERS, V152, P193, DOI 10.1016/j.jad.2013.09.010; Winer ES, 2011, PERS INDIV DIFFER, V51, P996, DOI 10.1016/j.paid.2011.08.010	41	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173439	10.1371/journal.pone.0173439	http://dx.doi.org/10.1371/journal.pone.0173439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273126	Green Submitted, Green Published, gold			2022-12-27	WOS:000396073700002
J	Karlsen, APH; Wetterslev, M; Hansen, SE; Hansen, MS; Mathiesen, O; Dahl, JB				Karlsen, Anders Peder Hojer; Wetterslev, Mik; Hansen, Signe Elisa; Hansen, Morten Sejer; Mathiesen, Ole; Dahl, Jorgen B.			Postoperative pain treatment after total knee arthroplasty: A systematic review	PLOS ONE			English	Review							FEMORAL NERVE BLOCK; LOCAL INFILTRATION ANALGESIA; REDUCED MORPHINE CONSUMPTION; PATIENT-CONTROLLED ANALGESIA; ADDUCTOR-CANAL-BLOCKADE; DOUBLE-BLIND; SINGLE-INJECTION; PERIARTICULAR INJECTION; MULTIMODAL ANALGESIA; PERIOPERATIVE GABAPENTIN	Introduction The aim of this systematic review was to document efficacy, safety and quality of evidence of analgesic interventions after total knee arthroplasty (TKA). Methods This PRISMA-compliant and PROSPERO-registered review includes all-language randomized controlled trials of medication-based analgesic interventions after TKA. Bias was evaluated according to Cochrane methodology. Outcomes were opioid consumption (primary), pain scores at rest and during mobilization, adverse events, and length of stay. Interventions investigated in three or more trials were meta-analysed. Outcomes were evaluated using forest plots, Grading of Recommendations Assessment, Development and Evaluation (GRADE), L'Abbe Plots and trial sequential analysis. Results The included 113 trials, investigating 37 different analgesic interventions, were characterized by unclear/high risk of bias, low assay sensitivity and considerable differences in pain assessment tools, basic analgesic regimens, and reporting of adverse events. In meta-analyses single and continuous femoral nerve block (FNB), intrathecal morphine, local infiltration analgesia, intraarticular injection of local anaesthetics, non-steroidal anti-inflammatory drugs, and gabapentinoids demonstrated significant analgesic effects. The 24-hour morphine-sparing effects ranged from 4.2 mg (CI: 1.3, 7.2; intraarticular local anaesthetics), to 16.6 mg (CI: 11.2, 22; single FNB). Pain relieving effects at rest at 6 hours ranged from 4 mm (CI:-10, 2; gabapentinoids), to 19 mm (CI: 8, 31; single FNB), and at 24 hours from 3 mm (CI:-2, 8; gabapentinoids), to 16 mm (CI: 8, 23; continuous FNB). GRADE-rated quality of evidence was generally low. Conclusion A low quality of evidence, small sample sizes and heterogeneity of trial designs prohibit designation of an optimal procedure-specific analgesic regimen after TKA.	[Karlsen, Anders Peder Hojer; Dahl, Jorgen B.] Bispebjerg & Frederiksberg Hosp, Dept Anaesthesia, Copenhagen, Denmark; [Karlsen, Anders Peder Hojer; Mathiesen, Ole] Zealand Univ Hosp, Dept Anaesthesia, Koege, Denmark; [Wetterslev, Mik] Copenhagen Univ Hosp, Rigshosp, Dept Anaesthesia, Copenhagen, Denmark; [Hansen, Signe Elisa] Slagelse Hosp, Dept Anaesthesia, Slagelse, Denmark; [Hansen, Morten Sejer] Rigshosp, Ctr Head & Orthopaed, Dept Anaesthesia, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Karlsen, APH (corresponding author), Bispebjerg & Frederiksberg Hosp, Dept Anaesthesia, Copenhagen, Denmark.; Karlsen, APH (corresponding author), Zealand Univ Hosp, Dept Anaesthesia, Koege, Denmark.	andersphkarlsen@gmail.com		karlsen, anders/0000-0002-0338-3751; Mathiesen, Ole/0000-0003-4544-0619				Abdallah FW, 2014, ANESTHESIOLOGY, V121, P1302, DOI 10.1097/ALN.0000000000000406; Abrisham SMJ, 2014, KNEE SURG SPORT TR A, V22, P1580, DOI 10.1007/s00167-012-2287-9; Adam F, 2005, ANESTH ANALG, V100, P475, DOI 10.1213/01.ANE.0000142117.82241.DC; Albrecht E, 2016, BRIT J ANAESTH, V116, P597, DOI 10.1093/bja/aew099; Ali A, 2015, ACTA ORTHOP, V86, P373, DOI 10.3109/17453674.2014.991629; Allen HW, 1998, ANESTH ANALG, V87, P93, DOI 10.1097/00000539-199807000-00020; Andersen HL, 2013, REGION ANESTH PAIN M, V38, P106, DOI 10.1097/AAP.0b013e31827900a9; Andersen KV, 2013, BRIT J ANAESTH, V111, P242, DOI 10.1093/bja/aet030; Aveline C, 2009, EUR J PAIN, V13, P613, DOI 10.1016/j.ejpain.2008.08.003; Axelsson K, 2005, ACTA ANAESTH SCAND, V49, P1191, DOI 10.1111/j.1399-6576.2005.00715.x; Badner NH, 1997, REGION ANESTH, V22, P347, DOI 10.1016/S1098-7339(97)80010-7; Badner NH, 1996, J BONE JOINT SURG AM, V78A, P734, DOI 10.2106/00004623-199605000-00013; Barrington JW, 2016, NO DIFFERENCE EARLY; Bengisun ZK, 2010, J ANESTH, V24, P694, DOI 10.1007/s00540-010-0970-x; Browne C, 2004, J ARTHROPLASTY, V19, P377, DOI 10.1016/j.arth.2003.10.012; Busch CA, 2006, J BONE JOINT SURG AM, V88A, P959, DOI 10.2106/JBJS.E.00344; Cappelleri G, 2011, REGION ANESTH PAIN M, V36, P489, DOI 10.1097/AAP.0b013e3182286a2b; Casati A, 2005, ANESTH ANALG, V100, P866, DOI 10.1213/01.ANE.0000143952.75985.8F; Casey G, 2006, ANESTH ANALG, V102, P504, DOI 10.1213/01.ane.0000194448.37407.6a; Cengiz P, 2014, JCPSP-J COLL PHYSICI, V24, P299, DOI 04.2014/JCPSP.299303; Chan EY, 2013, J ARTHROPLASTY, V28, P608, DOI 10.1016/j.arth.2012.06.039; Chan IA, 2016, CAN J ANESTH, V63, P569, DOI 10.1007/s12630-016-0597-y; Chan Min-Ho, 2012, Acta Anaesthesiol Taiwan, V50, P54, DOI 10.1016/j.aat.2012.05.007; Chinachoti Thitima, 2012, Journal of the Medical Association of Thailand, V95, P1536; Clarke HA, 2014, BRIT J ANAESTH, V113, P855, DOI 10.1093/bja/aeu202; Clarke H, 2009, PAIN RES MANAG, V14, P217, DOI 10.1155/2009/930609; Cole PJ, 2000, BRIT J ANAESTH, V85, P233, DOI 10.1093/bja/85.2.233; Daabiss MA, 2013, BRIT J MED PRACTITIO, V6; Dahl JB, 2014, ACTA ANAESTH SCAND, V58, P1165, DOI 10.1111/aas.12382; Dechartres A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2304; EDWARDS ND, 1992, ANESTH ANALG, V75, P265; Ekmekci P, 2010, ANESTEZI DERGISI, V18, P194; Essving P, 2010, ACTA ORTHOP, V81, P354, DOI 10.3109/17453674.2010.487241; Feng Yi, 2004, Zhonghua Wai Ke Za Zhi, V42, P617; Frassanito L, 2015, MINERVA ANESTESIOL, V81, P1184; Frassanito L, 2009, EUROPEAN J ANAESTHES, V26, P116; Fu PL, 2009, KNEE, V16, P280, DOI 10.1016/j.knee.2008.12.012; Ganapathy S, 1999, ANESTH ANALG, V89, P1197, DOI 10.1213/00000539-199911000-00021; Gomez-Cardero P, 2010, CLIN ORTHOP RELAT R, V468, P1242, DOI 10.1007/s11999-009-1202-2; Good Robert P, 2007, Am J Orthop (Belle Mead NJ), V36, P554; Sobrinho HG, 2012, REV BRAS ANESTESIOL, V62, P665, DOI 10.1016/S0034-7094(12)70165-4; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Hendolin H, 1996, ACTA ANAESTH SCAND, V40, P81, DOI 10.1111/j.1399-6576.1996.tb04391.x; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hirst GC, 1996, REGION ANESTH, V21, P292; Ho KY, 2010, BRIT J ANAESTH, V105, P371, DOI 10.1093/bja/aeq158; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Huang YM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-77; Hubbard RC, 2003, BRIT J ANAESTH, V90, P166, DOI 10.1093/bja/aeg038; Hunt KJ, 2009, J ARTHROPLASTY, V24, P533, DOI 10.1016/j.arth.2008.04.005; Hur MJ, 2007, KOREAN J ANESTHESIOL, V52, P172; Inan N, 2007, AGRI, V19, P38; JACOBSON L, 1989, ANN ROY COLL SURG, V71, P289; Jenstrup MT, 2012, ACTA ANAESTH SCAND, V56, P357, DOI 10.1111/j.1399-6576.2011.02621.x; Kaloul I, 2004, CAN J ANAESTH, V51, P45, DOI 10.1007/BF03018546; Kandasami M, 2009, KNEE, V16, P98, DOI 10.1016/j.knee.2008.10.007; Kardash K, 2007, ANESTH ANALG, V105, P853, DOI 10.1213/01.ane.0000278158.36843.f7; Karlsen APH, 2015, PAIN, V156, P8, DOI 10.1016/j.pain.0000000000000003; Kehlet H, 2003, LANCET, V362, P1921, DOI 10.1016/S0140-6736(03)14966-5; Kelly AM, 1998, ACAD EMERG MED, V5, P1086, DOI 10.1111/j.1553-2712.1998.tb02667.x; Kim TW, 2014, KNEE SURG SPORTS TRA; Kosel J, 2015, J ARTHROPLASTY, V30, P320, DOI 10.1016/j.arth.2014.07.016; Krishnan SH, 2016, J CLIN ANESTH, V33, P432, DOI 10.1016/j.jclinane.2016.04.021; Kunopart Mutita, 2014, Journal of the Medical Association of Thailand, V97, P195; Lauretti Gabriela R, 2013, J Anaesthesiol Clin Pharmacol, V29, P503, DOI 10.4103/0970-9185.119155; Lee AR, 2011, YONSEI MED J, V52, P145, DOI 10.3349/ymj.2011.52.1.145; Lee JK, 2014, J ARTHROPLASTY; Leownorasate Manoon, 2014, Journal of the Medical Association of Thailand, V97, P1332; [陆慧红 Lu Huihong], 2014, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V18, P529; Lunn TH, 2011, BRIT J ANAESTH, V106, P230, DOI 10.1093/bja/aeq333; Lunn TH, 2015, PAIN, V156, P2438, DOI 10.1097/j.pain.0000000000000309; Martinez Navas A, 2006, Rev Esp Anestesiol Reanim, V53, P214; Mathiesen O, 2014, ACTA ANAESTH SCAND, V58, P1182, DOI 10.1111/aas.12380; Mauerhan DR, 1997, J ARTHROPLASTY, V12, P546, DOI 10.1016/S0883-5403(97)90178-9; McNamee DA, 2002, ACTA ANAESTH SCAND, V46, P95, DOI 10.1034/j.1399-6576.2002.460117.x; McNamee DA, 2001, ACTA ANAESTH SCAND, V45, P477, DOI 10.1034/j.1399-6576.2001.045004477.x; Milani P, 2015, J ARTHROPLASTY, V30, P2038, DOI 10.1016/j.arth.2015.05.035; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Nakai T, 2013, J ORTHOP, V10, P92, DOI 10.1016/j.jor.2013.02.001; Ng HP, 2001, CAN J ANAESTH, V48, P1102; Niemelainen M, 2014, ACTA ORTHOP, P1; Niruthisard S, 2013, ASIAN BIOMED, V7, P579, DOI 10.5372/1905-7415.0704.215; Olive DJ, 2015, ANAESTH INTENS CARE, V43, P454, DOI 10.1177/0310057X1504300406; Ong Johnny C A, 2010, J Orthop Surg (Hong Kong), V18, P203; Ozen M, 2006, AGRI, V18, P44; Park CK, 2010, KOREAN J ANESTHESIOL, V58, P468, DOI 10.4097/kjae.2010.58.5.468; Park Chang Kil, 2009, Korean J Anesthesiol, V57, P69, DOI 10.4097/kjae.2009.57.1.69; Paul JE, 2013, CAN J ANESTH, V60, P423, DOI 10.1007/s12630-013-9902-1; Rashwan D, 2008, J MED SCI, V8, P395; Rawal N, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-300; Rosen Adam S, 2010, HSS J, V6, P155, DOI 10.1007/s11420-010-9155-2; Runge C, 2016, REGION ANESTH PAIN M, V41, P445, DOI 10.1097/AAP.0000000000000406; Safa B, 2014, J ARTHROPLASTY, V29, P1149, DOI 10.1016/j.arth.2013.11.020; Sahin L, 2014, AGRI, V26, P113, DOI 10.5505/agri.2014.83788; Garcia JBSG, 2010, REV BRAS ANESTESIOL, V60, P1, DOI 10.1590/S0034-70942010000100001; Sarridou DG, 2015, PAIN PHYSICIAN, V18, P267; Sathitkarnmanee T, 2014, J PAIN RES, V7, P449, DOI 10.2147/JPR.S66741; Sato K, 2014, REGION ANESTH PAIN M, V39, P225, DOI 10.1097/AAP.0000000000000076; Schotanus MG, 2015, KNEE SURG SPORTS TRA; Seah VWT, 2011, SINGAP MED J, V52, P19; Seet E, 2006, ANAESTH INTENS CARE, V34, P25, DOI 10.1177/0310057X0603400110; SERPELL MG, 1991, ANAESTHESIA, V46, P275, DOI 10.1111/j.1365-2044.1991.tb11495.x; Shah NA, 2015, J ARTHROPLASTY, V30, P1476, DOI 10.1016/j.arth.2015.03.006; Shen SJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/450805; Silvanto M, 2002, ACTA ANAESTH SCAND, V46, P322, DOI 10.1034/j.1399-6576.2002.t01-1-460316.x; 정문수, 2011, [Journal of the Korean Orthopaedic Association, 대한정형외과학회지], V46, P237; Song FJ, 1999, J CLIN EPIDEMIOL, V52, P725, DOI 10.1016/S0895-4356(99)00066-9; Stiller CO, 2007, ACTA ANAESTH SCAND, V51, P322, DOI 10.1111/j.1399-6576.2006.01191.x; Tan PH, 2001, CAN J ANAESTH, V48, P551, DOI 10.1007/BF03016831; Thoriund K, USER MANUAL TRIAL SE; Todd KH, 1996, ANN EMERG MED, V27, P485, DOI 10.1016/S0196-0644(96)70238-X; Tsukada S, 2016, BONE JOINT J, V98B, P194, DOI 10.1302/0301-620X.98B2.36596; Tugay N, 2006, NEUROSCIENCES, V11, P175; Vaishya R, 2015, ACTA ORTHOP BELG, V81, P720; Vendittoli PA, 2006, J BONE JOINT SURG AM, V88A, P282, DOI 10.2106/JBJS.E.00173; Wang H, 2002, REGION ANESTH PAIN M, V27, P139, DOI 10.1053/rapm.2002.29253; Watson MW, 2005, REGION ANESTH PAIN M, V30, P541, DOI 10.1016/j.rapm.2005.06.006; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Williams D, 2013, J ARTHROPLASTY, V28, P479, DOI 10.1016/j.arth.2012.07.016; Wyatt MC, 2015, BONE JOINT RES, V4, P11, DOI 10.1302/2046-3758.42.2000329; YaDeau JT, 2015, BRIT J ANAESTH, V115, P285, DOI 10.1093/bja/aev217; YaDeau JT, 2005, ANESTH ANALG, V101, P891, DOI 10.1213/01.ANE.0000159150.79908.21; Yue DB, 2013, CHINESE MED J-PEKING, V126, P3851, DOI 10.3760/cma.j.issn.0366-6999.20131389; Yuenyongviwat V, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/107309; [张俊 Zhang J], 2007, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V11, P8678; Zhang S, 2011, P I MECH ENG C-J MEC, V225, P1774, DOI 10.1177/0954406211403666; Zhu YZ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004082; Zhu Yunli, 2014, Eur J Orthop Surg Traumatol, V24, P395, DOI 10.1007/s00590-013-1203-4; 최현기, 2006, Korean Journal of Anesthesiology, V50, P546	130	83	86	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173107	10.1371/journal.pone.0173107	http://dx.doi.org/10.1371/journal.pone.0173107			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273133	Green Submitted, gold, Green Published			2022-12-27	WOS:000396073700038
J	Yan, D; Xiang, GX; Chai, XP; Qing, J; Shang, HQ; Zou, B; Mittal, R; Shen, J; Smith, RJH; Fan, YS; Blanton, SH; Tekin, M; Morton, C; Xing, WL; Cheng, J; Liu, XZ				Yan, Denise; Xiang, Guangxin; Chai, Xingping; Qing, Jie; Shang, Haiqiong; Zou, Bing; Mittal, Rahul; Shen, Jun; Smith, Richard J. H.; Fan, Yao-Shan; Blanton, Susan H.; Tekin, Mustafa; Morton, Cynthia; Xing, Wanli; Cheng, Jing; Liu, Xue Zhong			Screening of deafness-causing DNA variants that are common in patients of European ancestry using a microarray-based approach	PLOS ONE			English	Article							VESTIBULAR AQUEDUCT DFNB4; 26 GENE GJB2; HEARING-LOSS; PENDRED-SYNDROME; RECESSIVE DEAFNESS; MUTATION DETECTION; TRANSFER-RNA; CONNEXIN-26; IVS2-2A-GREATER-THAN-G; MULTICENTER	The unparalleled heterogeneity in genetic causes of hearing loss along with remarkable differences in prevalence of causative variants among ethnic groups makes single gene tests technically inefficient. Although hundreds of genes have been reported to be associated with nonsyndromic hearing loss (NSHL), GJB2, GJB6, SLC26A4, and mitochondrial (mt) MT-RNR1 and MTTS are the major contributors. In order to provide a faster, more comprehensive and cost effective assay, we constructed a DNA fluidic array, CapitalBioMiamiOtoArray, for the detection of sequence variants in five genes that are common in most populations of European descent. They consist of c.35delG, p.W44C, p.L90P, c.167delT (GJB2); 309kb deletion (GJB6); p.L236P, p.T416P (SLC26A4); and m.1555A>G, m.7444G>A (mtDNA). We have validated our hearing loss array by analyzing a total of 160 DNAs samples. Our results show 100% concordance between the fluidic array biochip-based approach and the established Sanger sequencing method, thus proving its robustness and reliability at a relatively low cost.	[Yan, Denise; Qing, Jie; Shang, Haiqiong; Zou, Bing; Mittal, Rahul; Blanton, Susan H.; Tekin, Mustafa; Liu, Xue Zhong] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA; [Xiang, Guangxin; Chai, Xingping; Xing, Wanli; Cheng, Jing] Natl Engn Res Ctr Beijing Biochip Technol, Beijing, Peoples R China; [Chai, Xingping; Xing, Wanli; Cheng, Jing; Liu, Xue Zhong] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Shen, Jun; Morton, Cynthia] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Shen, Jun; Morton, Cynthia] Harvard Med Sch, Boston, MA USA; [Shen, Jun] Partners Personalized Med, Mol Med Lab, Cambridge, MA USA; [Smith, Richard J. H.] Univ Iowa, Carver Coll Med, Dept Otolaryngol Head & Neck Surg, Iowa City, IA USA; [Fan, Yao-Shan; Blanton, Susan H.; Tekin, Mustafa] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Fan, Yao-Shan; Liu, Xue Zhong] Univ Miami, Miller Sch Med, Dr John T Macdonald Dept Human Genet, Miami, FL 33136 USA; [Fan, Yao-Shan; Liu, Xue Zhong] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genet, Miami, FL 33136 USA; [Morton, Cynthia] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, 75 Francis St, Boston, MA 02115 USA; [Morton, Cynthia] Univ Manchester, Div Evolut & Genom Sci, Sch Biol Sci, Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England	University of Miami; Tsinghua University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Iowa; University of Miami; University of Miami; University of Miami; Harvard University; Brigham & Women's Hospital; University of Manchester	Liu, XZ (corresponding author), Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA.; Cheng, J (corresponding author), Natl Engn Res Ctr Beijing Biochip Technol, Beijing, Peoples R China.; Cheng, J; Liu, XZ (corresponding author), Tsinghua Univ, Sch Med, Beijing, Peoples R China.; Liu, XZ (corresponding author), Univ Miami, Miller Sch Med, Dr John T Macdonald Dept Human Genet, Miami, FL 33136 USA.; Liu, XZ (corresponding author), Univ Miami, Miller Sch Med, John P Hussman Inst Human Genet, Miami, FL 33136 USA.	jcheng@tsinghua.edu.cn; xliu@med.miami.edu	Blanton, Susan Halloran/ABF-1323-2021; Tekin, Mustafa/ABG-7627-2020	Smith, Richard/0000-0003-1201-6731; Tekin, Mustafa/0000-0002-3525-7960	National Institutes of Health/National Institute on Deafness and Other Communication Disorders [R01 DC05575, R01 DC01246, R01 DC012115, R01 DC015052]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005575, R01DC009645, R01DC015052, R01DC012115] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	XZL's research is supported by R01 DC05575, R01 DC01246, and R01 DC012115 (National Institutes of Health/National Institute on Deafness and Other Communication Disorders). CCM and JS are supported by R01 DC015052 (National Institutes of Health/National Institute on Deafness and Other Communication Disorders). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; XZL's research is supported by R01 DC05575, R01 DC01246, and R01 DC012115 (National Institutes of Health/National Institute on Deafness and Other Communication Disorders). CCM and JS are supported by R01 DC015052 (National Institutes of Health/National Institute on Deafness and Other Communication Disorders) and acknowledge the support of David and Sharon Neskey. We thank Dr. Andrew Griffith and Parna Chattaraj (National Institute on Deafness and Other Communication Disorders) for providing the control DNA samples with the known GJB2 and SLC26A4 mutations.	Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; [Anonymous], 2012, PREV BLINDN DEAFN; Arnos KS, 2003, EAR HEARING, V24, P324, DOI 10.1097/01.AUD.0000079800.64741.CF; Martins FTA, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-112; BarskyFirkser L, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.6.e4; Cremers FPM, 2007, J MED GENET, V44, P153, DOI 10.1136/jmg.2006.044784; Cremonesi L, 2007, HEMOGLOBIN, V31, P289, DOI 10.1080/03630260701459366; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; del Castillo I, 2003, AM J HUM GENET, V73, P1452, DOI 10.1086/380205; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Johnson JL, 2005, PEDIATRICS, V116, P663, DOI 10.1542/peds.2004-1688; Kennedy CR, 2006, NEW ENGL J MED, V354, P2131, DOI 10.1056/NEJMoa054915; Kenneson A, 2002, GENET MED, V4, P258, DOI 10.1097/00125817-200207000-00004; Keren R, 2002, PEDIATRICS, V110, P855, DOI 10.1542/peds.110.5.855; Kothiyal P, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-10; Li CX, 2008, HUM MUTAT, V29, P306, DOI 10.1002/humu.20622; Liu XZ, 2002, HUM GENET, V111, P394, DOI 10.1007/s00439-002-0811-6; LONGO MC, 1990, GENE, V93, P125, DOI 10.1016/0378-1119(90)90145-H; Marres HA, 1998, DIS OF THE EAR; Mason JA, 1998, PEDIATRICS, V101, P221, DOI 10.1542/peds.101.2.221; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Pandya A, 2003, GENET MED, V5, P295, DOI 10.1097/01.GIM.0000078026.01140.68; Pandya A, 1999, AM J HUM GENET, V65, P1803, DOI 10.1086/302658; Park HJ, 2000, LARYNGOSCOPE, V110, P1535, DOI 10.1097/00005537-200009000-00023; Parving A, 1999, ACTA PAEDIATR, V88, P69, DOI 10.1080/080352599750029439; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Rodriguez-Paris J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011804; Tang HY, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-30; Tang HY, 2002, GENET MED, V4, P336, DOI 10.1097/00125817-200209000-00004; Teek R, 2009, INT J PEDIATR OTORHI, V73, P103, DOI 10.1016/j.ijporl.2008.10.003; Usami SI, 2008, ACTA OTO-LARYNGOL, V128, P446, DOI 10.1080/00016480701785046; Van Hauwe P, 1998, HUM MOL GENET, V7, P1099, DOI 10.1093/hmg/7.7.1099; Vohr BR, 1998, J PEDIATR-US, V133, P353, DOI 10.1016/S0022-3476(98)70268-9; Waldmuller S, 2008, CLIN CHEM, V54, P682, DOI 10.1373/clinchem.2007.099119; Wu CC, 2010, AUDIOL NEURO-OTOL, V15, P57, DOI 10.1159/000231567; Xing GQ, 2007, CELL RES, V17, P227, DOI 10.1038/sj.cr.7310124; Yan D, 2003, HUM GENET, V114, P44, DOI 10.1007/s00439-003-1018-1; Yang T, 2007, AM J HUM GENET, V80, P1055, DOI 10.1086/518314; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605; Zhang GB, 2011, BIOSENS BIOELECTRON, V26, P4708, DOI 10.1016/j.bios.2011.05.031; Zhu J, 2014, JALA-J LAB AUTOM, V19, P144, DOI 10.1177/2211068213491096	42	18	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0169219	10.1371/journal.pone.0169219	http://dx.doi.org/10.1371/journal.pone.0169219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273078	gold, Green Published, Green Submitted			2022-12-27	WOS:000396073700090
J	Chani, B; Puri, V; Sobti, RC; Jha, V; Puri, S				Chani, Baldeep; Puri, Veena; Sobti, Ranbir C.; Jha, Vivekanand; Puri, Sanjeev			Decellularized scaffold of cryopreserved rat kidney retains its recellularization potential	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MARROW-DERIVED CELLS; MULTIPOTENT STROMAL CELLS; BONE-MARROW; EXTRACELLULAR-MATRIX; INJURED TISSUES; REPAIR; REGENERATION; CONTRIBUTE; HOME	The multi-cellular nature of renal tissue makes it the most challenging organ for regeneration. Therefore, till date whole organ transplantations remain the definitive treatment for the end stage renal disease (ESRD). The shortage of available organs for the transplantation has, thus, remained a major concern as well as an unsolved problem. In this regard generation of whole organ scaffold through decellularization followed by regeneration of the whole organ by recellularization is being viewed as a potential alternative for generating functional tissues. Despite its growing interest, the optimal processing to achieve functional organ still remains unsolved. The biggest challenge remains is the time line for obtaining kidney. Keeping these facts in mind, we have assessed the effects of cryostorage (3 months) on renal tissue architecture and its potential for decellularization and recellularization in comparison to the freshly isolated kidneys. The light microscopy exploiting different microscopic stains as well as immuno-histochemistry and Scanning electron microscopy (SEM) demonstrated that ECM framework is well retained following kidney cryopreservation. The strength of these structures was reinforced by calculating mechanical stress which confirmed the similarity between the freshly isolated and cryopreserved tissue. The recellularization of these bio-scaffolds, with mesenchymal stem cells quickly repopulated the decellularized structures irrespective of the kidneys status, i.e. freshly isolated or the cryopreserved. The growth pattern employing mesenchymal stem cells demonstrated their equivalent recellularization potential. Based on these observations, it may be concluded that cryopreserved kidneys can be exploited as scaffolds for future development of functional organ.	[Chani, Baldeep; Puri, Sanjeev] Panjab Univ, Ctr Stem Cell Tissue Engn & Biomed Excellence, Chandigarh, India; [Puri, Veena] Panjab Univ, Ctr Syst Biol & Bioinformat, Chandigarh, India; [Sobti, Ranbir C.] Panjab Univ, Dept Biotechnol, Chandigarh, India; [Jha, Vivekanand] George Inst Global Hlth India, Dept Nephrol, New Delhi, India; [Jha, Vivekanand] Univ Oxford, New Delhi, India; [Puri, Sanjeev] Panjab Univ, Univ Inst Engn & Technol, Biotechnol Branch, Chandigarh, India	Panjab University; Panjab University; Panjab University; University of Oxford; Panjab University	Puri, S (corresponding author), Panjab Univ, Ctr Stem Cell Tissue Engn & Biomed Excellence, Chandigarh, India.; Puri, S (corresponding author), Panjab Univ, Univ Inst Engn & Technol, Biotechnol Branch, Chandigarh, India.	spuri_1111@yahoo.com	sobti, ranbir/AAX-8037-2021; puri, veena/AAH-7207-2021	Puri, Sanjeev/0000-0002-4314-9871; puri, veena/0000-0002-0639-5897; Puri, Sanjeev/0000-0002-3967-987X; Jha, Vivekanand/0000-0002-8015-9470	Council of Scientific and Industrial Research (CSIR), New Delhi, India [09/135(0681)/2012-EMR-I]; PURSE Grant from Department of Science and Technology, New Delhi [136-137/RPC/3/6/2016- 38/RPC/29/4/2016]	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); PURSE Grant from Department of Science and Technology, New Delhi	This work is funded by Council of Scientific and Industrial Research (CSIR), New Delhi, India (BC, Fellowship award no. 09/135(0681)/2012-EMR-I), and PURSE Grant from Department of Science and Technology, New Delhi, to Center for Stem Cell and Tissue Engineering, Panjab University Chandigarh, India (vide letters no.136-137/RPC/3/6/2016- 38/RPC/29/4/2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AH, 2010, LAB INVEST, V90, P985, DOI 10.1038/labinvest.2010.86; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Bonandrini B, 2014, TISSUE ENG PT A, V20, P1486, DOI [10.1089/ten.tea.2013.0269, 10.1089/ten.TEA.2013.0269]; Burgkart R, 2014, TISSUE ENG PART C-ME, V20, P553, DOI [10.1089/ten.tec.2013.0270, 10.1089/ten.TEC.2013.0270]; Chapel A, 2003, J GENE MED, V5, P1028, DOI 10.1002/jgm.452; Choi S, 2009, STEM CELLS DEV, V18, P521, DOI 10.1089/scd.2008.0097; Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; El-Ansary M, 2012, NEPHROLOGY, V17, P650, DOI 10.1111/j.1440-1797.2012.01622.x; Ezquer FE, 2008, BIOL BLOOD MARROW TR, V14, P631, DOI 10.1016/j.bbmt.2008.01.006; Franquesa M, 2012, STEM CELLS DEV, V21, P3125, DOI 10.1089/scd.2012.0096; Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885; Gratzer PF, 2006, TISSUE ENG, V12, P2975, DOI 10.1089/ten.2006.12.2975; Hayakawa M, 2005, PEDIATR RES, V58, P323, DOI 10.1203/01.PDR.0000169997.45684.05; Humphreys BD, 2008, ANNU REV MED, V59, P311, DOI 10.1146/annurev.med.59.061506.154239; Ikarashi K, 2005, KIDNEY INT, V67, P1925, DOI 10.1111/j.1523-1755.2005.00291.x; Imasawa T, 2001, J AM SOC NEPHROL, V12, P1401, DOI 10.1681/ASN.V1271401; Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di; Ito T, 2001, J AM SOC NEPHROL, V12, P2625, DOI 10.1681/ASN.V12122625; Ito T, 2001, EXP NEPHROL, V9, P444; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Miner JH, 1999, KIDNEY INT, V56, P2016, DOI 10.1046/j.1523-1755.1999.00785.x; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Mouiseddine M, 2007, BRIT J RADIOL, V80, pS49, DOI 10.1259/bjr/25927054; Nakamura K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054036, 10.1371/journal.pone.0074720, 10.1371/journal.pone.0064134]; Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI [10.1089/ten.tea.2009.0602, 10.1089/ten.TEA.2009.0602]; Nasef A, 2009, INT J LAB HEMATOL, V31, P9, DOI 10.1111/j.1751-553X.2007.00997.x; Nasef A, 2007, TRANSPLANTATION, V84, P231, DOI 10.1097/01.tp.0000267918.07906.08; Nasef A, 2007, GENE EXPRESSION, V13, P217; O'Neill JD, 2013, BIOMATERIALS, V34, P9830, DOI 10.1016/j.biomaterials.2013.09.022; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Poulsom R, 2001, J PATHOL, V195, P229, DOI 10.1002/path.976; Prodromidi EI, 2006, STEM CELLS, V24, P2448, DOI 10.1634/stemcells.2006-0201; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; Rookmaaker MB, 2003, AM J PATHOL, V163, P553, DOI 10.1016/S0002-9440(10)63683-8; Ross EA, 2009, J AM SOC NEPHROL, V20, P2338, DOI 10.1681/ASN.2008111196; Sambanis A, 2000, Diabetes Technol Ther, V2, P81, DOI 10.1089/152091599316784; Semedo P, 2009, STEM CELLS, V27, P3063, DOI 10.1002/stem.214; Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P7321, DOI 10.1073/pnas.0601436103; Sullivan DC, 2012, BIOMATERIALS, V33, P7756, DOI 10.1016/j.biomaterials.2012.07.023; Tang HL, 2012, ULTRASOUND MED BIOL, V38, P661, DOI 10.1016/j.ultrasmedbio.2012.01.003; Totonelli G, 2012, BIOMATERIALS, V33, P3401, DOI 10.1016/j.biomaterials.2012.01.012; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Volarevic V, 2011, STEM CELLS, V29, P5, DOI 10.1002/stem.556; Wang Y, 2005, HEPATOLOGY, V53, P293; Wise AF, 2012, NEPHROLOGY, V17, P1, DOI 10.1111/j.1440-1797.2011.01501.x; Yen TH, 2007, CELL PROLIFERAT, V40, P143, DOI 10.1111/j.1365-2184.2007.00423.x	54	25	29	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173040	10.1371/journal.pone.0173040	http://dx.doi.org/10.1371/journal.pone.0173040			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267813	Green Published, Green Submitted, gold			2022-12-27	WOS:000396060600009
J	Chen, Q; Li, N; Wang, X; Ma, L; Huang, JB; Huang, GH				Chen, Qi; Li, Ni; Wang, Xing; Ma, Li; Huang, Jian-Bin; Huang, Guo-Hua			Age-stage, two-sex life table of Parapoynx crisonalis (Lepidoptera: Pyralidae) at different temperatures	PLOS ONE			English	Article							DIFFERENT BEAN CULTIVARS; CONSTANT TEMPERATURES; SPODOPTERA-EXIGUA; APHIDIDAE; PARAMETERS; NOCTUIDAE; HYMENOPTERA; POPULATION; HOMOPTERA; HEMIPTERA	Parapoynx crisonalis is an important pest of many aquatic vegetables including water chestnuts. Understanding the relationship between temperature variations and the population growth rates of P. crisonalis is essential to predicting its population dynamics in water chestnuts ponds. These relationships were examined in this study based on the age-stage, two-sex life table of P. crisonalis developed in the laboratory at 21, 24, 27, 30, 33 and 36 degrees C. The results showed that the values of S-xj (age-stage-specific survival rate), f(xj) (age-stage-specific fecundity), l(x) (age specific survival rate) and m(x) (age-specific fecundity) increased as the temperature rose from 21 to 27 degrees C, then decreased from 30 to 36 degrees C. Temperature also had a significant effect on the net reproductive rate (R-0), gross reproductive rate (GRR), intrinsic rate of increase (r) and finite rate of increase (gimel.). The value of these parameters were at low levels at 21, 33, and 36 degrees C. Further, the r value decreased as the temperature rose from 24 to 30 degrees C, while the GRR reached its highest level at 27 degrees C. The results indicated that optimal growth and development of P. crisonalis occurred at temperatures between 24 degrees C to 30 degrees C when compared to the lowest temperature (21 degrees C) and higher temperatures of 33 degrees C and 36 degrees C.	[Chen, Qi; Li, Ni; Wang, Xing; Ma, Li; Huang, Guo-Hua] Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China; [Chen, Qi; Li, Ni; Wang, Xing; Ma, Li; Huang, Jian-Bin; Huang, Guo-Hua] Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China	Hunan Agricultural University	Huang, GH (corresponding author), Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China.; Huang, GH (corresponding author), Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China.	ghhuang@hunau.edu.cn			National Scientific and Technological Supporting Program of China [2012BAD27602]	National Scientific and Technological Supporting Program of China	The present research was supported by a grant from the National Scientific and Technological Supporting Program of China (No. 2012BAD27602). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami S, 2014, ARTHROPOD-PLANT INTE, V8, P475, DOI 10.1007/s11829-014-9330-3; Bennett C.A., 1999, P 10 INT S BIOL CONT, P307; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; Carey JR, 1993, APPL DEMOGRAPHY BIOL, P211; Chen FQ, 2006, AQUAT INSECT, V28, P291, DOI 10.1080/01650420601099204; Chi H, 2006, ENVIRON ENTOMOL, V35, P10, DOI 10.1603/0046-225X-35.1.10; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; CHI H, 1988, ENVIRON ENTOMOL, V17, P18, DOI 10.1093/ee/17.1.18; CHI H, 1990, J ECON ENTOMOL, V83, P1143, DOI 10.1093/jee/83.4.1143; CHI H, 1985, Bulletin of the Institute of Zoology Academia Sinica (Taipei), V24, P225; Cividanes Francisco J., 2003, Bragantia, V62, P61, DOI 10.1590/S0006-87052003000100008; Davis T., 2012, REV STATUS MICROLEPI; DEEVEY ES, 1947, Q REV BIOL, V22, P283, DOI 10.1086/395888; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fernandes FS, 2013, FLA ENTOMOL, V96, P92, DOI 10.1653/024.096.0112; Golizadeh Ali, 2009, Journal of Asia-Pacific Entomology, V12, P207, DOI 10.1016/j.aspen.2009.05.002; GOODMAN D, 1982, AM NAT, V119, P803, DOI 10.1086/283956; Habeck DH, 2005, AUST J ENTOMOL, V44, P354, DOI 10.1111/j.1440-6055.2005.00503.x; Huang G. H., 2013, COLOR HDB INSECT PES, P109; Huang YB, 2013, J APPL ENTOMOL, V137, P327, DOI 10.1111/jen.12002; Huang Yu-Bing, 2012, Insect Science, V19, P263, DOI 10.1111/j.1744-7917.2011.01424.x; Jha K. R., 2012, ENVIRON ENTOMOL, V41, P30; Karimi-Malati A, 2014, J ASIA-PAC ENTOMOL, V17, P349, DOI 10.1016/j.aspen.2014.03.002; Karimi-Malati A, 2014, ENVIRON ENTOMOL, V43, P795, DOI 10.1603/EN11272; Khanamani M, 2013, INT J ACAROL, V39, P638, DOI 10.1080/01647954.2013.861867; Marchioro CA, 2011, NEOTROP ENTOMOL, V40, P533, DOI 10.1590/S1519-566X2011000500003; Mehrparvar M, 2007, EUR J ENTOMOL, V104, P631, DOI 10.14411/eje.2007.078; Naseri B, 2014, J AGR SCI TECH-IRAN, V16, P19; Park HH, 2014, J ASIA-PAC ENTOMOL, V17, P83, DOI 10.1016/j.aspen.2013.11.003; Ramalho FS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122490; Ratte H.T., 1985, P33; Razmjou J, 2006, J ECON ENTOMOL, V99, P1820, DOI 10.1603/0022-0493-99.5.1820; Southwood TRE, 2000, ECOLOGICAL METHODS; Southwood TRE., 1978, ECOLOGICAL METHODS P; Speidel Wolfgang, 1999, Tijdschrift voor Entomologie, V142, P125; Tanaka F, 1978, JAPANESE J APPL ENTO; Vasicek A, 2002, PESQUI AGROPECU BRAS, V37, P407, DOI 10.1590/S0100-204X2002000300023; Yen Shen-Horn, 2004, P545; Yu JZ, 2013, BIOL CONTROL, V64, P1, DOI 10.1016/j.biocontrol.2012.10.002; Yu-Bing H., 2011, J AGR FOOD RES, V60, P337; Zhang P, 2015, PHYTOPARASITICA, V43, P107, DOI 10.1007/s12600-014-0420-7; Zhang ZJ, 2007, J APPL ENTOMOL, V131, P347, DOI 10.1111/j.1439-0418.2007.01186.x; Zhu FL, 2015, AUSTRAL ENTOMOL, V54, P71, DOI 10.1111/aen.12094	43	35	38	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173380	10.1371/journal.pone.0173380	http://dx.doi.org/10.1371/journal.pone.0173380			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264022	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300061
J	Egger, J; Gall, M; Tax, A; Ucal, M; Zefferer, U; Li, X; von Campe, G; Schafer, U; Schmalstieg, D; Chen, XJ				Egger, Jan; Gall, Markus; Tax, Alois; Uecal, Muammer; Zefferer, Ulrike; Li, Xing; von Campe, Gord; Schaefer, Ute; Schmalstieg, Dieter; Chen, Xiaojun			Interactive reconstructions of cranial 3D implants under MeVisLab as an alternative to commercial planning software	PLOS ONE			English	Article							CRANIOPLASTY; BONE	In this publication, the interactive planning and reconstruction of cranial 3D Implants under the medical prototyping platform MeVisLab as alternative to commercial planning software is introduced. In doing so, a MeVisLab prototype consisting of a customized data-flow network and an own C++ module was set up. As a result, the Computer-Aided Design (CAD) software prototype guides a user through the whole workflow to generate an implant. Therefore, the workflow begins with loading and mirroring the patients head for an initial curvature of the implant. Then, the user can perform an additional Laplacian smoothing, followed by a Delaunay triangulation. The result is an aesthetic looking and well-fitting 3D implant, which can be stored in a CAD file format, e.g. STereoLithography (STL), for 3D printing. The 3D printed implant can finally be used for an in-depth pre-surgical evaluation or even as a real implant for the patient. In a nutshell, our research and development shows that a customized MeVisLab software prototype can be used as an alternative to complex commercial planning software, which may also not be available in every clinic. Finally, not to conform ourselves directly to available commercial software and look for other options that might improve the workflow.	[Egger, Jan; Gall, Markus; Schmalstieg, Dieter] Graz Univ Technol, Fac Comp Sci & Biomed Engn, Inst Comp Graph & Vis, Inffeldgasse 16, Graz, Austria; [Egger, Jan] BioTechMed Graz, Krenngasse 37-1, Graz, Austria; [Tax, Alois; Uecal, Muammer; Zefferer, Ulrike; von Campe, Gord; Schaefer, Ute] Med Univ Graz, Dept Neurosurg, Auenbruggerpl 29, Graz, Austria; [Li, Xing; Chen, Xiaojun] Shanghai Jiao Tong Univ, Inst Biomed Mfg & Life Qual Engn, Sch Mech Engn, Shanghai, Peoples R China	Graz University of Technology; Medical University of Graz; Shanghai Jiao Tong University	Egger, J (corresponding author), Graz Univ Technol, Fac Comp Sci & Biomed Engn, Inst Comp Graph & Vis, Inffeldgasse 16, Graz, Austria.; Egger, J (corresponding author), BioTechMed Graz, Krenngasse 37-1, Graz, Austria.; Chen, XJ (corresponding author), Shanghai Jiao Tong Univ, Inst Biomed Mfg & Life Qual Engn, Sch Mech Engn, Shanghai, Peoples R China.	egger@tugraz.at; xiaojunchen@163.com	Üçal, Muammer/AFS-9448-2022	Chen, Xiaojun/0000-0002-0298-4491	BioTechMed-Graz in Austria (Hardware accelerated intelligent medical imaging); Research & Technology House (F&T-Haus) at the Graz University of Technology; Natural Science Foundation of China [81511130089]; Foundation of Science and Technology Commission of Shanghai Municipality [14441901002, 15510722200, 16441908400]	BioTechMed-Graz in Austria (Hardware accelerated intelligent medical imaging); Research & Technology House (F&T-Haus) at the Graz University of Technology; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The work received funding from BioTechMed-Graz in Austria (Hardware accelerated intelligent medical imaging) and the 6th Call of the Initial Funding Program from the Research & Technology House (F&T-Haus) at the Graz University of Technology (PI: Jan Egger). Dr. Xiaojun Chen receives support by the Natural Science Foundation of China (Grant No.: 81511130089) and the Foundation of Science and Technology Commission of Shanghai Municipality (Grants No.: 14441901002, 15510722200 and 16441908400).	Allen I.E., 2007, QUAL PROG, V40, P64, DOI DOI 10.1111/J.1365-2929.2004.02012.X; Amenta N, 1999, J ALGORITHMS, V30, P302, DOI 10.1006/jagm.1998.0984; Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6; Chen XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20280; Chen XJ, 2015, J BIOMED INFORM, V55, P124, DOI 10.1016/j.jbi.2015.04.003; Chulvi V, 2013, REV FACULTAD INGENIE, V68, P95; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Egger J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01364; Egger J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051788; Egger J, 2012, INT J MED ROBOT COMP, V8, P282, DOI 10.1002/rcs.1415; FIELD DA, 1988, COMMUN APPL NUMER M, V4, P709, DOI 10.1002/cnm.1630040603; Gall M, 2016, CRANIAL DEFECT DATAS; Gilardino MS, 2015, J CRANIOFAC SURG, V1, P113; Gopi M, 2000, COMPUT GRAPH FORUM, V19, pC467, DOI 10.1111/1467-8659.00439; Gordon CR, 2014, OPER NEUROSURG, V10, P179, DOI 10.1227/NEU.0000000000000296; Hausdorft F, 2002, GESAMMELTE WERKE, VII; Itokawa H, 2007, BIOMATERIALS, V28, P4922, DOI 10.1016/j.biomaterials.2007.08.001; Lee MY, 2003, ENGINEERING IN MEDIC, V21, P38; Li X, 2016, INT J CARS, V11, pS241; Li X, 2011, COMPUT GRAPH-UK, V35, P885, DOI 10.1016/j.cag.2011.01.015; Lo Lun-Jou, 2004, Chang Gung Med J, V27, P283; Mangubat E, 2015, NEUROLOGIST, V19, P135, DOI 10.1097/NRL.0000000000000024; Marreiros FMM, 2016, INT J COMPUT ASS RAD, V11, P2217, DOI 10.1007/s11548-016-1454-8; Parthasarathy Jayanthi, 2014, Ann Maxillofac Surg, V4, P9, DOI 10.4103/2231-0746.133065; Prumper J, 1997, SOFTWARE ERGONOMIE 9; Replogle RE, 1996, NEUROSURGERY, V39, P747, DOI 10.1097/00006123-199610000-00020; Sampat MP, 2006, IEEE INT C IM PROC, P1; Sprio S, 2016, J APPL BIOMATER FUNC, V14, pE470, DOI 10.5301/jabfm.5000293; Tam MD, 2012, J RADIOL CASE REP, V6, P31, DOI 10.3941/jrcr.v6i1.889; van der Meer WJ, 2013, BRIT J ORAL MAX SURG, V51, P450, DOI 10.1016/j.bjoms.2012.11.012; Yu W, 2012, GRAPH MODELS, V74, P140, DOI 10.1016/j.gmod.2012.03.011	31	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172694	10.1371/journal.pone.0172694	http://dx.doi.org/10.1371/journal.pone.0172694			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264062	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300014
J	Keddy, KH; Takuva, S; Musekiwa, A; Puren, AJ; Sooka, A; Karstaedt, A; Klugman, KP; Angulo, FJ				Keddy, Karen H.; Takuva, Simbarashe; Musekiwa, Alfred; Puren, Adrian J.; Sooka, Arvinda; Karstaedt, Alan; Klugman, Keith P.; Angulo, Frederick J.			An association between decreasing incidence of invasive non-typhoidal salmonellosis and increased use of antiretroviral therapy, Gauteng Province, South Africa, 2003-2013	PLOS ONE			English	Article							GLOBAL BURDEN; DISEASE; TYPHIMURIUM; HIV; TUBERCULOSIS; HEALTH; KENYA	Background HIV-infected persons are at increased risk of opportunistic infections, including invasive nontyphoidal Salmonella (iNTS) infections; antiretroviral therapy (ART) reduces this risk. We explored changing iNTS incidence associated with increasing ART availability in South Africa. Methods Laboratory-based surveillance for iNTS was conducted in Gauteng Province, South Africa, with verification using the National Health Laboratory Service's Central Data Warehouse (CDW), between 2003 and 2013. Isolates were serotyped at the Centre for Enteric Diseases. CDW data on patient numbers obtaining HIV viral load measurements provided estimates of numbers of HIV-infected patients receiving ART. A Poisson regression model was used to measure the changing incidence of iNTS infection from 2003 to 2013. The correlation between the incidence of iNTS and ART use from 2004 to 2013 was determined using Pearson's correlation coefficient. Results From 2003-2013, the incidence of iNTS per 100,000 population per year decreased from 5.0 to 2.2 (p < .001). From 2004 to 2013, the incidence per 100,000 population of HIV viral load testing increased from 75.2 to 3,620.3 (p < .001). The most common serotypes causing invasive disease were Salmonella enterica serovar Typhimurium (Salmonella Typhimurium), and Salmonella Enteritidis: 2,469 (55.4%) and 1,156 (25.9%) of 4,459 isolates serotyped, respectively. A strong negative correlation was observed between decreasing iNTS incidence and increasing ART use from 2004 to 2013 (r = -0.94, p < .001). Similarly, decreasing incidence of invasive Salmonella Typhimurium infection correlated with increasing ART use (r = -0.93, p <.001). Incidence of invasive Salmonella Enteritidis infection increased, however (r = 0.95, p <.001). Between 2003 and 2004, fewer adult men than women presented with iNTS (male-to- female rate ratio 0.73 and 0.89, respectively). This was reversed from 2005 through 2013 (ranging from 1.07 in 2005 to 1.44 in 2013). Adult men accessed ART less (male-to-female rate ratio ranging from 0.61 [2004] to 0.67 [2013]). Conclusions The incidence of iNTS infections including Salmonella Typhimurium decreased significantly in Gauteng Province in association with increased ART utilization. Adult men accessed ART programs less than women, translating into increasing iNTS incidence in this group. Monitoring iNTS incidence may assist in monitoring the ART program. Increasing incidence of invasive Salmonella Enteritidis infections needs further elucidation.	[Keddy, Karen H.] Natl Inst Communicable Dis, Ctr Enter Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Keddy, Karen H.; Puren, Adrian J.; Karstaedt, Alan] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Takuva, Simbarashe] CARTA Africa, Nairobi, Kenya; [Takuva, Simbarashe; Puren, Adrian J.] Natl Inst Communicable Dis, Ctr HIV, Natl Hlth Lab Serv, Johannesburg, South Africa; [Musekiwa, Alfred] South Africa Global Dis Detect Ctr, Int Emerging Infect Program, Ctr Dis Control & Prevent, Pretoria, South Africa; [Karstaedt, Alan] Chris Hani Baragwanath Hosp, Dept Med, Johannesburg, South Africa; [Klugman, Keith P.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Angulo, Frederick J.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); Bill & Melinda Gates Foundation; Centers for Disease Control & Prevention - USA	Keddy, KH (corresponding author), Natl Inst Communicable Dis, Ctr Enter Dis, Natl Hlth Lab Serv, Johannesburg, South Africa.; Keddy, KH (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa.	karenk@nicd.ac.za	Puren, Adrian/W-1679-2018; Keddy, Karen Helena/AAZ-2189-2020; Puren, Adrian/AAC-2065-2020; Takuva, Simba/G-7735-2012	Puren, Adrian/0000-0001-7531-4010; Keddy, Karen Helena/0000-0001-8640-2235; Puren, Adrian/0000-0001-7531-4010; Takuva, Simba/0000-0001-6030-2359; Musekiwa, Alfred/0000-0001-5880-3680	National Institute for Communicable Diseases/National Health Laboratory Service (South Africa); Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [5U2GPS001328]; United States Agency for International Developments Antimicrobial Resistance Initiative; Centers for Disease Control and Prevention (CDC), Atlanta, Georgia [U60/CCU022088]; HHS Centers for Disease Control and Prevention (CDC); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP); Global AIDS Program (GAP) [U62/PSO022901]	National Institute for Communicable Diseases/National Health Laboratory Service (South Africa); Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)); United States Agency for International Developments Antimicrobial Resistance Initiative(United States Agency for International Development (USAID)); Centers for Disease Control and Prevention (CDC), Atlanta, Georgia(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); HHS Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Global AIDS Program (GAP)	This research has been supported by National Institute for Communicable Diseases/National Health Laboratory Service (South Africa) (www.nicd.ac.za) and the Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of [5U2GPS001328] and, in part, for 2003-2006 by funds from the United States Agency for International Developments Antimicrobial Resistance Initiative, transferred via a cooperative agreement [number U60/CCU022088] from the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia. For 20072009, it was supported by the HHS Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Global AIDS Program (GAP) Cooperative Agreement [U62/PSO022901](www.cdc.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actuarial Society of South Africa, 2011, ASSA PROV OUTP 11021; Ao TT, 2015, EMERG INFECT DIS, V21, P941, DOI 10.3201/eid2106.140999; Bor J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001905; Feasey NA, 2016, NAT GENET, V48, P1211, DOI 10.1038/ng.3644; Feasey NA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003979; Feasey NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092226; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Hawkes C, 2006, B WORLD HEALTH ORGAN, V84, P984, DOI 10.2471/BLT.05.025650; Kariuki S, 2006, J MED MICROBIOL, V55, P585, DOI 10.1099/jmm.0.46375-0; Keddy KH, 2015, CLIN INFECT DIS, V61, pS272, DOI 10.1093/cid/civ685; Keddy KH, 2009, J INFECT DEV COUNTR, V3, P585, DOI 10.3855/jidc.549; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Muthumbi E, 2015, CLIN INFECT DIS, V61, pS290, DOI 10.1093/cid/civ737; Nanoo A, 2015, LANCET INFECT DIS, V15, P1066, DOI 10.1016/S1473-3099(15)00147-4; National Department of Health, 2014, NAT PROV HIV E UNPUB; National Department of Health SA, 2003, COMPR HIV AIDS CAR M; Nunes MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027929; Nunes MC, 2011, AIDS, V25, P453, DOI 10.1097/QAD.0b013e328341b7f1; Okoro CK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003611; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Rehle T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133255; Smith AM, 2014, J CLIN MICROBIOL, V52, P627, DOI 10.1128/JCM.02422-13; Tabu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031237; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tomita A, 2014, AIDS BEHAV, V18, P1801, DOI 10.1007/s10461-014-0800-5; Verani JR, 2015, CLIN INFECT DIS, V61, pS302, DOI 10.1093/cid/civ728	27	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173091	10.1371/journal.pone.0173091	http://dx.doi.org/10.1371/journal.pone.0173091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264046	Green Submitted, Green Published, gold			2022-12-27	WOS:000396054300037
J	Takahashi, M; Nishida, S; Nakamura, M; Kobayashi, M; Matsui, K; Ito, E; Usui, A; Inoue, Y				Takahashi, Masayoshi; Nishida, Shingo; Nakamura, Masaki; Kobayashi, Mina; Matsui, Kentaro; Ito, Eiki; Usui, Akira; Inoue, Yuichi			Restless legs syndrome augmentation among Japanese patients receiving pramipexole therapy: Rate and risk factors in a retrospective study	PLOS ONE			English	Article							SYNDROME RLS; RATING-SCALE; MANAGEMENT; ASSOCIATION; DIAGNOSIS; CONSENSUS; LEVODOPA; FERRITIN	To investigate the rate of and risk factors for restless legs syndrome (RLS) augmentation in Japanese patients receiving pramipexole (PPX) treatment. Records of 231 consecutive patients with idiopathic RLS who received PPX therapy for more than one month in a single sleep disorder center were analyzed retrospectively. Augmentation was diagnosed based on the Max Planck Institute criteria; associated factors were identified by logistic regression analysis. Mean age at PPX initiation was 60.6 +/- 14.9 years and mean treatment duration was 48.5 +/- 26.4 months. Augmentation was diagnosed in 21 patients (9.1%). Daily PPX dose and treatment duration were significantly associated with augmentation. By analyzing the receiver operating characteristic curve, a PPX dose of 0.375 mg/day was found to be the optimal cut-off value for predicting augmentation. After stratifying patients according to PPX treatment duration, at median treatment duration of 46 months, optimal cut-off values for daily doses were 0.375 and 0.500 mg/day for <46 months and >= 46 months of treatment, respectively. The RLS augmentation with PPX treatment in Japanese patients was occurred at rate of 9.1%, being quite compatible with previously reported rates in Caucasian patients. The symptom could appear within a relatively short period after starting the treatment in possibly vulnerable cases even with a smaller drug dose. Our results support the importance of keeping doses of PPX low throughout the RLS treatment course to prevent augmentation.	[Takahashi, Masayoshi; Nakamura, Masaki; Ito, Eiki; Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Tokyo, Japan; [Nishida, Shingo; Nakamura, Masaki; Kobayashi, Mina; Matsui, Kentaro; Ito, Eiki; Usui, Akira; Inoue, Yuichi] Neuropsychiat Res Inst, Japan Somnol Ctr, Tokyo, Japan; [Nishida, Shingo] Maezawa Hosp, Ashikaga, Tochigi, Japan; [Matsui, Kentaro] Tokyo Womens Med Univ, Dept Psychiat, Tokyo, Japan	Tokyo Medical University; Tokyo Women's Medical University	Inoue, Y (corresponding author), Tokyo Med Univ, Dept Somnol, Tokyo, Japan.; Inoue, Y (corresponding author), Neuropsychiat Res Inst, Japan Somnol Ctr, Tokyo, Japan.	inoue@somnology.com		Matsui, Kentaro/0000-0003-4538-5381	JSPS KAKENHI Grant [24621011]; Health and Labour Sciences Research Grants for Comprehensive Research on Persons with Disabilities from the Japan Agency for Medical Research and Development	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health and Labour Sciences Research Grants for Comprehensive Research on Persons with Disabilities from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by JSPS KAKENHI Grant Number 24621011 and the Health and Labour Sciences Research Grants for Comprehensive Research on Persons with Disabilities from the Japan Agency for Medical Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RP, 2011, SLEEP MED, V12, P431, DOI 10.1016/j.sleep.2011.03.003; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Ferini-Strambi L, 2002, SLEEP MED, V3, pS23, DOI 10.1016/S1389-9457(02)00144-2; Frauscher B, 2009, SLEEP MED, V10, P611, DOI 10.1016/j.sleep.2008.09.007; Garcia-Borreguero D, 2007, SLEEP MED, V8, P520, DOI 10.1016/j.sleep.2007.03.022; Garci-Borreguero D, 2007, SLEEP MED, V8, P455, DOI 10.1016/j.sleep.2007.03.023; Garcia-Borreguero D, 2013, SLEEP MED, V14, P675, DOI 10.1016/j.sleep.2013.05.016; Garcia-Borreguero D, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-28; Garcia-Borreguero D, 2010, SLEEP MED REV, V14, P339, DOI 10.1016/j.smrv.2009.11.006; Hening WA, 2009, SLEEP MED, V10, P976, DOI 10.1016/j.sleep.2008.09.015; Hogl B, 2011, SLEEP MED, V12, P351, DOI 10.1016/j.sleep.2010.12.007; Inoue Y, 2013, PSYCHIAT CLIN NEUROS, V67, P412, DOI 10.1111/pcn.12074; Jeon JY, 2015, SLEEP BREATH, V19, P523, DOI 10.1007/s11325-014-1041-6; Lipford MC, 2012, SLEEP MED, V13, P1280, DOI 10.1016/j.sleep.2012.08.004; Silber MH, 2003, SLEEP, V26, P819, DOI 10.1093/sleep/26.7.819; Silver N, 2011, SLEEP MED, V12, P440, DOI 10.1016/j.sleep.2010.11.002; Trenkwalder C, 2008, SLEEP MED, V9, P572, DOI 10.1016/j.sleep.2007.07.020; Trenkwalder C, 2015, NAT REV NEUROL, V11, P434, DOI 10.1038/nrneurol.2015.122; Winkelman JW, 2004, SLEEP MED, V5, P9, DOI 10.1016/j.sleep.2003.07.005	19	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173535	10.1371/journal.pone.0173535	http://dx.doi.org/10.1371/journal.pone.0173535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264052	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300069
J	Berdugo-Cely, J; Valbuena, RI; Sanchez-Betancourt, E; Barrero, LS; Yockteng, R				Berdugo-Cely, Jhon; Ivan Valbuena, Raul; Sanchez-Betancourt, Erika; Stella Barrero, Luz; Yockteng, Roxana			Genetic diversity and association mapping in the Colombian Central Collection of Solanum tuberosum L. Andigenum group using SNPs markers	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; AGRONOMICAL TRAITS; POTATO GERMPLASM; LATE BLIGHT; R-PACKAGE; SSR; RESISTANCE; SOFTWARE	The potato (Solanum tuberosum L.) is the fourth most important crop food in the world and Colombia has one of the most important collections of potato germplasm in the world (the Colombian Central Collection-CCC). Little is known about its potential as a source of genetic diversity for molecular breeding programs. In this study, we analyzed 809 Andigenum group accessions from the CCC using 5968 SNPs to determine: 1) the genetic diversity and population structure of the Andigenum germplasm and 2) the usefulness of this collection to map qualitative traits across the potato genome. The genetic structure analysis based on principal components, cluster analyses, and Bayesian inference revealed that the CCC can be subdivided into two main groups associated with their ploidy level: Phureja (diploid) and Andigena (tetraploid). The Andigena population was more genetically diverse but less genetically substructured than the Phureja population (three vs. five subpopulations, respectively). The association mapping analysis of qualitative morphological data using 4666 SNPs showed 23 markers significantly associated with nine morphological traits. The present study showed that the CCC is a highly diverse germplasm collection genetically and phenotypically, useful to implement association mapping in order to identify genes related to traits of interest and to assist future potato genetic breeding programs.	[Berdugo-Cely, Jhon; Ivan Valbuena, Raul; Sanchez-Betancourt, Erika; Stella Barrero, Luz; Yockteng, Roxana] Colombian Agr Res Corp CORPOICA Mosquera, Cundinamarca, Colombia; [Yockteng, Roxana] Museum Natl Hist Nat, CNRS, UMR 7205, Paris, France	Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Yockteng, R (corresponding author), Colombian Agr Res Corp CORPOICA Mosquera, Cundinamarca, Colombia.; Yockteng, R (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7205, Paris, France.	ryockteng@corpoica.org.co		Sanchez-Betancourt, Erika/0000-0002-3024-3180; Yockteng, Roxana/0000-0003-2133-6139; Berdugo-Cely, Jhon A./0000-0002-2675-0462	Colombian Ministry of Agriculture (Ministerio de Agricultura y Desarrollo Rural de Colombia); Colombian Ministry of Agriculture	Colombian Ministry of Agriculture (Ministerio de Agricultura y Desarrollo Rural de Colombia); Colombian Ministry of Agriculture	Support was provided by the Colombian Ministry of Agriculture (Ministerio de Agricultura y Desarrollo Rural de Colombia).; We thank the Potato Germplasm Bank of CORPOICA for providing the germplasm material and associated information of the CCC used in this study. The authors thank Ivania Ceron for assistance in revising the final version of the manuscript. This study was funded by the Colombian Ministry of Agriculture.	Abouzied HM, 2013, BRIT BIOTECHNOL J, P390, DOI DOI 10.9734/BBJ/2013/4340; Adetunji I, 2014, THEOR APPL GENET, V127, P559, DOI 10.1007/s00122-013-2239-x; Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Akkale C, 2010, TURK J FIELD CROPS, V15, P73; Alvarez M., 2014, THESIS; Ammar MH, 2015, SAUDI J BIOL SCI, V22, P340, DOI 10.1016/j.sjbs.2015.02.005; Arslanoglu F, 2008, TURK J FIELD CROPS, V13, P70; Arslanoglu F, 2011, AFR J BIOTECHNOL, V10, P922; Azizi A, 2012, CHEM BIODIVERS, V9, P2784, DOI 10.1002/cbdv.201200125; Bernal Ángela María, 2006, Agron. colomb., V24, P226; Bornet B, 2002, GENOME, V45, P481, DOI 10.1139/G02-002; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bradshaw JE., 2006, POTATO RES, V49, P49, DOI [10.1007/s11540-006-9002-5, DOI 10.1007/S11540-006-9002-5]; Brown CR, 2003, AM J POTATO RES, V80, P241, DOI 10.1007/BF02855360; Burlingame B, 2009, J FOOD COMPOS ANAL, V22, P494, DOI 10.1016/j.jfca.2009.09.001; Carputo D, 2003, GENETICS, V163, P287; Carputo D, 2013, PLANT GENET RESOUR-C, V11, P131, DOI 10.1017/S1479262112000500; Chen HD, 2014, MOL PLANT, V7, P541, DOI 10.1093/mp/sst135; CIPAR M. S., 1964, AMER POTATO J, V41, P155, DOI 10.1007/BF02855317; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Das AB, 2010, CROP BREED APPL BIOT, V10, P238, DOI 10.1590/S1984-70332010000300009; del Rio AH, 2002, AM J POTATO RES, V79, P335, DOI 10.1007/BF02870170; Dhoop BB, THEOR APPL; Di Rienzo J. A., 2014, INFOSTAT VERSION 201; Duarte-Delgado D, 2015, THESIS; Ducreux LJM, 2008, J EXP BOT, V59, P4219, DOI 10.1093/jxb/ern264; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eichhorn S, 2005, FOOD RES INT, V38, P943, DOI 10.1016/j.foodres.2005.03.011; Endelman JB, 2016, THEOR APPL GENET, V129, P935, DOI 10.1007/s00122-016-2673-7; Esfahani ST, 2009, CROP BREED APPL BIOT, V9, P75, DOI 10.12702/1984-7033.v09n01a11; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felcher KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036347; Felsenstein J., 2013, PHYLIP PHYLOGENY INF; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Fu YB, 2009, AM J POTATO RES, V86, P38, DOI 10.1007/s12230-008-9059-6; Galani YJH, 2015, J PLANT SCI, V3, P191; Gebhardt C, 2004, MOL BREEDING, V13, P93, DOI 10.1023/B:MOLB.0000012878.89855.df; Ghebreslassie B. M., 2015, American Journal of Plant Sciences, V6, P2122, DOI 10.4236/ajps.2015.613213; Ghislain M, 2006, THEOR APPL GENET, V113, P1515, DOI 10.1007/s00122-006-0399-7; Ghislain M, 2004, THEOR APPL GENET, V108, P881, DOI 10.1007/s00122-003-1494-7; Gomez R., 2006, MANUAL CARACTERIZACI, P26; Guevara, 2011, THESIS; Hackett CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063939; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hanneman R. E. Jr., 1994, Biosafety for sustainable agriculture: sharing biotechnology regulatory experiences of the Western Hemisphere., P47; Hao DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142585; Hardigan MA, 2014, PLANT GENOME, V8, P1; HAWKES JG, 1990, POTATO EVOLUTION BIO; Hirsch CN, 2013, G3-GENES GENOM GENET, V3, P1003, DOI 10.1534/g3.113.005595; Hoque M. E., 2013, SAARC Journal of Agriculture, V11, P95; Human Z, 2002, AM J BOT, V89, P947, DOI 10.3732/ajb.89.6.947; Jansky SH, 2015, AM J BOT, V102, P1213, DOI 10.3732/ajb.1500203; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Juyo D, 2015, CROP SCI, V55, P760, DOI 10.2135/cropsci2014.07.0524; Karuri HW, 2010, INT J AGRIC BIOL, V12, P33; Keilwagen J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05231; Kujal Sheetal, 2005, Potato Journal (Shimla), V32, P17; Li JQ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-484; Liao H, 2014, ACTA BIOL CRACOV BOT, V56, P16, DOI 10.2478/abcsb-2014-0003; Lindqvist-Kreuze H, 2014, PHYTOPATHOLOGY, V104, P624, DOI 10.1094/PHYTO-10-13-0270-R; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu NJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S26; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Madronero I. C., 2013, Revista Temas Agrarios, V18, P50; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; MANTEL N, 1967, CANCER RES, V27, P209; Massa AN, 2015, G3-GENES GENOM GENET, V5, P2357, DOI 10.1534/g3.115.019646; Mattila P, 2007, J FOOD COMPOS ANAL, V20, P152, DOI 10.1016/j.jfca.2006.05.007; McGregor CE, 2000, EUPHYTICA, V113, P135, DOI 10.1023/A:1003925620546; McGregor CE, 2002, THEOR APPL GENET, V104, P146, DOI 10.1007/s001220200018; Milbourne D, 2007, GENOME MAPPING MOL B, V3, P206; Moreno J, 2006, REV CORPOICA CIENC T, V4, P1; Morris WL, 2008, AM J POTATO RES, V85, P286, DOI 10.1007/s12230-008-9031-5; Mosquera T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156254; Navarro C, 2010, REV CIENC AGRIC, V27, P27; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nunziata A., 2010, American Journal of Plant Sciences, V1, P95, DOI 10.4236/ajps.2010.12012; Obidiegwu JE, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0195-y; Onamu Rose, 2014, Rev. Mex. Cienc. Agríc, V5, P561; Pal BP, 1942, NATURE, V149, P246, DOI 10.1038/149246a0; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Patwardhan A., 2014, J PHYLOGENETICS EVOL, DOI [10.4172/2329-9002.1000131, DOI 10.4172/2329-9002.1000131]; Pavek JJ, 2001, AM J POTATO RES, V78, P433, DOI 10.1007/BF02896375; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pembleton LW, 2013, MOL ECOL RESOUR, V13, P946, DOI 10.1111/1755-0998.12129; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Reid A, 2011, EUPHYTICA, V182, P239, DOI 10.1007/s10681-011-0462-6; Rosyara UR, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.08.0073; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruggieri V, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0337-9; de Galarreta JIR, 2011, GENET RESOUR CROP EV, V58, P383, DOI 10.1007/s10722-010-9583-3; Sakiroglu M, 2012, THEOR APPL GENET, V125, P577, DOI 10.1007/s00122-012-1854-2; Sehgal D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132112; Sharma SK, 2013, G3-GENES GENOM GENET, V3, P2031, DOI 10.1534/g3.113.007153; Sharma V, 2014, MOL PHYLOGENET EVOL, V73, P10, DOI 10.1016/j.ympev.2014.01.003; Sim SC, 2011, HEREDITY, V106, P927, DOI 10.1038/hdy.2010.139; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Simko I, 2006, GENETICS, V173, P2237, DOI 10.1534/genetics.106.060905; Solano J, 2013, ELECTRON J BIOTECHN, V16, DOI 10.2225/vol16-issue6-fulltext-15; Solano-Solis J, 2007, ELECT J BIOTECHNOL, V10; Spooner DM, 2008, CROP SCI, V48, pS27, DOI 10.2135/cropsci2007.09.0504tpg; Spooner DM, 2007, P NATL ACAD SCI USA, V104, P19398, DOI 10.1073/pnas.0709796104; Spooner DM, 2010, AM J BOT, V97, P2049, DOI 10.3732/ajb.1000277; Spooner DM, 2005, P NATL ACAD SCI USA, V102, P14694, DOI 10.1073/pnas.0507400102; Spooner DM, 1996, THEOR APPL GENET, V92, P532, DOI 10.1007/BF00224555; Stich B, 2013, PLANT BREEDING, V132, P718, DOI 10.1111/pbr.12102; Sukhotu T, 2006, GENOME, V49, P636, DOI 10.1139/G06-014; Urbany C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-7; Uribe F, 2011, THESIS; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; Vieira EA, 2007, GENET MOL BIOL, V30, P392, DOI 10.1590/S1415-47572007000300016; Vos PG, 2017, THEOR APPL GENET, V130, P123, DOI 10.1007/s00122-016-2798-8; Vos PG, 2015, THEOR APPL GENET, V128, P2387, DOI 10.1007/s00122-015-2593-y; Wang XM, 2012, INT J MOL SCI, V13, P3900, DOI 10.3390/ijms13033900; Wurschum T, 2013, THEOR APPL GENET, V126, P1477, DOI 10.1007/s00122-013-2065-1; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Zhao YL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086308, 10.1371/journal.pone.0099704]	123	39	40	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173039	10.1371/journal.pone.0173039	http://dx.doi.org/10.1371/journal.pone.0173039			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257509	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100051
J	Lindqvist, A; Ekelund, M; Garcia-Vaz, E; Stahlman, M; Pierzynowski, S; Gomez, MF; Rehfeld, JF; Groop, L; Hedenbro, J; Wierup, N; Spegel, P				Lindqvist, Andreas; Ekelund, Mikael; Garcia-Vaz, Eliana; Stahlman, Marcus; Pierzynowski, Stefan; Gomez, Maria F.; Rehfeld, Jens F.; Groop, Leif; Hedenbro, Jan; Wierup, Nils; Spegel, Peter			The impact of Roux-en-Y gastric bypass surgery on normal metabolism in a porcine	PLOS ONE			English	Article							BETA-CELL FUNCTION; LOW-CALORIE DIET; BARIATRIC SURGERY; WEIGHT-LOSS; BILE-ACIDS; INSULIN SENSITIVITY; LIPOPROTEINS; MAINTENANCE; SECRETION; MASS	Background A growing body of literature on Roux-en-Y gastric bypass surgery (RYGB) has generated inconclusive results on the mechanism underlying the beneficial effects on weight loss and glycaemia, partially due to the problems of designing clinical studies with the appropriate controls. Moreover, RYGB is only performed in obese individuals, in whom metabolism is perturbed and not completely understood. Methods In an attempt to isolate the effects of RYGB and its effects on normal metabolism, we investigated the effect of RYGB in lean pigs, using sham-operated pair-fed pigs as controls. Two weeks post-surgery, pigs were subjected to an intravenous glucose tolerance test (IVGTT) and circulating metabolites, hormones and lipids measured. Bile acid composition was profiled after extraction from blood, faeces and the gallbladder. Results A similar weight development in both groups of pigs validated our experimental model. Despite similar changes in fasting insulin, RYGB-pigs had lower fasting glucose levels. During an IVGTT RYGB-pigs had higher insulin and lower glucose levels. VLDL and IDL were lower in RYGB-than in sham-pigs. RYGB-pigs had increased levels of most amino acids, including branched-chain amino acids, but these were more efficiently suppressed by glucose. Levels of bile acids in the gallbladder were higher, whereas plasma and faecal bile acid levels were lower in RYGB-than in sham-pigs. Conclusion In a lean model RYGB caused lower plasma lipid and bile acid levels, which were compensated for by increased plasma amino acids, suggesting a switch from lipid to protein metabolism during fasting in the immediate postoperative period.	[Lindqvist, Andreas; Hedenbro, Jan; Wierup, Nils] Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Neuroendocrine Cell Biol, Malmo, Sweden; [Ekelund, Mikael] Lund Univ, Dept Clin Sci Malmo, Dept Surg, Lund, Sweden; [Garcia-Vaz, Eliana; Gomez, Maria F.] Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Vasc ET Coupling, Malmo, Sweden; [Stahlman, Marcus] Univ Gothenburg, Dept Mol & Clin Med, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden; [Stahlman, Marcus] Univ Gothenburg, Wallenberg Lab, Gothenburg, Sweden; [Pierzynowski, Stefan] Lund Univ, Dept Cell & Organism Biol, Lund, Sweden; [Pierzynowski, Stefan] Innovat Ctr STB, Tczew, Poland; [Rehfeld, Jens F.] Univ Copenhagen, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark; [Groop, Leif] Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Diabet & Endocrinol, Malmo, Sweden; [Hedenbro, Jan] Lund Univ, Dept Clin Sci Lund, Surg, Lund, Sweden; [Spegel, Peter] Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Mol Metab, Malmo, Sweden; [Spegel, Peter] Lund Univ, Dept Chem, Ctr Anal & Synth, Lund, Sweden	Lund University; Lund University; Lund University; University of Gothenburg; University of Gothenburg; Lund University; Rigshospitalet; University of Copenhagen; Lund University; Lund University; Lund University; Lund University	Spegel, P (corresponding author), Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Mol Metab, Malmo, Sweden.; Spegel, P (corresponding author), Lund Univ, Dept Chem, Ctr Anal & Synth, Lund, Sweden.	peter.spegel@chem.lu.se	Spégel, Peter/G-9947-2018; Gomez, Maria F/D-3696-2014; StÃhlman, Marcus/M-4597-2019	Spégel, Peter/0000-0002-6092-2387; Gomez, Maria F/0000-0001-6210-3142; Henricsson, Marcus/0000-0002-4202-0339; Pierzynowski, Stefan Grzegorz/0000-0002-0308-3214	Swedish Diabetes Foundation; Royal Physiographic Society; Diabetes Wellness; Novo Nordisk Foundation; PahIsson; Crafoord Foundations; Swedish Research Council [521-2007-4037, 20084216, 2011-3900, 2009-1039, 349-2008-6589]; European Research Council [GA 269045]; Wallenberg foundation [KAW 20090243]; Lundberg foundation [359]; EU grant ENGAGE; Novo Nordisk Fonden [NNF15OC0016154] Funding Source: researchfish	Swedish Diabetes Foundation; Royal Physiographic Society; Diabetes Wellness; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); PahIsson; Crafoord Foundations; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Wallenberg foundation(European Commission); Lundberg foundation(European Commission); EU grant ENGAGE; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Swedish Diabetes Foundation (PS, NW), the Royal Physiographic Society (PS), The Diabetes Wellness (NW), the Novo Nordisk Foundation (PS), PahIsson (PS, NW), and Crafoord Foundations (PS), the Swedish Research Council incl. project grant (LG: Dnr. 521-2007-4037, NW: Dnr. 20084216, MG: Dnr. 2011-3900), strategic research area grant (EXODIAB: Dnr. 2009-1039) and Linnaeus grant (LUDC: Dnr. 349-2008-6589), an Advanced Research Grant from the European Research Council for (LG: GA 269045) as well as equipment grants from Wallenberg (KAW 20090243) and Lundberg foundation (grant nr. 359). In addition, the project was funded by the EU grant ENGAGE. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aguiar EJ, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-2; [Anonymous], DIABETES; Bojsen-Moller KN, 2013, J CLIN ENDOCR METAB, V98, pE1066, DOI 10.1210/jc.2013-1286; Breen DM, 2012, NAT MED, V18, P950, DOI 10.1038/nm.2745; Carmena R, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000131511.50734.44; Dirksen C, 2012, DIABETOLOGIA, V55, P1890, DOI 10.1007/s00125-012-2556-7; Dixon JB, 2011, NAT REV GASTRO HEPAT, V8, P429, DOI 10.1038/nrgastro.2011.112; Gloy VL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5934; Gustavsson C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012699; Hodis HN, 1997, CIRCULATION, V95, P2022, DOI 10.1161/01.CIR.95.8.2022; Jackness C, 2013, DIABETES, V62, P3027, DOI 10.2337/db12-1762; Jacobsen SH, 2012, OBES SURG, V22, P1084, DOI 10.1007/s11695-012-0621-4; Johansson K, 2014, AM J CLIN NUTR, V99, P14, DOI 10.3945/ajcn.113.070052; Jorgensen NB, 2013, DIABETES, V62, P3044, DOI 10.2337/db13-0022; Kashyap SR, 2013, DIABETES CARE, V36, P2175, DOI 10.2337/dc12-1596; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Kumar R, 2011, SURGERY, V149, P654, DOI 10.1016/j.surg.2010.11.015; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Lien LF, 2009, OMICS, V13, P21, DOI 10.1089/omi.2008.0035; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Lindqvist A, 2014, DIABETES, V63, P1665, DOI 10.2337/db13-0969; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Litten-Brown JC, 2010, ANIMAL, V4, P899, DOI 10.1017/S1751731110000200; MANN JI, 1980, DIABETOLOGIA, V18, P89, DOI 10.1007/BF00290483; Mutch DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007905; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Odstrcil EA, 2010, AM J CLIN NUTR, V92, P704, DOI 10.3945/ajcn.2010.29870; Peterli R, 2012, OBES SURG, V22, P740, DOI 10.1007/s11695-012-0622-3; Pihlajamaki J, 2010, METABOLISM, V59, P866, DOI 10.1016/j.metabol.2009.10.004; Pournaras DJ, 2012, ENDOCRINOLOGY, V153, P3613, DOI 10.1210/en.2011-2145; RAPP JH, 1994, ARTERIOSCLER THROMB, V14, P1767, DOI 10.1161/01.ATV.14.11.1767; Rehfeld JF, 1998, CLIN CHEM, V44, P991; Ryan KK, 2014, NATURE, V509, P183, DOI 10.1038/nature13135; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Sham JG, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/526972; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Smushkin G, 2012, DIABETES, V61, P1082, DOI [10.2337/db11-1732, 10.2337/db12-0923]; Spegel P, 2013, DIABETES, V62, P653, DOI 10.2337/db12-0827; Steinert RE, 2013, OBESITY, V21, pE660, DOI 10.1002/oby.20522; Tremaroli V, 2015, CELL METAB, V22, P228, DOI 10.1016/j.cmet.2015.07.009; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Tura A, 2010, DIABETOLOGIA, V53, P144, DOI 10.1007/s00125-009-1547-9; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510	45	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173137	10.1371/journal.pone.013137	http://dx.doi.org/10.1371/journal.pone.013137			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257455				2022-12-27	WOS:000396021100064
J	Montanari, SR; Hobbs, JPA; Pratchett, MS; Bay, LK; van Herwerden, L				Montanari, Stefano R.; Hobbs, Jean-Paul A.; Pratchett, Morgan S.; Bay, Line K.; van Herwerden, Lynne			Naturally occurring hybrids of coral reef butterflyfishes have similar fitness compared to parental species	PLOS ONE			English	Article							STICKLEBACK GASTEROSTEUS-ACULEATUS; EVOLUTIONARY HISTORY; FEEDING FISHES; INDIAN-OCEAN; HYBRIDIZATION; CONSERVATION; SPECIATION; ZONE; CHAETODONTIDAE; INTROGRESSION	Hybridisation can produce evolutionary novelty by increasing fitness and adaptive capacity. Heterosis, or hybrid vigour, has been documented in many plant and animal taxa, and is a notable consequence of hybridisation that has been exploited for decades in agriculture and aquaculture. On the contrary, loss of fitness in naturally occurring hybrid taxa has been observed in many cases. This can have negative consequences for the parental species involved (wasted reproductive effort), and has raised concerns for species conservation. This study evaluates the relative fitness of previously documented butterflyfish hybrids of the genus Chaetodon from the Indo-Pacific suture zone at Christmas Island. Histological examination confirmed the reproductive viability of Chaetodon hybrids. Examination of liver lipid content showed that hybrid body condition was not significantly different from parent species body condition. Lastly, size at age data revealed no difference in growth rates and asymptotic length between hybrids and parent species. Based on the traits measured in this study, naturally occurring hybrids of Chaetodon butterflyfishes have similar fitness to their parental species, and are unlikely to supplant parental species under current environmental conditions at the suture zone. However, given sufficient fitness and ongoing genetic exchange between the respective parental species, hybrids are likely to persist within the suture zone.	[Montanari, Stefano R.] James Cook Univ North Queensland, Coll Sci & Engn, Australian Inst Marine Sci, AIMS JCU, Townsville, Qld, Australia; [Hobbs, Jean-Paul A.] Curtin Univ, Dept Environm & Agr, Bentley, WA, Australia; [Pratchett, Morgan S.] James Cook Univ North Queensland, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Bay, Line K.] Australian Inst Marine Sci, Townsville, Qld, Australia; [van Herwerden, Lynne] James Cook Univ North Queensland, Coll Sci & Engn, Townsville, Qld, Australia; [van Herwerden, Lynne] James Cook Univ North Queensland, Ctr Comparat Genom, Townsville, Qld, Australia	Australian Institute of Marine Science; James Cook University; Curtin University; James Cook University; Australian Institute of Marine Science; James Cook University; James Cook University	Montanari, SR (corresponding author), James Cook Univ North Queensland, Coll Sci & Engn, Australian Inst Marine Sci, AIMS JCU, Townsville, Qld, Australia.	stefanomontanari@gmail.com	Pratchett, Morgan/AAW-5179-2020; van Herwerden, Lynne/I-1087-2012	Pratchett, Morgan/0000-0002-1862-8459; van Herwerden, Lynne/0000-0001-6717-8995; Bay, Line/0000-0002-9760-2977	Australian Institute of Marine Science (AIMS@JCU)	Australian Institute of Marine Science (AIMS@JCU)	This work was supported by Australian Institute of Marine Science (AIMS@JCU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Allen G.R., 1998, GUIDE ANGELFISHES BU; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; [Anonymous], 1963, ANIMAL SPECIES EVOLU; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Arnold ML, 2010, TRENDS ECOL EVOL, V25, P530, DOI 10.1016/j.tree.2010.06.005; ARNOLD ML, 1993, J HERED, V84, P13, DOI 10.1093/oxfordjournals.jhered.a111269; Barber Bruce J., 2006, Developments in Aquaculture and Fisheries Science, V35, P357; Bartley DM, 2000, REV FISH BIOL FISHER, V10, P325, DOI 10.1023/A:1016691725361; Bellwood DR, 2010, J EVOLUTION BIOL, V23, P335, DOI 10.1111/j.1420-9101.2009.01904.x; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Cancela ML, 2010, INTRODUCTION TO MARINE GENOMICS, P213, DOI 10.1007/978-90-481-8639-6_7; CARNEY SE, 1994, AM J BOT, V81, P1169, DOI 10.2307/2445479; Chen ZJ, 2013, NAT REV GENET, V14, P471, DOI 10.1038/nrg3503; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; CRUZAN MB, 1993, EVOLUTION, V47, P1432, DOI 10.1111/j.1558-5646.1993.tb02165.x; DiBattista J.D., 2015, J BIOGEOGRAPHY; DiBattista JD, 2013, J BIOGEOGR, V40, P1170, DOI 10.1111/jbi.12068; DiBattista JD, 2012, CORAL REEFS, V31, P839, DOI 10.1007/s00338-012-0907-y; Gardner J, 1997, ADV MAR BIOL, V31, P78; Hobbs J-PA, 2013, BIOL BUTTERFLYFISHES; Hobbs JPA, 2014, RAFFLES B ZOOL, P220; Hobbs JPA, 2014, RAFFLES B ZOOL, P184; Hobbs JPA, 2009, BIOL LETTERS, V5, P258, DOI 10.1098/rsbl.2008.0561; Hobbs JPA, 2014, MAR POLICY, V44, P149, DOI 10.1016/j.marpol.2013.08.020; Hoey J, 2007, CORAL REEFS, V26, P603, DOI 10.1007/s00338-007-0246-6; Hoffmeister TS, 2005, ECOSYSTEMS, V8, P657, DOI 10.1007/s10021-003-0138-8; Huff D. D., 2010, EXAMINING GENETIC DI; Huff DD, 2011, MOL ECOL, V20, P4246, DOI 10.1111/j.1365-294X.2011.05271.x; Johansen JL, 2011, GLOBAL CHANGE BIOL, V17, P2971, DOI 10.1111/j.1365-2486.2011.02436.x; Lavretsky P, 2016, MOL ECOL, V25, P661, DOI 10.1111/mec.13487; MacCallum CJ, 1998, EVOLUTION, V52, P227, DOI 10.1111/j.1558-5646.1998.tb05156.x; Mallet J, 2001, J EVOLUTION BIOL, V14, P887, DOI 10.1046/j.1420-9101.2001.00342.x; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Messmer V, 2016, GLOBAL CHANGE BIOL; Montanari SR, 2016, REV FISH BIOL FISHER, P1; Montanari SR, 2014, MOL ECOL, V23, P2757, DOI 10.1111/mec.12762; Montanari SR, 2012, ECOL EVOL, V2, P310, DOI 10.1002/ece3.83; Payet SD, 2016, CORAL REEFS, V35, P1157, DOI 10.1007/s00338-016-1482-4; Pratchett M.S., 2007, RAFFLES B ZOOL, V14, P155; Pratchett MS, 2006, CORAL REEFS, V25, P85, DOI 10.1007/s00338-005-0081-6; Pratchett MS, 2005, MAR BIOL, V148, P373, DOI 10.1007/s00227-005-0084-4; Pratchett MS, 2001, CORAL REEFS, V20, P13, DOI 10.1007/s003380000113; PYLE RL, 1994, ENVIRON BIOL FISH, V41, P127; REMINGTON C L, 1968, Evolutionary Biology (New York), P321; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Richards ZT, 2015, CURR ZOOL, V61, P132, DOI 10.1093/czoolo/61.1.132; Riginos C, 2007, MOL ECOL, V16, P3971, DOI 10.1111/j.1365-294X.2007.03505.x; Rosenfield JA, 2004, CONSERV BIOL, V18, P1589, DOI 10.1111/j.1523-1739.2004.00356.x; Schilthuizen M, 2011, HEREDITY, V107, P95, DOI 10.1038/hdy.2010.170; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Secor DH, 1990, MANUAL OTOLITH REMOV; Seehausen O, 2006, CURR BIOL, V16, pR334, DOI 10.1016/j.cub.2006.03.080; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2003, P ROY SOC B-BIOL SCI, V270, P129, DOI 10.1098/rspb.2002.2153; SHULL GH, 1948, GENETICS, V33, P439; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; Taylor EB, 2012, EVOLUTION, V66, P240, DOI 10.1111/j.1558-5646.2011.01439.x; THEILACKER GH, 1978, FISH B-NOAA, V76, P403; Thompson WL, 2004, SAMPLING RARE ELUSIV; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Woods A, 1994, LAB HISTOPATHOLOGY C; Yaakub SM, 2006, MOL PHYLOGENET EVOL, V40, P84, DOI 10.1016/j.ympev.2006.02.012; Yabuta S, 2014, BIOLOGY OF BUTTERFLYFISHES, P200	68	6	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173212	10.1371/journal.pone.0173212	http://dx.doi.org/10.1371/journal.pone.0173212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257492	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100078
J	Sawada, N; Wark, PA; Merritt, MA; Tsugane, S; Ward, HA; Rinaldi, S; Weiderpass, E; Dartois, L; His, M; Boutron-Ruault, MC; Turzanski-Fortner, R; Kaaks, R; Overvad, K; Redondo, ML; Travier, N; Molina-Portillo, E; Dorronsoro, M; Cirera, L; Ardanaz, E; Perez-Cornago, A; Trichopoulou, A; Lagiou, P; Valanou, E; Masala, G; Pala, V; Peeters, PHM; van der Schouw, YT; Melander, O; Manjer, J; da Silva, M; Skeie, G; Tjonneland, A; Olsen, A; Gunter, MJ; Riboli, E; Cross, AJ				Sawada, Norie; Wark, Petra A.; Merritt, Melissa A.; Tsugane, Shoichiro; Ward, Heather A.; Rinaldi, Sabina; Weiderpass, Elisabete; Dartois, Laureen; His, Mathilde; Boutron-Ruault, Marie-Christine; Turzanski-Fortner, Renee; Kaaks, Rudolf; Overvad, Kim; Redondo, Maria-Luisa; Travier, Noemie; Molina-Portillo, Elena; Dorronsoro, Miren; Cirera, Lluis; Ardanaz, Eva; Perez-Cornago, Aurora; Trichopoulou, Antonia; Lagiou, Pagona; Valanou, Elissavet; Masala, Giovanna; Pala, Valeria; Peeters, Petra H. M.; van der Schouw, Yvonne T.; Melander, Olle; Manjer, Jonas; da Silva, Marisa; Skeie, Guri; Tjonneland, Anne; Olsen, Anja; Gunter, Marc J.; Riboli, Elio; Cross, Amanda J.			The association between adult attained height and sitting height with mortality in the European Prospective Investigation into Cancer and Nutrition (EPIC)	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; GROWTH-FACTOR-I; CARDIOVASCULAR-DISEASE; LUNG-FUNCTION; RISK-FACTORS; LEG LENGTH; FOLLOW-UP; REGRESSION-MODELS; IGF-I; POPULATION	Adult height and sitting height may reflect genetic and environmental factors, including early life nutrition, physical and social environments. Previous studies have reported divergent associations for height and chronic disease mortality, with positive associations observed for cancer mortality but inverse associations for circulatory disease mortality. Sitting height might be more strongly associated with insulin resistance; however, data on sitting height and mortality is sparse. Using the European Prospective Investigation into Cancer and Nutrition study, a prospective cohort of 409,748 individuals, we examined adult height and sitting height in relation to all-cause and cause-specific mortality. Height was measured in the majority of participants; sitting height was measured in similar to 253,000 participants. During an average of 12.5 years of follow-up, 29,810 deaths (11,931 from cancer and 7,346 from circulatory disease) were identified. Hazard ratios (HR) with 95% confidence intervals (CI) for death were calculated using multivariable Cox regression within quintiles of height. Height was positively associated with cancer mortality (men: HRQ5 vs. Q1 = 1.11, 95% CI = 1.00-1.24; women: HRQ5 vs. Q1 = 1.17, 95% CI = 1.07-1.28). In contrast, height was inversely associated with circulatory disease mortality (men: HRQ5 vs. Q1 = 0.63, 95% CI = 0.56 - 0.71; women: HRQ5 vs. Q1 = 0.81, 95% CI = 0.70 - 0.93). Although sitting height was not associated with cancer mortality, it was inversely associated with circulatory disease (men: HRQ5 vs. Q1 = 0.64, 95% CI = 0.55 - 0.75; women: HRQ5 vs. Q1 = 0.60, 95% CI = 0.49 - 0.74) and respiratory disease mortality (men: HRQ5 vs. Q1 = 0.45, 95% CI = 0.28 - 0.71; women: HRQ5 vs. Q1 = 0.60, 95% CI = 0.40 - 0.89). We observed opposing effects of height on cancer and circulatory disease mortality. Sitting height was inversely associated with circulatory disease and respiratory disease mortality.	[Sawada, Norie; Wark, Petra A.; Merritt, Melissa A.; Ward, Heather A.; Riboli, Elio; Cross, Amanda J.] Imperial Coll London, Sch Publ Hlth, London, England; [Sawada, Norie; Tsugane, Shoichiro] Natl Canc Ctr, Ctr Publ Hlth Sci, Tokyo, Japan; [Rinaldi, Sabina; Gunter, Marc J.] Int Agcy Res Canc, Lyon, France; [Weiderpass, Elisabete; da Silva, Marisa; Skeie, Guri] Univ Tromso, Dept Community Med, Fac Hlth Sci, Tromso, Norway; [Weiderpass, Elisabete] Canc Registry Norway, Inst Populat Based Canc Res, Dept Res, Oslo, Norway; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete] Folkhalsan Res Ctr, Genet Epidemiol Grp, Helsinki, Finland; [Dartois, Laureen; His, Mathilde; Boutron-Ruault, Marie-Christine] Univ Paris Saclay, Hlth Generat Team, Univ Paris Sud, CESP,UVSQ,INSERM, Villejuif, France; [Turzanski-Fortner, Renee; Kaaks, Rudolf] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Overvad, Kim] Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark; [Overvad, Kim] Aalborg Univ Hosp, Dept Cardiol, Aalborg Hosp, Sci & Innovat Ctr, Aalborg, Denmark; [Redondo, Maria-Luisa] Publ Hlth Directorate, Asturias, Spain; [Travier, Noemie] Catalan Inst Oncol, Unit Nutr & Canc, Canc Epidemiol Res Program, Lhospitalet De Llobregat, Spain; [Molina-Portillo, Elena] Univ Granada, Hosp Univ Granada, Escuela Andaluza Salud Publ, Inst Invest Biosanitaria Ibs Granada, Granada, Spain; [Molina-Portillo, Elena; Ardanaz, Eva] CIBER Epidemiol & Salud Publ, Madrid, Spain; [Dorronsoro, Miren] Basque Reg Hlth Dept, Publ Hlth Direct, San Sebastian, Spain; [Dorronsoro, Miren] Basque Reg Hlth Dept, Biodonostia Ciberesp, San Sebastian, Spain; [Cirera, Lluis] Murcias Reg Hlth Council, Unidad Registro & Estadist Mortalidad, Unit Mortal Coding & Stat, Serv Epidemiol,Consejer Sanidad,Dept Epidemiol, Murcia, Spain; [Ardanaz, Eva] Navara Publ Hlth Inst, Pamplona, Spain; [Ardanaz, Eva] Navara Inst Hlth Res, IdiSNA, Pamplona, Spain; [Perez-Cornago, Aurora] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England; [Trichopoulou, Antonia; Lagiou, Pagona; Valanou, Elissavet] Hellen Hlth Fdn, Athens, Greece; [Trichopoulou, Antonia; Lagiou, Pagona] Univ Athens, Unit Nutr Epidemiol & Nutr Publ Hlth, WHO Collaborating Ctr Nutr & Hlth, Dept Hyg Epidemiol & Med Stat,Med Sch, Athens, Greece; [Lagiou, Pagona] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Masala, Giovanna] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Pala, Valeria] Fdn IRCCS Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy; [Peeters, Petra H. M.; van der Schouw, Yvonne T.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Manjer, Jonas] Lund Univ, Dept Surg, Skane Univ Hosp Malmo, Malmo, Sweden; [Tjonneland, Anne; Olsen, Anja] Danish Canc Soc Res Ctr, Copenhagen, Denmark	Imperial College London; National Cancer Center - Japan; World Health Organization; International Agency for Research on Cancer (IARC); UiT The Arctic University of Tromso; University of Oslo; Karolinska Institutet; Folkhalsan Research Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; German Cancer Research Center (DKFZ); Aarhus University; Aalborg University; Aalborg University Hospital; Catalan Institute of Oncology; Escuela Andaluza de Salud Publica; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Oxford; National & Kapodistrian University of Athens; Harvard University; Harvard T.H. Chan School of Public Health; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Fondazione IRCCS Istituto Nazionale Tumori Milan; Utrecht University; Utrecht University Medical Center; Lund University; Lund University; Skane University Hospital; Danish Cancer Society	Cross, AJ (corresponding author), Imperial Coll London, Sch Publ Hlth, London, England.	amanda.cross@imperial.ac.uk	Boutron-Ruault, Marie-Christine/H-3936-2014; Weiderpass, Elisabete/AAP-2747-2021; Pala, Valeria/K-4738-2016; Perez-Cornago, Aurora/C-1097-2016; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Gunter, Marc/AAP-8621-2020; Masala, Giovanna/AAC-5474-2022; MOLINA PORTILLO, ELENA/ABA-3364-2021; Tsugane, Shoichiro/A-2424-2015; van der Schouw, Yvonne T./F-8327-2014; Weiderpass, Elisabete/M-4029-2016; Wark, Petra/C-1752-2016	Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Weiderpass, Elisabete/0000-0003-2237-0128; Pala, Valeria/0000-0001-5438-970X; Perez-Cornago, Aurora/0000-0002-5652-356X; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Masala, Giovanna/0000-0002-5758-9069; MOLINA PORTILLO, ELENA/0000-0002-9955-3080; Tsugane, Shoichiro/0000-0003-4105-2774; van der Schouw, Yvonne T./0000-0002-4605-435X; Weiderpass, Elisabete/0000-0003-2237-0128; Riboli, Elio/0000-0001-6795-6080; His, Mathilde/0000-0003-3850-8291; Travier, Noemie/0000-0001-5228-7769; Valanou, Elissavet Maria/0000-0003-1970-6460; Skeie, Guri/0000-0003-2476-4251; Olsen, Anja/0000-0003-4788-503X; da Silva, Marisa/0000-0003-1215-8625; Wark, Petra/0000-0003-1020-4640; Melander, Olle/0000-0002-2581-484X; Tjonneland, Anne/0000-0003-4385-2097; Overvad, Kim/0000-0001-6429-7921; Rasul, holem/0000-0003-0579-9029	European Commission (DG-SANCO); International Agency for Research on Cancer; Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de ('Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); German Cancer Aid; German Cancer Research Center (DKFZ); Federal Ministry of Education and Research (BMBF); Deutsche Krebshilfe; Deutsches Krebsforschungszentrum; Federal Ministry of Education and Research (Germany); Hellenic Health Foundation (Greece); Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF); Statistics Netherlands (The Netherlands); Nordforsk, Nordic Centre of Excellence programme on Food, Nutrition and Health (Norway); Health Research Fund (FIS) [PH3/00061]; Regional Government of Andalucia [PI13/01162]; Regional Government of Asturias [PI13/01162]; Regional Government of Basque Country [PI13/01162]; Regional Government of Murcia [PI13/01162]; Regional Government of Navarra [PI13/01162]; ISCIII RETIC [RD06/0020]; AGAUR, Generalitat de Catalunya [2014 SGR 726]; Health Research Funds [RD12/0036/0018]; European Regional Development Fund (ERDF) (Spain); Swedish Cancer Society; Swedish Research Council; County Councils of Skke and Vasterbotten (Sweden); Cancer Research UK [14136, C570/A16491, C8221/A19170]; Medical Research Council [1000143, MR/M012190/1];  [ERC-2009-AdG 232997]; MRC [MR/N003284/1] Funding Source: UKRI; Cancer Research UK [16491] Funding Source: researchfish; Medical Research Council [G1000143, G0401527, MR/N003284/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish	European Commission (DG-SANCO)(European CommissionEuropean Commission Joint Research Centre); International Agency for Research on Cancer; Danish Cancer Society (Denmark)(Danish Cancer Society); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de ('Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); German Cancer Aid(Deutsche Krebshilfe); German Cancer Research Center (DKFZ)(Helmholtz Association); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsches Krebsforschungszentrum; Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF)); Hellenic Health Foundation (Greece); Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy and National Research Council (Italy)(Fondazione AIRC per la ricerca sul cancro); Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland)(Netherlands Organization for Scientific Research (NWO)); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); Statistics Netherlands (The Netherlands)(Netherlands Government); Nordforsk, Nordic Centre of Excellence programme on Food, Nutrition and Health (Norway); Health Research Fund (FIS)(Instituto de Salud Carlos III); Regional Government of Andalucia(Junta de Andalucia); Regional Government of Asturias(Principality of Asturias); Regional Government of Basque Country(Basque Government); Regional Government of Murcia; Regional Government of Navarra; ISCIII RETIC(Instituto de Salud Carlos III); AGAUR, Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Health Research Funds; European Regional Development Fund (ERDF) (Spain)(European Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); County Councils of Skke and Vasterbotten (Sweden); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The coordination of EPIC is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de ('Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); German Cancer Aid, German Cancer Research Center (DKFZ), Federal Ministry of Education and Research (BMBF), Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); the Hellenic Health Foundation (Greece); Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); ERC-2009-AdG 232997 and Nordforsk, Nordic Centre of Excellence programme on Food, Nutrition and Health (Norway); Health Research Fund (FIS), PH3/00061 to Granada, PI13/01162 to EPIC-Murcia, Regional Governments of Andalucia, Asturias, Basque Country, Murcia and Navarra, ISCIII RETIC (RD06/0020), AGAUR, Generalitat de Catalunya (exp. 2014 SGR 726), Health Research Funds RD12/0036/0018, European Regional Development Fund (ERDF) "A way to build Europe" (Spain); Swedish Cancer Society, Swedish Research Council and County Councils of Skke and Vasterbotten (Sweden); Cancer Research UK (14136 to EPIC-Norfolk; C570/A16491 and C8221/A19170 to EPIC-Oxford), Medical Research Council (1000143 to EPIC -Norfolk, MR/M012190/1 to EPIC-Oxford) (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBANES D, 1988, CANCER RES, V48, P1658; ALBANES D, 1988, JNCI-J NATL CANCER I, V80, P772, DOI 10.1093/jnci/80.10.772; Batty GD, 2006, EUR J EPIDEMIOL, V21, P795, DOI 10.1007/s10654-006-9057-2; Batty GD, 2009, ECON HUM BIOL, V7, P137, DOI 10.1016/j.ehb.2009.06.004; Cao Y, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju085; Cheng G, 2012, NUTR REV, V70, P133, DOI 10.1111/j.1753-4887.2011.00461.x; Cogliano VJ, 2011, JNCI-J NATL CANCER I, V103, P1827, DOI 10.1093/jnci/djr483; Cox AM, 2006, LANCET NEUROL, V5, P181, DOI 10.1016/S1474-4422(06)70351-9; Crowe FL, 2011, ANN HUM BIOL, V38, P194, DOI 10.3109/03014460.2010.507221; Ferrari P, 2002, PUBLIC HEALTH NUTR, V5, P1329, DOI 10.1079/PHN2002409; Gallo V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039013; Givvin K. B., 2008, PRINCIPAL LEADERSHIP, V8, P22, DOI DOI 10.1186/1471-2466-8-22; Goodman-Gruen D, 2000, J AM GERIATR SOC, V48, P860, DOI 10.1111/j.1532-5415.2000.tb04774.x; Gunnell D, 2002, INT J EPIDEMIOL, V31, P390, DOI 10.1093/ije/31.2.390; Gunnell DJ, 1998, J EPIDEMIOL COMMUN H, V52, P142, DOI 10.1136/jech.52.3.142; Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1147, DOI 10.1079/PHN2002396; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Heinzl H, 1997, COMPUT METH PROG BIO, V54, P201, DOI 10.1016/S0169-2607(97)00043-6; Honjo K, 2011, EUR J EPIDEMIOL, V26, P13, DOI 10.1007/s10654-010-9515-8; Iso H, 2012, ATHEROSCLEROSIS, V224, P154, DOI 10.1016/j.atherosclerosis.2012.05.026; Janssen JAMJL, 1998, ARTERIOSCL THROM VAS, V18, P277, DOI 10.1161/01.ATV.18.2.277; Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kasuga M, 2013, CANCER SCI, V104, P965, DOI 10.1111/cas.12203; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Nelson CP, 2015, NEW ENGL J MED, V372, P1608, DOI 10.1056/NEJMoa1404881; Novosyadlyy R, 2010, CANCER RES, V70, P741, DOI 10.1158/0008-5472.CAN-09-2141; Orfei L, 2008, ARCH DIS CHILD, V93, P570, DOI 10.1136/adc.2006.112201; Research WCRFAIfC, FOOD NUTR PHYS ACT; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Rinaldi S, 2010, INT J CANCER, V126, P1702, DOI 10.1002/ijc.24927; Roddam AW, 2008, ANN INTERN MED, V149, P461, DOI 10.7326/0003-4819-149-7-200810070-00006; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P111, DOI 10.1007/s10654-013-9867-y; Shimizu Y, 2014, J STROKE CEREBROVASC, V23, P667, DOI 10.1016/j.jstrokecerebrovasdis.2013.06.009; Smith GD, 2001, J EPIDEMIOL COMMUN H, V55, P867, DOI 10.1136/jech.55.12.867; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Song YM, 2008, AM J EPIDEMIOL, V168, P497, DOI 10.1093/aje/kwn187; Tilling K, 2006, AM J EPIDEMIOL, V164, P136, DOI 10.1093/aje/kwj184; van der Pols JC, 2009, HEART, V95, P1600, DOI 10.1136/hrt.2009.168716; van der Pols JC, 2007, AM J CLIN NUTR, V86, P1722; Vasan RS, 2003, ANN INTERN MED, V139, P642, DOI 10.7326/0003-4819-139-8-200310210-00007; WALKER M, 1989, INT J EPIDEMIOL, V18, P602, DOI 10.1093/ije/18.3.602; Wang N, 2011, INT J EPIDEMIOL, V40, P1715, DOI 10.1093/ije/dyr173; Whitley E, 2012, J EPIDEMIOL COMMUN H, V66, P18, DOI 10.1136/jech.2009.104216; Wormser D, 2012, INT J EPIDEMIOL, V41, P1419, DOI 10.1093/ije/dys086	46	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173117	10.1371/journal.pone.0173117	http://dx.doi.org/10.1371/journal.pone.0173117			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257491	gold, Green Published			2022-12-27	WOS:000396021100059
J	Clink, DJ; Dillis, C; Feilen, KL; Beaudrot, L; Marshall, AJ				Clink, Dena J.; Dillis, Christopher; Feilen, Katie L.; Beaudrot, Lydia; Marshall, Andrew J.			Dietary diversity, feeding selectivity, and responses to fruit scarcity of two sympatric Bornean primates (Hylobates albibarbis and Presbytis rubicunda rubida)	PLOS ONE			English	Article							PALUNG-NATIONAL-PARK; FALLBACK FOODS; REPRODUCTIVE-BEHAVIOR; TAXONOMIC SUFFICIENCY; SEASONAL-VARIATION; LEAF MONKEYS; RAIN-FORESTS; GIBBONS; CHIMPANZEES; AVAILABILITY	Effectively characterizing primate diets is fundamental to understanding primate behavior, ecology and morphology. Examining temporal variation in a species' diet, as well as comparing the responses of different species to variation in resource availability, can enhance understanding of the evolution of morphology and socioecology. In this study, we use feeding data collected over five years to describe the diets of two sympatric Southeast Asian primate species of similar body size: white-bearded gibbons (Hylobates albibarbis) and red leaf monkeys (Presbytis rubicunda rubida), in Gunung Palung National Park, West Kalimantan, Indonesia. Long-term data sets are especially important for characterizing primate diets in Southeast Asia, where the forests exhibit supra-annual mast fruiting events. We found that gibbons were mainly frugivorous, with fruit and figs comprising 70% of their 145 independent feeding observations, whereas leaf monkeys ate a substantial amount of seeds (26%), fruits and figs (26.5%) and leaves (30%, n = 219 independent feeding observations). Leaf monkeys consumed a higher number of plant genera, and this was due mostly to the non-frugivorous portion of their diet. To investigate resource selection by these primates we utilized two different approaches: the Manly Selectivity Ratio, which did not take into account temporal variation of resource availability, and a model selection framework which did incorporate temporal variation. Both species selected figs (Ficus) more than predicted based on their availability under the Manly Selectivity Ratio. Model selection allowed us to determine how these primates alter the proportion of leaves, flowers, seeds, figs and fruit in their diets in response to variation in fruit availability. When fruits were scarce, both gibbons and leaf monkeys incorporated more leaves and figs into their diets, indicating that these two food classes are fallback foods for these primates. We discuss how different measures of resource selection can provide seemingly contradictory results, and emphasize the importance of long term studies that combine independent feeding observations with rigorous assessment of temporal variation in resource availability when modelling feeding selectivity.	[Clink, Dena J.] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Dillis, Christopher] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA; [Feilen, Katie L.] Disneys Anim Sci & Environm, Conservat Dept, Lake Buena Vista, FL USA; [Beaudrot, Lydia] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Beaudrot, Lydia] Univ Michigan, Michigan Soc Fellows, Ann Arbor, MI 48109 USA; [Marshall, Andrew J.] Univ Michigan, Dept Anthropol, Program Environm, Ann Arbor, MI 48109 USA; [Marshall, Andrew J.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Clink, DJ (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.	djclink@ucdavis.edu	Beaudrot, L./M-6936-2017	Beaudrot, L./0000-0001-8135-7519	UC Davis Hellman Fellowship; UC Davis Small Grant in Aid of Research, Effects of spatial and temporal variation in plant productivity on the population ecology of Bornean rainforest primates; Seneca Park Zoo; Mohamed bin Zayed Species Conservation Fund, Promoting gibbon conservation in Gunung Palung National Park, West Kalimantan through training and participatory monitoring activities with Indonesian university students and citizen scientists; Victoria University, Wellington, New Zealand; Orangutan Conservancy Grant; Leakey Foundation Research Grant; UC Davis New Research Initiatives, From individuals to landscapes: testing fundamental hypotheses about the reproduction of Bornean rainforest plants across a complex tropical landscape; Leakey Foundation Research Grant, Causes and consequences of habitat quality variation for Bornean primates; UC Davis Principal Investigator Bridge Program, Continued research on the population ecology of Bornean rainforest primates; Orangutan Conservancy, Infrastructure completion of the Cabang Panti Research Station and reestablishment of research at Gunung Palung; Disney's Animals, Science and Environment	UC Davis Hellman Fellowship; UC Davis Small Grant in Aid of Research, Effects of spatial and temporal variation in plant productivity on the population ecology of Bornean rainforest primates; Seneca Park Zoo; Mohamed bin Zayed Species Conservation Fund, Promoting gibbon conservation in Gunung Palung National Park, West Kalimantan through training and participatory monitoring activities with Indonesian university students and citizen scientists; Victoria University, Wellington, New Zealand; Orangutan Conservancy Grant; Leakey Foundation Research Grant; UC Davis New Research Initiatives, From individuals to landscapes: testing fundamental hypotheses about the reproduction of Bornean rainforest plants across a complex tropical landscape; Leakey Foundation Research Grant, Causes and consequences of habitat quality variation for Bornean primates; UC Davis Principal Investigator Bridge Program, Continued research on the population ecology of Bornean rainforest primates; Orangutan Conservancy, Infrastructure completion of the Cabang Panti Research Station and reestablishment of research at Gunung Palung; Disney's Animals, Science and Environment	This work was supported by: UC Davis Hellman Fellowship, 2009-2010, $25,500; UC Davis Small Grant in Aid of Research, Effects of spatial and temporal variation in plant productivity on the population ecology of Bornean rainforest primates, 2013, $2,000; UC Davis Small Grant in Aid of Research, Effects of spatial and temporal variation in plant productivity on the population ecology of Bornean rainforest primates, 2012, $2,000; Seneca Park Zoo, Grant for orangutan gibbon field research and habitat conservation, 2012, $750; Mohamed bin Zayed Species Conservation Fund, Promoting gibbon conservation in Gunung Palung National Park, West Kalimantan through training and participatory monitoring activities with Indonesian university students and citizen scientists, 2012, $10,000 (URL: http://www.speciesconservation.org/); Victoria University, Wellington, New Zealand, The importance of mast seeding for vertebrate community structure and dynamics, 2012, with Heiko U. Wittmer, $40,000 NZD; Victoria University, Wellington, New Zealand, The importance of mast seeding for community dynamics, 2011, with Heiko U. Wittmer, $4,000 NZD; UC Davis Small Grant in Aid of Research, Effects of spatial and temporal variation in plant productivity on the population ecology of Bornean rainforest primates, 2011, $2,000; Orangutan Conservancy Grant, Emergency funding for Gunung Palung, 2011, $9,000; Leakey Foundation Research Grant, Emergency funding for Gunung Palung, 2011, $6,000 (URL: http://leakeyfoundation.rg/grants/research-grants/); UC Davis Small Grant in Aid of Research, Effects of spatial and temporal variation in plant productivity on the population ecology of Bornean rainforest primates, 2010, $1,800; UC Davis New Research Initiatives, From individuals to landscapes: testing fundamental hypotheses about the reproduction of Bornean rainforest plants across a complex tropical landscape, 2009, $12,000; Leakey Foundation Research Grant, Causes and consequences of habitat quality variation for Bornean primates, 2009, $15,000 (URL: https://leakeyfoundation.org/ grants/research-grants/); UC Davis Principal Investigator Bridge Program, Continued research on the population ecology of Bornean rainforest primates, 2008, $12,000; UC Davis Small Grant in Aid of Research, Continued research on the population ecology of Bornean rainforest primates, 2008, $2,000; Orangutan Conservancy, Infrastructure completion of the Cabang Panti Research Station and reestablishment of research at Gunung Palung (with C. Knott), 2007, $10,000; UC Davis Small Grant in Aid of Research, Effects of spatial and temporal variation in plant productivity on the population ecology of Bornean rainforest primates, 2007, $2,000. Disney's Animals, Science and Environment provided support in the form of salaries for author KLF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bacci T, 2009, MAR ECOL-EVOL PERSP, V30, P13, DOI 10.1111/j.1439-0485.2009.00324.x; Beaudrot L, 2013, ECOGRAPHY, V36, P984, DOI 10.1111/j.1600-0587.2013.00122.x; Calenge C., 2006, ECOLOGICAL MODELLING; Cannon CH, 2007, CURR SCI INDIA, V93, P1558; Cannon CH, 2007, ECOL LETT, V10, P956, DOI 10.1111/j.1461-0248.2007.01089.x; CANT J G H, 1980, Primates, V21, P538, DOI 10.1007/BF02373842; Chainho P, 2007, HYDROBIOLOGIA, V587, P63, DOI 10.1007/s10750-007-0694-6; CHAPMAN C, 1987, FOLIA PRIMATOL, V49, P90, DOI 10.1159/000156311; CHAPMAN CA, 1991, FOLIA PRIMATOL, V56, P162, DOI 10.1159/000156542; CHIVERS DJ, 1980, J MORPHOL, V166, P337, DOI 10.1002/jmor.1051660306; Chivers DJ, 1994, FUNCTIONAL ANATOMY G; CLUTTONBROCK TH, 1977, J ZOOL, V183, P1, DOI 10.1111/j.1469-7998.1977.tb04171.x; Conklin-Brittain NL, 1998, INT J PRIMATOL, V19, P971, DOI 10.1023/A:1020370119096; Curran LM, 2000, ECOL MONOGR, V70, P101, DOI 10.1890/0012-9615(2000)070[0101:VRTSVI]2.0.CO;2; Davies A. Glyn, 1994, P285; DAVIES AG, 1988, BIOL J LINN SOC, V34, P33, DOI 10.1111/j.1095-8312.1988.tb01947.x; De Vleeschouwer KM, 2013, MULTILEVEL TRANSDISC; Dillis C, 2015, BIOTROPICA, V47, P85, DOI 10.1111/btp.12176; Fossey D, 1977, P415; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; Garcia LC, 2014, BIOTROPICA, V46, P114, DOI 10.1111/btp.12080; Hanya G, 2012, INT J PRIMATOL, V33, P322, DOI 10.1007/s10764-012-9580-9; Harris TR, 2010, BEHAV ECOL, V21, P46, DOI 10.1093/beheco/arp150; Harrison ME, 2011, INT J PRIMATOL, V32, P531, DOI 10.1007/s10764-010-9487-2; HARRISON MJS, 1983, ANIM BEHAV, V31, P969, DOI 10.1016/S0003-3472(83)80001-3; Hawes JE, 2014, OIKOS, V123, P365, DOI 10.1111/j.1600-0706.2013.00745.x; Hawes JE, 2013, INT J PRIMATOL, V34, P1081, DOI 10.1007/s10764-013-9738-0; Hemingway CA, 2005, CAM S BIO EVOL ANTHR, V44, P57, DOI 10.1017/CBO9780511542343.004; Isbell LA, 2002, BEHAVIOUR, V139, P177, DOI 10.1163/156853902760102645; Kay Robin N. B., 1994, P229; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Kim S, 2012, AM J PRIMATOL, V74, P1154, DOI 10.1002/ajp.22074; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Koch F, 2016, AM J PRIMATOL; LAMBERT FR, 1991, J ECOL, V79, P793, DOI 10.2307/2260668; Lambert J.E., 2007, PRIMATES PERSPECTIVE, P482, DOI DOI 10.1146/ANNUREV-ANTHRO-102313-025928; Lambert JE, 2004, AM J PHYS ANTHROPOL, V125, P363, DOI 10.1002/ajpa.10403; Lambert JE, 2015, ANNU REV ANTHROPOL, V44, P493, DOI 10.1146/annurev-anthro-102313-025928; LEIGHTON M, 1993, INT J PRIMATOL, V14, P257, DOI 10.1007/BF02192635; LEIGHTON M, 1983, P181; Liu XC, 2016, PRIMATES, V57, P479, DOI 10.1007/s10329-016-0535-1; Lucas Peter W., 1994, P173; Manly BF, 2002, RESOURCE SELECTION A, P1, DOI [10.1007/0-306-48151-0_1, DOI 10.1007/0-306-48151-0_1]; Marshall AJ, 2014, INT J PRIMATOL, V35, P1; Marshall AJ, 2004, THESIS; Marshall Andrew J., 2006, P313; Marshall AJ, 2007, INT J PRIMATOL, V28, P1218, DOI 10.1007/s10764-007-9218-5; Marshall AJ, 2013, TECH ECOL CONSERVAT, P103; Marshall AJ, 2010, DEV PRIMATOL-PROG PR, P157, DOI 10.1007/978-1-4419-1560-3_9; Marshall Andrew J., 2009, P97; Marshall AJ, 2009, AM J PHYS ANTHROPOL, V140, P603, DOI 10.1002/ajpa.21082; Marshall Andrew J., 2009, P161, DOI 10.1007/978-0-387-88604-6_9; McConkey Kim R., 2009, P189, DOI 10.1007/978-0-387-88604-6_10; McConkey KR, 2003, INT J PRIMATOL, V24, P19, DOI 10.1023/A:1021490327385; McConkey KR, 2002, INT J PRIMATOL, V23, P123, DOI 10.1023/A:1013253909046; McElreath R., 2012, RETHINKING STAT RETH; MCKEY D, 1978, SCIENCE, V202, P61; MOLE S, 1985, J CHEM ECOL, V11, P1323, DOI 10.1007/BF01024119; Oksanen J., 2007, COMMUN ECOL PACK, P631; Porter LM, 2001, INT J PRIMATOL, V22, P961, DOI 10.1023/A:1012013621258; R Core Team, 2021, R LANGUAGE ENV STAT; RAEMAEKERS J, 1978, FOLIA PRIMATOL, V30, P194, DOI 10.1159/000155863; ROSENBERGER AL, 1992, AM J PHYS ANTHROPOL, V88, P525, DOI 10.1002/ajpa.1330880408; Rothman JM, 2008, OECOLOGIA, V155, P111, DOI 10.1007/s00442-007-0901-1; Sakai S, 2002, BIOL J LINN SOC, V75, P233, DOI 10.1111/j.1095-8312.2002.tb01424.x; Sato H, 2016, INT J PRIMATOL, V37, P109, DOI 10.1007/s10764-015-9877-6; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Smith DAE, 2013, AM J PRIMATOL, V75, P848, DOI 10.1002/ajp.22148; Snaith TV, 2007, EVOL ANTHROPOL, V16, P94, DOI 10.1002/evan.20132; SUPRIATNA J, 1986, PRIMATES, V27, P185, DOI 10.1007/BF02382597; Terborgh J., 1983, 5 NEW WORLD PRIMATES; Timms LL, 2013, INSECT CONSERV DIVER, V6, P453, DOI 10.1111/icad.12004; TUTIN CEG, 1993, AM J PRIMATOL, V30, P195, DOI 10.1002/ajp.1350300305; UNGAR PS, 1995, INT J PRIMATOL, V16, P221, DOI 10.1007/BF02735479; VANSCHAIK CP, 1988, BEHAVIOUR, V105, P77, DOI 10.1163/156853988X00458; Vogel ER, 2009, AM J PHYS ANTHROPOL, V140, P716, DOI 10.1002/ajpa.21119; WATERMAN PG, 1992, CIBA F SYMP, V171, P255; Watts DP, 2012, AM J PRIMATOL, V74, P130, DOI 10.1002/ajp.21015; Wich SA, 2000, J TROP ECOL, V16, P563, DOI 10.1017/S0266467400001577; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447	81	12	13	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173369	10.1371/journal.pone.0173369	http://dx.doi.org/10.1371/journal.pone.0173369			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278215	gold, Green Published, Green Submitted			2022-12-27	WOS:000396087900078
J	Liu, TF; Luo, CL; Wang, J; Ma, J; Shu, DM; Lund, MS; Su, GS; Qu, H				Liu, Tianfei; Luo, Chenglong; Wang, Jie; Ma, Jie; Shu, Dingming; Lund, Mogens Sando; Su, Guosheng; Qu, Hao			Assessment of the genomic prediction accuracy for feed efficiency traits in meat-type chickens	PLOS ONE			English	Article							ESTIMATED BREEDING VALUES; GENETIC-PARAMETERS; CONVERSION RATIO; SELECTION; GROWTH; ASSOCIATION; RELIABILITY; PEDIGREE	Feed represents the major cost of chicken production. Selection for improving feed utilization is a feasible way to reduce feed cost and greenhouse gas emissions. The objectives of this study were to investigate the efficiency of genomic prediction for feed conversion ratio (FCR), residual feed intake (RFI), average daily gain (ADG) and average daily feed intake (ADFI) and to assess the impact of selection for feed efficiency traits FCR and RFI on eviscerating percentage (EP), breast muscle percentage (BMP) and leg muscle percentage (LMP) in meat-type chickens. Genomic prediction was assessed using a 4-fold cross-validation for two validation scenarios. The first scenario was a random family sampling validation (CVF), and the second scenario was a random individual sampling validation (CVR). Variance components were estimated based on the genomic relationship built with single nucleotide polymorphism markers. Genomic estimated breeding values (GEBV) were predicted using a genomic best linear unbiased prediction model. The accuracies of GEBV were evaluated in two ways: the correlation between GEBV and corrected phenotypic value divided by the square root of heritability, i.e., the correlation-based accuracy, and model-based theoretical accuracy. Breeding values were also predicted using a conventional pedigree-based best linear unbiased prediction model in order to compare accuracies of genomic and conventional predictions. The heritability estimates of FCR and RFI were 0.29 and 0.50, respectively. The heritability estimates of ADG, ADFI, EP, BMP and LMP ranged from 0.34 to 0.53. In the CVF scenario, the correlation-based accuracy and the theoretical accuracy of genomic prediction for FCR were slightly higher than those for RFI. The correlation-based accuracies for FCR, RFI, ADG and ADFI were 0.360, 0.284, 0.574 and 0.520, respectively, and the model-based theoretical accuracies were 0.420, 0.414, 0.401 and 0.382, respectively. In the CVR scenario, the correlation-based accuracy and the theoretical accuracy of genomic prediction for FCR was lower than RFI, which was different from the CVF scenario. The correlation-based accuracies for FCR, RFI, ADG and ADFI were 0.449, 0.593, 0.581 and 0.627, respectively, and the model-based theoretical accuracies were 0.577, 0.629, 0.631 and 0.638, respectively. The accuracies of genomic predictions were 0.371 and 0.322 higher than the conventional pedigree-based predictions for the CVF and CVR scenarios, respectively. The genetic correlations of FCR with EP, BMP and LMP were -0.427, -0.156 and -0.338, respectively. The correlations between RFI and the three carcass traits were -0.320, -0.404 and -0.353, respectively. These results indicate that RFI and FCR have a moderate accuracy of genomic prediction. Improving RFI and FCR could be favourable for EP, BMP and LMP. Compared with FCR, which can be improved by selection for ADG in typical meat-type chicken breeding programs, selection for RFI could lead to extra improvement in feed efficiency.	[Liu, Tianfei; Luo, Chenglong; Wang, Jie; Ma, Jie; Shu, Dingming; Qu, Hao] Guangdong Acad Agr Sci, Inst Anim Sci, Guangzhou, Guangdong, Peoples R China; [Liu, Tianfei; Luo, Chenglong; Wang, Jie; Shu, Dingming; Qu, Hao] State Key Lab Livestock & Poultry Breeding, Guangzhou, Guangdong, Peoples R China; [Ma, Jie] Guangdong Key Lab Anim Breeding & Nutr, Guangzhou, Guangdong, Peoples R China; [Lund, Mogens Sando; Su, Guosheng] Aarhus Univ, Dept Mol Biol & Genet, Ctr Quantitat Genet & Genom, Aarhus, Denmark	Guangdong Academy of Agricultural Sciences; Aarhus University	Qu, H (corresponding author), Guangdong Acad Agr Sci, Inst Anim Sci, Guangzhou, Guangdong, Peoples R China.	qhw03@163.com	Liu, Tianfei/X-9848-2019; Lund, Mogens S/I-4321-2016	Liu, Tianfei/0000-0003-1835-9807; 	Earmarked Fund for Modern Agro-Industry Technology Research System [nycytx-42]; Science and Technology Program of Guangzhou [201504010017]; Dean Fund of Guangdong Academy of Agricultural Science [201618]	Earmarked Fund for Modern Agro-Industry Technology Research System; Science and Technology Program of Guangzhou; Dean Fund of Guangdong Academy of Agricultural Science	This work was supported by the Earmarked Fund for Modern Agro-Industry Technology Research System (nycytx-42, http://www.moa.gov.cn/), the Science and Technology Program of Guangzhou (201504010017, http://www.gzsi.gov.cn/) and the Dean Fund of Guangdong Academy of Agricultural Science (201618,http://www.gdaas.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggrey SE, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-25; Berenos C, 2014, MOL ECOL, V23, P3434, DOI 10.1111/mec.12827; Cai W, 2008, J ANIM SCI, V86, P287, DOI 10.2527/jas.2007-0396; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de los Campos G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003608; Ding X, 2013, J DAIRY SCI, V96, P5315, DOI 10.3168/jds.2012-6194; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; GUNSETT FC, 1984, J ANIM SCI, V59, P1185, DOI 10.2527/jas1984.5951185x; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Hoque MA, 2009, J ANIM SCI, V87, P3069, DOI 10.2527/jas.2008-1268; Legarra A, 2008, GENETICS, V180, P611, DOI 10.1534/genetics.108.088575; Liu TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112685; Liu TF, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0110-y; LUITING P, 1990, WORLD POULTRY SCI J, V46, P133, DOI 10.1079/WPS19900017; Luo C, 2015, ANIM GENET, V46, P265, DOI 10.1111/age.12284; Madsen P, 2010, 9 WORLD C GEN APPL L; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen T, 2013, ANNU REV ANIM BIOSCI, V1, P221, DOI 10.1146/annurev-animal-031412-103705; N'Dri AL, 2006, BRIT POULTRY SCI, V47, P273, DOI 10.1080/00071660600753664; Santana MHA, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-21; Sheng ZY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-151; Su G, 2010, J DAIRY SCI, V93, P1175, DOI 10.3168/jds.2009-2192; Su GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045293; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Varkoohi S, 2010, POULTRY SCI, V89, P1590, DOI 10.3382/ps.2010-00744; Wang JL, 2016, THEOR POPUL BIOL, V107, P4, DOI 10.1016/j.tpb.2015.08.006; Willems OW, 2013, WORLD POULTRY SCI J, V69, P77, DOI 10.1017/S004393391300007X; Williams YJ, 2011, J DAIRY SCI, V94, P4715, DOI 10.3168/jds.2010-4015; Wolc A, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0133-5; Wolc A, 2013, POULTRY SCI, V92, P2270, DOI 10.3382/ps.2013-03085; Wolc A, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-23; Yeaman JC, 2013, J ANIM SCI, V91, P4628, DOI 10.2527/jas.2012-6226; Yuan JW, 2015, POULTRY SCI, V94, P1470, DOI 10.3382/ps/pev122	37	10	14	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173620	10.1371/journal.pone.0173620	http://dx.doi.org/10.1371/journal.pone.0173620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278209	Green Published, gold			2022-12-27	WOS:000396087900017
J	Ravenscroft, J; Liakata, M; Clare, A; Duma, D				Ravenscroft, James; Liakata, Maria; Clare, Amanda; Duma, Daniel			Measuring scientific impact beyond academia: An assessment of existing impact metrics and proposed improvements	PLOS ONE			English	Article							LEIDEN MANIFESTO; CITATION; ALTMETRICS	How does scientific research affect the world around us? Being able to answer this question is of great importance in order to appropriately channel efforts and resources in science. The impact by scientists in academia is currently measured by citation based metrics such as h-index, i-index and citation counts. These academic metrics aim to represent the dissemination of knowledge among scientists rather than the impact of the research on the wider world. In this work we are interested in measuring scientific impact beyond academia, on the economy, society, health and legislation (comprehensive impact). Indeed scientists are asked to demonstrate evidence of such comprehensive impact by authoring case studies in the context of the Research Excellence Framework (REF). We first investigate the extent to which existing citation based metrics can be indicative of comprehensive impact. We have collected all recent REF impact case studies from 2014 and we have linked these to papers in citation networks that we constructed and derived from CiteSeerX, arXiv and PubMed Central using a number of text processing and information retrieval techniques. We have demonstrated that existing citation-based metrics for impact measurement do not correlate well with REF impact results. We also consider metrics of online attention surrounding scientific works, such as those provided by the Altmetric API. We argue that in order to be able to evaluate wider non-academic impact we need to mine information from a much wider set of resources, including social media posts, press releases, news articles and political debates stemming from academic work. We also provide our data as a free and reusable collection for further analysis, including the PubMed citation network and the correspondence between REF case studies, grant applications and the academic literature.	[Ravenscroft, James; Liakata, Maria] Univ Warwick, Ctr Comp Sci, Coventry, W Midlands, England; [Clare, Amanda] Aberystwyth Univ, Dept Comp Sci, Aberystwyth, Dyfed, Wales; [Duma, Daniel] Univ Edinburgh, Sch Informat, Edinburgh, Midlothian, Scotland	University of Warwick; Aberystwyth University; University of Edinburgh	Ravenscroft, J (corresponding author), Univ Warwick, Ctr Comp Sci, Coventry, W Midlands, England.	j.ravenscroft@warwick.ac.uk		Ravenscroft, James/0000-0003-0293-9452; Clare, Amanda/0000-0001-8315-3659; Liakata, Maria/0000-0001-5765-0416	Engineering and Physical Sciences Research Council [1535875, 1643924] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Adie E, 2013, LEARN PUBL, V26, P11, DOI 10.1087/20130103; Bartneck C, 2011, SCIENTOMETRICS, V87, P85, DOI 10.1007/s11192-010-0306-5; Bornmann L, 2008, J DOC, V64, P45, DOI 10.1108/00220410810844150; Bornmann L, 2016, ONLINE INFORM REV, V40, P529, DOI 10.1108/OIR-09-2015-0314; Bornmann L, 2014, J INFORMETR, V8, P895, DOI 10.1016/j.joi.2014.09.005; Costas R, 2015, J ASSOC INF SCI TECH, V66, P2003, DOI 10.1002/asi.23309; Cronin B., 1984, ROLE SIGNIFICANCE CI; Edwards MA, 2016, ENVIRON ENG SCI; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Haak LL, 2012, LEARN PUBL, V25, P259, DOI 10.1087/20120404; Haunschild R, 2017, SCIENTOMETRICS, P1; Haustein S, 2016, J ASSOC INF SCI TECH, V67, P232, DOI 10.1002/asi.23456; Hicks Diana, 2015, Nature, V520, P429, DOI 10.1038/520429a; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Huang WY, 2014, ACM-IEEE J CONF DIG, P371, DOI 10.1109/JCDL.2014.6970192; Lane J, 2010, SCI SCI MEAS WORKSH; Largent MA, 2012, REV POLICY RES, V29, P431, DOI 10.1111/j.1541-1338.2012.00567.x; League of European Research Universities, 2015, NOT EV CAN BE COUNT; MCALLISTER PR, 1983, IEEE T ENG MANAGE, V30, P205, DOI 10.1109/TEM.1983.6448622; McKeown K, 2016, J ASSOC INF SCI TECH, V67, P2684, DOI 10.1002/asi.23612; Meho LI, 2007, PHYS WORLD, V20, P32; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Piwowar H, 2013, NATURE, V493, P159, DOI 10.1038/493159a; Priem, 2010, ALTMETRICS MANIFESTO; REF, 2011, ASS FRAM GUID SUBM; Rossner M, 2007, J CELL BIOL, V179, P1091, DOI 10.1083/jcb.200711140; Thelwall M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064841; Valenzuela Marco, 2015, AAAI WORKSH SCHOL BI; Vucovich LA, 2008, J MED LIBR ASSOC, V96, P63, DOI 10.3163/1536-5050.96.1.63; Waltman L., 2015, REV LIT CITATION IMP	30	90	95	8	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173152	10.1371/journal.pone.0173152	http://dx.doi.org/10.1371/journal.pone.0173152			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278243	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900050
J	Tam, LE; Kim, N; De Souza, GM				Tam, Laura E.; Kim, Namhee; De Souza, Grace M.			Effect of tooth whitening strips on fatigue resistance and flexural strength of bovine dentin in vitro	PLOS ONE			English	Article							CARBAMIDE PEROXIDE; FRACTURE-TOUGHNESS; BLEACHING AGENTS; COMPOSITE RESIN; PREVALENCE; ENAMEL; EFFICACY; MICROHARDNESS; 10-PERCENT; EXPOSURE	Objective To determine the effects of whitening strips on bovine dentin fatigue resistance and flexural strength in vitro. Materials and methods A total of eighty bovine dentin specimens (2x2x17mm) were treated with either: control glycerine gel on plastic film wrap or whitening strips containing 9.5% hydrogen peroxide. Treatment was applied for 30 minutes, twice a day, for 1- or 4-weeks. After the last treatment, ten specimens per group were randomly selected to undergo fatigue testing (10 6 cycles, 3Hz, 20N) while the other ten were subjected to flexural strength testing after ten days of storage in artificial saliva. Kaplan-Meier method with a log rank test, Wilcoxon test and Cox regression were used to assess fatigue test results (p<0.05). One-way ANOVA and Tukey's tests were used to compare the flexural strength results (p<0.05). Results There were significant differences in survival during the fatigue test among the groups (p<0.001). Treatment (control or bleach) was a significant factor for specimen survival (p<0.001, Exp(B) = 33.45). There were significant differences in mean flexural strength (p<0.001). No significant difference was found between "1-wk control" and "4-wk control". The mean flexural strength and fatigue resistance of the "4-wk bleach" were significantly lower than all the other groups. Conclusions The use of whitening strips reduced the fatigue resistance and flexural strength of bovine dentin in vitro. Until the effect of whitening strips on mechanical properties of human dentin is fully elucidated, it remains prudent to advise patients to avoid excessive direct use of whitening strips on dentin.	[Tam, Laura E.; Kim, Namhee; De Souza, Grace M.] Univ Toronto, Dept Clin Sci, Restorat Dent, Fac Dent, Toronto, ON, Canada	University of Toronto	Tam, LE (corresponding author), Univ Toronto, Dept Clin Sci, Restorat Dent, Fac Dent, Toronto, ON, Canada.	laura.tam@dentistry.utoronto.ca	de Souza, Grace M/H-2213-2018	de Souza, Grace M/0000-0002-7521-9723	Canadian Institute of Health Research Health Professional Summer Research Award	Canadian Institute of Health Research Health Professional Summer Research Award(Canadian Institutes of Health Research (CIHR))	The study was supported by a Canadian Institute of Health Research Health Professional Summer Research Award, 2014/2015 (NK). The whitening strips were provided by Proctor & Gamble Incorporated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablal MA, 2009, J DENT, V37, P835, DOI 10.1016/j.jdent.2009.06.016; ADIBFAR A, 1992, J ENDODONT, V18, P488, DOI 10.1016/S0099-2399(06)81348-8; Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; American Dental Association Council on Scientific Affairs, 2015, RES IMP PRACT DENT; Auschill TM, 2005, OPER DENT, V30, P156; Berger SB, 2012, ACTA ODONTOL SCAND, V70, P56, DOI 10.3109/00016357.2011.575176; BOWLES WH, 1987, J ENDODONT, V13, P375, DOI 10.1016/S0099-2399(87)80196-6; Cavalli V, 2009, INT ENDOD J, V42, P568, DOI 10.1111/j.1365-2591.2009.01543.x; Chng HK, 2004, J ORAL REHABIL, V31, P811, DOI 10.1111/j.1365-2842.2004.01298.x; Cvikl B, 2016, OPER DENT, V41, pE39, DOI 10.2341/15-010-L; Dietschi D, 2006, QUINTESSENCE INT, V37, P515; Eimar H, 2012, J DENT, V40, pE25, DOI 10.1016/j.jdent.2012.08.008; Forner L, 2009, J ENDODONT, V35, P1384, DOI 10.1016/j.joen.2009.06.023; Goldberg M, 2010, CLIN ORAL INVEST, V14, P1, DOI 10.1007/s00784-009-0302-4; Hasson H, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006202; Hosoya N, 2003, J DENT, V31, P543, DOI 10.1016/S0300-5712(03)00109-X; Joiner A, 2004, J DENT, V32, P3, DOI 10.1016/j.jdent.2003.10.013; Joiner A, 2006, J DENT, V34, P412, DOI 10.1016/j.jdent.2006.02.002; KHOCHT A, 1993, J PERIODONTOL, V64, P900, DOI 10.1902/jop.1993.64.9.900; Khoroushi M, 2011, OPER DENT, V36, P372, DOI 10.2341/10-280-L; Kinney JH, 2003, CRIT REV ORAL BIOL M, V14, P13, DOI 10.1177/154411130301400103; Kuga MC, 2012, DENT TRAUMATOL, V28, P238, DOI 10.1111/j.1600-9657.2011.01077.x; Kwon SR, 2013, AM J DENT, V26, P356; Leonard R H Jr, 1998, Compend Contin Educ Dent, V19, P766; Li Y, 2013, BRIT DENT J, V215, P29, DOI 10.1038/sj.bdj.2013.629; LOE H, 1992, J PERIODONTOL, V63, P489; Pegoraro LF, 2005, J AM DENT ASSOC, V136, P1694, DOI 10.14219/jada.archive.2005.0113; Price R B, 2000, J Can Dent Assoc, V66, P421; Rodrigues JA, 2001, AM J DENT, V14, P67; SANO H, 1994, J DENT RES, V73, P1205, DOI 10.1177/00220345940730061201; Sato C, 2013, J DENT RES, V92, P187, DOI 10.1177/0022034512470831; Smith BGN, 1997, J PROSTHET DENT, V78, P367, DOI 10.1016/S0022-3913(97)70043-X; Soares FZM, 2016, DENT MATER, V32, P1385, DOI 10.1016/j.dental.2016.09.019; Tam LE, 2007, J DENT RES, V86, P1193, DOI 10.1177/154405910708601210; Tam LE, 2013, OPER DENT, V38, P142, DOI 10.2341/12-127-C; Tam LE, 2007, J ESTHET RESTOR DENT, V19, P100, DOI 10.1111/j.1708-8240.2007.00075.x; Tam LE, 2015, J ESTHET RESTOR DENT, V27, P374, DOI 10.1111/jerd.12157; Teixeira EC, 2007, J MATER SCI-MATER M, V18, P1219, DOI 10.1007/s10856-007-0131-4; Thitinanthapan W, 1999, J Esthet Dent, V11, P259, DOI 10.1111/j.1708-8240.1999.tb00407.x; Titley KC, 1998, ARCH ORAL BIOL, V43, P305, DOI 10.1016/S0003-9969(97)00112-X; Toledano M, 2011, J ENDODONT, V37, P1668, DOI 10.1016/j.joen.2011.08.003; Tonami K, 1996, Dent Mater J, V15, P205; TORNECK CD, 1990, J ENDODONT, V16, P123, DOI 10.1016/S0099-2399(06)81588-8; Van't Spijker A, 2009, INT J PROSTHODONT, V22, P35; Wise R., 2004, J BUS STRAT, V25, P26, DOI [10.1108/02756660410558915, DOI 10.1108/02756660410558915]; Yassen Ghaeth H, 2011, J Oral Sci, V53, P273; Zantner C, 2007, DENT MATER, V23, P243, DOI 10.1016/j.dental.2006.06.044	47	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173480	10.1371/journal.pone.0173480	http://dx.doi.org/10.1371/journal.pone.0173480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278191	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900101
J	Yan, CR; Zhao, X; Zhang, QL; Huang, YF				Yan, Cairong; Zhao, Xue; Zhang, Qinglong; Huang, Yongfeng			Efficient string similarity join in multi-core and distributed systems	PLOS ONE			English	Article								In big data area a significant challenge about string similarity join is to find all similar pairs more efficiently. In this paper, we propose a parallel processing framework for efficient string similarity join. First, the input is split into some disjoint small subsets according to the joint frequency distribution and the interval distribution of strings. Then the filter-verification strategy is adopted in the computation of string similarity for each subset so that the number of candidate pairs is reduced before an effective pruning strategy is used to improve the performance. Finally, the operation of string join is executed in parallel. Para-Join algorithm based on the multi-threading technique is proposed to implement the framework in a multi-core system while Pada-Join algorithm based on Spark platform is proposed to implement the framework in a cluster system. We prove that Para-Join and Pada-Join cannot only avoid reduplicate computation but also ensure the completeness of the result. Experimental results show that Para-Join can achieve high efficiency and significantly outperform than state-of-the-art approaches, meanwhile, Pada-Join can work on large datasets.	[Yan, Cairong; Zhao, Xue; Zhang, Qinglong; Huang, Yongfeng] Donghua Univ, Sch Comp Sci & Technol, Shanghai, Peoples R China	Donghua University	Yan, CR (corresponding author), Donghua Univ, Sch Comp Sci & Technol, Shanghai, Peoples R China.	cryan@dhu.edu.cn			 [61402100]		This work was supported by grant No. 61402100 (2014). https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list.	Afrati FN, 2012, PROC INT CONF DATA, P498, DOI 10.1109/ICDE.2012.66; Alba A, 2012, IEEE ENG MED BIO, P6309, DOI 10.1109/EMBC.2012.6347436; Bayardo R.J., 2007, P 16 INT C WORLD WID, DOI DOI 10.1145/1242572.1242591; Chen Yi-Cheng, 2014, Application Research of Computers, V31, P3002, DOI 10.3969/j.issn.1001-3695.2014.10.028; Deng D, 2014, PROC INT CONF DATA, P340, DOI 10.1109/ICDE.2014.6816663; Jestes J., 2010, SIGMOD, P327; Jiang Y., 2013, P JOINT EDBTICDT 201, P341, DOI [10.1145/2457317.2457382, DOI 10.1145/2457317.2457382]; Jiang Y, 2014, PROC VLDB ENDOW, V7, P625, DOI 10.14778/2732296.2732299; Kim Y, 2012, PROC INT CONF DATA, P510, DOI 10.1109/ICDE.2012.87; Lu J., 2013, P 2013 ACM SIGMOD IN, P373, DOI [10.1145/2463676.2465313, DOI 10.1145/2463676.2465313]; Metwally A, 2012, PROC VLDB ENDOW, V5, P704, DOI 10.14778/2212351.2212353; Vernica R., 2010, P 2010 ACM SIGMOD IN, DOI DOI 10.1145/1807167.1807222; Wang J., 2012, ACM SIGMOD, P85; Wang JN, 2014, ACM T DATABASE SYST, V39, DOI 10.1145/2535628; Wang JN, 2010, PROC VLDB ENDOW, V3, P1219, DOI 10.14778/1920841.1920992; Wang JN, 2011, PROC INT CONF DATA, P458, DOI 10.1109/ICDE.2011.5767865; Wang W, 2009, ACM SIGMOD/PODS 2009 CONFERENCE, P759; Xiao C, 2011, ACM T DATABASE S AUG, V8, P1; Xu KF, 2013, PROCEDIA COMPUT SCI, V17, P523, DOI 10.1016/j.procs.2013.05.067; Yuan XP, 2012, J CENT SOUTH UNIV, V19, P2231, DOI 10.1007/s11771-012-1267-z; Zhang Z., 2010, SIGMOD, P915, DOI DOI 10.1145/1807167.1807266	21	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172526	10.1371/journal.pone.0172526	http://dx.doi.org/10.1371/journal.pone.0172526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278177	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900121
J	Borlee, F; Yzermans, CJ; Krop, E; Aalders, B; Rooijackers, J; Zock, JP; van Dijk, CE; Maassen, CBM; Schellevis, F; Heederik, D; Smit, LAM				Borlee, Floor; Yzermans, C. Joris; Krop, Esmeralda; Aalders, Bernadette; Rooijackers, Jos; Zock, Jan-Paul; van Dijk, Christel E.; Maassen, Catharina B. M.; Schellevis, Francois; Heederik, Dick; Smit, Lidwien A. M.			Spirometry, questionnaire and electronic medical record based COPD in a population survey: Comparing prevalence, level of agreement and associations with potential risk factors	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; IDENTIFY PATIENTS; DEFINITIONS; ASTHMA; EPIDEMIOLOGY; VALIDITY; HISTORY; COHORT; ADULTS	Background COPD-diagnosis is confirmed by post-bronchodilator (BD) spirometry. However, epidemiological studies often rely on pre-BD spirometry, self-reports, or medical records. This population-based study aims to determine COPD-prevalence based on four different operational definitions and their level of agreement, and to compare associations between COPD-definitions and risk factors. Methods COPD-prevalence in 1,793 adults from the general Dutch population (aged 18-70 years) was assessed based on self-reported data, Electronic Medical Records (EMR), and post-BD spirometry: using the FEV1/FVC below the lower limit of normal (LLN) and GOLD fixed cut-off (FEV1/FVC <0.70). Using spirometry as a reference, sensitivity was calculated for self-reported and EMR-based COPD. Associations between COPD and known risk factors were assessed with logistic regression. Data were collected as part of the cross-sectional VGO study (Livestock Farming and Neighboring Residents' Health Study). Results The highest prevalence was found based on spirometry (GOLD: 10.9%, LLN: 5.9%), followed by self-report (4.6%) and EMR (2.9%). Self-reported or EMR-based COPD identified less than 30% of all COPD-cases based on spirometry. The direction of association between known risk factors and COPD was similar across the four definitions, however, magnitude and significance varied. Especially indicators of allergy were more strongly associated with self-reported COPD compared to the other definitions. Conclusions COPD-prevalence varied depending on the used definition. A substantial number of subjects with spirometry-based COPD cannot be identified with questionnaires or medical records which can cause underestimation of COPD-prevalence. The influence of the different COPD-definitions on associations with known risk factors was limited.	[Borlee, Floor; Krop, Esmeralda; Heederik, Dick; Smit, Lidwien A. M.] Univ Utrecht, IRAS, Utrecht, Netherlands; [Borlee, Floor; Yzermans, C. Joris; Zock, Jan-Paul; van Dijk, Christel E.; Schellevis, Francois] NIVEL, Inst Hlth Serv Res, Utrecht, Netherlands; [Aalders, Bernadette; Rooijackers, Jos] Netherlands Expertise Ctr Occupat Resp Disorders, Utrecht, Netherlands; [Maassen, Catharina B. M.] Ctr Infect Dis Control, Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Schellevis, Francois] Vrije Univ Amsterdam, Dept Gen Practice & Elderly Care Med, EMGO Inst Hlth & Care Res, Med Ctr, Amsterdam, Netherlands	Utrecht University; Netherlands Institute for Health Services Research; Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam	Smit, LAM (corresponding author), Univ Utrecht, IRAS, Utrecht, Netherlands.	L.A.Smit@uu.nl	Zock, Jan-Paul/P-5034-2018; Smit, Lidwien AM/AFC-8689-2022	Zock, Jan-Paul/0000-0002-2941-6259; Smit, Lidwien AM/0000-0003-0292-0946; Krop, Esmeralda/0000-0002-6009-1181; Heederik, Dick/0000-0002-4550-1437	Ministry of Health, Welfare and Sports; Ministry of Economic Affairs of The Netherlands; Lung Foundation Netherlands [3.2.11.022]	Ministry of Health, Welfare and Sports; Ministry of Economic Affairs of The Netherlands(Ministry of Economic Affairs, Netherlands); Lung Foundation Netherlands	The Livestock Farming and Neighbouring Residents' Health (VGO) study was funded by the Ministry of Health, Welfare and Sports and the Ministry of Economic Affairs of The Netherlands. LAMS received also a grant from the Lung Foundation Netherlands (Grant number: 3.2.11.022) (www.longfonds.nl/) to support this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos EC, 2015, INT J CHRONIC OBSTR, V10, P2665, DOI 10.2147/COPD.S91392; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651, DOI 10.1136/oem.55.10.651; Borlee F, 2015, EUR RESPIR J, V46, P1605, DOI 10.1183/13993003.00265-2015; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Burney P, 2015, LUNG FUNCTION PROTOC; Celli BR, 2003, EUR RESPIR J, V22, P268, DOI 10.1183/09031936.03.00075102; Cooke CR, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-37; de Marco R, 2015, EUR RESPIR J, V46, P671, DOI 10.1183/09031936.00008615; de Marco R, 2011, AM J RESP CRIT CARE, V183, P891, DOI 10.1164/rccm.201007-1125OC; Dirven JAM, 2010, COPD, V7, P352, DOI 10.3109/15412555.2010.510547; Doekes G, 1996, OCCUP ENVIRON MED, V53, P63, DOI 10.1136/oem.53.1.63; Gupta RP, 2014, INT J TUBERC LUNG D, V18, P998, DOI 10.5588/ijtld.13.0910; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Jarvis D, 2013, EUR RESP J S57, V42, P1809; Kjeldgaard P, 2015, INT J CHRONIC OBSTR, V10, P407, DOI 10.2147/COPD.S76047; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leffondre K, 2002, AM J EPIDEMIOL, V156, P813, DOI 10.1093/aje/kwf122; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mohangoo AD, 2006, EUR J PUBLIC HEALTH, V16, P101, DOI 10.1093/eurpub/cki043; Murgia N, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-49; Peat JK, 2001, THORAX, V56, P406, DOI 10.1136/thorax.56.5.406; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Prieto-Centurion V, 2014, AM J RESP CRIT CARE, V190, P989, DOI 10.1164/rccm.201406-1166OC; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Romanelli AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149302; Schermer TRJ, 2008, EUR RESPIR J, V32, P945, DOI 10.1183/09031936.00170307; Shirtcliffe P, 2007, EUR RESPIR J, V30, P232, DOI 10.1183/09031936.00157906; van der Molen Thys, 2003, Health Qual Life Outcomes, V1, P13, DOI 10.1186/1477-7525-1-13; van Dijk CE, 2016, ENV POLLUT; van Dijk W, 2015, ANN FAM MED, V13, P41, DOI 10.1370/afm.1714; Verheij R.A., 2014, NIVEL ZORGREGISTRATI; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Viegi G, 2007, EUR RESPIR J, V30, P993, DOI 10.1183/09031936.00082507	34	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171494	10.1371/journal.pone.0171494	http://dx.doi.org/10.1371/journal.pone.0171494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273094	gold, Green Published, Green Submitted			2022-12-27	WOS:000396073700095
J	Clark-Knowles, KV; He, XH; Jardine, K; Coulombe, J; Dewar-Darch, D; Caron, AZ; Gray, DA; McBurney, MW				Clark-Knowles, Katherine V.; He, Xiaohong; Jardine, Karen; Coulombe, Josee; Dewar-Darch, Danielle; Caron, Annabelle Z.; Gray, Douglas A.; McBurney, Michael W.			Reversible modulation of SIRT1 activity in a mouse strain	PLOS ONE			English	Article							TAMOXIFEN-INDUCIBLE FORM; EMBRYONIC STEM-CELLS; DEACETYLASE ACTIVITY; MAMMALIAN MICRORNAS; SIR2-ALPHA PROTEIN; CHIMERIC PROTEINS; ESTROGEN-RECEPTOR; BINDING DOMAIN; MICE DEVELOP; SIRTUINS	The SIRT1 protein deacetylase is reported to have a remarkably wide spectrum of biological functions affecting such varied processes as aging, cancer, metabolism, neurodegeneration and immunity. However, the SIRT1 literature is also full of contradictions. To help establish the role(s) of SIRT1 in these and other biological processes, we set out to create a mouse in which the SIRT1 activity could be toggled between on and off states by fusing the estrogen receptor ligand-binding domain (ER) to the C terminus of the SIRT1 protein. We found that the catalytic activity of the SIRT1-ER fusion protein increased 4-5 fold in cells treated with its ligand, 4-hydroxy-tamoxifen (4OHT). The 4OHT-induced activation of SIRT1-ER was due in large part to a 2 to 4-fold increase in abundance of the SIRT1-ER protein in cells in culture and in tissues in vivo. This increase is reversible and is a consequence of 4OHTinduced stabilization of the SIRT1-ER protein. Since changes in SIRT1 level or activity of 2-4 fold are frequently reported to be sufficient to affect its biological functions, this mouse should be helpful in establishing the causal relationships between SIRT1 and the diseases and processes it affects.	[Clark-Knowles, Katherine V.; He, Xiaohong; Jardine, Karen; Coulombe, Josee; Dewar-Darch, Danielle; Caron, Annabelle Z.; Gray, Douglas A.; McBurney, Michael W.] Ottawa Hosp Res Inst, Program Canc Therapeut, Ottawa, ON, Canada; [Gray, Douglas A.; McBurney, Michael W.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [McBurney, Michael W.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	McBurney, MW (corresponding author), Ottawa Hosp Res Inst, Program Canc Therapeut, Ottawa, ON, Canada.	mmcburney@ohri.ca	/U-3554-2018	/0000-0002-8634-4984	Canadian Institute for Health Research [MOP-130575]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute for Health Research, MOP-130575. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Boily G, 2009, ONCOGENE, V28, P2882, DOI 10.1038/onc.2009.147; Boutant M, 2016, CELL REP, V14, P2068, DOI 10.1016/j.celrep.2016.02.007; Buelow B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003264; Campagna M, 2011, CELL DEATH DIFFER, V18, P72, DOI 10.1038/cdd.2010.77; Caron AZ, 2014, FASEB J, V28, P1306, DOI 10.1096/fj.13-243568; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Choi SE, 2013, MOL CELLS, V36, P385, DOI 10.1007/s10059-013-0297-1; Chu YY, 2008, GENESIS, V46, P530, DOI 10.1002/dvg.20426; Chuprin A, 2015, NAT IMMUNOL, V16, P737, DOI 10.1038/ni.3194; Clark-Knowles KV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082106; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DANIELIAN PS, 1993, MOL ENDOCRINOL, V7, P232, DOI 10.1210/me.7.2.232; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Garcia D, 2011, GENE DEV, V25, P1746, DOI 10.1101/gad.16722111; Ghosh HS, 2007, BIOCHEM J, V408, P105, DOI 10.1042/BJ20070817; Greulich H, 1998, J BIOL CHEM, V273, P13280, DOI 10.1074/jbc.273.21.13280; Guarente L, 2000, GENE DEV, V14, P1021; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Jones ME, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-51; Kiga K, 2014, RNA BIOL, V11, P1347, DOI 10.4161/rna.32093; Kong SY, 2012, IMMUNOL CELL BIOL, V90, P6, DOI 10.1038/icb.2011.102; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Lin Zhenghong, 2013, Genes Cancer, V4, P97, DOI 10.1177/1947601912475079; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.553; Liu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013533; Malaterre J, 2016, ONCOGENE, V35, P2475, DOI 10.1038/onc.2015.305; McBurney Michael W, 2013, Genes Cancer, V4, P125, DOI 10.1177/1947601912474893; McBurney MW, 2003, MOL CANCER RES, V1, P402; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mercken EM, 2014, AGING CELL, V13, P193, DOI 10.1111/acel.12151; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Naia L, 2015, BBA-MOL BASIS DIS, V1852, P2183, DOI 10.1016/j.bbadis.2015.07.003; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Picard D, 2000, METHOD ENZYMOL, V327, P385, DOI 10.1016/S0076-6879(00)27291-1; Picard Didier, 1994, Current Opinion in Biotechnology, V5, P511, DOI 10.1016/0958-1669(94)90066-3; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; SCHERRER LC, 1993, BIOCHEMISTRY-US, V32, P5381, DOI 10.1021/bi00071a013; Seifert EL, 2012, FASEB J, V26, P555, DOI 10.1096/fj.11-193979; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Wang H, 2016, AGING CELL; Whitfield Jonathan, 2015, Cold Spring Harb Protoc, V2015, P227, DOI 10.1101/pdb.top069815; Wierenga ATJ, 2008, MOL CELL BIOL, V28, P6668, DOI 10.1128/MCB.01025-08; Wilson CH, 2014, ONCOGENE, V33, P4877, DOI 10.1038/onc.2014.78; Yamakuchi M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00068; Yuan HF, 2013, ONCOTARGETS THER, V6, P1399, DOI 10.2147/OTT.S37750; Zhang DY, 2009, J BIOL CHEM, V284, P20917, DOI 10.1074/jbc.M109.020073	59	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173002	10.1371/journal.pone.0173002	http://dx.doi.org/10.1371/journal.pone.0173002			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273169	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700034
J	Hu, L; Yang, Z; Pan, XJ; Zhao, N; Peng, JH; Wan, CY				Hu, Lian; Yang, Zhi; Pan, Xiaojie; Zhao, Na; Peng, Jianhua; Wan, Chengyan			Use offish species from different trophic levels to control algae and water quality: An enclosure experiment in eutrophic area of Xiaojiang River	PLOS ONE			English	Article							3 GORGES RESERVOIR; FISH SILVER CARP; BIGHEAD CARP; ENVIRONMENTAL-FACTORS; BIOMANIPULATION; LAKE; PHYTOPLANKTON; IMPOUNDMENT; CHINA; PHOSPHORUS	The effects of stocking both filter-feeding fish and piscivorous fish were compared to the effects of stocking only filter-feeding fish for suppressing algal blooms and improving water quality in the impoundment area of Xiaojiang River where catfish were dominant. Using only filter-feeding fish for algal suppression and water quality control was more effective in the short-term, but use of both filter-feeding fish and piscivorous fish was better in the long-term. Obvious suppression of phytoplankton biomass (PB) only occurred during the first 14 days regardless of the fish stocked. Adding fish to the enclosure clearly alters phytoplankton community structure and introducing piscivorous fish to an enclosure stocked with filter-feeding fish changed the relative densities of dominant algae species. While stocking filter-feeding fish decreased total nitrogen concentration by removing phytoplankton, it did not effectively decrease total phosphorus and Chlorophyll a concentrations. Introducing piscivorous fish to the enclosure weakened the relationship between nutrients and phytoplankton. Results indicate that stocking only filter-feeding fish to improve water quality and suppress phytoplankton in an impoundment area is insufficient and other technologies and means should be applied simultaneously.	[Hu, Lian; Yang, Zhi; Pan, Xiaojie; Zhao, Na; Peng, Jianhua; Wan, Chengyan] Minist Water Resources, Key Lab, Minist Water Resources Ecol Impacts Hydraul Proje, Inst Hydroecol, Wuhan, Peoples R China; [Hu, Lian; Yang, Zhi; Pan, Xiaojie; Zhao, Na; Peng, Jianhua; Wan, Chengyan] Chinese Acad Sci, Wuhan, Peoples R China; [Hu, Lian; Yang, Zhi; Pan, Xiaojie; Zhao, Na; Peng, Jianhua; Wan, Chengyan] Hubei Prov Collaborat Innovat Ctr Water Resources, Wuhan, Peoples R China	Chinese Academy of Sciences; Ministry of Water Resources; Chinese Academy of Sciences	Wan, CY (corresponding author), Minist Water Resources, Key Lab, Minist Water Resources Ecol Impacts Hydraul Proje, Inst Hydroecol, Wuhan, Peoples R China.; Wan, CY (corresponding author), Chinese Acad Sci, Wuhan, Peoples R China.; Wan, CY (corresponding author), Hubei Prov Collaborat Innovat Ctr Water Resources, Wuhan, Peoples R China.	chywan@mail.ihe.ac.cn			Science and Technology Program for Water Pollution Control and Treatment [2013ZX07104-004]	Science and Technology Program for Water Pollution Control and Treatment	This work was supported by Science and Technology Program for Water Pollution Control and Treatment (2013ZX07104-004).	[Anonymous], 1980, FRESHWATER ALGAE CHI; [Anonymous], 2014, CURR WORLD ENVIRON, DOI 10.12944/CWE.9.1.15; Burns CW, 2014, NEW ZEAL J MAR FRESH, V48, P127, DOI 10.1080/00288330.2013.838589; Chen XJ, 2012, J HYDROECOL, V33, P1; CREMER MC, 1980, AQUACULTURE, V20, P57, DOI 10.1016/0044-8486(80)90061-7; Ding R., 1994, FISHES SICHUAN; Domaizon Isabelle, 1999, Annee Biologique, V38, P91; Dorantes-Aranda JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133549; Ekvall MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112956; Fukushima M, 1999, FRESHWATER BIOL, V42, P719, DOI 10.1046/j.1365-2427.1999.00507.x; Gehrke PC, 2002, RIVER RES APPL, V18, P265, DOI 10.1002/rra.669; Gibson John A.E., 1997, Proceedings of the NIPR Symposium on Polar Biology, V10, P77; Guo Jing-song, 2011, Huanjing Kexue, V32, P976; Ha JY, 2013, LIMNOLOGY, V14, P19, DOI 10.1007/s10201-012-0381-9; Hallett CS, 2016, HYDROBIOLOGIA, V763, P267, DOI 10.1007/s10750-015-2383-1; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Hu L, 2013, BIOMED RES INT, V2013, P1; Imteaz MA, 2009, WATER SCI TECHNOL, V60, P2599, DOI 10.2166/wst.2009.632; Jeong YH, 2014, J COASTAL RES, V30, P1278, DOI 10.2112/JCOASTRES-D-13-00081.1; Klug JL, 2015, NORTHEAST NAT, V22, P273, DOI 10.1656/045.022.0204; [李斌 Li Bin], 2013, [生态学报, Acta Ecologica Sinica], V33, P6704; Lian JJ, 2014, WATER-SUI, V6, P3200, DOI 10.3390/w6103200; Lieberman DM, 1996, J FRESHWATER ECOL, V11, P391, DOI 10.1080/02705060.1996.9664466; Ma H, 2010, J ENVIRON SCI, V22, P161, DOI 10.1016/S1001-0742(09)60088-7; Margolis BE, 2001, CAN J FISH AQUAT SCI, V58, P2271, DOI 10.1139/cjfas-58-11-2271; MEPPRC(Ministry of Environmental Protection of the People's Republic China), 2005, ENV EC MON B 3 GORG; Mims MC, 2013, FRESHWATER BIOL, V58, P50, DOI 10.1111/fwb.12037; Norusis, 2008, SPSS 16 0 GUIDE DATA; Patino R, 2014, HARMFUL ALGAE, V33, P1, DOI 10.1016/j.hal.2013.12.006; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Radke RJ, 2002, FRESHWATER BIOL, V47, P2337, DOI 10.1046/j.1365-2427.2002.00993.x; Rangel LM, 2012, HYDROBIOLOGIA, V693, P13, DOI 10.1007/s10750-012-1083-3; Sieben K, 2011, J EXP MAR BIOL ECOL, V397, P79, DOI 10.1016/j.jembe.2010.11.020; Skov C, 2002, FRESHWATER BIOL, V47, P2388, DOI 10.1046/j.1365-2427.2002.01012.x; Tuzun I, 1996, HYDROBIOLOGIA, V331, P79, DOI 10.1007/BF00025410; Van der Merwe D, 2015, TOXINS, V7, P1065, DOI 10.3390/toxins7041065; Vasek M, 2013, ECOL ENG, V52, P104, DOI 10.1016/j.ecoleng.2012.12.100; Vriesman ACVB, 2002, EUROPEAN RADIOLOGY, V37, P87; Waajen GWAM, 2016, ECOL ENG, V90, P141, DOI 10.1016/j.ecoleng.2016.01.036; Wang HJ, 2008, FRESHWATER BIOL, V53, P935, DOI 10.1111/j.1365-2427.2007.01950.x; Wang Liping, 2012, Hupo Kexue, V24, P232; Withers PJA, 2007, SOIL USE MANAGE, V23, P1, DOI 10.1111/j.1475-2743.2007.00116.x; Xie P., 2003, SILVER CARP BIGHEAD; Xu XB, 2013, EARTH-SCI REV, V124, P115, DOI 10.1016/j.earscirev.2013.05.007; Yang ZJ, 2010, SCI CHINA TECHNOL SC, V53, P1114, DOI 10.1007/s11431-009-0387-7; Yi CL, 2016, ECOL ENG, V89, P7, DOI 10.1016/j.ecoleng.2016.01.022; Zanden MJV, 2008, ECOLOGY, V83, P2152; Zhang X, 2006, AQUACULTURE, V257, P173, DOI 10.1016/j.aquaculture.2006.03.018; Zhang X, 2008, THESCIENTIFICWORLDJO, V8, P1184, DOI 10.1100/tsw.2008.144; Zhang ZY, 2013, ENVIRON SCI POLLUT R, V20, P7080, DOI 10.1007/s11356-013-1702-1; Zhao HJ, 2015, ECOL INDIC, V58, P113, DOI 10.1016/j.ecolind.2015.03.033; Zhu TS, 2016, ECOL ENG, V86, P113, DOI 10.1016/j.ecoleng.2015.10.031	52	7	7	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171953	10.1371/journal.pone.0171953	http://dx.doi.org/10.1371/journal.pone.0171953			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273091	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700064
J	Murison, DA; Ollivierre, JN; Huang, QY; Budil, DE; Beuning, PJ				Murison, David A.; Ollivierre, Jaylene N.; Huang, Qiuying; Budil, David E.; Beuning, Penny J.			Altering the N-terminal arms of the polymerase manager protein UmuD modulates protein interactions	PLOS ONE			English	Article							REPLICATIVE DNA-POLYMERASE; BETA-PROCESSIVITY CLAMP; ESCHERICHIA-COLI; SOS MUTAGENESIS; TRANSLESION SYNTHESIS; CLPXP PROTEASE; INTACT UMUD; RECA; CLEAVAGE; COMPLEX	Escherichia coli cells that are exposed to DNA damaging agents invoke the SOS response that involves expression of the umuD gene products, along with more than 50 other genes. Full-length UmuD is expressed as a 139-amino-acid protein, which eventually cleaves its Nterminal 24 amino acids to form UmuD '. The N-terminal arms of UmuD are dynamic and contain recognition sites for multiple partner proteins. Cleavage of UmuD to UmuD ' dramatically affects the function of the protein and activates UmuC for translesion synthesis ( TLS) by forming DNA Polymerase V. To probe the roles of the N-terminal arms in the cellular functions of the umuD gene products, we constructed additional N- terminal truncated versions of UmuD: UmuD 8 ( UmuD Delta 1-7) and UmuD 18 ( UmuD Delta 1-17). We found that the loss of just the N- terminal seven ( 7) amino acids of UmuD results in changes in conformation of the N- terminal arms, as determined by electron paramagnetic resonance spectroscopy with site-directed spin labeling. UmuD 8 is cleaved as efficiently as full-length UmuD in vitro and in vivo, but expression of a plasmid-borne non-cleavable variant of UmuD 8 causes hypersensitivity to UV irradiation, which we determined is the result of a copy-number effect. UmuD 18 does not cleave to form UmuD A, but confers resistance to UV radiation. Moreover, removal of the N- terminal seven residues of UmuD maintained its interactions with the alpha polymerase subunit of DNA polymerase III as well as its ability to disrupt interactions between alpha and the beta processivity clamp, whereas deletion of the N- terminal 17 residues resulted in decreases in binding to alpha and in the ability to disrupt the alpha-beta interaction. We find that UmuD 8 mimics full-length UmuD in many respects, whereas UmuD 18 lacks a number of functions characteristic of UmuD.	[Murison, David A.; Ollivierre, Jaylene N.; Huang, Qiuying; Budil, David E.; Beuning, Penny J.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA	Northeastern University	Beuning, PJ (corresponding author), Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA.	beuning@neu.edu	Budil, David E/B-3631-2018	Budil, David E/0000-0003-2384-7928; Beuning, Penny/0000-0002-7770-022X	National Science Foundation [MCB-0845033]; American Cancer Society [RSG-12-161-01-DMC]; Northeastern University Office of the Provost	National Science Foundation(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); Northeastern University Office of the Provost	This work was supported by generous financial support from the National Science Foundation [CAREER Award, MCB-0845033 to P.J. B.]; the American Cancer Society [Research Scholar Grant RSG-12-161-01-DMC to P.J.B.]; and the Northeastern University Office of the Provost (Undergraduate Research Grant to Q.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bailey S, 2006, CELL, V126, P893, DOI 10.1016/j.cell.2006.07.027; BATTISTA JR, 1990, P NATL ACAD SCI USA, V87, P7190, DOI 10.1073/pnas.87.18.7190; Becherel OJ, 1999, J MOL BIOL, V294, P299, DOI 10.1006/jmbi.1999.3272; Beuning PJ, 2006, METHOD ENZYMOL, V408, P318, DOI 10.1016/S0076-6879(06)08020-7; Beuning PJ, 2009, J BACTERIOL, V191, P5910, DOI 10.1128/JB.00292-09; Beuning PJ, 2006, J BIOL CHEM, V281, P9633, DOI 10.1074/jbc.M511101200; Boudsocq F, 1997, J MOL BIOL, V270, P201, DOI 10.1006/jmbi.1997.1098; BURCKHARDT SE, 1988, P NATL ACAD SCI USA, V85, P1811, DOI 10.1073/pnas.85.6.1811; Chaurasiya KR, 2013, NUCLEIC ACIDS RES, V41, P8959, DOI 10.1093/nar/gkt648; CHURCHWARD G, 1984, GENE, V31, P165, DOI 10.1016/0378-1119(84)90207-5; Courcelle CT, 2006, P NATL ACAD SCI USA, V103, P9154, DOI 10.1073/pnas.0600785103; Duzen JIM, 2004, DNA REPAIR, V3, P301, DOI 10.1016/j.dnarep.2003.11.008; Fang J, 2010, J MOL BIOL, V398, P40, DOI 10.1016/j.jmb.2010.02.040; Ferentz AE, 2001, EMBO J, V20, P4287, DOI 10.1093/emboj/20.15.4287; Frank EG, 1996, P NATL ACAD SCI USA, V93, P10291, DOI 10.1073/pnas.93.19.10291; Freidberg E. C., 2005, DNA REPAIR MUTAGENES; Godoy VG, 2007, MOL CELL, V28, P1058, DOI 10.1016/j.molcel.2007.10.025; Gonzalez M, 2000, EMBO J, V19, P5251, DOI 10.1093/emboj/19.19.5251; Gonzalez M, 2002, BIOESSAYS, V24, P141, DOI 10.1002/bies.10040; Guzzo A, 1996, J BACTERIOL, V178, P7295, DOI 10.1128/jb.178.24.7295-7303.1996; Han ES, 2006, NUCLEIC ACIDS RES, V34, P1084, DOI 10.1093/nar/gkj503; Hawver LA, 2011, J BACTERIOL, V193, P5400, DOI 10.1128/JB.05301-11; KATO T, 1977, MOL GEN GENET, V156, P121, DOI 10.1007/BF00283484; Kuban W, 2012, DNA REPAIR, V11, P726, DOI 10.1016/j.dnarep.2012.06.005; Lamers MH, 2006, CELL, V126, P881, DOI 10.1016/j.cell.2006.07.028; Lapenta F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152915; Lee MH, 1996, J BACTERIOL, V178, P7285, DOI 10.1128/jb.178.24.7285-7294.1996; LEE MH, 1994, J BACTERIOL, V176, P4825, DOI 10.1128/jb.176.16.4825-4837.1994; MARSH L, 1985, J BACTERIOL, V162, P155, DOI 10.1128/JB.162.1.155-161.1985; McDonald JP, 1998, P NATL ACAD SCI USA, V95, P1478, DOI 10.1073/pnas.95.4.1478; Neher SB, 2003, P NATL ACAD SCI USA, V100, P13219, DOI 10.1073/pnas.2235804100; NOHMI T, 1988, P NATL ACAD SCI USA, V85, P1816, DOI 10.1073/pnas.85.6.1816; Ollivierre JN, 2013, BBA-PROTEINS PROTEOM, V1834, P611, DOI 10.1016/j.bbapap.2012.11.008; Ollivierre JN, 2011, MOL BIOSYST, V7, P3183, DOI 10.1039/c1mb05334e; Ollivierre JN, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/947680; Ollivierre JN, 2011, J BIOL CHEM, V286, P3607, DOI 10.1074/jbc.M110.167254; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; Peat TS, 1996, NATURE, V380, P727, DOI 10.1038/380727a0; Rehrauer WM, 1998, J BIOL CHEM, V273, P32384, DOI 10.1074/jbc.273.49.32384; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; Shen X, 2003, J BIOL CHEM, V278, P52546, DOI 10.1074/jbc.M310127200; SHINAGAWA H, 1988, P NATL ACAD SCI USA, V85, P1806, DOI 10.1073/pnas.85.6.1806; Silva MC, 2012, NUCLEIC ACIDS RES, V40, P5511, DOI 10.1093/nar/gks229; Simmons LA, 2008, ECOSAL PLUS, V3; SOMMER S, 1993, MOL GEN GENET, V239, P137, DOI 10.1007/BF00281612; Sommer S, 1998, MOL MICROBIOL, V28, P281, DOI 10.1046/j.1365-2958.1998.00803.x; SOMMER S, 1993, MOL MICROBIOL, V10, P963, DOI 10.1111/j.1365-2958.1993.tb00968.x; Sommer S, 2000, MOL MICROBIOL, V35, P1443, DOI 10.1046/j.1365-2958.2000.01809.x; Sutton MD, 1999, P NATL ACAD SCI USA, V96, P12373, DOI 10.1073/pnas.96.22.12373; Sutton MD, 2002, DNA REPAIR, V1, P77, DOI 10.1016/S1568-7864(01)00006-4; Sutton MD, 2002, P NATL ACAD SCI USA, V99, P5307, DOI 10.1073/pnas.082322099; Sutton MD, 2001, J BACTERIOL, V183, P1215, DOI 10.1128/JB.183.4.1215-1224.2001; Sutton MD, 2001, J BACTERIOL, V183, P347, DOI 10.1128/JB.183.1.347-357.2001; Szpilewska H, 1995, BIOCHIMIE, V77, P848, DOI 10.1016/0300-9084(95)90002-0; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919	57	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173388	10.1371/journal.pone.0173388	http://dx.doi.org/10.1371/journal.pone.0173388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273172	Green Submitted, Green Published, gold			2022-12-27	WOS:000396073700057
J	Gott, C; Gates, T; Dermody, N; Brew, BJ; Cysique, LA				Gott, Chloe; Gates, Thomas; Dermody, Nadene; Brew, Bruce J.; Cysique, Lucette A.			Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity	PLOS ONE			English	Article							NEUROCOGNITIVE DISORDERS; NEUROPSYCHOLOGICAL FUNCTION; DEFICIT SCORES; CHRONICITY; IMPAIRMENT; MEMORY; COHORT; ADULTS; ERA; AGE	Background The longitudinal rate and profile of cognitive decline in persons with stable, treated, and virally suppressed HIV infection is not established. To address this question, the current study quantifies the rate of cognitive decline in a cohort of virally suppressed HIV+ persons using clinically relevant definitions of decline, and determine cognitive trajectories taking into account historical and baseline HAND status. Methods Ninety-six HIV+ (clinically stable and virally undetectable) and 44 demographically comparable HIV-participants underwent standard neuropsychological testing at baseline and 18-months follow-up. We described clinically relevant cognitive trajectories based on standard definitions of historical and baseline HAND status and cognitive decline. Historical, moderate to severe HAND was formally diagnosed at the start of the cART era in 15/96 participants based on clinical neurological and neuropsychological assessment. The same standard of care has been applied to all participants at St. Vincent's Hospital Infectious Disease Department for the duration of their HIV infection (median of 20 years). Results Relative to HIV-controls (4.5%), 14% of HIV+ participants declined (p = .11), they also scored significantly lower on the global change score (p = .03), processing speed (p = .02), and mental flexibility/inhibition (p = .02) domains. Having HAND at baseline significantly predicted cognitive decline at follow up (p = .005). We determined seven clinically relevant cognitive trajectories taking into account whether participant has a history of HAND prior to study entry (yes/no); their results on the baseline assessment (baseline impairment: yes/no) and their results on the 18-month follow up (decline or stable) which in order of prevalence were: 1) No HAND history, no baseline impairment, 18-month follow-up stable (39%), 2) No HAND history, baseline impairment, 18-month follow-up stable (35%), 3) History of HAND; baseline impairment, 18-month follow-up stable (9%) 4) No history of HAND, baseline impairment, 18-month follow-up decline (7%), 5) History of HAND, no baseline impairment, 18-month follow-up stable (3%), 6) No HAND history, no baseline impairment, 18-month follow- up decline (3%) 7) History of HAND, baseline impairment, 18-month follow-up decline (3%). There was no relationship between cognitive decline (taking into account historical and baseline HAND) and traditional HIV disease biomarkers. Conclusions Despite long-term viral suppression, we found mostly subclinical levels of decline in psychomotor speed and executive functioning (mental flexibility and cognitive inhibition); well-established markers of HAND progression. Moreover, 57% of our cohort is undergoing slow evolution of their disease, challenging the notion of prevalent neurocognitive stability in virally suppressed HIV infection.	[Gott, Chloe; Dermody, Nadene] Macquarie Univ, Dept Psychol, Sydney, NSW, Australia; [Gott, Chloe; Dermody, Nadene; Brew, Bruce J.; Cysique, Lucette A.] Univ New South Wales, Fac Med, Sydney, NSW, Australia; [Gates, Thomas; Brew, Bruce J.; Cysique, Lucette A.] St Vincents Hosp, Dept HIV, Darlinghurst, NSW, Australia; [Gates, Thomas; Brew, Bruce J.; Cysique, Lucette A.] St Vincents Hosp, Dept Neurol, Darlinghurst, NSW, Australia; [Gates, Thomas; Brew, Bruce J.; Cysique, Lucette A.] St Vincents Ctr, Appl Med Res Ctr, Peter Duncan Neurosci Unit, Darlinghurst, NSW, Australia; [Cysique, Lucette A.] Neurosci Res Australia NeuRA, Sydney, NSW, Australia	Macquarie University; University of New South Wales Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; Neuroscience Research Australia	Cysique, LA (corresponding author), Univ New South Wales, Fac Med, Sydney, NSW, Australia.; Cysique, LA (corresponding author), St Vincents Hosp, Dept HIV, Darlinghurst, NSW, Australia.; Cysique, LA (corresponding author), St Vincents Hosp, Dept Neurol, Darlinghurst, NSW, Australia.; Cysique, LA (corresponding author), St Vincents Ctr, Appl Med Res Ctr, Peter Duncan Neurosci Unit, Darlinghurst, NSW, Australia.	lcysique@unsw.edu.au	Cysique, Lucette A./U-1357-2017; Gates, Thomas/AAB-5623-2022	Cysique, Lucette A./0000-0002-7711-6373; Gates, Thomas/0000-0003-0113-8282; brew, bruce/0000-0003-0622-1392	NHMRC project grant [APP568746]; NHMRC Career Development Fellowship [APP1045400]; Peter Duncan Neuroscience Unit at St. Vincent's Hospital Applied Medical Research Centre	NHMRC project grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Peter Duncan Neuroscience Unit at St. Vincent's Hospital Applied Medical Research Centre	The study was funded by the NHMRC project grant (APP568746; CIA/PI Cysique) and NHMRC Career Development Fellowship (APP1045400; CIA/PI Cysique), and the support of the Peter Duncan Neuroscience Unit at St. Vincent's Hospital Applied Medical Research Centre (Director: Prof. Brew).	Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bischof GN, 2016, AMYLOID DEPOSITION Y; Blackstone K, 2012, CLIN NEUROPSYCHOL, V26, P894, DOI 10.1080/13854046.2012.694479; Brew BJ, 2009, J NEUROIMMUNE PHARM, V4, P163, DOI 10.1007/s11481-008-9143-1; Brouillette M-J, 2016, PLOS ONE IN PRESS, P1; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Chelune G. J., 1986, ADV CLIN NEUROPSYCHO, V3, P15, DOI DOI 10.1007/978-1-4613-2211-5_4; Cole MA, 2007, NEUROLOGY, V69, P2213, DOI 10.1212/01.WNL.0000277520.94788.82; Cysique L, 2012, NEUROBEHAV HIV MED, P63; Cysique LA, 2015, APOE ABNORMAL CSF AB, P4; Cysique LAJ, 2006, NEUROLOGY, V66, P1447, DOI 10.1212/01.wnl.0000210477.63851.d3; Cysique LA, 2016, J NEUROVIROL, V22, P56, DOI 10.1007/s13365-015-0368-5; Cysique LA, 2014, J NEUROVIROL, V20, P258, DOI 10.1007/s13365-014-0242-x; Cysique LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061738; Cysique LA, 2011, J CLIN EXP NEUROPSYC, V33, P505, DOI 10.1080/13803395.2010.535504; Cysique LA, 2010, AIDS, V24, P983, DOI 10.1097/QAD.0b013e32833336c8; Dore GJ, 2010, MARKED IMPROVEMENT S; Fellows RP, 2014, J CLIN EXP NEUROPSYC, V36, P806, DOI 10.1080/13803395.2014.943696; Gates TM, 2016, CNS DRUGS, V30, P53, DOI 10.1007/s40263-015-0302-7; Grant I, 2008, INT REV PSYCHIATR, V20, P33, DOI 10.1080/09540260701877894; Harezlak J, 2014, J NEUROVIROL, V20, P294, DOI 10.1007/s13365-014-0246-6; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton R.K., 2004, REVISED COMPREHENSIV; Heaton RK, 2015, CLIN INFECT DIS, V60, P473, DOI 10.1093/cid/ciu862; JANSSEN RS, 1991, NEUROLOGY, V41, P778; Lane TA, 2012, NEUROPSYCHOLOGY, V26, P713, DOI 10.1037/a0029964; Reger M, 2002, J INT NEUROPSYCH SOC, V8, P410, DOI 10.1017/S1355617702813212; Sacktor N, 2016, NEUROLOGY, V86, P334, DOI 10.1212/WNL.0000000000002277; Seider TR, 2014, J CLIN EXP NEUROPSYC, V36, P356, DOI 10.1080/13803395.2014.892061; Sheppard DP, 2015, CLIN NEUROPSYCHOL, V29, P656, DOI 10.1080/13854046.2015.1077995; The Kirby Institute, 2015, ANN SURV REP 2015; Wendelken LA, 2012, J NEUROVIROL, V18, P256, DOI 10.1007/s13365-012-0094-1; Woods SP, 2009, NEUROPSYCHOL REV, V19, P152, DOI 10.1007/s11065-009-9102-5	34	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0171887	10.1371/journal.pone.0171887	http://dx.doi.org/10.1371/journal.pone.0171887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5OE	28264037	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300005
J	Nishijima, R; Okamoto, Y; Hatano, H; Takumi, S				Nishijima, Ryo; Okamoto, Yuki; Hatano, Hitoshi; Takumi, Shigeo			Quantitative trait locus analysis for spikelet shape-related traits in wild wheat progenitor Aegilops tauschii: Implications for intraspecific diversification and subspecies differentiation	PLOS ONE			English	Article							HEXAPLOID WHEAT; D-GENOME; COMMON WHEAT; GENETIC-VARIATION; KERNEL SIZE; GRAIN-SIZE; COSS; EVOLUTION; IDENTIFICATION; POPULATIONS	Wild diploid wheat Aegilops tauschii, the D-genome progenitor of common wheat, carries large genetic variation in spikelet and grain morphology. Two differentiated subspecies of Ae. tauschii, subspecies tauschii and strangulata, have been traditionally defined based on differences in spikelet morphology. Here, we first assessed six spikelet shape-related traits among 199 Ae. tauschii accessions, and found that the accessions belonging to TauL1major lineage produced significantly longer spikes, higher spikelet density, and shorter, narrower spikelets than another major lineage, TauL2, in which the strangulata accessions are included. Next, we performed quantitative trait locus (QTL) analysis of the spikelet and grain shape using three mapping populations derived from interlineage crosses between TauL1 and TauL2 to identify the genetic loci for the morphological variations of the spikelet and grain shape in Ae. tauschii. Three major QTL regions for the examined traits were detected on chromosomes 3D, 4D and 7D. The 3D and 4D QTL regions for several spikelet shape-related traits were conserved in the three mapping populations, which indicated that the 3D and 4D QTLs contribute to divergence of the two major lineages. The 7D QTLs were found only in a mapping population from a cross of the two subspecies, suggesting that these 7D QTLs may be closely related to subspecies differentiation in Ae. tauschii. Thus, QTL analysis for spikelet and grain morphology may provide useful information to elucidate the evolutionary processes of intraspecific differentiation.	[Nishijima, Ryo; Okamoto, Yuki; Hatano, Hitoshi; Takumi, Shigeo] Kobe Univ, Grad Sch Agr Sci, Lab Plant Genet, Nada Ku, Kobe, Hyogo, Japan	Kobe University	Takumi, S (corresponding author), Kobe Univ, Grad Sch Agr Sci, Lab Plant Genet, Nada Ku, Kobe, Hyogo, Japan.	takumi@kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [21380005, 16H04862]; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Grant-in-Aid for Scientific Research (B) Nos. 21380005 and 16H04862) to ST, and by a Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists to RN.	[Anonymous], 2021, LANG ENV STAT COMP; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Breseghello F, 2007, FIELD CROP RES, V101, P172, DOI 10.1016/j.fcr.2006.11.008; Dudnikov AJ, 1998, HEREDITY, V80, P248, DOI 10.1038/sj.hdy.6882810; Dudnikov AJ, 2006, GENET RESOUR CROP EV, V53, P579, DOI 10.1007/s10722-004-2681-3; Dvorak J, 1998, THEOR APPL GENET, V97, P657, DOI 10.1007/s001220050942; EIG A, 1929, REPERT SPEC NOV RE S, V55, P1; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; HAMMER K, 1980, Kulturpflanze, V28, P33; Hirao K, 2015, GENES GENET SYST, V90, P283, DOI 10.1266/ggs.15-00035; Huang L, 2012, GENET RESOUR CROP EV, V59, P1027, DOI 10.1007/s10722-011-9741-2; Ishikawa G, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-135; Jafarzadeh J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162860; Jones H, 2013, THEOR APPL GENET, V126, P1793, DOI 10.1007/s00122-013-2093-x; Masaru IJC, 2012, DNA RES, V19, P487, DOI 10.1093/dnares/dss028; KIHARA H., 1949, Hereditas, P307; Kippes N, 2016, THEOR APPL GENET, V129, P1417, DOI 10.1007/s00122-016-2713-3; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Matsuoka Y, 2004, THEOR APPL GENET, V109, P1710, DOI 10.1007/s00122-004-1806-6; Matsuoka Y, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0496-9; Matsuoka Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068310; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Matsuoka Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003138; Matsuoka Y, 2009, PLANT SYST EVOL, V279, P233, DOI 10.1007/s00606-009-0159-7; Mizuno N, 2010, MOL ECOL, V19, P999, DOI 10.1111/j.1365-294X.2010.04537.x; MujeebKazi A, 1996, GENET RESOUR CROP EV, V43, P129, DOI 10.1007/BF00126756; Nakano H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121583; Nishijima R, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0246-y; Okamoto Y, 2013, BREEDING SCI, V63, P423, DOI 10.1270/jsbbs.63.423; Okamoto Y, 2013, EUPHYTICA, V194, P207, DOI 10.1007/s10681-013-0916-0; Okamoto Y, 2012, GENES GENET SYST, V87, P299, DOI 10.1266/ggs.87.299; Pestsova E, 2000, THEOR APPL GENET, V101, P100, DOI 10.1007/s001220051456; Rstudio Team, 2015, RSTUDIO INT DEV R; Saeidi H, 2006, GENET RESOUR CROP EV, V53, P1477, DOI 10.1007/s10722-005-7110-8; Saisho D, 2016, SCI REP-UK, V6, DOI 10.1038/srep38554; Shahinnia F, 2012, THEOR APPL GENET, V124, P373, DOI 10.1007/s00122-011-1712-7; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Takumi S, 2011, GENES GENET SYST, V86, P183, DOI 10.1266/ggs.86.183; Takumi S, 2009, BREEDING SCI, V59, P579, DOI 10.1270/jsbbs.59.579; TSUNEWAKI K, 1979, EUPHYTICA, V28, P579, DOI 10.1007/BF00038924; TSUNEWAKI K, 1966, JPN J BOT, V19, P175; VANSLAGEREN MW, 1994, WILD WHEATS MONOGRAP, P326; Wang JR, 2013, NEW PHYTOL, V198, P925, DOI 10.1111/nph.12164; Wang S., 2011, WINDOWS QTL CARTOGRA; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; ZOHARY D, 1969, EUPHYTICA, V18, P58	48	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173210	10.1371/journal.pone.0173210	http://dx.doi.org/10.1371/journal.pone.0173210			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264068	Green Submitted, Green Published, gold			2022-12-27	WOS:000396054300046
J	Schwab-Reese, LM; Parker, EA; Peek-Asa, C				Schwab-Reese, Laura M.; Parker, Edith A.; Peek-Asa, Corinne			Interactions of adolescent social experiences and dopamine genes to predict physical intimate partner violence perpetration	PLOS ONE			English	Article							TRANSPORTER GENE; RISK-FACTORS; ENVIRONMENT; DISADVANTAGE; EXPOSURE; PROGRAMS; DAT1; MAPS	Objectives We examined the interactions between three dopamine gene alleles (DAT1, DRD2, DRD4) previously associated with violent behavior and two components of the adolescent environment (exposure to violence, school social environment) to predict adulthood physical intimate partner violence (IPV) perpetration among white men and women. Methods We used data from Wave IV of the National Longitudinal Study of Adolescent to Adult Health, a cohort study following individuals from adolescence to adulthood. Based on the prior literature, we categorized participants as at risk for each of the three dopamine genes using this coding scheme: two 10-R alleles for DAT1; at least one A-1 allele for DRD2; at least one 7-R or 8-R allele for DRD4. Adolescent exposure to violence and school social environment was measured in 1994 and 1995 when participants were in high school or middle school. Intimate partner violence perpetration was measured in 2008 when participants were 24 to 32 years old. We used simple and multivariable logistic regression models, including interactions of genes and the adolescent environments for the analysis. Results Presence of risk alleles was not independently associated with IPV perpetration but increasing exposure to violence and disconnection from the school social environment was associated with physical IPV perpetration. The effects of these adolescent experiences on physical IPV perpetration varied by dopamine risk allele status. Among individuals with non-risk dopamine alleles, increased exposure to violence during adolescence and perception of disconnection from the school environment were significantly associated with increased odds of physical IPV perpetration, but individuals with high risk alleles, overall, did not experience the same increase. Conclusion Our results suggested the effects of adolescent environment on adulthood physical IPV perpetration varied by genetic factors. This analysis did not find a direct link between risk alleles and violence, but contributes to growing research indicating that if genetic factors contribute to perpetration, this relationship is likely complicated and the result of interactions with other factors.	[Schwab-Reese, Laura M.; Parker, Edith A.] Univ Iowa, Coll Publ Hlth, Dept Community & Behav Hlth, Iowa City, IA 52242 USA; [Peek-Asa, Corinne] Univ Iowa, Coll Publ Hlth, Dept Occupat & Environm, Iowa City, IA USA; [Schwab-Reese, Laura M.] Univ Colorado, Sch Med, Dept Pediat, Kempe Ctr Prevent & Treatment Child Abuse & Negle, Anschutz Med Campus, Aurora, CO 80045 USA	University of Iowa; University of Iowa; University of Colorado System; University of Colorado Anschutz Medical Campus	Schwab-Reese, LM (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Community & Behav Hlth, Iowa City, IA 52242 USA.; Schwab-Reese, LM (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Kempe Ctr Prevent & Treatment Child Abuse & Negle, Anschutz Med Campus, Aurora, CO 80045 USA.	laura.m.schwab@gmail.com		Schwab-Reese, Laura/0000-0002-9174-1730	University of Iowa Injury Prevention Research Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T42OH008491] Funding Source: NIH RePORTER	University of Iowa Injury Prevention Research Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	LMSR, EAP, and CPA received pilot funding from the University of Iowa Injury Prevention Research Center for this project. This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Information on how to obtain the Add Health data files is available on the Add Health website (http://www.cpc.unc.edu/addhealth). No direct support was received from grant P01-HD31921 for this analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Bakermans-Kranenburg MJ, 2011, DEV PSYCHOPATHOL, V23, P39, DOI 10.1017/S0954579410000635; Barnes JC, 2013, J PSYCHIATR RES, V47, P371, DOI 10.1016/j.jpsychires.2012.10.016; Barnes JC, 2013, J INTERPERS VIOLENCE, V28, P92, DOI 10.1177/0886260512448847; Beaver KM, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-30; Beaver KM, 2012, YOUTH VIOLENCE JUV J, V10, P25, DOI 10.1177/1541204011422085; Bell KM, 2008, CLIN PSYCHOL REV, V28, P1096, DOI 10.1016/j.cpr.2008.03.003; Black M.C., 2011, NATL INTIMATE PARTNE; Brookmeyer KA, 2006, J CLIN CHILD ADOLESC, V35, P504, DOI 10.1207/s15374424jccp3504_2; Capaldi DM, 2012, PARTN ABUSE, V3, P231, DOI 10.1891/1946-6560.3.2.231; Casey EA, 2010, J YOUTH ADOLESCENCE, V39, P620, DOI 10.1007/s10964-009-9423-y; Costa BM, 2015, AGGRESS VIOLENT BEH, V24, P261, DOI 10.1016/j.avb.2015.06.001; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Eckhardt CI, 2006, PUBLIC HEALTH REP, V121, P369, DOI 10.1177/003335490612100405; Falb KL, 2011, ARCH PEDIAT ADOL MED, V165, P890, DOI 10.1001/archpediatrics.2011.91; Ferguson CJ, 2008, CRIM JUSTICE BEHAV, V35, P311, DOI 10.1177/0093854807311719; Fuke S., 2001, Pharmacogenomics Journal, V1, P152; GELERNTER J, 1992, GENOMICS, V13, P208, DOI 10.1016/0888-7543(92)90222-E; Guo G, 2007, HUM GENET, V121, P125, DOI 10.1007/s00439-006-0244-8; Harris KM, 2009, NATL LONGITUDINAL ST; Hines Denise A, 2004, Violence Vict, V19, P701, DOI 10.1891/088667004780927729; Johnson SL, 2009, J SCHOOL HEALTH, V79, P451, DOI 10.1111/j.1746-1561.2009.00435.x; McNeely CA, 2002, J SCHOOL HEALTH, V72, P138, DOI 10.1111/j.1746-1561.2002.tb06533.x; Menard S, 2014, CHILD ABUSE NEGLECT, V38, P627, DOI 10.1016/j.chiabu.2014.02.001; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; National Library of Medicine, 2015, POLYM; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Raghavan C, 2006, VIOLENCE AGAINST WOM, V12, P1132, DOI 10.1177/1077801206294115; Raiford JL, 2013, J URBAN HEALTH, V90, P784, DOI 10.1007/s11524-012-9717-3; Ramirez M, 2012, J ADOLESCENT HEALTH, V51, P503, DOI 10.1016/j.jadohealth.2012.02.016; Renner LM, 2015, J FAM VIOLENCE, V30, P1069, DOI 10.1007/s10896-015-9737-3; Shorey RC, 2008, AGGRESS VIOLENT BEH, V13, P185, DOI 10.1016/j.avb.2008.03.003; Smolen A., 2013, ADD HLTH WAVE 4 DOCU; Stuart GL, 2014, VIOLENCE AGAINST WOM, V20, P385, DOI 10.1177/1077801214528587; Ttofi MM, 2011, J EXP CRIMINOL, V7, P27, DOI 10.1007/s11292-010-9109-1; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; Wang CX, 2013, THEOR PRACT, V52, P296, DOI 10.1080/00405841.2013.829735; Whitaker DJ, 2013, PARTN ABUSE, V4, P175, DOI 10.1891/1946-6560.4.2.175; Yoshihama M, 2005, SOC WORK RES, V29, P151, DOI 10.1093/swr/29.3.151	40	5	5	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172840	10.1371/journal.pone.0172840	http://dx.doi.org/10.1371/journal.pone.0172840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264032	gold, Green Published			2022-12-27	WOS:000396054300021
J	de Montalembert, M; Ribeil, JA; Brousse, V; Guerci-Bresler, A; Stamatoullas, A; Vannier, JP; Dumesnil, C; Lahary, A; Touati, M; Bouabdallah, K; Cavazzana, M; Chauzit, E; Baptiste, A; Lefebvre, T; Puy, H; Elie, C; Karim, Z; Ernst, O; Rose, C				de Montalembert, Mariane; Ribeil, Jean-Antoine; Brousse, Valentine; Guerci-Bresler, Agnes; Stamatoullas, Aspasia; Vannier, Jean-Pierre; Dumesnil, Cecile; Lahary, Agnes; Touati, Mohamed; Bouabdallah, Krimo; Cavazzana, Marina; Chauzit, Emmanuelle; Baptiste, Amandine; Lefebvre, Thibaud; Puy, Herve; Elie, Caroline; Karim, Zoubida; Ernst, Olivier; Rose, Christian			Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome	PLOS ONE			English	Article							BETA-THALASSEMIA; DEPENDENT PATIENTS; CHELATION; DISEASE; RESONANCE; ACCUMULATION; MORBIDITY; MORTALITY; CHILDREN; SURVIVAL	The risk and clinical significance of cardiac iron overload due to chronic transfusion varies with the underlying disease. Cardiac iron overload shortens the life expectancy of patients with thalassemia, whereas its effect is unclear in those with myelodysplastic syndromes (MDS). In patients with sickle cell anemia (SCA), iron does not seem to deposit quickly in the heart. Our primary objective was to assess through a multicentric study the prevalence of cardiac iron overload, defined as a cardiovascular magnetic resonance T2*<20 ms, in patients with thalassemia, SCA, or MDS. Patient inclusion criteria were an accurate record of erythrocyte concentrates (ECs) received, a transfusion history >8 ECs in the past year, and age older than 6 years. We included from 9 centers 20 patients with thalassemia, 41 with SCA, and 25 with MDS in 2012-2014. Erythrocytapharesis did not consistently prevent iron overload in patients with SCA. Cardiac iron overload was found in 3 (15%) patients with thalassemia, none with SCA, and 4 (16%) with MDS. The liver iron content (LIC) ranged from 10.4 to 15.2 mg/g dry weight, with no significant differences across groups (P = 0.29). Abnormal T2* was not significantly associated with any of the measures of transfusion or chelation. Ferritin levels showed a strong association with LIC. Non-transferrin-bound iron was high in the thalassemia and MDS groups but low in the SCA group (P<0.001). Hepcidin was low in thalassemia, normal in SCA, and markedly elevated in MDS ( P<0.001). Two mechanisms may explain that iron deposition largely spares the heart in SCA: the high level of erythropoiesis recycles the iron and the chronic inflammation retains iron within the macrophages. Thalassemia, in contrast, is characterized by inefficient erythropoiesis, unable to handle free iron. Iron accumulation varies widely in MDS syndromes due to the competing influences of abnormal erythropoiesis, excess iron supply, and inflammation.	[de Montalembert, Mariane; Brousse, Valentine] Necker Childrens Hosp, AP HP, Dept Pediat, Paris, France; [de Montalembert, Mariane; Brousse, Valentine; Lefebvre, Thibaud; Puy, Herve; Karim, Zoubida] Lab Excellence GR Ex, Paris, France; [Ribeil, Jean-Antoine; Cavazzana, Marina] Necker Childrens Hosp, AP HP, Biotherapy Dept, Paris, France; [Ribeil, Jean-Antoine; Cavazzana, Marina] Grp Hosp Univ Ouest, AP HP, Biotherapy Clin Investigat Ctr, INSERM, Paris, France; [Guerci-Bresler, Agnes] Hop Adultes Brabois, Dept Hematol, Vandoeuvre Les Nancy, France; [Stamatoullas, Aspasia] Ctr Henri Becquerel, Rouen, France; [Vannier, Jean-Pierre; Dumesnil, Cecile] Hop Charles Nicolle, Pediat Oncol & Hematol Unit, Rouen, France; [Lahary, Agnes] Hop Charles Nicolle, Dept Biochem, Rouen, France; [Touati, Mohamed] CHU, Serv Hematol Clin & Therapie Cellulaire, Limoges, France; [Bouabdallah, Krimo] Hop Haut Leveque, Serv Malad Sang, Pessac, France; [Cavazzana, Marina] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, Paris, France; [Cavazzana, Marina] INSERM, UMR 1163, Lab Human Lymphopoiesis, Paris, France; [Chauzit, Emmanuelle] CHU, Dept Pharmacol Clin & Toxicol, Bordeaux, France; [Baptiste, Amandine; Elie, Caroline] Necker Childrens Hosp, AP HP, Paris Descartes Clin Res Unit, Paris, France; [Lefebvre, Thibaud; Puy, Herve; Karim, Zoubida] Ctr Rech Inflammat, INSERM UMR 1149, ERL CNRS 8252, Paris, France; [Lefebvre, Thibaud; Puy, Herve] Louis Mourier Hosp, AP HP, French Ctr Porphyria, Colombes, France; [Ernst, Olivier] CHRU Lille, Hop Huriez, Dept Radiol, Lille, France; [Rose, Christian] Univ Catholique Lille, Hop St Vincent Paul, Hematol Clin, Lille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Nancy; UNICANCER; Centre Henri Becquerel; CHU de Rouen; CHU de Rouen; CHU Limoges; CHU Bordeaux; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite Catholique de Lille	de Montalembert, M (corresponding author), Necker Childrens Hosp, AP HP, Dept Pediat, Paris, France.	mariane.demontal@aphp.fr	PUY, HERVE/O-1785-2017; Ribeil, Jean-Antoine/F-7896-2017; Ribeil, Jean-Antoine/AAK-7979-2020	PUY, HERVE/0000-0003-3362-2634; Ribeil, Jean-Antoine/0000-0002-5733-9123; Ribeil, Jean-Antoine/0000-0002-4549-4783; KARIM, Zoubida/0000-0002-3724-5592; Cavazzana, Marina/0000-0002-0264-0891; Lefebvre, Thibaud/0000-0003-1398-6473	Novartis	Novartis(Novartis)	The authors received funding from Novartis for collecting the data. Novartis had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; Ballas SK, 2001, SEMIN HEMATOL, V38, P30, DOI 10.1053/shem.2001.20142; Borgna-Pignatti C, 2005, ANN NY ACAD SCI, V1054, P40, DOI 10.1196/annals.1345.006; Camaschella C, 2016, BR J HAEMATOL; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; Chauzit E, 2010, THER DRUG MONIT, V32, P476, DOI 10.1097/FTD.0b013e3181d8b37f; Darbari DS, 2006, AM J HEMATOL, V81, P858, DOI 10.1002/ajh.20685; Di Tucci AA, 2008, HAEMATOL-HEMATOL J, V93, P1385, DOI 10.3324/haematol.12759; Drasar E, 2011, BRIT J HAEMATOL, V152, P766, DOI 10.1111/j.1365-2141.2010.08451.x; Ernst O, 2013, Diagn Interv Imaging, V94, P601, DOI 10.1016/j.diii.2013.03.005; Fasano RM, 2016, TRANSFUSION, V56, P1707, DOI 10.1111/trf.13558; Fenaux P, 2009, BLOOD REV, V23, pS15, DOI 10.1016/S0268-960X(09)70005-0; Fung EB, 2008, TRANSFUSION, V48, P1971, DOI 10.1111/j.1537-2995.2008.01775.x; Fung EB, 2007, AM J HEMATOL, V82, P255, DOI 10.1002/ajh.20809; Fung EB, 2006, BRIT J HAEMATOL, V135, P574, DOI 10.1111/j.1365-2141.2006.06332.x; Gandon Y, 2004, LANCET, V363, P357, DOI 10.1016/S0140-6736(04)15436-6; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Hilliard LM, 1998, AM J HEMATOL, V59, P28, DOI 10.1002/(SICI)1096-8652(199809)59:1<28::AID-AJH6>3.0.CO;2-1; Karafin MS, 2015, BLOOD CELL MOL DIS, V55, P304, DOI 10.1016/j.bcmd.2015.07.010; Kaushik N, 2012, PEDIATR HEMAT ONCOL, V29, P254, DOI 10.3109/08880018.2011.630774; KIM HC, 1994, BLOOD, V83, P1136; Kremastinos DT, 2011, CIRCULATION, V124, P2253, DOI 10.1161/CIRCULATIONAHA.111.050773; Lucania G, 2011, BRIT J HAEMATOL, V154, P545, DOI 10.1111/j.1365-2141.2011.08769.x; Meloni A, 2014, AM J HEMATOL, V89, P678, DOI 10.1002/ajh.23721; Modell B, 2000, LANCET, V355, P2051, DOI 10.1016/S0140-6736(00)02357-6; Nemeth E, 2013, BLOOD, V122, P3, DOI 10.1182/blood-2013-05-502617; Noetzli LJ, 2008, BLOOD, V112, P2973, DOI 10.1182/blood-2008-04-148767; Pascal L, 2013, BRIT J HAEMATOL, V162, P413, DOI 10.1111/bjh.12368; Pinto V, 2015, CLIN CASE REP, V3, P952, DOI 10.1002/ccr3.407; Porter J, 2013, HEMATOL-AM SOC HEMAT, P447, DOI 10.1182/asheducation-2013.1.447; Porter JB, 2014, BRIT J HAEMATOL, V167, P692, DOI 10.1111/bjh.13081; Rose C, 2011, LEUKEMIA RES, V34, P864; Roy NBA, 2011, BRIT J HAEMATOL, V154, P521, DOI 10.1111/j.1365-2141.2011.08749.x; Santini V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023109; Shenoy N, 2014, BLOOD, V124, P873, DOI 10.1182/blood-2014-03-563221; Vichinsky E, 2005, AM J HEMATOL, V80, P70, DOI 10.1002/ajh.20402; Walter PB, 2006, BRIT J HAEMATOL, V135, P254, DOI 10.1111/j.1365-2141.2006.06277.x; Wood JC, 2004, BLOOD, V103, P1934, DOI 10.1182/blood-2003-06-1919; Wood JC, 2016, BRIT J HAEMATOL, V172, P122, DOI 10.1111/bjh.13791	40	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172147	10.1371/journal.pone.0172147	http://dx.doi.org/10.1371/journal.pone.0172147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257476	gold, Green Published, Green Submitted			2022-12-27	WOS:000396021100013
J	Hammer, A; Steiner, A; Kerry, G; Ranaie, G; Baer, I; Hammer, CM; Kunze, S; Steiner, HH				Hammer, Alexander; Steiner, Anahi; Kerry, Ghassan; Ranaie, Gholamreza; Baer, Ingrid; Hammer, Christian M.; Kunze, Stefan; Steiner, Hans-Herbert			Treatment of ruptured intracranial aneurysms yesterday and now	PLOS ONE			English	Article							LENGTH-OF-STAY; ENDOVASCULAR TREATMENT; SUBARACHNOID HEMORRHAGE; CEREBRAL ANEURYSMS; SINGLE-CENTER; COILING; TRIAL; OCCLUSION; SURVIVAL	Objective This prospective study is designed to detect changes in the treatment of ruptured intracranial aneurysms over a period of 17 years. Methods We compared 361 treated cases of aneurysm occlusion after subarachnoid hemorrhage from 1997 to 2003 with 281 cases from 2006 to 2014. Specialists of neuroradiology and vascular neurosurgery decided over the modality assignment. We established a prospective data acquisition in both groups to detect significant differences within a follow-up time of one year. With this setting we evaluated the treatment methods over time and compared endovascular with microsurgical treatment. Results When compared to the earlier group, microsurgical treatment was less frequently chosen in the more recent collective because of neck-configuration. Endovascular treatment was chosen more frequently over time (31.9% versus 48.8%). Occurrence of initial symptomatic ischemic stroke was significantly lower in the clipping group compared to the endovascular group and remained stable over time. The number of reinterventions due to refilled treated aneurysms significantly decreased in the endovascular group at one-year follow-up, but the significantly better occlusion-and reintervention-rate of the microsurgical group persisted. The rebleeding rate in the endovascular group at one year follow-up decreased from 6.1% to 2.2% and showed no statistically significant difference to the microsurgical group, anymore (endovascular 2.2% versus microsurgical 0.0%, p = 0.11). Conclusion Microsurgical clipping still has some advantages, however endovascular treatment is improving rapidly.	[Hammer, Alexander; Steiner, Anahi; Kerry, Ghassan; Ranaie, Gholamreza; Steiner, Hans-Herbert] Paracelsus Med Univ, Dept Neurosurg, Nurnberg, Bavaria, Germany; [Baer, Ingrid] Klinikum Nuremberg, Inst Radiol & Neuroradiol, Nurnberg, Bavaria, Germany; [Hammer, Christian M.] Univ Erlangen Nurnberg, Dept Anat 2, Univ Str 19, Erlangen, Bavaria, Germany; [Kunze, Stefan] Heidelberg Univ, Dept Neurosurg, Heidelberg, Baden Wuerttemb, Germany	Klinikum Nurnberg Nord; University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg	Hammer, A (corresponding author), Paracelsus Med Univ, Dept Neurosurg, Nurnberg, Bavaria, Germany.	alexander.hammer@klinikum-nuernberg.de						Ambrosi PB, 2015, INTERV NEURORADIOL, V21, P462, DOI 10.1177/1591019915590083; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; de Vries J, 2014, ACTA NEUROCHIR WIEN, V156, P66; de Vries J, 2014, ACTA NEUROCHIR, V156, P1259, DOI 10.1007/s00701-014-2101-1; Fleming JB, 2011, J NEUROSURG, V114, P1778, DOI 10.3171/2011.1.JNS101232; Hammer A, 2016, WORLD NEUROSURG; Hoh BL, 2004, ACTA NEUROCHIR, V146, P1177, DOI 10.1007/s00701-004-0349-6; Hoh BL, 2010, STROKE, V41, P337, DOI 10.1161/STROKEAHA.109.569269; Hoh BL, 2009, NEUROSURGERY, V64, P614, DOI 10.1227/01.NEU.0000340784.75352.A4; Johnston SC, 2008, STROKE, V39, P120, DOI 10.1161/STROKEAHA.107.495747; Krisht AF, 2006, NEUROSURGERY, V58, P207, DOI 10.1227/01.NEU.0000194638.61073.FC; Lucas CD, 2008, NEUROSURGERY, V62, P414, DOI 10.1227/01.NEU.0000297078.05799.FF; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Molyneux Andrew, 2002, J Stroke Cerebrovasc Dis, V11, P304, DOI 10.1053/jscd.2002.130390; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; O'Kelly CJ, 2010, J NEUROSURG, V113, P795, DOI 10.3171/2009.9.JNS081645; Park HK, 2005, AM J NEURORADIOL, V26, P506; Pierot L, 2015, J NEUROSURG, V18, P1; Piotin M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00041; Piotin M, 2010, STROKE, V41, P110, DOI 10.1161/STROKEAHA.109.558114; Raabe A, 2005, J NEUROSURG, V103, P982, DOI 10.3171/jns.2005.103.6.0982; Ryttlefors M, 2008, STROKE, V39, P2720, DOI 10.1161/STROKEAHA.107.506030; Sedat J, 2009, NEURORADIOLOGY, V51, P401, DOI 10.1007/s00234-009-0502-2; Spetzler RF, 2015, J NEUROSURG, V123, P609, DOI 10.3171/2014.9.JNS141749; Spetzler RF, 2013, J NEUROSURG, V119, P146, DOI 10.3171/2013.3.JNS12683; Sprengers ME, 2008, AM J NEURORADIOL, V29, P1768, DOI 10.3174/ajnr.A1181; Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087; van Rooij WJ, 2009, AM J NEURORADIOL, V30, P1646, DOI 10.3174/ajnr.A1673; Van Rooij WJ, 2014, INTERV NEURORADIOL, V20, P428, DOI 10.15274/NRJ-2014-10047; Zheng Y, 2015, J NEUROINTERV SURG	31	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172837	10.1371/journal.pone.0172837	http://dx.doi.org/10.1371/journal.pone.0172837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257502	Green Submitted, Green Published, gold			2022-12-27	WOS:000396021100029
J	Yasuike, M; Nishiki, I; Iwasaki, Y; Nakamura, Y; Fujiwara, A; Shimahara, Y; Kamaishi, T; Yoshida, T; Nagai, S; Kobayashi, T; Katoh, M				Yasuike, Motoshige; Nishiki, Issei; Iwasaki, Yuki; Nakamura, Yoji; Fujiwara, Atushi; Shimahara, Yoshiko; Kamaishi, Takashi; Yoshida, Terutoyo; Nagai, Satoshi; Kobayashi, Takanori; Katoh, Masaya			Analysis of the complete genome sequence of Nocardia seriolae UTF1, the causative agent of fish nocardiosis: The first reference genome sequence of the fish pathogenic Nocardia species	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IN-VITRO; RESISTANCE; PROTEIN; ANNOTATION; QUINQUERADIATA; DEGRADATION; TRANSPORTER; VIRULENCE; INSIGHTS	Nocardiosis caused by Nocardia seriolae is one of the major threats in the aquaculture of Seriola species (yellowtail; S. quinqueradiata, amberjack; S. dumerili and kingfish; S. lalandi) in Japan. Here, we report the complete nucleotide genome sequence of N. seriolae UTF1, isolated from a cultured yellowtail. The genome is a circular chromosome of 8,121,733 bp with a G+C content of 68.1% that encodes 7,697 predicted proteins. In the N. seriolae UTF1 predicted genes, we found orthologs of virulence factors of pathogenic mycobacteria and human clinical Nocardia isolates involved in host cell invasion, modulation of phagocyte function and survival inside the macrophages. The virulence factor candidates provide an essential basis for understanding their pathogenic mechanisms at the molecular level by the fish nocardiosis research community in future studies. We also found many potential antibiotic resistance genes on the N. seriolae UTF1 chromosome. Comparative analysis with the four existing complete genomes, N. farcinica IFM 10152, N. brasiliensis HUJEG-1 and N. cyriacigeorgica GUH-2 and N. nova SH22a, revealed that 2,745 orthologous genes were present in all five Nocardia genomes (core genes) and 1,982 genes were unique to N. seriolae UTF1. In particular, the N. seriolae UTF1 genome contains a greater number of mobile elements and genes of unknown function that comprise the differences in structure and gene content from the other Nocardia genomes. In addition, a lot of the N. seriolae UTF1-specific genes were assigned to the ABC transport system. Because of limited resources in ocean environments, these N. seriolae UTF1 specific ABC transporters might facilitate adaptation strategies essential for marine environment survival. Thus, the availability of the complete N. seriolae UTF1 genome sequence will provide a valuable resource for comparative genomic studies of N. seriolae isolates, as well as provide new insights into the ecological and functional diversity of the genus Nocardia.	[Yasuike, Motoshige; Nishiki, Issei; Iwasaki, Yuki; Nakamura, Yoji; Fujiwara, Atushi; Nagai, Satoshi; Katoh, Masaya] Japan Fisheries Res & Educ Agcy, Natl Res Inst Fisheries Sci, Res Ctr Bioinformat & Biosci, Yokohama, Kanagawa, Japan; [Shimahara, Yoshiko] Japan Fisheries Res & Educ Agcy, Natl Res Inst Aquaculture, Res Ctr Fish Dis, Saiki, Oita, Japan; [Kamaishi, Takashi] Minist Agr Forestry & Fisheries, Fisheries Agcy, Chiyoda Ku, Tokyo, Japan; [Yoshida, Terutoyo] Miyazaki Univ, Fac Agr, Miyazaki, Japan; [Kobayashi, Takanori] Japan Fisheries Res & Educ Agcy, Headquarters, Yokohama, Kanagawa, Japan; [Iwasaki, Yuki] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka, Japan	Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Ministry of Agriculture Forestry & Fisheries - Japan; University of Miyazaki; Japan Fisheries Research & Education Agency (FRA); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Yasuike, M; Fujiwara, A (corresponding author), Japan Fisheries Res & Educ Agcy, Natl Res Inst Fisheries Sci, Res Ctr Bioinformat & Biosci, Yokohama, Kanagawa, Japan.	yasuike@affrc.go.jp; jiwara@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This study was supported by a Grant-in-Aid (Marine Metagenomics for Monitoring the Coastal Microbiota) from the Ministry of Agriculture, Forestry and Fisheries of Japan (There are no grant number and the URLs.). (MK, T. Kobayashi, AF, SN, YS, T. Kamaishi, YN and MY received the funding).	Akhtar S, 2013, J BACTERIOL, V195, P4592, DOI 10.1128/JB.00698-13; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; BEAMAN BL, 1985, INFECT IMMUN, V47, P135, DOI 10.1128/IAI.47.1.135-141.1985; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Casali N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-60; Chen LH, 2016, NUCLEIC ACIDS RES, V44, pD694, DOI 10.1093/nar/gkv1239; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DeJongh M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-139; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Fraser CM, 2002, J BACTERIOL, V184, P6403, DOI 10.1128/JB.184.23.6403-6405.2002; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; Gonzalez-Carrillo C, 2016, INFECT IMMUN, V84, P2595, DOI 10.1128/IAI.00329-16; Hahn JS, 2002, J BACTERIOL, V184, P5214, DOI 10.1128/JB.184.19.5214-5222.2002; Hashemi-Shahraki A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17862; Imajoh M, 2016, GENOME ANNOUNC, V4; Imajoh M, 2015, GENOME ANNOUNC, V3; Ishikawa J, 2004, P NATL ACAD SCI USA, V101, P14925, DOI 10.1073/pnas.0406410101; Ismail TF, 2012, FISHERIES SCI, V78, P351, DOI 10.1007/s12562-011-0450-8; Ismail TF, 2011, FISH PATHOL, V46, P62, DOI 10.3147/jsfp.46.62; Ismail TF, 2011, FISHERIES SCI, V77, P113, DOI 10.1007/s12562-010-0302-y; Itano T, 2006, FISH PATHOL, V41, P135, DOI 10.3147/jsfp.41.135; Kandi V, 2015, CUREUS, V7, DOI 10.7759/cureus.304; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; Kariya T., 1968, FISH PATHOL, V3, P16, DOI [10.3147/jsfp.3.16, DOI 10.3147/JSFP.3.16]; Khan A, 2012, MICROBIOL-SGM, V158, P301, DOI 10.1099/mic.0.054759-0; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Koshkin A, 2004, ARCH BIOCHEM BIOPHYS, V427, P41, DOI 10.1016/j.abb.2004.04.017; Koshkin A, 2003, J BIOL CHEM, V278, P29502, DOI 10.1074/jbc.M303747200; Kristensen DM, 2010, BIOINFORMATICS, V26, P1481, DOI 10.1093/bioinformatics/btq229; KUDO T, 1988, INT J SYST BACTERIOL, V38, P173, DOI 10.1099/00207713-38-2-173; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; KUSUDA R, 1989, NIPPON SUISAN GAKK, V55, P1183; Labrie L., 2008, DIS ASIAN AQUACULTUR, P297; Lerner PI, 1996, CLIN INFECT DIS, V22, P891, DOI 10.1093/clinids/22.6.891; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Liu H, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00013; Luo Q, 2014, APPL ENVIRON MICROB, V80, P3895, DOI 10.1128/AEM.00473-14; Luo Q, 2014, ENVIRON MICROBIOL, V16, P29, DOI 10.1111/1462-2920.12221; Martino MC, 2001, INFECT IMMUN, V69, P1697, DOI 10.1128/IAI.69.3.1697-1703.2001; Miyamoto M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-699; Nakamura Y, 2016, GENE, V576, P676, DOI 10.1016/j.gene.2015.10.029; Nayak SK, 2014, FISH SHELLFISH IMMUN, V39, P354, DOI 10.1016/j.fsi.2014.05.015; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rahman A, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-35; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Rodriguez RL, MICROBE MAGAZINE; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Seo KS, 2012, INFECT IMMUN, V80, P3559, DOI 10.1128/IAI.00294-12; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Shimahara Y, 2008, J FISH DIS, V31, P481, DOI 10.1111/j.1365-2761.2008.00920.x; Shimahara Y, 2009, AQUACULTURE, V294, P165, DOI 10.1016/j.aquaculture.2009.06.017; Shin SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068824; Stadermann KB, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0726-6; Strauss EJ, 1997, SCIENCE, V276, P707, DOI 10.1126/science.276.5313.707; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Tamura T, 2012, ANTON LEEUW INT J G, V102, P481, DOI 10.1007/s10482-012-9780-5; Tang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041204; Tikhonova EB, 2007, MOL MICROBIOL, V63, P895, DOI 10.1111/j.1365-2958.2006.05549.x; Tillier ERM, 2000, NAT GENET, V26, P195, DOI 10.1038/79918; Varaldo PE, 2009, ANTIMICROB AGENTS CH, V53, P343, DOI 10.1128/AAC.00781-08; Vera-Cabrera L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065425; Verma H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1014; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992; Xia L, 2015, GENOME ANNOUNC, V3; Zhang F, 2011, MOL CELL BIOCHEM, V352, P1, DOI 10.1007/s11010-011-0733-5; Zhou B, 2010, P NATL ACAD SCI USA, V107, P4573, DOI 10.1073/pnas.0909133107; Zimmerli S, 1996, J CELL BIOL, V132, P49, DOI 10.1083/jcb.132.1.49; Zoropogui A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-286	77	26	29	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173198	10.1371/journal.pone.0173198	http://dx.doi.org/10.1371/journal.pone.0173198			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257489	Green Submitted, gold, Green Published			2022-12-27	WOS:000396021100074
J	Jamnadass, ESL; Keelan, JA; Russell-Smith, SN; Hickey, M; Maybery, MT; Whitehouse, AJO				Jamnadass, Esha S. L.; Keelan, Jeffrey A.; Russell-Smith, Suzanna N.; Hickey, Martha; Maybery, Murray T.; Whitehouse, Andrew J. O.			Umbilical cord androgens and estrogens in relation to verbal and nonverbal abilities at age 10 in the general population	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; PRENATAL TESTOSTERONE LEVELS; SEX-DIFFERENCES; MENTAL ROTATION; FETAL TESTOSTERONE; SOCIOECONOMIC-STATUS; LANGUAGE-DEVELOPMENT; COGNITIVE-ABILITIES; SPATIAL ABILITY; YOUNG-ADULTS	Sex differences in verbal and nonverbal abilities are a contentious area of research. Prenatal steroids have been shown to have masculinizing effects on the brain that may affect the development of nonverbal and verbal abilities in later life. The current study examined a wide range of biologically active sex steroids (both androgens and estrogens) in umbilical cord blood at birth in a large pregnancy cohort in relation to performance on nonverbal (Raven's Coloured Progressive Matrices) and verbal (Clinical Evaluation of Language Fundamentals-3 and the Peabody Picture Vocabulary Test-III) measures at age 10 years. Overall, Androgen and Estrogen composites in cord blood were not found to be predictive of performance on verbal and nonverbal measures at age 10. These data suggest that late gestation sex steroids do not exert a major effect on nonverbal and verbal abilities in middle childhood.	[Jamnadass, Esha S. L.; Russell-Smith, Suzanna N.; Maybery, Murray T.] Univ Western Australia, Sch Psychol, Perth, WA, Australia; [Jamnadass, Esha S. L.; Whitehouse, Andrew J. O.] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Keelan, Jeffrey A.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA, Australia; [Hickey, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Hickey, Martha] Royal Womens Hosp, Melbourne, Vic, Australia	University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Melbourne	Jamnadass, ESL (corresponding author), Univ Western Australia, Sch Psychol, Perth, WA, Australia.	esha.jamnadass@research.uwa.edu.au	Whitehouse, Andrew J.O./AGJ-2519-2022; Keelan, Jeffrey/G-2170-2011	Whitehouse, Andrew J.O./0000-0001-8722-1575; Keelan, Jeffrey/0000-0002-5403-6266; Maybery, Murray/0000-0002-3760-1382	University of Western Australia (UWA); Curtin University; Edith Cowan University; UWA Faculty of Medicine, Dentistry and Health Sciences; Raine Medical Research Foundation; Telethon Kids Institute; Women's and Infants Research Foundation; NHMRC [403968, 1003424, 1004065]; Australian Rotary Health; Women and Infants' Research Foundation	University of Western Australia (UWA); Curtin University; Edith Cowan University; UWA Faculty of Medicine, Dentistry and Health Sciences; Raine Medical Research Foundation; Telethon Kids Institute; Women's and Infants Research Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Rotary Health; Women and Infants' Research Foundation	The authors would like to acknowledge the National Health and Medical Research Council (NHMRC) and the Telethon Kids Institute for their long term contribution to funding the Raine study over the last 20 years. Core Management of the Raine study has been funded by the University of Western Australia (UWA), Curtin University, Edith Cowan University, the UWA Faculty of Medicine, Dentistry and Health Sciences, the Raine Medical Research Foundation, the Telethon Kids Institute, and the Women's and Infants Research Foundation. The two-year follow-up was funded by the NHMRC and the Raine Medical Research Foundation, and funding from the NHMRC (#403968) and Australian Rotary Health was used for the androgen analysis. AJOW (#1004065) and MH are funded by Career Development Fellowships from the NHMRC; JAK is funded by the Women and Infants' Research Foundation. This study was partly funded by NHMRC Project Grant # 1003424. The authors are extremely grateful to the study participants and their families, as well as the whole Raine Study Team which includes the Cohort Manager, Data Manager and data collection researchers.	ABRAMOVICH DR, 1974, J OBSTET GYN BR COMM, V81, P448; Alwin DF, 2001, J GERONTOL B-PSYCHOL, V56, pS151, DOI 10.1093/geronb/56.3.S151; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Auyeung B, 2012, PRIMATE MIND BUILT C, P194; Auyeung B, 2013, PFLUG ARCH EUR J PHY, V465, P557, DOI 10.1007/s00424-013-1268-2; Auyeung B, 2012, ARCH SEX BEHAV, V41, P571, DOI 10.1007/s10508-011-9864-8; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Berenbaum SA, 2012, BEHAV NEUROSCI, V126, P86, DOI 10.1037/a0026652; Blair Eve M, 2005, BMC Pediatr, V5, P13, DOI 10.1186/1471-2431-5-13; BOCHNER S, 1978, PSYCHOL SCHOOLS, V15, P320, DOI 10.1002/1520-6807(197807)15:3<320::AID-PITS2310150302>3.0.CO;2-B; Cohen-Bendahan CCC, 2005, NEUROSCI BIOBEHAV R, V29, P353, DOI 10.1016/j.neubiorev.2004.11.004; Dart D., 2014, J ENDOCR DISORD, V1, P1005; Dunn L.M., 1981, PEABODY PICTURE VOCA; FAIRWEATHER H, 1976, COGNITION, V4, P231, DOI 10.1016/0010-0277(76)90019-6; FINEGAN JAK, 1992, DEV PSYCHOL, V28, P1075, DOI 10.1037/0012-1649.28.6.1075; Galsworthy MJ, 2000, DEVELOPMENTAL SCI, V3, P206, DOI 10.1111/1467-7687.00114; GRIMSHAW GM, 1995, BRAIN COGNITION, V29, P85, DOI 10.1006/brcg.1995.1269; Halpern D.F., 2013, SEX DIFFERENCES COGN, V4; HAMPSON E, 1995, J PSYCHIATR NEUROSCI, V20, P397; Hampson E, 1998, DEV NEUROPSYCHOL, V14, P299, DOI 10.1080/87565649809540713; Hampson E, 2015, PSYCHONEUROENDOCRINO, V54, P60, DOI 10.1016/j.psyneuen.2015.01.022; Hampson E, 2014, HORM BEHAV, V65, P238, DOI 10.1016/j.yhbeh.2013.12.016; HEDGES LV, 1995, SCIENCE, V269, P41, DOI 10.1126/science.7604277; Hegarty M., 2005, CAM BRIDGE HDB VISUO, P121, DOI DOI 10.1017/CBO9780511610448.005; Hines M, 2003, BRAIN GENDER; Hines M, 2011, ANNU REV NEUROSCI, V34, P69, DOI 10.1146/annurev-neuro-061010-113654; Hines M, 2010, TRENDS COGN SCI, V14, P448, DOI 10.1016/j.tics.2010.07.005; Hoff-Ginsberg E, 1998, APPL PSYCHOLINGUIST, V19, P603, DOI 10.1017/S0142716400010389; Hollier LP, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00064; Hollier LP, 2013, BIOL PSYCHOL, V92, P212, DOI 10.1016/j.biopsycho.2012.10.016; Hollier LP, 2014, ADULT DIGIT RATIO 2D; Hutson JM., 2012, DISOERDERS SEX DEV, P23; HUTTENLOCHER J, 1991, DEV PSYCHOL, V27, P236, DOI 10.1037/0012-1649.27.2.236; Hyde JS, 2014, ANNU REV PSYCHOL, V65, P373, DOI 10.1146/annurev-psych-010213-115057; HYDE JS, 1988, PSYCHOL BULL, V104, P53, DOI 10.1037/0033-2909.104.1.53; JACKLIN CN, 1988, DEV PSYCHOBIOL, V21, P567, DOI 10.1002/dev.420210607; Jamnadass ESL, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9114-9; Keelan JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042827; Kimura D, 2003, SEX DIFFERENCES IN C; Knickmeyer R, 2014, FRONTIERS ENDOCRINOL, P5; Knickmeyer RC, 2006, EARLY HUM DEV, V82, P755, DOI 10.1016/j.earlhumdev.2006.09.014; Kraus C, 2008, M PLANCK I DEMOGRAPH, V1, P2008; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.1111/j.1467-8624.1985.tb00213.x; Lutchmaya S, 2002, INFANT BEHAV DEV, V25, P319, DOI 10.1016/S0163-6383(02)00095-4; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Lynn R, 2004, INTELLIGENCE, V32, P481, DOI 10.1016/j.intell.2004.06.008; Mazer NA, 2009, STEROIDS, V74, P512, DOI 10.1016/j.steroids.2009.01.008; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Pungello EP, 2009, DEV PSYCHOL, V45, P544, DOI 10.1037/a0013917; Puts DA, 2008, ARCH SEX BEHAV, V37, P100, DOI 10.1007/s10508-007-9271-3; Quinn PC, 2008, PSYCHOL SCI, V19, P1067, DOI 10.1111/j.1467-9280.2008.02201.x; Raven J, 2003, HANDBOOK OF NONVERBAL ASSESSMENT, P223; Raven J.C., 1938, PROGR MATRICES PERCE; RESKO JA, 1975, ENDOCRINOLOGY, V97, P425, DOI 10.1210/endo-97-2-425; RESNICK SM, 1986, DEV PSYCHOL, V22, P191, DOI 10.1037/0012-1649.22.2.191; Reynolds CR, 2007, ENCY SPECIAL ED; Sartorius G, 2009, ANN CLIN BIOCHEM, V46, P137, DOI 10.1258/acb.2008.008171; Semel E, 1997, CELF 3 CLIN EVALUATI; SERONFERRE M, 1993, ENDOCR REV, V14, P594, DOI 10.1210/er.14.5.594; SLOB AK, 1980, J ENDOCRINOL, V87, P81, DOI 10.1677/joe.0.0870081; TAN U, 1990, INT J NEUROSCI, V54, P283, DOI 10.3109/00207459008986645; TAN U, 1992, INT J NEUROSCI, V64, P213, DOI 10.3109/00207459209000548; Valla JM, 2011, PERSPECT PSYCHOL SCI, V6, P134, DOI 10.1177/1745691611400236; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Voyer D, 2011, PSYCHON B REV, V18, P267, DOI 10.3758/s13423-010-0042-0; WABER DP, 1976, SCIENCE, V192, P572, DOI 10.1126/science.1257795; Wallen K., 2002, HORMONES BRAIN BEHAV, P385, DOI DOI 10.1016/B978-012532104-4/50071-8; Wallentin M, 2009, BRAIN LANG, V108, P175, DOI 10.1016/j.bandl.2008.07.001; Whitehouse AJO, 2012, J CHILD PSYCHOL PSYC, V53, P726, DOI 10.1111/j.1469-7610.2011.02523.x; Whitehouse AJO, 2010, PSYCHONEUROENDOCRINO, V35, P1259, DOI 10.1016/j.psyneuen.2010.02.007; WILLIAMS CL, 1991, PSYCHONEUROENDOCRINO, V16, P155, DOI 10.1016/0306-4530(91)90076-6; ZLOTKIN SH, 1987, CLIN CHEM, V33, P411	74	1	1	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173493	10.1371/journal.pone.0173493	http://dx.doi.org/10.1371/journal.pone.0173493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278304	Green Published, gold			2022-12-27	WOS:000396087900002
J	Kamthan, A; Kamthan, M; Datta, A				Kamthan, Ayushi; Kamthan, Mohan; Datta, Asis			Expression of C-5 sterol desaturase from an edible mushroom in fisson yeast enhances its ethanol and thermotolerance	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SIMULTANEOUS SACCHARIFICATION; OXALATE DECARBOXYLASE; GENE; TOLERANCE; CLONING; IDENTIFICATION; BIOSYNTHESIS; ERGOSTEROL; GROWTH	Bioethanol is an environment friendly and renewable source of energy produced by the fermentation of agricultural raw material by a variety of microorganisms including yeast. Obtaining yeast strains that are tolerant to stresses like high levels of ethanol and high temperature is highly desirable as it reduces cost and increases yield during bioethanol production. Here, we report that heterologous expression of C-5 Sterol desaturase (FvC5SD)-an ergosterol biosynthesis enzyme from an edible mushroom Flammulina velutipes in fission yeast, not only imparts increased thermotolerance but also tolerance towards high ethanol concentration and low pH. This tolerance could be attributed to an increase of approximate to 1.5 fold in the level of ergosterol and oleic acid (C-18 unsaturated fatty acid) as analysed by gas chromatography-mass spectrometry. FvC5SD is a membrane localized iron binding enzyme that introduces double bond at C-5 position into the Delta 7-sterol substrates to yield Delta 5,7-sterols as products. In F.velutipes, FvC5SD transcript was observed to be upregulated by approximate to 5 fold under low pH condition and by approximate to 9 folds and approximate to 5 fold at 40 degrees C and 4 degrees C respectively when compared to normal growth temperature of 23 degrees C. Besides, susceptibility to cell wall inhibiting drugs like Congo red and Calcoflour white was also found to increase in FvC5SD expressing S. pombe strain. Alteration in membrane sterol and fatty acid composition could also lead to increase in susceptibility to cell wall inhibiting drugs. Thus, this study has immense industrial application and can be employed to ensure competitiveness of fermentation process.	[Kamthan, Ayushi; Kamthan, Mohan; Datta, Asis] Natl Inst Plant Genome Res, New Delhi, India; [Kamthan, Mohan] Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Datta, A (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	asis_datta@rediffmail.com		Kamthan, Mohan/0000-0001-8859-4699	Council of Scientific and Industrial Research; Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/01/CEIB/12/11/01]; Department of Biotechnology, Government of India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	AK thanks Council of Scientific and Industrial Research for fellowship. AD thanks Department of Biotechnology, Ministry of Science and Technology, Government of India. (BT/01/CEIB/12/11/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank confocal facility, NIPGR for immunoflourescence microscopy. AK thanks Council of Scientific and Industrial Research for fellowship. AD thanks Department of Biotechnology, Government of India, for funding the project. This article does not contain any studies with human participants or animals performed by any of the authors.	Abubaker H.O., 2012, J MICROBIOL RES, V2, P36, DOI 10.5923/j.microbiology.20120202.06; Alcazar-Fuoli L, 2006, ANTIMICROB AGENTS CH, V50, P453, DOI 10.1128/AAC.50.2.453-460.2006; ARTHINGTON BA, 1991, GENE, V102, P39, DOI 10.1016/0378-1119(91)90535-J; ArthingtonSkaggs BA, 1996, FEBS LETT, V392, P161, DOI 10.1016/0014-5793(96)00807-1; Azam M, 2002, BIOCHEM J, V367, P67, DOI 10.1042/BJ20011573; BANAT IM, 1992, WORLD J MICROB BIOT, V8, P259, DOI 10.1007/BF01201874; Banat IM, 1998, WORLD J MICROB BIOT, V14, P809, DOI 10.1023/A:1008802704374; BREIVIK ON, 1957, J AGR FOOD CHEM, V5, P360, DOI 10.1021/jf60075a005; Brumfield KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008659; CASEY GP, 1986, CRC CR REV MICROBIOL, V13, P219, DOI 10.3109/10408418609108739; Dahiya P, 2016, SCI REP-UK, V6, DOI 10.1038/srep27967; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Fiedurek J, 2011, POL J MICROBIOL, V60, P51, DOI 10.33073/pjm-2011-007; Forsburg Susan L, 2005, Gravit Space Biol Bull, V18, P3; Gachotte D, 1996, PLANT J, V9, P391, DOI 10.1046/j.1365-313X.1996.09030391.x; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GEBER A, 1995, ANTIMICROB AGENTS CH, V39, P2708, DOI 10.1128/AAC.39.12.2708; Ghosh D, 2000, NUCLEIC ACIDS RES, V28, P308, DOI 10.1093/nar/28.1.308; Guan WJ, 2016, BIORESOURCE TECHNOL, V200, P713, DOI 10.1016/j.biortech.2015.10.102; Hongay C, 2002, EMBO J, V21, P4114, DOI 10.1093/emboj/cdf415; Husselstein T, 1999, PLANT MOL BIOL, V39, P891, DOI 10.1023/A:1006113919172; Imai K, 2005, J BIOL CHEM, V280, P8275, DOI 10.1074/jbc.M409428200; INGRAM LO, 1984, ADV MICROB PHYSIOL, V25, P253; Inoue T, 2000, BIOSCI BIOTECH BIOCH, V64, P229, DOI 10.1271/bbb.64.229; Waki T, 2008, MICROBIOL-SGM, V154, P830, DOI 10.1099/mic.0.2007/011155-0; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Kadar Z, 2004, IND CROP PROD, V20, P103, DOI 10.1016/j.indcrop.2003.12.015; Kamthan A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00951; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Kawahata M, 2006, FEMS YEAST RES, V6, P924, DOI 10.1111/j.1567-1364.2006.00089.x; KAWATA S, 1985, J BIOL CHEM, V260, P6609; Kim J, 1996, APPL ENVIRON MICROB, V62, P1563, DOI 10.1128/AEM.62.5.1563-1569.1996; Kontoyiannis DP, 2002, LANCET, V359, P1135, DOI 10.1016/S0140-6736(02)08162-X; Limtong S, 2007, BIORESOURCE TECHNOL, V98, P3367, DOI 10.1016/j.biortech.2006.10.044; Linde M, 2008, BIOMASS BIOENERG, V32, P326, DOI 10.1016/j.biombioe.2007.09.013; LLOYD D, 1993, YEAST, V9, P825, DOI 10.1002/yea.320090803; Ly HV, 2002, LANGMUIR, V18, P8988, DOI 10.1021/la026010q; Matsushima M, 1996, CYTOGENET CELL GENET, V74, P252, DOI 10.1159/000134427; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MEHTA A, 1991, J BIOL CHEM, V266, P23548; Miyazaki Y, 1999, GENE, V236, P43, DOI 10.1016/S0378-1119(99)00263-2; Munn AL, 1999, MOL BIOL CELL, V10, P3943, DOI 10.1091/mbc.10.11.3943; NES WR, 1988, J BIOL CHEM, V263, P11844; NOVOTNY C, 1992, FOLIA MICROBIOL, V37, P43, DOI 10.1007/BF02814578; Nusblat AD, 2009, EUKARYOT CELL, V8, P1287, DOI 10.1128/EC.00057-09; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; OSUMI T, 1979, J BIOCHEM-TOKYO, V85, P819; PARKS LW, 1982, LIPIDS, V17, P187, DOI 10.1007/BF02535102; PESTI M, 1981, CURR MICROBIOL, V5, P187, DOI 10.1007/BF01578527; SMITH SJ, 1993, YEAST, V9, P1177, DOI 10.1002/yea.320091104; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Sturley SL, 2000, BBA-MOL CELL BIOL L, V1529, P155, DOI 10.1016/S1388-1981(00)00145-1; SUUTARI M, 1990, J GEN MICROBIOL, V136, P1469, DOI 10.1099/00221287-136-8-1469; Takagi H, 2005, APPL ENVIRON MICROB, V71, P8656, DOI 10.1128/AEM.71.12.8656-8662.2005; Taton M, 1996, ARCH BIOCHEM BIOPHYS, V325, P279, DOI 10.1006/abbi.1996.0035; Teixeira MC, 2009, APPL ENVIRON MICROB, V75, P5761, DOI 10.1128/AEM.00845-09; THOMAS DS, 1978, ARCH MICROBIOL, V117, P239, DOI 10.1007/BF00738541; Vik A, 2001, MOL CELL BIOL, V21, P6395, DOI 10.1128/MCB.21.19.6395-6405.2001; Vogl C, 2008, J BIOL CHEM, V283, P7379, DOI 10.1074/jbc.M708275200; Wachtler V, 2003, J CELL SCI, V116, P867, DOI 10.1242/jcs.00299; WATSON K, 1982, BIOTECHNOL LETT, V4, P397, DOI 10.1007/BF00135429; West AG, 1999, J MOL BIOL, V286, P1311, DOI 10.1006/jmbi.1999.2576; Yoshikawa K, 2009, FEMS YEAST RES, V9, P32, DOI 10.1111/j.1567-1364.2008.00456.x; You KM, 2003, APPL ENVIRON MICROB, V69, P1499, DOI 10.1128/AEM.69.3.1499-1503.2003	64	17	19	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173381	10.1371/journal.pone.0173381	http://dx.doi.org/10.1371/journal.pone.0173381			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278249	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900081
J	Park, JW; Park, KH; Jung, EY				Park, Jeong Woo; Park, Kyo Hoon; Jung, Eun Young			Clinical significance of histologic chorioamnionitis with a negative amniotic fluid culture in patients with preterm labor and premature membrane rupture	PLOS ONE			English	Article							ACUTE INFLAMMATORY LESIONS; INTRAAMNIOTIC INFECTION; GESTATIONAL-AGE; PREDICTIVE-VALUE; RISK-FACTOR; PLACENTA; DELIVERY; CYTOKINES; MORBIDITY; INVASION	Objective To evaluate the effect of histological chorioamnionitis (HCA) with a negative amniotic fluid (AF) culture on adverse pregnancy and neonatal outcomes and inflammatory status in the AF compartment in women with preterm labor or preterm premature rupture of membranes (PPROM). Methods This is a retrospective cohort study of 153 women diagnosed as having a preterm labor or PPROM (20-34 weeks) who delivered singleton gestations within 48 hours of amniocentesis. AF obtained through amniocentesis was cultured, and interleukin (IL)-6, IL-8, and metalloproteinase-9 (MMP-9) levels were determined. The placentas were examined histologically. Results The prevalence of HCA with negative AF culture was 23.5% (36/153). The women with HCA but with a negative AF culture (group 2) and those with a positive AF culture (group 3) had a significantly lower mean gestational age at amniocentesis and delivery than those with a negative AF culture and without HCA (group 1). Women in group 3 had the highest levels of AF IL-6, IL-8, and MMP-9, followed by those in group 2, and those in group 1. Composite neonatal morbidity was significantly higher in groups 2 and 3 than in group 1, but this was no longer significant after adjusting for confounders caused mainly by the impact of gestational age. Discussion In the women who delivered preterm neonates, HCA with a negative AF culture was associated with increased risks of preterm birth, intense intra-amniotic inflammatory response, and prematurity-associated composite neonatal morbidity, and its risks are similar to the risk posed by positive AF culture.	[Park, Jeong Woo; Park, Kyo Hoon] Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Park, Jeong Woo] Inje Univ, Coll Med, Dept Obstet & Gynecol, Ilsan Paik Hosp, Gyeonggi, South Korea; [Park, Kyo Hoon; Jung, Eun Young] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam, South Korea	Seoul National University (SNU); Inje University; Seoul National University (SNU)	Park, KH (corresponding author), Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea.; Park, KH (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam, South Korea.	pkh0419@snubh.org		Park, Jeong Woo/0000-0001-6499-0814	Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI 14C1798]	Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (Grant No. HI 14C1798).	Bersani I, 2012, J MATERN-FETAL NEO M, V25, P12, DOI 10.3109/14767058.2012.663161; Combs CA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.032; GIBBS RS, 1982, J INFECT DIS, V145, P1, DOI 10.1093/infdis/145.1.1; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; GYR TN, 1994, AM J OBSTET GYNECOL, V170, P223; HILLIER SL, 1993, OBSTET GYNECOL, V81, P941; Holst RM, 2006, ULTRASOUND OBST GYN, V28, P768, DOI 10.1002/uog.3837; Jacobsson B, 2009, ACTA OBSTET GYN SCAN, V88, P63, DOI 10.1080/00016340802572646; Kacerovsky M, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.028; Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040; Lau J, 2005, AM J OBSTET GYNECOL, V193, P708, DOI 10.1016/j.ajog.2005.01.017; Lee SY, 2013, J KOREAN MED SCI, V28, P1226, DOI 10.3346/jkms.2013.28.8.1226; Lee Y, 2015, J PERINAT MED, V43, P259, DOI 10.1515/jpm-2014-0035; Menon R, 2010, PLACENTA, V31, P113, DOI 10.1016/j.placenta.2009.11.012; Odibo A O, 1999, J Perinatol, V19, P407, DOI 10.1038/sj.jp.7200210; Oh KJ, 2011, PLACENTA, V32, P732, DOI 10.1016/j.placenta.2011.07.080; Park KH, 2012, REPROD SCI, V19, P658, DOI 10.1177/1933719111432869; Pettker CM, 2007, OBSTET GYNECOL, V109, P739, DOI 10.1097/01.AOG.0000255663.47512.23; Rodriguez-Trujillo A, 2016, ACTA OBSTET GYN SCAN, V95, P926, DOI 10.1111/aogs.12905; ROMERO R, 1992, AM J OBSTET GYNECOL, V166, P1382, DOI 10.1016/0002-9378(92)91609-E; Ryu A, 2013, ACTA OBSTET GYN SCAN, V92, P517, DOI 10.1111/aogs.12073; Thomas W, 2011, NEONATOLOGY, V99, P177, DOI 10.1159/000320170; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4	23	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173312	10.1371/journal.pone.0173312	http://dx.doi.org/10.1371/journal.pone.0173312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278303	Green Submitted, gold, Green Published			2022-12-27	WOS:000396087900072
J	Sousa, GR; Gomes, JAS; Damasio, MPS; Nunes, MCP; Costa, HS; Medeiros, NI; Fares, RCG; Chaves, AT; Correa-Oliveira, R; Rocha, MOC				Sousa, Giovane R.; Gomes, Juliana A. S.; Damasio, Marcos Paulo S.; Nunes, Maria Carmo P.; Costa, Henrique S.; Medeiros, Nayara I.; Fares, Rafaelle C. G.; Chaves, Ana Thereza; Correa-Oliveira, Rodrigo; Rocha, Manoel Otavio C.			The role of interleukin 17-mediated immune response in Chagas disease: High level is correlated with better left ventricular function	PLOS ONE			English	Article							T-CELLS; IL-17; CARDIOMYOPATHY; ECHOCARDIOGRAPHY; ASSOCIATION; MANAGEMENT; CAPACITY	Interleukin 17A (IL-17A) has been associated with protective rather than pathogenic response in Chagas disease (ChD). However, it is not established whether or not IL-17Amediated immune response is correlated with patient's left ventricular (LV) function in ChD. To address this question we have gathered cardiac functional parameters from ChD patients and analysed the possible relationship between their plasma IL-17A levels and LV function. Plasma IL-17A levels were measured by BD Cytometric Bead Array (CBA) in 240 patients with positive specific serology for Trypanosoma cruzi (T. cruzi) grouped as indeterminate (IND) and Chagas cardiomyopathy (CARD) forms. The levels of IL-17A in ChD patients were compared with 32 healthy individuals, mean age of 39 years, 50% male, that were also included as a control group (non-infected [NI]). The overall mean age of ChD patients was 46 years and 52% were male. The IND group included 95 asymptomatic patients, with ages ranging from 27 to 69 years (mean of 43 years), and 42.1% of them were male. The CARD group included 145 patients, which 58.6% were male, with ages ranging from 23 to 67 years (mean of 49). The IND group presented substantially higher levels of IL17A, median of 26.16 (3.66-48.33) as compared to both the CARD group, median of 13.89 (3.87-34.54) (P < 0.0001), and the NI group, median of 10.78 (6.23-22.26) (P < 0.0001). The data analysis demonstrated that the IND group comprises a significantly greater proportion (P < 0.001) of high IL-17A producers (52.6%, 50 of 95 subjects) than do the other groups. A significant direct correlation was verified between IL-17A levels and cardiac function expressed by LV ejection fraction (LVEF), LV diastolic diameter (LVDd), and body surface area (BSA)-indexed LVDd as well as ratio of the early diastolic transmitral flow velocity to early diastolic mitral annular velocity (E/e') in both groups. We demonstrated that plasma IL17A levels has an accurate sensitivity and specificity to predict heart failure in serology-positive patients and might be a useful parameter to distinguish patients with or without cardiac impairment. This study indicates a consistent relationship between high expression of IL17A and better LV in human chronic ChD. Our data raise the possibility that IL-17A plays an important immunomodulatory role in the chronic phase of ChD and might be involved in protection against myocardial damage.	[Sousa, Giovane R.; Gomes, Juliana A. S.; Nunes, Maria Carmo P.; Costa, Henrique S.; Chaves, Ana Thereza; Rocha, Manoel Otavio C.] Univ Fed Minas Gerais, Sch Med, Postgrad Course Infect Dis & Trop Med, Belo Horizonte, MG, Brazil; [Gomes, Juliana A. S.; Damasio, Marcos Paulo S.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Lab Cell Cell Interact, Belo Horizonte, MG, Brazil; [Medeiros, Nayara I.; Fares, Rafaelle C. G.; Correa-Oliveira, Rodrigo] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Cellular & Mol Immunol, Belo Horizonte, MG, Brazil; [Correa-Oliveira, Rodrigo] Natl Inst Sci & Technol Trop Dis INCT DT, Belo Horizonte, MG, Brazil; [Sousa, Giovane R.] Harvard Med Sch, Joslin Diabet Ctr, Immunobiol Sect, Boston, MA 02115 USA; [Damasio, Marcos Paulo S.] Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Dundee, Scotland; [Fares, Rafaelle C. G.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Dundee; US Food & Drug Administration (FDA)	Sousa, GR (corresponding author), Univ Fed Minas Gerais, Sch Med, Postgrad Course Infect Dis & Trop Med, Belo Horizonte, MG, Brazil.; Sousa, GR (corresponding author), Harvard Med Sch, Joslin Diabet Ctr, Immunobiol Sect, Boston, MA 02115 USA.	giovane.sousa@gmail.com	Gomes, Juliana A. S./M-4083-2017; Medeiros, Nayara I/F-3273-2018; Nunes, Maria Carmo/AAV-5185-2020; Rocha, Manoel Otávio C/H-4776-2013; Costa, Henrique Silveira/H-8286-2014; Sousa, Giovane R./H-6102-2016; Damasio, Marcos/AAJ-7196-2021	Gomes, Juliana A. S./0000-0002-8332-2907; Medeiros, Nayara I/0000-0002-5791-4802; Costa, Henrique Silveira/0000-0002-1426-7246; Sousa, Giovane R./0000-0003-0085-3882; Correa-Oliveira, Rodrigo/0000-0001-6419-9459; Fares Gusmao, Rafaelle/0000-0002-2186-4145	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [407692/2012-6, 478846/2009-6, 404151/2012-4, 475497/2007-4, 403592/2008-9, 308219/2012-0]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-02601-10, APQ-04129-10, PPM-00501-13]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, http//www.cripq.br, [407692/2012-6, 478846/2009-6, 404151/2012-4 (RCO), 475497/2007-4, 403592/2008-9, 308219/2012-0 (JASG)] and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, http://www.fapermg.br, [APQ-02601-10, APQ-04129-10, PPM-00501-13 (JASG)]. JASG, MCPN, RCO and MOCR are CNPq Research Fellows. GRS was supported by a Ph.D. Studentship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the colleagues of the Division of Echocardiography and of the Referral Outpatient Center for Chagas Disease at the Clinical Hospital, UFMG as well as of the Laboratory of Cellular and Molecular Immunology and of the Flow Cytometry facility at the Centro de Pesquisas Rene Rachou, FIOCRUZ for their technical assistance. The authors also thank the Program for Technological Development in Tools for Health PDTIS FIOCRUZ for the use of its facilities. We acknowledge Professor Paul Crocker at the Division of Cell Signalling and Immunology, University of Dundee, UK for helpful discussions. We are very grateful to all patients and control volunteers who participated in this study. This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil. JASG, MCPN, RCO and MOCR are CNPq Research Fellows. GRS was supported by a Ph.D. Studentship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Acquatella H, 2007, CIRCULATION, V115, P1124, DOI 10.1161/CIRCULATIONAHA.106.627323; Altman D.G., 1991, PRACTICAL STATISTIC; Basquiera AL, 2003, HEART, V89, P1186, DOI 10.1136/heart.89.10.1186; Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; Guedes PMD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000604; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Dutra WO, 2014, PARASITE IMMUNOL, V36, P377, DOI 10.1111/pim.12107; Gaffen S, 2016, NAT REV IMMUNOL, V16, P4, DOI 10.1038/nri.2015.2; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Garg AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003699; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Leon B, 2013, NAT IMMUNOL, V14, P419, DOI 10.1038/ni.2593; Lima MMO, 2013, INT J CARDIOL, V167, P2363, DOI 10.1016/j.ijcard.2012.11.055; Magalhaes LMD, 2013, J INFECT DIS, V207, P661, DOI 10.1093/infdis/jis724; Guedes PMM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001630; Miyazaki Y, 2010, J IMMUNOL, V185, P1150, DOI 10.4049/jimmunol.0900047; Nogueira LG, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/914326; Nunes MCP, 2011, INT J CARDIOL, V147, P294, DOI 10.1016/j.ijcard.2010.12.044; Nunes MCP, 2009, J AM SOC ECHOCARDIOG, V22, P82, DOI 10.1016/j.echo.2008.11.015; Nunes MP, 2012, J HEART LUNG TRANSPL, V31, P634, DOI 10.1016/j.healun.2012.01.865; Lima MMO, 2010, ECHOCARDIOGR-J CARD, V27, P519, DOI 10.1111/j.1540-8175.2009.01081.x; Pereira J B, 1992, Rev Soc Bras Med Trop, V25, P101, DOI 10.1590/S0037-86821992000200003; Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046; Perez AR, 2011, J NEUROIMMUNOL, V235, P84, DOI 10.1016/j.jneuroim.2011.03.010; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Ribeiro AL, 2012, NAT REV CARDIOL, V9, P576, DOI 10.1038/nrcardio.2012.109; Rocha MOC, 2009, MEM I OSWALDO CRUZ, V104, P159, DOI 10.1590/S0074-02762009000900022; Rocha MOC, 2003, FRONT BIOSCI-LANDMRK, V8, pE44, DOI 10.2741/926; Sabino EC, 2013, CIRCULATION, V127, P1105, DOI 10.1161/CIRCULATIONAHA.112.123612; Snedecor GW, 1980, STAT METHODS, V7th; Song XY, 2015, IMMUNITY, V43, P488, DOI 10.1016/j.immuni.2015.06.024; Song XY, 2013, CYTOKINE, V62, P175, DOI 10.1016/j.cyto.2013.03.014; Sousa GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087082; Boari JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002658; Wu L, 2014, J EXP MED, V211, P1441, DOI 10.1084/jem.20132126; Zhu S, 2012, CLIN SCI, V122, P487, DOI 10.1042/CS20110496	38	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172833	10.1371/journal.pone.0172833	http://dx.doi.org/10.1371/journal.pone.0172833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278264	Green Submitted, gold, Green Published			2022-12-27	WOS:000396087900130
J	Cheng, JJ; Romantsov, T; Engel, K; Doxey, AC; Rose, DR; Neufeld, JD; Charles, TC				Cheng, Jiujun; Romantsov, Tatyana; Engel, Katja; Doxey, Andrew C.; Rose, David R.; Neufeld, Josh D.; Charles, Trevor C.			Functional metagenomics reveals novel beta-galactosidases not predictable from gene sequences	PLOS ONE			English	Article							HOST-RANGE CLONING; ESCHERICHIA-COLI; LACTOSE HYDROLYSIS; DEFINED DELETIONS; PROTEIN FAMILIES; IDENTIFICATION; EXPRESSION; LIBRARIES; ENZYME; CONSTRUCTION	The techniques of metagenomics have allowed researchers to access the genomic potential of uncultivated microbes, but there remain significant barriers to determination of gene function based on DNA sequence alone. Functional metagenomics, in which DNA is cloned and expressed in surrogate hosts, can overcome these barriers, and make important contributions to the discovery of novel enzymes. In this study, a soil metagenomic library carried in an IncP cosmid was used for functional complementation for beta-galactosidase activity in both Sinorhizobium meliloti (alpha-Proteobacteria) and Escherichia coli (gamma-Proteobacteria) backgrounds. One a-galactosidase, encoded by six overlapping clones that were selected in both hosts, was identified as a member of glycoside hydrolase family 2. We could not identify ORFs obviously encoding possible beta-galactosidases in 19 other sequenced clones that were only able to complement S. meliloti. Based on low sequence identity to other known glycoside hydrolases, yet not beta-galactosidases, three of these ORFs were examined further. Biochemical analysis confirmed that all three encoded a-galactosidase activity. Lac36-W_ORF11 and Lac161_ORF7 had conserved domains, but lacked similarities to known glycoside hydrolases. Lac161_ORF10 had neither conserved domains nor similarity to known glycoside hydrolases. Bioinformatic and structural modeling implied that Lac161_ORF10 protein represented a novel enzyme family with a five-bladed propeller glycoside hydrolase domain. By discovering founding members of three novel a-galactosidase families, we have reinforced the value of functional metagenomics for isolating novel genes that could not have been predicted from DNA sequence analysis alone.	[Cheng, Jiujun; Romantsov, Tatyana; Engel, Katja; Doxey, Andrew C.; Rose, David R.; Neufeld, Josh D.; Charles, Trevor C.] Univ Waterloo, Dept Biol, Waterloo, ON, Canada	University of Waterloo	Charles, TC (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON, Canada.	trevor.charles@uwaterloo.ca	Cheng, Jiujun/AAG-8193-2019; Charles, Trevor C./A-5014-2010	Charles, Trevor C./0000-0002-0344-5932	Natural Sciences and Engineering Research Council of Canada [STPGP 381646 - 2009]; Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada Strategic Projects Grant STPGP 381646 - 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Julia Hanchard and Shirley Wong for technical assistance. This work was financially supported by a Strategic Projects grant and Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (NSERC).	Aakvik T, 2009, FEMS MICROBIOL LETT, V296, P149, DOI 10.1111/j.1574-6968.2009.01639.x; Anantharaman V, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-34; Andre I, 2014, CURR OPIN CHEM BIOL, V19, P17, DOI 10.1016/j.cbpa.2013.11.014; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beloqui A, 2010, APPL ENVIRON MICROB, V76, P5934, DOI 10.1128/AEM.00902-10; Biver S, 2013, J MICROBIOL BIOTECHN, V23, P850, DOI 10.4014/jmb.1212.12008; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHARLES TC, 1991, GENETICS, V127, P5; Cheng JJ, 2007, MICROBIOL-SGM, V153, P375, DOI 10.1099/mic.0.2006/001362-0; Cheng JJ, 2014, J MICROBIOL METH, V99, P27, DOI 10.1016/j.mimet.2014.01.015; Cowie A, 2006, APPL ENVIRON MICROB, V72, P7156, DOI 10.1128/AEM.01397-06; Craig JW, 2010, APPL ENVIRON MICROB, V76, P1633, DOI 10.1128/AEM.02169-09; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Doxey AC, 2015, ISME J, V9, P461, DOI 10.1038/ismej.2014.142; Erich S, 2015, J BIOTECHNOL, V210, P27, DOI 10.1016/j.jbiotec.2015.06.411; Ferrer M, 2009, J MOL MICROB BIOTECH, V16, P109, DOI 10.1159/000142898; Ferrer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038134; FINAN TM, 1984, J BACTERIOL, V159, P120, DOI 10.1128/JB.159.1.120-124.1984; Gabor EM, 2004, ENVIRON MICROBIOL, V6, P879, DOI 10.1111/j.1462-2920.2004.00640.x; Gosling A, 2010, FOOD CHEM, V121, P307, DOI 10.1016/j.foodchem.2009.12.063; Guimaraes PMR, 2010, BIOTECHNOL ADV, V28, P375, DOI 10.1016/j.biotechadv.2010.02.002; Gupta R, 2012, APPL BIOCHEM BIOTECH, V168, P1681, DOI 10.1007/s12010-012-9889-z; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hao YA, 2010, ENVIRON MICROBIOL, V12, P105, DOI 10.1111/j.1462-2920.2009.02049.x; Harju M, 2012, INT DAIRY J, V22, P104, DOI 10.1016/j.idairyj.2011.09.011; Iqbal HA, 2012, CURR OPIN CHEM BIOL, V16, P109, DOI 10.1016/j.cbpa.2012.02.015; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; Lam KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098968; Lammens W, 2009, J EXP BOT, V60, P727, DOI 10.1093/jxb/ern333; Li YC, 2015, BIORESOURCE TECHNOL, V198, P464, DOI 10.1016/j.biortech.2015.09.032; Li YG, 2005, ENVIRON MICROBIOL, V7, P1927, DOI 10.1111/j.1462-2920.2005.00853.x; LISSER S, 1993, NUCLEIC ACIDS RES, V21, P1507, DOI 10.1093/nar/21.7.1507; MacLellan SR, 2006, MICROBIOL-SGM, V152, P1751, DOI 10.1099/mic.0.28743-0; Ly MA, 2011, J MICROBIOL METH, V86, P320, DOI 10.1016/j.mimet.2011.06.005; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marrakchi M, 2008, MAT SCI ENG C-BIO S, V28, P872, DOI 10.1016/j.msec.2007.10.046; Martinez A, 2004, APPL ENVIRON MICROB, V70, P2452, DOI 10.1128/AEM.70.4.2452-2463.2004; Maruthamuthu M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2404-0; Matsuzawa T, 2017, APPL MICROBIOL BIOT, V101, P633, DOI 10.1007/s00253-016-7803-2; MEADE HM, 1982, J BACTERIOL, V149, P114, DOI 10.1128/JB.149.1.114-122.1982; MESELSON M, 1968, NATURE, V217, P1110, DOI 10.1038/2171110a0; Naumoff DG, 2001, PROTEINS, V42, P66, DOI 10.1002/1097-0134(20010101)42:1<66::AID-PROT70>3.0.CO;2-4; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Patil KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038581; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrenko P, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0195-4; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramirez-Escudero M, 2016, J BIOL CHEM, V291, P24200, DOI 10.1074/jbc.M116.747527; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shade A, 2012, ENVIRON MICROBIOL, V14, P2247, DOI 10.1111/j.1462-2920.2012.02817.x; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Taupp M, 2011, CURR OPIN BIOTECH, V22, P465, DOI 10.1016/j.copbio.2011.02.010; Ufarte L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00563; Vester JK, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-72; WALLENFELS K, 1961, ADV CARBOHYD CHEM, V16, P239; Wang CX, 2006, APPL ENVIRON MICROB, V72, P384, DOI 10.1128/AEM.72.1.384-391.2006; Wang K, 2010, APPL MICROBIOL BIOT, V88, P155, DOI 10.1007/s00253-010-2744-7; Wang SD, 2014, ENZYME MICROB TECH, V57, P26, DOI 10.1016/j.enzmictec.2014.01.007; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Wexler M, 2010, METHODS MOL BIOL, V668, P77, DOI 10.1007/978-1-60761-823-2_5; Wierzbicka-Wos A, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-22; Zhang X, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-237; Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275	67	24	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172545	10.1371/journal.pone.0172545	http://dx.doi.org/10.1371/journal.pone.0172545			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273103	Green Submitted, Green Published, gold			2022-12-27	WOS:000396073700079
J	Morton, CM				Morton, Cynthia M.			Phylogenetic relationships of Vepris (Rutaceae) inferred from chloroplast, nuclear, and morphological data	PLOS ONE			English	Article							CLADISTIC-ANALYSIS; NONCODING REGIONS; SUBFAMILIES; CONGRUENCE	The tribe Toddalieae Hook. F. (Rutaceae) has been controversial since its inception by Bentham and Hooker. The nine taxa examined, Acronychia J.R. & G. Foster, Diphasia Pierre, Diphasiopsis Mendonca, Fagaropsis Mildbr. ex. Siebenl., Oricia Pierre, Teclea Delile, Toddaliopsis Engl., Toddalia Juss. and Vepris Comm. ex. A. Juss, have been recognized under the tribe Toddalieae or Tribes Acronychia, Phellodendron and Toddalia. More recently Araliopsis Engl., Diphasia, Diphasiopsis, Oricia, Teclea, and Toddaliopsis have been incorporated into the genus Vepris, while Toddalia and Fagaropsis have continued to be recognized as closely related. For this study, sequence data of one non-coding chloroplast region (trnL-F) and one nuclear region (ITS) and various morphological characters, based on Mziray's taxonomic studies were examined to try to elucidate these relationships. This study found that the taxa Diphasia, Diphasiopsis, Oricia, Teclea, Toddaliopsis, Vepris, Toddalia eugeniifolia Engl. and Toddalia glomerata F. Hoffm. form a monophyletic group. Due to the amount of intrageneric and intraspecific variation, species delimitations were difficult to determine; however, these genera should be united into Vepris. The analyses also confirmed that Toddalia asiatica (L.) Lam., Zanthoxylon sp. and Fagaropsis angolensis (Engl.) H.M. Gardner are the closest relatives to this group.	[Morton, Cynthia M.] Pittsburgh Pk Conservancy, Pittsburgh, PA 15203 USA		Morton, CM (corresponding author), Pittsburgh Pk Conservancy, Pittsburgh, PA 15203 USA.	mortoncm100@gmail.com			National Geographic society [7638-04]	National Geographic society(National Geographic Society)	This work was supported by the National Geographic society 7638-04 to Cynthia Morton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelhans MS, 2011, ANN BOT-LONDON, V107, P1259, DOI 10.1093/aob/mcr076; Bayer RJ, 2009, AM J BOT, V96, P668, DOI 10.3732/ajb.0800341; Bazinet AL, 2014, SYST BIOL, V63, P812, DOI 10.1093/sysbio/syu031; Bentham G., 1867, GENERA PLANTARUM, V1, DOI 10.5962/bhl.title.747; Buerki S, 2009, MOL PHYLOGENET EVOL, V51, P238, DOI 10.1016/j.ympev.2009.01.012; Chase MW, 1999, AM J BOT, V86, P1191, DOI 10.2307/2656983; Compton JA, 1998, TAXON, V47, P593, DOI 10.2307/1223580; DA SILVA MFGF, 1988, PLANT SYST EVOL, V161, P97; Engler A., 1896, NATURLICHEN PFLANZEN, P95; Engler A, 1917, BOT JB, V54, P305; Engler H.G.A., 1931, NATURLICHEN PFLANZEN, P187; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Groppo M, 2008, AM J BOT, V95, P985, DOI 10.3732/ajb.2007313; Hall JB, 1979, P AETFAT, VIX, P105; HARTLEY TG, 1975, J ARNOLD ARBORETUM, V56, P164; Johnson LA, 1999, PLANT SYST EVOL, V214, P65, DOI 10.1007/BF00985732; Kokwaro OJ, 1982, FLORA TROPICAL E AFR; Maddison WP., 2000, MACCLADE ANAL PHYLOG; Manos PS, 1997, AM J BOT, V84, P1137, DOI 10.2307/2446156; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; Miller M.A., 2010, CIPRES PORTALS; Morton CM, 2003, AM J BOT, V90, P1463, DOI 10.3732/ajb.90.10.1463; Morton CM, 2014, MISSOURI BOT GARDENS, V94, P620, DOI [10.3417/2010034, DOI 10.3417/2010034]; Mziray W., 1992, ACTA U PUSALIENSES S, V30, P67; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Perrier H, 1948, MEM ACAD SCI PARIS 2, VLXVII, P15; Poon WS, 2007, SYST BOT, V32, P837, DOI 10.1600/036364407783390692; Ronquist F, 2005, MRBAYES; Salvo G, 2008, MOL PHYLOGENET EVOL, V49, P736, DOI 10.1016/j.ympev.2008.09.004; Salvo G, 2010, SYST BIOL, V59, P705, DOI 10.1093/sysbio/syq046; Scott KD, 2000, PLANT SYST EVOL, V223, P15, DOI 10.1007/BF00985324; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Verdoorn, 1926, KEW B, V9, P389; Wells JA, PLOS ONE UNPUB; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yingzhi L, 2007, J AM SOC HORTIC SCI, V132, P796, DOI 10.21273/JASHS.132.6.796	37	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172708	10.1371/journal.pone.0172708	http://dx.doi.org/10.1371/journal.pone.0172708			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273098	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700086
J	Son, SH; Choi, KH; Kim, SW				Son, Seok Hyun; Choi, Kyu Hye; Kim, Shin-Wook			Dosimetric comparison of simultaneous integrated boost with whole-breast irradiation for early breast cancer	PLOS ONE			English	Article							TUMOR BED; LOCAL-CONTROL; RADIOTHERAPY; SURVIVAL; ELECTRON; THERAPY	Purpose The purpose of this study was to identify a more suitable boost plan for simultaneously integrated boost scheme in patients with breast cancer by comparing among 3 types of whole-breast irradiation plus tumor bed boost plans. Methods Twenty patients who received radiotherapy following breast-conserving surgery for early breast cancer were enrolled in this study. We performed 1 type of electron plan (E1P plan) and 2 types of 3-dimensional conformal plans using a photon (P3P and P5P plans). The dosimetric parameters for the heart, total lung and the target volume between the 3 treatment types were compared. Results For the tumor bed, the difference in the mean dose between the 3 plans was maximally 0.1 Gy. For normal breast parenchyma, the difference in the mean dose between the 3 plans was maximally 1.1 Gy. In the dose range over the prescribed dose of 51 Gy, V-55 and V-60 in the E1P plan were lower than those in the P3P and P5P plans, which indicated that the E1P plan was more suitable than the P3P and P5P plans. In case of the heart and total lung, the values of clinically important parameters were slightly higher in the E1P plan than in the P3P and P5P plans. However, these differences were less than 2%. Conclusion We observed that a simple electron plan for tumor bed boost is preferable over multi-field photon plans in terms of the target volume coverage and normal tissue sparing.	[Son, Seok Hyun; Choi, Kyu Hye; Kim, Shin-Wook] Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Radiat Oncol, Seoul, South Korea	Catholic University of Korea	Son, SH (corresponding author), Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Radiat Oncol, Seoul, South Korea.	sonshyun@catholic.ac.kr		Son, Seok Hyun/0000-0002-2577-1915				Abe O, 2005, LANCET, V366, P2087; Aly MMOM, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0452-2; Bartelink H, 2007, J CLIN ONCOL, V25, P3259, DOI 10.1200/JCO.2007.11.4991; Chen GP, 2015, MED DOSIM, V40, P21, DOI 10.1016/j.meddos.2014.06.007; Chen XJ, 2014, INT J RADIAT ONCOL, V90, P1208, DOI 10.1016/j.ijrobp.2014.08.342; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Gagliardi G, 2010, INT J RADIAT ONCOL, V76, pS77, DOI 10.1016/j.ijrobp.2009.04.093; Ghoncheh Mahshid, 2016, Asian Pac J Cancer Prev, V17, P43; Guerrero M, 2004, INT J RADIAT ONCOL, V59, P1513, DOI 10.1016/j.ijrobp.2004.04.007; Marks LB, 2010, INT J RADIAT ONCOL, V76, pS70, DOI 10.1016/j.ijrobp.2009.06.091; Offersen BV, 2016, RADIOTHER ONCOL, V118, P205, DOI 10.1016/j.radonc.2015.12.027; Park K, 2015, RADIAT ONCOL J, V33, P242, DOI 10.3857/roj.2015.33.3.242; Park SH, 2013, J BREAST CANCER, V16, P300, DOI 10.4048/jbc.2013.16.3.300; Sautter-Bihl ML, 2006, STRAHLENTHER ONKOL, V182, P199, DOI 10.1007/s00066-006-6701-4; Toscas JI, 2010, RADIOTHER ONCOL, V96, P192, DOI 10.1016/j.radonc.2010.05.007; Van Parijs H, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-36; Wong P, 2011, INT J RADIAT ONCOL, V79, P39, DOI 10.1016/j.ijrobp.2009.10.023; Wu SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120811	18	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173552	10.1371/journal.pone.0173552	http://dx.doi.org/10.1371/journal.pone.0173552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273157	gold, Green Published, Green Submitted			2022-12-27	WOS:000396073700017
J	Santoro, M; D'Alessio, N; Cerrone, A; Lucibelli, MG; Borriello, G; Aloise, G; Auriemma, C; Riccone, N; Galiero, G				Santoro, Mario; D'Alessio, Nicola; Cerrone, Anna; Lucibelli, Maria Gabriella; Borriello, Giorgia; Aloise, Gaetano; Auriemma, Clementina; Riccone, Nunzia; Galiero, Giorgio			The Eurasian otter (Lutra lutra) as a potential host for rickettsial pathogens in southern Italy	PLOS ONE			English	Article							REAL-TIME PCR; VECTOR-BORNE PATHOGENS; FOXES VULPES-VULPES; EHRLICHIA-CANIS; ORDER CHLAMYDIALES; MOLECULAR EVIDENCE; DNA; INFECTION; TICKS; DOGS	Canine monocytic ehrlichiosis and rickettsiosis are zoonotic tick-borne diseases of canids caused by the intracellular obligate bacteria Ehrlichia canis and Rickettsia species respectively. In this study, we investigated using standard and real-time PCR and sequencing, the occurrence and molecular characterization of E. canis and Rickettsia species in the Eurasian otter (Lutra lutra) from the southern Italian population. Samples were screened by using molecular assays also for Neospora caninum, Toxoplasma gondii, Clamydophyla spp., Coxiella burnetii, Leishmania spp., Cryptosporidium spp., and Giardia spp. detection, and helminths were studied by traditional methods. Out of six carcasses tested, three were positive for E. canis and co-infection with Rickettsia sp. occurred in one of those. Sequences of the 16S rRNA E. canis gene were identical to each other but differed from most of those previously found in red foxes (Vulpes vulpes) and wolves (Canis lupus) from southern Italy. Helminths included just cystacanths of Sphaerirostris spp. from the intestine of two Eurasian otters and the nematode Angiostrongylus vasorum from the lungs of a single Eurasian otter. None of the samples was positive for the other investigated selected pathogens. This study is the first report on the evidence of infection by rickettsial pathogens in the Eurasian otter. The present result prompts some inquiries into the pathogenic role of those bacteria for the isolated sub-populations of the endangered Eurasian otter in southern Italy.	[Santoro, Mario; D'Alessio, Nicola; Cerrone, Anna; Lucibelli, Maria Gabriella; Borriello, Giorgia; Auriemma, Clementina; Riccone, Nunzia; Galiero, Giorgio] Ist Zooprofilatt Sperimentale Mezzogiorno, Naples, Italy; [Aloise, Gaetano] Univ Calabria, Museo Storia Nat Calabria, Cosenza, Italy; [Aloise, Gaetano] Univ Calabria, Orto Bot, Cosenza, Italy	IZS del Mezzogiorno; University of Calabria; University of Calabria	Santoro, M (corresponding author), Ist Zooprofilatt Sperimentale Mezzogiorno, Naples, Italy.	marisant@libero.it	Borriello, Giorgia/Z-5759-2019; Santoro, Mario/K-3251-2019	Santoro, Mario/0000-0002-6483-3103	Istituto Zooprofilattico del Mezzogiorno	Istituto Zooprofilattico del Mezzogiorno	The Italian Ministry of Health systematically support the Istituto Zooprofilattico del Mezzogiorno on surveys of infectious diseases of wildlife.	Cardoso L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0756-y; Carrasco SE, 2014, VET MICROBIOL, V170, P325, DOI 10.1016/j.vetmic.2014.02.021; Chinnadurai SK, 2010, J WILDLIFE DIS, V46, P947, DOI 10.7589/0090-3558-46.3.947; Christian Axel, 2012, Soil Organisms, V84, P481; Dantas-Torres F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-26; Dimitrova ZM, 1997, FOLIA PARASIT, V44, P224; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; Everett KDE, 1999, J CLIN MICROBIOL, V37, P575, DOI 10.1128/JCM.37.3.575-580.1999; Guy RA, 2003, APPL ENVIRON MICROB, V69, P5178, DOI 10.1128/AEM.69.9.5178-5185.2003; Haque R, 2007, AM J TROP MED HYG, V76, P713, DOI 10.4269/ajtmh.2007.76.713; Harrus S, 1998, J CLIN MICROBIOL, V36, P73, DOI 10.1128/JCM.36.1.73-76.1998; HARVEY JW, 1979, J AM VET MED ASSOC, V175, P901; Hodzic A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0692-x; Hornok S, 2013, ACTA VET HUNG, V61, P42, DOI 10.1556/AVet.2012.050; Hughes JM, 2008, EXP PARASITOL, V120, P255, DOI 10.1016/j.exppara.2008.07.011; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Loy A, 2010, HYSTRIX, V21, P19; Malatesta D, 2014, VET ITAL, V50, P199, DOI 10.12834/VetIt.40.1916.8; Mancini F, ANN 1 SUPER SANITA, V51, P284, DOI [10.4415/ANN_15_04_07, DOI 10.4415/AHINI150407]; Millan J, 2016, TICKS TICK-BORNE DIS, V7, P284, DOI 10.1016/j.ttbdis.2015.11.003; Mortarino M, 2014, PARASSITOLOGIA, V46, P163; Noeckler K., 2007, FAOWHOOIE GUIDELINES, P69; Ossewaarde JM, 1999, MICROBIOL-SGM, V145, P411, DOI 10.1099/13500872-145-2-411; Otranto D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-328; Perez M, 2006, ANN NY ACAD SCI, V1078, P110, DOI 10.1196/annals.1374.016; Prina E, 2007, MICROBES INFECT, V9, P1307, DOI 10.1016/j.micinf.2007.06.005; Rene-Martellet M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0613-4; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roulichova J, 2007, FOLIA ZOOL, V56, P440; Rovery C, 2008, EMERG INFECT DIS, V14, P1360, DOI 10.3201/eid1409.071133; Santoro M, 2016, PARASITOL RES, V115, P4427, DOI 10.1007/s00436-016-5213-0; Santoro M, 2015, ACTA PARASITOL, V60, P356, DOI 10.1515/ap-2015-0050; Santoro M, 2012, J PARASITOL, V98, P22, DOI 10.1645/GE-2924.1; Schex S, 2011, VECTOR-BORNE ZOONOT, V11, P493, DOI 10.1089/vbz.2010.0060; Schneeberger Peter M, 2010, Clin Vaccine Immunol, V17, P286, DOI 10.1128/CVI.00454-09; Sherrard-Smith E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047131; Solano-Gallego L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0824-3; Stich RW, 2008, VET PARASITOL, V158, P256, DOI 10.1016/j.vetpar.2008.09.013; Telford SR, 2008, TICKS: BIOLOGY, DISEASE AND CONTROL, P344, DOI 10.1017/CBO9780511551802.017; Tilburg JJHC, 2010, J CLIN MICROBIOL, V48, P3923, DOI 10.1128/JCM.01006-10; Torina A, 2013, TRANSBOUND EMERG DIS, V60, P125, DOI 10.1111/tbed.12137; TZIANABOS T, 1989, J CLIN MICROBIOL, V27, P2866, DOI 10.1128/JCM.27.12.2866-2868.1989; Waner T, 2014, VET J, V202, P618, DOI 10.1016/j.tvjl.2014.10.004; Zivkovic Z, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-7	44	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173556	10.1371/journal.pone.0173556	http://dx.doi.org/10.1371/journal.pone.0173556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267780	Green Published, gold, Green Submitted			2022-12-27	WOS:000396060600043
J	Lim, K; Hong, Y; Choi, Y; Byun, H				Lim, Kwangyong; Hong, Yongwon; Choi, Yeongwoo; Byun, Hyeran			Real-time traffic sign recognition based on a general purpose GPU and deep-learning	PLOS ONE			English	Article								We present a General Purpose Graphics Processing Unit (GPGPU) based real-time traffic sign detection and recognition method that is robust against illumination changes. There have been many approaches to traffic sign recognition in various research fields; however, previous approaches faced several limitations when under low illumination or wide variance of light conditions. To overcome these drawbacks and improve processing speeds, we propose a method that 1) is robust against illumination changes, 2) uses GPGPU-based real-time traffic sign detection, and 3) performs region detecting and recognition using a hierarchical model. This method produces stable results in low illumination environments. Both detection and hierarchical recognition are performed in real-time, and the proposed method achieves 0.97 F1-score on our collective dataset, which uses the Vienna convention traffic rules (Germany and South Korea).	[Lim, Kwangyong; Hong, Yongwon; Byun, Hyeran] Yonsei Univ, Dept Comp Sci, 50 Yonsei Ro, Seoul, South Korea; [Choi, Yeongwoo] Sookmyung Womens Univ, Dept Comp Sci, 47 Cheongpa Ro, Seoul, South Korea	Yonsei University; Sookmyung Women's University	Byun, H (corresponding author), Yonsei Univ, Dept Comp Sci, 50 Yonsei Ro, Seoul, South Korea.	hrbyun@yonsei.ac.kr			Institute for Information & Communications Technology Promotion (IITP) grant - Korean government (MSIP) [R7117-16-0157]	Institute for Information & Communications Technology Promotion (IITP) grant - Korean government (MSIP)	This work was supported by an Institute for Information & Communications Technology Promotion (IITP) grant funded by the Korean government (MSIP) (no. R7117-16-0157, Development of Smart Car Vision Techniques based on Deep Learning for Pedestrian Safety) (http://www.iitp.kr).	Abukhait J., 2012, 2012 IEEE INT C ELEC, P1; Bahlmann C, 2005, 2005 IEEE INTELLIGENT VEHICLES SYMPOSIUM PROCEEDINGS, P255; Barnes N, 2008, IEEE T INTELL TRANSP, V9, P322, DOI 10.1109/TITS.2008.922935; Belaroussi R., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P484, DOI 10.1109/ICPR.2010.1125; Chourasia Jitendra N., 2010, Proceedings of the Third International Conference on Emerging Trends in Engineering and Technology (ICETET 2010), P96, DOI 10.1109/ICETET.2010.69; Ciresan D, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P1918, DOI 10.1109/IJCNN.2011.6033458; Dollar P, 2014, IEEE T PATTERN ANAL, V36, P1532, DOI 10.1109/TPAMI.2014.2300479; Fleyeh H, 2004, CONF CYBERN INTELL S, P809, DOI 10.1109/ICCIS.2004.1460692; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Froba B, 2004, SIXTH IEEE INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION, PROCEEDINGS, P91, DOI 10.1109/AFGR.2004.1301514; Kiran CG, 2009, ICAPR 2009: SEVENTH INTERNATIONAL CONFERENCE ON ADVANCES IN PATTERN RECOGNITION, PROCEEDINGS, P87, DOI 10.1109/ICAPR.2009.58; Lienhart R, 2002, IEEE IMAGE PROC, P900; Ma XL, 2015, TRANSPORT RES C-EMER, V54, P187, DOI 10.1016/j.trc.2015.03.014; Ma XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119044; Mogelmose A, 2015, IEEE T INTELL TRANSP, V16, DOI 10.1109/TITS.2015.2433019; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Woong-Jae Won, 2008, 2008 IEEE Intelligent Vehicles Symposium (IV), P542, DOI 10.1109/IVS.2008.4621144; Zeng YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120885	18	24	28	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173317	10.1371/journal.pone.0173317	http://dx.doi.org/10.1371/journal.pone.0173317			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264011	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300051
J	Zapiola, ML; Mallory-Smith, CA				Zapiola, Maria Luz; Mallory-Smith, Carol Ann			Pollen-mediated gene flow from transgenic perennial creeping bentgrass and hybridization at the landscape level	PLOS ONE			English	Article							AGROSTIS-STOLONIFERA; ESTABLISHMENT; ESCAPE	The planting of 162 ha of transgenic glyphosate-resistant creeping bentgrass (Agrostis stolonifera) near Madras, OR, USA, allowed a unique opportunity to study gene flow over time from a perennial outcrossing species at the landscape level. While conducting a four year in situ survey, we collected panicles and leaf tissue samples from creeping bentgrass and its sexually compatible species. Seeds from the panicles were planted, and seedlings were tested in the greenhouse for expression of the transgene. Gene flow via pollen was found in all four years, at frequencies of 0.004 to 2.805%. Chloroplast markers, in combination with internal transcribed spacer nuclear sequence analysis, were used to aid in identification of transgenic interspecific and intergeneric hybrid seedlings found during the testing and of established plants that could not be positively identified in the field. Interspecific transgenic hybrids produced on redtop (Agrostis gigantea) plants in situ were identified three of the four years and one intergeneric transgenic creeping bentgrass x rabbitfoot grass (Polypogon monspeliensis) hybrid was identified in 2005. In addition, we confirmed a non-transgenic creeping bentgrass x redtop hybrid in situ, demonstrating that interspecific hybrids have established in the environment outside production fields. Results of this study should be considered for deregulation of transgenic events, studies of population dynamics, and prediction of gene flow in the environment.	[Zapiola, Maria Luz; Mallory-Smith, Carol Ann] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA; [Zapiola, Maria Luz] Pontificia Univ Catolica Argentina, Fac Ciencias Agr, Buenos Aires, DF, Argentina	Oregon State University; Pontifical Catholic University of Argentina	Zapiola, ML (corresponding author), Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA.; Zapiola, ML (corresponding author), Pontificia Univ Catolica Argentina, Fac Ciencias Agr, Buenos Aires, DF, Argentina.	malu.zapiola@gmail.com			US Department of Agriculture (USDA), Biotechnology Risk Assessment [2004-02875]; special grants from USDA-Animal and Plant Health Inspection Service (APHIS); Scotts Company	US Department of Agriculture (USDA), Biotechnology Risk Assessment(United States Department of Agriculture (USDA)); special grants from USDA-Animal and Plant Health Inspection Service (APHIS); Scotts Company	This study was funded in part by the US Department of Agriculture (USDA), Biotechnology Risk Assessment Grant number 2004-02875. Support also was received from special grants from USDA-Animal and Plant Health Inspection Service (APHIS) and The Scotts Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong TT, 2005, MOL ECOL, V14, P2111, DOI 10.1111/j.1365-294X.2005.02572.x; Belanger FC, 2003, CROP SCI, V43, P240, DOI 10.2135/cropsci2003.0240; EDGAR E, 1991, NEW ZEAL J BOT, V29, P139, DOI 10.1080/0028825X.1991.10416717; Ellstrand N. C., 2003, DANGEROUS LIAISONS C; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Fei S, 2004, IN VITRO CELL DEV-PL, V40, P266, DOI 10.1079/IVP2003522; Fei S, 2003, CROP SCI, V43, P2177, DOI 10.2135/cropsci2003.2177; Gardner DS, 2004, WEED TECHNOL, V18, P773, DOI 10.1614/WT-03-184R1; Hubbard CE Grasses, 1992, GUIDE THEIR STRUCTUR; Huelsenbeck JP, 2007, GENETICS, V175, P1787, DOI 10.1534/genetics.106.061317; Lee D, 2006, TRENDS BIOTECHNOL, V24, P109, DOI 10.1016/j.tibtech.2006.01.006; Zapiola ML, 2010, WEED SCI, V58, P223, DOI 10.1614/WS-D-09-00076.1; Mallory-Smith C, 2015, WEED SCI, V63, P12, DOI 10.1614/WS-D-13-00064.1; Mallory-Smith CA, 2011, J AGR FOOD CHEM, V59, P5813, DOI 10.1021/jf103389v; Marvier M, 2005, FRONT ECOL ENVIRON, V3, P99, DOI 10.2307/3868516; Messeguer J, 2003, PLANT CELL TISS ORG, V73, P201, DOI 10.1023/A:1023007606621; Nap JP, 2003, PLANT J, V33, P1, DOI 10.1046/j.0960-7412.2003.01602.x; Pfender W, 2007, CROP SCI, V47, P2529, DOI 10.2135/cropsci2007.01.0030; Reichman JR, 2006, MOL ECOL, V15, P4243, DOI 10.1111/j.1365-294X.2006.03072.x; Rieger MA, 1999, AUST J AGR RES, V50, P115, DOI 10.1071/A97138; Rozen S, 2000, Methods Mol Biol, V132, P365; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Wang ZY, 2012, ANN BOT-LONDON, V110, P1317, DOI 10.1093/aob/mcs027; Warnke S., 2003, TURFGRASS BIOL GENET, P175; Watrud LS, 2004, P NATL ACAD SCI USA, V101, P14533, DOI 10.1073/pnas.0405154101; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wipff J. K., 2001, International Turfgrass Society Research Journal, V9, P224; Zapiola ML, 2008, J APPL ECOL, V45, P486, DOI 10.1111/j.1365-2664.2007.01430.x; Zapiola ML, 2010, MOL ECOL RESOUR, V10, P738, DOI 10.1111/j.1755-0998.2009.02828.x; Zapiola ML, 2012, MOL ECOL, V21, P4663, DOI [10.1111/j.1365-294X.2012.05695.x, DOI 10.1111/J.1365-294X.2012.05695.X]	30	9	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173308	10.1371/journal.pone.0173308	http://dx.doi.org/10.1371/journal.pone.0173308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257488	Green Submitted, Green Published, gold			2022-12-27	WOS:000396021100085
J	Mao, YM; Kuo, SW; Chen, L; Heckman, CJ; Jiang, MC				Mao, Yimin; Kuo, Su-Wei; Chen, Le; Heckman, C. J.; Jiang, M. C.			The essential and downstream common proteins of amyotrophic lateral sclerosis: A protein-protein interaction network analysis	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; VALOSIN-CONTAINING PROTEIN; LARGE GENE LISTS; MESSENGER-RNA; HEXANUCLEOTIDE REPEAT; POLYUBIQUITIN GENE; SQSTM1 MUTATIONS; VCP MUTATIONS; PAGET-DISEASE; SPORADIC ALS	Amyotrophic Lateral Sclerosis (ALS) is a devastative neurodegenerative disease characterized by selective loss of motoneurons. While several breakthroughs have been made in identifying ALS genetic defects, the detailed molecular mechanisms are still unclear. These genetic defects involve in numerous biological processes, which converge to a common destiny: motoneuron degeneration. In addition, the common comorbid Frontotemporal Dementia (FTD) further complicates the investigation of ALS etiology. In this study, we aimed to explore the protein-protein interaction network built on known ALS-causative genes to identify essential proteins and common downstream proteins between classical ALS and ALS+FTD (classical ALS + ALS/FTD) groups. The results suggest that classical ALS and ALS+FTD share similar essential protein set (VCP, FUS, TDP-43 and hnRNPA1) but have distinctive functional enrichment profiles. Thus, disruptions to these essential proteins might cause motoneuron susceptible to cellular stresses and eventually vulnerable to proteinopathies. Moreover, we identified a common downstream protein, ubiquitin-C, extensively interconnected with ALS-causative proteins (22 out of 24) which was not linked to ALS previously. Our in silico approach provides the computational background for identifying ALS therapeutic targets, and points out the potential downstream common ground of ALS-causative mutations.	[Mao, Yimin; Chen, Le] Jiangxi Univ Sci & Technol, Inst Appl Sci, Ganzhou, Jiangxi, Peoples R China; [Mao, Yimin; Kuo, Su-Wei; Heckman, C. J.; Jiang, M. C.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Heckman, C. J.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Heckman, C. J.] Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA	Jiangxi University of Science & Technology; Northwestern University; Northwestern University; Northwestern University	Jiang, MC (corresponding author), Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA.	m-jiang@northwestern.edu		Heckman, CJ/0000-0002-1324-7278; Kuo, Su-Wei/0000-0002-7951-3970	Northwestern University [T32]; National Institute of Neurological Disorders and Stroke [NS07786303]; ALS Association [277]	Northwestern University; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ALS Association	This work was supported Northwestern University, Grant #T32 (http://www.nuin.northwestern.edu/inside-nuin/training-grants/training-in-the-neurobiology-of-movement-and-rehabilitation-sciences/) to SWK; the National Institute of Neurological Disorders and Stroke, Grant #NS07786303 (http://www.ninds.nih.gov/) to CJH and the ALS Association, Grant #277 (http://www.alsa.org/) to MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acencio ML, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-290; Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028; Batada NN, 2006, EVOLUTIONARY AND PHY; Bianchi M, 2015, GENE, V573, P100, DOI 10.1016/j.gene.2015.07.030; Brown K.J., 2007, ELECTRON J DIFFER EQ, V69, P1; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Chua HN, 2008, TOOLS ART INT 2008 I; Crinelli R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136882; de Pril R, 2010, MOL CELL NEUROSCI, V43, P281, DOI 10.1016/j.mcn.2009.12.001; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Estrada E, 2006, PROTEOMICS, V6, P35, DOI 10.1002/pmic.200500209; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Fecto F, 2011, J MOL NEUROSCI, V45, P663, DOI 10.1007/s12031-011-9637-9; Ferrari R, 2011, CURR ALZHEIMER RES, V8, P273, DOI 10.2174/156720511795563700; Fischer DF, 2003, FASEB J, V17, P2014, DOI 10.1096/fj.03-0205com; FORNACE AJ, 1989, NUCLEIC ACIDS RES, V17, P1215, DOI 10.1093/nar/17.3.1215; Genc E B, 2015, CEREB CORTEX; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Hallengren J, 2013, CELL BIOCHEM BIOPHYS, V67, P67, DOI 10.1007/s12013-013-9634-4; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hart GT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-236; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kondrashov FA, 2004, NUCLEIC ACIDS RES, V32, P1731, DOI 10.1093/nar/gkh330; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Lage K, 2014, BBA-MOL BASIS DIS, V1842, P1971, DOI 10.1016/j.bbadis.2014.05.028; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Li M, 2010, LECT N BIOINFORMAT, V6053, P89; Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Malaspina A, 2000, J NEUROCHEM, V75, P2511, DOI 10.1046/j.1471-4159.2000.0752511.x; Manavalan A, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.76; Marinovic AC, 2002, J BIOL CHEM, V277, P16673, DOI 10.1074/jbc.M200501200; Marinovic AC, 2007, AM J PHYSIOL-RENAL, V292, pF660, DOI 10.1152/ajprenal.00178.2006; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mojsilovic-Petrovic J, 2009, J NEUROSCI, V29, P8236, DOI 10.1523/JNEUROSCI.1805-09.2009; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; da Silva JPM, 2008, PHYSICA A, V387, P1049, DOI 10.1016/j.physa.2007.10.044; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; O'Toole O, 2008, J NEUROL NEUROSUR PS, V79, P30, DOI 10.1136/jnnp.2007.117788; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Prudencio M, 2015, NAT NEUROSCI, V18, P1175, DOI 10.1038/nn.4065; Radici L, 2013, ADV BIOSCIENCE BIOTE, V2013; Ren J, 2011, LECT N BIOINFORMAT, V6674, P12, DOI 10.1007/978-3-642-21260-4_6; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Rubino E, 2012, NEUROLOGY, V79, P1556, DOI 10.1212/WNL.0b013e31826e25df; Ryu HW, 2011, BIOCHEM BIOPH RES CO, V404, P470, DOI 10.1016/j.bbrc.2010.12.004; Ryu KY, 2008, P NATL ACAD SCI USA, V105, P4016, DOI 10.1073/pnas.0800096105; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; Ryu KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032956; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Song CC, 2015, BBA-MOL CELL RES, V1853, P222, DOI 10.1016/j.bbamcr.2014.10.019; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sundaramoorthy V, 2014, HUM MOL GENET; Valdmanis PN, 2008, NEUROLOGY, V70, P144, DOI 10.1212/01.wnl.0000296811.19811.db; Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Wang T, 2015, NEUROBIOL AGING, V36, P527, DOI 10.1016/j.neurobiolaging.2014.07.044; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Webster CP, 2016, EMBO J; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zhang SH, 2006, COMPUT BIOL CHEM, V30, P445, DOI 10.1016/j.compbiolchem.2006.10.001; Zhang T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004693; Zheng B, 2010, FASEB J, V24, P2660, DOI 10.1096/fj.09-151480; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	86	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0172246	10.1371/journal.pone.0172246	http://dx.doi.org/10.1371/journal.pone.0172246			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282387	Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800009
J	Betekhtin, A; Rojek, M; Jaskowiak, J; Milewska-Hendel, A; Kwasniewska, J; Kostyukova, Y; Kurczynska, E; Rumyantseva, N; Hasterok, R				Betekhtin, Alexander; Rojek, Magdalena; Jaskowiak, Joanna; Milewska-Hendel, Anna; Kwasniewska, Jolanta; Kostyukova, Yulia; Kurczynska, Ewa; Rumyantseva, Natalya; Hasterok, Robert			Nuclear genome stability in long-term cultivated callus lines of Fagopyrum tataricum (L.) Gaertn	PLOS ONE			English	Article							SOMATIC EMBRYOGENESIS; TISSUE-CULTURE; ARABIDOPSIS-THALIANA; PHENOLIC-COMPOUNDS; TETRAPLOID PLANTS; CELLS; REGENERATION; PLURIPOTENT; PROTOPLASTS; INSTABILITY	Long-term cultivated Fagopyrum tataricum (L.) Gaertn. (Tartary buckwheat) morphogenic and non-morphogenic callus lines are interesting systems for gaining a better understanding of the mechanisms that are responsible for the genetic stability and instability of a plant tissue culture. In this work, we used histological sections and transmission electron microscopy to identify and describe the morphology of the nuclei of all of the analysed callus lines. We demonstrated that the embryogenic callus cells had prominent round nuclei that did not contain heterochromatin clumps in contrast to the non-morphogenic callus lines, in which we found nuclei that had multiple lobes. Flow cytometry analysis revealed significant differences in the relative DNA content between the analysed calli. All of the analysed morphogenic callus lines had peaks from 2C to 8C as compared to the non-morphogenic callus lines, whose peaks did not reflect any regular DNA content and exceeded 8C and 16C for the line 6p1 and 16C and 32C for the callus line 10p(2)A. The results showed that non-morphogenic calli are of an aneuploid nature. The TUNEL test enabled us to visualise the nuclei that had DNA fragmentation in both the morphogenic and non-morphogenic lines. We revealed significantly higher frequencies of positively labelled nuclei in the non-morphogenic lines than in the morphogenic lines. In the case of the morphogenic lines, the highest observed frequency of TUNEL-positive nuclei was 7.7% for lines 2-3. In the non-morphogenic calli, the highest level of DNA damage (68.5%) was revealed in line 6p1. These results clearly indicate greater genome stability in the morphogenic lines.	[Betekhtin, Alexander; Rojek, Magdalena; Jaskowiak, Joanna; Kwasniewska, Jolanta; Hasterok, Robert] Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland; [Milewska-Hendel, Anna; Kurczynska, Ewa] Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Cell Biol, Katowice, Poland; [Kostyukova, Yulia; Rumyantseva, Natalya] Russian Acad Sci, Kazan Inst Biochem & Biophys, Lab Physiol & Genet Plant Cell Cultures, Kazan Sci Ctr, Kazan, Russia; [Rumyantseva, Natalya] Kazan Fed Univ, Inst Fundamental Med & Biol, Dept Bot & Plant Physiol, Kazan, Russia	University of Silesia in Katowice; University of Silesia in Katowice; Russian Academy of Sciences; Kazan Scientific Centre of the Russian Academy of Sciences; Kazan Institute of Biochemistry & Biophysics; Kazan Federal University	Betekhtin, A (corresponding author), Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland.	alexander.betekhtin@us.edu.pl	Rumyantseva, Natalya I./K-1350-2018; Kwasniewska, Jolanta/ABF-1547-2020; Hasterok, Robert/A-1629-2008; Костюкова, Юлия/ABE-8066-2021; Betekhtin, Alexander/O-4619-2018	Betekhtin, Alexander/0000-0001-6146-1669; Kostukova, Ulia/0000-0001-5313-3542; Kurczynska, Ewa/0000-0003-0772-8961; Milewska-Hendel, Anna/0000-0002-9066-477X; Kwasniewska, Jolanta/0000-0002-8965-8727; Hasterok, Robert/0000-0001-6667-2721				Bairu MW, 2011, PLANT GROWTH REGUL, V63, P147, DOI 10.1007/s10725-010-9554-x; Baranek M, 2010, PLANT CELL TISS ORG, V101, P11, DOI 10.1007/s11240-009-9656-1; Bourdon M, 2012, DEVELOPMENT, V139, P3817, DOI 10.1242/dev.084053; BRAR DS, 1998, SOMACLONAL VARIATION, P15, DOI DOI 10.1007/978-94-015-9125-6_2; Brian J, 2004, STUDY NEW HLTH FOODS; CHEN CC, 1980, CAN J GENET CYTOL, V22, P607, DOI 10.1139/g80-066; Combrinck S, 2007, ANN BOT-LONDON, V99, P1111, DOI 10.1093/aob/mcm064; Danilova MF, 1980, RHIZODERMIS; de Almeida M, 2012, PLANT CELL REP, V31, P1495, DOI 10.1007/s00299-012-1264-6; Fabjan N, 2003, J AGR FOOD CHEM, V51, P6452, DOI 10.1021/jf034543e; Filipecki M, 2006, J APPL GENET, V47, P17, DOI 10.1007/BF03194594; FISHER DB, 1968, HISTOCHEMISTRY, V16, P92, DOI 10.1007/BF00306214; FRANKLIN CI, 1989, PLANT CELL REP, V8, P101, DOI 10.1007/BF00716849; Fras A, 2007, PLANT CELL REP, V26, P1933, DOI 10.1007/s00299-007-0415-7; Fras A, 2004, GENETICA, V121, P145, DOI 10.1023/B:GENE.0000040375.18684.82; Fras A, 2003, ACTA BIOL CRACOV BOT, V45, P145; GALBRAITH DW, 1991, PLANT PHYSIOL, V96, P985, DOI 10.1104/pp.96.3.985; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; GILISSEN LJW, 1993, PLANT SCI, V91, P171, DOI 10.1016/0168-9452(93)90140-U; Gregory T. Ryan, 2005, P3; Gumerova EA, 2015, RUSS J PLANT PHYSL+, V62, P195, DOI 10.1134/S1021443715020077; Hasler J, 2003, BIOL CELL, V95, P357, DOI 10.1016/S0248-4900(03)00077-7; HIROCHIKA H, 1993, EMBO J, V12, P2521, DOI 10.1002/j.1460-2075.1993.tb05907.x; Jain SM, 2001, EUPHYTICA, V118, P153, DOI 10.1023/A:1004124519479; Jaligot E, 2004, GENOME, V47, P224, DOI 10.1139/G03-085; Prado MJ, 2010, PLANT CELL TISS ORG, V103, P49, DOI 10.1007/s11240-010-9753-1; JHA S, 1989, CYTOLOGIA, V54, P687, DOI 10.1508/cytologia.54.687; Joachimiak A, 2003, ACTA SOC BOT POL, V72, P11, DOI 10.5586/asbp.2003.002; Johnston JW, 2009, PLANT PHYSIOL BIOCH, V47, P123, DOI 10.1016/j.plaphy.2008.10.008; Kamalova GV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P686, DOI 10.1134/S0006297909060145; KARP A, 1995, EUPHYTICA, V85, P295, DOI 10.1007/BF00023959; Karp A, 1994, PLANT CELL TISSUE CU, P139; Kreft M, 2016, NUTR RES REV, V29, P30, DOI 10.1017/S0954422415000190; Kubalakova M, 1996, BIOL PLANTARUM, V38, P475, DOI 10.1007/BF02896685; Kwasniewska J, 2012, ACTA BIOL CRACOV BOT, V54, P93, DOI 10.2478/v10182-012-0028-5; LAVANIA UC, 1988, PROTOPLASMA, V145, P55, DOI 10.1007/BF01323256; LEDILY F, 1993, IN VITRO CELL DEV-PL, V29P, P149, DOI 10.1007/BF02632027; Li XQ, 2002, J PLANT PHYSIOL, V159, P1229, DOI 10.1078/0176-1617-00899; LINGLEE M, 1977, NEW PHYTOL, V78, P313, DOI 10.1111/j.1469-8137.1977.tb04835.x; LoSchiavo F, 2000, EUR J CELL BIOL, V79, P294, DOI 10.1078/S0171-9335(04)70032-1; Makowczynska J, 2000, ACTA SOC BOT POL, V69, P245, DOI 10.5586/asbp.2000.031; Nakano M, 2003, PLANT CELL TISS ORG, V72, P63, DOI 10.1023/A:1021290106221; NOVAK FJ, 1980, Z PFLANZENZUCHT, V84, P250; Ochatt SJ, 2000, PLANT SCI, V156, P177, DOI 10.1016/S0168-9452(00)00250-8; PHILLIPS GC, 1979, CROP SCI, V19, P59, DOI 10.2135/cropsci1979.0011183X001900010014x; PHILLIPS RL, 1994, P NATL ACAD SCI USA, V91, P5222, DOI 10.1073/pnas.91.12.5222; PIJNACKER LP, 1990, PLANT CELL TISS ORG, V21, P153, DOI 10.1007/BF00033435; Potocka I, 2012, PLANT CELL REP, V31, P2031, DOI 10.1007/s00299-012-1314-0; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Roux NS, 2004, DETECTING PLOIDY LEV; ROY SC, 1980, PROTOPLASMA, V102, P171, DOI 10.1007/BF01276957; Rumiantseva N I, 2004, Prikl Biokhim Mikrobiol, V40, P571; Rumyantseva N I, 2003, Dokl Biol Sci, V391, P375, DOI 10.1023/A:1025127323165; RUMYANTSEVA N I, 1989, Fiziologiya Rastenii (Moscow), V36, P187; SENGUPTA J, 1988, BIOL PLANTARUM, V30, P247, DOI 10.1007/BF02878202; Soukupova J, 2000, NEW PHYTOL, V146, P403, DOI 10.1046/j.1469-8137.2000.00666.x; Steadman KJ, 2001, J SCI FOOD AGR, V81, P1094, DOI 10.1002/jsfa.914; Tomiczak K, 2016, PLANT CELL TISS ORG, V126, P319, DOI 10.1007/s11240-016-1000-y; TRUMP BF, 1961, J ULTRA MOL STRUCT R, V5, P343, DOI 10.1016/S0022-5320(61)80011-7; Vasilyev AE., 1980, SECRETORY STRUCTURES; Verdeil JL, 2007, TRENDS PLANT SCI, V12, P245, DOI 10.1016/j.tplants.2007.04.002; Wood M, 1998, PLANT SCI, V131, P149, DOI 10.1016/S0168-9452(97)00253-7; WYMAN J, 1992, PLANT SCI, V85, P189, DOI 10.1016/0168-9452(92)90115-3; Zidorn C., 2008, Scientia Pharmaceutica, V76, P743, DOI 10.3797/scipharm.0810-25	64	11	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173537	10.1371/journal.pone.0173537	http://dx.doi.org/10.1371/journal.pone.0173537			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278222	gold, Green Published, Green Submitted			2022-12-27	WOS:000396087900009
J	Bullock, B; Murray, G; Meyer, D				Bullock, Ben; Murray, Greg; Meyer, Denny			Highs and lows, ups and downs: Meteorology and mood in bipolar disorder	PLOS ONE			English	Article							SEASONAL-VARIATION; CIRCADIAN-RHYTHMS; LIFE EVENTS; SYMPTOMS; WEATHER; SLEEP; CHRONORECORD	Seasonal variation of manic and depressive symptoms is a controversial topic in bipolar disorder research. Several studies report seasonal patterns of hospital admissions for depression and mania and variation in symptoms that appear to follow a seasonal pattern, whereas others fail to report such patterns. Differences in research methodologies, data analysis strategies, and temporal resolution of data may partly explain the variation in findings between studies. The current study adds a novel perspective to the literature by investigating specific meteorological factors such as atmospheric pressure, hours of sunshine, relative humidity, and daily maximum and minimum temperatures as more proximal predictors of self-reported daily mood change in people diagnosed with bipolar disorder. The results showed that daily maximum temperature was the only meteorological variable to predict clinically-relevant mood change, with increases in temperature associated with greater odds of a transition into manic mood states. The mediating effects of sleep and activity were also investigated and suggest at least partial influence on the prospective relationship between maximum temperature and mood. Limitations include the small sample size and the fact that the number and valence of social interactions and exposure to natural light were not investigated as potentially important mediators of relationships between meteorological factors and mood. The current data make an important contribution to the literature, serving to clarify the specific meteorological factors that influence mood change in bipolar disorder. From a clinical perspective, greater understanding of seasonal patterns of symptoms in bipolar disorder will help mood episode prophylaxis in vulnerable individuals.	[Bullock, Ben; Murray, Greg] Swinburne Univ Technol, Dept Psychol Sci, Melbourne, Vic, Australia; [Meyer, Denny] Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Melbourne, Vic, Australia	Swinburne University of Technology; Swinburne University of Technology	Bullock, B (corresponding author), Swinburne Univ Technol, Dept Psychol Sci, Melbourne, Vic, Australia.	bbullock@swin.edu.au	Murray, Greg/N-8933-2017	Murray, Greg/0000-0001-7208-5603; Bullock, Ben/0000-0003-1459-9061				Akhter A, 2013, BIPOLAR DISORD, V15, P377, DOI 10.1111/bdi.12072; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2013, HLM 7 01 FOR WINDOWS; Bauer M, 2004, BIPOLAR DISORD, V6, P67, DOI 10.1046/j.1399-5618.2003.00085.x; Bauer M, 2008, PSYCHIAT RES, V159, P359, DOI 10.1016/j.psychres.2007.04.013; Bauer M, 2009, J AFFECT DISORDERS, V116, P170, DOI 10.1016/j.jad.2008.11.014; Boland EM, 2012, J AFFECT DISORDERS, V139, P264, DOI 10.1016/j.jad.2012.01.038; Christensen EM, 2008, NORD J PSYCHIAT, V62, P55, DOI 10.1080/08039480801970049; Faurholt-Jepsen M, 2016, PSYCHIAT RES, V237, P166, DOI 10.1016/j.psychres.2016.01.047; Friedman E, 2006, ACTA PSYCHIAT SCAND, V113, P510, DOI 10.1111/j.1600-0447.2005.00701.x; Geoffroy PA, 2014, J AFFECT DISORDERS, V168, P210, DOI 10.1016/j.jad.2014.07.002; Harvey AG, 2008, AM J PSYCHIAT, V165, P820, DOI 10.1176/appi.ajp.2008.08010098; Harvey AG, 2012, PSYCHOL BULL, V138, P77, DOI 10.1037/a0025730; Huibers MJH, 2010, PSYCHIAT RES, V180, P143, DOI 10.1016/j.psychres.2009.09.016; Johnson SL, 2016, PSYCHIAT CLIN N AM, V39, P87, DOI 10.1016/j.psc.2015.09.003; Judd LL, 2003, INT J NEUROPSYCHOPH, V6, P127, DOI 10.1017/S1461145703003341; Klimstra TA, 2011, EMOTION, V11, P1495, DOI 10.1037/a0024649; Koots L, 2011, J INDIVID DIFFER, V32, P74, DOI 10.1027/1614-0001/a000037; Kripke DF, 2015, F1000 RES, V4; Maj M, 2002, AM J PSYCHIAT, V159, P1711, DOI 10.1176/appi.ajp.159.10.1711; Malhi GS, 2015, AUST NZ J PSYCHIAT, V49, P1087, DOI 10.1177/0004867415617657; Murray G, 2011, BIPOLAR DISORD, V13, P687, DOI 10.1111/j.1399-5618.2011.00959.x; Murray G, 2010, BIPOLAR DISORD, V12, P459, DOI 10.1111/j.1399-5618.2010.00843.x; Pail G, 2011, NEUROPSYCHOBIOLOGY, V64, P152, DOI 10.1159/000328950; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Traffanstedt MK, 2016, CLINICAL PSYCHOLOGIC; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; vanSomeren EJW, 1996, BIOL PSYCHIAT, V40, P259, DOI 10.1016/0006-3223(95)00370-3; Watson D., 2000, MOOD TEMPERAMENT; Yen CF, 2007, BIPOLAR DISORD, V9, P238, DOI 10.1111/j.1399-5618.2007.00407.x	30	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173431	10.1371/journal.pone.0173431	http://dx.doi.org/10.1371/journal.pone.0173431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278268	gold, Green Published			2022-12-27	WOS:000396087900092
J	Hu, HY; Yan, HJ; Liu, XY; Xu, XQ; Xu, JS; Qiu, T; Shi, LE; Fu, GF; Huan, XP; McFarland, W; Wei, CY				Hu, Haiyang; Yan, Hongjing; Liu, Xiaoyan; Xu, Xiaoqin; Xu, Jinshui; Qiu, Tao; Shi, Ling-en; Fu, Gengfeng; Huan, Xiping; McFarland, Willi; Wei, Chongyi			Trends in late HIV diagnosis among men who have sex with men in Jiangsu province, China: Results from four consecutive community-based surveys, 2011-2014	PLOS ONE			English	Article							PREVALENCE; INFECTION; SYPHILIS; PREVENTION; SAMPLES; ONLINE; MSM	Objectives To examine trends in HIV testing, late HIV diagnosis and associated factors among men who have sex with men (MSM) in Jiangsu province, China. Methods Four consecutive community-based cross-sectional surveys were conducted among MSM from 2011 to 2014 in eight cities in the province. Participants were recruited from MSM venues and via the internet. HIV bio-behavioral surveys were conducted to collect demographic and behavioral data and measure HIV infection. HIV-infected participants with CD4 counts less than 350 cells/uL were defined as having a late HIV diagnosis. Chi-square trend tests were used to compare temporal changes over the years and multivariable logistic regression analyses were used to identify factors associated with late diagnosis. Results A total of 2,441, 2,677, 2,591 and 2,610 participants were enrolled in 2011, 2012, 2013 and 2014, respectively. Testing for HIV in the last 12 months decreased over the time period, from 59.9% to 52.5% (p< 0.001). Late HIV diagnosis remained high and steady, ranging from 33.3% to 44.2% over the years with no significant change over time (p = 0.418). MSM who were older than 24 years (aOR = 1.748, p = 0.020 for 25-39 years old; aOR = 3.148, p< 0.001 for 40 years old or older), were recruited via internet (aOR = 1.596, p = 0.024), and did not have an HIV test in the past 12 months (aOR = 3.385, p< 0.001) were more likely to be late diagnosed. Conclusions Our study showed a plateau in HIV testing among MSM in China, in parallel to high levels of late diagnosis. Emerging and innovative strategies such as HIV self-testing and reaching more MSM by internet, both highly acceptable to MSM in China, may reduce late diagnosis.	[Hu, Haiyang; Yan, Hongjing; Liu, Xiaoyan; Xu, Xiaoqin; Xu, Jinshui; Qiu, Tao; Shi, Ling-en; Fu, Gengfeng; Huan, Xiping] Jiangsu Prov Ctr Dis Control & Prevent, Inst HIV AIDS STI Prevent & Control, Nanjing, Jiangsu, Peoples R China; [McFarland, Willi; Wei, Chongyi] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [McFarland, Willi; Wei, Chongyi] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA; [McFarland, Willi] San Francisco Dept Publ Hlth, San Francisco, CA USA	Jiangsu Provincial Center for Disease Control & Prevention; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco Department of Public Health	Wei, CY (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.; Wei, CY (corresponding author), Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA.	Chongyi.Wei@ucsf.edu			Preventive Medicine Program of Jiangsu Provincial Health Department [Y2013051]; Jiangsu Department of Health [H201330]; National Natural Science Foundation of China [81373125]; University of California, San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS) - U.S. NIMH [R25MH064712]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH064712, P30MH062246] Funding Source: NIH RePORTER	Preventive Medicine Program of Jiangsu Provincial Health Department; Jiangsu Department of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of California, San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS) - U.S. NIMH; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Preventive Medicine Program of Jiangsu Provincial Health Department (Grant No. Y2013051), Jiangsu Department of Health (Grant No. H201330), and the National Natural Science Foundation of China (Grant No. 81373125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to acknowledge the support from the University of California, San Francisco's International Traineeships in AIDS Prevention Studies (ITAPS) funded by a grant from the U.S. NIMH (grant number: R25MH064712).	Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Chinese Center for Disease Control and Prevention, 2011, OP MAN NAT AIDS SENT; Choi KH, 2006, AIDS EDUC PREV, V18, P33, DOI 10.1521/aeap.2006.18.1.33; Chow EPF, 2012, HIV MED, V13, P255, DOI 10.1111/j.1468-1293.2011.00974.x; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dai SY, 2015, J MED VIROL, V87, P970, DOI 10.1002/jmv.24066; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Han L, 2014, JAIDS-J ACQ IMM DEF, V67, P216, DOI 10.1097/QAI.0000000000000278; Jiang HB, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001511; Lorente N, 2012, AIDS CARE, V24, P1039, DOI 10.1080/09540121.2012.668171; Mao YR, 2010, INT J EPIDEMIOL, V39, pII79, DOI 10.1093/ije/dyq213; Ministry of Health in People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Ministry of Health of the People's Republic of China, 2012, 2012 CHIN AIDS RESP; Rou KM, 2010, INT J EPIDEMIOL, V39, pII38, DOI 10.1093/ije/dyq211; Shi LE, 2016, LGBT HEALTH, V3, P238, DOI 10.1089/lgbt.2014.0129; Tang HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096098; Wang KL, 2012, INT J EPIDEMIOL, V41, P423, DOI 10.1093/ije/dyr182; Wang Xue-Qing, 2008, BMC Biochemistry, V9, P30, DOI 10.1186/1471-2091-9-30; Wei CY, 2014, AIDS CARE, V26, P372, DOI 10.1080/09540121.2013.824538; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Yan HJ, 2015, AIDS BEHAV, V19, P485, DOI 10.1007/s10461-014-0968-8; Yang HT, 2014, CLIN INFECT DIS, V58, P1753, DOI 10.1093/cid/ciu175; Zeng G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/602719; Zhang DP, 2008, AIDS CARE, V20, P1128, DOI 10.1080/09540120701842829; Zou HC, 2012, AIDS BEHAV, V16, P1717, DOI 10.1007/s10461-012-0225-y	25	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172664	10.1371/journal.pone.0172664	http://dx.doi.org/10.1371/journal.pone.0172664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278195	gold, Green Published			2022-12-27	WOS:000396087900126
J	Jiang, F; Meng, D; Weng, MQ; Zhu, WS; Wu, WX; Kasper, D; Walker, WA				Jiang, Fei; Meng, Di; Weng, Meiqian; Zhu, Weishu; Wu, Wenxue; Kasper, Dennis; Walker, W. Allan			The symbiotic bacterial surface factor polysaccharide A on Bacteroides fragilis inhibits IL-1 beta-induced inflammation in human fetal enterocytes via toll receptors 2 and 4	PLOS ONE			English	Article							DEVELOPING HUMAN INTESTINE; NECROTIZING ENTEROCOLITIS; CAPSULAR POLYSACCHARIDE; BIOSYNTHESIS LOCUS; COLONIZATION; RECOGNITION; MATURATION; EPITHELIUM; MUCOSAL	Colonizing bacteria interacting with the immature, unlike the mature, human intestine favors inflammation over immune homeostasis. As a result, ten percent of premature infants under 1500 grams weight develop an inflammatory necrosis of the intestine after birth, e.g., necrotizing enterocolitis (NEC). NEC is a major health problem in this population causing extensive morbidity and mortality and an enormous expenditure of health care dollars. NEC can be prevented by giving preterm infants their mother's expressed breast milk or ingesting selective probiotic organisms. Vaginally delivered, breast fed newborns develop health promoting bacteria "pioneer" bacteria) which preferentially stimulate intestinal host defense andanti-inflammation. One such "pioneer" organism is Bacteroides fragilis with a polysaccharide (PSA) on its capsule. B. fragilis has been shown developmentally in intestinal lymphocytes and dendritic cells to produce a balanced T-helper cell (TH1/TH2) response and to reduce intestinal inflammation by activity through the TLR2 receptor stimulating IL-10 which inhibits IL-17 causing inflammation. No studies have been done on the role of B. fragilis PSA on fetal enterocytes and its increased inflammation. Accordingly, using human and mouse fetal intestinal models, we have shown that B. fragilis with PSA and PSA alone inhibits IL1a-induced IL-8 inflammation in fetal and NEC intestine. We have also begun to define the mechanism for this unique inflammation noted in fetal intestine. We have shown that B. fragilis PSA anti-inflammation requires both the TLR2 and TLR4 receptor and is in part mediated by the AP1 transcription factor (TLR2) which is developmentally regulated. These observations may help to devise future preventative treatments of premature infants against NEC.	[Jiang, Fei; Wu, Wenxue] China Agr Univ, Coll Vet Med, Lab Rapid Diagnost Technol Anim Dis, Beijing, Peoples R China; [Jiang, Fei; Meng, Di; Weng, Meiqian; Zhu, Weishu; Walker, W. Allan] Massachusetts Gen Hosp Children, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA; [Jiang, Fei; Meng, Di; Weng, Meiqian; Zhu, Weishu; Walker, W. Allan] Harvard Med Sch, Charlestown, MA 02129 USA; [Kasper, Dennis] Harvard Med Sch, Dept Microbiol & Mol Genet, Boston, MA USA	China Agricultural University; Harvard University; Harvard Medical School	Walker, WA (corresponding author), Massachusetts Gen Hosp Children, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA.; Walker, WA (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.	wwalker@partners.org			National Institutes of Child Health and Human Development [R01-HD01237, R01-HD059126]; National Institutes of Digestive Disease and Kidney Disease [P01-DK033506, P30-DK040561]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Digestive Disease and Kidney Disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Child Health and Human Development - R01-HD01237; R01-HD059126- WAW; National Institutes of Digestive Disease and Kidney Disease - P01-DK033506; P30-DK040561 -WAW.	AlFaleh Khalid, 2014, Evid Based Child Health, V9, P584, DOI 10.1002/ebch.1976; AlFaleh K, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005496.pub4; Baumann H, 1999, BIOCHEMISTRY-US, V31, P4081; Cahill CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145184; Claud EC, 2004, P NATL ACAD SCI USA, V101, P7404, DOI 10.1073/pnas.0401710101; Comstock LE, 1999, INFECT IMMUN, V67, P3525, DOI 10.1128/IAI.67.7.3525-3532.1999; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; Ganguli K, 2013, AM J PHYSIOL-GASTR L, V304, pG132, DOI 10.1152/ajpgi.00142.2012; Grave GD, 2007, PEDIATR RES, V62, P510, DOI 10.1203/PDR.0b013e318142580a; Gribar SC, 2008, J LEUKOCYTE BIOL, V83, P493, DOI 10.1189/jlb.0607358; Houghteling PD, 2015, J PEDIATR GASTR NUTR, V60, P294, DOI 10.1097/MPG.0000000000000597; Jost T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044595; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Maeshima N, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00003; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Meng D, 2016, AM J PHYSL GASTROINT; Meng D, 2007, AM J PHYSIOL-GASTR L, V293, pG780, DOI 10.1152/ajpgi.00010.2007; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Nanthakumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017776; Nanthakumar NN, 2005, AM J PHYSIOL-GASTR L, V288, pG85, DOI 10.1152/ajpgi.00169.2004; Nanthakumar NN, 2003, AM J PHYSIOL-REG I, V285, pR162, DOI 10.1152/ajpregu.00721.2001; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Noverr MC, 2005, CLIN EXP ALLERGY, V35, P1511, DOI 10.1111/j.1365-2222.2005.02379.x; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Sanderson IR, 1996, P NATL ACAD SCI USA, V93, P7717, DOI 10.1073/pnas.93.15.7717; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x; TZIANABOS AO, 1992, J BIOL CHEM, V267, P18230; Underwood MA, 2014, PEDIATR RES, V76, P326, DOI 10.1038/pr.2014.102; Van Haver ER, 2009, J PEDIATR GASTR NUTR, V49, P90, DOI 10.1097/MPG.0b013e31818de393; Viscardi RM, 1997, PEDIATR PATHOL LAB M, V17, P547, DOI 10.1080/107710497174516	35	30	35	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172738	10.1371/journal.pone.0172738	http://dx.doi.org/10.1371/journal.pone.0172738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278201	gold, Green Submitted, Green Published			2022-12-27	WOS:000396087900127
J	Trabado, S; Al-Salameh, A; Croixmarie, V; Masson, P; Corruble, E; Feve, B; Colle, R; Ripoll, L; Walther, B; Boursier-Neyret, C; Werner, E; Becquemont, L; Chanson, P				Trabado, Severine; Al-Salameh, Abdallah; Croixmarie, Vincent; Masson, Perrine; Corruble, Emmanuelle; Feve, Bruno; Colle, Romain; Ripoll, Laurent; Walther, Bernard; Boursier-Neyret, Claire; Werner, Erwan; Becquemont, Laurent; Chanson, Philippe			The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age	PLOS ONE			English	Article							PHOSPHATIDYLCHOLINE TRANSFER PROTEIN; OXIDATIVE STRESS; PPAR-ALPHA; ATHEROSCLEROSIS; SPHINGOMYELIN; DISEASE; ADULTS; LONGEVITY; INSIGHTS; LIGAND	Metabolomic approaches are increasingly used to identify new disease biomarkers, yet normal values of many plasma metabolites remain poorly defined. The aim of this study was to define the "normal" metabolome in healthy volunteers. We included 800 French volunteers aged between 18 and 86, equally distributed according to sex, free of any medication and considered healthy on the basis of their medical history, clinical examination and standard laboratory tests. We quantified 185 plasma metabolites, including amino acids, biogenic amines, acylcarnitines, phosphatidylcholines, sphingomyelins and hexose, using tandem mass spectrometry with the Biocrates AbsoluteIDQ p180 kit. Principal components analysis was applied to identify the main factors responsible for metabolome variability and orthogonal projection to latent structures analysis was employed to confirm the observed patterns and identify pattern- related metabolites. We established a plasma metabolite reference dataset for 144/185 metabolites. Total blood cholesterol, gender and age were identified as the principal factors explaining metabolome variability. High total blood cholesterol levels were associated with higher plasma sphingomyelins and phosphatidylcholines concentrations. Compared to women, men had higher concentrations of creatinine, branched-chain amino acids and lyso-phosphatidylcholines, and lower concentrations of sphingomyelins and phosphatidylcholines. Elderly healthy subjects had higher sphingomyelins and phosphatidylcholines plasma levels than young subjects. We established reference human metabolome values in a large and well-defined population of French healthy volunteers. This study provides an essential baseline for defining the "normal" metabolome and its main sources of variation.	[Trabado, Severine] Hop Univ Paris Sud, Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Trabado, Severine; Chanson, Philippe] Univ Paris Saclay, Fac Med Paris Sud, Inserm U1185, Le Kremlin Bicetre, France; [Al-Salameh, Abdallah; Chanson, Philippe] Hop Univ Paris Sud, Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France; [Croixmarie, Vincent; Ripoll, Laurent] Inst Rech Int Servier, Suresnes, France; [Masson, Perrine; Walther, Bernard; Boursier-Neyret, Claire; Werner, Erwan] Technol Servier, Orleans, France; [Corruble, Emmanuelle; Colle, Romain] Univ Paris Sud, INSERM UMR 1178, Equipe Depress & Antidepresseurs, Hop Bicetre,AP HP,Serv Psychiat, Le Kremlin Bicetre, France; [Feve, Bruno] UPMC Univ Paris 06, INSERM UMR S938, Ctr Rech St Antoine, Hop St Antoine,AP HP, Paris, France; [Becquemont, Laurent] Univ Paris Sud, Hop Bicetre,CEA,DSV IMETI,IDMIT,Div Immunovirol, AP HP,Fac Med Paris Sud,Dept Pharmacol,UMR 1184, INSERM Ctr Immunol Infect Virales & Malad Autoim, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Servier; Institut de Recherches Internationales Servier; Servier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; CEA; UDICE-French Research Universities; Universite Paris Saclay	Trabado, S (corresponding author), Hop Univ Paris Sud, Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France.	severine.trabado@aphp.fr	Colle, romain/D-9144-2017; Al-Salameh, Abdallah/S-7043-2016; Chanson, Philippe/F-8511-2013	Al-Salameh, Abdallah/0000-0002-7951-9926; Chanson, Philippe/0000-0001-5096-5722; Feve, Bruno/0000-0001-6577-9009; Trabado, Severine/0000-0002-1925-1999; Colle, Romain/0000-0002-2549-4495	national grant (PHRC) [AOM09122]; Assistance Publique-Hopitaux de Paris (APHP, Paris, France)	national grant (PHRC); Assistance Publique-Hopitaux de Paris (APHP, Paris, France)	The VARIETE study was financed by a national grant (PHRC, AOM09122) and sponsored by Assistance Publique-Hopitaux de Paris (APHP, Paris, France). Metabolomic analyses were performed at Technologie Servier (Orleans, France). One or more of the authors are employed by a commercial company: "Technologie Servier, [VC, PM, LR, BW, CBN, EW]. These authors performed metabolomic analyses, statistical analyses, data collection and analyses and preparation of the manuscript.	ARMSTRONG MD, 1973, METABOLISM, V22, P561, DOI 10.1016/0026-0495(73)90069-3; Bouchard-Mercier A, 2013, NUTR J, V12; Breier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089728; Bub A, 2016, JMIR RES PROTOC, V5, P225, DOI 10.2196/resprot.5792; Carayol M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135437; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chanson P, 2016, J CLIN ENDOCR METAB; Clement AB, 2009, J NEUROCHEM, V111, P669, DOI 10.1111/j.1471-4159.2009.06360.x; Correl Niaudet C, 2010, MUTAT RES-REV MUTAT, V704, P61; de Brouwer APM, 2002, EXP CELL RES, V274, P100, DOI 10.1006/excr.2001.5460; Draisma HHM, 2015, NAT COMMUN, P6; Dunn WB, 2015, METABOLOMICS, V11, P9, DOI 10.1007/s11306-014-0707-1; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; Ersoy BA, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004111; Everett JR, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00297; Floegel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021103; Furse S, 2015, MOL MEMBR BIOL, V32, P117, DOI 10.3109/09687688.2015.1066894; Gonzalez-Covarrubias V, 2013, AGING CELL, V12, P426, DOI 10.1111/acel.12064; Guertin KA, 2014, AM J CLIN NUTR, V100, P208, DOI 10.3945/ajcn.113.078758; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Ichi I, 2009, TOXICOLOGY, V261, P33, DOI 10.1016/j.tox.2009.04.040; Ishikawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091806; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Krumsiek J, 2015, METABOLOMICS, V11, P1815, DOI 10.1007/s11306-015-0829-0; Matsumoto T, 2007, CURR MED CHEM, V14, P3209, DOI 10.2174/092986707782793899; Mecocci P, 1996, NEUROSCI LETT, V207, P129, DOI 10.1016/0304-3940(96)12509-X; MERRILL AH, 1985, LIPIDS, V20, P252, DOI 10.1007/BF02534197; Mielke MM, 2015, AGING CELL, V14, P112, DOI 10.1111/acel.12275; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Nelson J, 2006, AM J EPIDEMIOL, V163, P903, DOI 10.1093/aje/kwj140; Nicholson JK, 2012, EXPERT OPIN DRUG MET, V8, P135, DOI 10.1517/17425255.2012.646987; Nikkila Janne, 2008, Mol Syst Biol, V4, P197, DOI 10.1038/msb.2008.34; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Piccinini M, 2010, MOL NEUROBIOL, V41, P314, DOI 10.1007/s12035-009-8096-6; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Reuter SE, 2008, ANN CLIN BIOCHEM, V45, P585, DOI 10.1258/acb.2008.008045; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Sakai H, 2014, J BIOL CHEM, V289, P26607, DOI 10.1074/jbc.M114.590950; Shin SY, 2014, GENOME MED, V6, DOI 10.1186/gm542; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Smith AR, 2006, AGING CELL, V5, P391, DOI 10.1111/j.1474-9726.2006.00232.x; Souberbielle JC, 2016, ENDOCRINE, V53, P543, DOI 10.1007/s12020-016-0960-3; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Vaarhorst AAM, 2011, AGE, V33, P219, DOI 10.1007/s11357-010-9172-6; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73; Yeboah J, 2010, ARTERIOSCL THROM VAS, V30, P628, DOI 10.1161/ATVBAHA.109.199281; Yet I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153672; Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x	51	83	84	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173615	10.1371/journal.pone.0173615	http://dx.doi.org/10.1371/journal.pone.0173615			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278231	gold, Green Submitted, Green Published			2022-12-27	WOS:000396087900016
J	Verhagen, JH; Lexmond, P; Vuong, O; Schutten, M; Guldemeester, J; Osterhaus, ADME; Elbers, ARW; Slaterus, R; Hornman, M; Koch, G; Fouchier, RAM				Verhagen, Josanne H.; Lexmond, Pascal; Vuong, Oanh; Schutten, Martin; Guldemeester, Judith; Osterhaus, Albert D. M. E.; Elbers, Armin R. W.; Slaterus, Roy; Hornman, Menno; Koch, Guus; Fouchier, Ron A. M.			Discordant detection of avian influenza virus subtypes in time and space between poultry and wild birds; Towards improvement of surveillance programs	PLOS ONE			English	Article							A VIRUSES; HUMAN INFECTION; NETHERLANDS; PATTERNS; DUCKS; PERFORMANCE; AUSTRALIA; EVOLUTION; CHICKENS; OUTBREAK	Avian influenza viruses from wild birds can cause outbreaks in poultry, and occasionally infect humans upon exposure to infected poultry. Identification and characterization of viral reservoirs and transmission routes is important to develop strategies that prevent infection of poultry, and subsequently virus transmission between poultry holdings and to humans. Based on spatial, temporal and phylogenetic analyses of data generated as part of intense and large-scale influenza surveillance programs in wild birds and poultry in the Netherlands from 2006 to 2011, we demonstrate that LPAIV subtype distribution differed between wild birds and poultry, suggestive of host-range restrictions. LPAIV isolated from Dutch poultry were genetically most closely related to LPAIV isolated from wild birds in the Netherlands or occasionally elsewhere in Western Europe. However, a relatively long time interval was observed between the isolations of related viruses from wild birds and poultry. Spatial analyses provided evidence for mallards (Anas platyrhynchos) being more abundant near primary infected poultry farms. Detailed year-round investigation of virus prevalence and wild bird species distribution and behavior near poultry farms should be used to improve risk assessment in relation to avian influenza virus introduction and retarget avian influenza surveillance programs.	[Verhagen, Josanne H.; Lexmond, Pascal; Vuong, Oanh; Schutten, Martin; Guldemeester, Judith; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Elbers, Armin R. W.; Koch, Guus] Cent Vet Inst part Wageningen UR, Lelystad, Netherlands; [Slaterus, Roy; Hornman, Menno] Sovon, Dutch Ctr Field Ornithol, Nijmegen, Netherlands; [Verhagen, Josanne H.] Linnaeus Univ, Dept Biol & Environm Sci, Kalmar, Sweden; [Osterhaus, Albert D. M. E.] Vet Univ Hannover, Res Ctr Emerging Infect & Zoonoses, Hannover, Germany	Erasmus University Rotterdam; Erasmus MC; Wageningen University & Research; Linnaeus University; University of Veterinary Medicine Hannover, Foundation	Fouchier, RAM (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl	Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; Verhagen, Josanne/0000-0003-3133-5228	Dutch Ministry of Economic Affairs [TRCDR/2006/7406]; European Research Council project FLUPLAN [250136]; European Union's Horizon [643476]; NIAID/NIH [HHSN272201400008C]; Ministry of Infrastructure and the Environment	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); European Research Council project FLUPLAN; European Union's Horizon; NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Infrastructure and the Environment	This study was sponsored by grants from the Dutch Ministry of Economic Affairs contract no. TRCDR/2006/7406, European Research Council project FLUPLAN (250136), European Union's Horizon 2020 grant no. 643476 "COMPARE" and NIAID/NIH contract no. HHSN272201400008C.; The authors thank Ger van der Water and Dries Oomen for logistical and technical assistance. We thank Teun de Vaal, Bert Pellegrom, Hans Zantinge, Arie Keijzer, Jan Berkhouwer, Jan Slijkerman, Dick Jonkers, Engbert van Oort, Gerard Miiskens, David Kleijn, Frank Majoor, Kees Oosterbeek for sampling wild birds, and veterinarians of various practices for sampling poultry, and Sjaak de Wit of the Animal Health Service (GD Deventer) for providing farm data. The Dutch waterbird census scheme is part of a governmental ecological surveillance (NEM), carried out in association with Dutch Statistics and supported by Dutch Ministry of Economic Affairs and the Ministry of Infrastructure and the Environment.	Arzey GG, 2012, EMERG INFECT DIS, V18, P814, DOI 10.3201/eid1805.111852; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Berhane Y, 2009, EMERG INFECT DIS, V15, P1492, DOI 10.3201/eid1509.080231; Brown J, 2012, AVIAN DIS, V56, P969, DOI 10.1637/10158-040912-Reg.1; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Daoust PY, 2013, VET PATHOL, V50, P548, DOI 10.1177/0300985812469633; de Wit JJ, 2004, AVIAN PATHOL, V33, P565, DOI 10.1080/03079450400013196; DEBOER GF, 1990, ARCH VIROL, V115, P47, DOI 10.1007/BF01310622; Elbers ARW, 2005, AVIAN PATHOL, V34, P181, DOI 10.1080/03079450500096497; Fereidouni SR, 2014, INFLUENZA OTHER RESP, V8, P613, DOI 10.1111/irv.12275; Ferro PJ, 2010, EMERG INFECT DIS, V16, P1224, DOI 10.3201/eid1608.091864; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gilbert M, 2012, SPAT SPATIO-TEMPORAL, V3, P173, DOI 10.1016/j.sste.2012.01.002; Gonzales J., 2012, THESIS; Gonzales JL, 2010, INFLUENZA OTHER RESP, V4, P91, DOI 10.1111/j.1750-2659.2009.00126.x; Gonzales JL, 2013, INFLUENZA OTHER RESP, V7, P6, DOI 10.1111/j.1750-2659.2012.00348.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HALVORSON DA, 1985, APPL ENVIRON MICROB, V49, P914, DOI 10.1128/AEM.49.4.914-919.1985; Hansbro PM, 2010, EMERG INFECT DIS, V16, P1896, DOI 10.3201/eid1612.100776; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hornman M, 2012, WATERVOGELS NEDERLAN; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Jourdain E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024155; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Latorre-Margalef N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0098; Lebarbenchon C, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-328; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2009, J CLIN MICROBIOL, V47, P666, DOI 10.1128/JCM.01625-08; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Ostrowsky B, 2012, EMERG INFECT DIS, V18, P1128, DOI 10.3201/eid1807.111913; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Post J, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-23; Ramey AM, 2014, J WILDLIFE DIS, V50, P916, DOI 10.7589/2013-09-232; Sharp GB, 1997, J VIROL, V71, P6128, DOI 10.1128/JVI.71.8.6128-6135.1997; Si YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053362; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Tonnessen R, 2011, AVIAN DIS, V55, P680, DOI 10.1637/9701-030411-ResNote.1; Velkers FC, 2006, VET REC, V159, P403, DOI 10.1136/vr.159.13.403; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Welby S, 2010, AVIAN DIS, V54, P597, DOI 10.1637/8749-033009-Reg.1; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010	47	32	34	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173470	10.1371/journal.pone.0173470	http://dx.doi.org/10.1371/journal.pone.0173470			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278281	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900097
J	Eberlein, T; Wohlrab, S; Rost, B; John, U; Bach, LT; Riebesell, U; van de Waal, DB				Eberlein, Tim; Wohlrab, Sylke; Rost, Bjoern; John, Uwe; Bach, Lennart T.; Riebesell, Ulf; Van de Waal, Dedmer B.			Effects of ocean acidification on primary production in a coastal North Sea phytoplankton community	PLOS ONE			English	Article							INORGANIC CARBON ACQUISITION; CONCENTRATING MECHANISMS; MARINE-PHYTOPLANKTON; CO2 CONCENTRATION; TECHNICAL NOTE; USE EFFICIENCY; ELEVATED CO2; DIATOM; GROWTH; BLOOM	We studied the effect of ocean acidification (OA) on a coastal North Sea plankton community in a long-term mesocosm CO2-enrichment experiment (BIOACID II long-term mesocosm study). From March to July 2013, 10 mesocosms of 19 m length with a volume of 47.5 to 55.9 m(-3) were deployed in the Gullmar Fjord, Sweden. CO2 concentrations were enriched in five mesocosms to reach average CO2 partial pressures (pCO(2)) of 760 mu atm. The remaining five mesocosms were used as control at ambient pCO(2) of 380 mu atm. Our paper is part of a PLOS collection on this long-term mesocosm experiment. Here, we here tested the effect of OA on total primary production (PPT) by performing C-14-based bottle incubations for 24 h. Furthermore, photoacclimation was assessed by conducting C-14-based hotosynthesis-irradiance response (P/I) curves. Changes in chlorophyll a concentrations over time were reflected in the development of PPT, and showed higher phytoplankton biomass build-up under OA. We observed two subsequent phytoplankton blooms in all mesocosms, with peaks in PPT around day 33 and day 56. OA had no significant effect on PPT, except for a marginal increase during the second phytoplankton bloom when inorganic nutrients were already depleted. Maximum light use efficiencies and light saturation indices calculated from the P/I curves changed simultaneously in all mesocosms, and suggest that OA did not alter phytoplankton photoacclimation. Despite large variability in time-integrated productivity estimates among replicates, our overall results indicate that coastal phytoplankton communities can be affected by OA at certain times of the seasonal succession with potential consequences for ecosystem functioning.	[Eberlein, Tim; Wohlrab, Sylke; Rost, Bjoern; John, Uwe; Van de Waal, Dedmer B.] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Handelshafen 12, Bremerhaven, Germany; [John, Uwe] Helmholtz Inst Funct Marine Biodivers Oldenburg H, Carl von Ossietzky Str, Oldenburg, Germany; [Bach, Lennart T.; Riebesell, Ulf] GEOMAR Helmholtz Ctr Ocean Res Kiel, Dusternbrooker Weg 20, Kiel, Germany; [Van de Waal, Dedmer B.] NIOO KNAW, Netherlands Inst Ecol, Wageningen, Netherlands	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Eberlein, T (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Handelshafen 12, Bremerhaven, Germany.	tim.eberlein@rub.de	Riebesell, Ulf/AAC-9717-2020; Rost, Bjoern/B-4447-2015; Van de Waal, Dedmer B/B-8002-2012; KNAW, NIOO-KNAW/A-4320-2012	Rost, Bjoern/0000-0001-5452-5505; Van de Waal, Dedmer B/0000-0001-8803-1247; KNAW, NIOO-KNAW/0000-0002-3835-159X; Bach, Lennart/0000-0003-0202-3671; Wohlrab, Sylke/0000-0003-3190-0880; Riebesell, Ulf/0000-0002-9442-452X	German Federal Ministry of Science and Education (BMBF) [FKZ 03F0655A]; EU [227799]; Royal Swedish Academy of Sciences	German Federal Ministry of Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Royal Swedish Academy of Sciences	This project was funded by the German Federal Ministry of Science and Education (BMBF) in the framework of the BIOACID II project (grant no. FKZ 03F0655A). SW, TE and DBvdW received support from the EU FP7 research infrastructure initiative 'Association of European Marine Biological Laboratories' (ASSEMBLE (grant no. 227799), and SW from the Royal Swedish Academy of Sciences.r We thank the Sven Loven Centre for Marine Sciences, Kristineberg, for their hospitality and help during the field work. We thank Amy Forsberg-Grivogiannis for her great help during the field work. We also gratefully acknowledge the captain and crew of RV ALKOR for their work transporting, deploying and recovering the mesocosms during cruises AL406 and AL420. This project was funded by the German Federal Ministry of Science and Education (BMBF) in the framework of the BIOACID II project (grant no. FKZ 03F0655A). SW, TE and DBvdW received support from the EU FP7 research infrastructure initiative 'Association of European Marine Biological Laboratories' (ASSEMBLE (grant no. 227799), and SW from the Royal Swedish Academy of Sciences.	Bach LT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159068; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; BENDER M, 1987, LIMNOL OCEANOGR, V32, P1085, DOI 10.4319/lo.1987.32.5.1085; Boxhammer T, 2016, BIOGEOSCIENCES, V13, P2849, DOI 10.5194/bg-13-2849-2016; Brading P, 2013, NEW PHYTOL, V200, P432, DOI 10.1111/nph.12379; Burkhardt S, 1999, LIMNOL OCEANOGR, V44, P683, DOI 10.4319/lo.1999.44.3.0683; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Eberlein T, 2016, MAR ECOL PROG SER, V543, P127, DOI 10.3354/meps11568; Egge JK, 2009, BIOGEOSCIENCES, V6, P877, DOI 10.5194/bg-6-877-2009; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Engel A, 2013, BIOGEOSCIENCES, V10, P1291, DOI 10.5194/bg-10-1291-2013; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Hopkinson BM, 2010, LIMNOL OCEANOGR, V55, P2011, DOI 10.4319/lo.2010.55.5.2011; Hoppe CJM, 2015, NEW PHYTOL, V207, P159, DOI 10.1111/nph.13334; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; Kranz SA, 2009, LIMNOL OCEANOGR, V54, P548, DOI 10.4319/lo.2009.54.2.0548; Lindahl O, 1998, ICES J MAR SCI, V55, P723, DOI 10.1006/jmsc.1998.0379; Lindahl O, 1995, ECOLOGY OF FJORDS AND COASTAL WATERS, P105; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Paul AJ, 2015, BIOGEOSCIENCES, V12, P6181, DOI 10.5194/bg-12-6181-2015; RAVEN JA, 1991, PLANT CELL ENVIRON, V14, P779, DOI 10.1111/j.1365-3040.1991.tb01442.x; Raven JA, 1997, ADV BOT RES, V27, P85; Raven JA, 2014, PHOTOSYNTH RES, V121, P111, DOI 10.1007/s11120-013-9962-7; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riebesell U, 2013, BIOGEOSCIENCES, V10, P1835, DOI 10.5194/bg-10-1835-2013; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Rost B, 2008, MAR ECOL PROG SER, V373, P227, DOI 10.3354/meps07776; Roy T, 2011, J CLIMATE, V24, P2300, DOI 10.1175/2010JCLI3787.1; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sala MM, 2016, ICES J MAR SCI, V73, P670, DOI 10.1093/icesjms/fsv130; Schaum E, 2013, NAT CLIM CHANGE, V3, P298, DOI 10.1038/NCLIMATE1774; Steemann-Nielsen E, 1952, J CONS CONS PERM INT, V18, P117, DOI DOI 10.1093/ICESJMS/18.2.117; Stocker T F, 2013, CLIM CHANG 2013 PHYS; Tiselius P, 1996, J PLANKTON RES, V18, P133, DOI 10.1093/plankt/18.2.133; Trimborn S, 2008, PHYSIOL PLANTARUM, V133, P92, DOI 10.1111/j.1399-3054.2007.01038.x; Waite AM, 2006, MAR ECOL PROG SER, V326, P77, DOI 10.3354/meps326077; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010; Young JN, 2016, J EXP BOT	40	22	22	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172594	10.1371/journal.pone.0172594	http://dx.doi.org/10.1371/journal.pone.0172594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273107	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700080
J	Gargano, F; Tamburino, L; Bagarello, F; Bravo, G				Gargano, Francesco; Tamburino, Lucia; Bagarello, Fabio; Bravo, Giangiacomo			Large-scale effects of migration and conflict in pre-agricultural groups: Insights from a dynamic model	PLOS ONE			English	Article							HUNTER-GATHERERS; EVOLUTION	The debate on the causes of conflict in human societies has deep roots. In particular, the extent of conflict in hunter-gatherer groups remains unclear. Some authors suggest that large-scale violence only arose with the spreading of agriculture and the building of complex societies. To shed light on this issue, we developed a model based on operatorial techniques simulating population-resource dynamics within a two-dimensional lattice, with humans and natural resources interacting in each cell of the lattice. The model outcomes under different conditions were compared with recently available demographic data for prehistoric South America. Only under conditions that include migration among cells and conflict was the model able to consistently reproduce the empirical data at a continental scale. We argue that the interplay between resource competition, migration, and conflict drove the population dynamics of South America after the colonization phase and before the introduction of agriculture. The relation between population and resources indeed emerged as a key factor leading to migration and conflict once the carrying capacity of the environment has been reached.	[Gargano, Francesco; Bagarello, Fabio] Univ Palermo, DEIM, Dept Energy Engn Informat & Math Models, Palermo, Italy; [Tamburino, Lucia] Linnaeus Univ, Dept Math, Vaxjo, Sweden; [Bagarello, Fabio] INFN, Natl Inst Nucl Phys, Naples, Italy; [Bravo, Giangiacomo] Linnaeus Univ, Dept Social Studies, Vaxjo, Sweden; [Bravo, Giangiacomo] Linnaeus Univ, DISA LNU, Ctr Data Intens Sci & Applicat, Vaxjo, Sweden	University of Palermo; Linnaeus University; Istituto Nazionale di Fisica Nucleare (INFN); Linnaeus University; Linnaeus University	Bravo, G (corresponding author), Linnaeus Univ, Dept Social Studies, Vaxjo, Sweden.; Bravo, G (corresponding author), Linnaeus Univ, DISA LNU, Ctr Data Intens Sci & Applicat, Vaxjo, Sweden.	giangiacomo.bravo@lnu.se	Tamburino, Lucia/GWV-9928-2022; Gargano, Francesco/J-8576-2015	Tamburino, Lucia/0000-0003-1974-7158; Gargano, Francesco/0000-0002-6453-4883; Bravo, Giangiacomo/0000-0003-2837-0137				Allen MW, 2016, P NATL ACAD SCI USA, V113, P12120, DOI 10.1073/pnas.1607996113; Allen MW., 2014, VIOLENCE WARFARE HUN; [Anonymous], 1965, ADV QUANTUM MECH; Arim M, 2006, P NATL ACAD SCI USA, V103, P374, DOI 10.1073/pnas.0504272102; Bagarello F., 2012, QUANTUM DYNAMICS CLA; Bagarello F, 2015, APPL MATH MODEL, V39, P2276, DOI 10.1016/j.apm.2014.10.038; Bagarello F, 2013, MATH MOD METH APPL S, V23, P471, DOI 10.1142/S0218202512500534; Boserup E, 2005, CONDITIONS AGR GROWT; Bowles S, 2012, SCIENCE, V336, P876, DOI 10.1126/science.1217336; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Bravo G, 2011, J ENVIRON MANAGE, V92, P2865, DOI 10.1016/j.jenvman.2011.06.010; Frank AB, 2014, P NATL ACAD SCI USA, V111, P17356, DOI 10.1073/pnas.1400229111; Fry DouglasP., 2013, WAR PEACE HUMAN NATU; Gat Azar, 2006, WAR HUMAN CIVILIZATI; Goldberg A, 2016, NATURE, V532, P232, DOI 10.1038/nature17176; Guilaine J, 2005, THE ORIGINS OF WAR V; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; Helbling J, 1999, SOCIOLOGUS, V49, P103; Homer-Dixon T.F., 1999, ENV SCARCITY VIOLENC; Lawler A, 2012, SCIENCE, V336, P832, DOI 10.1126/science.336.6083.832; Lawler A, 2012, SCIENCE, V336, P829, DOI 10.1126/science.336.6083.829; Meyer C, 2015, P NATL ACAD SCI USA, V112, P11217, DOI 10.1073/pnas.1504365112; OCONNELL RL, 1997, RIDE 2 HORSEMAN BIRT; Perman R., 2003, NATURAL RESOURCE ENV, VVolume 6; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sala N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126589; Schleussner CF, 2016, P NATL ACAD SCI USA, V113, P9216, DOI 10.1073/pnas.1601611113; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931	29	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172262	10.1371/journal.pone.0172262	http://dx.doi.org/10.1371/journal.pone.0172262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273114	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700071
J	Liu, FY; Liu, DQ; Malekian, R; Li, ZX; Wang, DQ				Liu, Fengyun; Liu, Deqiang; Malekian, Reza; Li, Zhixiong; Wang, Deqing			A measurement model for real estate bubble size based on the panel data analysis: An empirical case study	PLOS ONE			English	Article							HOUSING PRICE BUBBLES; CHINA; MARKETS	Employing the fundamental value of real estate determined by the economic fundamentals, a measurement model for real estate bubble size is established based on the panel data analysis. Using this model, real estate bubble sizes in various regions in Japan in the late 1980s and in recent China are examined. Two panel models for Japan provide results, which are consistent with the reality in the 1980s where a commercial land price bubble appeared in most area and was much larger than that of residential land. This provides evidence of the reliability of our model, overcoming the limit of existing literature with this method. The same models for housing prices in China at both the provincial and city levels show that contrary to the concern of serious housing price bubble in China, over-valuing in recent China is much smaller than that in 1980s Japan.	[Liu, Fengyun; Wang, Deqing] China Univ Min & Technol, Xuzhou, Jiangsu, Peoples R China; [Liu, Deqiang] Kyoto Univ, Dept Econ, Kyoto, Kyoto, Japan; [Malekian, Reza] Univ Pretoria, Dept Elect Elect & Comp Engn, Pretoria, Gauteng, South Africa; [Li, Zhixiong] UNSW Australia, Dept Mfg & Mech Engn, Sydney, NSW, Australia	China University of Mining & Technology; Kyoto University; University of Pretoria; University of New South Wales Sydney	Liu, FY (corresponding author), China Univ Min & Technol, Xuzhou, Jiangsu, Peoples R China.	liufengyun@cumt.edu.cn	Liu, Fengyun/ABA-6174-2021; Li, Zhixiong/G-8418-2018	Li, Zhixiong/0000-0002-7265-0008	"A Study on Spatial Effects of Regional Systemic Financial Risks Led by Real Estate Market in Jiangsu Province" from Social Science Scientific Fund of Jiangsu Province [15EYD004]; "A Study on Regional Systemic Financial Risks Led by Real Estate in China" from China Post-doctor Scientific Fund [2016M591948]; "Methodology of Functional Data Mining with Its Application in Financial Market" from Humanities and Social Science Foundation of Ministry of Education of China [15YJCZH162]; China University of Mining Technology	"A Study on Spatial Effects of Regional Systemic Financial Risks Led by Real Estate Market in Jiangsu Province" from Social Science Scientific Fund of Jiangsu Province; "A Study on Regional Systemic Financial Risks Led by Real Estate in China" from China Post-doctor Scientific Fund; "Methodology of Functional Data Mining with Its Application in Financial Market" from Humanities and Social Science Foundation of Ministry of Education of China; China University of Mining Technology	We acknowledge the support from the following research projects: "A Study on Spatial Effects of Regional Systemic Financial Risks Led by Real Estate Market in Jiangsu Province" (15EYD004) from Social Science Scientific Fund of Jiangsu Province; "A Study on Regional Systemic Financial Risks Led by Real Estate in China" (2016M591948) from China Post-doctor Scientific Fund; "Methodology of Functional Data Mining with Its Application in Financial Market" (15YJCZH162) from Humanities and Social Science Foundation of Ministry of Education of China; "Sailing Plan" from China University of Mining & Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JesseM., 1994, NATL BUREAU EC RES, V104, P50; Black A, 2006, J BUS FINAN ACCOUNT, V33, P1535, DOI 10.1111/j.1468-5957.2006.00638.x; Blanchard O.J., 1983, 945 NBER; Clark SP, 2011, Q REV ECON FINANC, V51, P189, DOI 10.1016/j.qref.2010.12.001; Hasan I, 2009, J BANK FINANC, V33, P157, DOI 10.1016/j.jbankfin.2007.11.016; Himmelberg C., 2005, 11643 NBER; Hlavacek M, 2011, FINANC UVER, V61, P67; Hott C, 2008, J REAL ESTATE FINANC, V36, P427, DOI 10.1007/s11146-007-9097-8; Hui ECM, 2006, J REAL ESTATE FINANC, V33, P299, DOI 10.1007/s11146-006-0335-2; Hui ECM, 2014, LAND USE POLICY, V39, P96, DOI 10.1016/j.landusepol.2014.04.003; JENSEN RC, 1991, REGIONAL INPUT-OUTPUT MODELLING, P228; Kindleberger CP, 1987, NEW PALGRAVE DICT EC, P281; Mikhed V, 2009, J REAL ESTATE FINANC, V38, P366, DOI 10.1007/s11146-007-9090-2; Noguchi Y., 1994, HOUSING MARKETS US J, P11; Quigley JM, 2002, WORKING PAPER, V2, P1; Ren Y, 2012, CHINA ECON REV, V23, P786, DOI 10.1016/j.chieco.2012.04.001; Shih YN, 2014, HABITAT INT, V43, P142, DOI 10.1016/j.habitatint.2014.02.008; Sun LJ, 2008, CHINA WORLD ECON, V16, P34, DOI 10.1111/j.1749-124X.2008.00098.x; Thakur Sudhir K., 2008, Structural Change and Economic Dynamics, V19, P132, DOI 10.1016/j.strueco.2007.07.001; Thakur S. K., 2012, STRUCTURAL CHANGE EC, V23, P92; Wang HW, 2012, J REAL ESTATE RES, V34, P275; Yu HY, 2011, CHINA WORLD ECON, V19, P56, DOI 10.1111/j.1749-124X.2011.01266.x	22	18	19	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173287	10.1371/journal.pone.0173287	http://dx.doi.org/10.1371/journal.pone.0173287			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273141	gold, Green Submitted, Green Published			2022-12-27	WOS:000396073700052
J	Liu, JJW; Vickers, K; Reed, M; Hadad, M				Liu, Jenny J. W.; Vickers, Kristin; Reed, Maureen; Hadad, Marilyn			Re-conceptualizing stress: Shifting views on the consequences of stress and its effects on stress reactivity	PLOS ONE			English	Article							35-PERCENT CARBON-DIOXIDE; PHYSIOLOGICAL-RESPONSES; REAPPRAISING AROUSAL; ASSOCIATION; INTEGRATION; MATTER	Background The consequences of stress are typically regarded from a deficit-oriented approach, conceptualizing stress to be entirely negative in its outcomes. This approach is unbalanced, and may further hinder individuals from engaging in adaptive coping. In the current study, we explored whether negative views and beliefs regarding stress interacted with a stress framing manipulation (positive, neutral and negative) on measures of stress reactivity for both psychosocial and physiological stressors. Method Ninety participants were randomized into one of three framing conditions that conceptualized the experience of stress in balanced, unbalanced-negative or unbalanced-positive ways. After watching a video on stress, participants underwent a psychosocial (Trier Social Stress Test), or a physiological (CO2 challenge) method of stress-induction. Subjective and objective markers of stress were assessed. Results Most of the sampled population regarded stress as negative prior to framing. Further, subjective and objective reactivity were greater to the TSST compared to the CO2 challenge. Additionally, significant cubic trends were observed in the interactions of stress framing and stress-induction methodologies on heart rate and blood pressure. Balanced framing conditions in the TSST group had a significantly larger decrease in heart rate and diastolic blood pressure following stress compared to the positive and negative framing conditions. Conclusion Findings confirmed a deficit-orientation of stress within the sampled population. In addition, results highlighted the relative efficacy of the TSST compared to CO2 as a method of stress provocation. Finally, individuals in framing conditions that posited stress outcomes in unbalanced manners responded to stressors less efficiently. This suggests that unbalanced framing of stress may have set forth unrealistic expectations regarding stress that later hindered individuals from adaptive responses to stress. Potential benefits of alternative conceptualizations of stress on stress reactivity are discussed, and suggestions for future research are made.	[Liu, Jenny J. W.; Vickers, Kristin; Reed, Maureen; Hadad, Marilyn] Ryerson Univ, Dept Psychol, Toronto, ON, Canada	Toronto Metropolitan University	Vickers, K (corresponding author), Ryerson Univ, Dept Psychol, Toronto, ON, Canada.	kvickers@psych.ryerson.ca			Joseph-Armand Bombardier Canada Graduate Scholarships Program Master's Scholarships from Social Sciences and Humanities Research Council of Canada	Joseph-Armand Bombardier Canada Graduate Scholarships Program Master's Scholarships from Social Sciences and Humanities Research Council of Canada	This research was supported by the Joseph-Armand Bombardier Canada Graduate Scholarships Program Master's Scholarships from Social Sciences and Humanities Research Council of Canada ($17500 - http.//www.sshrc-crsh.gc.ca/funding-firiancement/programs-programmes/fellottishipstcgs_masters-besc_maitrisetenlaspx).	Beltzer ML, 2014, EMOTION, V14, P761, DOI 10.1037/a0036326; Cohen GL, 2006, SCIENCE, V313, P1307, DOI 10.1126/science.1128317; Cohen J.E., 1988, STAT POWER ANAL BEHA; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Gruber J, 2011, CURR DIR PSYCHOL SCI, V20, P217, DOI 10.1177/0963721411414632; Harrington R., 2013, STRESS HLTH WELL BEI; Jamieson JP, 2013, CLIN PSYCHOL SCI, V1, P363, DOI 10.1177/2167702613482119; Jamieson JP, 2012, J EXP PSYCHOL GEN, V141, P417, DOI 10.1037/a0025719; Jamieson JP, 2010, J EXP SOC PSYCHOL, V46, P208, DOI 10.1016/j.jesp.2009.08.015; Kaye J, 2004, J NEUROENDOCRINOL, V16, P256, DOI 10.1111/j.0953-8194.2004.01158.x; Keller A, 2012, HEALTH PSYCHOL, V31, P677, DOI 10.1037/a0026743; Kelly MM, 2008, J BEHAV THER EXP PSY, V39, P87, DOI 10.1016/j.jbtep.2007.02.003; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Lazarus R. S., 1984, STRESS APPRAISAL COP; Liu JJW, 2015, ADV PSYCHOL RES, P125; Lupien S., 2012, WELL STRESSED MANAGE; Michie S, 2002, OCCUP ENVIRON MED, V59, P67, DOI 10.1136/oem.59.1.67; Nelson DL, 2004, BEHAV RES METH INS C, V36, P402, DOI 10.3758/BF03195588; Schmidt NB, 2007, J ANXIETY DISORD, V21, P302, DOI 10.1016/j.janxdis.2006.06.002; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Skoluda N, 2015, PSYCHONEUROENDOCRINO, V51, P227, DOI 10.1016/j.psyneuen.2014.10.002; Stratakis CA, 1995, ANN NY ACAD SCI, V771, P1, DOI 10.1111/j.1749-6632.1995.tb44666.x; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Telch MJ, 2011, J ANXIETY DISORD, V25, P645, DOI 10.1016/j.janxdis.2011.02.005; van Duinen MA, 2005, J PSYCHOPHARMACOL, V19, P243, DOI 10.1177/0269881105051527; Vickers K, 2012, CLIN PSYCHOL REV, V32, P153, DOI 10.1016/j.cpr.2011.12.004; Wetherell MA, 2006, PSYCHONEUROENDOCRINO, V31, P736, DOI 10.1016/j.psyneuen.2006.02.005; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; Wolkowitz O. M., 2003, PSYCHONEUROENDOCRINO; Woznica A, 2015, PSYCHIAT RES, V228, P571, DOI 10.1016/j.psychres.2015.05.050	31	18	18	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173188	10.1371/journal.pone.0173188	http://dx.doi.org/10.1371/journal.pone.0173188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273132	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700044
J	Stille, L; Norin, E; Sikstrom, S				Stille, Lotta; Norin, Emelie; Sikstrom, Sverker			Self-delivered misinformation - Merging the choice blindness and misinformation effect paradigms	PLOS ONE			English	Article							MISLEADING POSTEVENT INFORMATION; FACIAL RECOGNITION DECISIONS; EYEWITNESS MEMORY; PERIPHERAL MISINFORMATION; FORCED CONFABULATION; LEADING QUESTIONS; FALSE MEMORIES; SUGGESTIBILITY; RECALL; CONFIDENCE	Choice blindness is the failure to detect a discrepancy between a choice and its outcome. The misinformation effect occurs when the recollection of an event changes because new, misleading information about the event is received. The purpose of this study was to merge the choice blindness and misinformation effect paradigms, and thus examine whether choice blindness can be created for individuals' recollections of a witnessed event, and whether this will affect their later recollections of the event. Thus, as a way of delivering misinformation the participants ostensibly became their own source of the misleading information. The participants watched a short film and filled out a questionnaire about events shown in the film. Some of their answers were then manipulated using reattachable stickers, which allowed alteration of their original answers. The participants gave justifications for their manipulated choices, and later their recollection of the original event was tested through another questionnaire. Choice blindness was created for a majority of the participants. A majority of the choice blind participants later changed their reported recollection of the event in line with the manipulations, whereas only a small minority of the participants in the control condition changed their recollection. This study provides new information about the misinformation effect, suggesting that this effect also can occur when misinformation is given immediately following presentation of the original stimuli, and about choice blindness and its effects on the recollections of events. The results suggest that memory blindness can be created when people inadvertently supply themselves with misleading information about an event, causing a change in their recollection.	[Stille, Lotta; Norin, Emelie; Sikstrom, Sverker] Lund Univ, Dept Psychol, Lund, Sweden	Lund University	Sikstrom, S (corresponding author), Lund Univ, Dept Psychol, Lund, Sweden.	sverker.sikstrom@psy.lu.se		Sikstrom, Sverker/0000-0003-2644-9626	Swedish research council [2015-01229]	Swedish research council(Swedish Research CouncilEuropean Commission)	This research was supported by a research grant from the Swedish research council (Dnr. 2015-01229).	Ackil JK, 1998, DEV PSYCHOL, V34, P1358, DOI 10.1037/0012-1649.34.6.1358; Allwood CM, 2005, PSYCHOL CRIME LAW, V11, P183, DOI 10.1080/10683160512331329943; Blank H, 2014, J APPL RES MEM COGN, V3, P77, DOI 10.1016/j.jarmac.2014.03.005; CECI SJ, 1987, J EXP PSYCHOL GEN, V116, P38, DOI 10.1037/0096-3445.116.1.38; Chan JC, 2009, PSYCHOL SCI, V20, P66, DOI 10.1111/j.1467-9280.2008.02245.x; Cochran KJ, 2016, MEM COGNITION, V44, P717, DOI 10.3758/s13421-016-0594-y; Dalton AL, 2006, MEMORY, V14, P486, DOI 10.1080/09658210500495073; DODD DH, 1980, J VERB LEARN VERB BE, V19, P695, DOI 10.1016/S0022-5371(80)90379-5; Gabbert F, 2012, APPL COGNITIVE PSYCH, V26, P568, DOI 10.1002/acp.2828; Gordon LT, 2014, MEM COGNITION, V42, P186, DOI 10.3758/s13421-013-0361-2; Granhag PA, 1997, J APPL PSYCHOL, V82, P599; Greene E, 1980, LAW HUMAN BEHAV, V4, P323, DOI [DOI 10.1007/BF01040624, 10.1007/BF01040624]; Hall L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060554; Hall L, 2010, COGNITION, V117, P54, DOI 10.1016/j.cognition.2010.06.010; Johansson P, 2005, SCIENCE, V310, P116, DOI 10.1126/science.1111709; Johansson P, 2012, PLOS ONE, V7, P1; Johansson P., 2007, TECHNICAL REPORT IEI, V107, P83; Johansson P, 2008, PSYCHOLOGIA, V51, P142, DOI 10.2117/psysoc.2008.142; Johansson P, 2006, CONSCIOUS COGN, V15, P673, DOI 10.1016/j.concog.2006.09.004; Johansson P, 2014, J BEHAV DECIS MAKING, V27, P281, DOI 10.1002/bdm.1807; LAMPINEN JM, 1995, J APPL PSYCHOL, V80, P621, DOI 10.1037/0021-9010.80.5.621; Lind A, 2014, PSYCHOL SCI, V25, P1198, DOI 10.1177/0956797614529797; Loftus, 1991, CANADIAN PSYCHOL, V32, P645, DOI [https://doi.org/10.1037/h0084648, DOI 10.1037/H0084648]; LOFTUS EF, 1975, COGNITIVE PSYCHOL, V7, P560, DOI 10.1016/0010-0285(75)90023-7; Loftus EF, 2005, LEARN MEMORY, V12, P361, DOI 10.1101/lm.94705; LOFTUS EF, 1978, J EXP PSYCHOL-HUM L, V4, P19, DOI 10.1037/0278-7393.4.1.19; Luna K, 2009, SPAN J PSYCHOL, V12, P405, DOI 10.1017/S1138741600001797; Mahe A, 2015, EUR REV APPL PSYCHOL, V65, P155, DOI 10.1016/j.erap.2015.03.001; MCCLOSKEY M, 1985, J EXP PSYCHOL GEN, V114, P1, DOI 10.1037/0096-3445.114.1.1; McLaughlin O., 2013, JUDGM DECIS MAK, V8, P561; Memon A, 2010, LAW HUMAN BEHAV, V34, P105, DOI 10.1007/s10979-008-9172-6; Oeberst A, 2012, COGNITION, V125, P141, DOI 10.1016/j.cognition.2012.07.009; Orwell George, 1949, 1984, VCentennial; Parnamets P., 2015, P 37 ANN C COGNITIVE, P1823; Roediger HL, 2006, PSYCHOL SCI, V17, P249, DOI 10.1111/j.1467-9280.2006.01693.x; Roediger HL, 1996, J MEM LANG, V35, P300, DOI 10.1006/jmla.1996.0017; Sagana A, 2014, APPL COGNITIVE PSYCH, V28, P753, DOI 10.1002/acp.3062; Sagana A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00449; Sagana A, 2013, BEHAV SCI LAW, V31, P624, DOI 10.1002/bsl.2082; Sarwar F, 2014, EUR J PSYCHOL APPL L, V6, P17, DOI 10.5093/ejpalc2014a3; Sauerland M, 2013, LEGAL CRIMINOL PSYCH, V18, P371, DOI 10.1111/j.2044-8333.2012.02049.x; Sauerland M, 2013, BEHAV SCI LAW, V31, P239, DOI 10.1002/bsl.2063; Skagerberg EM, 2008, MEMORY, V16, P436, DOI 10.1080/09658210802019696; SMITH VL, 1987, J APPL PSYCHOL, V72, P294; Steenfeldt-Kristensen C, 2013, I-PERCEPTION, V4, P207, DOI 10.1068/i0581sas; Sutherland R, 2001, APPL COGNITIVE PSYCH, V15, P249, DOI 10.1002/acp.700; Taya F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108515; Thomas AK, 2010, J MEM LANG, V63, P149, DOI 10.1016/j.jml.2010.04.004; TOUSIGNANT JP, 1986, MEM COGNITION, V14, P329, DOI 10.3758/BF03202511; Underwood J, 1998, PSYCHON B REV, V5, P449, DOI 10.3758/BF03208820; Vornik LA, 2003, MEMORY, V11, P101, DOI 10.1080/741938170; Wang E, 2014, PSYCHOL CRIME LAW, V20, P619, DOI 10.1080/1068316X.2013.854788; Wilford MM, 2014, J EXP PSYCHOL-APPL, V20, P81, DOI 10.1037/xap0000001; Wright DB, 2000, BRIT J PSYCHOL, V91, P189, DOI 10.1348/000712600161781; Zaragoza M.S., 2007, DO JUSTICE LET SKY F, P35; Zaragoza MS, 2001, PSYCHOL SCI, V12, P473, DOI 10.1111/1467-9280.00388	56	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173606	10.1371/journal.pone.0173606	http://dx.doi.org/10.1371/journal.pone.0173606			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273151	gold, Green Published, Green Submitted			2022-12-27	WOS:000396073700021
J	Wade, MJ; Oakley, J; Harbisher, S; Parker, NG; Dolfing, J				Wade, Matthew J.; Oakley, Jordan; Harbisher, Sophie; Parker, Nicholas G.; Dolfing, Jan			MI-Sim: A MATLAB package for the numerical analysis of microbial ecological interactions	PLOS ONE			English	Article							ANAEROBIC-DIGESTION; MATHEMATICAL-MODEL; CHEMOSTAT; BIFURCATION; STABILITY	Food-webs and other classes of ecological network motifs, are a means of describing feeding relationships between consumers and producers in an ecosystem. They have application across scales where they differ only in the underlying characteristics of the organisms and substrates describing the system. Mathematical modelling, using mechanistic approaches to describe the dynamic behaviour and properties of the system through sets of ordinary differential equations, has been used extensively in ecology. Models allow simulation of the dynamics of the various motifs and their numerical analysis provides a greater understanding of the interplay between the system components and their intrinsic properties. We have developed the MI-Sim software for use with MATLAB to allow a rigorous and rapid numerical analysis of several common ecological motifs. MI-Sim contains a series of the most commonly used motifs such as cooperation, competition and predation. It does not require detailed knowledge of mathematical analytical techniques and is offered as a single graphical user interface containing all input and output options. The tools available in the current version of MI-Sim include model simulation, steady-state existence and stability analysis, and basin of attraction analysis. The software includes seven ecological interaction motifs and seven growth function models. Unlike other system analysis tools, MI-Sim is designed as a simple and user-friendly tool specific to ecological population type models, allowing for rapid assessment of their dynamical and behavioural properties.	[Wade, Matthew J.; Dolfing, Jan] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Oakley, Jordan; Harbisher, Sophie; Parker, Nicholas G.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Wade, MJ (corresponding author), Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	matthew.wade@ncl.ac.uk	Parker, Nicholas G/E-4753-2011; Dolfing, Jan/B-8641-2015; Wade, Matthew John/Q-3951-2018	Parker, Nicholas G/0000-0002-7238-8492; Dolfing, Jan/0000-0002-7220-530X; Wade, Matthew John/0000-0001-9824-7121	Biotechnology and Biological Sciences Research Council UK [BB/K003240/2]; Institute of Sustainability, Newcastle University; Biotechnology and Biological Sciences Research Council [BB/K003240/2] Funding Source: researchfish; BBSRC [BB/K003240/2] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute of Sustainability, Newcastle University; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MJW and JD acknowledge the Biotechnology and Biological Sciences Research Council UK (BB/K003240/2 Engineering synthetic microbial communities for biomethane production) for funding the project (www.bbsrc.ac.uk/). MJW, JO and SH developed the software with funding provided by the Institute of Sustainability, Newcastle University (http//www.ncl.ac.uk/sustainabily/).; This work was funded by the Biotechnology and Biological Sciences Research Council UK (BB/K003240/2 Engineering synthetic microbial communities for biomethane production) and by the Institute of Sustainability, Newcastle University. The authors would like to thank George Stagg at Newcastle University for his help in setting-up the github repository.	Amend JP, 2001, FEMS MICROBIOL REV, V25, P175, DOI 10.1016/S0168-6445(00)00062-0; ARIS R, 1977, BIOTECHNOL BIOENG, V19, P1375, DOI 10.1002/bit.260190910; Arnalcios M, 2015, WATER RES, V70, P458, DOI 10.1016/j.watres.2014.11.046; Bascompte J, 2005, ECOLOGY, V86, P2868, DOI 10.1890/05-0101; Batstone DJ, 2002, WATER SCI TECHNOL, V45, P65; Bungay H R 3rd, 1968, Adv Appl Microbiol, V10, P269, DOI 10.1016/S0065-2164(08)70194-1; BUTLER GJ, 1983, J MATH BIOL, V17, P133, DOI 10.1007/BF00305755; Clewley R H, 2007, PYDSTOOL SOFTWARE EN; Dhooge A, 2003, ACM T MATH SOFTWARE, V29, P141, DOI 10.1145/779359.779362; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Escalante AE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00143; Fassoni AC, 2014, ECOL COMPLEX, V18, P39, DOI 10.1016/j.ecocom.2013.12.004; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; GILPIN ME, 1972, SCIENCE, V177, P902, DOI 10.1126/science.177.4052.902; Gonzalez-Cabaleiro R, 2013, ENERG ENVIRON SCI, V6, P3780, DOI 10.1039/c3ee42754d; Govorukhin VN, 2004, MATLAB BASED VERSION; Grosskopf T, 2016, ISME J, V10, P2725, DOI 10.1038/ismej.2016.49; Grosskopf T, 2014, CURR OPIN MICROBIOL, V18, P72, DOI 10.1016/j.mib.2014.02.002; Harry Dankowicz., 2013, RECIPES CONTINUATION, DOI 10.1137/1.9781611972573; Hellweger FL, 2016, NAT REV MICROBIOL, V14, P461, DOI 10.1038/nrmicro.2016.62; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; KREIKENBOHM R, 1986, FEMS MICROBIOL ECOL, V38, P131, DOI 10.1016/0378-1097(86)90044-3; LAUWERIER H A, 1986, IMA Journal of Mathematics Applied in Medicine and Biology, V3, P191; Levy R, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0588-y; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Rodriguez J, 2008, TRENDS BIOTECHNOL, V26, P366, DOI 10.1016/j.tibtech.2008.04.003; Sivaprakash B, 2011, INT J COMP APPL, V3, P15; Song HS, 2014, PROCESSES, V2, P711, DOI 10.3390/pr2040711; Van Nes E, 2017, GRIND FOR MATLAB; Wade MJ, 2016, J THEOR BIOL, V389, P171, DOI 10.1016/j.jtbi.2015.10.032; Weedermann M, 2013, J BIOL DYNAM, V7, P59, DOI 10.1080/17513758.2012.755573; Xu AP, 2011, J THEOR BIOL, V276, P35, DOI 10.1016/j.jtbi.2011.01.026; Zomorrodi AR, 2016, J MOL BIOL, V428, P837, DOI 10.1016/j.jmb.2015.10.019	35	3	3	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173249	10.1371/journal.pone.0173249	http://dx.doi.org/10.1371/journal.pone.0173249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273164	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700048
J	Hu, ZZ; Zhu, FM; Zhang, N; Zhang, CX; Pei, GC; Wang, PG; Yang, J; Guo, YJ; Wang, M; Wang, YX; Yang, Q; Zhu, H; Liao, WH; Zhang, ZG; Yao, Y; Zeng, R; Xu, G				Hu, Zhizhi; Zhu, Fengmin; Zhang, Nan; Zhang, Chunxiu; Pei, Guangchang; Wang, Pengge; Yang, Juan; Guo, Yujiao; Wang, Meng; Wang, Yuxi; Yang, Qian; Zhu, Han; Liao, Wenhui; Zhang, Zhiguo; Yao, Ying; Zeng, Rui; Xu, Gang			Impact of arteriovenous fistula blood flow on serum il-6, cardiovascular events and death: An ambispective cohort analysis of 64 Chinese hemodialysis patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INTERLEUKIN-6 LEVELS; MICROINFLAMMATORY STATE; VASCULAR ACCESS; RENAL-DISEASE; MORTALITY; MALNUTRITION; PREDICTOR; INFLAMMATION; ALBUMIN	Flows (Qa) of arteriovenous fistula (AVF) impact the dialysis adequacy in hemodialysis (HD) patients. However, data for different access flow levels on outcomes related to long-term dialysis patients, especially in Chinese patients, are limited. Herein, we performed an ambispective, mono-centric cohort study investigating the association between the AVF flows and inflammation, cardiovascular events and deaths in Chinese hemodialysis patients bearing a radio-cephalic fistula (AVF) from 2009 to 2015. Twenty-three patients (35.9%) developed at least one episode of cardiovascular disease (CVD) in two years after AVF creation. AVF Qa, IL-6 and hsCRP were significantly higher in patients with CVD than in patients without CVD. Multi-factorial binary logistic regression analysis found that the independent and strongest risk factor for CVD in HD patients was serum IL-6, which showed a positive association with AVF Qa levels in patients. Therefore, the linkage between AVF Qa tertiles and adverse clinical outcomes (cardiovascular events and mortality) was examined over a median follow-up of five years. IL-6 was significantly increased in the high AVF Qa (>1027.13 ml/min) group. Patients with median AVF Qa showed the lowest morbidity and mortality of CVD according to the AVF Qa tertiles, whereas higher Qa was associated with a higher risk of CVD, and lower AVF Qa (600 ml/min <= AVF Qa <821.12 ml/min) had a higher risk of non-CVD death. Therefore, keeping the AVF Qa at an optimal level (821.12 to 1027.13 ml/min) would benefit HD patients, improve long-term clinical outcomes and lower AVF-induced inflammation.	[Hu, Zhizhi; Zhu, Fengmin; Zhang, Nan; Zhang, Chunxiu; Pei, Guangchang; Wang, Pengge; Yang, Juan; Guo, Yujiao; Wang, Meng; Wang, Yuxi; Yang, Qian; Zhu, Han; Yao, Ying; Zeng, Rui; Xu, Gang] Huazhong Univ Sci & Technol, Tongji Hosp, Div Nephrol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Zhang, Nan] Jining Med Univ, Affiliated Hosp, Dept Nephrol, Jining, Shandong, Peoples R China; [Liao, Wenhui] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Geriatr, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Zhang, Zhiguo] Huazhong Univ Sci & Technol, Sch Med & Hlth Management, Tongji Med Coll, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Jining Medical University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zeng, R; Xu, G (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Div Nephrol, Tongji Med Coll, Wuhan, Hubei, Peoples R China.	zengrui@tjh.tjmu.edu.cn; xugang@tjh.tjmu.edu.cn	Zeng, RUI/AAF-7238-2019; Yang, Juan/ABF-4433-2021; Zeng, Rui/GRY-0646-2022	Zeng, Rui/0000-0003-1188-3198	National Natural Science Foundation of China [81270770, 81470948, 81270771, 81370798, 81170686]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grants 81270770, 81470948, 81270771, 81370798 and 81170686).	[Anonymous], 2001, AMERICAN JOURNAL OF, V37, pS137; Basile C, 2008, NEPHROL DIAL TRANSPL, V23, P282, DOI 10.1093/ndt/gfm549; BATAILLE R, 1992, ARTHRITIS RHEUM-US, V35, P982, DOI 10.1002/art.1780350824; Begin V, 2002, AM J KIDNEY DIS, V40, P1277, DOI 10.1053/ajkd.2002.36898; Bode AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034491; BRESCIA MJ, 1966, NEW ENGL J MED, V275, P1089, DOI 10.1056/NEJM196611172752002; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Honda H, 2006, AM J KIDNEY DIS, V47, P139, DOI 10.1053/j.ajkd.2005.09.014; Hoshi T, 2005, STROKE, V36, P768, DOI 10.1161/01.STR.0000158915.28329.51; Hua Jincheng, 2015, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V27, P354, DOI 10.3760/cma.j.issn.2095-4352.2015.05.007; Kaizu Y, 1998, AM J KIDNEY DIS, V31, P93, DOI 10.1053/ajkd.1998.v31.pm9428458; Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549, DOI 10.1681/ASN.V1271549; Kobayashi S, 2003, BIOCHEM BIOPH RES CO, V308, P306, DOI 10.1016/S0006-291X(03)01362-7; Korsheed S, 2009, HEMODIAL INT, V13, P505, DOI 10.1111/j.1542-4758.2009.00384.x; Lameire N, 2012, NEPHROL DIAL TRANSPL, V27, P3758, DOI 10.1093/ndt/gfs275; Langer S, 2011, MAGN RESON IMAGING, V29, P57, DOI 10.1016/j.mri.2010.07.010; Memoli B, 2002, AM J KIDNEY DIS, V39, P266, DOI 10.1053/ajkd.2002.30545; Neyra NR, 1998, KIDNEY INT, V54, P1714, DOI 10.1046/j.1523-1755.1998.00145.x; Owen WF, 1998, KIDNEY INT, V54, P627, DOI 10.1046/j.1523-1755.1998.00032.x; Panichi V, 2004, NEPHROL DIAL TRANSPL, V19, P1154, DOI 10.1093/ndt/gfh052; Pecoits-Filho R, 2002, NEPHROL DIAL TRANSPL, V17, P1684, DOI 10.1093/ndt/17.9.1684; Qureshi AR, 2002, J AM SOC NEPHROL, V13, pS28; Rao M, 2005, AM J KIDNEY DIS, V45, P324, DOI 10.1053/j.ajkd.2004.09.018; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Schomig M, 2000, BLOOD PURIFICAT, V18, P327, DOI 10.1159/000014457; Stenvinkel P, 2002, AM J KIDNEY DIS, V39, P274, DOI 10.1053/ajkd.2002.30546; Wollert K C, 2001, Heart Fail Rev, V6, P95; Yao Q, 2004, ASAIO J, V50, pLII, DOI 10.1097/01.MAT.0000147958.87989.EB; Yun KA, 2004, SCAND J CLIN LAB INV, V64, P223, DOI 10.1080/00365510410005749	29	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0172490	10.1371/journal.pone.0172490	http://dx.doi.org/10.1371/journal.pone.0172490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267753	gold, Green Published, Green Submitted			2022-12-27	WOS:000396060600052
J	Paolin, A; Trojan, D; Petit, P; Coato, P; Rigoli, R				Paolin, Adolfo; Trojan, Diletta; Petit, Pieter; Coato, Paola; Rigoli, Roberto			Evaluation of allograft contamination and decontamination at the Treviso Tissue Bank Foundation: A retrospective study of 11,129 tissues	PLOS ONE			English	Article							HEART-VALVE; BONE; INFECTION; CULTURES; DONORS; STERILIZATION; PROCUREMENT; FROZEN	Microbiological contamination of retrieved tissues has become a very important topic and a critical aspect in the safety of allografts. We have analysed contamination in 11,129 tissues with a longitudinal contamination profile for each individual tissue. More specifically, 10,035 musculoskeletal tissues and 1,094 cardiovascular tissues were retrieved from a total of 763 multi-tissue donors, of whom 105 were heart-beating donors as well as organ donors, while the remaining 658 were non-heart beating donors and tissue donors only. All tissues were decontaminated twice, the first time immediately after retrieval and the second time after processing. Each tissue was submitted to microbiological culture three times, i.e., upon retrieval (Time 1), after the first decontamination (Time 2) and after the second decontamination (Time 3). The contamination rate for musculoskeletal tissues was 52%, 16.2% and 0.5% at Time 1, 2 and 3, respectively. The contamination rate for cardiovascular tissues was 84%, 42% and 6%. More than one strain was simultaneously present in 10.8% of musculoskeletal tissues and 44.6% of cardiovascular tissues. Out of 8,560 non-heart-beating donor musculoskeletal tissues, 4,689 (54.8%), 1,383 (16.2%) and 42 (0.5%) were contaminated at Time 1, Time 2 and Time 3, respectively. Out of 1,475 heart-beating donor musculoskeletal tissues, 522 (35.4%) 113 (7.7%) and 2 (0.1%) tissues were found to be contaminated at Time 1, 2 and 3, respectively. Out of 984 non-heart beating donor cardiovascular tissues, 869 (88.3%), 449 (45.6%) and 69 (7%) proved positive at Time 1, 2 and 3 respectively, while 50 (45.5%) and 10 (9.1%) heart-beating donor cardiovascular tissues were contaminated at Time 1 and 2. No tissue was contaminated at Time 3. Based on our methods, the two-step decontamination approach is mandatory in order to drastically reduce the number of tissues found to be positive at the end of the process.	[Paolin, Adolfo; Trojan, Diletta] Treviso Tissue Bank Fdn, Treviso, Italy; [Petit, Pieter] Fdn European Tissue Banks, Berlin, Germany; [Coato, Paola; Rigoli, Roberto] Reg Hosp, Dept Clin Pathol, Treviso, Italy		Paolin, A (corresponding author), Treviso Tissue Bank Fdn, Treviso, Italy.	apaolin@fbtv-treviso.org						BROCKBANK KGM, 1993, CRYOBIOLOGY, V30, P19, DOI 10.1006/cryo.1993.1003; Buzzi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112679; de By TMMH, 2012, HEART LUNG VESSEL, V4, P251; Deijkers RLM, 1997, J BONE JOINT SURG BR, V79B, P161, DOI 10.1302/0301-620X.79B1.7137; Eastlund T., 2004, ADV TISSUE BANKING, V7, P51, DOI DOI 10.1142/9789812796646_0003; Eastlund Ted, 2006, Cell and Tissue Banking, V7, P147, DOI 10.1007/s10561-006-0003-z; Fan YD, 2012, CELL TISSUE BANK, V13, P297, DOI 10.1007/s10561-011-9255-3; GALL K, 1995, J THORAC CARDIOV SUR, V110, P680, DOI 10.1016/S0022-5223(95)70099-4; Gatto C, 2013, CELL TISSUE BANK, V14, P107, DOI 10.1007/s10561-012-9305-5; Germain M, 2010, CELL TISSUE BANK, V11, P197, DOI 10.1007/s10561-009-9155-y; GOTTESDIENER KM, 1989, ANN INTERN MED, V110, P1001, DOI 10.7326/0003-4819-110-12-1001; Hamer AJ, 1996, J BONE JOINT SURG BR, V78B, P363, DOI 10.1302/0301-620X.78B3.0780363; Heng WL, 2013, J TRANSPLANT, V2013, DOI 10.1155/2013/163150; Ibrahim T, 2004, INT ORTHOP, V28, P315, DOI 10.1007/s00264-004-0579-5; Ireland Lyn, 2005, Cell and Tissue Banking, V6, P181, DOI 10.1007/s10561-005-7365-5; Jashari R., 2007, Cell and Tissue Banking, V8, P247, DOI 10.1007/s10561-007-9040-5; Johnson DL, 1998, ANN THORAC SURG, V66, pS221, DOI 10.1016/S0003-4975(98)01033-9; Lannau B, 2015, CELL TISSUE BANK, V16, P65, DOI 10.1007/s10561-014-9439-8; MARTINEZ OV, 1985, DIAGN MICR INFEC DIS, V3, P193, DOI 10.1016/0732-8893(85)90031-8; MUNTING E, 1988, ACTA ORTHOP SCAND, V59, P34, DOI 10.3109/17453678809149340; Steffen V, 2016, J THORAC CARDIOV SUR, V151, P1251, DOI 10.1016/j.jtcvs.2015.11.029; Tabaku M., 2004, Cell and Tissue Banking, V5, P261, DOI 10.1007/s10561-004-1440-1; TOMFORD WW, 1990, J BONE JOINT SURG AM, V72A, P1137, DOI 10.2106/00004623-199072080-00003; van Kats JP, 2010, EUR J CARDIO-THORAC, V37, P163, DOI 10.1016/j.ejcts.2009.07.011; VEEN MR, 1994, CLIN ORTHOP RELAT R, P259; Vehmeyer S, 2002, ACTA ORTHOP SCAND, V73, P678, DOI 10.3109/17453670209178036	26	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173154	10.1371/journal.pone.0173154	http://dx.doi.org/10.1371/journal.pone.0173154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267776	gold, Green Submitted, Green Published			2022-12-27	WOS:000396060600011
J	Purohit, T; Qin, ZP; Quan, CJ; Lin, ZH; Quan, TH				Purohit, Trupta; Qin, Zhaoping; Quan, Chunji; Lin, Zhenhua; Quan, Taihao			Smad3-dependent CCN2 mediates fibronectin expression in human skin dermal fibroblasts	PLOS ONE			English	Article							TISSUE-GROWTH-FACTOR; MOUSE FIBROSIS MODEL; FACTOR-BETA; TGF-BETA; IN-VIVO; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; TUBULOINTERSTITIAL FIBROSIS; ULTRAVIOLET-IRRADIATION; EMBRYONIC FIBROBLASTS	The potential involvement of connective tissue growth factor (CCN2/CTGF) in extracellular matrix (ECM) production is recognized. However, the role CCN2 in fibronectin (FN) gene expression has remained incompletely understood and even controversial. Here we report that CCN2 is absolutely necessary for FN expression in primary human skin dermal fibroblasts, the major cells responsible for ECM production in skin. Gain-and loss-of-function approaches demonstrate that CCN2 is an essential component of FN expression in both basal and stimulation by TGF-beta signaling, the major regulator of FN expression. CCN2 is significantly induced by Smad3, a critical mediator of TGF-beta signaling. CCN2 acts as a downstream mediator of TGF-beta/Smad signaling and acting synergistically with TGF-beta to regulate FN gene expression. Finally, we observed that CCN2 and FN predominantly expressed in the dermis of normal human skin, stromal tissues of skin squamous cell carcinoma (SCC), and simultaneously induced in wounded human skin in vivo. These findings provide evidence that CCN2 is responsible for mediating the stimulatory effects of TGF-beta/ Smad on FN gene expression, and attenuation of CCN2 expression may benefit to reduce fibrotic ECM microenvironment in disease skin.	[Purohit, Trupta] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Qin, Zhaoping; Quan, Taihao] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA; [Quan, Chunji; Lin, Zhenhua] Yanbian Univ, Coll Med, Dept Pathol, Yanji, Peoples R China; [Quan, Chunji; Lin, Zhenhua] Yanbian Univ, Coll Med, Canc Res Ctr, Yanji, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yanbian University; Yanbian University	Quan, TH (corresponding author), Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA.	thquan@umich.edu		Quan, Taihao/0000-0002-0954-5109	NIH [AG019364]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the NIH (AG019364 to T Quan). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Akamine R, 2007, J BIOCHEM BIOPH METH, V70, P481, DOI 10.1016/j.jbbm.2006.11.008; Argyropoulos AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153806; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Bonniaud P, 2004, AM J RESP CELL MOL, V31, P510, DOI 10.1165/rcmb.2004-0158OC; Bornstein S, 2007, MOL CARCINOGEN, V46, P660, DOI 10.1002/mc.20336; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Brigstock DR, 2003, J CLIN PATHOL-MOL PA, V56, P127, DOI 10.1136/mp.56.2.127; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen YL, 2004, MOL BIOL CELL, V15, P5635, DOI 10.1091/mbc.E04-06-0490; Chujo S, 2005, J CELL PHYSIOL, V203, P447, DOI 10.1002/jcp.20251; CLARK RAF, 1983, J INVEST DERMATOL, V81, P475, DOI 10.1111/1523-1747.ep12522718; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7; Morales MG, 2011, J PATHOL, V225, P490, DOI 10.1002/path.2952; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gore-Hyer E, 2002, AM J PHYSIOL-RENAL, V283, pF707, DOI 10.1152/ajprenal.00007.2002; GRINNELL F, 1981, J INVEST DERMATOL, V76, P181, DOI 10.1111/1523-1747.ep12525694; GRINNELL F, 1984, J CELL BIOCHEM, V26, P107, DOI 10.1002/jcb.240260206; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Gupta S, 2000, KIDNEY INT, V58, P1389, DOI 10.1046/j.1523-1755.2000.00301.x; Han SW, 2006, CANCER RES, V66, P315, DOI 10.1158/0008-5472.CAN-05-2367; Heng ECK, 2006, J CELL BIOCHEM, V98, P409, DOI 10.1002/jcb.20810; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Inazaki K, 2004, KIDNEY INT, V66, P597, DOI 10.1111/j.1523-1755.2004.00779.x; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jedsadayanmata A, 1999, J BIOL CHEM, V274, P24321, DOI 10.1074/jbc.274.34.24321; Kretschmer A, 2003, ONCOGENE, V22, P6748, DOI 10.1038/sj.onc.1206791; Lakos G, 2004, AM J PATHOL, V165, P203, DOI 10.1016/S0002-9440(10)63289-0; Leask A, 2001, J CLIN PATHOL-MOL PA, V54, P180, DOI 10.1136/mp.54.3.180; Liu SX, 2014, WOUND REPAIR REGEN, V22, P119, DOI 10.1111/wrr.12131; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Mori Y, 2008, EXP CELL RES, V314, P1094, DOI 10.1016/j.yexcr.2007.12.010; Nishida T, 2003, J CELL PHYSIOL, V196, P265, DOI 10.1002/jcp.10277; Nishida T, 2007, J CELL COMMUN SIGNAL, V1, P45, DOI 10.1007/s12079-007-0005-z; Orringer JS, 2012, DERMATOL SURG, V38, P1668, DOI 10.1111/j.1524-4725.2012.02518.x; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Parapuram SK, 2015, MATRIX BIOL, V43, P35, DOI 10.1016/j.matbio.2015.01.017; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Qi W, 2005, AM J PHYSIOL-RENAL, V288, pF800, DOI 10.1152/ajprenal.00179.2004; Quan T, 2002, J INVEST DERMATOL, V119, P499, DOI 10.1046/j.1523-1747.2002.01834.x; Quan TH, 2010, J INVEST DERMATOL, V130, P415, DOI 10.1038/jid.2009.224; Quan TH, 2002, J INVEST DERMATOL, V118, P402, DOI 10.1046/j.0022-202x.2001.01678.x; Raghu G, 2016, EUR RESPIR J, V47, P1481, DOI 10.1183/13993003.01030-2015; Roberts AB, 2001, CHEST, V120, p43S, DOI 10.1378/chest.120.1_suppl.S43-a; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Shi-Wen X, 2006, J BIOL CHEM, V281, P10715, DOI 10.1074/jbc.M511343200; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Wahab NA, 2001, BIOCHEM J, V359, P77, DOI 10.1042/0264-6021:3590077; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4; Yang M, 2004, FASEB J, V18, P1920, DOI 10.1096/fj.04-2357fje; Yeger H, 2007, J CELL COMMUN SIGNAL, V1, P159, DOI 10.1007/s12079-008-0022-6; Yokoi H, 2002, AM J PHYSIOL-RENAL, V282, pF933, DOI 10.1152/ajprenal.00122.2001	60	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173191	10.1371/journal.pone.0173191	http://dx.doi.org/10.1371/journal.pone.0173191			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267785	Green Submitted, gold, Green Published			2022-12-27	WOS:000396060600012
J	Gebhardt, MJ; Jacobson, RK; Shuman, HA				Gebhardt, Michael J.; Jacobson, Rachael K.; Shuman, Howard A.			Seeing red; the development of pON. mCherry, a broad-host range constitutive expression plasmid for Gram-negative bacteria	PLOS ONE			English	Article							INTRACELLULAR MULTIPLICATION; LEGIONELLA-PNEUMOPHILA; ESCHERICHIA-COLI; LAC REPRESSOR; VECTORS; PROMOTERS; TRAITS; SYSTEM; GROWTH	The development of plasmid-mediated gene expression control in bacteria revolutionized the field of bacteriology. Many of these expression control systems rely on the addition of small molecules, generally metabolites or non-metabolized analogs thereof, to the growth medium to induce expression of the genes of interest. The paradigmatic example of an expression control system is the lac system from Escherichia coli, which typically relies on the Ptac promoter and the Lac repressor, LacI. In many cases, however, constitutive gene expression is desired, and other experimental approaches require the coordinated control of multiple genes. While multiple systems have been developed for use in E. coli and its close relatives, the utility and/or functionality of these tools does not always translate to other species. For example, for the Gram-negative pathogen, Legionella pneumophila, a causative agent of Legionnaires' Disease, the aforementioned Ptac system represents the only well-established expression control system. In order to enhance the tools available to study bacterial gene expression in L. pneumophila, we developed a plasmid, pON. mCherry, which confers constitutive gene expression from a mutagenized LacI binding site. We demonstrate that pON. mCherry neither interferes with other plasmids harboring an intact LacI-Ptac expression system nor alters the growth of Legionella species during intracellular growth. Furthermore, the broad-host range plasmid backbone of pON. mCherry allows constitutive gene expression in a wide variety of Gram-negative bacterial species, making pON. mCherry a useful tool for the greater research community.	[Gebhardt, Michael J.; Jacobson, Rachael K.; Shuman, Howard A.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Gebhardt, MJ (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.	mgebhardt@uchicago.edu	Gebhardt, Michael/HHN-0863-2022	Gebhardt, Michael/0000-0002-1213-8408				Alli OAT, 2003, MICROBIOL-SGM, V149, P631, DOI 10.1099/mic.0.25980-0; Amaro F, 2015, ISME J, V9, P1607, DOI 10.1038/ismej.2014.248; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; Bertram R, 2008, MICROB BIOTECHNOL, V1, P2, DOI 10.1111/j.1751-7915.2007.00001.x; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hervet E, 2011, INFECT IMMUN, V79, P1936, DOI 10.1128/IAI.00805-10; Hovel-Miner G, 2009, J BACTERIOL, V191, P2461, DOI 10.1128/JB.01578-08; Isenman HL, 2016, RESPIROLOGY, V21, P1292, DOI 10.1111/resp.12808; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kalodimos CG, 2002, EMBO J, V21, P2866, DOI 10.1093/emboj/cdf318; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; Khodr A, 2016, INFECT GENET EVOL, V43, P108, DOI 10.1016/j.meegid.2016.04.033; Lessard JC, 2013, METHOD ENZYMOL, V533, P181, DOI 10.1016/B978-0-12-420067-8.00011-8; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Neumeister B, 2004, METH MOL B, V268, P141; PFAHL M, 1976, J BACTERIOL, V128, P257, DOI 10.1128/JB.128.1.257-263.1976; Shuman HA, 2003, NAT REV GENET, V4, P419, DOI 10.1038/nrg1087; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Tiaden A, 2007, CELL MICROBIOL, V9, P2903, DOI 10.1111/j.1462-5822.2007.01005.x; Whiley H, 2011, EMERG INFECT DIS, V17, P579, DOI 10.3201/eid1704.100446	21	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173116	10.1371/journal.pone.0173116	http://dx.doi.org/10.1371/journal.pone.0173116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257493	gold, Green Submitted, Green Published			2022-12-27	WOS:000396021100058
J	Samalin, L; de Chazeron, I; Belzeaux, R; Llorca, PM				Samalin, Ludovic; de Chazeron, Ingrid; Belzeaux, Raoul; Llorca, Pierre-Michel			Exploratory analysis of the French version of the beliefs about medicines questionnaire in patients with severe mental disorders: Factorial structure and reliability in specific populations of schizophrenic, bipolar and depressive patients	PLOS ONE			English	Article							MEDICATION NONADHERENCE; SUBJECTIVE RESPONSE; MOOD DISORDERS; ADHERENCE; VALIDATION; OUTPATIENTS; ADAPTATION; PREDICTORS; ATTITUDES; NUMBER	Objectives The aims of our study were to explore the factor structure and psychometric properties of the French version of the Beliefs about Medicines Questionnaire (BMQ) in patients with severe mental illness and in specific populations of patients with schizophrenia, bipolar disorder and major depressive disorder. Methods A cross-sectional study including patients with schizophrenia, bipolar disorder and major depressive disorder was conducted (n = 150). Principal component analysis (PCA), reliability and validity of the French version of the BMQ were performed. Results PCA revealed a two-factor structure similar to the original structure for the BMQ-Specific scale but only a one-component solution for the BMQ-General scale in both the total sample and the three subgroups. These subscales have satisfactory internal consistency. Validity was supported by the significant correlations of all BMQ subscales with the Drug Attitude Inventory. Conclusion The French version of the BMQ appears as a three-dimensional scale and presents satisfactory psychometric properties for use in patients with severe mental illness as well as specific populations of patients with schizophrenia, bipolar disorder and major depressive disorder.	[Samalin, Ludovic; de Chazeron, Ingrid; Llorca, Pierre-Michel] Univ Auvergne, CHU Clermont Ferrand, Dept Adult Psychiat, EA, Clermont Ferrand, France; [Samalin, Ludovic] Univ Barcelona, CIBERSAM, IDIBAPS, Bipolar Disorder Unit,Inst Neurosci,Hosp Clin, Barcelona, Catalonia, Spain; [Samalin, Ludovic; Belzeaux, Raoul; Llorca, Pierre-Michel] Fdn FondaMental, Creteil, France; [Belzeaux, Raoul] Hop St Marguerite, AP HM, Bipolar Disorder Expert Ctr, Marseille, France; [Belzeaux, Raoul] McGill Univ, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Dept Psychiat, Montreal, PQ, Canada	CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; McGill University	Samalin, L (corresponding author), Univ Auvergne, CHU Clermont Ferrand, Dept Adult Psychiat, EA, Clermont Ferrand, France.; Samalin, L (corresponding author), Univ Barcelona, CIBERSAM, IDIBAPS, Bipolar Disorder Unit,Inst Neurosci,Hosp Clin, Barcelona, Catalonia, Spain.; Samalin, L (corresponding author), Fdn FondaMental, Creteil, France.	lsamalin@chu-clermontferrand.fr	Fond, Guillaume/D-7646-2011; Samalin, Ludovic/AAP-6362-2020; Belzeaux, Raoul/AGZ-3125-2022	Fond, Guillaume/0000-0003-3249-2030; 				Aikens JE, 2005, ANN FAM MED, V3, P23, DOI 10.1370/afm.238; Argentero P, 2010, EPIDEMIOL PSICHIAT S, V19, P86; AWAD AG, 1993, SCHIZOPHRENIA BULL, V19, P609, DOI 10.1093/schbul/19.3.609; Beck EM, 2012, J NERV MENT DIS, V200, P33, DOI 10.1097/NMD.0b013e31823e5875; Beck EM, 2011, SCHIZOPHR RES, V132, P42, DOI 10.1016/j.schres.2011.07.019; Bonsack C, 1998, ENCEPHALE, V24, P315; Brain C, 2013, EUR NEUROPSYCHOPHARM, V23, P1754, DOI 10.1016/j.euroneuro.2013.09.001; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Clatworthy J, 2009, J AFFECT DISORDERS, V116, P51, DOI 10.1016/j.jad.2008.11.004; De las Cuevas C, 2011, HUM PSYCHOPHARM CLIN, V26, P140, DOI 10.1002/hup.1185; de Winter JCF, 2009, MULTIVAR BEHAV RES, V44, P147, DOI 10.1080/00273170902794206; Dinno A, 2009, MULTIVAR BEHAV RES, V44, P362, DOI 10.1080/00273170902938969; Fall E, 2014, EUR REV APPL PSYCHOL, V64, P335, DOI 10.1016/j.erap.2014.08.005; Higashi K, 2013, THER ADV PSYCHOPHARM, V3, P200, DOI 10.1177/2045125312474019; HOGAN TP, 1983, PSYCHOL MED, V13, P177, DOI 10.1017/S0033291700050182; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Horne R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080633; Acosta FJ, 2012, WORLD J PSYCHIATR, V2, P74, DOI 10.5498/wjp.v2.i5.74; Jonsdottir H, 2009, ACTA PSYCHIAT SCAND, V119, P78, DOI 10.1111/j.1600-0447.2008.01279.x; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Komninos I, 2012, EUR J PERS CENT HLTH, V1, P224; Lacro JP, 2002, J CLIN PSYCHIAT, V63, P892, DOI 10.4088/JCP.v63n1007; Llorca PM, 2008, PSYCHIAT RES, V161, P235, DOI 10.1016/j.psychres.2007.07.012; Mahler C, 2012, J EVAL CLIN PRACT, V18, P409, DOI 10.1111/j.1365-2753.2010.01589.x; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Novick D, 2010, PSYCHIAT RES, V176, P109, DOI 10.1016/j.psychres.2009.05.004; Pelissolo A, 2007, ENCEPHALE, V33, P32; Pompili M, 2013, EXPERT REV NEUROTHER, V13, P809, DOI 10.1586/14737175.2013.811976; Pompili M, 2009, EXPERT REV NEUROTHER, V9, P985, DOI [10.1586/ern.09.62, 10.1586/ERN.09.62]; Salgado T, 2013, SAO PAULO MED J, V131, P88, DOI 10.1590/S1516-31802013000100018; van der Eijk C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118900; Velligan DI, 2009, J CLIN PSYCHIAT, V70, P6	34	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173267	10.1371/journal.pone.0173267	http://dx.doi.org/10.1371/journal.pone.0173267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257447	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100080
J	Li, HL; Gu, XH; Li, BJ; Chen, X; Lin, HR; Xia, JH				Li, Hong Lian; Gu, Xiao Hui; Li, Bi Jun; Chen, Xiao; Lin, Hao Ran; Xia, Jun Hong			Characterization and functional analysis of hypoxia-inducible factor HIF1 alpha and its inhibitor HIF1 alpha n in tilapia	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; HIF-ALPHA ISOFORMS; AQUATIC HYPOXIA; GENE-EXPRESSION; FACTOR-I; TRANSCRIPTIONAL REGULATION; CARDIORESPIRATORY FUNCTION; BLOOD PARAMETERS; FISH; OXYGEN	Hypoxia is a major cause of fish morbidity and mortality in the aquatic environment. Hypoxia-inducible factors are very important modulators in the transcriptional response to hypoxic stress. In this study, we characterized and conducted functional analysis of hypoxia-inducible factor HIF1 alpha and its inhibitor HIF1 alpha n in Nile tilapia (Oreochromis niloticus). By cloning and Sanger sequencing, we obtained the full length cDNA sequences for HIF1 alpha (2686bp) and HIF1 alpha n (1308bp), respectively. The CDS of HIF1 alpha includes 15 exons encoding 768 amino acid residues and the CDS of HIF1 alpha n contains 8 exons encoding 354 amino acid residues. The complete CDS sequences of HIF1 alpha and HIF1 alpha n cloned from tilapia shared very high homology with known genes from other fishes. HIF1 alpha show differentiated expression in different tissues (brain, heart, gill, spleen, liver) and at different hypoxia exposure times (6h, 12h, 24h). HIF1 alpha n expression level under hypoxia is generally increased (6h, 12h, 24h) and shows extremely highly upregulation in brain tissue under hypoxia. A functional determination site analysis in the protein sequences between fish and land animals identified 21 amino acid sites in HIF1 alpha and 2 sites in HIF1 alpha n as significantly associated sites (alpha = 0.05). Phylogenetic tree-based positive selection analysis suggested 22 sites in HIF1 alpha as positively selected sites with a p-value of at least 95% for fish lineages compared to the land animals. Our study could be important for clarifying the mechanism of fish adaptation to aquatic hypoxia environment.	[Xia, Jun Hong] Sun Yat Sen Univ, Coll Life Sci, Inst Aquat Econ Anim, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; Sun Yat Sen Univ, Coll Life Sci, Guangdong Prov Key Lab Aquat Econ Anim, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xia, JH (corresponding author), Sun Yat Sen Univ, Coll Life Sci, Inst Aquat Econ Anim, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.	xiajunh3@mail.sysu.edu.cn	LI, HONGLIAN/Q-9905-2019; lin, haoran/GXH-3030-2022; li, bijun/AAP-8969-2020	Bijun, Li/0000-0003-4435-4364	National Natural Science Foundation of China [31572612]; Natural Science Foundation of Guangdong Province, China [2015A030313150]; Special Fund for Marine Fisheries-Scientific Research of Guangdong Province [A201501A04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Special Fund for Marine Fisheries-Scientific Research of Guangdong Province	This work was supported by the National Natural Science Foundation of China (No.31572612), Natural Science Foundation of Guangdong Province, China (No. 2015A030313150), Special Fund for Marine Fisheries-Scientific Research of Guangdong Province (A201501A04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affonso EG, 2002, COMP BIOCHEM PHYS C, V133, P375, DOI 10.1016/S1532-0456(02)00127-8; Baptista RB, 2016, FISH PHYSL BIOCH; Belao TC, 2015, COMP BIOCHEM PHYS A, V187, P130, DOI 10.1016/j.cbpa.2015.05.010; Belao TC, 2011, J COMP PHYSIOL B, V181, P905, DOI 10.1007/s00360-011-0577-z; Bernier NJ, 2012, J EXP BIOL, V215, P2273, DOI 10.1242/jeb.066183; Bersten DC, 2013, NAT REV CANCER, V13, P827, DOI 10.1038/nrc3621; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Cheung CHY, 2014, ECOTOXICOLOGY, V23, P1260, DOI 10.1007/s10646-014-1269-8; Chi W, 2013, FEBS OPEN BIO, V3, P479, DOI 10.1016/j.fob.2013.09.004; Choi K, 2007, J AQUAT ANIM HEALTH, V19, P128, DOI 10.1577/H06-010.1; Del Rizzo PA, 2012, MOL CELL BIOL, V32, P4044, DOI 10.1128/MCB.00513-12; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farcy E, 2007, COMP BIOCHEM PHYS B, V146, P540, DOI 10.1016/j.cbpb.2006.12.006; Froehlich HE, 2015, COMP BIOCHEM PHYS A, V189, P58, DOI 10.1016/j.cbpa.2015.07.016; Gallage S, 2016, FISH SHELLFISH IMMUN, V51, P271, DOI 10.1016/j.fsi.2016.02.024; Geng X, 2014, COMP BIOCHEM PHYS B, V169, P38, DOI 10.1016/j.cbpb.2013.12.007; Gil M, 2013, MOL BIOL EVOL, V30, P1270, DOI 10.1093/molbev/mst034; Guzy RD, 2007, ANTIOXID REDOX SIGN, V9, P1317, DOI 10.1089/ars.2007.1708; Heise K, 2006, COMP BIOCHEM PHYS A, V143, P494, DOI 10.1016/j.cbpa.2006.01.014; Jessen LE, 2013, NUCLEIC ACIDS RES, V41, pW286, DOI 10.1093/nar/gkt497; Kajimura S, 2006, MOL CELL BIOL, V26, P1142, DOI 10.1128/MCB.26.3.1142-1155.2006; Kietzmann T, 2003, BLOOD, V101, P907, DOI 10.1182/blood-2002-06-1693; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Landry CA, 2007, COMP BIOCHEM PHYS A, V148, P317, DOI 10.1016/j.cbpa.2007.04.023; Law SHW, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-15; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mandic M, 2009, P ROY SOC B-BIOL SCI, V276, P735, DOI 10.1098/rspb.2008.1235; Mu WJ, 2015, MAR ENVIRON RES, V110, P142, DOI 10.1016/j.marenvres.2015.04.008; Neilan RM, 2014, J THEOR BIOL, V343, P54, DOI 10.1016/j.jtbi.2013.11.004; Nikinmaa M, 2005, AM J PHYSIOL-REG I, V288, pR1079, DOI 10.1152/ajpregu.00626.2004; Rahman MS, 2007, GENE, V396, P273, DOI 10.1016/j.gene.2007.03.009; Ranwez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022594; Ravenna L, 2016, FEBS J, V283, P993, DOI 10.1111/febs.13572; Rimoldi S, 2012, MOL BIOL REP, V39, P4009, DOI 10.1007/s11033-011-1181-8; Rissanen E, 2006, J EXP BIOL, V209, P994, DOI 10.1242/jeb.02103; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Shang EHH, 2004, ENVIRON SCI TECHNOL, V38, P4763, DOI 10.1021/es0496423; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Shen RJ, 2010, COMP BIOCHEM PHYS B, V157, P273, DOI 10.1016/j.cbpb.2010.06.013; So JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109517; Soitamo AJ, 2001, J BIOL CHEM, V276, P19699, DOI 10.1074/jbc.M009057200; Speers-Roesch B, 2013, J COMP PHYSIOL B, V183, P773, DOI 10.1007/s00360-013-0750-7; Speers-Roesch B, 2010, AM J PHYSIOL-REG I, V298, pR104, DOI 10.1152/ajpregu.00418.2009; Sun SM, 2016, COMP BIOCHEM PHYS B, V196, P48, DOI 10.1016/j.cbpb.2016.02.002; Tarhonskaya H, 2015, J BIOL CHEM, V290, P19726, DOI 10.1074/jbc.M115.653014; Urbina MA, 2012, J COMP PHYSIOL B, V182, P1057, DOI 10.1007/s00360-012-0678-3; Val AL, 2015, COMP BIOCHEM PHYS A, V184, P125, DOI 10.1016/j.cbpa.2015.02.020; van Rooijen E, 2011, METHOD CELL BIOL, V105, P163, DOI 10.1016/B978-0-12-381320-6.00007-2; Vianen GJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE318, DOI 10.1152/ajpendo.00187.2001; Wang Y, 2015, GENOME BIOL EVOL, V7, P2970, DOI 10.1093/gbe/evv192; Wang Y, 2015, GENE, V565, P211, DOI 10.1016/j.gene.2015.04.023; Wu RSS, 2003, ENVIRON SCI TECHNOL, V37, P1137, DOI 10.1021/es0258327; Xiao WH, 2015, SCI CHINA LIFE SCI, V58, P148, DOI 10.1007/s11427-015-4801-z; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zeraik VM, 2013, COMP BIOCHEM PHYS A, V166, P17, DOI 10.1016/j.cbpa.2013.04.024; Zhao Y, 2014, BIOCHEM BIOPH RES CO, V454, P183, DOI 10.1016/j.bbrc.2014.10.068; Zhu CD, 2013, J COMP PHYSIOL B, V183, P1005, DOI 10.1007/s00360-013-0762-3	61	23	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173478	10.1371/journal.pone.0173478	http://dx.doi.org/10.1371/journal.pone.0173478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278251	gold, Green Published, Green Submitted			2022-12-27	WOS:000396087900100
J	Marshall, N; Adger, N; Attwood, S; Brown, K; Crissman, C; Cvitanovic, C; De Young, C; Gooch, M; James, C; Jessen, S; Johnson, D; Marshall, P; Park, S; Wachenfeld, D; Wrigley, D				Marshall, Nadine; Adger, Neil; Attwood, Simon; Brown, Katrina; Crissman, Charles; Cvitanovic, Christopher; De Young, Cassandra; Gooch, Margaret; James, Craig; Jessen, Sabine; Johnson, Dave; Marshall, Paul; Park, Sarah; Wachenfeld, Dave; Wrigley, Damian			Empirically derived guidance for social scientists to influence environmental policy	PLOS ONE			English	Article							RELEVANT CONSERVATION SCIENCE; MARINE PROTECTED AREAS; KNOWLEDGE EXCHANGE; RESOURCE-MANAGEMENT; DECISION-MAKING; PARTICIPATION; RESEARCHERS; CHALLENGES; MAKERS; INTERDISCIPLINARY	Failure to stem trends of ecological disruption and associated loss of ecosystem services worldwide is partly due to the inadequate integration of the human dimension into environmental decision-making. Decision-makers need knowledge of the human dimension of resource systems and of the social consequences of decision-making if environmental management is to be effective and adaptive. Social scientists have a central role to play, but little guidance exists to help them influence decision-making processes. We distil 348 years of cumulative experience shared by 31 environmental experts across three continents into advice for social scientists seeking to increase their influence in the environmental policy arena. Results focus on the importance of process, engagement, empathy and acumen and reveal the importance of understanding and actively participating in policy processes through co-producing knowledge and building trust. The insights gained during this research might empower a science-driven cultural change in science-policy relations for the routine integration of the human dimension in environmental decision making; ultimately for an improved outlook for earth's ecosystems and the billions of people that depend on them.	[Marshall, Nadine] James Cook Univ, CSIRO Land & Water, ATSIP Bldg, Townsville, Qld, Australia; [Marshall, Nadine] James Cook Univ, Coll Environm & Marine Sci, Townsville, Qld, Australia; [Adger, Neil] Univ Exeter, Coll Life & Environm Sci, Geog, Rennes Dr, Exeter, Devon, England; [Attwood, Simon] Biodivers Int, Bayan Lepas, Penang, Malaysia; [Attwood, Simon; Park, Sarah] Univ East Anglia, Sch Environm Sci, Norwich Res Pk, Norwich, Norfolk, England; [Brown, Katrina] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Crissman, Charles] World Fish Ctr, Bayan Lepas, Penang, Malaysia; [Cvitanovic, Christopher] Univ Tasmania, Ctr Marine Socioecol, Battery Point, Tas, Australia; [De Young, Cassandra] Food & Agr Org, Viale Terme di Caracalla, Rome, Italy; [Gooch, Margaret; Wachenfeld, Dave] Great Barrier Reef Marine Pk Author, Townsville, Qld, Australia; [James, Craig] CSIRO Land & Water, Canberra, ACT, Australia; [Jessen, Sabine] Canadian Pk & Wilderness Soc, Vancouver, BC, Canada; [Jessen, Sabine] Simon Fraser Univ, Vancouver, BC, Canada; [Johnson, Dave] Dept Environm, Canberra, ACT, Australia; [Marshall, Paul] Univ Queensland, Ctr Biodivers & Conservat Sci, St Lucia, Qld, Australia; [Park, Sarah] Univ East Anglia, Sch Int Dev, Norwich Res Pk, Norwich, Norfolk, England	Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University; James Cook University; University of Exeter; University of East Anglia; University of Exeter; CGIAR; Worldfish; University of Tasmania; Food & Agriculture Organization of the United Nations (FAO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Simon Fraser University; University of Queensland; University of East Anglia	Marshall, N (corresponding author), James Cook Univ, CSIRO Land & Water, ATSIP Bldg, Townsville, Qld, Australia.; Marshall, N (corresponding author), James Cook Univ, Coll Environm & Marine Sci, Townsville, Qld, Australia.	nadine.marshall@csiro.au	Marshall, Nadine/D-9339-2011; Adger, Neil/F-7676-2010; Elias, Dereje/GPF-8075-2022	Marshall, Nadine/0000-0003-4463-3558; Adger, Neil/0000-0003-4244-2854; Gooch, Margaret/0000-0002-3788-0617; Cvitanovic, Christopher/0000-0002-2565-3396	Commonwealth Scientific and Industrial Research Organisation (CSIRO) via a Julius Career Award	Commonwealth Scientific and Industrial Research Organisation (CSIRO) via a Julius Career Award	This research was funded by the Commonwealth Scientific and Industrial Research Organisation (CSIRO) via a Julius Career Award to the primary author.; This research was funded by the Commonwealth Scientific and Industrial Research Organisation (CSIRO) via a Julius Career Award to the primary author. Sincere thanks are also extended to the 31 interview participants.	Adams WM, 2013, ORYX, V47, P329, DOI 10.1017/S0030605312001470; Adger WN, 2011, GLOBAL ENVIRON POLIT, V11, P1, DOI 10.1162/GLEP_a_00051; Agrawal A, 2006, CONSERV BIOL, V20, P681, DOI 10.1111/j.1523-1739.2006.00468.x; Boyd I, 2013, NATURE, V501, P159, DOI 10.1038/501159a; Cash DW, 2003, P NATL ACAD SCI USA, V100, P8086, DOI 10.1073/pnas.1231332100; Cook CN, 2013, CONSERV BIOL, V27, P669, DOI 10.1111/cobi.12050; Cvitanovic C, 2016, CLIM RISK MANAG, V11, P53, DOI 10.1016/j.crm.2016.01.003; Cvitanovic C, 2015, MAR POLICY, V52, P38, DOI 10.1016/j.marpol.2014.10.026; Cvitanovic C, 2013, J ENVIRON MANAGE, V114, P84, DOI 10.1016/j.jenvman.2012.10.051; Cvitanovic C, 2015, OCEAN COASTAL MANAGE; Endter-Wada J, 1998, ECOL APPL, V8, P891, DOI 10.1890/1051-0761(1998)008[0891:AFFUSS]2.0.CO;2; Fazey I, 2014, GLOBAL ENVIRON CHANG, V25, P204, DOI 10.1016/j.gloenvcha.2013.12.012; Fazey I, 2013, ENVIRON CONSERV, V40, P19, DOI 10.1017/S037689291200029X; Fish RD, 2011, PROG PHYS GEOG, V35, P671, DOI 10.1177/0309133311420941; Freudenburg WR, 2002, SOC SCI QUART, V83, P119, DOI 10.1111/1540-6237.00074; Game ET, 2015, CONSERV LETT, V8, P309, DOI 10.1111/conl.12207; Gibbons Philip, 2008, Ecological Management & Restoration, V9, P182, DOI 10.1111/j.1442-8903.2008.00416.x; Heck N, 2015, FISH RES, V167, P30, DOI 10.1016/j.fishres.2015.01.008; Jacobson N, 2004, SCI COMMUN, V25, P246, DOI 10.1177/1075547003262038; Jones PJS, 2006, MAR POLICY, V30, P143, DOI 10.1016/j.marpol.2004.10.003; Juntti M, 2009, ENVIRON SCI POLICY, V12, P207, DOI 10.1016/j.envsci.2008.12.007; Kalfagianni A, 2013, INNOVATION-ABINGDON, V26, P231, DOI 10.1080/13511610.2013.771888; Kates RW, 2001, SCIENCE, V292, P641, DOI 10.1126/science.1059386; Kittinger JN, 2012, ECOL SOC, V17, DOI 10.5751/ES-05115-170417; Lacey J, 2015, GLOBAL ENVIRON CHANG, V32, P200, DOI 10.1016/j.gloenvcha.2015.03.011; Lubchenco J, 1998, SCIENCE, V279, P491, DOI 10.1126/science.279.5350.491; Mascia MB, 2003, CONSERV BIOL, V17, P649, DOI 10.1046/j.1523-1739.2003.01738.x; Mascia MB, 2003, CONSERV BIOL, V17, P630, DOI 10.1046/j.1523-1739.2003.01454.x; McClanahan TR, 2008, CONSERV LETT, V1, P53, DOI 10.1111/j.1755-263X.2008.00008_1.x; Mcleod E, 2015, CONSERV LETT, P9; Reed MS, 2014, J ENVIRON MANAGE, V146, P337, DOI 10.1016/j.jenvman.2014.07.021; Rockstrom J, 2009, ECOLOGY SOC; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rose DC, 2015, CONSERV BIOL, V29, P748, DOI 10.1111/cobi.12444; Roux DJ, 2010, ENVIRON SCI POLICY, V13, P733, DOI 10.1016/j.envsci.2010.08.002; Rudd MA, 2011, CONSERV BIOL, V25, P476, DOI 10.1111/j.1523-1739.2010.01625.x; Sarewitz D, 2004, ENVIRON SCI POLICY, V7, P385, DOI 10.1016/j.envsci.2004.06.001; Sarewitz D, 2007, ENVIRON SCI POLICY, V10, P5, DOI 10.1016/j.envsci.2006.10.001; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Shanley P, 2009, BIOTROPICA, V41, P535, DOI 10.1111/j.1744-7429.2009.00561.x; Squires D, 2009, FISH FISH SER, V31, P637, DOI 10.1007/978-1-4020-9210-7_32; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Symes D, 1996, SOCIOL RURALIS, V36, P146, DOI 10.1111/j.1467-9523.1996.tb00011.x; van Kerkoff L, 2002, THESIS; Varjopuro R, 2008, MAR POLICY, V32, P147, DOI 10.1016/j.marpol.2007.09.001; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; Young JC, 2014, BIODIVERS CONSERV, V23, P387, DOI 10.1007/s10531-013-0607-0; Young K., 2002, SOC POLICY SOC, V1, P215, DOI DOI 10.1017/S1474746402003068	48	43	43	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0171950	10.1371/journal.pone.0171950	http://dx.doi.org/10.1371/journal.pone.0171950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278238	Green Accepted, Green Published, gold			2022-12-27	WOS:000396087900113
J	Amdahl, H; Haapasalo, K; Tan, L; Meri, T; Kuusela, PI; van Strijp, JA; Rooijakkers, S; Jokiranta, TS				Amdahl, Hanne; Haapasalo, Karita; Tan, Lydia; Meri, Taru; Kuusela, Pentti I.; van Strijp, Jos A.; Rooijakkers, Suzan; Jokiranta, T. Sakari			Staphylococcal protein Ecb impairs complement receptor-1 mediated recognition of opsonized bacteria	PLOS ONE			English	Article							FIBRINOGEN-BINDING PROTEIN; HEMOLYTIC-UREMIC SYNDROME; INHIBITOR FACTOR-H; HUMAN-NEUTROPHILS; IMMUNE EVASION; AUREUS; INNATE; C-3; C3B; REGULATORS	Staphyloccus aureus is a major human pathogen leading frequently to sepsis and soft tissue infections with abscesses. Multiple virulence factors including several immune modulating molecules contribute to its survival in the host. When S. aureus invades the human body, one of the first line defenses is the complement system, which opsonizes the bacteria with C3b and attract neutrophils by release of chemotactic peptides. Neutrophils express Complement receptor-1 [CR1, CD35) that interacts with the C3b-opsonized particles and thereby plays an important role in pathogen recognition by phagocytic cells. In this study we observed that a fraction of S. aureus culture supernatant prevented binding of C3b to neutrophils. This fraction consisted of S. aureus leukocidins and Efb. The C-terminus of Efb is known to bind C3b and shares significant sequence homology to the extracellular complement binding protein [Ecb). Here we show that S. aureus Ecb displays various mechanisms to block bacterial recognition by neutrophils. The presence of Ecb blocked direct interaction between soluble CR1 and C3b and reduced the cofactor activity of CR1 in proteolytic inactivation of C3b. Furthermore, Ecb could dose-dependently prevent recognition of C3b by cell-bound CR1 that lead to impaired phagocytosis of NHS-opsonized S. aureus. Phagocytosis was furthermore reduced in the presence of soluble CR1 [sCR1). These data indicate that the staphylococcal protein Ecb prevents recognition of C3b opsonized bacteria by neutrophil CR1 leading to impaired killing by phagocytosis and thereby contribute to immune evasion of S. aureus.	[Amdahl, Hanne; Haapasalo, Karita; Kuusela, Pentti I.; Jokiranta, T. Sakari] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland; [Amdahl, Hanne; Haapasalo, Karita; Jokiranta, T. Sakari] Univ Helsinki, Res Programs Unit, Immunobiol, Helsinki, Finland; [Tan, Lydia; van Strijp, Jos A.; Rooijakkers, Suzan] Univ Med Ctr Utrecht, Med Microbiol, Utrecht, Netherlands; [Meri, Taru] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Kuusela, Pentti I.] Univ Helsinki, Div Clin Microbiol, Cent Hosp Lab, Helsinki, Finland	University of Helsinki; University of Helsinki; Utrecht University; Utrecht University Medical Center; University of Helsinki; University of Helsinki	Jokiranta, TS (corresponding author), Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland.; Jokiranta, TS (corresponding author), Univ Helsinki, Res Programs Unit, Immunobiol, Helsinki, Finland.; Rooijakkers, S (corresponding author), Univ Med Ctr Utrecht, Med Microbiol, Utrecht, Netherlands.	S.H.M.Rooijakkers@umcutrecht.nl; sakari.jokiranta@helsinki.fi	van Strijp, Jos A.G./J-9549-2014	van Strijp, Jos A.G./0000-0001-6253-0830; Haapasalo, Karita/0000-0002-9619-625X	Finnish Cultural Foundation [00131060, 00142390]; Academy of Finland [128646, 259793]; Sigrid Juselius Foundation	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was financially supported by The Finnish Cultural Foundation (grants 00131060 and 00142390), https://skr.fi, The Academy of Finland (grants 128646 and 259793), www.aka.fi, and The Sigrid Juselius Foundation, www..sigridjuselius.fi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge help from the technicians at the Haartman Institute and the Research Programs Unit, Immunobiology. This work was financially supported by The Finnish Cultural Foundation (grants 00131060 and 00142390), the Academy of Finland (grants 128646 and 259793) and the Sigrid Juselius Foundation.	Amdahl H, 2013, J IMMUNOL, V191, P1775, DOI 10.4049/jimmunol.1300638; Amdahl H, 2011, MOL IMMUNOL, V48, P697, DOI 10.1016/j.molimm.2010.11.015; Austen K F, 1979, Adv Exp Med Biol, V120B, P3; Benoit LA, 2005, J IMMUNOL, V175, P3542, DOI 10.4049/jimmunol.175.6.3542; Berends ETM, 2015, MOL IMMUNOL, V65, P328, DOI 10.1016/j.molimm.2015.01.020; BERGER M, 1984, J CLIN INVEST, V74, P1566, DOI 10.1172/JCI111572; Bexborn F, 2009, J BIOMED MATER RES A, V89A, P951, DOI 10.1002/jbm.a.32034; Blanc C, 2012, J IMMUNOL, V189, P3528, DOI 10.4049/jimmunol.1200679; BODEN MK, 1994, MOL MICROBIOL, V12, P599, DOI 10.1111/j.1365-2958.1994.tb01046.x; Burman JD, 2008, J BIOL CHEM, V283, P17579, DOI 10.1074/jbc.M800265200; Cunnion KM, 2004, J LAB CLIN MED, V143, P358, DOI 10.1016/j.lab.2004.03.005; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; EASMON CSF, 1976, INFECT IMMUN, V13, P399, DOI 10.1128/IAI.13.2.399-406.1976; FEARON DT, 1979, P NATL ACAD SCI USA, V76, P5867, DOI 10.1073/pnas.76.11.5867; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; FEARON DT, 1977, J EXP MED, V146, P22, DOI 10.1084/jem.146.1.22; Friberg N, 2008, J IMMUNOL, V181, P8624, DOI 10.4049/jimmunol.181.12.8624; GORDON DL, 1988, J INFECT DIS, V157, P697, DOI 10.1093/infdis/157.4.697; Haapasalo K, 2008, MOL MICROBIOL, V70, P583, DOI 10.1111/j.1365-2958.2008.06347.x; Hadders MA, 2012, CELL REP, V1, P200, DOI 10.1016/j.celrep.2012.02.003; Hallstrom T, 2008, J IMMUNOL, V181, P537, DOI 10.4049/jimmunol.181.1.537; Hammel M, 2007, PROTEIN SCI, V16, P2605, DOI 10.1110/ps.073170807; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Jongerius I, 2012, J INNATE IMMUN, V4, P301, DOI 10.1159/000334604; Jongerius I, 2010, J BIOL CHEM, V285, P14973, DOI 10.1074/jbc.M109.091975; Jongerius I, 2010, J IMMUNOL, V184, P420, DOI 10.4049/jimmunol.0902865; Ko YP, 2011, J BIOL CHEM, V286, P9865, DOI 10.1074/jbc.M110.199687; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476; KOISTINEN V, 1989, COMPLEMENT INFLAMMAT, V6, P270, DOI 10.1159/000463102; Lee LYL, 2004, J BIOL CHEM, V279, P50710, DOI 10.1074/jbc.M408570200; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; McCarthy AJ, 2013, INFECT GENET EVOL, V19, P7, DOI 10.1016/j.meegid.2013.06.012; Meri T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003308; Meri T, 2002, INFECT IMMUN, V70, P5185, DOI 10.1128/IAI.70.9.5185-5192.2002; Mollnes TE, 2002, BLOOD, V100, P1869; Mullaly SC, 2006, J IMMUNOL, V177, P8154, DOI 10.4049/jimmunol.177.11.8154; NEWMAN SL, 1985, J EXP MED, V161, P1414, DOI 10.1084/jem.161.6.1414; Nuutila J, 2013, HUM IMMUNOL, V74, P522, DOI [10.1016/j.humimm.2013.01.011, 10.]; PANGBURN MK, 1986, J IMMUNOL, V136, P2216; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; ROSS GD, 1978, J EXP MED, V147, P730, DOI 10.1084/jem.147.3.730; SCHIFFERLI JA, 1986, NEW ENGL J MED, V315, P488; SCHREIBER RD, 1979, J EXP MED, V149, P870, DOI 10.1084/jem.149.4.870; SENGELOV H, 1994, J IMMUNOL, V153, P804; Serruto D, 2010, NAT REV MICROBIOL, V8, P393, DOI 10.1038/nrmicro2366; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Todd RF, 1996, J CLIN INVEST, V98, P1, DOI 10.1172/JCI118752; Troelstra A, 1997, J LEUKOCYTE BIOL, V61, P173, DOI 10.1002/jlb.61.2.173; VERBRUGH HA, 1982, J IMMUNOL, V129, P1681; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755	54	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172675	10.1371/journal.pone.0172675	http://dx.doi.org/10.1371/journal.pone.0172675			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273167	gold, Green Published			2022-12-27	WOS:000396073700085
J	Leng, F; Xu, C; Xia, XY; Pan, XM				Leng, Fei; Xu, Chao; Xia, Xia-Yu; Pan, Xian-Ming			Establishing knowledge on the sequence arrangement pattern of nucleated protein folding	PLOS ONE			English	Article							THERMOPHILIC PROTEINS; MESOPHILIC ORGANISMS; SALT BRIDGES; SIDE-CHAIN; STABILITY; THERMOSTABILITY; ENZYMES; MECHANISM; RESIDUES; PACKING	The heat-tolerance mechanisms of (hyper)thermophilic proteins provide a unique opportunity to investigate the unsolved protein folding problem. In an attempt to determine whether the interval between residues in sequence might play a role in determining thermostability, we constructed a sequence interval-dependent value function to calculate the residue pair frequency. Additionally, we identified a new sequence arrangement pattern, where like-charged residues tend to be adjacently assembled, while unlike-charged residues are distributed over longer intervals, using statistical analysis of a large sequence database. This finding indicated that increasing the intervals between unlike-charged residues can increase protein thermostability, with the arrangement patterns of these charged residues serving as thermodynamically favorable nucleation points for protein folding. Additionally, we identified that the residue pairs K-E, R-E, L-V and V-V involving long sequence intervals play important roles involving increased protein thermostability. This work demonstrated a novel approach for considering sequence intervals as keys to understanding protein folding. Our findings of novel relationships between residue arrangement and protein thermostability can be used in industry and academia to aid the design of thermostable proteins.	[Leng, Fei; Xu, Chao; Xia, Xia-Yu; Pan, Xian-Ming] Tsinghua Univ, Sch Life Sci, Key Lab Bioinformat, Minist Educ, Beijing, Peoples R China	Tsinghua University	Pan, XM (corresponding author), Tsinghua Univ, Sch Life Sci, Key Lab Bioinformat, Minist Educ, Beijing, Peoples R China.	pan-xm@mail.tsinghua.edu.cn			National Natural Science Foundation of China [20143000221, 20141301071]; Ministry of Science and Technology of China [20151860049]; International Development Research Center, Ottawa, Canada [104519-010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); International Development Research Center, Ottawa, Canada	This work was supported in part by grants 20143000221 and 20141301071 from the National Natural Science Foundation of China, 20151860049 from the Ministry of Science and Technology of China and 104519-010 from the International Development Research Center, Ottawa, Canada.	ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bauer MW, 1998, BIOCHEMISTRY-US, V37, P17170, DOI 10.1021/bi9814944; Berezovsky IN, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035002; Chakravarty S, 2002, BIOCHEMISTRY-US, V41, P8152, DOI 10.1021/bi025523t; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Daniel RM, 2010, TRENDS BIOCHEM SCI, V35, P584, DOI 10.1016/j.tibs.2010.05.001; Das Rajdeep, 2000, Functional and Integrative Genomics, V1, P76, DOI 10.1007/s101420050009; de Carvalho CCCR, 2011, BIOTECHNOL ADV, V29, P75, DOI 10.1016/j.biotechadv.2010.09.001; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Galzitskaya Oxana V., 2008, Journal of Bioinformatics and Computational Biology, V6, P667, DOI 10.1142/S0219720008003618; Ge M, 2008, J BIOL CHEM, V283, P31690, DOI 10.1074/jbc.M805750200; Glyakina AV, 2007, BIOINFORMATICS, V23, P2231, DOI 10.1093/bioinformatics/btm345; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; Hamelryck T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013714; Haney P, 1997, PROTEINS, V28, P117, DOI 10.1002/(SICI)1097-0134(199705)28:1<117::AID-PROT12>3.0.CO;2-M; Hong H, 2006, NAT CHEM BIOL, V2, P627, DOI 10.1038/nchembio827; Karshikoff A, 1998, PROTEIN ENG, V11, P867, DOI 10.1093/protein/11.10.867; Katava M, 2016, J PHYS CHEM B, V120, P2721, DOI 10.1021/acs.jpcb.6b00306; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; Lassila KS, 2002, PROTEIN SCI, V11, P688, DOI 10.1110/ps.23502; Lee CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112751; Li PY, 2015, J BIOL CHEM, V290, P11188, DOI 10.1074/jbc.M115.646182; Li YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-62; Luisi DL, 2003, BIOCHEMISTRY-US, V42, P7050, DOI 10.1021/bi027202n; Ma BG, 2010, STRUCTURE, V18, P819, DOI 10.1016/j.str.2010.04.004; Mamonova TB, 2013, BBA-PROTEINS PROTEOM, V1834, P854, DOI 10.1016/j.bbapap.2013.02.011; Pack SP, 2013, APPL BIOCHEM BIOTECH, V171, P1212, DOI 10.1007/s12010-013-0195-1; Panja AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131495; Porter JL, 2015, ACS CHEM BIOL, V10, P611, DOI 10.1021/cb500809f; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Sammond DW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145848; Sippl MJ, 1996, FOLD DES, V1, P289, DOI 10.1016/S1359-0278(96)00042-9; Tompa DR, 2016, J MOL GRAPH MODEL, V64, P85, DOI 10.1016/j.jmgm.2016.01.001; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; VIEILLE C, 1995, APPL ENVIRON MICROB, V61, P1867, DOI 10.1128/AEM.61.5.1867-1875.1995	39	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173583	10.1371/journal.pone.0173583	http://dx.doi.org/10.1371/journal.pone.0173583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273143	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700019
J	Villalobos, A; Allen-Leigh, B; Salazar-Alberto, J; De Castro, F; Barrientos-Gutierrez, T; Leyva-Lopez, A; Rojas-Martinez, R				Villalobos, Aremis; Allen-Leigh, Betania; Salazar-Alberto, Javier; De Castro, Filipa; Barrientos-Gutierrez, Tonatiuh; Leyva-Lopez, Ahidee; Rojas-Martinez, Rosalba			Quality of reproductive healthcare for adolescents: A nationally representative survey of providers in Mexico	PLOS ONE			English	Article							FAMILY-PLANNING-SERVICES; YOUNG-PEOPLE; ADULT WOMEN; RIGHTS	Objective Adolescents need sexual and reproductive health services but little is known about quality of-care in lower-and middle-income countries where most of the world's adolescents reside. Quality-of-care has important implications as lower quality may be linked to higher unplanned pregnancy and sexually transmitted infection rates. This study sought to generate evidence about quality-of-care in public sexual and reproductive health services for adolescents. Methods This cross-sectional study had a complex, probabilistic, stratified sampling design, representative at the national, regional and rural/urban level in Mexico, collecting provider questionnaires at 505 primary care units in 2012. A sexual and reproductive quality-of-healthcare index was defined and multinomial logistic regression was utilized in 2015. Results At the national level 13.9% (95% CI: 6.9-26.0) of healthcare units provide low quality, 68.6% (95% CI: 58.4-77.3) medium quality and 17.5% (95% CI: 11.9-25.0) high quality reproductive healthcare services to adolescents. Urban or metropolitan primary care units were at least 10 times more likely to provide high quality care than those in rural areas. Units with a space specifically for counseling adolescents were at least 8 times more likely to provide high quality care. Ministry of Health clinics provided the lowest quality of service, while those from Social Security for the Underserved provided the best. Conclusions The study indicates higher quality sexual and reproductive healthcare services are needed. In Mexico and other middle-to low-income countries where quality-of-care has been shown to be a problem, incorporating adolescent-friendly, gender-equity and rights-based perspectives could contribute to improvement. Setting and disseminating standards for care in guidelines and providing tools such as algorithms could help healthcare personnel provide higher quality care.	[Villalobos, Aremis; Allen-Leigh, Betania; De Castro, Filipa; Rojas-Martinez, Rosalba] Natl Inst Publ Hlth, Ctr Populat Hlth Res, Div Reprod Hlth, Publ Hlth Methods Dept, Mexico City, DF, Mexico; [Salazar-Alberto, Javier] Colectivo Sol AC, Mexico City, DF, Mexico; [Barrientos-Gutierrez, Tonatiuh] Natl Inst Publ Hlth, Ctr Populat Hlth Res, Div Reprod Hlth, Mexico City, DF, Mexico; [Leyva-Lopez, Ahidee] Natl Inst Publ Hlth, Ctr Populat Hlth Res, Div Reprod Hlth, Gender & Hlth Dept, Cuernavaca, Morelos, Mexico	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica	Allen-Leigh, B; De Castro, F (corresponding author), Natl Inst Publ Hlth, Ctr Populat Hlth Res, Div Reprod Hlth, Publ Hlth Methods Dept, Mexico City, DF, Mexico.	ballen@insp.mx; fcastro@insp.mx		Barrientos-Gutierrez, Tonatiuh/0000-0002-0826-9106; Rojas, Rosalba/0000-0003-4474-7926; Leyva, Ahidee/0000-0002-8413-0771	INMujeres	INMujeres	INMujeres (www.inmujores.gob.mx) provided funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamchak S, 2000, TOOL SERIES USAID, V5; Allen-Leigh B, 2011, 14 PUBL HLTH RES C N; Allen-Leigh B, 2013, SALUD PUBLICA MEXICO, V55, pS235, DOI 10.21149/spm.v55s2.5120; [Anonymous], 2014, MILL DEV GOALS REP 2; [Anonymous], 2009, COST EFF CLIM CHANG; Barber SL, 2007, HEALTH AFFAIR, V26, pW310, DOI 10.1377/hlthaff.26.3.w310; Barroso C, 2014, GLOB PUBLIC HEALTH, V9, P639, DOI 10.1080/17441692.2014.917198; Bearinger LH, 2007, LANCET, V369, P1220, DOI 10.1016/S0140-6736(07)60367-5; Becker D, 2007, PERSPECT SEX REPRO H, V39, P206, DOI 10.1363/3920607; Bonilla-Chacin ME., 2013, UNICO STUDIES SERIES, V1; Brindis CD, 2005, J ADOLESCENT HEALTH, V37, P155, DOI 10.1016/j.jadohealth.2004.09.015; BRUCE J, 1990, STUD FAMILY PLANN, V21, P61, DOI 10.2307/1966669; Chandra-Mouli V., 2013, INT C FAM PLANN; Darney BG, 2016, INT J GYNECOL OBSTET, V134, P22, DOI 10.1016/j.ijgo.2015.12.003; Dumitru A., 2022, CONNECTING NATURE GU; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Goicolea I, 2017, GLOB PUBLIC HEALTH, V12, P1004, DOI 10.1080/17441692.2015.1123752; Goicolea Isabel, 2012, Glob Health Action, V5, DOI 10.3402/gha.v5i0.18748; Gomez Vinales C, 2011, GUIA ENFOQUE INTEGRA; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Gottschalk LB, 2014, CONTRACEPTION, V90, P211, DOI 10.1016/j.contraception.2014.04.017; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 2001, MED CARE, V39, pII46; Hock-Long L, 2003, PERSPECT SEX REPRO H, V35, P144, DOI 10.1363/3514403; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Instituto Nacional de Estadistica y Geografia (INEGI), 2010, ENADID ENC NAC DIN D; JAIN AK, 1989, STUD FAMILY PLANN, V20, P1, DOI 10.2307/1966656; Jaruseviciene L, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20444; Juarez F, 2010, NECESIDADES SALUD SE; Li C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-31; Lohr Sharon, 2000, MUESTREO DISENO ANAL; Lundgren RI, 2012, EUR J CONTRACEP REPR, V17, P254, DOI 10.3109/13625187.2012.677077; Maharaj P, 2005, Curationis, V28, P52; Mendoza-Victorino D, 2010, SITUACION DEMOGRAFIC, P25; Gutierrez JP, 2013, SALUD PUBLICA MEXICO, V55, pS83; Sen G, 2014, GLOB PUBLIC HEALTH, V9, P599, DOI 10.1080/17441692.2014.917197; Senderowitz J., 1999, RES PROGRAM POLICY S; Senderowitz J, TECHNICAL ASSISTANCE; Senderowitz J, 2002, MODULE 16 REPROD HLT; Tafese F, 2013, ETHIOP J HEALTH SCI, V23, P245, DOI 10.4314/ejhs.v23i3.7; Tylee A, 2007, LANCET, V369, P1565, DOI 10.1016/S0140-6736(07)60371-7; WHO, 2012, MAK HLTH SERV AD FRI; World Health Organization, 2011, WHO GUID PREV EARL P; World Health Organization, 2012, PREV EARL PREGN POOR; World Health Organization (WHO), 2012, EV POL EXP ACC FAM P	45	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173342	10.1371/journal.pone.0173342	http://dx.doi.org/10.1371/journal.pone.0173342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273129	gold, Green Published, Green Submitted			2022-12-27	WOS:000396073700054
J	Elsherif, MM; Saban, MI; Rotshtein, P				Elsherif, Mahmoud Medhat; Saban, Muhammet Ikbal; Rotshtein, Pia			The perceptual saliency of fearful eyes and smiles: A signal detection study	PLOS ONE			English	Article							FACIAL EXPRESSIONS; VISUAL-PERCEPTION; NATURAL SCENES; RESPONSE BIAS; TIME-COURSE; FACES; RECOGNITION; AMYGDALA; ATTENTION; EMOTION	Facial features differ in the amount of expressive information they convey. Specifically, eyes are argued to be essential for fear recognition, while smiles are crucial for recognising happy expressions. In three experiments, we tested whether expression modulates the perceptual saliency of diagnostic facial features and whether the feature's saliency depends on the face configuration. Participants were presented with masked facial features or noise at perceptual conscious threshold. The task was to indicate whether eyes (experiments 1-3A) or a mouth (experiment 3B) was present. The expression of the face and its configuration (i.e. spatial arrangement of the features) were manipulated. Experiment 1 compared fearful with neutral expressions, experiments 2 and 3 compared fearful versus happy expressions. The detection accuracy data was analysed using Signal Detection Theory (SDT), to examine the effects of expression and configuration on perceptual precision (d') and response bias (c), separately. Across all three experiments, fearful eyes were detected better (higher d') than neutral and happy eyes. Eyes were more precisely detected than mouths, whereas smiles were detected better than fearful mouths. The configuration of the features had no consistent effects across the experiments on the ability to detect expressive features. But facial configuration affected consistently the response bias. Participants used a more liberal criterion for detecting the eyes in canonical configuration and fearful expression. Finally, the power in low spatial frequency of a feature predicted its discriminability index. The results suggest that expressive features are perceptually more salient with a higher d' due to changes at the low-level visual properties, with emotions and configuration affecting perception through top-down processes, as reflected by the response bias.	[Elsherif, Mahmoud Medhat; Rotshtein, Pia] Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England; [Saban, Muhammet Ikbal] Univ Ghent, Dept Expt Psychol, Ghent, Belgium	University of Birmingham; Ghent University	Elsherif, MM; Rotshtein, P (corresponding author), Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England.	Mahmoud.medhat.elsherif@gmail.com; P.Rotshtein@bham.ac.uk	Elsherif, Mahmoud/AAG-8739-2021	Elsherif, Mahmoud/0000-0002-0540-3998; Rotshtein, Pia/0000-0002-0301-9511; Sahan, Muhammet Ikbal/0000-0002-4359-676X	Economic and Social Research Council; Medical Research Council	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Economic and Social Research Council, http://www.esrc.ac.uk/, and Medical Research Council, http://www.mrc.ac.uk/: PR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Avidan G, 2002, J NEUROPHYSIOL, V87, P3102, DOI 10.1152/jn.2002.87.6.3102; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; Calvo MG, 2008, J EXP PSYCHOL GEN, V137, P471, DOI 10.1037/a0012771; Calvo MG, 2013, NEUROPSYCHOLOGIA, V51, P2051, DOI 10.1016/j.neuropsychologia.2013.07.010; Calvo MG, 2012, COGNITION, V125, P373, DOI 10.1016/j.cognition.2012.07.021; Calvo MG, 2011, VISION RES, V51, P1751, DOI 10.1016/j.visres.2011.06.001; Dasilva EB, 2016, NEUROIMAGE, V127, P227, DOI 10.1016/j.neuroimage.2015.12.020; Delorme A, 1999, NEUROCOMPUTING, V26-7, P663, DOI 10.1016/S0925-2312(98)00158-1; Djukic A, 2014, PEDIATR NEUROL, V51, P650, DOI 10.1016/j.pediatrneurol.2014.07.022; Dolan RJ, 2003, ANN NY ACAD SCI, V985, P348, DOI 10.1111/j.1749-6632.2003.tb07093.x; Dougal S, 2007, PSYCHON B REV, V14, P423, DOI 10.3758/BF03194083; Eisenbarth H, 2011, EMOTION, V11, P860, DOI 10.1037/a0022758; Ekman P., 1975, UNMASKING FACE; Ekman P., 1976, PICTURES FACIAL AFFE; Emery NJ, 1997, J COMP PSYCHOL, V111, P286, DOI 10.1037/0735-7036.111.3.286; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Gamer M, 2009, J NEUROSCI, V29, P9123, DOI 10.1523/JNEUROSCI.1883-09.2009; Gillespie SM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00552; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Gullberg M, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P685, DOI 10.1016/B978-044451020-4/50037-2; Hegde J, 2008, PROG NEUROBIOL, V84, P405, DOI 10.1016/j.pneurobio.2007.09.001; JANIK SW, 1978, PERCEPT MOTOR SKILL, V47, P857, DOI 10.2466/pms.1978.47.3.857; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; KAPLAN E, 1986, P NATL ACAD SCI USA, V83, P2755, DOI 10.1073/pnas.83.8.2755; Kaplan G, 2002, INT J PRIMATOL, V23, P501, DOI 10.1023/A:1014913532057; KEATING CF, 1982, PERCEPTION, V11, P211, DOI 10.1068/p110211; KIROUAC G, 1984, PERCEPT MOTOR SKILL, V59, P147, DOI 10.2466/pms.1984.59.1.147; Kobayashi H, 1997, NATURE, V387, P767, DOI 10.1038/42842; Kohler CG, 2004, PSYCHIAT RES, V128, P235, DOI 10.1016/j.psychres.2004.07.003; KRAUT RE, 1979, J PERS SOC PSYCHOL, V37, P1539, DOI 10.1037/0022-3514.37.9.1539; Kveraga K, 2007, J NEUROSCI, V27, P13232, DOI 10.1523/JNEUROSCI.3481-07.2007; Le S, 2003, COGNITIVE BRAIN RES, V17, P26, DOI 10.1016/S0926-6410(03)00077-6; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; MCKELVIE SJ, 1995, BRIT J SOC PSYCHOL, V34, P325, DOI 10.1111/j.2044-8309.1995.tb01067.x; Miskovic V, 2015, BIOL PSYCHOL, V106, P11, DOI 10.1016/j.biopsycho.2015.01.012; Morris JS, 2002, NEUROIMAGE, V17, P214, DOI 10.1006/nimg.2002.1220; Nummenmaa L, 2015, EMOTION, V15, P243, DOI 10.1037/emo0000042; Ogawa T, 1999, PERCEPT MOTOR SKILL, V89, P557; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Ohman A., 1993, HDB EMOTIONS, P511; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Peossa L, 2013, CAMBRIDGE HDB AFFECT, P357; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Richler JJ, 2008, J EXP PSYCHOL LEARN, V34, P328, DOI 10.1037/0278-7393.34.2.328; Richler JJ, 2014, PSYCHOL BULL, V140, P1281, DOI 10.1037/a0037004; Richler JJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00553; Richler JJ, 2011, J VISION, V11, DOI 10.1167/11.13.17; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Rotshtein P, 2007, J COGNITIVE NEUROSCI, V19, P1435, DOI 10.1162/jocn.2007.19.9.1435; Rotshtein P, 2010, J VISION, V10, DOI 10.1167/10.10.25; Rotshtein P, 2010, HUM BRAIN MAPP, V31, P1089, DOI 10.1002/hbm.20921; Schurgin MW, 2014, J VISION, V14, DOI 10.1167/14.13.14; Skottun BC, 2000, VISION RES, V40, P111, DOI 10.1016/S0042-6989(99)00170-4; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Spezio ML, 2007, J NEUROSCI, V27, P3994, DOI 10.1523/JNEUROSCI.3789-06.2007; Spillmann L, 1996, TRENDS NEUROSCI, V19, P428; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Steegen S, 2016, PERSPECT PSYCHOL SCI, V11, P702, DOI 10.1177/1745691616658637; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Stone A, 2004, PSYCHON B REV, V11, P469, DOI 10.3758/BF03196597; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Treue S, 2003, CURR OPIN NEUROBIOL, V13, P428, DOI 10.1016/S0959-4388(03)00105-3; UWANO T, 1995, NEUROSCIENCE, V68, P339, DOI 10.1016/0306-4522(95)00125-3; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Wannig A, 2011, NAT NEUROSCI, V14, P1243, DOI 10.1038/nn.2910; Wells LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168307; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Winston JS, 2003, CURR BIOL, V13, P1824, DOI 10.1016/j.cub.2003.09.038; Zhang XL, 2012, NEURON, V73, P183, DOI 10.1016/j.neuron.2011.10.035; Zhaoping L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040014	80	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173199	10.1371/journal.pone.0173199	http://dx.doi.org/10.1371/journal.pone.0173199			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5QM	28267761	Green Published, Green Submitted, gold			2022-12-27	WOS:000396060600013
J	Pollack, TM; Duong, HT; Pham, TT; Do, CD; Colby, D				Pollack, Todd M.; Duong, Hao T.; Pham, Thuy T.; Do, Cuong D.; Colby, Donn			Cigarette smoking is associated with high HIV viral load among adults presenting for antiretroviral therapy in Vietnam	PLOS ONE			English	Article							DISEASE PROGRESSION; ALCOHOL-CONSUMPTION; INFECTED PATIENTS; HEPATITIS-B; VIRUS LOAD; CELL COUNT; SET-POINT; IMPACT; COHORT; TUBERCULOSIS	High HIV viral load (VL >100,000 cp/ml) is associated with increased HIV transmission risk, faster progression to AIDS, and reduced response to some antiretroviral regimens. To better understand factors associated with high VL, we examined characteristics of patients presenting for treatment in Hanoi, Vietnam. We examined baseline data from the Viral Load Monitoring in Vietnam Study, a randomized controlled trial of routine VL monitoring in a population starting antiretroviral therapy (ART) at a clinic in Hanoi. Patients with prior treatment failure or ART resistance were excluded. Characteristics examined included demographics, clinical and laboratory data, and substance use. Logistic regression was used to calculate crude and adjusted odds ratios (aOR) and 95% confidence intervals (95% CI). Out of 636 patients, 62.7% were male, 72.9% were >= 30 years old, and 28.3% had a history of drug injection. Median CD4 was 132 cells/mm3, and 34.9% were clinical stage IV. Active cigarette smoking was reported by 36.3% with 14.0% smoking >10 cigarettes per day. Alcohol consumption was reported by 20.1% with 6.1% having >= 5 drinks per event. Overall 53.0% had a VL >100,000 cp/ml. Male gender, low body weight, low CD4 count, prior TB, and cigarette smoking were associated with high VL. Those who smoked 1-10 cigarettes per day were more likely to have high VL (aOR = 1.99, 95% CI = 1.15-3.45), while the smaller number of patients who smoked >10 cigarettes per day had a non-significant trend toward higher VL (aOR = 1.41, 95% CI = 0.75-2.66). Alcohol consumption was not significantly associated with high VL. Tobacco use is increasingly recognized as a contributor to premature morbidity and mortality among HIV-infected patients. In our study, cigarette smoking in the last 30 days was associated with a 1.5 to 2-fold higher odds of having an HIV VL >100,000 cp/ml among patients presenting for ART. These findings provide further evidence of the negative effects of tobacco use among HIV-infected patients.	[Pollack, Todd M.; Duong, Hao T.; Pham, Thuy T.] Partnership Hlth Adv Vietnam HAIVN, Hanoi, Vietnam; [Pollack, Todd M.] Harvard Med Sch, BIDMC, Boston, MA 02115 USA; [Pham, Thuy T.; Do, Cuong D.] BMH, Dept Infect Dis, Hanoi, Vietnam; [Colby, Donn] HCMC, Ctr Appl Res Men & Community Hlth CARMAH, Hanoi, Vietnam; [Colby, Donn] Thai Red Cross AIDS Res Ctr, SEARCH, Bangkok, Thailand	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Thai Red Cross Society	Pollack, TM (corresponding author), Partnership Hlth Adv Vietnam HAIVN, Hanoi, Vietnam.; Pollack, TM (corresponding author), Harvard Med Sch, BIDMC, Boston, MA 02115 USA.	todd@haivn.org		colby, donn j./0000-0003-3931-5926	Roche Molecular Systems, Inc. (RMS);  [L974]	Roche Molecular Systems, Inc. (RMS); 	This study was funded by a research grant from Roche Molecular Systems, Inc. (RMS); contract No. L974. RMS developed the COBAS (R) AmpliPrep/COBAS (R) TaqMan (R) HIV-1 Test which was used in the study for measuring plasma HIV viral load. RMS has had no role in the study design; collection, analysis, and interpretation of data, writing of the paper, and/or decision to submit for publication.	Akhtar-Khaleel WZ, 2016, AIDS BEHAV, V20, P622, DOI 10.1007/s10461-015-1099-6; Ande A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122402; [Anonymous], 2015, NAT AD TOB QUEST 201; Ansari-Moghaddam A, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.6618; Badri M, 2001, INT J TUBERC LUNG D, V5, P225; Baum MK, 2010, AIDS RES HUM RETROV, V26, P511, DOI 10.1089/aid.2009.0211; Buchacz K, 2004, SYPHILIS INCREASES H, P2075; Chakravarti Anita, 2005, Trop Gastroenterol, V26, P183; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Conen A, 2013, JAIDS-J ACQ IMM DEF, V64, P472, DOI 10.1097/QAI.0b013e3182a61ea9; Cuong DD, 2012, SCAND J INFECT DIS, V44, P201, DOI 10.3109/00365548.2011.631937; Donnelly CA, 2005, HIV MED, V6, P170, DOI 10.1111/j.1468-1293.2005.00285.x; Donovan RM, 1996, J INFECT DIS, V174, P401, DOI 10.1093/infdis/174.2.401; Duffus WA, 2005, INT J STD AIDS, V16, P733, DOI 10.1258/095646205774763298; Feldman DN, 2009, AIDS EDUC PREV, V21, P81, DOI 10.1521/aeap.2009.21.3_supp.81; Feldman JG, 2006, AM J PUBLIC HEALTH, V96, P1060, DOI 10.2105/AJPH.2005.062745; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; French AL, 2007, J INFECT DIS, V195, P1437, DOI 10.1086/515578; Gandhi M, 2002, CLIN INFECT DIS, V35, P313, DOI 10.1086/341249; Goletti D, 1996, J IMMUNOL, V157, P1271; Gray RH, 2004, J INFECT DIS, V189, P1209, DOI 10.1086/382750; Kabali C, 2011, AIDS CARE, V23, P947, DOI 10.1080/09540121.2010.542128; Kalichman SC, 2014, INT J BEHAV MED, V21, P811, DOI 10.1007/s12529-013-9353-7; Kato M, 2014, CURR HIV-AIDS REP, V11, P487, DOI 10.1007/s11904-014-0235-7; McLean RC, 2011, J CARDIOVASC SURG, V52, P877; Mdodo R, 2015, ANN INTERN MED, V162, P335, DOI 10.7326/M14-0954; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Miguez-Burbano MJ, 2003, ADDICT BIOL, V8, P39, DOI 10.1080/1355621031000069864; Miller V, 2002, J INFECT DIS, V186, P189, DOI 10.1086/341466; MOH, 2015, GUID HIV AIDS DIAGN; MOH, 2011, GUID HIV AIDS DIGAN; Molina PE, 2014, ALCOHOL CLIN EXP RES, V38, P2335, DOI 10.1111/acer.12507; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Nakagawa F, 2014, AIDS, V28, P1351, DOI 10.1097/QAD.0000000000000224; National Cancer Institute, TOB US 2015; National Committee for AIDS Drug and Prostitution Prevention and Control, 2014, DRUG PROS PREV CONTR; National Institute on Alcohol Abuse and Alcoholism, ALC FACTS STAT 2016; Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003; Phillips AN, 2001, JAMA-J AM MED ASSOC, V286, P2560; Rangarajan S, 2014, RISK FACTORS DELAYED, P9; Rangarajan S, 2016, J VIRUS ERAD, V2, P36; Samet JH, 2007, JAIDS-J ACQ IMM DEF, V46, P194, DOI 10.1097/QAI.0b013e318142aabb; Sax PE, 2009, NEW ENGL J MED, V361, P2230, DOI 10.1056/NEJMoa0906768; Sobell LC, ALCOHOL CONSUMPTION, P75; Substance Abuse and Mental Health Services Administration (SAMHSA), BING DRINK TERM PATT; Toossi Z, 2001, CLIN EXP IMMUNOL, V123, P233, DOI 10.1046/j.1365-2249.2001.01401.x; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Williams BG, 2011, CURR HIV RES, V9, P367, DOI 10.2174/157016211798038533; Zarski JP, 1998, J HEPATOL, V28, P27, DOI 10.1016/S0168-8278(98)80198-0; Zhang X, 2013, CLIN VACCINE IMMUNOL, V20, P1048, DOI 10.1128/CVI.00015-13	51	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173534	10.1371/journal.pone.0173534	http://dx.doi.org/10.1371/journal.pone.0173534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5QM	28267790	Green Published, gold, Green Submitted			2022-12-27	WOS:000396060600042
J	Wendebourg, MJ; Heesen, C; Finlayson, M; Meyer, B; Pottgen, J; Kopke, S				Wendebourg, Maria Janina; Heesen, Christoph; Finlayson, Marcia; Meyer, Bjoern; Poettgen, Jana; Koepke, Sascha			Patient education for people with multiple sclerosis-associated fatigue: A systematic review	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIORAL THERAPY; ENERGY-CONSERVATION COURSE; MANAGEMENT PROGRAM FACETS; FOLLOW-UP; HEALTH; IMPACT; INTERVENTIONS; DEPRESSION; SCALE	Background Multiple Sclerosis (MS) is an inflammatory and neurodegenerative disease often causing decreased quality of life, social withdrawal and unemployment. Studies examining the effect of pharmacological interventions demonstrated only minor effects, whereas non-pharmacological interventions as e.g. patient education programs have shown promising results. Objective We aim to systematically review the literature to determine the effect of patient education programs on fatigue in MS. Methods We conducted a comprehensive search in PubMed for randomized controlled trials (RCTs) that evaluated patient education programs for MS-related fatigue. Interventions evaluating physical exercise and/or pharmacological treatments were not included. Meta-analyses were performed using the generic inverse variance method. Results The search identified 856 citations. After full-text screening we identified ten trials that met the inclusion criteria. Data of 1021 participants were analyzed. Meta-analyses showed significant positive effects on fatigue severity (weighted mean difference -0.43; 95% CI-0.74 to-0.11) and fatigue impact (-0.48;-0.82 to-0.15), but not for depression (-0.35 (95% CI-0.75 to 0.05; p = 0.08). Essentially, we categorized patient education programs into two types: firstly, interventions with a focus on cognitive-behavioral therapy (CBT) and secondly, interventions that teach patients ways of managing daily fatigue. CBT-based approaches seem to generate better results in reducing patient-reported fatigue severity. Analysing CBT studies only, the pooled weighted mean difference for fatigue severity was -0.60 (95% CI; -1.08 to -0.11) compared to non-CBT approaches (-0.20; 95% CI;-0.60 to -0.19). Furthermore, interventions employing an individual approach seem to reduce fatigue more effectively than group-based approaches (pooled weighted mean difference for fatigue severity in face-to-face studies was -0.80 (95% CI;-1.13 to -0.47) compared to group-based studies with -0,17 (95% CI; -0,39 to 0,05). Longest follow-up data were available for 12 months post-intervention. Conclusion Overall, included studies demonstrated that educational programs and especially CBTbased approaches have a positive effect on reducing fatigue. Since fatigue is thought to be a multidimensional symptom, it should be treated with a multidimensional approach targeting patients' behavior as well as their emotional and mental attitude towards fatigue. However, the clinical relevance of the treatment effects i.e. the relevance for patients' daily functioning remains unclear and long-term effects, i.e. sustainability of effects beyond 6 months, warrants further work. This review has been registered in the PROSPERO international prospective register of systematic reviews data base (Registration number: CRD42014014224).	[Wendebourg, Maria Janina; Heesen, Christoph; Poettgen, Jana] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol, Hamburg, Germany; [Wendebourg, Maria Janina; Heesen, Christoph; Poettgen, Jana] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Finlayson, Marcia] Queens Univ, Sch Rehabil Therapy, Kingston, ON, Canada; [Meyer, Bjoern] GAIA AG, Hamburg, Germany; [Koepke, Sascha] Univ Lubeck, Inst Social Med & Epidemiol, Nursing Res Unit, Lubeck, Germany; [Wendebourg, Maria Janina] Univ Basel Hosp, Neurol Clin & Policlin, Basel, Switzerland	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Queens University - Canada; University of Lubeck; University of Basel	Wendebourg, MJ (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol, Hamburg, Germany.; Wendebourg, MJ (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.	mjwendebourg@gmail.com	; Meyer, Bjorn/C-8787-2012	Wendebourg, Maria Janina/0000-0003-4812-8807; Meyer, Bjorn/0000-0003-1100-0260				Amtmann D, 2012, REHABIL PSYCHOL, V57, P159, DOI 10.1037/a0027890; Asano M, 2014, MULT SCLER INT, V2014, DOI 10.1155/2014/798285; Bol Y, 2009, J PSYCHOSOM RES, V66, P3, DOI 10.1016/j.jpsychores.2008.05.003; Braley TJ, 2010, SLEEP, V33, P1061, DOI 10.1093/sleep/33.8.1061; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Finlayson M, 2011, MULT SCLER J, V17, P1130, DOI 10.1177/1352458511404272; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Fuhrer MJ, 2003, AM J PHYS MED REHAB, V82, pS8, DOI 10.1097/01.PHM.0000086995.80644.D7; Ghahari S, 2010, CLIN REHABIL, V24, P727, DOI 10.1177/0269215509360648; Grossman P, 2010, NEUROLOGY, V75, P1141, DOI 10.1212/WNL.0b013e3181f4d80d; Guyatt G, GRADE GUIDELINES 1 I; Hall AK, 2015, ANNU REV PUBL HEALTH, V36, P393, DOI 10.1146/annurev-publhealth-031914-122855; Heine M, 2012, COCHRANY LIB     JUL; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hugos CL, 2010, MULT SCLER J, V16, P724, DOI 10.1177/1352458510364536; Katchamart W, 2011, J CLIN EPIDEMIOL, V64, P805, DOI 10.1016/j.jclinepi.2010.06.004; Knoop H, 2012, PSYCHOL MED, V42, P205, DOI 10.1017/S0033291711000924; Kos D, 2007, MULT SCLER J, V13, P996, DOI 10.1177/1352458507078392; Kos D, 2005, MULT SCLER, V11, P76, DOI 10.1191/1352458505ms1117oa; Krupp LB, 2010, EXPERT REV NEUROTHER, V10, P1437, DOI [10.1586/ern.10.99, 10.1586/ERN.10.99]; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lustria MLA, 2009, PATIENT EDUC COUNS, V74, P156, DOI 10.1016/j.pec.2008.08.023; Mathiowetz VG, 2005, MULT SCLER J, V11, P592, DOI 10.1191/1352458505ms1198oa; Mathiowetz VG, 2007, INT J REHABIL RES, V30, P305, DOI 10.1097/MRR.0b013e3282f14434; Mills RJ, 2008, QJM-INT J MED, V101, P49, DOI 10.1093/qjmed/hcm122; Moller F, 2011, MULT SCLER J, V17, P1002, DOI 10.1177/1352458511402410; Mohr DC, 2003, PSYCHOSOM MED, V65, P542, DOI 10.1097/01.PSY.0000074757.11682.96; Moss-Morris R, 2012, BEHAV RES THER, V50, P415, DOI 10.1016/j.brat.2012.03.001; Noar SM, 2007, PSYCHOL BULL, V133, P673, DOI 10.1037/0033-2909.133.4.673; Patti F, 2014, NEUROEPIDEMIOLOGY, V42, P211, DOI 10.1159/000360423; Smith MM, 2005, MULT SCLER J, V11, P602, DOI 10.1191/1352458505ms1204oa; Strober LB, 2012, MULT SCLER J, V18, P647, DOI 10.1177/1352458511426735; The Nordic Cochrane Centre The Cochrane Collaboration, 2014, REVIEW MANAGER REVMA; Thomas PW, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-109; Thomas S, 2013, J NEUROL NEUROSUR PS, V84, P1092, DOI 10.1136/jnnp-2012-303816; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010939; van Kessel K, 2008, PSYCHOSOM MED, V70, P205, DOI 10.1097/PSY.0b013e3181643065; Vucic S, 2010, CLIN NEUROPHYSIOL, V121, P809, DOI 10.1016/j.clinph.2009.12.013	39	27	27	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173025	10.1371/journal.pone.0173025	http://dx.doi.org/10.1371/journal.pone.0173025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5QM	28267811	Green Published, gold, Green Submitted			2022-12-27	WOS:000396060600007
J	Barbieri, NL; Nielsen, DW; Wannemuehler, Y; Cavender, T; Hussein, A; Yan, SG; Nolan, LK; Logue, CM				Barbieri, Nicolle Lima; Nielsen, Daniel W.; Wannemuehler, Yvonne; Cavender, Tia; Hussein, Ashraf; Yan, Shi-gan; Nolan, Lisa K.; Logue, Catherine M.			mcr-1 identified in Avian Pathogenic Escherichia coli (APEC)	PLOS ONE			English	Article							RESISTANCE GENE MCR-1; SPECTRUM BETA-LACTAMASE; FOOD ANIMALS; SALMONELLA-ENTERICA; HUMAN-ORIGIN; PLASMID; EMERGENCE; VIRULENCE; STRAINS; EGYPT	Antimicrobial resistance associated with colistin has emerged as a significant concern worldwide threatening the use of one of the most important antimicrobials for treating human disease. Here, we examined a collection (n = 980) of Avian Pathogenic Escherichia coli (APEC) isolated from poultry with colibacillosis from the US and internationally for the presence of mcr-1 and mcr-2, genes known to encode colistin resistance. Included in the analysis was an additional set of avian fecal E. coli (AFEC) (n = 220) isolates from healthy birds for comparative analysis. The mcr-1 gene was detected in a total of 12 isolates recovered from diseased production birds from China and Egypt. No mcr genes were detected in the healthy fecal isolates. The full mcr-1 gene from positive isolates was sequenced using specifically designed primers and were compared with sequences currently described in NCBI. mcr-1 positive isolates were also assessed for phenotypic colistin resistance and extended spectrum beta lactam phenotypes and genotypes. This study has identified mcr-1 in APEC isolates dating back to at least 2010 and suggests that animal husbandry practices could result in a potential source of resistance to the human food chain in countries where application of colistin in animal health is practiced.	[Barbieri, Nicolle Lima; Nielsen, Daniel W.; Wannemuehler, Yvonne; Cavender, Tia; Nolan, Lisa K.; Logue, Catherine M.] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, 1802 Univ Blvd,VMRI 5 Ames, Ames, IA 50011 USA; [Hussein, Ashraf] Zagazig Univ, Dept Avian & Rabbit Med, Fac Vet Med, Zagazig, Egypt; [Yan, Shi-gan] Qilu Univ Technol, Sch Bioengn, Jinan, Shandong, Peoples R China	Iowa State University; Egyptian Knowledge Bank (EKB); Zagazig University; Qilu University of Technology	Logue, CM (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, 1802 Univ Blvd,VMRI 5 Ames, Ames, IA 50011 USA.	cmlogue@iastate.edu	hussein, ashraf/AAA-6212-2021; Barbieri, Nicolle Lima/L-6477-2013; Barbieri, Nicolle/AAB-3223-2020	Barbieri, Nicolle Lima/0000-0002-8223-6580; Nielsen, Daniel/0000-0002-6642-1399; Logue, Catherine/0000-0002-6098-2662	College of Veterinary Medicine; Iowa State University	College of Veterinary Medicine; Iowa State University	Funding for this project was provided by the Dean's Office, College of Veterinary Medicine and the Vice President for Research Office, Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072322; Barbieri NL, 2015, FOODBORNE PATHOG DIS, V12, P74, DOI 10.1089/fpd.2014.1815; Brinas L, 2002, ANTIMICROB AGENTS CH, V46, P3156, DOI 10.1128/AAC.46.10.3156-3163.2002; Campos J., 2016, EURO SURVEILL, V21; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Castanheira M, 2016, ANTIMICROB AGENTS CH, V60, P5623, DOI 10.1128/AAC.01267-16; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Coetzee I, 2016, SAMJ S AFR MED J, V106, P35, DOI [10.7196/SAMJ.2016.v106i5.10710, 10.7196/samj.2016.v106i5.10710]; Di Pilato V, 2016, ANTIMICROBIAL AGENTS; Doumith M, 2016, J ANTIMICROB CHEMOTH, V71, P2300, DOI 10.1093/jac/dkw093; El Garch F, 2016, CLIN MICROBIOLOGY IN; Elnahriry SS, 2016, ANTIMICROB AGENTS CH, V60, P3249, DOI 10.1128/AAC.00269-16; Ewers C, 2016, GENOME ANNOUNC, V4; Falgenhauer L, 2016, EMERG INFECT DIS, V22, P1689, DOI 10.3201/eid2209.160692; Fernandes MR, 2016, ANTIMICROBIAL AGENTS; Grami R, 2016, EURO SURVEILL, V21; Grobner S, 2009, J MED MICROBIOL, V58, P912, DOI 10.1099/jmm.0.005850-0; Haenni M, 2016, ANTIMICROBIAL AGENTS; Haenni M, 2016, LANCET INFECT DIS, V16, P281, DOI 10.1016/S1473-3099(16)00007-4; Hasman H, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.49.30085; Hussein AHM, 2013, AVIAN DIS, V57, P602, DOI 10.1637/10503-012513-Reg.1; Irrgang A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159863; Johnson TJ, 2012, PLASMID, V68, P43, DOI 10.1016/j.plasmid.2012.03.001; Johnson TJ, 2009, METHODS MOL BIOL, V551, P27, DOI 10.1007/978-1-60327-999-4_3; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Khalifa HO, 2016, INT J ANTIMICROB AG, V47, P413, DOI 10.1016/j.ijantimicag.2016.02.011; Li A, 2016, ANTIMICROBIAL AGENTS; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Lo WU, 2014, J MED MICROBIOL, V63, P835, DOI 10.1099/jmm.0.074021-0; Logue CM, 2012, APPL ENVIRON MICROB, V78, P5824, DOI 10.1128/AEM.07869-11; Maluta RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105016; Maynard C, 2004, J CLIN MICROBIOL, V42, P5444, DOI 10.1128/JCM.42.12.5444-5452.2004; McGann P, 2016, ANTIMICROBIAL AGENTS; Meinersmann RJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02244-16; Meinersmann RJ, 2016, GENOME ANNOUNCEMENTS, V4; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; Nolan LK, 2013, COLIBACILLOSIS; Nordmann P, 2016, EUROPEAN J CLIN MICR; Perreten V, 2016, ANTIMICROBIAL AGENTS; Perreten V, 2016, ANTIMICROB AGENTS CH, V60, P4414, DOI 10.1128/AAC.00548-16; Perrin-Guyomard A, 2016, EURO SURVEILL, V21; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; Schwarz S, 2016, J ANTIMICROB CHEMOTH, V71, P2066, DOI 10.1093/jac/dkw274; Sellera FP, 2016, J ANTIMICROB CHEMOTH; Shen ZQ, 2016, LANCET INFECT DIS, V16, P293, DOI 10.1016/S1473-3099(16)00061-X; Singer RS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00028; Skyberg JA, 2006, INFECT IMMUN, V74, P6287, DOI 10.1128/IAI.00363-06; Teo JQ, 2016, ANTIMICROBIAL AGENTS; Tivendale KA, 2004, INFECT IMMUN, V72, P6554, DOI 10.1128/IAI.72.11.6554-6560.2004; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P979, DOI 10.15585/mmwr.mm6536e3; Veldman K, 2016, J ANTIMICROB CHEMOTH, V71, P2340, DOI 10.1093/jac/dkw181; Wang Y, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.260; Xavier B. B., 2016, EURO SURVEILL, V21; Yang R, 2016, PROCEEDINGS OF THE 2016 12TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION (WCICA), P1, DOI 10.1109/WCICA.2016.7578286; Yang YQ, 2016, J ANTIMICROB CHEMOTH, V71, P2336, DOI 10.1093/jac/dkw243; Zhao FF, 2016, ANTIMICROB AGENTS CH, V60, P7498, DOI 10.1128/AAC.01165-16; Zhao SH, 2001, ANTIMICROB AGENTS CH, V45, P3647, DOI 10.1128/AAC.45.12.3647-3650.2001; Zhi CP, 2016, LANCET INFECT DIS, V16, P292, DOI 10.1016/S1473-3099(16)00063-3; Zurfluh K, 2016, GENOME ANNOUNCEMENTS, V4	61	55	56	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							E0172997	10.1371/journal.pone.0172997	http://dx.doi.org/10.1371/journal.pone.0172997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264015	Green Submitted, gold, Green Published			2022-12-27	WOS:000396054300031
J	Imanishi, Y; Fukuma, S; Karaboyas, A; Robinson, BM; Pisoni, RL; Nomura, T; Akiba, T; Akizawa, T; Kurokawa, K; Saito, A; Fukuhara, S; Inaba, M				Imanishi, Yasuo; Fukuma, Shingo; Karaboyas, Angelo; Robinson, Bruce M.; Pisoni, Ronald L.; Nomura, Takanobu; Akiba, Takashi; Akizawa, Tadao; Kurokawa, Kiyoshi; Saito, Akira; Fukuhara, Shunichi; Inaba, Masaaki			Associations of employment status and educational levels with mortality and hospitalization in the dialysis outcomes and practice patterns study in Japan	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SOCIAL ADAPTABILITY INDEX; SOCIOECONOMIC-STATUS; HEMODIALYSIS-PATIENTS; INTERNATIONAL HEMODIALYSIS; MULTILEVEL ANALYSIS; ELDERLY POPULATION; INCOME INEQUALITY; HEALTH; DOPPS	Background Socioeconomic status (SES) factors such as employment, educational attainment, income, and marital status can affect the health and well-being of the general population and have been associated with the prevalence of chronic kidney disease (CKD). However, no studies to date in Japan have reported on the prognosis of patients with CKD with respect to SES. This study aimed to investigate the influences of employment and education level on mortality and hospitalization among maintenance hemodialysis (HD) patients in Japan. Methods Data on 7974 HD patients enrolled in Dialysis Outcomes and Practice Patterns Study phases 1-4 (1999-2011) in Japan were analysed. Employment status, education level, demographic data, and comorbidities were abstracted at entry into DOPPS from patient records. Mortality and hospitalization events were collected during follow-up. Patients on dialysis < 120 days at study entry were excluded from the analyses. Cox regression modelled the association between employment and both mortality and hospitalization among patients < 60 years old. The association between education and outcomes was also assessed. The association between patient characteristics and employment among patients < 60 years old was assessed using logistic regression. Results During a median follow-up of 24.9 months (interquartile range, 18.4-32.0), 10% of patients died and 43% of patients had an inpatient hospitalization. Unemployment was associated with mortality (hazard ratio [HR] = 1.57; 95% confidence interval [CI]: 1.05-2.36) and hospitalization (HR = 1.25; 95% CI: 1.08-1.44). Compared to patients who graduated from university, patients with less than a high school (HS) education and patients who graduated HS with some college tended to have elevated mortality (HR = 1.41; 95% CI, 1.04-1.92 and HR = 1.36; 95% CI: 1.02-1.82, respectively) but were not at risk for increased hospitalizations. Factors associated with unemployment included lower level of education, older age, female gender, longer vintage, and several comorbidities. Conclusions Employment and education status were inversely associated with mortality in patients on maintenance HD in Japan. Employment but not education was also inversely associated with hospitalizations. After adjustment for comorbidities, the associations with clinical outcomes tended to be stronger for employment than education status.	[Imanishi, Yasuo; Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka, Japan; [Fukuma, Shingo; Fukuhara, Shunichi] Kyoto Univ, Dept Healthcare Epidemiol, Sch Publ Hlth, Grad Sch Med, Kyoto, Japan; [Karaboyas, Angelo; Robinson, Bruce M.; Pisoni, Ronald L.] Arbor Res Collaborat Hlth, Ann Arbor, MI USA; [Robinson, Bruce M.] Univ Michigan, Ann Arbor, MI 48109 USA; [Nomura, Takanobu] Kyowa Hakko Kirin Co Ltd, Med Affairs, Kyowa, Tokyo, Japan; [Akiba, Takashi] Tokyo Womens Med Univ, Dept Blood Purificat & Internal Med, Kidney Ctr, Tokyo, Japan; [Akizawa, Tadao] Showa Univ, Sch Med, Div Nephrol, Dept Med, Tokyo, Japan; [Kurokawa, Kiyoshi] Natl Grad Inst Policy Studies, Tokyo, Japan; [Saito, Akira] Shonantobu Gen Hosp, Div Nephrol, Kanagawa, Japan; [Saito, Akira] Shonantobu Gen Hosp, Dialysis Ctr, Kanagawa, Japan; [Fukuhara, Shunichi] Fukushima Med Univ, Ctr Innovat Res Communities & Clin Excellence, Fukushima, Japan	Osaka Metropolitan University; Kyoto University; Arbor Research Collaborative for Health; University of Michigan System; University of Michigan; Kyowa Kirin Ltd; Tokyo Women's Medical University; Showa University; National Graduate Institute for Policy Studies; Fukushima Medical University	Imanishi, Y (corresponding author), Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka, Japan.	imanishi@med.osaka-cu.ac.jp			Amgen; Kyowa Hakko Kirin; AbbVie; Sanofi Renal; Baxter Healthcare; Vifor Fresenius Medical Care Renal Pharma; Keryx Biopharmaceuticals; Merck Sharp Dohme; Proteon Therapeutics; Relypsa; F. Hoffmann-LaRoche; BHC Medical; Janssen; Takeda; Hexal; DGfN; Shire; WiNe Institute; Japanese Society for Peritoneal Dialysis (JSPD); Kyowa Hakko Kirin, Co.Ltd.	Amgen(Amgen); Kyowa Hakko Kirin(Kyowa Kirin Ltd); AbbVie(AbbVie); Sanofi Renal; Baxter Healthcare; Vifor Fresenius Medical Care Renal Pharma; Keryx Biopharmaceuticals; Merck Sharp Dohme(Merck & Company); Proteon Therapeutics; Relypsa; F. Hoffmann-LaRoche(Hoffmann-La Roche); BHC Medical; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Takeda(Takeda Pharmaceutical Company Ltd); Hexal; DGfN; Shire; WiNe Institute; Japanese Society for Peritoneal Dialysis (JSPD); Kyowa Hakko Kirin, Co.Ltd.(Kyowa Kirin Ltd)	The DOPPS Program is supported by Amgen, Kyowa Hakko Kirin, AbbVie, Sanofi Renal, Baxter Healthcare, and Vifor Fresenius Medical Care Renal Pharma. Additional support for specific projects and countries is provided by Keryx Biopharmaceuticals, Merck Sharp & Dohme, Proteon Therapeutics, Relypsa, and F. Hoffmann-LaRoche; in Canada by Amgen, BHC Medical, Janssen, Takeda, and the Kidney Foundation of Canada (for logistics support); in Germany by Hexal, DGfN, Shire, and the WiNe Institute; and for PDOPPS in Japan by the Japanese Society for Peritoneal Dialysis (JSPD). All support is provided without restrictions on publications. Kyowa Hakko Kirin, Co.Ltd. provided support in the form of salaries for authors T.N., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1016/S0272-6386(03)00916-8; Edwards M, 2009, PATIENT EDUC COUNS, V75, P37, DOI 10.1016/j.pec.2008.09.025; Fedewa SA, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-136; Fored CM, 2003, NEPHROL DIAL TRANSPL, V18, P82, DOI 10.1093/ndt/18.1.82; Fujino Y, 2005, PREV MED, V40, P444, DOI 10.1016/j.ypmed.2004.07.002; Fukuda Y, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-53; Fukuda Y, 2004, SOC SCI MED, V59, P2435, DOI 10.1016/j.socscimed.2004.04.012; Giskes K, 2002, PUBLIC HEALTH NUTR, V5, P663, DOI 10.1079/PHN2002339; Goldfarb-Rumyantzev AS, 2010, NEPHROL DIAL TRANSPL, V25, P3672, DOI 10.1093/ndt/gfq177; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Gray L, 2009, PUBLIC HEALTH NUTR, V12, P1351, DOI 10.1017/S1368980008004047; Ishikawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040664; Kagamimori S, 2009, SOC SCI MED, V68, P2152, DOI 10.1016/j.socscimed.2009.03.030; Keita AD, 2009, J AM DIET ASSOC, V109, P1612, DOI 10.1016/j.jada.2009.06.373; Lopes AA, 2007, NEPHROL DIAL TRANSPL, V22, P3538, DOI 10.1093/ndt/gfm453; Lopes AA, 2010, J RENAL NUTR, V20, P224, DOI 10.1053/j.jrn.2009.10.002; Marinovich S, 2012, NEFROLOGIA, V32, P79, DOI 10.3265/Nefrologia.pre2011.Nov.11110; Marmot M, 2001, NEW ENGL J MED, V345, P134, DOI 10.1056/NEJM200107123450210; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; McClellan WM, 2010, AM J NEPHROL, V32, P38, DOI 10.1159/000313883; Merkin SS, 2007, SOC SCI MED, V65, P809, DOI 10.1016/j.socscimed.2007.04.011; Merkin SS, 2005, AM J KIDNEY DIS, V46, P203, DOI 10.1053/j.ajkd.2005.04.033; Pickett KE, 2015, PEDIATRICS, V135, pS39, DOI 10.1542/peds.2014-3549E; Pifer TB, 2002, KIDNEY INT, V62, P2238, DOI 10.1046/j.1523-1755.2002.00658.x; Pisoni RL, 2004, AM J KIDNEY DIS, V44, pS7, DOI 10.1053/j.ajkd.2004.08.005; Robinson BM, 2014, KIDNEY INT, V85, P158, DOI 10.1038/ki.2013.252; Robinson BM, 2009, CLIN J AM SOC NEPHRO, V4, pS12, DOI 10.2215/CJN.04720709; Sandhu GS, 2011, NEPHROL DIAL TRANSPL, V26, P2667, DOI 10.1093/ndt/gfq789; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Young EW, 2000, KIDNEY INT, V57, pS74, DOI 10.1046/j.1523-1755.2000.07413.x	30	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0170731	10.1371/journal.pone.0170731	http://dx.doi.org/10.1371/journal.pone.0170731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5OE	28264035	gold, Green Published, Green Submitted			2022-12-27	WOS:000396054300003
J	Bayat, M; Denis, M; Gregory, A; Mehrmohammadi, M; Kumar, V; Meixner, D; Fazzio, RT; Fatemi, M; Alizad, A				Bayat, Mahdi; Denis, Max; Gregory, Adriana; Mehrmohammadi, Mohammad; Kumar, Viksit; Meixner, Duane; Fazzio, Robert T.; Fatemi, Mostafa; Alizad, Azra			Diagnostic features of quantitative combpush shear elastography for breast lesion differentiation	PLOS ONE			English	Article							WAVE ELASTOGRAPHY; ULTRASOUND; US; MAMMOGRAPHY; BENIGN; MASSES	Background Lesion stiffness measured by shear wave elastography has shown to effectively separate benign from malignant breast masses. The aim of this study was to evaluate different aspects of Comb-push Ultrasound Shear Elastography (CUSE) performance in differentiating breast masses. Methods With written signed informed consent, this HIPAA-compliant, IRB approved prospective study included patients from April 2014 through August 2016 with breast masses identified on conventional imaging. Data from 223 patients (19 - 85 years, mean 59.93 +/- 14.96 years) with 227 suspicious breast masses identifiable by ultrasound (mean size 1.83 +/- 2.45cm) were analyzed. CUSE was performed on all patients. Three regions of interest (ROI), 3 mm in diameter each, were selected inside the lesion on the B-mode ultrasound which also appeared in the corresponding shear wave map. Lesion elasticity values were measured in terms of the Young's modulus. In correlation to pathology results, statistical analyses were performed. Results Pathology revealed 108 lesions as malignant and 115 lesions as benign. Additionally, 4 lesions (BI-RADS 2 and 3) were considered benign and were not biopsied. Average lesion stiffness measured by CUSE resulted in 84.26% sensitivity (91 of 108), 89.92% specificity (107 of 119), 85.6% positive predictive value, 89% negative predictive value and 0.91 area under the curve (P< 0.0001). Stiffness maps showed spatial continuity such that maximum and average elasticity did not have significantly different results (P > 0.21). Conclusion CUSE was able to distinguish between benign and malignant breast masses with high sensitivity and specificity. Continuity of stiffness maps allowed for choosing multiple quantification ROIs which covered large areas of lesions and resulted in similar diagnostic performance based on average and maximum elasticity. The overall results of this study, highlights the clinical value of CUSE in differentiation of breast masses based on their stiffness.	[Bayat, Mahdi; Gregory, Adriana; Mehrmohammadi, Mohammad; Kumar, Viksit; Fatemi, Mostafa; Alizad, Azra] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Denis, Max; Meixner, Duane; Fazzio, Robert T.; Alizad, Azra] Mayo Clin, Coll Med, Dept Radiol, Rochester, MN 55905 USA; [Alizad, Azra] Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA; [Mehrmohammadi, Mohammad] Wayne State Univ, Dept Biomed Engn, 42 W Warren Ave, Detroit, MI USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Wayne State University	Alizad, A (corresponding author), Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.; Alizad, A (corresponding author), Mayo Clin, Coll Med, Dept Radiol, Rochester, MN 55905 USA.; Alizad, A (corresponding author), Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA.	aza@mayo.edu		Fatemi, Mostafa/0000-0002-6603-9077; Alizad, Azra/0000-0002-7658-1572; Mehrmohammadi, Mohammad/0000-0002-9264-9354; Bayat, Mahdi/0000-0001-9069-0823	NIH-National Cancer Institute [R01CA148994, R01CA148994-S1, R01CA168575, R01EB017213, R01CA174723]; National Institute of Biomedical Imaging and Bioengineering [R01EB017213]; NATIONAL CANCER INSTITUTE [R01CA148994] Funding Source: NIH RePORTER	NIH-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by grants R01CA148994, R01CA148994-S1, R01CA168575, R01EB017213 and R01CA174723 from the NIH-National Cancer Institute and R01EB017213 from the National Institute of Biomedical Imaging and Bioengineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Institute of Ultrasound in Medicine, 2009, J Ultrasound Med, V28, P105; Athanasiou A, 2010, RADIOLOGY, V256, P297, DOI 10.1148/radiol.10090385; Barr RG, 2014, RADIOLOGY; Barr RG, 2012, J ULTRAS MED, V31, P347, DOI 10.7863/jum.2012.31.3.347; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Burnside ES, 2007, RADIOLOGY, V245, P401, DOI 10.1148/radiol.2452061805; Cosgrove DO, 2012, EUR RADIOL, V22, P1023, DOI 10.1007/s00330-011-2340-y; Denis M, 2015, PLOS ONE, V10; Denis M, 2015, IEEE T ULTRASON FERR, V62, P1644, DOI 10.1109/TUFFC.2015.007043; Evans A, 2012, BRIT J CANCER, V107, P224, DOI 10.1038/bjc.2012.253; Evans A, 2012, BR J CANC; Evans A, 2012, RADIOLOGY, V263, P673, DOI 10.1148/radiol.12111317; Evans A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2787; Gregory A, 2015, ENG MED BIOL SOC EMB; Gregory A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137898; Kolb TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667; Li G., 2013, PLOS ONE, V8; Mehrmohammadi M, 2015, COMB PUSH ULTRASOUND; Neetu G, 2010, CASE REP ONCOL, V3, P245, DOI 10.1159/000318641; Nightingale K, 2002, P 2002 IEEE INT S; Nothacker M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-335; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Schaefer FKW, 2011, EUR J RADIOL, V77, P450, DOI 10.1016/j.ejrad.2009.08.026; SEWELL CW, 1995, RADIOL CLIN N AM, V33, P1067; Song PF, 2015, IEEE T ULTRASON FERR, V62, P290, DOI 10.1109/TUFFC.2014.006628; Song PF, 2012, IEEE T MED IMAGING, V31, P1821, DOI 10.1109/TMI.2012.2205586; Tang L, 2015, INT J CLIN EXP MED, V8, P10920; Yao MH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/142504; Zhou JQ, 2014, RADIOLOGY, V272, P63, DOI 10.1148/radiol.14130818	32	26	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172801	10.1371/journal.pone.0172801	http://dx.doi.org/10.1371/journal.pone.0172801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257467	gold, Green Published, Green Submitted			2022-12-27	WOS:000396021100028
J	Celis, JS; Edgell, DR; Stelbrink, B; Wibberg, D; Hauffe, T; Blom, J; Kalinowski, J; Wilke, T				Celis, Juan Sebastian; Edgell, David R.; Stelbrink, Bjoern; Wibberg, Daniel; Hauffe, Torsten; Blom, Jochen; Kalinowski, Joern; Wilke, Thomas			Evolutionary and biogeographical implications of degraded LAGLIDADG endonuclease functionality and group I intron occurrence in stony corals (Scleractinia) and mushroom corals (Corallimorpharia)	PLOS ONE			English	Article							MITOCHONDRIAL COX1 GENE; HOMING ENDONUCLEASE; HORIZONTAL TRANSFER; GENOME; DNA; SEQUENCES; PROTEIN; REEF; METAZOAN; RNA	Group I introns and homing endonuclease genes (HEGs) are mobile genetic elements, capable of invading target sequences in intron-less genomes. LAGLIDADG HEGs are the largest family of endonucleases, playing a key role in the mobility of group I introns in a process known as 'homing'. Group I introns and HEGs are rare in metazoans, and can be mainly found inserted in the COXI gene of some sponges and cnidarians, including stony corals (Scleractinia) and mushroom corals (Corallimorpharia). Vertical and horizontal intron transfer mechanisms have been proposed as explanations for intron occurrence in cnidarians. However, the central role of LAGLIDADG motifs in intron mobility mechanisms remains poorly understood. To resolve questions regarding the evolutionary origin and distribution of group I introns and HEGs in Scleractinia and Corallimorpharia, we examined intron/HEGs sequences within a comprehensive phylogenetic framework. Analyses of LAGLIDADG motif conservation showed a high degree of degradation in complex Scleractinia and Corallimorpharia. Moreover, the two motifs lack the respective acidic residues necessary for metal-ion binding and catalysis, potentially impairing horizontal intron mobility. In contrast, both motifs are highly conserved within robust Scleractinia, indicating a fully functional endonuclease capable of promoting horizontal intron transference. A higher rate of non-synonymous substitutions (K-a) detected in the HEGs of complex Scleractinia and Corallimorpharia suggests degradation of the HEG, whereas lower K-a rates in robust Scleractinia are consistent with a scenario of purifying selection. Molecular-clock analyses and ancestral inference of intron type indicated an earlier intron insertion in complex Scleractinia and Corallimorpharia in comparison to robust Scleractinia. These findings suggest that the lack of horizontal intron transfers in the former two groups is related to an age-dependent degradation of the endonuclease activity. Moreover, they also explain the peculiar geographical patterns of introns in stony and mushroom corals.	[Celis, Juan Sebastian; Stelbrink, Bjoern; Hauffe, Torsten; Wilke, Thomas] Justus Liebig Univ, Anim Ecol & Systemat, Giessen, Hessen, Germany; [Celis, Juan Sebastian; Wilke, Thomas] Corp Ctr Excellence Marine Sci CEMarin, Bogota, Colombia; [Edgell, David R.] Western Univ, Sch Med & Dent, Dept Biochem, London, ON, Canada; [Wibberg, Daniel; Kalinowski, Joern] Univ Bielefeld, Inst Genome Res & Syst Biol CeBiTec, Dept Biochem, Bielefeld, Germany; [Blom, Jochen] Justus Liebig Univ, Bioinformat & Syst Biol, Giessen, Germany	Justus Liebig University Giessen; Western University (University of Western Ontario); University of Bielefeld; Justus Liebig University Giessen	Celis, JS (corresponding author), Justus Liebig Univ, Anim Ecol & Systemat, Giessen, Hessen, Germany.; Celis, JS (corresponding author), Corp Ctr Excellence Marine Sci CEMarin, Bogota, Colombia.	Juan.S.Celis-Melo@bio.uni-giessen.de	Wilke, Thomas/G-1517-2012; Edgell, David/AAJ-1971-2020; Stelbrink, Björn/Y-5023-2019	Wilke, Thomas/0000-0001-8263-7758; Stelbrink, Björn/0000-0002-7471-4992; Hauffe, Torsten/0000-0001-5711-9457	German Academic Exchange Service [A1372429]; Corporation Center of Excellence in Marine Sciences [80221287]	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Corporation Center of Excellence in Marine Sciences	JSC was funded jointly by the German Academic Exchange Service (Grant number A1372429. https://www.daad.de/en/) and the Corporation Center of Excellence in Marine Sciences (Grant Number 80221287. http://cemarin.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-161; Beagley CT, 1996, P NATL ACAD SCI USA, V93, P5619, DOI 10.1073/pnas.93.11.5619; Belfort Marlene, 2002, P761; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Burt A, 2006, GENES CONFLICT BIOL; CECH TR, 1994, NAT STRUCT BIOL, V1, P273, DOI 10.1038/nsb0594-273; Celis JS, 2016, MITOCHONDRIAL DNA A, V27, P3695, DOI 10.3109/19401736.2015.1079860; Chevalier B, 2005, NUCL ACID M, V16, P33; Cho YR, 1999, MOL BIOL EVOL, V16, P1155, DOI 10.1093/oxfordjournals.molbev.a026206; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; den Dunnen JT, 2016, HUM MUTAT, V37, P564, DOI 10.1002/humu.22981; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgell DR, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-22; Edgell DR, 2009, CURR BIOL, V19, pR115, DOI 10.1016/j.cub.2008.12.019; Edgell DR, 2003, CURR BIOL, V13, P973, DOI 10.1016/S0960-9822(03)00340-3; Emblem A, 2014, MOL PHYLOGENET EVOL, V75, P184, DOI 10.1016/j.ympev.2014.02.016; Fluegel Erik, 2002, P391; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fukami H, 2005, CORAL REEFS, V24, P410, DOI 10.1007/s00338-005-0023-3; Fukami H, 2007, J MOL EVOL, V64, P591, DOI 10.1007/s00239-006-0279-4; Goddard MR, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000003; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Haugen P, 2004, NUCLEIC ACIDS RES, V32, P2049, DOI 10.1093/nar/gkh520; Hausner G, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-8; Huchon D, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0556-1; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kiessling W, 2011, GLOBAL CHANGE BIOL, V17, P56, DOI 10.1111/j.1365-2486.2010.02204.x; Kiessling W, 2009, PALAIOS, V24, P657, DOI 10.2110/palo.2009.p09-030r; Kitahara MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094774; Kitahara MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011490; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Koufopanou V, 2002, MOL BIOL EVOL, V19, P239, DOI 10.1093/oxfordjournals.molbev.a004077; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LAMBOWITZ AM, 1990, TRENDS BIOCHEM SCI, V15, P440, DOI 10.1016/0968-0004(90)90283-H; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leprieur F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11461; Lin MF, 2014, GENOME BIOL EVOL, V6, P1086, DOI 10.1093/gbe/evu084; LOIZOS N, 1994, P NATL ACAD SCI USA, V91, P11983, DOI 10.1073/pnas.91.25.11983; Lucas P, 2001, NUCLEIC ACIDS RES, V29, P960, DOI 10.1093/nar/29.4.960; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Miller M.A., 2010, P GAT COMP ENV WORKS; NEI M, 1986, MOL BIOL EVOL, V3, P418; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2013, R LANG ENV STAT COMP; Rambaut A., TRACER V 1 5; Renema W, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500850; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Roman J, 1998, P NATL ACAD SCI USA, V95, P2134, DOI 10.1073/pnas.95.5.2134; Romano SL, 2000, B MAR SCI, V67, P1043; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Roy AC, 2016, NUCLEIC ACIDS RES, V44, P7350, DOI 10.1093/nar/gkw614; Sandegren L, 2005, NUCLEIC ACIDS RES, V33, P6203, DOI 10.1093/nar/gki932; Scalley-Kim M, 2007, J MOL BIOL, V372, P1305, DOI 10.1016/j.jmb.2007.07.052; Simpson C, 2011, EVOLUTION, V65, P3274, DOI 10.1111/j.1558-5646.2011.01365.x; Stoddard BL, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-7; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Stolarski J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-316; Swithers KS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-303; Szitenberg A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-288; Wang XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002723	69	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173734	10.1371/journal.pone.0173734	http://dx.doi.org/10.1371/journal.pone.0173734			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278261	Green Submitted, gold, Green Published			2022-12-27	WOS:000396087900035
J	Rizos, G; Papadopoulos, S; Kompatsiaris, Y				Rizos, Georgios; Papadopoulos, Symeon; Kompatsiaris, Yiannis			Multilabel user classification using the community structure of online networks	PLOS ONE			English	Article							ALGORITHM	We study the problem of semi-supervised, multi-label user classification of networked data in the online social platform setting. We propose a framework that combines unsupervised community extraction and supervised, community-based feature weighting before training a classifier. We introduce Approximate Regularized Commute-Time Embedding (ARCTE), an algorithm that projects the users of a social graph onto a latent space, but instead of packing the global structure into a matrix of predefined rank, as many spectral and neural representation learning methods do, it extracts local communities for all users in the graph in order to learn a sparse embedding. To this end, we employ an improvement of personalized PageRank algorithms for searching locally in each user's graph structure. Then, we perform supervised community feature weighting in order to boost the importance of highly predictive communities. We assess our method performance on the problem of user classification by performing an extensive comparative study among various recent methods based on graph embeddings. The comparison shows that ARCTE significantly outperforms the competition in almost all cases, achieving up to 35% relative improvement compared to the second best competing method in terms of F1-score.	[Rizos, Georgios; Papadopoulos, Symeon; Kompatsiaris, Yiannis] CERTH, Inst Informat Technol, Thermi, Greece	Centre for Research & Technology Hellas	Rizos, G (corresponding author), CERTH, Inst Informat Technol, Thermi, Greece.	georgerizos@iti.gr	Papadopoulos, Symeon/AET-0683-2022; Kompatsiaris, Ioannis/P-8594-2015	Kompatsiaris, Ioannis/0000-0001-6447-9020; Papadopoulos, Symeon/0000-0002-5441-7341; Rizos, Georgios/0000-0003-2483-5574	Community Research and Development Information Service of the European Commission [610928]	Community Research and Development Information Service of the European Commission	GR, SP and YK received support from the Community Research and Development Information Service of the European Commission under the contract number 610928. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel F, 2011, LECT NOTES COMPUT SC, V7031, P1, DOI 10.1007/978-3-642-25073-6_1; Andersen R, 2006, ANN IEEE SYMP FOUND, P475; [Anonymous], J STAT MECH THEORY E; Avrachenkov K., 2012, P SIAM C DAT MIN SDM, V9; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Bhattacharya P., 2014, P 17 ACM C COMP SUPP, P197, DOI DOI 10.1145/2531602.2531636; Bonchi F, 2012, INTERNET MATH, V8, P73, DOI 10.1080/15427951.2012.625256; Chi EH, 2008, INFORM SEEKING CAN B; Deng ZH, 2004, LECT NOTES COMPUT SC, V3007, P588; Devooght R, 2014, WWW'14: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P213, DOI 10.1145/2566486.2567986; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fouss F, 2012, NEURAL NETWORKS, V31, P53, DOI 10.1016/j.neunet.2012.03.001; Ghosh S., 2012, P 21 INT C WORLD WID, P61, DOI DOI 10.1145/2187836.2187846; Greene D., 2013, P WEBSCI 2013, P1; Greene D., 2012, P 4 ACM RECSYS WORKS, P29, DOI [10.1145/2365934.2365941, DOI 10.1145/2365934.2365941]; Gupta P., 2013, P 22 INT C WORLD WID, P505, DOI [DOI 10.1145/2488388.2488433, 10.1145/2488388.2488433]; Haveliwava T. H., 2002, P 11 INT C WORLD WID, P517, DOI [DOI 10.1145/511446.511513, 10.1145/511446.511513]; Henderson K., 2012, P 18 ACM SIGKDD INT, P1231; Hu X, 2013, 23 INT JOINT C ART I, P2633; Hu X., 2009, P CIKM, V18, P919, DOI DOI 10.1145/1645953.1646071; Jeh G., 2002, P 8 ACM SIGKDD INT C, P538; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lehoucq R.B., 1998, ARPACK USERS GUIDE S, V6; Li J., 2016, ARXIV160107996; Lin F, 2008, ICWSM; Lu Q., 2003, P 20 INT C MACH LEAR, P496, DOI DOI 10.5555/3041838.3041901; Macskassy SA, 2003, DTIC DOCUMENT; Macskassy SA, 2007, J MACH LEARN RES, V8, P935; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mislove A., 2010, P 3 ACM INT C WEB SE, P251, DOI DOI 10.1145/1718487.1718519; Mislove A, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P29; O'Callaghan D, 2014, ARXIV14017535; OCallaghan D., 2013, PROC 5 ANN ACM WEB S, P276, DOI [10.1145/2464464.2464495, DOI 10.1145/2464464.2464495]; Papadimitriou A, 2012, J SYST SOFTWARE, V85, P2119, DOI 10.1016/j.jss.2012.04.019; Papadopoulos S, 2014, SNOW DC WWW, P1; Papadopoulos S, 2012, DATA MIN KNOWL DISC, V24, P515, DOI 10.1007/s10618-011-0224-z; Pennacchiotti M., 2011, P 17 ACM SIGKDD INT, P430, DOI DOI 10.1145/2020408.2020477; Perozzi Bryan, 2014, KDD, P701, DOI DOI 10.1145/2623330.2623732; Sen P, 2008, AI MAG, V29, P93, DOI 10.1609/aimag.v29i3.2157; Sharma N, 2012, ACM SIGCOMM COMP COM, V42, P533, DOI 10.1145/2377677.2377782; Smith LM, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042813; Spielman DA, 2008, ARXIV08093232; Spielman DA, 2011, SIAM J COMPUT, V40, P981, DOI 10.1137/08074489X; Tang J, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P1067, DOI 10.1145/2736277.2741093; Tang L., 2009, P 18 ACM C INFORM KN, P1107; Tang L, 2011, DATA MIN KNOWL DISC, V23, P447, DOI 10.1007/s10618-010-0210-x; Tang L, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P817; Teng S., 2006, CS0607105 ARXIV; Tsoumakas G., 2007, INT J DATA WAREHOUS, V3, P1; Wagner C, 2013, 2013 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM), P303, DOI 10.1109/SocialCom.2013.49; Wang XF, 2013, KNOWL INF SYST, V36, P517, DOI 10.1007/s10115-012-0555-0; Whang JJ, 2013, PROCEEDINGS OF THE 22ND ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM'13), P2099, DOI 10.1145/2505515.2505535; Yang Jaewon, 2013, P 6 ACM INT C WEB SE, P587, DOI [DOI 10.1145/2433396.2433471, 10.1145/2433396.2433471]; Yang Y, 1997, ICML, P412, DOI DOI 10.1093/BI0INF0RMATICS/BTH267; Zhang YD, 2011, DIGIT SIGNAL PROCESS, V21, P517, DOI 10.1016/j.dsp.2011.02.004; Zhou D., 2005, P 22 INT C MACH LEAR, P1036, DOI DOI 10.1145/1102351.1102482	58	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173347	10.1371/journal.pone.0173347	http://dx.doi.org/10.1371/journal.pone.0173347			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278242	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900074
J	Takahara, I; Akazawa, Y; Tabuchi, M; Matsuda, K; Miyaaki, H; Kido, Y; Kanda, Y; Taura, N; Ohnita, K; Takeshima, F; Sakai, Y; Eguchi, S; Nakashima, M; Nakao, K				Takahara, Ikuko; Akazawa, Yuko; Tabuchi, Maiko; Matsuda, Katsuya; Miyaaki, Hisamitsu; Kido, Youko; Kanda, Yasuko; Taura, Naota; Ohnita, Ken; Takeshima, Fuminao; Sakai, Yusuke; Eguchi, Susumu; Nakashima, Masahiro; Nakao, Kazuhiko			Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice	PLOS ONE			English	Article							TRANSCRIPTION FACTOR XBP1; ER STRESS; SIGNALING PATHWAY; MESSENGER-RNA; STEATOHEPATITIS; LIPOAPOPTOSIS; CELLS; LIPOGENESIS; OBESITY; BIM	Background and aims A high serum level of saturated free fatty acids (FFAs) is associated with the development of nonalcoholic fatty liver disease (NAFLD). X-box binding protein-1 (XBP-1) is activated by FFA treatment upon splicing. XBP-1 is a transcription factor induced by the endoplasmic reticulum (ER) stress sensor endoribonuclease inositol-requiring enzyme 1 alpha (IRE1 alpha). However, the role of XBP-1 in NAFLD remains relatively unexplored. Toyocamycin was recently reported to attenuate the activation of XBP-1, possibly by inducing a conformational change in IRE1 alpha. In this study, we examined the effect of toyocamycin on hepatocyte lipoapoptosis and steatosis. We also explored the effects of toyocamycin in a mouse model of NAFLD. Methods Huh-7 cells and isolated rat primary hepatocytes were treated with palmitic acid (PA), which is a saturated FFA, in the presence or absence of toyocamycin. In addition, male C57BL/6J mice were fed a diet rich in saturated fat, fructose, and cholesterol (FFC) for 4 months, after which the effect of toyocamycin was assessed. Results Toyocamycin attenuated FFA-induced steatosis. It also significantly reduced PA-induced hepatocyte lipoapoptosis. In addition, toyocamycin reduced the expression of cytosine-cytosine-adenosine-adenosine-thymidine enhancer-binding protein homologous protein (CHOP), which is a key player in ER stress-mediated apoptosis, as well as its downstream cell death modulator, death receptor 5. In the in vivo study, toyocamycin ameliorated the liver injury caused by FFC-induced NAFLD. It also reduced hepatic steatosis and the expression of lipogenic genes. Conclusions The data we obtained suggest that toyocamycin attenuates hepatocyte lipogenesis and ameliorates NAFLD in vivo and may therefore be beneficial in the treatment of NAFLD in humans.	[Takahara, Ikuko; Akazawa, Yuko; Tabuchi, Maiko; Miyaaki, Hisamitsu; Kido, Youko; Kanda, Yasuko; Taura, Naota; Ohnita, Ken; Takeshima, Fuminao; Nakao, Kazuhiko] Nagasaki Univ, Sch Med, Div Gastroenterol & Hepatol, Nagasaki, Japan; [Matsuda, Katsuya; Nakashima, Masahiro] Nagasaki Univ, Atom Bomb Dis Inst, Dept Tumor & Diagnost Pathol, Nagasaki, Japan; [Sakai, Yusuke; Eguchi, Susumu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Akazawa, Y (corresponding author), Nagasaki Univ, Sch Med, Div Gastroenterol & Hepatol, Nagasaki, Japan.	akazaway@nagasaki-u.ac.jp		Eguchi, Susumu/0000-0002-7876-0152; Sakai, Yusuke/0000-0001-7999-9731	Japan Society for the Promotion of Science (JSPS) Kakenhi [24790709]	Japan Society for the Promotion of Science (JSPS) Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science (JSPS) Kakenhi [grant numbers 24790709 YA] https://www.jsps.go.jp/english/index.html.r We thank Mr. Tsutomu Kanda for his excellent support during the study. This study was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI [grant number 24790709 YA].	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Cao J, 2012, MOL CELL BIOCHEM, V364, P115, DOI 10.1007/s11010-011-1211-9; Cazanave SC, 2011, J BIOL CHEM, V286, P39336, DOI 10.1074/jbc.M111.280420; Cazanave SC, 2009, HEPATOLOGY, V50, P1009, DOI 10.1002/hep.23188; Cazanave SC, 2009, J BIOL CHEM, V284, P26591, DOI 10.1074/jbc.M109.022491; Charlton M, 2011, AM J PHYSIOL-GASTR L, V301, pG825, DOI 10.1152/ajpgi.00145.2011; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Feldstein AE, 2006, AM J PHYSIOL-GASTR L, V290, pG1339, DOI 10.1152/ajpgi.00509.2005; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Franca LM, 2014, BIOCHEM BIOPH RES CO, V443, P725, DOI 10.1016/j.bbrc.2013.12.042; Glimcher LH, 2009, ANN NY ACAD SCI, V1173, pE2, DOI 10.1111/j.1749-6632.2009.04956.x; Hirsova P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070599; Hu FL, 2011, EUR J IMMUNOL, V41, P1086, DOI 10.1002/eji.201040831; Ibrahim SH, 2014, LIVER INT, V34, P427, DOI 10.1111/liv.12353; Ibrahim SH, 2011, J HEPATOL, V54, P765, DOI 10.1016/j.jhep.2010.09.039; Kakazu E, 2015, J LIPID RES; Kitai Y, 2013, GENES CELLS, V18, P798, DOI 10.1111/gtc.12074; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Liu XY, 2015, AM J PHYSIOL-GASTR L, V309, pG965, DOI 10.1152/ajpgi.00132.2015; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Mhaidat NM, 2015, J CHEMOTHER; Ning J, 2011, ENDOCRINOLOGY, V152, P2247, DOI 10.1210/en.2010-1036; Olivares S, 2015, J BIOL CHEM; OSADA H, 1989, J ANTIBIOT, V42, P102, DOI 10.7164/antibiotics.42.102; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rajapaksa G., 2014, ONCOGENE; Reimold AM, 2000, GENE DEV, V14, P152; Ri M, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.26; Rinella Mary E, 2011, Hepatology, V54, P1600, DOI 10.1002/hep.24553; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Sharma M, 2012, J HEPATOL, V56, P192, DOI 10.1016/j.jhep.2011.03.019; Ye DW, 2012, GUT, V61, P1058, DOI 10.1136/gutjnl-2011-300269; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	39	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0170591	10.1371/journal.pone.0170591	http://dx.doi.org/10.1371/journal.pone.0170591			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278289	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900107
J	Chowdhury, R; Taneja, S; Bhandari, N; Sinha, B; Upadhyay, RP; Bhan, MK; Strand, TA				Chowdhury, Ranadip; Taneja, Sunita; Bhandari, Nita; Sinha, Bireshwar; Upadhyay, Ravi Prakash; Bhan, Maharaj Kishan; Strand, Tor A.			Vitamin-D deficiency predicts infections in young north Indian children: A secondary data analysis	PLOS ONE			English	Article							LOWER RESPIRATORY-INFECTION; ZINC SUPPLEMENTATION; CHILDHOOD DIARRHEA; PNEUMONIA; MALNUTRITION; NUTRITION; RECEPTOR; DISEASE; RISK	Background Recent studies have demonstrated a relationship between poor vitamin D status and respiratory infections and diarrhea among young children. Acute lower respiratory infections (ALRI) and diarrhea are among the two most important causes of death in under-5 children. In this paper, we examined the extent to which vitamin-D deficiency (<10 ng/ml) predicts ALRI, clinical pneumonia and diarrhea among 6 to 30 months old children. Methods We used data from a randomized controlled trial (RCT) of daily folic acid and/or vitamin B12 supplementation for six months in 6 to 30 months old children conducted in Delhi, India. Generalized estimating equations (GEE) were used to examine the associations between vitamin-D deficiency and episodes of ALRI, clinical pneumonia and diarrhea. Results Of the 960 subjects who had vitamin-D concentrations measured, 331(34.5%) were vitamin-D deficient. We found, after controlling for relevant potential confounders (age, sex, breastfeeding status, wasting, stunting, underweight, anemia status and season), that the risk of ALRI was significantly higher among vitamin-D deficient (OR 1.26; 95% CI: 1.03 to 1.55) compared to vitamin-D-replete children in the six months follow-up period. Vitamin-D status was not associated with episodes of diarrhea or clinical pneumonia. Conclusion Vitamin-D deficiency is common in young children in New Delhi and is associated with a higher risk of ALRI. The role of vitamin D in Indian children needs to be elucidated in further studies.	[Chowdhury, Ranadip; Taneja, Sunita; Bhandari, Nita; Sinha, Bireshwar; Upadhyay, Ravi Prakash] Soc Appl Studies, Ctr Hlth Res & Dev, New Delhi, India; [Bhan, Maharaj Kishan] Indian Inst Technol Delhi, New Delhi, India; [Bhan, Maharaj Kishan] BIRAC, Knowledge Integrat & Translat Platform KnIT, New Delhi, India; [Strand, Tor A.] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth, Ctr Int Hlth, Bergen, Norway; [Strand, Tor A.] Innlandet Hosp Trust, Dept Res, Brumunddal, Norway	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Biotechnology Industry Research Assistance Council (BIRAC); University of Bergen; Innlandet Hospital Trust	Chowdhury, R (corresponding author), Soc Appl Studies, Ctr Hlth Res & Dev, New Delhi, India.	ranadip.chowdhury@sas.org.in	Strand, Tor/D-9836-2016; Chowdhury, Ranadip/P-2416-2019	Strand, Tor/0000-0002-4038-151X; Chowdhury, Ranadip/0000-0002-0055-6653	Centre for Intervention Science in Maternal and Child Health (CISMAC GRANTS) [250216, 223269]; Research Council of Norway through its Centres of Excellence scheme; University of Bergen (UiB), Norway; South-Eastern Norway Regional Health Authority [2012090]; Thrasher Research Fund [9144]; Centre for Intervention Science in Maternal and Child Health (RCN Project) [223269]; Centre for International Health, University of Bergen (Norway); Knowledge Integration and Technology Platform (KnIT); Grand Challenges Initiative of the Department of Biotechnology and Biotechnology Industry Research Assistance Council (BIRAC) of Government of India; Bill & Melinda Gates Foundation (USA); Centre for Intervention Science in Maternal and Child Health (CISMAC) [223269]	Centre for Intervention Science in Maternal and Child Health (CISMAC GRANTS); Research Council of Norway through its Centres of Excellence scheme; University of Bergen (UiB), Norway; South-Eastern Norway Regional Health Authority; Thrasher Research Fund; Centre for Intervention Science in Maternal and Child Health (RCN Project); Centre for International Health, University of Bergen (Norway); Knowledge Integration and Technology Platform (KnIT); Grand Challenges Initiative of the Department of Biotechnology and Biotechnology Industry Research Assistance Council (BIRAC) of Government of India; Bill & Melinda Gates Foundation (USA)(Bill & Melinda Gates Foundation); Centre for Intervention Science in Maternal and Child Health (CISMAC)	The study was supported by grants from the Centre for Intervention Science in Maternal and Child Health (CISMAC GRANTS 250216) (CISMAC; project number 223269), which is funded by the Research Council of Norway through its Centres of Excellence scheme and the University of Bergen (UiB), Norway. The implementation of the main trial was supported by grants from the South-Eastern Norway Regional Health Authority (grant no. 2012090) and Thrasher Research Fund (grant no. 9144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the input from Ratnasamy Selvakumar, Department of Biochemistry from Christian Medical College, Vellore, India for biochemical analysis. The Society for Applied Studies acknowledges the core support provided by the Department of Maternal, Newborn, Child and Adolescent Health, World Health Organisation, Geneva (WHO Collaborating Centre IND-096) and the Centre for Intervention Science in Maternal and Child Health (RCN Project No. 223269), Centre for International Health, University of Bergen (Norway). We also acknowledge the support extended by the Knowledge Integration and Technology Platform (KnIT), a Grand Challenges Initiative of the Department of Biotechnology and Biotechnology Industry Research Assistance Council (BIRAC) of Government of India and Bill & Melinda Gates Foundation (USA). We also acknowledge Centre for Intervention Science in Maternal and Child Health (CISMAC; project number 223269), which is funded by the Research Council of Norway through its Centres of Excellence scheme and the University of Bergen (UiB), Norway. The implementation of the main trial was supported by grants from the South-Eastern Norway Regional Health Authority (grant no. 2012090) and Thrasher Research Fund (grant no. 9144).	Abba K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-88; Ahmed AMS, 2016, EUR J CLIN NUTR, V70, P620, DOI 10.1038/ejcn.2016.7; Aluisio AR, 2013, PEDIATRICS, V132, pE832, DOI 10.1542/peds.2012-3986; Bhandari N, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e86; Bhandari N, 2002, BRIT MED J, V324, P1358, DOI 10.1136/bmj.324.7350.1358; Bhutta ZA, 2013, PEDIATRICS, V131, P634, DOI 10.1542/peds.2012-3737; Bikle DD, 2008, CURR OPIN NEPHROL HY, V17, P348, DOI 10.1097/MNH.0b013e3282ff64a3; Cantorna MT, 2000, P SOC EXP BIOL MED, V223, P230, DOI 10.1046/j.1525-1373.2000.22333.x; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Costelloe SJ, 2009, ANN CLIN BIOCHEM, V46, P86, DOI 10.1258/acb.2008.008157; Craig TA, 2001, RAPID COMMUN MASS SP, V15, P1011, DOI 10.1002/rcm.332; El Sakka AS, 2014, EGYPT PEDIATR ASSO, V62, P1, DOI 10.1016/j.epag.2013.12.001; Esposito S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1196-1; Fischer Walker Christa L, 2012, BMC Public Health, V12, P220, DOI 10.1186/1471-2458-12-220; Gopalan C, 1996, NUTR VALUE INDIAN FO, P45; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Harinarayan C V, 2009, J Assoc Physicians India, V57, P40; Harinarayan CV, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.23873; Holick MF, 2010, ENDOCRIN METAB CLIN, V39, P381, DOI [10.1016/j.rdc.2012.03.013, 10.1016/j.ecl.2010.02.016]; Hollis BW, 2015, PEDIATRICS, V136, P625, DOI 10.1542/peds.2015-1669; Hollis BW, 2004, J CLIN ENDOCR METAB, V89, P3149, DOI 10.1210/jc.2004-0682; Hughes DA, 2009, CLIN EXP IMMUNOL, V158, P20, DOI 10.1111/j.1365-2249.2009.04001.x; Kamen DL, 2010, J MOL MED BERL, V88, P50; Karatekin G, 2009, EUR J CLIN NUTR, V63, P473, DOI 10.1038/sj.ejcn.1602960; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Lamberg-Allardt C, 2006, PROG BIOPHYS MOL BIO, V92, P33, DOI 10.1016/j.pbiomolbio.2006.02.017; Lassi ZS, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005978.pub3; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mayo-Wilson E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009384.pub2; Mayo-Wilson E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5094; Muhe L, 1997, LANCET, V349, P1801, DOI 10.1016/S0140-6736(96)12098-5; Norris JM, 2001, LANCET, V358, P1476, DOI 10.1016/S0140-6736(01)06570-9; Pichler J, 2002, PEDIATR RES, V52, P12, DOI 10.1203/01.PDR.0000017267.23950.48; Puri S, 2008, BRIT J NUTR, V99, P876, DOI 10.1017/S0007114507831758; Quraishi SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081120; Ren Jing, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P519; Ritu G, 2014, NUTRIENTS, V6, P729, DOI 10.3390/nu6020729; Rodriguez L, 2011, INT J ENV RES PUB HE, V8, P1174, DOI 10.3390/ijerph8041174; Roth DE, 2010, ACTA PAEDIATR, V99, P389, DOI 10.1111/j.1651-2227.2009.01594.x; Roth DE, 2009, EUR J CLIN NUTR, V63, P297, DOI 10.1038/sj.ejcn.1602946; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Spiro A, 2014, NUTR BULL, V39, P322, DOI 10.1111/nbu.12108; Sun J, 2010, CURR OPIN GASTROEN, V26, P591, DOI 10.1097/MOG.0b013e32833d4b9f; Taneja S, 2013, AM J CLIN NUTR, V98, P731, DOI 10.3945/ajcn.113.059592; Thornton KA, 2013, PEDIATR INFECT DIS J, V32, P585, DOI 10.1097/INF.0b013e3182868989; Ulak M, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030149; Wayse V, 2004, EUR J CLIN NUTR, V58, P563, DOI 10.1038/sj.ejcn.1601845; Wei R, 2015, NUTRIENTS, V7, P8251, DOI 10.3390/nu7105392; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240; World Health Organization, 2003, INT MAN CHILDH ILLN; Yakoob MY, 2016, COCHRANE DB SYST REV, V11, DOI [10.1002/14651858.CD008824.pub2, DOI 10.1002/14651858.CD008824.PUB2]	52	14	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0170509	10.1371/journal.pone.0170509	http://dx.doi.org/10.1371/journal.pone.0170509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273084	gold, Green Submitted, Green Published			2022-12-27	WOS:000396073700091
J	Rosique-Esteban, N; Diaz-Lopez, A; Martinez-Gonzalez, MA; Corella, D; Goday, A; Martinez, JA; Romaguera, D; Vioque, J; Aros, F; Garcia-Rios, A; Tinahones, F; Estruch, R; Fernandez-Garcia, JC; Lapetra, J; Serra-Majem, L; Pinto, X; Tur, JA; Bueno-Cavanillas, A; Vidal, J; Delgado-Rodriguez, M; Daimiel, L; Vazquez, C; Rubio, MA; Ros, E; Salas-Salvado, J				Rosique-Esteban, Nuria; Diaz-Lopez, Andres; Martinez-Gonzalez, Miguel A.; Corella, Dolores; Goday, Albert; Alfredo Martinez, J.; Romaguera, Dora; Vioque, Jesus; Aros, Fernando; Garcia-Rios, Antonio; Tinahones, Francisco; Estruch, Ramon; Carlos Fernandez-Garcia, Jose; Lapetra, Jose; Serra-Majem, Luis; Pinto, Xavier; Tur, Josep A.; Bueno-Cavanillas, Aurora; Vidal, Josep; Delgado-Rodriguez, Miguel; Daimiel, Lidia; Vazquez, Clotilde; Angel Rubio, Miguel; Ros, Emilio; Salas-Salvado, Jordi		PREDIMED-PLUS Investigators	Leisure-time physical activity, sedentary behaviors, sleep, and cardiometabolic risk factors at baseline in the PREDIMED-PLUS intervention trial: A cross-sectional analysis	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; HEALTH OUTCOMES; SITTING TIME; ADULTS; ASSOCIATIONS; OBESITY; TELEVISION; MORTALITY; METAANALYSIS; DURATION	Limited data exists on the interrelationships between physical activity (PA), sedentary behaviors and sleep concerning cardiometabolic risk factors in aged adults at high cardiovascular disease risk. Our aim was to examine independent and joint associations between time spent in leisure-time PA, sedentary behaviors and sleep on the prevalence of obesity, type 2 diabetes (T2D) and components of the metabolic syndrome (MetS) in Mediterranean individuals at high cardiovascular risk. Cross-sectional analyses were performed on baseline data from 5776 Spanish adults (aged 55-75y in men; 60-75y in women) with overweight/ obesity and MetS, from October 2013 to October 2016, in the PREDIMED-PLUS trial. Employing multivariable-adjusted Cox regression with robust variance and constant time (given the cross-sectional design), higher prevalence of obesity, T2D and abdominal obesity as component of the MetS were associated with greater time in TV-viewing (Relative Risk, RR: 1.02, 95%Cl: 1.01, 1.03; RR:1.04, 95`)/X1: 1.02, 1.06 and RR: 1.01 95`)/X1: 1.00, 1.02; respectively, all P<.01). Conversely, greater time in moderate-vigorous PA (MVPA) was associated with lower prevalence of obesity, T2D, abdominal obesity and low HDL-cholesterol (RR: 0.95, 95%Cl: 0.93, 0.97; RR: 0.94, 95%Cl: 0.89, 0.99; RR: 0.97, 95%Cl: 0.96, 0.98; and RR: 0.95, 95%Cl: 0.91, 0.99, respectively, all P<.05). For these outcomes, theoretically substituting 1-h/day of MVPA for 1-h/day TV-viewing was also significantly associated with lower prevalence (RR 0.91 to 0.97, all P <.05). Similar lower RR in these outcomes was observed when substituting 1-h/day of MVPA for 1-h/day of sleeping. Longer time watching TV and not meeting MVPA recommendations were jointly associated with higher RR of the prevalence of obesity and T2D. We concluded that, in senior individuals at high cardiovascular risk, greater time spent on MVPA and fewer on sedentary behaviors was inversely associated with prevalence of obesity, T2D, and some of the components of MetS.	[Rosique-Esteban, Nuria; Diaz-Lopez, Andres; Salas-Salvado, Jordi] Univ Rovira & Virgili, Human Nutr Unit, Univ Hosp St Joan de Reus, Dept Biochem & Biotechnol,Pere Virgili Inst Hlth, Reus, Spain; [Rosique-Esteban, Nuria; Diaz-Lopez, Andres; Martinez-Gonzalez, Miguel A.; Corella, Dolores; Goday, Albert; Alfredo Martinez, J.; Romaguera, Dora; Aros, Fernando; Garcia-Rios, Antonio; Tinahones, Francisco; Estruch, Ramon; Carlos Fernandez-Garcia, Jose; Lapetra, Jose; Serra-Majem, Luis; Pinto, Xavier; Tur, Josep A.; Vazquez, Clotilde; Ros, Emilio; Salas-Salvado, Jordi] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain; [Martinez-Gonzalez, Miguel A.] Univ Navarra, Navarra Inst Hlth Res, Dept Prevent Med & Publ Hlth, Pamplona, Spain; [Corella, Dolores] Univ Valencia, Dept Prevent Med, Valencia, Spain; [Goday, Albert] Univ Autonoma Barcelona, Dept Med, Hosp del Mar, Serv Endocrinol, Barcelona, Spain; [Alfredo Martinez, J.] Univ Navarra, Ctr Nutr Res, Dept Nutr Food Sci & Physiol, Pamplona, Spain; [Romaguera, Dora] Univ Hosp Son Espases, Inst Invest Sanitaria Palma IdISPa, Palma De Mallorca, Spain; [Vioque, Jesus] Univ Miguel Hernandez, Alicante, Spain; [Vioque, Jesus; Bueno-Cavanillas, Aurora] Inst Salud Carlos III, CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Aros, Fernando] Univ Hosp Araba, Dept Cardiol, Vitoria, Spain; [Garcia-Rios, Antonio] Univ Cordoba, Lipids & Atherosclerosis Unit, Dept Internal Med, Reina Sofia Univ Hosp,IMIBIC, Cordoba, Spain; [Tinahones, Francisco] Univ Malaga, Virgen de la Victoria Hosp, Dept Endocrinol & Nutr, Malaga, Spain; [Estruch, Ramon] Univ Barcelona, IDIBAPS, August Pi & Sunyer Biomed Res Inst, Dept Internal Med,Hosp Clin, Barcelona, Spain; [Carlos Fernandez-Garcia, Jose] Univ Malaga, Fac Ciencias Educ, Inst Invest Biomed Malaga IBIMA, Malaga, Spain; [Lapetra, Jose] Dist Sanitario Atenc Primaria Sevilla, Dept Family Med, Seville, Spain; [Serra-Majem, Luis] Univ Las Palmas Gran Canaria, Res Inst Biomed & Hlth Sci, Las Palmas Gran Canaria, Spain; [Pinto, Xavier] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Lipid Unit, Dept Internal Med, Barcelona, Spain; [Tur, Josep A.] Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain; [Bueno-Cavanillas, Aurora] Univ Granada, Dept Prevent Med & Publ Hlth, Granada, Spain; [Vidal, Josep] Hosp Clin Barcelona, Dept Endocrinol & Nutr, Barcelona, Spain; [Vidal, Josep] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain; [Delgado-Rodriguez, Miguel] Univ Jaen, Dept Hlth Sci, Jaen, Spain; [Delgado-Rodriguez, Miguel] Inst Salud Carlos III, CIBERESP, Madrid, Spain; [Daimiel, Lidia] CNIC, Dept Cardiovasc Epidemiol & Populat Genet, Madrid, Spain; [Daimiel, Lidia] Food Inst, Madrid Inst Adv Studies IMDEA, Madrid, Spain; [Vazquez, Clotilde] Fdn Jimenez Diaz, Univ Hosp, Dept Endocrinol & Nutr, Madrid, Spain; [Angel Rubio, Miguel] Hosp Clin San Carlos, IdISSC, Endocrinol & Nutr Dept, Madrid, Spain; [Ros, Emilio] Univ Barcelona, IDIBAPS, Hosp Clin, Dept Lipids, Barcelona, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Navarra; University of Valencia; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Navarra; Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; University Hospital of Araba; Universidad de Cordoba; Universidad de Malaga; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidad de Malaga; Universidad de Las Palmas de Gran Canaria; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Universitat de les Illes Balears; University of Granada; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidad de Jaen; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Fundacion Jimenez Diaz; Hospital Clinico San Carlos; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Salas-Salvado, J (corresponding author), Univ Rovira & Virgili, Human Nutr Unit, Univ Hosp St Joan de Reus, Dept Biochem & Biotechnol,Pere Virgili Inst Hlth, Reus, Spain.; Salas-Salvado, J (corresponding author), Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain.	jordi.salas@urv.cat	Romaguera, Dora/ABE-7004-2020; Tur, Josep/AAE-5748-2020; Martin, Vicente/ABF-2276-2021; Estruch, Ramon/AAZ-3723-2020; García, José Carlos Fernández/B-3723-2013; Bueno-Cavanillas, Aurora/O-1513-2015; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Mas, S/T-1489-2018; Martin, Vicente/GRE-8306-2022; Martin, Vicente/A-1597-2008; Salas-Salvado, Jordi/C-7229-2017; vioque, jesus/A-1066-2008; Romaguera, Dora/AAB-2852-2020; Serra-Majem, Lluis/I-6708-2019; Pintó, Xavier/AGI-4297-2022; Tinahones, Francisco José/AAB-2882-2020; Rubio, Miguel Angel/GRJ-0134-2022; Mico, Victor/M-7763-2014; Daimiel-Ruiz, Lidia Angeles/M-7779-2014	Romaguera, Dora/0000-0002-5762-8558; Tur, Josep/0000-0002-6940-0761; García, José Carlos Fernández/0000-0003-2308-2865; Bueno-Cavanillas, Aurora/0000-0002-0649-3016; Mas, S/0000-0001-6604-3327; Martin, Vicente/0000-0003-0552-2804; Martin, Vicente/0000-0003-0552-2804; Salas-Salvado, Jordi/0000-0003-2700-7459; vioque, jesus/0000-0002-2284-148X; Serra-Majem, Lluis/0000-0002-9658-9061; Pintó, Xavier/0000-0002-2216-2444; Rubio, Miguel Angel/0000-0002-0495-6240; Sagarra Alamo, Ramon/0000-0002-5544-0172; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808; Mico, Victor/0000-0003-0681-7962; Daimiel-Ruiz, Lidia Angeles/0000-0001-9898-6629; Tinahones, Francisco J/0000-0001-6871-4403; Compan Gabucio, Laura M/0000-0001-5324-1535; Ros, Emilio/0000-0002-2573-1294; Vidal, Josep/0000-0002-4564-4518; Diaz-Lopez, Andres/0000-0002-7500-5629	Spanish Ministry of Health (Carlos III Health Institute) through the Fondo de Investigacion para la Salud (FIS); European Regional Development Fund [PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14- 00696, PI14/01206, PI14/01919, PI14/00853]; European Research Council [340918]; Recercaixa grant [2013ACUP00194]; Consejeria de Salud de la Junta de Andalucia [PI0458/2013]; SEMERGEN grant; Catalan Government; Secretaria dUniversitats i Recerca del Departament dEconomia i Coneixement de la Generalitat de Catalunya	Spanish Ministry of Health (Carlos III Health Institute) through the Fondo de Investigacion para la Salud (FIS); European Regional Development Fund(European Commission); European Research Council(European Research Council (ERC)European Commission); Recercaixa grant; Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); SEMERGEN grant; Catalan Government; Secretaria dUniversitats i Recerca del Departament dEconomia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya)	This study was funded by the Spanish Ministry of Health (Carlos III Health Institute) through the Fondo de Investigacion para la Salud (FIS), which is co-funded by the European Regional Development Fund (two coordinated FIS projects leaded by Jordi Salas-Salvado and Josep Vidal, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728 PI13/01090 PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14- 00696, PI14/01206, PI14/01919, PI14/00853), the European Research Council (Advanced Research Grant 2013-2018; 340918) granted to MAMG, the Recercaixa grant 2013 (2013ACUP00194), the grant from the Consejeria de Salud de la Junta de Andalucia (PI0458/2013), and the SEMERGEN grant. NRE has been beneficiary of a predoctoral FIAGAUR 2016 Grant from the Catalan Government; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya. None of the funding sources took part in the design, collection, analysis or interpretation of the data, or in the decision to submit the manuscript for publication. CIBERobn (Centros de Investigacion Biomedica en Red: Obesidad y Nutricion), CIBEResp (Centros de Investigacion Biomedica en Red: Epidemiologia y Salud Publica) and CIBERdem (Centros de Investigacion Biomedica en Red: Diabetes y Enfermedades Metabolicas asociadas) are initiatives of ISCIII, Madrid, Spain.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bailey DP, 2016, APPL PHYSIOL NUTR ME, V41, P324, DOI 10.1139/apnm-2015-0462; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Basterra-Gortari FJ, 2014, J AM HEART ASSOC, V3, P1; Batacan RB, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/596367; Bell JA, 2014, DIABETOLOGIA, V57, P2048, DOI 10.1007/s00125-014-3323-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Brocklebank LA, 2015, PREV MED, V76, P92, DOI 10.1016/j.ypmed.2015.04.013; Buman MP, 2014, AM J EPIDEMIOL, V179, P323, DOI 10.1093/aje/kwt292; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chastin SFM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139984; Chau JY, 2014, J SCI MED SPORT, V17, P78, DOI 10.1016/j.jsams.2013.03.004; Clark BK, 2011, RELATIONSHIP TELEVIS, P822; Cornelissen VA, 2009, J HYPERTENS, V27, P753, DOI 10.1097/HJH.0b013e328322cf60; DIETZ WH, 1985, PEDIATRICS, V75, P807; Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4; Ekblom-Bak E, 2015, EUR J PREV CARDIOL; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Falconer CL, 2015, MED SCI SPORT EXER, V47, P2070, DOI 10.1249/MSS.0000000000000651; Fogelholm M, 2007, INT J OBESITY, V31, P1713, DOI 10.1038/sj.ijo.0803663; Grandner MA, 2014, SLEEP MED, V15, P42, DOI 10.1016/j.sleep.2013.09.012; Grontved A, 2011, JAMA, V305; Hamer M, 2014, MED SCI SPORT EXER, V46, P1946, DOI 10.1249/MSS.0000000000000317; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; Hoevenaar-blom MP, 2011, CARDIOVASCULAR DIS, V34; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Kelley GA, 2006, METABOLISM, V55, P1500, DOI 10.1016/j.metabol.2006.06.021; Lahjibi E, 2013, DIABETES METAB, V39, P217, DOI 10.1016/j.diabet.2012.12.006; Lamb MJE, 2016, DIABETOLOGIA, V59, P110, DOI 10.1007/s00125-015-3756-8; Lee J., 1994, INT J EPIDEMIOL, V23; Lin XC, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002014; Maher CA, 2013, OBESITY, V21, pE730, DOI 10.1002/oby.20430; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Mekary RA, 2013, AM J EPIDEMIOL, V178, P474, DOI 10.1093/aje/kws590; Mekary RA, 2009, AM J EPIDEMIOL, V170, P519, DOI 10.1093/aje/kwp163; Molina L, 2016, PLOS ONE IN PRESS; Owen N, 2010, MAYO CLIN PROC, V85, P1138, DOI 10.4065/mcp.2010.0444; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Same RV, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-015-0678-5; Sperry SD, 2015, SLEEP, V38, P1269, DOI 10.5665/sleep.4906; Stamatakis E, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0280-7; Stamatakis E, 2012, INT J EPIDEMIOL, V41, P1328, DOI 10.1093/ije/dys077; Sugiyama T, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-35; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008; Vioque J, 2000, INT J OBESITY, V24, P1683, DOI 10.1038/sj.ijo.0801434; Warburton DER, 2016, CAN J CARDIOL, V32, P495, DOI 10.1016/j.cjca.2016.01.024; Watson NF, 2015, SLEEP, V38, P843, DOI 10.5665/sleep.4716; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wijndaele K, 2014, DIABETOLOGIA, V57, P305, DOI 10.1007/s00125-013-3102-y; Wijndaele K, 2010, MED SCI SPORT EXER, V42, P1511, DOI 10.1249/MSS.0b013e3181d322ac; Wong PM, 2015, J CLIN ENDOCR METAB, V100, P4612, DOI 10.1210/jc.2015-2923	58	45	45	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172253	10.1371/journal.pone.0172253	http://dx.doi.org/10.1371/journal.pone.0172253			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273154	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700070
J	Yang, SB; Li, XF; Wu, C; He, X; Zhong, Y				Yang, Shaobo; Li, Xingfei; Wu, Chao; He, Xin; Zhong, Ying			Application of the PJ and NPS evaporation duct models over the South China Sea (SCS) in winter	PLOS ONE			English	Article								The detection of duct height has a significant effect on marine radar or wireless apparatus applications. The paper presents two models to verify the adaptation of evaporation duct models in the SCS in winter. A meteorological gradient instrument used to measure evaporation ducts was fabricated using hydrological and meteorological sensors at different heights. An experiment on the adaptive characteristics of evaporation duct models was carried out over the SCS. The heights of the evaporation ducts were measured by means of log-linear fit, Paulus-Jeske (PJ) and Naval Postgraduate School (NPS) models. The results showed that NPS model offered significant advantages in stability compared with the PJ model. According the collected data computed by the NPS model, the mean deviation (MD) was -1.7 m, and the Standard Deviation (STD) of the MD was 0.8 m compared with the true value. The NPS model may be more suitable for estimating the evaporation duct height in the SCS in winter due to its simpler system characteristics compared with meteorological gradient instruments.	[Yang, Shaobo; Li, Xingfei; Wu, Chao; He, Xin; Zhong, Ying] Tianjin Univ, State Key Lab Precis Measuring Technol & Instrume, Tianjin, Peoples R China	Tianjin University	Li, XF (corresponding author), Tianjin Univ, State Key Lab Precis Measuring Technol & Instrume, Tianjin, Peoples R China.	lixftju@sina.com						Babin SM, 1997, J APPL METEOROL, V36, P193, DOI 10.1175/1520-0450(1997)036<0193:ANMOTO>2.0.CO;2; Babin SM, 2002, J APPL METEOROL, V41, P434, DOI 10.1175/1520-0450(2002)041<0434:LBEDMC>2.0.CO;2; Cheng YH, 2013, CHINESE J RADIO SCI, V28, P797; Cheng YH, 2016, CHIN J OCEANOL LIMN, V34, P619, DOI 10.1007/s00343-016-4275-2; Cheng YH, 2015, ACTA OCEANOL SIN, V34, P63, DOI 10.1007/s13131-015-0749-x; [成印河 Cheng Yinhe], 2013, [地球科学进展, Advance in Earth Sciences], V28, P318; Ding J L, 2008, MARIN SCI B, V28, P86; Edson JB, 2013, J PHYS OCEANOGR, V43, P1589, DOI 10.1175/JPO-D-12-0173.1; Jeske H, 1971, STATE RADAR RANGE 2; Jobson Harvey E., 1984, METEOROLOGY, V33, P267; Lowry AR, 2002, RADIO SCI, V37, DOI 10.1029/2000RS002565; Patterson WL, 2002, IEEE RAD C, P891; Rogers LT, 1997, RADIO SCI, V32, P79, DOI 10.1029/96RS02904; Tian B, 2009, SHIP SCI TECHNOLOGY, V31, P96; Yang C, 2014, RADIOENGINEERING, V2, P96; Yang KD, 2009, ACTA PHYS SIN-CH ED, V58, P7339, DOI 10.7498/aps.58.7339; Yang SB, 2016, MICROCHIM ACTA, P1; Yardim C, 2007, STAT ESTIMATION TRAC; Yardim C, 2009, RADIO SCI, V44, DOI 10.1029/2008RS003897; Zhang J., 2012, PESTICIDE SCI ADM, V12, P20; Zhang L, 2010, WIREL NETW MOB COMMU, P1; Zhao XF, 2013, CHINESE SCI BULL, V58, P2794, DOI 10.1007/s11434-013-5942-8; Zhao XF, 2012, IEEE T ANTENN PROPAG, V60, P1020, DOI 10.1109/TAP.2011.2173115; Zhu MY, 2012, PHYSCS PROC, V33, P1670, DOI 10.1016/j.phpro.2012.05.269	24	12	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172284	10.1371/journal.pone.0172284	http://dx.doi.org/10.1371/journal.pone.0172284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273113	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700072
J	Fan, Q; Xie, ZX; Xie, ZQ; Deng, XW; Xie, LJ; Huang, L; Luo, SS; Huang, JL; Zhang, YF; Zeng, TT; Wang, S; Liu, JB; Pang, YS				Fan, Qing; Xie, Zhixun; Xie, Zhiqin; Deng, Xianwen; Xie, Liji; Huang, Li; Luo, Sisi; Huang, Jiaoling; Zhang, Yanfang; Zeng, Tingting; Wang, Sheng; Liu, Jiabo; Pang, Yaoshan			Development of a GeXP-multiplex PCR assay for the simultaneous detection and differentiation of six cattle viruses (vol 12, e0171287, 2017)	PLOS ONE			English	Correction															Guangxi Key Technologies Research and Development Program [0992033-5]; Guangxi Government Senior Scientist Foundation [2011B020]; Guangxi Natural Science Foundation [2016GXNSFCA380003]	Guangxi Key Technologies Research and Development Program; Guangxi Government Senior Scientist Foundation; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	There is an error in the Funding section. The correct funding information is as follows: This work was supported by the Guangxi Key Technologies Research and Development Program (0992033-5), Guangxi Government Senior Scientist Foundation (2011B020), and Guangxi Natural Science Foundation (2016GXNSFCA380003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fan Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171287	1	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173829	10.1371/journal.pone.0173829	http://dx.doi.org/10.1371/journal.pone.0173829			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267781	Green Submitted, Green Published, gold			2022-12-27	WOS:000396060600049
J	Aslam, M; Arif, OH; Jun, CH				Aslam, Muhammad; Arif, Osama H.; Jun, Chi-Hyuck			An attribute control chart for a Weibull distribution under accelerated hybrid censoring	PLOS ONE			English	Article							EXACT LIKELIHOOD INFERENCE; STEP-STRESS MODEL; EXPONENTIAL-DISTRIBUTION	In this article, an attribute control chart has been proposed using the accelerated hybrid censoring logic for the monitoring of defective items whose life follows a Weibull distribution. The product can be tested by introducing the acceleration factor based on different pressurized conditions such as stress, load, strain, temperature, etc. The control limits are derived based on the binomial distribution, but the fraction defective is expressed only through the shape parameter, the acceleration factor and the test duration constant. Tables of the average run lengths have been generated for different process parameters to assess the performance of the proposed control chart. Simulation studies have been performed for the practical use, where the proposed chart is compared with the Shewhart np chart for demonstration of the detection power of a process shift.	[Aslam, Muhammad; Arif, Osama H.] King Abdulaziz Univ, Dept Stat, Fac Sci, Jeddah, Saudi Arabia; [Jun, Chi-Hyuck] POSTECH, Dept Ind & Management Engn, Pohang, South Korea	King Abdulaziz University; Pohang University of Science & Technology (POSTECH)	Aslam, M (corresponding author), King Abdulaziz Univ, Dept Stat, Fac Sci, Jeddah, Saudi Arabia.	aslam_ravian@hotmail.com	Jun, Chi-Hyuck/AAE-1695-2019; Aslam, Muhammad/GRS-8220-2022; Aslam, Muhammad/E-6354-2015; Arif, Osama/L-7302-2015	Aslam, Muhammad/0000-0002-6071-5468; Aslam, Muhammad/0000-0003-0644-1950; Arif, Osama/0000-0001-5798-0706	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia [D1435-1006-130]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia; DSR	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia, under grant No. (D1435-1006-130). The authors, therefore, acknowledge with thanks DSR technical and financial support.	Ahmad L, 2014, T I MEAS CONTROL, V36, P367, DOI 10.1177/0142331213502070; Aslam M., 2016, QUALITY RELIABILITY; Aslam M, 2015, P I MECH ENG O-J RIS, V229, P193, DOI 10.1177/1748006X15572499; Bagdonaviius V., 2001, ACCELERATED LIFE MOD, DOI 10.1201/9781420035872; Balakrishnan N, 2008, J STAT COMPUT SIM, V78, P475, DOI 10.1080/00949650601158336; Balakrishnan N, 2007, J STAT PLAN INFER, V137, P2543, DOI 10.1016/j.jspi.2006.04.017; Balakrishnan N, 2007, J STAT PLAN INFER, V137, P3268, DOI 10.1016/j.jspi.2007.03.011; Balakrishnan N, 2013, COMPUT STAT DATA AN, V57, P166, DOI 10.1016/j.csda.2012.03.025; Bao L., 2011, SPIE LASE; Carson PK, 2008, IND ENG CHEM RES, V47, P405, DOI 10.1021/ie070589b; Chandrasekar B, 2004, NAV RES LOG, V51, P994, DOI 10.1002/nav.20038; Childs A, 2003, ANN I STAT MATH, V55, P319, DOI 10.1023/A:1026326020003; EPSTEIN B, 1954, ANN MATH STAT, V25, P555, DOI 10.1214/aoms/1177728723; FAIRBANKS K, 1982, J AM STAT ASSOC, V77, P137, DOI 10.2307/2287779; Gupta RD, 1998, COMMUN STAT-THEOR M, V27, P3065, DOI 10.1080/03610929808832273; Knoth S., 2007, SEQUENTIAL ANAL, V26, P251, DOI [10.1080/07474940701404823, DOI 10.1080/07474940701404823]; Li ZH, 2014, J STAT COMPUT SIM, V84, P1779, DOI 10.1080/00949655.2013.766737; Loughmiller D., 2011, QUALITY RELIABILITY; Meeker WQ., 2013, STAT METHODS RELIABI; Montgomery D.C., 2011, INTRO STAT QUALITY C, V6th; Nelson WB, 1990, ACCELERATED LIFE TES; Vigrass W., 2010, CALCULATIONS SEMICON; Yen FY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065440	23	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173406	10.1371/journal.pone.0173406	http://dx.doi.org/10.1371/journal.pone.0173406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257479	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100089
J	Chen, XW; Wang, J; Qian, L; Gaughan, S; Xiang, W; Ai, T; Fan, ZM; Wang, CH				Chen, Xiaowen; Wang, Jun; Qian, Long; Gaughan, Sarah; Xiang, Wei; Ai, Tao; Fan, Zhenming; Wang, Chenghui			Domestication drive the changes of immune and digestive system of Eurasian perch (Perca fluviatilis)	PLOS ONE			English	Article							RNA-SEQ DATA; WILD; GROWTH; ADAPTATION; ANNOTATION; ALIGNMENT; GENETICS; GENOMICS; ANIMALS; BIOLOGY	Domestication has altered a variety of traits within the Eurasian perch (Perca fluviatilis), including phenotypic, physiological and behavioral traits of Eurasian perch (Perca fluviatilis). Little is known, however, about the genetic changes between domesticated and wild Eurasian perch. In this study, we assembled a high-quality de novo reference transcriptome and identified differentially expressed genes between wild and domesticated Eurasian perch. A total of 113,709 transcripts were assembled, and 58,380 transcripts were annotated. Transcriptomic comparison revealed 630 differentially expressed genes between domesticated and wild Eurasian perch. Within domesticated Eurasian perch there were 412 genes that were up-regulated including MHCI, MHCII, chia, ighm within immune system development. There were 218 genes including try1, ctrl, ctrb, cela3b, cpa1 and cpb1, which were down-regulated that were associated with digestive processes. Our results indicated domestication drives the changes of immune and digestive system of Eurasian perch. Our study not only provide valuable genetic resources for further studies in Eurasian perch, but also provide novel insights into the genetic basis of physiological changes in Eurasian perch during domestication process.	[Chen, Xiaowen; Wang, Jun; Wang, Chenghui] Shanghai Ocean Univ, Key Lab Freshwater Fisheries Germplasm Resources, Minist Agr, Shanghai, Peoples R China; [Qian, Long; Xiang, Wei; Ai, Tao; Fan, Zhenming] Xinjiang Prod & Construct Corps, Fisheries Technol Extens Stn, Urumqi, Xinjiang, Peoples R China; [Gaughan, Sarah] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; University of Nebraska System	Wang, CH (corresponding author), Shanghai Ocean Univ, Key Lab Freshwater Fisheries Germplasm Resources, Minist Agr, Shanghai, Peoples R China.; Fan, ZM (corresponding author), Xinjiang Prod & Construct Corps, Fisheries Technol Extens Stn, Urumqi, Xinjiang, Peoples R China.	btscf@sina.com; wangch@shou.edu.cn		wang, jun/0000-0002-6591-3316	National Key Technology Support Program [2012BAD25B10-03]; Shanghai collaborative Innovation Center for Aquatic Animal Genetics and Breeding Project [ZF1206]; Shanghai Ocean University [A2- 0203-00-100220]; National Science Foundation East Asia and Pacific Summer Institutes for U.S. Graduate Students [1613917]	National Key Technology Support Program(National Key Technology R&D Program); Shanghai collaborative Innovation Center for Aquatic Animal Genetics and Breeding Project; Shanghai Ocean University; National Science Foundation East Asia and Pacific Summer Institutes for U.S. Graduate Students	This work was supported by the National Key Technology Support Program (Grant No.2012BAD25B10-03), the Shanghai collaborative Innovation Center for Aquatic Animal Genetics and Breeding Project (ZF1206), Shanghai Ocean University funding (Grant no A2- 0203-00-100220), and National Science Foundation East Asia and Pacific Summer Institutes for U.S. Graduate Students (1613917).	[Anonymous], 2010, IMMUNE REDISTRIBUTIO; [Anonymous], 2004, FOOD COMPETITION AND, P329; Ao JQ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005118; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Belteky J, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160033; Ben Khadher S, 2016, AQUACULT REP, V3, P136, DOI 10.1016/j.aqrep.2015.12.003; Bolger AM, 2014, BIOINFORMATICS; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuvier-Peres A, 2001, FISH PHYSIOL BIOCHEM, V24, P279, DOI 10.1023/A:1015033300526; Devlin RH, 2013, J ANIM SCI, V91, P5247, DOI 10.2527/jas.2013-6612; Dong YH, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/903186; Douxfils J, 2011, FISH SHELLFISH IMMUN, V31, P1113, DOI 10.1016/j.fsi.2011.10.001; Douxfils J, 2011, COMP BIOCHEM PHYS A, V159, P92, DOI 10.1016/j.cbpa.2011.01.021; Douxfils J, 2015, DOMESTICATION RESPON, P743; Douxfils J, 2012, FISH SHELLFISH IMMUN, V33, P1112, DOI 10.1016/j.fsi.2012.08.013; FAO, 2016, CONTRIBUTING FOOD SE; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Huang SX, 2005, J BIOL CHEM, V280, P21183, DOI 10.1074/jbc.M501087200; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Jankowska B, 2007, CZECH J ANIM SCI, V52, P260, DOI 10.17221/2279-CJAS; Jankowska B, 2010, FOOD CHEM, V118, P764, DOI 10.1016/j.foodchem.2009.05.055; Jentoft S, 2005, COMP BIOCHEM PHYS A, V141, P353, DOI 10.1016/j.cbpb.2005.06.006; Krist'an J, 2012, TURK J FISH AQUAT SC, V12, P191, DOI 10.4194/1303-2712-v12_2_01; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larson G, 2014, P NATL ACAD SCI USA, V111, P6139, DOI 10.1073/pnas.1323964111; Larson G, 2013, TRENDS GENET, V29, P197, DOI 10.1016/j.tig.2013.01.003; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li QH, 2012, GENOMICS, V100, P314, DOI 10.1016/j.ygeno.2012.07.008; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzen K, 2012, BIOL REV, V87, P639, DOI 10.1111/j.1469-185X.2011.00215.x; Luczynska J, 2016, TURKISH J FISHERIES, V16; Mairesse G, 2005, AQUACULTURE, V246, P295, DOI 10.1016/j.aquaculture.2004.09.023; Malmstrom M, 2016, NAT GENET; Mandiki S.N.M., 2011, P298; Mirkena T, 2010, LIVEST SCI, V132, P1, DOI 10.1016/j.livsci.2010.05.003; Montague MJ, 2014, P NATL ACAD SCI USA, V111, P17230, DOI 10.1073/pnas.1410083111; Nguyen NH, 2016, FISH FISH, V17, P483, DOI 10.1111/faf.12122; Pimakhin A, 2015, J APPL ICHTHYOL, V31, P56, DOI 10.1111/jai.12901; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Ren M L Y G, 2002, FISHERIES RESOURCES, P139; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rougeot C, 2007, AQUACULTURE, V272, pS306, DOI 10.1016/j.aquaculture.2007.07.175; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Sullivan KM, 2016, FOOD CULT SOC, V19, P625, DOI 10.1080/15528014.2016.1209290; Teletchea, 2016, NATURAL RESOURCES, V7, P399, DOI [10.4236/nr.2016.76034, DOI 10.4236/nr.2016.76034, DOI 10.4236/NR.2016.76034]; Teletchea F, 2014, FISH FISH, V15, P181, DOI 10.1111/faf.12006; TISCH R, 1988, P NATL ACAD SCI USA, V85, P6914, DOI 10.1073/pnas.85.18.6914; Toth AL, 2007, TRENDS GENET, V23, P334, DOI 10.1016/j.tig.2007.05.001; Tymchuk W, 2009, GEN COMP ENDOCR, V164, P175, DOI 10.1016/j.ygcen.2009.05.015; Wang FH, 2010, FISH SHELLFISH IMMUN, V29, P32, DOI 10.1016/j.fsi.2010.01.006; Wang FH, 2011, FISH SHELLFISH IMMUN, V30, P1095, DOI 10.1016/j.fsi.2011.02.004; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Whiteley AR, 2008, GENETICS, V180, P147, DOI 10.1534/genetics.108.089938; Yan Jiang YT, 2007, J AQUACULTURE, V28; Zeder MA, 2012, J ANTHROPOL RES, V68, P161, DOI 10.3998/jar.0521004.0068.201	59	18	18	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172903	10.1371/journal.pone.0172903	http://dx.doi.org/10.1371/journal.pone.0172903			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257494	gold, Green Published, Green Submitted			2022-12-27	WOS:000396021100040
J	Grabarczyk, DB; Berks, BC				Grabarczyk, Daniel B.; Berks, Ben C.			Intermediates in the Sox sulfur oxidation pathway are bound to a sulfane conjugate of the carrier protein SoxYZ	PLOS ONE			English	Article							PARACOCCUS-PANTOTROPHUS GB17; MULTI-ENZYME SYSTEM; THIOSULFATE OXIDATION; THIOBACILLUS-VERSUTUS; STRUCTURAL BASIS; CYCLE; MECHANISM; SITE; A2	The Sox pathway found in many sulfur bacteria oxidizes thiosulfate to sulfate. Pathway intermediates are covalently bound to a cysteine residue in the carrier protein SoxYZ. We have used biochemical complementation by SoxYZ-conjugates to probe the identity of the intermediates in the Sox pathway. We find that unconjugated SoxYZ and SoxYZ-S-sulfonate are unlikely to be intermediates during normal turnover in disagreement with current models. By contrast, conjugates with multiple sulfane atoms are readily metabolised by the Sox pathway. The most parsimonious interpretation of these data is that the true carrier species in the Sox pathway is a SoxYZ-S-sulfane adduct.	[Grabarczyk, Daniel B.; Berks, Ben C.] Univ Oxford, Dept Biochem, Oxford, England; [Grabarczyk, Daniel B.] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2,Haus D15, Wurzburg, Germany	University of Oxford; University of Wurzburg	Grabarczyk, DB; Berks, BC (corresponding author), Univ Oxford, Dept Biochem, Oxford, England.; Grabarczyk, DB (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2,Haus D15, Wurzburg, Germany.	daniel.grabarczyk@virchow.uni-wuerzburg.de; ben.berks@bioch.ox.ac.uk		Grabarczyk, Daniel/0000-0003-0216-7085	Biotechnology and Biological Research Council	Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Research Council (GB) through a studentship to DBG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Friedrich CG, 2000, J BACTERIOL, V182, P4677, DOI 10.1128/JB.182.17.4677-4687.2000; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Grabarczyk DB, 2015, P NATL ACAD SCI USA, V112, pE7166, DOI 10.1073/pnas.1506386112; Grabarczyk DB, 2015, J BIOL CHEM, V290, P9209, DOI 10.1074/jbc.M114.618025; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Knofel T, 1999, NAT STRUCT BIOL, V6, P448; Kurth JM, 2016, J BIOL CHEM; LU WP, 1984, J GEN MICROBIOL, V130, P1683; LU WP, 1985, BIOCHIM BIOPHYS ACTA, V828, P116, DOI 10.1016/0167-4838(85)90046-9; LU WP, 1983, J GEN MICROBIOL, V129, P3549; Ogawa T, 2010, BIOSCI BIOTECH BIOCH, V74, P771, DOI 10.1271/bbb.90815; Quentmeier A, 2001, FEBS LETT, V503, P168, DOI 10.1016/S0014-5793(01)02727-2; Quentmeier A, 2008, FEBS LETT, V582, P3701, DOI 10.1016/j.febslet.2008.09.043; Quentmeier A, 2007, BIOCHEMISTRY-US, V46, P10990, DOI 10.1021/bi700378k; Rawlings DE, 2007, MICROBIOL-SGM, V153, P315, DOI 10.1099/mic.0.2006/001206-0; Rossi G, 2014, ADV BIOCHEM ENG BIOT, V142, P147, DOI 10.1007/10_2013_178; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; Sauve V, 2009, J BIOL CHEM, V284, P21707, DOI 10.1074/jbc.M109.002709; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; VISHNIAC W, 1957, BACTERIOL REV, V21, P195, DOI 10.1128/MMBR.21.3.195-213.1957; Zander U, 2011, J BIOL CHEM, V286, P8349, DOI 10.1074/jbc.M110.193631	23	25	27	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173395	10.1371/journal.pone.0173395	http://dx.doi.org/10.1371/journal.pone.0173395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257465	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100088
J	Janssen, T; Karssen, G; Topalovic, O; Coyne, D; Bert, W				Janssen, Toon; Karssen, Gerrit; Topalovic, Olivera; Coyne, Danny; Bert, Wim			Integrative taxonomy of root-knot nematodes reveals multiple independent origins of mitotic parthenogenesis	PLOS ONE			English	Article							GENUS MELOIDOGYNE; SPECIES IDENTIFICATION; FEMALE GONODUCT; RIBOSOMAL-RNA; EVOLUTION; COFFEE; DNA; DIVERSITY; DIAGNOSIS; GENES	During sampling of several Coffea arabica plantations in Tanzania severe root galling, caused by a root-knot nematode was observed. From pure cultures, morphology and morphometrics of juveniles and females matched perfectly with Meloidogyne africana, whereas morphology of the males matched identically with those of Meloidogyne decalineata. Based on their Cox1 sequence, however, the recovered juveniles, females and males were confirmed to belong to the same species, creating a taxonomic conundrum. Adding further to this puzzle, re-examination of M. oteifae type material showed insufficient morphological evidence to maintain its status as a separate species. Consequently, M. decalineata and M. oteifae are synonymized with M. africana, which is herewith redescribed based on results of light and scanning electron microscopy, ribosomal and mitochondrial DNA sequences, isozyme electrophoresis, along with bionomic and cytogenetic features. Multi-gene phylogenetic analysis placed M. africana outside of the three major clades, together with M. coffeicola, M. ichinohei andM. camelliae. This phylogenetic position was confirmed by several morphological features, including cellular structure of the spermatheca, egg mass position, perineal pattern and head shape. Moreover, M. africana was found to be a polyphagous species, demonstrating that "early-branching" Meloidogyne spp. are not as oligophagous as had previously been assumed. Cytogenetic information indicates M. africana (2n = 21) and M. ardenensis (2n = 51-54) to be a triploid mitotic parthenogenetic species, revealing at least four independent origins of mitotic parthenogenesis within the genus Meloidogyne. Furthermore, M. mali (n = 12) was found to reproduce by amphimixis, indicating that amphimictic species with a limited number of chromosomes are widespread in the genus, potentially reflecting the ancestral state of the genus. The wide variation in chromosome numbers and associated changes in reproduction modes indicate that cytogenetic evolution played a crucial role in the speciation of root-knot nematodes and plant-parasitic nematodes in general.	[Janssen, Toon; Karssen, Gerrit; Topalovic, Olivera; Bert, Wim] Univ Ghent, Dept Biol, Nematol Res Unit, Ghent, Belgium; [Janssen, Toon] Vrije Univ Brussel, UZ Brussel, Ctr Med Genet Reprod & Genet Reprod Genet & Regen, Brussels, Belgium; [Karssen, Gerrit; Topalovic, Olivera] HC Wageningen, Wageningen Nematode Collect, Natl Plant Protect Org, Wageningen, Netherlands; [Coyne, Danny] ICIPE, Int Inst Trop Agr, Nairobi, Kenya	Ghent University; University Hospital Brussels; Vrije Universiteit Brussel; International Centre of Insect Physiology & Ecology (ICIPE)	Janssen, T (corresponding author), Univ Ghent, Dept Biol, Nematol Res Unit, KL Ledeganckstr, Ghent, Belgium.	toon.janssen88@gmail.com	Topalović, Olivera/AAM-2208-2020; Bert, Wim/D-4511-2013	Bert, Wim/0000-0002-5864-412X; Janssen, Toon/0000-0001-9914-3906; van Tienoven, Theun Pieter/0000-0003-1532-254X; Topalovic, Olivera/0000-0003-3839-1839	special research fund from Ghent University [01N02312]	special research fund from Ghent University	This work was supported by a special research fund from Ghent University 01N02312.; The authors would like to thank Myrtle Verhaeven and the nematology lab of IITA for assistance during sampling in Tanzania, Dr. Hans Helder for kindly sharing DNA extraction of Meloidogyne sp. MHMH-2008, Prof. Wilfrida Decraemer for well-appreciated taxonomic advice, Prof. Jonathan D. Eisenback for contributing preliminary molecular results of Meloidogyne kikuyensis and Marjolein Couvreur for SEM analysis. We are especially grateful to the nematology lab from the National Plant Protection Organization Wageningen for technical support and the maintenance of the greenhouse cultures. This work was supported by a special research fund UGent 01N02312.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Ahmed M, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.362.6352; Araki M., 1992, JAP J NEMATOL, P11; Bert W, 2002, NEMATOLOGY, V4, P953, DOI 10.1163/156854102321122575; Bert W, 2003, NEMATOLOGY, V5, P293, DOI 10.1163/156854103767139761; Bert W, 2008, MOL PHYLOGENET EVOL, V48, P728, DOI 10.1016/j.ympev.2008.04.011; Blok Vivian C., 2009, P98, DOI 10.1079/9781845934927.0098; BOWLES J, 1992, MOL BIOCHEM PARASIT, V54, P165, DOI 10.1016/0166-6851(92)90109-W; BRIDGE J., 1984, COFFEE NEMATODE SURV; Brito JA, 2016, DISEASE NOTES, V100, P1246; Campos V.P., 1990, P387; Campos Vicente Paulo, 2005, P529, DOI 10.1079/9780851997278.0529; Carneiro Regina M. D. G., 2008, P87, DOI 10.1007/978-1-4020-8720-2_6; Carneiro RMDG, 2000, NEMATOLOGY, V2, P645, DOI 10.1163/156854100509510; Castagnone-Sereno P, 2006, HEREDITY, V96, P282, DOI 10.1038/sj.hdy.6800794; Castagnone-Sereno P, 2013, ANNU REV PHYTOPATHOL, V51, P203, DOI 10.1146/annurev-phyto-082712-102300; CASTAGNONESERENO P, 1993, HEREDITY, V70, P195, DOI 10.1038/hdy.1993.29; CHITWOOD BG, 1960, PHYTOPATHOLOGY, V50, P631; Chitwood DJ, 2010, ROOT-KNOT NEMATODES, P182, DOI 10.1079/9781845934927.0182; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Correa VR, 2013, EUR J PLANT PATHOL, V137, P305, DOI 10.1007/s10658-013-0242-3; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Almeida AMSF, 2002, J NEMATOL, V34, P140; De Giorgi C, 2002, MOL BIOCHEM PARASIT, V124, P91, DOI 10.1016/S0166-6851(02)00161-5; De Grisse A., 1960, Nematologica, V5, P303; De Ley IT, 2002, J NEMATOL, V34, P319; De Ley P, 1999, NEMATOLOGY, V1, P591, DOI 10.1163/156854199508559; DeGiorgi C, 1996, GENE, V170, P261, DOI 10.1016/0378-1119(95)00894-2; Derycke S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013716; Eisenback JD, 1988, J NEMATOL; Eisenback Jonathan D., 2009, P18, DOI 10.1079/9781845934927.0018; Eisenback Jonathan D., 1991, P191; Elling AA, 2013, PHYTOPATHOLOGY, V103, P1092, DOI 10.1094/PHYTO-01-13-0019-RVW; ELMILIGY IA, 1968, NEMATOLOGICA, V14, P577, DOI 10.1163/187529268X00282; Eyualem A, 2003, J NEMATOL, V35, P119; Geraert E., 1983, Systematics Association Special Volume Series, P73; GOLDEN AM, 1979, J NEMATOL, V11, P175; Holterman M, 2009, PHYTOPATHOLOGY, V99, P227, DOI 10.1094/PHYTO-99-3-0227; Hooper D. J., 1986, Laboratory methods for work with plant and soil nematodes., P5; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hugall A, 1999, MOL BIOL EVOL, V16, P157, DOI 10.1093/oxfordjournals.molbev.a026098; Humphreys-Pereira DA, 2014, NEMATOLOGY, V16, P643, DOI 10.1163/15685411-00002794; Hunt David J., 2009, P55, DOI 10.1079/9781845934927.0055; International Coffee Organization (ICO), 2014, WORLD COFF TRAD 1963; International Coffee Organization (ICO), 2015, SUST COFF SECT AFR, P1; Janssen T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22591; Jepson S.B., 1987, IDENTIFICATION ROOT; Jorge AS, 2016, PLANT DIS, V100, P2173, DOI 10.1094/PDIS-03-16-0294-PDN; KARSSEN G, 1995, ELECTROPHORESIS, V16, P105, DOI 10.1002/elps.1150160119; Karssen G., 2002, PLANT PARASIT NEMAT, P93; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kiewnick S, 2014, EUR J PLANT PATHOL, V140, P97, DOI 10.1007/s10658-014-0446-1; Lordello LGE, 1960, REV BRAS BIOL, P375; Lordello R. R. A., 1980, Revista de Agricultura, Piracicaba, Brazil, V55, P238; Lukhtanov VA, 2005, NATURE, V436, P385, DOI 10.1038/nature03704; Maddison WP, 2016, MESQUITE A MODULAR S; Maleita CM, 2016, PLANT DIS, V100, P1725, DOI 10.1094/PDIS-01-16-0112-RE; Maleita CM, 2012, PLANT DIS, V96, P865, DOI 10.1094/PDIS-09-11-0769-RE; MARAIS M, 1991, Phytophylactica, V23, P265; Melters DP, 2012, CHROMOSOME RES, V20, P579, DOI 10.1007/s10577-012-9292-1; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Onkendi EM, 2014, PLANT PATHOL, V63, P727, DOI 10.1111/ppa.12202; PAPADOPOULOU J, 1982, J NEMATOL, V14, P549; PARLEVLIET J E, 1971, Acta Horticulturae (Wageningen), V21, P201; Plantard O, 2007, J NEMATOL, V39, P127; Randig O, 2002, GENOME, V45, P862, DOI [10.1139/g02-054, 10.1139/G02-054]; ROMAN J, 1969, J NEMATOL, V1, P357; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHRADER F, 1956, CHROMOSOMA, V7, P469; SEINHORST J. W., 1962, NEMATOLOGICA, V8, P29; SOHLENIUS B, 1987, BIOL FERT SOILS, V3, P19, DOI 10.1007/BF00260574; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Subbotin SA, 2008, MOL PHYLOGENET EVOL, V48, P491, DOI 10.1016/j.ympev.2008.04.028; Tang CQ, 2012, P NATL ACAD SCI USA, V109, P16208, DOI 10.1073/pnas.1209160109; Tomalova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038656; TRIANTAPHYLLOU A C, 1990, Revue de Nematologie, V13, P175; Triantaphyllou A. C., 1985, An advanced treatise on Meloidogyne.Volume II: Methodology., P107; Triantaphyllou A. C., 1962, Nematologica, V7, P105; Triantaphyllou A.C., 1983, Systematics Association Special Volume Series, P55; TRIANTAPHYLLOU A C, 1984, Revue de Nematologie, V7, P65; Triantaphyllou A.C., 1985, ADV TREATISE MELOIDO, VI, P113; TRIANTAPHYLLOU AC, 1963, J MORPHOL, V113, P489, DOI 10.1002/jmor.1051130309; TRIANTAPHYLLOU AC, 1966, J MORPHOL, V118, P403, DOI 10.1002/jmor.1051180308; TRIANTAPHYLLOU AC, 1980, ANNU REV PHYTOPATHOL, V18, P333, DOI 10.1146/annurev.py.18.090180.002001; TRIANTAPHYLLOU AC, 1973, ANNU REV PHYTOPATHOL, V11, P441, DOI 10.1146/annurev.py.11.090173.002301; Triantaphyllou AC, 1997, FUND APPL NEMATOL, V20, P385; TRIANTAPHYLLOU AC, 1987, J NEMATOL, V19, P1; Trisciuzzi N, 2014, EUR J PLANT PATHOL, V138, P231, DOI 10.1007/s10658-013-0337-x; van Bezooijen J., 2006, METHODS TECHNIQUES N; Van der Beek JG, 1998, FUND APPL NEMATOL, V21, P393; Vega FE, 2003, NATURE, V425, P343, DOI 10.1038/425343a; WHITEHEAD A G, 1968, Transactions of the Zoological Society of London, V31, P263; Whitehead A. G, 1959, NEMATOLOGICA, V4, P272; WHITEHEAD AG, 1969, NEMATOLOGICA, V15, P315, DOI 10.1163/187529269X00362; YASSIN A.M., 1982, P 3 RES PLANN C ROOT, P131; Ye WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143556; Yoder M, 2006, NEMATOLOGY, V8, P367, DOI 10.1163/156854106778493448	97	24	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172190	10.1371/journal.pone.0172190	http://dx.doi.org/10.1371/journal.pone.0172190			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257464	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100014
J	Muhr, LSA; Hortlund, M; Bzhalava, Z; Kleppe, SN; Bzhalava, D; Hultin, E; Dillner, J				Muhr, Laila Sara Arroyo; Hortlund, Maria; Bzhalava, Zurab; Kleppe, Sara Nordqvist; Bzhalava, Davit; Hultin, Emilie; Dillner, Joakim			Viruses in case series of tumors: Consistent presence in different cancers in the same subject	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS-DNA; ORGAN TRANSPLANT RECIPIENTS; NONMELANOMA SKIN-CANCER; BETAPAPILLOMAVIRUSES; DIVERSITY; VIREMIA; RISK; CELL	Studies investigating presence of viruses in cancer often analyze case series of cancers, resulting in detection of many viruses that are not etiologically linked to the tumors where they are found. The incidence of virus-associated cancers is greatly increased in immuno-compromised individuals. Non-melanoma skin cancer (NMSC) is also greatly increased and a variety of viruses have been detected in NMSC. As immunosuppressed patients often develop multiple independent NMSCs, we reasoned that viruses consistently present in independent tumors might be more likely to be involved in tumorigenesis. We sequenced 8 different NMSCs from 1 patient in comparison to 8 different NMSCs from 8 different patients. Among the latter, 12 different virus sequences were detected, but none in more than 1 tumor each. In contrast, the patient with multiple NMSCs had human papillomavirus type 15 and type 38 present in 6 out of 8 NMSCs.	[Muhr, Laila Sara Arroyo; Hortlund, Maria; Bzhalava, Zurab; Kleppe, Sara Nordqvist; Bzhalava, Davit; Hultin, Emilie; Dillner, Joakim] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden	Karolinska Institutet	Dillner, J (corresponding author), Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden.	joakim.dillner@ki.se	Hortlund, Maria/AAA-1613-2020	Hortlund, Maria/0000-0002-2627-4451; Arroyo Muhr, Laila Sara/0000-0003-2498-5206; Hultin, Emilie/0000-0003-2169-0840; Nordqvist Kleppe, Sara/0000-0002-8892-7497	Swedish Research Council [K2015-57X-21044-07-3]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council, grant number K2015-57X-21044-07-3 (www.vr.se). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari MM, 2008, J INVEST DERMATOL, V128, P1409, DOI 10.1038/sj.jid.5701227; Berg D, 2002, J AM ACAD DERMATOL, V47, P1, DOI 10.1067/mjd.2002.125579; Bhatia K, 2012, CURR OPIN ONCOL, V24, P537, DOI 10.1097/CCO.0b013e328355e115; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Bzhalava D, 2013, PLOS ONE, V8; Bzhalava D, 2016, INT J CANCER, V138, P2212, DOI 10.1002/ijc.29666; Bzhalava D, 2012, VIROLOGY, V432, P427, DOI 10.1016/j.virol.2012.06.022; Bzhalava Z, 2016, SCI REPORTS; Collett D, 2010, AM J TRANSPLANT, V10, P1889, DOI 10.1111/j.1600-6143.2010.03181.x; de Koning MNC, 2007, J GEN VIROL, V88, P1489, DOI 10.1099/vir.0.82732-0; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Dichosa AEK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037387; Ekstrom J, 2013, VIROLOGY, V447, P300, DOI 10.1016/j.virol.2013.09.010; Engels EA, 2011, JAMA-J AM MED ASSOC, V306, P1891, DOI 10.1001/jama.2011.1592; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Forslund O, 2004, J INVEST DERMATOL, V123, P388, DOI 10.1111/j.0022-202X.2004.23205.x; Forslund O, 2003, J CUTAN PATHOL, V30, P423, DOI 10.1034/j.1600-0560.2003.00092.x; Forslund O, 2007, J GEN VIROL, V88, P2662, DOI 10.1099/vir.0.82911-0; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hazard K, 2006, INT J CANCER, V119, P1073, DOI 10.1002/ijc.21920; Johansson H, 2013, VIROLOGY, V440, P1, DOI 10.1016/j.virol.2013.01.023; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Mackintosh LJ, 2009, BRIT J DERMATOL, V161, P56, DOI 10.1111/j.1365-2133.2009.09146.x; Meiring TL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-164; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Muhr LSA, 2015, INT J CANCER, V136, P2546, DOI 10.1002/ijc.29325; Muhr LSA, 2015, VIROLOGY, V485, P283, DOI 10.1016/j.virol.2015.07.023; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Saiki R. K., 1992, BIOTECHNOLOGY, V24, P476; Skewes-Cox P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105067; Smelov V, 2016, SCI REP-UK, V6, DOI 10.1038/srep25235; van Leeuwen MT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c570; Vasiljevic N, 2008, J GEN VIROL, V89, P2467, DOI 10.1099/vir.0.2008/001925-0; Vasiljevic N, 2007, J GEN VIROL, V88, P1479, DOI 10.1099/vir.0.82679-0; Wang J, 2011, APPL ENVIRON MICROB, V77, P4241, DOI 10.1128/AEM.01834-10; Weissenborn SJ, 2005, J INVEST DERMATOL, V125, P93, DOI 10.1111/j.0022-202X.2005.23733.x; World Health Organization and International Agency for Research on Cancer, 2007, IARC MONOGRAPHS EVAL, V90, P348; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943	41	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172308	10.1371/journal.pone.0172308	http://dx.doi.org/10.1371/journal.pone.0172308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257474	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100015
J	Kreusser, MM; Lehmann, LH; Haass, M; Buss, SJ; Katus, HA; Lossnitzer, D				Kreusser, Michael M.; Lehmann, Lorenz H.; Haass, Markus; Buss, Sebastian J.; Katus, Hugo A.; Lossnitzer, Dirk			Depletion of cardiac catecholamine stores impairs cardiac norepinephrine re-uptake by downregulation of the norepinephrine transporter	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; HEART-FAILURE; SYMPATHETIC ACTIVATION; INDUCED REDUCTION; NEURONAL UPTAKE; RECEPTORS; PLASMA; ABNORMALITIES; ENDOTHELIN; SPILLOVER	In heart failure (HF), a disturbed cardiac norepinephrine (NE) homeostasis is characterized by depleted cardiac NE stores, impairment of the cardiac NE re-uptake by the neuronal norepinephrine transporter (NET) and enhanced cardiac NE net release. Reduced cardiac NE content appears to be caused by enhanced cardiac NE net release from sympathetic neurons in HF, triggered by neurohumoral activation. However, it remains unclear whether reduced NE itself has an impact on cardiac NE re-uptake, independent of neurohumoral activation. Here, we evaluated whether depletion of cardiac NE stores alone can regulate cardiac NE re-uptake. Treatment of Wistar rats with reserpine (5 mg/kg/d) for one (1d) or five days (5d) resulted in markedly reduced cardiac NE content, comparable to NE stores in experimental HF due to pressure overload. In order to assess cardiac NE re-uptake, the specific cardiac [H-3]-NE uptake via the NET in a Langendorff preparation was measured. Reserpine treatment led to decreased NE re-uptake at 1d and 5d compared to saline treatment. Expression of tyrosine hydroxylase (TH), the rate-limiting enzyme of the NE synthesis, was elevated in left stellate ganglia after reserpine. Mechanistically, measurement of NET mRNA expression in left stellate ganglia and myocardial NET density revealed a posttranscriptional downregulation of the NET by reserpine. In summary, present data demonstrate that depletion of cardiac NE stores alone is sufficient to impair cardiac NE re-uptake via downregulation of the NET, independent of systemic neurohumoral activation. Knowledge about the regulation of the cardiac NE homeostasis may offer novel therapeutic strategies in HF.	[Kreusser, Michael M.; Lehmann, Lorenz H.; Buss, Sebastian J.; Katus, Hugo A.] Heidelberg Univ, Dept Cardiol, Heidelberg, Germany; [Kreusser, Michael M.; Lehmann, Lorenz H.; Buss, Sebastian J.; Katus, Hugo A.; Lossnitzer, Dirk] German Ctr Cardiovasc Res, DZHK, Heidelberg, Germany; [Haass, Markus] Theresienkrankenhaus, Dept Cardiol, Mannheim, Germany; [Lossnitzer, Dirk] Univ Hosp Mannheim, Dept Cardiol, Mannheim, Germany	Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; Ruprecht Karls University Heidelberg	Kreusser, MM (corresponding author), Heidelberg Univ, Dept Cardiol, Heidelberg, Germany.; Kreusser, MM (corresponding author), German Ctr Cardiovasc Res, DZHK, Heidelberg, Germany.	michael.kreusser@med.uni-heidelberg.de	Lehmann, Lorenz/AAP-9161-2021	Lehmann, Lorenz/0000-0001-5077-8580	German Society of Cardiology (DGK); DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung German Center for Cardiovascular Research); BMBF (German Ministry of Education and Research)	German Society of Cardiology (DGK); DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung German Center for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	M.M.K. was supported by a scholarship from the German Society of Cardiology (DGK). H.A. K. was supported by the DZHK (Deutsches Zentrum fOr Herz-Kreislauf-Forschung - German Center for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The expert technical assistance of Silvia Harrack, Jutta Krebs, and Michaela Oestringer is gratefully acknowledged. M.M.K. was supported by a scholarship from the German Society of Cardiology (DGK). H.A.K. was supported by the DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung German Center for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research).	Apparsundaram S, 1998, J PHARMACOL EXP THER, V287, P733; Backs J, 2001, J MOL CELL CARDIOL, V33, P461, DOI 10.1006/jmcc.2000.1319; Backs J, 2005, CARDIOVASC RES, V67, P283, DOI 10.1016/j.cardiores.2005.03.018; BANERJEE A, 1993, CIRC RES, V73, P656, DOI 10.1161/01.RES.73.4.656; BOHM M, 1995, J AM COLL CARDIOL, V25, P146, DOI 10.1016/0735-1097(94)00353-R; Buss SJ, 2006, ENDOCRINOLOGY, V147, P2526, DOI 10.1210/en.2005-1167; CHIDSEY CA, 1966, PHARMACOL REV, V18, P685; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; DELEHANTY JM, 1994, AM J PHYSIOL, V266, pH930, DOI 10.1152/ajpheart.1994.266.3.H930; Deng MX, 2016, J NEUROCHEM, V139, P197, DOI 10.1111/jnc.13761; Eisenhofer G, 1996, CIRCULATION, V93, P1667, DOI 10.1161/01.CIR.93.9.1667; Eisenhofer G, 2001, PHARMACOL THERAPEUT, V91, P35, DOI 10.1016/S0163-7258(01)00144-9; HALARIS AE, 1975, EUR J PHARMACOL, V32, P93, DOI 10.1016/0014-2999(75)90327-1; HASKING GJ, 1986, CIRCULATION, V73, P615, DOI 10.1161/01.CIR.73.4.615; HENRY JP, 1989, BIOCHEM PHARMACOL, V38, P2395, DOI 10.1016/0006-2952(89)90082-8; Ieda M, 2004, J CLIN INVEST, V113, P876, DOI 10.1172/JCI200419480; IKEDA J, 1991, J AUTONOM NERV SYST, V34, P231, DOI 10.1016/0165-1838(91)90089-L; Kaludercic N, 2010, CIRC RES, V106, P193, DOI 10.1161/CIRCRESAHA.109.198366; Kawai H, 1999, AM J PHYSIOL-HEART C, V277, pH1609, DOI 10.1152/ajpheart.1999.277.4.H1609; Kaye DM, 2000, CIRC RES, V86, pE80, DOI 10.1161/01.RES.86.7.e80; Kolettis TM, 2014, LIFE SCI, V118, P281, DOI 10.1016/j.lfs.2014.01.069; Kopin IJ, 1998, AM J PHYSIOL-REG I, V275, pR165, DOI 10.1152/ajpregu.1998.275.1.R165; Kreusser MM, 2008, J MOL CELL CARDIOL, V44, P380, DOI 10.1016/j.yjmcc.2007.10.019; Kreusser MM, 2014, AM J PHYSIOL-HEART C, V307, pH1169, DOI 10.1152/ajpheart.00193.2014; Kreusser MM, 2006, HYPERTENSION, V47, P209, DOI 10.1161/01.HYP.0000200157.25792.26; Kristen AV, 2006, J CARD FAIL, V12, P577, DOI 10.1016/j.cardfail.2006.05.006; La Rocca HPB, 2001, EUR HEART J, V22, P1136, DOI 10.1053/euhj.2000.2407; LEE CM, 1983, SCIENCE, V220, P626, DOI 10.1126/science.6301013; Lehmann LH, 2014, LIFE SCI, V118, P165, DOI 10.1016/j.lfs.2014.03.005; Lehmann LH, 2014, P NATL ACAD SCI USA, V111, P13499, DOI 10.1073/pnas.1409026111; LEIMBACH WN, 1986, CIRCULATION, V73, P913, DOI 10.1161/01.CIR.73.5.913; Liang CS, 2007, ACTA PHARMACOL SIN, V28, P921, DOI 10.1111/j.1745-7254.2007.00585.x; LIANG CS, 1989, J CLIN INVEST, V84, P1267, DOI 10.1172/JCI114294; Lymperopoulos A, 2007, NAT MED, V13, P315, DOI 10.1038/nm1553; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; Mandela P, 2006, J NEUROCHEM, V97, P310, DOI 10.1111/j.1471-4159.2006.03717.x; Mandela P, 2010, NEUROCHEM INT, V56, P760, DOI 10.1016/j.neuint.2010.02.011; Mao WK, 2005, AM J PHYSIOL-HEART C, V288, pH2381, DOI 10.1152/ajpheart.00904.2004; Mao WK, 2004, AM J PHYSIOL-HEART C, V287, pH29, DOI 10.1152/ajpheart.01168.2003; Martinez-Olivares R, 2006, AUTON NEUROSCI-BASIC, V128, P64, DOI 10.1016/j.autneu.2006.04.004; MELIKIAN HE, 1994, J BIOL CHEM, V269, P12290; MERLET P, 1992, J NUCL MED, V33, P471; Ogita H, 2001, HEART, V86, P656, DOI 10.1136/heart.86.6.656; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Qin FZ, 2002, AM J PHYSIOL-HEART C, V282, pH363, DOI 10.1152/ajpheart.00319.2001; Rundqvist B, 1997, CIRCULATION, V95, P169, DOI 10.1161/01.CIR.95.1.169; SCHOMIG A, 1988, CIRC RES, V63, P214, DOI 10.1161/01.RES.63.1.214; SNYDER S H, 1970, Biological Psychiatry, V2, P367; SOLE MJ, 1977, CIRC RES, V41, P814, DOI 10.1161/01.RES.41.6.814; World Medical A. & American Physiological, 2002, AM J PHYSIOL-REG I, V283, pR281	51	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0172070	10.1371/journal.pone.0172070	http://dx.doi.org/10.1371/journal.pone.0172070			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282374	Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800006
J	Cho, HY; Jung, I; Kwon, JY; Kim, SJ; Park, YW; Kim, YH				Cho, Hee Young; Jung, Inkyung; Kwon, Ja-Young; Kim, So Jung; Park, Yong Won; Kim, Young-Han			The Delta Neutrophil Index as a predictive marker of histological chorioamnionitis in patients with preterm premature rupture of membranes: A retrospective study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INTRAAMNIOTIC INFECTION; INTRAUTERINE INFECTION; WOMEN; GRANULOCYTE; PERFORMANCE; FUNISITIS; COUNT; LABOR; AGE	Background Histological chorioamnionitis (HCA) is related to perinatal morbidity. However, there is no definite diagnostic method for detecting chorioamnionitis before delivery. Methods We evaluated whether the delta neutrophil index (DNI) was an effective early marker of HCA in patients with preterm premature rupture of membranes (PPROM). We retrospectively evaluated 149 women diagnosed with PPROM (gestational age, 20(+0) to 36(+6) weeks) at Severance Hospital from January 2013 to December 2014. The women were categorized into the following two groups: (a) PPROM without HCA and (b) PPROM with HCA. The maternal white blood cell (WBC) count, neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP) level, and DNI were measured at admission. The DNI has been reported to reflect the fraction of circulating immature granulocytes associated with infection. Results Of the 149 patients, 87 were included in the PPROM without HCA group and 62 were included in the PPROM with HCA group. The interval between admission and delivery was significantly shorter in the PPROM with HCA group than in the PPROM without HCA group. There was no significant difference in the maternal WBC count. The serum CRP level, NLR, and DNI were significantly lower in the PPROM without HCA group than in the PPROM with HCA group, while the lymphocyte count was significantly lower in the PPROM with HCA group than in the PPROM without HCA group. A predictive equation was generated by combining the DNI, lymphocyte count, and CRP level, and the sensitivity and specificity for predicting a placental inflammatory response were 69.1% and 70.5%, respectively. Conclusions The DNI could be a predictive marker for HCA in patients with PPROM. Our predictive equation involving the DNI, lymphocyte count, and CRP level may be helpful for predicting the placental inflammatory response in patients with PPROM.	[Cho, Hee Young; Kwon, Ja-Young; Park, Yong Won; Kim, Young-Han] Yonsei Univ, Yonsei Univ Hlth Syst, Coll Med, Dept Obstet & Gynecol,Inst Womens Life Med Sci, Seoul, South Korea; [Cho, Hee Young] CHA Univ, CHA Bundang Med Ctr, Dept Obstet & Gynecol, Seongnam, South Korea; [Jung, Inkyung] Yonsei Univ, Coll Med, Dept Biostat & Med Informat, Seoul, South Korea; [Kim, So Jung] Yonsei Univ, Coll Med, Dept Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, YH (corresponding author), Yonsei Univ, Yonsei Univ Hlth Syst, Coll Med, Dept Obstet & Gynecol,Inst Womens Life Med Sci, Seoul, South Korea.	yhkim522@yuhs.ac		Kwon, Ja-Young/0000-0003-3009-6325; Cho, Hee Young/0000-0001-7064-5056; Jung, Inkyung/0000-0003-3780-3213; Kim, Young-Han/0000-0003-0645-6028				Ansari-Lari MA, 2003, AM J CLIN PATHOL, V120, P795, DOI 10.1309/LT30BV9UJJV9CFHQ; Beazley D, 1996, SEMIN PERINATOL, V20, P409, DOI 10.1016/S0146-0005(96)80008-5; Berger A, 2009, J PERINAT MED, V37, P72, DOI 10.1515/JPM.2009.016; Cecic I, 2002, CANCER LETT, V183, P43, DOI 10.1016/S0304-3835(02)00092-7; Croci DO, 2007, CANCER IMMUNOL IMMUN, V56, P1687, DOI 10.1007/s00262-007-0343-y; Denison FC, 1997, BRIT J OBSTET GYNAEC, V104, P851, DOI 10.1111/j.1471-0528.1997.tb12035.x; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Harris Neil, 2005, Lab Hematol, V11, P47, DOI 10.1532/LH96.04075; Henderson J.J., 2012, J MATERN-FETAL NEO M, V25, P642; HyunNahm C, 2008, ANN CLIN LAB SCI, V38, P241; Kadanali S, 1997, INT J GYNECOL OBSTET, V58, P269, DOI 10.1016/S0020-7292(97)00085-4; Kemp K, 2002, INFECT IMMUN, V70, P5019, DOI 10.1128/IAI.70.9.5019-5025.2002; Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040; Kim H, 2014, CLIN LAB, V60, P2015, DOI 10.7754/Clin.Lab.2014.140528; Kim MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107880; Kim MA, 2011, EUR J CLIN INVEST, V41, P773, DOI 10.1111/j.1365-2362.2011.02469.x; Kim OH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148799; KURKI T, 1990, ARCH GYNECOL OBSTET, V247, P31, DOI 10.1007/BF02390652; Lee SY, 2012, J KOREAN MED SCI, V27, P674, DOI 10.3346/jkms.2012.27.6.674; Lim TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086884; MAZOR M, 1993, J REPROD MED, V38, P799; Nigro KG, 2005, AM J CLIN PATHOL, V123, P618, DOI 10.1309/73H7K7UBW816PBJJ; Nunez J, 2008, AM J CARDIOL, V101, P747, DOI 10.1016/j.amjcard.2007.11.004; POTKUL RK, 1985, AM J OBSTET GYNECOL, V153, P642, DOI 10.1016/S0002-9378(85)80249-0; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Roberts DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031819; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; ROMERO R, 1993, AM J OBSTET GYNECOL, V169, P839, DOI 10.1016/0002-9378(93)90014-A; Romero R, 2007, NUTR REV, V65, pS194, DOI 10.1301/nr.2007.dec.S194-S202; Romero R, 2015, J PERINAT MED, V43, P19, DOI 10.1515/jpm-2014-0249; Romero R, 2014, AM J REPROD IMMUNOL, V71, P330, DOI 10.1111/aji.12189; Ryu A, 2013, ACTA OBSTET GYN SCAN, V92, P517, DOI 10.1111/aogs.12073; Seok Y, 2012, SHOCK, V37, P242, DOI 10.1097/SHK.0b013e3182454acf; Suliman MARM, 2010, ARCH MED RES, V41, P618, DOI 10.1016/j.arcmed.2010.11.006; Vaisbuch E, 2002, J PERINAT MED, V30, P287, DOI 10.1515/JPM.2002.041; WATTS DH, 1993, OBSTET GYNECOL, V82, P509; Yune HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120677	37	9	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173382	10.1371/journal.pone.0173382	http://dx.doi.org/10.1371/journal.pone.0173382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278168	gold, Green Published, Green Submitted			2022-12-27	WOS:000396087900082
J	Gordya, N; Yakovlev, A; Kruglikova, A; Tulin, D; Potolitsina, E; Suborova, T; Bordo, D; Rosano, C; Chernysh, S				Gordya, Natalia; Yakovlev, Andrey; Kruglikova, Anastasia; Tulin, Dmitry; Potolitsina, Evdokia; Suborova, Tatyana; Bordo, Domenico; Rosano, Camillo; Chernysh, Sergey			Natural antimicrobial peptide complexes in the fighting of antibiotic resistant biofilms: Calliphora vicina medicinal maggots	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; INSECT	Biofilms, sedimented microbial communities embedded in a biopolymer matrix cause vast majority of human bacterial infections and many severe complications such as chronic inflammatory diseases and cancer. Biofilms' resistance to the host immunity and antibiotics makes this kind of infection particularly intractable. Antimicrobial peptides (AMPs) are a ubiquitous facet of innate immunity in animals. However, AMPs activity was studied mainly on planktonic bacteria and little is known about their effects on biofilms. We studied structure and anti-biofilm activity of AMP complex produced by the maggots of blowfly Calliphora vicina living in environments extremely contaminated by biofilm-forming germs. The complex exhibits strong cell killing and matrix destroying activity against human pathogenic antibiotic resistant Escherichia coli, Staphylococcus aureus and Acinetobacter baumannii biofilms as well as non-toxicity to human immune cells. The complex was found to contain AMPs from defensin, cecropin, diptericin and proline-rich peptide families simultaneously expressed in response to bacterial infection and encoded by hundreds mRNA isoforms. All the families combine cell killing and matrix destruction mechanisms, but the ratio of these effects and antibacterial activity spectrum are specific to each family. These molecules dramatically extend the list of known anti-biofilm AMPs. However, pharmacological development of the complex as a whole can provide significant advantages compared with a conventional one-component approach. In particular, a similar level of activity against biofilm and planktonic bacteria (MBEC/MIC ratio) provides the complex advantage over conventional antibiotics. Available methods of the complex in situ and in vitro biosynthesis make this idea practicable.	[Gordya, Natalia; Yakovlev, Andrey; Kruglikova, Anastasia; Tulin, Dmitry; Potolitsina, Evdokia; Chernysh, Sergey] St Petersburg State Univ, Lab Insect Biopharmacol & Immunol, Fac Biol, St Petersburg, Russia; [Suborova, Tatyana] Kirov Mil Med Acad, Res Ctr, St Petersburg, Russia; [Bordo, Domenico; Rosano, Camillo] IRCCS AOU San Martino IST, Natl Inst Canc Res, Genoa, Italy	Saint Petersburg State University; University of Genoa; IRCCS AOU San Martino IST	Chernysh, S (corresponding author), St Petersburg State Univ, Lab Insect Biopharmacol & Immunol, Fac Biol, St Petersburg, Russia.	sichernysh1951@gmail.com	Andrey, Yakovlev Yu/G-1002-2015; Rosano, Camillo/D-5386-2011; Rosano, Camillo/AAA-9954-2021; Kruglikova, Anastasia/E-7127-2016	Rosano, Camillo/0000-0003-2949-9215; Rosano, Camillo/0000-0003-2949-9215; Yakovlev, Andrey/0000-0003-2985-3907; Kruglikova, Anastasia/0000-0002-3809-7229	Russian Science Foundation [16-14-00048]	Russian Science Foundation(Russian Science Foundation (RSF))	The study was supported by a grant from the Russian Science Foundation (URL http://rscf.ru/), grant No 16-14-00048 (SC, NG, AY, DT, EP, AK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Batoni G, 2016, BBA-BIOMEMBRANES, V1858, P1044, DOI 10.1016/j.bbamem.2015.10.013; Bell G, 2003, MICROBIOL-SGM, V149, P1367, DOI 10.1099/mic.0.26265-0; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; Cerovsky V, 2010, CELL MOL LIFE SCI, V67, P455, DOI 10.1007/s00018-009-0194-0; Chernysh S, 2002, P NATL ACAD SCI USA, V99, P12628, DOI 10.1073/pnas.192301899; Chernysh SI, 2011, J EVOL BIOCHEM PHYS+, V47, P524, DOI 10.1134/S0022093011060032; Chernysh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130788; Chernysh Sergey I., 2000, Entomological Science, V3, P139; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Cohen RJ, 2005, J UROLOGY, V173, P1969, DOI 10.1097/01.ju.0000158161.15277.78; Collins D, 2011, LANCET ONCOL, V12, P504, DOI 10.1016/S1470-2045(10)70186-8; Di Luca M, 2014, PATHOG DIS, V70, P257, DOI 10.1111/2049-632X.12151; Dufour D., 2010, ENDODONTIC TOPICS, V22, P2, DOI [10.1111/j.1601-1546.2012.00277.x|, DOI 10.1111/J.1601-1546.2012.00277.X, DOI 10.1111/J.1601-1546.2012.00277.X|]; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; Gupta P, 2016, ARCH MICROBIOL, V198, P1, DOI 10.1007/s00203-015-1148-6; Habets MGJL, 2012, BIOL LETTERS, V8, P416, DOI 10.1098/rsbl.2011.1203; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Johnson CH, 2015, CELL METAB, V21, P891, DOI 10.1016/j.cmet.2015.04.011; Kacprzyk L, 2007, BBA-BIOMEMBRANES, V1768, P2667, DOI 10.1016/j.bbamem.2007.06.020; KEPPI E, 1989, ARCH INSECT BIOCHEM, V10, P229, DOI 10.1002/arch.940100306; Knezevic P, 2008, J MICROBIOL METH, V74, P114, DOI 10.1016/j.mimet.2008.03.005; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Leid JG, 2009, MICROBE, V4, P66; McCafferty DG, 1999, CURR OPIN CHEM BIOL, V3, P672, DOI 10.1016/S1367-5931(99)00025-3; Mylonakis E, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0290; Napier BA, 2013, MBIO, V4, DOI 10.1128/mBio.00021-13; NESIN AP, 1995, APPL ENTOMOL ZOOL, V30, P351; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Palm-Apergi C, 2008, J CONTROL RELEASE, V132, P49, DOI 10.1016/j.jconrel.2008.08.011; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Pinto-Santini D, 2005, CANCER EPIDEM BIOMAR, V14, P1853, DOI 10.1158/1055-9965.EPI-04-0784; Pletzer D, 2016, CURR OPIN MICROBIOL, V33, P35, DOI 10.1016/j.mib.2016.05.016; Poppel AK, 2015, ANTIMICROB AGENTS CH, V59, P2508, DOI 10.1128/AAC.05180-14; Rahnamaeian M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0293; Rao VP, 2006, CANCER RES, V66, P7395, DOI 10.1158/0008-5472.CAN-06-0558; Ratcliffe N, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/904958; Riddell CE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1031; Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004; Sherman RA, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/592419; Strempel N, 2015, CURR PHARM DESIGN, V21, P67, DOI 10.2174/1381612820666140905124312; Tonk M, 2016, APPL MICROBIOL BIOT, V100, P7397, DOI 10.1007/s00253-016-7718-y; Wiesner J, 2011, BIOL INSPIR SYST, V2, P29, DOI 10.1007/978-90-481-9641-8_3; Yakovlev AY, 2016, IN VITRO CELL DEV; Yan H, 2001, ANTIMICROB AGENTS CH, V45, P1558, DOI 10.1128/AAC.45.5.1558-1560.2001; Yu GZ, 2016, ANTIMICROB AGENTS CH, V60, P1717, DOI 10.1128/AAC.02434-15; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhan P, 2011, EUR J CANCER, V47, P742, DOI 10.1016/j.ejca.2010.11.003	49	46	51	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173559	10.1371/journal.pone.0173559	http://dx.doi.org/10.1371/journal.pone.0173559			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278280	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900012
J	Lima, PDA; Chen, ZL; Tayab, A; Murphy, MSQ; Pudwell, J; Smith, GN; Croy, BA				Lima, Patricia D. A.; Chen, Zhilin; Tayab, Aysha; Murphy, Malia S. Q.; Pudwell, Jessica; Smith, Graeme N.; Croy, B. Anne			Circulating progenitor and angiogenic cell frequencies are abnormally static over pregnancy in women with preconception diabetes: A pilot study	PLOS ONE			English	Article							COMPLICATIONS; PREECLAMPSIA; EPC	Type 1 and 2 diabetes decrease the frequencies and functional capacities of circulating angiogenic cells (CAC). Diabetes also elevates gestational complications. These observations may be interrelated. We undertook pilot studies to address the hypothesis that preconception diabetes deviates known gestational increases in CACs. Cross-sectional study of type 1 diabetic, type 2 diabetic and normoglycemic pregnant women was conducted at 1st, 2nd, and 3rd trimester and compared to a 6mo postpartum surrogate baseline. Circulating progenitor cells (CPC; CD34+CD45dimSSlow) and CACs (CD34+CD45dimSSlow expressing CD133 without or with KDR) were quantified by flow cytometry and by colony assay (CFU-Hill). In pregnant normoglycemic women, CD34+CD45dimSSlow cell frequency was greater in 1st and 3rd trimester than postpartum but frequency of these cells was static over type 1 or 2 diabetic pregnancies. Type 1 and type 2 diabetic women showed CACs variance versus normal controls. Type 1 diabetic women had more total CD34+KDR+ CACs in 1st trimester and a higher ratio of CD133+KDR+ to total CD133+ cells in 1st and 2nd trimesters than control women, demonstrating an unbalance in CD133+KDR+ CACs. Type 2 diabetic women had more CD133+KDR+ CACs in 1st trimester and fewer CD133+KDR- CACs at mid-late pregnancy than normal pregnant women. Thus, pregnancy stage-specific physiological fluctuation in CPCs (CD34+) and CACs (CD133+KDR+ and CD133+KDR-) did not occur in type 1 and type 2 diabetic women. Early outgrowth colonies were stable across normal and diabetic pregnancies. Therefore, preconception diabetes blocks the normal dynamic pattern of CAC frequencies across gestation but does not alter colony growth. The differences between diabetic and typical women were seen at specific gestational stages that may be critical for initiation of the uterine vascular pathologies characterizing diabetic gestations.	[Lima, Patricia D. A.; Chen, Zhilin; Tayab, Aysha; Croy, B. Anne] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Murphy, Malia S. Q.; Pudwell, Jessica; Smith, Graeme N.] Queens Univ, Dept Obstet & Gynecol, Kingston, ON, Canada; [Lima, Patricia D. A.] Ottawa Hosp, Res Inst, Dept Obstet & Gynecol, Ottawa, ON, Canada	Queens University - Canada; Queens University - Canada; University of Ottawa; Ottawa Hospital Research Institute	Lima, PDA (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.; Lima, PDA (corresponding author), Ottawa Hosp, Res Inst, Dept Obstet & Gynecol, Ottawa, ON, Canada.	limapda@gmail.com	Smith, Graeme Neil/ABB-6863-2021	Smith, Graeme Neil/0000-0002-3128-4523; Pudwell, Jessica/0000-0002-7000-2605; Murphy, Malia/0000-0002-4566-4957; Lima, Patricia/0000-0002-6456-2470				Acosta JC, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.10.913; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Briguori C, 2010, FASEB J, V24, P1981, DOI 10.1096/fj.09-138198; Buemi M, 2007, AM J OBSTET GYNECOL, V196, P68, DOI 10.1016/j.ajog.2006.08.032; Bulut D, 2007, CLIN RES CARDIOL, V96, P258, DOI 10.1007/s00392-007-0494-z; Chapman AB, 1998, KIDNEY INT, V54, P2056, DOI 10.1046/j.1523-1755.1998.00217.x; Churdchomjan W, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-5; DiPersio JF, 2011, NEW ENGL J MED, V365, P2536, DOI 10.1056/NEJMcibr1112347; Evers IN, 2004, BMJ-BRIT MED J, V328, P915, DOI 10.1136/bmj.38043.583160.EE; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fadini GP, 2014, STEM CELL TRANSL MED, V3, P949, DOI 10.5966/sctm.2014-0052; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Fadini GP, 2006, DIABETES CARE, V29, P714, DOI 10.2337/diacare.29.03.06.dc05-1834; Flo K, 2016, ACTA OBSTET GYN SCAN, V95, P225, DOI 10.1111/aogs.12802; Hernandez SL, 2014, DIABETES CARE, V37, P2193, DOI 10.2337/dc13-2547; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Holmes VA, 2013, DIABETES CARE, V36, P3671, DOI 10.2337/dc13-0944; Howangyin KY, 2014, ARTERIOSCL THROM VAS, V34, P1126, DOI 10.1161/ATVBAHA.114.303090; Hubel CA, 2011, PREGNANCY HYPERTENS, V1, P48, DOI 10.1016/j.preghy.2010.11.001; Jo DY, 2000, J CLIN INVEST, V105, P101, DOI 10.1172/JCI7954; Karumanchi SA, 2016, HYPERTENSION, V67, P238, DOI 10.1161/HYPERTENSIONAHA.115.05024; Lash GE, 2016, J LEUKOCYTE BIOL, V100, P315, DOI 10.1189/jlb.1A0815-351R; Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Liguori A, 2008, EUR J HAEMATOL, V80, P258, DOI 10.1111/j.1600-0609.2007.01007.x; Lima PDA, 2014, CELL MOL IMMUNOL, V11, P522, DOI 10.1038/cmi.2014.63; Luppi P, 2010, REPROD SCI, V17, P643, DOI 10.1177/1933719110366164; Maiorino MI, 2015, ENDOCRINE, V48, P342, DOI 10.1007/s12020-014-0277-z; Martinez-Varea A, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/128616; Osol G, 2009, PHYSIOLOGY, V24, P58, DOI 10.1152/physiol.00033.2008; Parsanezhad ME, 2015, J CHIN MED ASSOC, V78, P345, DOI 10.1016/j.jcma.2015.03.013; Perricone R, 2003, AM J REPROD IMMUNOL, V50, P232, DOI 10.1034/j.1600-0897.2003.00083.x; Petersen OFaye, 2006, HDB PLACENTAL PATHOL; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; PIJNENBORG R, 1983, PLACENTA, V4, P397, DOI 10.1016/S0143-4004(83)80043-5; Rigato M, 2015, J CLIN ENDOCR METAB, V100, P2666, DOI 10.1210/jc.2015-1687; Sanghavi M, 2014, CIRCULATION, V130, P1003, DOI 10.1161/CIRCULATIONAHA.114.009029; Scarpellini F, 2009, HUM REPROD, V24, P2703, DOI 10.1093/humrep/dep240; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Taylor R, 2007, BMJ-BRIT MED J, V334, P742, DOI 10.1136/bmj.39154.700417.BE; Valgimigli M, 2004, CIRCULATION, V110, P1209, DOI 10.1161/01.CIR.0000136813.89036.21; Wu X, 2005, J IMMUNOL, V175, P61, DOI 10.4049/jimmunol.175.1.61	43	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172988	10.1371/journal.pone.0172988	http://dx.doi.org/10.1371/journal.pone.0172988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278173	gold, Green Published, Green Submitted			2022-12-27	WOS:000396087900132
J	Souza, HR; de Azevedo, LR; Possebon, L; Costa, SD; Iyomasa-Pilon, MM; Oliani, SM; Girol, AP				Souza, Helena Ribeiro; de Azevedo, Lucas Ribeiro; Possebon, Lucas; Costa, Sara de Souza; Iyomasa-Pilon, Melina Mizusaki; Oliani, Sonia Maria; Girol, Ana Paula			Heterogeneity of mast cells and expression of Annexin A1 protein in a second degree burn model with silver sulfadiazine treatment	PLOS ONE			English	Article							LEVEL LASER THERAPY; CHYMASE; SKIN; INFLAMMATION; ACTIVATION; PROTEASES; TRYPTASE; PEPTIDE; SCAR; CYTOKINES	Mast cells (MCs) participate in all stages of skin healing and one of their mediators is the Annexin A1 protein (AnxA1), linked to inflammation, proliferation, migration and apoptosis processes, but not studied in thermal burns yet. Therefore, our objectives were to evaluate the behavior of MCs and AnxA1 in a second degree burn model, treated or not with silver sulfadiazine 1% (SDP 1%) and associated to macrophages quantification and cytokines dosages. MCs counts showed few cells in the early stages of repair but increased MCs in the final phases in the untreated group. The normal skin presented numerous tryptase-positive MCs that were reduced after burning in all analyzed periods. Differently, few chymasepositive MCs were observed in the early stages of healing, however, increased chymasepositive MCs were found at the final phase in the untreated group. MCs also showed high immunoreactivity for AnxA1 on day 3 in both groups. In the tissue there was a strong protein expression in the early stages of healing, but in the final phases only in the SDP treated animals. TNF-alpha, IL-1 beta, IL-6, IL-10 and MCP-1 levels and macrophages quantification were increased in inflammation and reepithelialization phases. Reduced IL-1 beta, IL-6 and IL-10 levels and numerous macrophages occurred in the treated animals during tissue repair. Our results indicate modulation in the profile of MCs and AnxA1expression during healing by the treatment with SDP 1%, pointing them as targets for therapeutic interventions on skin burns.	[Souza, Helena Ribeiro; Iyomasa-Pilon, Melina Mizusaki; Girol, Ana Paula] Integrated Coll Padre Albino Fdn FIPA, Sao Paulo, Brazil; [Souza, Helena Ribeiro; de Azevedo, Lucas Ribeiro; Possebon, Lucas; Costa, Sara de Souza; Oliani, Sonia Maria; Girol, Ana Paula] Sao Paulo State Univ UNESP, Lab Immunomorphol, Dept Biol, Sao Paulo, Brazil	Universidade Estadual Paulista	Girol, AP (corresponding author), Integrated Coll Padre Albino Fdn FIPA, Sao Paulo, Brazil.; Girol, AP (corresponding author), Sao Paulo State Univ UNESP, Lab Immunomorphol, Dept Biol, Sao Paulo, Brazil.	anapaulagirol@hotmail.com	Girol, Ana P/O-1716-2013; Possebon, Lucas P/G-1132-2015; Oliani, Sonia Maria/E-3476-2012; Costa, Sara Souza/X-7128-2018	Girol, Ana P/0000-0002-8760-8945; Possebon, Lucas P/0000-0002-7065-526X; Oliani, Sonia Maria/0000-0003-0918-2130; Costa, Sara Souza/0000-0002-9359-5482	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/en/); APG. The funding agency was instrumental in the acquisition of equipment and supplies for laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	amazo AS, 2011, BMC IMMUNOL, V12, P1; Artuc M, 2002, J INVEST DERMATOL, V119, P411, DOI 10.1046/j.1523-1747.2002.01838.x; Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010; Babcock GF, 2012, INFLAMMATION, V35, P259, DOI 10.1007/s10753-011-9313-9; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bastian Boris C., 1993, Journal of Dermatological Science, V6, P225, DOI 10.1016/0923-1811(93)90043-O; Bayat M, 2005, J PHOTOCH PHOTOBIO B, V78, P171, DOI 10.1016/j.jphotobiol.2004.08.012; Bayat M, 2008, J REHABIL RES DEV, V45, P931, DOI 10.1682/JRRD.2007.07.0110; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Bizzarro V., 2012, PLOS ONE, V7, P1; Boudhraa Z, 2014, CLIN EXP METASTAS, V31, P749, DOI 10.1007/s10585-014-9665-2; Cote MC, 2010, J BIOL CHEM, V285, P8013, DOI 10.1074/jbc.M109.098665; D'Acquisto F, 2008, BRIT J PHARMACOL, V155, P152, DOI 10.1038/bjp.2008.252; Del Gaudio P, 2015, CARBOHYD POLYM, V115, P629, DOI 10.1016/j.carbpol.2014.09.040; Dong XL, 2015, EXP THER MED, V9, P955, DOI 10.3892/etm.2015.2216; Dong XL, 2014, INT J CLIN EXP PATHO, V7, P3596; Dong XL, 2013, EXP THER MED, V5, P643, DOI 10.3892/etm.2012.836; Dong XL, 2012, MOL MED REP, V5, P1487, DOI 10.3892/mmr.2012.851; Douaiher J, 2014, ADV IMMUNOL, V122, P211, DOI 10.1016/B978-0-12-800267-4.00006-7; Ehrlich HP, 2013, ADV WOUND CARE, V2, P113, DOI 10.1089/wound.2012.0414; Evers LH, 2010, EXP DERMATOL, V19, P777, DOI 10.1111/j.1600-0625.2010.01105.x; Feyerabend TB, 2005, MOL CELL BIOL, V25, P6199, DOI 10.1128/MCB.25.14.6199-6210.2005; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; GAMELLI RL, 1993, SURG GYNECOL OBSTET, V177, P115; Gauglitz GG, 2008, SHOCK, V30, P503, DOI 10.1097/SHK.0b013e31816e3373; Gavins FNE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00354; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Girol AP, 2013, J IMMUNOL, V190, P5689, DOI 10.4049/jimmunol.1202030; Guo CM, 2013, FUTURE ONCOL, V9, P1773, DOI [10.2217/FON.13.114, 10.2217/fon.13.114]; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harunari N, 2006, BURNS, V32, P669, DOI 10.1016/j.burns.2006.03.015; Hermes B, 2000, J INVEST DERMATOL, V114, P51, DOI 10.1046/j.1523-1747.2000.00837.x; Huttunen M, 2000, EXP DERMATOL, V9, P258, DOI 10.1034/j.1600-0625.2000.009004258.x; Jia Y, 2013, J CELL PHYSIOL, V228, P476, DOI 10.1002/jcp.24156; Kamal AM, 2005, MEM I OSWALDO CRUZ, V100, P39, DOI 10.1590/S0074-02762005000900008; Kubo H, 2014, LEGAL MED-TOKYO, V16, P8, DOI 10.1016/j.legalmed.2013.10.002; da Silva HAL, 2015, REV SOC BRAS MED TRO, V48, P560, DOI 10.1590/0037-8682-0183-2015; Leoni G, 2015, MUCOSAL IMMUNOL, V8, P959, DOI 10.1038/mi.2015.63; Leoni G, 2015, J CLIN INVEST, V125, P1215, DOI 10.1172/JCI76693; Leoni G, 2013, J CLIN INVEST, V123, P443, DOI 10.1172/JCI65831; LEVISCHAFFER F, 1995, J INVEST DERMATOL, V104, P999, DOI 10.1111/1523-1747.ep12606237; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Ma F, 2008, STEM CELLS, V26, P706, DOI 10.1634/stemcells.2007-0348; Marx David E, 2014, Burns, V40 Suppl 1, pS9, DOI 10.1016/j.burns.2014.09.010; Meng Z, 2014, LUPUS, V23, P183, DOI 10.1177/0961203313513820; Meyerholz DK, 2009, INT J EXP PATHOL, V90, P26, DOI 10.1111/j.1365-2613.2008.00617.x; Nakazawa S, 2014, EUR J IMMUNOL, V44, P204, DOI 10.1002/eji.201343838; Neymeyer H, 2015, ACTA PHYSIOL, V215, P144, DOI 10.1111/apha.12586; Nishikori Y, 1998, ARCH DERMATOL RES, V290, P553, DOI 10.1007/s004030050351; Oliani SM, 2008, INFLAMM RES, V57, P450, DOI 10.1007/s00011-008-7222-7; Oliani SM, 2000, LAB INVEST, V80, P1429, DOI 10.1038/labinvest.3780150; Oppeltz RF, 2012, CYTOKINE, V60, P528, DOI 10.1016/j.cyto.2012.07.003; Parihar A, 2008, BURNS, V34, P6, DOI 10.1016/j.burns.2007.04.009; Patel N, 2008, AESTHET PLAST SURG, V32, P470, DOI 10.1007/s00266-008-9120-3; Paula R, 2015, J MOL HISTOL, V46, P33, DOI 10.1007/s10735-014-9595-y; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Richardson P, 2009, BURNS, V35, P921, DOI 10.1016/j.burns.2009.03.003; SAARINEN J, 1994, J BIOL CHEM, V269, P18134; Saito N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008227; Sato-Matsumura KC, 2000, ARCH DERMATOL RES, V292, P496, DOI 10.1007/s004030000172; SatoMatsumura KC, 1996, ARCH DERMATOL RES, V288, P565, DOI 10.1007/BF02505257; Stroncek John D., 2008, P3; Summer GJ, 2007, J PAIN, V8, P533, DOI 10.1016/j.jpain.2007.02.426; Takeo M, 2015, COLD SPRING HARB PER, P51; Teixeira RAP, 2013, J TISSUE ENG REGEN M, V10, P524; Trentin PG, 2015, BRIT J PHARMACOL, V172, P3058, DOI 10.1111/bph.13109; Welle M, 1997, J LEUKOCYTE BIOL, V61, P233, DOI 10.1002/jlb.61.3.233; Weller K, 2006, FASEB J, V20, P2366, DOI 10.1096/fj.06-5837fje; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Yeh FL, 2009, BURNS, V35, P348, DOI 10.1016/j.burns.2008.06.018	70	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173417	10.1371/journal.pone.0173417	http://dx.doi.org/10.1371/journal.pone.0173417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278234	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900089
J	Dayer, JA; Siegrist, CA; Huttner, A				Dayer, Julie-Anne; Siegrist, Claire-Anne; Huttner, Angela			Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous survey	PLOS ONE			English	Article								The continued participation of volunteers in clinical trials is crucial to advances in healthcare. Few data are available regarding the satisfaction and impressions of healthy volunteers after participation in phase I trials, many of which lead to unexpected adverse events. We report feedback from over 100 adult volunteers who took part in a first-in-human trial conducted in a high-income country testing an experimental Ebola vaccine causing significant reactogenicity, as well as unexpected arthritis in one fifth of participants. The anonymous, internet-based satisfaction survey was sent by email to all participants upon their completion of this one-year trial; it asked 24 questions concerning volunteers' motivations, impressions of the trial experience, and overall satisfaction. Answers were summarized using descriptive statistics. Of the 115 trial participants, 103 (90%) filled out the survey. Fifty-five respondents (53%) were male. Thirty-five respondents (34%) were healthcare workers, many of whom would deploy to Ebola-affected countries. All respondents cited scientific advancement as their chief motivation for participation, while 100/103 (97%) and 61/103 (59%) reported additional "humanitarian reasons" and potential protection from Ebolavirus, respectively. Although investigators had documented adverse events in 97% of trial participants, only 74 of 103 respondents (72%) recalled experiencing an adverse event. All reported an overall positive experience, and 93/103 (90%) a willingness to participate in future trials. Given the high level of satisfaction, no significant associations could be detected between trial experiences and satisfaction, even among respondents reporting adverse events lasting weeks or months. Despite considerable reactogenicity and unexpected vaccine-related arthritis, all survey respondents reported overall satisfaction. While this trial's context was unique, the positive feedback is likely due at least in part to the intense communication of trial information to participants, which included both general findings and personalized results.	[Dayer, Julie-Anne; Huttner, Angela] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland; [Dayer, Julie-Anne; Siegrist, Claire-Anne; Huttner, Angela] Fac Med, Geneva, Switzerland; [Siegrist, Claire-Anne; Huttner, Angela] Univ Hosp Geneva, Ctr Vaccinol, Geneva, Switzerland; [Siegrist, Claire-Anne] Fac Med, WHO Collaborating Ctr Vaccine Immunol, Geneva, Switzerland; [Huttner, Angela] Univ Hosp Geneva, Infect Control Program, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Huttner, A (corresponding author), Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland.; Huttner, A (corresponding author), Fac Med, Geneva, Switzerland.; Huttner, A (corresponding author), Univ Hosp Geneva, Ctr Vaccinol, Geneva, Switzerland.; Huttner, A (corresponding author), Univ Hosp Geneva, Infect Control Program, Geneva, Switzerland.	angela.huttner@hcuge.ch	Huttner, Angela/AAM-1197-2020	Huttner, Angela/0000-0002-8380-368X	Wellcome Trust Foundation	Wellcome Trust Foundation(Wellcome Trust)	The phase I clinical trial and the work on this survey were funded by the Wellcome Trust Foundation through a grant to the World Health Organization (https://wellcome.ac.uk/). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924; Attarwala H, 2010, J Young Pharm, V2, P332, DOI 10.4103/0975-1483.66810; Casassus B, 2016, LANCET, V387, P634, DOI 10.1016/S0140-6736(16)00318-4; Chu SH, 2012, CONTEMP CLIN TRIALS, V33, P611, DOI 10.1016/j.cct.2012.02.018; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Huttner A, 2015, LANCET INFECT DIS, V15, P1156, DOI 10.1016/S1473-3099(15)00154-1; Nisbetter R. E., 1977, J PERS SOC PSYCHOL, V35, P250, DOI DOI 10.1037/0022-3514.35.4.250; Regules JA, 2015, N ENGL J MED	8	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173148	10.1371/journal.pone.0173148	http://dx.doi.org/10.1371/journal.pone.0173148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273130	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700042
J	Hundsdoerfer, AK; Kitching, IJ				Hundsdoerfer, Anna K.; Kitching, Ian J.			Historic DNA for taxonomy and conservation: A case-study of a century-old Hawaiian hawkmoth type (Lepidoptera: Sphingidae)	PLOS ONE			English	Article							GENUS HYLES LEPIDOPTERA; MOLECULAR PHYLOGENY; MITOCHONDRIAL; PLIOCENE; SEA	Analysing historic DNA from museum specimens offers the unique opportunity to study the molecular systematics and phylogenetics of rare and possibly extinct taxa. In the Hawaiian fauna, the hawkmoth, Hyles calida calida, occurs on several of the main islands and is quite frequent, whereas Hyles c. hawaiiensis is restricted to the Island of Hawaii where it appears to be very rare. Analysis of mitochondrial DNA sequences shows that Hyles c. hawaiiensis differs from the nominotypical subspecies by an average p-distance of 2.8%, which is of a similar order of magnitude to that found between other species of Hyles, suggesting that Hyles c. hawaiiensis should perhaps be awarded species status, although more data are required for a formal taxonomic revision. Given the rarity of this taxon, these analyses should be undertaken urgently so that conservation measures can be implemented before it becomes extinct.	[Hundsdoerfer, Anna K.] Senckenberg Nat Hist Collect Dresden, Dresden, Germany; [Kitching, Ian J.] Nat Hist Museum, Dept Life Sci, London, England	Senckenberg Gesellschaft fur Naturforschung (SGN); Natural History Museum London	Hundsdoerfer, AK (corresponding author), Senckenberg Nat Hist Collect Dresden, Dresden, Germany.	anna.hundsdoerfer@senckenberg.de		Hundsdoerfer, Anna/0000-0001-5594-4154	DFG [HU 1561/1-1, HU 1561/1-2]; EU's Improving Human Potential program SYNTHESYS [GB-TAF-3410, GB-TAF-5177]; Open Access Fund of the Leibniz Association, AKH's Senckenberg research budget [923042]; NHMUK Department of Life Sciences Funds	DFG(German Research Foundation (DFG)); EU's Improving Human Potential program SYNTHESYS; Open Access Fund of the Leibniz Association, AKH's Senckenberg research budget; NHMUK Department of Life Sciences Funds	This work was supported by the DFG [grant numbers HU 1561/1-1 and 1-2 awarded to AKH]; and the EU's Improving Human Potential program SYNTHESYS [grant numbers GB-TAF-3410, GB-TAF-5177 awarded to AKH and IJK]. The publication of this article was funded by the Open Access Fund of the Leibniz Association, AKH's Senckenberg research budget [number 923042] and the NHMUK Department of Life Sciences Funds.	Butler AG, 1881, ANN MAGAZINE NATURAL, V7, p[317, 92]; DABRERA B, 1986, SPHINGIDAE MUNDI HAW; DANNER F, 1998, HERBIPOLIANA, V4, P1; Dwyer GS, 2009, PHILOS T R SOC A, V367, P157, DOI 10.1098/rsta.2008.0222; Hundsdoerfer AK, 2005, MOL PHYLOGENET EVOL, V35, P442, DOI 10.1016/j.ympev.2005.02.004; Hundsdoerfer AK, ZOOLOGICA S IN PRESS; Hundsdoerfer AK, 2011, ZOOL SCR, V40, P403, DOI 10.1111/j.1463-6409.2011.00477.x; Hundsdoerfer AK, 2010, ARTHROPOD SYST PHYLO, V68, P151; Hundsdoerfer AK, 2009, MOL PHYLOGENET EVOL, V52, P852, DOI 10.1016/j.ympev.2009.05.023; Kitching I. J., 2000, HAWKMOTHS WORLD ANNO; Kitching I. J., 2016, SPHINGIDAE TAXONOMIC; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Mende MB, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-83; Meyrick E., 1899, FAUNA HAWAIIENSIS, VI, P123; Nishida G.M, 1992, HAWAIIAN TERRESTRIAL; Rothschild LW, 1895, NOVITATES ZOOLOGICAE, V2; Rothschild LW, 1915, SOME NEW SPHINGIDAE, V22, P291; Sharp D., 1899, FAUNA HAWAIIENSIS ZO; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stroynowski Z, 2015, PALEOCEANOGRAPHY, V30, P1641, DOI 10.1002/2015PA002866; Stuckas H, 2011, J ZOOL SYST EVOL RES, V49, P335, DOI 10.1111/j.1439-0469.2011.00632.x; Swezey OH., 1944, P HAWAIIAN ENTOMOLOG, V12, P22; Swezey OH., 1954, FOREST ENTOMOLOGY HA, V44, P1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WILSON JT, 1963, CAN J PHYS, V41, P863, DOI 10.1139/p63-094; Zimmermann EC, 1958, INSECTS HAWAII, V7, P1; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	32	5	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173255	10.1371/journal.pone.0173255	http://dx.doi.org/10.1371/journal.pone.0173255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273123	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700049
J	Jeong, SR; Yang, HY; Hwang, HY				Jeong, Seri; Yang, Heeyoung; Hwang, Hyunyong			Evaluation of an automated connective tissue disease screening assay in Korean patients with systemic rheumatic diseases	PLOS ONE			English	Article							ANTINUCLEAR ANTIBODY; LUPUS-ERYTHEMATOSUS; CLASSIFICATION CRITERIA; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; GENERAL-POPULATION; NUCLEAR ANTIGENS; IMMUNOFLUORESCENCE; AUTOANTIBODIES; GUIDELINES	This study aimed to evaluate the diagnostic utilities of the automated connective tissues disease screening assay, CTD screen, in patients with systemic rheumatic diseases. A total of 1093 serum samples were assayed using CTD screen and indirect immunofluorescent (IIF) methods. Among them, 162 were diagnosed with systemic rheumatic disease, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and mixed connective tissue disease (MCT). The remaining 931 with non-systemic rheumatic disease were assigned to the control group. The median ratios of CTD screen tests were significantly higher in the systemic rheumatic disease group than in the control group. The positive likelihood ratios of the CTD screen were higher than those of IIF in patients with total rheumatic diseases (4.1 vs. 1.6), including SLE (24.3 vs. 10.7). The areas under the receiver operating characteristic curves (ROC-AUCs) of the CTD screen for discriminating total rheumatic diseases, RA, SLE, and MCT from controls were 0.68, 0.56, 0.92 and 0.80, respectively. The ROC-AUCs of the combinations with IIF were significantly higher in patients with total rheumatic diseases (0.72) and MCT (0.85) than in those of the CTD screen alone. Multivariate analysis indicated that both the CTD screen and IIF were independent variables for predicting systemic rheumatic disease. CTD screen alone and in combination with IIF were a valuable diagnostic tool for predicting systemic rheumatic diseases, particularly for SLE.	[Jeong, Seri; Hwang, Hyunyong] Kosin Univ, Coll Med, Dept Lab Med, Busan, South Korea; [Yang, Heeyoung] Paju Hosp, Gyeonggi Prov Med Ctr, Dept Lab Med, Gyeonggi, South Korea		Hwang, HY (corresponding author), Kosin Univ, Coll Med, Dept Lab Med, Busan, South Korea.	terminom@gmail.com	Hwang, Hyunyong/AAH-1041-2020; Hwang, Hyunyong/AAC-7027-2022	Hwang, Hyunyong/0000-0003-0662-3041	College of Medicine, Kosin University [2016]	College of Medicine, Kosin University	The funding source was College of Medicine, Kosin University (Award number: 2016) and the grant recipient was Seri Jeong, M.D., Ph.D., who had roles in study validation, formal analysis, investigation, data curation, original draft preparation, and visualization. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALARCONSEGOVIA D, 1989, J RHEUMATOL, V16, P328; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Benito-Garcia E, 2004, ARTHRIT RHEUM-ARTHR, V51, P1030, DOI 10.1002/art.20836; Bernardini S, 2004, CLIN CHEM LAB MED, V42, P1155, DOI 10.1515/CCLM.2004.235; Bizzaro N, 2004, CLIN EXP RHEUMATOL, V22, P349; Bonilla E, 2007, CLIN IMMUNOL, V124, P18, DOI 10.1016/j.clim.2007.04.010; Bossuyt X, 2005, CLIN CHEM, V51, P2426, DOI 10.1373/clinchem.2005.058552; Bossuyt X, 2009, AUTOIMMUN REV, V8, P543, DOI 10.1016/j.autrev.2009.01.013; CHELLINGWORTH MC, 1984, RHEUMATOL INT, V4, P23, DOI 10.1007/BF00683880; Colglazier CL, 2005, SOUTH MED J, V98, P185, DOI 10.1097/01.SMJ.0000153572.22346.E9; Doria A, 2010, AUTOIMMUN REV, V10, P55, DOI 10.1016/j.autrev.2010.08.014; Fenger M, 2004, CLIN CHEM, V50, P2141, DOI 10.1373/clinchem.2004.038422; Gonzalez C, 2005, CLIN CHIM ACTA, V359, P109, DOI 10.1016/j.cccn.2005.03.042; GRANT KD, 1981, J RHEUMATOL, V8, P587; Guo Ya-Ping, 2014, Curr Ther Res Clin Exp, V76, P116, DOI 10.1016/j.curtheres.2014.06.004; Hanly JG, 2010, J IMMUNOL METHODS, V352, P147, DOI 10.1016/j.jim.2009.10.003; Hayashi N, 2008, MOD RHEUMATOL, V18, P153, DOI 10.1007/s10165-008-0028-1; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Jeong S, 2012, CLIN CHIM ACTA, V414, P93, DOI 10.1016/j.cca.2012.08.018; Kavanaugh A, 2000, ARCH PATHOL LAB MED, V124, P71; Kavanaugh AF, 2002, ARTHRIT RHEUM-ARTHR, V47, P546, DOI 10.1002/art.10558; Kroshinsky D, 2009, NEW ENGL J MED, V360, P711, DOI 10.1056/NEJMcpc0807822; Lee JW, 2016, LUPUS; Linden A, 2006, J EVAL CLIN PRACT, V12, P132, DOI 10.1111/j.1365-2753.2005.00598.x; Meroni PL, 2010, ANN RHEUM DIS, V69, P1420, DOI 10.1136/ard.2009.127100; Op De Beeck K, 2011, AUTOIMMUN REV, V10, P801, DOI 10.1016/j.autrev.2011.06.005; Parker JC, 2011, J CLIN PATHOL, V64, P631, DOI 10.1136/jcp.2010.084756; Peene I, 2001, ANN RHEUM DIS, V60, P1131, DOI 10.1136/ard.60.12.1131; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Simmons SC, 2015, AM J NEPHROL, V42, P451, DOI 10.1159/000443747; Solomon DH, 2002, ARTHRIT RHEUM-ARTHR, V47, P434, DOI 10.1002/art.10561; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	37	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173597	10.1371/journal.pone.0173597	http://dx.doi.org/10.1371/journal.pone.0173597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273146	gold, Green Submitted, Green Published			2022-12-27	WOS:000396073700020
J	Marcus, AF; Illescas, AH; Hohl, BC; Llanos, AAM				Marcus, Andrea Fleisch; Illescas, Alex H.; Hohl, Bernadette C.; Llanos, Adana A. M.			Relationships between social isolation, neighborhood poverty, and cancer mortality in a population-based study of US adults	PLOS ONE			English	Article							BREAST-CANCER; SOCIOECONOMIC-STATUS; NETWORKS; DISPARITIES; SUPPORT; HEALTH; RISK; INTEGRATION; ASSOCIATIONS; INEQUALITIES	Background Social isolation is an important determinant of all-cause mortality, with evidence suggesting an association with cancer-specific mortality as well. In this study, we examined the associations between social isolation and neighborhood poverty ( independently and jointly) on cancer mortality in a population-based sample of US adults. Methods Using data from the Third National Health and Nutrition Examination Survey ( NHANES III; 1988-1994), NHANES III Linked Mortality File ( through 2011) and 1990 Census, we estimated the relationship between social isolation and high neighborhood poverty and time-tocancer death using multivariable-adjusted Cox proportional hazards models. We examined the associations of each factor independently and explored the multiplicative and additive interaction effects on cancer mortality risk and also analyzed these associations by sex. Results Among 16 044 US adults with 17-23 years of follow-up, there were 1133 cancer deaths. Social isolation ( HR 1.25, 95% CI: 1.01-1.54) and high neighborhood poverty ( HR 1.31, 95% CI: 1.08-1.60) were associated with increased risk of cancer mortality adjusting for age, sex, and race/ethnicity; in sex-specific estimates this increase in risk was evident among females only ( HR 1.39, 95% CI: 1.04-1.86). These associations were attenuated upon further adjustment for socioeconomic status. There was no evidence of joint effects of social isolation and high neighborhood poverty on cancer mortality overall or in the sex-stratified models. Conclusions These findings suggest that social isolation and higher neighborhood poverty are independently associated with increased risk of cancer mortality, although there is no evidence to support our a priori hypothesis of a joint	[Marcus, Andrea Fleisch; Illescas, Alex H.] Rutgers Sch Hlth Profess, Dept Nutr Sci, Newark, NJ 07107 USA; [Marcus, Andrea Fleisch; Hohl, Bernadette C.; Llanos, Adana A. M.] Rutgers Sch Publ Hlth, Dept Epidemiol, Piscataway, NJ 08854 USA; [Hohl, Bernadette C.] Rutgers Sch Criminal Justice, Newark, NJ USA; [Llanos, Adana A. M.] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Marcus, AF (corresponding author), Rutgers Sch Hlth Profess, Dept Nutr Sci, Newark, NJ 07107 USA.; Marcus, AF (corresponding author), Rutgers Sch Publ Hlth, Dept Epidemiol, Piscataway, NJ 08854 USA.	andreafleischmarcus@gmail.com	Llanos, Adana A.M./J-8695-2019	Llanos, Adana A.M./0000-0001-9954-9121; Fleisch Marcus, Andrea/0000-0001-6557-3748	Rutgers SHP Faculty Development; Cancer Center Support Grant [P30 CA072720]; Rutgers SHRP Faculty Development	Rutgers SHP Faculty Development; Cancer Center Support Grant; Rutgers SHRP Faculty Development	This study was supported by Rutgers SHP Faculty Development funding and by and Cancer Center Support Grant P30 CA072720 (Rutgers Cancer Institute of New Jersey). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially supported by Rutgers SHRP Faculty Development funding and by the Cancer Center Support Grant P30 CA072720 (Rutgers Cancer Institute of New Jersey). We sincerely thank Jing Tian, PhD at the National Center for Health Statistics Research Data Center for preparation of the data. The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of the Research Data Center, the National Center for Health Statistics, or the Centers for Disease Control and Prevention.	Beasley JM, 2010, J CANCER SURVIV, V4, P372, DOI 10.1007/s11764-010-0139-5; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Bradley CJ, 2002, J NATL CANCER I, V94, P490; Ertel KA, 2008, AM J PUBLIC HEALTH, V98, P1215, DOI 10.2105/AJPH.2007.113654; Ford ES, 2006, ANN EPIDEMIOL, V16, P78, DOI 10.1016/j.annepidem.2005.08.005; Galea S, 2011, AM J PUBLIC HEALTH, V101, P1456, DOI 10.2105/AJPH.2010.300086; Ginsburg O., 2016, LANCET; Gomez SL, 2015, CANCER-AM CANCER SOC, V121, P2314, DOI 10.1002/cncr.29345; Hinzey A, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0700-x; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Ikeda A, 2013, CANCER CAUSE CONTROL, V24, P847, DOI 10.1007/s10552-013-0147-7; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kawachi I, 1996, J EPIDEMIOL COMMUN H, V50, P245, DOI 10.1136/jech.50.3.245; Kish Jonathan K., 2014, Journal of the National Cancer Institute Monographs, P236, DOI 10.1093/jncimonographs/lgu020; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Krieger N, 2003, AM J PUBLIC HEALTH, V93, P1655, DOI 10.2105/AJPH.93.10.1655; Krieger N, 2005, AM J PUBLIC HEALTH, V95, P312, DOI 10.2105/AJPH.2003.032482; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Krieger N, 2012, AM J PUBLIC HEALTH, V102, P936, DOI 10.2105/AJPH.2011.300544; Kroenke CH, 2013, BREAST CANCER RES TR, V139, P515, DOI 10.1007/s10549-013-2477-2; Kroenke CH, 2013, BREAST CANCER RES TR, V137, P261, DOI 10.1007/s10549-012-2253-8; Kroenke CH, 2006, J CLIN ONCOL, V24, P1105, DOI 10.1200/JCO.2005.04.2846; Lutgendorf SK, 2012, J CLIN ONCOL, V30, P2885, DOI 10.1200/JCO.2011.39.4411; Marcus AF, 2016, ANN EPIDEMIOL, V26, P261, DOI 10.1016/j.annepidem.2016.02.006; Marcus AF, 2015, AM J COMMUN PSYCHOL, V56, P134, DOI 10.1007/s10464-015-9732-0; Markossian TW, 2013, HEALTH SERV RES; Nagayoshi M, 2014, STROKE, V45, P2868, DOI 10.1161/STROKEAHA.114.005815; National Center for Health Statistics, 1996, 3 NAT HLTH NUTR EX S; National Center for Health Statistics, 2013, 3 NAT HLTH EX SURV N; [National Center for Health Statistics US Department of Health and Human Services], 2009, NAT HLTH NUTR EX SUR; O'Campo P, 2015, HEALTH PLACE, V31, P65, DOI 10.1016/j.healthplace.2014.11.001; O'Campo P, 2009, HEALTH PLACE, V15, P56, DOI 10.1016/j.healthplace.2008.02.004; Pantell M, 2013, AM J PUBLIC HEALTH, V103, P2056, DOI 10.2105/AJPH.2013.301261; Pinquart M, 2010, CRIT REV ONCOL HEMAT, V75, P122, DOI 10.1016/j.critrevonc.2009.06.003; Plickert G, 2007, SOC NETWORKS, V29, P405, DOI 10.1016/j.socnet.2007.01.007; Roux AVD, 2008, J EPIDEMIOL COMMUN H, V62, P957, DOI 10.1136/jech.2007.064311; Samuel LJ, 2015, PREV MED, V71, P61, DOI 10.1016/j.ypmed.2014.12.008; Schulz AJ, 2013, HEALTH PLACE, V24, P147, DOI 10.1016/j.healthplace.2013.09.005; Schulz AJ, 2012, AM J PUBLIC HEALTH, V102, P1706, DOI 10.2105/AJPH.2011.300412; SEEMAN TE, 1987, AM J EPIDEMIOL, V126, P714, DOI 10.1093/oxfordjournals.aje.a114711; Sposto R, 2016, CANCER EPIDEM BIOMAR, V25, P1064, DOI 10.1158/1055-9965.EPI-15-1326; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Stringhini S, 2012, AM J EPIDEMIOL, V175, P1275, DOI 10.1093/aje/kwr461; Subramanian SV, 2005, AM J PUBLIC HEALTH, V95, P260, DOI 10.2105/AJPH.2003.034132; The Public Health Disparities Geocoding Project, 2004, PUBL HLTH DISP GEOC; Tian N, 2012, WOMEN HEALTH ISS, V22, pE267, DOI 10.1016/j.whi.2011.11.007; Turesky RJ, 2003, CHEM RES TOXICOL, V16, P1162, DOI 10.1021/tx030029r; Warner ET, 2015, J CLIN ONCOL, V33, P2254, DOI 10.1200/JCO.2014.57.1349; Whitman S, 2012, CANCER EPIDEMIOL, V36, pE147, DOI 10.1016/j.canep.2011.10.012	51	46	46	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173370	10.1371/journal.pone.0173370	http://dx.doi.org/10.1371/journal.pone.0173370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273125	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700056
J	Fauser, BCJM; Donnez, J; Bouchard, P; Barlow, DH; Vazquez, F; Arriagada, P; Skouby, SO; Palacios, S; Tomaszewski, J; Lemieszczuk, B; William, ARW				Fauser, Bart C. J. M.; Donnez, Jacques; Bouchard, Philippe; Barlow, David H.; Vazquez, Francisco; Arriagada, Pablo; Skouby, Sven O.; Palacios, Santiago; Tomaszewski, Janusz; Lemieszczuk, Boguslaw; William, Alistair R. W.			Safety after extended repeated use of ulipristal acetate for uterine fibroids	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR MODULATORS; LONG-TERM; ENDOMETRIAL HYPERPLASIA	Objective To assess long term safety of extended repeated 3-month courses of ulipristal acetate (UPA) 10 mg/day, for up to 8 courses, with focus on endometrial and laboratory safety parameters. Methods This long-term, multi-center, open-label cohort, follow up study consisted of up to 8 consecutive 3-month courses of daily UPA 10 mg, each separated by a drug free period of 2 spontaneous menstrual bleeds. Sixty-four pre-menopausal women, with moderate to severe symptomatic uterine myoma(s) and heavy bleeding were enrolled and were studied for approximately 4 years. The main outcome measures were endometrial histology, laboratory parameters and general safety. Results All data was reported in a descriptive manner with no formal statistical comparisons. In the 64 women, non-physiological changes (mostly cyst formation, epithelial and vascular changes) in endometrial histology at screening and after treatment courses 4 and 8 were observed in 18.0%, 21.4% and 16.3% of biopsies, respectively. After treatment cessation, such changes were observed in 9.1% of biopsies. All endometrial biopsies were benign after course 8. The median endometrial thickness was 7.0 mm, 10-18 days after the start of menses following treatment courses 5-8, compared to 9.0 mm at screening (before UPA treatment). No changes in the number and type of laboratory results outside the normal ranges were observed with the increasing treatment courses. In total, adverse events were reported in 10 (16%), 12 (19%), 8 (14%) and 5 (9%) subjects, during treatment courses 5, 6, 7 and 8, respectively of which the most frequent adverse events were headache and hot flush. Conclusion The results of this study further support the safety profile of extended repeated 3 months treatment of symptomatic fibroids with ulipristal acetate 10 mg/day. Repeated UPA treatment courses did not result in any changes of concern in endometrial histology, endometrial thickness, or laboratory safety measures.	[Fauser, Bart C. J. M.] Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands; [Donnez, Jacques] Soc Rech Infertil, Brussels, Belgium; [Bouchard, Philippe] Hosp St Antoine, AP HP, Endocrinol Unit, Paris, France; [Barlow, David H.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Barlow, David H.] Hamad Med Corp, Doha, Qatar; [Vazquez, Francisco] Ctr Estudios Obstet & Ginecol Asociado, Lugo, Spain; [Arriagada, Pablo] Gedeon Richter PregLem SA, Geneva, Switzerland; [Skouby, Sven O.] Univ Copenhagen, Fac Hlth & Med Sci, Herlev Gentofte Hosp, Div Reprod Endocrinol,Dept OB GYN, Copenhagen, Denmark; [Palacios, Santiago] Palacios Inst Womens Hlth, Madrid, Spain; [Tomaszewski, Janusz] Prywatna Klin Polozniczo Ginekol, Bialystok, Poland; [Lemieszczuk, Boguslaw] Gabinet Lekarski Specjalisty Sonus, Warsaw, Poland; [William, Alistair R. W.] Univ Edinburgh, Royal Infirm Edinburgh, Dept Pathol, Edinburgh, Midlothian, Scotland	Utrecht University; Utrecht University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Glasgow; Hamad Medical Corporation; University of Copenhagen; Royal Infirmary of Edinburgh; University of Edinburgh	Fauser, BCJM (corresponding author), Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands.	B.C.Fauser@umcutrecht.nl	PALACIOS, SANTIAGO DR/H-1818-2012; Barlow, David/F-8738-2011	Palacios, Santiago/0000-0003-2229-1200; skouby, sven olaf/0000-0002-9022-8951	Gedeon Richter/Preg Lem S.A. Geneva, Switzerland	Gedeon Richter/Preg Lem S.A. Geneva, Switzerland	This study was funded by Gedeon Richter/Preg Lem S.A. Geneva, Switzerland. The funders had a role in study design, data collection and analysis, and medical writing support for the authors.	Bestel E, 2014, EXPERT REV ENDOCRINO, V9, P79, DOI 10.1586/17446651.2014.862495; Bouchard P, 2011, FERTIL STERIL, V96, P1175, DOI 10.1016/j.fertnstert.2011.08.021; Donnez J, 2016, FERTIL STERIL, V105, P165, DOI 10.1016/j.fertnstert.2015.09.032; Donnez J, 2014, FERTIL STERIL, V101, P1565, DOI 10.1016/j.fertnstert.2014.02.008; Donnez J, 2012, NEW ENGL J MED, V366, P421, DOI 10.1056/NEJMoa1103180; Donnez J, 2012, NEW ENGL J MED, V366, P409, DOI 10.1056/NEJMoa1103182; KURMAN RJ, 1985, CANCER, V56, P403, DOI 10.1002/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X; Lacey JV, 2010, J CLIN ONCOL, V28, P788, DOI 10.1200/JCO.2009.24.1315; Luyckx M, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1253; Mutter GL, 2008, MODERN PATHOL, V21, P591, DOI 10.1038/modpathol.2008.19; Williams ARW, 2012, INT J GYNECOL PATHOL, V31, P556, DOI 10.1097/PGP.0b013e318251035b	11	40	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173523	10.1371/journal.pone.0173523	http://dx.doi.org/10.1371/journal.pone.0173523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267814	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000396060600041
J	Pfeiffer, W; Braun, J; Burchell, J; Witte, CL; Rideout, BA				Pfeiffer, Wayne; Braun, Josephine; Burchell, Jennifer; Witte, Carmel L.; Rideout, Bruce A.			Whole-genome analysis of mycobacteria from birds at the San Diego Zoo	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; AVIUM SUBSP-AVIUM; TUBERCULOSIS TRANSMISSION; DIVERSITY; IDENTIFICATION; INFECTIONS; STRAINS; LEVEL	Methods Mycobacteria isolated from more than 100 birds diagnosed with avian mycobacteriosis at the San Diego Zoo and its Safari Park were cultured postmortem and had their whole genomes sequenced. Computational workflows were developed and applied to identify the mycobacterial species in each DNA sample, to find single-nucleotide polymorphisms (SNPs) between samples of the same species, to further differentiate SNPs between as many as three different genotypes within a single sample, and to identify which samples are closely clustered genomically. Results Nine species of mycobacteria were found in 123 samples from 105 birds. The most common species were Mycobacterium avium and Mycobacterium genavense, which were in 49 and 48 birds, respectively. Most birds contained only a single mycobacterial species, but two birds contained a mixture of two species. The M. avium samples represent diverse strains of M. avium avium and M. avium hominissuis, with many pairs of samples differing by hundreds or thousands of SNPs across their common genome. By contrast, the M. genavense samples are much closer genomically; samples from 46 of 48 birds differ from each other by less than 110 SNPs. Some birds contained two, three, or even four genotypes of the same bacterial species. Such infections were found in 4 of 49 birds (8%) with M. avium and in 11 of 48 birds (23%) with M. genavense. Most were mixed infections, in which the bird was infected by multiple mycobacterial strains, but three infections with two genotypes differing by <= 10 SNPs were likely the result of within-host evolution. The samples from 31 birds with M. avium can be grouped into nine clusters within which any sample is <= 12 SNPs from at least one other sample in the cluster. Similarly, the samples from 40 birds with M. genavense can be grouped into ten such clusters. Information about these genomic clusters is being used in an ongoing, companion study of mycobacterial transmission to help inform management of bird collections.	[Pfeiffer, Wayne] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Braun, Josephine; Burchell, Jennifer; Witte, Carmel L.; Rideout, Bruce A.] San Diego Zoo Global, Wildlife Dis Labs, San Diego, CA USA	University of California System; University of California San Diego	Pfeiffer, W (corresponding author), Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA.	pfeiffer@sdsc.edu	DeHovitz Braun, Joan/D-8690-2018	DeHovitz Braun, Joan/0000-0001-9975-7959	Ellen Browning Scripps Foundation; McBeth Foundation; National Science Foundation	Ellen Browning Scripps Foundation; McBeth Foundation; National Science Foundation(National Science Foundation (NSF))	This study was funded in large part by the Ellen Browning Scripps Foundation. Additional funds were provided by the McBeth Foundation. The funders had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Rachael Keeler for assistance with data tracking and organization as well as all other Wildlife Disease Laboratories personnel that helped identify cases and handle samples. In addition, WP gratefully acknowledges helpful discussions with Steven Head regarding whole-genome sequencing, Zamin Iqbal and Madhusudan Gujral regarding variant calling, and Mark Miller regarding interpretation of the results. All computer analyses, except for the FastQC and FigTree processing, were run on the Gordon supercomputer at the San Diego Supercomputer Center, which is supported by the National Science Foundation.	Ahlstrom C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1387-6; ARBEIT RD, 1993, J INFECT DIS, V167, P1384, DOI 10.1093/infdis/167.6.1384; BODDINGHAUS B, 1990, J CLIN MICROBIOL, V28, P1751; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Cohen T, 2012, CLIN MICROBIOL REV, V25, P708, DOI 10.1128/CMR.00021-12; Dvorska L, 2007, VET MICROBIOL, V119, P366, DOI 10.1016/j.vetmic.2006.09.010; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Hanekom M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070178; Hatherell HA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0566-x; Hoop RK, 1996, J CLIN MICROBIOL, V34, P991, DOI 10.1128/JCM.34.4.991-992.1996; Kauppinen J, 2001, VET MICROBIOL, V81, P41, DOI 10.1016/S0378-1135(01)00330-3; Kay GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7717; Lieberman TD, 2016, NAT MED, V22, P1470, DOI 10.1038/nm.4205; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Pankhurst LJ, 2016, LANCET RESP MED, V4, P49, DOI 10.1016/S2213-2600(15)00466-X; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Schrenzel M, 2008, VET MICROBIOL, V126, P122, DOI 10.1016/j.vetmic.2007.06.016; Shamputa IC, 2004, J CLIN MICROBIOL, V42, P5528, DOI 10.1128/JCM.42.12.5528-5536.2004; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; Shitaye JE, 2008, VET MICROBIOL, V127, P155, DOI 10.1016/j.vetmic.2007.07.026; TAKEWAKI S, 1993, J CLIN MICROBIOL, V31, P446, DOI 10.1128/JCM.31.2.446-450.1993; TELENTI A, 1993, J CLIN MICROBIOL, V31, P175, DOI 10.1128/JCM.31.2.175-178.1993; Tell LA, 2001, REV SCI TECH OIE, V20, P180, DOI 10.20506/rst.20.1.1273; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; Witte CL, 2008, J VET DIAGN INVEST, V20, P186, DOI 10.1177/104063870802000207; Worby CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003549	28	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173464	10.1371/journal.pone.0173464	http://dx.doi.org/10.1371/journal.pone.0173464			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267758	Green Published, gold, Green Submitted			2022-12-27	WOS:000396060600034
J	Kang, ZH; Zhang, X; Ding, SM; Tang, CF; Wang, YY; de Jong, H; Cameron, SL; Wang, MQ; Yang, D				Kang, Zehui; Zhang, Xiao; Ding, Shuangmei; Tang, Chufei; Wang, Yuyu; de Jong, Herman; Cameron, Stephen L.; Wang, Mengqing; Yang, Ding			Transcriptomes of three species of Tipuloidea (Diptera, Tipulomorpha) and implications for phylogeny of Tipulomorpha	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; GENE ONTOLOGY; GENOME; EVOLUTION; NEMATOCERA; INSIGHTS; DATABASE; INSECTA; MAFFT; TREE	Tipulomorpha has long been a problematic taxon in terms of familial composition, phylogenetic relationships among families and position relative to other `lower' Diptera. Whole-transcriptome shotgun sequencing provides a powerful basis for phylogenetic studies. We performed de novo transcriptome sequencing to produce the first transcriptome datasets representing the families Pediciidae, Limoniidae and Cylindrotomidae using high-throughput sequencing technologies. We assembled cDNA libraries for Pedicia vetusta (Alexander) (Pediciidae), Rhipidia sejuga Zhang, Li and Yang (Limoniidae) and Liogma simplicicornis Alexander (Cylindrotomidae). Using the Illumina RNA-Seq method, we obtained 28,252, 44,152 and 44,281 unigenes, from the three respective species. Based on sequence similarity searches, 12,475 (44.16%), 20,334 (46.05%) and 17,478 (39.47%) genes were identified. Analysis of genes highly conserved at the amino acid sequence level revealed there were 1,709 single-copy orthologs genes across the analyzed species. Phylogenetic trees constructed using maximum likelihood (ML) based on the 1,709 single-copy orthologs genes indicated that the relationship between the four major infraorders of lower Diptera was: Culicomorpha + (Tipulomorpha + (Psychodomorpha + (Bibionomorpha + Brachycera))). Trichoceridae belongs within Tipulomorpha as the sister-group of Tipuloidea. Highly supported relationships within the Tipuloidea are Pediciidae + (Limoniidae + (Cylindrotomidae + Tipulidae)). Four-cluster likelihood mapping was used to study potential incongruent signals supporting other topologies, however, results were congruent with the ML tree.	[Kang, Zehui; Zhang, Xiao; Ding, Shuangmei; Tang, Chufei; Wang, Yuyu; Wang, Mengqing; Yang, Ding] China Agr Univ, Dept Entomol, Beijing, Peoples R China; [de Jong, Herman] Darwinweg, Nat Biodivers Ctr, Cr Leiden, Netherlands; [Cameron, Stephen L.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Wang, Mengqing] Chinese Acad Agr Sci, Inst Plant Protect, Beijing, Peoples R China	China Agricultural University; Naturalis Biodiversity Center; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wang, MQ; Yang, D (corresponding author), China Agr Univ, Dept Entomol, Beijing, Peoples R China.; Wang, MQ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Beijing, Peoples R China.	mengqingsw@163.com; dyangcau@126.com	Wang, Yuyu/J-3117-2019; Zhang, Xiao/AAD-7627-2020; Cameron, Stephen L/A-3742-2008	Cameron, Stephen L/0000-0002-6694-4130; Kang, Zehui/0000-0003-1961-9578; Tang, Chufei/0000-0001-6266-4900; Zhang, Xiao/0000-0002-8054-0968	National Natural Science Foundation of China [31320103902, 31272354]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31320103902 and 31272354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CP., 1919, MEMOIRS CORNELL U AG, V25, P767; Alexander CP., 1920, MEMOIRS CORNELL U AG, V38, P691; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beckenbach AT, 2012, GENOME BIOL EVOL, V4, P89, DOI 10.1093/gbe/evr131; Bertone MA, 2008, SYST ENTOMOL, V33, P668, DOI 10.1111/j.1365-3113.2008.00437.x; Blagoderov V., 2007, AM MUSEUM NOVITATES, V3572; Brodo F., 1984, THESIS; Ribeiro GC, 2008, INVERTEBR SYST, V22, P627, DOI 10.1071/IS08017; DAHL C, 1980, ZOOL SCR, V9, P165, DOI 10.1111/j.1463-6409.1980.tb00662.x; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Friedrich M, 1997, MOL BIOL EVOL, V14, P644, DOI 10.1093/oxfordjournals.molbev.a025804; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths GCD, 1990, QUAEST ENTOMOL, V26, P117; Hennig W., 1954, Beitraege zur Entomologie Berlin, V4, P245; Hennig W., 1973, Handbuch der Zoologie, V4(2), P1; Hennig W., 1981, INSECT PHYLOGENY; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jong HD, 2007, HYDROBIOLOGIA, V595, P457; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; KRZEMINSKI W, 1992, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V65, P39; Lambkin CL, 2013, SYST ENTOMOL, V38, P164, DOI 10.1111/j.1365-3113.2012.00652.x; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Michelsen V, 1996, ZOOL J LINN SOC-LOND, V117, P71; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; OOSTERBROEK P, 1991, Tijdschrift voor Entomologie, V134, P211; OOSTERBROEK P, 1995, ZOOL J LINN SOC-LOND, V115, P267, DOI 10.1111/j.1096-3642.1995.tb02462.x; Oosterbroek P., CATALOGUE CRANEFLIES; Peters RS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-52; Petersen MJ, 2010, SYST ENTOMOL, V35, P526, DOI 10.1111/j.1365-3113.2010.00524.x; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Savchenko E.N., 1979, Tijdschrift voor Entomologie, V122, P91; Savchenko EN., 1966, TIPULIDAE FAUNA UKRA, V14, P1; Savchenko EN, 1983, FAUNA USSR DIPTERA, V127, P1; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; STARY J, 1992, Acta Zoologica Cracoviensia, V35, P11; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Wood D.M, 1989, MANUAL NEARCTIC DIPT, V3, P1333; Yeates DK, 2005, EVOLUTIONARY BIOL FL; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	45	12	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173207	10.1371/journal.pone.0173207	http://dx.doi.org/10.1371/journal.pone.0173207			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264066	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300045
J	Otterpohl, KL; Gould, KA				Otterpohl, Karla L.; Gould, Karen A.			Evaluation of Rint1 as a modifier of intestinal tumorigenesis and cancer risk	PLOS ONE			English	Article							GOLGI-ER RETROGRADE; RAD50-INTERACTING PROTEIN; COMPLEX; ZW10; LOCALIZATION; TRAFFICKING; BREAST; LOCUS; MOM5	The Rad50 Interacting Protein 1 (Rint1) influences cellular homeostasis through maintenance of endoplasmic reticulum, Golgi and centrosome integrity and regulation of vesicle transport, autophagy and the G(2)/M checkpoint. Rint1 has been postulated to function as a tumor suppressor as well as an oncogene, with its role depending perhaps upon the precise cellular and/or experimental context. In humans, heterozygosity for germline missense variants in RINT1 have, in some studies, been associated with increased risk of both breast and Lynch syndrome type cancers. However, it is not known if these germline variants represent loss of function alleles or gain of function alleles. Based upon these findings, as well as our initial consideration of Rint1 as a potential candidate for Mom5, a genetic modifier of intestinal tumorigenesis in Apc(Min/+) mice, we sought to explicitly examine the impact of Rint1 on tumorigenesis in Apc(Min/+) mice. However, heterozygosity for a knockout of Rint1 had no impact on tumorigenesis in Rint1(+/-); Apc(Min/+) mice. Likewise, we found no evidence to suggest that the remaining Rint1 allele was lost somatically in intestinal tumors in Apc(Min/+) mice. Interestingly, in contrast to what has been observed in Rint1(+/-) mice on a mixed genetic background, Rint1(+/-) mice on a pure C57BL/6J background did not show spontaneous tumor development. We also evaluated colorectal cancer data available in the COSMIC and ONCOMINE databases and found that RINT1 overexpression, as well as the presence of somatic missense mutations in RINT1 were associated with colorectal cancer development. In vitro evaluation of two missense variants in RINT1 suggested that such variants do have the potential to impact RINT1 function.	[Otterpohl, Karla L.; Gould, Karen A.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Otterpohl, Karla L.] Sanford Res, Childrens Hlth Res Ctr, Sioux Falls, SD USA	University of Nebraska System; University of Nebraska Medical Center; Sanford Health	Gould, KA (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.	kagould@unmc.edu			NCRR [5P20RR016469, RR018788]; National Institute for General Medical Science (NIGMS) [8P20GM103427, P20GM103471]	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute for General Medical Science (NIGMS)	The University of Nebraska DNA Sequencing Core receives partial support from the NCRR (5P20RR016469, RR018788) and the National Institute for General Medical Science (NIGMS) (8P20GM103427, P20GM103471). The author(s) received no other specific funding for this work.	Arasaki K, 2007, BIOCHEM BIOPH RES CO, V359, P811, DOI 10.1016/j.bbrc.2007.05.188; Arasaki K, 2006, MOL BIOL CELL, V17, P2780, DOI 10.1091/mbc.E05-10-0973; Arasaki K, 2013, MOL BIOL CELL, V24, P2907, DOI 10.1091/mbc.E13-01-0014; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Grigaravicius P, 2016, CELL DEATH DIFFER, V23, P454, DOI 10.1038/cdd.2015.113; Haines DC, 2001, TOXICOL PATHOL, V29, P653, DOI 10.1080/019262301753385988; He SS, 2014, AUTOPHAGY, V10, P180, DOI 10.4161/auto.26917; He SS, 2013, NAT CELL BIOL, V15, P1206, DOI 10.1038/ncb2848; Hirose H, 2004, EMBO J, V23, P1267, DOI 10.1038/sj.emboj.7600135; Kong LJ, 2006, MOL CELL, V22, P63, DOI 10.1016/j.molcel.2006.02.016; Li N, 2016, BREAST CANCER RES TR, V159, P385, DOI 10.1007/s10549-016-3944-3; Lin XQ, 2007, MOL CELL BIOL, V27, P4905, DOI 10.1128/MCB.02396-06; Oikarinen SI, 2009, CARCINOGENESIS, V30, P1591, DOI 10.1093/carcin/bgp159; Otterpohl KL, 2015, MAMM GENOME, V26, P235, DOI 10.1007/s00335-015-9567-x; Park DJ, 2014, CANCER DISCOV, V4, P804, DOI 10.1158/2159-8290.CD-14-0212; Quayle SN, 2012, NEURO-ONCOLOGY, V14, P1325, DOI 10.1093/neuonc/nos246; Xiao J, 2001, J BIOL CHEM, V276, P6105, DOI 10.1074/jbc.M008893200	17	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172247	10.1371/journal.pone.0172247	http://dx.doi.org/10.1371/journal.pone.0172247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264000	Green Submitted, gold, Green Published			2022-12-27	WOS:000396054300009
J	Liu, CQ; Hu, KD; Li, TT; Yang, Y; Yang, F; Li, YH; Liu, HP; Chen, XY; Zhang, H				Liu, Cheng-Qian; Hu, Kang-Di; Li, Ting-Ting; Yang, Ying; Yang, Feng; Li, Yan-Hong; Liu, He-Ping; Chen, Xiao-Yan; Zhang, Hua			Polygalacturonase gene pgxB in Aspergillus niger is a virulence factor in apple fruit	PLOS ONE			English	Article							ENDOPOLYGALACTURONASE; ENZYMES; FAMILY; FLAVUS; LYASE; PATHOGENICITY; DEGRADATION; DISRUPTION; EXPRESSION; HOST	Aspergillus niger, a saprophytic fungus, is widely distributed in soil, air and cereals, and can cause postharvest diseases in fruit. Polygalacturonase (PG) is one of the main enzymes in fungal pathogens to degrade plant cell wall. To evaluate whether the deletion of an exopolygalacturonase gene pgxB would influence fungal pathogenicity to fruit, pgxB gene was deleted in Aspergillus niger MA 70.15 (wild type) via homologous recombination. The Delta pgx13 mutant showed similar growth behavior compared with the wild type. Pectin medium induced significant higher expression of all pectinase genes in both wild type and Delta pgx13 in comparison to potato dextrose agar medium. However, the Delta pgxB mutant was less virulent on apple fruits as the necrosis diameter caused by Delta pgxB mutant was significantly smaller than that of wild type. Results of quantitive-PCR showed that, in the process of infection in apple fruit, gene expressions of polygalacturonase genes pgal, pgall, pgaA, pgaC, pgaD and pgaE were enhanced in Delta pgxB mutant in comparison to wild type. These results prove that, despite the increased gene expression of other polygalacturonase genes in Delta pgxB mutant, the lack of pgxB gene significantly reduced the virulence of A. niger on apple fruit, suggesting that pgxB plays an important role in the infection process on the apple fruit.	[Liu, Cheng-Qian; Hu, Kang-Di; Li, Ting-Ting; Li, Yan-Hong; Chen, Xiao-Yan; Zhang, Hua] Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Peoples R China; [Yang, Ying] Anhui Jianzhu Univ, Coll Environm & Energy Engn, Hefei, Peoples R China; [Yang, Feng] Xuhuai Dist Jiangsu Prov, Xuzhou Inst Agr Sci, Xuzhou, Peoples R China; [Li, Yan-Hong; Liu, He-Ping] Anhui Siping Food Dev Co Ltd, Tongling, Peoples R China	Hefei University of Technology; Anhui Jianzhu University; Jiangsu Academy of Agricultural Sciences	Zhang, H (corresponding author), Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Peoples R China.	hzhanglab@hfut.edu.cn	chen, xi/GXH-3653-2022; chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022		National Natural Science Foundation of China; Anhui Provincial Science and Technology Major Project; Anhui Provincial Education Department; Anhui Siping Food Development Co. Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Science and Technology Major Project; Anhui Provincial Education Department; Anhui Siping Food Development Co. Ltd.	The funders National Natural Science Foundation of China, Anhui Provincial Science and Technology Major Project, and Anhui Provincial Education Department had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Anhui Siping Food Development Co. Ltd. provided support in the form of salaries for authors YHL and HPL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baltz RH, 2010, MANUAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, THIRD EDITION, P1; Barras F, 2003, ANNU REV PHYTOPATHOL, V32, P201; Benen JAE, 1999, EUR J BIOCHEM, V259, P577, DOI 10.1046/j.1432-1327.1999.00080.x; BUSSINK HJD, 1992, EUR J BIOCHEM, V208, P83, DOI 10.1111/j.1432-1033.1992.tb17161.x; Collmer A, 2003, ANNU REV PHYTOPATHOL, V24, P383; COTTY PJ, 1990, APPL ENVIRON MICROB, V56, P3885, DOI 10.1128/AEM.56.12.3885-3887.1990; De Lorenzo G, 2002, CURR OPIN PLANT BIOL, V5, P295, DOI 10.1016/S1369-5266(02)00271-6; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Delmas S, 2014, APPL ENVIRON MICROB, V80, P3484, DOI 10.1128/AEM.00625-14; Di Pietro A, 2003, MOL PLANT PATHOL, V4, P315, DOI [10.1046/j.1364-3703.2003.00180.x, 10.1046/J.1364-3703.2003.00180.X]; Garcia-Maceira FI, 2000, MOL PLANT MICROBE IN, V13, P359, DOI 10.1094/MPMI.2000.13.4.359; GYSLER C, 1990, GENE, V89, P101, DOI 10.1016/0378-1119(90)90211-9; HARMSEN JAM, 1990, CURR GENET, V18, P161, DOI 10.1007/BF00312604; Have AT, 2002, CONTRIBUTION CELL WA, P341; Herron SR, 2000, P NATL ACAD SCI USA, V97, P8762, DOI 10.1073/pnas.97.16.8762; Isshiki A, 2001, MOL PLANT MICROBE IN, V14, P749, DOI 10.1094/MPMI.2001.14.6.749; Jayani RS, 2005, PROCESS BIOCHEM, V40, P2931, DOI 10.1016/j.procbio.2005.03.026; Kars I, 2005, PLANT J, V43, P213, DOI 10.1111/j.1365-313X.2005.02436.x; Kars I., 2007, BOTRYTIS BIOL PATHOL, P99; KUSTERSVANSOMEREN M, 1992, MOL GEN GENET, V234, P113, DOI 10.1007/BF00272352; Liu N, 2015, PLOS ONE, V11; Maldonado MC, 1989, SCI ALIMENTS; Martens-Uzunova ES, 2006, BIOCHEM J, V400, P43, DOI 10.1042/BJ20060703; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Oeser B, 2002, FUNGAL GENET BIOL, V36, P176, DOI 10.1016/S1087-1845(02)00020-8; Parenicova L, 2000, BIOCHEM J, V345, P637, DOI 10.1042/0264-6021:3450637; Parenicova L, 1998, EUR J BIOCHEM, V251, P72, DOI 10.1046/j.1432-1327.1998.2510072.x; Parenicova L, 2000, FEBS LETT, V467, P333, DOI 10.1016/S0014-5793(00)01173-X; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Ramesh MV, 1996, J BACTERIOL, V178, P3899, DOI 10.1128/jb.178.13.3899-3907.1996; Reignault P, 2008, EUR J PLANT PATHOL, V120, P1, DOI 10.1007/s10658-007-9184-y; Rogers LM, 2000, P NATL ACAD SCI USA, V97, P9813, DOI 10.1073/pnas.160271497; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Schuster E, 2002, APPL MICROBIOL BIOT, V59, P426, DOI 10.1007/s00253-002-1032-6; SCOTTCRAIG JS, 1990, PLANT CELL, V2, P1191, DOI 10.1105/tpc.2.12.1191; Shieh MT, 1997, APPL ENVIRON MICROB, V63, P3548, DOI 10.1128/AEM.63.9.3548-3552.1997; Solis-Pereira S, 1990, APPL MICROBIOL BIOT, V39, P36; Strauss MLA, 2001, J APPL MICROBIOL, V91, P182, DOI 10.1046/j.1365-2672.2001.01379.x; Sun WX, 2009, GENESIS, V47, P535, DOI 10.1002/dvg.20530; ten Have A, 1998, MOL PLANT MICROBE IN, V11, P1009, DOI 10.1094/MPMI.1998.11.10.1009; Valette-Collet O, 2003, MOL PLANT MICROBE IN, V16, P360, DOI 10.1094/MPMI.2003.16.4.360; Yakoby N, 2001, MOL PLANT MICROBE IN, V14, P988, DOI 10.1094/MPMI.2001.14.8.988	43	19	20	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173277	10.1371/journal.pone.0173277	http://dx.doi.org/10.1371/journal.pone.0173277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257463	Green Submitted, gold, Green Published			2022-12-27	WOS:000396021100081
J	Matthews, H; Deakin, J; Rajab, M; Idris-Usman, M; Nirmalan, NJ				Matthews, Holly; Deakin, Jon; Rajab, May; Idris-Usman, Maryam; Nirmalan, Niroshini J.			Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations	PLOS ONE			English	Article							FALCIPARUM IN-VITRO; PLASMODIUM-FALCIPARUM; COMBINATION; ATOVAQUONE; RESISTANT; ANTAGONISM; PROGUANIL; MECHANISM; DIHYDROARTEMISININ; AMODIAQUINE	The widespread introduction of artemisinin-based combination therapy has contributed to recent reductions in malaria mortality. Combination therapies have a range of advantages, including synergism, toxicity reduction, and delaying the onset of resistance acquisition. Unfortunately, antimalarial combination therapy is limited by the depleting repertoire of effective drugs with distinct target pathways. To fast-track antimalarial drug discovery, we have previously employed drug-repositioning to identify the anti-amoebic drug, emetine dihydrochloride hydrate, as a potential candidate for repositioned use against malaria. Despite its 1000-fold increase in in vitro antimalarial potency (ED50 47 nM) compared with its anti-amoebic potency (ED50 26-32 uM), practical use of the compound has been limited by dose-dependent toxicity (emesis and cardiotoxicity). Identification of a synergistic partner drug would present an opportunity for dose-reduction, thus increasing the therapeutic window. The lack of reliable and standardised methodology to enable the in vitro definition of synergistic potential for antimalarials is a major drawback. Here we use isobologram and combination-index data generated by CalcuSyn software analyses (Biosoft v2.1) to define drug interactivity in an objective, automated manner. The method, based on the median effect principle proposed by Chou and Talalay, was initially validated for antimalarial application using the known synergistic combination (atovaquone-proguanil). The combination was used to further understand the relationship between SYBR Green viability and cytocidal versus cytostatic effects of drugs at higher levels of inhibition. We report here the use of the optimised Chou Talalay method to define synergistic antimalarial drug interactivity between emetine dihydrochloride hydrate and atovaquone. The novel findings present a potential route to harness the nanomolar antimalarial efficacy of this affordable natural product.	[Matthews, Holly; Deakin, Jon; Rajab, May; Idris-Usman, Maryam; Nirmalan, Niroshini J.] Univ Salford, Environm & Life Sci, Manchester, England; [Matthews, Holly] Imperial Coll, Dept Life Sci, Fac Nat Sci, London, England	University of Salford; Imperial College London	Nirmalan, NJ (corresponding author), Univ Salford, Environm & Life Sci, Manchester, England.	n.j.nirmalan@salford.ac.uk	Idris-Usman, Maryam/AAD-8484-2022		University of Salford	University of Salford	The authors received no specific funding for the project except for the PhD studentship awarded by the University of Salford for HM.	Akinboye E. S., 2011, Open Natural Products Journal, V4, P8, DOI 10.2174/1874848101104010008; Akinboye ES, 2012, J MED CHEM, V55, P7450, DOI 10.1021/jm300426q; Andrews KT, 2014, INT J PARASITOL-DRUG, V4, P95, DOI 10.1016/j.ijpddr.2014.02.002; Bansal Devendra, 2004, Ann Clin Microbiol Antimicrob, V3, P27, DOI 10.1186/1476-0711-3-27; Bell A, 2005, FEMS MICROBIOL LETT, V253, P171, DOI 10.1016/j.femsle.2005.09.035; Bhattacharya A, 2009, EUR J MED CHEM, V44, P3388, DOI 10.1016/j.ejmech.2009.02.008; CANFIELD CJ, 1995, EXP PARASITOL, V80, P373, DOI 10.1006/expr.1995.1049; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Co EMA, 2009, ANTIMICROB AGENTS CH, V53, P2557, DOI 10.1128/AAC.01370-08; Corral MJ, 2014, ANTIMICROB AGENTS CH, V58, P1596, DOI 10.1128/AAC.00710-13; Feng JY, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-44; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; Fivelman QL, 2007, ANTIMICROB AGENTS CH, V51, P2265, DOI 10.1128/AAC.01479-06; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Goodman CD, 2016, SCIENCE, V352, P349, DOI 10.1126/science.aad9279; Gorka AP, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-332; GROLLMAN AP, 1966, P NATL ACAD SCI USA, V56, P1867, DOI 10.1073/pnas.56.6.1867; Harasym TO, 2010, METHODS MOL BIOL, V596, P291, DOI 10.1007/978-1-60761-416-6_13; Hu Y, 2010, P NATL ACAD SCI USA, V107, P5955, DOI 10.1073/pnas.0912327107; Keiser J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-292; Keiser J, 2011, J ANTIMICROB CHEMOTH, V66, P1791, DOI 10.1093/jac/dkr178; Khositnithikul R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-23; Kremsner PG, 2004, LANCET, V364, P285, DOI 10.1016/S0140-6736(04)16680-4; Lucumi E, 2010, ANTIMICROB AGENTS CH, V54, P3597, DOI 10.1128/AAC.00431-10; Mariga ST, 2005, ACTA TROP, V93, P221, DOI 10.1016/j.actatropica.2005.01.007; Matthews H, 2013, DRUG REPOSITIONING R; Mott BT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13891; Painter HJ, 2010, ANTIMICROB AGENTS CH, V54, P5281, DOI 10.1128/AAC.00937-10; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Radloff PD, 1996, LANCET, V347, P1511, DOI 10.1016/S0140-6736(96)90671-6; Read M, 1993, Methods Mol Biol, V21, P43; Reynolds CP, 2005, METH MOLEC MED, V110, P173; Sanz LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030949; Srivastava IK, 1999, ANTIMICROB AGENTS CH, V43, P1334, DOI 10.1128/AAC.43.6.1334; Vivas L, 2007, J ANTIMICROB CHEMOTH, V59, P658, DOI 10.1093/jac/dkl563; Wein S, 2010, J CLIN MICROBIOL, V48, P1651, DOI 10.1128/JCM.02250-09; Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	40	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173303	10.1371/journal.pone.0173303	http://dx.doi.org/10.1371/journal.pone.0173303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257497	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100084
J	Pathmanathan, I; Dokubo, EK; Shiraishi, RW; Agolory, SG; Auld, AF; Onotu, D; Odafe, S; Dalhatu, I; Abiri, O; Debem, HC; Bashorun, A; Ellerbrock, T				Pathmanathan, Ishani; Dokubo, E. Kainne; Shiraishi, Ray W.; Agolory, Simon G.; Auld, Andrew F.; Onotu, Dennis; Odafe, Solomon; Dalhatu, Ibrahim; Abiri, Oseni; Debem, Henry C.; Bashorun, Adebobola; Ellerbrock, Tedd			Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012	PLOS ONE			English	Article							SOUTH-AFRICA; IMMUNE RECONSTITUTION; TREATMENT OUTCOMES; RISK-FACTORS; PREVENTION; COHORT	Background Nigeria had the most AIDS-related deaths worldwide in 2014 (170,000), and 46% were associated with tuberculosis (TB). Although treatment of people living with HIV (PLHIV) with antiretroviral therapy (ART) reduces TB-associated morbidity and mortality, incident TB can occur while on ART. We estimated incidence and characterized factors associated with TB after ART initiation in Nigeria. Methods We analyzed retrospective cohort data from a nationally representative sample of adult patients on ART. Data were abstracted from 3,496 patient records, and analyses were weighted and controlled for a complex survey design. We performed domain analyses on patients without documented TB disease and used a Cox proportional hazard model to assess factors associated with TB incidence after ART. Results At ART initiation, 3,350 patients (95.8%) were not receiving TB treatment. TB incidence after ART initiation was 0.57 per 100 person-years, and significantly higher for patients with CD4<50/mu L (adjusted hazard ratio [AHR]: 4.2, 95% confidence interval [CI]: 1.4-12.7) compared with CD4 >= 200/mu L. Patients with suspected but untreated TB at ART initiation and those with a history of prior TB were more likely to develop incident TB (AHR: 12.2, 95% CI: 4.5-33.5 and AHR: 17.6, 95% CI: 3.5-87.9, respectively). Conclusion Incidence of TB among PLHIV after ART initiation was low, and predicted by advanced HIV, prior TB, and suspected but untreated TB. Study results suggest a need for improved TB screening and diagnosis, particularly among high-risk PLHIV initiating ART, and reinforce the benefit of early ART and other TB prevention efforts.	[Pathmanathan, Ishani; Dokubo, E. Kainne; Shiraishi, Ray W.; Agolory, Simon G.; Auld, Andrew F.; Ellerbrock, Tedd] US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA 30333 USA; [Pathmanathan, Ishani] US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Onotu, Dennis; Odafe, Solomon; Dalhatu, Ibrahim; Debem, Henry C.] US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA USA; [Abiri, Oseni] Univ S Alabama, Dept Nursing, Mobile, AL USA; [Bashorun, Adebobola] Fed Minist Hlth, Div HIV AIDS, Abuja, Nigeria	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of South Alabama	Pathmanathan, I (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA 30333 USA.; Pathmanathan, I (corresponding author), US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	ydi6@cdc.gov	Odafe, Solomon/AAJ-2390-2020; Agolory, Simon/AIF-4664-2022	Agolory, Simon/0000-0001-5023-5754; Dokubo, Emily Kainne/0000-0002-1499-0151; Shiraishi, Ray/0000-0001-7640-0666; Auld, Andrew/0000-0001-5089-9163	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	The study and writing of this report has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC).	Akanbi MO, 2013, AIDS RES HUM RETROV, V29, P931, DOI [10.1089/aid.2012.0231, 10.1089/AID.2012.0231]; [Anonymous], 2015, AIDS CHANG EV; Auld AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054665; Bassett IV, 2010, CLIN INFECT DIS, V51, P823, DOI 10.1086/656282; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Dalhatu I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165528; Dembele M, 2010, INT J TUBERC LUNG D, V14, P318; Dokubo KE, 2014, MMWR-MORBID MORTAL W, V63, P1172; Evans D, 2013, AIDS RES HUM RETROV, V29, P892, DOI [10.1089/aid.2012.0215, 10.1089/AID.2012.0215]; Federal Republic of Nigeria, 2012, 1 NAT TB PREV SURV 2; Hermans SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010527; Howard AA, 2012, JAIDS-J ACQ IMM DEF, V60, pS136, DOI 10.1097/QAI.0b013e31825cfe8e; Kufa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111209; Lawn SD, 2008, AM J RESP CRIT CARE, V177, P680, DOI 10.1164/rccm.200709-1311PP; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Liu EJ, 2015, AIDS, V29, P1391, DOI 10.1097/QAD.0000000000000705; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Naidoo K, 2013, CURR OPIN INFECT DIS, V26, P35, DOI 10.1097/QCO.0b013e32835ba8f9; National Agency for the Control of AIDS, 2015, FED REP NIG GLOB AID; Nglazi MD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-21; Nigeria Federal Ministry of Health, 2008, NAT TUB LEPR CONTR P; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; UNAIDS, 2015, AIDS CHANG EV MDG 6; UNAIDS, 2014, THE GAP REP; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; World Health Organization, 2011, WHO GUID INT TUB CAS; World Health Organization, 2012, WHO POL COLL TB HIV; World Health Organization, 2015, GLOB TUB REP 2014; World Health Organization, 2010, WHO PRIOR RES QUEST; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	33	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173309	10.1371/journal.pone.0173309	http://dx.doi.org/10.1371/journal.pone.0173309			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282390	Green Published, gold, Green Submitted			2022-12-27	WOS:000396091800028
J	Shinkins, B; Nicholson, BD; Primrose, J; Perera, R; James, T; Pugh, S; Mant, D				Shinkins, Bethany; Nicholson, Brian D.; Primrose, John; Perera, Rafael; James, Timothy; Pugh, Sian; Mant, David			The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN; COLON-CANCER; ROC CURVES; FOLLOW-UP; SURVIVAL	Objective To evaluate the diagnostic accuracy of a single CEA (carcinoembryonic antigen) blood test in detecting colorectal cancer recurrence. Background Patients who have undergone curative resection for primary colorectal cancer are typically followed up with scheduled CEA testing for 5 years. Decisions to investigate further (usually by CT imaging) are based on single test results, reflecting international guidelines. Methods A secondary analysis was undertaken of data from the FACS trial (two arms included CEA testing). The composite reference standard applied included CT-CAP imaging, clinical assessment and colonoscopy. Accuracy in detecting recurrence was evaluated in terms of sensitivity, specificity, likelihood ratios, predictive values, time-dependent area under the ROC curves, and operational performance when used prospectively in clinical practice are reported. Results Of 582 patients, 104 (17.9%) developed recurrence during the 5 year follow-up period. Applying the recommended threshold of 5 mu g/L achieves at best 50.0% sensitivity (95% CI: 40.1-59.9%); in prospective use in clinical practice it would lead to 56 missed recurrences (53.8%; 95% CI: 44.2-64.4%) and 89 false alarms (56.7% of 157 patients referred for investigation). Applying a lower threshold of 2.5 mu g/L would reduce the number of missed recurrences to 36.5% (95% CI: 26.5-46.5%) but would increase the false alarms to 84.2% (924/mu 1097 referred). Some patients are more prone to false alarms than others-at the 5 mu g/L threshold, the 89 episodes of unnecessary investigation were clustered in 29 individuals. Conclusion Our results demonstrated very low sensitivity for CEA, bringing to question whether it could ever be used as an independent triage test. It is not feasible to improve the diagnostic performance of a single test result by reducing the recommended action threshold because of the workload and false alarms generated. Current national and international guidelines merit reevaluation and options to improve performance, such as making clinical decisions on the basis of CEA trend, should be further assessed.	[Shinkins, Bethany] Univ Leeds, Acad Unit Hlth Econ, Test Evaluat Grp, Leeds LS2 9JT, W Yorkshire, England; [Nicholson, Brian D.; Perera, Rafael; Mant, David] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX1 2JD, England; [Primrose, John; Pugh, Sian] Univ Southampton, Acad Unit Canc Sci, Southampton SO9 5NH, Hants, England; [James, Timothy] Oxford Univ Hosp NHS Fdn Trust, Oxford, England	University of Leeds; University of Oxford; University of Southampton; Oxford University Hospitals NHS Foundation Trust	Shinkins, B (corresponding author), Univ Leeds, Acad Unit Hlth Econ, Test Evaluat Grp, Leeds LS2 9JT, W Yorkshire, England.	b.shinkins@leeds.ac.uk	Shinkins, Bethany/AAX-4045-2020	Primrose, John/0000-0002-2069-7605; Perera, Rafael/0000-0003-2418-2091; Shinkins, Bethany/0000-0001-5350-1018	UK National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme [99/10/99, 11/136/81]; NIHR Leeds Diagnostic Evidence Co-operative; UK NIHR HTA; MRC [MR/M018423/1] Funding Source: UKRI; Medical Research Council [MR/M018423/1] Funding Source: researchfish; National Institute for Health Research [99/10/99, SPCR-047, 11/136/81] Funding Source: researchfish	UK National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme; NIHR Leeds Diagnostic Evidence Co-operative; UK NIHR HTA; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Both the main FAGS project and this sub study on CEA were funded by the UK National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme (project numbers 99/10/99 and 11/136/81). Bethany Shinkins is currently supported by the NIHR Leeds Diagnostic Evidence Co-operative. The funding agency (UK NIHR HTA) had no role in: the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; nor decision to submit the manuscript for publication.	CARL J, 1993, SCAND J CLIN LAB INV, V53, P751, DOI 10.3109/00365519309092581; Engstrom PF, 2009, J NATL COMPR CANC NE, V7, P778, DOI 10.6004/jnccn.2009.0056; Guthrie JA, 2002, ABDOM IMAGING, V27, P570, DOI 10.1007/s00261-001-0081-0; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Hellinger Michael D, 2006, Clin Colon Rectal Surg, V19, P228, DOI 10.1055/s-2006-956445; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Litvak A, 2014, J NATL COMPR CANC NE, V12, P907, DOI 10.6004/jnccn.2014.0085; MINTON JP, 1978, CANCER, V42, P1422, DOI 10.1002/1097-0142(197809)42:3+<1422::AID-CNCR2820420807>3.0.CO;2-1; NICE, 2011, NICE CLIN GUID CG131; Nicholson BD, 2016, JAMA-J AM MED ASSOC, V316, P1310, DOI 10.1001/jama.2016.11212; Nicholson BD, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011134.pub2; Primrose JN, 2014, JAMA-J AM MED ASSOC, V311, P263, DOI 10.1001/jama.2013.285718; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shinkins B, 2014, CLIN CHEM, V60, P1572, DOI 10.1373/clinchem.2014.228601; STAAB HJ, 1985, AM J SURG, V149, P198, DOI 10.1016/S0002-9610(85)80064-7; Tan E, 2009, SURG ONCOL, V18, P15, DOI 10.1016/j.suronc.2008.05.008	16	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0171810	10.1371/journal.pone.0171810	http://dx.doi.org/10.1371/journal.pone.0171810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282381	Green Published, gold, Green Accepted			2022-12-27	WOS:000396091800003
J	Naz, S; Page, A; Agho, KE				Naz, Sabrina; Page, Andrew; Agho, Kingsley Emwinyore			Household air pollution from use of cooking fuel and under-five mortality: The role of breastfeeding status and kitchen location in Pakistan	PLOS ONE			English	Article							BIOMASS FUEL; RESPIRATORY ILLNESS; CHILD-MORTALITY; SOLID-FUEL; HEALTH; BANGLADESH; INDIA; EXPOSURE; RISK; INFANTS	Household air pollution (HAP) mainly from cooking fuel is one of the major causes of respiratory illness and deaths among young children in low and middle-income countries like Pakistan. This study investigates for the first time the association between HAP from cooking fuel and under-five mortality using the 2013 Pakistan Demographic and Health Survey (PDHS) data. Multi-level logistic regression models were used to examine the association between HAP and under-five mortality in a total of 11,507 living children across four age-groups (neonatal aged 0-28 days, post-neonatal aged 1-11 months, child aged 12-59 months and under-five aged 0-59 months). Use of cooking fuel was weakly associated with total under-five mortality (OR = 1.22, 95% CI = 0.92-1.64, P = 0.170), with stronger associations evident for sub-group analyses of children aged 12-59 months (OR = 1.98, 95% CI = 0.75-5.25, P = 0.169). Strong associations between use of cooking fuel and mortality were evident (ORs >5) in those aged 12-59 months for households without a separate kitchen using polluting fuels, and in children whose mother never breastfed. The results of this study suggest that HAP from cooking fuel is associated with a modest increase in the risk of death among children under five years of age in Pakistan, but particularly in those aged 12-59 months, and those living in poorer socioeconomic conditions. To reduce exposure to cooking fuel which is a preventable determinant of under-five mortality in Pakistan, the challenge remains to promote behavioural interventions such as breastfeeding in infancy period, keeping young children away from the cooking area, and improvements in housing and kitchen design.	[Naz, Sabrina; Page, Andrew] Univ Western Sydney, Sch Med, Ctr Hlth Res, Campbelltown Campus, Penrith, NSW, Australia; [Agho, Kingsley Emwinyore] Univ Western Sydney, Sch Sci & Hlth, Campbelltown Campus, Penrith, NSW, Australia	Western Sydney University; Western Sydney University	Naz, S (corresponding author), Univ Western Sydney, Sch Med, Ctr Hlth Res, Campbelltown Campus, Penrith, NSW, Australia.	sabrinanaz@gmail.com	Agho, Kingsley/AAW-5622-2021; Agho, Kingsley/AAE-9971-2020	Agho, Kingsley/0000-0003-4111-3207; Naz, Sabrina/0000-0002-0338-1203				Ahmed Z, 2015, INT J HLTH SYSTEM DI, V3, P19, DOI DOI 10.4103/2347-9019.168569; [Anonymous], 2014, BURD DIS JOINT EFF H; [Anonymous], 2011, ENCY ENV HLTH; Arifeen S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e67; Bassani DG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-491; Bates MN, 2013, ENVIRON HEALTH PERSP, V121, P637, DOI 10.1289/ehp.1205491; Bhutto AW, 2011, RENEW SUST ENERG REV, V15, P3207, DOI 10.1016/j.rser.2011.04.015; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Choi JY, 2015, OCCUP ENVIRON MED, V72, P114, DOI 10.1136/oemed-2014-102472; Cushing AH, 1998, AM J EPIDEMIOL, V147, P863, DOI 10.1093/oxfordjournals.aje.a009540; Dasgupta S, 2006, INDOOR AIR, V16, P426, DOI 10.1111/j.1600-0668.2006.00436.x; DSouza RM, 1997, J BIOSOC SCI, V29, P271, DOI 10.1017/S002193209700271X; Epstein MB, 2013, INT J HYG ENVIR HEAL, V216, P523, DOI 10.1016/j.ijheh.2012.12.006; Ezeh OK, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-113; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fullerton DG, 2008, T ROY SOC TROP MED H, V102, P843, DOI 10.1016/j.trstmh.2008.05.028; Gurley ES, 2013, INDOOR AIR, V23, P379, DOI 10.1111/ina.12038; Heinig MJ, 2001, PEDIATR CLIN N AM, V48, P105, DOI 10.1016/S0031-3955(05)70288-1; IGME U, 2015, LEV TRENDS CHILD MOR; IHME, 2010, GLOB BURD DIS GBD PR; Jan I, 2012, RENEW SUST ENERG REV, V16, P3200, DOI 10.1016/j.rser.2012.02.038; Janjua NZ, 2012, PUBLIC HEALTH, V126, P855, DOI 10.1016/j.puhe.2012.06.012; Kashima S, 2010, J OCCUP ENVIRON MED, V52, P340, DOI 10.1097/JOM.0b013e3181d44e3f; Khalequzzaman M, 2007, INDOOR AIR, V17, P297, DOI 10.1111/j.1600-0668.2007.00477.x; Khalequzzaman Md, 2011, Environmental Health and Preventive Medicine, V16, P375, DOI 10.1007/s12199-011-0208-z; Khalequzzaman Md., 2010, Environmental Health and Preventive Medicine, V15, P236, DOI 10.1007/s12199-009-0133-6; Khushk WA, 2005, INDOOR AIR, V15, P311, DOI 10.1111/j.1600-0668.2005.00367.x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ministry of Planning DaR, 2013, PAK MILL DEV GOALS R; Mir AA, 2012, BIRTH, V1; Munroe RL, 2012, INT J ENVIRON HEAL R, V22, P156, DOI 10.1080/09603123.2011.628642; Naeher LP, 2007, INHAL TOXICOL, V19, P67, DOI 10.1080/08958370600985875; Nasir ZA, 2015, J INTEGR ENVIRON SCI, V12, P107, DOI 10.1080/1943815X.2015.1005105; Nasir ZA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024002; National Institute of Population Studies II, 2013, PAK DEM HLTH SURV 20; Naz S, 2016, ENV HLTH, V15, DOI [10.1111/f.1600-0668.2007.00477.x, DOI 10.1111/F.1600-0668.2007.00477.X]; Naz S, 2015, INT J ENV RES PUB HE, V12, P12847, DOI 10.3390/ijerph121012847; Pandey S, 2013, MATERN CHILD HLTH J, V17, P1499, DOI 10.1007/s10995-012-1163-z; Prasad R, 2012, DRUG DISCOVERIES THE, V6; Pronczuk-Garbino J., 2005, CHILDRENS HLTH ENV G; Rehfuess EA, 2009, J EPIDEMIOL COMMUN H, V63, P887, DOI 10.1136/jech.2008.082685; Rinne ST, 2007, AM J TROP MED HYG, V76, P585, DOI 10.4269/ajtmh.2007.76.585; Rutstein SO, 2006, GUIDE DHS STAT; Tielsch JM, 2009, INT J EPIDEMIOL, V38, P1351, DOI 10.1093/ije/dyp286; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; WHO, 2009, DEATHS DALYS ATTR SE; WHO, 2006, EXPOSURE ASSESSMENT; Wichmann J, 2006, MATERN CHILD HLTH J, V10, P553, DOI 10.1007/s10995-006-0121-z	48	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173256	10.1371/journal.pone.0173256	http://dx.doi.org/10.1371/journal.pone.0173256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278260	Green Published, gold			2022-12-27	WOS:000396087900061
J	Santos, BR; Lecke, SB; Spritzer, PM				Santos, Betania Rodrigues; Lecke, Sheila Bunecker; Spritzer, Poli Mara			Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; GENOME-WIDE ASSOCIATION; D-RECEPTOR GENE; INSULIN-RESISTANCE; PLASMA-CONCENTRATIONS; GLUCOSE-TOLERANCE; HYPOVITAMINOSIS-D; AFRICAN-AMERICAN; OBESE CHILDREN; D DEFICIENCY	Vitamin D deficiency has been related to metabolic syndrome (MetS) in polycystic ovary syndrome (PCOS). The vitamin D-binding protein (DBP) is the main protein involved in vitamin D transport. Two single-nucleotide polymorphisms (SNPs) of the DBP gene, rs4588 and rs7041, have been associated with low circulating levels of 25-hydroxyvitamin D [25 (OH) D] in various populations, but not in women with PCOS. Therefore, we determined the genotype and haplotype distribution of DBP gene polymorphisms and investigated the associations between these genetic variants and their haplotypes with PCOS, MetS, and 25(OH) D levels in women with PCOS and controls from the South of Brazil. The sample included 291 women (191 with PCOS and 100 controls). All participants were genotyped for polymorphisms rs2282679, rs4588, and rs7041. Serum 25(OH) D levels were determined in a subset of 102 participants. Women with PCOS were younger and had significantly higher body mass index, blood pressure, and insulin resistance than the control group (p< 0.05). The prevalence of MetS in PCOS and controls was 26.5% and 4.8% respectively. Levels of 25 (OH) D were lower in PCOS women with MetS, even after adjustment for age (p = 0.033). No associations were observed between PCOS and the polymorphisms or their haplotypes. A higher frequency of genotype TT of rs7041 was found in PCOS participants with MetS (OR: 2.21, 95% CI: 1.08-4.52; p = 0.027). This same genotype was associated with lower 25 (OH) D levels in both PCOS and control women (OR: 4.40, 95% CI: 1.62-12.00; p = 0.002). In conclusion, these findings indicate that DBP gene polymorphisms and their haplotypes are not directly associated with PCOS. In contrast, the TT genotype of SNP rs7041 was associated with MetS in PCOS women, and with lower 25(OH) D levels in both PCOS and control groups.	[Santos, Betania Rodrigues; Lecke, Sheila Bunecker; Spritzer, Poli Mara] Hosp Clin Porto Alegre, Gynecol Endocrinol Unit, Div Endocrinol, Porto Alegre, RS, Brazil; [Santos, Betania Rodrigues; Spritzer, Poli Mara] Univ Fed Rio Grande do Sul, Mol Endocrinol Lab, Dept Physiol, Porto Alegre, RS, Brazil; [Lecke, Sheila Bunecker] Fed Univ Hlth Sci Porto Alegre, Dept Diagnost Methods, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Spritzer, PM (corresponding author), Hosp Clin Porto Alegre, Gynecol Endocrinol Unit, Div Endocrinol, Porto Alegre, RS, Brazil.; Spritzer, PM (corresponding author), Univ Fed Rio Grande do Sul, Mol Endocrinol Lab, Dept Physiol, Porto Alegre, RS, Brazil.	spritzer@ufrgs.br	Spritzer, Poli Mara/R-8405-2019; Santos, Betânia R/J-4568-2013; Spritzer, Poli/A-3357-2019	Spritzer, Poli Mara/0000-0002-5204-107X; Rodrigues dos Santos, Betania/0000-0003-3748-0856	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazilian National Institute of Hormones and Women's Health [CNPq/INCT573747/2008-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Post-Doc grant)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazilian National Institute of Hormones and Women's Health; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Post-Doc grant)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazilian National Institute of Hormones and Women's Health (CNPq/INCT573747/2008-3) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Post-Doc grant to BRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alemzadeh R, 2008, METABOLISM, V57, P183, DOI 10.1016/j.metabol.2007.08.023; Ashraf A, 2009, J CLIN ENDOCR METAB, V94, P3200, DOI 10.1210/jc.2009-0445; Asuncion M, 2000, J CLIN ENDOCR METAB, V85, P2434, DOI 10.1210/jc.85.7.2434; Aydin Y, 2015, J PEDIATR ADOL GYNEC, V28, P271, DOI 10.1016/j.jpag.2014.08.011; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Baier LJ, 1998, J CLIN ENDOCR METAB, V83, P2993, DOI 10.1210/jc.83.8.2993; Carpenter TO, 2013, J BONE MINER RES, V28, P213, DOI 10.1002/jbmr.1735; Chun RF, 2012, CELL BIOCHEM FUNCT, V30, P445, DOI 10.1002/cbf.2835; Dasgupta S, 2015, INDIAN J MED RES, V142, P276, DOI 10.4103/0971-5916.166587; Delvin EE, 2010, J NUTR, V140, P987, DOI 10.3945/jn.109.112250; Di Domenico K, 2013, FERTIL STERIL, V99, P286, DOI 10.1016/j.fertnstert.2012.08.049; El-Shal AS, 2013, MOL BIOL REP, V40, P6063, DOI 10.1007/s11033-013-2716-y; Fang Y, 2009, CALCIFIED TISSUE INT, V85, P85, DOI 10.1007/s00223-009-9251-9; FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gozdzik A, 2011, J STEROID BIOCHEM, V127, P405, DOI 10.1016/j.jsbmb.2011.05.009; Graff SK, 2013, FERTIL STERIL, V100, P1081, DOI 10.1016/j.fertnstert.2013.06.005; Hahn S, 2006, EXP CLIN ENDOCR DIAB, V114, P577, DOI 10.1055/s-2006-948308; He CL, 2015, NUTRIENTS, V7, P4555, DOI 10.3390/nu7064555; Hirai M, 2000, J CLIN ENDOCR METAB, V85, P1951, DOI 10.1210/jc.85.5.1951; Irani M, 2014, FERTIL STERIL, V102, P460, DOI 10.1016/j.fertnstert.2014.04.046; Joham AE, 2016, MOL NUTR FOOD RES, V60, P110, DOI 10.1002/mnfr.201500259; Johnson MD, 2010, J PEDIATR-US, V156, P444, DOI 10.1016/j.jpeds.2009.09.070; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Lauridsen AL, 2001, CLIN CHEM, V47, P753; Lu L, 2012, HUM GENET, V131, P505, DOI 10.1007/s00439-011-1099-1; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Michos ED, 2015, ATHEROSCLEROSIS, V241, P12, DOI 10.1016/j.atherosclerosis.2015.04.803; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mishra S, 2016, J CLIN DIAGNOSTIC RE, V10, pBC01; Palomer X, 2008, DIABETES OBES METAB, V10, P185, DOI 10.1111/j.1463-1326.2007.00710.x; Ramos RB, 2015, GENE, V560, P25, DOI 10.1016/j.gene.2015.01.012; Ramos RB, 2013, EUR J ENDOCRINOL, V169, P569, DOI 10.1530/EJE-13-0105; Reinchr T, 2007, EUR J ENDOCRINOL, V157, P225, DOI 10.1530/EJE-07-0188; Reis JP, 2009, PEDIATRICS, V124, pE371, DOI 10.1542/peds.2009-0213; Robien K, 2013, BRIT J NUTR, V109, P493, DOI 10.1017/S0007114512001675; Santos BR, 2013, HORM RES PAEDIAT, V79, P162, DOI 10.1159/000348847; Sinotte M, 2009, AM J CLIN NUTR, V89, P634, DOI 10.3945/ajcn.2008.26445; Speeckaert M, 2006, CLIN CHIM ACTA, V372, P33, DOI 10.1016/j.cca.2006.03.011; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Taes YEC, 2006, BONE, V38, P701, DOI 10.1016/j.bone.2005.10.006; Takiar R, 2015, BONE, V78, P94, DOI 10.1016/j.bone.2015.04.029; Toscani M, 2007, METABOLISM, V56, P992, DOI 10.1016/j.metabol.2007.03.006; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Wehr E, 2009, EUR J ENDOCRINOL, V161, P575, DOI 10.1530/EJE-09-0432; Wehr E, 2011, EUR J ENDOCRINOL, V164, P741, DOI 10.1530/EJE-11-0134; Winters SJ, 2009, METABOLISM, V58, P438, DOI 10.1016/j.metabol.2008.10.017; Ye WZ, 2001, METABOLISM, V50, P366, DOI 10.1053/meta.2001.20172; Yildizhan R, 2009, ARCH GYNECOL OBSTET, V280, P559, DOI 10.1007/s00404-009-0958-7	53	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173695	10.1371/journal.pone.0173695	http://dx.doi.org/10.1371/journal.pone.0173695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278285	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900029
J	Tettelbach, ST; Europe, JR; Tettelbach, CRH; Havelin, J; Rodgers, BS; Furman, BT; Velasquez, M				Tettelbach, Stephen T.; Europe, James R.; Tettelbach, Christian R. H.; Havelin, Jason; Rodgers, Brooke S.; Furman, Bradley T.; Velasquez, Marissa			Hard clam walking: Active horizontal locomotion of adult Mercenaria mercenaria at the sediment surface and behavioral suppression after extensive sampling	PLOS ONE			English	Article							ELLIPTIO-COMPLANATA MOLLUSCA; CRAWLING BEHAVIOR; FERTILIZATION SUCCESS; SPATIAL-DISTRIBUTION; BURROWING BEHAVIOR; MACOMA-BALTHICA; BODY-SIZE; BIVALVIA; MUSSELS; AGGREGATION	Locomotion of infaunal bivalve mollusks primarily consists of vertical movements related to burrowing; horizontal movements have only been reported for a few species. Here, we characterize hard clam walking: active horizontal locomotion of adults (up to 118 mm shell length, SL) of the commercially important species, Mercenaria mercenaria, at the sediment surface-a behavior only briefly noted in the literature. We opportunistically observed walking over a 10-yr period, at 9 different sites in the Peconic Bays, New York, USA, and tested several hypotheses for the underlying cause of this behavior through quantitative field sampling and reproductive analyses. Hard clam walking was exhibited by males and females at equal frequency, predominantly during June/July and October, when clams were in peak spawning condition. Extensive walking behavior appears to be cued by a minimum population density; we suggest it may be mediated by unidentified pheromone(s), infaunal pressure waves and/or other unidentified factors. There was no directionality exhibited by walking clams, but individuals in an area of extensive walking were highly aggregated and walking clams were significantly more likely to move toward a member of the opposite sex. Thus, we conclude that hard clam walking serves to aggregate mature individuals prior to spawning, thereby facilitating greater fertilization success. In the process of investigating this behavior, however, we apparently oversampled one population and reduced clam densities below the estimated minimum threshold density and, in so doing, suppressed extensive walking for a period of > 3 years running. This not only reinforces the importance of detailed field investigations of species biology and ecology, even for those that are considered to be well studied, but also highlights the need for greater awareness of the potential for research activities to affect focal species behavior.	[Tettelbach, Stephen T.] LIU Post, Dept Biol, Brookville, NY 11548 USA; [Europe, James R.] NOAA, Southeast Fisheries Sci Ctr, Miami, FL USA; [Tettelbach, Christian R. H.] Univ Calif Berkeley, Coll Nat Resources, Berkeley, CA USA; [Havelin, Jason] Cornell Cooperat Extens Suffolk Cty, Marine Program, Southold, NY USA; [Rodgers, Brooke S.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY USA; [Furman, Bradley T.] Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA; [Velasquez, Marissa] Cornell Univ, Dept Biol, Ithaca, NY USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Berkeley; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Virginia; Cornell University	Tettelbach, ST (corresponding author), LIU Post, Dept Biol, Brookville, NY 11548 USA.	Stephen.Tettelbach@liu.edu		Tettelbach, Stephen/0000-0003-3715-1235; Furman, Bradley/0000-0002-9284-8388	Suffolk County Water Quality Protection and Restoration Program [HSN1]; Long Island University; Suffolk County (NY) Water Quality Protection and Restoration Program	Suffolk County Water Quality Protection and Restoration Program; Long Island University; Suffolk County (NY) Water Quality Protection and Restoration Program	Funding which helped support the project activities was obtained from the Suffolk County Water Quality Protection and Restoration Program (http://www.suffolkcountyny.gov/Departments/ EnconomicDevelopmentandPlanning/PlanningandEnvironment/WaterOualityImprovement aspx), under contract # HSN1 to Cornell Cooperative Extension of Suffolk County (Christopher F. Smith) and Long Island University (STT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for funding from the Suffolk County (NY) Water Quality Protection and Restoration Program. We thank the following individuals for their assistance: Scott Hughes, Brigid Maloney, Matthew Schwartz, Michael Cotrone, Justin Ecret and Hailey Brosnan (field work); Bassem Allam (histological analyses); Matthew Harke and Christopher Gobler (chlorophyll analyses). We also appreciate the thoughtful and constructive comments of the Academic Editor and two reviewers.	AHN IY, 1993, MAR ECOL PROG SER, V99, P61; Alcock J., 1989, ANIMAL BEHAV EVOLUTI; Amyot JP, 1998, FRESHWATER BIOL, V39, P351, DOI 10.1046/j.1365-2427.1998.00289.x; Amyot JP, 1997, FRESHWATER BIOL, V37, P345, DOI 10.1046/j.1365-2427.1997.00158.x; ANSELL A. D., 1967, PROC MALACOL SOC LONDON, V37, P395; Ansell A. D., 1969, Proceedings of the Malacological Society of London, V38, P387; ANSELL AD, 1967, J EXP BIOL, V46, P105; BALFOUR DL, 1995, J FRESHWATER ECOL, V10, P255, DOI 10.1080/02705060.1995.9663445; Barnes RD, 1974, INVERTEBRATE ZOOLOGY; BELDING DL, 1912, REPORT QUAHOG OYSTER; BOTTON M L, 1988, Journal of Shellfish Research, V7, P407; Carriker MR, 2001, DEV AQUAC FISH SCI, V31, P283; Catton CA, 2013, J SHELLFISH RES, V32, P181, DOI 10.2983/035.032.0124; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Clements JC, 2015, J SHELLFISH RES, V34, P619; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; Cote IM, 1999, J EXP MAR BIOL ECOL, V235, P201, DOI 10.1016/S0022-0981(98)00155-5; Cyr H, 2009, J N AM BENTHOL SOC, V28, P319, DOI 10.1899/08-133.1; Candido LTD, 2007, BELG J ZOOL, V137, P11; DOW RL, 1955, SCIENCE, V122, P641, DOI 10.1126/science.122.3171.641; DOWNING JA, 1993, J N AM BENTHOL SOC, V12, P148, DOI 10.2307/1467344; Fegley Sr, 2001, DEV AQUAC FISH SCI, V31, P383; Ferguson C. D., 2009, THESIS; Folk RL, 1974, PETROGRAPHY SEDIMENT; Fraenkel G S, 1927, Z VERGL PHYSIOL, V6, P167, DOI 10.1007/BF00333682; HARGER J R E, 1970, Veliger, V12, P401; Huang DW, 2007, J EXP MAR BIOL ECOL, V342, P269, DOI 10.1016/j.jembe.2006.10.051; HURLBERT SH, 1990, OIKOS, V58, P257, DOI 10.2307/3545216; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; Kappes H, 2012, AQUAT SCI, V74, P1, DOI 10.1007/s00027-011-0187-6; Kim Y, 2004, J SHELLFISH RES, V23, P429; Knights AM, 2010, MAR ECOL PROG SER, V404, P79, DOI 10.3354/meps08480; Kraeuter JN, 2001, DEV AQUAC FISH SCI, V31, P441; Kraeuter JN, 2005, J SHELLFISH RES, V24, P1043; Levinton J. S., 2014, MARINE BIOL FUNCTION; LEVITAN DR, 1992, ECOLOGY, V73, P248, DOI 10.2307/1938736; LEVITAN DR, 1991, BIOL BULL-US, V181, P261, DOI 10.2307/1542097; Liermann M, 2001, FISH FISH, V2, P33, DOI 10.1046/j.1467-2979.2001.00029.x; LLOYD M, 1967, J ANIM ECOL, V36, P1, DOI 10.2307/3012; Malinowski SR, 1985, THESIS; Minteer BA, 2014, SCIENCE, V344, P260, DOI 10.1126/science.1250953; Morisita M., 1959, MEMOIRS FS KYUSHU U, V2, P215; Mouritsen KN, 1997, OIKOS, V79, P513, DOI 10.2307/3546895; Nelson TC, 1940, J EXP ZOOL, V85, P299, DOI 10.1002/jez.1400850207; New York State Department of Environmental Conservation, 2015, SHELLF HARV LIM; Newell RIE, 2009, MAR ECOL PROG SER, V387, P179, DOI 10.3354/meps08083; PADILLA DK, 2011, J SHELLFISH RES, V30, P540; Prezant RS, 2010, GEOARCHAEOLOGY ST CA, P237; QUAYLE D. B., 1949, PROC MALACOL SOC LONDON, V28, P31; ROBERTS D, 1989, J EXP MAR BIOL ECOL, V126, P271, DOI 10.1016/0022-0981(89)90192-5; Saarinen M, 2003, J MOLLUS STUD, V69, P81, DOI 10.1093/mollus/69.1.81; Schwalb AN, 2007, J N AM BENTHOL SOC, V26, P261, DOI 10.1899/0887-3593(2007)26[261:HAVMOU]2.0.CO;2; SEED R, 1969, OECOLOGIA, V3, P277, DOI 10.1007/BF00390380; Seuront L, 2014, P NATL ACAD SCI USA, V111, P2206, DOI 10.1073/pnas.1322363111; STANLEY SM, 1975, ANNU REV EARTH PL SC, V3, P361, DOI 10.1146/annurev.ea.03.050175.002045; STOKESBURY KDE, 1993, MAR ECOL PROG SER, V96, P159, DOI 10.3354/meps096159; Stoner AW, 2000, MAR ECOL PROG SER, V202, P297, DOI 10.3354/meps202297; SWENNEN C, 1974, Netherlands Journal of Sea Research, V8, P108, DOI 10.1016/0077-7579(74)90029-5; Tallqvist M, 2001, MAR ECOL PROG SER, V212, P183, DOI 10.3354/meps212183; TAN WH, 1975, AQUACULTURE, V6, P357, DOI 10.1016/0044-8486(75)90114-3; Tettelbach ST, 2015, MAR ECOL PROG SER, V529, P121, DOI 10.3354/meps11263; Tettelbach ST, 2013, MAR ECOL PROG SER, V478, P153, DOI 10.3354/meps10111; TRIPPEL EA, 1995, BIOSCIENCE, V45, P759, DOI 10.2307/1312628; Trueman E. R., 1966, Proceedings of the Malacological Society of London, V37, P97; TRUEMAN ER, 1966, J EXP BIOL, V44, P469; Veness C., CALCULATE DISTANCE B; WELLS HW, 1957, ECOLOGY, V38, P123, DOI 10.2307/1932134; Wethey DS, 2005, BIOL BULL-US, V209, P139, DOI 10.2307/3593131; WILKENS LA, 2006, SCALLOPS BIOL ECOLOG, P317; Yenni G, 2012, ECOLOGY, V93, P456, DOI 10.1890/11-1087.1; Yonge C. M., 1976, LIVING MARINE MOLLUS; Yund PO, 2003, LIMNOL OCEANOGR, V48, P795, DOI 10.4319/lo.2003.48.2.0795; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	73	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173626	10.1371/journal.pone.0173626	http://dx.doi.org/10.1371/journal.pone.0173626			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278288	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900021
J	Sharpe, SA; White, AD; Sibley, L; Gleeson, F; Hall, GA; Basaraba, RJ; McIntyre, A; Clark, SO; Gooch, K; Marsh, PD; Williams, A; Dennis, MJ				Sharpe, S. A.; White, A. D.; Sibley, L.; Gleeson, F.; Hall, G. A.; Basaraba, R. J.; McIntyre, A.; Clark, S. O.; Gooch, K.; Marsh, P. D.; Williams, A.; Dennis, M. J.			An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques	PLOS ONE			English	Article							MONKEYS MACACA-FASCICULARIS; MHC CLASS-I; MYCOBACTERIUM-TUBERCULOSIS; RHESUS MACAQUES; BCG VACCINATION; INFECTION; HAPLOTYPES; METAANALYSIS; ORIGIN	Background New interventions for tuberculosis are urgently needed. Non-human primate (NHP) models provide the most relevant pre-clinical models of human disease and play a critical role in vaccine development. Models utilising Asian cynomolgus macaque populations are well established but the restricted genetic diversity of the Mauritian cynomolgus macaques may be of added value. Methods Mauritian cynomolgus macaques were exposed to a range of doses of M. tuberculosis delivered by aerosol, and the outcome was assessed using clinical, imaging and pathology based measures. Results All macaques developed characteristic clinical signs and disease features of tuberculosis (TB). Disease burden and the ability to control disease were dependent on exposure dose. Mauritian cynomolgus macaques showed less variation in pulmonary disease burden and total gross pathology scores within exposure dose groups than either Indian rhesus macaques or Chinese cynomolgus macaques Conclusions The genetic homogeneity of Mauritian cynomolgus macaques makes them a potentially useful model of human tuberculosis.	[Sharpe, S. A.; White, A. D.; Sibley, L.; Hall, G. A.; Clark, S. O.; Gooch, K.; Marsh, P. D.; Williams, A.; Dennis, M. J.] Publ Hlth England, Natl Infect Serv, Salisbury SP4 0JG, Wilts, England; [Gleeson, F.; McIntyre, A.] Churchill Hosp, Oxford, England; [Basaraba, R. J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA	Public Health England; University of Oxford; Colorado State University	Sharpe, SA (corresponding author), Publ Hlth England, Natl Infect Serv, Salisbury SP4 0JG, Wilts, England.	sally.sharpe@phe.gov.uk		Sibley, Laura/0000-0002-4188-3423; McIntyre, Anthony/0000-0001-9868-6183; Gleeson, Fergus/0000-0002-5121-3917; White, Andrew/0000-0001-9481-0079; clark, simon/0000-0003-1923-6120	Department of Health, UK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106733, R21AI107254] Funding Source: NIH RePORTER	Department of Health, UK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Department of Health, UK.	Basaraba RJ, 2008, TUBERCULOSIS, V88, pS35, DOI 10.1016/S1472-9792(08)70035-0; Borsetti A, 2012, TISSUE ANTIGENS, V80, P36, DOI 10.1111/j.1399-0039.2012.01875.x; Borsetti A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093235; Bourges-Abella N, 2014, J MED PRIMATOL, V43, P1, DOI 10.1111/jmp.12077; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Clark SO, 2011, J APPL MICROBIOL, V111, P350, DOI 10.1111/j.1365-2672.2011.05069.x; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Drevon-Gaillot E, 2006, EXP TOXICOL PATHOL, V58, P77, DOI 10.1016/j.etp.2006.07.003; DRUETT HA, 1969, J HYG-CAMB, V67, P437, DOI 10.1017/S0022172400041851; Florese RH, 2008, VACCINE, V26, P3312, DOI 10.1016/j.vaccine.2008.03.100; Greene JM, 2010, J VIROL, V84, P3362, DOI 10.1128/JVI.02028-09; Greene JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002384; HARPER GJ, 1953, J HYG-CAMBRIDGE, V51, P372, DOI 10.1017/S0022172400015801; Kanthaswamy S, 2013, J MED PRIMATOL, V42, P120, DOI 10.1111/jmp.12043; Kaushal D, 2012, J MED PRIMATOL, V41, P191, DOI 10.1111/j.1600-0684.2012.00536.x; Krebs KC, 2005, J IMMUNOL, V175, P5230, DOI 10.4049/jimmunol.175.8.5230; Langermans JAM, 2001, P NATL ACAD SCI USA, V98, P11497, DOI 10.1073/pnas.201404898; LAWLER SH, 1995, AM J PHYS ANTHROPOL, V96, P133, DOI 10.1002/ajpa.1330960203; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; Luetjens CM, 2012, REGUL TOXICOL PHARM, V63, P391, DOI 10.1016/j.yrtph.2012.05.003; Mee ET, 2010, TISSUE ANTIGENS, V76, P223, DOI 10.1111/j.1399-0039.2010.01500.x; Mee ET, 2009, IMMUNOGENETICS, V61, P327, DOI 10.1007/s00251-009-0369-8; Mee ET, 2009, J MED PRIMATOL, V38, P1, DOI 10.1111/j.1600-0684.2008.00299.x; O'Connor SL, 2007, IMMUNOGENETICS, V59, P449, DOI 10.1007/s00251-007-0209-7; O'Connor SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000524; Pena JC, 2015, INFECT IMMUN, V83, P852, DOI 10.1128/IAI.02850-14; Reed SG, 2009, P NATL ACAD SCI USA, V106, P2301, DOI 10.1073/pnas.0712077106; Scanga CA, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018564; Seekatz AM, 2013, PLOS ONE, V8; Sharpe SA, 2010, CLIN VACCINE IMMUNOL, V17, P1170, DOI 10.1128/CVI.00079-10; Sharpe SA, 2009, TUBERCULOSIS, V89, P405, DOI 10.1016/j.tube.2009.09.002; Sharpe S, 2016, TUBERCULOSIS, V96, P1, DOI 10.1016/j.tube.2015.10.004; Sibley L, 2016, TUBERCULOSIS, V96, P141, DOI 10.1016/j.tube.2015.11.004; Sugawara I, 2007, TUBERCULOSIS, V87, P518, DOI 10.1016/j.tube.2007.06.002; Sui Yongjun, 2013, Curr Protoc Immunol, V102, DOI 10.1002/0471142735.im1214s102; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Walsh GP, 1996, NAT MED, V2, P430, DOI 10.1038/nm0496-430; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	39	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171906	10.1371/journal.pone.0171906	http://dx.doi.org/10.1371/journal.pone.0171906			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273087	Green Published, gold			2022-12-27	WOS:000396073700061
J	He, S; Wang, H; Liu, R; He, MN; Che, TD; Jin, L; Deng, LM; Tian, SL; Li, Y; Lu, HF; Li, XW; Jiang, Z; Li, DY; Li, MZ				He, Shen; Wang, Hong; Liu, Rui; He, Mengnan; Che, Tiandong; Jin, Long; Deng, Lamei; Tian, Shilin; Li, Yan; Lu, Hongfeng; Li, Xuewei; Jiang, Zhi; Li, Diyan; Li, Mingzhou			mRNA N-6-methyladenosine methylation of postnatal liver development in pig	PLOS ONE			English	Article							EXPRESSION; M(6)A; CELLS; AMIDINOTRANSFERASE; ENRICHMENT; PROTEINS; HOMOLOG; MOUSE; EDEM2; FATE	N-6-methyladenosine (m(6)A) is a ubiquitous reversible epigenetic RNA modification that plays an important role in the regulation of post-transcriptional protein coding gene expression. Liver is a vital organ and plays a major role in metabolism with numerous functions. Information concerning the dynamic patterns of mRNA m(6)A methylation during postnatal development of liver has been long overdue and elucidation of this information will benefit for further deciphering a multitude of functional outcomes of mRNA m(6)A methylation. Here, we profile transcriptome-wide m(6)A in porcine liver at three developmental stages: newborn (0 day), suckling (21 days) and adult (2 years). About 33% of transcribed genes were modified by m(6)A, with 1.33 to 1.42 m(6)A peaks per modified gene. m(6)A was distributed predominantly around stop codons. The consensus motif sequence RRm(6)ACH was observed in 78.90% of m(6)A peaks. A negative correlation (average Pearson's r = -0.45, P < 10(-16)) was found between levels of m(6)A methylation and gene expression. Functional enrichment analysis of genes consistently modified by m(6)A methylation at all three stages showed genes relevant to important functions, including regulation of growth and development, regulation of metabolic processes and protein catabolic processes. Genes with higher m(6)A methylation and lower expression levels at any particular stage were associated with the biological processes required for or unique to that stage. We suggest that differential m(6)A methylation may be important for the regulation of nutrient metabolism in porcine liver.	[He, Shen; Liu, Rui; He, Mengnan; Che, Tiandong; Jin, Long; Tian, Shilin; Li, Xuewei; Li, Diyan; Li, Mingzhou] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Chengdu, Sichuan, Peoples R China; [Wang, Hong; Deng, Lamei; Tian, Shilin; Li, Yan; Lu, Hongfeng; Jiang, Zhi] Novogene Bioinformat Inst, Beijing, Peoples R China	Sichuan Agricultural University	Li, DY; Li, MZ (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Chengdu, Sichuan, Peoples R China.; Jiang, Z (corresponding author), Novogene Bioinformat Inst, Beijing, Peoples R China.	jiangzhi@novogene.com; diyanli@sicau.edu.cn; mingzhou.li@sicau.edu.cn	Tian, Shilin/AAP-9998-2020	Li, Mingzhou/0000-0001-8681-7684; Tian, Shilin/0000-0001-8958-1806; Li, Diyan/0000-0001-7490-3550	National High Technology Research and Development Program of China (863 Program) [2013AA102502]; Sichuan Provincial Department of Science and Technology Program [2015JQ0023]; National Natural Science Foundation of China [31530073, 31522055, 31472081, 31401073]; National Program for Support of Top-notch Young Professionals; Program for Innovative Research Team of Sichuan Province [2015TD0012]; Fund of Fok Ying-Tung Education Foundation [141117]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Sichuan Provincial Department of Science and Technology Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for Support of Top-notch Young Professionals; Program for Innovative Research Team of Sichuan Province; Fund of Fok Ying-Tung Education Foundation	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program) (2013AA102502), Sichuan Provincial Department of Science and Technology Program (2015JQ0023), the National Natural Science Foundation of China (31530073, 31522055, 31472081 and 31401073), the National Program for Support of Top-notch Young Professionals, the Program for Innovative Research Team of Sichuan Province (2015TD0012), and the Fund of Fok Ying-Tung Education Foundation (141117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshagen K., 2015, PANVASCULAR MED, P3607; AHERNE FX, 1992, VET CLIN N AM-FOOD A, V8, P589, DOI 10.1016/S0749-0720(15)30706-4; Anders S., 2013, DIFFERENTIAL EXPRESS; Andrada A.D., 2004, SPAN J AGRIC RES, P333, DOI [10.5424/sjar/2004023-102, DOI 10.5424/SJAR/2004023-102]; Antony AC, 2004, J CLIN INVEST, V113, P285, DOI 10.1172/JCI200411548; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bailey TL, 2012, NUCLEIC ACIDS RES, V40, P610; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bodi Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132090; Boschi-Muller S, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1392, DOI 10.1134/S0006297913130026; Council N, 2012, NUTR REQ SWIN; CSEPANY T, 1990, J BIOL CHEM, V265, P20117; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dourmad JY, 2002, J ANIM SCI, V80, P2144; Faust GG, 2014, BIOINFORMATICS, V30, P2503, DOI 10.1093/bioinformatics/btu314; Feranchak AP, 2004, GASTROENTEROLOGY, V127, P903, DOI 10.1053/j.gastro.2004.06.047; Fontana RJ, 1999, GASTROENTEROLOGY, V117, P89, DOI 10.1016/S0016-5085(99)70554-8; Gilbert WV, 2016, SCIENCE, V352, P1408, DOI 10.1126/science.aad8711; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humm A, 1997, EMBO J, V16, P3373, DOI 10.1093/emboj/16.12.3373; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; LEE SL, 1978, ARTHRITIS RHEUM, V21, P958, DOI 10.1002/art.1780210813; LEONG SR, 1992, MOL ENDOCRINOL, V6, P870, DOI 10.1210/me.6.6.870; LEVIS R, 1978, J MOL BIOL, V120, P487, DOI 10.1016/0022-2836(78)90350-9; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lima J P, 1980, Arq Gastroenterol, V17, P149; Liu N, 2016, NAT STRUCT MOL BIOL, V23, P98, DOI 10.1038/nsmb.3162; Luo GZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6630; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Maity A, 2015, FEBS J; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Merregaert J, 2010, J BIOL CHEM, V285, P37823, DOI 10.1074/jbc.M110.136408; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Ninagawa S, 2014, J CELL BIOL, V206, P347, DOI 10.1083/jcb.201404075; Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; Pemberton TA, 2014, BIOCHEMISTRY-US, V53, P1350, DOI 10.1021/bi500048b; Phillips DH, 1999, MUTAT RES-GEN TOX EN, V443, P139, DOI 10.1016/S1383-5742(99)00016-2; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Reinke H, 2016, GASTROENTEROLOGY, V150, P574, DOI 10.1053/j.gastro.2015.11.043; Riedel TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026021; SENO M, 1995, BBA-GENE STRUCT EXPR, V1261, P424, DOI 10.1016/0167-4781(95)00040-N; Shimada T, 2006, DRUG METAB PHARMACOK, V21, P257, DOI 10.2133/dmpk.21.257; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Toki T, 1997, ONCOGENE, V14, P1901, DOI 10.1038/sj.onc.1201024; Urban A, 2009, J BIOL CHEM, V284, P5845, DOI 10.1074/jbc.M807986200; Vakharia DD, 2001, TOXICOL APPL PHARM, V170, P93, DOI 10.1006/taap.2000.9087; Wahl B, 2010, J BIOL CHEM, V285, P37847, DOI 10.1074/jbc.M110.169532; Wan YZ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0839-2; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Wang YC, 2011, J NUTR, V141, P777, DOI 10.3945/jn.110.135954; WEI CM, 1976, BIOCHEMISTRY-US, V15, P397, DOI 10.1021/bi00647a024; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zahid H, 2016, BIOCHEM J, V473, P43, DOI 10.1042/BJ20150836; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao BS, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0609-1; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883; Zhu YF, 2001, MOL CELL BIOCHEM, V221, P139, DOI 10.1023/A:1010946414017	60	35	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173421	10.1371/journal.pone.0173421	http://dx.doi.org/10.1371/journal.pone.0173421			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267806	gold, Green Published, Green Submitted			2022-12-27	WOS:000396060600031
J	Liang, C; Pauly, D				Liang, Cui; Pauly, Daniel			Fisheries impacts on China's coastal ecosystems: Unmasking a pervasive 'fishing down' effect	PLOS ONE			English	Article							TROPHIC-LEVEL; MARINE; EXPANSION; CATCH	Intensive fishing can strongly impact marine ecosystems; among other things, it usually causes the mean trophic level of the catches to decline, an indicator of the occurrence of the `fishing down' (FD) phenomenon. Although FD occurs throughout the world oceans, it can easily be masked by diverse factors, which has misled authors as to its generality. In this contribution, which uses the East China Sea as an example, we explore the masking effect on FD of the taxonomic coarseness of catch data, of assuming that individual sizes remain constant after intensive fishing, and the geographic expansion of fisheries. The result showed that all of these masking factors occur in the East China Sea, where only a few species are reported separately and the bulk of the catch is pooled into non-informative 'mixed fishes'. Also, the small mesh sizes and intensive fishing have reduced the sizes of fish and their trophic levels, while the fisheries have expanded offshore. Overall, taking the masking factors into account, the fishing down effect, i.e., the decline of the mean trophic level of the catch between 1979 and 2014 is in the order of 0.15 TL per decade, i.e., one of the highest estimates of FD in the world. Some ecological implications are presented.	[Liang, Cui] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Fujian Province, Peoples R China; [Pauly, Daniel] Univ British Columbia, Sea Us, Inst Ocean & Fisheries, Vancouver, BC, Canada	Xiamen University; University of British Columbia	Liang, C (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Fujian Province, Peoples R China.	cui-liang@hotmail.com	Pauly, Daniel Marc/AAY-2316-2021; Hsieh, Chih-hao/B-3797-2008	Pauly, Daniel/0000-0003-3756-4793; Hsieh, Chih-hao/0000-0001-5935-7272	Paul G. Allen Family Foundation; China Scholarship Council [201506310099]	Paul G. Allen Family Foundation; China Scholarship Council(China Scholarship Council)	This work was supported by Paul G. Allen Family Foundation (DP), URL: http://www.pgafamilyfoundation.org/, and China Scholarship Council (CL), Grant number: 201506310099, URL: http://en.csc.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], UNEP LARGE MARINE EC; Banobi JA, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00142.1; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Beverton R.J.H., 1957, FISHERY INVESTIGAT 2, VXIX; Bhathal B, 2008, FISH RES, V91, P26, DOI 10.1016/j.fishres.2007.10.022; Branch TA, 2016, FISH FISH, V17, P1094, DOI 10.1111/faf.12160; Branch TA, 2010, NATURE, V468, P431, DOI 10.1038/nature09528; Caddy J.F., 1998, SCIENCE, V282, p1383a, DOI 10.1126/science.282.5393.1383a; Cao L, 2015, SCIENCE, V347, P133, DOI 10.1126/science.1260149; Chassot E, 2008, J FISH BIOL, V73, P763, DOI 10.1111/j.1095-8649.2008.01938.x; Chinese State Council, 1979, STAT COUNC STAT APPR; Du Jianguo, 2014, Biodiversity Science, V22, P532, DOI 10.3724/SP.J.1003.2014.13200; FAO, 2014, YB 2012 FISH AQ STAT; Fisheries and Fishery Administration of the Ministry of Agriculture, 1979, CHINA FISHERY STAT Y; Garibaldi L, 2012, MAR POLICY, V36, P760, DOI 10.1016/j.marpol.2011.10.024; Gascuel D, 2016, FISH FISH, V17, P31, DOI 10.1111/faf.12090; GAUSE G. F., 1934, SCIENCE, V79, P16, DOI 10.1126/science.79.2036.16-a; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Huang Y., 1990, MODERN FISHERIES INF, V5, P13; Kleisner K, 2014, MAR ECOL PROG SER, V512, P185, DOI 10.3354/meps10949; Liang C, 2017, J APPL ICHTHYOLOGY; Lin Long-shan, 2008, Marine Fisheries, V30, P126; Milessi AC, 2005, FISH RES, V74, P223, DOI 10.1016/j.fishres.2005.02.002; Pang L., 2001, FISHERIES CTR RES RE, V9, P1; Parsons Timothy R., 1996, P352; Pauly D, 2005, B MAR SCI, V76, P197; Pauly D, 2005, PHILOS T ROY SOC B, V360, P415, DOI 10.1098/rstb.2004.1597; Pauly D, 2001, CAN J FISH AQUAT SCI, V58, P51, DOI 10.1139/cjfas-58-1-51; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2000, AM SCI, V88, P46; PAULY D, 1980, J CONSEIL, V39, P175; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pauly D, 1998, SCI AAAS WEEKLY PAPE, V282, P1516; Pauly D., 1986, 1 ASIAN FISHERIES FO, P491; Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244; Pauly D, 2014, FISH FISH, V15, P474, DOI 10.1111/faf.12032; Stergiou K, 2000, FISHING MEDITERRANEA, V26, P30; Stergiou KI, 2001, REV FISH BIOL FISHER, V11, P217, DOI 10.1023/A:1020556722822; Stergiou KI, 2011, MAR ECOL PROG SER, V441, P295, DOI 10.3354/meps09377; Swartz W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015143; Valtysson Hthorn, 2003, COMPETITIVENESS GLOB, P12; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Watson RA, 2013, FISH RES, V140, P63, DOI 10.1016/j.fishres.2012.12.004; Wei Chen, 2006, FOSHAN CERAMICS, V16, P7; Zeller D, 2016, MAR POLICY, V70, P145, DOI 10.1016/j.marpol.2016.04.046	46	32	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173296	10.1371/journal.pone.0173296	http://dx.doi.org/10.1371/journal.pone.0173296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267755	Green Published, gold, Green Submitted			2022-12-27	WOS:000396060600020
J	Mattei, G; Magliaro, C; Giusti, S; Ramachandran, SD; Heinz, S; Braspenning, J; Ahluwalia, A				Mattei, Giorgio; Magliaro, Chiara; Giusti, Serena; Ramachandran, Sarada Devi; Heinz, Stefan; Braspenning, Joris; Ahluwalia, Arti			On the adhesion-cohesion balance and oxygen consumption characteristics of liver organoids	PLOS ONE			English	Article							VISCOELASTIC CHARACTERIZATION; MECHANICAL-PROPERTIES; CELL-CULTURE; IN-VITRO; HEPATOCYTES; BIOREACTOR; SCAFFOLDS; SOFT	Liver organoids (LOs) are of interest in tissue replacement, hepatotoxicity and pathophysiological studies. However, it is still unclear what triggers LO self-assembly and what the optimal environment is for their culture. Hypothesizing that LO formation occurs as a result of a fine balance between cell-substrate adhesion and cell-cell cohesion, we used 3 cell types (hepatocytes, liver sinusoidal endothelial cells and mesenchymal stem cells) to investigate LO self-assembly on different substrates keeping the culture parameters (e.g. culture media, cell types/number) and substrate stiffness constant. As cellular spheroids may suffer from oxygen depletion in the core, we also sought to identify the optimal culture conditions for LOs in order to guarantee an adequate supply of oxygen during proliferation and differentiation. The oxygen consumption characteristics of LOs were measured using an O-2 sensor and used to model the O-2 concentration gradient in the organoids. We show that no LO formation occurs on highly adhesive hepatic extra-cellular matrix-based substrates, suggesting that cellular aggregation requires an optimal trade-off between the adhesiveness of a substrate and the cohesive forces between cells and that this balance is modulated by substrate mechanics. Thus, in addition to substrate stiffness, physicochemical properties, which are also critical for cell adhesion, play a role in LO self-assembly.	[Mattei, Giorgio; Magliaro, Chiara; Giusti, Serena; Ahluwalia, Arti] Univ Pisa, Res Ctr E Piaggio, Pisa, Italy; [Ramachandran, Sarada Devi; Heinz, Stefan] Medicyte GmbH, Heidelberg, Germany; [Braspenning, Joris] Univ Hosp Wuerzburg, Tissue Engn & Regenerat Med, Roentgering, Wuerzburg, Germany	University of Pisa; University of Wurzburg	Ahluwalia, A (corresponding author), Univ Pisa, Res Ctr E Piaggio, Pisa, Italy.	arti.ahluwalia@centropiaggio.unipi.it	Kostjuka, Milana/ABA-6395-2021	Mattei, Giorgio/0000-0003-0441-9653; Ahluwalia, Arti/0000-0001-5370-6750	European Union [304961]	European Union(European Commission)	The work leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement 304961 (ReLiver, http://cordis.europa.eu/project/rcn/104054_en.html). The funder provided support in the form of salaries for authors SDR, SH, JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen JW, 2003, BIOTECHNOL BIOENG, V82, P253, DOI 10.1002/bit.10569; Burkard A, 2012, XENOBIOTICA, V42, P939, DOI 10.3109/00498254.2012.675093; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; FOY BD, 1994, CELL TRANSPLANT, V3, P515, DOI 10.1177/096368979400300609; FRISANCHO AR, 1975, SCIENCE, V187, P313, DOI 10.1126/science.1089311; Gentile P, 2012, J BIOMED MATER RES A, V100A, P2654, DOI 10.1002/jbm.a.34205; Giulitti S, 2013, LAB CHIP, V13, P4430, DOI 10.1039/c3lc50643f; Gonzalez R.C., 2010, DIGITAL IMAGE PROCES, V3rd ed.; Jelen C, 2013, MAT SCI ENG C-MATER, V33, P28, DOI 10.1016/j.msec.2012.07.046; Kane RJ, 2012, J MECH BEHAV BIOMED, V7, P41, DOI 10.1016/j.jmbbm.2011.09.010; Kutty MN, 1987, SITE SELECTION FOR A; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee JS, 2014, BIOMACROMOLECULES, V15, P206, DOI 10.1021/bm4015039; Lee MY, 2006, AM J PHYSIOL-GASTR L, V291, pG744, DOI 10.1152/ajpgi.00551.2005; Leturque A, 2005, J PHYSIOL BIOCHEM, V61, P529, DOI 10.1007/BF03168378; Lu YH, 2012, BIOTECHNOL BIOENG, V109, P595, DOI 10.1002/bit.23349; Maes M, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00405; Mattei G, 2015, J MECH BEHAV BIOMED, V50, P150, DOI 10.1016/j.jmbbm.2015.06.015; Mattei G, 2014, J BIOMECH, V47, P2641, DOI 10.1016/j.jbiomech.2014.05.017; Mattei G, 2014, ACTA BIOMATER, V10, P875, DOI 10.1016/j.actbio.2013.10.023; Mattei G, 2016, ACTA BIOMATER, V45, P60, DOI 10.1016/j.actbio.2016.08.055; Mattei G, 2014, PROCESSES, V2, P548, DOI 10.3390/pr2030548; Mattei G, 2015, SCI REP-UK, V5, DOI 10.1038/srep10778; Mazzei D, 2010, BIOTECHNOL BIOENG, V106, P127, DOI 10.1002/bit.22671; Normand V, 2000, BIOMACROMOLECULES, V1, P730, DOI 10.1021/bm005583j; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pinkse GGM, 2004, LIVER INT, V24, P218, DOI 10.1111/j.1478-3231.2004.0914.x; Ramachandran SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139345; Regehr KJ, 2009, LAB CHIP, V9, P2132, DOI 10.1039/b903043c; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Smith I, 2015, NEUROSCI LETT, V609, P198, DOI 10.1016/j.neulet.2015.10.044; Smith MK, 2007, J BIOMED MATER RES A, V80A, P520, DOI 10.1002/jbm.a.30930; Soares CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038147; Speicher T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4862; Takebe T, 2015, CELL STEM CELL, V16, P556, DOI 10.1016/j.stem.2015.03.004; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Tan GDS, 2013, BIOTECHNOL BIOENG, V110, P1663, DOI 10.1002/bit.24822; Tirella A, 2014, J BIOMED MATER RES A, V102, P3352, DOI 10.1002/jbm.a.34914; Wen YA, 2009, TOXICOL IN VITRO, V23, P744, DOI 10.1016/j.tiv.2009.02.009; Zawada RJX, 2009, BIOCHEM CELL BIOL, V87, P541, DOI [10.1139/O09-011, 10.1139/o09-011]	40	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173206	10.1371/journal.pone.0173206	http://dx.doi.org/10.1371/journal.pone.0173206			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267799	Green Published, Green Submitted, gold			2022-12-27	WOS:000396060600014
J	Sun, XB; Zhao, DL; Liu, Y; Liu, YX; Yuan, ZS; Wang, JL; Xue, FZ				Sun, Xiubin; Zhao, Deli; Liu, Yi; Liu, Yunxia; Yuan, Zhongshang; Wang, Jialin; Xue, Fuzhong			The long-term spatial-temporal trends and burden of esophageal cancer in one high-risk area: A population-registered study in Feicheng, China	PLOS ONE			English	Article							DISEASE; INJURY	Background Feicheng County is a high-risk area for esophageal cancer in Shandong province, China. It is important to determine the long-term spatio-temporal trends in epidemiological characteristics and the burden of esophageal cancer, especially since the implementation of the national esophageal cancer screening program for early detection and treatment in 2005. Methods The data collected in Feicheng County from 2001 to 2012 was extracted from the whole population cancer registry system. The incidence, mortality, disability-adjusted life years (DALY) and changing trends in esophageal cancer according to age and sex were calculated and described. Results The incidence rate of esophageal cancer in Feicheng was consistently high, and increased significantly for male, but not for female from 2001 to 2012, according to the joinpoint regression analysis. The highest and lowest yearly crude incidence rates were 160.78 and 95.97 per 100000 for males, and 81.36 and 52.17 per 100000 for females. The highest and lowest crude yearly mortality rates were 122.26 and 94.40 per 100000 for males, and 60.75 and 49.35 per 100000for females. Esophageal squamous cell carcinoma was the main pathology type and the tumor location changed significantly from 2001 to 2012. Overall, the DALY remained roughly stable and was estimated as 11.50 for males and 4.90 for females per 1000 people. The burden was mainly caused by premature death. There is an obvious spatial pattern in the distribution of incidence density and burden. Conclusion Esophageal cancer remains a public health issue in Feicheng County with a high incidence, mortality and disease burden. The incidence and burden have obvious spatial heterogeneity, and further studies should be conducted to identify geographical risk factors for precise local prevention and control measures.	[Sun, Xiubin; Liu, Yi; Liu, Yunxia; Yuan, Zhongshang; Xue, Fuzhong] Shandong Univ, Sch Publ Hlth, Dept Biostat, Jinan, Shandong, Peoples R China; [Zhao, Deli] Feicheng Peoples Hosp, Canc Res Ctr, Tumor Preventat & Therapeut Base Shandong Prov, Feicheng, Shandong, Peoples R China; [Wang, Jialin] Shandong Univ, Shandong Canc Hosp, Shandong Acad Med Sci, Jinan, Shandong, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Jinan	Xue, FZ (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Biostat, Jinan, Shandong, Peoples R China.; Wang, JL (corresponding author), Shandong Univ, Shandong Canc Hosp, Shandong Acad Med Sci, Jinan, Shandong, Peoples R China.	Wangjialin6681@sina.com; xuefzh@sdu.edu.cn	Xue, Fuzhong/AAG-4808-2020; Yuan, Zhongshang/GVT-8351-2022	Xue, Fuzhong/0000-0003-0378-7956	Natural Science Foundation of Shandong province [ZR2016HM42]; Project of science and technology plan of Shandong Provincial Academy of Medical Sciences [2014-15]	Natural Science Foundation of Shandong province(Natural Science Foundation of Shandong Province); Project of science and technology plan of Shandong Provincial Academy of Medical Sciences	This study was funded by grants from the Natural Science Foundation of Shandong province (no. ZR2016HM42) and Project of science and technology plan of Shandong Provincial Academy of Medical Sciences (no. 2014-15).	Chen Wan-qing, 2012, Zhonghua Zhong Liu Za Zhi, V34, P517, DOI 10.3760/cma.j.issn.0253-3766.2012.07.010; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen Wen, 2016, Computer Aided Engineering, V25, P1, DOI 10.13340/j.cae.2016.03.001; Henry MACD, 2014, ACTA CIR BRAS, V29, P389, DOI 10.1590/S0102-86502014000600007; de Larrea-Baz NF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-42; Gallus S, 2001, BRIT J CANCER, V85, P341, DOI 10.1054/bjoc.2001.1898; Ghasemi-Kebria F, 2013, CANCER EPIDEMIOL, V37, P290, DOI 10.1016/j.canep.2013.01.010; [郭晓雷 Guo Xiaolei], 2010, [中国公共卫生, China Public Health], V26, P813; Hao J, 2012, CHINESE CANC REGISTR; He Yu-tong, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P127; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kominski GF, 2002, PUBLIC HEALTH REP, V117, P185, DOI 10.1016/S0033-3549(04)50125-5; Lapostolle A, 2008, EUR J PUBLIC HEALTH, V18, P195, DOI 10.1093/eurpub/ckm109; Li Man, 2004, Asian Pac J Cancer Prev, V5, P414; Liu ST, 2013, INT J PHOTOENERGY, V2013, DOI 10.1155/2013/172010; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1; Ma Hengmin, 2014, CHIN J CANC PREV TRE, V21, P498; Mathers CD, 2001, B WORLD HEALTH ORGAN, V79, P1076; Mayne ST, 2002, J NUTR, V132, p3467S, DOI 10.1093/jn/132.11.3467S; Murray C.J, 1996, GLOBAL BURDEN DIS CO; Rahimzadeh-Barzoki H, 2014, SAUDI MED J, V35, P617; Sun Jiandong, 2007, CHINESE HLTH EC MAGA, V26, P64; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Vos T, 2000, B WORLD HEALTH ORGAN, V78, P427; Wang Tao, 2007, CHINESE J PUBLIC HLT, V23, P506; Wu KS, 2008, SCI TOTAL ENVIRON, V393, P219, DOI 10.1016/j.scitotenv.2007.12.029; Zeng Hong-mei, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P593; Zhao Deli, 2010, CHINA CANC, V19, P235	29	12	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173211	10.1371/journal.pone.0173211	http://dx.doi.org/10.1371/journal.pone.0173211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267769	Green Submitted, gold, Green Published			2022-12-27	WOS:000396060600015
J	Trudell, AS; Tuuli, MG; Colditz, GA; Macones, GA; Odibo, AO				Trudell, Amanda S.; Tuuli, Methodius G.; Colditz, Graham A.; Macones, George A.; Odibo, Anthony O.			A stillbirth calculator: Development and internal validation of a clinical prediction model to quantify stillbirth risk	PLOS ONE			English	Article							UTERINE ARTERY DOPPLER; BREAST-CANCER; INFANT-DEATH; PREGNANCY; INDEX; AGE	Objective To generate a clinical prediction tool for stillbirth that combines maternal risk factors to provide an evidence based approach for the identification of women who will benefit most from antenatal testing for stillbirth prevention. Design Retrospective cohort study Setting Midwestern United States quaternary referral center Population Singleton pregnancies undergoing second trimester anatomic survey from 1999-2009. Pregnancies with incomplete follow-up were excluded. Methods Candidate predictors were identified from the literature and univariate analysis. Backward stepwise logistic regression with statistical comparison of model discrimination, calibration and clinical performance was used to generate final models for the prediction of stillbirth. Internal validation was performed using bootstrapping with 1,000 repetitions. A stillbirth risk calculator and stillbirth risk score were developed for the prediction of stillbirth at or beyond 32 weeks excluding fetal anomalies and aneuploidy. Statistical and clinical cut-points were identified and the tools compared using the Integrated Discrimination Improvement. Main outcome measures Antepartum stillbirth Results 64,173 women met inclusion criteria. The final stillbirth risk calculator and score included maternal age, black race, nulliparity, body mass index, smoking, chronic hypertension and pre-gestational diabetes. The stillbirth calculator and simple risk score demonstrated modest discrimination but clinically significant performance with no difference in overall performance between the tools [(AUC 0.66 95% CI 0.60-0.72) and (AUC 0.64 95% CI 0.58-0.70), (p = 0.25)]. Conclusion A stillbirth risk score was developed incorporating maternal risk factors easily ascertained during prenatal care to determine an individual woman's risk for stillbirth and provide an evidenced based approach to the initiation of antenatal testing for the prediction and prevention of stillbirth.	[Trudell, Amanda S.] Mercy Hosp St Louis, Dept Obstet & Gynecol, Midwest Maternal Fetal Med, St Louis, MO USA; [Tuuli, Methodius G.; Macones, George A.] Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, St Louis, MO 63110 USA; [Colditz, Graham A.] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth, St Louis, MO 63110 USA; [Odibo, Anthony O.] Univ S Florida, Moorsani Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Tampa, FL USA	Saint Johns Mercy Medical Center; Washington University (WUSTL); Washington University (WUSTL); State University System of Florida; University of South Florida	Trudell, AS (corresponding author), Mercy Hosp St Louis, Dept Obstet & Gynecol, Midwest Maternal Fetal Med, St Louis, MO USA.	dr.atrudell@gmail.com	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NIH [2T32HD055172-06]; Washington University Institute of Clinical and Translational Sciences Grant [UL1TR000448]; Foundation from Barnes-Jewish Hospital, St Louis	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Institute of Clinical and Translational Sciences Grant; Foundation from Barnes-Jewish Hospital, St Louis	At the time of this work Dr. Trudell was supported by NIH T32 Grant #2T32HD055172-06 (PI G. Macones) and by Washington University Institute of Clinical and Translational Sciences Grant #UL1TR000448 (PI B. Evanoff). G Colditz is supported by the Foundation from Barnes-Jewish Hospital, St Louis.	Akolekar R, 2016, ULTRASOUND OBSTET GY; [Anonymous], 2014, Obstet Gynecol, V124, P182, DOI 10.1097/01.AOG.0000451759.90082.7b; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; FREEMAN RK, 1982, AM J OBSTET GYNECOL, V143, P771, DOI 10.1016/0002-9378(82)90008-4; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Goldenberg RL, 2011, LANCET, V377, P1798, DOI 10.1016/S0140-6736(10)62235-0; Liu XH, 2012, STAT MED, V31, P2676, DOI 10.1002/sim.4509; Odibo AO, 2011, J MATERN-FETAL NEO M, V24, P411, DOI 10.3109/14767058.2010.506566; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Poon LCY, 2013, FETAL DIAGN THER, V33, P28, DOI 10.1159/000342109; Reddy UM, 2006, AM J OBSTET GYNECOL, V195, P764, DOI 10.1016/j.ajog.2006.06.019; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; Rosenstein MG, 2012, OBSTET GYNECOL, V120, P76, DOI 10.1097/AOG.0b013e31825bd286; Singh T, 2012, OBSTET GYNECOL, V119, P256, DOI 10.1097/AOG.0b013e318242ad81; Smith GCS, 2007, OBSTET GYNECOL, V109, P144, DOI 10.1097/01.AOG.0000248536.94919.e3; Trudell AS, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.04.021; Yao RF, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.044; Yerlikaya G, 2016, ULTRASOUND OBST GYN, V48, P607, DOI 10.1002/uog.17290; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	26	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173461	10.1371/journal.pone.0173461	http://dx.doi.org/10.1371/journal.pone.0173461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267756	gold, Green Published, Green Submitted			2022-12-27	WOS:000396060600033
J	Woods, B; Manca, A; Weatherly, H; Saramago, P; Sideris, E; Giannopoulou, C; Rice, S; Corbett, M; Vickers, A; Bowes, M; MacPherson, H; Sculpher, M				Woods, Beth; Manca, Andrea; Weatherly, Helen; Saramago, Pedro; Sideris, Eleftherios; Giannopoulou, Christina; Rice, Stephen; Corbett, Mark; Vickers, Andrew; Bowes, Matthew; MacPherson, Hugh; Sculpher, Mark			Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee	PLOS ONE			English	Article							INDIVIDUAL-PATIENT-DATA; EQ-5D UTILITY VALUES; EULAR RECOMMENDATIONS; NETWORK METAANALYSIS; TASK-FORCE; ACUPUNCTURE; MANAGEMENT; PAIN; RESPONSES; TRIALS	Background There is limited information on the costs and benefits of alternative adjunct non pharmacological treatments for knee osteoarthritis and little guidance on which should be prioritised for commissioning within the NHS. This study estimates the costs and benefits of acupuncture, braces, heat treatment, insoles, interferential therapy, laser/light therapy, manual therapy, neuromuscular electrical stimulation, pulsed electrical stimulation, pulsed electromagnetic fields, static magnets and transcutaneous electrical nerve Stimulation (TENS), based on all relevant data, to facilitate a more complete assessment of value. Methods Data from 88 randomised controlled trials including 7,507 patients were obtained from a systematic review. The studies reported a wide range of outcomes. These were converted into EQ-5D index values using prediction models, and synthesised using network meta-analysis. Analyses were conducted including firstly all trials and secondly only trials with low risk of selection bias. Resource use was estimated from trials, expert opinion and the literature. A decision analytic model synthesised all evidence to assess interventions over a typical treatment period (constant benefit over eight weeks or linear increase in effect over weeks zero to eight and dissipation over weeks eight to 16). Results When all trials are considered, TENS is cost-effective at thresholds of 20-30,000 pound per QALY with an incremental cost-effectiveness ratio of 2,690 pound per QALY vs. usual care. When trials with a low risk of selection bias are considered, acupuncture is cost-effective with an incremental cost-effectiveness ratio of 13,502 pound per QALY vs. TENS. The results of the analysis were sensitive to varying the intensity, with which interventions were delivered, and the magnitude and duration of intervention effects on EQ-5D. Conclusions Using the 20,000 per QALY NICE threshold results in TENS being cost-effective if all trials are considered. If only higher quality trials are considered, acupuncture is cost-effective at this threshold, and thresholds down to 14,000 per QALY.	[Woods, Beth; Manca, Andrea; Weatherly, Helen; Saramago, Pedro; Sideris, Eleftherios; Giannopoulou, Christina; Sculpher, Mark] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Rice, Stephen; Corbett, Mark] Univ York, Ctr Reviews & Disseminat, York, N Yorkshire, England; [Vickers, Andrew] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Bowes, Matthew] York Teaching Hosp NHS Fdn Trust, York, N Yorkshire, England; [MacPherson, Hugh] Univ York, Dept Hlth Sci, York, N Yorkshire, England	University of York - UK; University of York - UK; Memorial Sloan Kettering Cancer Center; University of York - UK	Woods, B (corresponding author), Univ York, Ctr Hlth Econ, York, N Yorkshire, England.	Beth.woods@york.ac.uk		Sculpher, Mark/0000-0003-3746-9913; Woods, Bethan Sarah/0000-0002-7669-9415	National Institute for Health Research (NIHR) [RP-PG-0707-10186]; R21 from the National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health (NIH) [AT0041891]; Samueli Institute; NIHR [CDF-2009-02-21]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006794] Funding Source: NIH RePORTER; National Institute for Health Research [CDF-2009-02-21, RP-PG-0707-10186] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); R21 from the National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health (NIH); Samueli Institute; NIHR(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the National Institute for Health Research (NIHR) under Programme Grants for Applied Research [Grant number: RP-PG-0707-10186]. The views expressed in this presentation are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The Acupuncture Trialists' Collaboration (ATC) is funded by an R21 [Grant number: AT0041891] from the National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health (NIH) to Dr Vickers and by a grant from the Samueli Institute. AM contribution was made under the terms of a Career Development research training fellowship issued by the NIHR [Grant number: CDF-2009-02-21]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedoyin RA, 2002, PHYSIOTHERAPY, V88, P493, DOI [10.1016/S0031-9406(05)60851-6, DOI 10.1016/S0031-9406(05)60851-6]; [Anonymous], METHODS ESTIMATION N; Barton GR, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-51; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Burch FX, 2008, OSTEOARTHR CARTILAGE, V16, P865, DOI 10.1016/j.joca.2007.11.013; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Claxton K, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16460; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Corbett MS, 2013, OSTEOARTHR CARTILAGE, V21, P1290, DOI 10.1016/j.joca.2013.05.007; Corbett MS, 2012, 40 CTR REV DISS; Curtis L, 2013, UNIT COSTS HLTH SOCI; Dakin H, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-151; Dias S, 2013, MED DECIS MAKING, V33, P618, DOI 10.1177/0272989X13485157; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; Fernandes L, 2013, ANN RHEUM DIS, V72, P1125, DOI 10.1136/annrheumdis-2012-202745; Gray AM, 2006, MED DECIS MAKING, V26, P18, DOI 10.1177/0272989X05284108; Gu NY, 2012, PATIENT, V5, P185, DOI 10.2165/11630970-000000000-00000; Gundog M, 2012, AM J PHYS MED REHAB, V91, P107, DOI 10.1097/PHM.0b013e3182328687; healthandcare. co. uk, 2014, BAUERF GEN TRAIN KNE; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Longworth L, 2013, VALUE HEALTH, V16, P202, DOI 10.1016/j.jval.2012.10.010; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; MacPherson H, 2016, PAIN; MacPherson H, PROGRAMME G IN PRESS; MacPherson H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093739; Maund E, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16110; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; National Institute for Health and Care Excellence, 2014, OST CAR MAN AD; Nuesch E, 2009, ARTHRIT RHEUM-ARTHR, V61, P1633, DOI 10.1002/art.24894; Penninsula Community Health, POD DISCH LETT; Rowen D, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-27; Saramago P, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0224-1; Underwood M, 2008, HLTH TECHNOLOGY ASSE, V12, P22; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654	37	36	36	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0172749	10.1371/journal.pone.0172749	http://dx.doi.org/10.1371/journal.pone.0172749			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267751	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000396060600002
J	Naudinot, N; Bourdier, C; Laforge, M; Paris, C; Bellot-Gurlet, L; Beyries, S; Thery-Parisot, I; Le Goffic, M				Naudinot, Nicolas; Bourdier, Camille; Laforge, Marine; Paris, Celine; Bellot-Gurlet, Ludovic; Beyries, Sylvie; Thery-Parisot, Isabelle; Le Goffic, Michel			Divergence in the evolution of Paleolithic symbolic and technological systems: The shining bull and engraved tablets of Rocher de l'Imperatrice	PLOS ONE			English	Article							RUEIL-MALMAISON; PARIS BASIN; LOWER LEVEL; FEDERMESSER; OCCUPATION	The development of the Azilian in Western Europe 14,000 years ago is considered a "revolution" in Upper Paleolithic Archaeology. One of the main elements of this rapid social restructuring is the abandonment of naturalistic figurative art on portable pieces or on cave walls in the Magdalenian in favor of abstract expression on small pebbles. Recent work shows that the transformation of human societies between the Magdalenian and the Azilian was more gradual. The discovery of a new Early Azilian site with decorated stones in France supports this hypothesis. While major changes in stone tool technology between the Magdalenian and Azilian clearly mark important adaptive changes, the discovery of 45 engraved schist tablets from archaeological layers at Le Rocher de l'Imperatrice attests to iconographic continuity together with special valorization of aurochs as shown by a "shining" bull depiction. This evidence suggests that some cultural features such as iconography may lag far behind technological changes. We also argue that eventual change in symbolic expression, which includes the later disappearance of figurative art, provides new insight into the probable restructuring of the societies.	[Naudinot, Nicolas; Beyries, Sylvie; Thery-Parisot, Isabelle] Univ Cote dAzur, CNRS, CEPAM, UMR, Nice, France; [Bourdier, Camille] Univ Toulouse II Jean Jaures, TRACES UMR, Toulouse, France; [Laforge, Marine] EVEHA, Etud & Valorisat Archeol, Rennes, France; [Laforge, Marine] Inst Univ Europeen Mer, UMR LETG Brest Geomer Littoral Environm Teledetec, Plouzane, France; [Paris, Celine; Bellot-Gurlet, Ludovic] Univ Pierre & Marie Curie Paris 6, Sorbonne Univ, MONARIS UMR, UPMC,CNRS, Paris, France; [Le Goffic, Michel] UMR CReAAH 6566, Rennes, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Universite de Toulouse; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Naudinot, N (corresponding author), Univ Cote dAzur, CNRS, CEPAM, UMR, Nice, France.	nicolas.naudinot@cepam.cnrs.fr	Bellot-Gurlet, Ludovic/G-7132-2012	Bellot-Gurlet, Ludovic/0000-0002-7995-6261; Bourdier, Camille/0000-0003-4432-1722; Thery-Parisot, Isabelle/0000-0003-3766-0750	Service Regional de l'Archeologie de Bretagne (Ministere de la Culture et de la Communication)	Service Regional de l'Archeologie de Bretagne (Ministere de la Culture et de la Communication)	The excavation of this site was funded by: Service Regional de l'Archeologie de Bretagne (Ministere de la Culture et de la Communication), http://www.culturecommunication.gouv.fr/Regions/Drac-Bretagne/La-DRAC-et-ses-services/ AnnuaireOrganigranne/Pole-architecture-et-patrimoine/Service-regional-de-1-archeologie, and Conseil departemental du Finistere, https://www.finistere.fr/. This is not a grant but a funding for Archaeology from the Ministry of Culture of France. We do not have any grant numbers.	Appelaniz J.M., 1987, ART OBJETS PALE LOLI, P105; Aujoulat N., 2011, MILLE FEMMES FIN TEM, P89; Baffier D., 1996, MEM SOC PREHIST FRAN, P82; Barandiaran I., 1996, LART PREHISTORIQUE P, P88; Bereiziat G., 2011, THESIS; Bertran P., 2004, DEPOTS PENTE CONTINE; Bignon O, 2006, ANTHROPOLOGIE, V110, P401, DOI 10.1016/j.anthro.2006.06.001; Bodu P., 2000, MEMOIRES MUSEE PREHI, V7, P315; Bodu P., 1996, FOUILLES PINCEVENT, P69; Bodu P., 1991, OBSERVER ACTION TECH, P102; Bodu P, 2008, ANTHROPOLOGIE, V112, P509, DOI 10.1016/j.anthro.2008.06.004; BORDES F., 1974, B SOC PREHISTORIQUE, V71, P115; Bosinski G., 2001, MAGDALENIEN FUNDPLAT, V8; Breuil H., 1913, 14 SESS INT ANTHR AR; Bueno Ramirez P., 2009, ARTE PREHISTORICO AI, P259; BUISSON D, 1989, B SOC PREHISTORIQUE, V86, P183; Cacho C., 2014, PLEISTOCENE HOLOCENE, P568; Celerier G., 1998, PALEO, V10, P233, DOI DOI 10.3406/PAL.1998.1138; Clottes J., 1992, B SOC PREHISTORIQUE, V89, P270; Clottes J., 2003, GROTTE VACHE ARIEGE; COLLECTIF, 1996, ART PREHISTORIQUE PY; Corchon M. S., 2004, SOC PALEOLITICO REGI, V8, P425; Coudret P, 2006, BULL SOC PREHIST FR, V103, P729, DOI 10.3406/bspf.2006.13502; Couraud C., 1985, ART AZILIEN ORIGINE; Deffarge R., 1975, GALLIA PREHISTOIRE, V18, P1; Demoule J.-P., 2007, REVOLUTION NEOLITHIQ; DErrico F., 1994, ART GRAVE AZILIEN TE; Dujardin V., 2005, GROTTE BOIS RAGOT GO; Fagnart J.-P., 1997, FIN TEMPS GLACIAIRES; Fat Cheung C., 2014, GROUPES CULTURELS TR, P17; Figueiredo SS., 2014, INT NEWSLETTER ROCK, V68, P12; Fosse P., 1997, TARDIGLACIAIRE EUROP, P233; Fritz C., 1999, DOCUMENTS ARCHEOLOGI, V75; Fritz C, 2011, BULL SOC PREHIST FR, V108, P27, DOI 10.3406/bspf.2011.13991; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; GARCIA-DIEZ M., 2015, J ANTHROPOL ARCHAEOL, V3, P23; Gonzalez Morales M. R., 1991, PERSPECTIVES PARADIG, P205; Gonzalez Sainz C., 2005, ACT 4 C ARQ PEN FAR; Gonzalez-Sainz C., 2004, SOC PALEOLITICO REGI, P275; Guesquiere E., 2010, MESOLITHIQUE FRANCE; Guilaine J, 2003, ARTS SYMBOLES NEOLIT; Guilaine J., 2007, EXCAVACIONS BALMA MA, P62; Inizan M-L, 1992, PREHISTOIRE PIERRE T; Langlais M., 2010, SOC MAGDALENIENNES L; Leroi-Gourhan A., 1965, PREHISTOIRE ART OCCI; Lorblanchet M., 1996, LA VIE PREHISTORIQUE, P282; Lorblanchet M., 1987, ART OBJETS PALEOLITH, P31; Man-Estier E., 2013, BAR INT SERIES, V2496, P7; Martin Y., 1973, ART PALEOLITHIQUE GO; Mevel L., 2011, THESIS; Mevel L, 2013, BULL SOC PREHIST FR, V110, P657, DOI 10.3406/bspf.2013.14319; Moure A., 2000, ACT 3 C ARQ PEN VIL, P461; Naudinot N., ATLANTIC ME IN PRESS; Naudinot N., 2010, THESIS; Oberlin C., 2005, GROTTE BOIS RAGOT GO, P401; Paillet P., 2014, GRANDS SITES ART MAG, P29; Paillet P., 2014, GROUPES CULTURELS TR, P129; Paillet P., 2016, BAR INT SERIES, P88; Pelegrin J., 2000, MEMOIRES PREHISTOIRE, P73; Pelegrin J., 1995, TECHNOLOGIE LITHIQUE, V20; Piette Edouard, 1907, ART PENDANT AGE RENN; Quirico E, 2005, SPECTROCHIM ACTA A, V61, P2368, DOI 10.1016/j.saa.2005.02.015; Rivero O, 2014, BULL SOC PREHIST FR, V111, P255, DOI 10.3406/bspf.2014.14397; Romero-Sarmiento MF, 2014, ORG GEOCHEM, V71, P7, DOI 10.1016/j.orggeochem.2014.03.008; Roussot A., 1987, ART OBJETS PALEOLITH, P189; Sainz CG, 2007, PALAEOLITHIC CAVE AR, P247; Simmonet R., 1967, B SOC PREHISTORIQUE, V64, P175; Street M, 2006, BULL SOC PREHIST FR, V103, P753, DOI 10.3406/bspf.2006.13504; The A venin A, 1983, GALLIA PREHISTOIRE, V26, P139; Tixier J, 1980, PUBLICATIONS DE LURA, V28; Tosello G., 2003, PIERRES GRAVE PERIGO; Utrilla P, 2015, QUATERN INT, V364, P294, DOI 10.1016/j.quaint.2014.06.022; Valentin, 1997, B SOC PREHISTORIQUE, V94, P341, DOI DOI 10.3406/BSPF.1997.10698; Valentin B., 2005, GROTTE BOIS RAGOT GO, P89; Valentin B., 2008, JALONS PALEOHISTOIRE; Van Vliet-Lanoe B., 1988, THESIS; VANSTEIJN H, 1995, PERMAFROST PERIGLAC, V6, P125, DOI 10.1002/ppp.3430060210	77	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173037	10.1371/journal.pone.0173037	http://dx.doi.org/10.1371/journal.pone.0173037			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257445	gold, Green Published, Green Submitted			2022-12-27	WOS:000396021100050
J	Ravindran, D; Ridiandries, A; Vanags, LZ; Henriquez, R; Cartland, S; Tan, JTM; Bursill, CA				Ravindran, Dhanya; Ridiandries, Anisyah; Vanags, Laura Z.; Henriquez, Rodney; Cartland, Sian; Tan, Joanne T. M.; Bursill, Christina A.			Chemokine binding protein 'M3' limits atherosclerosis in apolipoprotein E-/- mice	PLOS ONE			English	Article							E-KNOCKOUT MICE; NF-KAPPA-B; FRACTALKINE CX3CL1; PLAQUE-FORMATION; LESION FORMATION; GENE-TRANSFER; INFLAMMATION; INHIBITION; DISEASE; RECRUITMENT	Chemokines are important in macrophage recruitment and the progression of atherosclerosis. The 'M3' chemokine binding protein inactivates key chemokines involved in atherosclerosis (e.g. CCL2, CCL5 and CX(3)CL1). We aimed to determine the effect of M3 on plaque development and composition. In vitro chemotaxis studies confirmed that M3 protein inhibited the activity of chemokines CCL2, CCL5 and CX(3)CL1 as primary human monocyte migration as well as CCR2-, CCR5- and CX(3)CR1-directed migration was attenuated by M3. In vivo, adenoviruses encoding M3 (AdM3) or green fluorescence protein (AdGFP; control) were infused systemically into apolipoprotein (apo)-E-/- mice. Two models of atherosclerosis development were used in which the rate of plaque progression was varied by diet including: (1) a 'rapid promotion' model (6-week high-fat-fed) and (2) a 'slow progression' model (12-week chow-fed). Plasma chemokine activity was suppressed in AdM3-infused mice as indicated by significantly less monocyte migration towards AdM3 mouse plasma ex vivo (29.56%, p = 0.014). In the 'slow progression' model AdM3 mice had reduced lesion area (45.3%, p = 0.035) and increased aortic smooth muscle cell a-actin expression (60.3%, p = 0.014). The reduction in lesion size could not be explained by changes in circulating inflammatory monocytes as they were higher in the AdM3 group. In the 'rapid promotion' model AdM3 mice had no changes in plaque size but reduced plaque macrophage content (46.8%, p = 0.006) and suppressed lipid deposition in thoracic aortas (66.9%, p<0.05). There was also a reduction in phosphorylated p65, the active subunit of NF-kappa b, in the aortas of AdM3 mice (37.3%, p<0.0001). M3 inhibited liver CCL2 concentrations in both models with no change in CCL5 or systemic chemokine levels. These findings show M3 causes varying effects on atherosclerosis progression and plaque composition depending on the rate of lesion progression. Overall, our studies support a promising role for chemokine inhibition with M3 for the treatment of atherosclerosis.	[Ravindran, Dhanya; Ridiandries, Anisyah; Vanags, Laura Z.; Henriquez, Rodney; Cartland, Sian; Tan, Joanne T. M.; Bursill, Christina A.] Heart Res Inst, Sydney, NSW, Australia; [Ravindran, Dhanya; Ridiandries, Anisyah; Vanags, Laura Z.; Cartland, Sian; Tan, Joanne T. M.; Bursill, Christina A.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia	University of Sydney; Heart Research Institute; University of Sydney	Bursill, CA (corresponding author), Heart Res Inst, Sydney, NSW, Australia.; Bursill, CA (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.	bursillc@hri.org.au	Ridiandries, Anisyah/I-4360-2017; Tan, Joanne Tsui Ming/Y-4423-2019; Tan, Ming-Jen/A-3862-2011	Ridiandries, Anisyah/0000-0001-8996-6896; Tan, Joanne Tsui Ming/0000-0003-1875-4882; Bursill, Christina/0000-0002-0682-8760; Tan, Ming-Jen/0000-0002-3583-1723; Cartland, Sian/0000-0003-1723-2679; Henriquez, Rodney/0000-0002-2959-2260	Heart Research Institute, Sydney, Australia	Heart Research Institute, Sydney, Australia	This work was funded by the Heart Research Institute, Sydney, Australia (www.hri.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; Alexander JM, 2002, CELL, V111, P343, DOI 10.1016/S0092-8674(02)01007-3; Belvoncikova P, 2008, ACTA VIROL, V52, P91; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Bursi CA, 2004, CURR OPIN LIPIDOL, V15, P145, DOI [10.1097/00041433-200404000-00007, 10.1097/01.mol.0000124526.75650.13]; Bursill CA, 2009, GENE THER, V16, P93, DOI 10.1038/gt.2008.141; Bursill CA, 2004, CIRCULATION, V110, P2460, DOI 10.1161/01.CIR.0000145122.58420.CO; Bursill CA, 2003, IMMUNOBIOLOGY, V207, P187, DOI 10.1078/0171-2985-00228; Chandrasekar B, 2003, BIOCHEM J, V373, P547, DOI 10.1042/BJ20030207; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Jones BA, 2010, MOL INTERV, V10, P263, DOI 10.1124/mi.10.5.3; Langenfeld MR, 2001, CLIN SCI, V101, P731, DOI 10.1042/CS20010110; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Lin BH, 1999, CELL DEATH DIFFER, V6, P570, DOI 10.1038/sj.cdd.4400528; Mach F, 2001, Curr Atheroscler Rep, V3, P243, DOI 10.1007/s11883-001-0067-y; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Ni WH, 2001, CIRCULATION, V103, P2096; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Prosser HCG, 2014, CARDIOVASC RES, V101, P145, DOI 10.1093/cvr/cvt234; Pyo R, 2004, AM J PATHOL, V164, P2289, DOI 10.1016/S0002-9440(10)63785-6; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; SCHALL TJ, 1994, CURR OPIN IMMUNOL, V6, P865, DOI 10.1016/0952-7915(94)90006-X; Schober A, 2002, CIRCULATION, V106, P1523, DOI 10.1161/01.CIR.0000028590.02477.6F; Shang LM, 2009, GASTROENTEROLOGY, V137, P1006, DOI 10.1053/j.gastro.2009.05.055; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Wong BWC, 2002, CARDIOVASC PATHOL, V11, P332, DOI 10.1016/S1054-8807(02)00111-4	33	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173224	10.1371/journal.pone.0173224	http://dx.doi.org/10.1371/journal.pone.0173224			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282403	Green Published, Green Submitted, gold			2022-12-27	WOS:000396091800023
J	Ikhlef, S; Berrougui, H; Simo, OK; Zerif, E; Khalil, A				Ikhlef, Souade; Berrougui, Hicham; Simo, Olivier Kamtchueng; Zerif, Echarki; Khalil, Abdelouahed			Human paraoxonase 1 overexpression in mice stimulates HDL cholesterol efflux and reverse cholesterol transport	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEINS; ABCA1 MESSENGER-RNA; HEART-DISEASE RISK; SERUM PARAOXONASE; PON1 ACTIVITY; MACROPHAGES; ATHEROSCLEROSIS; BINDING; PATHWAY; ASSOCIATION	This study was aimed to investigate the effect of human PON1 overexpression in mice on cholesterol efflux and reverse cholesterol transport. PON1 overexpression in PON1-Tg mice induced a significant 3-fold (p<0.0001) increase in plasma paraoxonase activity and a significant similar to 30% (p<0.0001) increase in the capacity of HDL to mediate cholesterol efflux from J774 macrophages compared to wild-type mice. It also caused a significant 4fold increase (p<0.0001) in the capacity of macrophages to transfer cholesterol to apoA-1, a significant 2-fold (p<0.0003) increase in ABCA1 mRNA and protein expression, and a significant increase in the expression of PPAR. (p<0.0003 and p<0.04, respectively) and LXR alpha (p<0.0001 and p<0.01, respectively) mRNA and protein compared to macrophages from wild-type mice. Moreover, transfection of J774 macrophages with human PON1 also increased ABCA1, PPAR. and LXRa protein expression and stimulates macrophages cholesterol efflux to apo A1. In vivo measurements showed that the overexpression of PON1 significantly increases the fecal elimination of macrophage-derived cholesterol in PON1-Tg mice. Overall, our results suggested that the overexpression of PON1 in mice may contribute to the regulation of the cholesterol homeostasis by improving the capacity of HDL to mediate cholesterol efflux and by stimulating reverse cholesterol transport.	[Ikhlef, Souade; Berrougui, Hicham; Simo, Olivier Kamtchueng; Khalil, Abdelouahed] Res Ctr Aging, Sherbrooke, PQ, Canada; [Berrougui, Hicham] Univ Sultan Moulay Slimane, Polydisciplinary Fac, Dept Biol, Beni Mellal, Morocco; [Zerif, Echarki] Univ Sherbrooke, Ctr Rech Clin CHUS, Div Immunol, Dept Pediat, Sherbrooke, PQ, Canada; [Khalil, Abdelouahed] Univ Sherbrooke, Fac Med & Hlth Sci, Geriatr Serv, Dept Med, Sherbrooke, PQ, Canada	Sultan Moulay Slimane University of Beni Mellal; University of Sherbrooke; University of Sherbrooke	Khalil, A (corresponding author), Res Ctr Aging, Sherbrooke, PQ, Canada.; Khalil, A (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Geriatr Serv, Dept Med, Sherbrooke, PQ, Canada.	a.khalil@usherbrooke.ca		berrougui, hicham/0000-0002-0546-6534; Khalil, Abdelouahed/0000-0003-0817-3160	Canadian Institutes of Health Research [MOP-89912, IAO-134212]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work was supported by Canadian Institutes of Health Research (MOP-89912 and IAO-134212).	Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Berrougui H, 2012, FREE RADICAL BIOL ME; Berrougui H, 2012, J CLIN LIPIDOL, V6, P524, DOI 10.1016/j.jacl.2012.04.004; Berrougui H, 2012, FREE RADICAL BIO MED, V52, P1372, DOI 10.1016/j.freeradbiomed.2012.01.019; Berti JA, 2005, BRAZ J MED BIOL RES, V38, P391, DOI 10.1590/S0100-879X2005000300010; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; BLATTER MC, 1993, EUR J BIOCHEM, V211, P871, DOI 10.1111/j.1432-1033.1993.tb17620.x; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Feng B, 2002, J BIOL CHEM, V277, P43271, DOI 10.1074/jbc.M207532200; Field FJ, 2010, J LIPID RES, V51, P1407, DOI 10.1194/jlr.M002410; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Helal O, 2013, BRIT J NUTR, V109, P1844, DOI 10.1017/S0007114512003856; Hou M, 2007, CELL BIOCHEM FUNCT, V25, P33, DOI 10.1002/cbf.1374; Ikhlef S, 2016, FEBS LETT, V590, P1614, DOI 10.1002/1873-3468.12198; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Joy T, 2009, CURR OPIN CARDIOL, V24, P364, DOI 10.1097/HCO.0b013e32832ac166; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kielar D, 2001, CLIN CHEM, V47, P2089; Linton S, 2001, EXP GERONTOL, V36, P1503, DOI 10.1016/S0531-5565(01)00136-X; Loued S, 2012, LIFE SCI, V90, P82, DOI 10.1016/j.lfs.2011.10.018; Mukhamedova N, 2008, J LIPID RES, V49, P2312, DOI 10.1194/jlr.M800095-JLR200; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Rosenblat M, 2006, J BIOL CHEM, V281, P7657, DOI 10.1074/jbc.M512595200; Rosenblat M, 2005, ATHEROSCLEROSIS, V179, P69, DOI 10.1016/j.atherosclerosis.2004.10.028; Rosenblat M, 2006, ATHEROSCLEROSIS, V187, P74, DOI 10.1016/j.athersclerosis.2005.08.026; Seres I, 2004, EXP GERONTOL, V39, P59, DOI 10.1016/j.exger.2003.08.001; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Tward A, 2002, CIRCULATION, V106, P484, DOI 10.1161/01.CIR.0000023623.87083.4F; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Wang MS, 2012, DNA CELL BIOL, V31, P975, DOI 10.1089/dna.2011.1478; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421; Xia M, 2005, J BIOL CHEM, V280, P36792, DOI 10.1074/jbc.M505047200; Zhang B, 2003, CLIN NEPHROL, V60, P257; Zhao Y, 2012, MOL GENET METAB, V105, P141, DOI 10.1016/j.ymgme.2011.09.018; Zhu Y, 2005, CARDIOVASC RES, V68, P425, DOI 10.1016/j.cardiores.2005.07.003	44	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173385	10.1371/journal.pone.0173385	http://dx.doi.org/10.1371/journal.pone.0173385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278274	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900084
J	Choo, B; Zhu, M; Qu, QM; Yu, XB; Jia, LT; Zhao, WJ				Choo, Brian; Zhu, Min; Qu, Qingming; Yu, Xiaobo; Jia, Liantao; Zhao, Wenjin			A new osteichthyan from the late Silurian of Yunnan, China	PLOS ONE			English	Article							RAY-FINNED FISHES; SCALE MORPHOLOGY; SHEDS LIGHT; BONY FISHES; ORIGIN; GNATHOSTOME; ANDREOLEPIS; PLACODERM; VERTEBRATES; CHARACTERS	Our understanding of early gnathostome evolution has been hampered by a generally scant fossil record beyond the Devonian. Recent discoveries from the late Silurian Xiaoxiang Fauna of Yunnan, China, have yielded significant new information, including the earliest articulated osteichthyan fossils from the Ludlow-aged Kuanti Formation. Here we describe the partial postcranium of a new primitive bony fish from the Kuanti Formation that represents the second known taxon of pre-Devonian osteichthyan revealing articulated remains. The new form, Sparalepis tingi gen. et sp. nov., displays similarities with Guiyu and Psarolepis, including a spine-bearing pectoral girdle and a placoderm-like dermal pelvic girdle, a structure only recently identified in early osteichthyans. The squamation with particularly thick rhombic scales shares an overall morphological similarity to that of Psarolepis. However, the anterior flank scales of Sparalepis possess an unusual interlocking system of ventral bulges embraced by dorsal concavities on the outer surfaces. A phylogenetic analysis resolves Sparalepis within a previously recovered cluster of stem-sarcopterygians including Guiyu, Psarolepis and Achoania. The high diversity of osteichthyans from the Ludlow of Yunnan strongly contrasts with other Silurian vertebrate assemblages, suggesting that the South China block may have been an early center of diversification for early gnathostomes, well before the advent of the Devonian "Age of Fishes".	[Choo, Brian; Zhu, Min; Yu, Xiaobo; Jia, Liantao; Zhao, Wenjin] Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China; [Choo, Brian] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA, Australia; [Zhu, Min; Zhao, Wenjin] Univ Chinese Acad Sci, Coll Earth Sci, Beijing, Peoples R China; [Qu, Qingming] Uppsala Univ, Dept Physiol & Dev Biol, Subdept Evolutionary Organismal Biol, Uppsala, Sweden; [Qu, Qingming] Univ Ottawa, Ctr Adv Res Environm Genom, Ottawa, ON, Canada; [Yu, Xiaobo] Kean Univ, Dept Biol Sci, Union, NJ USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Flinders University South Australia; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Uppsala University; University of Ottawa	Choo, B; Zhu, M (corresponding author), Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China.; Choo, B (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA, Australia.; Zhu, M (corresponding author), Univ Chinese Acad Sci, Coll Earth Sci, Beijing, Peoples R China.	brian.choo@flinders.edu.au; zhumin@ivpp.ac.cn	Yu, Xiaobo/G-7160-2011; min, zhu/AAL-6712-2021; Zhu, Min/E-8728-2012	Yu, Xiaobo/0000-0001-9600-7888; Zhu, Min/0000-0002-4786-0898; Choo, Brian/0000-0002-9983-0762; Zhao, Wenjin/0000-0002-9649-2171	National Nature Science Foundation of China [41530102]; Chinese Academy of Sciences [QYZDJ-SSW-DQC002]; Australian Research Council [DE160100247]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Australian Research Council(Australian Research Council)	Funding was provided by the National Nature Science Foundation of China (41530102), Chinese Academy of Sciences (QYZDJ-SSW-DQC002; Funds for Paleontology Fieldwork and Fossil Preparation), and Australian Research Council (Discovery Project DE160100247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; BLIECK A, 1991, SPEC PAP PALAEONTOL, V44, P345; Blieck Alain, 2000, Courier Forschungsinstitut Senckenberg, V223, P223; Botella H, 2007, NATURE, V448, P583, DOI 10.1038/nature05989; Brazeau MD, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2210; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Burrow Carole J., 1999, Records of the Western Australian Museum Supplement, V57, P1; Burrow Carole J., 1995, Geobios Memoire Special (Villeurbanne), V19, P327; Chang M.M., 1984, Proceedings of the Linnean Society of New South Wales, V107, P171; Chang Meemann, 1993, Memoir of the Association of Australasian Palaeontologists, V15, P183; Chen DL, 2016, NATURE, V539, P237, DOI 10.1038/nature19812; Chen DL, 2012, HIST BIOL, V24, P411, DOI 10.1080/08912963.2012.668187; Choo B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05242; Choo B, 2011, EARTH ENV SCI T R SO, V102, P77, DOI 10.1017/S1755691011011029; Choo B, 2009, ACTA ZOOL-STOCKHOLM, V90, P194, DOI 10.1111/j.1463-6395.2008.00370.x; Coates MI, 2009, NATURE, V458, P413, DOI 10.1038/458413a; Cunningham JA, 2012, BIOL LETTERS, V8, P833, DOI 10.1098/rsbl.2012.0357; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Esi D.N.., 1990, PALEONTOL J+, V1990, P90; Fang R.S., 1985, MIDDLE SILURIAN EARL; Friedman M, 2010, J VERTEBR PALEONTOL, V30, P36, DOI 10.1080/02724630903409071; Friedman M, 2006, J PALEONTOL, V80, P1186, DOI 10.1666/0022-3360(2006)80[1186:ANAFTF]2.0.CO;2; Giles S, 2015, PALAEONTOLOGY, V58, P849, DOI 10.1111/pala.12182; Giles S, 2015, NATURE, V520, P82, DOI 10.1038/nature14065; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Janvier P., 1996, EARLY VERTEBRATES; Johanson Z, 2005, BIOL REV, V80, P303, DOI 10.1017/S1464793104006682; Karatajute-Talimaa Valentina, 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P39; Long J.A., 1988, Memoir of the Association of Australasian Palaeontologists, V7, P1; Long JA, 2015, NATURE, V517, P196, DOI 10.1038/nature13825; Lu J, 2016, CURRENT BIOL; Lu J, 2016, CURR BIOL, V26, P1602, DOI 10.1016/j.cub.2016.04.045; Lu J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2170; Maddison WP., 2021, MESQUITE MODULAR SYS; Marss Tiiu, 2001, Proceedings of the Estonian Academy of Sciences Geology, V50, P174; Pan J., 1986, PROFESSIONAL PAPERS, P67; Qiao T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163157; Qu Qing-Ming, 2010, Palaeoworld, V19, P146, DOI 10.1016/j.palwor.2009.11.003; Qu QM, 2015, NATURE, V526, P108, DOI 10.1038/nature15259; Qu QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061485; RICHTER M, 1995, ZOOL J LINN SOC-LOND, V114, P173, DOI 10.1006/zjls.1995.0023; Sansom IJ, 1996, NATURE, V379, P628, DOI 10.1038/379628a0; Schultze HP, 2001, SYST ASSOC SPEC VOL, V61, P315; Ting V. K., 1937, Bulletin of the Geological Society of China, V16, P1; Trinajstic K, 1999, ALCHERINGA, V23, P9, DOI 10.1080/03115519908619335; Turner S, 2004, CRIT MOM PERSP EARTH, P327; Zhang Guo-Rui, 2010, Palaeoworld, V19, P129, DOI 10.1016/j.palwor.2009.11.006; Zhao Wen-Jin, 2010, Palaeoworld, V19, P4, DOI 10.1016/j.palwor.2009.11.007; Zhu M, 2004, NATURE, V432, P94, DOI 10.1038/nature02843; Zhu M, 2001, SYST ASSOC SPEC VOL, V61, P289; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2006, NATURE, V441, P77, DOI 10.1038/nature04563; Zhu M, 2001, NATURE, V410, P81, DOI 10.1038/35065078; Zhu M., 2009, RENDICONTI SOC PALEO, V3, P357; Zhu M, 2016, SCIENCE, V354, P334, DOI 10.1126/science.aah3764; Zhu M, 2014, NATL SCI REV, V1, P490, DOI 10.1093/nsr/nwu062; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; Zhu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035103; Zhu M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1764; Zhu M, 2009, BIOL LETTERS, V5, P372, DOI 10.1098/rsbl.2008.0784; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855; [No title captured]	63	20	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0170929	10.1371/journal.pone.0170929	http://dx.doi.org/10.1371/journal.pone.0170929			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273081	gold, Green Published, Green Submitted			2022-12-27	WOS:000396073700092
J	Kohanoff, J; Artacho, E				Kohanoff, Jorge; Artacho, Emilio			Water radiolysis by low-energy carbon projectiles from first-principles molecular dynamics	PLOS ONE			English	Article							LIQUID WATER; IONS; DISSOCIATION; IONIZATION; AMMONIA; ICE	Water radiolysis by low-energy carbon projectiles is studied by first-principles molecular dynamics. Carbon projectiles of kinetic energies between 175 eV and 2.8 keV are shot across liquid water. Apart from translational, rotational and vibrational excitation, they produce water dissociation. The most abundant products are H and OH fragments. We find that the maximum spatial production of radiolysis products, not only occurs at low velocities, but also well below the maximum of energy deposition, reaching one H every 5 angstrom at the lowest speed studied (1 Bohr/fs), dissociative collisions being more significant at low velocity while the amount of energy required to dissociate water is constant and much smaller than the projectile's energy. A substantial fraction of the energy transferred to fragments, especially for high velocity projectiles, is in the form of kinetic energy, such fragments becoming secondary projectiles themselves. High velocity projectiles give rise to well-defined binary collisions, which should be amenable to binary approximations. This is not the case for lower velocities, where multiple collision events are observed. H secondary projectiles tend to move as radicals at high velocity, as cations when slower. We observe the generation of new species such as hydrogen peroxide and formic acid. The former occurs when an O radical created in the collision process attacks a water molecule at the O site. The latter when the C projectile is completely stopped and reacts with two water molecules.	[Kohanoff, Jorge; Artacho, Emilio] Queens Univ Belfast, Atomist Simulat Ctr, Belfast BT7 1NN, Antrim, North Ireland; [Kohanoff, Jorge] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Artacho, Emilio] Univ Cambridge, Cavendish Lab, Theory Condensed Matter, Cambridge CB3 0HE, England; [Artacho, Emilio] CIC Nanogune, Tolosa Hiribidea 76, San Sebastian 20018, Spain; [Artacho, Emilio] DIPC, Tolosa Hiribidea 76, San Sebastian 20018, Spain; [Artacho, Emilio] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain	Queens University Belfast; University of Cambridge; University of Cambridge; Basque Foundation for Science	Kohanoff, J (corresponding author), Queens Univ Belfast, Atomist Simulat Ctr, Belfast BT7 1NN, Antrim, North Ireland.; Kohanoff, J (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	j.kohanoff@qub.ac.uk	Artacho, Emilio/G-2616-2015; Kohanoff, Jorge/H-9874-2015	Artacho, Emilio/0000-0001-9357-1547; Kohanoff, Jorge/0000-0002-8237-7543	Wellcome Trust [084069/Z/07/Z]; Electron-Stopping, European Commission, Marie-Curie CIG [333813]; Spanish Ministry of Science [FIS2012-37549-C05]; Programa Red Guipuzcoana de Ciencia, Tecnologia e Innovacion, Diputacion Foral de Gipuzkoa [97/14]; UKCP [EP/F037325/1]; EPSRC [EP/F037325/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F037325/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Electron-Stopping, European Commission, Marie-Curie CIG; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Programa Red Guipuzcoana de Ciencia, Tecnologia e Innovacion, Diputacion Foral de Gipuzkoa; UKCP; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Wellcome Trust: flexible travel award 084069/Z/07/Z, https://wellcome.ac.uk/; Electron-Stopping 333813, European Commission, Marie-Curie CIG, http://ec.europa.eu/research/mariecurieactions/; FIS2012-37549-C05, Spanish Ministry of Science, http://www.idi.mineco.gob.es/stfls/MICINN/Ayudas/; Exp. 97/14 (Wet Nanoscopy) from the Programa Red Guipuzcoana de Ciencia, Tecnologia e Innovacion, Diputacion Foral de Gipuzkoa, http://www.gipuzkoa.eus/subvenciones/; and UKCP consortium EP/F037325/1, http://www.ukcp.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artacho E, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/27/275211; Baldacchino G, 2008, RAD CHEM BASICS APPL, P53; Blanksby SJ, 2003, ACCOUNTS CHEM RES, V36, P255, DOI 10.1021/ar020230d; Cavazzoni C, 1999, SCIENCE, V283, P44, DOI 10.1126/science.283.5398.44; Cobut V, 1998, RADIAT PHYS CHEM, V51, P85, DOI [10.1016/S0969-806X(97)00060-1, DOI 10.1016/S0969-806X(97)00060-1]; Deng ZW, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.243203; Emfietzoglou D, 2007, NUCL INSTRUM METH B, V257, P609, DOI 10.1016/j.nimb.2007.01.049; Fernandez-Serra MV, 2004, J CHEM PHYS, V121, P11136, DOI 10.1063/1.1813431; Gaigeot MP, 2007, J PHYS B-AT MOL OPT, V40, P1, DOI 10.1088/0953-4075/40/1/001; Grimes C.A., 2008, LIGHT WATER HYDROGEN, DOI [10.1007/978-0-387-68238-9, DOI 10.1007/978-0-387-68238-9]; HOLZAPFEL WB, 1969, J CHEM PHYS, V50, P4424, DOI 10.1063/1.1670914; Hunniford CA, 2007, PHYS MED BIOL, V52, P3729, DOI 10.1088/0031-9155/52/13/005; Kohanoff J, 2008, AIP CONF PROC, V1080, P78, DOI 10.1063/1.3058991; Markin SN, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.113201; McBride EJ, 2014, J PHYS CHEM A, V118, P6991, DOI 10.1021/jp502738x; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pruneda JM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.235501; Pruneda JM, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.035106; Soler JM, 2002, J PHYS-CONDENS MAT, V14, P2745, DOI 10.1088/0953-8984/14/11/302; Solov'yov AV, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011909; Von Sonntag C, 1987, CHEM BASIS RAD BIOL; WILSON WE, 1984, J CHEM PHYS, V80, P5631, DOI 10.1063/1.446628; Ziegler J. F., 1985, STOPPING RANGE IONS, V1	23	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0171820	10.1371/journal.pone.0171820	http://dx.doi.org/10.1371/journal.pone.0171820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267804	Green Submitted, Green Published, gold			2022-12-27	WOS:000396060600056
J	Liu, JM; Tong, WL; Chen, XY; Zhou, Y; Chen, WZ; Huang, SH; Liu, ZL				Liu, Jia-Ming; Tong, Wei-Lai; Chen, Xuan-Yin; Zhou, Yang; Chen, Wen-Zhao; Huang, Shan-Hu; Liu, Zhi-Li			The incidences and risk factors related to early dysphagia after anterior cervical spine surgery: A prospective study	PLOS ONE			English	Article							OROPHARYNGEAL DYSPHAGIA; OUTCOMES TOOL; SWAL-QOL; DISKECTOMY; FUSION; ADULTS	Dysphagia is a common complication following anterior cervical spine surgery (ACSS). The incidences of dysphagia were variable and controversial. The purpose of this study was to determine the incidence of early dysphagia after ACSS with a new scoring system, and to identify the risk factors of it. A prospective study was carried out and patients who underwent ACSS from March 2014 to August 2014 in our hospital were included in this study. A self-designed dysphagia questionnaire was delivered to all of the patients from the first day to the fifth day after ACSS. Perioperative characteristics of patients were recorded, and incidences and risk factors of dysphagia were analyzed. A total of 104 patients who underwent ACSS were included and incidences of dysphagia from the first to the fifth day after ACSS was 87.5%, 79.81%, 62.14%, 50% and 44.23%, respectively. There was a good correlation between the new dysphagia scoring system and Bazaz scoring system (P < 0.001). Operative time and body mass index (BMI) were the risk factors for dysphagia during the first to the second day postoperatively. However, the dC2-C7angle was the main risk factor for dysphagia from the third to the fifth day after surgery. There were comparatively high incidences of early dysphagia after ACSS, which may be ascribed to operative time, BMI and the dC2-C7 angle.	[Liu, Jia-Ming; Tong, Wei-Lai; Chen, Xuan-Yin; Zhou, Yang; Chen, Wen-Zhao; Huang, Shan-Hu; Liu, Zhi-Li] Nanchang Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Nanchang, Jiangxi, Peoples R China	Nanchang University	Liu, ZL (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Nanchang, Jiangxi, Peoples R China.	liuzhiliyfy@163.com			National Natural Science Foundation of China [81560435]; Department of Science and Technology Program Funds of Jiangxi Province, China [20123BBG70245, 20121BBG70037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology Program Funds of Jiangxi Province, China	Funded by National Natural Science Foundation of China 81560435 (Jia-Ming Liu) and Department of Science and Technology Program Funds of Jiangxi Province, China 20123BBG70245, 20121BBG70037 (Dr. Zhili Liu).	Baron EM, 2003, ANN OTO RHINOL LARYN, V112, P921, DOI 10.1177/000348940311201102; Bazaz R, 2002, SPINE, V27, P2453, DOI 10.1097/00007632-200211150-00007; Buttermann GR, 2008, SPINE J, V8, P426, DOI 10.1016/j.spinee.2006.12.006; Campbell PG, 2010, WORLD NEUROSURG, V74, P363, DOI 10.1016/j.wneu.2010.05.034; Cho SK, 2013, BONE JOINT J, V95B, P868, DOI 10.1302/0301-620X.95B7.31029; Edwards CC, 2004, J BONE JOINT SURG AM, V86A, P251, DOI 10.2106/00004623-200402000-00006; Fehlings MG, 2012, J NEUROSURG-SPINE, V16, P425, DOI 10.3171/2012.1.SPINE11467; Joaquim AF, 2014, SPINE J, V14, P2246, DOI 10.1016/j.spinee.2014.03.030; Kalb S, 2012, WORLD NEUROSURG, V77, P183, DOI 10.1016/j.wneu.2011.07.004; Kepler CK, 2012, SPINE J, V12, P639, DOI 10.1016/j.spinee.2012.03.024; Lee MJ, 2007, SPINE J, V7, P141, DOI 10.1016/j.spinee.2006.02.024; McAfee PC, 2010, J SPINAL DISORD TECH, V23, P1, DOI 10.1097/BSD.0b013e31819e2ab8; McHorney CA, 2000, DYSPHAGIA, V15, P122, DOI 10.1007/s004550010013; McHorney CA, 2002, DYSPHAGIA, V17, P97, DOI 10.1007/s00455-001-0109-1; Olsson EC, 2015, ORTHOPEDICS, V38, pE319, DOI 10.3928/01477447-20150402-61; Rihn JA, 2011, CLIN ORTHOP RELAT R, V469, P658, DOI 10.1007/s11999-010-1731-8; Skeppholm M, 2012, SPINE, V37, P996, DOI 10.1097/BRS.0b013e31823a7a5b; Tian W, 2013, DYSPHAGIA, V28, P131, DOI 10.1007/s00455-012-9421-1; Winslow CP, 2001, ARCH OTOLARYNGOL, V127, P51, DOI 10.1001/archotol.127.1.51	19	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173364	10.1371/journal.pone.0173364	http://dx.doi.org/10.1371/journal.pone.0173364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267777	Green Published, gold, Green Submitted			2022-12-27	WOS:000396060600026
J	Zhang, WX; Yu, DL; Peng, JH; Xu, JJ; Wei, YP				Zhang, Wenxiong; Yu, Dongliang; Peng, Jinhua; Xu, Jianjun; Wei, Yiping			Gastric-tube versus whole-stomach esophagectomy for esophageal cancer: A systematic review and meta-analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; INTRATHORACIC STOMACH; RECONSTRUCTION; IMPACT; WIDTH	Objectives To conduct a systematic review and meta-analysis of studies comparing the gastric-tube vs. whole-stomach for esophageal cancer in order to determine the optimal surgical technique of esophagectomy. Methods A comprehensive literature search was performed using PubMed, EMBASE, ScienceDirect, Ovid MEDLINE, Cochrane Library, Web of Science, Google Scholar, and Scopus. Clinical trials that compared the gastric-tube versus whole-stomach for esophageal cancer were selected. The clinical endpoints included anastomotic leakage, anastomotic stenosis, reflux esophagitis, pneumonia, delayed gastric emptying, and thoracic stomach syndrome. Results A total of 6 articles (1571 patients) were included. Compared to the whole-stomach approach, the gastric-tube approach was associated with a lower incidence of reflux esophagitis (95% confidence interval [CI]: 0.16 to 0.81, p = 0.01) and thoracic stomach syndrome (95% CI: 0.17 to 0.55, p < 0.0001). The rates of anastomotic leakage, anastomotic stenosis, pneumonia, and delayed gastric emptying did not significantly differ between the two groups. Conclusions The gastric-tube esophagectomy is superior to the whole-stomach approach, as it is associated with a lower incidence of postoperative reflux esophagitis and thoracic stomach syndrome. Our findings must be validated in large-scale randomized controlled trials.	[Zhang, Wenxiong; Yu, Dongliang; Peng, Jinhua; Xu, Jianjun; Wei, Yiping] Nanchang Univ, Affiliated Hosp 2, Dept Cardiothorac Surg, Nanchang, Jiangxi, Peoples R China	Nanchang University	Wei, YP (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Cardiothorac Surg, Nanchang, Jiangxi, Peoples R China.	weiyiping2015@163.com						BARBERA L, 1994, ZBL CHIR, V119, P240; Best LM, 2016, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858.CD011498.pub2, DOI 10.1002/14651858.CDO11498.PUB2]; BONAVINA L, 1992, BRIT J SURG, V79, P529, DOI 10.1002/bjs.1800790618; Boyle NH, 1999, J AM COLL SURGEONS, V188, P498, DOI 10.1016/S1072-7515(99)00016-2; Chen SW, 2011, ACTA MED U MED TONGJ, V40, P593; COLLARD JM, 1995, ANN THORAC SURG, V60, P261, DOI 10.1016/0003-4975(95)00411-D; D'Journo XB, 2008, DIS ESOPHAGUS, V21, P377, DOI 10.1111/j.1442-2050.2008.00849.x; Djarv T, 2008, BRIT J SURG, V95, P1121, DOI 10.1002/bjs.6293; DOMERGUE J, 1990, SURG GYNECOL OBSTET, V171, P107; Guo W, 2016, SURG ENDOSC, V30, P3873, DOI 10.1007/s00464-015-4692-x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Korenaga D, 1998, HEPATO-GASTROENTEROL, V45, P2179; Lerut TE, 2004, BEST PRACT RES CL GA, V18, P901, DOI 10.1016/j.bpg.2004.06.029; Li Lin-jun, 2013, Zhonghua Yi Xue Za Zhi, V93, P2790; Li LJ, 2009, CHINESE J CLIN ONCOL, V36, P1131; Li LJ, 2009, CHINESE J CLIN ONCOL, V36, P1125; Matsuda T, 2010, AM J SURG, V199, P61; Panebianco V, 2006, EUR J CARDIO-THORAC, V30, P663, DOI 10.1016/j.ejcts.2006.07.007; Pauthner M, 2015, VISZERALMEDIZIN, V31, P326, DOI 10.1159/000441049; Pierie J P, 1998, Dis Esophagus, V11, P231; Rice T W, 2016, Dis Esophagus, V29, P707, DOI 10.1111/dote.12493; Rino Y, 2014, BMC MED IMAGING, V14, DOI 10.1186/1471-2342-14-18; Shu YS, 2013, IRISH J MED SCI, V182, P477, DOI 10.1007/s11845-013-0917-y; Tabira Y, 2004, AM J SURG, V187, P417, DOI 10.1016/j.amjsurg.2003.12.008; Wells G.A., NEWCASTLE OTTAWA SCA; Zhang C, 2011, EUR J CARDIO-THORAC, V39, P109, DOI 10.1016/j.ejcts.2010.04.032; Zhang M, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0568-0; Zhang R, 2011, ONCOL LETT, V11, P2507; [张雪飞 Zhang Xuefei], 2012, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V12, P1367; Zhou C, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0661-z	31	14	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173416	10.1371/journal.pone.0173416	http://dx.doi.org/10.1371/journal.pone.0173416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267808	Green Published, Green Submitted, gold			2022-12-27	WOS:000396060600029
J	Uchida, R; Nakata, K; Kawano, F; Yonetani, Y; Ogasawara, I; Nakai, N; Mae, T; Matsuo, T; Tachibana, Y; Yokoi, H; Yoshikawa, H				Uchida, Ryohei; Nakata, Ken; Kawano, Fuminori; Yonetani, Yasukazu; Ogasawara, Issei; Nakai, Naoya; Mae, Tatsuo; Matsuo, Tomohiko; Tachibana, Yuta; Yokoi, Hiroyuki; Yoshikawa, Hideki			Vibration acceleration promotes bone formation in rodent models	PLOS ONE			English	Article							FREQUENCY MECHANICAL STIMULI; LOW-MAGNITUDE; TRABECULAR BONE; LOW-LEVEL; MORPHOGENETIC PROTEIN; WEIGHT-BEARING; LOW-INTENSITY; ENHANCE; RATS; STRENGTH	All living tissues and cells on Earth are subject to gravitational acceleration, but no reports have verified whether acceleration mode influences bone formation and healing. Therefore, this study was to compare the effects of two acceleration modes, vibration and constant (centrifugal) accelerations, on bone formation and healing in the trunk using BMP 2-induced ectopic bone formation (EBF) mouse model and a rib fracture healing (RFH) rat model. Additionally, we tried to verify the difference in mechanism of effect on bone formation by accelerations between these two models. Three groups (low-and high-magnitude vibration and control-VA groups) were evaluated in the vibration acceleration study, and two groups (centrifuge acceleration and control-CA groups) were used in the constant acceleration study. In each model, the intervention was applied for ten minutes per day from three days after surgery for eleven days (EBF model) or nine days (RFH model). All animals were sacrificed the day after the intervention ended. In the EBF model, ectopic bone was evaluated by macroscopic and histological observations, wet weight, radiography and microfocus computed tomography (micro-CT). In the RFH model, whole fracture-repaired ribs were excised with removal of soft tissue, and evaluated radiologically and histologically. Ectopic bones in the low-magnitude group (EBF model) had significantly greater wet weight and were significantly larger (macroscopically and radiographically) than those in the other two groups, whereas the size and wet weight of ectopic bones in the centrifuge acceleration group showed no significant difference compared those in control-CA group. All ectopic bones showed calcified trabeculae and maturated bone marrow. Micro-CT showed that bone volume (BV) in the low-magnitude group of EBF model was significantly higher than those in the other two groups (3.1 1.2mm(3) v.s. 1.8 1.2mm(3) in high-magnitude group and 1.3 0.9mm(3) in control-VA group), but BV in the centrifuge acceleration group had no significant difference compared those in control-CA group. Union rate and BV in the low-magnitude group of RFH model were also significantly higher than those in the other groups (Union rate: 60% v.s. 0% in the high-magnitude group and 10% in the control-VA group, BV: 0.69 0.30mm(3) v.s. 0.15 0.09mm(3) in high-magnitude group and 0.22 0.17mm(3) in control-VA group). BV/TV in the low-magnitude group of RFH model was significantly higher than that in control-VA group (59.4 14.9% v.s. 35.8 13.5%). On the other hand, radiographic union rate (10% in centrifuge acceleration group v.s. 20% in control-CA group) and micro-CT parameters in RFH model were not significantly different between two groups in the constant acceleration studies. Radiographic images of non-union rib fractures showed cartilage at the fracture site and poor new bone formation, whereas union samples showed only new bone. In conclusion, low-magnitude vibration acceleration promoted bone formation at the trunk in both BMP-induced ectopic bone formation and rib fracture healing models. However, the micro-CT parameters were not similar between two models, which suggested that there might be difference in the mechanism of effect by vibration between two models.	[Uchida, Ryohei; Yonetani, Yasukazu; Mae, Tatsuo; Matsuo, Tomohiko; Tachibana, Yuta; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthoped Surg, Osaka, Japan; [Uchida, Ryohei] Seifu Hosp, Dept Sports Med, Osaka, Japan; [Uchida, Ryohei; Nakata, Ken; Kawano, Fuminori; Ogasawara, Issei; Nakai, Naoya; Yokoi, Hiroyuki] Osaka Univ, Grad Sch Med, Dept Med Sports & Performing Arts, Osaka, Japan	Osaka University; Osaka University	Nakata, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Med Sports & Performing Arts, Osaka, Japan.	ken.nakata7@gmail.com	米谷, 泰一/AAO-2767-2021; Uchida, Ryohei/AAW-7733-2021		PROTEA JAPAN Company, Limited [J167701901]; Department of Medicine for Sports and Performing Arts, Osaka University Graduate School of Medicine; Grants-in-Aid for Scientific Research [26293336] Funding Source: KAKEN	PROTEA JAPAN Company, Limited; Department of Medicine for Sports and Performing Arts, Osaka University Graduate School of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided by PROTEA JAPAN Company, Limited [http://www.protea.co.jp], grant number J167701901. The initial of author who received the funding is K.N (Department of Medicine for Sports and Performing Arts, Osaka University Graduate School of Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Flieger J, 1998, CALCIFIED TISSUE INT, V63, P510, DOI 10.1007/s002239900566; Garman R, 2007, J ORTHOP RES, V25, P732, DOI 10.1002/jor.20354; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; Goodship AE, 2009, J ORTHOP RES, V27, P922, DOI 10.1002/jor.20824; Harrison A, 2016, ULTRASONICS, V70, P45, DOI 10.1016/j.ultras.2016.03.016; HASHIMOTO J, 1989, BONE, V10, P453, DOI 10.1016/8756-3282(89)90078-1; Hsieh YF, 2001, J BONE MINER RES, V16, P918, DOI 10.1359/jbmr.2001.16.5.918; MAHY PR, 1988, CLIN ORTHOP RELAT R, P236; Martin-Badosa E, 2003, COMPUT MED IMAG GRAP, V27, P447, DOI 10.1016/S0895-6111(03)00031-4; Martinez DA, 1998, AVIAT SPACE ENVIR MD, V69, pA17; Oxlund BS, 2003, BONE, V32, P69, DOI 10.1016/S8756-3282(02)00916-X; Ozcivici E, 2007, J BIOMECH, V40, P3404, DOI 10.1016/j.jbiomech.2007.05.015; Rubin C, 2002, J BONE MINER RES, V17, P349, DOI 10.1359/jbmr.2002.17.2.349; Rubin C, 2001, FASEB J, V15, P2225, DOI 10.1096/fj.01-0166com; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Rubin CT, 2001, DRUG DISCOV TODAY, V6, P848, DOI 10.1016/S1359-6446(01)01872-4; TAKAOKA K, 1988, CLIN ORTHOP RELAT R, P250; Torvinen S., 2003, EFFECT OF WHOLE BODY; Verschueren SMP, 2004, J BONE MINER RES, V19, P352, DOI 10.1359/JBMR.0301245; Vico L, 1999, EUR J APPL PHYSIOL, V80, P360, DOI 10.1007/s004210050604; von Stengel S, 2011, MED SCI SPORT EXER, V43, P1071, DOI 10.1249/MSS.0b013e318202f3d3; Ward K, 2004, J BONE MINER RES, V19, P360, DOI 10.1359/JBMR.040129; WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8; Wenger KH, 2010, BONE, V47, P746, DOI 10.1016/j.bone.2010.07.014; Xie LQ, 2006, BONE, V39, P1059, DOI 10.1016/j.bone.2006.05.012; Yoshikawa H, 2009, CLIN ORTHOP RELAT R, V467, P3087, DOI 10.1007/s11999-009-0976-6	27	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172614	10.1371/journal.pone.0172614	http://dx.doi.org/10.1371/journal.pone.0172614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264058	Green Published, Green Submitted, gold			2022-12-27	WOS:000396054300013
J	Carr, JS; King, S; Dekaney, CM				Carr, Jacquelyn S.; King, Stephanie; Dekaney, Christopher M.			Depletion of enteric bacteria diminishes leukocyte infiltration following doxorubicin-induced small intestinal damage in mice	PLOS ONE			English	Article							STREPTOCOCCUS-THERMOPHILUS TH-4; CYTO-TOXIC DRUGS; REPERFUSION INJURY; GUT MICROBIOTA; CELLS; APOPTOSIS; MUCOSITIS; RESPONSES; ACTIVATION; MECHANISMS	Background & aims While enteric bacteria have been shown to play a critical role in other forms of intestinal damage, their role in mediating the response to the chemotherapeutic drug Doxorubicin (Doxo) is unclear. In this study, we used a mouse model of intestinal bacterial depletion to evaluate the role enteric bacteria play in mediating Doxo-induced small intestinal damage and, more specifically, in mediating chemokine expression and leukocyte infiltration following Doxo treatment. An understanding of this pathway may allow for development of intervention strategies to reduce chemotherapy-induced small intestinal damage. Methods Mice were treated with (Abx) or without (NoAbx) oral antibiotics in drinking water for four weeks and then with Doxo. Jejunal tissues were collected at various time points following Doxo treatment and stained and analyzed for apoptosis, crypt damage and restitution, and macrophage and neutrophil number. In addition, RNA expression of inflammatory markers (TNF alpha, IL1-beta, IL-10) and cytokines (CCL2, CC7, KC) was assessed by qRT-PCR. Results In NoAbx mice Doxo-induced damage was associated with rapid induction of apoptosis in jejunal crypt epithelium and an increase weight loss and crypt loss. In addition, we observed an increase in immune-modulating chemokines CCL2, CCL7 and KC and infiltration of macrophages and neutrophils. In contrast, while still positive for induction of apoptosis following Doxo treatment, Abx mice showed neither the overall weight loss nor crypt loss seen in NoAbx mice nor the increased chemokine expression and leukocyte infiltration. Conclusion Enteric bacteria play a critical role in Doxo-induced small intestinal damage and are associated with an increase in immune-modulating chemokines and cells. Manipulation of enteric bacteria or the damage pathway may allow for prevention or treatment of chemotherapy induced small intestinal damage.	[Carr, Jacquelyn S.; Dekaney, Christopher M.] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA; [King, Stephanie; Dekaney, Christopher M.] NC State Univ, Dept Mol Biomed Sci, Raleigh, NC 27695 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Dekaney, CM (corresponding author), Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA.; Dekaney, CM (corresponding author), NC State Univ, Dept Mol Biomed Sci, Raleigh, NC 27695 USA.	chris_dekaney@ncsu.edu	, Histology Research Core Facility/ABF-6317-2021	Dekaney, Christopher/0000-0002-3252-1199	National Institutes of Health [DK100508, DK007737]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007737, R01DK100508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health, Grant #DK100508 to CMD and Grant #DK007737 to JSC (nitabov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhinder G, 2014, INFECT IMMUN, V82, P3753, DOI 10.1128/IAI.02045-14; BJARNASON I, 1991, GUT, V32, P275, DOI 10.1136/gut.32.3.275; Bojarski C, 2000, ANN NY ACAD SCI, V915, P270; BORDEN EC, 1987, J CLIN ONCOL, V5, P840, DOI 10.1200/JCO.1987.5.6.840; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Chen LW, 2008, SHOCK, V30, P563, DOI 10.1097/SHK.0b013e31816a3458; Coiffier B, 2010, BLOOD, V116, P2040, DOI 10.1182/blood-2010-03-276246; Dekaney CM, 2009, AM J PHYSIOL-GASTR L, V297, pG461, DOI 10.1152/ajpgi.90446.2008; Frantz AL, 2012, MUCOSAL IMMUNOL, V5, P501, DOI 10.1038/mi.2012.23; Goto S, 1996, ANTICANCER RES, V16, P2507; Hans W, 2000, EUR J GASTROEN HEPAT, V12, P267, DOI 10.1097/00042737-200012030-00002; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; IJIRI K, 1983, BRIT J CANCER, V47, P175, DOI 10.1038/bjc.1983.25; Kaczmarek A, 2012, J PATHOL, V226, P598, DOI 10.1002/path.3009; King SL, 2013, AM J PHYSIOL-GASTR L, V305, pG151, DOI 10.1152/ajpgi.00441.2012; Konaka A, 1999, PHARMACOL RES, V40, P517, DOI 10.1006/phrs.1999.0550; Marshman E, 2001, J PATHOL, V195, P285; Mizutani H, 2005, LIFE SCI, V76, P1439, DOI 10.1016/j.lfs.2004.05.040; MOORE JV, 1985, CANCER CHEMOTH PHARM, V15, P11; MOWAT AM, 1989, IMMUNOLOGY, V68, P18; Muhlbauer M, 2013, INFLAMM BOWEL DIS, V19, P2857, DOI 10.1097/01.MIB.0000435445.96933.37; Nakao T, 2012, J SURG RES, V173, P341, DOI 10.1016/j.jss.2010.10.003; Nigro G, 2014, CELL HOST MICROBE, V15, P792, DOI 10.1016/j.chom.2014.05.003; Nishikawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108494; Norris B, 2000, J CLIN ONCOL, V18, P2385, DOI 10.1200/JCO.2000.18.12.2385; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Rigby RJ, 2016, GUT MICROBES, V7, P414, DOI 10.1080/19490976.2016.1215806; Roulis M, 2015, MUCOSAL IMMUNOL; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Seiler KM, 2015, CELL TISSUE RES, V361, P427, DOI 10.1007/s00441-015-2111-1; SISLEY AC, 1994, J SURG RES, V57, P192, DOI 10.1006/jsre.1994.1130; Sun Z, 1998, SCAND J GASTROENTERO, V33, P415; Touchefeu Y, 2014, ALIMENT PHARM THER, V40, P409, DOI 10.1111/apt.12878; Wang HR, 2013, SCAND J GASTROENTERO, V48, P959, DOI 10.3109/00365521.2013.812142; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Watanabe T, 2008, GUT, V57, P181, DOI 10.1136/gut.2007.125963; Watanabe T, 2012, AM J PHYSIOL-GASTR L, V303, pG324, DOI 10.1152/ajpgi.00075.2012; Whitford EJ, 2009, CANCER BIOL THER, V8, P505, DOI 10.4161/cbt.8.6.7594; Xu Y, 2002, ANN ONCOL, V13, P1841, DOI 10.1093/annonc/mdf337; Xuan WJ, 2015, J LEUKOCYTE BIOL, V97, P61, DOI 10.1189/jlb.1A0314-170R; YAMADA T, 1993, INFLAMMATION, V17, P641, DOI 10.1007/BF00920471; Yeung CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138746; ZIMMERMAN BJ, 1992, SURG CLIN N AM, V72, P65	46	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173429	10.1371/journal.pone.0173429	http://dx.doi.org/10.1371/journal.pone.0173429			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257503	gold, Green Published, Green Submitted			2022-12-27	WOS:000396021100090
J	Eldridge, MDB; Miller, EJ; Neaves, LE; Zenger, KR; Herbert, CA				Eldridge, Mark D. B.; Miller, Emily J.; Neaves, Linda E.; Zenger, Kyall R.; Herbert, Catherine A.			Extensive genetic differentiation detected within a model marsupial, the tammar wallaby (Notamacropus eugenii)	PLOS ONE			English	Article							SOUTH-EASTERN AUSTRALIA; MACROPUS-EUGENII; ISLAND POPULATIONS; LINKAGE MAP; NEW-ZEALAND; NORTHERN AUSTRALIA; GREY KANGAROOS; FULIGINOSUS; DIVERSITY; GIGANTEUS	The tammar wallaby (Notamacropus eugenii) is one of the most intensively studied of all macropodids and was the first Australasian marsupial to have its genome sequenced. However, comparatively little is known about genetic diversity and differentiation amongst the morphologically distinct allopatric populations of tammar wallabies found in Western (WA) and South Australia (SA). Here we compare autosomal and Y-linked microsatellite genotypes, as well as sequence data (similar to 600 bp) from the mitochondrial DNA (mtDNA) control region (CR) in tammar wallabies from across its distribution. Levels of diversity at autosomal microsatellite loci were typically high in the WA mainland and Kangaroo Island (SA) populations (A = 8.9 - 10.6; He = 0.77 - 0.78) but significantly reduced in other endemic island populations (A = 3.8 - 4.1; He = 0.41 - 0.48). Autosomal and Y-linked microsatellite loci revealed a pattern of significant differentiation amongst populations, especially between SA and WA. The Kangaroo Island and introduced New Zealand population showed limited differentiation. Multiple divergent mtDNA CR haplotypes were identified within both SA and WA populations. The CR haplotypes of tammar wallabies from SA and WA show reciprocal monophyly and are highly divergent (14.5%), with levels of sequence divergence more typical of different species. Within WA tammar wallabies, island populations each have unique clusters of highly related CR haplotypes and each is most closely related to different WA mainland haplotypes. Y-linked microsatellite haplotypes show a similar pattern of divergence although levels of diversity are lower. In light of these differences, we suggest that two subspecies of tammar wallaby be recognized; Notamacropus eugenii eugenii in SA and N. eugenii derbianus in WA. The extensive neutral genetic diversity and inter-population differentiation identified within tammar wallabies should further increase the species value and usefulness as a model organism.	[Eldridge, Mark D. B.; Neaves, Linda E.] Australian Museum Res Inst, Sydney, NSW, Australia; [Eldridge, Mark D. B.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Miller, Emily J.; Herbert, Catherine A.] Univ New South Wales, Sch Biol Earth & Environm Sci, Kensington, NSW, Australia; [Neaves, Linda E.] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Zenger, Kyall R.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Zenger, Kyall R.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia; [Miller, Emily J.] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia; [Herbert, Catherine A.] Univ Sydney, Fac Vet Sci, Camperdown, NSW, Australia	Australian Museum; Macquarie University; University of New South Wales Sydney; James Cook University; James Cook University; University of Sydney; University of Sydney	Eldridge, MDB (corresponding author), Australian Museum Res Inst, Sydney, NSW, Australia.; Eldridge, MDB (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	mark.eldridge@austmus.gov.au	Neaves, Linda/AAY-6886-2020; Zenger, Kyall R/ABD-2101-2020; Herbert, Cathy/AAB-6609-2019	Neaves, Linda/0000-0002-5626-1029; Zenger, Kyall R/0000-0001-6817-8786; Herbert, Cathy/0000-0003-0174-0898; Eldridge, Mark/0000-0002-7109-0600	Australian Research Council Fellowship Scheme [F19905373]	Australian Research Council Fellowship Scheme(Australian Research Council)	This work was supported by the Australian Research Council Fellowship Scheme. Grant F19905373 (ME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Ian, 1995, CALMScience, V1, P259; Alsemgeest J, 2013, VET IMMUNOL IMMUNOP, V155, P139, DOI 10.1016/j.vetimm.2013.06.009; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Aplin KP, 2015, ZOOTAXA, V4055, P1, DOI 10.11646/zootaxa.4055.1.1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Browning TL, 2001, CONSERV GENET, V2, P145, DOI 10.1023/A:1011850201944; Calaby J.H., 1988, Zoological Catalogue of Australia, V5, P60; COOPER DW, 1994, MAMM GENOME, V5, P531, DOI 10.1007/BF00354925; Coulson, 2010, MACROPODS BIOL KANGA; Crowther MS, 2002, AUST J ZOOL, V50, P627, DOI 10.1071/ZO02030; Deakin JE, 2010, MARSUPIAL GENETICS AND GENOMICS, P1, DOI 10.1007/978-90-481-9023-2; DEH, 2004, REINTR MAINL SA TAMM; Donnellan SC, 2009, EMU, V109, P143, DOI 10.1071/MU07011; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eldridge M.D.B., 2015, HDB MAMMALS WORLD, P630; Eldridge MDB, 2010, MARSUPIAL GENETICS AND GENOMICS, P461, DOI 10.1007/978-90-481-9023-2_22; Eldridge MDB, 2004, CONSERV GENET, V5, P325, DOI 10.1023/B:COGE.0000031148.59923.aa; Eldridge MDB, 2001, AUST J ZOOL, V49, P323, DOI 10.1071/ZO00082; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FORD J, 1987, EMU, V87, P158, DOI 10.1071/MU9870158; Frankham R, 2017, GENETIC MANAGEMENT OF FRAGMENTED ANIMAL AND PLANT POPULATIONS, P1, DOI 10.1093/oso/9780198783398.001.0001; Frankham R, 2012, HEREDITY, V108, P167, DOI 10.1038/hdy.2011.66; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Frankham R, 2012, BIOL CONSERV, V153, P25, DOI 10.1016/j.biocon.2012.04.034; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Fumagalli L, 1997, MOL ECOL, V6, P1199, DOI 10.1046/j.1365-294X.1997.00298.x; Gamat M, 2015, SEX DEV, V9, P216, DOI 10.1159/000439499; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Graves JAM, 2013, ANNU REV GENOM HUM G, V14, P393, DOI 10.1146/annurev-genom-091212-153452; Hadley C, 2009, AUST J ZOOL, V57, P337, DOI 10.1071/ZO08098; Haio A. B., 1961, Journal of the Royal Society of Western Australia, V44, P84; Hetz JA, 2016, MOL CELL ENDOCRINOL, V428, P148, DOI 10.1016/j.mce.2016.03.030; Hickford D, 2009, TAMMAR WALLABY MACRO, P449; HINDS LA, 1990, AUST J ZOOL, V37, P223; HINDS LA, 2008, MAMMALS AUSTR, P330; How RA, 2009, J ZOOL, V278, P206, DOI 10.1111/j.1469-7998.2009.00569.x; Jackson S. M, 2015, TAXONOMY AUSTR MAMMA; KEAST ALLEN, 1961, BULL MUS COMP ZOOL HARVARD UNIV, V123, P303; Keogh JS, 2005, EVOLUTION, V59, P226; King CM., 2005, HDB NZ MAMMALS; Kinnear JE, 2002, BIOL CONSERV, V108, P335, DOI 10.1016/S0006-3207(02)00116-7; KIRSCH J A W, 1972, Australian Journal of Zoology, V20, P315, DOI 10.1071/ZO9720315; Le Page SL, 2000, MOL ECOL, V9, P753, DOI 10.1046/j.1365-294x.2000.00922.x; MacDonald AJ, 2014, HEREDITY, V112, P333, DOI 10.1038/hdy.2013.109; MacDonald AJ, 2006, MOL ECOL NOTES, V6, P1202, DOI 10.1111/j.1471-8286.2006.01491.x; Macqueen P, 2009, MOL ECOL, V18, P3291, DOI 10.1111/j.1365-294X.2009.04262.x; Maxwell S., 1996, 1996 ACTION PLAN AUS; McKenzie LM, 1997, J HERED, V88, P398, DOI 10.1093/oxfordjournals.jhered.a023125; MCKENZIE LM, 1993, CYTOGENET CELL GENET, V64, P264, DOI 10.1159/000133590; McKenzie LM, 1995, ANZCCART NEWS, V8, P1; Menkhorst P.W., 2011, FIELD GUIDE MAMMALS, V3rd; Miller EJ, 2010, MACROPODS: THE BIOLOGY OF KANGAROOS, WALLABIES AND RAT-KANGAROOS, P77; Miller EJ, 2011, CONSERV GENET, V12, P1619, DOI 10.1007/s10592-011-0265-2; Miller EJ, 2010, REPROD FERT DEVELOP, V22, P539, DOI 10.1071/RD09061; Modepalli V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1012; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Neaves LE, 2010, HEREDITY, V104, P502, DOI 10.1038/hdy.2009.137; Neaves LE, 2013, AUST J ZOOL, V61, P58, DOI 10.1071/ZO12087; Neaves LE, 2012, J BIOGEOGR, V39, P1545, DOI 10.1111/j.1365-2699.2012.02702.x; Neaves LE, 2009, MOL ECOL, V18, P3363, DOI 10.1111/j.1365-294X.2009.04293.x; OLIVER AJ, 1979, AUST J ZOOL, V27, P363, DOI 10.1071/ZO9790363; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; POOLE WE, 1974, AUST J ZOOL, V22, P277, DOI 10.1071/ZO9740277; POOLE WE, 1991, WILDLIFE RES, V18, P625, DOI 10.1071/WR9910625; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Renfree MB, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r81; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robinson A., 1996, S AUSTR OFFSHORE ISL; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Salinas M, 2009, AUST J ZOOL, V57, P41, DOI 10.1071/ZO08097; Schodde R, 1999, DIRECTORY AUSTR BIRD; Spencer PBS, 2001, AUST J ZOOL, V49, P369, DOI 10.1071/ZO00080; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Taylor AC, 1999, ANIM CONSERV, V2, P195, DOI 10.1111/j.1469-1795.1999.tb00065.x; Taylor AC, 1999, ANIM CONSERV, V2, P41, DOI 10.1111/j.1469-1795.1999.tb00047.x; Taylor AC, 1998, MOL ECOL, V7, P925; Telfer WR, 2010, AUST J ZOOL, V58, P104, DOI 10.1071/ZO09119; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toon A, 2010, MOL ECOL, V19, P2980, DOI 10.1111/j.1365-294X.2010.04730.x; Toon A, 2007, MOL ECOL, V16, P2525, DOI 10.1111/j.1365-294X.2007.03289.x; Tyndale-Biscoe CH, 1988, DEV MARSUPIAL MODELS; Tyndale-Biscoe CH., 1987, REPROD PHYSL MARSUPI; TyndaleBiscoe H, 2005, LIFE OF MARSUPIALS, P1; Wang CW, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-72; Wang CW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-422; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright M, 1999, KANGAROO ISLAND TAMM; Zenger KR, 2005, CONSERV GENET, V6, P193, DOI 10.1007/s10592-004-7828-4; Zenger KR, 2001, MOL ECOL NOTES, V1, P98, DOI 10.1046/j.1471-8278.2001.00044.x; Zenger KR, 2001, ANIM GENET, V32, P166, DOI 10.1046/j.1365-2052.2001.0723d.x; Zenger KR, 2002, GENETICS, V162, P321	100	7	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172777	10.1371/journal.pone.0172777	http://dx.doi.org/10.1371/journal.pone.0172777			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257440	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000396021100027
J	Kido, Y; Kayama, M				Kido, Yoshifumi; Kayama, Mami			Consumer providers' experiences of recovery and concerns as members of a psychiatric multidisciplinary outreach team: A qualitative descriptive study from the Japan Outreach Model Project 2011-2014	PLOS ONE			English	Article							SEVERE MENTAL-ILLNESS; PEER SUPPORT; SERVICES; STRATEGIES; BENEFITS; CLIENTS; STAFF	Objective The objective of this study was to clarify consumer providers (CPs) subjective experiences as members of a psychiatric multidisciplinary outreach team that provided services to individuals with a mental illness living in the community. Methods A qualitative descriptive study was conducted through semi-structured interviews. Participants were clients hired as CPs in the Japanese Outreach Model Project from September 2011 until March 2014. Of the seventeen CPs, nine participated in this study. We looked at the CPs' subjective experiences of fulfillment and difficulty. Results In the process of providing services, CPs experienced both achievements and concerns. They had a sense of achievement by caring for their clients and they experienced that they themselves were recovering. They were also concerned about having inadequate knowledge and skills to provide psychiatric services to their clients. Further, there were concerns about their dual role on the multidisciplinary team and being support staff while they were still using mental health services themselves. Conclusion The results show that the activities of CPs included fulfillment, recovery, and dilemmas. Clarifications will likely contribute to an increase in understanding and cooperation between CPs and other professionals with whom they work. Further studies are needed to investigate policies related to mental health consumers who are also providers of mental health services.	[Kido, Yoshifumi] Mie Prefectural Coll Nursing, Dept Psychiat Nursing, Tsu, Mie, Japan; [Kayama, Mami] St Lukes Int Univ, Grad Sch Nursing, Dept Psychiat & Mental Hlth Nursing, Chuo Ku, Tokyo, Japan	St. Luke's International Hospital	Kido, Y (corresponding author), Mie Prefectural Coll Nursing, Dept Psychiat Nursing, Tsu, Mie, Japan.	yoshifumi-tky@umin.ac.jp			JSPS KAKENHI [24792592]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the JSPS 2012 KAKENHI Grants-in-Aid for Scientific Research (grant number: 24792592).	Anthony WilliamA, 1993, PSYCHOSOC REHABIL, V16, P11, DOI [10.1037/h0095655, DOI 10.1037/H0095655]; Carlson LS, 2001, COMMUNITY MENT HLT J, V37, P199, DOI 10.1023/A:1017569913118; Chiba R, 2011, SHEISHINKA KANGO JPN, V38, P48; Chinman MJ, 2001, COMMUNITY MENT HLT J, V37, P215, DOI 10.1023/A:1017577029956; Clarke G N, 2000, Ment Health Serv Res, V2, P155, DOI 10.1023/A:1010141826867; Copeland M., 2002, OCCUP THER MENT HEAL, V14, P127, DOI [10.1300/J004v17n03_09, DOI 10.1300/J004V17N03_09, 10.1300/j004v17n03_09]; Corrigan PW, 2006, PSYCHIAT SERV, V57, P1493, DOI 10.1176/appi.ps.57.10.1493; Davidson L, 1999, CLIN PSYCHOL-SCI PR, V6, P165, DOI 10.1093/clipsy/6.2.165; Deegan P.E., 1988, PSYCHOSOC REHABIL, V11, P11, DOI [10.1037/h0099565, DOI 10.1037/H0099565]; Doherty I, 2004, J MENTAL HLTH, V13, P71, DOI DOI 10.1080/09638230410001654576; Fisk D, 2000, PSYCHIATR REHABIL J, V23, P244, DOI 10.1037/h0095161; Gates LB, 2007, ADM POLICY MENT HLTH, V34, P293, DOI 10.1007/s10488-006-0109-4; Kayama M, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0311-y; Klein AR, 1998, RES SOCIAL WORK PRAC, V8, P529, DOI 10.1177/104973159800800503; Landers GM, 2011, COMMUNITY MENT HLT J, V47, P106, DOI 10.1007/s10597-009-9218-3; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Ministry of Health Labor and Welfare, 2004, REF VIS MENT HLTHC W; Ministry of Health Labor and Welfare, 2014, CONCR DIR DISCH COMM; Ministry of Health Labor and Welfare, 2009, PLAN FURTH REF MENT; Mowbray CT, 1998, J BEHAV HEALTH SER R, V25, P397, DOI 10.1007/BF02287510; Nonaka T., 2005, SEISHIN IGAKU, V47, P952; Pitt V, 2013, COCHRANE DATABASE SY, V28; Reynolds W, 2004, J Psychiatr Ment Health Nurs, V11, P82, DOI 10.1111/j.1365-2850.2004.00692.x; Riffer NW, 2000, PSYCHIATR REHABIL J, V23, P281, DOI 10.1037/h0095157; Schmidt LT, 2008, AM J PSYCHIATR REHAB, V11, P310, DOI 10.1080/15487760802186253; Sells D, 2006, PSYCHIAT SERV, V57, P1179, DOI 10.1176/appi.ps.57.8.1179; Sledge WH, 2011, PSYCHIAT SERV, V62, P541, DOI 10.1176/ps.62.5.pss6205_0541; Solomon P, 2004, PSYCHIATR REHABIL J, V27, P392, DOI 10.2975/27.2004.392.401; van Vugt MD, 2012, PSYCHIAT SERV, V63, P477, DOI 10.1176/appi.ps.201000549; Yokoyama M., 2011, CONDUCT REPORT QUALI	30	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173330	10.1371/journal.pone.0173330	http://dx.doi.org/10.1371/journal.pone.0173330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5BR	28257462	Green Published, gold, Green Submitted			2022-12-27	WOS:000396021100087
J	Pascacio-Villafan, C; Birke, A; Williams, T; Aluja, M				Pascacio-Villafan, Carlos; Birke, Andrea; Williams, Trevor; Aluja, Martin			Modeling the cost-effectiveness of insect rearing on artificial diets: A test with a tephritid fly used in the sterile insect technique	PLOS ONE			English	Article							ABBREVIATUS COLEOPTERA-CURCULIONIDAE; DIPTERA-TEPHRITIDAE; LARVAL DIET; PERFORMANCE; PROTEIN; GROWTH; ENERGY; FEASIBILITY; PROGRAMS; FEEDS	We modeled the cost-effectiveness of rearing Anastrepha ludens, a major fruit fly pest currently mass reared for sterilization and release in pest control programs implementing the sterile insect technique (SIT). An optimization model was generated by combining response surface models of artificial diet cost savings with models of A. ludens pupation, pupal weight, larval development time and adult emergence as a function of mixtures of yeast, a costly ingredient, with corn flour and corncob fractions in the diet. Our model revealed several yeast-reduced mixtures that could be used to prepare diets that were considerably cheaper than a standard diet used for mass rearing. Models predicted a similar production of insects (pupation and adult emergence), with statistically similar pupal weights and larval development times between yeast-reduced diets and the standard mass rearing diet formulation. Annual savings from using the modified diets could be up to 5.9% of the annual cost of yeast, corn flour and corncob fractions used in the standard diet, representing a potential saving of US $27.45 per ton of diet (US $47,496 in the case of the mean annual production of 1,730.29 tons of artificial diet in the Moscafrut mass rearing facility at Metapa, Chiapas, Mexico). Implementation of the yeast-reduced diet on an experimental scale at mass rearing facilities is still required to confirm the suitability of new mixtures of artificial diet for rearing A. ludens for use in SIT. This should include the examination of critical quality control parameters of flies such as adult flight ability, starvation resistance and male sexual competitiveness across various generations. The method used here could be useful for improving the cost-effectiveness of invertebrate or vertebrate mass rearing diets worldwide.	[Pascacio-Villafan, Carlos; Birke, Andrea; Williams, Trevor; Aluja, Martin] Inst Ecol AC, Cluster Cient & Tecnol BioMim, Red Manejo Biorrac Plagas & Vectores, Xalapa, Veracruz, Mexico	Instituto de Ecologia - Mexico	Pascacio-Villafan, C; Aluja, M (corresponding author), Inst Ecol AC, Cluster Cient & Tecnol BioMim, Red Manejo Biorrac Plagas & Vectores, Xalapa, Veracruz, Mexico.	cpascacio@hotmail.com; martin.aluja@inecol.mx	Biewendt, Andrea Barbara Birke/Q-6287-2018; Pascacio-Villafán, Carlos/Q-6202-2018; Williams, Trevor/F-1447-2011; Williams, Trevor/ABG-3961-2020; Aluja, Martín/Q-6810-2018	Biewendt, Andrea Barbara Birke/0000-0001-5870-3153; Pascacio-Villafán, Carlos/0000-0002-1431-9667; Williams, Trevor/0000-0003-3414-3440; Aluja, Martín/0000-0002-2936-3011	Asociacion de Productores, Empacadores y Exportadores de Aguacate de Mexico, A.C. (APEAM); Campana Nacional contra Moscas de la Fruta SAGARPA-IICA-INECOL; Campana Nacional contra Moscas de la Fruta SAGARPA-CONACOFI-INECOL; Institute de Ecologia, A.C. (INECOL); Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT	Asociacion de Productores, Empacadores y Exportadores de Aguacate de Mexico, A.C. (APEAM); Campana Nacional contra Moscas de la Fruta SAGARPA-IICA-INECOL; Campana Nacional contra Moscas de la Fruta SAGARPA-CONACOFI-INECOL; Institute de Ecologia, A.C. (INECOL); Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding was provided by the Asociacion de Productores, Empacadores y Exportadores de Aguacate de Mexico, A.C. (APEAM), the Campana Nacional contra Moscas de la Fruta SAGARPA-IICA-INECOL and SAGARPA-CONACOFI-INECOL and the Institute de Ecologia, A.C. (INECOL). CP-V gratefully acknowledges a student scholarship from the Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluja M, 2009, BIOCONTROL SCI TECHN, V19, P49, DOI 10.1080/09583150802377373; Anderson M.J., 2016, RSM SIMPLIFIED OPTIM; Anderson-Cook C.M., 2016, RESPONSE SURFACE MET; Basurco V, 2015, J APPL POULTRY RES, V24, P304, DOI 10.3382/japr/pfv030; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Catacutan MR, 2002, AQUACULTURE, V208, P113, DOI 10.1016/S0044-8486(01)00709-8; Chaudhury MF, 2007, J ECON ENTOMOL, V100, P241, DOI 10.1603/0022-0493(2007)100[241:ACFDFS]2.0.CO;2; Cohen AC, 2004, INSECT DIETS SCI TEC; Cohen Allen Carson, 2001, American Entomologist, V47, P198; Cook R. D., 1982, RESIDUALS AND INFLUE; Cornell J.A., 2011, PRIMER EXPT MIXTURES; De Santis C, 2015, AQUACULTURE, V444, P70, DOI 10.1016/j.aquaculture.2015.03.024; Direccion General de Sanidad Vegetal-Direccion de Moscas de la Fruta (DGSV-DMF), 2009, CRIA MAS AN LUD; Dominguez J., 2010, MOSCAS FRUTA FUNDAME, P259; Ekesi S, 2007, ANN ENTOMOL SOC AM, V100, P562, DOI 10.1603/0013-8746(2007)100[562:ATASRO]2.0.CO;2; Enkerlin WR, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P651, DOI 10.1007/1-4020-4051-2_25; Estes AM, 2012, J APPL ENTOMOL, V136, P1, DOI 10.1111/j.1439-0418.2011.01620.x; FAO/IAEA/USDA, 2014, MAN PROD QUAL CONTR; Forster IP, 2010, AQUACULTURE, V298, P260, DOI 10.1016/j.aquaculture.2009.10.023; Garcia S, 2011, AQUACULT NUTR, V17, pE174, DOI 10.1111/j.1365-2095.2009.00746.x; Gutierrez J. M., 2013, PROGRAMAS MOSCAS FRU; Hernandez E, 2014, INT J TROP INSECT SC, V34, pS13, DOI 10.1017/S1742758414000046; Hernandez E, 2010, FLA ENTOMOL, V93, P167, DOI 10.1653/024.093.0204; Jeffs A, 2000, J WORLD AQUACULT SOC, V31, P30, DOI 10.1111/j.1749-7345.2000.tb00695.x; Lapointe SL, 2008, J INSECT PHYSIOL, V54, P1157, DOI 10.1016/j.jinsphys.2008.04.020; Lapointe SL, 2010, ENVIRON ENTOMOL, V39, P670, DOI 10.1603/EN09304; Lapointe SL, 2010, FLA ENTOMOL, V93, P56, DOI 10.1653/024.093.0108; Liu SY, 2015, 26 ANN AUSTR POULTR, P52; Moadeli T, 2016, J PEST SCI; Myers R., 1990, CLASSICAL MODERN REG; Pascacio-Villafan C, 2015, J ECON ENTOMOL, V108, P53, DOI 10.1093/jee/tou033; Pascacio-Villafan C, 2016, SCI REP-UK, V6, DOI 10.1038/srep29413; RIVERA J. Pedro, 2012, Acta Zool. Mex, V28, P102; PIEPEL GF, 1994, J QUAL TECHNOL, V26, P177, DOI 10.1080/00224065.1994.11979525; PINSON E, 1993, FRUIT FLIES, P285; Pinson E, 1990, PROGRAMA Y RESUMENES, P147; Ramirez F, 2016, 9 M WORK GROUP FRUIT; Rempoulakis P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157679; Rull J, 2012, ENTOMOL EXP APPL, V142, P78, DOI 10.1111/j.1570-7458.2011.01196.x; Ruohonen K, 2004, AQUACULT NUTR, V10, P145, DOI 10.1111/j.1365-2095.2004.00277.x; Ruohonen K, 2003, AQUACULTURE, V225, P27, DOI 10.1016/S0044-8486(03)00275-8; Sartori D, 2016, AQUACULT NUTR, V22, P1214, DOI 10.1111/anu.12326; TANAKA N, 1972, J ECON ENTOMOL, V65, P866, DOI 10.1093/jee/65.3.866; Weisberg S., 1985, APPL LINEAR REGRESSI; Welsch R, 1980, REGRESSION DIAGNOSTI; Woyengo TA, 2014, J ANIM SCI, V92, P1293, DOI 10.2527/jas.2013-7169; Zar J.H, 2010, BIOSTATICAL ANAL	47	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173205	10.1371/journal.pone.0173205	http://dx.doi.org/10.1371/journal.pone.0173205			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257496	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100077
J	Batista, MEP; Silva, DD; Sales, MAF; Sa, AA; Saraiva, AAF; Loiola, MIB				Peixoto Batista, Maria Edenilce; Silva, Delmira da Costa; Sales, Marcos A. F.; Sa, Artur A.; Saraiva, Antonio A. F.; Bezerra Loiola, Maria Iracema			New data on the stem and leaf anatomy of two conifers from the Lower Cretaceous of the Araripe Basin, northeastern Brazil, and their taxonomic and paleoecological implications	PLOS ONE			English	Article							CHEIROLEPIDIACEOUS CONIFERS; SP-NOV; PSEUDOFRENELOPSIS; BRACHYPHYLLUM; BEDS; PROVINCE; XYLEM; AFFINITIES; EVOLUTION; DISCOVERY	Pseudofrenelopsis and Brachyphyllum are two conifers that were part of the Lower Cretaceous (Aptian) taphoflora of the Crato Formation, Araripe Basin, northeastern Brazil. The former genus includes, so far, P. capillata and indeterminate species, whilst the latter is mainly represented by B. obesum, the most common plant megafossil recovered from that stratigraphic unit. Here, the stem and leaf anatomy of Pseudofrenelopsis sp. and B. obesum specimens is revisited, including the first report of some epidermal and vascular traits for both taxa from the Crato Formation. Along with its paleoecological significance, the new data suggest the presence of more than one Pseudofrenelopsis species in the Aptian taphoflora of the Araripe Basin and further support the taxonomic placement of B. obesum within Araucariaceae.	[Peixoto Batista, Maria Edenilce] Univ Fed Ceara, Dept Biol, Programa Posgrad Ecol & Recursos Nat, Fortaleza, Ceara, Brazil; [Silva, Delmira da Costa] Univ Estadual Santa Cruz, Dept Ciencias Biol, Santa Cruz, BA, Brazil; [Sales, Marcos A. F.] Univ Fed Rio Grande do Sul, Programa Posgrad Geociencias, Inst Geociencias, Porto Alegre, RS, Brazil; [Sa, Artur A.] Univ Tras Os Montes & Alto Douro, Dept Geol, Vila Real, Portugal; [Sa, Artur A.] Univ Coimbra, Ctr Geociencias, Coimbra, Portugal; [Saraiva, Antonio A. F.] Univ Reg Cariri, Dept Ciencias Biol, Crato, Ceara, Brazil; [Bezerra Loiola, Maria Iracema] Univ Fed Ceara, Dept Biol, Fortaleza, Ceara, Brazil	Universidade Federal do Ceara; Universidade Estadual de Santa Cruz; Universidade Federal do Rio Grande do Sul; University of Tras-os-Montes & Alto Douro; Universidade de Coimbra; Universidade Regional do Cariri; Universidade Federal do Ceara	Batista, MEP (corresponding author), Univ Fed Ceara, Dept Biol, Programa Posgrad Ecol & Recursos Nat, Fortaleza, Ceara, Brazil.	edenilcebio@hotmail.com	A, Artur/N-7826-2013; Batista, Maria Edenilce Peixoto/AAA-9029-2021; Loiola, Maria Iracema Bezerra/I-2458-2012; SILVA, DELMIRA C/F-3433-2010	A, Artur/0000-0003-0811-2413; Batista, Maria Edenilce Peixoto/0000-0002-1239-0902; Loiola, Maria Iracema Bezerra/0000-0003-3389-5560; SILVA, DELMIRA C/0000-0003-4587-2526; Fontenele Sales, Marcos Andre/0000-0002-2292-578X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by a Ph.D. grant to MEPB by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and a productivity grant to MIBL by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). There was no additional external funding received for this study.	Alroy J., ONLINE PALEOGEOGRAPH; ALVIN KL, 1982, REV PALAEOBOT PALYNO, V37, P71, DOI 10.1016/0034-6667(82)90038-0; ALVIN KL, 1981, PALAEONTOLOGY, V24, P759; ASH SR, 1973, J PALEONTOL, V47, P46; Assine M.l., 1992, BRAZ J GEOL, V22, P289, DOI DOI 10.25249/0375-7536.1992289300; Assine ML., 2007, B GEOCIENCIAS PETROB, V15, P371; Axsmith BJ, 2006, CRETACEOUS RES, V27, P309, DOI 10.1016/j.cretres.2005.07.001; Baas P, 2004, IAWA J, V25, P1, DOI 10.1163/22941932-90000349; Barral A, 2016, PALAEOGEOGR PALAEOCL, V443, P107, DOI 10.1016/j.palaeo.2015.11.026; Berendse F, 2009, ECOL LETT, V12, P865, DOI 10.1111/j.1461-0248.2009.01342.x; Bernardes-de-Oliveira M.E.C., 2014, PALEONTOLOGIA CENARI, V5, P101; Biffin E, 2012, P ROY SOC B-BIOL SCI, V279, P341, DOI 10.1098/rspb.2011.0559; Bouche PS, 2014, J EXP BOT, V65, P4419, DOI 10.1093/jxb/eru218; CAO ZY, 1994, CRETACEOUS RES, V15, P317, DOI 10.1006/cres.1994.1020; Carlquist S, 1975, ECOLOGICAL STRATEGIE; da Conceicao DM, 2016, J S AM EARTH SCI, V70, P308, DOI 10.1016/j.jsames.2016.05.015; Du BX, 2013, CRETACEOUS RES, V41, P242, DOI 10.1016/j.cretres.2012.12.009; Du BX, 2014, CRETACEOUS RES, V48, P193, DOI 10.1016/j.cretres.2013.12.003; Duarte L, 1985, AN 8 C BRAS PAL SOC, P557; Fahn A, 1992, XEROPHYTES; Gerards T, 2007, IAWA J, V28, P49, DOI 10.1163/22941932-90001618; Grigore M.N, 2014, HALOPHYTES INTEGRATI; Grissino-Mayer HD., 1999, FAMILIAR RING INTRO, P3; Harris T.M., 1979, YORKSHIRE JURASSIC F; Heer O, 1881, CONTRIBUTIONS FLORE; Hill CR, 2012, ACTA PALAEONTOL SIN, V51, P395; Holden R, 1915, BOT GAZ, V60, P215, DOI 10.1086/331636; Hollick A, 1906, AM NAT, V40, P189, DOI 10.1086/278613; Jordan GJ, 2008, AM J BOT, V95, P521, DOI 10.3732/ajb.2007333; Karakitsios V, 2015, NEUES JAHRB GEOL P-A, V278, P79, DOI 10.1127/njgpa/2015/0518; Kendall, 1947, J NAT HIST, V14, P225, DOI DOI 10.1080/00222934708654632; KENDALL MABEL W., 1949, ANN AND MAG HIST 12TH SER, V2, P308; KERP H, 1990, Palaios, V5, P548, DOI 10.2307/3514861; Kozlowski T.T., 1971, GROWTH DEV TREES; Kunzmann L, 2004, MITT MUS NATURKD BER, V7, P155, DOI DOI 10.5194/FR-7-155-2004; Kvacek Jiri, 2007, Acta Palaeobotanica, V47, P25; Landrum JV, 2006, J PLANT RES, V119, P497, DOI 10.1007/s10265-006-0013-8; LEWIS MC, 1972, SCI PROGRESS-UK, V60, P25; LORCH J, 1968, Journal of the Linnean Society of London Botany, V61, P177; Martill DM, 2007, CRATO FOSSIL BEDS BR, P8, DOI DOI 10.1017/CBO9780511535512.003; Metcalfe C.R., 1983, NORD J BOT, V4, P668; Meyen S.V., 1987, FUNDAMENTALS PALAEOB; Mohr BAR, 2000, INT J PLANT SCI, V161, pS155, DOI 10.1086/317580; Mohr BAR, 2007, CRATO FOSSIL BEDS BR, P537, DOI DOI 10.1017/CBO9780511535512.020; Mussa D, 1991, B RESUMOS SBP, P115; Neumann V.H., 1999, B RESUMOS EXPANDIDOS, P279; Neumann V.H.M.L., 1999, THESIS U BARCELONA F; Ng FSP, 2013, J TROP FOR SCI, V25, P437; Oliveira, 2007, PALEONTOLOGIA CENARI, P203; Philippe M, 2008, REV PALAEOBOT PALYNO, V148, P184, DOI 10.1016/j.revpalbo.2007.09.004; Pires EF, 2011, AN ACAD BRAS CIENC, V83, P409, DOI 10.1590/S0001-37652011005000005; Poole I, 2001, PALAEONTOLOGY, V44, P1081, DOI 10.1111/1475-4983.00216; RAAB M, 1986, REV PALAEOBOT PALYNO, V46, P227, DOI 10.1016/0034-6667(86)90016-3; Saiki K, 1999, PALEONTOL RES, V3, P29; Seward AC, 1895, CATALOGUE MESOZOIC P; SPERRY JS, 1990, PLANT CELL ENVIRON, V13, P427, DOI 10.1111/j.1365-3040.1990.tb01319.x; SRINIVASAN V, 1995, REV PALAEOBOT PALYNO, V89, P257, DOI 10.1016/0034-6667(95)00010-8; STOCKEY RA, 1986, BOT GAZ, V147, P508, DOI 10.1086/337619; Sucerquia PA, 2006, THESIS; Sucerquia PA, 2013, THESIS; Sucerquia PA, 2015, REV PALAEOBOT PALYNO, V222, P116, DOI 10.1016/j.revpalbo.2015.07.012; Sun BN, 2011, ISL ARC, V20, P43, DOI 10.1111/j.1440-1738.2010.00719.x; Syampungani S., 2010, J ECOLOGY NATURAL EN, V2, P167; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; Thompson WP, 1912, BOT GAZ, V54, P0063, DOI 10.1086/330864; Traverso, 1966, AMEGHINIANA, V4, P189; TYREE MT, 1994, IAWA J, V15, P335, DOI 10.1163/22941932-90001369; Valenca L. M. M., 2003, Geologica Acta, V1, P261; van der Ham RWJM, 2003, REV PALAEOBOT PALYNO, V127, P77, DOI 10.1016/S0034-6667(03)00095-2; Viana M.S.S., 2002, SITIOS GEOLOGICOS PA, P113; Viana MSS, 1993, ANUARIO I GEOCIENCIA, V16, P110; Watson J, 1999, CRETACEOUS RES, V20, P315, DOI 10.1006/cres.1999.0152; WATSON J, 1977, Palaeontology (Oxford), V20, P715; WATSON J, 1987, REV PALAEOBOT PALYNO, V51, P169, DOI 10.1016/0034-6667(87)90028-5; Watson J., 1988, ORIGIN EVOLUTION GYM, P382; Yabe A., 2004, MEMOIR FUKUI PREFERU, V3, P23; Yang XJ, 2009, REV PALAEOBOT PALYNO, V153, P8, DOI 10.1016/j.revpalbo.2008.06.002; Yang XJ, 2007, ACTA GEOL SIN-ENGL, V81, P905; ZHOU ZY, 1983, PALAEONTOLOGY, V26, P789; ZHOU ZY, 1995, REV PALAEOBOT PALYNO, V84, P419, DOI 10.1016/0034-6667(94)00078-X	80	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173090	10.1371/journal.pone.0173090	http://dx.doi.org/10.1371/journal.pone.0173090			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257466	Green Submitted, Green Published, gold			2022-12-27	WOS:000396021100057
J	Laurens, MB; Kouriba, B; Bergmann-Leitner, E; Angov, E; Coulibaly, D; Diarra, I; Daou, M; Niangaly, A; Blackwelder, WC; Wu, YK; Cohen, J; Ballou, WR; Vekemans, J; Lanar, DE; Dutta, S; Diggs, C; Soisson, L; Heppner, DG; Doumbo, OK; Plowe, CV; Thera, MA				Laurens, Matthew B.; Kouriba, Bourema; Bergmann-Leitner, Elke; Angov, Evelina; Coulibaly, Drissa; Diarra, Issa; Daou, Modibo; Niangaly, Amadou; Blackwelder, William C.; Wu, Yukun; Cohen, Joe; Ballou, W. Ripley; Vekemans, Johan; Lanar, David E.; Dutta, Sheetij; Diggs, Carter; Soisson, Lorraine; Heppner, D. Gray; Doumbo, Ogobara K.; Plowe, Christopher V.; Thera, Mahamadou A.			Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; GLUTAMATE-RICH PROTEIN; IN-VITRO; CLINICAL MALARIA; PARASITE GROWTH; ANTIBODIES; PROTECTION; TRIAL; COOPERATION; SERA	The blood-stage malaria vaccine FMP2.1/AS02A, comprised of recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1) and the adjuvant system AS02A, had strain-specific efficacy against clinical malaria caused by P. falciparum with the vaccine strain 3D7 AMA1 sequence. To evaluate a potential correlate of protection, we measured the ability of participant sera to inhibit growth of 3D7 and FVO strains in vitro using high-throughput growth inhibition assay (GIA) testing. Sera from 400 children randomized to receive either malaria vaccine or a control rabies vaccine were assessed at baseline and over two annual malaria transmission seasons after immunization. Baseline GIA against vaccine strain 3D7 and FVO strain was similar in both groups, but more children in the malaria vaccine group than in the control group had 3D7 and FVO GIA activity >= 15% 30 days after the last vaccination (day 90) (49% vs. 16%, p<0.0001; and 71.8% vs. 60.4%, p = 0.02). From baseline to day 90, 3D7 GIA in the vaccine group was 7.4 times the mean increase in the control group (p<0.0001). In AMA1 vaccinees, 3D7 GIA activity subsequently returned to baseline one year after vaccination (day 364) and did not correlate with efficacy in the extended efficacy time period to day 730. In Cox proportional hazards regression models with time-varying covariates, there was a slight suggestion of an association between 3D7 GIA activity and increased risk of clinical malaria between day 90 and day 240. We conclude that vaccination with this AMA1-based malaria vaccine increased inhibition of parasite growth, but this increase was not associated with allele-specific efficacy in the first malaria season. These results provide a framework for testing functional immune correlates of protection against clinical malaria in field trials, and will help to guide similar analyses for next-generation malaria vaccines.	[Laurens, Matthew B.; Blackwelder, William C.; Wu, Yukun; Plowe, Christopher V.] Univ Maryland, Sch Med, Inst Global Hlth, Div Malaria Res, Baltimore, MD 21201 USA; [Kouriba, Bourema; Coulibaly, Drissa; Diarra, Issa; Daou, Modibo; Niangaly, Amadou; Doumbo, Ogobara K.; Thera, Mahamadou A.] Malaria Res & Training Ctr, Bamako, Mali; [Bergmann-Leitner, Elke; Angov, Evelina; Lanar, David E.; Dutta, Sheetij; Heppner, D. Gray] Walter Reed Army Inst Res, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [Cohen, Joe; Ballou, W. Ripley; Vekemans, Johan] GSK Vaccines, Rixensart, Belgium; [Diggs, Carter; Soisson, Lorraine] US Agcy Int Dev, Malaria Vaccine Dev Program, Washington, DC 20523 USA; [Vekemans, Johan] World Hlth Org, Geneva, Switzerland	University System of Maryland; University of Maryland Baltimore; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); GlaxoSmithKline; United States Agency for International Development (USAID); World Health Organization	Laurens, MB (corresponding author), Univ Maryland, Sch Med, Inst Global Hlth, Div Malaria Res, Baltimore, MD 21201 USA.	mlaurens@medicine.umaryland.edu	Bergmann-Leitner, Elke S./B-3548-2011; Bergmann-Leitner, Elke/I-5431-2019; Laurens, Matthew/E-7293-2013	Bergmann-Leitner, Elke S./0000-0002-8571-8956; Bergmann-Leitner, Elke/0000-0002-8571-8956; Thera, Mahamadou A/0000-0002-2679-035X; Laurens, Matthew/0000-0003-3874-581X	National Institute of Allergy and Infectious Diseases [N01AI85346, U19AI065683, HHSN272200800013C]; Fogarty International Center, National Institutes of Health [D43TW001589]; Department of Defense [W81XWH-06-1-0427]; U.S. Agency for International Development for site development and the conduct of the trial; U.S. Agency for International Development; Military Infectious Diseases Research Program, Fort Detrick, MD; Doris Duke Charitable Foundation Distinguished Clinical Scientist Award; Howard Hughes Medical Institute	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Department of Defense(United States Department of Defense); U.S. Agency for International Development for site development and the conduct of the trial; U.S. Agency for International Development(United States Agency for International Development (USAID)); Military Infectious Diseases Research Program, Fort Detrick, MD; Doris Duke Charitable Foundation Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Supported by a contract (N01AI85346) and a cooperative agreement (U19AI065683) from the National Institute of Allergy and Infectious Diseases, a grant (D43TW001589) from the Fogarty International Center, National Institutes of Health, and a contract (W81XWH-06-1-0427) from the Department of Defense and the U.S. Agency for International Development for site development and the conduct of the trial; by a contract (HHSN272200800013C) from the National Institute of Allergy and Infectious Diseases for data management and statistical support; by grants from the U.S. Agency for International Development and the Military Infectious Diseases Research Program, Fort Detrick, MD, for vaccine production and laboratory assays; and by the Doris Duke Charitable Foundation Distinguished Clinical Scientist Award and an award from the Howard Hughes Medical Institute (to Dr. Plowe). The funder provided support in the form of salaries for authors [ML, DC, BK, ID, AN, WCB, OD, CP, MT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki S, 2002, J BIOL CHEM, V277, P47533, DOI 10.1074/jbc.M207145200; Bejon P, 2011, J INFECT DIS, V204, P9, DOI 10.1093/infdis/jir222; Bergmann-Leitner ES, 2006, AM J TROP MED HYG, V75, P437, DOI 10.4269/ajtmh.2006.75.437; Bergmann-Leitner ES, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-129; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Chuang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055571; Crompton PD, 2010, INFECT IMMUN, V78, P737, DOI 10.1128/IAI.00960-09; Dent AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003557; Duncan EH, 2015, METHODS MOL BIOL, V1325, P153, DOI 10.1007/978-1-4939-2815-6_13; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Greenhouse B, 2011, J INFECT DIS, V204, P19, DOI 10.1093/infdis/jir223; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; McCallum FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003571; Miura K, 2009, CLIN VACCINE IMMUNOL, V16, P963, DOI 10.1128/CVI.00042-09; Mullen GED, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002940; Oeuvray C, 2000, INFECT IMMUN, V68, P2617, DOI 10.1128/IAI.68.5.2617-2620.2000; OEUVRAY C, 1994, BLOOD, V84, P1594; Ouattara A, 2013, J INFECT DIS, V207, P511, DOI 10.1093/infdis/jis709; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Schwenk R, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-376; Shi YP, 1999, AM J TROP MED HYG, V60, P135, DOI 10.4269/ajtmh.1999.60.135; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257; Theisen M, 1998, INFECT IMMUN, V66, P11, DOI 10.1128/IAI.66.1.11-17.1998; Thera MA, 2010, AM J TROP MED HYG, V85, P354; Thera MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001465; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115	29	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2017	12	3							e0173294	10.1371/journal.pone.0173294	http://dx.doi.org/10.1371/journal.pone.0173294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6CJ	28282396	Green Submitted, Green Published, gold			2022-12-27	WOS:000396091800027
J	Blundell, KLIM; Pal, M; Roe, SM; Pearl, LH; Prodromou, C				Blundell, Katie L. I. M.; Pal, Mohinder; Roe, S. Mark; Pearl, Laurence H.; Prodromou, Chrisostomos			The structure of FKBP38 in complex with the MEEVD tetratricopeptide binding-motif of Hsp90	PLOS ONE			English	Article							ATPASE ACTIVITY; PROTEIN; BCL-2; DIMERIZATION; RECOGNITION; INHIBITOR; APOPTOSIS; INTERACTS; DOMAIN; NS5A	Tetratricopeptide (TPR) domains are known protein interaction domains. We show that the TPR domain of FKBP8 selectively binds Hsp90, and interactions upstream of the conserved MEEVD motif are critical for tight binding. In contrast FKBP8 failed to bind intact Hsp70. The PPIase domain was not essential for the interaction with Hsp90 and binding was completely encompassed by the TPR domain alone. The conformation adopted by Hsp90 peptides, containing the conserved MEEVD motif, in the crystal structure were similar to that seen for the TPR domains of CHIP, AIP and Tah1. The carboxylate clamp interactions with bound Hsp90 peptide were a critical component of the interaction and mutation of Lys 307, involved in the carboxylate clamp, completely disrupted the interaction with Hsp90. FKBP8 binding to Hsp90 did not substantially influence its ATPase activity.	[Blundell, Katie L. I. M.; Pal, Mohinder; Roe, S. Mark; Pearl, Laurence H.; Prodromou, Chrisostomos] Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Prodromou, C (corresponding author), Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	chris.prodromou@sussex.ac.uk	Prodromou, Chrisostomos/ABA-9133-2021	Prodromou, Chrisostomos/0000-0003-4320-1147; Pal, Mohinder/0000-0002-8025-0119; Roe, Mark/0000-0002-7371-9855	Wellcome Trust [095605/Z11/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust, 095605/Z11/Z (https://wellcome.ac.uk).; We thank the Wellcome Trust for their financial support (095605/Z11/Z) and Diamond Light Source for access to beamline 104_1 (MX10088) that contributed to the results presented here.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Bricogne G, BUSTER TNT 2 10 2; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, DOI [10.1038/sj.emboj.7600739, DOI 10.1038/SJ.EMBOJ.7600739]; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erdmann F, 2007, FEBS LETT, V581, P5709, DOI 10.1016/j.febslet.2007.11.037; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; LAM E, 1995, GENE, V160, P297, DOI 10.1016/0378-1119(95)00216-S; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Liang J, 1999, ACTA CRYSTALLOGR D, V55, P736, DOI 10.1107/S0907444998014747; Maestre-Martinez M, 2006, J BIOMOL NMR, V34, P197, DOI 10.1007/s10858-006-0018-6; Maestre-Martinez M, 2010, BIOL CHEM, V391, P1157, DOI 10.1515/BC.2010.122; Morgan RML, 2015, ACTA CRYSTALLOGR D, V71, P1197, DOI 10.1107/S1399004715004551; Morgan RML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053339; Nielsen JV, 2004, GENOMICS, V83, P181, DOI 10.1016/j.ygeno.2003.07.001; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 2016, BIOCHEM J, V473, P2439, DOI 10.1042/BCJ20160005; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Sauter NK, 2004, J APPL CRYSTALLOGR, V37, P399, DOI 10.1107/S0021889804005874; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Schrodinger L., PYMOL MOL GRAPHICS S; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; SIEKIERKA JJ, 1989, J IMMUNOL, V143, P1580; Taguwa S, 2008, J VIROL, V82, P2631, DOI 10.1128/JVI.02153-07; Taguwa S, 2009, J VIROL, V83, P10427, DOI 10.1128/JVI.01035-09; Tong MM, 2016, CURR MOL PHARMACOL, V9, P48, DOI 10.2174/1874467208666150519113541; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wallace AC, 1996, BIOCHEM SOC T, V24, P280, DOI 10.1042/bst0240280; Wang JD, 2006, FEBS LETT, V580, P4392, DOI 10.1016/j.febslet.2006.07.002; WILSON KP, 1995, ACTA CRYSTALLOGR D, V51, P511, DOI 10.1107/S0907444994014514; Wu BL, 2004, P NATL ACAD SCI USA, V101, P8348, DOI 10.1073/pnas.0305969101; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	46	18	19	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173543	10.1371/journal.pone.0173543	http://dx.doi.org/10.1371/journal.pone.0173543			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278223	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000396087900010
J	Cockrell, DC; Long, CM; Robertson, SJ; Shannon, JG; Miller, HE; Myers, L; Larson, CL; Starr, T; Beare, PA; Heinzen, RA				Cockrell, Diane C.; Long, Carrie M.; Robertson, Shelly J.; Shannon, Jeffrey G.; Miller, Heather E.; Myers, Lara; Larson, Charles L.; Starr, Tregei; Beare, Paul A.; Heinzen, Robert A.			Robust growth of avirulent phase II Coxiella burnetii in bone marrow-derived murine macrophages	PLOS ONE			English	Article							PARASITOPHOROUS VACUOLE MATURATION; Q-FEVER; IN-VITRO; ALVEOLAR MACROPHAGES; NATURAL-RESISTANCE; EFFECTOR PROTEINS; MOUSE MACROPHAGES; HOST-CELL; INFECTION; LIPOPOLYSACCHARIDE	Published data show that murine bone marrow-derived macrophages (BMDM) restrict growth of avirulent phase II, but not virulent phase I, Coxiella burnetii. Growth restriction of phase II bacteria is thought to result from potentiated recognition of pathogen-associated molecular patterns, which leads to production of inhibitory effector molecules. Past studies have used conditioned medium from L-929 murine fibroblasts as a source of macrophagecolony stimulating factor (M-CSF) to promote differentiation of bone marrow-derived myeloid precursors into macrophages. However, uncharacterized components of conditioned medium, such as variable amounts of type I interferons, can affect macrophage activation status and their permissiveness for infection. In the current study, we show that the C. burnetii Nine Mile phase II (NMII) strain grows robustly in primary macrophages from C57BL/6J mice when bone marrow cells are differentiated with recombinant murine M-CSF (rmMCSF). Bacteria were readily internalized by BMDM, and replicated within degradative, LAMP1-positive vacuoles to achieve roughly 3 logs of growth over 6 days. Uninfected BMDM did not appreciably express CD38 or Egr2, markers of classically (M1) and alternatively (M2) activated macrophages, respectively, nor did infection change the lack of polarization. In accordance with an M0 phenotype, infected BMDM produced moderate amounts of TNF and nitric oxide. Similar NMII growth results were obtained using C57BL/6J myeloid progenitors immortalized with an estrogen-regulated Hoxb8 (ER-Hoxb8) oncogene. To demonstrate the utility of the ER-Hoxb8 system, myeloid progenitors from natural resistance-associated macrophage protein 1 (Nramp1) C57BL/6J knock-in mice were transduced with ER-Hoxb8, and macrophages were derived from immortalized progenitors using rmM-CSF and infected with NMII. No difference in growth was observed when compared to macrophages from wild type mice, indicating depletion of metal ions by the Nramp1 transporter does not negatively impact NMII growth. Results with NMII were recapitulated in primary macrophages where C57BL/6J Nramp1+ BMDM efficiently killed Salmonella enterica serovar Typhimurium. M-CSF differentiated murine macrophages from bone marrow and conditional ER-Hoxb8 myeloid progenitors will be useful ex vivo models for studying Coxiella-macrophage interactions.	[Cockrell, Diane C.; Long, Carrie M.; Miller, Heather E.; Larson, Charles L.; Beare, Paul A.; Heinzen, Robert A.] NIAID, Coxiella Pathogenesis Sect, Bacteriol Lab, Rocky Mt Labs,NIH, Hamilton, MT USA; [Robertson, Shelly J.] NIAID, Innate Immun & Pathogenesis Unit, Virol Lab, Rocky Mt Labs,NIH, Hamilton, MT USA; [Shannon, Jeffrey G.] NIAID, Plague Sect, Lab Zoonot Pathogens, Rocky Mt Labs,NIH, Hamilton, MT USA; [Myers, Lara] NIAID, Retroviral Immunol Sect, Persistent Viral Dis Lab, Rocky Mt Labs,NIH, Hamilton, MT USA; [Starr, Tregei] NIAID, Salmonella Host Cell Interact Sect, Bacteriol Lab, Rocky Mt Labs,NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Heinzen, RA (corresponding author), NIAID, Coxiella Pathogenesis Sect, Bacteriol Lab, Rocky Mt Labs,NIH, Hamilton, MT USA.	rheinzen@niaid.nih.gov	Long, Carrie Mae/U-2169-2019	Long, Carrie Mae/0000-0001-5030-975X	National Institute of Allergy and Infectious Diseases, National Institutes of Health [1 Z1A A100931]; Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000931] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health (grant number 1 Z1A A100931).; This work was supported by funding from the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases (RAH)	Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Appelberg R, 2006, J LEUKOCYTE BIOL, V79, P1117, DOI 10.1189/jlb.0206079; Barry AO, 2012, CELL HOST MICROBE, V12, P751, DOI 10.1016/j.chom.2012.10.015; Battisti JM, 2011, MICROBIOL-SGM, V157, P966, DOI 10.1099/mic.0.046649-0; Beare PA, 2006, J BACTERIOL, V188, P2309, DOI 10.1128/JB.188.7.2309-2324.2006; Beare PA, 2014, J BACTERIOL, V196, P1925, DOI 10.1128/JB.01532-14; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bradley WP, 2016, INFECT IMMUN, V84, P998, DOI 10.1128/IAI.01536-15; Briggs HL, 2008, INFECT IMMUN, V76, P2189, DOI 10.1128/IAI.01609-07; Brown DE, 2013, VET PATHOL, V50, P867, DOI 10.1177/0300985813478213; Chow SH, 2016, CELL MICROBIOL, V18, P466, DOI 10.1111/cmi.12573; Coleman SA, 2004, J BACTERIOL, V186, P7344, DOI 10.1128/JB.186.21.7344-7352.2004; Crane DD, 2013, CLIN VACCINE IMMUNOL, V20, P1531, DOI 10.1128/CVI.00319-13; Cunha LD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10205; Diacovich L, 2010, NAT REV MICROBIOL, V8, P117, DOI 10.1038/nrmicro2295; Fernandes TD, 2016, INFECT IMMUN, V84, P2439, DOI 10.1128/IAI.00411-16; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Ghigo E, 2012, ADV EXP MED BIOL, V984, P141, DOI 10.1007/978-94-007-4315-1_8; Goncalves R, 2015, CURR PROTOC IMMUN, V111; Govoni G, 1999, INFECT IMMUN, V67, P2225, DOI 10.1128/IAI.67.5.2225-2232.1999; Govoni G, 1996, INFECT IMMUN, V64, P2923, DOI 10.1128/IAI.64.8.2923-2929.1996; Graham JG, 2013, CELL MICROBIOL, V15, P1012, DOI 10.1111/cmi.12096; HACKSTADT T, 1985, INFECT IMMUN, V48, P359, DOI 10.1128/IAI.48.2.359-365.1985; HACKSTADT T, 1981, P NATL ACAD SCI-BIOL, V78, P3240, DOI 10.1073/pnas.78.5.3240; HACKSTADT T, 1988, INFECT IMMUN, V56, P802, DOI 10.1128/IAI.56.4.802-807.1988; Helbig KJ, 2003, GENES IMMUN, V4, P82, DOI 10.1038/sj.gene.6363912; Howe D, 2002, INFECT IMMUN, V70, P5140, DOI 10.1128/IAI.70.9.5140-5147.2002; Howe D, 2010, INFECT IMMUN, V78, P3465, DOI 10.1128/IAI.00406-10; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Klingenbeck L, 2013, CELL MICROBIOL, V15, P675, DOI 10.1111/cmi.12066; Larson CL, 2016, FUTURE MICROBIOL, V11, P919, DOI 10.2217/fmb-2016-0044; Larson CL, 2015, INFECT IMMUN, V83, P661, DOI 10.1128/IAI.02763-14; Lathrop SK, 2015, INFECT IMMUN, V83, P2661, DOI 10.1128/IAI.00033-15; Lee CM, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-30; Loomis WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111763; Luhrmann A, 2010, P NATL ACAD SCI USA, V107, P18997, DOI 10.1073/pnas.1004380107; Martinez E, 2016, P NATL ACAD SCI USA, V113, pE3260, DOI 10.1073/pnas.1522811113; Mekada K, 2009, EXP ANIM TOKYO, V58, P141, DOI 10.1538/expanim.58.141; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Newton HJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004286; Newton HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054566; Ochoa-Reparaz J, 2007, INFECT IMMUN, V75, P5845, DOI 10.1128/IAI.00901-07; Omsland A, 2011, APPL ENVIRON MICROB, V77, P3720, DOI 10.1128/AEM.02826-10; Price JV, 2014, IMMUNITY, V41, P685, DOI 10.1016/j.immuni.2014.10.015; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Rosas M, 2011, EUR J IMMUNOL, V41, P356, DOI 10.1002/eji.201040962; Sauer JD, 2005, INFECT IMMUN, V73, P4494, DOI 10.1128/IAI.73.8.4494-4504.2005; SCOTT GH, 1987, J GEN MICROBIOL, V133, P691; Shannon JG, 2005, ANN NY ACAD SCI, V1063, P154, DOI 10.1196/annals.1355.024; Shannon JG, 2009, IMMUNOL RES, V43, P138, DOI 10.1007/s12026-008-8059-4; Shannon JG, 2005, P NATL ACAD SCI USA, V102, P8722, DOI 10.1073/pnas.0501863102; Stein A, 2005, INFECT IMMUN, V73, P2469, DOI 10.1128/IAI.73.4.2469-2477.2005; Swanson MS, 2006, J IMMUNOL, V177, P4945, DOI 10.4049/jimmunol.177.8.4945; TIGERTT WD, 1961, BACTERIOL REV, V25, P285, DOI 10.1128/MMBR.25.3.285-293.1961; Toman R, 1996, CARBOHYD RES, V283, P175, DOI 10.1016/0008-6215(96)87610-5; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; WARREN MK, 1985, J IMMUNOL, V134, P982; Wessling-Resnick M, 2015, J BIOL CHEM, V290, P18984, DOI 10.1074/jbc.R115.643973; Winchell CG, 2014, INFECT IMMUN, V82, P2229, DOI 10.1128/IAI.01236-13; Zamboni DS, 2004, J BIOL CHEM, V279, P54405, DOI 10.1074/jbc.M410340200; Zamboni DS, 2004, INFECT IMMUN, V72, P2395, DOI 10.1128/IAI.72.4.2395-2399.2004; Zamboni DS, 2004, INFECT IMMUN, V72, P2075, DOI 10.1128/IAI.72.4.2075-2080.2004; Zamboni DS, 2003, INFECT IMMUN, V71, P1225, DOI 10.1128/IAI.71.3.1225-1233.2003	67	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173528	10.1371/journal.pone.0173528	http://dx.doi.org/10.1371/journal.pone.0173528			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278296	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900007
J	Dungan, JA; Chakroff, A; Young, L				Dungan, James A.; Chakroff, Alek; Young, Liane			The relevance of moral norms in distinct relational contexts: Purity versus harm norms regulate self-directed actions	PLOS ONE			English	Article							DISGUST; ROLES; ANGER; AVOIDANCE; EVOLUTION; ATTITUDES; ALTRUISM; EMOTIONS; LIBERALS; JUDGMENT	Recent efforts to partition the space of morality have focused on the descriptive content of distinct moral domains (e.g., harm versus purity), or alternatively, the relationship between the perpetrator and victim of moral violations. Across three studies, we demonstrate that harm and purity norms are relevant in distinct relational contexts. Moral judgments of purity violations, compared to harm violations, are relatively more sensitive to the negative impact perpetrators have on themselves versus other victims (Study 1). This pattern replicates across a wide array of harm and purity violations varying in severity (Studies 2 and 3). Moreover, while perceptions of harm predict moral judgment consistently across relational contexts, perceptions of purity predict moral judgment more for self-directed actions, where perpetrators violate themselves, compared to dyadic actions, where perpetrators violate other victims (Study 3). Together, these studies reveal how an action's content and its relational context interact to influence moral judgment, providing novel insights into the adaptive functions of harm and purity norms.	[Dungan, James A.; Chakroff, Alek; Young, Liane] Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA	Boston College	Dungan, JA (corresponding author), Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA.	james.dungan@bc.edu			National Science Foundation [1258923]; John Templeton Foundation; Alfred P. Sloan Foundation [BR2012]	National Science Foundation(National Science Foundation (NSF)); John Templeton Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This research was supported by a National Science Foundation Graduate Research Fellowship (grant #1258923) awarded to J.A.D. and grants from the John Templeton Foundation and the Alfred P. Sloan Foundation (grant #BR2012) awarded to L.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appiah K., 2006, COSMOPOLITANISM ETHI; Atran Scott, 2010, Biology Theory, V5, P18, DOI 10.1162/BIOT_a_00018; Barrett HC, 2016, P NATL ACAD SCI USA, V113, P4688, DOI 10.1073/pnas.1522070113; Buchtel EE, 2015, PERS SOC PSYCHOL B, V41, P1382, DOI 10.1177/0146167215595606; Buck DM, 2013, J PERS SOC PSYCHOL, V105, P941, DOI 10.1037/a0034145; Chakroff A, 2016, SOC COGN AFFECT NEUR, V11, P476, DOI 10.1093/scan/nsv131; Chakroff A, 2015, COGNITION, V136, P30, DOI 10.1016/j.cognition.2014.11.034; Chakroff A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074434; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Chapman HA, 2013, PSYCHOL BULL, V139, P300, DOI 10.1037/a0030964; Crockett MJ, 2014, P NATL ACAD SCI USA, V111, P17320, DOI 10.1073/pnas.1408988111; Cushman F, 2008, COGNITION, V108, P353, DOI 10.1016/j.cognition.2008.03.006; Danovitch J, 2009, EMOTION, V9, P107, DOI 10.1037/a0014113; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety J, 2011, ANN NY ACAD SCI, V1231, P35, DOI 10.1111/j.1749-6632.2011.06027.x; Dehghani M, 2016, J EXP PSYCHOL GEN, V145, P366, DOI 10.1037/xge0000139; DeScioli P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046963; DeScioli P, 2011, PSYCHOL SCI, V22, P442, DOI 10.1177/0956797611400616; DeScioli P, 2009, COGNITION, V112, P281, DOI 10.1016/j.cognition.2009.05.008; Dungan J., 2012, COMPANION MORAL ANTH, V32, P578; Dungan J., 2015, EMERGING TRENDS SOCI; Fessler DMT, 2004, EVOL HUM BEHAV, V25, P277, DOI 10.1016/j.evolhumbehav.2004.05.004; Fiske AP, 1997, POLIT PSYCHOL, V18, P255, DOI 10.1111/0162-895X.00058; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graham J, 2013, ADV EXP SOC PSYCHOL, V47, P55, DOI 10.1016/B978-0-12-407236-7.00002-4; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Gray K., 2012, SOCIAL PSYCHOL MORAL, P109; Gray K, 2014, J EXP PSYCHOL GEN, V143, P1600, DOI 10.1037/a0036149; Gray K, 2012, PSYCHOL INQ, V23, P101, DOI 10.1080/1047840X.2012.651387; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haidt J, 1996, EUR J SOC PSYCHOL, V26, P201, DOI 10.1002/(SICI)1099-0992(199603)26:2<201::AID-EJSP745>3.0.CO;2-J; HAIDT J, 1993, J PERS SOC PSYCHOL, V65, P613, DOI 10.1037/0022-3514.65.4.613; Haidt Jonathan., 2007, INNATE MIND, V3, P367, DOI DOI 10.1093/ACPROF:OSO/9780195332834.001.0001; Helzer EG, ATLAS MORAL IN PRESS; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Inbar Y, 2009, EMOTION, V9, P435, DOI 10.1037/a0015960; Koleva SP, 2012, J RES PERS, V46, P184, DOI 10.1016/j.jrp.2012.01.006; Kurzban R, 2012, EVOL HUM BEHAV, V33, P323, DOI 10.1016/j.evolhumbehav.2011.11.002; Mikhail J, 2007, TRENDS COGN SCI, V11, P143, DOI 10.1016/j.tics.2006.12.007; Park JH, 2003, J NONVERBAL BEHAV, V27, P65, DOI 10.1023/A:1023910408854; Piazza J, 2013, COGNITION EMOTION, V27, P707, DOI 10.1080/02699931.2012.736859; Rai TS, 2011, PSYCHOL REV, V118, P57, DOI 10.1037/a0021867; Rottman J, 2014, COGNITION, V130, P217, DOI 10.1016/j.cognition.2013.11.007; Rozin P, 1999, J PERS SOC PSYCHOL, V76, P574, DOI 10.1037/0022-3514.76.4.574; Rozin P, 2008, HDB EMOTIONS, P637; Rozin P, 2009, SCIENCE, V323, P1179, DOI 10.1126/science.1170492; Russell PS, 2013, PSYCHOL BULL, V139, P328, DOI 10.1037/a0029319; Russell PS, 2011, EMOTION, V11, P233, DOI 10.1037/a0022598; Russell PS, 2011, SOC PSYCHOL PERS SCI, V2, P360, DOI 10.1177/1948550610391678; Schaller M, 2011, CURR DIR PSYCHOL SCI, V20, P99, DOI 10.1177/0963721411402596; Schein C, 2015, PERS SOC PSYCHOL B, V41, P1147, DOI 10.1177/0146167215591501; Shweder R.A., 1987, EMERGENCE MORALITY Y, P1, DOI DOI 10.1017/CBO9781139173728.005; Sosis R, 2003, CROSS-CULT RES, V37, P211, DOI 10.1177/1069397103037002003; Tannenbaum D, 2011, J EXP SOC PSYCHOL, V47, P1249, DOI 10.1016/j.jesp.2011.05.010; Tybur JM, 2013, PSYCHOL REV, V120, P65, DOI 10.1037/a0030778; Tybur JM, 2009, J PERS SOC PSYCHOL, V97, P103, DOI 10.1037/a0015474; Uhlmann EL, 2015, PERSPECT PSYCHOL SCI, V10, P72, DOI 10.1177/1745691614556679; Uhlmann EL, 2014, SOC PSYCHOL PERS SCI, V5, P279, DOI 10.1177/1948550613497238; van Leeuwen F, 2012, EVOL HUM BEHAV, V33, P429, DOI 10.1016/j.evolhumbehav.2011.12.005; Vauclair CM, 2011, EUR J SOC PSYCHOL, V41, P645, DOI 10.1002/ejsp.794; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Waytz A, 2013, J EXP SOC PSYCHOL, V49, P1027, DOI 10.1016/j.jesp.2013.07.002; Waytz A, 2010, J PERS SOC PSYCHOL, V99, P410, DOI 10.1037/a0020240; Young L, 2013, SOC PERSONAL PSYCHOL, V7, P585, DOI 10.1111/spc3.12044; Young L, 2011, COGNITION, V120, P202, DOI 10.1016/j.cognition.2011.04.005	65	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173405	10.1371/journal.pone.0173405	http://dx.doi.org/10.1371/journal.pone.0173405			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278214	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900087
J	Fagbamila, IO; Barco, L; Mancin, M; Kwaga, J; Ngulukun, SS; Zavagnin, P; Lettini, AA; Lorenzetto, M; Abdu, PA; Kabir, J; Umoh, J; Ricci, A; Muhammad, M				Fagbamila, Idowu Oluwabunmi; Barco, Lisa; Mancin, Marzia; Kwaga, Jacob; Ngulukun, Sati Samuel; Zavagnin, Paola; Lettini, Antonia Anna; Lorenzetto, Monica; Abdu, Paul Ayuba; Kabir, Junaidu; Umoh, Jarlath; Ricci, Antonia; Muhammad, Maryam			Salmonella serovars and their distribution in Nigerian commercial chicken layer farms	PLOS ONE			English	Article							FOOD-PRODUCING ANIMALS; POULTRY; ENTERICA; RESISTANT; SURVEILLANCE; ENVIRONMENT; INFECTIONS	Commercial poultry farms (n degrees 523), located in all the six regions of Nigeria were sampled with a view to generate baseline information about the distribution of Salmonella serovars in this country. Five different matrices (litter, dust, faeces, feed and water) were collected from each visited farm. Salmonella was isolated from at least one of the five matrices in 228 farms, with a farm prevalence of 43.6% (CI95[39.7-48.3%]). Altogether, 370 of 2615 samples collected (14.1%, CI95[12.8; 15.5%]) contained Salmonella. Considering the number of positive farms and the number of positive samples, it was evident that for the majority of the sampled farms, few samples were positive for Salmonella. With regard to the matrices, there was no difference in Salmonella prevalence among the five matrices considered. Of the 370 isolates serotyped, eighty-two different serotypes were identified and Salmonella Kentucky was identified as having the highest isolation rate in all the matrices sampled (16.2%), followed by S. Poona and S. Elisabethville. S. Kentucky was distributed across the country, whereas the other less frequent serovars had a more circumscribed diffusion. This is one of few comprehensive studies on the occurrence and distribution of Salmonella in commercial chicken layer farms from all the six regions of Nigeria. The relatively high prevalence rate documented in this study may be attributed to the generally poor infrastructure and low biosecurity measures in controlling stray animals, rodents and humans. Data collected could be valuable for instituting effective intervention strategies for Salmonella control in Nigeria and also in other developing countries with a similar poultry industry structure, with the final aim of reducing Salmonella spread in animals and ultimately in humans.	[Fagbamila, Idowu Oluwabunmi; Ngulukun, Sati Samuel; Muhammad, Maryam] Natl Inst Vet Res, Bacterial Res Div, Vom, Plateau State, Nigeria; [Barco, Lisa; Mancin, Marzia; Zavagnin, Paola; Lettini, Antonia Anna; Lorenzetto, Monica; Ricci, Antonia] Inst Zooprofilatt Sperimentale Venezie, Reference Lab Salmonella, Padua, Italy; [Kwaga, Jacob; Kabir, Junaidu; Umoh, Jarlath] Ahmadu Bello Univ, Dept Vet Publ Hlth & Prevent Med, Zaria, Nigeria; [Abdu, Paul Ayuba] Ahmadu Bello Univ, Fac Vet Med, Dept Med, Zaria, Nigeria	IZS delle Venezie; Ahmadu Bello University; Ahmadu Bello University	Barco, L (corresponding author), Inst Zooprofilatt Sperimentale Venezie, Reference Lab Salmonella, Padua, Italy.	lbarco@izsvenezie.it	Fagbamila, Idowu Oluwabunmi/GWZ-9428-2022; Ricci, Antonia/AAA-9473-2019; Barco, Lisa/K-2284-2016	Ricci, Antonia/0000-0002-4774-9655; mancin, marzia/0000-0002-7260-6031; Barco, Lisa/0000-0002-6247-248X; Lettini, Antonia Anna/0000-0001-9644-5992; Fagbamila, Idowu Oluwabunmi/0000-0002-7483-5284; , Monica/0000-0003-4729-0300	Federal Government of Nigeria through the Competitive Agriculture Research Grant Scheme (CARGS) [24]; International Centre for Genetic Engineering and Biotechnology (ICGEB) SMART fellowship [S/NIG 14-02]	Federal Government of Nigeria through the Competitive Agriculture Research Grant Scheme (CARGS); International Centre for Genetic Engineering and Biotechnology (ICGEB) SMART fellowship	The Federal Government of Nigeria through the Competitive Agriculture Research Grant Scheme (CARGS) funded the investigation (Sampling, Culture and isolation) (Grant Number: CARGS/RFA 2 No. 24). International Centre for Genetic Engineering and Biotechnology (ICGEB) SMART fellowship (Fellowship Reference Number: S/NIG 14-02).	AHO M, 1992, INT J FOOD MICROBIOL, V15, P225, DOI 10.1016/0168-1605(92)90053-6; Andoh LA, 2016, EPIDEMIOL INFECT, P1; Antunes P, 2011, J ANTIMICROB CHEMOTH, V66, P2028, DOI 10.1093/jac/dkr228; Ao TT, 2015, EMERG INFECT DIS; Barbour EK, 2015, J INFECT DEV COUNTR, V9, P1, DOI 10.3855/jidc.5065; Barua H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035914; Bettridge JM, 2014, PREV VET MED, V117, P358, DOI 10.1016/j.prevetmed.2014.07.002; Carrique-Mas JJ, 2008, LETT APPL MICROBIOL, V47, P514, DOI 10.1111/j.1472-765X.2008.02450.x; Carrique-Mas JJ, 2009, EPIDEMIOL INFECT, V137, P837, DOI 10.1017/S0950268808001568; Castillo A, 2004, J FOOD PROTECT, V67, P713, DOI 10.4315/0362-028X-67.4.713; Davies RH, 1996, VET MICROBIOL, V50, P117, DOI 10.1016/0378-1135(96)00031-4; Dione MM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001148; EFSA, 2007, EFSA J, V97; EFSA, EFSA J; European Centre for Disease Prevention and Control, 2013, ANS, P103; Folorunso O R, 2014, Pak J Biol Sci, V17, P74, DOI 10.3923/pjbs.2014.74.79; Food and Agricultural Organization (FAO), 2008, ASSESSMENT OF THE NI; Food and Agricultural Organization (FAO), 2006, THE STRUCTURE AND IM; Food and Agricultural Organization (FAO), 2015, DATA SOURCE 2015 FAO; Freitas N.O.C., 2010, J POULT SCI, V12, P1; Gast RK, 2007, AVIAN DIS, V51, P817, DOI 10.1637/8090-081807.1; Grimont PAD, 2007, ANTIGENIC FORMULAE O; Humphrey T, 2006, BRIT POULTRY SCI, V47, P379, DOI 10.1080/00071660600829084; Idowu F., 2010, International Journal of Poultry Science, V9, P959; International Organization for Standardization (ISO), ISO 6579 2002 FDAMD; Ishihara K, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-35; Issenhuth-Jeanjean S, 2014, RES MICROBIOL, V165, P526, DOI DOI 10.1018/L/533552014/07.004; Jones FT, 2004, POULTRY SCI, V83, P384, DOI 10.1093/ps/83.3.384; Kagambega A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-253; Kuroki T, 2015, JPN J INFECT DIS, V68, P333, DOI 10.7883/yoken.JJID.2014.490; Le Hello S, 2013, LANCET INFECT DIS, V13, P672, DOI 10.1016/S1473-3099(13)70124-5; Le Hello S, 2011, J INFECT DIS, V204, P675, DOI 10.1093/infdis/jir409; Lettini AA, 2015, ZOONOSES AND PUBLIC; Magwedere K, 2015, CLIN INFECT DIS, V61, pS283, DOI 10.1093/cid/civ663; Mamman P.H., 2014, INT J PUBLIC HLTH EP, V3, P82; MBUKO IJ, 2009, J BACTERIOLOGY RES, V1, P1; Molbak K, 2015, FOODBORNE INFECTIONS, P57; Muhammad M., 2009, International Journal of Poultry Science, V8, P656; Muhammad M, 2010, VET MICROBIOL, V140, P131, DOI 10.1016/j.vetmic.2009.07.009; Ogunleye AO, 2012, J INFECT DEV COUNTR, V6, P483, DOI 10.3855/jidc.1988; Onunkwo O., 1978, Kenya Veterinarian, V2, P33; Orji MU, 2005, INT J INFECT DIS, V9, P86, DOI 10.1016/j.ijid.2004.04.016; Osiyemi T I, 1976, Bull Anim Health Prod Afr, V24, P261; Raufu I, 2013, J APPL MICROBIOL, V115, P1059, DOI 10.1111/jam.12304; Sanchez S, 2002, J AM VET MED ASSOC, V221, P492, DOI 10.2460/javma.2002.221.492; Smith S, 2016, EUR J CLIN MICROBIOL, V35, P1913, DOI 10.1007/s10096-016-2760-3; Tabo JA, 2013, VET MICROBIOL, V166, P293, DOI 10.1016/j.vetmic.2013.05.010; Thrusfield M, 2007, VETERINARY EPIDEMIOL; Useh NM, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00315-16; Wales A, 2007, AVIAN PATHOL, V36, P187, DOI 10.1080/03079450701338755; Walters MS, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1735	51	37	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173097	10.1371/journal.pone.0173097	http://dx.doi.org/10.1371/journal.pone.0173097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278292	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900046
J	Fajardo, VA; Gamu, D; Mitchell, A; Bloemberg, D; Bombardier, E; Chambers, PJ; Bellissimo, C; Quadrilatero, J; Tupling, AR				Fajardo, Val A.; Gamu, Daniel; Mitchell, Andrew; Bloemberg, Darin; Bombardier, Eric; Chambers, Paige J.; Bellissimo, Catherine; Quadrilatero, Joe; Tupling, A. Russell			Sarcolipin deletion exacerbates soleus muscle atrophy and weakness in phospholamban overexpressing mice	PLOS ONE			English	Article							CALCINEURIN-A-ALPHA; HEAVY-CHAIN GENE; SARCO(ENDO)PLASMIC RETICULUM CA2+-ATPASES; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; CENTRONUCLEAR MYOPATHY; IN-VIVO; NFATC2-DEPENDENT PATHWAY; CONTRACTILE FUNCTION; CRUCIAL REGULATOR	Sarcolipin (SLN) and phospholamban (PLN) are two small proteins that regulate the sarco (endo)plasmic reticulum Ca2+-ATPase pumps. In a recent study, we discovered that Pln overexpression (Pln(OE)) in slow-twitch type I skeletal muscle fibers drastically impaired SERCA function and caused a centronuclear myopathy-like phenotype, severe muscle atrophy and weakness, and an 8 to 9-fold upregulation of SLN protein in the soleus muscles. Here, we sought to determine the physiological role of SLN upregulation, and based on its role as a SERCA inhibitor, we hypothesized that it would represent a maladaptive response that contributes to the SERCA dysfunction and the overall myopathy observed in the Pln(OE) mice. To this end, we crossed Sln-null (Sln(KO) mice with Pln(OE) mice to generate a Pln(OE)/Sln(KO) mouse colony and assessed SERCA function, CNM pathology, in vitro contractility, muscle mass, calcineurin signaling, daily activity and food intake, and proteolytic enzyme activity. Our results indicate that genetic deletion of Sin did not improve SERCA function nor rescue the CNM phenotype, but did result in exacerbated muscle atrophy and weakness, due to a failure to induce type II fiber compensatory hypertrophy and a reduction in total myofiber count. Mechanistically, our findings suggest that impaired calcineurin activation and resultant decreased expression of stabilin-2, and/or impaired autophagic signaling could be involved. Future studies should examine these possibilities. In conclusion, our study demonstrates the importance of SLN upregulation in combating muscle myopathy in the Pln(OE) mice, and since SLN is upregulated across several myopathies, our findings may reveal SLN as a novel and universal therapeutic target.	[Fajardo, Val A.; Gamu, Daniel; Mitchell, Andrew; Bloemberg, Darin; Bombardier, Eric; Chambers, Paige J.; Bellissimo, Catherine; Quadrilatero, Joe; Tupling, A. Russell] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Tupling, AR (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada.	rtupling@uwaterloo.ca			Canadian Institutes of Health Research [MOP 86618, MOP 47296]; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by research grants from the Canadian Institutes of Health Research (MOP 86618 and MOP 47296 to A.R.T). A doctoral award from the Canadian Institutes of Health Research supported V.A.F. and doctoral awards from the Natural Sciences and Engineering Research Council supported A.M. and D.B.	Al-Qusairi L, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-26; Al-Qusairi L, 2009, P NATL ACAD SCI USA, V106, P18763, DOI 10.1073/pnas.0900705106; Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8; Altamirano F, 2012, J BIOL CHEM, V287, P20876, DOI 10.1074/jbc.M112.344929; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bombardier E, 2013, FASEB J, V27, P3871, DOI 10.1096/fj.13-230631; Bombardier E, 2013, FEBS LETT, V587, P1687, DOI 10.1016/j.febslet.2013.04.019; Calvo AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032632; Campanaro S, 2002, HUM MOL GENET, V11, P3283, DOI 10.1093/hmg/11.26.3283; Chakkalakal JV, 2004, HUM MOL GENET, V13, P379, DOI 10.1093/hmg/ddh037; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; Dowling J, 2014, NEUROTHERAPEUTICS, V11, P773, DOI 10.1007/s13311-014-0300-3; Dowling JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000372; Duhamel TA, 2007, J APPL PHYSIOL, V103, P1986, DOI 10.1152/japplphysiol.01440.2006; Dunn SE, 2000, J CELL BIOL, V151, P663, DOI 10.1083/jcb.151.3.663; Dunn SE, 1999, J BIOL CHEM, V274, P21908, DOI 10.1074/jbc.274.31.21908; Fajardo VA, 2015, DIS MODEL MECH, V8, P999, DOI 10.1242/dmm.020859; Fajardo VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084304; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Gamu D, 2014, EXERC SPORT SCI REV, V42, P136, DOI 10.1249/JES.0000000000000016; Gayan-Ramirez G, 2000, J PHYSIOL-LONDON, V524, P387, DOI 10.1111/j.1469-7793.2000.t01-2-00387.x; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Horsley V, 2003, J CELL BIOL, V161, P111, DOI 10.1083/jcb.200208085; Ito N, 2013, NAT MED, V19, P101, DOI 10.1038/nm.3019; Jungbluth H, 2007, NEUROMUSCULAR DISORD, V17, P338, DOI 10.1016/j.nmd.2007.01.016; Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26; KNOTTS S, 1994, J BIOL CHEM, V269, P31275; Liu N, 2011, J CLIN INVEST, V121, P3258, DOI 10.1172/JCI46267; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Maurya SK, 2015, J BIOL CHEM, V290, P10840, DOI 10.1074/jbc.M115.636878; Michel RN, 2004, P NUTR SOC, V63, P341, DOI 10.1079/PNS2004362; Michel RN, 2007, APPL PHYSIOL NUTR ME, V32, P921, DOI 10.1139/H07-093; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P719, DOI 10.1113/jphysiol.2012.243279; Murphy RM, 2006, J PHYSIOL-LONDON, V576, P595, DOI 10.1113/jphysiol.2006.114090; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Nakagawa O, 2005, GENE DEV, V19, P2066, DOI 10.1101/gad.1338705; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; Ottenheijm CAC, 2008, FASEB J, V22, P2912, DOI 10.1096/fj.07-104372; Park SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10871; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Parsons SA, 2003, MOL CELL BIOL, V23, P4331, DOI 10.1128/MCB.23.12.4331-4343.2003; Pauly M, 2012, AM J PATHOL, V181, P583, DOI 10.1016/j.ajpath.2012.04.004; Radley-Crabb Hannah G, 2011, PLoS Curr, V3, pRRN1276, DOI 10.1371/currents.RRN1276; RINDT H, 1993, J BIOL CHEM, V268, P5332; RINDT H, 1995, P NATL ACAD SCI USA, V92, P1540, DOI 10.1073/pnas.92.5.1540; Romero NB, 2010, NEUROMUSCULAR DISORD, V20, P223, DOI 10.1016/j.nmd.2010.01.014; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Sakuma K, 2003, ACTA NEUROPATHOL, V105, P271, DOI 10.1007/s00401-002-0647-0; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Schneider JS, 2013, J MUSCLE RES CELL M, V34, P349, DOI 10.1007/s10974-013-9350-0; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Serrano AL, 2001, P NATL ACAD SCI USA, V98, P13108, DOI 10.1073/pnas.231148598; Shaikh SA, 2016, J MOL CELL CARDIOL, V91, P81, DOI 10.1016/j.yjmcc.2015.12.030; Song QJ, 2004, FASEB J, V18, P974, DOI 10.1096/fj.03-1058fje; Sopariwala DH, 2015, J APPL PHYSIOL, V118, P1050, DOI 10.1152/japplphysiol.01066.2014; St-Pierre SJG, 2004, FASEB J, V18, P1937, DOI 10.1096/fj.04-1859fje; Stupka N, 2008, AM J PHYSIOL-REG I, V294, pR983, DOI 10.1152/ajpregu.00375.2007; Stupka N, 2007, AM J PHYSIOL-REG I, V293, pR686, DOI 10.1152/ajpregu.00612.2006; Stupka N, 2006, NEUROMUSCULAR DISORD, V16, P337, DOI 10.1016/j.nmd.2006.03.003; Tupling AR, 2011, AM J PHYSIOL-CELL PH, V301, pC841, DOI 10.1152/ajpcell.00409.2010; Tupling AR, 2002, J BIOL CHEM, V277, P44740, DOI 10.1074/jbc.M206171200; Tupling R, 2002, J APPL PHYSIOL, V92, P1603, DOI 10.1152/japplphysiol.00756.2001; Wilmshurst JM, 2010, ANN NEUROL, V68, P717, DOI 10.1002/ana.22119; ZUBRZYCKAGAARN E, 1984, J BIOENERG BIOMEMBR, V16, P441, DOI 10.1007/BF00743238	74	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173708	10.1371/journal.pone.0173708	http://dx.doi.org/10.1371/journal.pone.0173708			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278204	Green Submitted, Green Published, gold			2022-12-27	WOS:000396087900031
J	Snell, J; Meeter, M; Grainger, J				Snell, Joshua; Meeter, Martijn; Grainger, Jonathan			Evidence for simultaneous syntactic processing of multiple words during reading	PLOS ONE			English	Article							PARAFOVEAL PREVIEW BENEFIT; EYE-MOVEMENTS; PERCEPTUAL SPAN; MODEL; ATTENTION; FIXATION; CONTEXT; SWIFT	A hotly debated issue in reading research concerns the extent to which readers process parafoveal words, and how parafoveal information might influence foveal word recognition. We investigated syntactic word processing both in sentence reading and in reading isolated foveal words when these were flanked by parafoveal words. In Experiment 1 we found a syntactic parafoveal preview benefit in sentence reading, meaning that fixation durations on target words were decreased when there was a syntactically congruent preview word at the target location (n) during the fixation on the pre-target (n-1). In Experiment 2 we used a flanker paradigm in which participants had to classify foveal target words as either noun or verb, when those targets were flanked by syntactically congruent or incongruent words (stimulus on-time 170 ms). Lower response times and error rates in the congruent condition suggested that higher-order (syntactic) information can be integrated across foveal and parafoveal words. Although higher-order parafoveal-on-foveal effects have been elusive in sentence reading, results from our flanker paradigm show that the reading system can extract higher-order information from multiple words in a single glance. We propose a model of reading to account for the present findings.	[Snell, Joshua; Grainger, Jonathan] Aix Marseille Univ, Marseille, France; [Snell, Joshua] Brain & Language Res Inst, Aix En Provence, France; [Meeter, Martijn] Vrije Univ, Amsterdam, Netherlands; [Grainger, Jonathan] Ctr Natl Rech Sci, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS)	Snell, J (corresponding author), Aix Marseille Univ, Marseille, France.; Snell, J (corresponding author), Brain & Language Res Inst, Aix En Provence, France.	Joshua.snell@hotmail.com	Grainger, Jonathan/C-9299-2009; Meeter, Martijn/A-2926-2009	Meeter, Martijn/0000-0002-5112-6717	French National Research Agency (ANR) [ANR-11-LABX-0036, ANR-15-CE33-0002-01]; personal research fund of Martijn Meeter	French National Research Agency (ANR)(French National Research Agency (ANR)); personal research fund of Martijn Meeter	This research was supported by grants ANR-11-LABX-0036 and ANR-15-CE33-0002-01 from the French National Research Agency (ANR) and the personal research fund of Martijn Meeter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele B, 2013, J EXP PSYCHOL HUMAN, V39, P526, DOI 10.1037/a0029492; Baayen R. H., 2008, ANAL LINGUISTIC DATA, DOI [10.1017/CBO9780511801686, DOI 10.1017/CBO9780511801686]; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bertram Raymond, 2007, P391, DOI 10.1016/B978-008044980-7/50019-7; Boston MF, 2011, LANG COGNITIVE PROC, V26, P301, DOI 10.1080/01690965.2010.492228; Brothers T., 2016, J EXPT PSYC IN PRESS; Dalmaijer ES, 2014, BEHAV RES METHODS, V46, P913, DOI 10.3758/s13428-013-0422-2; Dare N, 2013, Q J EXP PSYCHOL, V66, P487, DOI 10.1080/17470218.2012.703212; Deutsch A, 2005, LANG COGNITIVE PROC, V20, P341, DOI 10.1080/01690960444000115; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; FLOWERS JH, 1982, PERCEPT PSYCHOPHYS, V32, P581, DOI 10.3758/BF03204214; Grabbe JW, 2013, EXP AGING RES, V39, P419, DOI 10.1080/0361073X.2013.808110; Grainger J, 2014, ACTA PSYCHOL, V146, P35, DOI 10.1016/j.actpsy.2013.11.014; Hohenstein S, 2014, J EXP PSYCHOL LEARN, V40, P166, DOI 10.1037/a0033670; Hohenstein S, 2010, J EXP PSYCHOL LEARN, V36, P1150, DOI 10.1037/a0020233; HYONA J, 1995, J EXP PSYCHOL HUMAN, V21, P68, DOI 10.1037/0096-1523.21.1.68; Inhoff A., 2000, READING PERCEPTUAL P; Jordan TR, 2014, PSYCHON B REV, V21, P505, DOI 10.3758/s13423-013-0510-4; Jordan TR, 2002, J EXP PSYCHOL LEARN, V28, P34, DOI 10.1037//0278-7393.28.1.34; Juhasz BJ, 2009, Q J EXP PSYCHOL, V62, P1356, DOI 10.1080/17470210802400010; Keuleers E, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00174; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; MCCONKIE GW, 1975, PERCEPT PSYCHOPHYS, V17, P578, DOI 10.3758/BF03203972; Paterson KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088358; Radach R, 2004, EUR J COGN PSYCHOL, V16, P3, DOI 10.1080/09541440340000295; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1975, COGNITIVE PSYCHOL, V7, P65, DOI 10.1016/0010-0285(75)90005-5; Rayner K, 2014, PSYCHON B REV, V21, P1067, DOI 10.3758/s13423-014-0582-9; Reichle ED, 2006, COGN SYST RES, V7, P4, DOI 10.1016/j.cogsys.2005.07.002; Reingold EM, 2004, J EXP PSYCHOL HUMAN, V30, P194, DOI 10.1037/0096-1523.30.1.194; Risse S, 2014, VIS COGN, V22, P283, DOI 10.1080/13506285.2014.881444; Schotter ER, 2015, J MEM LANG, V83, P118, DOI 10.1016/j.jml.2015.04.005; Schotter ER, 2013, J MEM LANG, V69, P619, DOI 10.1016/j.jml.2013.09.002; Schotter ER, 2012, ATTEN PERCEPT PSYCHO, V74, P5, DOI 10.3758/s13414-011-0219-2; Snell J., 2017, Q J EXPT PSYCHOL; Snell J., LANGUAGE CO IN PRESS; Veldre A, 2015, J EXP PSYCHOL HUMAN, V41, P219, DOI 10.1037/xhp0000017; Vitu F, 2004, EUR J COGN PSYCHOL, V16, P154, DOI 10.1080/09541440340000178; Yan M, 2012, J EXP PSYCHOL LEARN, V38, P1069, DOI 10.1037/a0026935; Yen MH, 2008, MEM COGNITION, V36, P1033, DOI 10.3758/MC.36.5.1033	42	53	54	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173720	10.1371/journal.pone.0173720	http://dx.doi.org/10.1371/journal.pone.0173720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278305	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900033
J	Starke, SD; Baber, C				Starke, Sandra Dorothee; Baber, Chris			Movement consistency during repetitive tool use action	PLOS ONE			English	Article							STEP FREQUENCY; BOUNCING TASK; WALKING SPEED; RESONANCE; MUSCLE; CONSTRAINTS; AFFORDANCES; PERFORMANCE; LOCOMOTION; SELECTION	The consistency and repeatability of movement patterns has been of long-standing interest in locomotor biomechanics, but less well explored in other domains. Tool use is one of such a domain; while the complex dynamics of the human-tool-environment system have been approached from various angles, to date it remains unknown how the rhythmicity of repetitive tool-using action emerges. To examine whether the spontaneously adopted movement frequency is a variable susceptible to individual execution approaches or emerges as constant behaviour, we recorded sawing motion across a range of 14 experimental conditions using various manipulations. This was compared to free and pantomimed arm movements. We found that a mean (SD) sawing frequency of 2.0 (0.4) Hz was employed across experimental conditions. Most experimental conditions did not significantly affect the sawing frequency, signifying the robustness of this spontaneously emerging movement. Free horizontal arm translation and miming of sawing was performed at half the movement frequency with more than double the excursion distance, showing that not all arm movements spontaneously emerge at the observed sawing parameters. Observed movement frequencies across all conditions could be closely predicted from movement time reference data for generic arm movements found in the Methods Time Measurement literature, highlighting a generic biomechanical relationship between the time taken for a given distance travelled underlying the observed behaviour. We conclude that our findings lend support to the hypothesis that repetitive movements during tool use are executed according to generic and predictable musculoskeletal mechanics and constraints, albeit in the context of the general task (sawing) and environmental constraints such as friction, rather than being subject to task-specific control or individual cognitive schemata.	[Starke, Sandra Dorothee; Baber, Chris] Univ Birmingham, Sch Engn, Coll Engn & Phys Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Starke, SD (corresponding author), Univ Birmingham, Sch Engn, Coll Engn & Phys Sci, Birmingham B15 2TT, W Midlands, England.	SandraDStarke@gmail.com	Baber, Chris/A-7412-2014	Baber, Chris/0000-0002-1830-2272; Starke, Sandra/0000-0002-1434-7094				[Anonymous], 2003, COGNITION TOOL USE F; Baber C, 2015, APPL ERGON, V51, P211, DOI 10.1016/j.apergo.2015.05.002; Bach P, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00254; Barnes R. M., 1980, MOTION TIME STUDY DE; Bernstein N, 1967, COORDINATION REGULAT; Bertram JEA, 2001, J THEOR BIOL, V209, P445, DOI 10.1006/jtbi.2001.2279; Bril B, 2010, J EXP PSYCHOL HUMAN, V36, P825, DOI 10.1037/a0018171; Brisswalter J, 2000, INT J SPORTS MED, V21, P60; Bullock D, 1992, P INT JOINT C NEUR N, P91; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Connick MJ, 2014, GAIT POSTURE, V39, P634, DOI 10.1016/j.gaitpost.2013.07.112; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; Dean JC, 2011, J APPL PHYSIOL, V110, P873, DOI 10.1152/japplphysiol.00505.2010; DRILLIS R, 1963, HUM FACTORS, V5, P467, DOI 10.1177/001872086300500505; DRILLIS RJ, 1963, HUM FACTORS, V5, P427, DOI 10.1177/001872086300500502; Habes Daniel J., 1993, INT J IND ERGONOM, V12, P199; HAMMARSKJOLD E, 1990, CLIN BIOMECH, V5, P81, DOI 10.1016/0268-0033(90)90042-5; HOLT KG, 1990, HUM MOVEMENT SCI, V9, P55, DOI 10.1016/0167-9457(90)90035-C; HOLT KG, 1995, J MOTOR BEHAV, V27, P164, DOI 10.1080/00222895.1995.9941708; HOYT DF, 1981, NATURE, V292, P239, DOI 10.1038/292239a0; Ishibashi H, 2000, CAN J PHYSIOL PHARM, V78, P958, DOI 10.1139/cjpp-78-11-958; Jagacinski R.J., 2003, CONTROL THEORY HUMAN; Jancke L, 1998, NEUROSCI LETT, V252, P37, DOI 10.1016/S0304-3940(98)00540-0; Johnson-Frey SH, 2004, TRENDS COGN SCI, V8, P71, DOI 10.1016/j.tics.2003.12.002; JONES GM, 1971, J PHYSIOL-LONDON, V219, P709, DOI 10.1113/jphysiol.1971.sp009684; KEELE SW, 1968, PSYCHOL BULL, V70, P387, DOI 10.1037/h0026739; KUNESCH E, 1989, EXP BRAIN RES, V78, P539; LEIST A, 1987, HUM NEUROBIOL, V6, P19; Lutz K, 2005, NEUROSCI LETT, V373, P61, DOI 10.1016/j.neulet.2004.09.058; Mayr M, 2003, TECHNISCHE MECH; Mayville JM, 1999, EXP BRAIN RES, V127, P371, DOI 10.1007/s002210050805; Medler S, 2009, COMP BIOCHEM PHYS A, V152, P407, DOI 10.1016/j.cbpa.2008.11.021; Merritt KJ, 2012, J NEUROPHYSIOL, V107, P2244, DOI 10.1152/jn.00984.2011; NEILSON PD, 1972, MED BIOL ENG, V10, P450, DOI 10.1007/BF02474193; Osiurak F, 2010, PSYCHOL REV, V117, P517, DOI 10.1037/a0019004; Pagliara R, 2014, J EXP BIOL, V217, P2939, DOI 10.1242/jeb.105270; PEW RW, 1967, IEEE TRANS HUM FACT, VHFE8, P130, DOI 10.1109/THFE.1967.233630; Raburn CE, 2011, J EXP BIOL, V214, P3768, DOI 10.1242/jeb.058743; RALSTON H J, 1958, Int Z Angew Physiol, V17, P277; Rein R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113567; Sardroodian M, 2015, GAIT POSTURE, V42, P60, DOI 10.1016/j.gaitpost.2015.04.003; Schmidt RA, 2003, RES Q EXERCISE SPORT, V74, P366, DOI 10.1080/02701367.2003.10609106; Snaterse M, 2011, J APPL PHYSIOL, V110, P1682, DOI 10.1152/japplphysiol.00536.2010; Takeshita D, 2006, J APPL PHYSIOL, V101, P111, DOI 10.1152/japplphysiol.01084.2005; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; TURVEY MT, 1988, J THEOR BIOL, V130, P285, DOI 10.1016/S0022-5193(88)80031-6; Vaesen K, 2012, BEHAV BRAIN SCI, V35, P203, DOI 10.1017/S0140525X11001452; van Noorden L, 1999, J NEW MUSIC RES, V28, P43, DOI 10.1076/jnmr.28.1.43.3122; Wagman JB, 2001, ECOL PSYCHOL, V13, P173, DOI 10.1207/S15326969ECO1303_1; Will U, 2007, NEUROSCI LETT, V424, P55, DOI 10.1016/j.neulet.2007.07.036; ZARRUGH MY, 1978, EUR J APPL PHYSIOL O, V38, P215, DOI 10.1007/BF00430080	51	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173281	10.1371/journal.pone.0173281	http://dx.doi.org/10.1371/journal.pone.0173281			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278273	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000396087900066
J	Yu, X; Zhang, Q; Zhao, Y; Schwarz, BJ; Stallone, JN; Heaps, CL; Han, GC				Yu, Xuan; Zhang, Qiao; Zhao, Yan; Schwarz, Benjamin J.; Stallone, John N.; Heaps, Cristine L.; Han, Guichun			Activation of G protein-coupled estrogen receptor 1 induces coronary artery relaxation via Epac/Rap1-mediated inhibition of RhoA/Rho kinase pathway in parallel with PKA	PLOS ONE			English	Article							SMOOTH-MUSCLE CONTRACTION; CA2+ SENSITIZATION; BLOOD-PRESSURE; K+ CHANNELS; EPAC; CAMP; ENDOTHELIUM; PHOSPHORYLATION; CELLS; GPER	Previously, we reported that cAMP/PKA signaling is involved in GPER-mediated coronary relaxation by activating MLCP via inhibition of RhoA pathway. In the current study, we tested the hypothesis that activation of GPER induces coronary artery relaxation via inhibition of RhoA/Rho kinase pathway by cAMP downstream targets, exchange proteins directly activated by cAMP (Epac) as well as PKA. Our results show that Epac inhibitors, brefeldin A (BFA, 50 mu M), or ESI-09 (20 mu M), or CE3F4 (100 mu M), all partially inhibited porcine coronary artery relaxation response to the selective GPER agonist, G-1 (0.3-3 mu M); while concurrent administration of BFA and PKI (5 mu M), a PKA inhibitor, almost completely blocked the relaxation effect of G-1. The Epac specific agonist, 8-CPT-2Me-cAMP (007, 1-100 mu M), induced a concentration-dependent relaxation response. Furthermore, the activity of Ras-related protein 1 (Rap1) was up regulated by G-1 (1 mu M) treatment of porcine coronary artery smooth muscle cells (CASMCs). Phosphorylation of vasodilator-stimulated phosphoprotein (p-VASP) was elevated by G-1 (1 mu M) treatment, but not by 007 (50 mu M); and the effect of G-1 on p-VASP was blocked by PKI, but not by ESI-09, an Epac antagonist. RhoA activity was similarly down regulated by G-1 and 007, whereas ESI-09 restored most of the reduced RhoA activity by G-1 treatment. Furthermore, G-1 decreased PGF2 alpha-induced p-MYPT1, which was partially reversed with either ESI-09 or PKI; whereas, concurrent administration of ESI-09 and PKI totally prevented the inhibitory effect of G-1. The inhibitory effects of G-1 on p-MLC levels in CASMCs were mostly restored by either ESI-09 or PKI. These results demonstrate that activation of GPER induces coronary artery relaxation via concurrent inhibition of RhoA/Rho kinase by Epac/Rap1 and PKA. GPER could be a potential drug target for preventing and treating cardiovascular diseases.	[Yu, Xuan; Zhang, Qiao; Zhao, Yan; Schwarz, Benjamin J.; Stallone, John N.; Heaps, Cristine L.; Han, Guichun] Texas A&M Univ, Dept Physiol & Pharmacol, College Stn, TX 77843 USA; [Zhang, Qiao] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiovasc Surg, Wuhan, Peoples R China; [Zhao, Yan] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Xian, Peoples R China; [Stallone, John N.; Han, Guichun] Texas A&M Univ, Michael E DeBakey Inst, Womens Hlth Div, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Huazhong University of Science & Technology; Xi'an Jiaotong University; Texas A&M University System; Texas A&M University College Station	Han, GC (corresponding author), Texas A&M Univ, Dept Physiol & Pharmacol, College Stn, TX 77843 USA.; Han, GC (corresponding author), Texas A&M Univ, Michael E DeBakey Inst, Womens Hlth Div, College Stn, TX 77843 USA.	ghan@cvm.tamu.edu		Yu, Xuan/0000-0003-3343-7105	American Heart Association [15BGIA25060013]	American Heart Association(American Heart Association)	The funder is American Heart Association. Grant number is: 15BGIA25060013. http://www.heart.org/HEARTORG/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calderon-Sanchez E, 2009, CARDIOVASC RES, V83, P717, DOI 10.1093/cvr/cvp161; Chrzanowska-Wodnicka M, 2013, EXP CELL RES, V319, P2350, DOI 10.1016/j.yexcr.2013.07.022; Courilleau D, 2012, J BIOL CHEM, V287, P44192, DOI 10.1074/jbc.M112.422956; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; Deschamps AM, 2009, AM J PHYSIOL-HEART C, V297, pH1806, DOI 10.1152/ajpheart.00283.2009; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Guilluy C, 2008, CIRC RES, V102, P1265, DOI 10.1161/CIRCRESAHA.107.164764; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Han GC, 2013, PHARMACOL RES, V71, P53, DOI 10.1016/j.phrs.2013.02.008; Han GC, 2009, J PHARMACOL EXP THER, V329, P850, DOI 10.1124/jpet.108.149112; Hewer RC, 2011, J MOL CELL CARDIOL, V50, P87, DOI 10.1016/j.yjmcc.2010.10.010; Jeyaraj SC, 2011, LIFE SCI, V88, P645, DOI 10.1016/j.lfs.2011.01.023; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Kitazawa T, 2003, J PHYSIOL-LONDON, V546, P879, DOI 10.1113/jphysiol.2002.029306; Lakshmikanthan S, 2015, EMBO REP, V16, P628, DOI 10.15252/embr.201439846; Lakshmikanthan S, 2014, ARTERIOSCL THROM VAS, V34, P1486, DOI 10.1161/ATVBAHA.114.303678; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064771; Lindsey SH, 2009, ENDOCRINOLOGY, V150, P3753, DOI 10.1210/en.2008-1664; METRICH M, 2009, PFLUGERS ARCH, V459, P535, DOI DOI 10.1007/S00424-009-0747-Y; Meyer MR, 2010, PHARMACOLOGY, V86, P58, DOI 10.1159/000315497; Meyer MR, 2009, MOL CELL ENDOCRINOL, V308, P9, DOI 10.1016/j.mce.2009.03.009; Nini L, 2010, ANAL BIOCHEM, V398, P135, DOI 10.1016/j.ab.2009.11.011; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Purves GI, 2009, J PHYSIOL-LONDON, V587, P3639, DOI 10.1113/jphysiol.2009.173534; Rajagopal S, 2013, AM J PHYSIOL-GASTR L, V304, pG527, DOI 10.1152/ajpgi.00388.2012; Roberts OL, 2014, BIOCHEM SOC T, V42, P89, DOI 10.1042/BST20130253; Roberts OL, 2013, J PHYSIOL-LONDON, V591, P5107, DOI 10.1113/jphysiol.2013.262006; Sukhanova I F, 2006, Dokl Biol Sci, V411, P441, DOI 10.1134/S0012496606060044; White RE, 2005, AM J PHYSIOL-HEART C, V289, pH1468, DOI 10.1152/ajpheart.01173.2004; White RE, 2002, CARDIOVASC RES, V53, P650, DOI 10.1016/S0008-6363(01)00428-X; Yu X, 2014, AM J PHYSIOL-ENDOC M, V307, pE398, DOI 10.1152/ajpendo.00534.2013; Yu X, 2011, AM J PHYSIOL-ENDOC M, V301, pE882, DOI 10.1152/ajpendo.00037.2011; Zhang B, 2010, J IMMUNOL, V184, P4087, DOI 10.4049/jimmunol.0902339; Zhu YM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09344; Zieba BJ, 2011, J BIOL CHEM, V286, P16681, DOI 10.1074/jbc.M110.205062	36	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173085	10.1371/journal.pone.0173085	http://dx.doi.org/10.1371/journal.pone.0173085			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278256	Green Submitted, gold, Green Published			2022-12-27	WOS:000396087900045
J	Detollenaere, J; Willems, S; Baert, S				Detollenaere, Jens; Willems, Sara; Baert, Stijn			Volunteering, income and health	PLOS ONE			English	Article							LATER LIFE; OLDER-ADULTS; WELL; WORK; DEPRESSION; INTERVENTION; BENEFITS; OUTCOMES; PROGRAM; MODELS	Separate literatures have related volunteering to health gains and income gains. We study the association between volunteering, income and health within one statistical framework. A state-of-the-art mediation analysis is conducted on data concerning the health, volunteering and sociodemographic characteristics of 42926 individuals within 29 European countries. We find that volunteering is positively associated to self-rated health. This association is partially mediated by household income.	[Detollenaere, Jens; Willems, Sara] Univ Ghent, Dept Family Med & Primary Hlth Care, Ghent, Belgium; [Baert, Stijn] Univ Ghent, Dept Social Econ, Ghent, Belgium; [Baert, Stijn] Res Fdn Flanders, Brussels, Belgium; [Baert, Stijn] Univ Antwerp, Dept Sociol, Antwerp, Belgium; [Baert, Stijn] Catholic Univ Louvain, IRES, Louvain La Neuve, Belgium; [Baert, Stijn] Inst Study Labor IZA, Bonn, Germany	Ghent University; Ghent University; University of Antwerp; Universite Catholique Louvain; IZA Institute Labor Economics	Detollenaere, J (corresponding author), Univ Ghent, Dept Family Med & Primary Hlth Care, Ghent, Belgium.	Jens.Detollenaere@UGent.be	Willems, Sara/AFU-7707-2022; Willems, Sara/AAI-4851-2021	Willems, Sara/0000-0002-6349-7785; Baert, Stijn/0000-0002-1660-5165; Detollenaere, Jens/0000-0003-0261-8819				Anderson ND, 2014, PSYCHOL BULL, V140, P1505, DOI 10.1037/a0037610; Baert S, 2015, IZA DISCUSSION PAPER, V9649; Baert S, 2016, ECON LETT, V146, P95, DOI 10.1016/j.econlet.2016.07.035; BOLLEN KA, 1981, AM SOCIOL REV, V46, P232, DOI 10.2307/2094981; Borgonovi F, 2008, SOC SCI MED, V66, P2321, DOI 10.1016/j.socscimed.2008.01.011; Brown SL, 2015, NEUROSCI BIOBEHAV R, V55, P1, DOI 10.1016/j.neubiorev.2015.04.004; Carlson MC, 2008, GERONTOLOGIST, V48, P793, DOI 10.1093/geront/48.6.793; CATALANO R, 1987, AM J COMMUN PSYCHOL, V15, P633, DOI 10.1007/BF00929916; Choi NG, 2011, AGEING SOC, V31, P590, DOI 10.1017/S0144686X10001224; Cohen A, 2009, NONPROF VOLUNT SEC Q, V38, P522, DOI 10.1177/0899764008320196; Cozzi G, 2013, IZA DISCUSSION PAPER, V7697; Day KM, 1997, APPL ECON, V29, P707, DOI 10.1080/000368497326642; Day KM, 1998, CAN J ECON, V31, P1179, DOI 10.2307/136465; De Maeseneer J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652553; Ettner SL, 1996, J HEALTH ECON, V15, P67, DOI 10.1016/0167-6296(95)00032-1; Frijters P, 2005, J HEALTH ECON, V24, P997, DOI 10.1016/j.jhealeco.2005.01.004; Goldman-Mellor SJ, 2010, INT J MENT HEALTH, V39, P6, DOI 10.2753/IMH0020-7411390201; Hackl F, 2007, KYKLOS, V60, P77, DOI 10.1111/j.1467-6435.2007.00360.x; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jenkinson CE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-773; JOHNSON DR, 1983, AM SOCIOL REV, V48, P398, DOI 10.2307/2095231; Kirk RE, 1996, EDUC PSYCHOL MEAS, V56, P746, DOI 10.1177/0013164496056005002; Li YQ, 2005, J HEALTH SOC BEHAV, V46, P68, DOI 10.1177/002214650504600106; Li YQ, 2006, SOC FORCES, V85, P497, DOI 10.1353/sof.2006.0132; Luoh MC, 2002, J HEALTH SOC BEHAV, V43, P490, DOI 10.2307/3090239; McDougle L, 2014, SOC INDIC RES, V117, P337, DOI 10.1007/s11205-013-0336-5; Mcdowell I., 2006, MEASURING HLTH GUIDE, V3, P37, DOI [DOI 10.1093/ACPROF:OSO/9780195165678.001.0001, 10.1093/acprof:oso/9780195165678.001.0001]; Musick MA, 2003, SOC SCI MED, V56, P259, DOI 10.1016/S0277-9536(02)00025-4; Norwegian Centre for Research Data, 2012, ESS6 NORW CTR RES DA; Oswald AJ, 2010, SCIENCE, V327, P576, DOI 10.1126/science.1180606; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Pillemer K, 2010, GERONTOLOGIST, V50, P594, DOI 10.1093/geront/gnq007; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Prouteau L., 2006, J SOCIO-ECON, V35, P992, DOI [https://doi.org/10.1016/j.socec.2005.11.021, DOI 10.1016/J.SOCEC.2005.11.021, 10.1016/j.socec.2005.11.021, DOI 10.1016/J.S0CEC.2005.11.021]; Rijken M, 2014, HEALTH EXPECT, V17, P608, DOI 10.1111/j.1369-7625.2012.00786.x; Rumbaut RG, 2006, J AM ETHNIC HIST, V25, P160; Sauer RM, 2015, INT ECON REV, V56, P537, DOI 10.1111/iere.12114; Schwartz CE, 2009, J HAPPINESS STUD, V10, P431, DOI 10.1007/s10902-008-9098-1; Snead MC., 2014, WILEY BLACKWELL ENCY; Tan EJ, 2006, J URBAN HEALTH, V83, P954, DOI 10.1007/s11524-006-9060-7; Thoits PA, 2001, J HEALTH SOC BEHAV, V42, P115, DOI 10.2307/3090173; Urbanos-Garrido RM, 2015, EUR J HEALTH ECON, V16, P175, DOI 10.1007/s10198-014-0563-y; Van Willigen M, 2000, J GERONTOL B-PSYCHOL, V55, pS308, DOI 10.1093/geronb/55.5.S308; Vinokur AD, 1996, J PERS SOC PSYCHOL, V71, P166, DOI 10.1037/0022-3514.71.1.166	45	16	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173139	10.1371/journal.pone.0173139	http://dx.doi.org/10.1371/journal.pone.0173139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273163	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700041
J	Menning, S; de Ruiter, MB; Veltman, DJ; Boogerd, W; Oldenburg, HSA; Reneman, L; Schagen, SB				Menning, Sanne; de Ruiter, Michiel B.; Veltman, Dick J.; Boogerd, Willem; Oldenburg, Hester S. A.; Reneman, Liesbeth; Schagen, Sanne B.			Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type	PLOS ONE			English	Article							CHEMOTHERAPY; IMPAIRMENT; TASK; SURVIVORS; THERAPY; SYSTEM; MRI	Background Cognitive problems in breast cancer patients are common after systemic treatment, particularly chemotherapy. An increasing number of fMRI studies show altered brain activation in breast cancer patients after treatment, suggestive of neurotoxicity. Previous prospective fMRI studies administered a single cognitive task. The current study employed two task paradigms to evaluate whether treatment-induced changes depend on the probed cognitive domain. Methods Participants were breast cancer patients scheduled to receive systemic treatment (anthracycline-based chemotherapy +/- endocrine treatment, n = 28), or no systemic treatment (n = 24) and no-cancer controls (n = 31). Assessment took place before adjuvant treatment and six months after chemotherapy, or at similar intervals. Blood oxygen level dependent (BOLD) activation and performance were measured during an executive functioning task and an episodic memory task. Group-by-time interactions were analyzed using a flexible factorial design. Results Task performance did not differ between patient groups and did not change over time. Breast cancer patients who received systemic treatment, however, showed increased parietal activation compared to baseline with increasing executive functioning task load compared to breast cancer patients who did not receive systemic treatment. This hyperactivation was accompanied by worse physical functioning, higher levels of fatigue and more cognitive complaints. In contrast, in breast cancer patients who did not receive systemic treatment, parietal activation normalized over time compared to the other two groups. Conclusions Parietal hyperactivation after systemic treatment in the context of stable levels of executive task performance is compatible with a compensatory processing account of hyperactivation or maintain adequate performance levels. This over-recruitment of brain regions depends on the probed cognitive domain and may represent a response to decreased neural integrity after systemic treatment. Overall these results suggest different neurobehavioral trajectories in breast cancer patients depending on treatment type.	[Menning, Sanne; de Ruiter, Michiel B.; Schagen, Sanne B.] Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands; [Menning, Sanne; de Ruiter, Michiel B.; Reneman, Liesbeth] Univ Amsterdam, Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Veltman, Dick J.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Boogerd, Willem] Netherlands Canc Inst, Dept Neurooncol, Amsterdam, Netherlands; [Oldenburg, Hester S. A.] Netherlands Canc Inst, Dept Surg Oncol, Amsterdam, Netherlands	Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Netherlands Cancer Institute; Netherlands Cancer Institute	Schagen, SB (corresponding author), Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands.	s.schagen@nki.nl		Reneman, Liesbeth/0000-0002-5912-9971	Dutch Cancer Society [KWF 2009-4284]	Dutch Cancer Society(KWF Kankerbestrijding)	This work as supported by a grant from the Dutch Cancer Society (www.kwf.nl), grant number (KWF 2009-4284) to SBS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Berman MG, 2014, HEALTH PSYCHOL, V33, P222, DOI 10.1037/a0033425; Cheung YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081234; Cimprich B, 2010, J CLIN EXP NEUROPSYC, V32, P324, DOI 10.1080/13803390903032537; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; de Ruiter MB, 2013, BRAIN IMAGING BEHAV, V7, P388, DOI 10.1007/s11682-013-9249-9; de Ruiter MB, 2011, HUM BRAIN MAPP, V32, P1206, DOI 10.1002/hbm.21102; Dekkers AMM, 2010, COMMUNITY MENT HLT J, V46, P20, DOI 10.1007/s10597-009-9195-6; Deprez S, 2014, J CLIN ONCOL, V32, P2031, DOI 10.1200/JCO.2013.53.6219; Ferguson RJ, 2007, J CLIN ONCOL, V25, P3866, DOI 10.1200/JCO.2007.10.8639; Flandin G, 2016, ANAL FAMILY WISE ERR, P1; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Hermelink K, 2015, JNCI-J NATL CANCER I, V107; HESBACHER PT, 1980, J CLIN PSYCHIAT, V41, P6; Jager G, 2007, EUR NEUROPSYCHOPHARM, V17, P289, DOI 10.1016/j.euroneuro.2006.10.003; Joly F, 2015, J PAIN SYMPTOM MANAG, V50, P830, DOI 10.1016/j.jpainsymman.2015.06.019; Kesler S. R., 2015, JAMA ONCOL, V2, P1, DOI DOI 10.1001/JAMAONCOL.2015.4333; Mazaika P, 2009, HUM BRAIN MAPP; McDonald BC, 2012, J CLIN ONCOL, V30, P2500, DOI 10.1200/JCO.2011.38.5674; Menning S, 2016, J PAIN SYMPTOM MANAG, V52, P560, DOI 10.1016/j.jpainsymman.2016.04.012; Menning S, 2015, NEUROIMAGE-CLIN, V7, P547, DOI 10.1016/j.nicl.2015.02.005; Schagen S B, 2014, EJC Suppl, V12, P29, DOI 10.1016/j.ejcsup.2014.03.003; Schilder CMT, 2010, CRIT REV ONCOL HEMAT, V76, P133, DOI 10.1016/j.critrevonc.2009.11.001; Schilder CM, 2010, J CLIN ONCOL, V28, P1294, DOI 10.1200/JCO.2008.21.3553; Schmand B., 1992, NEDERLANDSE LEESTEST; Seigers R, 2013, BRAIN IMAGING BEHAV, V7, P453, DOI 10.1007/s11682-013-9250-3; Silverman DHS, 2007, BREAST CANCER RES TR, V103, P303, DOI 10.1007/s10549-006-9380-z; Stewart A.L., 1992, MEASURING FUNCTIONIN; Stouten-Kemperman MM, 2015, J INT NEUROPSYCH SOC, V21, P50, DOI 10.1017/S1355617714001015; van den Heuvel OA, 2003, NEUROIMAGE, V18, P367, DOI 10.1016/S1053-8119(02)00010-1; Wald FDM., 1990, NEDERLANDS TIJDSCHRI, V45, P86; Wefel JS, 2015, CA-CANCER J CLIN, V65, P123, DOI 10.3322/caac.21258; Wefel JS, 2011, LANCET ONCOL, V12, P703, DOI 10.1016/S1470-2045(10)70294-1; Weiss D.S., 1997, ASSESSING PSYCHOL TR, P399, DOI DOI 10.1037/T12199-000; Zunini RAL, 2013, BRAIN IMAGING BEHAV, V7, P460, DOI 10.1007/s11682-012-9213-0; Zwart W, 2015, NAT REV CLIN ONCOL, V12, P597, DOI 10.1038/nrclinonc.2015.124	36	33	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0171724	10.1371/journal.pone.0171724	http://dx.doi.org/10.1371/journal.pone.0171724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5QM	28267750	Green Submitted, Green Published, gold			2022-12-27	WOS:000396060600057
J	Shields, RK; Anand, R; Clarke, LG; Paronish, JA; Weirich, M; Perone, H; Kieserman, J; Freedy, H; Andrzejewski, C; Bonilla, H				Shields, Ryan K.; Anand, Rohit; Clarke, Lloyd G.; Paronish, Julie A.; Weirich, Matthew; Perone, Hanna; Kieserman, Jake; Freedy, Henry; Andrzejewski, Christina; Bonilla, Hector			Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; INTRAVENOUS COLISTIN; PROSPECTIVE COHORT; INDUCED NEPHROTOXICITY; RENAL DYSFUNCTION; SERUM CREATININE; POLYMYXIN-B; RAT MODEL; METHANESULFONATE; CARE	Background Acute kidney injury (AKI) remains a treatment-limiting toxicity of colistin. Recently developed clinical practice guidelines from the Kidney Disease: Improving Global Outcomes (KDIGO) group have harmonized definitions of AKI, but have not been widely applied to patients receiving colistin. Methods We retrospectively defined AKI by KDIGO definitions among adult patients receiving intravenous colistin for >= 3 days. Risk factors for AKI within 48 hours and 7 days of initiating colistin were determined by multivariable logistic regression. Results Among 249 patients treated with colistin, rates of AKI were 12% and 29% at 48 hours and 7 days, respectively. At 48 hours, patients in the intensive care unit were at increased risk for AKI. Within 7 days, colistin daily doses >5mg/kg, chronic liver disease, and concomitant vancomycin were independent predictors. Seven percent of patients required renal replacement therapy at a median of 5 days (range: 3-7) following colistin initiation. Conclusion Safe use of colistin is promoted by early detection of AKI with KDIGO criteria, avoiding nephrotoxins, and limiting duration of therapy.	[Shields, Ryan K.; Anand, Rohit; Clarke, Lloyd G.; Paronish, Julie A.; Weirich, Matthew; Perone, Hanna; Kieserman, Jake; Bonilla, Hector] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Freedy, Henry; Andrzejewski, Christina; Bonilla, Hector] UPMC Mercy Hosp, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shields, RK (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.	shieldsrk@upmc.edu	Perone, Hanna/AAR-1847-2021	Perone, Hanna/0000-0002-1572-8657; Bonilla, Hector/0000-0002-0513-8733	National Institutes of Health (NIH) [K08AI114883]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI114883] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by funding provided by the National Institutes of Health (NIH) under award number K08AI114883 awarded to R. K. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Collins JM, 2013, PHARMACOTHERAPY, V33, P812, DOI 10.1002/phar.1271; Dalfino L, 2015, CLIN INFECT DIS, V61, P1771, DOI 10.1093/cid/civ717; DeRyke CA, 2010, ANTIMICROB AGENTS CH, V54, P4503, DOI 10.1128/AAC.01707-09; Doshi NM, 2011, PHARMACOTHERAPY, V31, P1257, DOI 10.1592/phco.31.12.1257; Elefritz JL, 2016, J INTENSIVE CARE MED; Elyasi S, 2012, EUR J CLIN PHARMACOL, V68, P1243, DOI 10.1007/s00228-012-1259-9; Fiaccadori E, 2016, AM J KIDNEY DIS, V68, P296, DOI 10.1053/j.ajkd.2016.03.421; Garcia-Tsao G, 2008, HEPATOLOGY, V48, P2064, DOI 10.1002/hep.22605; Garonzik SM, 2011, ANTIMICROB AGENTS CH, V55, P3284, DOI 10.1128/AAC.01733-10; Ghlissi Z, 2014, ENVIRON TOXICOL PHAR, V37, P960, DOI 10.1016/j.etap.2014.03.004; Hartzell JD, 2009, CLIN INFECT DIS, V48, P1724, DOI 10.1086/599225; Javan AO, 2015, EUR J CLIN PHARMACOL, V71, P801, DOI 10.1007/s00228-015-1865-4; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Ko HJ, 2011, NEPHRON CLIN PRACT, V117, pC284, DOI 10.1159/000320746; Kwon JA, 2010, INT J ANTIMICROB AG, V35, P473, DOI 10.1016/j.ijantimicag.2009.12.002; Luo XY, 2014, CRIT CARE, V18, DOI 10.1186/cc13977; Nation RL, 2016, DOSING GUIDANCE INTR; Nation RL, 2015, UPDATED US EUROPEAN; Nation RL, 2016, CLIN INFECT DIS, V62, P552, DOI 10.1093/cid/civ964; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Binh NG, 2015, INT J INFECT DIS, V35, P18, DOI 10.1016/j.ijid.2015.03.020; O'Hara JA, 2013, ANTIMICROB AGENTS CH, V57, P2103, DOI 10.1128/AAC.02501-12; Omrani AS, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0062-8; Ozkan G, 2012, KIDNEY BLOOD PRESS R, V35, P445, DOI 10.1159/000337926; Palevsky PM, 2013, AM J KIDNEY DIS, V61, P649, DOI 10.1053/j.ajkd.2013.02.349; Phe K, 2014, ANTIMICROB AGENTS CH, V58, P6946, DOI 10.1128/AAC.03776-14; Pogue JM, 2011, CLIN INFECT DIS, V53, P879, DOI 10.1093/cid/cir611; Rigatto MH, 2016, ANTIMICROB AGENTS CH, V60, P2443, DOI 10.1128/AAC.02634-15; Rocco M, 2013, CRIT CARE, V17, DOI 10.1186/cc12853; Samra Manpreet, 2012, Perm J, V16, P51; Slack A, 2010, CRIT CARE, V14, DOI 10.1186/cc8855; Tanita Marcos Toshyiuki, 2013, Rev. bras. ter. intensiva, V25, P297, DOI 10.5935/0103-507X.20130051; Tuon FF, 2014, INT J ANTIMICROB AG, V43, P349, DOI 10.1016/j.ijantimicag.2013.12.002; Yousef JM, 2011, ANTIMICROB AGENTS CH, V55, P4044, DOI 10.1128/AAC.00328-11	36	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173286	10.1371/journal.pone.0173286	http://dx.doi.org/10.1371/journal.pone.0173286			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267779	Green Published, gold, Green Submitted			2022-12-27	WOS:000396060600019
J	North, BJ; Almeciga-Pinto, I; Tamang, D; Yang, M; Jones, SS; Quayle, SN				North, Brian J.; Almeciga-Pinto, Ingrid; Tamang, David; Yang, Min; Jones, Simon S.; Quayle, Steven N.			Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; REFRACTORY MULTIPLE-MYELOMA; C-MYC; IMMUNOMODULATORY DRUGS; DOWN-REGULATION; CANCER CELLS; LENALIDOMIDE; EXPRESSION; SURVIVIN; DEGRADATION	Thalidomide-based Immunomodulatory Drugs (IMiDs((R))), including lenalidomide and pomalidomide, are effective therapeutics for multiple myeloma. These agents have been approved with, or are under clinical development with, other targeted therapies including proteasome inhibitors, alpha CD38 monoclonal antibodies, as well as histone deacetylase (HDAC) inhibitors for combination therapy. HDAC inhibitors broadly targeting Class I and IIb HDACs have shown potent preclinical efficacy but have frequently demonstrated an undesirable safety profile in combination therapy approaches in clinical studies. Therefore, development of more selective HDAC inhibitors could provide enhanced efficacy with reduced side effects in combination with IMiDs((R)) for the treatment of B-cell malignancies, including multiple myeloma. Here, the second generation selective HDAC6 inhibitor citarinostat (ACY-241), with a more favorable safety profile than non-selective pan-HDAC inhibitors, is shown to synergize with pomalidomide in in vitro assays through promoting greater apoptosis and cell cycle arrest. Furthermore, utilizing a multiple myeloma in vivo murine xenograft model, combination treatment with pomalidomide and ACY-241 leads to increased tumor growth inhibition. At the molecular level, combination treatment with ACY-241 and pomalidomide leads to greater suppression of the pro-survival factors survivin, Myc, and IRF4. The results presented here demonstrate synergy between pomalidomide and ACY-241 in both in vitro and in vivo preclinical models, providing further impetus for clinical development of ACY-241 for use in combination with IMiDs for patients with multiple myeloma and potentially other B-cell malignancies.	[North, Brian J.; Almeciga-Pinto, Ingrid; Tamang, David; Yang, Min; Jones, Simon S.; Quayle, Steven N.] Acetylon Pharmaceut, Boston, MA 02210 USA		Jones, SS (corresponding author), Acetylon Pharmaceut, Boston, MA 02210 USA.	sjones@acetylon.com			Acetylon Pharmaceuticals	Acetylon Pharmaceuticals	Funding was provided by Acetylon Pharmaceuticals (http://www.acetylon.com). The funder provided support in the form of research materials and salaries for BJN, IAP, DT, MY, SSJ, and SNQ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andhavarapu S, 2013, EXPERT REV HEMATOL, V6, P69, DOI [10.1586/EHM.12.62, 10.1586/ehm.12.62]; Bjorklund CC, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.66; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Campbell RA, 2010, EUR J HAEMATOL, V84, P201, DOI 10.1111/j.1600-0609.2009.01384.x; Canella A, 2015, ONCOTARGET, V6, P31134, DOI 10.18632/oncotarget.5290; Chen Hong Ping, 2015, Critical Reviews in Oncogenesis, V20, P35; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Garg H, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0326-1; Harada T, 2016, INT J HEMATOL, V104, P300, DOI 10.1007/s12185-016-2008-0; Hideshima T, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.38; Holien T, 2012, BLOOD, V120, P2450, DOI 10.1182/blood-2011-08-371567; Hsu YF, 2012, BBA-GEN SUBJECTS, V1820, P104, DOI 10.1016/j.bbagen.2011.11.011; Huang PY, 2017, ONCOTARGET, V8, P2694, DOI 10.18632/oncotarget.13738; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kaufman JL, 2013, CL LYMPH MYELOM LEUK, V13, P370, DOI 10.1016/j.clml.2013.03.016; Kim SH, 2016, ENDOCRINE, V51, P274, DOI 10.1007/s12020-015-0706-7; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lee HC, 2016, CURR HEMATOL MALIG R, V11, P148, DOI 10.1007/s11899-016-0312-7; Lee JH, 2010, EPIGENOMICS-UK, V2, P723, DOI [10.2217/epi.10.59, 10.2217/EPI.10.59]; Li H, 2004, BIOCHEM BIOPH RES CO, V324, P860, DOI 10.1016/j.bbrc.2004.09.130; Li Y., 2016, COLD SPRING HARB PER, V6; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lopez-Girona A, 2011, BRIT J HAEMATOL, V154, P325, DOI 10.1111/j.1365-2141.2011.08689.x; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Mahalingam D, 2010, CLIN CANCER RES, V16, P141, DOI 10.1158/1078-0432.CCR-09-1385; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Romagnoli M, 2007, LEUKEMIA, V21, P1070, DOI 10.1038/sj.leu.2404602; Santo L, 2012, BLOOD, V119, P2579, DOI 10.1182/blood-2011-10-387365; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Shabason JE, 2010, ONCOLOGY-NY, V24, P180; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shin DY, 2015, CANCER LETT, V364, P89, DOI 10.1016/j.canlet.2015.03.016; Subramanian S, 2010, PHARMACEUTICALS, V3, P2751, DOI 10.3390/ph3092751; Wang SL, 2016, ONCOTARGET, V7, P37693, DOI 10.18632/oncotarget.9264; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Xu YX, 2005, INT J MOL MED, V15, P169; Yee AJ, 2016, LANCET ONCOL, V17, P1569, DOI 10.1016/S1470-2045(16)30375-8; Zhang H, 2016, HEPATOL RES; Zhang P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136193	41	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173507	10.1371/journal.pone.0173507	http://dx.doi.org/10.1371/journal.pone.0173507			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264055	gold, Green Published, Green Submitted			2022-12-27	WOS:000396054300067
J	Helenius, LK; Saiz, E				Helenius, Laura K.; Saiz, Enric			Feeding behaviour of the nauplii of the marine calanoid copepod Paracartia grani Sars: Functional response, prey size spectrum, and effects of the presence of alternative prey	PLOS ONE			English	Article							ACARTIA-TONSA; FOOD SELECTION; PLANKTONIC COPEPODS; ADULT FEMALES; FRESH-WATER; RATES; DISCRIMINATION; CAPABILITIES; BACTERIVORY; PARTICLES	Laboratory feeding experiments were conducted to study the functional response and prey size spectrum of the young naupliar stages of the calanoid copepod Paracartia grani Sars. Experiments were conducted on a range of microalgal prey of varying sizes and motility patterns. Significant feeding was found in all prey of a size range of 4.5-19.8 mu m, with Holling type III functional responses observed for most prey types. The highest clearance rates occurred when nauplii fed on the dinoflagellate Heterocapsa sp. and the diatom Thalassiosira weissflogii (respectively, 0.61 and 0.70 mL ind(-1) d(-1)), suggesting an optimal prey: predator ratio of 0.09. Additional experiments were conducted to examine the effects of the presence of alternative prey (either Heterocapsa sp. or Gymnodinium litoralis) on the functional response to the haptophyte Isochrysis galbana. In the bialgal mixtures, clearance and ingestion rates of I. galbana along the range of the functional response were significantly reduced as a result of selectivity towards the larger, alternative prey. Paradoxically, relatively large prey trigger a perception response in the nauplii, but most likely such prey cannot be completely ingested and a certain degree of sloppy feeding may occur. Our results are further evidence of the complex prey-specific feeding interactions that are likely to occur in natural assemblages with several available prey types.	[Helenius, Laura K.] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Helenius, Laura K.] Univ Helsinki, Tvarminne Zool Stn, Hango, Finland; [Saiz, Enric] CSIC, Inst Ciencias Mar, Barcelona, Catalunya, Spain	University of Helsinki; University of Helsinki; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Helenius, LK (corresponding author), Univ Helsinki, Dept Environm Sci, Helsinki, Finland.; Helenius, LK (corresponding author), Univ Helsinki, Tvarminne Zool Stn, Hango, Finland.	laura.helenius@alumni.helsinki.fi	Saiz, Enric/K-4263-2014	Saiz, Enric/0000-0003-2611-0067	Walter and Andree de Nottbeck Foundation; University of Helsinki; Ministerio de Economia, Industria y Competitividad [CTM2011-23480, CGL2014-59227-R]; FEDER, EU	Walter and Andree de Nottbeck Foundation; University of Helsinki; Ministerio de Economia, Industria y Competitividad(Spanish Government); FEDER, EU(European Commission)	LH was funded by the Walter and Andree de Nottbeck Foundation (http://www.nottbeck.org/en) and University of Helsinki (https://www.heisinki.fi/en). ES was funded by projects CTM2011-23480 and CGL2014-59227-R of the Ministerio de Economia, Industria y Competitividad (http://www.mineco.gob.es/portal/site/mineco/) (cofinanced with FEDER funds, EU) (http://ec.europa.eu/regional_policy/es/funding/erdf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN JD, 1977, MAR BIOL, V43, P317, DOI 10.1007/BF00396926; Almeda R, 2010, J EXP MAR BIOL ECOL, V387, P24, DOI 10.1016/j.jembe.2010.03.002; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; BERGGREEN U, 1988, MAR BIOL, V99, P341, DOI 10.1007/BF02112126; Borg CMA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047486; Bruno E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047906; Calbet A, 2001, J PLANKTON RES, V23, P319, DOI 10.1093/plankt/23.3.319; COWLES TJ, 1988, MAR BIOL, V100, P41, DOI 10.1007/BF00392953; Cyr H, 1998, CAN J FISH AQUAT SCI, V55, P414, DOI 10.1139/cjfas-55-2-414; DEMOTT WR, 1986, OECOLOGIA, V69, P334, DOI 10.1007/BF00377053; DEMOTT WR, 1989, LIMNOL OCEANOGR, V34, P140, DOI 10.4319/lo.1989.34.1.0140; DEMOTT WR, 1988, LIMNOL OCEANOGR, V33, P397, DOI 10.4319/lo.1988.33.3.0397; DONAGHAY PL, 1979, MAR BIOL, V52, P137, DOI 10.1007/BF00390421; FANTA E S, 1976, Boletim de Zoologia, V1, P205; FANTA E S, 1972, Crustaceana (Leiden), V23, P165, DOI 10.1163/156854072X00345; FERNANDEZ F, 1979, MAR BIOL, V53, P131, DOI 10.1007/BF00389185; FERNANDEZ F, 1979, Journal of Plankton Research, V1, P313, DOI 10.1093/plankt/1.4.313; Finlay K, 2004, ICES J MAR SCI, V61, P552, DOI 10.1016/j.icesjms.2004.03.010; Moller EF, 2007, LIMNOL OCEANOGR, V52, P79, DOI 10.4319/lo.2007.52.1.0079; FROST BW, 1977, LIMNOL OCEANOGR, V22, P472, DOI 10.4319/lo.1977.22.3.0472; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Garrido S, 2015, MAR ECOL PROG SER, V539, P271, DOI 10.3354/meps11506; Garrido S, 2013, J PLANKTON RES, V35, P843, DOI 10.1093/plankt/fbt037; Gentleman W, 2003, DEEP-SEA RES PT II, V50, P2847, DOI 10.1016/J.DSR2.2003.07.001; Gentleman WC, 2008, J PLANKTON RES, V30, P1215, DOI 10.1093/plankt/fbn078; GILL CW, 1988, MAR ECOL PROG SER, V43, P269, DOI 10.3354/meps043269; Gismervik I, 1997, MAR ECOL PROG SER, V157, P247, DOI 10.3354/meps157247; Goncalves RJ, 2015, LIMNOL OCEANOGR, V60, P1286, DOI 10.1002/lno.10102; Goncalves RJ, 2014, MAR ECOL PROG SER, V517, P61, DOI 10.3354/meps11039; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; Henriksen CI, 2007, MAR ECOL PROG SER, V331, P119, DOI 10.3354/meps331119; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; HOLLING C. S., 1966, Memoirs of the Entomology Society of Canada; Isari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084742; Isari S, 2011, J PLANKTON RES, V33, P715, DOI 10.1093/plankt/fbq149; Kiorboe T, 1996, MAR ECOL PROG SER, V143, P65, DOI 10.3354/meps143065; KIORBOE T, 1985, MAR ECOL PROG SER, V26, P85, DOI 10.3354/meps026085; Kiorboe T, 1998, HYDROBIOLOGIA, V363, P13, DOI 10.1023/A:1003173721751; Kiorboe T, 2016, LIMNOL OCEANOGR, V61, P1169, DOI 10.1002/lno.10293; LANDRY MR, 1981, MAR BIOL, V65, P77, DOI 10.1007/BF00397070; Meyer B, 2002, HELGOLAND MAR RES, V56, P169, DOI 10.1007/s10152-002-0105-3; Morozov A, 2012, PROG OCEANOGR, V103, P80, DOI 10.1016/j.pocean.2012.04.001; MULLIN MM, 1963, LIMNOL OCEANOGR, V8, P239, DOI 10.4319/lo.1963.8.2.0239; Mullin MM, 1988, THEORY BIOL PHYSICAL, P297; PAFFENHOFER GA, 1989, MAR ECOL PROG SER, V57, P129, DOI 10.3354/meps057129; PAFFENHOFER GA, 1978, MAR BIOL, V48, P143, DOI 10.1007/BF00395014; PAFFENHOFER GA, 1988, MAR ECOL PROG SER, V42, P33, DOI 10.3354/meps042033; POULET SA, 1977, J FISH RES BOARD CAN, V34, P2381, DOI 10.1139/f77-319; POULET SA, 1974, MAR BIOL, V25, P109, DOI 10.1007/BF00389260; Price H.J., 1985, Advances in Limnology, V21, P115; PRICE HJ, 1983, LIMNOL OCEANOGR, V28, P116, DOI 10.4319/lo.1983.28.1.0116; ROFF JC, 1995, AQUAT MICROB ECOL, V9, P165, DOI 10.3354/ame009165; Romera-Castillo C, 2010, LIMNOL OCEANOGR, V55, P446, DOI 10.4319/lo.2010.55.1.0446; Sabates A, 2000, MAR ECOL PROG SER, V201, P261, DOI 10.3354/meps201261; SAIZ E, 1994, LIMNOL OCEANOGR, V39, P1566, DOI 10.4319/lo.1994.39.7.1566; SAIZ E, 1995, MAR ECOL PROG SER, V122, P147, DOI 10.3354/meps122147; Saiz E, 2003, LIMNOL OCEANOGR, V48, P1304, DOI 10.4319/lo.2003.48.3.1304; Saiz E, 2007, LIMNOL OCEANOGR, V52, P668, DOI 10.4319/lo.2007.52.2.0668; Saiz E, 2014, LIMNOL OCEANOGR, V59, P2077, DOI 10.4319/lo.2014.59.6.2077; Saiz E, 2011, HYDROBIOLOGIA, V666, P181, DOI 10.1007/s10750-010-0421-6; Sarnelle O, 2008, ECOLOGY, V89, P1723, DOI 10.1890/07-0935.1; Smith JK, 2008, J PLANKTON RES, V30, P937, DOI 10.1093/plankt/fbn050; Tiselius P, 2013, LIMNOL OCEANOGR, V58, P1657, DOI 10.4319/lo.2013.58.5.1657; Titelman J, 2003, MAR ECOL PROG SER, V247, P123, DOI 10.3354/meps247123; Turner JT, 2015, PROG OCEANOGR, V130, P205, DOI 10.1016/j.pocean.2014.08.005; TURNER JT, 1992, J EXP MAR BIOL ECOL, V160, P149, DOI 10.1016/0022-0981(92)90235-3; Turner JT, 2004, ZOOL STUD, V43, P255; VANDERPLOEG HA, 1988, B MAR SCI, V43, P377; VANDERPLOEG HA, 1984, J PLANKTON RES, V6, P919, DOI 10.1093/plankt/6.6.919; Vanderploeg Henry A., 1994, P205; Vilela MH, 1972, NOTAS ESTUDOS I BIOL, V40; WILSON DS, 1973, ECOLOGY, V54, P909, DOI 10.2307/1935688	72	16	16	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172902	10.1371/journal.pone.0172902	http://dx.doi.org/10.1371/journal.pone.0172902			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257517	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100039
J	Liu, SL; Metcalfe, A; Leon, JA; Sauve, R; Kramer, MS; Joseph, KS				Liu, Shiliang; Metcalfe, Amy; Leon, Juan Andres; Sauve, Reg; Kramer, Michael S.; Joseph, K. S.		Canadian Perinatal Surveillance	Evaluation of the INTERGROWTH-21st project newborn standard for use in Canada	PLOS ONE			English	Article							FETAL-GROWTH; BIRTH-WEIGHT; INTERNATIONAL STANDARDS; GESTATIONAL-AGE; MORTALITY; PREGNANCY; MORBIDITY; INFANTS; RISK	Objective To evaluate the performance of the INTERGROWTH-21 st Project newborn standard vis-avis the current Canadian birth weight-for-gestational age reference. Methods All hospital-based singleton live births in Canada (excluding Quebec) between 2002 and 2012 with a gestational age between 33 and 42 weeks were included using information obtained from the Canadian Institute for Health Information. Small-and large-for gestational age centile categories of the INTERGROWTH standard and Canadian reference were contrasted in terms of frequency distributions and rates of composite neonatal morbidity/mortality. Results Among 2,753,817 singleton live births, 0.87% and 9.63% were < 3 rd centile and > 97 th centile, respectively, of the INTERGROWTH standard, while 2.27% and 3.55% were < 3 rd centile and > 97 th centile, respectively, of the Canadian reference. Infants < 3 rd centile and > 97 th centile had a composite neonatal morbidity/mortality rate of 46.4 and 12.9 per 1,000 live births, respectively, under the INTERGROWTH standard and 30.9 and 16.6 per 1,000 live births, respectively, under the Canadian reference. The INTERGROWTH standard < 3 rd centile and > 97 th centile categories had detection rates of 3.14% and 9.74%, respectively, for composite neonatal morbidity/mortality compared with 5.48% and 4.60%, respectively for the Canadian reference. Similar patterns were evident in high-and low-risk subpopulations. Conclusions The centile distribution of the INTERGROWTH newborn standard is left shifted compared with the Canadian reference, and this shift alters the frequencies and neonatal morbidity/mortality rates associated with specific centile categories. Further outcome-based research is required for defining abnormal growth categories before the INTERGROWTH newborn standard can be used.	[Liu, Shiliang; Leon, Juan Andres] Publ Hlth Agcy Canada, Maternal Child & Youth Hlth, Surveillance & Epidemiol Div, Ctr Chron Dis Prevent, Ottawa, ON, Canada; [Metcalfe, Amy] Univ Calgary, Dept Obstet & Gynecol, Calgary, AB, Canada; [Metcalfe, Amy; Sauve, Reg] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Sauve, Reg] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Kramer, Michael S.] McGill Univ, Dept Pediat, Montreal, PQ, Canada; [Kramer, Michael S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Joseph, K. S.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada; [Joseph, K. S.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Joseph, K. S.] Womens & Childrens Hosp, Vancouver, BC, Canada; [Joseph, K. S.] Hlth Ctr British Columbia, Vancouver, BC, Canada	Public Health Agency of Canada; University of Calgary; University of Calgary; University of Calgary; McGill University; McGill University; University of British Columbia; University of British Columbia	Liu, SL (corresponding author), Publ Hlth Agcy Canada, Maternal Child & Youth Hlth, Surveillance & Epidemiol Div, Ctr Chron Dis Prevent, Ottawa, ON, Canada.	kjoseph@cw.bc.ca		Joseph, K.S./0000-0003-2317-5607	BC Children's Hospital Research Institute; Canadian Institutes of Health Research [APR-126338]; Public Health Agency of Canada	BC Children's Hospital Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada	K.S. Joseph's work is supported by the Investigator Grant Awards Program of the BC Children's Hospital Research Institute and a Chair Award from the Canadian Institutes of Health Research (APR-126338). Funding for Open access publication was provided by the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PS, 2014, LANCET DIABETES ENDO, V2, P773, DOI 10.1016/S2213-8587(14)70186-X; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Copel JA, 2014, OBSTET GYNECOL, V123, P1057, DOI 10.1097/AOG.0000000000000232; Evans N, 2007, ARCH DIS CHILD-FETAL, V92, pF34, DOI 10.1136/adc.2006.094169; Francis JH, 2014, AUST NZ J OBSTET GYN, V54, P354, DOI 10.1111/ajo.12205; Gardosi J, 2014, LANCET DIABETES ENDO, V2, P773, DOI 10.1016/S2213-8587(14)70188-3; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Joseph KS, 2011, BJOG-INT J OBSTET GY, V118, P1617, DOI 10.1111/j.1471-0528.2011.03128.x; Joseph KS, 2009, CHRONIC DIS CAN, V29, P96; Joseph KS, 2009, AM J EPIDEMIOL, V169, P616, DOI 10.1093/aje/kwn374; Kramer M, 2015, B NUTR FDN INDIA, V36, P1; Kramer MS, 1998, EUR J CLIN NUTR, V52, pS29; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Mortensen LH, 2009, J EPIDEMIOL COMMUN H, V63, P281, DOI 10.1136/jech.2008.076364; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; Piper JM, 1996, OBSTET GYNECOL, V87, P169, DOI 10.1016/0029-7844(95)00400-9; Seeds JW, 1998, AM J OBSTET GYNECOL, V178, P658, DOI 10.1016/S0002-9378(98)70475-2; Seravalli V, 2015, OBSTET GYN CLIN N AM, V42, P275, DOI 10.1016/j.ogc.2015.01.005; Steer PJ, 2014, LANCET DIABETES ENDO, V2, P766, DOI 10.1016/S2213-8587(14)70157-3; TYSON JE, 1995, PEDIATRICS, V95, P534; Unterscheider J, 2013, AM J OBSTET GYNECOL, V208, DOI [10. 1016/j. ajog. 2013. 02. 007, DOI 10.1016/J.AJ0G.2013.02.007]; Vasak B, 2015, ULTRASOUND OBST GYN, V45, P162, DOI 10.1002/uog.14644; Villar J, 2014, LANCET DIABETES ENDO, V2, P781, DOI 10.1016/S2213-8587(14)70121-4; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; Wen S W, 1997, Chronic Dis Can, V18, P113; WHO, 2009, WHO CHILD GROWTH STA; YOON JJ, 1980, PEDIATRICS, V65, P735	28	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0172910	10.1371/journal.pone.0172910	http://dx.doi.org/10.1371/journal.pone.0172910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257473	Green Submitted, gold, Green Published			2022-12-27	WOS:000396021100042
J	Diwadkar, VA; Asemi, A; Burgess, A; Chowdury, A; Bressler, SL				Diwadkar, Vaibhav A.; Asemi, Avisa; Burgess, Ashley; Chowdury, Asadur; Bressler, Steven L.			Potentiation of motor sub-networks for motor control but not working memory: Interaction of dACC and SMA revealed by resting- state directed functional connectivity	PLOS ONE			English	Article							DORSAL ANTERIOR CINGULATE; HUMAN BRAIN; FMRI DATA; CORTEX; SCHIZOPHRENIA; TASK; FLUCTUATIONS; ACTIVATION; COGNITION; MRI	The dorsal Anterior Cingulate Cortex (dACC) and the Supplementary Motor Area (SMA) are known to interact during motor coordination behavior. We previously discovered that the directional influences underlying this interaction in a visuo-motor coordination task are asymmetric, with the dACC! SMA influence being significantly greater than that in the reverse direction. To assess the specificity of this effect, here we undertook an analysis of the interaction between dACC and SMA in two distinct contexts. In addition to the motor coordination task, we also assessed these effects during a (n-back) working memory task. We applied directed functional connectivity analysis to these two task paradigms, and also to the rest condition of each paradigm, in which rest blocks were interspersed with task blocks. We report here that the previously known asymmetric interaction between dACC and SMA, with dACC! SMA dominating, was significantly larger in the motor coordination task than the memory task. Moreover the asymmetry between dACC and SMA was reversed during the rest condition of the motor coordination task, but not of the working memory task. In sum, the dACC! SMA influence was significantly greater in the motor task than the memory task condition, and the SMA! dACC influence was significantly greater in the motor rest than the memory rest condition. We interpret these results as suggesting that the potentiation of motor sub-networks during the motor rest condition supports the motor control of SMA by dACC during the active motor task condition.	[Diwadkar, Vaibhav A.; Burgess, Ashley; Chowdury, Asadur] Wayne State Univ, Dept Psychiat & Behav Neurosci, Sch Med, Detroit, MI 48207 USA; [Asemi, Avisa; Bressler, Steven L.] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA; [Bressler, Steven L.] Florida Atlantic Univ, Dept Psychol, Boca Raton, FL 33431 USA	Wayne State University; State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University	Diwadkar, VA (corresponding author), Wayne State Univ, Dept Psychiat & Behav Neurosci, Sch Med, Detroit, MI 48207 USA.	vdiwadka@med.wayne.edu		Chowdury, Asadur/0000-0002-5653-9721	Career Development Chair from Wayne State University; Charles H. Gershenson Distinguished Faculty Fellowship from Wayne State University; Lyckaki-Young Fund from the State of Michigan; Prechter Family Bipolar Foundation; Children's Hospital of Michigan Foundation; Children's Research Center of Michigan; Cohen Neuroscience Endowment; National Institute of Mental Health [MH 59299, MH111177]	Career Development Chair from Wayne State University; Charles H. Gershenson Distinguished Faculty Fellowship from Wayne State University; Lyckaki-Young Fund from the State of Michigan; Prechter Family Bipolar Foundation; Children's Hospital of Michigan Foundation; Children's Research Center of Michigan; Cohen Neuroscience Endowment; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Preparation of this work was supported by a Career Development Chair from Wayne State University, the Charles H. Gershenson Distinguished Faculty Fellowship from Wayne State University, the Lyckaki-Young Fund from the State of Michigan, the Prechter Family Bipolar Foundation, the Childrens Hospital of Michigan Foundation, the Childrens Research Center of Michigan, the Cohen Neuroscience Endowment, and the National Institute of Mental Health (MH 59299, MH111177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asemi A, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00309; Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; Bakshi N, 2011, J PSYCHIATR RES, V45, P1067, DOI 10.1016/j.jpsychires.2011.01.002; Banyai M, 2011, NEUROIMAGE, V58, P870, DOI 10.1016/j.neuroimage.2011.06.046; Bastos AM, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00175; Bazan PR, 2015, BRAIN CONNECT, V5, P631, DOI 10.1089/brain.2014.0332; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Breukelaar IA, 2016, HUMAN BRAIN MAPPING; Cummiford CM, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0934-0; De Pasquale F., 2015, CEREB CORTEX; de Zwart JA, 2013, BRAIN TOPOGR, V26, P525, DOI 10.1007/s10548-013-0290-1; Deco G, 2014, J NEUROSCI, V34, P7886, DOI 10.1523/JNEUROSCI.5068-13.2014; Deco G, 2013, TRENDS NEUROSCI, V36, P268, DOI 10.1016/j.tins.2013.03.001; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Diwadkar VA, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00149; Diwadkar VA, 2011, PSYCHIAT RES-NEUROIM, V192, P91, DOI 10.1016/j.pscychresns.2010.12.005; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Driver ID, 2016, J NEUROSCI, V36, P8541, DOI 10.1523/JNEUROSCI.4263-15.2016; Eickhoff SB, 2010, J NEUROSCI, V30, P6409, DOI 10.1523/JNEUROSCI.5664-09.2010; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Gopinath K, 2011, NEUROIMAGE, V54, P380, DOI 10.1016/j.neuroimage.2010.07.021; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Hoffstaedter F., 2014, BRAIN STRUCT FUNCT; Hoffstaedter F, 2013, HUMAN BRAIN MAPPING; Kellermann TS, 2013, NEUROIMAGE, V72, P69, DOI 10.1016/j.neuroimage.2013.01.046; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2009, NEUROIMAGE, V45, P1080, DOI 10.1016/j.neuroimage.2009.01.010; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Ponce-Alvarez A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004445; Price CJ, 2005, COGN NEUROPSYCHOL, V22, P262, DOI 10.1080/02643290442000095; Raichle ME, 2002, P NATL ACAD SCI USA, V99, P10237, DOI 10.1073/pnas.172399499; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Silverstein BH, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00132; Singh KD, 2012, NEUROIMAGE, V62, P1121, DOI 10.1016/j.neuroimage.2012.01.028; Tang W, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002513; van den Bosch GE, 2014, HUM BRAIN MAPP, V35, P698, DOI 10.1002/hbm.22193; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Wickens T.D., 2001, ELEMENTARY SIGNAL DE	46	23	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172531	10.1371/journal.pone.0172531	http://dx.doi.org/10.1371/journal.pone.0172531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278267	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900122
J	Kala, P; Novotny, T; Andrsova, I; Benesova, K; Holicka, M; Jarkovsky, J; Hnatkova, K; Koc, L; Mikolaskova, M; Novakova, T; Ondrus, T; Privarova, L; Spinar, J; Malik, M				Kala, Petr; Novotny, Tomas; Andrsova, Irena; Benesova, Klara; Holicka, Maria; Jarkovsky, Jiri; Hnatkova, Katerina; Koc, Lumir; Mikolaskova, Monika; Novakova, Tereza; Ondrus, Tomas; Privarova, Lenka; Spinar, Jindrich; Malik, Marek			Higher incidence of hypotension episodes in women during the sub-acute phase of ST elevation myocardial infarction and relationship to covariates	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; TROPONIN-T ASSAY; PRIMARY ANGIOPLASTY; EJECTION FRACTION; HEART-ASSOCIATION; FAILURE; SEX; GUIDELINE; TRIAL	Objective The introduction of primary percutaneous coronary intervention (PPCI) has modified the profile of ST elevation myocardial infarction (STEMI) patients. Occurrence and prognostic significance of hypotension episodes are not known in PPCI treated STEMI patients. It is also not known whether and/or how the hypotension episodes correlate with the degree of myocardial damage and whether there are any sex differences. Methods Data of 293 consecutive STEMI patients (189 males) treated by PPCI and without cardiogenic shock were analyzed. Blood pressure was measured noninvasively. A hypotensive episode was defined as a systolic blood pressure below 90 mmHg over a period of at least 30 minutes. Results A hypotensive episode was observed in 92 patients (31.4%). Female sex was the strongest independent predictor of hypotension episodes (p < 0.0001), while there was no relationship to electrocardiographic STEMI localization. Hypotensive patients had significantly higher levels of troponin T and brain natriuretic peptide; hypotensive episodes were particularly frequent in women with increased troponin T. Treatment with angiotensin-converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB) and betablockers was less frequent in hypotensive patients. After a mean 20-month follow-up, all-cause mortality did not differ between hypotensive patients and others. However, mortality in hypotensive patients who did not tolerate ACEI/ARB therapy was significantly higher compared to other hypotensive patients (p = 0.016). Conclusion Hypotension episodes are not uncommon in the sub-acute phase of contemporarily treated STEMI patients with a striking difference between sexes-female sex was the strongest independent predictor of hypotension episodes. Hypotensive episodes may lead to a delay in pharmacotherapy which influences prognosis. Higher incidence of hypotension in women could at least partially explain the sex-related differences in the use of cardiovascular pharmacotherapy which was repeatedly observed in various studies.	[Kala, Petr; Novotny, Tomas; Andrsova, Irena; Holicka, Maria; Koc, Lumir; Mikolaskova, Monika; Novakova, Tereza; Ondrus, Tomas; Privarova, Lenka; Spinar, Jindrich] Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic; [Kala, Petr; Novotny, Tomas; Andrsova, Irena; Holicka, Maria; Koc, Lumir; Mikolaskova, Monika; Novakova, Tereza; Ondrus, Tomas; Privarova, Lenka; Spinar, Jindrich] Masaryk Univ, Fac Med, Brno, Czech Republic; [Benesova, Klara; Jarkovsky, Jiri] Masaryk Univ, Inst Biostat & Anal, Fac Med, Brno, Czech Republic; [Hnatkova, Katerina; Malik, Marek] Imperial Coll, Natl Heart & Lung Inst, London, England	University Hospital Brno; Masaryk University Brno; Institute of Biostatistics & Analyses; Masaryk University Brno; Imperial College London	Novotny, T (corresponding author), Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic.; Novotny, T (corresponding author), Masaryk Univ, Fac Med, Brno, Czech Republic.	novotny-t@seznam.cz	Novotny, Tomas/ABD-5968-2020; Ondrus, Tomas/AAV-2604-2021; Jarkovsky, Jiri/G-5494-2017	Ondrus, Tomas/0000-0002-6621-0364; Novotny, Tomas/0000-0002-0292-4034; Malik, Marek/0000-0002-3792-1407	Ministry of Health of the Czech Republic [NT/13767-4]; British Heart Foundation [NH/16/2/32499] Funding Source: researchfish	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); British Heart Foundation(British Heart Foundation)	The research was supported by the grant NT/13767-4 of the Ministry of Health of the Czech Republic (http://www.macr.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2015, J WOMENS HEALTH, V24, P859, DOI 10.1089/jwh.2015.5412; [Anonymous], 2016, LANCET, V387, P506, DOI 10.1016/S0140-6736(16)00267-1; Borlaug BA, 2011, CIRCULATION, V123, P2006, DOI 10.1161/CIRCULATIONAHA.110.954388; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Collinson PO, 2011, HEART, V97, P169, DOI 10.1136/hrt.2010.212175; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Gore MO, 2014, J AM COLL CARDIOL, V63, P1441, DOI 10.1016/j.jacc.2013.12.032; Hsich EM, 2013, AM HEART J, V166, P1063, DOI 10.1016/j.ahj.2013.08.029; HUME R, 1966, J CLIN PATHOL, V19, P389, DOI 10.1136/jcp.19.4.389; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Koopman C, 2013, EUR HEART J, V34, P3198, DOI 10.1093/eurheartj/eht368; LEW AS, 1985, CIRCULATION, V72, P1321, DOI 10.1161/01.CIR.72.6.1321; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Rao ACR, 2003, HEART, V89, P559, DOI 10.1136/heart.89.5.559; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Villa C, CLIN PHYSL FUNCT IMA; Widimsky P, 2003, EUR HEART J, V24, P94, DOI 10.1016/S0195-668X(02)00468-2	20	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173699	10.1371/journal.pone.0173699	http://dx.doi.org/10.1371/journal.pone.0173699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278275	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900030
J	Leal-Soto, F; Ferrer-Urbina, R				Leal-Soto, Francisco; Ferrer-Urbina, Rodrigo			Three-factor structure for Epistemic Belief Inventory: A cross-validation study	PLOS ONE			English	Article							EXPLORATORY FACTOR-ANALYSIS; EPISTEMOLOGICAL BELIEFS; PRESERVICE TEACHERS; PERSONAL EPISTEMOLOGY; COLLEGE-STUDENTS; LEARNING SCIENCE; SELF-REGULATION; KNOWLEDGE; PERFORMANCE; MOTIVATION	Research on epistemic beliefs has been hampered by lack of validated models and measurement instruments. The most widely used instrument is the Epistemological Questionnaire, which has been criticized for validity, and it has been proposed a new instrument based in the Epistemological Questionnaire: the Epistemic Belief Inventory. The Spanish-language version of Epistemic Belief Inventory was applied to 1,785 Chilean high school students. Exploratory and confirmatory factor analyses in independent subsamples were performed. A three factor structure emerged and was confirmed. Reliability was comparable to other studies, and the factor structure was invariant among randomized subsamples. The structure that was found does not replicate the one proposed originally, but results are interpreted in light of embedded systemic model of epistemological beliefs.	[Leal-Soto, Francisco] Univ Tarapaca Iquique, Dept Social Sci, Iquique, Chile; [Leal-Soto, Francisco] Ctr Res Inclus Educ, Vina Del Mar, Chile; [Ferrer-Urbina, Rodrigo] Univ Tarapaca Arica, Psychol & Philosophy Sch, Arica, Chile	Universidad de Tarapaca	Leal-Soto, F (corresponding author), Univ Tarapaca Iquique, Dept Social Sci, Iquique, Chile.; Leal-Soto, F (corresponding author), Ctr Res Inclus Educ, Vina Del Mar, Chile.	fleal@uta.cl	Ferrer-Urbina, Rodrigo/E-8230-2018; Leal-Soto, Francisco/AAE-3766-2020	Ferrer-Urbina, Rodrigo/0000-0001-5407-3158; Leal-Soto, Francisco/0000-0002-9032-8223	FONDECYT from the government of Chile [1110722]; CONICYT-PIA from the government of Chile [CIE160009]; government of Chile [CIE160009]	FONDECYT from the government of Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT-PIA from the government of Chile; government of Chile	The research was supported in part by FONDECYT (http://www.conicyt.cl/fondecyt/) grant 1110722 and the publication by CONICYT-PIA (http://www.conicyt.cl/pia/) grant CIE160009, both from the government of Chile to first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was supported in part by grant FONDECYT 1110722, and the publication by grant CIE160009, both from the government of Chile to first author. Authors acknowledge Antonella Bradayanes Saltori for her collaboration in gathering part of the data and preliminary analyses, comments of Dr. Jesus Alonso-Tapia on an earlier version of this manuscript, Daniela Ramirez Carrasco for assistance in references, and the anonymous reviewers for comments that help us to make the paper more precise and meaningful.	Abad F.J., 2011, MED CIENCIAS SOCIALE; Araya C., 2005, TECHNICAL REPORT; Asparouhov T, 2007, P 2007 JSM M SALT LA; Barnard L., 2008, MERLOT J ONLINE LEAR, V4, P261, DOI DOI 10.1007/S10648-006-9002-7; Barrett P, 2007, PERS INDIV DIFFER, V42, P815, DOI 10.1016/j.paid.2006.09.018; Baxter-Magolda M., 2002, PERSONAL EPISTEMOLOG, P63; Belenky M.F., 1997, WOMENS WAYS KNOWING, V6th ed.; Bell PD., 2006, PERSPECTIVES HLTH IN, V3, P1; Bendixen LD, 1998, J PSYCHOL, V132, P187, DOI 10.1080/00223989809599158; Bernardo ABI, 2008, J PSYCHOL, V142, P193, DOI 10.3200/JRLP.142.2.193-208; Braten I, 2005, BRIT J EDUC PSYCHOL, V75, P539, DOI 10.1348/000709905X25067; Braten I., 2005, Journal of Educational Computing Research, V33, P141, DOI 10.2190/E763-X0LN-6NMF-CB86; Bromme R., 2010, PERSONAL EPISTEMOLOG, P163, DOI DOI 10.1017/CBO9780511691904.006; Buehl MM, 2001, EDUC PSYCHOL REV, V13, P385, DOI 10.1023/A:1011917914756; Cam A, 2012, EDUC RES EVAL, V18, P441, DOI 10.1080/13803611.2012.689726; Chai C. S., 2011, INT J ED PSYCHOL ASS, V9, P1; Chiu YL, 2015, AUSTRALAS J EDUC TEC, V31, P486; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Juanas A, 2012, REV PSICODIDACT, V17, P1; Debacker TK, 2008, J EXP EDUC, V76, P281, DOI 10.3200/JEXE.76.3.281-314; Dunnell P. A., 1994, ROEPER REV, V16, P207, DOI DOI 10.1080/02783199409553575; Dweck C.S., 2000, SELF THEORIES THEIR, DOI DOI 10.4324/9781315783048; DWECK CS, 1988, PSYCHOL REV, V95, P256, DOI 10.1037/0033-295X.95.2.256; Ferguson LE, 2013, LEARN INSTR, V25, P49, DOI 10.1016/j.learninstruc.2012.11.003; García María Rosa, 2011, Psykhe, V20, P29, DOI 10.4067/S0718-22282011000100003; Garrido LE, 2011, EDUC PSYCHOL MEAS, V71, P551, DOI 10.1177/0013164410389489; Gaskin CJ, 2014, INT J NURS STUD, V51, P511, DOI 10.1016/j.ijnurstu.2013.10.005; Guerra P, 2008, THESIS; GUILFORD JP, 1980, BEHAV BRAIN SCI, V3, P591, DOI 10.1017/S0140525X00007020; Hammer D, 2002, PERSONAL EPISTEMOLOGY: THE PSYCHOLOGY OF BELIEFS ABOUT KNOWLEDGE KNOWING, P169; Hardre PL, 2007, BRIT J EDUC TECHNOL, V38, P5, DOI 10.1111/j.1467-8535.2006.00591.x; Henson RK, 2006, EDUC PSYCHOL MEAS, V66, P393, DOI 10.1177/0013164405282485; Ho HNJ, 2015, INT J SCI EDUC, V37, P2688, DOI 10.1080/09500693.2015.1100346; Hofer BK, 2010, METACOGN LEARN, V5, P113, DOI 10.1007/s11409-009-9051-7; Hofer BK, 1997, REV EDUC RES, V67, P88, DOI 10.2307/1170620; Hofer BK, 2001, EDUC PSYCHOL REV, V13, P353, DOI 10.1023/A:1011965830686; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Hosmer DW, 2004, EXPLORATORY CONFIRMA, V66, P57; Izquierdo I, 2014, PSICOTHEMA, V26, P395, DOI 10.7334/psicothema2013.349; JEHNG JCJ, 1993, CONTEMP EDUC PSYCHOL, V18, P23, DOI 10.1006/ceps.1993.1004; Jung S, 2013, BEHAV PROCESS, V97, P90, DOI 10.1016/j.beproc.2012.11.016; King P., 1994, DEV REFLECTIVE JUDGM; Kuhn D, 2000, COGNITIVE DEV, V15, P309, DOI 10.1016/S0885-2014(00)00030-7; Laster B. B., 2010, THESIS; Leal-Soto F, 2011, PSICOLOGIA ED PROPON, P147; Leal-Soto F, 2008, PROFESSION ENSEIGNAN, P123; Ledesma RD, 2007, PRACT ASSESS RES EVA, V12, P1, DOI [https://doi.org/10.7275/wjnc-nm63, DOI 10.7275/WJNC-NM63]; Lee WWS, 2015, ASIA-PAC EDUC RES, V24, P603, DOI 10.1007/s40299-014-0206-1; Martínez Vidal Rubén Darío, 2010, REDIE, V12, P1; Mason L, 2010, METACOGN LEARN, V5, P1, DOI [10.1007/s11409-009-9050-8, 10.1007/s11409-009-9048-2]; Michell AW, 2015, AM J OCCUPATIONAL TH, V69, P1; Mohamed M.T., 2013, J ED DEV PSYCHOL, V3, P158, DOI [https://doi.org/10.5539/jedp.v3n1p158, DOI 10.5539/JEDP.V3N1P158, DOI https://doi.org/10.5539/jedp.v3n1p158]; Moore WS, 2002, PERSONAL EPISTEMOLOGY: THE PSYCHOLOGY OF BELIEFS ABOUT KNOWLEDGE KNOWING, P17; Muis KR, 2013, J EDUC PSYCHOL, V105, P213, DOI 10.1037/a0029690; Muller S, 2008, REV EUROP FORMAC PRO, V45, P99; Nietfeld JL, 2003, CURR ISSUES ED, V6, P1; Nussbaum EM, 2003, CONTEMP EDUC PSYCHOL, V28, P573, DOI 10.1016/S0361-476X(02)00062-0; Olafson L, 2015, LEARN ENV RES, V13, P243; Paechter M., 2013, CURRENT ISSUES ED, V16, P100; Perry W.G., 1970, FORMS INTELLECTUAL E; QIAN GY, 1995, J EDUC PSYCHOL, V87, P282, DOI 10.1037/0022-0663.87.2.282; Ravindran B, 2005, J EDUC RES, V98, P222, DOI 10.3200/JOER.98.4.222-233; Richter T, 2010, METACOGN LEARN, V5, P47, DOI 10.1007/s11409-009-9038-4; Ruiz MA, 1992, PSICOTHEMA, V4, P543; Sánchez M María del Rosario, 2009, AVFT, V28, P31; Schmitt N, 1996, PSYCHOL ASSESSMENT, V8, P350, DOI 10.1037/1040-3590.8.4.350; SCHOMMER M, 1990, J EDUC PSYCHOL, V82, P498, DOI 10.1037/0022-0663.82.3.498; SCHOMMER M, 1993, J EDUC PSYCHOL, V85, P406, DOI 10.1037/0022-0663.85.3.406; SCHOMMER M, 1992, J EDUC PSYCHOL, V84, P435, DOI 10.1037/0022-0663.84.4.435; Schommer-Aikins M, 2004, EDUC PSYCHOL-US, V39, P19, DOI 10.1207/s15326985ep3901_3; Schommer-Aikins M, 2002, PERSONAL EPISTEMOLOGY: THE PSYCHOLOGY OF BELIEFS ABOUT KNOWLEDGE KNOWING, P103; Schommer-Aikins M, 2006, ED PSYCHOL, V26, P411, DOI DOI 10.1080/01443410500341304; Schommer-Aikins M, 2012, AN PSICOL-SPAIN, V28, P465, DOI 10.6018/analesps.28.2.125341; SCHRAW G, 1995, APPL COGNITIVE PSYCH, V9, P523, DOI 10.1002/acp.2350090605; Schraw G, 2002, PERSONAL EPISTEMOLOGY: THE PSYCHOLOGY OF BELIEFS ABOUT KNOWLEDGE KNOWING, P261; Schraw G, 2002, ISSUES ED, V8, P99, DOI DOI 10.1891/194589503787383109; Schraw G., 2013, INT SCHOLARLY RES NO, V2013, P1, DOI DOI 10.1155/2013/327680; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; So HJ, 2010, ASIA-PAC EDUC RES, V19, P79; Stromso HI, 2010, METACOGN LEARN, V5, P91, DOI 10.1007/s11409-009-9043-7; Teo T, 2012, ASIA-PAC EDUC RES, V21, P618; Treiblmaier H, 2010, INFORM MANAGE-AMSTER, V47, P197, DOI 10.1016/j.im.2010.02.002; Wang X, 2013, INT ED STUDIES, V6, P98; Welch A, 2013, EJSBS, V2, P278	84	2	2	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173295	10.1371/journal.pone.0173295	http://dx.doi.org/10.1371/journal.pone.0173295			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6AW	28278258	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900068
J	Mullin, JM; Diguilio, KM; Valenzano, MC; Deis, R; Thomas, S; Zurbach, EP; Abdulhaqq, S; Montaner, LJ				Mullin, James M.; Diguilio, Katherine M.; Valenzano, Mary C.; Deis, Rachael; Thomas, Sunil; Zurbach, E. Peter; Abdulhaqq, Shaheed; Montaner, Luis J.			Zinc reduces epithelial barrier compromise induced by human seminal plasma	PLOS ONE			English	Article							SEMEN-DERIVED ENHANCER; TIGHT JUNCTION DISRUPTION; GROWTH-FACTOR-BETA; ADENOCARCINOMA CELLS; VIRUS-INFECTION; HIV-1; TRANSMISSION; PATHOGENESIS; INHIBITION; MECHANISMS	Human semen has the potential to modulate the epithelial mucosal tissues it contacts, as seminal plasma (SP) is recognized to contain both pro-and anti-barrier components, yet its effects on epithelial barrier function are largely unknown. We addressed the role of human SP when exposed to the basal-lateral epithelial surface, a situation that would occur clinically with prior mechanical or disease-related injury of the human epithelial mucosal cell layers in contact with semen. The action of SP on claudins-2, -4, -5, and -7 expression, as well as on a target epithelium whose basolateral surface has been made accessible to SP, showed upregulation of claudins-4 and -5 in CACO-2 human epithelial cell layers, despite broad variance in SP-induced modulation of transepithelial electrical resistance and mannitol permeability. Upregulation of claudin-2 by SP also exhibited such variance by SP sample. We characterize individual effects on CACO-2 barrier function of nine factors known to be present abundantly in seminal plasma (zinc, EGF, citrate, spermine, fructose, urea, TGF, histone, inflammatory cytokines) to establish that zinc, spermine and fructose had significant potential to raise CACO-2 transepithelial resistance, whereas inflammatory cytokines and EGF decreased this measure of barrier function. The role of zinc as a dominant factor in determining higher levels of transepithelial resistance and lower levels of paracellular leak were confirmed by zinc chelation and exogenous zinc addition. As expected, SP presentation to the basolateral cell surface also caused a very dramatic yet transient elevation of pErk levels. Results suggest that increased zinc content in SP can compete against the barrier-compromising effect of negative modulators in SP when SP gains access to that epithelium's basolateral surface. Prophylactic elevation of zinc in an epithelial cell layer prior to contact by SP may help to protect an epithelial barrier from invasion by SP-containing STD microbial pathogens such as HPV or HIV.	[Mullin, James M.; Diguilio, Katherine M.; Valenzano, Mary C.; Thomas, Sunil] Lankenau Inst Med Res, Wynnewood, PA USA; [Deis, Rachael] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Zurbach, E. Peter] St Josephs Univ, Dept Chem, Philadelphia, PA 19131 USA; [Abdulhaqq, Shaheed; Montaner, Luis J.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA	Lankenau Medical Center; Lankenau Institute for Medical Research; Drexel University; Saint Joseph's University; The Wistar Institute	Mullin, JM (corresponding author), Lankenau Inst Med Res, Wynnewood, PA USA.	mullinj@mlhs.org	Mullin, James M./AAD-9348-2020	Mullin, James/0000-0001-5285-7530; Thomas, Sunil/0000-0003-4780-8851	National Institutes of Health [R01 AI094603, T32 AI070099]; Philadelphia Foundation (Robert I. Jacobs Fund); Penn Center for AIDS Research [P30 AI 045008]; Cancer Center Grant [P30 CA10815]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008, T32AI070099, R01AI094603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philadelphia Foundation (Robert I. Jacobs Fund); Penn Center for AIDS Research; Cancer Center Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grants R01 AI094603 to LJM and T32 AI070099 to SA. Additional support was provided to LJM by The Philadelphia Foundation (Robert I. Jacobs Fund), Henry S. Miller, Jr. and J. Kenneth Nimblett, the Penn Center for AIDS Research (P30 AI 045008), and Cancer Center Grant (P30 CA10815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulhaqq SA, MUCOSAL IMMUNOL; Allen SA, 2015, J VIROL, V89, P5569, DOI 10.1128/JVI.00309-15; Arens M, 2000, J CLIN MICROBIOL, V38, P1758, DOI 10.1128/JCM.38.5.1758-1762.2000; Bai L, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-77; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Battersby S, 2007, HUM REPROD, V22, P36, DOI 10.1093/humrep/del328; Baum MK, 2000, J NUTR, V130, p1421S, DOI 10.1093/jn/130.5.1421S; Bourne N, 2005, ANTIMICROB AGENTS CH, V49, P1181, DOI 10.1128/AAC.49.3.1181-1183.2005; Burgener A, 2015, CURR OPIN IMMUNOL, V36, P22, DOI 10.1016/j.coi.2015.06.004; Bzik VA, 2012, J PHARM PHARMACOL, V64, P644, DOI 10.1111/j.2042-7158.2011.01441.x; Cavarelli M, 2014, AM J REPROD IMMUNOL, V71, P537, DOI 10.1111/aji.12245; Cohen L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.262; COLLEEN S, 1975, SCAND J UROL NEPHROL, V9, P198, DOI 10.3109/00365597509134211; Delorme-Axford E, 2012, VIRUSES, V3, P2462, DOI [10.3390/43122462, DOI 10.3390/43122462]; Doncel GF, 2011, AM J REPROD IMMUNOL, V65, P292, DOI 10.1111/j.1600-0897.2010.00931.x; Gorodeski GI, 2007, ENDOCRINOLOGY, V148, P218, DOI 10.1210/en.2006-1120; Grande M, 2002, J CELL SCI, V115, P4227, DOI 10.1242/jcs.00091; Grant PM, 2012, J INFECT DIS, V206, P1715, DOI 10.1093/infdis/jis604; Grant-Tschudy KS, 2005, J REPROD IMMUNOL, V67, P1, DOI 10.1016/j.jri.2005.06.001; Guthrie GJ, 2015, AM J PHYSIOL-GASTR L, V308, pG171, DOI 10.1152/ajpgi.00021.2014; Guttman JA, 2009, BBA-BIOMEMBRANES, V1788, P832, DOI 10.1016/j.bbamem.2008.10.028; Hartjen P, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-2; Hasebe R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-165; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; Ho Y, 2008, MOL PHARMACOL, V74, P1141, DOI 10.1124/mol.108.049064; Howe KL, 2005, AM J PATHOL, V167, P1587, DOI 10.1016/S0002-9440(10)61243-6; Joseph T, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.101956; Kranjec C, 2011, J VIROL, V85, P1757, DOI 10.1128/JVI.01756-10; Lawrence P, 2012, AIDS, V26, P785, DOI 10.1097/QAD.0b013e328351426e; Ma JF, 2009, J MAGN RESON IMAGING, V29, P1154, DOI 10.1002/jmri.21746; Marconi M, 2009, INT BRAZ J UROL, V35, P299, DOI 10.1590/S1677-55382009000300006; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; Mori K, 2015, J DENT RES, V94, P1149, DOI 10.1177/0022034515589289; Muller M, 2006, ENDOCRINOLOGY, V147, P3356, DOI 10.1210/en.2005-1429; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Olsen JS, 2012, J BIOL CHEM, V287, P11842, DOI 10.1074/jbc.M111.314336; Preshaw PM, 2013, ENDOCRIN METAB CLIN, V42, P849, DOI 10.1016/j.ecl.2013.05.012; ROUSSET M, 1979, CANCER RES, V39, P531; Saitoh Y, 2015, SCIENCE, V347, P775, DOI 10.1126/science.1261833; Samet JM, 2003, TOXICOL APPL PHARM, V191, P86, DOI 10.1016/S0041-008X(03)00219-9; Sawada Norimasa, 2003, Medical Electron Microscopy, V36, P147, DOI 10.1007/s00795-003-0219-y; Scaldaferri F, 2012, J CLIN GASTROENTEROL, V46, pS12, DOI 10.1097/MCG.0b013e31826ae849; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Sheftic SR, 2012, EUR BIOPHYS J BIOPHY, V41, P695, DOI 10.1007/s00249-012-0846-0; Talukder P, 2011, INT IMMUNOPHARMACOL, V11, P141, DOI 10.1016/j.intimp.2010.10.010; Tan SY, 2014, LAB INVEST, V94, P777, DOI 10.1038/labinvest.2014.72; Tawar RG, 2015, SEMIN CELL DEV BIOL, V42, P39, DOI 10.1016/j.semcdb.2015.04.011; Tugizov SM, 2013, VIROLOGY, V446, P378, DOI 10.1016/j.virol.2013.08.018; Valenzano MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133926; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; Wang XL, 2013, MAR GENOM, V10, P1, DOI 10.1016/j.margen.2012.12.002; Wang XX, 2013, DIGEST DIS SCI, V58, P77, DOI 10.1007/s10620-012-2328-8; Wang Y, 2004, EXP EYE RES, V78, P125, DOI 10.1016/j.exer.2003.09.002; Yang RK, 2005, INTENS CARE MED, V31, P709, DOI 10.1007/s00134-005-2601-9; Yarbrough VL, 2015, HUM REPROD UPDATE, V21, P353, DOI 10.1093/humupd/dmu065; Yin Y, 2015, MUCOSAL IMMUNOL, V8, P799, DOI 10.1038/mi.2014.110; Yucel-Lindberg T, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.8; Zhong W, 2010, AM J PHYSIOL-GASTR L, V298, P18	58	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0170306	10.1371/journal.pone.0170306	http://dx.doi.org/10.1371/journal.pone.0170306			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278250	Green Published, gold, Green Submitted			2022-12-27	WOS:000396087900106
J	Reznick, DN; Furness, AI; Meredith, RW; Springer, MS				Reznick, David N.; Furness, Andrew I.; Meredith, Robert W.; Springer, Mark S.			The origin and biogeographic diversification of fishes in the family Poeciliidae	PLOS ONE			English	Article							MOLECULAR PHYLOGENETIC-RELATIONSHIPS; HISTORICAL BIOGEOGRAPHY; PERCIFORMES CICHLIDAE; TELEOSTEI; EVOLUTION; EOCENE; GENUS; CYPRINODONTIFORMES; ACTINOPTERYGII; SUPERFETATION	The fish subfamily Poeciliinae(sensu Parenti, 1981) is widely distributed across the Western Hemisphere and a dominant component of the fish communities of Central America. Poeciliids have figured prominently in previous studies on the roles of dispersal and vicariance in shaping current geographic distributions. Most recently, Hrbek et al. combined a DNA- based phylogeny of the family with geological models to provide a biogeographic perspective that emphasized the role of both vicariance and dispersal. Here we expand on that effort with a database enlarged in the quantity of sequence represented per species, in the number of species included, and in an enlarged and more balanced representation of the order Cyprinodontiformes. We combine a robust timetree based upon multiple fossil calibrations with enhanced biogeographic analyses that include ancestral area reconstructions to provide a detailed biogeographic history of this clade. Key features of our results are that the family originated in South America, but its major diversification dates to a later colonization of Central America. We also resolve additional colonizations among South, Central and North America and the Caribbean and consider how this reconstruction contributes to our understanding of the mechanisms of dispersal.	[Reznick, David N.; Springer, Mark S.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Furness, Andrew I.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Meredith, Robert W.] Montclair State Univ, Dept Biol & Mol Biol, Montclair, NJ USA	University of California System; University of California Riverside; University of California System; University of California Irvine; Montclair State University	Reznick, DN (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	david.reznick@ucr.edu		Furness, Andrew/0000-0001-7596-9623; reznick, david/0000-0002-1144-0568	Environmental Biology Division of the National Science Foundation (US) [DEB-0416085];  [DBI-1523666]; Direct For Biological Sciences [1523666] Funding Source: National Science Foundation	Environmental Biology Division of the National Science Foundation (US); ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Our project was funded by the Environmental Biology Division of the National Science Foundation (US) (https://www.nsf.gov/div/index.jsp?div=DEB) primarily with DEB-0416085 to DR (PI) and MS (co-PI). AF is currently supported by DBI-1523666.	Agorreta A, 2013, MOL PHYLOGENET EVOL, V66, P80, DOI 10.1016/j.ympev.2012.09.010; Alda F, 2013, MOL PHYLOGENET EVOL, V66, P1011, DOI 10.1016/j.ympev.2012.12.012; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Alvarado-Ortega J, 2008, J VERTEBR PALEONTOL, V28, P53, DOI 10.1671/0272-4634(2008)28[53:TASNTE]2.0.CO;2; Alvarez J, 1972, B SOC CIENCIAS NATUR, V6, P6; Arcila D, 2015, MOL PHYLOGENET EVOL, V82, P131, DOI 10.1016/j.ympev.2014.10.011; Arratia G., 1999, MESOZOIC FISHES; Arratia G., 1997, PALAEOICHTHYOLOGICA, V7, P1; Arratia Gloria, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P9; Arratia Gloria, 1999, P265; Arratia Gloria, 2000, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V3, P137; Bannikov AF, 2006, GEODIVERSITAS, V28, P249; Bell MA, 2009, COPEIA, P256, DOI 10.1643/CG-08-059; Benton MJ, 2015, PALAEONTOL ELECTRON, V18; Benton Michael J., 2009, P35; Bertini Reinaldo J., 1993, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V188, P71; Betancur R, 2013, SYST BIOL, V62, P763, DOI 10.1093/sysbio/syt039; Candeiro CRA, 2009, B GEOSCI, V84, P573, DOI 10.3140/bull.geosci.1101; Carnevale G, 2009, GEOBIOS VILLEURBANNE, V43, P283; Carnevale G, 2011, GEOL MAG, V148, P461, DOI 10.1017/S0016756810000907; Carnevale G, 2010, GEOBIOS-LYON, V43, P283, DOI 10.1016/j.geobios.2009.10.005; Chang MM, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)404<0001:ROEBAD>2.0.CO;2; Cione AL, 2002, J PALEONTOL, V76, P190, DOI 10.1666/0022-3360(2002)076<0190:TOKCTS>2.0.CO;2; Crowell J.C., 2003, EVOLUTION RIDGE BASI, V367, P157, DOI DOI 10.1130/0-8137-2367-1.157; Diogo R, 2009, INT J MORPHOL, V27, P333, DOI 10.4067/S0717-95022009000200008; Doadrio I, 2009, MOL PHYLOGENET EVOL, V50, P16, DOI 10.1016/j.ympev.2008.09.014; EVANS J.P., 2011, ECOLOGY EVOLUTION PO; Fara E, 2010, SER TELEOST FISH BIO, P173, DOI 10.1201/b10194-7; Filleul A, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)455<0001:ROSDOC>2.0.CO;2; Friedman M, 2009, P NATL ACAD SCI USA, V106, P5218, DOI 10.1073/pnas.0808468106; Furness AI, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2189; Gayet M., 1998, PHYLOGENY CLASSIFICA, P85; GRANDE L, 1985, B AM MUS NAT HIST, V181, P235; Ho ALFC, 2016, MOL PHYLOGENET EVOL, V101, P32, DOI 10.1016/j.ympev.2016.04.032; Hrbek T, 2007, MOL PHYLOGENET EVOL, V43, P986, DOI 10.1016/j.ympev.2006.06.009; Ingley SJ, 2015, MOL PHYLOGENET EVOL, V89, P104, DOI 10.1016/j.ympev.2015.04.013; Kriwet J, 2008, NATURWISSENSCHAFTEN, V95, P899, DOI 10.1007/s00114-008-0409-5; Lee DS, 1983, N CAROLINA BIOL SURV, V1983, P1; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Lucinda P.H.F., 2003, CHECK LIST FRESHWATE, P555; LYDEARD C, 1995, SYST BIOL, V44, P221, DOI 10.1093/sysbio/44.2.221; Maddison W.P., MESQUITE MODULAR SYS; Malabarba MC, 2010, J VERTEBR PALEONTOL, V30, P341, DOI 10.1080/02724631003618348; Malbarba Maria Claudia, 2010, P317; Mateos M, 2005, J BIOGEOGR, V32, P775, DOI 10.1111/j.1365-2699.2005.01236.x; Mateos M, 2002, EVOLUTION, V56, P972; Matzke N.J., 2012, FRONTIERS BIOGEOGRAP, V4, P210; Matzke N.J., 2013, FRONT BIOGEOGR, V5, P242, DOI [DOI 10.21425/F5FBG19694, 10.21425/F5FBG19694]; Matzke N.J., 2013, PACKAGE BIOGEOBEARS; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Meredith RW, 2011, MOL PHYLOGENET EVOL, V59, P148, DOI 10.1016/j.ympev.2011.01.014; Meredith RW, 2010, MOL PHYLOGENET EVOL, V55, P631, DOI 10.1016/j.ympev.2009.11.006; MEYER A, 1993, P ROY SOC B-BIOL SCI, V254, P153, DOI 10.1098/rspb.1993.0140; Miller R.R., 1986, P487; MILLER R R, 1974, Transactions of the San Diego Society of Natural History, V17, P235; Miya M, 2010, BMC EVOLUTIONARY BIO, V10; Morlo Michael, 2004, Courier Forschungsinstitut Senckenberg, V252, P95; Nolf D., 1990, Mississippi Geology, V10, P1; Nolf Dirk, 2003, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V73, P155; Nolf Dirk, 1996, P433; Palacios M, 2016, MOL PHYLOGENET EVOL, V103, P230, DOI 10.1016/j.ympev.2016.07.025; Parenti LR, 1981, B AM MUS NAT HIST, V168, P335, DOI DOI 10.1080/00222930210135631; Parenti Lynne R., 2005, P13; Perez PA, 2010, NEOTROP ICHTHYOL, V8, P631, DOI 10.1590/S1679-62252010000300008; Pires MN, 2011, FUNCT ECOL, V25, P757, DOI 10.1111/j.1365-2435.2011.01842.x; Pires MN, 2010, BIOL J LINN SOC, V99, P784, DOI 10.1111/j.1095-8312.2010.01391.x; Poeser FN., 2003, IBED IFBAED; Pollux BJA, 2009, ANNU REV ECOL EVOL S, V40, P271, DOI 10.1146/annurev.ecolsys.110308.120209; Pollux BJA, 2014, NATURE, P1; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Rauchenberger M, 1989, AM MUS NOVIT, V2951, P1; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Reznick DN, 2002, SCIENCE, V298, P1018, DOI 10.1126/science.1076018; Rosen D. E., 1963, Bulletin of the American Museum of Natural History, V126, P1; ROSEN DE, 1985, ANN MO BOT GARD, V72, P636, DOI 10.2307/2399218; ROSEN DE, 1975, SYST ZOOL, V24, P431, DOI 10.2307/2412905; Santini F, 2004, INTEGR COMP BIOL, V44, P349, DOI 10.1093/icb/44.5.349; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Schartl M, 2014, DIS MODEL MECH, V7, P181, DOI 10.1242/dmm.012245; Schwarzhans Werner, 2003, Geological Survey of Denmark and Greenland Bulletin, V2, P1; Silva HMA, 2011, AN ACAD BRAS CIENC, V83, P483, DOI 10.1590/S0001-37652011000200010; Smith ML., 1980, EVOLUTIONARY ECOLOGI; Smith WL, 2008, CLADISTICS, V24, P625, DOI 10.1111/j.1096-0031.2008.00210.x; Springer MS, 2011, PHILOS T R SOC B, V366, P2478, DOI 10.1098/rstb.2011.0023; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taverne L., 1981, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V51, P43; Tyler James C., 2006, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V30, P49; Uyeno T., 1962, Copeia, V1962, P520, DOI 10.2307/1441173; Van Der Laan R, 2014, ZOOTAXA, V3882, P1, DOI 10.11646/zootaxa.3882.1.1; Weaver PF, 2016, J BIOGEOGRAPHY; Webb SA, 2004, MOL PHYLOGENET EVOL, V30, P527, DOI 10.1016/S1055-7903(03)00257-4; Whitlock JA, 2010, J VERTEBR PALEONTOL, V30, P1037, DOI 10.1080/02724634.2010.483534; Wilson Mark V.H., 2010, P379; WILSON MVH, 1992, J PALEONTOL, V66, P839, DOI 10.1017/S0022336000020849; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	95	54	55	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0172546	10.1371/journal.pone.0172546	http://dx.doi.org/10.1371/journal.pone.0172546			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278162	gold, Green Submitted, Green Published			2022-12-27	WOS:000396087900123
J	Tolppanen, AM; Voutilainen, A; Taipale, H; Tanskanen, A; Lavikainen, P; Koponen, M; Tiihonen, J; Hartikainen, S				Tolppanen, Anna-Maija; Voutilainen, Ari; Taipale, Heidi; Tanskanen, Antti; Lavikainen, Piia; Koponen, Marjaana; Tiihonen, Jari; Hartikainen, Sirpa			Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011	PLOS ONE			English	Article							DRUG-USE; PRESCRIPTION; DEMENTIA; WARNINGS	Objectives To describe and compare temporal changes in prevalence and incidence of psychotropic use (antipsychotics, antidepressants and benzodiazepines and related drugs; BZDRs) in persons with newly diagnosed Alzheimer's disease (AD) between university hospital districts of Finland during 2005-2011. Methods The MEDALZ study includes all community-dwellers of Finland who received a clinically verified AD diagnosis in 2005-2011 (N = 70,718). Prevalent and incident use of psychotropics among those who had received AD diagnosis less than one year ago were compared in 2005-2011. Results Regional differences in psychotropic use between university hospital districts were more evident in 2005 than 2011 for prevalent use of any psychotropic, antipsychotic and BZDRs and incident use of any psychotropic and antipsychotics. Regional differences in prevalent antidepressant use and incident BZDR use remained similar during the follow-up, while differences in incident antidepressant use increased during the follow-up. The prevalence of any psychotropic use in 2005 varied between 44.7-50.7% and between 45.0-47.9% in 2011. Incidence of any psychotropic use in 2005 was between 8.6-12.1% and 6.2-8.2% in 2011. In 2005, the distribution of incident psychotropic use followed a large scale spatial variation that, however, did not correspond to university hospital districts. During the study period from 2005 to 2011 the cyclic spatial variation disappeared. No sign of adjacent hospital districts being more or less closely related to each other compared to hospital districts in general was detected. Conclusions Except for antidepressants, regional differences in psychotropic use have mainly diminished between 2005 and 2011. Our findings highlight the importance of acknowledging regional differences in a country with relatively homogeneous healthcare system and conducting future studies assessing the reasons behind these differences.	[Tolppanen, Anna-Maija; Taipale, Heidi; Lavikainen, Piia; Koponen, Marjaana; Hartikainen, Sirpa] Univ Eastern Finland, Sch Pharm, Kuopio, Finland; [Tolppanen, Anna-Maija] Univ Eastern Finland, Res Ctr Comparat Effectiveness & Patient Safety R, Kuopio, Finland; [Voutilainen, Ari] Univ Eastern Finland, Dept Nursing Sci, Kuopio, Finland; [Taipale, Heidi; Koponen, Marjaana; Hartikainen, Sirpa] Univ Eastern Finland, Kuopio Res Ctr Geriatr Care, Kuopio, Finland; [Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari] Niuvanniemi Hosp, Dept Forens Psychiat, Kuopio, Finland; [Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari; Hartikainen, Sirpa] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Tanskanen, Antti] Natl Inst Hlth & Welf, Helsinki, Finland; [Hartikainen, Sirpa] Kuopio Univ Hosp, Dept Psychiat, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Karolinska Institutet; Finland National Institute for Health & Welfare; Kuopio University Hospital; University of Eastern Finland	Tolppanen, AM (corresponding author), Univ Eastern Finland, Sch Pharm, Kuopio, Finland.; Tolppanen, AM (corresponding author), Univ Eastern Finland, Res Ctr Comparat Effectiveness & Patient Safety R, Kuopio, Finland.	anna-maija.tolppanen@uef.fi	Voutilainen, Ari/H-3406-2019; Tiihonen, Jari/G-3078-2012	Tiihonen, Jari/0000-0002-0400-6798; Lavikainen, Piia/0000-0003-3560-8860; Taipale, Heidi/0000-0002-3281-934X	University of Eastern Finland; Academy of Finland [295334, 307232]	University of Eastern Finland; Academy of Finland(Academy of Finland)	This study was funded by strategic funding from the University of Eastern Finland (http://www.uef.fi/en/etusivu), AMT and HT; Academy of Finland (grants 295334 and 307232, http://www.aka.fi/en), AMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Franchi C, 2012, EUR NEUROPSYCHOPHARM, V22, P569, DOI 10.1016/j.euroneuro.2011.12.009; Koponen M, 2015, BRIT J PSYCHIAT, V207, P444, DOI 10.1192/bjp.bp.114.162834; Martinez C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002080; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Norgaard A, 2016, J ALZHEIMERS DIS, V49, P211, DOI 10.3233/JAD-150481; Oksanen J., **DATA OBJECT**; Puranen A, INT J GERIA IN PRESS; Rikala M, 2010, DRUG AGING, V27, P337, DOI 10.2165/11315960-000000000-00000; Saarelainen L, 2016, J ALZHEIMERS DIS, V49, P809, DOI 10.3233/JAD-150630; Schulze J, 2013, PHARMACOEPIDEM DR S, V22, P1308, DOI 10.1002/pds.3527; Schulze J, 2013, EUR NEUROPSYCHOPHARM, V23, P1034, DOI 10.1016/j.euroneuro.2013.02.001; Suhonen Jaana, 2010, Duodecim, V126, P2167; Taipale H, 2016, LAAKARILEHTI, V71; Taipale H, 2014, EUR NEUROPSYCHOPHARM, V24, P1729, DOI 10.1016/j.euroneuro.2014.10.004; Tanskanen A, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0140-z; Tolppanen AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012100; Tolppanen Anna-Maija, 2013, Clin Epidemiol, V5, P277, DOI 10.2147/CLEP.S46622; Voutilainen A, 2015, SCAND J PUBLIC HLTH; Voutilainen A, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-11; Working group appointed by the Finnish Medical Society Duodecim Societas Gerontologica Fennica the Finnish Neurological Society Finnish Psychogeriatric Association and the Finnish Association for General Practice, 2010, FINN CURR CAR REC ME; World Health Organisation Collaborating Center for Drug Statistics Methodology, 2011, GUID ATC CLASS DDD A	23	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2017	12	3							e0173450	10.1371/journal.pone.0173450	http://dx.doi.org/10.1371/journal.pone.0173450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6AW	28278245	Green Published, Green Submitted, gold			2022-12-27	WOS:000396087900094
J	Ogihara, T; Mita, T; Osonoi, Y; Osonoi, T; Saito, M; Tamasawa, A; Nakayama, S; Someya, Y; Ishida, H; Gosho, M; Kanazawa, A; Watada, H				Ogihara, Takeshi; Mita, Tomoya; Osonoi, Yusuke; Osonoi, Takeshi; Saito, Miyoko; Tamasawa, Atsuko; Nakayama, Shiho; Someya, Yuki; Ishida, Hidenori; Gosho, Masahiko; Kanazawa, Akio; Watada, Hirotaka			Relationships between lifestyle patterns and cardio-renal-metabolic parameters in patients with type 2 diabetes mellitus: A cross-sectional study	PLOS ONE			English	Article							MORNINGNESS-EVENINGNESS QUESTIONNAIRE; CORONARY-HEART-DISEASE; SLEEP DURATION; ALCOHOL-CONSUMPTION; ARTERIAL STIFFNESS; PHYSICAL-ACTIVITY; GLYCEMIC CONTROL; RISK-FACTOR; DEPRESSION; SCORE	Introduction While individuals tend to show accumulation of certain lifestyle patterns, the effect of such patterns in real daily life on cardio-renal-metabolic parameters remains largely unknown. This study aimed to assess clustering of lifestyle patterns and investigate the relationships between such patterns and cardio-renal-metabolic parameters. Participants and methods The study participants were 726 Japanese type 2 diabetes mellitus (T2DM) outpatients free of history of cardiovascular diseases. The relationship between lifestyle patterns and cardiorenal-metabolic parameters was investigated by linear and logistic regression analyses. Results Factor analysis identified three lifestyle patterns. Subjects characterized by evening type, poor sleep quality and depressive status (type 1 pattern) had high levels of HbA1c, alanine aminotransferase and albuminuria. Subjects characterized by high consumption of food, alcohol and cigarettes (type 2 pattern) had high levels of gamma-glutamyl transpeptidase, triglycerides, HDL-cholesterol, blood pressure, and brachial-ankle pulse wave velocity. Subjects characterized by high physical activity (type 3 pattern) had low uric acid and mild elevation of alanine aminotransferase and aspartate aminotransferase. In multivariate regression analysis adjusted by age, gender and BMI, type 1 pattern was associated with higher HbA1c levels, systolic BP and brachial-ankle pulse wave velocity. Type 2 pattern was associated with higher HDL-cholesterol levels, triglycerides, aspartate aminotransferase, gamma-glutamyl transpeptidase levels, and diastolic BP. Conclusions The study identified three lifestyle patterns that were associated with distinct cardio-metabolic-renal parameters in T2DM patients.	[Ogihara, Takeshi; Mita, Tomoya; Osonoi, Yusuke; Nakayama, Shiho; Someya, Yuki; Kanazawa, Akio; Watada, Hirotaka] Dept Endocrinol & Metab, Tokyo, Japan; [Mita, Tomoya; Kanazawa, Akio; Watada, Hirotaka] Ctr Therapeut Innovat Diabet, Tokyo, Japan; [Osonoi, Takeshi; Saito, Miyoko; Tamasawa, Atsuko; Ishida, Hidenori] Naka Mem Clin, Naka, Ibaraki, Japan; [Gosho, Masahiko] Univ Tsukuba, Fac Med, Dept Clin Trial & Clin Epidemiol, Tsukuba, Ibaraki, Japan; [Watada, Hirotaka] Ctr Mol Diabetol, Tokyo, Japan; [Watada, Hirotaka] Juntendo Univ, Sportol Ctr, Grad Sch Med, Tokyo, Japan	University of Tsukuba; Juntendo University	Mita, T (corresponding author), Dept Endocrinol & Metab, Tokyo, Japan.	tom-m@juntendo.ac.jp		Mita, Tomoya/0000-0002-4401-2965; Watada, Hirotaka/0000-0001-5961-1816	Manpei Suzuki Diabetes Foundation [26-76]	Manpei Suzuki Diabetes Foundation	This study was supported by research grand from Manpei Suzuki Diabetes Foundation (to T.M., Number 26-76). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAN A, 1994, ADDICTION, V89, P455, DOI 10.1111/j.1360-0443.1994.tb00926.x; Agency SaT, 2005, STAND TABL FOOD COMP, V5th; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Balkau B, 2004, DIABETOLOGIA, V47, P2118, DOI 10.1007/s00125-004-1574-5; Beck A. T, 1996, CORPORATION; Broms U, 2011, ADDICTION, V106, P170, DOI 10.1111/j.1360-0443.2010.03112.x; Buysse D J, 1989, Psychiatry Res, V28, P193; Chaput JP, 2012, APPETITE, V59, P650, DOI 10.1016/j.appet.2012.07.012; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hu G, 2005, DIABETES CARE, V28, P799, DOI 10.2337/diacare.28.4.799; Iwasaki M, 2013, J DIABETES INVEST, V4, P376, DOI 10.1111/jdi.12047; Jin Z, 2013, ANN RHEUM DIS; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Lee JH, 2014, CHRONOBIOL INT, V31, P479, DOI 10.3109/07420528.2013.867864; Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Mahmood WAW, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/341506; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9; Nakamura M, 2010, HYPERTENS RES, V33, P1018, DOI 10.1038/hr.2010.126; Ohkuma T, 2013, DIABETES CARE, V36, P611, DOI 10.2337/dc12-0904; Osonoi Y, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0132-6; Osonoi Y, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0026-1; Osonoi Y, 2014, CHRONOBIOL INT, V31, P1017, DOI 10.3109/07420528.2014.943843; OSTBERG O, 1973, ERGONOMICS, V16, P203, DOI 10.1080/00140137308924497; Reutrakul S, 2013, DIABETES CARE, V36, P2523, DOI 10.2337/dc12-2697; Roeser K, 2012, PHYSIOL BEHAV, V106, P151, DOI 10.1016/j.physbeh.2012.01.023; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Seike N, 2008, ASIA PAC J CLIN NUTR, V17, P545; Sone H, 2010, DIABETOLOGIA, V53, P419, DOI 10.1007/s00125-009-1622-2; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Takeno K, 2012, AM J HYPERTENS, V25, P165, DOI 10.1038/ajh.2011.158; Trento M, 2008, ACTA DIABETOL, V45, P225, DOI 10.1007/s00592-008-0047-6; Tsuchida Y, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-9; Vgontzas AN, 1999, CLIN ENDOCRINOL, V51, P205, DOI 10.1046/j.1365-2265.1999.00763.x; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Williams CJ, 2007, DIABETES CARE, V30, P1233, DOI 10.2337/dc06-2107; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879	43	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173540	10.1371/journal.pone.0173540	http://dx.doi.org/10.1371/journal.pone.0173540			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5VL	28273173	Green Published, gold, Green Submitted			2022-12-27	WOS:000396073700015
J	Sheehan, DF; Criss, SD; Gazelle, GS; Pandharipande, PV; Kong, CY				Sheehan, Deirdre F.; Criss, Steven D.; Gazelle, G. Scott; Pandharipande, Pari V.; Kong, Chung Yin			Evaluating lung cancer screening in China: Implications for eligibility criteria design from a microsimulation modeling approach	PLOS ONE			English	Article							COST-EFFECTIVENESS; TOBACCO CONTROL; AIR-POLLUTION; RISK; MORTALITY; SMOKING; BENEFITS; PROGRAM; TRENDS	More than half of males in China are current smokers and evidence from western countries tells us that an unprecedented number of smoking-attributable deaths will occur as the Chinese population ages. We used the China Lung Cancer Policy Model (LCPM) to simulate effects of computed tomography (CT)-based lung cancer screening in China, comparing the impact of a screening guideline published in 2015 by a Chinese expert group to a version developed for the United States by the U.S. Centers for Medicare & Medicaid Services (CMS). The China LCPM, built using an existing lung cancer microsimulation model, can project population outcomes associated with interventions for smoking-related diseases. After calibrating the model to published Chinese smoking prevalence and lung cancer mortality rates, we simulated screening from 2016 to 2050 based on eligibility criteria from the CMS and Chinese guidelines, which differ by age to begin and end screening, pack-years smoked, and years since quitting. Outcomes included number of screens, mortality reduction, and life-years saved for each strategy. We projected that in the absence of screening, 14.98 million lung cancer deaths would occur between 2016 and 2050. Screening with the CMS guideline would prevent 0.72 million deaths and 5.8 million life-years lost, resulting in 6.58% and 1.97% mortality reduction in males and females, respectively. Screening with the Chinese guideline would prevent 0.74 million deaths and 6.6 million life-years lost, resulting in 6.30% and 2.79% mortality reduction in males and females, respectively. Through 2050, 1.43 billion screens would be required using the Chinese screening strategy, compared to 988 million screens using the CMS guideline. In conclusion, CT-based lung cancer screening implemented in 2016 and based on the Chinese screening guideline would prevent about 20,000 (2.9%) more lung cancer deaths through 2050, but would require about 445 million (44.7%) more screens than the CMS guideline.	[Sheehan, Deirdre F.; Criss, Steven D.; Gazelle, G. Scott; Pandharipande, Pari V.; Kong, Chung Yin] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Gazelle, G. Scott; Pandharipande, Pari V.; Kong, Chung Yin] Harvard Med Sch, Boston, MA 02115 USA; [Gazelle, G. Scott] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Kong, CY (corresponding author), Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA.; Kong, CY (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	joey@mgh-ita.org		Criss, Steven/0000-0002-9394-1381; Kong, Chung Yin/0000-0001-6431-7830	National Institutes of Health [U01CA199284]; NATIONAL CANCER INSTITUTE [U01CA199284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health, Grant number: U01CA199284, https://www.nih.gov/.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; [Anonymous], 2013, LARG STUD NEV SMOK S; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Cassidy A, 2008, BRIT J CANCER, V98, P270, DOI 10.1038/sj.bjc.6604158; Centers for Medicare & Medicaid Services (CMS), 2015, DEC MEM SCREEN LUNG; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen ZM, 2015, LANCET, V386, P1447, DOI 10.1016/S0140-6736(15)00340-2; CHNS, 2015, CHIN HLTH NUTR SURV; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; de Koning HJ, 2013, ANN INTERN MED; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; Institute for Health Metrics and Evaluation, 2015, GLOB BURD DIS DAT; International Agency for Research on Cancer, 2015, LUNG CANC EST INC MO; Knudsen AB, 2010, JNCI-J NATL CANCER I, V102, P1238, DOI 10.1093/jnci/djq242; Kong JY, 2014, RESPIROLOGY, V19, P1222, DOI 10.1111/resp.12373; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Levy David, 2014, BMJ, V348, pg1134, DOI 10.1136/bmj.g1134; Li KR, 2015, CANCER PREV RES, V8, P777, DOI 10.1158/1940-6207.CAPR-14-0424; Li Q, 2011, NEW ENGL J MED, V364, P2469, DOI 10.1056/NEJMc1102459; Loomis D, 2014, CHIN J CANCER, V33, P189, DOI 10.5732/cjc.014.10028; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; McMahon PM, 2008, RADIOLOGY, V248, P278, DOI 10.1148/radiol.2481071446; McMahon PM, 2012, RISK ANAL, V32, pS117, DOI 10.1111/j.1539-6924.2011.01652.x; McMahon PM, 2011, J THORAC ONCOL, V6, P1841, DOI 10.1097/JTO.0b013e31822e59b3; McMahon PM, 2008, CANCER-AM CANCER SOC, V113, P3440, DOI 10.1002/cncr.23962; Moolgavkar SH, 2012, JNCI-J NATL CANCER I, V104, P541, DOI 10.1093/jnci/djs136; Mu LN, 2013, CANCER CAUSE CONTROL, V24, P439, DOI 10.1007/s10552-012-0130-8; Qian JC, 2010, B WORLD HEALTH ORGAN, V88, P769, DOI 10.2471/BLT.09.064709; Rutter CM, 2011, MED DECIS MAKING, V31, P10, DOI 10.1177/0272989X10369005; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9; Sone S, 2007, LUNG CANCER, V58, P329, DOI 10.1016/j.lungcan.2007.06.022; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; ten Haaf K, 2015, J THORAC ONCOL, V10, P1285, DOI 10.1097/JTO.0000000000000593; United States Census Bureau, 2015, INT DAT BAS; Wang Y, 2012, SHANDONG AGR SCI, V5, P9; Zhao SJ, 2015, THORAC CANCER, V6, P385, DOI 10.1111/1759-7714.12253; Zhou QH, 2015, THORAC CANCER, V6, P812, DOI 10.1111/1759-7714.12287; Zhou QH, 2014, THORAC CANCER, V5, P197, DOI 10.1111/1759-7714.12078	39	9	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0173119	10.1371/journal.pone.0173119	http://dx.doi.org/10.1371/journal.pone.0173119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273181	Green Submitted, Green Published, gold			2022-12-27	WOS:000396073700040
J	Suld, K; Saarma, U; Valdmann, H				Suld, Karmen; Saarma, Urmas; Valdmann, Harri			Home ranges of raccoon dogs in managed and natural areas	PLOS ONE			English	Article							MEDIUM-SIZED CARNIVORES; NYCTEREUTES-PROCYONOIDES; SOUTHERN FINLAND; HABITAT USE; ECHINOCOCCUS-MULTILOCULARIS; BODY-TEMPERATURE; RABIES SPREAD; WINTER SLEEP; EUROPE; ESTONIA	Knowledge of space use is central to understand animals' role in ecosystems. The raccoon dog Nyctereutes procyonoides is considered as one of the most influential alien mesopredator species in Europe, having the potential to cause loss of local biodiversity and act as a vector for zoonotic diseases. We collared 12 animals to study their home range and habitat use in two areas with different management regimes in Estonia: in a protected natural area and in an intensively managed area. From May to October raccoon dogs inhabiting the natural area had considerably smaller home ranges compared to the managed area, 193.3ha +/- 37.3SD and 391.9ha +/- 292.9SD, respectively. This result contradicts somewhat earlier findings in other European raccoon dog populations, where the home range sizes in natural areas in summer and autumn period have usually been larger compared to managed areas. In both study areas raccoon dogs preferred watersides, where amphibians and other semiaquatic prey are abundant, to other habitats available in their home ranges. We also studied movements of a raccoon dog pair in the managed study area in winter period. Due to mild weather conditions during the study period, raccoon dogs changed their resting sites quite often, covering a relatively large 599 ha area from November 2012 to January 2013, indicating the absence of usual winter lethargy during the mild winters.	[Suld, Karmen; Saarma, Urmas; Valdmann, Harri] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Valdmann, H (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia.	harri.valdmann@ut.ee	Saarma, Urmas/AAC-9813-2019	Saarma, Urmas/0000-0002-3222-571X	Estonian Environmental Investment Centre [3-3/53]	Estonian Environmental Investment Centre	This work was supported by Estonian Environmental Investment Centre, Contract nr 3-3/53; Recipient Karmen SON.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Aul Juhan, 1957, EESTI NSV IMETAJAD; Drygala F, 2008, MAMM BIOL, V73, P371, DOI 10.1016/j.mambio.2007.09.005; Drygala F, 2013, EUR J WILDLIFE RES, V59, P683, DOI 10.1007/s10344-013-0722-y; Drygala F, 2008, WILDLIFE BIOL, V14, P457, DOI 10.2981/0909-6396-14.4.457; Genovesi Piero, 2009, V3, P119; Heptner VG, 1998, MAMMALS SOVIET UN 1A; Holmala K, 2009, ANN ZOOL FENN, V46, P233, DOI 10.5735/086.046.0401; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; JEDRZEJEWSKA B, 1998, ECOLOGICAL STUDIES, V135; Kauhala K, 2006, ACTA THERIOL, V51, P1, DOI 10.1007/BF03192650; Kauhala K, 1996, Z SAUGETIERKD, V61, P269; KAUHALA K, 1993, J ZOOL, V231, P95, DOI 10.1111/j.1469-7998.1993.tb05355.x; Kauhala K, 2001, ECOGRAPHY, V24, P151, DOI 10.1034/j.1600-0587.2001.240205.x; Kauhala K, 2008, ACTA THERIOL, V53, P333, DOI 10.1007/BF03195194; Kauhala K, 2007, MAMM BIOL, V72, P342, DOI 10.1016/j.mambio.2006.10.006; Kauhala K, 2011, CURR ZOOL, V57, P584, DOI 10.1093/czoolo/57.5.584; Kauhala K, 2010, ACTA THERIOL, V55, P371, DOI 10.4098/j.at.0001-7051.063.2009; Kauhala K, 2010, ACTA THERIOL, V55, P231, DOI 10.4098/j.at.0001-7051.040.2009; Keller Reuben P., 2011, Environmental Sciences Europe, V23, P23, DOI 10.1186/2190-4715-23-23; Laurimaa L, 2016, VET PARASITOL, V219, P24, DOI 10.1016/j.vetpar.2016.01.020; Laurimaa L, 2015, VET PARASITOL, V212, P200, DOI 10.1016/j.vetpar.2015.06.004; Laurimaa L, 2015, EMERG INFECT DIS, V21, P163, DOI 10.3201/eid2101.140136; Moks E, 2005, EMERG INFECT DIS, V11, P1973, DOI 10.3201/eid1112.050339; Mustonen AM, 2007, CHRONOBIOL INT, V24, P1095, DOI 10.1080/07420520701797999; Mustonen AM, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-27; Naaber J., 1971, EESTI LODUS, V14, P449; Neronov VM, 2008, INTEGR ZOOL, V3, P83, DOI 10.1111/j.1749-4877.2008.00084.x; Oja R., 2010, METSSEA SUS SCROFA L; Partel A, 2013, B OIE, V3, P58; Pavlov M. P., 1974, ACCLIMATIZATION GA 2; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Suld K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096358; Sutor A, 2012, EUR J WILDLIFE RES, V58, P85, DOI 10.1007/s10344-011-0546-6; Veeroja R., 2015, STATUS GAME POPULATI; Vila M, 2008, HDB ALIEN SPECIES EU, P265	36	6	6	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0171805	10.1371/journal.pone.0171805	http://dx.doi.org/10.1371/journal.pone.0171805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	28273085	Green Published, Green Submitted, gold			2022-12-27	WOS:000396073700060
J	Hjelmen, CE; Johnston, JS				Hjelmen, Carl E.; Johnston, J. Spencer			The mode and tempo of genome size evolution in the subgenus Sophophora	PLOS ONE			English	Article							NUCLEAR-DNA CONTENT; DETERMINANT; DROSOPHILA; INFERENCE; DURATION; MRBAYES; BIAS	Genome size varies widely across organisms, with no apparent tie to organismal complexity. While genome size is inherited, there is no established evolutionary model for this trait. Hypotheses have been postulated for the observed variation in genome sizes across species, most notably the effective population size hypothesis, the mutational equilibrium hypothesis, and the adaptive hypothesis. While much data has been collected on genome size, the above hypotheses have largely ignored impacts from phylogenetic relationships. In order to test these competing hypotheses, genome sizes of 87 Sophophora species were analyzed in a comparative phylogenetic approach using Pagel's parameters of evolution, Blomberg's K, Abouheif's C-mean and Moran's I. In addition to testing the mode and rate of genome size evolution in Sophophora species, the effect of number of taxa on detection of phylogenetic signal was analyzed for each of these comparative phylogenetic methods. Sophophora genome size was found to be dependent on the phylogeny, indicating that evolutionary time was important for predicting the variation among species. Genome size was found to evolve gradually on branches of the tree, with a rapid burst of change early in the phylogeny. These results suggest that Sophophora genome size has experienced gradual changes, which support the largely theoretical mutational equilibrium hypothesis. While some methods (Abouheif's C-mean and Moran's I) were found to be affected by increasing taxa numbers, more commonly used methods (lambda and Blomberg's K) were found to have increasing reliability with increasing taxa number, with significantly more support with fifteen or more taxa. Our results suggest that these comparative phylogenetic methods, with adequate taxon sampling, can be a powerful way to uncover the enigma that is genome size variation through incorporation of phylogenetic relationships.	[Hjelmen, Carl E.; Johnston, J. Spencer] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Hjelmen, CE (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	cehjelmen09@tamu.edu	Hjelmen, Carl/AAO-8084-2020	Hjelmen, Carl/0000-0003-3061-6458				Abouheif E, 1999, EVOL ECOL RES, V1, P895; BENNETT M D, 1971, Proceedings of the Royal Society of London Series B Biological Sciences, V178, P277; BENNETT MD, 1972, PROC R SOC SER B-BIO, V181, P109, DOI 10.1098/rspb.1972.0042; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; CAVALIERSMITH T, 1982, ANNU REV BIOPHYS BIO, V11, P273, DOI 10.1146/annurev.bb.11.060182.001421; Da Lage JL, 2007, J ZOOL SYST EVOL RES, V45, P47, DOI 10.1111/j.1439-0469.2006.00389.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drosophila 12 Genomes Consortium, 2007, NATURE, V450, P203; Gregory TR, 2008, HEREDITY, V101, P228, DOI 10.1038/hdy.2008.49; Gregory T. R., ANIMAL GENOME SIZE D; Gregory T. Ryan, 2005, P3; Gregory TR, 2004, GENE, V324, P15, DOI 10.1016/j.gene.2003.09.030; Gregory TR, 2005, ANN BOT-LONDON, V95, P133, DOI 10.1093/aob/mci009; Gregory TR, 2003, TRENDS GENET, V19, P485, DOI 10.1016/S0168-9525(03)00192-6; Gregory TR, 1999, GENOME RES, V9, P317; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; GROSSET L, 1975, CELL TISSUE KINET, V8, P91, DOI 10.1111/j.1365-2184.1975.tb01210.x; Hare EE, 2011, METHODS MOL BIOL, V772, P3, DOI 10.1007/978-1-61779-228-1_1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUELSENBECK JP, 2001, BIOMETRICS, V17, P754, DOI [DOI 10.1093/BIOINFORMATICS/17.8.754, DOI 10.1093/BI0INF0RMATICS/17.8.754]; Jombart T., 2008, ADEPHYLO EXPLORATORY; Kapusta A, 2017, P NATL ACAD SCI USA, V114, pE1460, DOI 10.1073/pnas.1616702114; Kellermann V, 2012, EVOLUTION, V66, P3377, DOI 10.1111/j.1558-5646.2012.01685.x; Kelly VE, 2012, PARKINSONS DIS-US, V2012, DOI [10.1155/2012/918719, 10.1073/pnas.1207553109]; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2007, ORIGINS GENOME ARCHI; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Oliver MJ, 2007, GENOME RES, V17, P594, DOI 10.1101/gr.6096207; Orme D., 2013, CAPER PACKAGE COMP A, V5, P1; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Palazzo AF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004351; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Petrov DA, 2002, THEOR POPUL BIOL, V61, P531, DOI 10.1006/tpbi.2002.1605; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; Petrov DA, 2000, SCIENCE, V287, P1060, DOI 10.1126/science.287.5455.1060; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; Powell J. R., 1997, PROGR PROSPECTS EVOL; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Sessegolo C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0407; van der Linde K, 2010, GENET RES, V92, P25, DOI 10.1017/S001667231000008X; VANTHOF J, 1963, P NATL ACAD SCI USA, V49, P897, DOI 10.1073/pnas.49.6.897; Vinogradov AE, 2004, CURR OPIN GENET DEV, V14, P620, DOI 10.1016/j.gde.2004.09.007; Whitney KD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001080	46	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173505	10.1371/journal.pone.0173505	http://dx.doi.org/10.1371/journal.pone.0173505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267812	Green Submitted, gold, Green Published			2022-12-27	WOS:000396060600039
J	Hojman, DA; Duarte, F; Ruiz-Tagle, J; Budnich, M; Delgado, C; Slachevsky, A				Hojman, Daniel A.; Duarte, Fabian; Ruiz-Tagle, Jaime; Budnich, Marilu; Delgado, Carolina; Slachevsky, Andrea			The cost of dementia in an unequal country: The case of Chile	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INFORMAL CARE; SOCIOECONOMIC INEQUALITIES; COGNITIVE DECLINE; ECONOMIC-IMPACT; RUD INSTRUMENT; UNITED-STATES; PEOPLE; DETERMINANTS; UNDERDIAGNOSIS	We study the economic cost of dementia in Chile, and its variation according to socioeconomic status (SES). We use primary data from a survey of 330 informal primary caregivers who completed both a RUD-Lite and a socio-demographic questionnaire to evaluate the severity of dementia and caregiver's burden. The costs of dementia are broken into three components: direct medical costs (medical care, drugs, tests); direct social costs (social service, daycare); and indirect costs (mostly associated to informal care). The average monthly cost per patient is estimated at US$ 1,463. Direct medical costs account for 20 per cent, direct social costs for 5 per cent and indirect costs for 75 per cent of the total cost. The mean monthly cost is found to be inversely related to SES, a pattern largely driven by indirect costs. The monthly cost for high SES is US$ 1,083 and US$ 1,588 for low SES. A multivariate regression analysis suggests that severity of dementia and caregiver's burden account for between 49 and 70 per cent of the difference in the indirect cost across SES. However, between one-third and one-half of the variation across SES is not due to gradient in severity of dementia. Direct medical costs increase in higher SES, reflecting differences in purchasing power, while indirect costs are inversely related to SES and more than compensate differences in medical costs. Moreover, in lower SES groups, female caregivers, typically family members who are inactive in the labor market, mostly provide informal care. The average annual cost of dementia in Chile (US$ 17,559) is lower in comparison to high-income countries (US$ 39,595) and the proportion of cost related to informal cost is higher (74 per cent compared to 40 per cent). SES is a key determinant in the cost of dementia. In the absence of universal access to treatment, part of the social cost of dementia potentially preserves or increases income and gender inequality.	[Hojman, Daniel A.; Duarte, Fabian; Ruiz-Tagle, Jaime] Univ Chile, Fac Econ & Business, Dept Econ, Santiago, Chile; [Hojman, Daniel A.; Duarte, Fabian] Ctr Social Conflict & Cohes Studies, Santiago, Chile; [Budnich, Marilu] Ctr KINTUN, Serv Salud Metropolitano Oriente, Santiago, Chile; [Delgado, Carolina] Hosp Clin Univ Chile, Neurol & Neurosurg Dept, Santiago, Chile; [Delgado, Carolina] Clin Santa Maria, Neurol & Neurosurg Dept, Santiago, Chile; [Slachevsky, Andrea] Univ Chile, Fac Med, ICBM, Physiopathol Dept, Santiago, Chile; [Slachevsky, Andrea] Univ Chile, Fac Med, East Neurosci Dept, Santiago, Chile; [Slachevsky, Andrea] Gerosci Ctr Brain Hlth & Metab GERO, Santiago, Chile; [Slachevsky, Andrea] Hosp Salvador, Dept Neurol, Cognit Neurol & Dementia, Santiago, Chile; [Slachevsky, Andrea] Clin Alemana Univ Desarrollo, Dept Med, Neurol Serv, Santiago, Chile; [Slachevsky, Andrea] Ctr Adv Res Educ, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad del Desarrollo	Hojman, DA (corresponding author), Univ Chile, Fac Econ & Business, Dept Econ, Santiago, Chile.; Hojman, DA (corresponding author), Ctr Social Conflict & Cohes Studies, Santiago, Chile.; Slachevsky, A (corresponding author), Univ Chile, Fac Med, ICBM, Physiopathol Dept, Santiago, Chile.; Slachevsky, A (corresponding author), Univ Chile, Fac Med, East Neurosci Dept, Santiago, Chile.; Slachevsky, A (corresponding author), Gerosci Ctr Brain Hlth & Metab GERO, Santiago, Chile.; Slachevsky, A (corresponding author), Hosp Salvador, Dept Neurol, Cognit Neurol & Dementia, Santiago, Chile.; Slachevsky, A (corresponding author), Clin Alemana Univ Desarrollo, Dept Med, Neurol Serv, Santiago, Chile.; Slachevsky, A (corresponding author), Ctr Adv Res Educ, Santiago, Chile.	dhojman@fen.uchile.cl; andrea.slachevsky@uchile.cl	Hojman, Daniel A/N-4178-2015; delgado, carolina/AAS-2383-2021; Slachevsky, Andrea/P-4039-2014	Hojman, Daniel A/0000-0001-7768-0065; delgado, carolina/0000-0001-5551-0065; Slachevsky, Andrea/0000-0001-6285-3189	CONICYT/FONDECYT Regular [1140423]; Project IV concurso de Investigacion SSMO Santiago-Chile; CONICYT /Associative Research Program / Grant Basal Funds for Centers of Excellence [FB 0003]; Centre for Social Conflict and Cohesion Studies [CONICYT/FONDAP/15130009];  [CONICYT/FONDAP/15150012]	CONICYT/FONDECYT Regular(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Project IV concurso de Investigacion SSMO Santiago-Chile; CONICYT /Associative Research Program / Grant Basal Funds for Centers of Excellence; Centre for Social Conflict and Cohesion Studies; 	The study was funded by CONICYT/FONDECYT Regular/1140423 (AS and CD; CONICYT/FONDAP/15150012 (AS); Project IV concurso de Investigacion SSMO Santiago-Chile (AS and MLB); CONICYT /Associative Research Program / Grant Basal Funds for Centers of Excellence FB 0003 (AS) and Centre for Social Conflict and Cohesion Studies (grant number CONICYT/FONDAP/15130009 (DH and FD). The funder had no role in study design, data collection, analysis, data interpretation, manuscript writing, or decision to submit for publication. All authors had responsibility for the decision to submit for publication.	Adimark, 2000, NIV SOC EC ES MAN AP; Allegri RF, 2007, INT PSYCHOGERIATR, V19, P705, DOI 10.1017/S1041610206003784; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; [Anonymous], 2015, LANCET NEUROL, V14, P1143, DOI 10.1016/S1474-4422(15)00307-5; ARAYA R, 1992, SOC PSYCH PSYCH EPID, V27, P168, DOI 10.1007/BF00789001; Atun R, 2015, LANCET, V385, P1230, DOI 10.1016/S0140-6736(14)61646-9; Bossert TJ, 2016, NEW ENGL J MED, V374, P1, DOI 10.1056/NEJMp1514202; Breinbauer H, 2009, REV MED CHILE, V137, P657, DOI /S0034-98872009000500009; Casey David A, 2010, P T, V35, P208; Cavallo MC, 1997, ALZ DIS ASSOC DIS, V11, P184; Chiatti C, 2015, INT PSYCHOGERIATR, V27, P1563, DOI 10.1017/S104161021500040X; Coduras A, 2010, J ALZHEIMERS DIS, V19, P601, DOI 10.3233/JAD-2010-1258; Connolly A, 2011, AGING MENT HEALTH, V15, P978, DOI 10.1080/13607863.2011.596805; Cotlear D, 2015, LANCET, V385, P1248, DOI 10.1016/S0140-6736(14)61647-0; Custodio N, 2014, DEMENT NEUROPSYCHOL, V9, P32; Cutler DM, 2011, HDB HLTH EC; Darba J, 2014, EUROPEAN J HLTH EC H; Dartigues JF, 2009, LANCET NEUROL, V8, P1082, DOI 10.1016/S1474-4422(09)70298-4; [Data Processing Co. Ltd Frekans Research Field], 2004, SOC CLAS; Dodel R, 2015, ALZHEIMERS DEMENT, V11, P933, DOI 10.1016/j.jalz.2015.02.005; Frenz P, 2014, HEALTH POLICY PLANN, V29, P717, DOI 10.1093/heapol/czt054; Fuentes Patricio, 2014, Dement. neuropsychol., V8, P317, DOI 10.1590/S1980-57642014DN84000003; Fuentes-Garcia A, 2013, GAC SANIT, V27, P226, DOI 10.1016/j.gaceta.2012.11.005; Fukami M., 1998, MONETARY VALUATION U; GONZALEZ F, 2009, ESTUDIO NACL DEPENDE; Gustavsson A, 2011, ALZHEIMERS DEMENT, V7, P466, DOI 10.1016/j.jalz.2010.06.002; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Jonsson B, 2000, DEMENTIA WPA SERIES, P335; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Kang IO, 2007, INT J GERIATR PSYCH, V22, P675, DOI 10.1002/gps.1729; Karlsson G, 1998, HLTH EC DEMENTIA, P161; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; Koopmanschap M, 1998, HLTH EC DEMENTIA, P245; Kotagal V, 2015, NEUROLOGY, V84, P64, DOI 10.1212/WNL.0000000000001096; Lanska DJ, 2002, NEUROLOGY, V58, P1718, DOI 10.1212/WNL.58.12.1718; Liu Z, 2013, THESIS; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Martin BC, 2000, ALZ DIS ASSOC DIS, V14, P151, DOI 10.1097/00002093-200007000-00006; McDaid D, 2001, INT J GERIATR PSYCH, V16, P400, DOI 10.1002/gps.353; Munoz-Neira C, 2012, DEMENT GERIATR COGN, V33, P361, DOI 10.1159/000338606; Nakamura AE, 2015, LANCET, V385, P418, DOI 10.1016/S0140-6736(15)60153-2; Pickett K., 2011, SPIRIT LEVEL WHY GRE; Prince M, 2015, WORLD ALZHEIMERS REP; Scarmeas N, 2006, J NEUROL NEUROSUR PS, V77, P308, DOI 10.1136/jnnp.2005.072306; Slachevsky A, 2013, J ALZHEIMERS DIS, V35, P297, DOI 10.3233/JAD-122086; Turro-Garriga O, 2015, ARCH GERONTOL GERIAT, V60, P448, DOI 10.1016/j.archger.2015.01.020; van den Berg B, 2006, SOC SCI MED, V62, P835, DOI 10.1016/j.socscimed.2005.06.046; van den Berg Bernard, 2004, Eur J Health Econ, V5, P36, DOI 10.1007/s10198-003-0189-y; Veras RP, 2008, PSYCHOGERIATRICS, V8, P88, DOI 10.1111/j.1479-8301.2008.00237.x; Wimo A, 2010, J NUTR HEALTH AGING, V14, P685, DOI 10.1007/s12603-010-0316-2; Wimo A, 2000, INT J GERIATR PSYCH, V15, P969, DOI 10.1002/1099-1166(200010)15:10<969::AID-GPS272>3.0.CO;2-9; Wimo A, 2010, GLOBALL EC IMPACT DE; Wimo A, 2013, ALZHEIMERS DEMENT, V9; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR	57	35	38	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0172204	10.1371/journal.pone.0172204	http://dx.doi.org/10.1371/journal.pone.0172204			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5QM	28267795	Green Published, gold, Green Submitted			2022-12-27	WOS:000396060600055
J	Penberthy, KK; Buckley, MW; Arandjelovic, S; Ravichandran, K				Penberthy, Kristen Kelley; Buckley, Monica Weaver; Arandjelovic, Sanja; Ravichandran, Kodi			Ex vivo modulation of the Foxo1 phosphorylation state does not lead to dysfunction of T regulatory cells	PLOS ONE			English	Article							FOXP3 EXPRESSION; PHOSPHATASE PP2A; ASTHMA; IL-10; DIFFERENTIATION; INDUCTION; PROTEINS; TREGS; GAMMA	Peripheral regulatory CD4(+) T cells (Treg cells) prevent maladaptive inflammatory responses to innocuous foreign antigens. Treg cell dysfunction has been linked to many inflammatory diseases, including allergic airway inflammation. Glucocorticoids that are used to treat allergic airway inflammation and asthma are thought to work in part by promoting Treg cell differentiation; patients who are refractory to these drugs have defective induction of anti-inflammatory Treg cells. Previous observations suggest that Treg cells deficient in the transcription factor FoxO1 are pro-inflammatory, and that FoxO1 activity is regulated by its phosphorylation status and nuclear localization. Here, we asked whether altering the phosphorylation state of FoxO1 through modulation of a regulatory phosphatase might affect Treg cell function. In a mouse model of house dust mite-induced allergic airway inflammation, we observed robust recruitment of Treg cells to the lungs and lymph nodes of diseased mice, without an apparent increase in the Treg cytokine interleukin-10 in the airways. Intriguingly, expression of PP2A, a serine/threonine phosphatase linked to the regulation of FoxO1 phosphorylation, was decreased in the mediastinal lymph nodes of HDM-treated mice, mirroring the decreased PP2A expression seen in peripheral blood monocytes of glucocorticoid-resistant asthmatic patients. When we asked whether modulation of PP2A activity alters Treg cell function via treatment with the PP2A inhibitor okadaic acid, we observed increased phosphorylation of FoxO1 and decreased nuclear localization. However, dysregulation of FoxO1 did not impair Treg cell differentiation ex vivo or cause Treg cells to adopt a pro-inflammatory phenotype. Moreover, inhibition of PP2A activity did not affect the suppressive function of Treg cells ex vivo. Collectively, these data suggest that modulation of the phosphorylation state of FoxO1 via PP2A inhibition does not modify Treg cell function ex vivo. Our data also highlight the caveat in using ex vivo assays of Treg cell differentiation and function, in that while these assays are useful, they may not fully recapitulate Treg cell phenotypes that are observed in vivo.	[Penberthy, Kristen Kelley; Buckley, Monica Weaver; Arandjelovic, Sanja; Ravichandran, Kodi] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA; [Penberthy, Kristen Kelley; Buckley, Monica Weaver; Arandjelovic, Sanja; Ravichandran, Kodi] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22903 USA; [Penberthy, Kristen Kelley; Buckley, Monica Weaver; Arandjelovic, Sanja; Ravichandran, Kodi] Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia; University of Virginia	Ravichandran, K (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA.; Ravichandran, K (corresponding author), Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22903 USA.; Ravichandran, K (corresponding author), Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22903 USA.	Ravi@virginia.edu		Ravichandran, Kodi/0000-0001-9049-1410	National Institute of General Medical Sciences [GM064709]; National Heart, Lung and Blood Institute [P01HL120840, F30 HL126385]; Center for Cell Clearance/University of Virginia School of Medicine; National Institute of Allergy and Infectious Disease NIH [T32 A1007496]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL126385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Center for Cell Clearance/University of Virginia School of Medicine; National Institute of Allergy and Infectious Disease NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by grants to K.S. R. from National Institute of General Medical Sciences (GM064709), National Heart, Lung and Blood Institute (P01HL120840), and the Center for Cell Clearance/University of Virginia School of Medicine. K.K.P. is supported by an National Heart, Lung and Blood Institute F30 award (F30 HL126385) and previously by the National Institute of Allergy and Infectious Disease NIH T32 Immunology Training Grant (T32 A1007496). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolidis SA, 2016, NAT IMMUNOL, V17, P556, DOI 10.1038/ni.3390; Bengtsson L, 2009, J CELL SCI, V122, P1248, DOI 10.1242/jcs.039552; Bohm L, 2015, J IMMUNOL, V194, P887, DOI 10.4049/jimmunol.1401612; Borish L, 1996, J ALLERGY CLIN IMMUN, V97, P1288, DOI 10.1016/S0091-6749(96)70197-5; Chang X, 2005, J EXP MED, V202, P1141, DOI 10.1084/jem.20050157; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Du XR, 2014, J IMMUNOL, V192, P1525, DOI 10.4049/jimmunol.1301060; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsu P, 2015, J IMMUNOL, V195, P3665, DOI 10.4049/jimmunol.1402898; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Karagiannidis C, 2004, J ALLERGY CLIN IMMUN, V114, P1425, DOI 10.1016/j.jaci.2004.07.014; Kennedy JL, 2012, CLIN EXP ALLERGY, V42, P659, DOI 10.1111/j.1365-2222.2011.03944.x; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kobayashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027627; Kumar Rakesh K., 2006, Inflammation & Allergy Drug Targets, V5, P253, DOI 10.2174/187152806779010909; Kurimchak A, 2012, GENE, V499, P1, DOI 10.1016/j.gene.2012.02.015; Kwak JH, 2008, J BIOL CHEM, V283, P19816, DOI 10.1074/jbc.M802285200; Lambrecht BN, 2013, EUR J IMMUNOL, V43, P3125, DOI 10.1002/eji.201343730; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Lin YL, 2008, ALLERGY, V63, P67, DOI 10.1111/j.1398-9995.2007.01526.x; Lu J, 2009, P NATL ACAD SCI USA, V106, P11697, DOI 10.1073/pnas.0905930106; Luo CT, 2016, NATURE, V529, P532, DOI 10.1038/nature16486; Mamessier E, 2008, ALLERGY, V63, P1202, DOI 10.1111/j.1398-9995.2008.01687.x; Martelli AM, 2012, BBA-MOL CELL RES, V1823, P2168, DOI 10.1016/j.bbamcr.2012.08.017; Mays LE, 2013, J CLIN INVEST, V123, P1216, DOI 10.1172/JCI65351; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nadeau K, 2010, J ALLERGY CLIN IMMUN, V126, P845, DOI 10.1016/j.jaci.2010.08.008; Nguyen Khoa D, 2010, Allergy Asthma Clin Immunol, V6, P4, DOI 10.1186/1710-1492-6-4; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Provoost S, 2009, ALLERGY, V64, P1539, DOI 10.1111/j.1398-9995.2009.02056.x; Puthanveetil P, 2013, CARDIOVASC RES, V97, P393, DOI 10.1093/cvr/cvs426; Raundhal M, 2015, J CLIN INVEST, V125, P3037, DOI 10.1172/JCI80911; Robinson DS, 2004, J CLIN INVEST, V114, P1389, DOI 10.1172/JCI200423595; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Swingle Mark, 2007, V365, P23; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Van Hoof C, 2004, CANCER CELL, V5, P105, DOI 10.1016/S1535-6108(04)00027-3; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	49	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2017	12	3							e0173386	10.1371/journal.pone.0173386	http://dx.doi.org/10.1371/journal.pone.0173386			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5QM	28267764	Green Published, Green Submitted, gold			2022-12-27	WOS:000396060600028
J	El-Sayed, YS; Lebda, MA; Hassinin, M; Noeman, SA				El-Sayed, Yasser S.; Lebda, Mohamed A.; Hassinin, Mohammed; Noeman, Saad A.			Retraction: Chicory (Cichorium intybus L.) Root Extract Regulates the Oxidative Status and Antioxidant Gene Transcripts in CCl4-Induced Hepatotoxicity (vol 10, e0121549, 2015)	PLOS ONE			English	Correction													El-Sayed, Yasser S./E-6400-2010	El-Sayed, Yasser S./0000-0003-3915-4640; noeman, saad/0000-0002-0964-6057				El-Sayed YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121549; Keshk WA, 2013, EGYPTIAN J BIOCH MOL, V32, P99; Soliman NA, 2014, EGYPTIAN J BIOCH MOL, V32, P115	3	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173587	10.1371/journal.pone.0173587	http://dx.doi.org/10.1371/journal.pone.0173587			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264014	Green Submitted, Green Published, gold			2022-12-27	WOS:000396054300070
J	Zhou, T; Souzeau, E; Sharma, S; Landers, J; Mills, R; Goldberg, I; Healey, PR; Graham, S; Hewitt, AW; Mackey, DA; Galanopoulos, A; Casson, RJ; Ruddle, JB; Ellis, J; Leo, P; Brown, MA; MacGregor, S; Lynn, DJ; Burdon, KP; Craig, JE				Zhou, Tiger; Souzeau, Emmanuelle; Sharma, Shiwani; Landers, John; Mills, Richard; Goldberg, Ivan; Healey, Paul R.; Graham, Stuart; Hewitt, Alex W.; Mackey, David A.; Galanopoulos, Anna; Casson, Robert J.; Ruddle, Jonathan B.; Ellis, Jonathan; Leo, Paul; Brown, Matthew A.; MacGregor, Stuart; Lynn, David J.; Burdon, Kathryn P.; Craig, Jamie E.			Whole exome sequencing implicates eye development, the unfolded protein response and plasma membrane homeostasis in primary open-angle glaucoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ENDOPLASMIC-RETICULUM STRESS; COPY NUMBER VARIATIONS; CHEMICAL CHAPERONE; MOUSE MODEL; CELL-DEATH; WILD-TYPE; MYOCILIN; MUTATIONS; LOCI	Purpose To identify biological processes associated with POAG and its subtypes, high-tension (HTG) and normal -tension glaucoma (NTG), by analyzing rare potentially damaging genetic variants. Methods A total of 122 and 65 unrelated HTG and NTG participants, respectively, with early onset advanced POAG, 103 non -glaucoma controls and 993 unscreened ethnicity-matched controls were included in this study. Study participants without myocilin disease-causing variants and non -glaucoma controls were subjected to whole exome sequencing on an Illumina HiSeq2000. Exomes of participants were sequenced on an Illumina HiSeq2000. Qualifying variants were rare in the general population (MAF < 0.001) and potentially functionally damaging (nonsense, frameshift, splice or predicted pathogenic using SIFT or Polyphen2 software). Genes showing enrichment of qualifying variants in cases were selected for pathway and network analysis using InnateDB. Results POAG cases showed enrichment of rare variants in camera -type eye development genes (p = 1.40x10-7, corrected p = 3.28x10-4). Implicated eye development genes were related to neuronal or retinal development. HTG cases were significantly enriched for key regulators in the unfolded protein response (UPR) (p = 7.72x10-5, corrected p = 0.013). The UPR is known to be involved in myocilin-related glaucoma; our results suggest the UPR has a role in non-myocilin causes of HTG. NTG cases showed enrichment in ion channel transport processes (p = 1.05x10-4, corrected p = 0.027) including calcium, chloride and phospholipid transporters involved in plasma membrane homeostasis. Network analysis also revealed enrichment of the MHC Class I antigen presentation pathway in HTG, and the EGFR1 and cell-cycle pathways in both HTG and NTG. Conclusion This study suggests that mutations in eye development genes are enriched in POAG. HTG can result from aberrant responses to protein misfolding which may be amenable to molecular chaperone therapy. NTG is associated with impaired plasma membrane homeostasis increasing susceptibility to apoptosis.	[Zhou, Tiger; Souzeau, Emmanuelle; Sharma, Shiwani; Landers, John; Mills, Richard; Burdon, Kathryn P.; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Bedford Pk, SA, Australia; [Goldberg, Ivan; Healey, Paul R.; Graham, Stuart] Univ Sydney, Discipline Ophthalmol, Sydney, NSW, Australia; [Goldberg, Ivan] Sydney Eye Hosp, Glaucoma Unit, Sydney, NSW, Australia; [Healey, Paul R.] Univ Sydney, Westmead Inst Med Res, Ctr Vis Res, Sydney, NSW, Australia; [Hewitt, Alex W.; Burdon, Kathryn P.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA, Australia; [Galanopoulos, Anna; Casson, Robert J.] Univ Adelaide, Discipline Ophthalmol & Visual Sci, Adelaide, SA, Australia; [Ruddle, Jonathan B.] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Ellis, Jonathan; Leo, Paul; Brown, Matthew A.] Univ Queensland, Diamantina Inst, Translat Res Inst, Princess Alexandra Hosp, Woolloongabba, Qld, Australia; [MacGregor, Stuart] Royal Brisbane Hosp, QIMR Berghofer Med Res Inst, Stat Genet, Brisbane, Qld, Australia; [Lynn, David J.] South Australian Med & Hlth Res Inst, Infect & Immun Theme, EMBL Australia Grp, Adelaide, SA, Australia; [Lynn, David J.] Flinders Univ S Australia, Sch Med, Adelaide, SA, Australia	Flinders University South Australia; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Tasmania; Menzies Institute for Medical Research; Lions Eye Institute; University of Western Australia; University of Adelaide; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Queensland; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Flinders University South Australia	Zhou, T (corresponding author), Flinders Univ S Australia, Dept Ophthalmol, Bedford Pk, SA, Australia.	tiger.zhou@sa.gov.au	Mackey, David A/H-5340-2014; Burdon, Kathryn/A-5026-2009; Burdon, Kathryn/AAD-2334-2022; Brown, Matthew A/E-5749-2010; Souzeau, Emmanuelle/AAB-5608-2022; Leo, Paul/R-4464-2019; Macgregor, Stuart/C-6442-2009; Ellis, Jonathan J/F-2920-2010	Mackey, David A/0000-0001-7914-4709; Burdon, Kathryn/0000-0001-8217-1249; Burdon, Kathryn/0000-0001-8217-1249; Brown, Matthew A/0000-0003-0538-8211; Souzeau, Emmanuelle/0000-0002-2015-6577; Macgregor, Stuart/0000-0001-6731-8142; Ellis, Jonathan J/0000-0003-0410-5064; Hewitt, Alex/0000-0002-5123-5999; Mills, Richard/0000-0002-7386-2571; Craig, Jamie/0000-0001-9955-9696; Sharma, Shiwani/0000-0002-0828-025X; Lynn, David/0000-0003-4664-1404; Graham, Stuart/0000-0001-7519-969X; Ellis, Jonathan/0000-0003-0218-546X	National Health and Medical Research Council (NHMRC) [APP1023911, APP1107098]; Australian Research Council Future Fellowship; EMBL Australia Group Leader award; NHMRC Practitioner Fellowship [APP1065433]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council); EMBL Australia Group Leader award; NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This project is supported by The National Health and Medical Research Council (NHMRC) Centres of Research Excellence scheme (APP1023911) and project grant (APP1107098). SM is supported by an Australian Research Council Future Fellowship. DJL is supported by an EMBL Australia Group Leader award. JEC is supported by an NHMRC Practitioner Fellowship (APP1065433). The funding organizations had no role in the design or conduct of this research.	Abu-Amero KK, 2013, OPHTHALMIC GENETICS; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anholt RRH, 2013, TRENDS MOL MED, V19, P586, DOI 10.1016/j.molmed.2013.06.005; Awadalla MS, 2015, AM J OPHTHALMOL, V159, P124, DOI 10.1016/j.ajo.2014.09.044; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Carbone MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020649; Carbone MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004216; Charitou T, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0205-1; Charlesworth J, 2010, INVEST OPHTH VIS SCI, V51, P3509, DOI 10.1167/iovs.09-4786; Cirulli ET, 2015, SCIENCE NEW YORK NY; Coleman JA, 2014, J CELL SCI, V127, P1138, DOI 10.1242/jcs.145052; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fingert JH, 2011, HUM MOL GENET, V20, P2482, DOI 10.1093/hmg/ddr123; Fromm JA, 2008, MOL CELL BIOL, V28, P6483, DOI 10.1128/MCB.00288-08; Gemenetzi M, 2012, EYE, V26, P355, DOI 10.1038/eye.2011.309; Gharahkhani P, 2014, NAT GENET, V46, P1120, DOI 10.1038/ng.3079; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Hu SS, 2010, MOL VIS, V16, P1585; Hu T, 2015, BIOCOMPUT-PAC SYM, P207; Huang XB, 2015, INT J MOL MED, V36, P1111, DOI 10.3892/ijmm.2015.2325; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Jakobs TC, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a020636; Jia LY, 2009, INVEST OPHTH VIS SCI, V50, P3743, DOI 10.1167/iovs.08-3151; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lu Y, 2013, NAT GENET, V45, P155, DOI 10.1038/ng.2506; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mackey DA, 2014, CURR OPIN OPHTHALMOL, V25, P386, DOI 10.1097/ICU.0000000000000090; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Rieck J, 2013, INVEST OPHTH VIS SCI, V54, P2393, DOI 10.1167/iovs.12-9781; Ruggiero L, 2012, P NATL ACAD SCI USA, V109, P8145, DOI 10.1073/pnas.1121101109; Sacca SC, 2015, J CELL PHYSIOL, V230, P510, DOI 10.1002/jcp.24826; Sakamoto K, 2014, EUR J PHARMACOL, V733, P13, DOI 10.1016/j.ejphar.2014.03.035; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Souzeau E, 2015, JAMA OPHTHALMOL, V133, P826, DOI 10.1001/jamaophthalmol.2015.0980; Souzeau E, 2012, CLIN EXP OPHTHALMOL, V40, P569, DOI 10.1111/j.1442-9071.2011.02742.x; Springelkamp H, 2015, GENET EPIDEMIOL, V39, P207, DOI 10.1002/gepi.21886; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Su CC, 2012, EYE, V26, P1369, DOI 10.1038/eye.2012.159; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ward NJ, 2014, J NEUROSCI, V34, P3161, DOI 10.1523/JNEUROSCI.4089-13.2014; Wolfs RCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1640, DOI 10.1001/archopht.116.12.1640; Xia CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052894; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Yam GHF, 2007, AM J PATHOL, V170, P100, DOI 10.2353/ajpath.2007.060806; Zode GS, 2012, INVEST OPHTH VIS SCI, V53, P1557, DOI 10.1167/iovs.11-8837; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	61	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0172427	10.1371/journal.pone.0172427	http://dx.doi.org/10.1371/journal.pone.0172427			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5OE	28264060	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000396054300012
J	Comte, A; Grafenhan, T; Links, MG; Hemmingsen, SM; Dumonceaux, TJ				Comte, Alexia; Grafenhan, Tom; Links, Matthew G.; Hemmingsen, Sean M.; Dumonceaux, Tim J.			Quantitative molecular diagnostic assays of grain washes for Claviceps purpurea are correlated with visual determinations of ergot contamination	PLOS ONE			English	Article							ALKALOIDS; REGION; WHEAT; DNA	We examined the epiphytic microbiome of cereal grain using the universal barcode chaperonin-60 (cpn60). Microbial community profiling of seed washes containing DNA extracts prepared from field-grown cereal grain detected sequences from a fungus identified only to Class Sordariomycetes. To identify the fungal sequence and to improve the reference database, we determined cpn60 sequences from field -collected and reference strains of the ergot fungus, Claviceps purpurea. These data allowed us to identify this fungal sequence as deriving from C. purpurea, and suggested that C. purpurea DNA is readily detectable on agricultural commodities, including those for which ergot was not identified as a grading factor. To get a sense of the prevalence and level of C. purpurea DNA in cereal grains, we developed a quantitative PCR assay based on the fungal internal transcribed spacer (ITS) and applied it to 137 samples from the 2014 crop year. The amount of Claviceps DNA quantified correlated strongly with the proportion of ergot sclerotia identified in each grain lot, although there was evidence that non -target organisms were responsible for some false positives with the ITS -based assay. We therefore developed a cpn60-targeted loop -mediated isothermal amplification assay and applied it to the same grain wash samples. The time to positive displayed a significant, inverse correlation to ergot levels determined by visual ratings. These results indicate that both laboratory -based and field -adaptable molecular diagnostic assays can be used to detect and quantify pathogen load in bulk commodities using cereal grain washes.	[Comte, Alexia; Links, Matthew G.; Dumonceaux, Tim J.] Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Saskatoon, SK, Canada; [Grafenhan, Tom] Canadian Grain Commiss, Grain Res Lab, Winnipeg, MB, Canada; [Links, Matthew G.] Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK, Canada; [Hemmingsen, Sean M.] Natl Res Council Canada, Saskatoon, SK, Canada; [Hemmingsen, Sean M.] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada; [Dumonceaux, Tim J.] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK, Canada	Agriculture & Agri Food Canada; University of Saskatchewan; National Research Council Canada; University of Saskatchewan; University of Saskatchewan	Dumonceaux, TJ (corresponding author), Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Saskatoon, SK, Canada.; Dumonceaux, TJ (corresponding author), Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK, Canada.	tim.dumonceaux@agr.gc.ca	Dumonceaux, Tim/H-4751-2019; Links, Matthew G./P-4949-2019	Dumonceaux, Tim/0000-0001-5165-0343; Links, Matthew G./0000-0003-1917-6789	Canadian Safety and Security Program (CSSP) [CRTI 09-462RD/CSSP 30w01]; Genomics Research and Development Initiative (GRDI) Quarantine and Invasive Species (QIS) project	Canadian Safety and Security Program (CSSP); Genomics Research and Development Initiative (GRDI) Quarantine and Invasive Species (QIS) project	This work was funded by the Canadian Safety and Security Program (CSSP) funded project CRTI 09-462RD/CSSP 30w01, and by the Genomics Research and Development Initiative (GRDI) Quarantine and Invasive Species (QIS) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman SC, 2015, PLANT DIS, V99, P1410, DOI 10.1094/PDIS-09-14-0978-RE; Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09; Comte A, 2016, DATA BRIEF UNPUB; Dahan ME, 2016, REUTERS; Flieger M, 1997, FOLIA MICROBIOL, V42, P3, DOI 10.1007/BF02898641; Guo QZ, 2016, J AGR FOOD CHEM, V64, P7033, DOI 10.1021/acs.jafc.6b02484; Hill JE, 2005, APPL ENVIRON MICROB, V71, P867, DOI 10.1128/AEM.71.2.867-875.2005; Hill JE, 2004, GENOME RES, V14, P1669, DOI 10.1101/gr.2649204; KENDRICK B, 1992, 5 KINGDOM; Levesque C, 2015, CRTI 09 462RD NEXT G; Links MG, 2014, NEW PHYTOL, V202, P542, DOI 10.1111/nph.12693; Links MG, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-23; Links MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049755; Magnuson BA, 2014, FOOD CHEM TOXICOL, V63, P91, DOI 10.1016/j.fct.2013.10.041; Oellig C, 2016, J CHROMATOGR A, V1441, P126, DOI 10.1016/j.chroma.2016.02.075; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POINAR G, 2015, PALAEODIVERSITY, P13; Schardl CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003323; Schellenberg J, 2011, METHODS MOL BIOL, V733, P143, DOI 10.1007/978-1-61779-089-8_10; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165995; Tittlemier SA, 2015, J AGR FOOD CHEM, V63, P6644, DOI 10.1021/acs.jafc.5b02977; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57	27	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173495	10.1371/journal.pone.0173495	http://dx.doi.org/10.1371/journal.pone.0173495			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257512	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100093
J	Otgonjargala, B; Becker, K; Batbaatar, G; Tsogtsaikhan, S; Enkhtsetseg, J; Enkhjargal, A; Pfeffer, K; Adams, O; Battogtokh, C; Henrich, B				Otgonjargala, Byambaa; Becker, Kathrin; Batbaatar, Gunchin; Tsogtsaikhan, Sandag; Enkhtsetseg, Jamsranjav; Enkhjargal, Altangerel; Pfeffer, Klaus; Adams, Ortwin; Battogtokh, Chimeddorj; Henrich, Birgit			Effect of Mycoplasma hominis and cytomegalovirus infection on pregnancy outcome: A prospective study of 200 Mongolian women and their newborns	PLOS ONE			English	Article							UREAPLASMA-UREALYTICUM; BACTERIAL VAGINOSIS; CHLAMYDIA-TRACHOMATIS; GENITAL MYCOPLASMA; PRETERM LABOR; PREVALENCE; TRACT; BIRTH; COLONIZATION; ASSOCIATION	In Mongolia, diagnostic tests for the detection of the sexually transmitted mycoplasmas, ureaplasmas, Herpes simplex virus (HSV), and cytomegalovirus (CMV) are currently not routinely used in clinical settings and the frequency of these STIs are enigmatic. The prevalence of these STI pathogens were prospectively evaluated among 200 Mongolian pregnant women and their newborns and correlated with pregnancy outcome. TaqMan PCRs were used to detect bacterial and viral STI pathogens in pre-birth vaginal swabs of the pregnant women and in oral swabs of their newborns. A standardized questionnaire concerning former and present pregnancies was developed and linear regression analysis was used to correlate pathogen detection with pregnancy outcome. Ureaplasmas were the most prevalent of the tested pathogens (positive in 90.5% positive women and 47.5% newborns), followed by mycoplasmas (32.5% and 7.5%), chlamydia (14.5% and 7.5%), trichomonas (8.5% and 4.0%) and gonococcus (0.5% and 0%). CMV was found in 46.5% of the pregnant women and in 10.5% of their newborns, whereas HSV-2 was detected in only two mothers. Multiple regression analyses indicate that colonization of the mothers with U. urealyticum, M. hominis, T. vaginalis or CMV is associated with transmission to newborns and that transmission of M. hominis or CMV from Mongolian pregnant women to offspring is associated with reduced neonatal length and gestational age. Thus, diagnostic tests for their detection should be implemented in the clinical settings in Mongolia.	[Otgonjargala, Byambaa; Batbaatar, Gunchin; Tsogtsaikhan, Sandag] Mongolian Natl Univ Med Sci, Sch Pharm & Biomed, Dept Microbiol & Immunol, Ulaanbaatar, Mongolia; [Becker, Kathrin] Univ Clin, Dept Orthodont, Dusseldorf, Germany; [Enkhtsetseg, Jamsranjav] Mongolian Natl Univ Med Sci, Sch Med, Dept Obstet & Gynecol, Ulaanbaatar, Mongolia; [Enkhjargal, Altangerel; Battogtokh, Chimeddorj] Inst Publ Hlth, Ctr Environm Hlth & Toxicol, Ulaanbaatar, Mongolia; [Pfeffer, Klaus; Henrich, Birgit] Heinrich Heine Univ, Inst Med Microbiol & Hosp Hyg, Dusseldorf, Germany; [Adams, Ortwin] Heinrich Heine Univ, Inst Virol, Dusseldorf, Germany	Mongolian National University of Medical Sciences; Mongolian National University of Medical Sciences; Mongolian National University of Medical Sciences; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Henrich, B (corresponding author), Heinrich Heine Univ, Inst Med Microbiol & Hosp Hyg, Dusseldorf, Germany.	Birgit.henrich@hhu.de	Becker, Kathrin/GPS-8383-2022; Becker, Kathrin/H-7656-2019; San, Tsogt/AAX-6434-2020	Becker, Kathrin/0000-0003-1936-4683; San, Tsogt/0000-0003-4916-5108; Batbaatar, Gunchin/0000-0002-6678-7569	German Foreign Exchange Service (DAAD) PAGEL project [54448058]	German Foreign Exchange Service (DAAD) PAGEL project(Deutscher Akademischer Austausch Dienst (DAAD))	This study had been supported by the German Foreign Exchange Service (DAAD) PAGEL project # 54448058. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2015, OBSTET GYNECOL, V125, P1510, DOI DOI 10.1097/01.AOG.0000466430.19823.53; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; Capoccia R, 2013, CURR OPIN INFECT DIS, V26, P231, DOI 10.1097/QCO.0b013e328360db58; Choi SJ, 2012, ANN LAB MED, V32, P194, DOI 10.3343/alm.2012.32.3.194; DaSilva O, 1997, PEDIATR INFECT DIS J, V16, P364, DOI 10.1097/00006454-199704000-00006; Dingens AS, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1073-y; Donders GGG, 2000, AM J OBSTET GYNECOL, V183, P431, DOI 10.1067/mob.2000.105738; El-Khier N. T. A., 2014, African Journal of Microbiology Research, V8, P2631; Foxman B, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.003; Garland S M, 2001, Infect Dis Obstet Gynecol, V9, P143, DOI 10.1155/S1064744901000254; Geisler WM, 2004, SEX TRANSM INFECT, V80, P401, DOI 10.1136/sti.2003.009134; Giakoumelou S, 2016, HUM REPROD UPDATE, V22, P116, DOI 10.1093/humupd/dmv041; Glaser K, 2015, EXPERT REV ANTI-INFE, V13, P233, DOI 10.1586/14787210.2015.999670; Kafetzis DA, 2004, CLIN INFECT DIS, V39, P1113, DOI 10.1086/424505; Kwak DW, 2014, J MATERN-FETAL NEO M, V27, P333, DOI 10.3109/14767058.2013.818124; Li LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116699; Ljubojevic S, 2010, ACTA DERMATOVENER CR, V18, P305; McDonagh S, 2004, J INFECT DIS, V190, P826, DOI 10.1086/422330; Megli C, 2016, AM J OBSTET GYNECOL, V214, pS271, DOI 10.1016/j.ajog.2015.10.540; Mobius N, 2012, METHODS MOL BIOL, V903, P235, DOI 10.1007/978-1-61779-937-2_15; Mussi-Pinhata MM, 2009, CLIN INFECT DIS, V49, P522, DOI 10.1086/600882; Naing ZW, 2016, AUST NZ J OBSTET GYN, V56, P9, DOI 10.1111/ajo.12408; Olomu IN, 2009, PEDIATRICS, V123, P1329, DOI 10.1542/peds.2008-1113; Onderdonk AB, 2016, CLIN MICROBIOL REV, V29, P223, DOI 10.1128/CMR.00075-15; Onderdonk AB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.068; Patel KK, 2011, RESPIROLOGY, V16, P1081, DOI 10.1111/j.1440-1843.2011.02016.x; Ross SA, 2005, J INFECT DIS, V192, P1727, DOI 10.1086/497150; RStudio, 2015, RSTUDIO INT DEV R; Schirm J, 2007, J MICROBIOL METH, V68, P243, DOI 10.1016/j.mimet.2006.08.002; Schonberger S, 2010, BIOL BLOOD MARROW TR, V16, P1428, DOI 10.1016/j.bbmt.2010.04.008; Seifoleslami M, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.16823; Silveira MF, 2009, INT J STD AIDS, V20, P465, DOI 10.1258/ijsa.2008.008388; Song D, 2014, CHINESE MED J-PEKING, V127, P3171, DOI 10.3760/cma.j.issn.0366-6999.20133072; Vouga M, 2014, CLIN MICROBIOL INFEC, V20, P1074, DOI 10.1111/1469-0691.12686	34	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2017	12	3							e0173283	10.1371/journal.pone.0173283	http://dx.doi.org/10.1371/journal.pone.0173283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5BR	28257513	Green Published, Green Submitted, gold			2022-12-27	WOS:000396021100083
J	Tashiro, M; Iwata, A; Yamauchi, M; Shimizu, K; Okada, A; Ishiguro, N; Inoshima, Y				Tashiro, Manami; Iwata, Ami; Yamauchi, Marika; Shimizu, Kaori; Okada, Ayaka; Ishiguro, Naotaka; Inoshima, Yasuo			The N-terminal region of serum amyloid A3 protein activates NF-kappa B and up-regulates MUC2 mucin mRNA expression in mouse colonic epithelial cells	PLOS ONE			English	Article							INFLAMMATORY RESPONSES; GENE-EXPRESSION; IN-VITRO; BACTERIA; ALPHA; MICE; DEXAMETHASONE; MICROBIOTA; CYTOKINES; PATHWAY	Serum amyloid A (SAA) is the major acute-phase protein and a precursor of amyloid A (AA) in AA amyloidosis in humans and animals. SAA isoforms have been identified in a wide variety of animals, such as SAA1, SAA2, SAA3, and SAA4 in mouse. Although the biological functions of SAA isoforms are not completely understood, recent studies have suggested that SAA3 plays a role in host defense. Expression of SAA3 is increased on the mouse colon surface in the presence of microbiota in vivo, and it increases mRNA expression of mucin 2 (MUC2) in murine colonic epithelial cells in vitro, which constitutes a protective mucus barrier in the intestinal tract. In this study, to identify responsible regions in SAA3 for MUC2 expression, recombinant murine SAA1 (rSAA1), rSAA3, and rSAA1/3, a chimera protein constructed with mature SAA1 (amino acids 1-36) and SAA3 (amino acids 37-103), and vice versa for rSAA3/1, were added to murine colonic epithelial CMT-93 cells, and the mRNA expressions of MUC2 and cytokines were measured. Inhibition assays with NF-kappa B inhibitor or TLR4/MD2 inhibitor were also performed. Up-regulation of MUC2 mRNA expression was strongly stimulated by rSAA3 and rSAA3/1, but not by rSAA1 or rSAA1/3. Moreover, NF-kappa B and TLR4/MD2 inhibitors suppressed the increase of MUC2 mRNA expression. These results suggest that the major responsible region for MUC2 expression exists in amino acids 1-36 of SAA3, and that up-regulations of MUC2 expression by SAA3 and SAA3/1 are involved with activation of NF-kappa B via the TLR4/MD2 complex.	[Tashiro, Manami; Iwata, Ami; Yamauchi, Marika; Shimizu, Kaori; Okada, Ayaka; Ishiguro, Naotaka; Inoshima, Yasuo] Gifu Univ, Fac Appl Biol Sci, Cooperat Dept Vet Med, Lab Food & Environm Hyg, Gifu, Japan; [Ishiguro, Naotaka; Inoshima, Yasuo] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan; [Inoshima, Yasuo] Gifu Univ GeFAH, Educ & Res Ctr Food Anim Hlth, Gifu, Gifu, Japan	Gifu University; Gifu University	Inoshima, Y (corresponding author), Gifu Univ, Fac Appl Biol Sci, Cooperat Dept Vet Med, Lab Food & Environm Hyg, Gifu, Japan.; Inoshima, Y (corresponding author), Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan.; Inoshima, Y (corresponding author), Gifu Univ GeFAH, Educ & Res Ctr Food Anim Hlth, Gifu, Gifu, Japan.	inoshima@gifu-u.ac.jp		Moriyama, Masafumi/0000-0003-2911-2244	Research Center for Zoonosis Control, Hokkaido University; Ministry of Education, Culture, Sports, Science and Technology, Japan; Ito Foundation, Japan;  [25292171];  [16H05027]	Research Center for Zoonosis Control, Hokkaido University; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ito Foundation, Japan; ; 	This study was partly supported by a Grant-in-Aid for Scientific Research (No. 25292171 and 16H05027) and the Grant for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University, from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This study was also supported in part by the Ito Foundation, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly supported by Grant-in-Aid for Scientific Research (No. 25292171 and 16H05027) and the Grant for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University, from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This study was also supported in part by the Ito Foundation, Japan.	Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bottero Virginie, 2003, Mol Diagn, V7, P187, DOI 10.2165/00066982-200307030-00008; Cadera EJ, 2009, J EXP MED, V206, P1803, DOI 10.1084/jem.20082815; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; Clarke LL, 2004, AM J PHYSIOL-GASTR L, V286, pG1050, DOI 10.1152/ajpgi.00393.2003; DEBEER MC, 1995, J LIPID RES, V36, P526; Deguchi A, 2013, J IMMUNOL, V191, P1856, DOI 10.4049/jimmunol.1201996; Dilly AK, 2015, TRANSL RES, V166, P344, DOI 10.1016/j.trsl.2015.03.004; Eckhardt ERM, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-133; Enss ML, 2000, INFLAMM RES, V49, P162, DOI 10.1007/s000110050576; Fasshauer M, 2004, J ENDOCRINOL, V183, P561, DOI 10.1677/joe.1.05699; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Iwashita J, 2003, IMMUNOL CELL BIOL, V81, P275, DOI 10.1046/j.1440-1711.2003.t01-1-01163.x; Kasahara DI, 2014, AM J PHYSIOL-LUNG C, V306, pL508, DOI 10.1152/ajplung.00235.2013; Loonen LMP, 2014, MUCOSAL IMMUNOL, V7, P939, DOI 10.1038/mi.2013.109; Mack DR, 2003, PEDIATR RES, V53, P137, DOI 10.1203/01.PDR.0000041517.15440.F3; MEEK RL, 1986, J EXP MED, V164, P2006, DOI 10.1084/jem.164.6.2006; Mejias-Luque R, 2008, BBA-MOL CELL RES, V1783, P1728, DOI 10.1016/j.bbamcr.2008.05.020; Obici L, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13580; Rahman A, 2011, CLIN EXP IMMUNOL, V163, P123, DOI 10.1111/j.1365-2249.2010.04282.x; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; Shah C, 2006, BLOOD, V108, P1751, DOI 10.1182/blood-2005-11-011932; Shigemura H, 2014, J VET MED SCI, V76, P985, DOI 10.1292/jvms.14-0007; SHIMIZU H, 1994, GENE, V149, P305; Son DS, 2004, ENDOCRINOLOGY, V145, P2245, DOI 10.1210/en.2003-1261; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Yang YH, 2004, ARTHRITIS RHEUM-US, V50, P976, DOI 10.1002/art.20201; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	30	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181796	10.1371/journal.pone.0181796	http://dx.doi.org/10.1371/journal.pone.0181796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738073	gold, Green Published, Green Submitted			2022-12-27	WOS:000406362700072
